data_1iez_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1iez _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.539 ' O ' ' CG1' ' A' ' 16' ' ' VAL . 28.2 Cg_endo . . . . . 0 C--O 1.202 -1.279 0 N-CA-C 110.928 -0.451 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -95.46 -46.36 6.72 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -77.4 -62.63 1.6 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 118.353 -1.339 . . . . 0.0 112.384 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.419 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 26.3 mmm180 -85.58 -10.15 56.31 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 117.538 -1.665 . . . . 0.0 112.981 -177.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.569 HG11 ' CD2' ' A' ' 208' ' ' TYR . 0.4 OUTLIER -85.93 -26.04 6.44 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.489 0 C-N-CA 114.386 -2.926 . . . . 0.0 108.391 176.11 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.72 -48.89 62.67 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 116.74 -1.984 . . . . 0.0 107.409 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -65.6 -33.2 75.35 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.524 -0.735 . . . . 0.0 109.36 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.423 ' O ' ' CD2' ' A' ' 23' ' ' LEU . . . -81.75 -22.03 37.49 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.182 -0.949 . . . . 0.0 109.234 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.536 ' HB2' ' O ' ' A' ' 16' ' ' VAL . 0.1 OUTLIER -53.89 -50.42 66.36 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.175 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.61 -51.51 55.5 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.234 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -47.31 -45.4 24.27 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.519 -0.738 . . . . 0.0 110.507 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.472 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 3.3 pp -91.08 -17.15 26.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.306 -0.871 . . . . 0.0 110.192 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 20' ' ' LEU . 0.9 OUTLIER -54.72 -23.05 15.92 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.273 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.4 41.98 1.11 Allowed 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 118.23 -1.388 . . . . 0.0 110.167 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.511 ' HA3' ' CZ ' ' A' ' 45' ' ' PHE . . . 53.83 31.79 47.12 Favored Glycine 0 C--N 1.291 -1.953 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 176.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -85.3 19.78 2.18 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 116.859 -1.937 . . . . 0.0 110.859 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 198' ' ' ALA . . . 98.3 105.73 2.51 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 119.524 -1.322 . . . . 0.0 113.085 173.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.473 ' CG1' ' HB ' ' A' ' 44' ' ' ILE . 3.2 p -145.33 118.65 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-N 120.096 1.948 . . . . 0.0 109.968 176.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.523 ' HB2' ' HA ' ' A' ' 42' ' ' ASP . 1.5 tmt? -105.78 151.78 24.05 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.063 -1.023 . . . . 0.0 110.69 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.455 HG13 ' CD2' ' A' ' 172' ' ' LEU . 4.5 p . . . . . 0 N--CA 1.494 1.729 0 O-C-N 120.898 -1.126 . . . . 0.0 109.504 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.523 ' HA ' ' HB2' ' A' ' 30' ' ' MET . 2.7 p30 . . . . . 0 N--CA 1.506 2.372 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.539 ' O ' ' O ' ' A' ' 171' ' ' VAL . 1.8 ttm -93.88 47.07 1.2 Allowed 'General case' 0 C--N 1.288 -2.104 0 O-C-N 120.886 -1.134 . . . . 0.0 113.778 -177.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.48 ' HA ' ' HG ' ' A' ' 172' ' ' LEU . 73.4 mt -68.49 20.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.534 3.75 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.524 ' CD1' ' CG ' ' A' ' 54' ' ' GLN . 2.3 m-85 -66.59 162.38 51.07 Favored Pre-proline 0 C--N 1.279 -2.472 0 O-C-N 121.008 -1.057 . . . . 0.0 113.631 -176.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.464 ' HD2' ' CD2' ' A' ' 45' ' ' PHE . 43.8 Cg_endo -66.92 133.73 32.2 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.895 2.397 . . . . 0.0 111.902 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.511 ' N ' ' HA2' ' A' ' 170' ' ' GLY . . . -65.76 -7.21 14.6 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.405 -0.81 . . . . 0.0 112.751 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.441 ' HB2' ' CB ' ' A' ' 123' ' ' ALA . 0.3 OUTLIER -109.99 -14.97 14.16 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.726 -1.234 . . . . 0.0 111.35 -179.307 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 51' ' ' THR . 25.2 m -132.62 59.73 1.72 Allowed 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.431 ' O ' ' CG2' ' A' ' 115' ' ' ILE . 6.3 mtp -62.67 86.08 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.469 ' N ' ' O ' ' A' ' 49' ' ' THR . 1.7 m -63.99 170.41 3.56 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.773 0.797 . . . . 0.0 110.217 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.441 ' CG2' HD11 ' A' ' 115' ' ' ILE . 7.0 t -85.31 -3.72 8.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 121.731 -0.606 . . . . 0.0 109.586 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -52.86 -39.8 62.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.844 -1.16 . . . . 0.0 108.867 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.524 ' CG ' ' CD1' ' A' ' 45' ' ' PHE . 17.6 mm-40 -82.08 -39.04 23.98 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.449 ' HB3' ' CB ' ' A' ' 111' ' ' ALA . 19.0 mmt -57.24 -39.11 74.89 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.097 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.05 -54.29 48.62 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.213 -0.93 . . . . 0.0 108.649 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.432 HD12 ' CE ' ' A' ' 197' ' ' MET . 6.2 tt -63.8 -22.01 66.71 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.699 -0.801 . . . . 0.0 109.464 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.424 ' HB ' ' HA ' ' A' ' 55' ' ' MET . 1.1 m -88.64 -22.8 23.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -0.795 . . . . 0.0 110.265 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.433 ' N ' ' O ' ' A' ' 55' ' ' MET . 22.7 mt -76.83 -23.1 15.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.045 -1.035 . . . . 0.0 109.322 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.53 -64.07 1.1 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.406 -0.809 . . . . 0.0 110.659 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -125.98 42.87 3.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.157 -0.964 . . . . 0.0 111.666 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 58' ' ' THR . . . -155.2 -175.39 26.2 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 119.166 -1.492 . . . . 0.0 109.741 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.424 ' O ' ' CG2' ' A' ' 58' ' ' THR . 16.8 t -128.37 178.62 6.15 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.11 67.45 0.26 Allowed Glycine 1 C--N 1.253 -4.062 0 N-CA-C 107.42 -2.272 . . . . 0.0 107.42 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.408 HG23 ' CE1' ' A' ' 138' ' ' PHE . 25.1 mm -133.25 84.41 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 114.11 -1.045 . . . . 0.0 108.413 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.493 ' O ' ' CZ ' ' A' ' 138' ' ' PHE . 29.4 m -103.65 152.55 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.55 -0.719 . . . . 0.0 111.591 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.468 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 5.3 t -77.55 122.08 24.77 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.081 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 139' ' ' PRO . 3.1 mm? -87.21 126.24 34.69 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 122.174 0.988 . . . . 0.0 109.404 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.492 ' HB3' ' HA ' ' A' ' 158' ' ' ILE . 3.6 m -89.59 125.08 35.09 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.763 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 158' ' ' ILE . 16.7 tt -138.74 129.46 34.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.083 -1.01 . . . . 0.0 109.853 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.425 ' OG1' ' CG1' ' A' ' 158' ' ' ILE . 1.2 m -89.22 160.37 16.98 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.095 -1.003 . . . . 0.0 109.942 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.417 ' HA ' ' NH1' ' A' ' 75' ' ' ARG . 9.1 pt-20 -50.9 -24.42 3.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.442 -0.786 . . . . 0.0 110.142 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.47 -32.9 19.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 110.041 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -49.7 74.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 109.939 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.464 ' CD ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -70.91 -34.68 71.77 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.187 0.994 . . . . 0.0 108.565 179.113 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.649 ' O ' ' N ' ' A' ' 79' ' ' ASP . 3.0 tttp -53.38 -66.17 0.44 Allowed 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -46.34 -32.7 3.33 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 124.039 0.837 . . . . 0.0 109.431 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.582 ' O ' ' N ' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -97.74 43.65 1.06 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 176.059 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 76' ' ' LYS . 11.6 t70 -28.97 76.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 123.553 1.644 . . . . 0.0 113.031 -172.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -151.25 100.05 3.02 Favored Pre-proline 0 C--N 1.283 -2.304 0 CA-C-N 112.765 -2.016 . . . . 0.0 110.314 177.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -106.62 92.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 N-CA-C 108.808 -1.266 . . . . 0.0 108.808 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.509 ' CB ' ' CG1' ' A' ' 97' ' ' VAL . 3.6 mtt -103.12 46.01 0.94 Allowed 'General case' 0 N--CA 1.483 1.215 0 O-C-N 120.588 -1.32 . . . . 0.0 108.723 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.91 123.54 2.37 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.038 0.447 . . . . 0.0 110.23 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.479 HG22 ' CB ' ' A' ' 95' ' ' PHE . 32.8 m . . . . . 0 N--CA 1.494 1.765 0 C-N-CA 118.614 -1.235 . . . . 0.0 110.61 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CB ' HG22 ' A' ' 84' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 122.415 1.102 . . . . 0.0 112.246 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.428 ' CG2' ' O ' ' A' ' 139' ' ' PRO . 35.3 m -59.66 81.05 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.274 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.509 ' CG1' ' CB ' ' A' ' 82' ' ' MET . 7.4 p -33.48 151.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 CA-C-O 122.577 1.18 . . . . 0.0 113.085 -174.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 137' ' ' VAL . 51.1 p -69.67 -178.38 1.46 Allowed 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.535 -175.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.508 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 16.0 pt -146.99 131.64 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 133' ' ' ARG . 3.6 tt0 -103.54 125.12 49.9 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.069 -1.452 . . . . 0.0 113.491 -176.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.53 ' HA ' ' CD1' ' A' ' 131' ' ' LEU . . . -51.37 95.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.473 -0.767 . . . . 0.0 110.855 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 100' ' ' GLU . . . -80.5 2.63 24.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.629 -0.669 . . . . 0.0 110.14 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.444 ' CB ' ' HA ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -86.42 15.29 5.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.078 -1.014 . . . . 0.0 110.931 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.7 25.02 1.17 Allowed Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.522 -1.323 . . . . 0.0 112.11 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.485 HG21 ' CB ' ' A' ' 117' ' ' THR . 13.0 t -130.17 121.83 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.156 -1.202 . . . . 0.0 109.195 177.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 p -145.91 59.06 1.24 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.594 -1.316 . . . . 0.0 111.523 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.422 ' CG2' ' OG ' ' A' ' 110' ' ' SER . 1.6 m -138.91 -31.97 0.7 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.805 -1.184 . . . . 0.0 110.983 176.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.23 -32.25 1.12 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.14 57.21 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.733 -1.451 . . . . 0.0 109.375 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.46 ' O ' ' N ' ' A' ' 112' ' ' ALA . 1.2 m -129.87 57.44 1.68 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.201 -0.937 . . . . 0.0 109.257 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.449 ' CB ' ' HB3' ' A' ' 55' ' ' MET . . . -34.81 -29.85 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -82.41 -74.86 0.33 Allowed 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.063 -1.023 . . . . 0.0 110.157 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -67.07 -15.62 63.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.564 -0.71 . . . . 0.0 110.87 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.458 ' CB ' ' O ' ' A' ' 110' ' ' SER . 51.2 ttt85 -87.84 -46.79 9.12 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.057 -1.027 . . . . 0.0 110.032 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.487 HD11 HG23 ' A' ' 115' ' ' ILE . 35.1 mt -66.07 -10.96 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.679 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.7 m -87.69 -52.5 5.28 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.485 ' CB ' HG21 ' A' ' 105' ' ' VAL . 9.3 p -72.62 -42.9 63.96 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.692 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.447 ' N ' HG21 ' A' ' 105' ' ' VAL . 47.6 t -57.19 -43.45 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.876 -1.14 . . . . 0.0 108.811 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -49.33 -39.38 31.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.348 -0.845 . . . . 0.0 109.307 178.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.74 -11.62 24.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.709 -0.619 . . . . 0.0 111.043 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 117' ' ' THR . . . -97.25 -59.93 1.69 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.857 -1.152 . . . . 0.0 112.68 -177.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.435 HG21 ' CG1' ' A' ' 118' ' ' VAL . 19.1 tt -66.7 -19.8 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 120.41 -1.431 . . . . 0.0 108.849 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.441 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . . . -106.58 72.49 0.91 Allowed 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.506 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.426 ' HB3' ' CG ' ' A' ' 127' ' ' LYS . 11.8 t0 -98.41 -53.1 3.43 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.335 1.064 . . . . 0.0 110.077 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 124.08 -37.28 2.71 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 106.169 -2.773 . . . . 0.0 106.169 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -132.98 100.51 4.91 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.431 ' N ' ' CD ' ' A' ' 128' ' ' PRO . 23.4 mtpp -130.98 54.55 15.08 Favored Pre-proline 0 C--N 1.307 -1.242 0 O-C-N 120.773 -1.204 . . . . 0.0 110.92 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 127' ' ' LYS . 44.1 Cg_endo -72.05 -26.47 18.28 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 N-CA-C 106.921 -1.992 . . . . 0.0 106.921 176.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.79 -18.09 6.15 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.043 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.427 ' HB3' ' NZ ' ' A' ' 127' ' ' LYS . 27.6 m-20 -78.24 9.82 3.5 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.8 -1.187 . . . . 0.0 112.27 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.53 ' CD1' ' HA ' ' A' ' 101' ' ' ALA . 2.6 tp -135.08 89.62 2.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.882 -1.136 . . . . 0.0 108.566 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.506 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 36.4 p-10 -116.38 107.6 15.01 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.373 -0.829 . . . . 0.0 111.933 -178.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.677 ' HB2' ' HA ' ' A' ' 134' ' ' PRO 0.269 4.9 ppt_? -82.89 179.93 1.74 Allowed Pre-proline 0 N--CA 1.499 1.976 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.646 -177.525 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.677 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 48.8 Cg_endo -71.68 124.96 9.07 Favored 'Cis proline' 0 N--CA 1.504 2.122 0 C-N-CA 123.352 -1.52 . . . . 0.0 112.299 8.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 137' ' ' VAL . . . -123.98 39.9 2.06 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 53.1 m80 31.21 38.22 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 122.162 0.982 . . . . 0.0 111.914 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 98' ' ' THR . 54.5 t -126.85 103.11 10.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 176.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.493 ' CZ ' ' O ' ' A' ' 66' ' ' VAL . 6.3 p90 -107.52 89.35 4.93 Favored Pre-proline 0 N--CA 1.492 1.659 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.962 -175.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 56.0 Cg_endo -77.34 124.42 7.13 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 124.125 1.592 . . . . 0.0 110.366 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.1 tp -102.65 126.53 49.78 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 56.3 ttp85 -63.64 117.91 7.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.061 -1.024 . . . . 0.0 109.958 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.438 ' CB ' ' HA ' ' A' ' 155' ' ' GLU . . . -130.03 134.17 47.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.578 -0.701 . . . . 0.0 110.516 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.418 ' O ' ' CG2' ' A' ' 158' ' ' ILE . 0.3 OUTLIER -56.26 133.03 52.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.829 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.436 ' HA ' ' CG2' ' A' ' 158' ' ' ILE . . . -81.87 115.2 20.96 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.408 -0.807 . . . . 0.0 111.173 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.472 ' CA ' ' NH2' ' A' ' 209' ' ' ARG . . . 86.63 -8.01 77.05 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.56 13.98 60.89 Favored Glycine 0 N--CA 1.483 1.815 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.529 ' CG2' ' CB ' ' A' ' 156' ' ' ALA . 7.6 p -59.7 -14.3 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.931 -1.335 . . . . 0.0 109.971 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.446 ' CD2' ' HA ' ' A' ' 207' ' ' ALA . 1.0 OUTLIER -92.17 20.13 6.24 Favored 'General case' 0 C--O 1.21 -1.004 0 C-N-CA 116.479 -2.088 . . . . 0.0 110.731 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.6 m -129.39 58.49 1.62 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 101.935 -3.357 . . . . 0.0 101.935 168.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.44 ' HG3' ' CG ' ' A' ' 155' ' ' GLU . 0.2 OUTLIER -153.76 146.11 23.93 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 113.486 -1.688 . . . . 0.0 111.903 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -103.95 34.72 5.55 Favored Glycine 0 N--CA 1.481 1.683 0 N-CA-C 106.124 -2.79 . . . . 0.0 106.124 173.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -145.34 165.98 27.74 Favored Glycine 0 N--CA 1.479 1.501 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.48 ' CB ' ' CD1' ' A' ' 202' ' ' ILE . 2.3 p-80 -90.84 -6.04 54.79 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.921 -0.752 . . . . 0.0 109.484 176.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.412 ' HA ' HG22 ' A' ' 157' ' ' THR . 62.6 m -56.17 -61.71 2.2 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 122.54 1.162 . . . . 0.0 109.353 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.44 ' CG ' ' HG3' ' A' ' 150' ' ' ARG . 9.2 mp0 -57.89 -20.75 39.23 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.529 ' CB ' ' CG2' ' A' ' 147' ' ' VAL . . . -83.35 1.73 39.78 Favored 'General case' 0 C--O 1.201 -1.478 0 O-C-N 121.602 -0.686 . . . . 0.0 109.929 177.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 154' ' ' THR . 68.8 p -82.2 -51.19 8.18 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.496 HG13 ' HB2' ' A' ' 168' ' ' PRO . 3.8 tp -65.76 -31.58 54.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.418 ' OD2' ' N ' ' A' ' 145' ' ' GLY . 0.4 OUTLIER -80.56 -18.41 48.46 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.764 ' HA ' ' CD2' ' A' ' 163' ' ' LEU . 1.2 mt -63.41 -37.64 88.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.038 -1.039 . . . . 0.0 110.375 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.507 ' CG ' ' HA3' ' A' ' 170' ' ' GLY . 88.7 mmm -81.53 -27.74 34.28 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.423 HG22 ' NE ' ' A' ' 209' ' ' ARG . 3.6 m -66.3 -48.79 69.23 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.764 ' CD2' ' HA ' ' A' ' 160' ' ' LEU . 4.2 pp -72.57 -4.83 33.12 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.369 -0.832 . . . . 0.0 109.328 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' A' ' 20' ' ' LEU . . . -108.06 18.85 20.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.662 -1.274 . . . . 0.0 109.983 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 59.14 41.86 96.82 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 107.337 -2.305 . . . . 0.0 107.337 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.438 ' CB ' ' HE3' ' A' ' 161' ' ' MET . 1.5 m-85 -138.49 139.29 38.72 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.925 0.869 . . . . 0.0 111.134 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -50.2 134.23 23.49 Favored Pre-proline 0 N--CA 1.498 1.965 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 177.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.505 ' HA ' ' HB2' ' A' ' 161' ' ' MET . 37.3 Cg_endo -64.81 84.46 0.17 Allowed 'Trans proline' 0 C--N 1.298 -2.114 0 C-N-CA 116.593 -1.805 . . . . 0.0 112.911 -174.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 167' ' ' LYS . . . -156.81 111.72 2.81 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 101.399 -3.556 . . . . 0.0 101.399 173.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.511 ' HA2' ' N ' ' A' ' 47' ' ' ALA . . . -157.73 167.76 34.23 Favored Glycine 0 N--CA 1.486 1.996 0 C-N-CA 116.454 -2.784 . . . . 0.0 113.314 -174.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.539 ' O ' ' O ' ' A' ' 43' ' ' MET . 28.5 m -112.46 156.49 13.48 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.526 HD22 ' CD2' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -157.68 114.0 2.88 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.639 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 43' ' ' MET . 34.1 t -130.66 162.25 29.82 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 120.569 -1.332 . . . . 0.0 112.05 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.27 -169.06 1.45 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.199 -0.938 . . . . 0.0 109.491 178.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.459 ' CD2' ' CB ' ' A' ' 192' ' ' ALA . 5.2 mt . . . . . 0 N--CA 1.497 1.911 0 O-C-N 120.89 -1.132 . . . . 0.0 109.582 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.433 ' CB ' ' HB2' ' A' ' 175' ' ' LEU . . . . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 121.4 0.619 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -136.8 161.68 35.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.353 -0.842 . . . . 0.0 110.333 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . 60.85 160.02 0.11 Allowed Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.349 -0.844 . . . . 0.0 110.871 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.4 -26.76 24.23 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.739 1.389 . . . . 0.0 110.578 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -60.66 -34.98 75.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.089 -1.007 . . . . 0.0 109.864 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . 0.425 ' O ' ' CD1' ' A' ' 175' ' ' LEU . 5.4 t -74.59 -53.99 8.33 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.362 -0.836 . . . . 0.0 110.218 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.441 HG13 ' CD2' ' A' ' 199' ' ' LEU . 9.6 tp -62.02 -25.08 36.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 O-C-N 120.653 -1.279 . . . . 0.0 107.644 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 194' ' ' LYS . 36.8 tt0 -64.65 -33.74 76.64 Favored 'General case' 0 C--O 1.194 -1.822 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.313 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 191' ' ' PHE . 0.0 OUTLIER -57.65 -54.94 41.18 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.349 -1.469 . . . . 0.0 108.925 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.459 ' CB ' ' CD2' ' A' ' 175' ' ' LEU . . . -69.87 -44.83 69.01 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.707 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . 0.602 ' HA ' ' HB2' ' A' ' 197' ' ' MET . 1.6 m-20 -82.19 -29.99 31.17 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.061 -1.056 . . . . 0.0 112.902 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 190' ' ' GLU . 15.6 tttt -55.42 -36.64 66.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.462 -1.399 . . . . 0.0 109.384 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -81.8 -52.83 6.73 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 116.116 -2.234 . . . . 0.0 111.781 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.468 ' O ' ' CG ' ' A' ' 197' ' ' MET . 89.4 m-20 -115.58 28.34 8.73 Favored 'General case' 0 N--CA 1.51 2.571 0 C-N-CA 117.073 -1.851 . . . . 0.0 115.254 177.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' MET . . . . . 0.602 ' HB2' ' HA ' ' A' ' 193' ' ' ASN . 0.8 OUTLIER -160.21 149.96 17.93 Favored 'General case' 0 N--CA 1.514 2.745 0 CA-C-N 121.991 2.178 . . . . 0.0 113.613 179.267 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 28' ' ' GLY . . . -86.73 148.51 25.4 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.416 -1.428 . . . . 0.0 108.482 175.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.538 ' CD1' ' HA ' ' A' ' 190' ' ' GLU . 4.1 mt -122.72 144.3 49.24 Favored 'General case' 0 N--CA 1.511 2.62 0 O-C-N 120.264 -1.523 . . . . 0.0 111.639 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.4 p -149.94 -178.92 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.269 -0.894 . . . . 0.0 110.179 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 23.5 p -105.54 179.84 4.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.014 . . . . 0.0 110.849 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.486 HD11 HG22 ' A' ' 202' ' ' ILE . 4.5 tt -111.96 -32.51 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.446 -0.784 . . . . 0.0 110.349 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.444 ' N ' HG23 ' A' ' 202' ' ' ILE . 0.8 OUTLIER -50.89 -65.06 0.62 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.108 -0.995 . . . . 0.0 110.528 -179.462 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.82 -35.78 59.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.294 -0.879 . . . . 0.0 110.442 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.511 ' CD2' HD22 ' A' ' 163' ' ' LEU . 6.3 tt -52.92 -43.61 66.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.096 -1.003 . . . . 0.0 110.285 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.459 ' CG2' HG23 ' A' ' 147' ' ' VAL . 1.0 OUTLIER -71.08 -40.35 75.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 O-C-N 120.965 -1.084 . . . . 0.0 108.456 -179.375 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.446 ' HA ' ' CD2' ' A' ' 148' ' ' LEU . . . -55.72 -23.82 31.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.074 -1.016 . . . . 0.0 108.497 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.569 ' CD2' HG11 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -75.81 -35.92 59.87 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.09 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.472 ' NH2' ' CA ' ' A' ' 145' ' ' GLY . 2.3 tmt_? -55.49 -44.14 76.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.834 . . . . 0.0 109.627 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.65 -37.31 79.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.432 -0.793 . . . . 0.0 110.157 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -65.07 -22.98 67.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.347 -0.846 . . . . 0.0 110.173 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.18 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.48 ' CB ' ' HB2' ' A' ' 208' ' ' TYR . 22.5 Cg_endo . . . . . 0 C--O 1.215 -0.632 0 CA-C-O 121.485 0.536 . . . . 0.0 111.736 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.438 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 14.1 m-85 -93.54 -37.2 12.03 Favored 'General case' 0 C--N 1.278 -2.511 0 C-N-CA 119.24 -0.984 . . . . 0.0 113.504 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -79.25 -63.33 1.44 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.606 -1.238 . . . . 0.0 112.635 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.446 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 1.8 tpt180 -90.84 -14.94 30.86 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 118.746 -1.182 . . . . 0.0 111.929 -178.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.465 ' CG1' ' HB2' ' A' ' 205' ' ' LEU . 2.3 t -98.81 -19.0 6.08 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 C-N-CA 116.359 -2.136 . . . . 0.0 109.615 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 13' ' ' PHE . 3.7 tt0 -83.26 -41.5 18.27 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 176.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -74.04 -22.38 59.57 Favored 'General case' 0 C--N 1.307 -1.239 0 O-C-N 121.749 -0.595 . . . . 0.0 109.504 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 15' ' ' ARG . . . -75.52 -51.94 11.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.016 -1.052 . . . . 0.0 108.992 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.472 ' O ' ' CB ' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -49.48 -33.23 13.85 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.442 -0.786 . . . . 0.0 109.8 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.42 ' HA ' ' HB2' ' A' ' 24' ' ' ARG . . . -78.0 -68.41 0.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.972 0.891 . . . . 0.0 109.614 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.92 -29.2 1.9 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.495 -0.753 . . . . 0.0 110.135 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.478 ' CB ' ' HB ' ' A' ' 29' ' ' VAL . 1.9 mm? -101.09 -15.37 17.43 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.799 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -50.23 -24.47 2.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.079 -1.013 . . . . 0.0 108.571 178.286 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.73 42.76 1.11 Allowed 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 118.49 -1.284 . . . . 0.0 110.35 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.51 ' HA2' ' CZ ' ' A' ' 45' ' ' PHE . . . 55.2 25.91 41.33 Favored Glycine 0 C--N 1.291 -1.934 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 176.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.23 17.6 5.03 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 116.36 -2.136 . . . . 0.0 110.97 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.469 ' HA3' ' CG ' ' A' ' 197' ' ' MET . . . 96.69 108.87 2.54 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 118.893 -1.622 . . . . 0.0 115.113 172.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.478 ' HB ' ' CB ' ' A' ' 23' ' ' LEU . 5.8 p -140.69 124.88 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-N 119.539 1.669 . . . . 0.0 108.345 175.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.48 ' CB ' ' HA ' ' A' ' 42' ' ' ASP . 0.5 OUTLIER -109.03 158.59 17.59 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.869 -1.145 . . . . 0.0 113.312 -177.474 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.503 ' CG2' ' CD1' ' A' ' 205' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.541 -0.724 . . . . 0.0 109.3 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.481 ' HB2' ' CB ' ' A' ' 174' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.501 2.095 0 CA-C-O 121.27 0.557 . . . . 0.0 111.597 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.605 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -95.34 53.92 1.56 Allowed 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.29 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.477 ' O ' ' CG2' ' A' ' 44' ' ' ILE . 94.2 mt -61.22 19.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.527 3.391 0 O-C-N 120.428 -1.42 . . . . 0.0 111.991 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.605 ' H ' ' C ' ' A' ' 43' ' ' MET . 22.4 m-85 -85.06 165.09 38.69 Favored Pre-proline 0 C--N 1.291 -1.952 0 O-C-N 120.972 -1.08 . . . . 0.0 112.341 -177.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.49 ' HD3' ' CD2' ' A' ' 166' ' ' PHE . 40.8 Cg_endo -62.79 133.53 42.41 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 122.444 2.096 . . . . 0.0 114.106 -176.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.431 ' CB ' HG11 ' A' ' 171' ' ' VAL . . . -69.22 -2.7 11.2 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.263 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 15.7 tt0 -80.1 -14.99 58.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.906 -1.121 . . . . 0.0 109.653 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 51' ' ' THR . 6.3 t -130.81 58.99 1.68 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 177.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.424 ' CE ' HD12 ' A' ' 68' ' ' LEU . 15.3 ttm -51.53 88.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.673 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.497 ' N ' ' O ' ' A' ' 49' ' ' THR . 3.2 m -64.65 157.45 27.16 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.693 0.759 . . . . 0.0 110.267 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.484 ' N ' HG12 ' A' ' 115' ' ' ILE . 2.1 p -71.65 -4.87 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.655 -0.653 . . . . 0.0 109.907 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -55.15 -31.41 61.3 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.795 -1.19 . . . . 0.0 108.445 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.472 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -87.77 -38.27 15.9 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.19 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.404 ' HB3' ' CB ' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -71.87 -40.02 69.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.817 -1.177 . . . . 0.0 109.275 179.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.3 -47.08 85.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.558 -0.714 . . . . 0.0 110.772 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.472 ' CD2' ' HA ' ' A' ' 54' ' ' GLN . 0.8 OUTLIER -57.05 -34.14 67.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.079 -1.013 . . . . 0.0 110.987 -179.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.477 ' CA ' ' O ' ' A' ' 62' ' ' GLY . 33.2 p -79.54 -46.72 16.82 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.19 -0.944 . . . . 0.0 111.139 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.0 mt -54.22 -20.42 4.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 O-C-N 121.094 -1.004 . . . . 0.0 110.28 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.477 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 2.9 mtp180 -97.92 -44.56 6.64 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.158 -0.964 . . . . 0.0 113.169 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.477 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 48.5 m80 -125.43 -17.84 5.47 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -176.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.477 ' O ' ' CA ' ' A' ' 58' ' ' THR . . . -165.18 -169.09 28.34 Favored Glycine 0 N--CA 1.503 3.129 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.708 -177.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.6 t -143.1 96.37 2.91 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 102.27 -3.233 . . . . 0.0 102.27 175.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.35 72.38 0.46 Allowed Glycine 0 C--N 1.26 -3.681 1 N-CA-C 101.97 -4.452 . . . . 0.0 101.97 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.463 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 38.7 mt -60.14 145.28 12.04 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.816 0 CA-C-N 113.613 -1.293 . . . . 0.0 110.067 -176.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.483 ' CG1' ' CB ' ' A' ' 173' ' ' CYS . 35.2 m -55.98 152.28 2.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.863 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 171' ' ' VAL . 78.9 m -83.03 132.77 35.12 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 139' ' ' PRO . 2.9 mm? -89.18 97.98 11.51 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.037 -1.065 . . . . 0.0 108.936 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.448 ' HB2' ' N ' ' A' ' 170' ' ' GLY . 34.3 m -64.41 125.73 25.58 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 118.776 -1.17 . . . . 0.0 109.794 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.436 ' CG2' ' HB2' ' A' ' 139' ' ' PRO . 15.2 tt -133.23 146.88 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.017 -1.052 . . . . 0.0 109.823 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.432 ' CG2' HG12 ' A' ' 158' ' ' ILE . 0.3 OUTLIER -108.62 151.97 25.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 109.643 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -50.25 -24.68 3.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.264 -0.897 . . . . 0.0 110.053 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -88.23 -38.24 15.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.323 -0.861 . . . . 0.0 109.969 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -52.45 63.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.346 -0.846 . . . . 0.0 109.562 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -62.84 -40.85 98.7 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.112 0.958 . . . . 0.0 108.784 179.031 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.63 ' O ' ' N ' ' A' ' 79' ' ' ASP . 7.9 tttm -49.53 -62.04 1.77 Allowed 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -47.66 -31.3 4.48 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 121.884 0.849 . . . . 0.0 108.945 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' A' ' 80' ' ' LEU . 3.0 mt -96.69 44.55 1.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 175.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.63 ' N ' ' O ' ' A' ' 76' ' ' LYS . 20.9 t0 -26.81 78.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 123.85 1.786 . . . . 0.0 112.893 -172.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.547 ' N ' ' O ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -150.77 106.36 3.06 Favored Pre-proline 0 C--N 1.286 -2.189 0 CA-C-N 112.315 -2.221 . . . . 0.0 110.181 177.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -92.07 94.06 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 N-CA-C 107.852 -1.634 . . . . 0.0 107.852 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.498 ' CG ' ' HB ' ' A' ' 97' ' ' VAL . 2.8 mmt -99.63 44.45 1.02 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.16 -0.962 . . . . 0.0 109.875 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.3 tpt -68.51 103.07 1.58 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.053 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.479 ' CG2' ' CG2' ' A' ' 97' ' ' VAL . 11.0 t . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.533 ' O ' ' N ' ' A' ' 97' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.329 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 139' ' ' PRO . 2.8 m -59.25 79.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 95' ' ' PHE . 18.8 t -35.47 151.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 CA-C-O 123.023 1.392 . . . . 0.0 113.412 -173.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.479 ' CB ' ' O ' ' A' ' 137' ' ' VAL . 0.7 OUTLIER -69.64 179.5 2.12 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 113.793 -1.549 . . . . 0.0 113.157 -176.187 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.527 ' HA ' ' HB3' ' A' ' 133' ' ' ARG . 19.8 pt -141.9 131.81 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -177.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 132' ' ' ASN . 1.6 tm-20 -111.81 133.94 53.69 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 117.758 -1.577 . . . . 0.0 112.875 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.484 ' HA ' HD21 ' A' ' 131' ' ' LEU . . . -52.72 93.28 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.064 -1.023 . . . . 0.0 110.039 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 100' ' ' GLU . . . -82.55 3.82 27.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.965 -1.084 . . . . 0.0 110.911 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -113.02 54.92 0.71 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.775 -1.203 . . . . 0.0 112.236 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.44 -36.41 2.58 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 118.875 -1.631 . . . . 0.0 112.42 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.433 ' HB ' ' CB ' ' A' ' 101' ' ' ALA . 0.8 OUTLIER -100.99 124.4 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 120.962 -1.316 . . . . 0.0 110.187 -178.394 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 p -145.24 61.11 1.3 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.591 -1.318 . . . . 0.0 111.422 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.4 ' C ' ' H ' ' A' ' 109' ' ' VAL . 1.7 p -135.3 -32.27 0.94 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.889 -1.132 . . . . 0.0 110.323 177.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.9 -30.37 0.1 Allowed Glycine 0 N--CA 1.499 2.881 0 O-C-N 121.599 -0.688 . . . . 0.0 113.238 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.4 ' H ' ' C ' ' A' ' 107' ' ' THR . 2.3 t -128.63 57.12 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.377 -1.661 . . . . 0.0 110.38 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -129.43 56.94 1.68 Allowed 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.128 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.441 ' HA ' ' CD1' ' A' ' 115' ' ' ILE . . . -31.53 -32.29 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -84.28 -77.37 0.27 Allowed 'General case' 0 C--N 1.29 -1.993 0 O-C-N 120.837 -1.165 . . . . 0.0 109.558 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.18 -15.94 28.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.448 -0.782 . . . . 0.0 110.737 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 110' ' ' SER . 2.4 ttt180 -90.67 -36.73 14.18 Favored 'General case' 0 C--O 1.202 -1.416 0 O-C-N 121.001 -1.062 . . . . 0.0 110.261 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.484 HG12 ' N ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -62.0 -15.37 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 118.417 -1.313 . . . . 0.0 108.956 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.5 m -88.6 -55.27 3.78 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 121' ' ' ALA . 53.2 p -67.49 -14.0 62.54 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.424 178.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 114' ' ' ARG . 2.6 t -73.66 -48.64 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -50.52 -36.2 33.02 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.132 178.471 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.44 -13.8 22.86 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.281 0.563 . . . . 0.0 110.476 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 117' ' ' THR . . . -55.58 -56.48 19.82 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.252 -0.905 . . . . 0.0 109.773 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 19.1 tt -93.69 14.47 2.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 118.677 -1.209 . . . . 0.0 110.243 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -108.83 72.38 0.82 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 118.973 -1.091 . . . . 0.0 111.136 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.447 ' CB ' ' HD2' ' A' ' 127' ' ' LYS . 5.1 t70 -99.3 -35.61 9.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.998 -1.064 . . . . 0.0 110.381 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 106.04 -38.37 3.34 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 105.28 -3.128 . . . . 0.0 105.28 -176.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -133.34 98.86 4.35 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 128' ' ' PRO . 5.4 tptt -132.33 52.94 9.91 Favored Pre-proline 0 C--N 1.307 -1.28 0 O-C-N 120.767 -1.208 . . . . 0.0 110.86 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 127' ' ' LYS . 49.4 Cg_endo -78.0 -35.65 1.31 Allowed 'Trans proline' 0 C--N 1.3 -2.009 0 N-CA-C 106.911 -1.996 . . . . 0.0 106.911 176.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.4 t -126.71 -0.29 6.74 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.345 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.426 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . 0.8 OUTLIER -77.4 9.4 3.26 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.634 -1.292 . . . . 0.0 112.718 -177.61 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.484 HD21 ' HA ' ' A' ' 101' ' ' ALA . 29.7 mt -117.87 124.89 49.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.716 -1.24 . . . . 0.0 109.337 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.514 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 1.3 m-80 -116.85 93.58 4.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.089 -1.007 . . . . 0.0 112.952 -177.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.71 ' HB2' ' HA ' ' A' ' 134' ' ' PRO 0.274 0.0 OUTLIER -80.71 172.12 10.6 Favored Pre-proline 0 N--CA 1.501 2.101 0 O-C-N 121.815 -0.553 . . . . 0.0 110.72 -179.556 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.71 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 48.2 Cg_endo -73.14 129.75 18.44 Favored 'Cis proline' 0 N--CA 1.502 1.995 0 C-N-CA 123.043 -1.649 . . . . 0.0 112.559 7.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.427 ' HA3' ' CG ' ' A' ' 100' ' ' GLU . . . -123.6 47.31 1.03 Allowed Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 135' ' ' GLY . 49.6 m80 31.19 38.1 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 122.143 0.973 . . . . 0.0 112.07 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 98' ' ' THR . 31.3 t -129.43 92.44 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 176.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.463 ' CZ ' HG22 ' A' ' 65' ' ' ILE . 10.4 p90 -107.09 101.91 40.45 Favored Pre-proline 0 N--CA 1.495 1.797 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.218 -176.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 53.2 Cg_endo -98.38 155.59 0.78 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.785 1.413 . . . . 0.0 111.078 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.3 mp -127.29 116.59 20.78 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -63.52 115.66 4.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.058 -1.026 . . . . 0.0 110.696 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 155' ' ' GLU . . . -130.67 135.5 47.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.765 -0.584 . . . . 0.0 110.13 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.38 143.23 19.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.941 -1.099 . . . . 0.0 110.092 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -100.4 115.76 30.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.502 -0.749 . . . . 0.0 111.622 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.417 ' N ' ' OD2' ' A' ' 159' ' ' ASP . . . 104.02 -15.0 52.05 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.77 13.1 57.9 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.483 HG22 ' N ' ' A' ' 156' ' ' ALA . 7.2 p -65.52 -9.09 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.095 -1.239 . . . . 0.0 110.276 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.431 HD22 ' CG1' ' A' ' 147' ' ' VAL . 4.0 mm? -87.82 15.92 6.47 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 115.683 -2.407 . . . . 0.0 110.079 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.0 m -131.11 60.94 1.65 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 100.937 -3.727 . . . . 0.0 100.937 167.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.78 140.03 22.23 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 113.876 -1.511 . . . . 0.0 112.774 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -104.03 34.83 5.47 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 106.44 -2.664 . . . . 0.0 106.44 173.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.3 160.88 27.92 Favored Glycine 0 N--CA 1.478 1.493 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.43 ' HB3' ' CD1' ' A' ' 202' ' ' ILE . 4.4 p-80 -90.0 -5.5 56.6 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.653 -0.91 . . . . 0.0 109.309 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.412 ' O ' ' CB ' ' A' ' 142' ' ' ALA . 6.3 m -54.54 -59.22 4.98 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.076 -1.015 . . . . 0.0 109.437 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.453 ' HA ' ' CB ' ' A' ' 142' ' ' ALA . 21.2 tt0 -57.93 -22.12 47.25 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.483 ' N ' HG22 ' A' ' 147' ' ' VAL . . . -91.38 8.04 38.15 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 121.715 -0.616 . . . . 0.0 109.377 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.493 ' CG2' ' N ' ' A' ' 158' ' ' ILE . 0.6 OUTLIER -92.51 -51.69 5.0 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.375 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.493 ' N ' ' CG2' ' A' ' 157' ' ' THR . 6.1 tp -72.77 -32.37 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 176.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.417 ' OD2' ' N ' ' A' ' 145' ' ' GLY . 11.7 t0 -71.61 -22.28 61.73 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.684 ' HA ' ' CD2' ' A' ' 163' ' ' LEU . 0.4 OUTLIER -60.22 -30.98 69.75 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.906 0.86 . . . . 0.0 109.466 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.477 ' HB2' ' HA ' ' A' ' 168' ' ' PRO . 37.2 mmt -83.42 -26.91 29.95 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.456 ' CG2' ' NE ' ' A' ' 209' ' ' ARG . 2.5 m -71.45 -36.87 71.37 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 176.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.684 ' CD2' ' HA ' ' A' ' 160' ' ' LEU . 3.9 pp -82.03 -4.2 56.24 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.251 -0.98 . . . . 0.0 108.698 177.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -109.52 12.1 24.6 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.38 -1.45 . . . . 0.0 109.865 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 58.5 42.49 95.94 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.49 ' CD2' ' HD3' ' A' ' 46' ' ' PRO . 6.3 m-85 -135.41 139.98 44.58 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 122.369 1.081 . . . . 0.0 112.093 -176.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 169' ' ' ALA . 5.1 mttt -48.98 136.6 13.93 Favored Pre-proline 0 N--CA 1.501 2.091 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 177.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.477 ' HA ' ' HB2' ' A' ' 161' ' ' MET . 37.4 Cg_endo -63.86 84.6 0.14 Allowed 'Trans proline' 0 C--N 1.301 -1.962 0 C-N-CA 116.59 -1.806 . . . . 0.0 113.225 -173.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 167' ' ' LYS . . . -155.94 123.82 5.66 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 100.581 -3.859 . . . . 0.0 100.581 172.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.448 ' N ' ' HB2' ' A' ' 69' ' ' CYS . . . -153.64 159.56 28.74 Favored Glycine 0 N--CA 1.502 3.085 0 CA-C-N 123.869 3.031 . . . . 0.0 113.199 -174.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.443 ' HB ' ' CB ' ' A' ' 66' ' ' VAL . 2.9 m -149.65 98.8 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 118.503 -1.279 . . . . 0.0 109.601 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.515 HD13 HD21 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -109.75 105.81 15.2 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 117.185 -1.806 . . . . 0.0 113.787 -179.506 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.483 ' CB ' ' CG1' ' A' ' 66' ' ' VAL . 49.5 t -137.88 159.9 40.76 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.481 ' CB ' ' HB2' ' A' ' 42' ' ' ASP . 1.2 mm-40 174.64 85.68 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.968 0 O-C-N 119.842 -1.786 . . . . 0.0 112.689 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.496 HD22 ' CB ' ' A' ' 188' ' ' CYS . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.891 0 O-C-N 121.206 -0.934 . . . . 0.0 110.83 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.465 ' HB2' ' CE2' ' A' ' 191' ' ' PHE . . . . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.358 0.599 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -129.11 100.41 5.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -0.857 . . . . 0.0 109.442 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.48 ' CB ' ' HD2' ' A' ' 186' ' ' PRO . . . -179.85 -177.18 0.21 Allowed Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.336 -0.852 . . . . 0.0 109.298 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 185' ' ' ALA . 42.8 Cg_endo -70.2 -23.39 28.86 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.342 1.18 . . . . 0.0 110.143 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.423 ' O ' ' CB ' ' A' ' 190' ' ' GLU . 0.4 OUTLIER -81.79 -28.24 33.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.033 -1.042 . . . . 0.0 108.56 178.601 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . 0.509 ' HA ' ' CE1' ' A' ' 191' ' ' PHE . 37.1 m -66.33 -51.56 56.01 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.44 ' CD1' ' O ' ' A' ' 174' ' ' GLU . 8.0 tp -58.34 -27.8 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.44 ' HA ' ' HB3' ' A' ' 193' ' ' ASN . 1.0 OUTLIER -60.14 -25.46 65.51 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 176.646 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.509 ' CE1' ' HA ' ' A' ' 188' ' ' CYS . 12.9 m-30 -55.76 -57.48 11.85 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 123.296 1.522 . . . . 0.0 108.093 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 197' ' ' MET . . . -64.17 -46.61 83.25 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.562 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . 0.624 ' HA ' ' CB ' ' A' ' 197' ' ' MET . 1.9 t30 -65.05 -11.88 44.33 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.472 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 190' ' ' GLU . 7.6 tmtt? -78.2 -37.11 46.37 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 117.372 -1.731 . . . . 0.0 111.06 -178.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -108.66 -54.25 2.54 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 115.684 -2.406 . . . . 0.0 111.952 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -114.67 34.63 4.67 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.322 -1.351 . . . . 0.0 113.784 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' MET . . . . . 0.624 ' CB ' ' HA ' ' A' ' 193' ' ' ASN . 2.2 mtt -151.42 150.63 30.67 Favored 'General case' 0 N--CA 1.518 2.949 0 CA-C-N 123.113 2.688 . . . . 0.0 115.466 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.41 ' HB1' HD12 ' A' ' 23' ' ' LEU . . . -110.26 147.72 33.28 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.257 -0.902 . . . . 0.0 108.779 177.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.469 ' HA ' ' HB3' ' A' ' 30' ' ' MET . 10.0 mt -123.51 130.58 52.9 Favored 'General case' 0 N--CA 1.511 2.585 0 O-C-N 120.277 -1.514 . . . . 0.0 111.161 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.436 ' CG1' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER -109.3 -160.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 120.791 -1.193 . . . . 0.0 111.027 179.232 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.434 ' N ' ' CG1' ' A' ' 200' ' ' VAL . 0.6 OUTLIER -108.44 -179.92 4.01 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.422 -0.799 . . . . 0.0 110.435 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.438 HD13 HG23 ' A' ' 202' ' ' ILE . 12.9 tt -106.66 -41.91 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.417 -0.802 . . . . 0.0 111.3 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.451 ' O ' ' CG2' ' A' ' 206' ' ' VAL . 0.2 OUTLIER -90.38 -40.52 12.02 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.991 -1.068 . . . . 0.0 111.262 -178.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -63.37 -45.1 92.71 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.704 -1.247 . . . . 0.0 110.441 -179.454 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.51 ' O ' ' HB3' ' A' ' 208' ' ' TYR . 0.4 OUTLIER -71.28 -31.53 67.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.156 -0.965 . . . . 0.0 112.354 -178.504 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.467 ' CB ' HG12 ' A' ' 147' ' ' VAL . 3.7 m -62.32 -29.57 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 119.707 -1.871 . . . . 0.0 106.995 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 211' ' ' ALA . . . -64.61 -38.46 91.08 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.51 ' HB3' ' O ' ' A' ' 205' ' ' LEU . 0.2 OUTLIER -56.87 -36.11 69.69 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.313 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.456 ' NE ' ' CG2' ' A' ' 162' ' ' THR . 0.0 OUTLIER -74.01 -55.26 6.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.418 -0.801 . . . . 0.0 110.0 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.433 ' N ' ' HD3' ' A' ' 209' ' ' ARG . 22.9 tt0 -68.83 -56.35 8.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 110.714 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 207' ' ' ALA . . . -51.19 -31.52 20.53 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.322 -0.861 . . . . 0.0 110.443 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.427 ' CB ' ' O ' ' A' ' 208' ' ' TYR . 48.9 t-80 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.183 -0.948 . . . . 0.0 110.182 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.461 ' CB ' ' O ' ' A' ' 204' ' ' ASP . 18.7 Cg_endo . . . . . 0 N--CA 1.487 1.146 0 N-CA-C 110.455 -0.633 . . . . 0.0 110.455 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.444 ' C ' ' CD1' ' A' ' 13' ' ' PHE . 9.8 t80 -87.19 -42.65 12.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.904 -0.498 . . . . 0.0 111.628 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.433 ' HA ' ' CB ' ' A' ' 17' ' ' GLU . 15.9 tt0 -89.37 -16.14 31.7 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.723 -1.236 . . . . 0.0 111.916 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.431 ' CD ' HG23 ' A' ' 200' ' ' VAL . 2.0 ttm180 -72.9 -64.46 0.96 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 105.977 -1.861 . . . . 0.0 105.977 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.587 ' CG1' ' CD2' ' A' ' 208' ' ' TYR . 7.3 p -62.22 -21.21 26.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 C-N-CA 118.721 -1.192 . . . . 0.0 108.323 176.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.433 ' CB ' ' HA ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -57.11 -35.17 69.13 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 119.92 -1.737 . . . . 0.0 106.458 177.092 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 22' ' ' ALA . 2.9 m-20 -73.98 -29.37 61.94 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 176.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.521 ' HB1' ' O ' ' A' ' 16' ' ' VAL . . . -67.83 -50.58 55.94 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.489 ' CD2' ' HA ' ' A' ' 164' ' ' ALA . 0.2 OUTLIER -61.43 -50.77 71.46 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 177.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.08 -26.22 62.27 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.668 -1.27 . . . . 0.0 107.966 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 18' ' ' ASN . . . -80.34 -32.55 37.83 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.499 -0.751 . . . . 0.0 109.064 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.539 ' CD2' ' CD2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -50.35 -25.44 3.84 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.093 -1.004 . . . . 0.0 108.83 177.881 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.44 -26.38 15.87 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 22' ' ' ALA . 1.3 tp10 -144.69 81.09 1.65 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 123.866 1.793 . . . . 0.0 107.241 177.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 126.58 48.8 0.18 Allowed Glycine 0 C--N 1.276 -2.77 1 N-CA-C 102.617 -4.193 . . . . 0.0 102.617 -175.145 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.413 ' N ' ' OD1' ' A' ' 196' ' ' ASN . 1.3 mtt180 -62.78 65.39 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 122.023 0.916 . . . . 0.0 111.715 -175.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 26' ' ' GLY . . . 176.64 98.19 0.11 Allowed Glycine 0 C--N 1.291 -1.964 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 198' ' ' ALA . 24.6 t -127.0 135.17 64.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 119.161 -1.016 . . . . 0.0 110.134 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.457 ' CG ' HD21 ' A' ' 199' ' ' LEU . 0.1 OUTLIER -100.31 161.24 13.74 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.352 -179.444 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.455 ' CG2' HD11 ' A' ' 205' ' ' LEU . 11.1 p . . . . . 0 C--N 1.298 -1.651 0 CA-C-O 121.682 0.753 . . . . 0.0 109.263 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.456 ' HA ' ' CA ' ' A' ' 30' ' ' MET . 20.1 t70 . . . . . 0 N--CA 1.51 2.542 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.643 ' O ' ' O ' ' A' ' 171' ' ' VAL . 0.0 OUTLIER -93.23 51.13 1.6 Allowed 'General case' 0 C--N 1.293 -1.891 0 O-C-N 120.776 -1.203 . . . . 0.0 113.476 -177.037 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.467 ' CD1' ' HB ' ' A' ' 29' ' ' VAL . 20.7 pt -66.13 27.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 O-C-N 119.464 -2.023 . . . . 0.0 112.397 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.539 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 31.4 m-85 -92.6 158.94 37.51 Favored Pre-proline 0 N--CA 1.505 2.292 0 O-C-N 121.064 -1.023 . . . . 0.0 113.184 -177.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.435 ' HA ' HD22 ' A' ' 160' ' ' LEU . 43.5 Cg_endo -66.53 130.86 24.6 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.245 1.963 . . . . 0.0 111.251 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.492 ' N ' ' CB ' ' A' ' 169' ' ' ALA . . . -58.9 -10.6 2.57 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 121.478 -0.764 . . . . 0.0 112.903 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 35.9 mt-10 -97.62 -2.58 41.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.631 -1.293 . . . . 0.0 109.542 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.86 57.08 1.82 Allowed 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 176.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.455 ' CG ' HG12 ' A' ' 115' ' ' ILE . 25.4 tpp -63.26 86.93 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.526 -178.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.468 HG23 ' CE2' ' A' ' 45' ' ' PHE . 9.2 t -66.17 128.2 35.16 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.458 -0.776 . . . . 0.0 109.089 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.505 ' N ' HG22 ' A' ' 115' ' ' ILE . 2.8 p -73.85 -2.56 3.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.534 -0.729 . . . . 0.0 109.484 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.49 -36.48 73.83 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.603 -1.239 . . . . 0.0 107.958 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.466 ' HB3' ' CG ' ' A' ' 43' ' ' MET . 1.0 OUTLIER -81.27 -53.96 5.9 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.828 179.023 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.426 ' O ' ' CG1' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -54.56 -24.21 19.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.35 -0.844 . . . . 0.0 109.277 179.257 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.75 -46.87 64.9 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.322 -0.861 . . . . 0.0 109.896 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.448 ' CD1' ' CD2' ' A' ' 175' ' ' LEU . 0.7 OUTLIER -68.21 -36.6 79.79 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.057 -1.057 . . . . 0.0 109.952 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.414 ' OG1' ' CE ' ' A' ' 43' ' ' MET . 1.1 m -75.29 -58.17 3.44 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.198 -0.939 . . . . 0.0 110.511 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.427 ' CD1' ' HB2' ' A' ' 111' ' ' ALA . 96.5 mt -52.71 -22.09 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.941 . . . . 0.0 110.411 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -76.54 -40.62 49.31 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.282 -0.887 . . . . 0.0 111.15 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.01 -5.81 8.44 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.776 -1.203 . . . . 0.0 112.626 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.99 -170.62 23.75 Favored Glycine 0 N--CA 1.496 2.633 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.158 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.4 t -141.24 101.73 4.08 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 102.26 -3.237 . . . . 0.0 102.26 176.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 66' ' ' VAL . . . -111.43 76.8 0.23 Allowed Glycine 0 C--N 1.26 -3.69 0 N-CA-C 104.612 -3.395 . . . . 0.0 104.612 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.553 ' CG1' ' CZ ' ' A' ' 138' ' ' PHE . 1.2 tt -58.19 94.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 CA-C-O 123.498 1.618 . . . . 0.0 108.811 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.499 ' O ' ' CE1' ' A' ' 138' ' ' PHE . 1.4 p -52.55 154.23 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.134 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 171' ' ' VAL . 44.5 t -75.93 162.64 27.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.174 -0.954 . . . . 0.0 110.131 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.625 ' O ' ' HA ' ' A' ' 139' ' ' PRO . 0.3 OUTLIER -125.13 92.67 3.69 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.7 -1.25 . . . . 0.0 108.474 178.497 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.467 ' CB ' ' HB ' ' A' ' 157' ' ' THR . 1.8 t -93.25 153.88 18.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.428 -1.42 . . . . 0.0 113.073 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' A' ' 75' ' ' ARG . 3.7 pt -155.29 147.51 12.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.048 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.457 ' N ' ' CB ' ' A' ' 75' ' ' ARG . 5.1 m -77.86 176.17 9.32 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 120.452 -1.405 . . . . 0.0 108.896 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' A' ' 76' ' ' LYS . 7.6 tt0 -95.16 -11.18 28.58 Favored 'General case' 0 C--N 1.284 -2.244 0 O-C-N 121.291 -0.881 . . . . 0.0 110.282 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -90.64 -75.26 0.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.591 -1.244 . . . . 0.0 111.557 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.58 -26.3 37.98 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 119.391 -0.923 . . . . 0.0 108.961 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.545 ' O ' ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -85.8 -27.47 25.14 Favored 'General case' 0 C--O 1.192 -1.967 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.359 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.1 OUTLIER -68.17 -41.78 81.0 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 121.157 1.799 . . . . 0.0 108.022 178.051 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.75 -58.28 6.85 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.614 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.424 ' CD1' ' C ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -89.09 -32.05 17.73 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 118.1 -1.44 . . . . 0.0 108.925 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 75' ' ' ARG . 1.4 t0 -116.03 75.32 0.94 Allowed 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.716 -0.615 . . . . 0.0 109.569 177.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.551 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -75.46 126.68 87.3 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.669 -1.269 . . . . 0.0 111.827 -177.669 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.428 ' CB ' ' HB3' ' A' ' 141' ' ' ARG . 55.2 Cg_endo -90.82 98.72 0.24 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 122.627 0.803 . . . . 0.0 110.038 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.468 ' O ' ' N ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -87.59 97.85 11.09 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.194 -0.941 . . . . 0.0 109.027 179.212 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.0 mtt -47.03 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.624 -0.672 . . . . 0.0 110.543 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.468 ' N ' ' O ' ' A' ' 82' ' ' MET . 14.7 p . . . . . 0 N--CA 1.495 1.811 0 C-N-CA 119.456 -0.897 . . . . 0.0 110.778 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.467 ' O ' ' N ' ' A' ' 97' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 122.555 1.169 . . . . 0.0 111.447 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.445 ' HB ' ' O ' ' A' ' 139' ' ' PRO . 4.0 m -60.23 78.05 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.343 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' A' ' 95' ' ' PHE . 2.6 p -32.99 149.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 CA-C-O 122.615 1.198 . . . . 0.0 112.183 -176.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.509 ' CG2' ' O ' ' A' ' 137' ' ' VAL . 5.4 p -70.29 -174.86 0.89 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.915 -175.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.488 ' CG1' ' HB3' ' A' ' 131' ' ' LEU 0.27 0.1 OUTLIER -146.44 136.61 17.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 -179.679 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.559 ' CB ' ' O ' ' A' ' 132' ' ' ASN . 46.7 tt0 -91.83 107.07 18.94 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 117.449 -1.7 . . . . 0.0 112.683 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.483 ' HA ' ' CD2' ' A' ' 131' ' ' LEU . . . -49.96 93.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.424 0.631 . . . . 0.0 110.754 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 130' ' ' ASP . . . -98.35 0.34 45.28 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.717 -1.24 . . . . 0.0 109.513 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.439 ' HB3' ' CB ' ' A' ' 121' ' ' ALA . 12.5 tt0 -82.81 13.74 3.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.062 -1.024 . . . . 0.0 111.299 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.404 ' O ' ' HB ' ' A' ' 117' ' ' THR . . . 128.31 25.41 1.06 Allowed Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.31 -1.424 . . . . 0.0 112.562 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.511 ' CG2' ' CB ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -161.0 118.03 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 O-C-N 120.92 -1.341 . . . . 0.0 110.742 177.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 101' ' ' ALA . 32.0 p -147.68 59.48 1.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.462 -1.399 . . . . 0.0 112.131 176.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.454 ' CG2' ' HG2' ' A' ' 114' ' ' ARG . 7.6 t -137.49 -28.02 0.92 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 120.528 -1.358 . . . . 0.0 110.706 176.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 107' ' ' THR . . . 82.26 -28.32 3.4 Favored Glycine 0 N--CA 1.487 2.1 0 O-C-N 121.389 -0.82 . . . . 0.0 111.797 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.08 53.46 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 120.513 -1.581 . . . . 0.0 111.782 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.489 ' HB3' ' HB2' ' A' ' 114' ' ' ARG . 6.6 t -132.8 54.61 1.94 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.571 ' O ' ' HB ' ' A' ' 115' ' ' ILE . . . -41.0 -24.68 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -177.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -78.04 -77.68 0.15 Allowed 'General case' 0 C--N 1.29 -2.017 0 O-C-N 120.289 -1.507 . . . . 0.0 109.913 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.34 -19.78 60.93 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.609 -0.682 . . . . 0.0 112.292 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.489 ' HB2' ' HB3' ' A' ' 110' ' ' SER . 1.4 mpt_? -95.5 -40.29 9.54 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 118.06 -1.456 . . . . 0.0 111.69 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.571 ' HB ' ' O ' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -67.98 -11.85 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 117.272 -1.771 . . . . 0.0 108.645 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.433 ' O ' ' CG ' ' A' ' 119' ' ' ARG . 20.7 p -83.04 -53.34 5.88 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 176.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 121' ' ' ALA . 0.2 OUTLIER -73.56 -23.44 59.97 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.805 178.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 115' ' ' ILE . 2.8 t -63.43 -55.92 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.081 -1.012 . . . . 0.0 109.263 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 116' ' ' THR . 36.4 ptt85 -52.18 -33.3 40.01 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.719 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.414 ' N ' ' HG3' ' A' ' 119' ' ' ARG . . . -94.27 -9.49 35.91 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.826 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.511 ' CB ' ' CG2' ' A' ' 105' ' ' VAL . . . -98.49 -53.72 3.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.952 -1.093 . . . . 0.0 112.561 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.424 ' CD1' ' HA ' ' A' ' 48' ' ' GLU . 2.5 pp -67.93 -17.56 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.523 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -107.24 74.1 0.96 Allowed 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.648 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.47 ' HB3' ' CG ' ' A' ' 127' ' ' LYS . 17.5 t70 -97.29 -63.09 1.16 Allowed 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 122.451 1.12 . . . . 0.0 110.256 178.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 126.8 -39.69 1.92 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.711 -2.156 . . . . 0.0 107.711 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -135.86 94.36 3.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.311 -1.111 . . . . 0.0 109.39 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.47 ' CG ' ' HB3' ' A' ' 124' ' ' ASP . 10.8 mmmt -136.9 57.94 17.15 Favored Pre-proline 0 C--N 1.308 -1.23 0 O-C-N 120.702 -1.249 . . . . 0.0 110.57 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.67 -16.22 52.56 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 N-CA-C 108.389 -1.427 . . . . 0.0 108.389 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.9 m -123.28 -25.38 4.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.577 -0.702 . . . . 0.0 111.373 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.462 ' CB ' ' HD2' ' A' ' 127' ' ' LYS . 2.8 t70 -78.39 10.0 3.45 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.749 -1.219 . . . . 0.0 112.428 -178.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.488 ' HB3' ' CG1' ' A' ' 99' ' ' ILE . 8.3 mt -140.32 96.56 3.06 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.687 -1.258 . . . . 0.0 108.671 178.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 0.6 OUTLIER -117.88 98.04 6.14 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.266 -0.896 . . . . 0.0 112.31 -178.045 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.722 ' HB2' ' HA ' ' A' ' 134' ' ' PRO . 0.0 OUTLIER -79.5 171.92 11.23 Favored Pre-proline 0 N--CA 1.503 2.214 0 O-C-N 121.717 -0.615 . . . . 0.0 111.305 -178.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.722 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 48.2 Cg_endo -73.16 130.84 21.12 Favored 'Cis proline' 0 N--CA 1.505 2.192 0 C-N-CA 123.405 -1.498 . . . . 0.0 113.432 7.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 100' ' ' GLU . . . -132.46 63.6 0.62 Allowed Glycine 0 N--CA 1.499 2.858 0 C-N-CA 119.844 -1.169 . . . . 0.0 111.88 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.505 ' O ' ' CE2' ' A' ' 138' ' ' PHE . 57.4 m80 30.46 38.45 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.986 -0.714 . . . . 0.0 112.801 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.509 ' O ' ' CG2' ' A' ' 98' ' ' THR . 2.2 t -108.24 132.56 55.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.553 ' CZ ' ' CG1' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -122.69 84.88 49.1 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 120.47 -1.394 . . . . 0.0 108.381 -176.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.625 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 55.6 Cg_endo -104.3 159.33 0.21 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.961 1.774 . . . . 0.0 114.07 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.438 ' HA ' ' HB ' ' A' ' 96' ' ' THR . 0.5 OUTLIER -142.67 112.38 6.86 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 176.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.428 ' HB3' ' CB ' ' A' ' 81' ' ' PRO . 2.6 ptt85 -64.77 147.1 53.82 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.033 -1.042 . . . . 0.0 111.724 -176.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -129.55 132.15 46.75 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.69 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.39 143.85 27.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.171 -0.955 . . . . 0.0 109.909 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.18 100.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.407 -0.808 . . . . 0.0 109.42 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.425 ' HA2' ' NH2' ' A' ' 209' ' ' ARG . . . 88.66 20.8 46.14 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.33 13.18 61.68 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.548 ' CG2' ' HA ' ' A' ' 155' ' ' GLU . 0.3 OUTLIER -95.1 25.35 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 O-C-N 120.987 -1.302 . . . . 0.0 108.903 178.705 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.418 HD11 ' CG1' ' A' ' 206' ' ' VAL . 4.5 mm? -93.8 39.32 1.07 Allowed 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 102.36 -3.2 . . . . 0.0 102.36 172.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.519 ' H ' ' C ' ' A' ' 147' ' ' VAL . 48.8 m -102.6 92.25 4.56 Favored 'General case' 0 N--CA 1.409 -2.489 1 N-CA-C 99.002 -4.444 . . . . 0.0 99.002 177.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.503 ' O ' ' C ' ' A' ' 151' ' ' GLY . 0.2 OUTLIER -44.49 163.01 0.02 OUTLIER 'General case' 0 C--N 1.26 -3.316 0 CA-C-N 112.694 -2.048 . . . . 0.0 109.232 -173.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 150' ' ' ARG . . . -14.48 82.88 0.0 OUTLIER Glycine 0 N--CA 1.515 3.964 0 CA-C-O 124.179 1.988 . . . . 0.0 112.856 -169.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 150' ' ' ARG . . . -114.55 -157.83 11.99 Favored Glycine 0 N--CA 1.472 1.084 0 N-CA-C 106.984 -2.447 . . . . 0.0 106.984 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -92.83 -33.79 14.11 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.07 -1.253 . . . . 0.0 110.114 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.451 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 41.6 p -97.0 -3.31 41.76 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.435 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.548 ' HA ' ' CG2' ' A' ' 147' ' ' VAL . 0.1 OUTLIER -53.69 -32.26 51.06 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -175.318 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.462 ' CB ' HD23 ' A' ' 172' ' ' LEU . . . -113.89 5.25 16.15 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.153 -1.592 . . . . 0.0 112.336 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -89.4 -51.36 5.59 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.946 179.543 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.43 HD13 ' CA ' ' A' ' 70' ' ' ILE . 1.1 tp -90.25 -27.01 5.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 116.844 -1.942 . . . . 0.0 107.255 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 162' ' ' THR . 12.4 t70 -62.13 -23.65 66.69 Favored 'General case' 0 C--O 1.199 -1.601 0 C-N-CA 115.877 -2.329 . . . . 0.0 105.099 172.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.562 ' HA ' ' HB2' ' A' ' 163' ' ' LEU . 0.3 OUTLIER -49.96 -45.13 51.14 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.373 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.503 ' CB ' ' HA ' ' A' ' 168' ' ' PRO . 5.7 ptt? -52.35 -36.37 53.38 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.008 176.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 159' ' ' ASP . 4.5 m -79.59 -43.92 22.02 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.575 HD13 ' CD2' ' A' ' 205' ' ' LEU . 0.4 OUTLIER -35.54 -37.07 0.08 Allowed 'General case' 0 N--CA 1.517 2.907 0 CA-C-O 122.216 1.008 . . . . 0.0 109.094 178.184 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.489 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -106.93 -26.99 10.96 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.913 0.863 . . . . 0.0 108.828 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 162' ' ' THR . . . 108.93 -25.89 17.32 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -148.98 57.65 1.03 Allowed 'General case' 0 N--CA 1.505 2.297 0 C-N-CA 117.477 -1.689 . . . . 0.0 113.132 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 169' ' ' ALA . 18.3 mmtt -129.3 73.88 81.36 Favored Pre-proline 0 C--N 1.3 -1.564 0 O-C-N 120.485 -1.385 . . . . 0.0 107.758 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.503 ' HA ' ' CB ' ' A' ' 161' ' ' MET . 39.5 Cg_endo -67.4 84.44 0.36 Allowed 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 116.236 -2.043 . . . . 0.0 110.107 -176.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.492 ' CB ' ' N ' ' A' ' 47' ' ' ALA 0.265 . . -159.56 164.43 34.27 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 176.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -157.63 108.88 0.38 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 118.406 -1.854 . . . . 0.0 109.969 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.643 ' O ' ' O ' ' A' ' 43' ' ' MET . 0.1 OUTLIER -133.14 92.68 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.196 -1.725 0 C-N-CA 116.952 -1.899 . . . . 0.0 109.491 177.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.506 HD13 ' CD1' ' A' ' 160' ' ' LEU . 10.0 mp -103.86 145.4 30.17 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.16 0.505 . . . . 0.0 109.826 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.493 ' N ' ' HB2' ' A' ' 43' ' ' MET . 1.1 t -130.73 167.54 18.66 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.112 -0.993 . . . . 0.0 110.724 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.401 ' N ' ' SG ' ' A' ' 173' ' ' CYS . 13.6 mm-40 -115.28 126.19 54.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.166 -0.959 . . . . 0.0 109.843 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.448 ' CD2' ' CD1' ' A' ' 57' ' ' LEU . 3.3 tm? . . . . . 0 N--CA 1.497 1.878 0 O-C-N 121.074 -1.016 . . . . 0.0 110.359 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.486 ' CB ' ' CB ' ' A' ' 188' ' ' CYS . . . . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 121.375 0.607 . . . . 0.0 110.047 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 188' ' ' CYS . 0.6 OUTLIER -79.07 125.08 28.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.462 -0.774 . . . . 0.0 109.923 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.426 ' N ' ' HD2' ' A' ' 186' ' ' PRO . . . -38.14 -54.03 2.72 Favored Pre-proline 0 N--CA 1.501 2.084 0 O-C-N 121.809 -0.557 . . . . 0.0 112.391 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 185' ' ' ALA . 47.5 Cg_endo -74.15 -35.12 4.31 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.41 1.216 . . . . 0.0 111.329 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.64 -59.3 2.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.076 -1.015 . . . . 0.0 111.514 -179.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . 0.486 ' CB ' ' CB ' ' A' ' 183' ' ' ALA . 12.3 p -53.15 -40.09 64.03 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.173 -0.954 . . . . 0.0 110.231 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.449 HG12 ' CG ' ' A' ' 30' ' ' MET . 3.7 tp -73.33 -29.09 26.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 120.703 -1.248 . . . . 0.0 108.254 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 194' ' ' LYS . 0.1 OUTLIER -58.31 -20.51 43.62 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.759 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.469 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.2 OUTLIER -76.49 -53.85 7.53 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 178.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -56.28 -25.6 48.82 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' A' ' 197' ' ' MET . 0.0 OUTLIER -89.38 -23.61 22.15 Favored 'General case' 0 C--O 1.194 -1.863 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 190' ' ' GLU . 0.0 OUTLIER -52.07 -35.59 47.94 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 119.578 -1.951 . . . . 0.0 110.459 -178.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.5 -43.27 6.59 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 117.612 -1.635 . . . . 0.0 108.495 176.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.442 ' HB3' ' N ' ' A' ' 28' ' ' GLY . 81.1 m-20 -103.91 56.22 0.73 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 176.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' MET . . . . . 0.551 ' N ' ' O ' ' A' ' 193' ' ' ASN . 0.4 OUTLIER -66.59 74.72 0.1 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 -172.513 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.594 ' O ' ' HA ' ' A' ' 29' ' ' VAL . . . -131.01 99.25 4.83 Favored 'General case' 0 C--O 1.197 -1.701 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 172.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.457 HD21 ' CG ' ' A' ' 30' ' ' MET . 44.2 mt -118.21 131.57 56.37 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 119.68 -1.888 . . . . 0.0 111.448 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.431 HG23 ' CD ' ' A' ' 15' ' ' ARG . 0.5 OUTLIER -129.87 -159.22 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.313 -0.867 . . . . 0.0 111.352 -179.429 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.424 ' N ' HG11 ' A' ' 200' ' ' VAL . 1.7 p -125.46 177.64 6.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.488 -0.758 . . . . 0.0 109.955 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.445 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 1.4 tp -91.46 -44.46 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.214 -0.929 . . . . 0.0 111.752 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.428 ' N ' HG22 ' A' ' 202' ' ' ILE . 43.9 mt-10 -60.17 -61.9 2.26 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.693 -1.254 . . . . 0.0 110.223 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.461 ' O ' ' CB ' ' A' ' 12' ' ' PRO . 2.7 m-20 -57.74 -16.95 12.71 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.366 -0.834 . . . . 0.0 110.696 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.575 ' CD2' HD13 ' A' ' 163' ' ' LEU . 8.4 tt -68.05 -61.15 1.99 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.236 -1.54 . . . . 0.0 110.353 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.503 HG21 HG11 ' A' ' 147' ' ' VAL . 2.4 t -60.93 -16.66 14.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 119.848 -1.782 . . . . 0.0 109.277 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.457 ' CB ' ' HB2' ' A' ' 12' ' ' PRO . . . -60.58 -32.77 71.86 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 105.329 -2.101 . . . . 0.0 105.329 174.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.587 ' CD2' ' CG1' ' A' ' 16' ' ' VAL 0.273 1.1 t80 -50.81 -41.98 57.79 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 175.101 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.437 ' CG ' HG22 ' A' ' 162' ' ' THR . 1.3 ttt85 -78.43 -62.77 1.58 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.153 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -50.41 -37.2 36.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.192 -0.943 . . . . 0.0 110.409 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 207' ' ' ALA . . . -74.75 -26.91 60.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.396 -0.815 . . . . 0.0 110.152 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . 0.404 ' O ' ' CD2' ' A' ' 212' ' ' HIS . 9.0 t60 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 110.18 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.464 ' CB ' ' HB2' ' A' ' 208' ' ' TYR . 34.3 Cg_endo . . . . . 0 C--O 1.208 -1.012 0 N-CA-C 109.712 -0.918 . . . . 0.0 109.712 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.34 -45.27 7.89 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -178.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -81.91 -58.43 2.98 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.259 -1.376 . . . . 0.0 111.524 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.46 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -82.65 -15.26 52.73 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 118.666 -1.214 . . . . 0.0 112.531 -178.253 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.579 HG11 ' CG ' ' A' ' 208' ' ' TYR . 1.1 t -97.94 -29.92 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 116.422 -2.111 . . . . 0.0 110.444 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -73.28 -37.06 66.38 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 115.986 -2.286 . . . . 0.0 107.037 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.426 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 5.4 t30 -74.96 -26.27 59.47 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 24' ' ' ARG . . . -90.77 -17.01 27.38 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.207 -0.933 . . . . 0.0 109.598 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.469 ' CD1' ' NH2' ' A' ' 24' ' ' ARG . 0.9 OUTLIER -69.29 -51.5 36.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.943 -1.098 . . . . 0.0 109.605 179.472 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 25' ' ' GLU . . . -89.49 -46.22 8.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.076 -1.015 . . . . 0.0 111.034 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 18' ' ' ASN . . . -72.23 -39.54 68.42 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.148 -0.97 . . . . 0.0 111.876 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 28' ' ' GLY . 56.8 mt -105.05 -24.1 12.85 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.878 -1.139 . . . . 0.0 112.664 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.498 ' NH2' ' CD1' ' A' ' 163' ' ' LEU . 0.4 OUTLIER -100.34 -6.2 26.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.569 -1.332 . . . . 0.0 110.714 -179.288 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 21' ' ' ALA . 3.2 tt0 -101.25 44.4 1.01 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 118.117 -1.433 . . . . 0.0 107.949 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.02 2.67 12.43 Favored Glycine 0 C--N 1.296 -1.692 0 C-N-CA 119.911 -1.138 . . . . 0.0 112.616 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.55 22.04 5.99 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 121.313 2.557 . . . . 0.0 115.944 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 97.09 108.74 2.6 Favored Glycine 0 N--CA 1.501 3.009 0 C-N-CA 117.923 -2.084 . . . . 0.0 116.819 171.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.452 ' CG1' ' HD2' ' A' ' 24' ' ' ARG . 30.7 t -140.77 122.08 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.439 -1.624 . . . . 0.0 106.814 173.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.526 ' HB2' ' CD2' ' A' ' 199' ' ' LEU . 1.1 mtt -123.55 150.03 44.53 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 118.727 -1.189 . . . . 0.0 113.937 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.495 ' HB ' ' HB ' ' A' ' 201' ' ' THR . 1.1 p . . . . . 0 N--CA 1.498 1.939 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.582 ' HB2' ' N ' ' A' ' 174' ' ' GLU . 7.9 m-20 . . . . . 0 N--CA 1.5 2.059 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.565 ' HB3' ' HA ' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -85.71 59.81 5.86 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.233 -0.917 . . . . 0.0 111.233 -178.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.58 ' CD1' ' HB ' ' A' ' 201' ' ' THR . 41.9 mt -56.73 22.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.94 0 O-C-N 120.489 -1.382 . . . . 0.0 114.531 -175.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 43' ' ' MET . 32.3 m-85 -82.92 161.53 57.8 Favored Pre-proline 0 C--N 1.292 -1.919 0 O-C-N 120.344 -1.473 . . . . 0.0 110.557 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.467 ' HB3' ' CB ' ' A' ' 167' ' ' LYS . 48.0 Cg_endo -70.21 131.83 21.39 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.791 1.661 . . . . 0.0 111.434 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.473 ' HB2' ' CB ' ' A' ' 169' ' ' ALA . . . -61.9 -13.65 26.75 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.467 -0.771 . . . . 0.0 111.774 -178.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.439 ' HA ' ' CB ' ' A' ' 123' ' ' ALA . 0.2 OUTLIER -88.83 -8.71 53.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.038 -1.039 . . . . 0.0 109.088 178.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.456 ' O ' ' N ' ' A' ' 51' ' ' THR . 0.7 OUTLIER -133.9 57.92 1.79 Allowed 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 176.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.495 ' O ' ' CG2' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -60.12 87.6 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.456 ' N ' ' O ' ' A' ' 49' ' ' THR . 13.6 m -64.88 155.59 33.7 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.608 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.444 ' N ' HG21 ' A' ' 115' ' ' ILE . 14.1 t -71.33 -4.89 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.525 -0.734 . . . . 0.0 110.098 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.46 ' OE1' ' CZ ' ' A' ' 45' ' ' PHE . 3.1 mt-10 -57.24 -25.72 59.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.886 -1.134 . . . . 0.0 108.959 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.457 ' CB ' ' HG3' ' A' ' 43' ' ' MET . 0.1 OUTLIER -75.72 -54.15 7.4 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.708 0.765 . . . . 0.0 110.552 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.448 ' O ' ' CG2' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -66.36 -45.47 80.0 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.608 -178.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.405 ' O ' HG22 ' A' ' 59' ' ' ILE . . . -54.75 -44.51 73.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.086 -1.009 . . . . 0.0 110.649 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.468 ' CB ' ' HG2' ' A' ' 174' ' ' GLU . 3.1 tt -67.09 -56.01 11.86 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.195 -0.941 . . . . 0.0 109.607 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 62' ' ' GLY . 11.8 p -65.16 -51.77 59.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.969 -1.082 . . . . 0.0 111.441 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.448 ' CG2' ' O ' ' A' ' 55' ' ' MET . 7.7 tt -49.92 -25.68 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.053 -1.03 . . . . 0.0 109.198 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -66.52 -61.72 1.84 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.996 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -129.33 -11.77 4.56 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 118.108 -1.437 . . . . 0.0 114.028 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 58' ' ' THR . . . -132.06 -169.67 12.37 Favored Glycine 0 N--CA 1.498 2.796 0 O-C-N 120.468 -1.395 . . . . 0.0 112.12 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.4 t -135.28 104.75 6.0 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 101.122 -3.658 . . . . 0.0 101.122 176.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.472 ' CA ' ' HB3' ' A' ' 173' ' ' CYS . . . -103.32 73.76 0.28 Allowed Glycine 0 C--N 1.262 -3.545 0 N-CA-C 107.781 -2.128 . . . . 0.0 107.781 -176.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.546 ' CG1' ' CD2' ' A' ' 138' ' ' PHE . 0.6 OUTLIER -65.2 90.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.272 -2.765 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.617 ' O ' ' CD1' ' A' ' 138' ' ' PHE . 28.3 m -51.41 155.57 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 122.049 0.928 . . . . 0.0 113.375 -177.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 171' ' ' VAL . 61.6 m -90.37 111.7 23.02 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -88.44 91.97 9.0 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.452 ' HB3' ' CG2' ' A' ' 157' ' ' THR . 26.4 p -78.35 161.66 27.03 Favored 'General case' 0 C--N 1.285 -2.204 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.929 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.562 ' HB ' ' HB3' ' A' ' 75' ' ' ARG . 1.1 pt -151.48 147.84 15.11 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.459 ' CG2' ' HB2' ' A' ' 75' ' ' ARG . 10.3 t -79.89 172.21 14.09 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 120.294 -1.504 . . . . 0.0 107.939 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.476 ' O ' ' CB ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -92.46 -10.98 35.92 Favored 'General case' 0 C--N 1.276 -2.587 0 O-C-N 121.321 -0.862 . . . . 0.0 109.855 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.95 -72.67 0.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.751 -1.218 . . . . 0.0 111.9 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -87.8 -35.27 17.93 Favored 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 119.346 -0.942 . . . . 0.0 109.137 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.562 ' HB3' ' HB ' ' A' ' 70' ' ' ILE . 3.0 mmt180 -69.7 -31.29 69.23 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.004 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.485 ' CG ' ' CD1' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -69.76 -44.22 70.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.236 -1.54 . . . . 0.0 109.075 178.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -41.88 -55.11 3.2 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.768 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.498 ' CD1' ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -104.97 -27.97 11.36 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 117.673 -1.611 . . . . 0.0 110.149 178.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.498 ' N ' ' CD1' ' A' ' 78' ' ' LEU . 22.6 t0 -115.8 72.9 0.82 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.793 -1.192 . . . . 0.0 110.115 176.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.485 ' CD1' ' CG ' ' A' ' 76' ' ' LYS . 13.9 tp -80.42 121.25 81.32 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.568 -1.332 . . . . 0.0 109.301 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.455 ' HA ' ' HB ' ' A' ' 97' ' ' VAL . 54.0 Cg_endo -89.4 93.81 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.573 1.301 . . . . 0.0 109.596 178.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.425 ' O ' ' C ' ' A' ' 83' ' ' MET . 1.2 ttt -96.84 42.95 1.08 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.172 -0.955 . . . . 0.0 109.879 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.484 ' HA ' ' CA ' ' A' ' 96' ' ' THR . 0.0 OUTLIER 16.8 107.99 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' A' ' 84' ' ' VAL . 7.2 p . . . . . 0 N--CA 1.487 1.413 0 C-N-CA 117.277 -1.769 . . . . 0.0 112.635 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.495 ' CD2' HD23 ' A' ' 140' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 122.031 0.92 . . . . 0.0 110.638 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.484 ' CA ' ' HA ' ' A' ' 83' ' ' MET . 0.7 OUTLIER -133.73 37.38 3.28 Favored 'General case' 0 N--CA 1.515 2.809 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -179.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.455 ' HB ' ' HA ' ' A' ' 81' ' ' PRO . 0.9 OUTLIER -115.52 110.29 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 O-C-N 120.546 -1.346 . . . . 0.0 110.319 178.283 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.492 ' HA ' ' HG3' ' A' ' 139' ' ' PRO . 14.9 p -75.45 177.19 6.86 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.123 -0.985 . . . . 0.0 110.439 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.492 ' CA ' ' HB3' ' A' ' 133' ' ' ARG . 27.9 pt -142.31 135.81 28.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 132' ' ' ASN . 10.9 tt0 -86.17 113.37 22.15 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 117.072 -1.851 . . . . 0.0 110.961 -176.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.532 ' HA ' ' CD2' ' A' ' 131' ' ' LEU . . . -53.02 91.7 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.648 0.737 . . . . 0.0 109.929 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 100' ' ' GLU . . . -106.29 -0.43 24.39 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.407 -0.808 . . . . 0.0 110.504 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.439 ' HB2' ' CB ' ' A' ' 129' ' ' SER . 27.6 tt0 -86.89 26.97 1.05 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.915 -1.115 . . . . 0.0 111.896 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.94 -38.68 2.11 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.422 -1.37 . . . . 0.0 111.466 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 5.4 p -101.39 125.7 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.104 -1.233 . . . . 0.0 110.331 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.5 m -143.06 59.62 1.41 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.853 -1.155 . . . . 0.0 110.565 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.9 m -137.27 -30.76 0.84 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.091 -1.005 . . . . 0.0 110.564 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.417 ' CA ' ' CE1' ' A' ' 136' ' ' HIS . . . 78.62 -30.81 1.95 Allowed Glycine 0 N--CA 1.494 2.52 0 O-C-N 121.565 -0.71 . . . . 0.0 111.329 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.17 58.57 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.85 -1.383 . . . . 0.0 109.347 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 112' ' ' ALA . 0.5 OUTLIER -128.23 57.49 1.57 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.298 -0.876 . . . . 0.0 109.057 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.455 ' O ' ' CG1' ' A' ' 115' ' ' ILE . . . -33.48 -29.95 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -81.05 -76.94 0.22 Allowed 'General case' 0 C--N 1.291 -1.972 0 O-C-N 120.893 -1.129 . . . . 0.0 110.13 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.81 -13.94 62.71 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.563 -0.711 . . . . 0.0 111.18 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.46 ' HB3' ' O ' ' A' ' 110' ' ' SER . 0.1 OUTLIER -89.65 -44.44 10.05 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.96 -1.087 . . . . 0.0 110.506 -179.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.495 ' CG2' ' O ' ' A' ' 50' ' ' MET . 18.4 mm -64.6 -16.92 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.668 -1.213 . . . . 0.0 110.739 -178.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 68.8 p -88.28 -53.45 4.69 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.866 -1.133 . . . . 0.0 108.704 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.492 ' HB ' ' HB ' ' A' ' 105' ' ' VAL . 60.0 m -71.39 -43.19 67.31 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.544 -0.863 . . . . 0.0 110.004 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.442 ' CG1' ' O ' ' A' ' 114' ' ' ARG . 4.4 p -52.72 -40.13 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 120.577 -1.327 . . . . 0.0 109.866 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 54.2 ttt180 -51.31 -53.47 35.64 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.851 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -99.29 -6.99 27.01 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 117' ' ' THR . . . -98.35 -26.36 14.52 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 116.056 1.872 . . . . 0.0 116.056 -174.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.439 HD13 ' CB ' ' A' ' 123' ' ' ALA . 2.6 pp -121.02 -37.7 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 121.112 1.778 . . . . 0.0 112.091 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.439 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . . . -103.98 75.26 1.27 Allowed 'General case' 0 C--N 1.263 -3.166 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.392 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.479 ' CB ' ' CD ' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -97.27 -54.96 2.99 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.297 1.046 . . . . 0.0 110.154 177.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 124.07 -39.94 2.05 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 105.729 -2.949 . . . . 0.0 105.729 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -134.63 96.76 3.63 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 175.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.479 ' CD ' ' CB ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -131.75 123.45 19.22 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 120.857 -1.152 . . . . 0.0 113.373 -176.267 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.43 ' HD2' ' CE ' ' A' ' 127' ' ' LYS . 51.8 Cg_endo -81.38 21.02 0.95 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.656 1.345 . . . . 0.0 108.79 175.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 131' ' ' LEU . 2.0 m -92.9 42.29 1.1 Allowed 'General case' 0 C--O 1.202 -1.418 0 O-C-N 121.412 -0.805 . . . . 0.0 109.018 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -26.51 79.37 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 123.991 1.853 . . . . 0.0 111.798 -176.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.579 ' N ' ' O ' ' A' ' 129' ' ' SER 0.255 5.4 mt -61.44 125.35 23.48 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 112.069 -2.332 . . . . 0.0 108.047 -178.148 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 15.7 p-10 -113.68 99.51 7.78 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.409 -0.807 . . . . 0.0 111.738 -177.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.704 ' HB2' ' HA ' ' A' ' 134' ' ' PRO 0.282 0.5 OUTLIER -82.58 -178.43 1.18 Allowed Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 122.031 -0.418 . . . . 0.0 111.203 -177.611 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.704 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 48.5 Cg_endo -72.69 123.39 8.23 Favored 'Cis proline' 0 N--CA 1.503 2.063 0 C-N-CA 123.674 -1.386 . . . . 0.0 113.327 8.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.439 ' C ' ' CG ' ' A' ' 136' ' ' HIS . . . -124.04 60.03 0.61 Allowed Glycine 0 N--CA 1.5 2.907 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.105 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.472 ' O ' ' CE2' ' A' ' 138' ' ' PHE . 25.5 p80 32.1 37.97 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.665 0 O-C-N 121.745 -0.856 . . . . 0.0 112.271 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.451 ' HB ' ' CB ' ' A' ' 98' ' ' THR . 54.4 t -91.04 154.87 3.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.617 ' CD1' ' O ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -123.6 84.06 53.37 Favored Pre-proline 0 C--N 1.281 -2.376 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 -178.32 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.492 ' HG3' ' HA ' ' A' ' 98' ' ' THR . 54.9 Cg_endo -98.42 140.84 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.737 1.388 . . . . 0.0 113.674 -176.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.495 HD23 ' CD2' ' A' ' 95' ' ' PHE . 36.1 mt -136.7 112.8 9.73 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.463 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.401 ' CD ' ' HG2' ' A' ' 81' ' ' PRO . 11.1 ttt180 -69.95 127.0 31.36 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.085 -1.009 . . . . 0.0 109.874 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.49 ' CB ' ' CG2' ' A' ' 158' ' ' ILE . . . -132.75 133.19 43.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.063 -1.023 . . . . 0.0 111.329 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -58.84 143.09 48.56 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.247 -0.908 . . . . 0.0 109.532 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.27 106.27 5.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.421 -0.799 . . . . 0.0 110.568 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 86.54 20.98 53.03 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.83 12.85 62.57 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.464 ' HA ' ' HG3' ' A' ' 155' ' ' GLU . 13.6 p -104.57 18.76 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.972 -1.311 . . . . 0.0 109.427 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.438 ' CD1' ' HA ' ' A' ' 207' ' ' ALA . 3.7 mm? -94.86 20.39 8.88 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 117.331 -1.748 . . . . 0.0 108.306 176.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 151' ' ' GLY . 29.4 m -126.99 73.46 1.42 Allowed 'General case' 0 C--N 1.29 -1.987 1 N-CA-C 96.183 -5.488 . . . . 0.0 96.183 168.515 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.437 ' CD ' ' HA ' ' A' ' 203' ' ' GLU . 0.1 OUTLIER -67.21 71.85 0.11 Allowed 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 113.553 -1.658 . . . . 0.0 115.033 -168.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 149' ' ' THR . . . -116.93 28.68 7.21 Favored Glycine 0 N--CA 1.475 1.281 0 N-CA-C 105.611 -2.996 . . . . 0.0 105.611 169.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -148.74 131.38 3.72 Favored Glycine 0 C--N 1.303 -1.265 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.445 ' ND1' ' O ' ' A' ' 153' ' ' HIS . 1.6 t60 -89.79 -5.37 56.99 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.433 ' CG2' ' N ' ' A' ' 155' ' ' GLU . 14.9 t -93.38 -46.51 7.31 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.225 -0.922 . . . . 0.0 110.821 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.464 ' HG3' ' HA ' ' A' ' 147' ' ' VAL . 1.2 pt-20 -59.61 -20.73 57.94 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.468 ' HA ' ' CB ' ' A' ' 159' ' ' ASP . . . -86.77 5.66 35.34 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 121.356 -0.84 . . . . 0.0 108.943 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.52 ' O ' ' CB ' ' A' ' 160' ' ' LEU . 2.5 m -87.05 -51.12 6.19 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.49 ' CG2' ' CB ' ' A' ' 142' ' ' ALA . 4.4 tp -74.39 -17.44 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 115.96 -2.296 . . . . 0.0 106.404 175.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.468 ' CB ' ' HA ' ' A' ' 156' ' ' ALA . 18.9 t70 -62.21 -29.84 70.67 Favored 'General case' 0 C--O 1.206 -1.215 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 173.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.563 ' N ' HD22 ' A' ' 163' ' ' LEU . 1.7 tm? -50.23 -43.75 53.05 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 176.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.49 ' HB3' ' O ' ' A' ' 158' ' ' ILE . 0.0 OUTLIER -52.76 -36.21 57.6 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.75 178.508 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 159' ' ' ASP . 1.5 m -93.17 -51.44 5.02 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.563 HD22 ' N ' ' A' ' 160' ' ' LEU . 1.8 pp -57.41 -14.47 4.85 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.501 -1.374 . . . . 0.0 111.679 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.404 ' HA ' HD13 ' A' ' 20' ' ' LEU . . . -77.16 -30.78 55.15 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 120.593 -1.317 . . . . 0.0 108.392 176.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 106.27 -35.43 5.05 Favored Glycine 0 N--CA 1.493 2.475 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.326 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.74 48.19 0.39 Allowed 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 117.792 -1.563 . . . . 0.0 113.097 172.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.467 ' CB ' ' HB3' ' A' ' 46' ' ' PRO . 40.4 mmtt -135.95 83.46 34.26 Favored Pre-proline 0 C--N 1.289 -2.061 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 174.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.464 ' HA ' ' HB2' ' A' ' 161' ' ' MET . 44.5 Cg_endo -73.65 81.02 1.91 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 114.781 -3.013 . . . . 0.0 113.798 -173.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.473 ' CB ' ' HB2' ' A' ' 47' ' ' ALA . . . -165.76 168.38 16.12 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 171.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.427 ' CA ' ' SG ' ' A' ' 69' ' ' CYS . . . -156.99 129.02 2.29 Favored Glycine 0 N--CA 1.504 3.184 0 C-N-CA 118.28 -1.914 . . . . 0.0 110.276 177.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 43' ' ' MET . 6.5 m -141.42 101.43 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.565 ' HA ' ' HB3' ' A' ' 43' ' ' MET . 0.0 OUTLIER -125.86 101.08 6.67 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 117.177 -1.809 . . . . 0.0 115.045 -176.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.477 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 1.1 m -140.79 141.87 34.74 Favored 'General case' 0 N--CA 1.514 2.736 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 173.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.582 ' N ' ' HB2' ' A' ' 42' ' ' ASP . 3.5 tt0 176.82 87.32 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.33 0 CA-C-N 122.632 2.469 . . . . 0.0 115.473 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.436 HD22 ' O ' ' A' ' 188' ' ' CYS . 0.3 OUTLIER . . . . . 0 N--CA 1.508 2.464 0 O-C-N 120.452 -1.405 . . . . 0.0 109.108 175.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 121.223 0.535 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 9.5 mtt-85 -105.26 100.15 9.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.341 -0.85 . . . . 0.0 109.825 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.458 ' CB ' ' HD2' ' A' ' 186' ' ' PRO . . . 172.92 178.93 0.12 Allowed Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.309 -0.869 . . . . 0.0 109.831 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.458 ' HD2' ' CB ' ' A' ' 185' ' ' ALA . 43.0 Cg_endo -69.5 -7.72 21.72 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.303 1.159 . . . . 0.0 110.422 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.5 -41.66 19.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.972 -1.08 . . . . 0.0 109.992 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . 0.48 ' O ' ' HB3' ' A' ' 191' ' ' PHE . 16.8 p -67.43 -36.32 80.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.966 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.45 ' CG1' ' CB ' ' A' ' 30' ' ' MET . 5.2 tp -73.98 -28.33 23.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.754 -1.216 . . . . 0.0 109.079 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 193' ' ' ASN . 35.9 tt0 -71.05 -19.01 62.54 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.721 0.772 . . . . 0.0 109.05 177.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.48 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.7 OUTLIER -75.99 -48.42 21.12 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.128 0.966 . . . . 0.0 109.513 -179.413 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.455 ' CB ' ' HE2' ' A' ' 30' ' ' MET . . . -73.79 -35.35 64.92 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 178.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . 0.552 ' HA ' ' HB2' ' A' ' 197' ' ' MET . 1.7 t30 -56.33 -23.36 36.72 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.3 -40.92 20.81 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 118.099 -1.441 . . . . 0.0 112.741 -176.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.25 -56.03 2.6 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 114.966 -2.694 . . . . 0.0 112.055 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.422 ' O ' ' HG2' ' A' ' 197' ' ' MET . 0.1 OUTLIER -117.05 33.74 5.46 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.073 -1.451 . . . . 0.0 113.773 176.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' MET . . . . . 0.552 ' HB2' ' HA ' ' A' ' 193' ' ' ASN . 15.3 mmt -150.35 151.69 33.25 Favored 'General case' 0 N--CA 1.517 2.896 0 CA-C-N 123.034 2.652 . . . . 0.0 114.53 -178.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.431 ' CB ' ' HB3' ' A' ' 23' ' ' LEU . . . -111.59 155.73 22.89 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.033 -1.042 . . . . 0.0 108.916 177.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.526 ' CD2' ' HB2' ' A' ' 30' ' ' MET . 48.1 mt -125.58 133.19 52.36 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 120.552 -1.342 . . . . 0.0 109.676 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.486 ' CG2' HG22 ' A' ' 16' ' ' VAL . 1.3 p -170.82 18.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.521 -1.362 . . . . 0.0 113.287 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.58 ' HB ' ' CD1' ' A' ' 44' ' ' ILE 0.271 87.0 m -133.33 150.24 51.87 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 -176.149 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.48 ' CB ' ' O ' ' A' ' 201' ' ' THR . 3.6 tp 149.85 -76.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.844 0 C-N-CA 124.99 1.316 . . . . 0.0 109.704 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.437 ' HA ' ' CD ' ' A' ' 150' ' ' ARG . 1.9 tt0 -93.79 -59.56 1.96 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.337 -1.477 . . . . 0.0 110.723 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.33 -50.32 73.42 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.225 -0.922 . . . . 0.0 111.508 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.544 ' O ' ' HB3' ' A' ' 208' ' ' TYR . 3.2 tt -60.5 -23.63 64.68 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.069 -1.019 . . . . 0.0 113.244 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 203' ' ' GLU . 16.5 m -77.98 -34.82 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 119.65 -1.906 . . . . 0.0 108.14 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.438 ' HA ' ' CD1' ' A' ' 148' ' ' LEU . . . -68.82 -14.62 63.14 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 174.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.579 ' CG ' HG11 ' A' ' 16' ' ' VAL . 7.6 t80 -81.71 -26.71 34.38 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.798 -0.563 . . . . 0.0 109.608 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.499 ' HG3' ' N ' ' A' ' 210' ' ' GLN . 0.2 OUTLIER -75.82 -25.77 56.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.096 -1.003 . . . . 0.0 108.69 177.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.499 ' N ' ' HG3' ' A' ' 209' ' ' ARG . 6.8 tt0 -82.72 -59.15 2.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.412 -0.805 . . . . 0.0 109.885 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -51.77 -27.1 11.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.485 -0.759 . . . . 0.0 110.223 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 109.999 179.772 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 14' ' ' GLU . 20.5 Cg_endo . . . . . 0 N--CA 1.508 2.334 0 N-CA-C 106.551 -2.134 . . . . 0.0 106.551 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.699 ' HA ' HG23 ' A' ' 16' ' ' VAL 0.27 16.1 t80 -40.15 -26.83 0.03 OUTLIER 'General case' 0 C--O 1.184 -2.352 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.733 169.098 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 12' ' ' PRO . 1.0 OUTLIER -43.09 -38.14 2.26 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.085 -1.634 . . . . 0.0 109.082 179.28 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.7 mmt-85 -61.78 -46.37 89.87 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 176.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.699 HG23 ' HA ' ' A' ' 13' ' ' PHE . 15.7 m -79.34 -12.67 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 C-N-CA 117.684 -1.606 . . . . 0.0 109.875 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.498 ' HA ' ' CE1' ' A' ' 13' ' ' PHE . 35.1 tt0 -53.88 -34.54 59.73 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -79.11 -33.08 44.69 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.484 ' CB ' ' HA ' ' A' ' 16' ' ' VAL . . . -70.49 -64.87 0.81 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.5 -0.75 . . . . 0.0 110.834 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.465 ' CD2' ' HA ' ' A' ' 164' ' ' ALA . 0.0 OUTLIER -54.66 -43.95 72.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.2 -0.938 . . . . 0.0 109.127 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 17' ' ' GLU . . . -53.68 -28.37 33.03 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 25' ' ' GLU . . . -78.24 -33.52 49.7 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 3.8 tt -44.52 -28.04 0.53 Allowed 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.84 0.829 . . . . 0.0 109.582 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.53 -30.84 12.64 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 22' ' ' ALA . 0.2 OUTLIER -147.7 82.65 1.52 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 123.439 1.59 . . . . 0.0 108.191 177.457 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 126.57 50.64 0.17 Allowed Glycine 0 C--N 1.275 -2.821 1 N-CA-C 102.076 -4.409 . . . . 0.0 102.076 -174.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.439 ' HA ' ' HA ' ' A' ' 23' ' ' LEU . 3.1 mtm180 -55.92 91.16 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 122.942 1.353 . . . . 0.0 110.429 -173.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.449 ' HA2' ' CZ ' ' A' ' 45' ' ' PHE . . . 176.48 105.95 0.19 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.124 -1.512 . . . . 0.0 113.189 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.445 ' CG1' HG12 ' A' ' 44' ' ' ILE . 1.1 p -140.34 99.21 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.528 ' HB2' ' CD2' ' A' ' 199' ' ' LEU . 4.9 mtt -97.96 130.42 44.82 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.864 -1.147 . . . . 0.0 114.072 -173.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.499 ' CG1' ' CD1' ' A' ' 205' ' ' LEU . 35.6 m . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.4 -0.812 . . . . 0.0 109.707 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 30' ' ' MET . 5.2 m-20 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 122.281 1.038 . . . . 0.0 111.834 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.555 ' O ' ' O ' ' A' ' 171' ' ' VAL . 0.0 OUTLIER -85.87 54.41 3.12 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.511 -0.743 . . . . 0.0 110.382 -179.173 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.526 ' HA ' ' HG ' ' A' ' 172' ' ' LEU . 3.0 pt -63.77 26.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.534 3.763 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 -175.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.471 ' CD2' ' HB3' ' A' ' 54' ' ' GLN . 9.7 m-85 -67.81 161.68 64.68 Favored Pre-proline 0 C--N 1.283 -2.309 0 O-C-N 121.372 -0.83 . . . . 0.0 112.193 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.451 ' HB3' ' HB3' ' A' ' 167' ' ' LYS . 45.6 Cg_endo -68.83 129.58 18.87 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.524 1.483 . . . . 0.0 110.52 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.458 ' HA ' ' CG1' ' A' ' 171' ' ' VAL . . . -70.47 -2.59 14.38 Favored 'General case' 0 N--CA 1.508 2.441 0 C-N-CA 119.195 -1.002 . . . . 0.0 112.554 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -85.73 -23.55 27.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.737 -1.227 . . . . 0.0 109.315 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 51' ' ' THR . 51.7 m -132.42 60.56 1.69 Allowed 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 177.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.41 ' O ' HG13 ' A' ' 115' ' ' ILE . 0.4 OUTLIER -52.48 88.09 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.263 0.554 . . . . 0.0 110.056 -178.739 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.49 ' N ' ' O ' ' A' ' 49' ' ' THR . 1.6 m -66.18 153.42 42.48 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.616 0.722 . . . . 0.0 109.777 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.49 ' N ' ' CG1' ' A' ' 115' ' ' ILE . 1.7 p -73.91 -3.78 4.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.569 -0.707 . . . . 0.0 109.668 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.404 ' CG ' ' HB2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -55.8 -32.63 63.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.742 -1.224 . . . . 0.0 108.53 179.287 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.471 ' HB3' ' CD2' ' A' ' 45' ' ' PHE . 10.2 pt20 -81.18 -32.89 33.38 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.51 0.671 . . . . 0.0 110.118 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.423 ' HB3' ' CD1' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -82.22 -46.42 13.75 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.38 -0.825 . . . . 0.0 110.263 -179.782 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -54.07 -45.05 71.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.951 -1.093 . . . . 0.0 110.142 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.479 ' CD1' ' CB ' ' A' ' 192' ' ' ALA . 7.3 tt -60.98 -53.21 60.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.384 -0.823 . . . . 0.0 110.359 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 62' ' ' GLY . 8.3 t -74.75 -47.44 31.16 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.422 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.443 HG22 HD12 ' A' ' 59' ' ' ILE . 40.8 mt -46.54 -26.03 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 120.649 -1.282 . . . . 0.0 110.222 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.49 -47.62 17.01 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.385 -0.822 . . . . 0.0 110.785 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -125.18 -7.01 7.1 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.636 -1.29 . . . . 0.0 114.068 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 58' ' ' THR . . . -157.05 -168.23 19.32 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 120.503 -1.373 . . . . 0.0 111.005 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.69 103.77 5.32 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 102.273 -3.232 . . . . 0.0 102.273 176.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.442 ' N ' ' OG1' ' A' ' 58' ' ' THR . . . -104.48 73.03 0.25 Allowed Glycine 0 C--N 1.264 -3.439 0 N-CA-C 106.381 -2.687 . . . . 0.0 106.381 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.519 HG22 ' CE1' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -65.72 90.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.031 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.478 ' O ' ' CE1' ' A' ' 138' ' ' PHE . 29.3 m -52.79 150.63 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.003 -177.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 171' ' ' VAL . 82.8 m -77.6 119.17 20.79 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 139' ' ' PRO . 0.6 OUTLIER -90.06 92.07 8.82 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 118.617 -1.233 . . . . 0.0 108.551 -179.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.47 ' HB2' ' HB ' ' A' ' 157' ' ' THR . 0.5 OUTLIER -87.57 145.51 26.18 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 122.339 1.066 . . . . 0.0 112.576 -178.062 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.481 ' CD1' ' HG3' ' A' ' 75' ' ' ARG . 9.9 pt -137.58 138.89 44.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.443 ' N ' HG12 ' A' ' 158' ' ' ILE . 50.0 m -78.59 143.18 36.69 Favored 'General case' 0 C--O 1.199 -1.588 0 O-C-N 120.549 -1.344 . . . . 0.0 108.769 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.435 ' HB3' ' CD ' ' A' ' 141' ' ' ARG . 6.1 pt-20 -41.53 -25.94 0.06 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.788 -0.57 . . . . 0.0 111.799 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 71' ' ' THR . 0.2 OUTLIER -84.46 -49.64 8.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.953 . . . . 0.0 110.496 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -80.83 -25.5 37.71 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.079 0.942 . . . . 0.0 108.666 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.568 ' O ' ' N ' ' A' ' 79' ' ' ASP . 6.5 ttp180 -59.01 -67.99 0.31 Allowed 'General case' 0 C--O 1.19 -2.028 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.437 ' HA ' ' CB ' ' A' ' 80' ' ' LEU . 0.4 OUTLIER -48.66 -55.13 12.17 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.244 -178.352 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -30.01 -50.34 0.12 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 124.362 1.039 . . . . 0.0 111.363 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.417 ' C ' ' CD1' ' A' ' 78' ' ' LEU . 1.6 tm? -134.78 -30.26 1.1 Allowed 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 118.286 -1.365 . . . . 0.0 111.48 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.568 ' N ' ' O ' ' A' ' 75' ' ' ARG . 58.7 m-20 -116.87 69.32 0.75 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.895 -1.128 . . . . 0.0 110.725 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -74.73 169.39 20.14 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 120.766 -1.209 . . . . 0.0 111.66 -179.114 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 80' ' ' LEU . 39.7 Cg_endo -65.77 113.33 2.5 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 O-C-N 122.551 0.764 . . . . 0.0 110.809 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.426 ' O ' ' C ' ' A' ' 83' ' ' MET . 1.0 OUTLIER -95.67 43.46 1.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 0.0 110.768 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.426 ' C ' ' O ' ' A' ' 82' ' ' MET . 3.9 ptt? 26.94 62.4 0.09 Allowed 'General case' 0 N--CA 1.51 2.532 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.45 ' CG2' ' HA ' ' A' ' 96' ' ' THR . 19.1 m . . . . . 0 N--CA 1.493 1.693 0 O-C-N 120.833 -1.167 . . . . 0.0 110.235 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.511 ' CD2' ' CB ' ' A' ' 138' ' ' PHE . 21.9 m-30 . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.45 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . 8.8 t -122.25 -1.15 9.24 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 117.974 -1.49 . . . . 0.0 114.762 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.576 ' HB ' ' HG2' ' A' ' 139' ' ' PRO . 57.0 t -119.14 79.88 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.619 0 C-N-CA 119.476 -0.889 . . . . 0.0 112.371 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.483 ' HA ' ' HB ' ' A' ' 137' ' ' VAL . 46.0 p -74.92 144.98 43.02 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 119.844 -1.785 . . . . 0.0 107.257 177.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.54 ' HA ' ' HB3' ' A' ' 133' ' ' ARG . 2.2 pt -146.86 125.31 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.121 -0.987 . . . . 0.0 110.568 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 6.9 tt0 -93.14 108.85 20.37 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 117.621 -1.632 . . . . 0.0 109.511 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.481 ' CB ' ' CG1' ' A' ' 105' ' ' VAL . . . -50.99 93.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.362 -0.836 . . . . 0.0 110.804 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 100' ' ' GLU . . . -84.18 2.49 39.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.452 -0.78 . . . . 0.0 110.428 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.72 4.21 14.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.993 -1.067 . . . . 0.0 110.702 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.14 26.98 1.16 Allowed Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.76 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.481 ' CG1' ' CB ' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -146.19 122.53 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.173 -1.192 . . . . 0.0 110.507 179.331 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.3 m -146.63 60.72 1.21 Allowed 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.044 -1.035 . . . . 0.0 110.401 176.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.1 m -135.65 -31.47 0.95 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.811 -1.181 . . . . 0.0 110.73 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.43 ' HA2' ' CZ ' ' A' ' 114' ' ' ARG . . . 74.21 -27.74 0.99 Allowed Glycine 0 N--CA 1.494 2.518 0 O-C-N 121.449 -0.782 . . . . 0.0 112.384 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.32 57.06 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.469 -1.607 . . . . 0.0 110.604 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 114' ' ' ARG . 2.7 t -129.47 54.4 1.83 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.33 -0.856 . . . . 0.0 108.695 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.442 ' HA ' ' CD1' ' A' ' 115' ' ' ILE . . . -34.14 -29.53 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -84.83 -77.58 0.27 Allowed 'General case' 0 C--N 1.288 -2.08 0 O-C-N 120.73 -1.231 . . . . 0.0 109.612 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.45 -17.38 30.63 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.503 -0.748 . . . . 0.0 110.235 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.496 ' CB ' ' O ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -89.62 -39.21 13.39 Favored 'General case' 0 C--O 1.203 -1.378 0 O-C-N 120.996 -1.065 . . . . 0.0 110.76 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.49 ' CG1' ' N ' ' A' ' 52' ' ' VAL . 1.0 OUTLIER -57.07 -18.4 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 120.306 -1.496 . . . . 0.0 109.368 -178.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.0 m -87.41 -52.93 5.09 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.85 -1.156 . . . . 0.0 108.062 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 121' ' ' ALA . 44.1 p -66.61 -36.85 83.59 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.493 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.469 ' CG1' ' HG2' ' A' ' 114' ' ' ARG . 26.6 m -53.89 -43.4 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 O-C-N 120.349 -1.469 . . . . 0.0 108.603 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.41 ' N ' HG23 ' A' ' 118' ' ' VAL . 0.6 OUTLIER -51.77 -32.18 29.89 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.792 -1.163 . . . . 0.0 107.879 177.223 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.422 ' O ' ' CB ' ' A' ' 123' ' ' ALA . . . -95.3 -19.59 19.85 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.167 178.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 117' ' ' THR . . . -53.72 -54.01 43.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.918 -1.114 . . . . 0.0 109.131 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 60.3 mt -88.83 23.32 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.525 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . -55.18 146.5 18.59 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.46 ' C ' ' O ' ' A' ' 123' ' ' ALA . 28.7 t70 -35.62 -80.19 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.792 0 CA-C-N 119.659 1.118 . . . . 0.0 110.093 -178.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 127' ' ' LYS . . . 54.46 34.5 54.94 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 118.133 -1.984 . . . . 0.0 109.786 174.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.32 91.16 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 123.29 1.519 . . . . 0.0 110.569 -174.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 125' ' ' GLY . 0.1 OUTLIER -137.93 127.28 14.91 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.428 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -53.67 -16.35 8.02 Favored 'Trans proline' 0 C--N 1.294 -2.337 0 O-C-N 122.703 0.844 . . . . 0.0 111.028 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.0 t -123.45 24.17 8.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.844 -1.16 . . . . 0.0 110.56 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.46 ' HB3' ' CB ' ' A' ' 127' ' ' LYS . 11.0 p30 -74.46 4.25 6.29 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.411 -1.431 . . . . 0.0 112.018 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.464 ' CD2' ' HA ' ' A' ' 101' ' ' ALA . 25.6 mt -143.1 110.83 5.89 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.6 OUTLIER -86.46 71.69 10.4 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -176.511 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.648 ' HB2' ' HA ' ' A' ' 134' ' ' PRO 0.257 0.0 OUTLIER -85.27 173.08 7.55 Favored Pre-proline 0 C--N 1.291 -1.95 0 O-C-N 121.549 -0.719 . . . . 0.0 110.064 179.966 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.648 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 47.5 Cg_endo -72.66 124.91 9.59 Favored 'Cis proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.832 -1.737 . . . . 0.0 111.524 7.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.439 ' O ' ' CG2' ' A' ' 137' ' ' VAL . . . -122.08 74.93 0.36 Allowed Glycine 0 N--CA 1.501 2.988 0 C-N-CA 119.452 -1.356 . . . . 0.0 111.866 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.493 ' O ' ' CE2' ' A' ' 138' ' ' PHE . 83.2 m-70 31.18 37.18 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 O-C-N 122.204 -0.586 . . . . 0.0 112.344 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.483 ' HB ' ' HA ' ' A' ' 98' ' ' THR . 69.3 t -106.07 135.04 45.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 176.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.519 ' CE1' HG22 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -126.52 81.59 67.93 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -177.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.576 ' HG2' ' HB ' ' A' ' 97' ' ' VAL . 64.3 Cg_endo -112.77 141.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.559 2.173 . . . . 0.0 113.495 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.413 ' CD2' ' HB ' ' A' ' 154' ' ' THR . 1.1 pp -127.53 148.87 50.33 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.454 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.455 ' HB2' ' CD ' ' A' ' 75' ' ' ARG . 0.9 OUTLIER -91.52 92.55 8.56 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.867 -1.145 . . . . 0.0 110.054 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.8 69.03 1.37 Allowed 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 118.542 -1.263 . . . . 0.0 113.1 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.449 ' CG ' HG23 ' A' ' 158' ' ' ILE . 19.6 tm0? -120.9 73.21 1.0 Allowed 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 117.751 -1.579 . . . . 0.0 112.213 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -127.64 38.52 4.03 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 117.733 -1.587 . . . . 0.0 111.459 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 74.44 -4.39 34.9 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 119.277 -1.44 . . . . 0.0 111.419 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.4 28.07 17.67 Favored Glycine 0 N--CA 1.485 1.91 0 O-C-N 120.665 -1.491 . . . . 0.0 113.417 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.521 HG21 ' CB ' ' A' ' 156' ' ' ALA . 1.5 p -60.48 -15.8 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 120.248 2.024 . . . . 0.0 107.822 177.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.48 ' CD2' ' CG1' ' A' ' 206' ' ' VAL . 75.3 mt -94.02 22.63 5.59 Favored 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 116.81 -1.956 . . . . 0.0 110.404 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.1 p -127.44 58.34 1.47 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 101.656 -3.461 . . . . 0.0 101.656 168.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.39 149.89 28.28 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 113.034 -1.894 . . . . 0.0 110.763 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -102.47 34.68 5.53 Favored Glycine 0 N--CA 1.483 1.768 0 N-CA-C 106.293 -2.723 . . . . 0.0 106.293 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -145.48 159.7 27.95 Favored Glycine 0 N--CA 1.478 1.45 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.486 ' CD2' ' HB3' ' A' ' 172' ' ' LEU . 29.2 p-80 -89.7 -4.72 57.59 Favored 'General case' 0 C--N 1.292 -1.921 0 O-C-N 121.657 -0.907 . . . . 0.0 108.845 176.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.413 ' HB ' ' CD2' ' A' ' 140' ' ' LEU . 1.1 p -51.53 -55.31 19.72 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.015 -1.053 . . . . 0.0 109.795 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 159' ' ' ASP . 24.6 mt-10 -59.51 -21.74 60.61 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.521 ' CB ' HG21 ' A' ' 147' ' ' VAL . . . -87.24 6.3 33.9 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.503 ' HA ' HD12 ' A' ' 172' ' ' LEU . 17.9 m -93.83 -51.06 5.06 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.159 -0.963 . . . . 0.0 109.52 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.58 ' O ' ' HB3' ' A' ' 161' ' ' MET . 9.7 tp -75.81 -34.15 27.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 116.238 -2.185 . . . . 0.0 105.126 175.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.444 ' O ' ' CB ' ' A' ' 162' ' ' THR . 0.8 OUTLIER -59.69 -25.56 64.87 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.084 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.527 ' HA ' ' CD1' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -58.78 -28.89 66.37 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.58 ' HB3' ' O ' ' A' ' 158' ' ' ILE . 5.6 ttt -51.59 -39.26 57.58 Favored 'General case' 0 N--CA 1.514 2.758 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 174.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.444 ' CB ' ' O ' ' A' ' 159' ' ' ASP . 1.2 m -68.52 -39.26 81.25 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.651 177.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.527 ' CD1' ' HA ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -52.1 -57.62 9.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.864 -1.148 . . . . 0.0 108.763 179.038 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.465 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -64.63 -27.4 68.91 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.14 0.972 . . . . 0.0 108.545 177.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 96.17 -27.84 15.24 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 166' ' ' PHE . 37.2 p90 -151.05 55.6 0.89 Allowed 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.166 -1.414 . . . . 0.0 112.292 175.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 46' ' ' PRO . 1.9 mttp -129.71 80.2 72.05 Favored Pre-proline 0 C--N 1.296 -1.739 0 CA-C-O 117.23 -1.367 . . . . 0.0 107.777 176.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.473 ' HA ' ' CG ' ' A' ' 161' ' ' MET . 43.2 Cg_endo -72.01 80.58 1.51 Allowed 'Trans proline' 0 C--N 1.32 -0.965 0 C-N-CA 115.367 -2.622 . . . . 0.0 110.636 -176.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.441 ' HB1' ' HB3' ' A' ' 47' ' ' ALA . . . -163.26 166.37 23.25 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 104.292 -2.485 . . . . 0.0 104.292 175.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.482 ' HA2' ' CD2' ' A' ' 160' ' ' LEU . . . -157.6 119.49 0.91 Allowed Glycine 0 N--CA 1.485 1.954 0 C-N-CA 116.721 -2.657 . . . . 0.0 112.479 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.555 ' O ' ' O ' ' A' ' 43' ' ' MET . 23.6 m -127.08 134.59 65.73 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.761 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 175.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.526 ' HG ' ' HA ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -149.88 113.67 5.06 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.696 -1.252 . . . . 0.0 109.39 -178.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.459 ' HB3' ' CG1' ' A' ' 66' ' ' VAL . 21.5 p -128.65 175.79 8.3 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 120.257 -1.527 . . . . 0.0 111.377 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.417 ' OE2' ' NH2' ' A' ' 184' ' ' ARG . 16.0 pm0 -113.05 154.63 26.23 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.106 -0.996 . . . . 0.0 110.558 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.434 ' CD2' ' HB3' ' A' ' 188' ' ' CYS . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.896 0 O-C-N 121.269 -0.895 . . . . 0.0 109.932 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.284 0.564 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . 0.417 ' NH2' ' OE2' ' A' ' 174' ' ' GLU . 0.2 OUTLIER -125.16 100.01 6.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.816 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.439 ' CB ' ' HD2' ' A' ' 186' ' ' PRO . . . 179.17 178.5 0.28 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.387 -0.821 . . . . 0.0 109.704 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.439 ' HD2' ' CB ' ' A' ' 185' ' ' ALA . 45.9 Cg_endo -72.65 -8.47 22.53 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.603 1.318 . . . . 0.0 110.767 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -81.45 -68.94 0.65 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.984 -1.073 . . . . 0.0 110.307 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . 0.434 ' HB3' ' CD2' ' A' ' 175' ' ' LEU . 0.4 OUTLIER -57.74 -30.41 65.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.428 -0.795 . . . . 0.0 110.097 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.491 ' CG2' ' CD2' ' A' ' 199' ' ' LEU . 27.2 mm -75.77 -26.3 17.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 120.951 -1.093 . . . . 0.0 109.102 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 186' ' ' PRO . 12.0 mt-10 -76.76 -19.38 57.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.474 -0.766 . . . . 0.0 109.092 177.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 192' ' ' ALA . 0.8 OUTLIER -70.27 -56.4 6.86 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.179 0.99 . . . . 0.0 108.764 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.488 ' N ' ' CD1' ' A' ' 191' ' ' PHE . . . -61.76 -41.78 98.14 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . 0.606 ' HA ' ' CB ' ' A' ' 197' ' ' MET . 2.2 t30 -66.33 -13.3 60.34 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.021 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.99 -37.33 47.45 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 117.636 -1.626 . . . . 0.0 111.578 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -108.79 -52.7 2.73 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 115.717 -2.393 . . . . 0.0 111.856 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.444 ' O ' ' HG2' ' A' ' 197' ' ' MET . 44.5 t30 -114.8 33.34 5.43 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.098 -1.441 . . . . 0.0 113.958 177.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' MET . . . . . 0.606 ' CB ' ' HA ' ' A' ' 193' ' ' ASN . 0.0 OUTLIER -151.45 149.71 29.58 Favored 'General case' 0 N--CA 1.52 3.067 0 CA-C-N 123.375 2.807 . . . . 0.0 115.163 -179.524 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.45 ' CB ' ' HA ' ' A' ' 19' ' ' ALA . . . -107.08 154.28 21.38 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 176.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.528 ' CD2' ' HB2' ' A' ' 30' ' ' MET . 43.7 mt -123.44 144.74 49.31 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.277 -1.514 . . . . 0.0 113.171 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.528 HG13 ' OH ' ' A' ' 208' ' ' TYR . 0.2 OUTLIER -120.28 -161.79 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.782 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.458 ' HB ' ' CB ' ' A' ' 204' ' ' ASP . 0.2 OUTLIER -132.97 142.78 49.04 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.946 -1.096 . . . . 0.0 108.468 177.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 5.2 tp -45.93 -46.67 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.196 -0.94 . . . . 0.0 111.56 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -91.9 -31.49 15.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.883 -1.135 . . . . 0.0 111.016 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.461 ' HA ' ' HB3' ' A' ' 207' ' ' ALA . 10.9 t70 -72.99 -39.14 66.32 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.267 -0.896 . . . . 0.0 112.121 -178.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.551 ' HA ' ' CE2' ' A' ' 208' ' ' TYR . 10.4 tt -58.22 -62.78 1.58 Allowed 'General case' 0 N--CA 1.484 1.264 0 O-C-N 120.687 -1.258 . . . . 0.0 110.641 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.531 ' N ' HD23 ' A' ' 205' ' ' LEU . 2.4 t -66.47 -13.55 16.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 C-N-CA 118.086 -1.445 . . . . 0.0 108.122 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.461 ' HB3' ' HA ' ' A' ' 204' ' ' ASP . . . -57.23 -33.18 67.3 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.591 ' CE2' HG21 ' A' ' 16' ' ' VAL . 4.7 m-30 -56.54 -52.38 65.01 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 175.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -41.84 97.38 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.761 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -53.92 -43.12 69.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 109.501 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -57.45 -35.14 69.75 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.47 -0.769 . . . . 0.0 109.221 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.539 -0.726 . . . . 0.0 109.839 179.4 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.511 ' O ' ' CG1' ' A' ' 16' ' ' VAL . 30.5 Cg_endo . . . . . 0 C--O 1.204 -1.196 0 N-CA-C 111.082 -0.392 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -86.99 -67.14 0.84 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 115.699 1.741 . . . . 0.0 115.699 -177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.56 -45.71 11.5 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 118.521 -1.272 . . . . 0.0 112.336 -175.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.444 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 28.0 mmt-85 -84.78 -12.26 54.04 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 118.238 -1.385 . . . . 0.0 113.325 -177.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.604 ' CG1' ' CE2' ' A' ' 208' ' ' TYR . 0.3 OUTLIER -95.16 -28.16 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 122.856 2.571 . . . . 0.0 108.69 176.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -66.29 -52.21 49.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 117.938 -1.505 . . . . 0.0 108.101 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -64.28 -33.93 76.96 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.186 -0.946 . . . . 0.0 108.722 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 23' ' ' LEU . . . -81.01 -5.86 58.1 Favored 'General case' 0 C--O 1.201 -1.47 0 O-C-N 121.188 -0.945 . . . . 0.0 108.606 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.558 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -68.08 -51.7 43.59 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.37 -49.92 73.03 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.472 ' C ' ' CB ' ' A' ' 27' ' ' ARG . . . -61.25 -28.57 69.26 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.61 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -60.5 -8.69 2.94 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.534 -0.729 . . . . 0.0 110.765 179.803 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.74 -37.35 10.34 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.384 -0.823 . . . . 0.0 108.969 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -151.57 90.28 1.55 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 123.267 1.508 . . . . 0.0 113.444 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.24 -18.35 5.83 Favored Glycine 0 C--N 1.272 -3.007 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.61 ' O ' ' HA ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -129.42 120.15 25.0 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 178.057 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -164.2 105.03 0.24 Allowed Glycine 0 C--N 1.27 -3.137 1 N-CA-C 103.017 -4.033 . . . . 0.0 103.017 -175.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.609 ' HB ' ' CB ' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -125.1 161.36 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 113.059 -1.57 . . . . 0.0 112.192 -172.442 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.58 ' CA ' ' HA ' ' A' ' 42' ' ' ASP . 1.4 tmm? -98.52 152.61 19.37 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.148 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.485 ' HB ' ' CG1' ' A' ' 202' ' ' ILE . 15.6 m . . . . . 0 C--N 1.29 -2.016 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.58 ' HA ' ' CA ' ' A' ' 30' ' ' MET . 8.3 t70 . . . . . 0 N--CA 1.51 2.548 0 CA-C-O 121.951 0.882 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.64 ' O ' ' O ' ' A' ' 171' ' ' VAL . 0.0 OUTLIER -93.89 54.45 1.96 Allowed 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -177.216 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.498 ' CD1' HG13 ' A' ' 29' ' ' VAL . 28.8 pt -64.5 23.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.524 3.265 0 O-C-N 118.93 -2.356 . . . . 0.0 113.282 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.52 ' H ' ' C ' ' A' ' 43' ' ' MET . 6.6 m-85 -77.21 164.4 58.93 Favored Pre-proline 0 N--CA 1.504 2.25 0 C-N-CA 123.805 0.842 . . . . 0.0 113.236 -178.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.444 ' HG2' ' CG2' ' A' ' 49' ' ' THR . 43.0 Cg_endo -66.79 132.8 29.57 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 122.843 2.362 . . . . 0.0 110.212 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.509 ' HB2' ' CB ' ' A' ' 169' ' ' ALA . . . -68.59 -2.71 9.58 Favored 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -176.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.436 ' HA ' ' CD1' ' A' ' 122' ' ' ILE . 5.7 tt0 -95.71 -22.64 17.42 Favored 'General case' 0 C--N 1.292 -1.905 0 O-C-N 120.662 -1.274 . . . . 0.0 110.491 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.444 ' CG2' ' HG2' ' A' ' 46' ' ' PRO . 4.6 t -134.38 59.02 1.75 Allowed 'General case' 0 C--N 1.315 -0.924 0 O-C-N 120.724 -1.235 . . . . 0.0 107.739 178.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.448 ' CG ' ' O ' ' A' ' 50' ' ' MET . 1.5 ppp? -65.0 88.74 0.07 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 49' ' ' THR . 24.4 m -59.32 147.92 34.16 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 122.139 0.971 . . . . 0.0 110.169 -176.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.459 ' N ' HD13 ' A' ' 115' ' ' ILE . 12.5 p -72.34 -3.26 3.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.505 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -58.96 -41.22 86.97 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.479 ' HG3' ' CZ ' ' A' ' 45' ' ' PHE . 8.8 mm-40 -81.44 -47.63 12.94 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.237 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.43 ' O ' ' CG2' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -54.17 -35.28 62.13 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.453 ' HA ' ' CG2' ' A' ' 59' ' ' ILE . . . -54.68 -47.3 73.81 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.8 tt -56.02 -53.65 54.35 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.811 0.815 . . . . 0.0 109.573 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.427 HG22 ' CE ' ' A' ' 43' ' ' MET . 0.9 OUTLIER -69.28 -58.29 4.23 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.605 -0.684 . . . . 0.0 111.23 -178.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.453 ' CG2' ' HA ' ' A' ' 56' ' ' ALA . 1.1 tp -52.47 -22.17 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.106 -0.996 . . . . 0.0 110.742 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.1 ttt-85 -74.8 -40.69 60.98 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.212 -0.93 . . . . 0.0 110.962 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -122.86 -1.37 8.9 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.958 -1.089 . . . . 0.0 112.129 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.66 -169.96 27.88 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.32 102.7 6.08 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 101.38 -3.563 . . . . 0.0 101.38 176.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 66' ' ' VAL . . . -104.81 74.97 0.24 Allowed Glycine 0 C--N 1.261 -3.625 0 N-CA-C 106.816 -2.514 . . . . 0.0 106.816 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.2 tp -62.47 90.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' A' ' 64' ' ' GLY . 35.5 m -52.13 152.46 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 114.468 -1.242 . . . . 0.0 114.054 -176.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 7.4 t -87.37 114.99 24.48 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.578 ' O ' ' HA ' ' A' ' 139' ' ' PRO . 3.6 mt -87.45 163.96 16.44 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.456 ' CB ' HD13 ' A' ' 158' ' ' ILE . 4.7 m -131.48 135.61 47.24 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 118.199 -1.4 . . . . 0.0 113.206 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.579 ' CG1' ' HB2' ' A' ' 139' ' ' PRO . 2.5 pp -148.82 177.15 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.0 m -111.4 159.15 18.29 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.145 -0.972 . . . . 0.0 110.531 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.439 ' N ' ' HB2' ' A' ' 141' ' ' ARG . 0.1 OUTLIER -49.13 -27.12 3.2 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.475 -0.766 . . . . 0.0 110.62 -179.846 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -56.9 -38.83 73.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 0.0 109.676 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.406 ' O ' ' HB3' ' A' ' 78' ' ' LEU . 1.8 mmt180 -78.26 -32.77 49.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.501 -0.749 . . . . 0.0 110.35 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.493 ' HG2' ' CD1' ' A' ' 70' ' ' ILE . 0.9 OUTLIER -78.72 -28.82 45.06 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.204 1.002 . . . . 0.0 108.535 179.013 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 79' ' ' ASP . 4.3 ttmm -56.51 -70.26 0.12 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -46.57 -41.04 13.82 Favored 'General case' 0 N--CA 1.508 2.444 0 CA-C-O 121.974 0.892 . . . . 0.0 109.864 177.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 80' ' ' LEU . 0.7 OUTLIER -96.39 45.77 1.06 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 176.229 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 76' ' ' LYS . 15.2 t70 -28.68 85.39 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 123.745 1.736 . . . . 0.0 112.329 -172.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -148.44 103.75 3.5 Favored Pre-proline 0 C--N 1.29 -2.009 0 CA-C-N 112.558 -2.11 . . . . 0.0 111.906 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -104.91 93.31 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.493 1.462 . . . . 0.0 108.635 175.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.458 ' CB ' ' HA ' ' A' ' 97' ' ' VAL . 14.7 mmt -103.31 107.72 18.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.673 -1.267 . . . . 0.0 111.156 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.426 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 10.6 tmm? -95.89 92.37 6.47 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.862 -1.149 . . . . 0.0 109.654 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.446 ' CG2' ' HB ' ' A' ' 96' ' ' THR . 3.8 m . . . . . 0 N--CA 1.501 2.113 0 C-N-CA 118.301 -1.359 . . . . 0.0 110.303 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.577 ' CE1' ' HB2' ' A' ' 140' ' ' LEU . 5.9 t80 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 122.007 0.908 . . . . 0.0 108.981 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.446 ' HB ' ' CG2' ' A' ' 84' ' ' VAL . 1.4 p -131.05 53.34 1.99 Allowed 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.629 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.458 ' HA ' ' CB ' ' A' ' 82' ' ' MET . 57.5 t -86.07 105.67 14.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 O-C-N 121.209 -0.932 . . . . 0.0 112.096 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 137' ' ' VAL . 1.0 OUTLIER -75.9 152.18 37.2 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 103.029 -2.952 . . . . 0.0 103.029 174.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.613 ' HA ' ' HB3' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -161.71 138.93 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 C-N-CA 116.708 -1.997 . . . . 0.0 111.513 -176.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.594 ' HB3' ' CB ' ' A' ' 132' ' ' ASN . 1.2 tp10 -99.11 126.5 44.87 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.301 -1.36 . . . . 0.0 111.346 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.469 ' HA ' ' CD2' ' A' ' 131' ' ' LEU . . . -51.24 115.6 1.64 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.41 -0.807 . . . . 0.0 110.886 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -115.74 -6.78 12.12 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.23 -0.919 . . . . 0.0 110.984 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -75.82 55.45 0.88 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.952 -1.093 . . . . 0.0 111.692 -178.649 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.422 ' O ' ' CG1' ' A' ' 105' ' ' VAL . . . 73.31 24.24 75.72 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.47 HG13 ' HA ' ' A' ' 117' ' ' THR . 5.2 m -158.25 122.39 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.8 m -148.38 63.8 1.08 Allowed 'General case' 0 N--CA 1.484 1.24 0 O-C-N 120.85 -1.156 . . . . 0.0 111.605 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.3 t -131.07 -30.76 1.74 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 118.618 -1.233 . . . . 0.0 110.099 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.409 ' O ' ' NH1' ' A' ' 114' ' ' ARG . . . 63.98 -19.06 0.09 OUTLIER Glycine 0 N--CA 1.5 2.93 0 O-C-N 121.484 -0.76 . . . . 0.0 113.377 178.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.86 55.54 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 119.71 1.755 . . . . 0.0 109.73 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 114' ' ' ARG . 28.6 p -133.2 66.15 1.57 Allowed 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 110' ' ' SER . . . -27.19 -39.92 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 121.506 0.669 . . . . 0.0 112.589 -177.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -78.59 -72.8 0.36 Allowed 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 122.147 0.975 . . . . 0.0 109.492 178.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -54.51 -23.35 16.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.167 -0.958 . . . . 0.0 109.241 178.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 110' ' ' SER . 0.3 OUTLIER -61.14 -45.61 93.97 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.549 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.491 ' CD1' ' N ' ' A' ' 115' ' ' ILE . 1.6 mm -65.13 -15.07 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 117.283 -1.767 . . . . 0.0 107.654 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 m -89.88 -31.29 17.39 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 175.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.47 ' HA ' HG13 ' A' ' 105' ' ' VAL . 91.0 m -70.8 -49.0 51.12 Favored 'General case' 0 C--O 1.204 -1.3 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.436 HG11 ' HG3' ' A' ' 50' ' ' MET . 10.1 p -53.43 -41.46 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 0.0 109.28 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.409 ' N ' ' CG1' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -57.88 -33.88 69.19 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.413 179.051 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.43 ' O ' ' CB ' ' A' ' 103' ' ' GLU . . . -94.03 -36.93 11.9 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.524 -0.735 . . . . 0.0 111.082 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.553 ' CB ' ' CE1' ' A' ' 138' ' ' PHE . . . -56.52 -56.72 17.76 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.03 -1.044 . . . . 0.0 109.407 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.437 ' CG2' ' HG3' ' A' ' 139' ' ' PRO . 1.6 pp -87.13 19.36 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.284 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . -72.76 146.72 46.18 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.454 ' C ' ' O ' ' A' ' 123' ' ' ALA . 16.8 m-20 -37.18 -79.14 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.721 0 CA-C-N 119.598 1.09 . . . . 0.0 109.595 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 127' ' ' LYS . . . 54.75 34.93 57.06 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.125 -1.988 . . . . 0.0 109.856 173.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.96 91.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 123.337 1.541 . . . . 0.0 110.233 -174.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 125' ' ' GLY . 1.9 mttt -137.97 126.57 14.45 Favored Pre-proline 0 C--N 1.303 -1.436 0 CA-C-N 113.377 -1.738 . . . . 0.0 106.422 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -54.69 -17.79 14.16 Favored 'Trans proline' 0 C--N 1.294 -2.315 0 O-C-N 122.61 0.795 . . . . 0.0 110.306 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 25.4 p -124.56 31.65 5.66 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.149 -0.969 . . . . 0.0 109.881 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.43 ' HB3' ' CD1' ' A' ' 78' ' ' LEU . 0.9 OUTLIER -73.77 3.84 5.98 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.524 -1.36 . . . . 0.0 111.797 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.469 ' CD2' ' HA ' ' A' ' 101' ' ' ALA . 30.7 mt -142.58 130.64 21.89 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.594 ' CB ' ' HB3' ' A' ' 100' ' ' GLU . 0.5 OUTLIER -81.52 72.87 8.58 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.326 -1.484 . . . . 0.0 111.639 -177.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.613 ' HB3' ' HA ' ' A' ' 99' ' ' ILE 0.263 0.0 OUTLIER -87.68 152.82 52.21 Favored Pre-proline 0 N--CA 1.502 2.141 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.545 179.72 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -78.36 141.41 64.94 Favored 'Cis proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.215 -1.994 . . . . 0.0 107.787 1.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.536 ' O ' ' O ' ' A' ' 136' ' ' HIS . . . -176.6 95.43 0.1 Allowed Glycine 0 N--CA 1.487 2.078 0 C-N-CA 117.879 -2.105 . . . . 0.0 111.291 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.536 ' O ' ' O ' ' A' ' 135' ' ' GLY . 12.2 m-70 47.3 101.81 0.01 OUTLIER 'General case' 0 C--O 1.206 -1.215 0 CA-C-O 124.283 1.992 . . . . 0.0 109.182 -177.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 98' ' ' THR . 19.2 m -49.15 154.48 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.686 0 CA-C-N 112.783 -2.008 . . . . 0.0 112.376 -174.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.553 ' CE1' ' CB ' ' A' ' 121' ' ' ALA . 1.5 m-85 -146.87 175.42 2.73 Favored Pre-proline 0 C--N 1.29 -1.997 0 CA-C-N 111.434 -2.621 . . . . 0.0 105.271 -174.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.579 ' HB2' ' CG1' ' A' ' 70' ' ' ILE . 38.4 Cg_endo -57.56 127.88 27.13 Favored 'Trans proline' 0 C--N 1.293 -2.354 0 CA-C-O 123.533 1.389 . . . . 0.0 115.11 -169.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.577 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . 14.6 mt -90.06 172.46 8.82 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 112.96 -1.927 . . . . 0.0 108.965 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.439 ' HB2' ' N ' ' A' ' 72' ' ' GLU . 12.8 ptt85 -126.13 85.16 2.35 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.119 -1.613 . . . . 0.0 115.0 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.563 ' CB ' ' CD1' ' A' ' 95' ' ' PHE . . . -141.48 79.69 1.7 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.742 -1.224 . . . . 0.0 110.837 176.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.466 ' CG ' ' CG2' ' A' ' 158' ' ' ILE . 0.5 OUTLIER -117.34 75.26 0.97 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.143 -1.598 . . . . 0.0 112.966 -179.353 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -127.04 43.37 3.13 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.637 -1.289 . . . . 0.0 110.982 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 75.83 37.08 40.12 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -100.54 12.35 59.74 Favored Glycine 0 N--CA 1.49 2.285 0 O-C-N 120.91 -1.347 . . . . 0.0 113.521 -176.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.487 HG22 ' N ' ' A' ' 156' ' ' ALA . 8.2 p -107.9 -13.9 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-N 120.312 2.056 . . . . 0.0 111.828 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.435 ' N ' ' CD2' ' A' ' 148' ' ' LEU . 4.6 mm? -87.42 13.28 10.25 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 115.041 -2.664 . . . . 0.0 109.876 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 84.2 m -132.93 62.15 1.66 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 100.548 -3.871 . . . . 0.0 100.548 167.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -148.27 135.15 20.05 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.072 -1.422 . . . . 0.0 113.831 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -104.26 36.25 4.5 Favored Glycine 0 N--CA 1.48 1.605 0 N-CA-C 106.177 -2.769 . . . . 0.0 106.177 173.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -142.31 163.8 27.05 Favored Glycine 0 N--CA 1.479 1.55 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.45 ' HA ' ' CB ' ' A' ' 156' ' ' ALA . 54.5 p-80 -90.98 -6.12 54.45 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.883 -0.774 . . . . 0.0 109.765 177.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.419 ' O ' HG21 ' A' ' 157' ' ' THR . 6.8 p -56.39 -64.99 0.68 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 122.362 1.077 . . . . 0.0 108.876 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.428 ' HB3' ' CA ' ' A' ' 147' ' ' VAL . 65.9 mm-40 -59.4 -22.16 60.99 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 177.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.508 ' HA ' ' CB ' ' A' ' 159' ' ' ASP . . . -86.02 4.37 38.18 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.226 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.482 ' O ' ' CB ' ' A' ' 160' ' ' LEU . 0.6 OUTLIER -83.07 -51.65 7.35 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.328 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.474 ' N ' ' CG2' ' A' ' 157' ' ' THR . 0.2 OUTLIER -74.87 -17.54 16.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 115.923 -2.311 . . . . 0.0 105.996 176.108 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.508 ' CB ' ' HA ' ' A' ' 156' ' ' ALA . 8.3 t70 -59.29 -26.71 65.19 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 173.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.561 ' HA ' ' CG ' ' A' ' 163' ' ' LEU . 0.4 OUTLIER -53.3 -41.33 65.52 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 175.175 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.501 ' HB2' ' HA ' ' A' ' 168' ' ' PRO . 0.0 OUTLIER -48.2 -33.45 8.54 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 176.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.488 ' N ' ' O ' ' A' ' 159' ' ' ASP . 1.3 m -93.29 -31.83 14.55 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.719 177.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.561 ' CG ' ' HA ' ' A' ' 160' ' ' LEU . 0.5 OUTLIER -36.34 -40.94 0.25 Allowed 'General case' 0 N--CA 1.521 3.102 0 O-C-N 121.489 -0.757 . . . . 0.0 110.071 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.443 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -94.49 -29.24 15.04 Favored 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.103 -0.998 . . . . 0.0 110.909 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.03 -29.99 10.76 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -149.93 47.28 0.93 Allowed 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 117.922 -1.511 . . . . 0.0 111.571 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 169' ' ' ALA . 2.5 mptp? -133.3 68.42 77.36 Favored Pre-proline 0 C--N 1.29 -2.019 0 N-CA-C 103.294 -2.854 . . . . 0.0 103.294 173.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.501 ' HA ' ' HB2' ' A' ' 161' ' ' MET . 42.4 Cg_endo -69.5 80.24 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 115.218 -2.721 . . . . 0.0 114.531 -170.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.509 ' CB ' ' HB2' ' A' ' 47' ' ' ALA . . . -164.29 166.11 21.2 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 171.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 68' ' ' LEU . . . -154.79 135.52 4.72 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 118.019 -2.039 . . . . 0.0 110.356 178.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.64 ' O ' ' O ' ' A' ' 43' ' ' MET . 2.9 p -121.4 89.83 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.191 -1.991 0 C-N-CA 117.374 -1.73 . . . . 0.0 107.376 177.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.488 HD12 ' CD2' ' A' ' 160' ' ' LEU . 9.1 mp -95.12 153.81 17.48 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 119.249 0.931 . . . . 0.0 110.11 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.482 ' N ' ' HB2' ' A' ' 43' ' ' MET . 35.7 t -124.71 162.63 23.79 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 122.023 0.916 . . . . 0.0 112.905 -177.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 174' ' ' GLU . 1.3 pt-20 -135.84 107.23 6.86 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 O-C-N 121.052 -1.03 . . . . 0.0 111.153 -178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.224 0.535 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . 0.423 ' CG ' ' O ' ' A' ' 184' ' ' ARG . 0.6 OUTLIER -140.69 100.27 3.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 110.07 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . 179.89 173.34 0.49 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 110.213 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.404 ' O ' ' HB2' ' A' ' 190' ' ' GLU . 43.6 Cg_endo -69.53 -15.64 38.08 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.66 1.348 . . . . 0.0 110.226 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -87.81 -36.8 17.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.11 -0.994 . . . . 0.0 109.855 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 191' ' ' PHE . 41.1 t -58.84 -49.3 78.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.394 -0.817 . . . . 0.0 109.462 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.485 HG12 ' CB ' ' A' ' 30' ' ' MET . 7.4 tp -76.84 -24.15 15.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.845 -1.159 . . . . 0.0 109.38 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.444 ' HA ' ' CB ' ' A' ' 193' ' ' ASN . 3.7 tt0 -57.41 -23.26 48.3 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.419 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 3.8 t80 -74.95 -46.19 37.21 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.429 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -65.77 -18.44 65.33 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 175.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 197' ' ' MET . 56.9 t30 -85.48 -7.76 58.73 Favored 'General case' 0 C--O 1.207 -1.159 0 O-C-N 121.896 -0.503 . . . . 0.0 109.696 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.59 -51.26 5.79 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.205 -1.559 . . . . 0.0 110.092 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.9 -41.06 12.0 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 118.268 -1.373 . . . . 0.0 107.599 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 198' ' ' ALA . 0.6 OUTLIER -99.34 52.17 0.94 Allowed 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' MET . . . . . 0.513 ' HA ' ' O ' ' A' ' 193' ' ' ASN . 45.5 ttm -66.72 74.25 0.1 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -173.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.609 ' CB ' ' HB ' ' A' ' 29' ' ' VAL . . . -134.1 106.4 7.18 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 104.057 -2.571 . . . . 0.0 104.057 172.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.438 ' HA ' HG22 ' A' ' 29' ' ' VAL . 2.9 tp -126.97 120.04 28.13 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 119.734 -1.854 . . . . 0.0 109.606 -177.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 4.5 p -124.08 -177.0 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.259 -0.901 . . . . 0.0 110.929 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.422 ' O ' ' HB2' ' A' ' 205' ' ' LEU . 5.5 p -121.01 135.99 55.09 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.117 -0.989 . . . . 0.0 110.501 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.485 ' CG1' ' HB ' ' A' ' 31' ' ' VAL . 68.7 mt -60.76 -37.77 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.483 -0.761 . . . . 0.0 112.093 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -45.16 -65.95 0.46 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.257 -0.902 . . . . 0.0 110.909 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -72.88 -17.85 61.48 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.167 -0.958 . . . . 0.0 110.098 179.237 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.494 ' O ' ' CB ' ' A' ' 208' ' ' TYR . 2.4 tm? -60.44 -68.35 0.31 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.08 -1.012 . . . . 0.0 109.564 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.463 HG12 ' CG1' ' A' ' 147' ' ' VAL . 11.5 m -63.92 -16.12 18.1 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 C-N-CA 117.922 -1.511 . . . . 0.0 109.356 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -56.6 -32.34 65.16 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 174.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.604 ' CE2' ' CG1' ' A' ' 16' ' ' VAL 0.286 0.9 OUTLIER -54.75 -52.15 63.45 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.108 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.436 ' HG3' ' CG2' ' A' ' 162' ' ' THR . 48.2 ttt180 -56.65 -45.73 81.44 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.6 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.417 ' OE1' ' N ' ' A' ' 211' ' ' ALA . 1.8 tm0? -69.2 -56.0 8.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.218 -0.926 . . . . 0.0 110.184 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . 0.417 ' N ' ' OE1' ' A' ' 210' ' ' GLN . . . -58.91 -27.42 65.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.438 -0.789 . . . . 0.0 110.182 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 70.6 t60 . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.863 . . . . 0.0 110.12 179.977 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.56 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 54.5 Cg_endo . . . . . 0 C--O 1.201 -1.333 0 N-CA-C 109.182 -1.122 . . . . 0.0 109.182 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.434 ' HA ' ' HB2' ' A' ' 208' ' ' TYR . 5.2 t80 -97.71 -70.62 0.71 Allowed 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -177.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -74.05 -41.37 61.87 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.798 -177.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -88.12 -17.24 31.42 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 118.258 -1.377 . . . . 0.0 111.96 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.636 ' O ' ' N ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -68.6 -28.08 38.78 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.151 0 C-N-CA 114.775 -2.77 . . . . 0.0 107.278 177.133 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 1.2 tm-20 -67.18 -54.7 18.69 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 117.493 -1.683 . . . . 0.0 107.415 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -62.6 -33.26 74.63 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.181 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.43 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . . . -88.12 -6.75 57.73 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.218 -0.926 . . . . 0.0 109.011 178.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 16' ' ' VAL . 0.2 OUTLIER -61.48 -49.67 75.82 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.383 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.94 -54.55 10.95 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.604 -0.838 . . . . 0.0 108.801 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.94 -40.35 43.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.501 -0.749 . . . . 0.0 110.231 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.435 ' HB3' ' CG1' ' A' ' 29' ' ' VAL . 43.8 mt -90.56 -16.74 28.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.343 -0.848 . . . . 0.0 110.051 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -61.81 -16.53 50.68 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.375 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -92.98 45.26 1.17 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 122.527 1.156 . . . . 0.0 109.968 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.535 ' HA2' ' CZ ' ' A' ' 45' ' ' PHE . . . 58.61 28.68 62.95 Favored Glycine 0 C--N 1.288 -2.114 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 177.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.2 ttt-85 -89.31 18.4 5.21 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 116.71 -1.996 . . . . 0.0 110.844 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.435 ' O ' ' CB ' ' A' ' 198' ' ' ALA . . . 96.81 107.11 2.4 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.129 -1.51 . . . . 0.0 115.388 172.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.511 ' CG2' ' CE2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -142.25 113.86 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 174.057 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.603 ' HB2' ' CD1' ' A' ' 199' ' ' LEU . 2.3 mtp -124.2 122.55 38.1 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.014 -1.054 . . . . 0.0 110.513 -174.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.439 ' CG2' ' HA ' ' A' ' 202' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 O-C-N 120.781 -1.2 . . . . 0.0 110.838 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.521 ' HA ' ' HB3' ' A' ' 30' ' ' MET . 2.4 p30 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 122.128 0.966 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.518 ' O ' ' O ' ' A' ' 171' ' ' VAL . 9.6 tpp -96.19 56.53 1.64 Allowed 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 123.567 0.747 . . . . 0.0 110.416 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.536 ' HA ' ' CD1' ' A' ' 172' ' ' LEU . 41.7 mt -60.73 34.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 O-C-N 121.159 -0.963 . . . . 0.0 113.557 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.535 ' CZ ' ' HA2' ' A' ' 26' ' ' GLY . 26.3 m-85 -111.52 162.03 22.81 Favored Pre-proline 0 N--CA 1.502 2.132 0 O-C-N 119.836 -1.79 . . . . 0.0 114.122 -175.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.63 131.36 17.19 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.374 2.049 . . . . 0.0 109.271 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.46 ' CB ' ' HB3' ' A' ' 169' ' ' ALA . . . -72.28 -1.47 15.44 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 120.785 -1.197 . . . . 0.0 113.132 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -93.46 -16.77 24.18 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.64 -1.288 . . . . 0.0 109.788 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.61 59.15 1.7 Allowed 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.509 ' O ' ' CG2' ' A' ' 115' ' ' ILE . 5.0 tpt -54.46 95.75 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.505 -178.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.0 p -66.53 133.48 50.44 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.478 HG21 ' CB ' ' A' ' 115' ' ' ILE . 2.6 t -77.98 -2.37 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.061 -1.024 . . . . 0.0 108.504 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 26' ' ' GLY . 0.6 OUTLIER -60.77 -40.8 93.92 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.254 -179.406 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.474 ' HG3' ' CD2' ' A' ' 45' ' ' PHE . 85.1 mm-40 -80.33 -24.14 40.1 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.594 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.431 ' CB ' HD13 ' A' ' 115' ' ' ILE . 11.2 tpt -82.49 -38.06 24.43 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.353 -0.842 . . . . 0.0 109.493 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.407 ' O ' HG21 ' A' ' 59' ' ' ILE . . . -57.93 -42.1 84.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.48 -0.762 . . . . 0.0 109.767 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.427 HD12 ' CE ' ' A' ' 197' ' ' MET . 5.8 tt -65.58 -48.71 71.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 109.322 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.502 ' O ' ' N ' ' A' ' 62' ' ' GLY . 37.0 p -67.02 -59.12 3.74 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.365 -0.835 . . . . 0.0 110.979 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 111' ' ' ALA . 11.3 tt -47.48 -24.79 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.17 -0.956 . . . . 0.0 111.022 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.8 ttt85 -72.07 -45.8 59.35 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.19 -0.944 . . . . 0.0 110.702 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -124.1 5.47 8.57 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.872 -1.143 . . . . 0.0 112.163 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 58' ' ' THR . . . -165.12 -169.27 28.52 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.5 p -139.91 102.26 4.37 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.33 72.91 0.22 Allowed Glycine 0 C--N 1.266 -3.352 0 N-CA-C 105.222 -3.151 . . . . 0.0 105.222 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.496 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 1.7 tt -63.07 106.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.6 0 CA-C-O 122.622 1.201 . . . . 0.0 107.906 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.461 ' CG1' ' HG2' ' A' ' 43' ' ' MET . 16.5 m -52.53 151.03 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 115.129 -0.942 . . . . 0.0 112.043 -177.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.469 ' O ' ' CG1' ' A' ' 171' ' ' VAL . 82.5 m -85.9 160.74 19.33 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.525 ' N ' ' CD1' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -137.87 91.76 2.61 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.012 -1.475 . . . . 0.0 108.094 178.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.444 ' CB ' ' OG1' ' A' ' 157' ' ' THR . 1.3 m -102.52 152.25 21.37 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 119.046 -1.062 . . . . 0.0 110.472 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.538 ' HA ' ' CD1' ' A' ' 158' ' ' ILE . 1.1 mt -152.6 -177.73 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.0 p -86.33 144.71 27.24 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -53.54 -20.03 4.48 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.208 -0.933 . . . . 0.0 110.379 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.422 ' O ' ' CG ' ' A' ' 77' ' ' GLN . 10.1 t70 -79.0 -37.58 38.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.153 -0.967 . . . . 0.0 110.951 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -85.95 -52.44 5.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.21 -0.931 . . . . 0.0 110.629 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.505 ' CD ' ' CD1' ' A' ' 70' ' ' ILE . 22.4 tpt180 -54.2 -53.93 46.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.166 -0.959 . . . . 0.0 109.54 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.588 ' HA ' ' CB ' ' A' ' 80' ' ' LEU . 1.1 mtpm? -60.43 -56.67 18.65 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.293 -0.879 . . . . 0.0 111.605 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.422 ' CG ' ' O ' ' A' ' 73' ' ' ASP . 4.9 mt-30 -27.29 -49.41 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.851 1.344 . . . . 0.0 110.997 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.505 ' CD1' ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -136.88 -27.52 1.0 Allowed 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 117.162 -1.815 . . . . 0.0 113.082 177.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.505 ' N ' ' CD1' ' A' ' 78' ' ' LEU . 65.9 t0 -121.15 62.97 0.88 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 117.363 -1.735 . . . . 0.0 115.438 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.588 ' CB ' ' HA ' ' A' ' 76' ' ' LYS . 2.2 tt -144.73 104.23 4.55 Favored Pre-proline 0 N--CA 1.506 2.348 0 C-N-CA 115.925 -2.31 . . . . 0.0 113.744 174.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.535 ' HG2' HG22 ' A' ' 97' ' ' VAL . 38.3 Cg_endo -101.56 96.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.3 -1.983 0 N-CA-C 107.257 -1.863 . . . . 0.0 107.257 174.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.442 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 9.4 ttt -88.8 45.48 1.29 Allowed 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.21 -0.932 . . . . 0.0 109.553 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.436 ' CB ' HG12 ' A' ' 97' ' ' VAL . 4.7 mmm -57.7 -11.51 2.23 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.655 -0.653 . . . . 0.0 110.656 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.462 ' CG2' HG11 ' A' ' 97' ' ' VAL . 53.6 t . . . . . 0 N--CA 1.5 2.053 0 C-N-CA 116.878 -1.929 . . . . 0.0 109.915 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.445 ' HB3' ' CB ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 123.144 1.45 . . . . 0.0 112.237 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.457 ' CG2' ' HG ' ' A' ' 80' ' ' LEU . 1.2 m -61.41 81.25 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.026 -1.443 . . . . 0.0 109.413 177.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.535 HG22 ' HG2' ' A' ' 81' ' ' PRO . 1.2 m -37.07 155.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.046 0 CA-C-O 122.259 1.028 . . . . 0.0 111.935 -175.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.428 ' CG2' ' O ' ' A' ' 137' ' ' VAL . 39.4 p -66.52 -176.88 0.5 Allowed 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -174.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 132' ' ' ASN . 1.1 pp -110.6 146.78 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 122.47 1.129 . . . . 0.0 113.545 -177.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.625 ' N ' ' H ' ' A' ' 133' ' ' ARG . 58.1 tt0 -93.65 163.27 13.61 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.428 ' CB ' ' HB ' ' A' ' 106' ' ' THR . . . -77.69 78.78 4.19 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 116.213 -2.195 . . . . 0.0 107.563 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 129' ' ' SER . . . -106.47 -37.54 6.46 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.456 ' HA ' ' CB ' ' A' ' 129' ' ' SER . 30.6 tp10 -74.43 -7.92 54.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.55 -0.719 . . . . 0.0 109.894 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.8 24.98 5.59 Favored Glycine 0 N--CA 1.481 1.651 0 C-N-CA 119.604 -1.284 . . . . 0.0 111.703 178.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.424 HG21 ' CB ' ' A' ' 120' ' ' ALA . 2.0 t -114.19 112.13 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 C-N-CA 118.011 -1.475 . . . . 0.0 108.016 177.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.428 ' HB ' ' CB ' ' A' ' 101' ' ' ALA . 5.6 t -157.39 66.92 0.5 Allowed 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.0 m -129.99 20.98 5.39 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.416 -1.427 . . . . 0.0 111.847 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.497 ' O ' ' N ' ' A' ' 110' ' ' SER . . . 96.55 47.44 2.34 Favored Glycine 0 N--CA 1.502 3.052 0 N-CA-C 107.137 -2.385 . . . . 0.0 107.137 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.489 ' O ' HG23 ' A' ' 109' ' ' VAL . 12.2 p -53.82 51.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -173.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 108' ' ' GLY . 1.9 m -135.29 12.21 3.54 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 117.053 -1.859 . . . . 0.0 112.405 172.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.435 ' HA ' ' CD1' ' A' ' 59' ' ' ILE . . . -122.12 -81.86 0.64 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 119.89 -1.756 . . . . 0.0 108.983 171.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' A' ' 116' ' ' THR . . . -98.7 -43.6 6.74 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 174.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.452 ' CB ' ' HA ' ' A' ' 109' ' ' VAL . 47.0 t0 -54.15 -29.74 46.58 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.472 ' HB2' ' CA ' ' A' ' 110' ' ' SER . 2.0 ttt180 -63.85 -51.29 65.3 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 175.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.509 ' CG2' ' O ' ' A' ' 50' ' ' MET 0.254 1.2 mp -67.31 -10.74 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.682 178.212 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.417 ' O ' ' CB ' ' A' ' 120' ' ' ALA . 54.9 m -90.43 -41.87 11.21 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.89 -1.131 . . . . 0.0 109.112 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.473 ' CB ' HG21 ' A' ' 109' ' ' VAL . 52.8 m -69.0 -29.13 67.25 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.384 -0.926 . . . . 0.0 108.783 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.429 ' CG1' ' O ' ' A' ' 47' ' ' ALA . 39.9 t -67.78 -44.01 85.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.08 -27.98 35.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.472 -0.767 . . . . 0.0 109.573 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.424 ' CB ' HG21 ' A' ' 105' ' ' VAL . . . -80.95 -51.92 8.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.514 -0.741 . . . . 0.0 109.516 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 117' ' ' THR . . . -54.86 -32.27 60.57 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.42 ' CG2' ' O ' ' A' ' 122' ' ' ILE . 71.1 mt -93.39 25.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.602 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 125' ' ' GLY . . . -37.63 150.82 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 O-C-N 122.056 -0.403 . . . . 0.0 111.48 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -26.99 -28.58 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 123' ' ' ALA . . . 129.93 -36.04 2.42 Favored Glycine 0 N--CA 1.493 2.448 0 O-C-N 120.282 -1.511 . . . . 0.0 110.61 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -87.92 93.64 9.53 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.761 -1.435 . . . . 0.0 107.14 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.448 ' HD2' ' CG ' ' A' ' 103' ' ' GLU . 8.3 ttpt -134.3 119.12 14.17 Favored Pre-proline 0 C--N 1.305 -1.35 0 O-C-N 121.226 -0.921 . . . . 0.0 111.19 -178.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -88.29 19.33 1.34 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 N-CA-C 108.178 -1.508 . . . . 0.0 108.178 176.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.688 ' O ' ' N ' ' A' ' 131' ' ' LEU . 0.7 OUTLIER -119.6 41.16 3.2 Favored 'General case' 0 C--O 1.203 -1.38 0 O-C-N 121.3 -0.875 . . . . 0.0 110.727 -177.345 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -37.4 74.6 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 123.236 1.493 . . . . 0.0 110.894 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.688 ' N ' ' O ' ' A' ' 129' ' ' SER . 0.2 OUTLIER -68.17 107.14 2.65 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 113.469 -1.696 . . . . 0.0 110.938 -176.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.505 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 12.9 p30 -137.4 48.02 2.06 Favored 'General case' 0 N--CA 1.52 3.071 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.625 ' H ' ' N ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER 173.22 108.69 0.06 OUTLIER Pre-proline 0 N--CA 1.51 2.545 0 O-C-N 119.147 -2.22 . . . . 0.0 112.051 174.444 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.408 ' HD2' ' O ' ' A' ' 134' ' ' PRO . 53.7 Cg_endo -134.48 119.46 0.0 OUTLIER 'Cis proline' 0 C--N 1.31 -1.466 0 N-CA-C 103.958 -3.131 . . . . 0.0 103.958 -9.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 137' ' ' VAL . . . -111.67 44.76 1.44 Allowed Glycine 0 N--CA 1.509 3.501 0 C-N-CA 118.063 -2.018 . . . . 0.0 113.106 -175.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.418 ' C ' ' O ' ' A' ' 135' ' ' GLY . 66.4 m170 31.0 37.31 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 122.246 1.022 . . . . 0.0 111.59 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.461 ' N ' ' O ' ' A' ' 135' ' ' GLY . 45.1 t -108.91 125.08 65.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.496 ' CZ ' HG12 ' A' ' 65' ' ' ILE . 2.4 p90 -118.77 85.27 27.39 Favored Pre-proline 0 C--N 1.294 -1.818 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.339 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.49 ' HA ' HD21 ' A' ' 68' ' ' LEU . 47.6 Cg_endo -95.46 153.36 1.58 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 N-CA-C 108.362 -1.438 . . . . 0.0 108.362 178.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.448 ' CD2' ' O ' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -150.37 153.03 35.31 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.788 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -65.01 120.0 11.81 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.39 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -129.49 133.12 47.1 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.091 -1.006 . . . . 0.0 111.472 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -78.05 143.73 37.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -0.835 . . . . 0.0 109.627 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -103.76 115.51 30.61 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.293 -0.879 . . . . 0.0 111.487 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.422 ' N ' ' OD2' ' A' ' 159' ' ' ASP . . . 117.57 -14.82 13.01 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.55 12.97 56.77 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.487 ' CG1' ' CG1' ' A' ' 206' ' ' VAL . 4.9 p -73.36 -24.61 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.148 -1.207 . . . . 0.0 110.968 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.98 17.95 7.29 Favored 'General case' 0 C--O 1.208 -1.13 0 C-N-CA 115.472 -2.491 . . . . 0.0 110.506 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 25.3 m -131.19 59.55 1.68 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 100.778 -3.786 . . . . 0.0 100.778 166.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.404 ' NE ' ' OE1' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -151.85 148.21 27.55 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 113.76 -1.564 . . . . 0.0 112.432 -178.277 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -104.27 35.3 5.14 Favored Glycine 0 N--CA 1.482 1.756 0 N-CA-C 106.179 -2.768 . . . . 0.0 106.179 173.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.1 135.19 6.11 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.473 ' CD2' HD12 ' A' ' 202' ' ' ILE . 54.1 m80 -74.51 -5.18 41.27 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.241 -1.152 . . . . 0.0 109.666 177.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 59.4 p -53.73 -56.71 15.02 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.942 -1.099 . . . . 0.0 109.687 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.442 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . 2.9 mp0 -58.02 -21.66 46.07 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.486 ' CB ' ' CG2' ' A' ' 147' ' ' VAL . . . -83.71 6.26 21.7 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.571 -0.705 . . . . 0.0 109.818 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.472 ' O ' ' CB ' ' A' ' 160' ' ' LEU . 59.8 p -93.49 -49.26 5.99 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.538 ' CD1' ' HA ' ' A' ' 70' ' ' ILE . 0.3 OUTLIER -80.09 -32.31 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 116.703 -1.999 . . . . 0.0 107.259 177.557 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.422 ' OD2' ' N ' ' A' ' 145' ' ' GLY . 8.7 t70 -61.29 -33.76 74.1 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 105.375 -2.084 . . . . 0.0 105.375 174.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.58 ' HA ' ' CD2' ' A' ' 163' ' ' LEU . 0.6 OUTLIER -47.22 -41.25 18.04 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 175.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.48 ' O ' ' N ' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -57.97 -48.4 80.08 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.911 178.508 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.459 ' N ' ' CG ' ' A' ' 161' ' ' MET . 0.0 OUTLIER -63.85 -34.85 78.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.009 -1.057 . . . . 0.0 111.698 -178.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.58 ' CD2' ' HA ' ' A' ' 160' ' ' LEU . 1.7 pp -93.33 -30.87 14.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.925 -1.109 . . . . 0.0 111.763 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.5 ' CB ' HD12 ' A' ' 160' ' ' LEU . . . -115.15 38.02 3.33 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -178.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 167' ' ' LYS . . . 112.78 70.61 0.56 Allowed Glycine 0 N--CA 1.513 3.784 0 C-N-CA 116.667 -2.683 . . . . 0.0 109.831 -177.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.496 ' O ' ' CD2' ' A' ' 166' ' ' PHE . 54.3 p90 -62.43 70.67 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 123.486 1.612 . . . . 0.0 115.099 -172.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.473 ' N ' ' O ' ' A' ' 165' ' ' GLY . 0.0 OUTLIER -113.22 131.95 22.65 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 100.792 -3.781 . . . . 0.0 100.792 171.49 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.43 ' HB2' ' CG2' ' A' ' 70' ' ' ILE . 38.1 Cg_endo -63.58 89.84 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 116.636 -1.776 . . . . 0.0 112.412 -173.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.46 ' HB3' ' CB ' ' A' ' 47' ' ' ALA 0.262 . . -158.18 153.8 26.3 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 176.085 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 157' ' ' THR . . . -147.37 113.52 0.65 Allowed Glycine 0 N--CA 1.497 2.739 0 C-N-CA 117.24 -2.41 . . . . 0.0 110.535 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.53 ' O ' HD12 ' A' ' 172' ' ' LEU . 1.1 m -125.72 144.02 37.23 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.447 0 C-N-CA 117.172 -1.811 . . . . 0.0 109.791 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.536 ' CD1' ' HA ' ' A' ' 44' ' ' ILE . 0.1 OUTLIER -159.69 113.63 2.27 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 177.269 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 1.9 t -126.96 178.0 6.26 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 119.642 -1.911 . . . . 0.0 112.042 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . 0.41 ' OE2' ' N ' ' A' ' 175' ' ' LEU . 1.6 tm-20 -120.62 148.35 44.01 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.924 -1.11 . . . . 0.0 110.27 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.41 ' N ' ' OE2' ' A' ' 174' ' ' GLU . 1.6 tp . . . . . 0 N--CA 1.499 1.993 0 O-C-N 121.038 -1.039 . . . . 0.0 110.11 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.437 ' HA ' ' CB ' ' A' ' 188' ' ' CYS . . . . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.2 0.524 . . . . 0.0 110.111 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . 0.419 ' O ' ' CB ' ' A' ' 185' ' ' ALA . 0.2 OUTLIER -140.11 162.15 35.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.876 . . . . 0.0 110.401 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.461 ' CB ' ' HD2' ' A' ' 186' ' ' PRO . . . 68.9 174.83 0.08 OUTLIER Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.42 -0.8 . . . . 0.0 110.865 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 185' ' ' ALA . 41.1 Cg_endo -66.38 -10.5 27.83 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.481 1.253 . . . . 0.0 110.957 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -72.9 -55.01 7.23 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.046 -1.034 . . . . 0.0 109.864 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . 0.437 ' CB ' ' HA ' ' A' ' 183' ' ' ALA . 24.0 p -58.79 -39.53 81.37 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.271 -0.893 . . . . 0.0 110.059 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.463 ' CD1' ' CB ' ' A' ' 42' ' ' ASP . 8.7 tp -73.63 -22.59 18.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 118.018 -1.473 . . . . 0.0 109.071 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -56.78 -33.63 66.83 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.435 ' C ' ' CD1' ' A' ' 191' ' ' PHE . 0.1 OUTLIER -66.03 -40.63 91.18 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 197' ' ' MET . . . -60.32 -49.32 78.05 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.969 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . 0.606 ' HA ' ' CB ' ' A' ' 197' ' ' MET . 0.1 OUTLIER -73.03 -11.49 60.58 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.282 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -73.75 -34.78 64.88 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 117.47 -1.692 . . . . 0.0 111.365 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -112.11 -52.47 2.78 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 116.165 -2.214 . . . . 0.0 111.489 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -114.2 32.6 5.79 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 117.859 -1.536 . . . . 0.0 114.238 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' MET . . . . . 0.606 ' CB ' ' HA ' ' A' ' 193' ' ' ASN . 0.1 OUTLIER -153.12 147.44 25.81 Favored 'General case' 0 N--CA 1.517 2.918 0 CA-C-N 123.396 2.816 . . . . 0.0 115.912 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 28' ' ' GLY . . . -95.36 127.62 41.55 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 175.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.603 ' CD1' ' HB2' ' A' ' 30' ' ' MET . 0.3 OUTLIER -114.92 107.35 15.28 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 120.41 -1.431 . . . . 0.0 113.512 -176.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.451 ' N ' ' O ' ' A' ' 30' ' ' MET . 4.4 p -100.05 -173.02 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.245 -0.91 . . . . 0.0 110.07 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 4.4 t -111.98 165.08 12.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.071 -1.018 . . . . 0.0 109.796 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.473 HD12 ' CD2' ' A' ' 153' ' ' HIS . 9.9 tt -81.39 -14.27 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.044 -1.035 . . . . 0.0 111.298 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.422 ' O ' ' CB ' ' A' ' 207' ' ' ALA . 2.1 mt-10 -90.1 -43.63 10.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.934 -1.104 . . . . 0.0 110.598 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -85.48 -14.73 45.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 111.404 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.493 ' O ' ' HB3' ' A' ' 208' ' ' TYR . 10.5 tt -77.0 -53.57 7.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.81 -1.181 . . . . 0.0 110.914 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.487 ' CG1' ' CG1' ' A' ' 147' ' ' VAL . 1.1 t -76.75 -29.33 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 117.875 -1.53 . . . . 0.0 107.765 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 203' ' ' GLU . . . -57.1 -30.95 64.79 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.609 ' CE2' ' CG1' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -62.82 -44.7 95.45 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 177.605 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.431 ' NE ' ' HB ' ' A' ' 162' ' ' THR . 54.7 ttt-85 -61.62 -52.15 65.58 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.739 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.76 -57.61 5.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 110.446 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 207' ' ' ALA . . . -51.51 -23.95 4.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.417 -0.802 . . . . 0.0 110.414 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.241 179.956 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.432 ' C ' ' N ' ' A' ' 14' ' ' GLU . 18.1 Cg_endo . . . . . 0 N--CA 1.518 2.921 0 CA-C-O 123.919 1.55 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.669 ' O ' ' N ' ' A' ' 16' ' ' VAL . 1.8 m-30 -51.54 -16.28 0.58 Allowed 'General case' 0 C--O 1.183 -2.413 0 O-C-N 119.747 -1.845 . . . . 0.0 106.619 168.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.506 ' HA ' ' CB ' ' A' ' 17' ' ' GLU . 2.8 mt-10 -44.45 -36.1 2.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.109 -1.62 . . . . 0.0 109.239 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -42.24 90.85 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 176.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.669 ' N ' ' O ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -74.91 -29.44 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.183 175.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.506 ' CB ' ' HA ' ' A' ' 14' ' ' GLU . 9.2 tt0 -56.64 -56.41 21.74 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.292 -1.505 . . . . 0.0 107.749 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' A' ' 198' ' ' ALA . 50.4 t-20 -53.35 -25.96 17.22 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.206 -0.997 . . . . 0.0 108.336 177.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.459 ' CB ' ' HB ' ' A' ' 200' ' ' VAL . . . -70.78 -66.43 0.61 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.588 0.709 . . . . 0.0 110.701 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.491 ' CD2' ' HA ' ' A' ' 164' ' ' ALA . 0.8 OUTLIER -78.92 -33.01 45.86 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.204 -0.935 . . . . 0.0 110.942 -178.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 17' ' ' GLU . . . -56.09 -32.5 64.2 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 25' ' ' GLU . . . -67.0 -35.79 80.74 Favored 'General case' 0 C--O 1.207 -1.166 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 176.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.448 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 3.1 tt -48.51 -26.24 2.07 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.164 -0.96 . . . . 0.0 109.75 178.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -91.06 -26.16 19.3 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.807 0.813 . . . . 0.0 108.833 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 22' ' ' ALA . 0.3 OUTLIER -144.42 78.98 1.59 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 177.436 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 126.0 52.59 0.16 Allowed Glycine 0 C--N 1.281 -2.499 1 N-CA-C 101.63 -4.588 . . . . 0.0 101.63 -173.147 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -56.18 80.6 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 122.936 1.35 . . . . 0.0 111.308 -173.526 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 26' ' ' GLY . . . 172.76 104.75 0.18 Allowed Glycine 0 N--CA 1.489 2.201 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.49 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.477 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 1.5 t -116.48 121.77 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.477 ' CB ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -111.77 131.48 55.29 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 117.996 -1.482 . . . . 0.0 110.52 -178.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 200' ' ' VAL . 14.7 p . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.435 -0.791 . . . . 0.0 110.219 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.477 ' HA ' ' CB ' ' A' ' 30' ' ' MET . 28.9 t70 . . . . . 0 N--CA 1.514 2.731 0 CA-C-O 121.853 0.835 . . . . 0.0 112.078 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.602 ' O ' ' O ' ' A' ' 171' ' ' VAL . 0.7 OUTLIER -94.66 52.42 1.52 Allowed 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 122.175 0.988 . . . . 0.0 113.094 -178.017 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.477 ' CG2' ' HB ' ' A' ' 29' ' ' VAL . 13.0 tt -63.48 19.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.846 0 O-C-N 119.399 -2.063 . . . . 0.0 113.154 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.504 ' H ' ' C ' ' A' ' 43' ' ' MET . 2.9 m-85 -81.92 162.97 55.58 Favored Pre-proline 0 N--CA 1.498 1.93 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -175.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.497 ' HG3' ' CE1' ' A' ' 166' ' ' PHE . 51.3 Cg_endo -69.82 131.23 20.71 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.642 2.228 . . . . 0.0 110.719 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.485 ' HB3' ' CB ' ' A' ' 169' ' ' ALA . . . -67.58 -20.45 65.38 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.297 -0.961 . . . . 0.0 112.029 -178.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.443 ' HA ' ' CG2' ' A' ' 122' ' ' ILE . 20.6 tt0 -76.52 -35.08 58.52 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.838 -1.163 . . . . 0.0 111.078 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.438 ' O ' ' N ' ' A' ' 51' ' ' THR . 4.7 t -132.87 58.81 1.75 Allowed 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.445 ' O ' HD11 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -65.4 88.13 0.08 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 179.069 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.441 ' HA ' HG12 ' A' ' 115' ' ' ILE . 11.4 m -59.07 170.04 0.96 Allowed 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.713 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.465 ' O ' ' N ' ' A' ' 56' ' ' ALA . 2.7 p -83.16 -2.3 6.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 O-C-N 121.341 -0.85 . . . . 0.0 110.063 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.28 -44.77 94.16 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.445 ' HB2' ' HG3' ' A' ' 43' ' ' MET . 0.0 OUTLIER -76.19 -35.83 58.94 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.458 178.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.418 ' HA ' ' OG1' ' A' ' 58' ' ' THR . 0.0 OUTLIER -70.51 -27.8 64.47 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.143 -0.973 . . . . 0.0 108.525 178.407 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 52' ' ' VAL . . . -56.46 -47.83 78.36 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.754 -0.591 . . . . 0.0 109.709 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.439 ' O ' ' CB ' ' A' ' 60' ' ' ARG . 6.7 tt -60.04 -56.81 17.11 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.026 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.47 ' CA ' ' HB2' ' A' ' 63' ' ' SER . 2.6 p -53.39 -36.0 60.97 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.423 -0.798 . . . . 0.0 109.79 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.47 ' CD1' ' CB ' ' A' ' 111' ' ' ALA . 51.2 mt -84.48 -11.33 11.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.568 -0.708 . . . . 0.0 109.178 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -51.53 -51.94 51.14 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.749 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.51 -37.38 2.36 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 116.583 -2.047 . . . . 0.0 112.07 176.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.02 107.53 0.21 Allowed Glycine 0 N--CA 1.499 2.839 0 C-N-CA 118.834 -1.65 . . . . 0.0 111.413 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.47 ' HB2' ' CA ' ' A' ' 58' ' ' THR . 0.6 OUTLIER -165.89 99.99 0.66 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 120.227 2.013 . . . . 0.0 105.69 172.476 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.456 ' O ' HD11 ' A' ' 65' ' ' ILE . . . -123.46 55.77 0.69 Allowed Glycine 0 C--N 1.283 -2.407 0 N-CA-C 106.364 -2.694 . . . . 0.0 106.364 176.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.501 HD12 ' CD2' ' A' ' 138' ' ' PHE . 20.5 mm -147.68 104.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 113.838 -1.181 . . . . 0.0 109.411 175.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.62 ' O ' ' CD1' ' A' ' 138' ' ' PHE . 25.5 t -114.96 154.28 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.568 -1.332 . . . . 0.0 110.66 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 171' ' ' VAL . 0.4 OUTLIER -92.15 120.16 32.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.022 -1.674 . . . . 0.0 108.524 178.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 139' ' ' PRO . 3.6 mm? -89.47 98.43 11.76 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.484 ' HB2' ' N ' ' A' ' 170' ' ' GLY . 66.3 m -66.1 129.1 38.63 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.638 -0.664 . . . . 0.0 109.779 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.482 ' CD1' ' CZ ' ' A' ' 75' ' ' ARG . 10.4 tt -153.99 164.79 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.928 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.4 ' N ' HG12 ' A' ' 70' ' ' ILE . 2.1 m -124.85 175.72 7.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.426 -0.797 . . . . 0.0 109.946 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 13.8 tt0 -73.91 -9.2 58.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.246 -0.909 . . . . 0.0 110.775 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -88.26 -39.87 14.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.972 -1.08 . . . . 0.0 110.53 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.84 -35.87 59.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.246 -0.909 . . . . 0.0 110.188 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.498 ' O ' ' C ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -78.48 -29.82 47.0 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.219 1.009 . . . . 0.0 108.6 179.095 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -53.15 -66.04 0.46 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.198 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -47.64 -33.37 6.65 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 122.089 0.947 . . . . 0.0 109.224 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.498 ' C ' ' O ' ' A' ' 75' ' ' ARG . 19.1 tp -96.55 47.13 1.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 175.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 76' ' ' LYS . 1.2 m-20 -22.39 83.9 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 124.458 2.075 . . . . 0.0 112.471 -171.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 78' ' ' LEU . 3.5 tm? -147.42 112.54 4.03 Favored Pre-proline 0 C--N 1.292 -1.905 0 CA-C-N 111.073 -2.785 . . . . 0.0 109.574 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.26 99.37 1.01 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.317 1.167 . . . . 0.0 111.046 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.466 ' O ' ' CG ' ' A' ' 82' ' ' MET . 3.6 ptt? -87.0 83.95 7.41 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.323 -0.861 . . . . 0.0 109.386 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.47 67.35 1.13 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.94 -1.1 . . . . 0.0 110.899 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.456 ' N ' ' HA ' ' A' ' 95' ' ' PHE . 82.8 t . . . . . 0 N--CA 1.495 1.818 0 O-C-N 121.046 -1.033 . . . . 0.0 109.217 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.52 3.052 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.45 ' CB ' ' O ' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -130.34 75.48 1.66 Allowed 'General case' 0 C--N 1.292 -1.906 0 O-C-N 121.303 -0.873 . . . . 0.0 110.997 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.443 ' HB ' ' HA ' ' A' ' 82' ' ' MET . 90.3 t -43.98 145.4 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.493 0 O-C-N 120.458 -1.401 . . . . 0.0 110.83 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.492 ' OG1' ' HA ' ' A' ' 134' ' ' PRO . 1.0 OUTLIER -73.98 -174.96 2.01 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.774 0.797 . . . . 0.0 112.329 -177.141 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.47 HG21 ' CG ' ' A' ' 131' ' ' LEU 0.302 0.1 OUTLIER -149.24 123.55 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -178.049 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 132' ' ' ASN . 3.9 tm-20 -91.2 105.36 17.74 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 117.775 -1.57 . . . . 0.0 112.715 -176.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.485 ' HA ' ' CD1' ' A' ' 131' ' ' LEU . . . -50.6 96.43 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.132 -0.98 . . . . 0.0 110.169 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 130' ' ' ASP . . . -103.16 2.87 35.12 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.114 -0.992 . . . . 0.0 110.061 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.426 ' HB3' ' CB ' ' A' ' 130' ' ' ASP . 7.7 pt-20 -112.26 45.36 1.29 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.066 -1.021 . . . . 0.0 111.448 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.429 ' O ' ' CG2' ' A' ' 117' ' ' THR . . . 127.65 -37.68 2.28 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 118.946 -1.597 . . . . 0.0 112.723 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.472 ' CA ' ' HB ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -101.43 121.76 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 O-C-N 120.823 -1.398 . . . . 0.0 111.113 -178.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.4 p -144.3 58.53 1.33 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.599 -1.24 . . . . 0.0 110.975 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.416 ' CG2' ' OG ' ' A' ' 110' ' ' SER . 23.9 m -139.52 -32.33 0.65 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.953 -1.092 . . . . 0.0 110.86 176.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.512 ' CA ' ' CD2' ' A' ' 136' ' ' HIS . . . 74.11 -31.96 0.94 Allowed Glycine 0 N--CA 1.493 2.467 0 O-C-N 121.688 -0.632 . . . . 0.0 111.526 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.442 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -131.02 58.0 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.707 -1.466 . . . . 0.0 109.84 179.298 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 114' ' ' ARG . 0.4 OUTLIER -129.54 57.04 1.68 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.028 -1.045 . . . . 0.0 109.579 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.47 ' CB ' ' CD1' ' A' ' 59' ' ' ILE . . . -32.9 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -85.14 -77.48 0.28 Allowed 'General case' 0 C--N 1.288 -2.095 0 O-C-N 120.554 -1.342 . . . . 0.0 109.558 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.02 -16.64 19.43 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.411 -0.806 . . . . 0.0 110.366 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.49 ' CB ' ' O ' ' A' ' 110' ' ' SER . 0.4 OUTLIER -88.77 -36.61 16.01 Favored 'General case' 0 C--O 1.2 -1.552 0 O-C-N 121.063 -1.023 . . . . 0.0 110.869 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.462 ' HB ' ' O ' ' A' ' 111' ' ' ALA . 0.9 OUTLIER -59.97 -17.19 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 C-N-CA 117.971 -1.491 . . . . 0.0 109.183 -179.153 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.8 m -89.09 -57.48 2.88 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.459 1.123 . . . . 0.0 108.491 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.472 ' HB ' ' CA ' ' A' ' 105' ' ' VAL . 2.0 p -62.71 -32.42 73.52 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.138 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.466 ' N ' ' O ' ' A' ' 114' ' ' ARG . 9.8 t -54.47 -47.55 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 -48.06 -29.46 3.56 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.69 -40.08 16.53 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.676 178.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.431 ' HB1' ' CG2' ' A' ' 105' ' ' VAL . . . -58.11 -50.77 72.32 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.756 -1.215 . . . . 0.0 109.798 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.443 ' CG2' ' HA ' ' A' ' 48' ' ' GLU . 26.5 mm -87.52 27.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.493 0.663 . . . . 0.0 109.741 178.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 125' ' ' GLY . . . -37.42 148.36 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.744 0.783 . . . . 0.0 112.37 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -41.37 -7.61 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 123' ' ' ALA . . . 131.61 28.87 0.61 Allowed Glycine 0 N--CA 1.495 2.633 0 O-C-N 119.8 -1.812 . . . . 0.0 110.775 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.78 167.62 13.03 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.31 -1.112 . . . . 0.0 108.504 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.407 ' C ' ' H ' ' A' ' 129' ' ' SER . 0.3 OUTLIER -62.98 124.07 82.35 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.401 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.32 16.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.51 1.268 . . . . 0.0 113.149 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 127' ' ' LYS . 0.1 OUTLIER -58.82 -27.62 65.26 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.177 -1.577 . . . . 0.0 108.768 179.221 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 38.5 m-20 -94.79 27.19 3.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.282 -0.886 . . . . 0.0 109.644 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.485 ' CD1' ' HA ' ' A' ' 101' ' ' ALA . 9.2 tp -141.38 83.88 1.89 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.274 -0.891 . . . . 0.0 109.191 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.541 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 3.4 m120 -120.32 101.11 7.57 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.099 -1.0 . . . . 0.0 111.995 -178.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.514 ' CB ' ' HA ' ' A' ' 134' ' ' PRO . 0.0 OUTLIER -83.15 -179.01 1.32 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.404 -0.81 . . . . 0.0 111.011 -178.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.514 ' HA ' ' CB ' ' A' ' 133' ' ' ARG . 48.6 Cg_endo -73.01 130.31 19.74 Favored 'Cis proline' 0 N--CA 1.5 1.863 0 C-N-CA 123.119 -1.617 . . . . 0.0 113.148 8.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.455 ' O ' ' CD2' ' A' ' 136' ' ' HIS . . . -132.3 67.95 0.55 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.512 ' CD2' ' CA ' ' A' ' 108' ' ' GLY . 8.5 p-80 32.08 36.59 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.484 0 O-C-N 122.105 -0.644 . . . . 0.0 112.075 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.458 ' CG2' ' O ' ' A' ' 99' ' ' ILE . 13.4 t -91.04 154.2 3.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 176.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.62 ' CD1' ' O ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -145.34 81.6 10.23 Favored Pre-proline 0 C--N 1.287 -2.139 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -178.667 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.503 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 52.3 Cg_endo -99.56 159.9 0.57 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.375 2.05 . . . . 0.0 111.857 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.434 ' N ' HG22 ' A' ' 96' ' ' THR . 10.9 tp -126.54 113.16 16.41 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -63.72 151.33 42.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.307 -0.871 . . . . 0.0 109.404 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.464 ' CA ' ' HA ' ' A' ' 156' ' ' ALA . . . -62.63 98.19 0.11 Allowed 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.039 0.924 . . . . 0.0 111.821 -177.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 156' ' ' ALA . 1.0 OUTLIER -100.68 146.8 26.74 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.153 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.79 116.0 31.16 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.669 -1.269 . . . . 0.0 112.592 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 112.67 -6.32 26.1 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.063 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.09 9.08 61.29 Favored Glycine 0 N--CA 1.502 3.048 0 C-N-CA 118.466 -1.826 . . . . 0.0 112.788 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.599 ' HB ' ' HA ' ' A' ' 155' ' ' GLU . 1.0 OUTLIER -116.48 -45.15 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.24 -1.741 . . . . 0.0 108.51 177.41 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.573 ' HG ' ' CD1' ' A' ' 202' ' ' ILE . 0.3 OUTLIER -106.77 84.29 1.97 Allowed 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 177.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.425 ' O ' ' CD ' ' A' ' 150' ' ' ARG . 5.1 m -74.3 63.96 1.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 125.335 2.493 . . . . 0.0 104.488 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.609 ' O ' ' N ' ' A' ' 152' ' ' GLY . 12.5 mmt180 -152.68 162.58 41.06 Favored 'General case' 0 C--N 1.271 -2.83 0 N-CA-C 100.23 -3.989 . . . . 0.0 100.23 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -60.57 55.91 0.02 OUTLIER Glycine 0 C--N 1.258 -3.772 0 C-N-CA 117.686 -2.197 . . . . 0.0 112.537 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 150' ' ' ARG . . . -119.28 128.7 7.73 Favored Glycine 0 C--O 1.215 -1.058 0 N-CA-C 106.28 -2.728 . . . . 0.0 106.28 176.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -90.72 1.35 56.93 Favored 'General case' 0 C--N 1.282 -2.344 0 O-C-N 121.969 -0.724 . . . . 0.0 109.312 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.548 ' HA ' ' CB ' ' A' ' 159' ' ' ASP . 1.9 p -51.52 -18.41 1.09 Allowed 'General case' 0 C--O 1.258 1.521 0 O-C-N 121.389 -0.819 . . . . 0.0 112.476 -176.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.733 ' O ' ' N ' ' A' ' 157' ' ' THR . 5.2 tp10 -48.0 -26.59 1.84 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.295 -0.962 . . . . 0.0 108.509 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.674 ' C ' ' H ' ' A' ' 158' ' ' ILE . . . -46.71 90.82 0.0 OUTLIER 'General case' 0 C--O 1.203 -1.379 0 N-CA-C 103.15 -2.908 . . . . 0.0 103.15 170.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.733 ' N ' ' O ' ' A' ' 155' ' ' GLU . 69.3 p -49.77 12.44 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -168.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.674 ' H ' ' C ' ' A' ' 156' ' ' ALA . 0.9 OUTLIER -107.75 -4.05 10.27 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.402 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 172.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.548 ' CB ' ' HA ' ' A' ' 154' ' ' THR . 0.2 OUTLIER -89.09 -33.57 17.06 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 103.174 -2.898 . . . . 0.0 103.174 173.778 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.481 ' CA ' HD22 ' A' ' 163' ' ' LEU . 2.3 mp -62.21 -51.6 67.14 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.74 176.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.589 ' HG3' ' O ' ' A' ' 158' ' ' ILE . 0.0 OUTLIER -48.74 -33.65 10.63 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.394 -1.441 . . . . 0.0 108.553 178.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.473 ' CG2' ' CZ ' ' A' ' 209' ' ' ARG . 1.3 m -57.88 -39.62 78.26 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 119.311 -0.955 . . . . 0.0 108.549 178.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.493 ' CD2' HD11 ' A' ' 205' ' ' LEU . 0.6 OUTLIER -67.26 -8.65 33.47 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.288 -0.965 . . . . 0.0 109.765 178.315 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.491 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -106.36 7.64 31.29 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 120.674 -1.266 . . . . 0.0 110.758 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 49.38 30.42 11.98 Favored Glycine 0 N--CA 1.5 2.951 0 N-CA-C 107.076 -2.41 . . . . 0.0 107.076 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.497 ' CE1' ' HG3' ' A' ' 46' ' ' PRO . 1.9 m-85 -120.19 146.1 46.34 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 122.828 1.299 . . . . 0.0 112.337 -176.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 169' ' ' ALA . 6.7 mtmm -43.9 139.33 2.98 Favored Pre-proline 0 N--CA 1.502 2.128 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.473 ' CB ' HG13 ' A' ' 158' ' ' ILE . 36.6 Cg_endo -61.89 84.93 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.033 0 C-N-CA 117.012 -1.526 . . . . 0.0 113.767 -172.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.485 ' CB ' ' HB3' ' A' ' 47' ' ' ALA . . . -156.04 162.69 40.27 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 172.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.484 ' N ' ' HB2' ' A' ' 69' ' ' CYS . . . -158.12 131.97 3.0 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 117.358 -2.353 . . . . 0.0 111.361 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.602 ' O ' ' O ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -119.71 89.5 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 117.969 -1.492 . . . . 0.0 107.138 176.6 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 43' ' ' MET . 3.0 mp -95.68 138.35 33.47 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.253 0.549 . . . . 0.0 110.374 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.444 ' N ' ' HB3' ' A' ' 43' ' ' MET . 2.8 t -129.59 176.2 8.18 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.897 -1.127 . . . . 0.0 111.064 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -111.45 -179.46 3.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.201 -0.937 . . . . 0.0 110.06 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 3.5 tm? . . . . . 0 N--CA 1.496 1.869 0 O-C-N 121.108 -0.995 . . . . 0.0 110.001 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.229 0.538 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . 0.413 ' O ' ' CG ' ' A' ' 184' ' ' ARG . 0.1 OUTLIER -140.23 100.2 3.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.901 . . . . 0.0 109.827 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.438 ' CB ' ' HD2' ' A' ' 186' ' ' PRO . . . -179.37 178.08 0.34 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.31 -0.869 . . . . 0.0 109.891 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 185' ' ' ALA . 45.3 Cg_endo -71.82 -16.92 29.49 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.608 1.32 . . . . 0.0 110.413 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -79.46 -31.56 42.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.087 -1.008 . . . . 0.0 110.067 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . 0.435 ' O ' ' HB3' ' A' ' 191' ' ' PHE . 14.0 m -74.35 -56.63 4.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.325 -0.859 . . . . 0.0 110.186 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.447 HG13 ' CD2' ' A' ' 199' ' ' LEU . 2.5 tp -61.7 -22.97 29.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.994 -1.066 . . . . 0.0 109.38 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.446 ' HA ' HD13 ' A' ' 199' ' ' LEU . 23.7 tt0 -81.61 -18.62 44.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.477 -0.764 . . . . 0.0 109.817 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.435 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.1 OUTLIER -71.34 -53.9 12.61 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.992 0.901 . . . . 0.0 109.36 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.431 ' CB ' HD11 ' A' ' 57' ' ' LEU . . . -69.6 -35.63 75.48 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . 0.562 ' HA ' ' CB ' ' A' ' 197' ' ' MET . 14.9 t30 -61.71 -18.6 60.32 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.915 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -81.79 -39.81 23.52 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.918 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -100.98 -54.72 2.74 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 115.499 -2.481 . . . . 0.0 111.892 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.4 ' O ' ' CE ' ' A' ' 197' ' ' MET . 39.6 m-80 -114.94 33.42 5.42 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.172 -1.411 . . . . 0.0 113.889 177.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' MET . . . . . 0.562 ' CB ' ' HA ' ' A' ' 193' ' ' ASN . 0.0 OUTLIER -152.14 148.99 28.29 Favored 'General case' 0 N--CA 1.515 2.803 0 CA-C-N 122.966 2.621 . . . . 0.0 115.632 -179.52 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 19' ' ' ALA . . . -113.12 125.64 54.59 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 176.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.462 ' CD2' ' HB2' ' A' ' 30' ' ' MET . 26.1 mt -94.09 144.47 25.46 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.546 -1.346 . . . . 0.0 112.971 -177.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.459 ' HB ' ' CB ' ' A' ' 19' ' ' ALA . 7.1 p -146.81 110.45 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.422 ' O ' ' CB ' ' A' ' 205' ' ' LEU . 23.9 p -70.69 147.96 48.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 111.707 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.573 ' CD1' ' HG ' ' A' ' 148' ' ' LEU . 0.0 OUTLIER -47.72 -38.52 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 121.304 0.573 . . . . 0.0 110.495 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.403 ' HA ' HD23 ' A' ' 148' ' ' LEU . 10.7 tt0 -48.13 -65.99 0.48 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.08 -1.012 . . . . 0.0 110.737 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 207' ' ' ALA . 6.4 m-20 -80.89 -25.16 37.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.745 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.562 ' HB3' ' HA ' ' A' ' 202' ' ' ILE . 3.1 tm? -64.75 -67.5 0.43 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.334 -0.853 . . . . 0.0 109.422 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.537 ' HB ' HD12 ' A' ' 202' ' ' ILE . 97.9 t -62.67 -21.99 28.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 118.048 -1.461 . . . . 0.0 108.364 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 211' ' ' ALA . . . -53.25 -28.89 29.73 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 175.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.532 ' HA ' ' CE1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -77.85 -36.59 49.82 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.473 ' CZ ' ' CG2' ' A' ' 162' ' ' THR . 16.1 tpt180 -78.6 -58.67 3.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.896 -1.127 . . . . 0.0 110.067 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -51.85 -36.54 48.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.167 -0.958 . . . . 0.0 110.351 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 207' ' ' ALA . . . -72.54 -29.15 63.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 110.222 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 58.1 t60 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.225 -0.922 . . . . 0.0 110.182 179.954 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.46 ' CB ' ' HB2' ' A' ' 208' ' ' TYR . 28.1 Cg_endo . . . . . 0 C--O 1.211 -0.84 0 N-CA-C 110.319 -0.685 . . . . 0.0 110.319 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -86.02 -56.17 3.59 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -93.5 -36.42 12.45 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 118.328 -1.349 . . . . 0.0 111.166 -176.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.483 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 8.3 mmt180 -78.83 -30.05 45.06 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 119.181 -1.007 . . . . 0.0 111.79 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.662 ' CG1' ' CD2' ' A' ' 208' ' ' TYR . 0.4 OUTLIER -89.55 -36.11 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 116.224 -2.19 . . . . 0.0 111.552 -179.167 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.476 ' N ' HG11 ' A' ' 16' ' ' VAL . 6.3 tp10 -63.16 -40.32 97.21 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 117.383 -1.727 . . . . 0.0 108.757 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.469 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 32.5 p-10 -84.38 -23.06 30.26 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.546 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 15' ' ' ARG . . . -71.63 -38.21 70.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.494 -1.379 . . . . 0.0 110.11 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.468 ' HA ' ' CG2' ' A' ' 29' ' ' VAL . 1.6 pp -73.35 -54.27 8.76 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.333 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.606 ' HA ' ' N ' ' A' ' 26' ' ' GLY . . . -69.21 -69.74 0.32 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.877 -1.139 . . . . 0.0 111.807 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 18' ' ' ASN . . . -50.09 -34.89 23.33 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.689 -1.142 . . . . 0.0 112.739 -177.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.473 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 2.6 tt -56.39 -59.89 4.32 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.82 -76.43 0.59 Allowed 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 117.686 -1.606 . . . . 0.0 108.15 173.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.445 ' CG ' ' HB2' ' A' ' 27' ' ' ARG . 5.7 pt-20 -167.28 45.78 0.05 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.102 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.606 ' N ' ' HA ' ' A' ' 21' ' ' ALA . . . 60.47 20.01 54.73 Favored Glycine 0 N--CA 1.481 1.698 0 N-CA-C 107.097 -2.401 . . . . 0.0 107.097 -176.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.52 ' CB ' ' CE1' ' A' ' 45' ' ' PHE . 6.6 mtt180 -118.31 39.25 3.48 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.467 -1.019 . . . . 0.0 109.792 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.453 ' CA ' ' HG3' ' A' ' 197' ' ' MET . . . 178.2 66.41 0.06 OUTLIER Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.317 -1.913 . . . . 0.0 108.317 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.547 ' HB ' ' CD1' ' A' ' 44' ' ' ILE . 6.1 t -144.75 116.97 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.511 ' CB ' HD21 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -84.41 146.37 27.69 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 119.838 -1.789 . . . . 0.0 113.313 -177.59 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.47 ' CG1' ' O ' ' A' ' 31' ' ' VAL . 14.8 p . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.502 2.138 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -31.35 -27.82 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.176 0 N-CA-C 116.906 2.187 . . . . 0.0 116.906 -174.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.547 ' CD1' ' HB ' ' A' ' 29' ' ' VAL . 0.8 OUTLIER -138.53 16.18 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.259 0 CA-C-O 122.695 1.236 . . . . 0.0 110.055 178.785 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.52 ' CE1' ' CB ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -68.66 161.48 70.54 Favored Pre-proline 0 C--N 1.288 -2.083 0 O-C-N 121.172 -0.955 . . . . 0.0 113.564 -175.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.529 ' HB3' ' CB ' ' A' ' 167' ' ' LYS . 55.8 Cg_endo -82.35 129.92 6.05 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 C-N-CA 122.058 1.839 . . . . 0.0 109.409 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.482 ' HB2' ' N ' ' A' ' 170' ' ' GLY . . . -71.69 -1.33 13.44 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.256 -0.903 . . . . 0.0 112.566 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.424 ' HA ' ' CG2' ' A' ' 122' ' ' ILE . 0.1 OUTLIER -86.83 -23.78 25.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.797 -1.19 . . . . 0.0 110.128 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 51' ' ' THR . 10.1 t -133.26 60.23 1.71 Allowed 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.445 ' HB2' ' CB ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -52.54 88.94 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.334 0.588 . . . . 0.0 109.739 -179.426 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.489 ' N ' ' O ' ' A' ' 49' ' ' THR . 26.2 p -61.95 172.58 1.31 Allowed 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.83 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.443 HG21 ' CD1' ' A' ' 115' ' ' ILE . 17.7 t -73.91 -5.1 6.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.533 -0.729 . . . . 0.0 110.12 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.428 ' O ' ' CD2' ' A' ' 57' ' ' LEU . 0.8 OUTLIER -50.6 -28.31 8.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.006 -1.059 . . . . 0.0 109.422 179.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.437 ' O ' ' CG2' ' A' ' 58' ' ' THR . 0.0 OUTLIER -86.95 -28.98 22.4 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.203 179.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.431 ' HB3' ' CB ' ' A' ' 111' ' ' ALA . 3.8 mmt -86.23 -41.13 14.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.265 -0.897 . . . . 0.0 109.528 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.46 -53.97 35.12 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.224 -0.923 . . . . 0.0 110.4 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.428 ' CD2' ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -64.03 -33.4 75.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.216 -0.927 . . . . 0.0 111.059 -179.273 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.475 ' CG2' ' N ' ' A' ' 59' ' ' ILE . 4.4 t -79.33 -46.86 16.87 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.739 -1.226 . . . . 0.0 110.836 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.475 ' N ' ' CG2' ' A' ' 58' ' ' THR . 72.1 mt -53.78 -21.93 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.841 -1.162 . . . . 0.0 109.578 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -84.83 -46.04 11.73 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.378 -0.826 . . . . 0.0 112.257 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.36 -15.04 6.3 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -177.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 58' ' ' THR . . . -164.36 -168.95 27.24 Favored Glycine 0 N--CA 1.502 3.081 0 C-N-CA 118.547 -1.787 . . . . 0.0 111.756 -176.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.6 t -126.57 102.35 7.06 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 101.32 -3.585 . . . . 0.0 101.32 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 66' ' ' VAL . . . -104.79 76.43 0.25 Allowed Glycine 0 C--N 1.26 -3.663 0 N-CA-C 105.804 -2.918 . . . . 0.0 105.804 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.48 HG23 ' CD2' ' A' ' 138' ' ' PHE . 3.2 mm -61.34 84.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.535 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.576 ' O ' ' CD1' ' A' ' 138' ' ' PHE . 26.5 m -52.72 157.09 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.508 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.311 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 171' ' ' VAL . 97.4 m -109.64 119.35 39.14 Favored 'General case' 0 C--N 1.29 -2.006 0 O-C-N 121.393 -0.817 . . . . 0.0 110.32 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.487 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -87.28 97.81 10.99 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.316 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 74.3 m -70.7 127.28 32.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.467 -0.77 . . . . 0.0 111.794 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.461 ' CD1' ' HB3' ' A' ' 79' ' ' ASP . 24.6 pt -115.97 162.47 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.457 ' CA ' HG12 ' A' ' 158' ' ' ILE . 1.6 m -81.03 170.62 15.99 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 120.55 -1.344 . . . . 0.0 109.7 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.47 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -95.4 -12.47 25.93 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.399 178.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -85.39 -73.18 0.45 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.915 -1.115 . . . . 0.0 111.901 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -85.98 -32.58 21.44 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 79' ' ' ASP . 10.8 mpt_? -74.07 -31.71 62.96 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.626 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 72' ' ' GLU . 18.2 tttt -72.93 -41.41 64.55 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 119.89 -1.756 . . . . 0.0 108.996 178.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -42.35 -54.1 3.92 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.298 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.483 HD11 ' HG2' ' A' ' 128' ' ' PRO . 0.4 OUTLIER -105.08 -29.49 10.37 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.049 -1.46 . . . . 0.0 109.156 178.35 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 75' ' ' ARG . 5.9 t0 -112.57 70.79 0.72 Allowed 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.997 0.903 . . . . 0.0 109.612 177.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.532 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -80.62 171.34 12.57 Favored Pre-proline 0 C--N 1.286 -2.157 0 O-C-N 121.277 -0.889 . . . . 0.0 112.173 -179.238 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.438 ' HB3' ' CG ' ' A' ' 141' ' ' ARG . 52.9 Cg_endo -84.22 97.79 0.73 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.11 1.058 . . . . 0.0 109.556 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' MET . . . . . 0.438 ' N ' HD23 ' A' ' 80' ' ' LEU . 2.8 ttt -97.39 95.76 7.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.11 -0.994 . . . . 0.0 110.641 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.87 95.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.062 -1.024 . . . . 0.0 110.689 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 82' ' ' MET . 93.7 t . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.903 . . . . 0.0 109.997 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.492 ' HA ' ' HB3' ' A' ' 140' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.405 ' O ' ' O ' ' A' ' 82' ' ' MET . 0.9 OUTLIER -127.66 14.92 7.03 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.501 ' O ' ' HD2' ' A' ' 139' ' ' PRO . 4.2 p -115.74 145.14 21.87 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 O-C-N 121.007 -1.058 . . . . 0.0 110.683 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.461 ' CB ' ' HA ' ' A' ' 134' ' ' PRO . 0.0 OUTLIER -123.87 -173.79 2.83 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.507 HG13 ' CG2' ' A' ' 137' ' ' VAL . 2.4 pp -145.8 122.82 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 C-N-CA 117.191 -1.803 . . . . 0.0 114.759 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.706 ' CA ' ' HG2' ' A' ' 133' ' ' ARG . 11.4 tm-20 -90.32 163.43 14.74 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.814 177.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.424 ' HB1' ' N ' ' A' ' 105' ' ' VAL . . . -51.73 88.18 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.63 -0.669 . . . . 0.0 112.546 -177.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 100' ' ' GLU . . . -84.19 -25.6 29.42 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 175.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.23 -6.5 11.31 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.748 -0.595 . . . . 0.0 110.115 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.52 27.47 0.97 Allowed Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.357 -1.401 . . . . 0.0 112.339 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.486 ' CB ' ' HA ' ' A' ' 117' ' ' THR . 7.0 m -139.88 123.53 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 120.954 -1.321 . . . . 0.0 110.655 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.401 ' HB ' ' HB3' ' A' ' 101' ' ' ALA . 10.9 t -148.21 63.86 1.1 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.713 -1.242 . . . . 0.0 111.618 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.418 ' C ' ' H ' ' A' ' 109' ' ' VAL . 6.3 t -131.41 -31.17 1.63 Allowed 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 118.438 -1.305 . . . . 0.0 110.331 177.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.425 ' HA2' ' NH1' ' A' ' 114' ' ' ARG . . . 60.7 -28.33 0.05 OUTLIER Glycine 0 N--CA 1.504 3.195 0 O-C-N 121.588 -0.695 . . . . 0.0 114.023 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.418 ' H ' ' C ' ' A' ' 107' ' ' THR . 11.1 t -125.46 55.82 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.225 -1.75 . . . . 0.0 110.127 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.597 ' O ' ' N ' ' A' ' 114' ' ' ARG . 9.3 t -133.99 71.41 1.46 Allowed 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.431 ' CB ' ' HB3' ' A' ' 55' ' ' MET . . . -25.74 -40.64 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.794 0 CA-C-O 121.59 0.71 . . . . 0.0 112.035 -177.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -69.22 -66.04 0.63 Allowed 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 122.562 1.172 . . . . 0.0 107.881 176.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 117' ' ' THR . 0.2 OUTLIER -64.41 -13.94 53.91 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.099 -1.001 . . . . 0.0 109.445 177.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 110' ' ' SER . 5.0 tpm_? -62.86 -42.92 99.94 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.2 -0.937 . . . . 0.0 108.707 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.487 ' CD1' ' N ' ' A' ' 115' ' ' ILE . 1.7 mp -76.75 -13.49 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 118.557 -1.257 . . . . 0.0 108.178 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.6 m -94.61 -20.92 19.17 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.23 -0.919 . . . . 0.0 108.828 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.488 ' N ' ' O ' ' A' ' 113' ' ' ASP . 26.0 p -83.73 -36.85 23.36 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.513 -0.742 . . . . 0.0 109.827 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.445 ' CB ' ' HB2' ' A' ' 50' ' ' MET . 14.2 p -73.99 -41.37 52.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 118.84 -1.144 . . . . 0.0 108.562 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.46 ' O ' ' CB ' ' A' ' 123' ' ' ALA . 3.3 ttt-85 -61.18 -31.41 71.16 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.133 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.427 ' CB ' HG13 ' A' ' 105' ' ' VAL . . . -95.34 -33.07 12.66 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.668 -0.645 . . . . 0.0 111.358 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.43 ' CB ' HD13 ' A' ' 99' ' ' ILE . . . -61.91 -58.16 8.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.027 -1.046 . . . . 0.0 109.712 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.424 ' CG2' ' HA ' ' A' ' 48' ' ' GLU . 0.7 OUTLIER -88.49 23.03 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.395 -0.815 . . . . 0.0 110.693 179.052 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 119' ' ' ARG . . . -95.96 114.81 26.56 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.583 ' C ' ' H ' ' A' ' 126' ' ' ALA . 5.4 t0 -89.99 -82.54 0.27 Allowed 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 117.783 -1.567 . . . . 0.0 113.405 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 124' ' ' ASP . . . 69.6 -43.36 0.46 Allowed Glycine 0 N--CA 1.513 3.797 0 N-CA-C 107.666 -2.173 . . . . 0.0 107.666 -176.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.583 ' H ' ' C ' ' A' ' 124' ' ' ASP . . . -135.72 165.71 24.94 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 103.578 -2.749 . . . . 0.0 103.578 176.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.439 ' C ' ' H ' ' A' ' 129' ' ' SER . 4.4 tttp -65.16 114.68 16.18 Favored Pre-proline 0 C--N 1.304 -1.411 0 CA-C-N 121.361 1.891 . . . . 0.0 108.094 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.483 ' HG2' HD11 ' A' ' 78' ' ' LEU . 35.1 Cg_endo -67.66 26.14 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.283 1.322 . . . . 0.0 112.18 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.439 ' H ' ' C ' ' A' ' 127' ' ' LYS . 0.3 OUTLIER -54.57 -10.16 0.4 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.464 -1.397 . . . . 0.0 111.176 -178.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.434 ' CB ' ' HA ' ' A' ' 102' ' ' ALA . 2.0 m-20 -72.3 9.04 1.11 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.601 -1.312 . . . . 0.0 110.417 177.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.475 ' CD2' ' CG2' ' A' ' 99' ' ' ILE . 4.7 tp -74.67 87.99 2.2 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.446 ' N ' ' HB3' ' A' ' 100' ' ' GLU . 1.6 t-20 -116.13 72.64 0.82 Allowed 'General case' 0 N--CA 1.509 2.501 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.706 ' HG2' ' CA ' ' A' ' 100' ' ' GLU 0.255 0.0 OUTLIER -97.58 -152.76 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.734 0 CA-C-O 115.115 -2.374 . . . . 0.0 110.168 179.163 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.658 ' HA ' ' HB3' ' A' ' 133' ' ' ARG . 56.5 Cg_endo -78.98 127.39 14.67 Favored 'Cis proline' 0 N--CA 1.524 3.31 0 N-CA-C 119.554 2.867 . . . . 0.0 119.554 18.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.592 ' CA ' ' HD2' ' A' ' 133' ' ' ARG . . . -126.99 71.87 0.47 Allowed Glycine 0 N--CA 1.511 3.655 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.338 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 49.3 m80 30.62 35.76 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.544 0 CA-C-O 121.418 0.628 . . . . 0.0 112.562 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.507 ' CG2' HG13 ' A' ' 99' ' ' ILE . 92.6 t -94.5 154.71 3.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.978 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 175.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.576 ' CD1' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -131.07 79.07 71.94 Favored Pre-proline 0 C--N 1.294 -1.822 0 C-N-CA 117.939 -1.505 . . . . 0.0 110.726 -176.698 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.501 ' HD2' ' O ' ' A' ' 97' ' ' VAL . 55.8 Cg_endo -107.61 156.44 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 123.515 2.81 . . . . 0.0 107.873 175.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.492 ' HB3' ' HA ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -145.93 140.81 27.21 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 120.722 -1.236 . . . . 0.0 109.715 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 143' ' ' GLN . 1.8 ptm180 -63.51 154.54 32.11 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.75 88.85 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.862 -1.135 . . . . 0.0 108.949 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 141' ' ' ARG . 0.1 OUTLIER -55.59 144.86 25.02 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.924 0.869 . . . . 0.0 111.021 -178.634 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . 0.412 ' N ' ' OE1' ' A' ' 143' ' ' GLN . . . -83.19 53.97 2.64 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.32 0.581 . . . . 0.0 109.504 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.49 ' N ' ' OG1' ' A' ' 154' ' ' THR . . . 147.2 19.8 0.1 Allowed Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.578 -1.296 . . . . 0.0 112.457 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.1 1.98 59.49 Favored Glycine 0 N--CA 1.503 3.138 0 C-N-CA 117.769 -2.158 . . . . 0.0 111.403 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 148' ' ' LEU . 0.3 OUTLIER -116.5 -43.77 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-O 123.943 1.83 . . . . 0.0 107.577 175.217 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.594 ' HA ' ' CD1' ' A' ' 202' ' ' ILE . 2.8 tp -111.6 70.03 0.7 Allowed 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.421 ' CG2' ' O ' ' A' ' 145' ' ' GLY . 46.7 p -77.07 63.39 2.34 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 125.243 2.449 . . . . 0.0 104.789 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.586 ' O ' ' N ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -153.58 155.31 35.9 Favored 'General case' 0 C--N 1.267 -2.993 0 N-CA-C 100.501 -3.888 . . . . 0.0 100.501 176.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.25 61.99 0.16 Allowed Glycine 0 C--N 1.261 -3.588 0 C-N-CA 117.144 -2.455 . . . . 0.0 109.386 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 150' ' ' ARG . . . -110.11 -161.57 18.56 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 120.198 -1.766 . . . . 0.0 110.696 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.649 ' O ' ' N ' ' A' ' 155' ' ' GLU . 10.7 t-80 -66.57 4.48 0.77 Allowed 'General case' 0 C--O 1.188 -2.173 0 CA-C-O 117.366 -1.302 . . . . 0.0 113.964 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.625 ' O ' ' N ' ' A' ' 157' ' ' THR . 15.0 t -24.23 -26.57 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.396 0 CA-C-N 120.797 1.635 . . . . 0.0 115.086 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.649 ' N ' ' O ' ' A' ' 153' ' ' HIS . 18.3 tt0 -56.32 -22.78 32.84 Favored 'General case' 0 N--CA 1.511 2.606 0 O-C-N 119.326 -2.109 . . . . 0.0 105.325 172.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.548 ' CA ' ' HB2' ' A' ' 159' ' ' ASP . . . -83.99 12.6 6.01 Favored 'General case' 0 C--O 1.206 -1.208 0 O-C-N 120.746 -1.221 . . . . 0.0 108.971 174.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.625 ' N ' ' O ' ' A' ' 154' ' ' THR . 20.5 m -63.71 -43.26 97.1 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 175.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.497 ' O ' ' HB3' ' A' ' 161' ' ' MET . 5.7 tp -70.19 -35.59 63.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 116.169 -2.212 . . . . 0.0 105.209 174.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.548 ' HB2' ' CA ' ' A' ' 156' ' ' ALA . 1.2 m-20 -59.1 -20.52 54.25 Favored 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 116.414 -2.114 . . . . 0.0 107.216 175.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.583 ' O ' ' HB2' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -61.87 -28.48 69.53 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 176.32 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.612 ' HB2' ' N ' ' A' ' 169' ' ' ALA . 3.2 ptt? -49.65 -34.29 17.9 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 174.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.486 ' CB ' ' O ' ' A' ' 159' ' ' ASP . 2.7 m -65.23 -29.52 70.32 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.093 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.583 ' HB2' ' O ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -41.7 -44.65 3.23 Favored 'General case' 0 N--CA 1.523 3.183 0 O-C-N 121.077 -1.014 . . . . 0.0 109.142 178.21 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -48.4 -29.15 3.73 Favored 'General case' 0 N--CA 1.517 2.89 0 CA-C-O 122.515 1.15 . . . . 0.0 109.753 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 106.44 -34.49 5.69 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.75 49.25 0.41 Allowed 'General case' 0 N--CA 1.508 2.472 0 C-N-CA 117.938 -1.505 . . . . 0.0 113.185 172.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.529 ' CB ' ' HB3' ' A' ' 46' ' ' PRO . 1.3 mmtt -135.02 124.11 16.28 Favored Pre-proline 0 C--N 1.292 -1.933 0 CA-C-O 116.305 -1.807 . . . . 0.0 106.872 175.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.43 ' HA ' ' HG3' ' A' ' 161' ' ' MET . 51.9 Cg_endo -91.6 75.94 0.59 Allowed 'Trans proline' 0 C--N 1.318 -1.068 0 C-N-CA 114.05 -3.5 . . . . 0.0 112.499 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.612 ' N ' ' HB2' ' A' ' 161' ' ' MET . . . -165.41 165.47 19.22 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 170.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.482 ' N ' ' HB2' ' A' ' 47' ' ' ALA . . . -139.45 129.02 4.19 Favored Glycine 0 N--CA 1.502 3.091 0 C-N-CA 118.596 -1.764 . . . . 0.0 109.737 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.49 ' O ' ' O ' ' A' ' 42' ' ' ASP . 5.5 p -133.09 95.07 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-N 119.664 1.732 . . . . 0.0 109.804 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 43' ' ' MET . 0.1 OUTLIER -95.08 143.34 26.61 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.605 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.455 ' HB3' ' CG1' ' A' ' 66' ' ' VAL . 5.6 p -107.43 175.05 5.62 Favored 'General case' 0 N--CA 1.515 2.78 0 O-C-N 120.632 -1.293 . . . . 0.0 112.175 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -143.71 119.01 10.2 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.313 -0.867 . . . . 0.0 111.558 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.401 ' CD2' ' SG ' ' A' ' 188' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.504 2.243 0 CA-C-O 121.821 0.82 . . . . 0.0 111.814 -178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.398 0.618 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . 0.426 ' CB ' ' SG ' ' A' ' 188' ' ' CYS . 3.4 mtp180 -147.14 161.95 39.85 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.338 -0.851 . . . . 0.0 109.036 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.542 ' CB ' ' CD ' ' A' ' 186' ' ' PRO . . . -145.87 -68.56 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.068 -1.02 . . . . 0.0 109.704 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . 0.542 ' CD ' ' CB ' ' A' ' 185' ' ' ALA . 45.0 Cg_endo -70.68 -36.99 7.5 Favored 'Trans proline' 0 C--N 1.316 -1.164 0 N-CA-C 109.11 -1.15 . . . . 0.0 109.11 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.402 ' HA ' ' HB2' ' A' ' 190' ' ' GLU . 0.2 OUTLIER -90.16 -16.85 28.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.632 -0.667 . . . . 0.0 109.942 179.197 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . 0.426 ' SG ' ' CB ' ' A' ' 184' ' ' ARG . 0.3 OUTLIER -60.67 -50.81 72.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.391 -0.818 . . . . 0.0 110.479 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.514 ' CG2' ' CD2' ' A' ' 199' ' ' LEU . 6.4 tp -94.77 -28.03 4.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.045 -1.034 . . . . 0.0 109.414 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' A' ' 194' ' ' LYS . 5.0 mm-40 -57.3 -19.99 25.57 Favored 'General case' 0 C--O 1.199 -1.591 0 O-C-N 120.578 -1.326 . . . . 0.0 107.688 175.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.513 ' CD2' ' N ' ' A' ' 192' ' ' ALA . 4.3 t80 -80.84 -62.25 1.72 Allowed 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 122.771 1.272 . . . . 0.0 108.89 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.513 ' N ' ' CD2' ' A' ' 191' ' ' PHE . . . -73.08 -38.53 66.38 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.483 -177.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . 0.521 ' HB3' ' HG ' ' A' ' 199' ' ' LEU . 12.0 m-20 -84.75 -25.12 28.48 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 118.968 -1.093 . . . . 0.0 112.557 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 190' ' ' GLU . 8.3 ttpt -61.76 -37.83 85.76 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 117.502 -1.679 . . . . 0.0 109.408 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -81.45 -51.64 8.1 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 116.206 -2.197 . . . . 0.0 112.085 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . 0.427 ' O ' ' CE ' ' A' ' 197' ' ' MET . 0.2 OUTLIER -112.89 33.2 5.16 Favored 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 117.792 -1.563 . . . . 0.0 113.736 177.647 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' MET . . . . . 0.507 ' HB3' ' CB ' ' A' ' 193' ' ' ASN . 0.0 OUTLIER -158.01 152.36 24.57 Favored 'General case' 0 N--CA 1.508 2.444 0 CA-C-N 121.209 1.822 . . . . 0.0 114.861 -179.104 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 28' ' ' GLY . . . -83.56 139.38 32.9 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 118.675 -1.21 . . . . 0.0 107.935 175.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.521 ' HG ' ' HB3' ' A' ' 193' ' ' ASN . 3.3 mt -118.96 113.66 21.34 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 120.165 -1.584 . . . . 0.0 112.293 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.484 ' CG1' ' O ' ' A' ' 30' ' ' MET . 8.7 p -124.89 177.59 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.661 0 O-C-N 121.243 -0.911 . . . . 0.0 108.615 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.42 ' O ' ' CB ' ' A' ' 205' ' ' LEU . 17.5 m -121.25 156.14 33.13 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.252 -1.53 . . . . 0.0 110.808 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.594 ' CD1' ' HA ' ' A' ' 148' ' ' LEU . 1.2 pp -61.21 -32.7 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 121.061 -1.024 . . . . 0.0 110.229 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 207' ' ' ALA . 2.3 tm-20 -42.28 -67.22 0.28 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.614 -0.679 . . . . 0.0 111.58 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.426 ' O ' ' CB ' ' A' ' 208' ' ' TYR . 3.4 m-20 -87.89 -10.47 50.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.078 -1.014 . . . . 0.0 110.766 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.56 ' O ' ' HB3' ' A' ' 208' ' ' TYR . 9.1 tt -84.38 -51.63 6.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 112.132 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.443 ' N ' HD22 ' A' ' 205' ' ' LEU . 0.1 OUTLIER -84.43 -27.91 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 119.942 -1.723 . . . . 0.0 107.539 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 203' ' ' GLU . . . -63.44 -31.59 72.79 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 173.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.662 ' CD2' ' CG1' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -58.3 -35.92 72.56 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.355 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -29.19 41.67 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.494 ' CG ' ' HB2' ' A' ' 153' ' ' HIS . 55.8 tt0 -69.28 -68.17 0.42 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 122.003 0.906 . . . . 0.0 108.654 178.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -48.66 -26.3 2.21 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.383 0.611 . . . . 0.0 110.23 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 10.3 t60 . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.344 -0.848 . . . . 0.0 110.173 179.655 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 N--CA 1.515 2.787 0 N-CA-C 108.468 -1.397 . . . . 0.0 108.468 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.599 ' O ' ' N ' ' A' ' 16' ' ' VAL 0.272 0.0 OUTLIER -46.75 -21.44 0.2 Allowed 'General case' 0 C--O 1.191 -1.977 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 169.886 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.426 ' HA ' ' HB2' ' A' ' 17' ' ' GLU . 32.6 tt0 -48.39 -39.8 23.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.073 -1.642 . . . . 0.0 108.334 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -42.73 99.71 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 175.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.599 ' N ' ' O ' ' A' ' 13' ' ' PHE . 0.4 OUTLIER -60.46 -34.9 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 118.979 -1.088 . . . . 0.0 108.218 175.577 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -51.92 -47.61 64.59 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.587 -1.321 . . . . 0.0 108.798 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.443 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 31.4 t-20 -53.27 -31.09 41.96 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 198' ' ' ALA . . . -89.56 -68.23 0.79 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 122.292 1.044 . . . . 0.0 110.358 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.558 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -47.98 -54.7 12.03 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.398 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.472 ' HA ' ' CB ' ' A' ' 24' ' ' ARG . . . -67.29 -41.59 85.15 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' A' ' 18' ' ' ASN . . . -32.63 -62.08 0.25 Allowed 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 121.045 0.45 . . . . 0.0 111.136 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.488 HD11 ' HA ' ' A' ' 197' ' ' MET . 2.4 mt -106.67 7.73 30.71 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.321 -1.352 . . . . 0.0 110.703 177.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.558 ' HB2' ' O ' ' A' ' 20' ' ' LEU . 59.3 ttp85 -55.26 -18.95 7.03 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.775 -1.203 . . . . 0.0 107.77 176.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -79.71 46.05 0.74 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 122.798 1.285 . . . . 0.0 109.839 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.495 ' HA2' ' CZ ' ' A' ' 45' ' ' PHE . . . 67.92 16.36 68.25 Favored Glycine 0 C--N 1.292 -1.897 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.991 176.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.447 ' O ' HD11 ' A' ' 23' ' ' LEU . 20.1 mtt180 -99.46 17.31 20.61 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 116.079 -2.248 . . . . 0.0 111.225 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 197' ' ' MET . . . 100.6 106.32 2.84 Favored Glycine 0 N--CA 1.496 2.685 0 C-N-CA 118.982 -1.58 . . . . 0.0 113.181 173.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.456 ' CG1' HG12 ' A' ' 44' ' ' ILE . 2.0 m -145.6 113.71 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 120.174 -1.78 . . . . 0.0 106.743 176.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.468 ' HA ' ' CB ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -75.27 75.17 2.39 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 116.104 -2.238 . . . . 0.0 107.72 -177.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.531 ' CG1' HG21 ' A' ' 200' ' ' VAL . 1.5 t . . . . . 0 C--N 1.287 -2.149 0 CA-C-N 113.773 -1.558 . . . . 0.0 108.17 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.559 ' HA ' ' CD1' ' A' ' 45' ' ' PHE . 25.4 t70 . . . . . 0 N--CA 1.497 1.883 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.468 ' CB ' ' HA ' ' A' ' 30' ' ' MET . 0.4 OUTLIER -81.45 17.16 1.44 Allowed 'General case' 0 N--CA 1.481 1.112 0 O-C-N 120.468 -1.395 . . . . 0.0 113.942 -177.388 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.517 ' CG2' ' CE1' ' A' ' 45' ' ' PHE . 5.2 tp -138.27 16.63 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.794 0 CA-C-O 121.792 0.806 . . . . 0.0 109.724 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.559 ' CD1' ' HA ' ' A' ' 42' ' ' ASP . 89.2 m-85 -107.81 160.1 28.02 Favored Pre-proline 0 N--CA 1.507 2.42 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -173.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -75.62 134.12 16.45 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 123.132 2.555 . . . . 0.0 111.974 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.467 ' CB ' ' CD1' ' A' ' 68' ' ' LEU . . . -50.71 -20.71 1.32 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.234 -0.917 . . . . 0.0 111.807 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -72.67 -26.81 61.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.044 -1.035 . . . . 0.0 110.562 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.492 ' O ' ' N ' ' A' ' 51' ' ' THR . 65.2 p -133.13 58.86 1.75 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . 0.462 ' O ' ' CG1' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -61.91 87.04 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.279 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.492 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -63.56 162.06 13.55 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 122.506 1.146 . . . . 0.0 112.109 -176.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.49 ' CG2' ' CB ' ' A' ' 111' ' ' ALA . 4.3 p -75.1 -2.22 3.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.142 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.473 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 23.8 mt-10 -46.28 -26.66 0.85 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.264 -0.897 . . . . 0.0 110.19 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.449 ' HG2' ' CG2' ' A' ' 66' ' ' VAL . 5.5 tp-100 -88.11 -49.85 6.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.526 -0.734 . . . . 0.0 109.32 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.445 ' O ' ' CG1' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -54.71 -47.09 74.14 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.578 -0.701 . . . . 0.0 109.785 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.04 -55.39 33.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 110.258 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.0 tt -59.27 -44.33 92.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.482 -0.761 . . . . 0.0 110.48 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.465 ' CG2' ' N ' ' A' ' 59' ' ' ILE . 3.0 t -74.94 -47.51 29.2 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.17 -0.956 . . . . 0.0 111.564 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.465 ' N ' ' CG2' ' A' ' 58' ' ' THR . 43.8 mt -47.97 -25.72 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.664 -1.272 . . . . 0.0 109.587 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -77.76 -47.85 18.01 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.49 -0.756 . . . . 0.0 110.826 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -125.31 -9.08 6.98 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 58' ' ' THR . . . -164.99 -168.16 26.7 Favored Glycine 0 N--CA 1.502 3.085 0 O-C-N 120.13 -1.606 . . . . 0.0 111.469 -177.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.1 t -133.11 103.26 5.93 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 101.71 -3.441 . . . . 0.0 101.71 176.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.449 ' N ' ' OG1' ' A' ' 58' ' ' THR . . . -104.63 73.76 0.24 Allowed Glycine 0 C--N 1.264 -3.447 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 -177.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.529 HG13 ' CD2' ' A' ' 138' ' ' PHE . 2.0 tp -64.26 97.2 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.822 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.597 ' O ' ' CD1' ' A' ' 138' ' ' PHE . 3.6 t -50.99 163.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.347 -177.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 80.3 m -111.19 114.81 28.3 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.031 0.919 . . . . 0.0 109.122 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 139' ' ' PRO . 0.1 OUTLIER -90.61 123.35 34.18 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.523 ' HB2' ' CG2' ' A' ' 157' ' ' THR . 0.1 OUTLIER -108.57 143.08 38.08 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 117.232 -1.787 . . . . 0.0 110.415 179.125 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.525 ' HB ' ' HB3' ' A' ' 75' ' ' ARG 0.25 2.0 pp -137.41 137.28 46.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.345 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.45 ' CG2' ' HB2' ' A' ' 75' ' ' ARG . 9.3 t -74.93 179.43 4.92 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.515 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 2.3 mp0 -90.48 -18.59 25.08 Favored 'General case' 0 C--N 1.275 -2.674 0 C-N-CA 119.366 -0.933 . . . . 0.0 110.815 -178.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.57 -74.68 0.19 Allowed 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.823 -1.151 . . . . 0.0 112.797 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -94.66 -37.74 11.17 Favored 'General case' 0 C--N 1.279 -2.463 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.294 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.525 ' HB3' ' HB ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -69.69 -24.84 63.64 Favored 'General case' 0 C--N 1.284 -2.269 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.543 -179.433 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 72' ' ' GLU . 7.5 tttt -81.41 -38.92 25.74 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 117.459 -1.696 . . . . 0.0 107.489 176.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -42.19 -42.39 3.0 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.409 0.623 . . . . 0.0 109.569 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.429 HD23 ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -107.87 -30.02 8.74 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.448 -1.301 . . . . 0.0 109.026 177.323 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.47 ' O ' ' CD1' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -114.15 69.12 0.7 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.724 178.004 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.515 ' HG ' ' CD ' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -111.45 149.05 40.08 Favored Pre-proline 0 C--N 1.295 -1.789 0 O-C-N 120.785 -1.197 . . . . 0.0 109.163 178.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.515 ' CD ' ' HG ' ' A' ' 80' ' ' LEU . 27.5 Cg_endo -50.86 96.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.187 0 O-C-N 123.393 1.207 . . . . 0.0 110.556 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.11 44.51 1.04 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.427 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 175.24 -54.89 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.138 -0.976 . . . . 0.0 109.73 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.532 ' CG2' ' HA ' ' A' ' 96' ' ' THR . 15.6 m . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.358 -0.839 . . . . 0.0 110.234 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.475 ' CE1' ' HB2' ' A' ' 138' ' ' PHE . 19.5 m-85 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.532 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . 70.4 p -118.05 -1.82 11.36 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.032 -1.467 . . . . 0.0 114.915 -177.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.478 ' HB ' ' HG2' ' A' ' 139' ' ' PRO . 1.8 t -121.89 86.52 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.268 -2.957 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.449 ' OG1' ' N ' ' A' ' 135' ' ' GLY . 8.9 t -73.71 123.87 24.92 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 176.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.512 ' HA ' ' HA ' ' A' ' 132' ' ' ASN . 7.7 pt -106.25 123.31 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.641 -1.287 . . . . 0.0 112.793 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 131' ' ' LEU . 0.2 OUTLIER -128.67 105.13 8.06 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.092 177.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.463 ' CA ' HD11 ' A' ' 131' ' ' LEU . . . -48.22 104.25 0.06 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 122.058 0.932 . . . . 0.0 110.62 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 130' ' ' ASP . . . -59.8 -10.9 4.31 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.285 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -0.49 14.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.987 -1.071 . . . . 0.0 111.285 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.76 27.41 0.96 Allowed Glycine 0 N--CA 1.494 2.563 0 C-N-CA 118.993 -1.575 . . . . 0.0 112.556 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.455 ' HB ' ' CB ' ' A' ' 101' ' ' ALA . 21.1 t -108.73 153.94 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.066 -1.255 . . . . 0.0 109.828 178.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.4 m -142.08 107.2 4.95 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 103.109 -2.922 . . . . 0.0 103.109 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.504 ' O ' ' C ' ' A' ' 108' ' ' GLY . 23.8 m -56.61 -24.71 49.77 Favored 'General case' 0 C--N 1.273 -2.736 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -175.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.842 ' O ' ' N ' ' A' ' 110' ' ' SER . . . 29.85 48.43 0.13 Allowed Glycine 0 N--CA 1.511 3.644 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 172.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.472 HG21 ' CG ' ' A' ' 136' ' ' HIS . 54.6 t -28.77 67.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.628 0 CA-C-O 125.289 2.471 . . . . 0.0 112.17 -168.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.842 ' N ' ' O ' ' A' ' 108' ' ' GLY . 7.8 t -130.88 65.32 1.55 Allowed 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 109.403 -3.544 . . . . 0.0 103.935 176.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.499 ' O ' ' HB ' ' A' ' 115' ' ' ILE . . . -30.02 -29.91 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.118 -1.401 . . . . 0.0 114.271 -175.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -62.0 -77.9 0.04 OUTLIER 'General case' 0 C--N 1.282 -2.346 0 O-C-N 120.198 -1.564 . . . . 0.0 109.584 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -75.03 -27.81 60.22 Favored 'General case' 0 C--N 1.289 -2.061 0 O-C-N 121.337 -0.852 . . . . 0.0 111.373 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.439 ' HG2' ' CA ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -83.0 -38.54 22.5 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.334 -178.347 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.499 ' HB ' ' O ' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -66.42 -12.84 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 116.849 -1.941 . . . . 0.0 108.013 178.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.5 m -74.35 -50.54 18.27 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 121' ' ' ALA . 3.9 p -70.63 -22.43 62.52 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.189 -0.944 . . . . 0.0 109.387 178.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.431 HG12 ' CG ' ' A' ' 50' ' ' MET . 63.0 t -66.8 -51.6 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.274 -0.891 . . . . 0.0 109.741 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.43 ' HG2' ' CG2' ' A' ' 49' ' ' THR . 5.5 ttp180 -51.53 -40.54 59.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.518 -0.739 . . . . 0.0 109.955 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.21 -8.49 39.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.583 -0.698 . . . . 0.0 110.572 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 117' ' ' THR . . . -68.31 -44.5 75.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.055 -1.028 . . . . 0.0 111.183 -178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 4.6 mt -83.3 9.34 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.542 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -107.08 71.43 0.83 Allowed 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.774 -1.171 . . . . 0.0 110.556 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.447 ' CB ' ' HD3' ' A' ' 127' ' ' LYS . 0.5 OUTLIER -99.0 -44.38 6.33 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.527 1.156 . . . . 0.0 109.319 177.6 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 124.64 -39.91 2.02 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 105.94 -2.864 . . . . 0.0 105.94 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -135.48 95.1 3.2 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.454 ' N ' ' CD ' ' A' ' 128' ' ' PRO . 7.7 tptt -136.57 53.45 7.49 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 120.784 -1.198 . . . . 0.0 109.761 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 127' ' ' LYS . 49.5 Cg_endo -77.4 -35.14 1.73 Allowed 'Trans proline' 0 C--N 1.3 -1.999 0 N-CA-C 107.552 -1.749 . . . . 0.0 107.552 178.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.3 p -125.86 -17.82 5.28 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.019 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.45 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -77.29 9.6 3.05 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.739 -1.226 . . . . 0.0 112.896 -177.359 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -140.94 74.79 1.47 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.541 -1.349 . . . . 0.0 109.561 179.04 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 0.7 OUTLIER -144.0 48.9 1.38 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.439 -1.413 . . . . 0.0 114.239 176.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.421 ' C ' ' CB ' ' A' ' 100' ' ' GLU . 2.1 mtm180 177.25 108.01 0.12 Allowed Pre-proline 0 N--CA 1.516 2.844 0 CA-C-N 121.897 2.135 . . . . 0.0 112.947 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -126.26 129.05 0.03 OUTLIER 'Cis proline' 0 C--N 1.312 -1.394 0 N-CA-C 103.557 -3.286 . . . . 0.0 103.557 -8.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 137' ' ' VAL . . . -113.65 33.36 5.54 Favored Glycine 0 N--CA 1.503 3.163 0 C-N-CA 117.54 -2.267 . . . . 0.0 113.791 -175.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.472 ' CG ' HG21 ' A' ' 109' ' ' VAL . 14.6 m-70 32.11 37.95 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.903 0 CA-C-N 119.049 1.424 . . . . 0.0 110.311 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.488 ' CG2' ' CG1' ' A' ' 99' ' ' ILE . 54.2 t -86.87 156.12 3.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.597 ' CD1' ' O ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -124.79 79.46 63.7 Favored Pre-proline 0 C--N 1.284 -2.275 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -178.641 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 52.0 Cg_endo -108.79 124.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.074 1.849 . . . . 0.0 110.83 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 140' ' ' LEU . 1.1 pp -128.99 136.82 50.85 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 119.485 -0.886 . . . . 0.0 108.898 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.469 ' CG ' ' CG ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -63.66 137.06 57.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.615 -1.303 . . . . 0.0 108.404 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.478 ' CB ' ' CG2' ' A' ' 158' ' ' ILE . . . -131.26 133.55 45.55 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.094 -1.043 . . . . 0.0 112.15 -178.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.16 143.46 45.24 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.537 -0.727 . . . . 0.0 109.724 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.48 115.71 8.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.478 -0.764 . . . . 0.0 110.6 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 86.93 14.93 63.87 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.14 13.64 63.15 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.489 HG23 ' CB ' ' A' ' 156' ' ' ALA . 14.5 p -89.94 -4.72 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.872 -1.37 . . . . 0.0 110.157 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.451 ' HG ' ' CG1' ' A' ' 206' ' ' VAL . 1.2 mp -90.06 17.56 6.8 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 116.139 -2.224 . . . . 0.0 110.148 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.4 p -130.59 60.99 1.62 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 101.171 -3.64 . . . . 0.0 101.171 168.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.436 ' HG3' ' CG ' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -149.97 140.49 22.47 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 113.794 -1.548 . . . . 0.0 112.755 -178.433 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.428 ' N ' ' HD3' ' A' ' 150' ' ' ARG . . . -104.0 35.09 5.28 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 106.148 -2.781 . . . . 0.0 106.148 173.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.24 163.35 27.8 Favored Glycine 0 N--CA 1.479 1.509 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' HIS . . . . . 0.479 ' CD2' HD11 ' A' ' 172' ' ' LEU . 2.8 p-80 -90.84 -5.03 56.12 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.646 -0.914 . . . . 0.0 109.552 177.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 60.0 p -53.37 -59.25 4.81 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.003 -1.061 . . . . 0.0 109.766 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 159' ' ' ASP . 63.3 mm-40 -59.59 -21.34 60.22 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.489 ' CB ' HG23 ' A' ' 147' ' ' VAL . . . -85.56 6.76 25.77 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.695 ' O ' ' HB3' ' A' ' 160' ' ' LEU . 27.3 m -91.99 -36.5 13.38 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.478 ' CG2' ' CB ' ' A' ' 142' ' ' ALA . 3.2 tp -85.83 -31.44 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 173.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 155' ' ' GLU . 1.7 t70 -56.68 -34.06 67.03 Favored 'General case' 0 C--O 1.199 -1.553 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 174.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.695 ' HB3' ' O ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -45.05 -37.42 4.14 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.349 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' MET . . . . . 0.571 ' HA ' ' HA ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -50.26 -45.33 54.12 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.871 178.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.442 HG23 ' NE ' ' A' ' 209' ' ' ARG . 4.3 t -97.56 -31.69 12.19 Favored 'General case' 0 N--CA 1.509 2.478 0 CA-C-O 121.895 0.855 . . . . 0.0 111.5 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.589 ' CB ' ' HA ' ' A' ' 160' ' ' LEU 0.272 0.2 OUTLIER -42.98 -58.11 2.56 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -178.58 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -110.13 2.24 19.31 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 118.874 -1.13 . . . . 0.0 113.003 -176.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 96.08 -19.2 55.51 Favored Glycine 0 C--N 1.29 -1.999 0 N-CA-C 108.21 -1.956 . . . . 0.0 108.21 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' PHE . . . . . 0.641 ' C ' ' HD3' ' A' ' 168' ' ' PRO . 0.1 OUTLIER -76.95 137.21 38.91 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.14 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 161' ' ' MET . 2.4 ttmt -121.55 56.47 6.37 Favored Pre-proline 0 C--N 1.31 -1.12 0 O-C-N 120.745 -1.222 . . . . 0.0 110.47 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.641 ' HD3' ' C ' ' A' ' 166' ' ' PHE . 56.5 Cg_endo -108.93 175.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.301 -1.966 0 N-CA-C 107.731 -1.681 . . . . 0.0 107.731 177.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' A' ' 47' ' ' ALA . . . -85.53 104.82 15.65 Favored 'General case' 0 C--N 1.261 -3.247 0 N-CA-C 101.42 -3.548 . . . . 0.0 101.42 173.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.443 ' O ' ' CG2' ' A' ' 157' ' ' THR . . . -93.75 154.52 21.68 Favored Glycine 0 C--N 1.297 -1.617 0 C-N-CA 119.048 -1.549 . . . . 0.0 111.103 -173.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 171' ' ' VAL 0.261 5.6 p -124.05 95.56 3.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LEU . . . . . 0.503 HD23 ' CG2' ' A' ' 157' ' ' THR . 0.3 OUTLIER -114.81 114.74 25.95 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 119.93 -1.731 . . . . 0.0 111.018 -178.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.464 ' HB2' ' CG2' ' A' ' 66' ' ' VAL . 4.9 t -109.79 175.64 5.37 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.547 -1.346 . . . . 0.0 110.943 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.73 -147.93 0.41 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.41 -0.806 . . . . 0.0 109.888 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.446 ' CB ' ' HA ' ' A' ' 189' ' ' ILE . 2.1 tm? . . . . . 0 N--CA 1.497 1.908 0 O-C-N 121.193 -0.942 . . . . 0.0 109.404 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.234 0.54 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ARG . . . . . 0.417 ' CG ' ' O ' ' A' ' 184' ' ' ARG . 2.9 ppt_? -139.98 100.45 3.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.304 -0.872 . . . . 0.0 109.911 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . 179.25 173.57 0.44 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.337 -0.852 . . . . 0.0 110.003 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.73 -11.59 26.04 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.644 1.339 . . . . 0.0 110.76 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -84.93 -63.37 1.34 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.063 -1.023 . . . . 0.0 110.522 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' CYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 191' ' ' PHE . 21.5 p -52.37 -37.56 56.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.01 . . . . 0.0 109.718 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.45 HG13 ' CD1' ' A' ' 199' ' ' LEU . 8.0 tp -73.62 -28.33 24.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 120.604 -1.31 . . . . 0.0 108.27 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -58.85 -20.0 46.82 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.126 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' PHE . . . . . 0.45 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.1 OUTLIER -75.34 -51.06 14.07 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.72 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . 0.427 ' HB2' ' CE ' ' A' ' 197' ' ' MET . . . -62.51 -38.5 90.18 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ASN . . . . . 0.51 ' HA ' ' CB ' ' A' ' 197' ' ' MET . 0.0 OUTLIER -64.52 -15.98 61.8 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.103 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.45 -36.75 22.1 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 117.892 -1.523 . . . . 0.0 112.477 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -104.33 -53.59 2.69 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 115.719 -2.392 . . . . 0.0 111.519 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -113.97 32.99 5.49 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.025 -1.47 . . . . 0.0 113.754 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' MET . . . . . 0.51 ' CB ' ' HA ' ' A' ' 193' ' ' ASN . 2.5 ttp -153.67 145.15 23.19 Favored 'General case' 0 N--CA 1.512 2.645 0 C-N-CA 115.065 -2.654 . . . . 0.0 115.441 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.487 ' CB ' ' HB2' ' A' ' 23' ' ' LEU . . . -91.4 142.88 27.2 Favored 'General case' 0 N--CA 1.51 2.568 0 O-C-N 120.884 -1.135 . . . . 0.0 108.128 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.45 ' CD1' HG13 ' A' ' 189' ' ' ILE . 3.0 tp -131.55 94.09 3.47 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.495 -1.378 . . . . 0.0 114.498 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.531 HG21 ' CG1' ' A' ' 31' ' ' VAL 0.253 6.8 m -57.87 -168.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 120.496 -1.378 . . . . 0.0 107.525 175.31 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 205' ' ' LEU . 23.8 m -119.03 110.59 17.28 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 174.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.4 ' HA ' ' HB3' ' A' ' 205' ' ' LEU . 16.6 mt -49.62 -21.99 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.343 -0.848 . . . . 0.0 111.838 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -66.64 0.52 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.814 -1.179 . . . . 0.0 109.334 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.463 ' O ' ' CE1' ' A' ' 208' ' ' TYR . 1.7 m-20 -66.14 -32.82 74.49 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.015 -1.053 . . . . 0.0 109.076 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.761 ' HA ' ' CE2' ' A' ' 208' ' ' TYR . 6.7 tt -45.86 -69.53 0.13 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 123.084 1.421 . . . . 0.0 112.459 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . 0.474 ' N ' HD23 ' A' ' 205' ' ' LEU . 1.4 t -68.42 -11.37 14.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 C-N-CA 117.758 -1.577 . . . . 0.0 108.845 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 204' ' ' ASP . . . -58.64 -30.49 67.33 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 175.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' TYR . . . . . 0.761 ' CE2' ' HA ' ' A' ' 205' ' ' LEU . 1.5 m-85 -62.59 -48.19 80.52 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 177.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ARG . . . . . 0.442 ' NE ' HG23 ' A' ' 162' ' ' THR . 17.8 tpt180 -65.56 -29.16 69.74 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.779 -1.168 . . . . 0.0 109.746 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -73.02 -35.29 66.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.03 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -73.57 -27.05 61.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.364 -0.835 . . . . 0.0 110.039 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 110.087 179.868 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.445 ' SD ' ' CE1' ' A' ' 195' ' ' HIS . 1.6 mtt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.223 0.535 . . . . 0.0 110.234 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.7 56.41 2.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.313 -0.867 . . . . 0.0 110.201 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.431 ' CB ' ' HG3' ' A' ' 194' ' ' LYS . 0.0 OUTLIER -94.11 -22.49 18.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.253 -0.905 . . . . 0.0 110.215 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 p -73.19 -4.75 34.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.882 . . . . 0.0 110.721 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.436 ' CB ' ' CB ' ' A' ' 198' ' ' ALA . 4.3 mm? -50.54 -59.9 3.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.908 -1.12 . . . . 0.0 110.665 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.469 ' CD1' ' HB3' ' A' ' 198' ' ' ALA . 0.3 OUTLIER -116.16 8.65 14.46 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.309 -0.869 . . . . 0.0 110.641 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.7 t -92.18 -64.68 1.08 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.842 -1.161 . . . . 0.0 110.146 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.6 t -92.36 3.94 54.41 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.326 -0.859 . . . . 0.0 109.173 177.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -142.03 73.62 1.42 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' CA ' ' HB2' ' A' ' 15' ' ' ARG . . . -164.49 97.2 0.14 Allowed Glycine 0 C--N 1.291 -1.955 0 N-CA-C 106.608 -2.597 . . . . 0.0 106.608 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.436 ' H ' ' HB2' ' A' ' 15' ' ' ARG . 0.4 OUTLIER -127.0 141.62 41.21 Favored Pre-proline 0 C--N 1.27 -2.872 1 N-CA-C 100.116 -4.031 . . . . 0.0 100.116 176.623 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.539 ' O ' ' CG1' ' A' ' 16' ' ' VAL . 28.2 Cg_endo -50.4 -46.12 30.79 Favored 'Trans proline' 0 C--N 1.273 -3.437 0 O-C-N 122.847 0.92 . . . . 0.0 110.928 -176.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -95.46 -46.36 6.72 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -77.4 -62.63 1.6 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 118.353 -1.339 . . . . 0.0 112.384 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.457 ' HB2' ' CA ' ' A' ' 10' ' ' GLY . 26.3 mmm180 -85.58 -10.15 56.31 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 117.538 -1.665 . . . . 0.0 112.981 -177.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.569 HG11 ' CD2' ' A' ' 208' ' ' TYR . 0.4 OUTLIER -85.93 -26.04 6.44 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.489 0 C-N-CA 114.386 -2.926 . . . . 0.0 108.391 176.11 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.72 -48.89 62.67 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 116.74 -1.984 . . . . 0.0 107.409 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -65.6 -33.2 75.35 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.524 -0.735 . . . . 0.0 109.36 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.423 ' O ' ' CD2' ' A' ' 23' ' ' LEU . . . -81.75 -22.03 37.49 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.182 -0.949 . . . . 0.0 109.234 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.536 ' HB2' ' O ' ' A' ' 16' ' ' VAL . 0.1 OUTLIER -53.89 -50.42 66.36 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.175 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.61 -51.51 55.5 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.234 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -47.31 -45.4 24.27 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.519 -0.738 . . . . 0.0 110.507 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.472 ' HB2' ' HB ' ' A' ' 29' ' ' VAL . 3.3 pp -91.08 -17.15 26.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.306 -0.871 . . . . 0.0 110.192 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 20' ' ' LEU . 0.9 OUTLIER -54.72 -23.05 15.92 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.273 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.4 41.98 1.11 Allowed 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 118.23 -1.388 . . . . 0.0 110.167 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.511 ' HA3' ' CZ ' ' A' ' 45' ' ' PHE . . . 53.83 31.79 47.12 Favored Glycine 0 C--N 1.291 -1.953 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 176.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -85.3 19.78 2.18 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 116.859 -1.937 . . . . 0.0 110.859 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.41 ' O ' ' HB3' ' A' ' 198' ' ' ALA . . . 98.3 105.73 2.51 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 119.524 -1.322 . . . . 0.0 113.085 173.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.473 ' CG1' ' HB ' ' A' ' 44' ' ' ILE . 3.2 p -145.33 118.65 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-N 120.096 1.948 . . . . 0.0 109.968 176.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.523 ' HB2' ' HA ' ' A' ' 42' ' ' ASP . 1.5 tmt? -105.78 151.78 24.05 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.063 -1.023 . . . . 0.0 110.69 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.455 HG13 ' CD2' ' A' ' 172' ' ' LEU . 4.5 p -124.44 115.27 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.898 -1.126 . . . . 0.0 109.504 177.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.44 ' HB3' ' CE ' ' A' ' 30' ' ' MET . 0.6 OUTLIER -105.47 152.46 22.99 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.711 -1.243 . . . . 0.0 110.674 -179.246 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.41 ' OD1' ' CG2' ' A' ' 202' ' ' ILE . 20.4 t0 -133.15 179.72 6.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.396 -0.815 . . . . 0.0 110.203 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -109.77 78.25 1.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.211 -0.93 . . . . 0.0 110.16 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -147.78 -166.11 2.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.283 -0.886 . . . . 0.0 110.191 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -96.31 -62.92 1.2 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.917 . . . . 0.0 110.235 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.2 139.2 29.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.257 -0.902 . . . . 0.0 110.188 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -129.05 141.82 51.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 110.255 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -173.28 -70.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.874 . . . . 0.0 110.118 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.467 ' OE2' ' CD2' ' A' ' 153' ' ' HIS . 14.0 mp0 -53.94 139.19 34.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 110.112 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.432 ' CA ' ' O ' ' A' ' 173' ' ' CYS . . . -175.93 -141.42 3.82 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 118.76 -1.686 . . . . 0.0 112.134 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.523 ' HA ' ' HB2' ' A' ' 30' ' ' MET . 2.7 p30 -45.26 -20.11 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.372 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.539 ' O ' ' O ' ' A' ' 171' ' ' VAL . 1.8 ttm -93.88 47.07 1.2 Allowed 'General case' 0 C--N 1.288 -2.104 0 O-C-N 120.886 -1.134 . . . . 0.0 113.778 -177.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.48 ' HA ' ' HG ' ' A' ' 172' ' ' LEU . 73.4 mt -68.49 20.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.534 3.75 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.524 ' CD1' ' CG ' ' A' ' 54' ' ' GLN . 2.3 m-85 -66.59 162.38 51.07 Favored Pre-proline 0 C--N 1.279 -2.472 0 O-C-N 121.008 -1.057 . . . . 0.0 113.631 -176.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.464 ' HD2' ' CD2' ' A' ' 45' ' ' PHE . 43.8 Cg_endo -66.92 133.73 32.2 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.895 2.397 . . . . 0.0 111.902 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.511 ' N ' ' HA2' ' A' ' 170' ' ' GLY . . . -65.76 -7.21 14.6 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.405 -0.81 . . . . 0.0 112.751 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.441 ' HB2' ' CB ' ' A' ' 123' ' ' ALA . 0.3 OUTLIER -109.99 -14.97 14.16 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.726 -1.234 . . . . 0.0 111.35 -179.307 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 51' ' ' THR . 25.2 m -132.62 59.73 1.72 Allowed 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.431 ' O ' ' CG2' ' A' ' 115' ' ' ILE . 6.3 mtp -62.67 86.08 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.469 ' N ' ' O ' ' A' ' 49' ' ' THR . 1.7 m -63.99 170.41 3.56 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.773 0.797 . . . . 0.0 110.217 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.441 ' CG2' HD11 ' A' ' 115' ' ' ILE . 7.0 t -85.31 -3.72 8.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 121.731 -0.606 . . . . 0.0 109.586 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -52.86 -39.8 62.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.844 -1.16 . . . . 0.0 108.867 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.524 ' CG ' ' CD1' ' A' ' 45' ' ' PHE . 17.6 mm-40 -82.08 -39.04 23.98 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.449 ' HB3' ' CB ' ' A' ' 111' ' ' ALA . 19.0 mmt -57.24 -39.11 74.89 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.097 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.05 -54.29 48.62 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.213 -0.93 . . . . 0.0 108.649 178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.432 HD12 ' CE ' ' A' ' 197' ' ' MET . 6.2 tt -63.8 -22.01 66.71 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.699 -0.801 . . . . 0.0 109.464 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.424 ' HB ' ' HA ' ' A' ' 55' ' ' MET . 1.1 m -88.64 -22.8 23.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -0.795 . . . . 0.0 110.265 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.433 ' N ' ' O ' ' A' ' 55' ' ' MET . 22.7 mt -76.83 -23.1 15.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.045 -1.035 . . . . 0.0 109.322 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.53 -64.07 1.1 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.406 -0.809 . . . . 0.0 110.659 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -125.98 42.87 3.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.157 -0.964 . . . . 0.0 111.666 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 58' ' ' THR . . . -155.2 -175.39 26.2 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 119.166 -1.492 . . . . 0.0 109.741 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.424 ' O ' ' CG2' ' A' ' 58' ' ' THR . 16.8 t -128.37 178.62 6.15 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.11 67.45 0.26 Allowed Glycine 1 C--N 1.253 -4.062 0 N-CA-C 107.42 -2.272 . . . . 0.0 107.42 178.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.408 HG23 ' CE1' ' A' ' 138' ' ' PHE . 25.1 mm -133.25 84.41 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 114.11 -1.045 . . . . 0.0 108.413 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.493 ' O ' ' CZ ' ' A' ' 138' ' ' PHE . 29.4 m -103.65 152.55 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.55 -0.719 . . . . 0.0 111.591 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.468 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 5.3 t -77.55 122.08 24.77 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.081 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.503 ' O ' ' HA ' ' A' ' 139' ' ' PRO . 3.1 mm? -87.21 126.24 34.69 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 122.174 0.988 . . . . 0.0 109.404 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.492 ' HB3' ' HA ' ' A' ' 158' ' ' ILE . 3.6 m -89.59 125.08 35.09 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.763 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 158' ' ' ILE . 16.7 tt -138.74 129.46 34.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.083 -1.01 . . . . 0.0 109.853 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.425 ' OG1' ' CG1' ' A' ' 158' ' ' ILE . 1.2 m -89.22 160.37 16.98 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.095 -1.003 . . . . 0.0 109.942 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.417 ' HA ' ' NH1' ' A' ' 75' ' ' ARG . 9.1 pt-20 -50.9 -24.42 3.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.442 -0.786 . . . . 0.0 110.142 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.47 -32.9 19.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 110.041 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.61 -49.7 74.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 109.939 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.464 ' CD ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -70.91 -34.68 71.77 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.187 0.994 . . . . 0.0 108.565 179.113 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.649 ' O ' ' N ' ' A' ' 79' ' ' ASP . 3.0 tttp -53.38 -66.17 0.44 Allowed 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -46.34 -32.7 3.33 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 124.039 0.837 . . . . 0.0 109.431 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.582 ' O ' ' N ' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -97.74 43.65 1.06 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 176.059 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 76' ' ' LYS . 11.6 t70 -28.97 76.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 123.553 1.644 . . . . 0.0 113.031 -172.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.582 ' N ' ' O ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -151.25 100.05 3.02 Favored Pre-proline 0 C--N 1.283 -2.304 0 CA-C-N 112.765 -2.016 . . . . 0.0 110.314 177.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -106.62 92.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 N-CA-C 108.808 -1.266 . . . . 0.0 108.808 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.509 ' CB ' ' CG1' ' A' ' 97' ' ' VAL . 3.6 mtt -103.12 46.01 0.94 Allowed 'General case' 0 N--CA 1.483 1.215 0 O-C-N 120.588 -1.32 . . . . 0.0 108.723 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.91 123.54 2.37 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.038 0.447 . . . . 0.0 110.23 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.479 HG22 ' CB ' ' A' ' 95' ' ' PHE . 32.8 m -83.36 104.39 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 118.614 -1.235 . . . . 0.0 110.61 -178.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 87' ' ' ASN . 7.0 pt-20 -101.48 44.16 1.03 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.502 0.668 . . . . 0.0 109.204 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.432 ' CB ' ' HB1' ' A' ' 90' ' ' ALA . 10.8 m-20 -61.59 81.05 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.62 0.724 . . . . 0.0 110.982 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.442 ' O ' ' CB ' ' A' ' 88' ' ' THR . 9.3 t-20 -46.19 118.22 1.83 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.622 -0.673 . . . . 0.0 110.89 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.442 ' CB ' ' O ' ' A' ' 87' ' ' ASN . 1.9 m 74.9 -55.38 0.65 Allowed 'General case' 0 N--CA 1.507 2.401 0 O-C-N 121.736 -0.603 . . . . 0.0 110.171 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.72 -25.07 6.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.927 -1.108 . . . . 0.0 109.559 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.439 ' CB ' HG21 ' A' ' 93' ' ' THR . . . -144.71 125.44 14.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.614 -0.679 . . . . 0.0 109.414 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -68.18 67.67 0.12 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.232 -0.917 . . . . 0.0 110.724 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 90' ' ' ALA . . . 51.99 39.03 48.13 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.439 HG21 ' CB ' ' A' ' 90' ' ' ALA . 10.2 t -57.61 -18.16 18.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.348 -1.089 . . . . 0.0 110.776 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.427 ' N ' HG23 ' A' ' 93' ' ' THR . . . 48.44 24.89 4.08 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.479 ' CB ' HG22 ' A' ' 84' ' ' VAL . 0.6 OUTLIER -58.6 100.14 0.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.309 -1.113 . . . . 0.0 112.246 -178.484 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.428 ' CG2' ' O ' ' A' ' 139' ' ' PRO . 35.3 m -59.66 81.05 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.274 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.509 ' CG1' ' CB ' ' A' ' 82' ' ' MET . 7.4 p -33.48 151.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 CA-C-O 122.577 1.18 . . . . 0.0 113.085 -174.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 137' ' ' VAL . 51.1 p -69.67 -178.38 1.46 Allowed 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.535 -175.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.508 ' HB ' ' HG ' ' A' ' 131' ' ' LEU . 16.0 pt -146.99 131.64 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.508 ' HB2' ' HA ' ' A' ' 133' ' ' ARG . 3.6 tt0 -103.54 125.12 49.9 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.069 -1.452 . . . . 0.0 113.491 -176.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.53 ' HA ' ' CD1' ' A' ' 131' ' ' LEU . . . -51.37 95.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.473 -0.767 . . . . 0.0 110.855 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 100' ' ' GLU . . . -80.5 2.63 24.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.629 -0.669 . . . . 0.0 110.14 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.444 ' CB ' ' HA ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -86.42 15.29 5.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.078 -1.014 . . . . 0.0 110.931 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.7 25.02 1.17 Allowed Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.522 -1.323 . . . . 0.0 112.11 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.485 HG21 ' CB ' ' A' ' 117' ' ' THR . 13.0 t -130.17 121.83 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.156 -1.202 . . . . 0.0 109.195 177.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 p -145.91 59.06 1.24 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.594 -1.316 . . . . 0.0 111.523 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.422 ' CG2' ' OG ' ' A' ' 110' ' ' SER . 1.6 m -138.91 -31.97 0.7 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.805 -1.184 . . . . 0.0 110.983 176.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.23 -32.25 1.12 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.14 57.21 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.733 -1.451 . . . . 0.0 109.375 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.46 ' O ' ' N ' ' A' ' 112' ' ' ALA . 1.2 m -129.87 57.44 1.68 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.201 -0.937 . . . . 0.0 109.257 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.449 ' CB ' ' HB3' ' A' ' 55' ' ' MET . . . -34.81 -29.85 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -82.41 -74.86 0.33 Allowed 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.063 -1.023 . . . . 0.0 110.157 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -67.07 -15.62 63.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.564 -0.71 . . . . 0.0 110.87 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.458 ' CB ' ' O ' ' A' ' 110' ' ' SER . 51.2 ttt85 -87.84 -46.79 9.12 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.057 -1.027 . . . . 0.0 110.032 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.487 HD11 HG23 ' A' ' 115' ' ' ILE . 35.1 mt -66.07 -10.96 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.679 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.7 m -87.69 -52.5 5.28 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.485 ' CB ' HG21 ' A' ' 105' ' ' VAL . 9.3 p -72.62 -42.9 63.96 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.692 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.447 ' N ' HG21 ' A' ' 105' ' ' VAL . 47.6 t -57.19 -43.45 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.876 -1.14 . . . . 0.0 108.811 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -49.33 -39.38 31.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.348 -0.845 . . . . 0.0 109.307 178.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.74 -11.62 24.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.709 -0.619 . . . . 0.0 111.043 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 117' ' ' THR . . . -97.25 -59.93 1.69 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.857 -1.152 . . . . 0.0 112.68 -177.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.435 HG21 ' CG1' ' A' ' 118' ' ' VAL . 19.1 tt -66.7 -19.8 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 120.41 -1.431 . . . . 0.0 108.849 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.441 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . . . -106.58 72.49 0.91 Allowed 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.506 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.426 ' HB3' ' CG ' ' A' ' 127' ' ' LYS . 11.8 t0 -98.41 -53.1 3.43 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.335 1.064 . . . . 0.0 110.077 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 124.08 -37.28 2.71 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 106.169 -2.773 . . . . 0.0 106.169 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -132.98 100.51 4.91 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.431 ' N ' ' CD ' ' A' ' 128' ' ' PRO . 23.4 mtpp -130.98 54.55 15.08 Favored Pre-proline 0 C--N 1.307 -1.242 0 O-C-N 120.773 -1.204 . . . . 0.0 110.92 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 127' ' ' LYS . 44.1 Cg_endo -72.05 -26.47 18.28 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 N-CA-C 106.921 -1.992 . . . . 0.0 106.921 176.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.79 -18.09 6.15 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.043 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.427 ' HB3' ' NZ ' ' A' ' 127' ' ' LYS . 27.6 m-20 -78.24 9.82 3.5 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.8 -1.187 . . . . 0.0 112.27 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.53 ' CD1' ' HA ' ' A' ' 101' ' ' ALA . 2.6 tp -135.08 89.62 2.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.882 -1.136 . . . . 0.0 108.566 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.506 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 36.4 p-10 -116.38 107.6 15.01 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.373 -0.829 . . . . 0.0 111.933 -178.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.677 ' HB2' ' HA ' ' A' ' 134' ' ' PRO 0.269 4.9 ppt_? -82.89 179.93 1.74 Allowed Pre-proline 0 N--CA 1.499 1.976 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.646 -177.525 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.677 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 48.8 Cg_endo -71.68 124.96 9.07 Favored 'Cis proline' 0 N--CA 1.504 2.122 0 C-N-CA 123.352 -1.52 . . . . 0.0 112.299 8.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 137' ' ' VAL . . . -123.98 39.9 2.06 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 53.1 m80 31.21 38.22 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 122.162 0.982 . . . . 0.0 111.914 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 98' ' ' THR . 54.5 t -126.85 103.11 10.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 176.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.493 ' CZ ' ' O ' ' A' ' 66' ' ' VAL . 6.3 p90 -107.52 89.35 4.93 Favored Pre-proline 0 N--CA 1.492 1.659 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.962 -175.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 56.0 Cg_endo -77.34 124.42 7.13 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 124.125 1.592 . . . . 0.0 110.366 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.1 tp -102.65 126.53 49.78 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 56.3 ttp85 -63.64 117.91 7.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.061 -1.024 . . . . 0.0 109.958 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.438 ' CB ' ' HA ' ' A' ' 155' ' ' GLU . . . -130.03 134.17 47.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.578 -0.701 . . . . 0.0 110.516 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.418 ' O ' ' CG2' ' A' ' 158' ' ' ILE . 0.3 OUTLIER -56.26 133.03 52.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.829 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.436 ' HA ' ' CG2' ' A' ' 158' ' ' ILE . . . -81.87 115.2 20.96 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.408 -0.807 . . . . 0.0 111.173 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.472 ' CA ' ' NH2' ' A' ' 209' ' ' ARG . . . 86.63 -8.01 77.05 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.56 13.98 60.89 Favored Glycine 0 N--CA 1.483 1.815 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.529 ' CG2' ' CB ' ' A' ' 156' ' ' ALA . 7.6 p -59.7 -14.3 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.931 -1.335 . . . . 0.0 109.971 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.446 ' CD2' ' HA ' ' A' ' 207' ' ' ALA . 1.0 OUTLIER -92.17 20.13 6.24 Favored 'General case' 0 C--O 1.21 -1.004 0 C-N-CA 116.479 -2.088 . . . . 0.0 110.731 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.6 m -129.39 58.49 1.62 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 101.935 -3.357 . . . . 0.0 101.935 168.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.44 ' HG3' ' CG ' ' A' ' 155' ' ' GLU . 0.2 OUTLIER -153.76 146.11 23.93 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 113.486 -1.688 . . . . 0.0 111.903 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -103.95 34.72 5.55 Favored Glycine 0 N--CA 1.481 1.683 0 N-CA-C 106.124 -2.79 . . . . 0.0 106.124 173.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -145.34 165.98 27.74 Favored Glycine 0 N--CA 1.479 1.501 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.48 ' CB ' ' CD1' ' A' ' 202' ' ' ILE . 2.3 p-80 -90.84 -6.04 54.79 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.921 -0.752 . . . . 0.0 109.484 176.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.412 ' HA ' HG22 ' A' ' 157' ' ' THR . 62.6 m -56.17 -61.71 2.2 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 122.54 1.162 . . . . 0.0 109.353 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.44 ' CG ' ' HG3' ' A' ' 150' ' ' ARG . 9.2 mp0 -57.89 -20.75 39.23 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.529 ' CB ' ' CG2' ' A' ' 147' ' ' VAL . . . -83.35 1.73 39.78 Favored 'General case' 0 C--O 1.201 -1.478 0 O-C-N 121.602 -0.686 . . . . 0.0 109.929 177.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 154' ' ' THR . 68.8 p -82.2 -51.19 8.18 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.496 HG13 ' HB2' ' A' ' 168' ' ' PRO . 3.8 tp -65.76 -31.58 54.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.418 ' OD2' ' N ' ' A' ' 145' ' ' GLY . 0.4 OUTLIER -80.56 -18.41 48.46 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.764 ' HA ' ' CD2' ' A' ' 163' ' ' LEU . 1.2 mt -63.41 -37.64 88.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.038 -1.039 . . . . 0.0 110.375 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.507 ' CG ' ' HA3' ' A' ' 170' ' ' GLY . 88.7 mmm -81.53 -27.74 34.28 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.423 HG22 ' NE ' ' A' ' 209' ' ' ARG . 3.6 m -66.3 -48.79 69.23 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.764 ' CD2' ' HA ' ' A' ' 160' ' ' LEU . 4.2 pp -72.57 -4.83 33.12 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.369 -0.832 . . . . 0.0 109.328 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.401 ' HA ' HD12 ' A' ' 20' ' ' LEU . . . -108.06 18.85 20.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.662 -1.274 . . . . 0.0 109.983 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 59.14 41.86 96.82 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 107.337 -2.305 . . . . 0.0 107.337 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.438 ' CB ' ' HE3' ' A' ' 161' ' ' MET . 1.5 m-85 -138.49 139.29 38.72 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.925 0.869 . . . . 0.0 111.134 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -50.2 134.23 23.49 Favored Pre-proline 0 N--CA 1.498 1.965 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 177.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.505 ' HA ' ' HB2' ' A' ' 161' ' ' MET . 37.3 Cg_endo -64.81 84.46 0.17 Allowed 'Trans proline' 0 C--N 1.298 -2.114 0 C-N-CA 116.593 -1.805 . . . . 0.0 112.911 -174.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 167' ' ' LYS . . . -156.81 111.72 2.81 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 101.399 -3.556 . . . . 0.0 101.399 173.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.511 ' HA2' ' N ' ' A' ' 47' ' ' ALA . . . -157.73 167.76 34.23 Favored Glycine 0 N--CA 1.486 1.996 0 C-N-CA 116.454 -2.784 . . . . 0.0 113.314 -174.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.539 ' O ' ' O ' ' A' ' 43' ' ' MET . 28.5 m -112.46 156.49 13.48 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.526 HD22 ' CD2' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -157.68 114.0 2.88 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.639 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 43' ' ' MET . 34.1 t -130.66 162.25 29.82 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 120.569 -1.332 . . . . 0.0 112.05 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.27 -169.06 1.45 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.199 -0.938 . . . . 0.0 109.491 178.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.459 ' CD2' ' CB ' ' A' ' 192' ' ' ALA . 5.2 mt -63.67 90.88 0.06 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.89 -1.132 . . . . 0.0 109.582 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 63' ' ' SER . 3.2 p -110.09 95.13 5.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.074 -1.016 . . . . 0.0 110.36 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -97.86 171.08 8.52 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.11 -0.994 . . . . 0.0 110.138 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -91.34 6.0 47.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.37 -0.831 . . . . 0.0 111.207 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.05 12.69 29.66 Favored 'General case' 0 C--N 1.289 -2.037 0 O-C-N 121.597 -0.689 . . . . 0.0 110.376 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 65.45 32.73 84.39 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 183' ' ' ALA . 78.5 p -81.95 98.96 8.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -1.121 . . . . 0.0 110.167 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 1.7 mmm -63.83 80.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.215 -0.928 . . . . 0.0 110.178 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.433 ' CB ' ' HB2' ' A' ' 175' ' ' LEU . . . -57.7 124.43 19.1 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.27 -0.894 . . . . 0.0 110.163 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -136.8 161.68 35.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.353 -0.842 . . . . 0.0 110.333 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . 60.85 160.02 0.11 Allowed Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.349 -0.844 . . . . 0.0 110.871 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.4 -26.76 24.23 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.739 1.389 . . . . 0.0 110.578 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -60.66 -34.98 75.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.089 -1.007 . . . . 0.0 109.864 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . 0.425 ' O ' ' CD1' ' A' ' 175' ' ' LEU . 5.4 t -74.59 -53.99 8.33 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.362 -0.836 . . . . 0.0 110.218 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.441 HG13 ' CD2' ' A' ' 199' ' ' LEU . 9.6 tp -62.02 -25.08 36.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 O-C-N 120.653 -1.279 . . . . 0.0 107.644 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 194' ' ' LYS . 36.8 tt0 -64.65 -33.74 76.64 Favored 'General case' 0 C--O 1.194 -1.822 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.313 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 191' ' ' PHE . 0.0 OUTLIER -57.65 -54.94 41.18 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.349 -1.469 . . . . 0.0 108.925 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.459 ' CB ' ' CD2' ' A' ' 175' ' ' LEU . . . -69.87 -44.83 69.01 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.707 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . 0.602 ' HA ' ' HB2' ' A' ' 197' ' ' MET . 1.6 m-20 -82.19 -29.99 31.17 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.061 -1.056 . . . . 0.0 112.902 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 190' ' ' GLU . 15.6 tttt -55.42 -36.64 66.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.462 -1.399 . . . . 0.0 109.384 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . 0.445 ' CE1' ' SD ' ' A' ' 1' ' ' MET . 24.0 m80 -81.8 -52.83 6.73 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 116.116 -2.234 . . . . 0.0 111.781 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.468 ' O ' ' CG ' ' A' ' 197' ' ' MET . 89.4 m-20 -115.58 28.34 8.73 Favored 'General case' 0 N--CA 1.51 2.571 0 C-N-CA 117.073 -1.851 . . . . 0.0 115.254 177.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' MET . . . . . 0.602 ' HB2' ' HA ' ' A' ' 193' ' ' ASN . 0.8 OUTLIER -160.21 149.96 17.93 Favored 'General case' 0 N--CA 1.514 2.745 0 CA-C-N 121.991 2.178 . . . . 0.0 113.613 179.267 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.469 ' HB3' ' CD1' ' A' ' 6' ' ' LEU . . . -86.73 148.51 25.4 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.416 -1.428 . . . . 0.0 108.482 175.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.538 ' CD1' ' HA ' ' A' ' 190' ' ' GLU . 4.1 mt -122.72 144.3 49.24 Favored 'General case' 0 N--CA 1.511 2.62 0 O-C-N 120.264 -1.523 . . . . 0.0 111.639 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.464 ' HB ' ' CD2' ' A' ' 6' ' ' LEU . 3.4 p -149.94 -178.92 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.269 -0.894 . . . . 0.0 110.179 178.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 23.5 p -105.54 179.84 4.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.014 . . . . 0.0 110.849 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.486 HD11 HG22 ' A' ' 202' ' ' ILE . 4.5 tt -111.96 -32.51 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.446 -0.784 . . . . 0.0 110.349 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.444 ' N ' HG23 ' A' ' 202' ' ' ILE . 0.8 OUTLIER -50.89 -65.06 0.62 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.108 -0.995 . . . . 0.0 110.528 -179.462 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.82 -35.78 59.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.294 -0.879 . . . . 0.0 110.442 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.511 ' CD2' HD22 ' A' ' 163' ' ' LEU . 6.3 tt -52.92 -43.61 66.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.096 -1.003 . . . . 0.0 110.285 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.459 ' CG2' HG23 ' A' ' 147' ' ' VAL . 1.0 OUTLIER -71.08 -40.35 75.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 O-C-N 120.965 -1.084 . . . . 0.0 108.456 -179.375 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.446 ' HA ' ' CD2' ' A' ' 148' ' ' LEU . . . -55.72 -23.82 31.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.074 -1.016 . . . . 0.0 108.497 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.569 ' CD2' HG11 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -75.81 -35.92 59.87 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.09 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.472 ' NH2' ' CA ' ' A' ' 145' ' ' GLY . 2.3 tmt_? -55.49 -44.14 76.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.834 . . . . 0.0 109.627 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.65 -37.31 79.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.432 -0.793 . . . . 0.0 110.157 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -65.07 -22.98 67.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.347 -0.846 . . . . 0.0 110.173 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -88.05 -22.0 24.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.18 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -106.47 9.56 31.62 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.219 -0.926 . . . . 0.0 110.68 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.89 147.08 51.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.998 -1.064 . . . . 0.0 110.125 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -122.92 126.91 48.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.9 . . . . 0.0 110.223 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -83.41 -22.56 32.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 110.193 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.221 179.979 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mmt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.287 0.565 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -110.96 55.83 0.64 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.249 -0.907 . . . . 0.0 110.222 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -90.27 -34.38 15.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.226 -0.921 . . . . 0.0 110.186 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.7 t -93.18 -4.99 51.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.392 -0.818 . . . . 0.0 110.721 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.36 -41.46 63.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.034 -1.041 . . . . 0.0 110.401 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.473 ' CD2' ' HA ' ' A' ' 200' ' ' VAL . 0.1 OUTLIER -116.13 18.22 15.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 110.392 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.0 -29.79 2.27 Favored 'General case' 0 N--CA 1.512 2.67 0 O-C-N 120.738 -1.227 . . . . 0.0 109.431 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.437 ' O ' ' CB ' ' A' ' 15' ' ' ARG . 2.6 m -87.97 38.98 0.87 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.463 ' N ' ' O ' ' A' ' 6' ' ' LEU . 18.5 p90 -67.26 44.25 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -172.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.38 76.44 0.13 Allowed Glycine 0 C--N 1.285 -2.278 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 169.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.451 ' OG1' ' CB ' ' A' ' 15' ' ' ARG . 0.1 OUTLIER -151.35 90.72 4.0 Favored Pre-proline 0 C--N 1.291 -1.946 0 N-CA-C 100.527 -3.879 . . . . 0.0 100.527 173.277 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.48 ' CB ' ' HB2' ' A' ' 208' ' ' TYR . 22.5 Cg_endo -46.6 -40.48 23.77 Favored 'Trans proline' 0 C--N 1.283 -2.875 0 O-C-N 123.048 1.025 . . . . 0.0 111.736 -172.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.438 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 14.1 m-85 -93.54 -37.2 12.03 Favored 'General case' 0 C--N 1.278 -2.511 0 C-N-CA 119.24 -0.984 . . . . 0.0 113.504 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -79.25 -63.33 1.44 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.606 -1.238 . . . . 0.0 112.635 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.451 ' CB ' ' OG1' ' A' ' 11' ' ' THR . 1.8 tpt180 -90.84 -14.94 30.86 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 118.746 -1.182 . . . . 0.0 111.929 -178.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.465 ' CG1' ' HB2' ' A' ' 205' ' ' LEU . 2.3 t -98.81 -19.0 6.08 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 C-N-CA 116.359 -2.136 . . . . 0.0 109.615 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 13' ' ' PHE . 3.7 tt0 -83.26 -41.5 18.27 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 176.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -74.04 -22.38 59.57 Favored 'General case' 0 C--N 1.307 -1.239 0 O-C-N 121.749 -0.595 . . . . 0.0 109.504 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.446 ' CB ' ' O ' ' A' ' 15' ' ' ARG . . . -75.52 -51.94 11.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.016 -1.052 . . . . 0.0 108.992 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.472 ' O ' ' CB ' ' A' ' 24' ' ' ARG . 0.4 OUTLIER -49.48 -33.23 13.85 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.442 -0.786 . . . . 0.0 109.8 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.42 ' HA ' ' HB2' ' A' ' 24' ' ' ARG . . . -78.0 -68.41 0.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.972 0.891 . . . . 0.0 109.614 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.92 -29.2 1.9 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.495 -0.753 . . . . 0.0 110.135 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.478 ' CB ' ' HB ' ' A' ' 29' ' ' VAL . 1.9 mm? -101.09 -15.37 17.43 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.799 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -50.23 -24.47 2.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.079 -1.013 . . . . 0.0 108.571 178.286 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.73 42.76 1.11 Allowed 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 118.49 -1.284 . . . . 0.0 110.35 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.51 ' HA2' ' CZ ' ' A' ' 45' ' ' PHE . . . 55.2 25.91 41.33 Favored Glycine 0 C--N 1.291 -1.934 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 176.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.23 17.6 5.03 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 116.36 -2.136 . . . . 0.0 110.97 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.469 ' HA3' ' CG ' ' A' ' 197' ' ' MET . . . 96.69 108.87 2.54 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 118.893 -1.622 . . . . 0.0 115.113 172.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.478 ' HB ' ' CB ' ' A' ' 23' ' ' LEU . 5.8 p -140.69 124.88 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-N 119.539 1.669 . . . . 0.0 108.345 175.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.51 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -109.03 158.59 17.59 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.869 -1.145 . . . . 0.0 113.312 -177.474 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.503 ' CG2' ' CD1' ' A' ' 205' ' ' LEU . 0.9 OUTLIER -124.87 110.01 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.541 -0.724 . . . . 0.0 109.3 178.125 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.437 ' CB ' ' HE3' ' A' ' 30' ' ' MET . 0.1 OUTLIER -176.44 154.59 1.31 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.254 -0.904 . . . . 0.0 110.199 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -154.06 -61.9 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 110.18 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -103.03 158.58 16.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.938 . . . . 0.0 110.215 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -56.8 136.96 55.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.21 -0.931 . . . . 0.0 110.184 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 38' ' ' GLU . 3.9 t0 -167.82 74.62 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 110.28 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 57.7 -85.56 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.368 -0.833 . . . . 0.0 110.456 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -85.57 112.22 20.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.014 -1.054 . . . . 0.0 110.208 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.423 ' HA ' ' CD2' ' A' ' 32' ' ' LEU . 0.7 OUTLIER -108.43 54.46 0.66 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.192 -0.942 . . . . 0.0 110.113 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.436 ' HB2' ' CD1' ' A' ' 189' ' ' ILE . 0.0 OUTLIER -176.35 127.01 0.2 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.166 -0.959 . . . . 0.0 110.17 -179.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 30' ' ' MET . . . -170.46 64.05 0.17 Allowed Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.556 -1.307 . . . . 0.0 110.758 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.481 ' HB2' ' CB ' ' A' ' 174' ' ' GLU . 0.7 OUTLIER -68.85 -8.0 39.73 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.526 -0.985 . . . . 0.0 111.597 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.605 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -95.34 53.92 1.56 Allowed 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.29 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.477 ' O ' ' CG2' ' A' ' 44' ' ' ILE . 94.2 mt -61.22 19.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.527 3.391 0 O-C-N 120.428 -1.42 . . . . 0.0 111.991 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.605 ' H ' ' C ' ' A' ' 43' ' ' MET . 22.4 m-85 -85.06 165.09 38.69 Favored Pre-proline 0 C--N 1.291 -1.952 0 O-C-N 120.972 -1.08 . . . . 0.0 112.341 -177.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.49 ' HD3' ' CD2' ' A' ' 166' ' ' PHE . 40.8 Cg_endo -62.79 133.53 42.41 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 122.444 2.096 . . . . 0.0 114.106 -176.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.431 ' CB ' HG11 ' A' ' 171' ' ' VAL . . . -69.22 -2.7 11.2 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.263 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 15.7 tt0 -80.1 -14.99 58.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.906 -1.121 . . . . 0.0 109.653 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 51' ' ' THR . 6.3 t -130.81 58.99 1.68 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 177.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.424 ' CE ' HD12 ' A' ' 68' ' ' LEU . 15.3 ttm -51.53 88.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.673 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.497 ' N ' ' O ' ' A' ' 49' ' ' THR . 3.2 m -64.65 157.45 27.16 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.693 0.759 . . . . 0.0 110.267 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.484 ' N ' HG12 ' A' ' 115' ' ' ILE . 2.1 p -71.65 -4.87 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.655 -0.653 . . . . 0.0 109.907 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -55.15 -31.41 61.3 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.795 -1.19 . . . . 0.0 108.445 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.472 ' HA ' ' CD2' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -87.77 -38.27 15.9 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.19 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.404 ' HB3' ' CB ' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -71.87 -40.02 69.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.817 -1.177 . . . . 0.0 109.275 179.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.3 -47.08 85.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.558 -0.714 . . . . 0.0 110.772 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.472 ' CD2' ' HA ' ' A' ' 54' ' ' GLN . 0.8 OUTLIER -57.05 -34.14 67.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.079 -1.013 . . . . 0.0 110.987 -179.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.477 ' CA ' ' O ' ' A' ' 62' ' ' GLY . 33.2 p -79.54 -46.72 16.82 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.19 -0.944 . . . . 0.0 111.139 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.0 mt -54.22 -20.42 4.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 O-C-N 121.094 -1.004 . . . . 0.0 110.28 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.477 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 2.9 mtp180 -97.92 -44.56 6.64 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.158 -0.964 . . . . 0.0 113.169 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.489 ' CD2' ' HA2' ' A' ' 180' ' ' GLY . 48.5 m80 -125.43 -17.84 5.47 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -176.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.477 ' O ' ' CA ' ' A' ' 58' ' ' THR . . . -165.18 -169.09 28.34 Favored Glycine 0 N--CA 1.503 3.129 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.708 -177.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.6 t -143.1 96.37 2.91 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 102.27 -3.233 . . . . 0.0 102.27 175.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.35 72.38 0.46 Allowed Glycine 0 C--N 1.26 -3.681 1 N-CA-C 101.97 -4.452 . . . . 0.0 101.97 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.463 HG22 ' CZ ' ' A' ' 138' ' ' PHE . 38.7 mt -60.14 145.28 12.04 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.816 0 CA-C-N 113.613 -1.293 . . . . 0.0 110.067 -176.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.483 ' CG1' ' CB ' ' A' ' 173' ' ' CYS . 35.2 m -55.98 152.28 2.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.863 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 171' ' ' VAL . 78.9 m -83.03 132.77 35.12 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.553 ' O ' ' HA ' ' A' ' 139' ' ' PRO . 2.9 mm? -89.18 97.98 11.51 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.037 -1.065 . . . . 0.0 108.936 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.448 ' HB2' ' N ' ' A' ' 170' ' ' GLY . 34.3 m -64.41 125.73 25.58 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 118.776 -1.17 . . . . 0.0 109.794 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.436 ' CG2' ' HB2' ' A' ' 139' ' ' PRO . 15.2 tt -133.23 146.88 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.017 -1.052 . . . . 0.0 109.823 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.432 ' CG2' HG12 ' A' ' 158' ' ' ILE . 0.3 OUTLIER -108.62 151.97 25.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 109.643 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -50.25 -24.68 3.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.264 -0.897 . . . . 0.0 110.053 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -88.23 -38.24 15.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.323 -0.861 . . . . 0.0 109.969 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -52.45 63.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.346 -0.846 . . . . 0.0 109.562 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.441 ' O ' ' C ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -62.84 -40.85 98.7 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.112 0.958 . . . . 0.0 108.784 179.031 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.63 ' O ' ' N ' ' A' ' 79' ' ' ASP . 7.9 tttm -49.53 -62.04 1.77 Allowed 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -47.66 -31.3 4.48 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 121.884 0.849 . . . . 0.0 108.945 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.547 ' O ' ' N ' ' A' ' 80' ' ' LEU . 3.0 mt -96.69 44.55 1.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 175.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.63 ' N ' ' O ' ' A' ' 76' ' ' LYS . 20.9 t0 -26.81 78.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 123.85 1.786 . . . . 0.0 112.893 -172.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.547 ' N ' ' O ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -150.77 106.36 3.06 Favored Pre-proline 0 C--N 1.286 -2.189 0 CA-C-N 112.315 -2.221 . . . . 0.0 110.181 177.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -92.07 94.06 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 N-CA-C 107.852 -1.634 . . . . 0.0 107.852 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.498 ' CG ' ' HB ' ' A' ' 97' ' ' VAL . 2.8 mmt -99.63 44.45 1.02 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.16 -0.962 . . . . 0.0 109.875 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.3 tpt -68.51 103.07 1.58 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.053 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.479 ' CG2' ' CG2' ' A' ' 97' ' ' VAL . 11.0 t -84.33 103.65 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -92.28 21.72 5.0 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.287 -0.883 . . . . 0.0 112.264 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.426 ' CB ' ' HA3' ' A' ' 92' ' ' GLY . 0.6 OUTLIER -68.52 82.15 0.26 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.996 -1.065 . . . . 0.0 108.326 178.293 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -43.11 104.76 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.476 -0.765 . . . . 0.0 112.028 -177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.468 ' CG2' ' CB ' ' A' ' 91' ' ' TYR . 10.0 m -164.11 166.57 21.17 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.77 -0.581 . . . . 0.0 109.481 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 t -59.97 -60.84 3.19 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.921 -1.112 . . . . 0.0 109.903 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -127.03 20.34 6.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.333 -0.854 . . . . 0.0 109.595 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.468 ' CB ' ' CG2' ' A' ' 88' ' ' THR . 0.4 OUTLIER -114.63 82.38 1.71 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.539 -0.726 . . . . 0.0 110.066 -179.645 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.448 ' HA2' ' CG1' ' A' ' 84' ' ' VAL . . . 82.86 40.87 9.13 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.1 t -71.37 53.52 0.2 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.848 -0.795 . . . . 0.0 110.479 178.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 84' ' ' VAL . . . 55.86 24.72 42.6 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 -176.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.533 ' O ' ' N ' ' A' ' 97' ' ' VAL . 0.5 OUTLIER -60.81 103.06 0.23 Allowed 'General case' 0 N--CA 1.486 1.329 0 O-C-N 122.136 -0.626 . . . . 0.0 112.661 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.423 ' HB ' ' O ' ' A' ' 139' ' ' PRO . 2.8 m -59.25 79.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 95' ' ' PHE . 18.8 t -35.47 151.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 CA-C-O 123.023 1.392 . . . . 0.0 113.412 -173.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.479 ' CB ' ' O ' ' A' ' 137' ' ' VAL . 0.7 OUTLIER -69.64 179.5 2.12 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 113.793 -1.549 . . . . 0.0 113.157 -176.187 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.527 ' HA ' ' HB3' ' A' ' 133' ' ' ARG . 19.8 pt -141.9 131.81 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -177.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 132' ' ' ASN . 1.6 tm-20 -111.81 133.94 53.69 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 117.758 -1.577 . . . . 0.0 112.875 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.484 ' HA ' HD21 ' A' ' 131' ' ' LEU . . . -52.72 93.28 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.064 -1.023 . . . . 0.0 110.039 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 100' ' ' GLU . . . -82.55 3.82 27.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.965 -1.084 . . . . 0.0 110.911 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -113.02 54.92 0.71 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.775 -1.203 . . . . 0.0 112.236 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.44 -36.41 2.58 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 118.875 -1.631 . . . . 0.0 112.42 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.433 ' HB ' ' CB ' ' A' ' 101' ' ' ALA . 0.8 OUTLIER -100.99 124.4 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 120.962 -1.316 . . . . 0.0 110.187 -178.394 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 p -145.24 61.11 1.3 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.591 -1.318 . . . . 0.0 111.422 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.4 ' C ' ' H ' ' A' ' 109' ' ' VAL . 1.7 p -135.3 -32.27 0.94 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.889 -1.132 . . . . 0.0 110.323 177.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.9 -30.37 0.1 Allowed Glycine 0 N--CA 1.499 2.881 0 O-C-N 121.599 -0.688 . . . . 0.0 113.238 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.4 ' H ' ' C ' ' A' ' 107' ' ' THR . 2.3 t -128.63 57.12 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.377 -1.661 . . . . 0.0 110.38 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -129.43 56.94 1.68 Allowed 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.128 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.441 ' HA ' ' CD1' ' A' ' 115' ' ' ILE . . . -31.53 -32.29 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -84.28 -77.37 0.27 Allowed 'General case' 0 C--N 1.29 -1.993 0 O-C-N 120.837 -1.165 . . . . 0.0 109.558 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.18 -15.94 28.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.448 -0.782 . . . . 0.0 110.737 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 110' ' ' SER . 2.4 ttt180 -90.67 -36.73 14.18 Favored 'General case' 0 C--O 1.202 -1.416 0 O-C-N 121.001 -1.062 . . . . 0.0 110.261 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.484 HG12 ' N ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -62.0 -15.37 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 118.417 -1.313 . . . . 0.0 108.956 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.5 m -88.6 -55.27 3.78 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.484 ' O ' ' N ' ' A' ' 121' ' ' ALA . 53.2 p -67.49 -14.0 62.54 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.424 178.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 114' ' ' ARG . 2.6 t -73.66 -48.64 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -50.52 -36.2 33.02 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.132 178.471 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.44 -13.8 22.86 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.281 0.563 . . . . 0.0 110.476 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 117' ' ' THR . . . -55.58 -56.48 19.82 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.252 -0.905 . . . . 0.0 109.773 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 19.1 tt -93.69 14.47 2.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 118.677 -1.209 . . . . 0.0 110.243 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -108.83 72.38 0.82 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 118.973 -1.091 . . . . 0.0 111.136 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.447 ' CB ' ' HD2' ' A' ' 127' ' ' LYS . 5.1 t70 -99.3 -35.61 9.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.998 -1.064 . . . . 0.0 110.381 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 106.04 -38.37 3.34 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 105.28 -3.128 . . . . 0.0 105.28 -176.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -133.34 98.86 4.35 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 128' ' ' PRO . 5.4 tptt -132.33 52.94 9.91 Favored Pre-proline 0 C--N 1.307 -1.28 0 O-C-N 120.767 -1.208 . . . . 0.0 110.86 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 127' ' ' LYS . 49.4 Cg_endo -78.0 -35.65 1.31 Allowed 'Trans proline' 0 C--N 1.3 -2.009 0 N-CA-C 106.911 -1.996 . . . . 0.0 106.911 176.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.4 t -126.71 -0.29 6.74 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.345 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.426 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . 0.8 OUTLIER -77.4 9.4 3.26 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.634 -1.292 . . . . 0.0 112.718 -177.61 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.484 HD21 ' HA ' ' A' ' 101' ' ' ALA . 29.7 mt -117.87 124.89 49.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.716 -1.24 . . . . 0.0 109.337 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.514 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 1.3 m-80 -116.85 93.58 4.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.089 -1.007 . . . . 0.0 112.952 -177.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.71 ' HB2' ' HA ' ' A' ' 134' ' ' PRO 0.274 0.0 OUTLIER -80.71 172.12 10.6 Favored Pre-proline 0 N--CA 1.501 2.101 0 O-C-N 121.815 -0.553 . . . . 0.0 110.72 -179.556 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.71 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 48.2 Cg_endo -73.14 129.75 18.44 Favored 'Cis proline' 0 N--CA 1.502 1.995 0 C-N-CA 123.043 -1.649 . . . . 0.0 112.559 7.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.427 ' HA3' ' CG ' ' A' ' 100' ' ' GLU . . . -123.6 47.31 1.03 Allowed Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 135' ' ' GLY . 49.6 m80 31.19 38.1 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 122.143 0.973 . . . . 0.0 112.07 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 98' ' ' THR . 31.3 t -129.43 92.44 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 176.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.463 ' CZ ' HG22 ' A' ' 65' ' ' ILE . 10.4 p90 -107.09 101.91 40.45 Favored Pre-proline 0 N--CA 1.495 1.797 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.218 -176.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 53.2 Cg_endo -98.38 155.59 0.78 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.785 1.413 . . . . 0.0 111.078 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 1.3 mp -127.29 116.59 20.78 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 9.2 ttm180 -63.52 115.66 4.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.058 -1.026 . . . . 0.0 110.696 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.453 ' CB ' ' HA ' ' A' ' 155' ' ' GLU . . . -130.67 135.5 47.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.765 -0.584 . . . . 0.0 110.13 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.38 143.23 19.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.941 -1.099 . . . . 0.0 110.092 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -100.4 115.76 30.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.502 -0.749 . . . . 0.0 111.622 -178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.417 ' N ' ' OD2' ' A' ' 159' ' ' ASP . . . 104.02 -15.0 52.05 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.77 13.1 57.9 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.483 HG22 ' N ' ' A' ' 156' ' ' ALA . 7.2 p -65.52 -9.09 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.095 -1.239 . . . . 0.0 110.276 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.431 HD22 ' CG1' ' A' ' 147' ' ' VAL . 4.0 mm? -87.82 15.92 6.47 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 115.683 -2.407 . . . . 0.0 110.079 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.0 m -131.11 60.94 1.65 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 100.937 -3.727 . . . . 0.0 100.937 167.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.78 140.03 22.23 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 113.876 -1.511 . . . . 0.0 112.774 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -104.03 34.83 5.47 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 106.44 -2.664 . . . . 0.0 106.44 173.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.3 160.88 27.92 Favored Glycine 0 N--CA 1.478 1.493 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.43 ' HB3' ' CD1' ' A' ' 202' ' ' ILE . 4.4 p-80 -90.0 -5.5 56.6 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.653 -0.91 . . . . 0.0 109.309 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.412 ' O ' ' CB ' ' A' ' 142' ' ' ALA . 6.3 m -54.54 -59.22 4.98 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.076 -1.015 . . . . 0.0 109.437 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.453 ' HA ' ' CB ' ' A' ' 142' ' ' ALA . 21.2 tt0 -57.93 -22.12 47.25 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.483 ' N ' HG22 ' A' ' 147' ' ' VAL . . . -91.38 8.04 38.15 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 121.715 -0.616 . . . . 0.0 109.377 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.493 ' CG2' ' N ' ' A' ' 158' ' ' ILE . 0.6 OUTLIER -92.51 -51.69 5.0 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.375 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.493 ' N ' ' CG2' ' A' ' 157' ' ' THR . 6.1 tp -72.77 -32.37 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 176.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.417 ' OD2' ' N ' ' A' ' 145' ' ' GLY . 11.7 t0 -71.61 -22.28 61.73 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.684 ' HA ' ' CD2' ' A' ' 163' ' ' LEU . 0.4 OUTLIER -60.22 -30.98 69.75 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.906 0.86 . . . . 0.0 109.466 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.477 ' HB2' ' HA ' ' A' ' 168' ' ' PRO . 37.2 mmt -83.42 -26.91 29.95 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.456 ' CG2' ' NE ' ' A' ' 209' ' ' ARG . 2.5 m -71.45 -36.87 71.37 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 176.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.684 ' CD2' ' HA ' ' A' ' 160' ' ' LEU . 3.9 pp -82.03 -4.2 56.24 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.251 -0.98 . . . . 0.0 108.698 177.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -109.52 12.1 24.6 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.38 -1.45 . . . . 0.0 109.865 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 58.5 42.49 95.94 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.49 ' CD2' ' HD3' ' A' ' 46' ' ' PRO . 6.3 m-85 -135.41 139.98 44.58 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 122.369 1.081 . . . . 0.0 112.093 -176.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 169' ' ' ALA . 5.1 mttt -48.98 136.6 13.93 Favored Pre-proline 0 N--CA 1.501 2.091 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 177.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.477 ' HA ' ' HB2' ' A' ' 161' ' ' MET . 37.4 Cg_endo -63.86 84.6 0.14 Allowed 'Trans proline' 0 C--N 1.301 -1.962 0 C-N-CA 116.59 -1.806 . . . . 0.0 113.225 -173.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 167' ' ' LYS . . . -155.94 123.82 5.66 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 100.581 -3.859 . . . . 0.0 100.581 172.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.448 ' N ' ' HB2' ' A' ' 69' ' ' CYS . . . -153.64 159.56 28.74 Favored Glycine 0 N--CA 1.502 3.085 0 CA-C-N 123.869 3.031 . . . . 0.0 113.199 -174.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.443 ' HB ' ' CB ' ' A' ' 66' ' ' VAL . 2.9 m -149.65 98.8 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 118.503 -1.279 . . . . 0.0 109.601 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.515 HD13 HD21 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -109.75 105.81 15.2 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 117.185 -1.806 . . . . 0.0 113.787 -179.506 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.483 ' CB ' ' CG1' ' A' ' 66' ' ' VAL . 49.5 t -137.88 159.9 40.76 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.481 ' CB ' ' HB2' ' A' ' 42' ' ' ASP . 1.2 mm-40 174.64 85.68 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.968 0 O-C-N 119.842 -1.786 . . . . 0.0 112.689 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.496 HD22 ' CB ' ' A' ' 188' ' ' CYS . 0.3 OUTLIER -127.84 104.99 8.13 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.206 -0.934 . . . . 0.0 110.83 178.719 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.436 ' CG2' ' HA ' ' A' ' 57' ' ' LEU . 1.2 p -140.43 104.57 4.8 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.126 -0.983 . . . . 0.0 110.412 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -98.26 147.55 24.52 Favored 'General case' 0 C--N 1.31 -1.125 0 O-C-N 120.802 -1.186 . . . . 0.0 109.132 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -82.37 5.91 18.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 111.274 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.31 15.34 13.93 Favored 'General case' 0 C--N 1.291 -1.963 0 O-C-N 121.527 -0.733 . . . . 0.0 110.42 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.489 ' HA2' ' CD2' ' A' ' 61' ' ' HIS . . . 56.19 38.78 78.93 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 6.6 m -98.18 98.31 9.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.341 -1.093 . . . . 0.0 111.131 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.424 ' CE ' ' O ' ' A' ' 61' ' ' HIS . 85.4 mtp -55.78 92.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.45 -0.781 . . . . 0.0 109.447 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.465 ' HB2' ' CE2' ' A' ' 191' ' ' PHE . . . -115.41 133.91 55.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.894 . . . . 0.0 110.879 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -129.11 100.41 5.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -0.857 . . . . 0.0 109.442 179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.48 ' CB ' ' HD2' ' A' ' 186' ' ' PRO . . . -179.85 -177.18 0.21 Allowed Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.336 -0.852 . . . . 0.0 109.298 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 185' ' ' ALA . 42.8 Cg_endo -70.2 -23.39 28.86 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.342 1.18 . . . . 0.0 110.143 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.423 ' O ' ' CB ' ' A' ' 190' ' ' GLU . 0.4 OUTLIER -81.79 -28.24 33.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.033 -1.042 . . . . 0.0 108.56 178.601 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . 0.509 ' HA ' ' CE1' ' A' ' 191' ' ' PHE . 37.1 m -66.33 -51.56 56.01 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.44 ' CD1' ' O ' ' A' ' 174' ' ' GLU . 8.0 tp -58.34 -27.8 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.44 ' HA ' ' HB3' ' A' ' 193' ' ' ASN . 1.0 OUTLIER -60.14 -25.46 65.51 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 176.646 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.509 ' CE1' ' HA ' ' A' ' 188' ' ' CYS . 12.9 m-30 -55.76 -57.48 11.85 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 123.296 1.522 . . . . 0.0 108.093 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 197' ' ' MET . . . -64.17 -46.61 83.25 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.562 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . 0.624 ' HA ' ' CB ' ' A' ' 197' ' ' MET . 1.9 t30 -65.05 -11.88 44.33 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.472 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 190' ' ' GLU . 7.6 tmtt? -78.2 -37.11 46.37 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 117.372 -1.731 . . . . 0.0 111.06 -178.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -108.66 -54.25 2.54 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 115.684 -2.406 . . . . 0.0 111.952 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -114.67 34.63 4.67 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.322 -1.351 . . . . 0.0 113.784 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' MET . . . . . 0.624 ' CB ' ' HA ' ' A' ' 193' ' ' ASN . 2.2 mtt -151.42 150.63 30.67 Favored 'General case' 0 N--CA 1.518 2.949 0 CA-C-N 123.113 2.688 . . . . 0.0 115.466 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.431 ' HB2' ' CD1' ' A' ' 6' ' ' LEU . . . -110.26 147.72 33.28 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.257 -0.902 . . . . 0.0 108.779 177.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.469 ' HA ' ' HB3' ' A' ' 30' ' ' MET . 10.0 mt -123.51 130.58 52.9 Favored 'General case' 0 N--CA 1.511 2.585 0 O-C-N 120.277 -1.514 . . . . 0.0 111.161 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.473 ' HA ' ' CD2' ' A' ' 6' ' ' LEU . 0.3 OUTLIER -109.3 -160.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 120.791 -1.193 . . . . 0.0 111.027 179.232 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.434 ' N ' ' CG1' ' A' ' 200' ' ' VAL . 0.6 OUTLIER -108.44 -179.92 4.01 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.422 -0.799 . . . . 0.0 110.435 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.438 HD13 HG23 ' A' ' 202' ' ' ILE . 12.9 tt -106.66 -41.91 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.417 -0.802 . . . . 0.0 111.3 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.451 ' O ' ' CG2' ' A' ' 206' ' ' VAL . 0.2 OUTLIER -90.38 -40.52 12.02 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.991 -1.068 . . . . 0.0 111.262 -178.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.401 ' O ' ' HB3' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -63.37 -45.1 92.71 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.704 -1.247 . . . . 0.0 110.441 -179.454 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.51 ' O ' ' HB3' ' A' ' 208' ' ' TYR . 0.4 OUTLIER -71.28 -31.53 67.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.156 -0.965 . . . . 0.0 112.354 -178.504 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.467 ' CB ' HG12 ' A' ' 147' ' ' VAL . 3.7 m -62.32 -29.57 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 119.707 -1.871 . . . . 0.0 106.995 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.428 ' O ' ' CB ' ' A' ' 211' ' ' ALA . . . -64.61 -38.46 91.08 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.51 ' HB3' ' O ' ' A' ' 205' ' ' LEU . 0.2 OUTLIER -56.87 -36.11 69.69 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.313 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.456 ' NE ' ' CG2' ' A' ' 162' ' ' THR . 0.0 OUTLIER -74.01 -55.26 6.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.418 -0.801 . . . . 0.0 110.0 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.433 ' N ' ' HD3' ' A' ' 209' ' ' ARG . 22.9 tt0 -68.83 -56.35 8.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 110.714 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 207' ' ' ALA . . . -51.19 -31.52 20.53 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.322 -0.861 . . . . 0.0 110.443 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.427 ' CB ' ' O ' ' A' ' 208' ' ' TYR . 48.9 t-80 -78.74 -24.84 44.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.183 -0.948 . . . . 0.0 110.182 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -116.84 25.98 10.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 110.176 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 14.2 ttp85 -62.47 147.09 49.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 110.255 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -115.87 85.98 2.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.247 -0.908 . . . . 0.0 110.23 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -73.41 174.95 7.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.906 . . . . 0.0 110.213 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.168 -179.981 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.218 0.532 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -99.83 55.8 0.95 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 110.232 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.418 ' O ' ' CB ' ' A' ' 7' ' ' SER . 31.6 tt0 -91.85 -22.13 20.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.297 -0.877 . . . . 0.0 110.11 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.9 m -60.97 -15.93 37.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.269 -0.894 . . . . 0.0 110.609 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 tp -49.55 -67.06 0.29 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.122 -0.986 . . . . 0.0 110.652 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.493 ' CD1' ' N ' ' A' ' 19' ' ' ALA . 0.3 OUTLIER -115.42 5.23 14.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -0.876 . . . . 0.0 110.715 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 3' ' ' GLN . 8.3 t -95.1 -66.21 0.93 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.614 -1.303 . . . . 0.0 111.885 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.26 13.15 32.36 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.198 -0.939 . . . . 0.0 112.034 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -141.2 58.7 1.53 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.796 -1.19 . . . . 0.0 109.887 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' A' ' 15' ' ' ARG . . . -164.21 167.98 38.42 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 107.392 -2.283 . . . . 0.0 107.392 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.51 ' O ' ' N ' ' A' ' 15' ' ' ARG . 34.4 p -127.87 149.39 70.56 Favored Pre-proline 0 C--N 1.256 -3.49 0 N-CA-C 102.995 -2.965 . . . . 0.0 102.995 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.461 ' CB ' ' O ' ' A' ' 204' ' ' ASP . 18.7 Cg_endo -40.34 -34.79 1.17 Allowed 'Trans proline' 0 C--N 1.288 -2.627 0 CA-C-N 119.767 0.952 . . . . 0.0 110.455 -176.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.444 ' C ' ' CD1' ' A' ' 13' ' ' PHE . 9.8 t80 -87.19 -42.65 12.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.904 -0.498 . . . . 0.0 111.628 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.433 ' HA ' ' CB ' ' A' ' 17' ' ' GLU . 15.9 tt0 -89.37 -16.14 31.7 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.723 -1.236 . . . . 0.0 111.916 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' A' ' 11' ' ' THR . 2.0 ttm180 -72.9 -64.46 0.96 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 105.977 -1.861 . . . . 0.0 105.977 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.587 ' CG1' ' CD2' ' A' ' 208' ' ' TYR . 7.3 p -62.22 -21.21 26.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 C-N-CA 118.721 -1.192 . . . . 0.0 108.323 176.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.433 ' CB ' ' HA ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -57.11 -35.17 69.13 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 119.92 -1.737 . . . . 0.0 106.458 177.092 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.452 ' O ' ' N ' ' A' ' 22' ' ' ALA . 2.9 m-20 -73.98 -29.37 61.94 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 176.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.521 ' HB1' ' O ' ' A' ' 16' ' ' VAL . . . -67.83 -50.58 55.94 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.489 ' CD2' ' HA ' ' A' ' 164' ' ' ALA . 0.2 OUTLIER -61.43 -50.77 71.46 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 177.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.08 -26.22 62.27 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.668 -1.27 . . . . 0.0 107.966 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.452 ' N ' ' O ' ' A' ' 18' ' ' ASN . . . -80.34 -32.55 37.83 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.499 -0.751 . . . . 0.0 109.064 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.539 ' CD2' ' CD2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -50.35 -25.44 3.84 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.093 -1.004 . . . . 0.0 108.83 177.881 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.44 -26.38 15.87 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 22' ' ' ALA . 1.3 tp10 -144.69 81.09 1.65 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 123.866 1.793 . . . . 0.0 107.241 177.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 126.58 48.8 0.18 Allowed Glycine 0 C--N 1.276 -2.77 1 N-CA-C 102.617 -4.193 . . . . 0.0 102.617 -175.145 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.413 ' N ' ' OD1' ' A' ' 196' ' ' ASN . 1.3 mtt180 -62.78 65.39 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 122.023 0.916 . . . . 0.0 111.715 -175.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 26' ' ' GLY . . . 176.64 98.19 0.11 Allowed Glycine 0 C--N 1.291 -1.964 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.594 ' HA ' ' O ' ' A' ' 198' ' ' ALA . 24.6 t -127.0 135.17 64.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 119.161 -1.016 . . . . 0.0 110.134 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.457 ' CG ' HD21 ' A' ' 199' ' ' LEU . 0.1 OUTLIER -100.31 161.24 13.74 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.352 -179.444 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.455 ' CG2' HD11 ' A' ' 205' ' ' LEU . 11.1 p -133.5 94.21 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.682 0.753 . . . . 0.0 109.263 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -43.72 108.37 0.11 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.534 -0.729 . . . . 0.0 111.63 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.425 ' OD2' ' CD1' ' A' ' 202' ' ' ILE . 4.8 t70 -93.7 -172.82 2.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.548 -0.72 . . . . 0.0 109.869 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -54.76 -174.42 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.162 -0.961 . . . . 0.0 110.134 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -89.47 161.13 16.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -0.937 . . . . 0.0 110.325 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 53.27 178.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 110.311 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.3 44.77 29.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.292 -0.88 . . . . 0.0 110.235 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -58.37 109.28 0.74 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.238 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -153.88 21.46 0.52 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.247 -0.908 . . . . 0.0 110.289 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.44 ' CA ' ' HB3' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -168.01 129.13 1.4 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.94 . . . . 0.0 110.355 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 173' ' ' CYS . . . -177.35 -119.86 0.61 Allowed Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.249 -1.453 . . . . 0.0 111.341 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.456 ' HA ' ' CA ' ' A' ' 30' ' ' MET . 20.1 t70 -34.98 -28.32 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -177.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.643 ' O ' ' O ' ' A' ' 171' ' ' VAL . 0.0 OUTLIER -93.23 51.13 1.6 Allowed 'General case' 0 C--N 1.293 -1.891 0 O-C-N 120.776 -1.203 . . . . 0.0 113.476 -177.037 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.467 ' CD1' ' HB ' ' A' ' 29' ' ' VAL . 20.7 pt -66.13 27.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 O-C-N 119.464 -2.023 . . . . 0.0 112.397 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.539 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 31.4 m-85 -92.6 158.94 37.51 Favored Pre-proline 0 N--CA 1.505 2.292 0 O-C-N 121.064 -1.023 . . . . 0.0 113.184 -177.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.435 ' HA ' HD22 ' A' ' 160' ' ' LEU . 43.5 Cg_endo -66.53 130.86 24.6 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.245 1.963 . . . . 0.0 111.251 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.492 ' N ' ' CB ' ' A' ' 169' ' ' ALA . . . -58.9 -10.6 2.57 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 121.478 -0.764 . . . . 0.0 112.903 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 35.9 mt-10 -97.62 -2.58 41.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.631 -1.293 . . . . 0.0 109.542 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.86 57.08 1.82 Allowed 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 176.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.455 ' CG ' HG12 ' A' ' 115' ' ' ILE . 25.4 tpp -63.26 86.93 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.526 -178.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.468 HG23 ' CE2' ' A' ' 45' ' ' PHE . 9.2 t -66.17 128.2 35.16 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.458 -0.776 . . . . 0.0 109.089 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.505 ' N ' HG22 ' A' ' 115' ' ' ILE . 2.8 p -73.85 -2.56 3.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.534 -0.729 . . . . 0.0 109.484 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.49 -36.48 73.83 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.603 -1.239 . . . . 0.0 107.958 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.466 ' HB3' ' CG ' ' A' ' 43' ' ' MET . 1.0 OUTLIER -81.27 -53.96 5.9 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.828 179.023 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.426 ' O ' ' CG1' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -54.56 -24.21 19.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.35 -0.844 . . . . 0.0 109.277 179.257 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.75 -46.87 64.9 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.322 -0.861 . . . . 0.0 109.896 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.448 ' CD1' ' CD2' ' A' ' 175' ' ' LEU . 0.7 OUTLIER -68.21 -36.6 79.79 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.057 -1.057 . . . . 0.0 109.952 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.414 ' OG1' ' CE ' ' A' ' 43' ' ' MET . 1.1 m -75.29 -58.17 3.44 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.198 -0.939 . . . . 0.0 110.511 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.427 ' CD1' ' HB2' ' A' ' 111' ' ' ALA . 96.5 mt -52.71 -22.09 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.941 . . . . 0.0 110.411 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -76.54 -40.62 49.31 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.282 -0.887 . . . . 0.0 111.15 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.425 ' CG ' ' OD1' ' A' ' 177' ' ' ASN . 0.1 OUTLIER -123.01 -5.81 8.44 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.776 -1.203 . . . . 0.0 112.626 -178.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.99 -170.62 23.75 Favored Glycine 0 N--CA 1.496 2.633 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.158 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.4 t -141.24 101.73 4.08 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 102.26 -3.237 . . . . 0.0 102.26 176.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 66' ' ' VAL . . . -111.43 76.8 0.23 Allowed Glycine 0 C--N 1.26 -3.69 0 N-CA-C 104.612 -3.395 . . . . 0.0 104.612 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.553 ' CG1' ' CZ ' ' A' ' 138' ' ' PHE . 1.2 tt -58.19 94.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 CA-C-O 123.498 1.618 . . . . 0.0 108.811 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.499 ' O ' ' CE1' ' A' ' 138' ' ' PHE . 1.4 p -52.55 154.23 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.134 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.576 ' O ' ' HA ' ' A' ' 171' ' ' VAL . 44.5 t -75.93 162.64 27.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.174 -0.954 . . . . 0.0 110.131 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.625 ' O ' ' HA ' ' A' ' 139' ' ' PRO . 0.3 OUTLIER -125.13 92.67 3.69 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.7 -1.25 . . . . 0.0 108.474 178.497 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.467 ' CB ' ' HB ' ' A' ' 157' ' ' THR . 1.8 t -93.25 153.88 18.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.428 -1.42 . . . . 0.0 113.073 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' A' ' 75' ' ' ARG . 3.7 pt -155.29 147.51 12.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.048 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.457 ' N ' ' CB ' ' A' ' 75' ' ' ARG . 5.1 m -77.86 176.17 9.32 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 120.452 -1.405 . . . . 0.0 108.896 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.482 ' O ' ' CB ' ' A' ' 76' ' ' LYS . 7.6 tt0 -95.16 -11.18 28.58 Favored 'General case' 0 C--N 1.284 -2.244 0 O-C-N 121.291 -0.881 . . . . 0.0 110.282 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -90.64 -75.26 0.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.591 -1.244 . . . . 0.0 111.557 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.58 -26.3 37.98 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 119.391 -0.923 . . . . 0.0 108.961 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.545 ' O ' ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -85.8 -27.47 25.14 Favored 'General case' 0 C--O 1.192 -1.967 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.359 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.1 OUTLIER -68.17 -41.78 81.0 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 121.157 1.799 . . . . 0.0 108.022 178.051 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.75 -58.28 6.85 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.614 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.424 ' CD1' ' C ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -89.09 -32.05 17.73 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 118.1 -1.44 . . . . 0.0 108.925 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 75' ' ' ARG . 1.4 t0 -116.03 75.32 0.94 Allowed 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.716 -0.615 . . . . 0.0 109.569 177.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.551 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -75.46 126.68 87.3 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.669 -1.269 . . . . 0.0 111.827 -177.669 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.428 ' CB ' ' HB3' ' A' ' 141' ' ' ARG . 55.2 Cg_endo -90.82 98.72 0.24 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 122.627 0.803 . . . . 0.0 110.038 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.468 ' O ' ' N ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -87.59 97.85 11.09 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.194 -0.941 . . . . 0.0 109.027 179.212 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.0 mtt -47.03 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.624 -0.672 . . . . 0.0 110.543 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.468 ' N ' ' O ' ' A' ' 82' ' ' MET . 14.7 p -88.11 125.37 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 119.456 -0.897 . . . . 0.0 110.778 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 90' ' ' ALA . 0.8 OUTLIER -98.27 27.6 4.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -0.912 . . . . 0.0 110.047 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -92.46 36.53 1.0 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.343 -0.848 . . . . 0.0 110.362 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.431 ' O ' ' N ' ' A' ' 89' ' ' SER . 1.1 m120 -105.09 78.15 1.37 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -0.911 . . . . 0.0 110.081 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 89' ' ' SER . 53.2 p 45.15 -92.41 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.716 -0.615 . . . . 0.0 111.026 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.431 ' N ' ' O ' ' A' ' 87' ' ' ASN . 0.2 OUTLIER -52.76 -37.64 59.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.84 -1.163 . . . . 0.0 110.297 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 85' ' ' GLU . . . 53.33 38.48 27.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -0.954 . . . . 0.0 110.236 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -100.15 77.12 1.96 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.299 -0.876 . . . . 0.0 110.199 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.47 39.02 83.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p -60.98 -17.87 54.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -1.117 . . . . 0.0 110.511 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.18 23.61 2.94 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.467 ' O ' ' N ' ' A' ' 97' ' ' VAL . 0.1 OUTLIER -59.74 100.51 0.09 Allowed 'General case' 0 N--CA 1.484 1.248 0 O-C-N 120.997 -1.296 . . . . 0.0 111.447 -179.354 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.445 ' HB ' ' O ' ' A' ' 139' ' ' PRO . 4.0 m -60.23 78.05 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.343 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' A' ' 95' ' ' PHE . 2.6 p -32.99 149.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 CA-C-O 122.615 1.198 . . . . 0.0 112.183 -176.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.509 ' CG2' ' O ' ' A' ' 137' ' ' VAL . 5.4 p -70.29 -174.86 0.89 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.915 -175.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.488 ' CG1' ' HB3' ' A' ' 131' ' ' LEU 0.27 0.1 OUTLIER -146.44 136.61 17.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 -179.679 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.559 ' CB ' ' O ' ' A' ' 132' ' ' ASN . 46.7 tt0 -91.83 107.07 18.94 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 117.449 -1.7 . . . . 0.0 112.683 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.483 ' HA ' ' CD2' ' A' ' 131' ' ' LEU . . . -49.96 93.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.424 0.631 . . . . 0.0 110.754 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.449 ' CB ' ' O ' ' A' ' 130' ' ' ASP . . . -98.35 0.34 45.28 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.717 -1.24 . . . . 0.0 109.513 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.439 ' HB3' ' CB ' ' A' ' 121' ' ' ALA . 12.5 tt0 -82.81 13.74 3.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.062 -1.024 . . . . 0.0 111.299 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.404 ' O ' ' HB ' ' A' ' 117' ' ' THR . . . 128.31 25.41 1.06 Allowed Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.31 -1.424 . . . . 0.0 112.562 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.511 ' CG2' ' CB ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -161.0 118.03 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 O-C-N 120.92 -1.341 . . . . 0.0 110.742 177.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 101' ' ' ALA . 32.0 p -147.68 59.48 1.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.462 -1.399 . . . . 0.0 112.131 176.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.454 ' CG2' ' HG2' ' A' ' 114' ' ' ARG . 7.6 t -137.49 -28.02 0.92 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 120.528 -1.358 . . . . 0.0 110.706 176.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 107' ' ' THR . . . 82.26 -28.32 3.4 Favored Glycine 0 N--CA 1.487 2.1 0 O-C-N 121.389 -0.82 . . . . 0.0 111.797 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.08 53.46 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 120.513 -1.581 . . . . 0.0 111.782 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.489 ' HB3' ' HB2' ' A' ' 114' ' ' ARG . 6.6 t -132.8 54.61 1.94 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.571 ' O ' ' HB ' ' A' ' 115' ' ' ILE . . . -41.0 -24.68 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -177.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -78.04 -77.68 0.15 Allowed 'General case' 0 C--N 1.29 -2.017 0 O-C-N 120.289 -1.507 . . . . 0.0 109.913 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.34 -19.78 60.93 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.609 -0.682 . . . . 0.0 112.292 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.489 ' HB2' ' HB3' ' A' ' 110' ' ' SER . 1.4 mpt_? -95.5 -40.29 9.54 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 118.06 -1.456 . . . . 0.0 111.69 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.571 ' HB ' ' O ' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -67.98 -11.85 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 117.272 -1.771 . . . . 0.0 108.645 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.433 ' O ' ' CG ' ' A' ' 119' ' ' ARG . 20.7 p -83.04 -53.34 5.88 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 176.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 121' ' ' ALA . 0.2 OUTLIER -73.56 -23.44 59.97 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.805 178.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 115' ' ' ILE . 2.8 t -63.43 -55.92 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.081 -1.012 . . . . 0.0 109.263 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.433 ' CG ' ' O ' ' A' ' 116' ' ' THR . 36.4 ptt85 -52.18 -33.3 40.01 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.719 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.414 ' N ' ' HG3' ' A' ' 119' ' ' ARG . . . -94.27 -9.49 35.91 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.826 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.511 ' CB ' ' CG2' ' A' ' 105' ' ' VAL . . . -98.49 -53.72 3.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.952 -1.093 . . . . 0.0 112.561 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.424 ' CD1' ' HA ' ' A' ' 48' ' ' GLU . 2.5 pp -67.93 -17.56 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.523 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -107.24 74.1 0.96 Allowed 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.648 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.47 ' HB3' ' CG ' ' A' ' 127' ' ' LYS . 17.5 t70 -97.29 -63.09 1.16 Allowed 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 122.451 1.12 . . . . 0.0 110.256 178.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 126.8 -39.69 1.92 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.711 -2.156 . . . . 0.0 107.711 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -135.86 94.36 3.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.311 -1.111 . . . . 0.0 109.39 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.47 ' CG ' ' HB3' ' A' ' 124' ' ' ASP . 10.8 mmmt -136.9 57.94 17.15 Favored Pre-proline 0 C--N 1.308 -1.23 0 O-C-N 120.702 -1.249 . . . . 0.0 110.57 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.67 -16.22 52.56 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 N-CA-C 108.389 -1.427 . . . . 0.0 108.389 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.9 m -123.28 -25.38 4.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.577 -0.702 . . . . 0.0 111.373 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.462 ' CB ' ' HD2' ' A' ' 127' ' ' LYS . 2.8 t70 -78.39 10.0 3.45 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.749 -1.219 . . . . 0.0 112.428 -178.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.488 ' HB3' ' CG1' ' A' ' 99' ' ' ILE . 8.3 mt -140.32 96.56 3.06 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.687 -1.258 . . . . 0.0 108.671 178.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 0.6 OUTLIER -117.88 98.04 6.14 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.266 -0.896 . . . . 0.0 112.31 -178.045 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.722 ' HB2' ' HA ' ' A' ' 134' ' ' PRO . 0.0 OUTLIER -79.5 171.92 11.23 Favored Pre-proline 0 N--CA 1.503 2.214 0 O-C-N 121.717 -0.615 . . . . 0.0 111.305 -178.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.722 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 48.2 Cg_endo -73.16 130.84 21.12 Favored 'Cis proline' 0 N--CA 1.505 2.192 0 C-N-CA 123.405 -1.498 . . . . 0.0 113.432 7.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 100' ' ' GLU . . . -132.46 63.6 0.62 Allowed Glycine 0 N--CA 1.499 2.858 0 C-N-CA 119.844 -1.169 . . . . 0.0 111.88 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.505 ' O ' ' CE2' ' A' ' 138' ' ' PHE . 57.4 m80 30.46 38.45 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.986 -0.714 . . . . 0.0 112.801 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.509 ' O ' ' CG2' ' A' ' 98' ' ' THR . 2.2 t -108.24 132.56 55.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.553 ' CZ ' ' CG1' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -122.69 84.88 49.1 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 120.47 -1.394 . . . . 0.0 108.381 -176.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.625 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 55.6 Cg_endo -104.3 159.33 0.21 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.961 1.774 . . . . 0.0 114.07 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.438 ' HA ' ' HB ' ' A' ' 96' ' ' THR . 0.5 OUTLIER -142.67 112.38 6.86 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 176.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.428 ' HB3' ' CB ' ' A' ' 81' ' ' PRO . 2.6 ptt85 -64.77 147.1 53.82 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.033 -1.042 . . . . 0.0 111.724 -176.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -129.55 132.15 46.75 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.69 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.39 143.85 27.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.171 -0.955 . . . . 0.0 109.909 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.18 100.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.407 -0.808 . . . . 0.0 109.42 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.425 ' HA2' ' NH2' ' A' ' 209' ' ' ARG . . . 88.66 20.8 46.14 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.33 13.18 61.68 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.548 ' CG2' ' HA ' ' A' ' 155' ' ' GLU . 0.3 OUTLIER -95.1 25.35 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 O-C-N 120.987 -1.302 . . . . 0.0 108.903 178.705 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.418 HD11 ' CG1' ' A' ' 206' ' ' VAL . 4.5 mm? -93.8 39.32 1.07 Allowed 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 102.36 -3.2 . . . . 0.0 102.36 172.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.519 ' H ' ' C ' ' A' ' 147' ' ' VAL . 48.8 m -102.6 92.25 4.56 Favored 'General case' 0 N--CA 1.409 -2.489 1 N-CA-C 99.002 -4.444 . . . . 0.0 99.002 177.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.503 ' O ' ' C ' ' A' ' 151' ' ' GLY . 0.2 OUTLIER -44.49 163.01 0.02 OUTLIER 'General case' 0 C--N 1.26 -3.316 0 CA-C-N 112.694 -2.048 . . . . 0.0 109.232 -173.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 150' ' ' ARG . . . -14.48 82.88 0.0 OUTLIER Glycine 0 N--CA 1.515 3.964 0 CA-C-O 124.179 1.988 . . . . 0.0 112.856 -169.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 150' ' ' ARG . . . -114.55 -157.83 11.99 Favored Glycine 0 N--CA 1.472 1.084 0 N-CA-C 106.984 -2.447 . . . . 0.0 106.984 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -92.83 -33.79 14.11 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.07 -1.253 . . . . 0.0 110.114 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.451 ' O ' ' CG2' ' A' ' 147' ' ' VAL . 41.6 p -97.0 -3.31 41.76 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.435 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.548 ' HA ' ' CG2' ' A' ' 147' ' ' VAL . 0.1 OUTLIER -53.69 -32.26 51.06 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -175.318 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.462 ' CB ' HD23 ' A' ' 172' ' ' LEU . . . -113.89 5.25 16.15 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.153 -1.592 . . . . 0.0 112.336 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -89.4 -51.36 5.59 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.946 179.543 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.43 HD13 ' CA ' ' A' ' 70' ' ' ILE . 1.1 tp -90.25 -27.01 5.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 116.844 -1.942 . . . . 0.0 107.255 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.515 ' O ' ' N ' ' A' ' 162' ' ' THR . 12.4 t70 -62.13 -23.65 66.69 Favored 'General case' 0 C--O 1.199 -1.601 0 C-N-CA 115.877 -2.329 . . . . 0.0 105.099 172.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.562 ' HA ' ' HB2' ' A' ' 163' ' ' LEU . 0.3 OUTLIER -49.96 -45.13 51.14 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.373 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.503 ' CB ' ' HA ' ' A' ' 168' ' ' PRO . 5.7 ptt? -52.35 -36.37 53.38 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.008 176.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 159' ' ' ASP . 4.5 m -79.59 -43.92 22.02 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.575 HD13 ' CD2' ' A' ' 205' ' ' LEU . 0.4 OUTLIER -35.54 -37.07 0.08 Allowed 'General case' 0 N--CA 1.517 2.907 0 CA-C-O 122.216 1.008 . . . . 0.0 109.094 178.184 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.489 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -106.93 -26.99 10.96 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.913 0.863 . . . . 0.0 108.828 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 162' ' ' THR . . . 108.93 -25.89 17.32 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -148.98 57.65 1.03 Allowed 'General case' 0 N--CA 1.505 2.297 0 C-N-CA 117.477 -1.689 . . . . 0.0 113.132 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 169' ' ' ALA . 18.3 mmtt -129.3 73.88 81.36 Favored Pre-proline 0 C--N 1.3 -1.564 0 O-C-N 120.485 -1.385 . . . . 0.0 107.758 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.503 ' HA ' ' CB ' ' A' ' 161' ' ' MET . 39.5 Cg_endo -67.4 84.44 0.36 Allowed 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 116.236 -2.043 . . . . 0.0 110.107 -176.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.492 ' CB ' ' N ' ' A' ' 47' ' ' ALA 0.265 . . -159.56 164.43 34.27 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 176.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -157.63 108.88 0.38 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 118.406 -1.854 . . . . 0.0 109.969 177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.643 ' O ' ' O ' ' A' ' 43' ' ' MET . 0.1 OUTLIER -133.14 92.68 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.196 -1.725 0 C-N-CA 116.952 -1.899 . . . . 0.0 109.491 177.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.506 HD13 ' CD1' ' A' ' 160' ' ' LEU . 10.0 mp -103.86 145.4 30.17 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.16 0.505 . . . . 0.0 109.826 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.493 ' N ' ' HB2' ' A' ' 43' ' ' MET . 1.1 t -130.73 167.54 18.66 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.112 -0.993 . . . . 0.0 110.724 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.401 ' N ' ' SG ' ' A' ' 173' ' ' CYS . 13.6 mm-40 -115.28 126.19 54.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.166 -0.959 . . . . 0.0 109.843 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.448 ' CD2' ' CD1' ' A' ' 57' ' ' LEU . 3.3 tm? -63.92 120.42 11.93 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.074 -1.016 . . . . 0.0 110.359 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 4.5 m -139.15 155.59 47.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 109.968 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.425 ' OD1' ' CG ' ' A' ' 61' ' ' HIS . 1.2 t-20 -106.45 163.58 12.74 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.119 -0.988 . . . . 0.0 110.026 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' HIS . 0.3 OUTLIER -90.51 6.5 43.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.407 -0.808 . . . . 0.0 110.951 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.17 16.07 25.38 Favored 'General case' 0 C--N 1.291 -1.968 0 O-C-N 121.636 -0.665 . . . . 0.0 110.205 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 61.42 21.95 60.66 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 183' ' ' ALA . 1.3 p -83.11 121.83 27.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -1.147 . . . . 0.0 110.044 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -60.54 85.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.879 . . . . 0.0 110.249 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.486 ' CB ' ' CB ' ' A' ' 188' ' ' CYS . . . -54.64 130.06 38.85 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.214 -0.929 . . . . 0.0 110.047 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 188' ' ' CYS . 0.6 OUTLIER -79.07 125.08 28.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.462 -0.774 . . . . 0.0 109.923 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.426 ' N ' ' HD2' ' A' ' 186' ' ' PRO . . . -38.14 -54.03 2.72 Favored Pre-proline 0 N--CA 1.501 2.084 0 O-C-N 121.809 -0.557 . . . . 0.0 112.391 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 185' ' ' ALA . 47.5 Cg_endo -74.15 -35.12 4.31 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.41 1.216 . . . . 0.0 111.329 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.64 -59.3 2.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.076 -1.015 . . . . 0.0 111.514 -179.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . 0.486 ' CB ' ' CB ' ' A' ' 183' ' ' ALA . 12.3 p -53.15 -40.09 64.03 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.173 -0.954 . . . . 0.0 110.231 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.449 HG12 ' CG ' ' A' ' 30' ' ' MET . 3.7 tp -73.33 -29.09 26.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 120.703 -1.248 . . . . 0.0 108.254 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 194' ' ' LYS . 0.1 OUTLIER -58.31 -20.51 43.62 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.759 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.469 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.2 OUTLIER -76.49 -53.85 7.53 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 178.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -56.28 -25.6 48.82 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . 0.551 ' O ' ' N ' ' A' ' 197' ' ' MET . 0.0 OUTLIER -89.38 -23.61 22.15 Favored 'General case' 0 C--O 1.194 -1.863 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 190' ' ' GLU . 0.0 OUTLIER -52.07 -35.59 47.94 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 119.578 -1.951 . . . . 0.0 110.459 -178.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.5 -43.27 6.59 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 117.612 -1.635 . . . . 0.0 108.495 176.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.442 ' HB3' ' N ' ' A' ' 28' ' ' GLY . 81.1 m-20 -103.91 56.22 0.73 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 176.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' MET . . . . . 0.551 ' N ' ' O ' ' A' ' 193' ' ' ASN . 0.4 OUTLIER -66.59 74.72 0.1 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 -172.513 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.594 ' O ' ' HA ' ' A' ' 29' ' ' VAL . . . -131.01 99.25 4.83 Favored 'General case' 0 C--O 1.197 -1.701 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 172.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.457 HD21 ' CG ' ' A' ' 30' ' ' MET . 44.2 mt -118.21 131.57 56.37 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 119.68 -1.888 . . . . 0.0 111.448 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.482 ' CG2' ' CD2' ' A' ' 6' ' ' LEU . 0.5 OUTLIER -129.87 -159.22 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.313 -0.867 . . . . 0.0 111.352 -179.429 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.424 ' N ' HG11 ' A' ' 200' ' ' VAL . 1.7 p -125.46 177.64 6.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.488 -0.758 . . . . 0.0 109.955 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.445 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 1.4 tp -91.46 -44.46 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.214 -0.929 . . . . 0.0 111.752 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.428 ' N ' HG22 ' A' ' 202' ' ' ILE . 43.9 mt-10 -60.17 -61.9 2.26 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.693 -1.254 . . . . 0.0 110.223 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.461 ' O ' ' CB ' ' A' ' 12' ' ' PRO . 2.7 m-20 -57.74 -16.95 12.71 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.366 -0.834 . . . . 0.0 110.696 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.575 ' CD2' HD13 ' A' ' 163' ' ' LEU . 8.4 tt -68.05 -61.15 1.99 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.236 -1.54 . . . . 0.0 110.353 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.503 HG21 HG11 ' A' ' 147' ' ' VAL . 2.4 t -60.93 -16.66 14.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 119.848 -1.782 . . . . 0.0 109.277 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.457 ' CB ' ' HB2' ' A' ' 12' ' ' PRO . . . -60.58 -32.77 71.86 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 105.329 -2.101 . . . . 0.0 105.329 174.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.587 ' CD2' ' CG1' ' A' ' 16' ' ' VAL 0.273 1.1 t80 -50.81 -41.98 57.79 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 175.101 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.437 ' CG ' HG22 ' A' ' 162' ' ' THR . 1.3 ttt85 -78.43 -62.77 1.58 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.153 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -50.41 -37.2 36.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.192 -0.943 . . . . 0.0 110.409 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 207' ' ' ALA . . . -74.75 -26.91 60.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.396 -0.815 . . . . 0.0 110.152 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.404 ' O ' ' CD2' ' A' ' 212' ' ' HIS . 9.0 t60 -68.65 -23.48 64.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 110.18 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -105.52 -9.17 17.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 110.677 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.6 148.06 25.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.068 -1.02 . . . . 0.0 110.223 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.409 ' O ' ' CG ' ' A' ' 215' ' ' LYS . 0.0 OUTLIER -113.36 85.35 2.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.194 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -72.46 -80.31 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.301 -0.875 . . . . 0.0 110.207 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.198 -179.979 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.23 0.538 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -84.39 55.55 3.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.912 . . . . 0.0 110.206 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -94.07 5.23 52.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.341 -0.85 . . . . 0.0 110.773 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.0 m -52.55 -23.08 5.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.938 -1.101 . . . . 0.0 110.402 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.3 tp -53.12 -50.58 64.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 110.26 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.531 HD22 ' N ' ' A' ' 200' ' ' VAL . 6.3 mt -116.03 17.28 15.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.4 -0.812 . . . . 0.0 109.884 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.2 t -77.42 -63.34 1.4 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.773 -1.204 . . . . 0.0 111.754 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.8 t -79.43 -18.22 52.66 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.126 -0.984 . . . . 0.0 110.585 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -139.68 58.42 1.61 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.405 ' HA2' ' HB3' ' A' ' 15' ' ' ARG . . . -168.25 97.53 0.13 Allowed Glycine 0 C--N 1.302 -1.356 0 N-CA-C 106.723 -2.551 . . . . 0.0 106.723 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.24 138.37 32.62 Favored Pre-proline 0 C--N 1.272 -2.8 0 N-CA-C 102.523 -3.14 . . . . 0.0 102.523 177.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.464 ' CB ' ' HB2' ' A' ' 208' ' ' TYR . 34.3 Cg_endo -58.82 -37.0 96.11 Favored 'Trans proline' 0 C--N 1.276 -3.257 0 O-C-N 123.123 1.065 . . . . 0.0 109.712 -177.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.34 -45.27 7.89 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -178.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -81.91 -58.43 2.98 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.259 -1.376 . . . . 0.0 111.524 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.46 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -82.65 -15.26 52.73 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 118.666 -1.214 . . . . 0.0 112.531 -178.253 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.579 HG11 ' CG ' ' A' ' 208' ' ' TYR . 1.1 t -97.94 -29.92 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 116.422 -2.111 . . . . 0.0 110.444 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -73.28 -37.06 66.38 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 115.986 -2.286 . . . . 0.0 107.037 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.426 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 5.4 t30 -74.96 -26.27 59.47 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 24' ' ' ARG . . . -90.77 -17.01 27.38 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.207 -0.933 . . . . 0.0 109.598 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.469 ' CD1' ' NH2' ' A' ' 24' ' ' ARG . 0.9 OUTLIER -69.29 -51.5 36.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.943 -1.098 . . . . 0.0 109.605 179.472 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.44 ' O ' ' CB ' ' A' ' 25' ' ' GLU . . . -89.49 -46.22 8.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.076 -1.015 . . . . 0.0 111.034 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 18' ' ' ASN . . . -72.23 -39.54 68.42 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.148 -0.97 . . . . 0.0 111.876 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 28' ' ' GLY . 56.8 mt -105.05 -24.1 12.85 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.878 -1.139 . . . . 0.0 112.664 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.498 ' NH2' ' CD1' ' A' ' 163' ' ' LEU . 0.4 OUTLIER -100.34 -6.2 26.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.569 -1.332 . . . . 0.0 110.714 -179.288 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.44 ' CB ' ' O ' ' A' ' 21' ' ' ALA . 3.2 tt0 -101.25 44.4 1.01 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 118.117 -1.433 . . . . 0.0 107.949 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.02 2.67 12.43 Favored Glycine 0 C--N 1.296 -1.692 0 C-N-CA 119.911 -1.138 . . . . 0.0 112.616 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.55 22.04 5.99 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 121.313 2.557 . . . . 0.0 115.944 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 23' ' ' LEU . . . 97.09 108.74 2.6 Favored Glycine 0 N--CA 1.501 3.009 0 C-N-CA 117.923 -2.084 . . . . 0.0 116.819 171.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.452 ' CG1' ' HD2' ' A' ' 24' ' ' ARG . 30.7 t -140.77 122.08 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.439 -1.624 . . . . 0.0 106.814 173.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.526 ' HB2' ' CD2' ' A' ' 199' ' ' LEU . 1.1 mtt -123.55 150.03 44.53 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 118.727 -1.189 . . . . 0.0 113.937 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.495 ' HB ' ' HB ' ' A' ' 201' ' ' THR . 1.1 p -133.09 133.03 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.413 HD11 ' N ' ' A' ' 41' ' ' GLY . 0.2 OUTLIER -154.98 -74.22 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.897 . . . . 0.0 110.218 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 t0 56.96 165.87 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.363 -0.836 . . . . 0.0 110.308 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 50.97 -150.54 0.26 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.183 -0.948 . . . . 0.0 110.423 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -142.32 72.21 1.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.888 . . . . 0.0 110.169 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.77 -166.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 110.298 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.21 -57.61 0.9 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.913 . . . . 0.0 110.232 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -132.04 90.99 2.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.248 -0.907 . . . . 0.0 110.286 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -175.42 -49.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.265 -0.897 . . . . 0.0 110.162 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.419 ' O ' ' NE2' ' A' ' 153' ' ' HIS . 0.0 OUTLIER 56.87 166.02 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.353 -0.842 . . . . 0.0 110.401 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.559 ' HA2' ' HB2' ' A' ' 172' ' ' LEU . . . -158.84 33.52 0.48 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.582 ' HB2' ' N ' ' A' ' 174' ' ' GLU . 7.9 m-20 -78.87 -39.61 34.74 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -176.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.565 ' HB3' ' HA ' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -85.71 59.81 5.86 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.233 -0.917 . . . . 0.0 111.233 -178.627 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.58 ' CD1' ' HB ' ' A' ' 201' ' ' THR . 41.9 mt -56.73 22.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.94 0 O-C-N 120.489 -1.382 . . . . 0.0 114.531 -175.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 43' ' ' MET . 32.3 m-85 -82.92 161.53 57.8 Favored Pre-proline 0 C--N 1.292 -1.919 0 O-C-N 120.344 -1.473 . . . . 0.0 110.557 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.467 ' HB3' ' CB ' ' A' ' 167' ' ' LYS . 48.0 Cg_endo -70.21 131.83 21.39 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.791 1.661 . . . . 0.0 111.434 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.473 ' HB2' ' CB ' ' A' ' 169' ' ' ALA . . . -61.9 -13.65 26.75 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.467 -0.771 . . . . 0.0 111.774 -178.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.439 ' HA ' ' CB ' ' A' ' 123' ' ' ALA . 0.2 OUTLIER -88.83 -8.71 53.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.038 -1.039 . . . . 0.0 109.088 178.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.456 ' O ' ' N ' ' A' ' 51' ' ' THR . 0.7 OUTLIER -133.9 57.92 1.79 Allowed 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 176.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.495 ' O ' ' CG2' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -60.12 87.6 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.456 ' N ' ' O ' ' A' ' 49' ' ' THR . 13.6 m -64.88 155.59 33.7 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.608 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.444 ' N ' HG21 ' A' ' 115' ' ' ILE . 14.1 t -71.33 -4.89 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.525 -0.734 . . . . 0.0 110.098 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.46 ' OE1' ' CZ ' ' A' ' 45' ' ' PHE . 3.1 mt-10 -57.24 -25.72 59.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.886 -1.134 . . . . 0.0 108.959 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.457 ' CB ' ' HG3' ' A' ' 43' ' ' MET . 0.1 OUTLIER -75.72 -54.15 7.4 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.708 0.765 . . . . 0.0 110.552 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.448 ' O ' ' CG2' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -66.36 -45.47 80.0 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.608 -178.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.405 ' O ' HG22 ' A' ' 59' ' ' ILE . . . -54.75 -44.51 73.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.086 -1.009 . . . . 0.0 110.649 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.468 ' CB ' ' HG2' ' A' ' 174' ' ' GLU . 3.1 tt -67.09 -56.01 11.86 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.195 -0.941 . . . . 0.0 109.607 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.441 ' O ' ' O ' ' A' ' 62' ' ' GLY . 11.8 p -65.16 -51.77 59.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.969 -1.082 . . . . 0.0 111.441 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.448 ' CG2' ' O ' ' A' ' 55' ' ' MET . 7.7 tt -49.92 -25.68 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.053 -1.03 . . . . 0.0 109.198 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.6 ttm180 -66.52 -61.72 1.84 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.996 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.488 ' CE1' ' HA ' ' A' ' 178' ' ' ASP . 5.6 m-70 -129.33 -11.77 4.56 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 118.108 -1.437 . . . . 0.0 114.028 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 58' ' ' THR . . . -132.06 -169.67 12.37 Favored Glycine 0 N--CA 1.498 2.796 0 O-C-N 120.468 -1.395 . . . . 0.0 112.12 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.4 t -135.28 104.75 6.0 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 101.122 -3.658 . . . . 0.0 101.122 176.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.472 ' CA ' ' HB3' ' A' ' 173' ' ' CYS . . . -103.32 73.76 0.28 Allowed Glycine 0 C--N 1.262 -3.545 0 N-CA-C 107.781 -2.128 . . . . 0.0 107.781 -176.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.546 ' CG1' ' CD2' ' A' ' 138' ' ' PHE . 0.6 OUTLIER -65.2 90.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.272 -2.765 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.617 ' O ' ' CD1' ' A' ' 138' ' ' PHE . 28.3 m -51.41 155.57 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 122.049 0.928 . . . . 0.0 113.375 -177.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 171' ' ' VAL . 61.6 m -90.37 111.7 23.02 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.518 ' N ' ' O ' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -88.44 91.97 9.0 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.452 ' HB3' ' CG2' ' A' ' 157' ' ' THR . 26.4 p -78.35 161.66 27.03 Favored 'General case' 0 C--N 1.285 -2.204 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.929 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.562 ' HB ' ' HB3' ' A' ' 75' ' ' ARG . 1.1 pt -151.48 147.84 15.11 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.459 ' CG2' ' HB2' ' A' ' 75' ' ' ARG . 10.3 t -79.89 172.21 14.09 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 120.294 -1.504 . . . . 0.0 107.939 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.476 ' O ' ' CB ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -92.46 -10.98 35.92 Favored 'General case' 0 C--N 1.276 -2.587 0 O-C-N 121.321 -0.862 . . . . 0.0 109.855 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.95 -72.67 0.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.751 -1.218 . . . . 0.0 111.9 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -87.8 -35.27 17.93 Favored 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 119.346 -0.942 . . . . 0.0 109.137 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.562 ' HB3' ' HB ' ' A' ' 70' ' ' ILE . 3.0 mmt180 -69.7 -31.29 69.23 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.004 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.485 ' CG ' ' CD1' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -69.76 -44.22 70.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.236 -1.54 . . . . 0.0 109.075 178.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -41.88 -55.11 3.2 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.768 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.498 ' CD1' ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -104.97 -27.97 11.36 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 117.673 -1.611 . . . . 0.0 110.149 178.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.498 ' N ' ' CD1' ' A' ' 78' ' ' LEU . 22.6 t0 -115.8 72.9 0.82 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.793 -1.192 . . . . 0.0 110.115 176.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.485 ' CD1' ' CG ' ' A' ' 76' ' ' LYS . 13.9 tp -80.42 121.25 81.32 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.568 -1.332 . . . . 0.0 109.301 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.455 ' HA ' ' HB ' ' A' ' 97' ' ' VAL . 54.0 Cg_endo -89.4 93.81 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.573 1.301 . . . . 0.0 109.596 178.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.425 ' O ' ' C ' ' A' ' 83' ' ' MET . 1.2 ttt -96.84 42.95 1.08 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.172 -0.955 . . . . 0.0 109.879 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.484 ' HA ' ' CA ' ' A' ' 96' ' ' THR . 0.0 OUTLIER 16.8 107.99 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' A' ' 84' ' ' VAL . 7.2 p -154.24 93.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 117.277 -1.769 . . . . 0.0 112.635 176.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -108.84 9.08 26.84 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.772 -1.171 . . . . 0.0 108.35 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 88' ' ' THR . 64.8 t-20 -136.62 81.59 1.89 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.449 ' O ' ' CG2' ' A' ' 88' ' ' THR . 11.9 t30 -44.52 87.79 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 119.286 0.948 . . . . 0.0 111.705 -178.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.532 ' N ' ' O ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER 176.04 -88.28 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.424 -0.797 . . . . 0.0 110.825 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.439 ' O ' ' CB ' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -103.27 -45.13 4.98 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.872 -1.143 . . . . 0.0 112.74 -178.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.439 ' CB ' ' O ' ' A' ' 89' ' ' SER . . . 71.5 149.28 0.09 Allowed 'General case' 0 N--CA 1.511 2.618 0 O-C-N 121.131 -0.981 . . . . 0.0 109.995 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -94.0 15.55 16.64 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.112 -0.993 . . . . 0.0 112.1 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 62.36 15.46 52.03 Favored Glycine 0 N--CA 1.497 2.761 0 O-C-N 120.903 -1.123 . . . . 0.0 111.943 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.424 ' CB ' ' HG3' ' A' ' 83' ' ' MET . 0.2 OUTLIER -64.06 -11.55 30.58 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.626 -1.514 . . . . 0.0 110.569 179.198 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.467 ' N ' ' HB2' ' A' ' 83' ' ' MET . . . 50.29 11.02 0.38 Allowed Glycine 0 N--CA 1.5 2.94 0 O-C-N 121.296 -0.877 . . . . 0.0 113.907 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.495 ' CD2' HD23 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -123.99 34.75 4.98 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 120.589 2.194 . . . . 0.0 110.638 178.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.484 ' CA ' ' HA ' ' A' ' 83' ' ' MET . 0.7 OUTLIER -133.73 37.38 3.28 Favored 'General case' 0 N--CA 1.515 2.809 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -179.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.455 ' HB ' ' HA ' ' A' ' 81' ' ' PRO . 0.9 OUTLIER -115.52 110.29 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 O-C-N 120.546 -1.346 . . . . 0.0 110.319 178.283 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.492 ' HA ' ' HG3' ' A' ' 139' ' ' PRO . 14.9 p -75.45 177.19 6.86 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.123 -0.985 . . . . 0.0 110.439 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.492 ' CA ' ' HB3' ' A' ' 133' ' ' ARG . 27.9 pt -142.31 135.81 28.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 132' ' ' ASN . 10.9 tt0 -86.17 113.37 22.15 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 117.072 -1.851 . . . . 0.0 110.961 -176.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.532 ' HA ' ' CD2' ' A' ' 131' ' ' LEU . . . -53.02 91.7 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.648 0.737 . . . . 0.0 109.929 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 100' ' ' GLU . . . -106.29 -0.43 24.39 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.407 -0.808 . . . . 0.0 110.504 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.439 ' HB2' ' CB ' ' A' ' 129' ' ' SER . 27.6 tt0 -86.89 26.97 1.05 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.915 -1.115 . . . . 0.0 111.896 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.94 -38.68 2.11 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.422 -1.37 . . . . 0.0 111.466 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.503 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 5.4 p -101.39 125.7 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.104 -1.233 . . . . 0.0 110.331 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.5 m -143.06 59.62 1.41 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.853 -1.155 . . . . 0.0 110.565 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.9 m -137.27 -30.76 0.84 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.091 -1.005 . . . . 0.0 110.564 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.417 ' CA ' ' CE1' ' A' ' 136' ' ' HIS . . . 78.62 -30.81 1.95 Allowed Glycine 0 N--CA 1.494 2.52 0 O-C-N 121.565 -0.71 . . . . 0.0 111.329 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.17 58.57 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.85 -1.383 . . . . 0.0 109.347 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 112' ' ' ALA . 0.5 OUTLIER -128.23 57.49 1.57 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.298 -0.876 . . . . 0.0 109.057 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.455 ' O ' ' CG1' ' A' ' 115' ' ' ILE . . . -33.48 -29.95 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -81.05 -76.94 0.22 Allowed 'General case' 0 C--N 1.291 -1.972 0 O-C-N 120.893 -1.129 . . . . 0.0 110.13 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.81 -13.94 62.71 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.563 -0.711 . . . . 0.0 111.18 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.46 ' HB3' ' O ' ' A' ' 110' ' ' SER . 0.1 OUTLIER -89.65 -44.44 10.05 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.96 -1.087 . . . . 0.0 110.506 -179.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.495 ' CG2' ' O ' ' A' ' 50' ' ' MET . 18.4 mm -64.6 -16.92 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.668 -1.213 . . . . 0.0 110.739 -178.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 68.8 p -88.28 -53.45 4.69 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.866 -1.133 . . . . 0.0 108.704 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.492 ' HB ' ' HB ' ' A' ' 105' ' ' VAL . 60.0 m -71.39 -43.19 67.31 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.544 -0.863 . . . . 0.0 110.004 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.442 ' CG1' ' O ' ' A' ' 114' ' ' ARG . 4.4 p -52.72 -40.13 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 120.577 -1.327 . . . . 0.0 109.866 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.436 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 54.2 ttt180 -51.31 -53.47 35.64 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.851 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -99.29 -6.99 27.01 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 117' ' ' THR . . . -98.35 -26.36 14.52 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 116.056 1.872 . . . . 0.0 116.056 -174.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.439 HD13 ' CB ' ' A' ' 123' ' ' ALA . 2.6 pp -121.02 -37.7 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 121.112 1.778 . . . . 0.0 112.091 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.439 ' CB ' ' HA ' ' A' ' 48' ' ' GLU . . . -103.98 75.26 1.27 Allowed 'General case' 0 C--N 1.263 -3.166 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.392 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.479 ' CB ' ' CD ' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -97.27 -54.96 2.99 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.297 1.046 . . . . 0.0 110.154 177.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 124.07 -39.94 2.05 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 105.729 -2.949 . . . . 0.0 105.729 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -134.63 96.76 3.63 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 175.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.479 ' CD ' ' CB ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -131.75 123.45 19.22 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 120.857 -1.152 . . . . 0.0 113.373 -176.267 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.43 ' HD2' ' CE ' ' A' ' 127' ' ' LYS . 51.8 Cg_endo -81.38 21.02 0.95 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.656 1.345 . . . . 0.0 108.79 175.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 131' ' ' LEU . 2.0 m -92.9 42.29 1.1 Allowed 'General case' 0 C--O 1.202 -1.418 0 O-C-N 121.412 -0.805 . . . . 0.0 109.018 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -26.51 79.37 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 123.991 1.853 . . . . 0.0 111.798 -176.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.579 ' N ' ' O ' ' A' ' 129' ' ' SER 0.255 5.4 mt -61.44 125.35 23.48 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 112.069 -2.332 . . . . 0.0 108.047 -178.148 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 15.7 p-10 -113.68 99.51 7.78 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.409 -0.807 . . . . 0.0 111.738 -177.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.704 ' HB2' ' HA ' ' A' ' 134' ' ' PRO 0.282 0.5 OUTLIER -82.58 -178.43 1.18 Allowed Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 122.031 -0.418 . . . . 0.0 111.203 -177.611 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.704 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 48.5 Cg_endo -72.69 123.39 8.23 Favored 'Cis proline' 0 N--CA 1.503 2.063 0 C-N-CA 123.674 -1.386 . . . . 0.0 113.327 8.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.439 ' C ' ' CG ' ' A' ' 136' ' ' HIS . . . -124.04 60.03 0.61 Allowed Glycine 0 N--CA 1.5 2.907 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.105 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.472 ' O ' ' CE2' ' A' ' 138' ' ' PHE . 25.5 p80 32.1 37.97 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.665 0 O-C-N 121.745 -0.856 . . . . 0.0 112.271 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.451 ' HB ' ' CB ' ' A' ' 98' ' ' THR . 54.4 t -91.04 154.87 3.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.617 ' CD1' ' O ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -123.6 84.06 53.37 Favored Pre-proline 0 C--N 1.281 -2.376 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 -178.32 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.492 ' HG3' ' HA ' ' A' ' 98' ' ' THR . 54.9 Cg_endo -98.42 140.84 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.737 1.388 . . . . 0.0 113.674 -176.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.495 HD23 ' CD2' ' A' ' 95' ' ' PHE . 36.1 mt -136.7 112.8 9.73 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.463 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.401 ' CD ' ' HG2' ' A' ' 81' ' ' PRO . 11.1 ttt180 -69.95 127.0 31.36 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.085 -1.009 . . . . 0.0 109.874 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.49 ' CB ' ' CG2' ' A' ' 158' ' ' ILE . . . -132.75 133.19 43.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.063 -1.023 . . . . 0.0 111.329 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -58.84 143.09 48.56 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.247 -0.908 . . . . 0.0 109.532 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.27 106.27 5.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.421 -0.799 . . . . 0.0 110.568 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 86.54 20.98 53.03 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.83 12.85 62.57 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.464 ' HA ' ' HG3' ' A' ' 155' ' ' GLU . 13.6 p -104.57 18.76 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.972 -1.311 . . . . 0.0 109.427 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.438 ' CD1' ' HA ' ' A' ' 207' ' ' ALA . 3.7 mm? -94.86 20.39 8.88 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 117.331 -1.748 . . . . 0.0 108.306 176.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 151' ' ' GLY . 29.4 m -126.99 73.46 1.42 Allowed 'General case' 0 C--N 1.29 -1.987 1 N-CA-C 96.183 -5.488 . . . . 0.0 96.183 168.515 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.437 ' CD ' ' HA ' ' A' ' 203' ' ' GLU . 0.1 OUTLIER -67.21 71.85 0.11 Allowed 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 113.553 -1.658 . . . . 0.0 115.033 -168.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 149' ' ' THR . . . -116.93 28.68 7.21 Favored Glycine 0 N--CA 1.475 1.281 0 N-CA-C 105.611 -2.996 . . . . 0.0 105.611 169.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -148.74 131.38 3.72 Favored Glycine 0 C--N 1.303 -1.265 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.502 ' CE1' ' HA3' ' A' ' 41' ' ' GLY . 1.6 t60 -89.79 -5.37 56.99 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.433 ' CG2' ' N ' ' A' ' 155' ' ' GLU . 14.9 t -93.38 -46.51 7.31 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.225 -0.922 . . . . 0.0 110.821 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.464 ' HG3' ' HA ' ' A' ' 147' ' ' VAL . 1.2 pt-20 -59.61 -20.73 57.94 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.468 ' HA ' ' CB ' ' A' ' 159' ' ' ASP . . . -86.77 5.66 35.34 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 121.356 -0.84 . . . . 0.0 108.943 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.52 ' O ' ' CB ' ' A' ' 160' ' ' LEU . 2.5 m -87.05 -51.12 6.19 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.49 ' CG2' ' CB ' ' A' ' 142' ' ' ALA . 4.4 tp -74.39 -17.44 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 115.96 -2.296 . . . . 0.0 106.404 175.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.468 ' CB ' ' HA ' ' A' ' 156' ' ' ALA . 18.9 t70 -62.21 -29.84 70.67 Favored 'General case' 0 C--O 1.206 -1.215 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 173.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.563 ' N ' HD22 ' A' ' 163' ' ' LEU . 1.7 tm? -50.23 -43.75 53.05 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 176.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.49 ' HB3' ' O ' ' A' ' 158' ' ' ILE . 0.0 OUTLIER -52.76 -36.21 57.6 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.75 178.508 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 159' ' ' ASP . 1.5 m -93.17 -51.44 5.02 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.563 HD22 ' N ' ' A' ' 160' ' ' LEU . 1.8 pp -57.41 -14.47 4.85 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.501 -1.374 . . . . 0.0 111.679 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.404 ' HA ' HD13 ' A' ' 20' ' ' LEU . . . -77.16 -30.78 55.15 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 120.593 -1.317 . . . . 0.0 108.392 176.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 106.27 -35.43 5.05 Favored Glycine 0 N--CA 1.493 2.475 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.326 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.74 48.19 0.39 Allowed 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 117.792 -1.563 . . . . 0.0 113.097 172.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.467 ' CB ' ' HB3' ' A' ' 46' ' ' PRO . 40.4 mmtt -135.95 83.46 34.26 Favored Pre-proline 0 C--N 1.289 -2.061 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 174.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.464 ' HA ' ' HB2' ' A' ' 161' ' ' MET . 44.5 Cg_endo -73.65 81.02 1.91 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 114.781 -3.013 . . . . 0.0 113.798 -173.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.473 ' CB ' ' HB2' ' A' ' 47' ' ' ALA . . . -165.76 168.38 16.12 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 171.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.427 ' CA ' ' SG ' ' A' ' 69' ' ' CYS . . . -156.99 129.02 2.29 Favored Glycine 0 N--CA 1.504 3.184 0 C-N-CA 118.28 -1.914 . . . . 0.0 110.276 177.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.503 ' O ' ' O ' ' A' ' 43' ' ' MET . 6.5 m -141.42 101.43 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.565 ' HA ' ' HB3' ' A' ' 43' ' ' MET . 0.0 OUTLIER -125.86 101.08 6.67 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 117.177 -1.809 . . . . 0.0 115.045 -176.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.477 ' HB2' ' HA ' ' A' ' 66' ' ' VAL . 1.1 m -140.79 141.87 34.74 Favored 'General case' 0 N--CA 1.514 2.736 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 173.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.582 ' N ' ' HB2' ' A' ' 42' ' ' ASP . 3.5 tt0 176.82 87.32 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.33 0 CA-C-N 122.632 2.469 . . . . 0.0 115.473 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.477 ' CD1' ' N ' ' A' ' 176' ' ' THR . 0.3 OUTLIER -128.2 135.0 49.12 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 120.452 -1.405 . . . . 0.0 109.108 175.331 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.497 ' O ' ' CE2' ' A' ' 191' ' ' PHE . 6.2 t -131.13 92.46 3.21 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.762 -1.211 . . . . 0.0 110.312 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.485 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 4.4 t-20 -121.81 142.25 50.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.425 -1.422 . . . . 0.0 111.385 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.488 ' HA ' ' CE1' ' A' ' 61' ' ' HIS . 9.7 p-10 -80.37 6.44 12.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.078 -1.013 . . . . 0.0 111.345 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.74 -18.68 28.9 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 121.453 -0.78 . . . . 0.0 110.119 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 76.41 23.4 70.79 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 183' ' ' ALA . 69.4 p -128.5 98.83 5.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.299 -1.118 . . . . 0.0 110.177 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.37 76.47 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 110.44 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 181' ' ' THR . . . -54.77 131.43 43.83 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.355 -0.841 . . . . 0.0 109.935 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 9.5 mtt-85 -105.26 100.15 9.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.341 -0.85 . . . . 0.0 109.825 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.458 ' CB ' ' HD2' ' A' ' 186' ' ' PRO . . . 172.92 178.93 0.12 Allowed Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.309 -0.869 . . . . 0.0 109.831 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.458 ' HD2' ' CB ' ' A' ' 185' ' ' ALA . 43.0 Cg_endo -69.5 -7.72 21.72 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.303 1.159 . . . . 0.0 110.422 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.5 -41.66 19.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.972 -1.08 . . . . 0.0 109.992 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . 0.48 ' O ' ' HB3' ' A' ' 191' ' ' PHE . 16.8 p -67.43 -36.32 80.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.966 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.45 ' CG1' ' CB ' ' A' ' 30' ' ' MET . 5.2 tp -73.98 -28.33 23.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.754 -1.216 . . . . 0.0 109.079 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.452 ' HA ' ' HB3' ' A' ' 193' ' ' ASN . 35.9 tt0 -71.05 -19.01 62.54 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.721 0.772 . . . . 0.0 109.05 177.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.497 ' CE2' ' O ' ' A' ' 176' ' ' THR . 0.7 OUTLIER -75.99 -48.42 21.12 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.128 0.966 . . . . 0.0 109.513 -179.413 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.455 ' CB ' ' HE2' ' A' ' 30' ' ' MET . . . -73.79 -35.35 64.92 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 178.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . 0.552 ' HA ' ' HB2' ' A' ' 197' ' ' MET . 1.7 t30 -56.33 -23.36 36.72 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.3 -40.92 20.81 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 118.099 -1.441 . . . . 0.0 112.741 -176.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.25 -56.03 2.6 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 114.966 -2.694 . . . . 0.0 112.055 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.422 ' O ' ' HG2' ' A' ' 197' ' ' MET . 0.1 OUTLIER -117.05 33.74 5.46 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.073 -1.451 . . . . 0.0 113.773 176.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' MET . . . . . 0.552 ' HB2' ' HA ' ' A' ' 193' ' ' ASN . 15.3 mmt -150.35 151.69 33.25 Favored 'General case' 0 N--CA 1.517 2.896 0 CA-C-N 123.034 2.652 . . . . 0.0 114.53 -178.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.431 ' CB ' ' HB3' ' A' ' 23' ' ' LEU . . . -111.59 155.73 22.89 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.033 -1.042 . . . . 0.0 108.916 177.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.526 ' CD2' ' HB2' ' A' ' 30' ' ' MET . 48.1 mt -125.58 133.19 52.36 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 120.552 -1.342 . . . . 0.0 109.676 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.531 ' N ' HD22 ' A' ' 6' ' ' LEU . 1.3 p -170.82 18.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.521 -1.362 . . . . 0.0 113.287 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.58 ' HB ' ' CD1' ' A' ' 44' ' ' ILE 0.271 87.0 m -133.33 150.24 51.87 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 -176.149 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.48 ' CB ' ' O ' ' A' ' 201' ' ' THR . 3.6 tp 149.85 -76.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.844 0 C-N-CA 124.99 1.316 . . . . 0.0 109.704 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.437 ' HA ' ' CD ' ' A' ' 150' ' ' ARG . 1.9 tt0 -93.79 -59.56 1.96 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.337 -1.477 . . . . 0.0 110.723 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.33 -50.32 73.42 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.225 -0.922 . . . . 0.0 111.508 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.544 ' O ' ' HB3' ' A' ' 208' ' ' TYR . 3.2 tt -60.5 -23.63 64.68 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.069 -1.019 . . . . 0.0 113.244 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.437 ' CG2' ' O ' ' A' ' 203' ' ' GLU . 16.5 m -77.98 -34.82 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 119.65 -1.906 . . . . 0.0 108.14 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.438 ' HA ' ' CD1' ' A' ' 148' ' ' LEU . . . -68.82 -14.62 63.14 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 174.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.579 ' CG ' HG11 ' A' ' 16' ' ' VAL . 7.6 t80 -81.71 -26.71 34.38 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.798 -0.563 . . . . 0.0 109.608 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.499 ' HG3' ' N ' ' A' ' 210' ' ' GLN . 0.2 OUTLIER -75.82 -25.77 56.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.096 -1.003 . . . . 0.0 108.69 177.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.499 ' N ' ' HG3' ' A' ' 209' ' ' ARG . 6.8 tt0 -82.72 -59.15 2.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.412 -0.805 . . . . 0.0 109.885 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -51.77 -27.1 11.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.485 -0.759 . . . . 0.0 110.223 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -75.37 -44.62 43.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 109.999 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . 0.413 ' OE1' ' CG2' ' A' ' 162' ' ' THR . 2.6 mt-10 -86.27 -9.26 56.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.32 -0.862 . . . . 0.0 110.59 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -111.06 148.08 33.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.001 -1.062 . . . . 0.0 110.205 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.08 104.8 4.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.176 -0.953 . . . . 0.0 110.292 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . 53.11 -173.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.333 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.225 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.299 0.571 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -88.18 58.09 4.6 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.904 . . . . 0.0 110.196 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.448 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 17.5 pt20 -71.41 -16.11 62.38 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.253 -0.904 . . . . 0.0 110.881 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 5' ' ' LEU . 1.5 p -64.42 -2.68 2.4 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.977 -1.077 . . . . 0.0 112.411 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.507 ' CB ' ' CZ ' ' A' ' 13' ' ' PHE . 3.7 mt -28.8 -71.39 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.577 HD11 ' CE2' ' A' ' 13' ' ' PHE . 0.4 OUTLIER -120.25 -49.42 2.28 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 117.399 -1.72 . . . . 0.0 115.172 -179.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.469 ' CB ' ' CG2' ' A' ' 11' ' ' THR . 1.6 t -100.49 -88.77 0.35 Allowed 'General case' 0 N--CA 1.51 2.563 0 CA-C-N 123.121 2.691 . . . . 0.0 111.33 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.414 ' N ' ' OG ' ' A' ' 7' ' ' SER . 75.7 p -116.66 -62.68 1.55 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 117.926 -1.51 . . . . 0.0 109.281 174.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 47.4 p90 -162.06 30.27 0.12 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.187 174.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.57 95.22 0.1 OUTLIER Glycine 0 N--CA 1.483 1.768 0 C-N-CA 118.625 -1.75 . . . . 0.0 109.826 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.584 ' C ' ' N ' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -130.2 164.04 43.62 Favored Pre-proline 0 C--N 1.273 -2.751 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 178.461 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 14' ' ' GLU . 20.5 Cg_endo -46.23 -16.12 0.21 Allowed 'Trans proline' 0 N--CA 1.508 2.334 0 N-CA-C 106.551 -2.134 . . . . 0.0 106.551 174.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.699 ' HA ' HG23 ' A' ' 16' ' ' VAL 0.27 16.1 t80 -40.15 -26.83 0.03 OUTLIER 'General case' 0 C--O 1.184 -2.352 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.733 169.098 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 12' ' ' PRO . 1.0 OUTLIER -43.09 -38.14 2.26 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.085 -1.634 . . . . 0.0 109.082 179.28 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.7 mmt-85 -61.78 -46.37 89.87 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 176.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.699 HG23 ' HA ' ' A' ' 13' ' ' PHE . 15.7 m -79.34 -12.67 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 C-N-CA 117.684 -1.606 . . . . 0.0 109.875 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.498 ' HA ' ' CE1' ' A' ' 13' ' ' PHE . 35.1 tt0 -53.88 -34.54 59.73 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -79.11 -33.08 44.69 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.484 ' CB ' ' HA ' ' A' ' 16' ' ' VAL . . . -70.49 -64.87 0.81 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.5 -0.75 . . . . 0.0 110.834 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.465 ' CD2' ' HA ' ' A' ' 164' ' ' ALA . 0.0 OUTLIER -54.66 -43.95 72.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.2 -0.938 . . . . 0.0 109.127 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 17' ' ' GLU . . . -53.68 -28.37 33.03 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 25' ' ' GLU . . . -78.24 -33.52 49.7 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 3.8 tt -44.52 -28.04 0.53 Allowed 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.84 0.829 . . . . 0.0 109.582 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.53 -30.84 12.64 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 22' ' ' ALA . 0.2 OUTLIER -147.7 82.65 1.52 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 123.439 1.59 . . . . 0.0 108.191 177.457 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 126.57 50.64 0.17 Allowed Glycine 0 C--N 1.275 -2.821 1 N-CA-C 102.076 -4.409 . . . . 0.0 102.076 -174.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.439 ' HA ' ' HA ' ' A' ' 23' ' ' LEU . 3.1 mtm180 -55.92 91.16 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 122.942 1.353 . . . . 0.0 110.429 -173.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.449 ' HA2' ' CZ ' ' A' ' 45' ' ' PHE . . . 176.48 105.95 0.19 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.124 -1.512 . . . . 0.0 113.189 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.445 ' CG1' HG12 ' A' ' 44' ' ' ILE . 1.1 p -140.34 99.21 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.528 ' HB2' ' CD2' ' A' ' 199' ' ' LEU . 4.9 mtt -97.96 130.42 44.82 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.864 -1.147 . . . . 0.0 114.072 -173.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.499 ' CG1' ' CD1' ' A' ' 205' ' ' LEU . 35.6 m -77.35 90.5 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.4 -0.812 . . . . 0.0 109.707 177.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.39 127.81 32.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.985 -1.072 . . . . 0.0 110.396 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -99.11 156.35 16.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.183 -0.948 . . . . 0.0 110.189 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -99.8 173.31 6.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 110.243 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 53.2 -178.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.336 -0.852 . . . . 0.0 110.212 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.27 114.38 28.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 110.202 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -138.15 175.33 9.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 110.167 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -103.51 49.49 0.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.328 -0.858 . . . . 0.0 110.238 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -175.25 135.13 0.33 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.203 -0.936 . . . . 0.0 110.279 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.469 ' O ' ' CG ' ' A' ' 153' ' ' HIS . 34.2 mt-10 -137.94 -71.77 0.42 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 110.209 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.426 ' HA3' HD23 ' A' ' 172' ' ' LEU . . . 100.96 55.66 0.92 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 30' ' ' MET . 5.2 m-20 -78.92 -37.88 38.72 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.169 -1.195 . . . . 0.0 111.834 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.555 ' O ' ' O ' ' A' ' 171' ' ' VAL . 0.0 OUTLIER -85.87 54.41 3.12 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.511 -0.743 . . . . 0.0 110.382 -179.173 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.526 ' HA ' ' HG ' ' A' ' 172' ' ' LEU . 3.0 pt -63.77 26.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.534 3.763 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 -175.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.471 ' CD2' ' HB3' ' A' ' 54' ' ' GLN . 9.7 m-85 -67.81 161.68 64.68 Favored Pre-proline 0 C--N 1.283 -2.309 0 O-C-N 121.372 -0.83 . . . . 0.0 112.193 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.451 ' HB3' ' HB3' ' A' ' 167' ' ' LYS . 45.6 Cg_endo -68.83 129.58 18.87 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.524 1.483 . . . . 0.0 110.52 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.458 ' HA ' ' CG1' ' A' ' 171' ' ' VAL . . . -70.47 -2.59 14.38 Favored 'General case' 0 N--CA 1.508 2.441 0 C-N-CA 119.195 -1.002 . . . . 0.0 112.554 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -85.73 -23.55 27.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.737 -1.227 . . . . 0.0 109.315 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 51' ' ' THR . 51.7 m -132.42 60.56 1.69 Allowed 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 177.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.41 ' O ' HG13 ' A' ' 115' ' ' ILE . 0.4 OUTLIER -52.48 88.09 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.263 0.554 . . . . 0.0 110.056 -178.739 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.49 ' N ' ' O ' ' A' ' 49' ' ' THR . 1.6 m -66.18 153.42 42.48 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.616 0.722 . . . . 0.0 109.777 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.49 ' N ' ' CG1' ' A' ' 115' ' ' ILE . 1.7 p -73.91 -3.78 4.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.569 -0.707 . . . . 0.0 109.668 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.404 ' CG ' ' HB2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -55.8 -32.63 63.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.742 -1.224 . . . . 0.0 108.53 179.287 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.471 ' HB3' ' CD2' ' A' ' 45' ' ' PHE . 10.2 pt20 -81.18 -32.89 33.38 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.51 0.671 . . . . 0.0 110.118 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.423 ' HB3' ' CD1' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -82.22 -46.42 13.75 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.38 -0.825 . . . . 0.0 110.263 -179.782 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -54.07 -45.05 71.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.951 -1.093 . . . . 0.0 110.142 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.479 ' CD1' ' CB ' ' A' ' 192' ' ' ALA . 7.3 tt -60.98 -53.21 60.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.384 -0.823 . . . . 0.0 110.359 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 62' ' ' GLY . 8.3 t -74.75 -47.44 31.16 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.422 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.443 HG22 HD12 ' A' ' 59' ' ' ILE . 40.8 mt -46.54 -26.03 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 120.649 -1.282 . . . . 0.0 110.222 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.49 -47.62 17.01 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.385 -0.822 . . . . 0.0 110.785 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -125.18 -7.01 7.1 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.636 -1.29 . . . . 0.0 114.068 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 58' ' ' THR . . . -157.05 -168.23 19.32 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 120.503 -1.373 . . . . 0.0 111.005 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.69 103.77 5.32 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 102.273 -3.232 . . . . 0.0 102.273 176.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.442 ' N ' ' OG1' ' A' ' 58' ' ' THR . . . -104.48 73.03 0.25 Allowed Glycine 0 C--N 1.264 -3.439 0 N-CA-C 106.381 -2.687 . . . . 0.0 106.381 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.519 HG22 ' CE1' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -65.72 90.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.031 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.478 ' O ' ' CE1' ' A' ' 138' ' ' PHE . 29.3 m -52.79 150.63 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.003 -177.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 171' ' ' VAL . 82.8 m -77.6 119.17 20.79 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 139' ' ' PRO . 0.6 OUTLIER -90.06 92.07 8.82 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 118.617 -1.233 . . . . 0.0 108.551 -179.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.47 ' HB2' ' HB ' ' A' ' 157' ' ' THR . 0.5 OUTLIER -87.57 145.51 26.18 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 122.339 1.066 . . . . 0.0 112.576 -178.062 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.481 ' CD1' ' HG3' ' A' ' 75' ' ' ARG . 9.9 pt -137.58 138.89 44.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.443 ' N ' HG12 ' A' ' 158' ' ' ILE . 50.0 m -78.59 143.18 36.69 Favored 'General case' 0 C--O 1.199 -1.588 0 O-C-N 120.549 -1.344 . . . . 0.0 108.769 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.435 ' HB3' ' CD ' ' A' ' 141' ' ' ARG . 6.1 pt-20 -41.53 -25.94 0.06 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.788 -0.57 . . . . 0.0 111.799 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 71' ' ' THR . 0.2 OUTLIER -84.46 -49.64 8.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.953 . . . . 0.0 110.496 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -80.83 -25.5 37.71 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.079 0.942 . . . . 0.0 108.666 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.568 ' O ' ' N ' ' A' ' 79' ' ' ASP . 6.5 ttp180 -59.01 -67.99 0.31 Allowed 'General case' 0 C--O 1.19 -2.028 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.437 ' HA ' ' CB ' ' A' ' 80' ' ' LEU . 0.4 OUTLIER -48.66 -55.13 12.17 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.244 -178.352 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -30.01 -50.34 0.12 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 124.362 1.039 . . . . 0.0 111.363 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.417 ' C ' ' CD1' ' A' ' 78' ' ' LEU . 1.6 tm? -134.78 -30.26 1.1 Allowed 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 118.286 -1.365 . . . . 0.0 111.48 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.568 ' N ' ' O ' ' A' ' 75' ' ' ARG . 58.7 m-20 -116.87 69.32 0.75 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.895 -1.128 . . . . 0.0 110.725 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -74.73 169.39 20.14 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 120.766 -1.209 . . . . 0.0 111.66 -179.114 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 80' ' ' LEU . 39.7 Cg_endo -65.77 113.33 2.5 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 O-C-N 122.551 0.764 . . . . 0.0 110.809 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.426 ' O ' ' C ' ' A' ' 83' ' ' MET . 1.0 OUTLIER -95.67 43.46 1.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 0.0 110.768 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.426 ' C ' ' O ' ' A' ' 82' ' ' MET . 3.9 ptt? 26.94 62.4 0.09 Allowed 'General case' 0 N--CA 1.51 2.532 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.45 ' CG2' ' HA ' ' A' ' 96' ' ' THR . 19.1 m -104.08 130.51 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.833 -1.167 . . . . 0.0 110.235 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -98.26 29.47 3.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 110.231 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -90.04 19.66 4.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.305 -0.872 . . . . 0.0 110.535 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 49.6 p30 -105.24 54.89 0.7 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.138 -0.977 . . . . 0.0 110.134 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.5 m -106.45 -64.7 1.14 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.108 -0.995 . . . . 0.0 110.268 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.78 -22.62 9.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.939 . . . . 0.0 110.175 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.425 ' HB3' ' CG2' ' A' ' 93' ' ' THR . . . -69.28 163.95 23.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 110.224 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -114.23 77.08 1.03 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -0.9 . . . . 0.0 110.411 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.402 ' HA3' ' NH2' ' A' ' 150' ' ' ARG . . . 77.02 39.18 28.36 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.486 ' HB ' ' CE2' ' A' ' 95' ' ' PHE . 45.4 p -89.36 -16.13 31.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.226 -1.161 . . . . 0.0 110.548 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.14 21.95 2.02 Favored Glycine 0 N--CA 1.493 2.446 0 O-C-N 121.355 -0.841 . . . . 0.0 111.241 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.511 ' CD2' ' CB ' ' A' ' 138' ' ' PHE . 21.9 m-30 -60.83 99.1 0.08 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.658 -1.495 . . . . 0.0 108.776 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.45 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . 8.8 t -122.25 -1.15 9.24 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 117.974 -1.49 . . . . 0.0 114.762 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.576 ' HB ' ' HG2' ' A' ' 139' ' ' PRO . 57.0 t -119.14 79.88 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.619 0 C-N-CA 119.476 -0.889 . . . . 0.0 112.371 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.483 ' HA ' ' HB ' ' A' ' 137' ' ' VAL . 46.0 p -74.92 144.98 43.02 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 119.844 -1.785 . . . . 0.0 107.257 177.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.54 ' HA ' ' HB3' ' A' ' 133' ' ' ARG . 2.2 pt -146.86 125.31 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.121 -0.987 . . . . 0.0 110.568 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 6.9 tt0 -93.14 108.85 20.37 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 117.621 -1.632 . . . . 0.0 109.511 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.481 ' CB ' ' CG1' ' A' ' 105' ' ' VAL . . . -50.99 93.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.362 -0.836 . . . . 0.0 110.804 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 100' ' ' GLU . . . -84.18 2.49 39.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.452 -0.78 . . . . 0.0 110.428 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.72 4.21 14.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.993 -1.067 . . . . 0.0 110.702 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.14 26.98 1.16 Allowed Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.76 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.481 ' CG1' ' CB ' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -146.19 122.53 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.173 -1.192 . . . . 0.0 110.507 179.331 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.3 m -146.63 60.72 1.21 Allowed 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.044 -1.035 . . . . 0.0 110.401 176.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.1 m -135.65 -31.47 0.95 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.811 -1.181 . . . . 0.0 110.73 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.43 ' HA2' ' CZ ' ' A' ' 114' ' ' ARG . . . 74.21 -27.74 0.99 Allowed Glycine 0 N--CA 1.494 2.518 0 O-C-N 121.449 -0.782 . . . . 0.0 112.384 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.32 57.06 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.469 -1.607 . . . . 0.0 110.604 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 114' ' ' ARG . 2.7 t -129.47 54.4 1.83 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.33 -0.856 . . . . 0.0 108.695 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.442 ' HA ' ' CD1' ' A' ' 115' ' ' ILE . . . -34.14 -29.53 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -84.83 -77.58 0.27 Allowed 'General case' 0 C--N 1.288 -2.08 0 O-C-N 120.73 -1.231 . . . . 0.0 109.612 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.45 -17.38 30.63 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.503 -0.748 . . . . 0.0 110.235 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.496 ' CB ' ' O ' ' A' ' 110' ' ' SER . 0.0 OUTLIER -89.62 -39.21 13.39 Favored 'General case' 0 C--O 1.203 -1.378 0 O-C-N 120.996 -1.065 . . . . 0.0 110.76 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.49 ' CG1' ' N ' ' A' ' 52' ' ' VAL . 1.0 OUTLIER -57.07 -18.4 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 120.306 -1.496 . . . . 0.0 109.368 -178.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.0 m -87.41 -52.93 5.09 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.85 -1.156 . . . . 0.0 108.062 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 121' ' ' ALA . 44.1 p -66.61 -36.85 83.59 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.493 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.469 ' CG1' ' HG2' ' A' ' 114' ' ' ARG . 26.6 m -53.89 -43.4 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 O-C-N 120.349 -1.469 . . . . 0.0 108.603 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.41 ' N ' HG23 ' A' ' 118' ' ' VAL . 0.6 OUTLIER -51.77 -32.18 29.89 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.792 -1.163 . . . . 0.0 107.879 177.223 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.422 ' O ' ' CB ' ' A' ' 123' ' ' ALA . . . -95.3 -19.59 19.85 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.167 178.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 117' ' ' THR . . . -53.72 -54.01 43.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.918 -1.114 . . . . 0.0 109.131 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 60.3 mt -88.83 23.32 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.525 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . -55.18 146.5 18.59 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.46 ' C ' ' O ' ' A' ' 123' ' ' ALA . 28.7 t70 -35.62 -80.19 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.792 0 CA-C-N 119.659 1.118 . . . . 0.0 110.093 -178.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 127' ' ' LYS . . . 54.46 34.5 54.94 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 118.133 -1.984 . . . . 0.0 109.786 174.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.32 91.16 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 123.29 1.519 . . . . 0.0 110.569 -174.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 125' ' ' GLY . 0.1 OUTLIER -137.93 127.28 14.91 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.428 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -53.67 -16.35 8.02 Favored 'Trans proline' 0 C--N 1.294 -2.337 0 O-C-N 122.703 0.844 . . . . 0.0 111.028 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.0 t -123.45 24.17 8.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.844 -1.16 . . . . 0.0 110.56 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.46 ' HB3' ' CB ' ' A' ' 127' ' ' LYS . 11.0 p30 -74.46 4.25 6.29 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.411 -1.431 . . . . 0.0 112.018 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.464 ' CD2' ' HA ' ' A' ' 101' ' ' ALA . 25.6 mt -143.1 110.83 5.89 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.6 OUTLIER -86.46 71.69 10.4 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -176.511 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.648 ' HB2' ' HA ' ' A' ' 134' ' ' PRO 0.257 0.0 OUTLIER -85.27 173.08 7.55 Favored Pre-proline 0 C--N 1.291 -1.95 0 O-C-N 121.549 -0.719 . . . . 0.0 110.064 179.966 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.648 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 47.5 Cg_endo -72.66 124.91 9.59 Favored 'Cis proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.832 -1.737 . . . . 0.0 111.524 7.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.439 ' O ' ' CG2' ' A' ' 137' ' ' VAL . . . -122.08 74.93 0.36 Allowed Glycine 0 N--CA 1.501 2.988 0 C-N-CA 119.452 -1.356 . . . . 0.0 111.866 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.493 ' O ' ' CE2' ' A' ' 138' ' ' PHE . 83.2 m-70 31.18 37.18 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 O-C-N 122.204 -0.586 . . . . 0.0 112.344 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.483 ' HB ' ' HA ' ' A' ' 98' ' ' THR . 69.3 t -106.07 135.04 45.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 176.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.519 ' CE1' HG22 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -126.52 81.59 67.93 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -177.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.576 ' HG2' ' HB ' ' A' ' 97' ' ' VAL . 64.3 Cg_endo -112.77 141.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.559 2.173 . . . . 0.0 113.495 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.42 ' CD2' ' O ' ' A' ' 93' ' ' THR . 1.1 pp -127.53 148.87 50.33 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.454 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.455 ' HB2' ' CD ' ' A' ' 75' ' ' ARG . 0.9 OUTLIER -91.52 92.55 8.56 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.867 -1.145 . . . . 0.0 110.054 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.8 69.03 1.37 Allowed 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 118.542 -1.263 . . . . 0.0 113.1 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.449 ' CG ' HG23 ' A' ' 158' ' ' ILE . 19.6 tm0? -120.9 73.21 1.0 Allowed 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 117.751 -1.579 . . . . 0.0 112.213 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -127.64 38.52 4.03 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 117.733 -1.587 . . . . 0.0 111.459 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 74.44 -4.39 34.9 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 119.277 -1.44 . . . . 0.0 111.419 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.4 28.07 17.67 Favored Glycine 0 N--CA 1.485 1.91 0 O-C-N 120.665 -1.491 . . . . 0.0 113.417 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.521 HG21 ' CB ' ' A' ' 156' ' ' ALA . 1.5 p -60.48 -15.8 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 120.248 2.024 . . . . 0.0 107.822 177.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.48 ' CD2' ' CG1' ' A' ' 206' ' ' VAL . 75.3 mt -94.02 22.63 5.59 Favored 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 116.81 -1.956 . . . . 0.0 110.404 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.1 p -127.44 58.34 1.47 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 101.656 -3.461 . . . . 0.0 101.656 168.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.402 ' NH2' ' HA3' ' A' ' 92' ' ' GLY . 0.0 OUTLIER -153.39 149.89 28.28 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 113.034 -1.894 . . . . 0.0 110.763 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -102.47 34.68 5.53 Favored Glycine 0 N--CA 1.483 1.768 0 N-CA-C 106.293 -2.723 . . . . 0.0 106.293 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -145.48 159.7 27.95 Favored Glycine 0 N--CA 1.478 1.45 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.486 ' CD2' ' HB3' ' A' ' 172' ' ' LEU . 29.2 p-80 -89.7 -4.72 57.59 Favored 'General case' 0 C--N 1.292 -1.921 0 O-C-N 121.657 -0.907 . . . . 0.0 108.845 176.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.413 ' HB ' ' CD2' ' A' ' 140' ' ' LEU . 1.1 p -51.53 -55.31 19.72 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.015 -1.053 . . . . 0.0 109.795 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 159' ' ' ASP . 24.6 mt-10 -59.51 -21.74 60.61 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.521 ' CB ' HG21 ' A' ' 147' ' ' VAL . . . -87.24 6.3 33.9 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.503 ' HA ' HD12 ' A' ' 172' ' ' LEU . 17.9 m -93.83 -51.06 5.06 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.159 -0.963 . . . . 0.0 109.52 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.58 ' O ' ' HB3' ' A' ' 161' ' ' MET . 9.7 tp -75.81 -34.15 27.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 116.238 -2.185 . . . . 0.0 105.126 175.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.444 ' O ' ' CB ' ' A' ' 162' ' ' THR . 0.8 OUTLIER -59.69 -25.56 64.87 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.084 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.527 ' HA ' ' CD1' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -58.78 -28.89 66.37 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.58 ' HB3' ' O ' ' A' ' 158' ' ' ILE . 5.6 ttt -51.59 -39.26 57.58 Favored 'General case' 0 N--CA 1.514 2.758 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 174.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.444 ' CB ' ' O ' ' A' ' 159' ' ' ASP . 1.2 m -68.52 -39.26 81.25 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.651 177.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.557 ' HG ' ' CD2' ' A' ' 6' ' ' LEU . 0.3 OUTLIER -52.1 -57.62 9.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.864 -1.148 . . . . 0.0 108.763 179.038 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.465 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -64.63 -27.4 68.91 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.14 0.972 . . . . 0.0 108.545 177.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 96.17 -27.84 15.24 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 166' ' ' PHE . 37.2 p90 -151.05 55.6 0.89 Allowed 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.166 -1.414 . . . . 0.0 112.292 175.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 46' ' ' PRO . 1.9 mttp -129.71 80.2 72.05 Favored Pre-proline 0 C--N 1.296 -1.739 0 CA-C-O 117.23 -1.367 . . . . 0.0 107.777 176.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.473 ' HA ' ' CG ' ' A' ' 161' ' ' MET . 43.2 Cg_endo -72.01 80.58 1.51 Allowed 'Trans proline' 0 C--N 1.32 -0.965 0 C-N-CA 115.367 -2.622 . . . . 0.0 110.636 -176.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.441 ' HB1' ' HB3' ' A' ' 47' ' ' ALA . . . -163.26 166.37 23.25 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 104.292 -2.485 . . . . 0.0 104.292 175.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.482 ' HA2' ' CD2' ' A' ' 160' ' ' LEU . . . -157.6 119.49 0.91 Allowed Glycine 0 N--CA 1.485 1.954 0 C-N-CA 116.721 -2.657 . . . . 0.0 112.479 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.555 ' O ' ' O ' ' A' ' 43' ' ' MET . 23.6 m -127.08 134.59 65.73 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.761 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 175.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.526 ' HG ' ' HA ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -149.88 113.67 5.06 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.696 -1.252 . . . . 0.0 109.39 -178.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.459 ' HB3' ' CG1' ' A' ' 66' ' ' VAL . 21.5 p -128.65 175.79 8.3 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 120.257 -1.527 . . . . 0.0 111.377 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.417 ' OE2' ' NH2' ' A' ' 184' ' ' ARG . 16.0 pm0 -113.05 154.63 26.23 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.106 -0.996 . . . . 0.0 110.558 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.434 ' CD2' ' HB3' ' A' ' 188' ' ' CYS . 0.4 OUTLIER -82.29 115.48 21.37 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.269 -0.895 . . . . 0.0 109.932 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -111.47 155.29 23.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 0.0 109.485 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -107.69 169.27 8.7 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.192 -0.943 . . . . 0.0 110.333 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.36 5.84 47.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.379 -0.826 . . . . 0.0 111.235 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -68.55 -15.91 63.69 Favored 'General case' 0 C--N 1.29 -2.008 0 O-C-N 121.534 -0.729 . . . . 0.0 110.179 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 103.73 23.23 8.4 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 183' ' ' ALA . 6.0 m -142.08 115.78 9.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -1.142 . . . . 0.0 110.154 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -52.42 95.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.313 -0.867 . . . . 0.0 110.267 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' A' ' 181' ' ' THR . . . -61.37 93.69 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.209 -0.932 . . . . 0.0 110.24 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.417 ' NH2' ' OE2' ' A' ' 174' ' ' GLU . 0.2 OUTLIER -125.16 100.01 6.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.816 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.439 ' CB ' ' HD2' ' A' ' 186' ' ' PRO . . . 179.17 178.5 0.28 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.387 -0.821 . . . . 0.0 109.704 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.439 ' HD2' ' CB ' ' A' ' 185' ' ' ALA . 45.9 Cg_endo -72.65 -8.47 22.53 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.603 1.318 . . . . 0.0 110.767 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -81.45 -68.94 0.65 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.984 -1.073 . . . . 0.0 110.307 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . 0.434 ' HB3' ' CD2' ' A' ' 175' ' ' LEU . 0.4 OUTLIER -57.74 -30.41 65.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.428 -0.795 . . . . 0.0 110.097 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.491 ' CG2' ' CD2' ' A' ' 199' ' ' LEU . 27.2 mm -75.77 -26.3 17.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 120.951 -1.093 . . . . 0.0 109.102 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 186' ' ' PRO . 12.0 mt-10 -76.76 -19.38 57.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.474 -0.766 . . . . 0.0 109.092 177.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 192' ' ' ALA . 0.8 OUTLIER -70.27 -56.4 6.86 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.179 0.99 . . . . 0.0 108.764 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.488 ' N ' ' CD1' ' A' ' 191' ' ' PHE . . . -61.76 -41.78 98.14 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . 0.606 ' HA ' ' CB ' ' A' ' 197' ' ' MET . 2.2 t30 -66.33 -13.3 60.34 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.021 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.99 -37.33 47.45 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 117.636 -1.626 . . . . 0.0 111.578 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -108.79 -52.7 2.73 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 115.717 -2.393 . . . . 0.0 111.856 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.444 ' O ' ' HG2' ' A' ' 197' ' ' MET . 44.5 t30 -114.8 33.34 5.43 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.098 -1.441 . . . . 0.0 113.958 177.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' MET . . . . . 0.606 ' CB ' ' HA ' ' A' ' 193' ' ' ASN . 0.0 OUTLIER -151.45 149.71 29.58 Favored 'General case' 0 N--CA 1.52 3.067 0 CA-C-N 123.375 2.807 . . . . 0.0 115.163 -179.524 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.45 ' CB ' ' HA ' ' A' ' 19' ' ' ALA . . . -107.08 154.28 21.38 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 176.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.528 ' CD2' ' HB2' ' A' ' 30' ' ' MET . 43.7 mt -123.44 144.74 49.31 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.277 -1.514 . . . . 0.0 113.171 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.528 HG13 ' OH ' ' A' ' 208' ' ' TYR . 0.2 OUTLIER -120.28 -161.79 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.782 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.458 ' HB ' ' CB ' ' A' ' 204' ' ' ASP . 0.2 OUTLIER -132.97 142.78 49.04 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.946 -1.096 . . . . 0.0 108.468 177.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 5.2 tp -45.93 -46.67 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.196 -0.94 . . . . 0.0 111.56 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -91.9 -31.49 15.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.883 -1.135 . . . . 0.0 111.016 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.461 ' HA ' ' HB3' ' A' ' 207' ' ' ALA . 10.9 t70 -72.99 -39.14 66.32 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.267 -0.896 . . . . 0.0 112.121 -178.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.551 ' HA ' ' CE2' ' A' ' 208' ' ' TYR . 10.4 tt -58.22 -62.78 1.58 Allowed 'General case' 0 N--CA 1.484 1.264 0 O-C-N 120.687 -1.258 . . . . 0.0 110.641 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.531 ' N ' HD23 ' A' ' 205' ' ' LEU . 2.4 t -66.47 -13.55 16.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 C-N-CA 118.086 -1.445 . . . . 0.0 108.122 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.461 ' HB3' ' HA ' ' A' ' 204' ' ' ASP . . . -57.23 -33.18 67.3 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.591 ' CE2' HG21 ' A' ' 16' ' ' VAL . 4.7 m-30 -56.54 -52.38 65.01 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 175.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -41.84 97.38 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.761 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -53.92 -43.12 69.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 109.501 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -57.45 -35.14 69.75 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.47 -0.769 . . . . 0.0 109.221 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . 0.466 ' CE1' ' O ' ' A' ' 7' ' ' SER . 2.7 t-160 -55.73 -45.79 77.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.539 -0.726 . . . . 0.0 109.839 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -89.01 -9.14 52.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.512 -0.742 . . . . 0.0 110.779 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.24 115.05 4.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.934 -1.104 . . . . 0.0 110.179 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -123.03 96.59 5.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.883 . . . . 0.0 110.188 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . 53.12 86.96 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.891 . . . . 0.0 110.279 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.231 179.995 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mtp . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.283 0.564 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -83.92 58.15 4.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.902 . . . . 0.0 110.224 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.2 5.97 18.12 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.373 -0.83 . . . . 0.0 110.818 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.5 p -46.94 -25.66 0.83 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.039 -1.038 . . . . 0.0 111.054 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.426 ' CD1' ' O ' ' A' ' 197' ' ' MET . 0.7 OUTLIER -67.26 -18.99 65.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.025 -1.047 . . . . 0.0 110.12 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.444 ' CD1' ' HB ' ' A' ' 200' ' ' VAL . 0.1 OUTLIER -113.13 -15.94 12.68 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.245 -0.91 . . . . 0.0 109.5 179.169 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.5 t -92.66 -63.09 1.27 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.992 -1.067 . . . . 0.0 109.801 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.463 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -77.44 -15.07 59.53 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.477 -0.764 . . . . 0.0 109.674 178.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.463 ' CD1' ' O ' ' A' ' 8' ' ' SER . 22.4 m-85 -134.76 57.24 1.81 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.435 ' N ' ' HB3' ' A' ' 15' ' ' ARG . . . -168.4 96.2 0.12 Allowed Glycine 0 C--N 1.299 -1.48 0 N-CA-C 105.366 -3.093 . . . . 0.0 105.366 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 16' ' ' VAL . 36.1 p -131.53 140.17 37.58 Favored Pre-proline 0 C--N 1.266 -3.042 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.511 ' O ' ' CG1' ' A' ' 16' ' ' VAL . 30.5 Cg_endo -54.33 -34.09 78.9 Favored 'Trans proline' 0 C--N 1.269 -3.611 0 O-C-N 122.82 0.905 . . . . 0.0 111.082 -177.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -86.99 -67.14 0.84 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 115.699 1.741 . . . . 0.0 115.699 -177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.56 -45.71 11.5 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 118.521 -1.272 . . . . 0.0 112.336 -175.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.444 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 28.0 mmt-85 -84.78 -12.26 54.04 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 118.238 -1.385 . . . . 0.0 113.325 -177.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.604 ' CG1' ' CE2' ' A' ' 208' ' ' TYR . 0.3 OUTLIER -95.16 -28.16 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 122.856 2.571 . . . . 0.0 108.69 176.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -66.29 -52.21 49.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 117.938 -1.505 . . . . 0.0 108.101 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -64.28 -33.93 76.96 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.186 -0.946 . . . . 0.0 108.722 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 23' ' ' LEU . . . -81.01 -5.86 58.1 Favored 'General case' 0 C--O 1.201 -1.47 0 O-C-N 121.188 -0.945 . . . . 0.0 108.606 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.558 ' HA ' ' HB2' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -68.08 -51.7 43.59 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.37 -49.92 73.03 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.472 ' C ' ' CB ' ' A' ' 27' ' ' ARG . . . -61.25 -28.57 69.26 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.61 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -60.5 -8.69 2.94 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.534 -0.729 . . . . 0.0 110.765 179.803 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.74 -37.35 10.34 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.384 -0.823 . . . . 0.0 108.969 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -151.57 90.28 1.55 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 123.267 1.508 . . . . 0.0 113.444 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.24 -18.35 5.83 Favored Glycine 0 C--N 1.272 -3.007 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.61 ' O ' ' HA ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -129.42 120.15 25.0 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 178.057 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -164.2 105.03 0.24 Allowed Glycine 0 C--N 1.27 -3.137 1 N-CA-C 103.017 -4.033 . . . . 0.0 103.017 -175.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.609 ' HB ' ' CB ' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -125.1 161.36 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 113.059 -1.57 . . . . 0.0 112.192 -172.442 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.58 ' CA ' ' HA ' ' A' ' 42' ' ' ASP . 1.4 tmm? -98.52 152.61 19.37 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.148 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.485 ' HB ' ' CG1' ' A' ' 202' ' ' ILE . 15.6 m -116.46 127.13 74.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.44 ' HA ' ' CD1' ' A' ' 202' ' ' ILE . 5.1 tt -158.66 -72.04 0.09 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.057 -1.027 . . . . 0.0 110.492 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.437 ' HB2' ' CA ' ' A' ' 201' ' ' THR . 22.0 t0 60.18 155.92 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.236 -0.915 . . . . 0.0 110.098 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 53.35 -150.99 0.34 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.149 -0.97 . . . . 0.0 110.113 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -146.67 121.13 9.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.92 . . . . 0.0 110.186 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.417 ' O ' ' ND2' ' A' ' 39' ' ' ASN . 9.4 m-20 -157.21 83.91 0.93 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 0.0 110.337 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.74 -167.96 0.05 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 110.362 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -70.9 76.16 0.63 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.261 -0.899 . . . . 0.0 110.238 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.469 ' HA ' ' CE1' ' A' ' 153' ' ' HIS . 0.9 OUTLIER -100.78 60.28 0.96 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 110.066 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.429 ' CB ' ' HA ' ' A' ' 174' ' ' GLU . 31.4 mt-10 -85.55 -166.72 1.6 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 110.409 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.45 ' C ' ' HA ' ' A' ' 30' ' ' MET . . . 163.15 33.47 0.02 OUTLIER Glycine 0 N--CA 1.493 2.452 0 C-N-CA 120.014 -1.088 . . . . 0.0 110.55 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.58 ' HA ' ' CA ' ' A' ' 30' ' ' MET . 8.3 t70 -43.61 -25.52 0.17 Allowed 'General case' 0 N--CA 1.51 2.548 0 O-C-N 121.009 -1.289 . . . . 0.0 111.268 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.64 ' O ' ' O ' ' A' ' 171' ' ' VAL . 0.0 OUTLIER -93.89 54.45 1.96 Allowed 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -177.216 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.498 ' CD1' HG13 ' A' ' 29' ' ' VAL . 28.8 pt -64.5 23.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.524 3.265 0 O-C-N 118.93 -2.356 . . . . 0.0 113.282 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.52 ' H ' ' C ' ' A' ' 43' ' ' MET . 6.6 m-85 -77.21 164.4 58.93 Favored Pre-proline 0 N--CA 1.504 2.25 0 C-N-CA 123.805 0.842 . . . . 0.0 113.236 -178.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.444 ' HG2' ' CG2' ' A' ' 49' ' ' THR . 43.0 Cg_endo -66.79 132.8 29.57 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 122.843 2.362 . . . . 0.0 110.212 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.509 ' HB2' ' CB ' ' A' ' 169' ' ' ALA . . . -68.59 -2.71 9.58 Favored 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -176.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.436 ' HA ' ' CD1' ' A' ' 122' ' ' ILE . 5.7 tt0 -95.71 -22.64 17.42 Favored 'General case' 0 C--N 1.292 -1.905 0 O-C-N 120.662 -1.274 . . . . 0.0 110.491 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.444 ' CG2' ' HG2' ' A' ' 46' ' ' PRO . 4.6 t -134.38 59.02 1.75 Allowed 'General case' 0 C--N 1.315 -0.924 0 O-C-N 120.724 -1.235 . . . . 0.0 107.739 178.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.448 ' CG ' ' O ' ' A' ' 50' ' ' MET . 1.5 ppp? -65.0 88.74 0.07 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 49' ' ' THR . 24.4 m -59.32 147.92 34.16 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 122.139 0.971 . . . . 0.0 110.169 -176.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.459 ' N ' HD13 ' A' ' 115' ' ' ILE . 12.5 p -72.34 -3.26 3.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.505 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -58.96 -41.22 86.97 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.479 ' HG3' ' CZ ' ' A' ' 45' ' ' PHE . 8.8 mm-40 -81.44 -47.63 12.94 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.237 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.43 ' O ' ' CG2' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -54.17 -35.28 62.13 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.453 ' HA ' ' CG2' ' A' ' 59' ' ' ILE . . . -54.68 -47.3 73.81 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.8 tt -56.02 -53.65 54.35 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.811 0.815 . . . . 0.0 109.573 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.427 HG22 ' CE ' ' A' ' 43' ' ' MET . 0.9 OUTLIER -69.28 -58.29 4.23 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.605 -0.684 . . . . 0.0 111.23 -178.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.453 ' CG2' ' HA ' ' A' ' 56' ' ' ALA . 1.1 tp -52.47 -22.17 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.106 -0.996 . . . . 0.0 110.742 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.1 ttt-85 -74.8 -40.69 60.98 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.212 -0.93 . . . . 0.0 110.962 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -122.86 -1.37 8.9 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.958 -1.089 . . . . 0.0 112.129 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.66 -169.96 27.88 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.32 102.7 6.08 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 101.38 -3.563 . . . . 0.0 101.38 176.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 66' ' ' VAL . . . -104.81 74.97 0.24 Allowed Glycine 0 C--N 1.261 -3.625 0 N-CA-C 106.816 -2.514 . . . . 0.0 106.816 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.2 tp -62.47 90.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.446 ' N ' ' O ' ' A' ' 64' ' ' GLY . 35.5 m -52.13 152.46 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 114.468 -1.242 . . . . 0.0 114.054 -176.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 7.4 t -87.37 114.99 24.48 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.578 ' O ' ' HA ' ' A' ' 139' ' ' PRO . 3.6 mt -87.45 163.96 16.44 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.456 ' CB ' HD13 ' A' ' 158' ' ' ILE . 4.7 m -131.48 135.61 47.24 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 118.199 -1.4 . . . . 0.0 113.206 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.579 ' CG1' ' HB2' ' A' ' 139' ' ' PRO . 2.5 pp -148.82 177.15 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 18.0 m -111.4 159.15 18.29 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.145 -0.972 . . . . 0.0 110.531 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.439 ' N ' ' HB2' ' A' ' 141' ' ' ARG . 0.1 OUTLIER -49.13 -27.12 3.2 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.475 -0.766 . . . . 0.0 110.62 -179.846 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -56.9 -38.83 73.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 0.0 109.676 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.406 ' O ' ' HB3' ' A' ' 78' ' ' LEU . 1.8 mmt180 -78.26 -32.77 49.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.501 -0.749 . . . . 0.0 110.35 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.493 ' HG2' ' CD1' ' A' ' 70' ' ' ILE . 0.9 OUTLIER -78.72 -28.82 45.06 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.204 1.002 . . . . 0.0 108.535 179.013 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 79' ' ' ASP . 4.3 ttmm -56.51 -70.26 0.12 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -46.57 -41.04 13.82 Favored 'General case' 0 N--CA 1.508 2.444 0 CA-C-O 121.974 0.892 . . . . 0.0 109.864 177.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 80' ' ' LEU . 0.7 OUTLIER -96.39 45.77 1.06 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 176.229 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 76' ' ' LYS . 15.2 t70 -28.68 85.39 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 123.745 1.736 . . . . 0.0 112.329 -172.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -148.44 103.75 3.5 Favored Pre-proline 0 C--N 1.29 -2.009 0 CA-C-N 112.558 -2.11 . . . . 0.0 111.906 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -104.91 93.31 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.493 1.462 . . . . 0.0 108.635 175.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.458 ' CB ' ' HA ' ' A' ' 97' ' ' VAL . 14.7 mmt -103.31 107.72 18.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.673 -1.267 . . . . 0.0 111.156 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.426 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 10.6 tmm? -95.89 92.37 6.47 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.862 -1.149 . . . . 0.0 109.654 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.446 ' CG2' ' HB ' ' A' ' 96' ' ' THR . 3.8 m -87.81 148.46 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 118.301 -1.359 . . . . 0.0 110.303 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -92.7 22.8 4.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.329 -0.857 . . . . 0.0 110.629 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -106.68 18.36 21.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.135 -0.978 . . . . 0.0 110.286 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.473 ' CB ' ' CG2' ' A' ' 96' ' ' THR . 30.2 t30 -106.69 74.39 1.0 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 109.85 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 54.7 -141.99 0.83 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.089 -1.007 . . . . 0.0 109.512 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -50.33 -59.96 3.46 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.747 -1.221 . . . . 0.0 110.351 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 53.1 98.33 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.895 . . . . 0.0 110.456 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.472 ' CZ ' ' OG1' ' A' ' 93' ' ' THR . 37.3 p90 -114.48 41.98 2.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.314 -0.866 . . . . 0.0 110.388 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.33 39.92 25.19 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.472 ' OG1' ' CZ ' ' A' ' 91' ' ' TYR . 30.5 m -86.67 14.69 6.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.239 -1.154 . . . . 0.0 110.89 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.14 23.15 2.6 Favored Glycine 0 N--CA 1.496 2.677 0 O-C-N 120.956 -1.09 . . . . 0.0 110.711 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.577 ' CE1' ' HB2' ' A' ' 140' ' ' LEU . 5.9 t80 -120.47 36.67 4.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.049 -1.265 . . . . 0.0 108.981 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.473 ' CG2' ' CB ' ' A' ' 87' ' ' ASN . 1.4 p -131.05 53.34 1.99 Allowed 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.629 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.458 ' HA ' ' CB ' ' A' ' 82' ' ' MET . 57.5 t -86.07 105.67 14.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 O-C-N 121.209 -0.932 . . . . 0.0 112.096 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 137' ' ' VAL . 1.0 OUTLIER -75.9 152.18 37.2 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 103.029 -2.952 . . . . 0.0 103.029 174.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.613 ' HA ' ' HB3' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -161.71 138.93 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 C-N-CA 116.708 -1.997 . . . . 0.0 111.513 -176.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.594 ' HB3' ' CB ' ' A' ' 132' ' ' ASN . 1.2 tp10 -99.11 126.5 44.87 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.301 -1.36 . . . . 0.0 111.346 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.469 ' HA ' ' CD2' ' A' ' 131' ' ' LEU . . . -51.24 115.6 1.64 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.41 -0.807 . . . . 0.0 110.886 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -115.74 -6.78 12.12 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.23 -0.919 . . . . 0.0 110.984 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.43 ' CB ' ' O ' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -75.82 55.45 0.88 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.952 -1.093 . . . . 0.0 111.692 -178.649 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.422 ' O ' ' CG1' ' A' ' 105' ' ' VAL . . . 73.31 24.24 75.72 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.47 HG13 ' HA ' ' A' ' 117' ' ' THR . 5.2 m -158.25 122.39 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.8 m -148.38 63.8 1.08 Allowed 'General case' 0 N--CA 1.484 1.24 0 O-C-N 120.85 -1.156 . . . . 0.0 111.605 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.3 t -131.07 -30.76 1.74 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 118.618 -1.233 . . . . 0.0 110.099 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.409 ' O ' ' NH1' ' A' ' 114' ' ' ARG . . . 63.98 -19.06 0.09 OUTLIER Glycine 0 N--CA 1.5 2.93 0 O-C-N 121.484 -0.76 . . . . 0.0 113.377 178.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.86 55.54 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 119.71 1.755 . . . . 0.0 109.73 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 114' ' ' ARG . 28.6 p -133.2 66.15 1.57 Allowed 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 110' ' ' SER . . . -27.19 -39.92 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 121.506 0.669 . . . . 0.0 112.589 -177.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -78.59 -72.8 0.36 Allowed 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 122.147 0.975 . . . . 0.0 109.492 178.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -54.51 -23.35 16.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.167 -0.958 . . . . 0.0 109.241 178.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 110' ' ' SER . 0.3 OUTLIER -61.14 -45.61 93.97 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.549 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.491 ' CD1' ' N ' ' A' ' 115' ' ' ILE . 1.6 mm -65.13 -15.07 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 117.283 -1.767 . . . . 0.0 107.654 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 m -89.88 -31.29 17.39 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 175.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.47 ' HA ' HG13 ' A' ' 105' ' ' VAL . 91.0 m -70.8 -49.0 51.12 Favored 'General case' 0 C--O 1.204 -1.3 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.436 HG11 ' HG3' ' A' ' 50' ' ' MET . 10.1 p -53.43 -41.46 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 0.0 109.28 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.409 ' N ' ' CG1' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -57.88 -33.88 69.19 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.413 179.051 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.43 ' O ' ' CB ' ' A' ' 103' ' ' GLU . . . -94.03 -36.93 11.9 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.524 -0.735 . . . . 0.0 111.082 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.553 ' CB ' ' CE1' ' A' ' 138' ' ' PHE . . . -56.52 -56.72 17.76 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.03 -1.044 . . . . 0.0 109.407 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.437 ' CG2' ' HG3' ' A' ' 139' ' ' PRO . 1.6 pp -87.13 19.36 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.284 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . -72.76 146.72 46.18 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.454 ' C ' ' O ' ' A' ' 123' ' ' ALA . 16.8 m-20 -37.18 -79.14 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.721 0 CA-C-N 119.598 1.09 . . . . 0.0 109.595 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 127' ' ' LYS . . . 54.75 34.93 57.06 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.125 -1.988 . . . . 0.0 109.856 173.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -58.96 91.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 123.337 1.541 . . . . 0.0 110.233 -174.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 125' ' ' GLY . 1.9 mttt -137.97 126.57 14.45 Favored Pre-proline 0 C--N 1.303 -1.436 0 CA-C-N 113.377 -1.738 . . . . 0.0 106.422 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -54.69 -17.79 14.16 Favored 'Trans proline' 0 C--N 1.294 -2.315 0 O-C-N 122.61 0.795 . . . . 0.0 110.306 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 25.4 p -124.56 31.65 5.66 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.149 -0.969 . . . . 0.0 109.881 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.43 ' HB3' ' CD1' ' A' ' 78' ' ' LEU . 0.9 OUTLIER -73.77 3.84 5.98 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.524 -1.36 . . . . 0.0 111.797 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.469 ' CD2' ' HA ' ' A' ' 101' ' ' ALA . 30.7 mt -142.58 130.64 21.89 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.594 ' CB ' ' HB3' ' A' ' 100' ' ' GLU . 0.5 OUTLIER -81.52 72.87 8.58 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.326 -1.484 . . . . 0.0 111.639 -177.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.613 ' HB3' ' HA ' ' A' ' 99' ' ' ILE 0.263 0.0 OUTLIER -87.68 152.82 52.21 Favored Pre-proline 0 N--CA 1.502 2.141 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.545 179.72 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -78.36 141.41 64.94 Favored 'Cis proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.215 -1.994 . . . . 0.0 107.787 1.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.536 ' O ' ' O ' ' A' ' 136' ' ' HIS . . . -176.6 95.43 0.1 Allowed Glycine 0 N--CA 1.487 2.078 0 C-N-CA 117.879 -2.105 . . . . 0.0 111.291 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.536 ' O ' ' O ' ' A' ' 135' ' ' GLY . 12.2 m-70 47.3 101.81 0.01 OUTLIER 'General case' 0 C--O 1.206 -1.215 0 CA-C-O 124.283 1.992 . . . . 0.0 109.182 -177.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 98' ' ' THR . 19.2 m -49.15 154.48 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.686 0 CA-C-N 112.783 -2.008 . . . . 0.0 112.376 -174.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.553 ' CE1' ' CB ' ' A' ' 121' ' ' ALA . 1.5 m-85 -146.87 175.42 2.73 Favored Pre-proline 0 C--N 1.29 -1.997 0 CA-C-N 111.434 -2.621 . . . . 0.0 105.271 -174.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.579 ' HB2' ' CG1' ' A' ' 70' ' ' ILE . 38.4 Cg_endo -57.56 127.88 27.13 Favored 'Trans proline' 0 C--N 1.293 -2.354 0 CA-C-O 123.533 1.389 . . . . 0.0 115.11 -169.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.577 ' HB2' ' CE1' ' A' ' 95' ' ' PHE . 14.6 mt -90.06 172.46 8.82 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 112.96 -1.927 . . . . 0.0 108.965 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.439 ' HB2' ' N ' ' A' ' 72' ' ' GLU . 12.8 ptt85 -126.13 85.16 2.35 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.119 -1.613 . . . . 0.0 115.0 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.563 ' CB ' ' CD1' ' A' ' 95' ' ' PHE . . . -141.48 79.69 1.7 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.742 -1.224 . . . . 0.0 110.837 176.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.466 ' CG ' ' CG2' ' A' ' 158' ' ' ILE . 0.5 OUTLIER -117.34 75.26 0.97 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.143 -1.598 . . . . 0.0 112.966 -179.353 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -127.04 43.37 3.13 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.637 -1.289 . . . . 0.0 110.982 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 75.83 37.08 40.12 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -100.54 12.35 59.74 Favored Glycine 0 N--CA 1.49 2.285 0 O-C-N 120.91 -1.347 . . . . 0.0 113.521 -176.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.487 HG22 ' N ' ' A' ' 156' ' ' ALA . 8.2 p -107.9 -13.9 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-N 120.312 2.056 . . . . 0.0 111.828 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.435 ' N ' ' CD2' ' A' ' 148' ' ' LEU . 4.6 mm? -87.42 13.28 10.25 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 115.041 -2.664 . . . . 0.0 109.876 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 84.2 m -132.93 62.15 1.66 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 100.548 -3.871 . . . . 0.0 100.548 167.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -148.27 135.15 20.05 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.072 -1.422 . . . . 0.0 113.831 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -104.26 36.25 4.5 Favored Glycine 0 N--CA 1.48 1.605 0 N-CA-C 106.177 -2.769 . . . . 0.0 106.177 173.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -142.31 163.8 27.05 Favored Glycine 0 N--CA 1.479 1.55 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.469 ' CE1' ' HA ' ' A' ' 39' ' ' ASN . 54.5 p-80 -90.98 -6.12 54.45 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.883 -0.774 . . . . 0.0 109.765 177.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.419 ' O ' HG21 ' A' ' 157' ' ' THR . 6.8 p -56.39 -64.99 0.68 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 122.362 1.077 . . . . 0.0 108.876 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.428 ' HB3' ' CA ' ' A' ' 147' ' ' VAL . 65.9 mm-40 -59.4 -22.16 60.99 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 177.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.508 ' HA ' ' CB ' ' A' ' 159' ' ' ASP . . . -86.02 4.37 38.18 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.226 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.482 ' O ' ' CB ' ' A' ' 160' ' ' LEU . 0.6 OUTLIER -83.07 -51.65 7.35 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.328 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.474 ' N ' ' CG2' ' A' ' 157' ' ' THR . 0.2 OUTLIER -74.87 -17.54 16.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 115.923 -2.311 . . . . 0.0 105.996 176.108 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.508 ' CB ' ' HA ' ' A' ' 156' ' ' ALA . 8.3 t70 -59.29 -26.71 65.19 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 173.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.561 ' HA ' ' CG ' ' A' ' 163' ' ' LEU . 0.4 OUTLIER -53.3 -41.33 65.52 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 175.175 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.501 ' HB2' ' HA ' ' A' ' 168' ' ' PRO . 0.0 OUTLIER -48.2 -33.45 8.54 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 176.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.488 ' N ' ' O ' ' A' ' 159' ' ' ASP . 1.3 m -93.29 -31.83 14.55 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.719 177.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.561 ' CG ' ' HA ' ' A' ' 160' ' ' LEU . 0.5 OUTLIER -36.34 -40.94 0.25 Allowed 'General case' 0 N--CA 1.521 3.102 0 O-C-N 121.489 -0.757 . . . . 0.0 110.071 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.443 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -94.49 -29.24 15.04 Favored 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.103 -0.998 . . . . 0.0 110.909 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.03 -29.99 10.76 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -149.93 47.28 0.93 Allowed 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 117.922 -1.511 . . . . 0.0 111.571 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 169' ' ' ALA . 2.5 mptp? -133.3 68.42 77.36 Favored Pre-proline 0 C--N 1.29 -2.019 0 N-CA-C 103.294 -2.854 . . . . 0.0 103.294 173.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.501 ' HA ' ' HB2' ' A' ' 161' ' ' MET . 42.4 Cg_endo -69.5 80.24 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 115.218 -2.721 . . . . 0.0 114.531 -170.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.509 ' CB ' ' HB2' ' A' ' 47' ' ' ALA . . . -164.29 166.11 21.2 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 171.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 68' ' ' LEU . . . -154.79 135.52 4.72 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 118.019 -2.039 . . . . 0.0 110.356 178.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.64 ' O ' ' O ' ' A' ' 43' ' ' MET . 2.9 p -121.4 89.83 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.191 -1.991 0 C-N-CA 117.374 -1.73 . . . . 0.0 107.376 177.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.488 HD12 ' CD2' ' A' ' 160' ' ' LEU . 9.1 mp -95.12 153.81 17.48 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 119.249 0.931 . . . . 0.0 110.11 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.482 ' N ' ' HB2' ' A' ' 43' ' ' MET . 35.7 t -124.71 162.63 23.79 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 122.023 0.916 . . . . 0.0 112.905 -177.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.429 ' HA ' ' CB ' ' A' ' 40' ' ' GLU . 1.3 pt-20 -135.84 107.23 6.86 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.36 139.62 58.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.052 -1.03 . . . . 0.0 111.153 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.402 ' HA ' ' CB ' ' A' ' 183' ' ' ALA . 98.7 m -139.19 155.54 47.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.678 -0.639 . . . . 0.0 109.555 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -93.46 168.26 11.17 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.957 -1.089 . . . . 0.0 110.252 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -91.3 6.59 44.67 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.714 0.769 . . . . 0.0 111.027 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.14 7.38 19.07 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.659 -0.651 . . . . 0.0 110.514 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 78.32 22.51 67.6 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 183' ' ' ALA . 98.2 m -121.91 109.23 14.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -1.149 . . . . 0.0 109.991 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 51.9 mtm -51.65 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.286 -0.884 . . . . 0.0 110.316 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.402 ' CB ' ' HA ' ' A' ' 176' ' ' THR . . . -54.63 111.06 0.73 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -0.922 . . . . 0.0 110.016 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.423 ' CG ' ' O ' ' A' ' 184' ' ' ARG . 0.6 OUTLIER -140.69 100.27 3.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 110.07 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . 179.89 173.34 0.49 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 110.213 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.404 ' O ' ' HB2' ' A' ' 190' ' ' GLU . 43.6 Cg_endo -69.53 -15.64 38.08 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.66 1.348 . . . . 0.0 110.226 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -87.81 -36.8 17.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.11 -0.994 . . . . 0.0 109.855 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . 0.419 ' O ' ' HB3' ' A' ' 191' ' ' PHE . 41.1 t -58.84 -49.3 78.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.394 -0.817 . . . . 0.0 109.462 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.485 HG12 ' CB ' ' A' ' 30' ' ' MET . 7.4 tp -76.84 -24.15 15.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.845 -1.159 . . . . 0.0 109.38 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.444 ' HA ' ' CB ' ' A' ' 193' ' ' ASN . 3.7 tt0 -57.41 -23.26 48.3 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.419 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 3.8 t80 -74.95 -46.19 37.21 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.429 ' CB ' HD13 ' A' ' 189' ' ' ILE . . . -65.77 -18.44 65.33 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 175.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 197' ' ' MET . 56.9 t30 -85.48 -7.76 58.73 Favored 'General case' 0 C--O 1.207 -1.159 0 O-C-N 121.896 -0.503 . . . . 0.0 109.696 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.59 -51.26 5.79 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.205 -1.559 . . . . 0.0 110.092 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.9 -41.06 12.0 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 118.268 -1.373 . . . . 0.0 107.599 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 198' ' ' ALA . 0.6 OUTLIER -99.34 52.17 0.94 Allowed 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' MET . . . . . 0.513 ' HA ' ' O ' ' A' ' 193' ' ' ASN . 45.5 ttm -66.72 74.25 0.1 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -173.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.609 ' CB ' ' HB ' ' A' ' 29' ' ' VAL . . . -134.1 106.4 7.18 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 104.057 -2.571 . . . . 0.0 104.057 172.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.438 ' HA ' HG22 ' A' ' 29' ' ' VAL . 2.9 tp -126.97 120.04 28.13 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 119.734 -1.854 . . . . 0.0 109.606 -177.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.444 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 4.5 p -124.08 -177.0 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.259 -0.901 . . . . 0.0 110.929 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.437 ' CA ' ' HB2' ' A' ' 33' ' ' ASP . 5.5 p -121.01 135.99 55.09 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.117 -0.989 . . . . 0.0 110.501 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.485 ' CG1' ' HB ' ' A' ' 31' ' ' VAL . 68.7 mt -60.76 -37.77 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.483 -0.761 . . . . 0.0 112.093 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -45.16 -65.95 0.46 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.257 -0.902 . . . . 0.0 110.909 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 12' ' ' PRO . 0.6 OUTLIER -72.88 -17.85 61.48 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.167 -0.958 . . . . 0.0 110.098 179.237 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.494 ' O ' ' CB ' ' A' ' 208' ' ' TYR . 2.4 tm? -60.44 -68.35 0.31 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.08 -1.012 . . . . 0.0 109.564 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.463 HG12 ' CG1' ' A' ' 147' ' ' VAL . 11.5 m -63.92 -16.12 18.1 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 C-N-CA 117.922 -1.511 . . . . 0.0 109.356 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -56.6 -32.34 65.16 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 174.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.604 ' CE2' ' CG1' ' A' ' 16' ' ' VAL 0.286 0.9 OUTLIER -54.75 -52.15 63.45 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.108 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.436 ' HG3' ' CG2' ' A' ' 162' ' ' THR . 48.2 ttt180 -56.65 -45.73 81.44 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.6 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.417 ' OE1' ' N ' ' A' ' 211' ' ' ALA . 1.8 tm0? -69.2 -56.0 8.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.218 -0.926 . . . . 0.0 110.184 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . 0.417 ' N ' ' OE1' ' A' ' 210' ' ' GLN . . . -58.91 -27.42 65.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.438 -0.789 . . . . 0.0 110.182 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -72.39 -28.03 62.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.863 . . . . 0.0 110.12 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -89.39 -9.24 51.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -0.869 . . . . 0.0 110.662 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.67 101.67 0.49 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.969 -1.082 . . . . 0.0 110.162 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' A' ' 217' ' ' SER . 19.2 mttt -96.55 98.07 9.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.215 -0.928 . . . . 0.0 110.222 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . 57.75 -85.5 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.437 -0.789 . . . . 0.0 110.475 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 215' ' ' LYS . 9.3 t . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.0 -1.062 . . . . 0.0 110.19 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.255 0.55 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -109.75 55.81 0.63 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 110.201 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.47 -20.97 49.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 110.222 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.4 ' HA ' ' CB ' ' A' ' 7' ' ' SER . 10.0 t -72.56 -4.93 33.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.873 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 tp -51.49 -65.02 0.63 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.012 -1.055 . . . . 0.0 110.579 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.488 ' CD2' ' CG2' ' A' ' 200' ' ' VAL . 1.2 tt -89.93 17.57 6.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 110.279 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.4 ' CB ' ' HA ' ' A' ' 4' ' ' THR . 15.8 m -92.6 -63.3 1.24 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.092 -1.005 . . . . 0.0 111.305 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 t -89.73 -24.98 21.4 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.124 -0.985 . . . . 0.0 110.202 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -131.63 58.04 1.74 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.579 ' C ' ' HD3' ' A' ' 12' ' ' PRO . . . -133.24 -174.78 13.69 Favored Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 105.184 -3.166 . . . . 0.0 105.184 -177.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.553 ' O ' ' CB ' ' A' ' 16' ' ' VAL 0.251 43.2 p -129.09 65.06 73.09 Favored Pre-proline 0 C--N 1.252 -3.634 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 176.334 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.579 ' HD3' ' C ' ' A' ' 10' ' ' GLY . 54.5 Cg_endo -90.19 -58.07 0.02 OUTLIER 'Trans proline' 0 C--O 1.201 -1.333 0 O-C-N 124.487 1.783 . . . . 0.0 109.182 178.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.434 ' HA ' ' HB2' ' A' ' 208' ' ' TYR . 5.2 t80 -97.71 -70.62 0.71 Allowed 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -177.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -74.05 -41.37 61.87 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.798 -177.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.509 ' CB ' ' HA ' ' A' ' 11' ' ' THR . 1.7 mmt180 -88.12 -17.24 31.42 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 118.258 -1.377 . . . . 0.0 111.96 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.636 ' O ' ' N ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -68.6 -28.08 38.78 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.151 0 C-N-CA 114.775 -2.77 . . . . 0.0 107.278 177.133 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 1.2 tm-20 -67.18 -54.7 18.69 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 117.493 -1.683 . . . . 0.0 107.415 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -62.6 -33.26 74.63 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.181 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.43 ' HB3' ' CD1' ' A' ' 23' ' ' LEU . . . -88.12 -6.75 57.73 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.218 -0.926 . . . . 0.0 109.011 178.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 16' ' ' VAL . 0.2 OUTLIER -61.48 -49.67 75.82 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.383 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.94 -54.55 10.95 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.604 -0.838 . . . . 0.0 108.801 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.94 -40.35 43.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.501 -0.749 . . . . 0.0 110.231 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.435 ' HB3' ' CG1' ' A' ' 29' ' ' VAL . 43.8 mt -90.56 -16.74 28.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.343 -0.848 . . . . 0.0 110.051 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -61.81 -16.53 50.68 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.375 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -92.98 45.26 1.17 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 122.527 1.156 . . . . 0.0 109.968 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.535 ' HA2' ' CZ ' ' A' ' 45' ' ' PHE . . . 58.61 28.68 62.95 Favored Glycine 0 C--N 1.288 -2.114 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 177.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.2 ttt-85 -89.31 18.4 5.21 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 116.71 -1.996 . . . . 0.0 110.844 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.435 ' O ' ' CB ' ' A' ' 198' ' ' ALA . . . 96.81 107.11 2.4 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.129 -1.51 . . . . 0.0 115.388 172.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.511 ' CG2' ' CE2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -142.25 113.86 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 174.057 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.603 ' HB2' ' CD1' ' A' ' 199' ' ' LEU . 2.3 mtp -124.2 122.55 38.1 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.014 -1.054 . . . . 0.0 110.513 -174.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.439 ' CG2' ' HA ' ' A' ' 202' ' ' ILE . 0.8 OUTLIER -102.25 125.86 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.781 -1.2 . . . . 0.0 110.838 -179.598 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.435 ' CD1' ' HA ' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -177.27 155.27 1.11 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 0.0 110.094 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 29.3 p-10 -174.53 128.54 0.33 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.163 -0.961 . . . . 0.0 110.372 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.3 t0 53.39 97.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -0.94 . . . . 0.0 110.383 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.414 ' OE2' ' N ' ' A' ' 185' ' ' ALA . 40.8 tt0 -79.61 95.29 5.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.896 . . . . 0.0 110.162 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -80.3 -70.34 0.53 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 110.233 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.04 -25.44 7.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.284 -0.885 . . . . 0.0 110.193 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.84 -69.77 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.301 -0.874 . . . . 0.0 110.29 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.407 ' CB ' ' HA ' ' A' ' 35' ' ' GLU . 2.1 m120 53.32 91.77 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.281 -0.887 . . . . 0.0 110.182 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.435 ' HA ' ' CD1' ' A' ' 32' ' ' LEU . 26.1 mt-10 -148.0 116.69 6.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.323 -0.861 . . . . 0.0 110.182 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.452 ' O ' HD13 ' A' ' 172' ' ' LEU . . . -177.75 42.18 0.09 OUTLIER Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.36 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.521 ' HA ' ' HB3' ' A' ' 30' ' ' MET . 2.4 p30 -77.15 -6.94 54.82 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.763 -1.434 . . . . 0.0 110.973 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.518 ' O ' ' O ' ' A' ' 171' ' ' VAL . 9.6 tpp -96.19 56.53 1.64 Allowed 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 123.567 0.747 . . . . 0.0 110.416 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.536 ' HA ' ' CD1' ' A' ' 172' ' ' LEU . 41.7 mt -60.73 34.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 O-C-N 121.159 -0.963 . . . . 0.0 113.557 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.535 ' CZ ' ' HA2' ' A' ' 26' ' ' GLY . 26.3 m-85 -111.52 162.03 22.81 Favored Pre-proline 0 N--CA 1.502 2.132 0 O-C-N 119.836 -1.79 . . . . 0.0 114.122 -175.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.63 131.36 17.19 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.374 2.049 . . . . 0.0 109.271 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.46 ' CB ' ' HB3' ' A' ' 169' ' ' ALA . . . -72.28 -1.47 15.44 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 120.785 -1.197 . . . . 0.0 113.132 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -93.46 -16.77 24.18 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.64 -1.288 . . . . 0.0 109.788 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.61 59.15 1.7 Allowed 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 177.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.509 ' O ' ' CG2' ' A' ' 115' ' ' ILE . 5.0 tpt -54.46 95.75 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.505 -178.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.0 p -66.53 133.48 50.44 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.478 HG21 ' CB ' ' A' ' 115' ' ' ILE . 2.6 t -77.98 -2.37 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.061 -1.024 . . . . 0.0 108.504 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 26' ' ' GLY . 0.6 OUTLIER -60.77 -40.8 93.92 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.254 -179.406 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.474 ' HG3' ' CD2' ' A' ' 45' ' ' PHE . 85.1 mm-40 -80.33 -24.14 40.1 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.594 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.431 ' CB ' HD13 ' A' ' 115' ' ' ILE . 11.2 tpt -82.49 -38.06 24.43 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.353 -0.842 . . . . 0.0 109.493 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.407 ' O ' HG21 ' A' ' 59' ' ' ILE . . . -57.93 -42.1 84.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.48 -0.762 . . . . 0.0 109.767 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.427 HD12 ' CE ' ' A' ' 197' ' ' MET . 5.8 tt -65.58 -48.71 71.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 109.322 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.502 ' O ' ' N ' ' A' ' 62' ' ' GLY . 37.0 p -67.02 -59.12 3.74 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.365 -0.835 . . . . 0.0 110.979 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 111' ' ' ALA . 11.3 tt -47.48 -24.79 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.17 -0.956 . . . . 0.0 111.022 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.8 ttt85 -72.07 -45.8 59.35 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.19 -0.944 . . . . 0.0 110.702 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -124.1 5.47 8.57 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.872 -1.143 . . . . 0.0 112.163 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 58' ' ' THR . . . -165.12 -169.27 28.52 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.5 p -139.91 102.26 4.37 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.33 72.91 0.22 Allowed Glycine 0 C--N 1.266 -3.352 0 N-CA-C 105.222 -3.151 . . . . 0.0 105.222 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.496 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 1.7 tt -63.07 106.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.6 0 CA-C-O 122.622 1.201 . . . . 0.0 107.906 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.461 ' CG1' ' HG2' ' A' ' 43' ' ' MET . 16.5 m -52.53 151.03 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 115.129 -0.942 . . . . 0.0 112.043 -177.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.469 ' O ' ' CG1' ' A' ' 171' ' ' VAL . 82.5 m -85.9 160.74 19.33 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.525 ' N ' ' CD1' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -137.87 91.76 2.61 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.012 -1.475 . . . . 0.0 108.094 178.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.444 ' CB ' ' OG1' ' A' ' 157' ' ' THR . 1.3 m -102.52 152.25 21.37 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 119.046 -1.062 . . . . 0.0 110.472 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.538 ' HA ' ' CD1' ' A' ' 158' ' ' ILE . 1.1 mt -152.6 -177.73 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.0 p -86.33 144.71 27.24 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -53.54 -20.03 4.48 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.208 -0.933 . . . . 0.0 110.379 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.422 ' O ' ' CG ' ' A' ' 77' ' ' GLN . 10.1 t70 -79.0 -37.58 38.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.153 -0.967 . . . . 0.0 110.951 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -85.95 -52.44 5.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.21 -0.931 . . . . 0.0 110.629 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.505 ' CD ' ' CD1' ' A' ' 70' ' ' ILE . 22.4 tpt180 -54.2 -53.93 46.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.166 -0.959 . . . . 0.0 109.54 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.588 ' HA ' ' CB ' ' A' ' 80' ' ' LEU . 1.1 mtpm? -60.43 -56.67 18.65 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.293 -0.879 . . . . 0.0 111.605 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.422 ' CG ' ' O ' ' A' ' 73' ' ' ASP . 4.9 mt-30 -27.29 -49.41 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.851 1.344 . . . . 0.0 110.997 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.505 ' CD1' ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -136.88 -27.52 1.0 Allowed 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 117.162 -1.815 . . . . 0.0 113.082 177.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.505 ' N ' ' CD1' ' A' ' 78' ' ' LEU . 65.9 t0 -121.15 62.97 0.88 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 117.363 -1.735 . . . . 0.0 115.438 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.588 ' CB ' ' HA ' ' A' ' 76' ' ' LYS . 2.2 tt -144.73 104.23 4.55 Favored Pre-proline 0 N--CA 1.506 2.348 0 C-N-CA 115.925 -2.31 . . . . 0.0 113.744 174.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.535 ' HG2' HG22 ' A' ' 97' ' ' VAL . 38.3 Cg_endo -101.56 96.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.3 -1.983 0 N-CA-C 107.257 -1.863 . . . . 0.0 107.257 174.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.442 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 9.4 ttt -88.8 45.48 1.29 Allowed 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.21 -0.932 . . . . 0.0 109.553 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.436 ' CB ' HG12 ' A' ' 97' ' ' VAL . 4.7 mmm -57.7 -11.51 2.23 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.655 -0.653 . . . . 0.0 110.656 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.47 ' CG1' ' ND2' ' A' ' 86' ' ' ASN . 53.6 t -86.52 102.23 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 C-N-CA 116.878 -1.929 . . . . 0.0 109.915 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -101.53 30.85 4.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.681 -0.637 . . . . 0.0 109.681 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.47 ' ND2' ' CG1' ' A' ' 84' ' ' VAL . 34.2 p30 -64.11 80.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.27 -0.893 . . . . 0.0 110.665 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.418 ' N ' ' O ' ' A' ' 85' ' ' GLU . 2.3 m120 -103.14 54.4 0.76 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.359 -0.838 . . . . 0.0 109.717 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.2 p -141.78 -81.42 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.375 -0.828 . . . . 0.0 109.51 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.63 -26.78 64.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.209 -0.932 . . . . 0.0 109.28 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.413 ' CB ' ' OG1' ' A' ' 93' ' ' THR . . . -114.48 174.73 5.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.523 -0.736 . . . . 0.0 109.724 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -114.51 77.71 1.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.1 -1.0 . . . . 0.0 110.836 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.66 42.73 16.66 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.317 -1.42 . . . . 0.0 109.688 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.426 HG23 ' CD2' ' A' ' 95' ' ' PHE . 1.5 m -48.58 -21.74 0.63 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.071 -1.252 . . . . 0.0 111.33 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 96' ' ' THR . . . 46.21 26.4 2.24 Favored Glycine 0 N--CA 1.497 2.758 0 O-C-N 120.939 -1.101 . . . . 0.0 110.951 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.445 ' HB3' ' CB ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -57.05 87.56 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 123.144 1.45 . . . . 0.0 112.237 -177.628 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.457 ' CG2' ' HG ' ' A' ' 80' ' ' LEU . 1.2 m -61.41 81.25 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.026 -1.443 . . . . 0.0 109.413 177.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.535 HG22 ' HG2' ' A' ' 81' ' ' PRO . 1.2 m -37.07 155.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.046 0 CA-C-O 122.259 1.028 . . . . 0.0 111.935 -175.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.428 ' CG2' ' O ' ' A' ' 137' ' ' VAL . 39.4 p -66.52 -176.88 0.5 Allowed 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -174.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 132' ' ' ASN . 1.1 pp -110.6 146.78 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 122.47 1.129 . . . . 0.0 113.545 -177.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.625 ' N ' ' H ' ' A' ' 133' ' ' ARG . 58.1 tt0 -93.65 163.27 13.61 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.428 ' CB ' ' HB ' ' A' ' 106' ' ' THR . . . -77.69 78.78 4.19 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 116.213 -2.195 . . . . 0.0 107.563 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 129' ' ' SER . . . -106.47 -37.54 6.46 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.456 ' HA ' ' CB ' ' A' ' 129' ' ' SER . 30.6 tp10 -74.43 -7.92 54.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.55 -0.719 . . . . 0.0 109.894 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.8 24.98 5.59 Favored Glycine 0 N--CA 1.481 1.651 0 C-N-CA 119.604 -1.284 . . . . 0.0 111.703 178.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.424 HG21 ' CB ' ' A' ' 120' ' ' ALA . 2.0 t -114.19 112.13 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 C-N-CA 118.011 -1.475 . . . . 0.0 108.016 177.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.428 ' HB ' ' CB ' ' A' ' 101' ' ' ALA . 5.6 t -157.39 66.92 0.5 Allowed 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.0 m -129.99 20.98 5.39 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.416 -1.427 . . . . 0.0 111.847 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.497 ' O ' ' N ' ' A' ' 110' ' ' SER . . . 96.55 47.44 2.34 Favored Glycine 0 N--CA 1.502 3.052 0 N-CA-C 107.137 -2.385 . . . . 0.0 107.137 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.489 ' O ' HG23 ' A' ' 109' ' ' VAL . 12.2 p -53.82 51.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -173.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 108' ' ' GLY . 1.9 m -135.29 12.21 3.54 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 117.053 -1.859 . . . . 0.0 112.405 172.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.435 ' HA ' ' CD1' ' A' ' 59' ' ' ILE . . . -122.12 -81.86 0.64 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 119.89 -1.756 . . . . 0.0 108.983 171.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' A' ' 116' ' ' THR . . . -98.7 -43.6 6.74 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 174.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.452 ' CB ' ' HA ' ' A' ' 109' ' ' VAL . 47.0 t0 -54.15 -29.74 46.58 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.472 ' HB2' ' CA ' ' A' ' 110' ' ' SER . 2.0 ttt180 -63.85 -51.29 65.3 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 175.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.509 ' CG2' ' O ' ' A' ' 50' ' ' MET 0.254 1.2 mp -67.31 -10.74 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.682 178.212 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.417 ' O ' ' CB ' ' A' ' 120' ' ' ALA . 54.9 m -90.43 -41.87 11.21 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.89 -1.131 . . . . 0.0 109.112 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.473 ' CB ' HG21 ' A' ' 109' ' ' VAL . 52.8 m -69.0 -29.13 67.25 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.384 -0.926 . . . . 0.0 108.783 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.429 ' CG1' ' O ' ' A' ' 47' ' ' ALA . 39.9 t -67.78 -44.01 85.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.08 -27.98 35.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.472 -0.767 . . . . 0.0 109.573 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.424 ' CB ' HG21 ' A' ' 105' ' ' VAL . . . -80.95 -51.92 8.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.514 -0.741 . . . . 0.0 109.516 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 117' ' ' THR . . . -54.86 -32.27 60.57 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.42 ' CG2' ' O ' ' A' ' 122' ' ' ILE . 71.1 mt -93.39 25.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.602 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.543 ' O ' ' N ' ' A' ' 125' ' ' GLY . . . -37.63 150.82 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 O-C-N 122.056 -0.403 . . . . 0.0 111.48 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -26.99 -28.58 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 123' ' ' ALA . . . 129.93 -36.04 2.42 Favored Glycine 0 N--CA 1.493 2.448 0 O-C-N 120.282 -1.511 . . . . 0.0 110.61 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -87.92 93.64 9.53 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.761 -1.435 . . . . 0.0 107.14 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.448 ' HD2' ' CG ' ' A' ' 103' ' ' GLU . 8.3 ttpt -134.3 119.12 14.17 Favored Pre-proline 0 C--N 1.305 -1.35 0 O-C-N 121.226 -0.921 . . . . 0.0 111.19 -178.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -88.29 19.33 1.34 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 N-CA-C 108.178 -1.508 . . . . 0.0 108.178 176.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.688 ' O ' ' N ' ' A' ' 131' ' ' LEU . 0.7 OUTLIER -119.6 41.16 3.2 Favored 'General case' 0 C--O 1.203 -1.38 0 O-C-N 121.3 -0.875 . . . . 0.0 110.727 -177.345 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -37.4 74.6 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 123.236 1.493 . . . . 0.0 110.894 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.688 ' N ' ' O ' ' A' ' 129' ' ' SER . 0.2 OUTLIER -68.17 107.14 2.65 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 113.469 -1.696 . . . . 0.0 110.938 -176.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.505 ' HB2' ' CB ' ' A' ' 81' ' ' PRO . 12.9 p30 -137.4 48.02 2.06 Favored 'General case' 0 N--CA 1.52 3.071 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.625 ' H ' ' N ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER 173.22 108.69 0.06 OUTLIER Pre-proline 0 N--CA 1.51 2.545 0 O-C-N 119.147 -2.22 . . . . 0.0 112.051 174.444 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.408 ' HD2' ' O ' ' A' ' 134' ' ' PRO . 53.7 Cg_endo -134.48 119.46 0.0 OUTLIER 'Cis proline' 0 C--N 1.31 -1.466 0 N-CA-C 103.958 -3.131 . . . . 0.0 103.958 -9.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 137' ' ' VAL . . . -111.67 44.76 1.44 Allowed Glycine 0 N--CA 1.509 3.501 0 C-N-CA 118.063 -2.018 . . . . 0.0 113.106 -175.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.418 ' C ' ' O ' ' A' ' 135' ' ' GLY . 66.4 m170 31.0 37.31 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 122.246 1.022 . . . . 0.0 111.59 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.461 ' N ' ' O ' ' A' ' 135' ' ' GLY . 45.1 t -108.91 125.08 65.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.496 ' CZ ' HG12 ' A' ' 65' ' ' ILE . 2.4 p90 -118.77 85.27 27.39 Favored Pre-proline 0 C--N 1.294 -1.818 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.339 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.49 ' HA ' HD21 ' A' ' 68' ' ' LEU . 47.6 Cg_endo -95.46 153.36 1.58 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 N-CA-C 108.362 -1.438 . . . . 0.0 108.362 178.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.448 ' CD2' ' O ' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -150.37 153.03 35.31 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.788 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -65.01 120.0 11.81 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.39 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -129.49 133.12 47.1 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.091 -1.006 . . . . 0.0 111.472 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -78.05 143.73 37.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -0.835 . . . . 0.0 109.627 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -103.76 115.51 30.61 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.293 -0.879 . . . . 0.0 111.487 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.422 ' N ' ' OD2' ' A' ' 159' ' ' ASP . . . 117.57 -14.82 13.01 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.55 12.97 56.77 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.487 ' CG1' ' CG1' ' A' ' 206' ' ' VAL . 4.9 p -73.36 -24.61 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.148 -1.207 . . . . 0.0 110.968 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.98 17.95 7.29 Favored 'General case' 0 C--O 1.208 -1.13 0 C-N-CA 115.472 -2.491 . . . . 0.0 110.506 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 25.3 m -131.19 59.55 1.68 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 100.778 -3.786 . . . . 0.0 100.778 166.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.404 ' NE ' ' OE1' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -151.85 148.21 27.55 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 113.76 -1.564 . . . . 0.0 112.432 -178.277 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -104.27 35.3 5.14 Favored Glycine 0 N--CA 1.482 1.756 0 N-CA-C 106.179 -2.768 . . . . 0.0 106.179 173.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.1 135.19 6.11 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.473 ' CD2' HD12 ' A' ' 202' ' ' ILE . 54.1 m80 -74.51 -5.18 41.27 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.241 -1.152 . . . . 0.0 109.666 177.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 59.4 p -53.73 -56.71 15.02 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.942 -1.099 . . . . 0.0 109.687 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.442 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . 2.9 mp0 -58.02 -21.66 46.07 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.486 ' CB ' ' CG2' ' A' ' 147' ' ' VAL . . . -83.71 6.26 21.7 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.571 -0.705 . . . . 0.0 109.818 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.472 ' O ' ' CB ' ' A' ' 160' ' ' LEU . 59.8 p -93.49 -49.26 5.99 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.538 ' CD1' ' HA ' ' A' ' 70' ' ' ILE . 0.3 OUTLIER -80.09 -32.31 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 116.703 -1.999 . . . . 0.0 107.259 177.557 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.422 ' OD2' ' N ' ' A' ' 145' ' ' GLY . 8.7 t70 -61.29 -33.76 74.1 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 105.375 -2.084 . . . . 0.0 105.375 174.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.58 ' HA ' ' CD2' ' A' ' 163' ' ' LEU . 0.6 OUTLIER -47.22 -41.25 18.04 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 175.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.48 ' O ' ' N ' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -57.97 -48.4 80.08 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.911 178.508 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.459 ' N ' ' CG ' ' A' ' 161' ' ' MET . 0.0 OUTLIER -63.85 -34.85 78.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.009 -1.057 . . . . 0.0 111.698 -178.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.58 ' CD2' ' HA ' ' A' ' 160' ' ' LEU . 1.7 pp -93.33 -30.87 14.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.925 -1.109 . . . . 0.0 111.763 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.5 ' CB ' HD12 ' A' ' 160' ' ' LEU . . . -115.15 38.02 3.33 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -178.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 167' ' ' LYS . . . 112.78 70.61 0.56 Allowed Glycine 0 N--CA 1.513 3.784 0 C-N-CA 116.667 -2.683 . . . . 0.0 109.831 -177.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.496 ' O ' ' CD2' ' A' ' 166' ' ' PHE . 54.3 p90 -62.43 70.67 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 123.486 1.612 . . . . 0.0 115.099 -172.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.473 ' N ' ' O ' ' A' ' 165' ' ' GLY . 0.0 OUTLIER -113.22 131.95 22.65 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 100.792 -3.781 . . . . 0.0 100.792 171.49 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.43 ' HB2' ' CG2' ' A' ' 70' ' ' ILE . 38.1 Cg_endo -63.58 89.84 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 116.636 -1.776 . . . . 0.0 112.412 -173.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.46 ' HB3' ' CB ' ' A' ' 47' ' ' ALA 0.262 . . -158.18 153.8 26.3 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 176.085 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 157' ' ' THR . . . -147.37 113.52 0.65 Allowed Glycine 0 N--CA 1.497 2.739 0 C-N-CA 117.24 -2.41 . . . . 0.0 110.535 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.53 ' O ' HD12 ' A' ' 172' ' ' LEU . 1.1 m -125.72 144.02 37.23 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.447 0 C-N-CA 117.172 -1.811 . . . . 0.0 109.791 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.536 ' CD1' ' HA ' ' A' ' 44' ' ' ILE . 0.1 OUTLIER -159.69 113.63 2.27 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 177.269 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 1.9 t -126.96 178.0 6.26 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 119.642 -1.911 . . . . 0.0 112.042 -178.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.41 ' OE2' ' N ' ' A' ' 175' ' ' LEU . 1.6 tm-20 -120.62 148.35 44.01 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.924 -1.11 . . . . 0.0 110.27 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.41 ' N ' ' OE2' ' A' ' 174' ' ' GLU . 1.6 tp -69.57 93.07 0.67 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.038 -1.039 . . . . 0.0 110.11 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 9.5 t -139.0 153.69 48.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 110.15 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . 0.432 ' CB ' ' HA2' ' A' ' 62' ' ' GLY . 55.4 t-20 -121.13 157.01 31.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 110.042 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 178' ' ' ASP . 21.5 p-10 -85.51 6.52 26.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.261 -0.899 . . . . 0.0 111.248 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.08 -22.16 20.87 Favored 'General case' 0 C--N 1.29 -2.011 0 O-C-N 121.566 -0.709 . . . . 0.0 110.289 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 105.72 46.0 1.25 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 26.9 m -92.28 159.15 15.75 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.36 -1.082 . . . . 0.0 109.945 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 11.5 mtm -82.69 53.19 2.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.415 -0.803 . . . . 0.0 110.389 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.437 ' HA ' ' CB ' ' A' ' 188' ' ' CYS . . . -105.31 85.22 2.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.202 -0.936 . . . . 0.0 110.111 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.419 ' O ' ' CB ' ' A' ' 185' ' ' ALA . 0.2 OUTLIER -140.11 162.15 35.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.876 . . . . 0.0 110.401 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.461 ' CB ' ' HD2' ' A' ' 186' ' ' PRO . . . 68.9 174.83 0.08 OUTLIER Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.42 -0.8 . . . . 0.0 110.865 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 185' ' ' ALA . 41.1 Cg_endo -66.38 -10.5 27.83 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.481 1.253 . . . . 0.0 110.957 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -72.9 -55.01 7.23 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.046 -1.034 . . . . 0.0 109.864 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . 0.437 ' CB ' ' HA ' ' A' ' 183' ' ' ALA . 24.0 p -58.79 -39.53 81.37 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.271 -0.893 . . . . 0.0 110.059 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.463 ' CD1' ' CB ' ' A' ' 42' ' ' ASP . 8.7 tp -73.63 -22.59 18.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 118.018 -1.473 . . . . 0.0 109.071 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -56.78 -33.63 66.83 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.435 ' C ' ' CD1' ' A' ' 191' ' ' PHE . 0.1 OUTLIER -66.03 -40.63 91.18 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 197' ' ' MET . . . -60.32 -49.32 78.05 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.969 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . 0.606 ' HA ' ' CB ' ' A' ' 197' ' ' MET . 0.1 OUTLIER -73.03 -11.49 60.58 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.282 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -73.75 -34.78 64.88 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 117.47 -1.692 . . . . 0.0 111.365 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -112.11 -52.47 2.78 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 116.165 -2.214 . . . . 0.0 111.489 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -114.2 32.6 5.79 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 117.859 -1.536 . . . . 0.0 114.238 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' MET . . . . . 0.606 ' CB ' ' HA ' ' A' ' 193' ' ' ASN . 0.1 OUTLIER -153.12 147.44 25.81 Favored 'General case' 0 N--CA 1.517 2.918 0 CA-C-N 123.396 2.816 . . . . 0.0 115.912 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 28' ' ' GLY . . . -95.36 127.62 41.55 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 175.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.603 ' CD1' ' HB2' ' A' ' 30' ' ' MET . 0.3 OUTLIER -114.92 107.35 15.28 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 120.41 -1.431 . . . . 0.0 113.512 -176.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.488 ' CG2' ' CD2' ' A' ' 6' ' ' LEU . 4.4 p -100.05 -173.02 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.245 -0.91 . . . . 0.0 110.07 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' THR . . . . . . . . . . . . . 4.4 t -111.98 165.08 12.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.071 -1.018 . . . . 0.0 109.796 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.473 HD12 ' CD2' ' A' ' 153' ' ' HIS . 9.9 tt -81.39 -14.27 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.044 -1.035 . . . . 0.0 111.298 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.422 ' O ' ' CB ' ' A' ' 207' ' ' ALA . 2.1 mt-10 -90.1 -43.63 10.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.934 -1.104 . . . . 0.0 110.598 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -85.48 -14.73 45.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 111.404 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.493 ' O ' ' HB3' ' A' ' 208' ' ' TYR . 10.5 tt -77.0 -53.57 7.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.81 -1.181 . . . . 0.0 110.914 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.487 ' CG1' ' CG1' ' A' ' 147' ' ' VAL . 1.1 t -76.75 -29.33 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 117.875 -1.53 . . . . 0.0 107.765 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 203' ' ' GLU . . . -57.1 -30.95 64.79 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.609 ' CE2' ' CG1' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -62.82 -44.7 95.45 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 177.605 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.431 ' NE ' ' HB ' ' A' ' 162' ' ' THR . 54.7 ttt-85 -61.62 -52.15 65.58 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.739 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.76 -57.61 5.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 110.446 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 207' ' ' ALA . . . -51.51 -23.95 4.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.417 -0.802 . . . . 0.0 110.414 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -82.97 -25.55 32.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.241 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.41 24.91 10.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.186 -0.946 . . . . 0.0 110.183 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -92.6 148.13 22.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.261 -0.899 . . . . 0.0 110.194 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -63.02 86.21 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.932 . . . . 0.0 110.181 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -142.71 160.48 40.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.185 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.191 179.955 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.235 0.541 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -97.83 55.26 1.18 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 0.0 110.234 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -11.49 60.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.93 . . . . 0.0 110.594 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.2 p -68.97 -8.1 41.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.076 -1.015 . . . . 0.0 110.866 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.88 -24.87 3.9 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.871 -1.143 . . . . 0.0 110.413 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.551 HD21 HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -112.04 -15.56 13.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.212 -0.93 . . . . 0.0 110.115 179.651 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.9 m -92.49 -42.91 9.46 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.09 -1.006 . . . . 0.0 109.786 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.1 p -94.14 25.48 3.75 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.746 0.784 . . . . 0.0 109.288 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.9 79.79 1.73 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.39 92.3 1.29 Allowed Glycine 0 C--N 1.291 -1.959 0 N-CA-C 106.089 -2.805 . . . . 0.0 106.089 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.684 ' O ' ' N ' ' A' ' 14' ' ' GLU . 0.2 OUTLIER -127.32 168.24 15.5 Favored Pre-proline 0 C--N 1.27 -2.878 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.438 ' HD2' ' CG2' ' A' ' 11' ' ' THR . 18.1 Cg_endo -42.08 -19.22 0.1 OUTLIER 'Trans proline' 0 N--CA 1.518 2.921 0 CA-C-N 122.499 1.928 . . . . 0.0 109.321 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.669 ' O ' ' N ' ' A' ' 16' ' ' VAL . 1.8 m-30 -51.54 -16.28 0.58 Allowed 'General case' 0 C--O 1.183 -2.413 0 O-C-N 119.747 -1.845 . . . . 0.0 106.619 168.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.684 ' N ' ' O ' ' A' ' 11' ' ' THR . 2.8 mt-10 -44.45 -36.1 2.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.109 -1.62 . . . . 0.0 109.239 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -42.24 90.85 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 176.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.669 ' N ' ' O ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -74.91 -29.44 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.183 175.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.506 ' CB ' ' HA ' ' A' ' 14' ' ' GLU . 9.2 tt0 -56.64 -56.41 21.74 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.292 -1.505 . . . . 0.0 107.749 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.424 ' O ' ' CB ' ' A' ' 198' ' ' ALA . 50.4 t-20 -53.35 -25.96 17.22 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.206 -0.997 . . . . 0.0 108.336 177.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.459 ' CB ' ' HB ' ' A' ' 200' ' ' VAL . . . -70.78 -66.43 0.61 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.588 0.709 . . . . 0.0 110.701 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.496 ' HB2' HD22 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -78.92 -33.01 45.86 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.204 -0.935 . . . . 0.0 110.942 -178.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 17' ' ' GLU . . . -56.09 -32.5 64.2 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.436 ' O ' ' N ' ' A' ' 25' ' ' GLU . . . -67.0 -35.79 80.74 Favored 'General case' 0 C--O 1.207 -1.166 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 176.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.448 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 3.1 tt -48.51 -26.24 2.07 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.164 -0.96 . . . . 0.0 109.75 178.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -91.06 -26.16 19.3 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.807 0.813 . . . . 0.0 108.833 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 22' ' ' ALA . 0.3 OUTLIER -144.42 78.98 1.59 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 177.436 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 126.0 52.59 0.16 Allowed Glycine 0 C--N 1.281 -2.499 1 N-CA-C 101.63 -4.588 . . . . 0.0 101.63 -173.147 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -56.18 80.6 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 122.936 1.35 . . . . 0.0 111.308 -173.526 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 26' ' ' GLY . . . 172.76 104.75 0.18 Allowed Glycine 0 N--CA 1.489 2.201 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.49 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.477 ' HB ' ' CG2' ' A' ' 44' ' ' ILE . 1.5 t -116.48 121.77 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.477 ' CB ' ' HA ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -111.77 131.48 55.29 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 117.996 -1.482 . . . . 0.0 110.52 -178.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 200' ' ' VAL . 14.7 p -121.48 128.94 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.435 -0.791 . . . . 0.0 110.219 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.412 ' CD1' ' O ' ' A' ' 39' ' ' ASN . 2.6 tt -174.9 164.25 3.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -0.894 . . . . 0.0 110.11 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -174.98 -66.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.277 -0.89 . . . . 0.0 110.193 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.24 100.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 0.0 110.19 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.12 62.23 0.31 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.9 . . . . 0.0 110.199 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.71 -54.38 9.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 110.256 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -174.31 -72.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.894 . . . . 0.0 110.185 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.41 100.72 6.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.326 -0.859 . . . . 0.0 110.177 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.412 ' O ' ' CD1' ' A' ' 32' ' ' LEU . 2.5 m-20 -122.44 138.56 54.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.896 . . . . 0.0 110.212 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.426 ' HB3' ' CA ' ' A' ' 173' ' ' CYS . 18.6 mm-40 -95.8 -171.1 2.27 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.236 -0.915 . . . . 0.0 109.912 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.421 ' C ' ' HA ' ' A' ' 30' ' ' MET . . . 166.61 -61.58 0.22 Allowed Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.496 -1.335 . . . . 0.0 110.844 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.477 ' HA ' ' CB ' ' A' ' 30' ' ' MET . 28.9 t70 -36.75 -31.6 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.731 0 O-C-N 121.619 -0.93 . . . . 0.0 112.078 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.602 ' O ' ' O ' ' A' ' 171' ' ' VAL . 0.7 OUTLIER -94.66 52.42 1.52 Allowed 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 122.175 0.988 . . . . 0.0 113.094 -178.017 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.477 ' CG2' ' HB ' ' A' ' 29' ' ' VAL . 13.0 tt -63.48 19.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.846 0 O-C-N 119.399 -2.063 . . . . 0.0 113.154 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.504 ' H ' ' C ' ' A' ' 43' ' ' MET . 2.9 m-85 -81.92 162.97 55.58 Favored Pre-proline 0 N--CA 1.498 1.93 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -175.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.497 ' HG3' ' CE1' ' A' ' 166' ' ' PHE . 51.3 Cg_endo -69.82 131.23 20.71 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.642 2.228 . . . . 0.0 110.719 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.485 ' HB3' ' CB ' ' A' ' 169' ' ' ALA . . . -67.58 -20.45 65.38 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.297 -0.961 . . . . 0.0 112.029 -178.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.443 ' HA ' ' CG2' ' A' ' 122' ' ' ILE . 20.6 tt0 -76.52 -35.08 58.52 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.838 -1.163 . . . . 0.0 111.078 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.438 ' O ' ' N ' ' A' ' 51' ' ' THR . 4.7 t -132.87 58.81 1.75 Allowed 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.445 ' O ' HD11 ' A' ' 115' ' ' ILE . 0.3 OUTLIER -65.4 88.13 0.08 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 179.069 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.441 ' HA ' HG12 ' A' ' 115' ' ' ILE . 11.4 m -59.07 170.04 0.96 Allowed 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.713 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.465 ' O ' ' N ' ' A' ' 56' ' ' ALA . 2.7 p -83.16 -2.3 6.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 O-C-N 121.341 -0.85 . . . . 0.0 110.063 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.28 -44.77 94.16 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.445 ' HB2' ' HG3' ' A' ' 43' ' ' MET . 0.0 OUTLIER -76.19 -35.83 58.94 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.458 178.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.418 ' HA ' ' OG1' ' A' ' 58' ' ' THR . 0.0 OUTLIER -70.51 -27.8 64.47 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.143 -0.973 . . . . 0.0 108.525 178.407 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 52' ' ' VAL . . . -56.46 -47.83 78.36 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.754 -0.591 . . . . 0.0 109.709 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.439 ' O ' ' CB ' ' A' ' 60' ' ' ARG . 6.7 tt -60.04 -56.81 17.11 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.026 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.47 ' CA ' ' HB2' ' A' ' 63' ' ' SER . 2.6 p -53.39 -36.0 60.97 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.423 -0.798 . . . . 0.0 109.79 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.47 ' CD1' ' CB ' ' A' ' 111' ' ' ALA . 51.2 mt -84.48 -11.33 11.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.568 -0.708 . . . . 0.0 109.178 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -51.53 -51.94 51.14 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.749 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.475 ' CD2' ' HB3' ' A' ' 178' ' ' ASP . 0.1 OUTLIER -125.51 -37.38 2.36 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 116.583 -2.047 . . . . 0.0 112.07 176.143 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' A' ' 176' ' ' THR . . . 175.02 107.53 0.21 Allowed Glycine 0 N--CA 1.499 2.839 0 C-N-CA 118.834 -1.65 . . . . 0.0 111.413 174.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.47 ' HB2' ' CA ' ' A' ' 58' ' ' THR . 0.6 OUTLIER -165.89 99.99 0.66 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 120.227 2.013 . . . . 0.0 105.69 172.476 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.456 ' O ' HD11 ' A' ' 65' ' ' ILE . . . -123.46 55.77 0.69 Allowed Glycine 0 C--N 1.283 -2.407 0 N-CA-C 106.364 -2.694 . . . . 0.0 106.364 176.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.501 HD12 ' CD2' ' A' ' 138' ' ' PHE . 20.5 mm -147.68 104.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 113.838 -1.181 . . . . 0.0 109.411 175.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.62 ' O ' ' CD1' ' A' ' 138' ' ' PHE . 25.5 t -114.96 154.28 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.568 -1.332 . . . . 0.0 110.66 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 171' ' ' VAL . 0.4 OUTLIER -92.15 120.16 32.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.022 -1.674 . . . . 0.0 108.524 178.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 139' ' ' PRO . 3.6 mm? -89.47 98.43 11.76 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.484 ' HB2' ' N ' ' A' ' 170' ' ' GLY . 66.3 m -66.1 129.1 38.63 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.638 -0.664 . . . . 0.0 109.779 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.482 ' CD1' ' CZ ' ' A' ' 75' ' ' ARG . 10.4 tt -153.99 164.79 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.928 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.4 ' N ' HG12 ' A' ' 70' ' ' ILE . 2.1 m -124.85 175.72 7.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.426 -0.797 . . . . 0.0 109.946 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 13.8 tt0 -73.91 -9.2 58.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.246 -0.909 . . . . 0.0 110.775 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -88.26 -39.87 14.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.972 -1.08 . . . . 0.0 110.53 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.84 -35.87 59.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.246 -0.909 . . . . 0.0 110.188 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.498 ' O ' ' C ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -78.48 -29.82 47.0 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.219 1.009 . . . . 0.0 108.6 179.095 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -53.15 -66.04 0.46 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.198 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -47.64 -33.37 6.65 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 122.089 0.947 . . . . 0.0 109.224 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.498 ' C ' ' O ' ' A' ' 75' ' ' ARG . 19.1 tp -96.55 47.13 1.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 175.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 76' ' ' LYS . 1.2 m-20 -22.39 83.9 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 124.458 2.075 . . . . 0.0 112.471 -171.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 78' ' ' LEU . 3.5 tm? -147.42 112.54 4.03 Favored Pre-proline 0 C--N 1.292 -1.905 0 CA-C-N 111.073 -2.785 . . . . 0.0 109.574 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.26 99.37 1.01 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.317 1.167 . . . . 0.0 111.046 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.466 ' O ' ' CG ' ' A' ' 82' ' ' MET . 3.6 ptt? -87.0 83.95 7.41 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.323 -0.861 . . . . 0.0 109.386 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.47 67.35 1.13 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.94 -1.1 . . . . 0.0 110.899 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.456 ' N ' ' HA ' ' A' ' 95' ' ' PHE . 82.8 t -85.91 104.39 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.046 -1.033 . . . . 0.0 109.217 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -98.75 26.73 5.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.129 -0.982 . . . . 0.0 111.219 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -89.95 17.45 6.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.901 -1.124 . . . . 0.0 110.325 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -107.85 82.76 1.69 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.213 -0.929 . . . . 0.0 110.163 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 54.84 -152.97 0.33 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.055 -1.028 . . . . 0.0 109.956 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.6 t -101.37 -60.57 1.5 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.124 -0.985 . . . . 0.0 110.679 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.12 26.49 3.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.194 -0.941 . . . . 0.0 110.116 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.05 79.4 1.25 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.44 -0.787 . . . . 0.0 109.918 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.3 42.82 11.27 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.3 p -48.3 -20.01 0.35 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.403 -1.057 . . . . 0.0 111.654 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.27 26.02 4.57 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 120.656 -1.278 . . . . 0.0 110.676 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -61.96 47.16 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.052 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -178.581 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.45 ' CB ' ' O ' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -130.34 75.48 1.66 Allowed 'General case' 0 C--N 1.292 -1.906 0 O-C-N 121.303 -0.873 . . . . 0.0 110.997 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.443 ' HB ' ' HA ' ' A' ' 82' ' ' MET . 90.3 t -43.98 145.4 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.493 0 O-C-N 120.458 -1.401 . . . . 0.0 110.83 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.492 ' OG1' ' HA ' ' A' ' 134' ' ' PRO . 1.0 OUTLIER -73.98 -174.96 2.01 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.774 0.797 . . . . 0.0 112.329 -177.141 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.47 HG21 ' CG ' ' A' ' 131' ' ' LEU 0.302 0.1 OUTLIER -149.24 123.55 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -178.049 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 132' ' ' ASN . 3.9 tm-20 -91.2 105.36 17.74 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 117.775 -1.57 . . . . 0.0 112.715 -176.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.485 ' HA ' ' CD1' ' A' ' 131' ' ' LEU . . . -50.6 96.43 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.132 -0.98 . . . . 0.0 110.169 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 130' ' ' ASP . . . -103.16 2.87 35.12 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.114 -0.992 . . . . 0.0 110.061 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.426 ' HB3' ' CB ' ' A' ' 130' ' ' ASP . 7.7 pt-20 -112.26 45.36 1.29 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.066 -1.021 . . . . 0.0 111.448 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.429 ' O ' ' CG2' ' A' ' 117' ' ' THR . . . 127.65 -37.68 2.28 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 118.946 -1.597 . . . . 0.0 112.723 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.472 ' CA ' ' HB ' ' A' ' 117' ' ' THR . 0.0 OUTLIER -101.43 121.76 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 O-C-N 120.823 -1.398 . . . . 0.0 111.113 -178.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.4 p -144.3 58.53 1.33 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.599 -1.24 . . . . 0.0 110.975 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.416 ' CG2' ' OG ' ' A' ' 110' ' ' SER . 23.9 m -139.52 -32.33 0.65 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.953 -1.092 . . . . 0.0 110.86 176.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.512 ' CA ' ' CD2' ' A' ' 136' ' ' HIS . . . 74.11 -31.96 0.94 Allowed Glycine 0 N--CA 1.493 2.467 0 O-C-N 121.688 -0.632 . . . . 0.0 111.526 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.442 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -131.02 58.0 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.707 -1.466 . . . . 0.0 109.84 179.298 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 114' ' ' ARG . 0.4 OUTLIER -129.54 57.04 1.68 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.028 -1.045 . . . . 0.0 109.579 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.47 ' CB ' ' CD1' ' A' ' 59' ' ' ILE . . . -32.9 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -85.14 -77.48 0.28 Allowed 'General case' 0 C--N 1.288 -2.095 0 O-C-N 120.554 -1.342 . . . . 0.0 109.558 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.02 -16.64 19.43 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.411 -0.806 . . . . 0.0 110.366 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.49 ' CB ' ' O ' ' A' ' 110' ' ' SER . 0.4 OUTLIER -88.77 -36.61 16.01 Favored 'General case' 0 C--O 1.2 -1.552 0 O-C-N 121.063 -1.023 . . . . 0.0 110.869 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.462 ' HB ' ' O ' ' A' ' 111' ' ' ALA . 0.9 OUTLIER -59.97 -17.19 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 C-N-CA 117.971 -1.491 . . . . 0.0 109.183 -179.153 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.8 m -89.09 -57.48 2.88 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.459 1.123 . . . . 0.0 108.491 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.472 ' HB ' ' CA ' ' A' ' 105' ' ' VAL . 2.0 p -62.71 -32.42 73.52 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.138 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.466 ' N ' ' O ' ' A' ' 114' ' ' ARG . 9.8 t -54.47 -47.55 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 -48.06 -29.46 3.56 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -85.69 -40.08 16.53 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.676 178.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.431 ' HB1' ' CG2' ' A' ' 105' ' ' VAL . . . -58.11 -50.77 72.32 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.756 -1.215 . . . . 0.0 109.798 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.443 ' CG2' ' HA ' ' A' ' 48' ' ' GLU . 26.5 mm -87.52 27.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.493 0.663 . . . . 0.0 109.741 178.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.459 ' O ' ' N ' ' A' ' 125' ' ' GLY . . . -37.42 148.36 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.744 0.783 . . . . 0.0 112.37 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -41.37 -7.61 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 123' ' ' ALA . . . 131.61 28.87 0.61 Allowed Glycine 0 N--CA 1.495 2.633 0 O-C-N 119.8 -1.812 . . . . 0.0 110.775 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.78 167.62 13.03 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.31 -1.112 . . . . 0.0 108.504 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.407 ' C ' ' H ' ' A' ' 129' ' ' SER . 0.3 OUTLIER -62.98 124.07 82.35 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.401 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.32 16.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.51 1.268 . . . . 0.0 113.149 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 127' ' ' LYS . 0.1 OUTLIER -58.82 -27.62 65.26 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.177 -1.577 . . . . 0.0 108.768 179.221 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.436 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 38.5 m-20 -94.79 27.19 3.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.282 -0.886 . . . . 0.0 109.644 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.485 ' CD1' ' HA ' ' A' ' 101' ' ' ALA . 9.2 tp -141.38 83.88 1.89 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.274 -0.891 . . . . 0.0 109.191 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.541 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 3.4 m120 -120.32 101.11 7.57 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.099 -1.0 . . . . 0.0 111.995 -178.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.514 ' CB ' ' HA ' ' A' ' 134' ' ' PRO . 0.0 OUTLIER -83.15 -179.01 1.32 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.404 -0.81 . . . . 0.0 111.011 -178.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.514 ' HA ' ' CB ' ' A' ' 133' ' ' ARG . 48.6 Cg_endo -73.01 130.31 19.74 Favored 'Cis proline' 0 N--CA 1.5 1.863 0 C-N-CA 123.119 -1.617 . . . . 0.0 113.148 8.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.455 ' O ' ' CD2' ' A' ' 136' ' ' HIS . . . -132.3 67.95 0.55 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.512 ' CD2' ' CA ' ' A' ' 108' ' ' GLY . 8.5 p-80 32.08 36.59 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.484 0 O-C-N 122.105 -0.644 . . . . 0.0 112.075 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.458 ' CG2' ' O ' ' A' ' 99' ' ' ILE . 13.4 t -91.04 154.2 3.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 176.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.62 ' CD1' ' O ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -145.34 81.6 10.23 Favored Pre-proline 0 C--N 1.287 -2.139 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -178.667 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.503 ' HA ' ' HB2' ' A' ' 68' ' ' LEU . 52.3 Cg_endo -99.56 159.9 0.57 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.375 2.05 . . . . 0.0 111.857 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.434 ' N ' HG22 ' A' ' 96' ' ' THR . 10.9 tp -126.54 113.16 16.41 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -63.72 151.33 42.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.307 -0.871 . . . . 0.0 109.404 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.464 ' CA ' ' HA ' ' A' ' 156' ' ' ALA . . . -62.63 98.19 0.11 Allowed 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.039 0.924 . . . . 0.0 111.821 -177.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 156' ' ' ALA . 1.0 OUTLIER -100.68 146.8 26.74 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.153 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.79 116.0 31.16 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.669 -1.269 . . . . 0.0 112.592 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 112.67 -6.32 26.1 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.063 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.09 9.08 61.29 Favored Glycine 0 N--CA 1.502 3.048 0 C-N-CA 118.466 -1.826 . . . . 0.0 112.788 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.599 ' HB ' ' HA ' ' A' ' 155' ' ' GLU . 1.0 OUTLIER -116.48 -45.15 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.24 -1.741 . . . . 0.0 108.51 177.41 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.573 ' HG ' ' CD1' ' A' ' 202' ' ' ILE . 0.3 OUTLIER -106.77 84.29 1.97 Allowed 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 177.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.425 ' O ' ' CD ' ' A' ' 150' ' ' ARG . 5.1 m -74.3 63.96 1.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 125.335 2.493 . . . . 0.0 104.488 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.609 ' O ' ' N ' ' A' ' 152' ' ' GLY . 12.5 mmt180 -152.68 162.58 41.06 Favored 'General case' 0 C--N 1.271 -2.83 0 N-CA-C 100.23 -3.989 . . . . 0.0 100.23 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -60.57 55.91 0.02 OUTLIER Glycine 0 C--N 1.258 -3.772 0 C-N-CA 117.686 -2.197 . . . . 0.0 112.537 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 150' ' ' ARG . . . -119.28 128.7 7.73 Favored Glycine 0 C--O 1.215 -1.058 0 N-CA-C 106.28 -2.728 . . . . 0.0 106.28 176.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -90.72 1.35 56.93 Favored 'General case' 0 C--N 1.282 -2.344 0 O-C-N 121.969 -0.724 . . . . 0.0 109.312 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.548 ' HA ' ' CB ' ' A' ' 159' ' ' ASP . 1.9 p -51.52 -18.41 1.09 Allowed 'General case' 0 C--O 1.258 1.521 0 O-C-N 121.389 -0.819 . . . . 0.0 112.476 -176.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.733 ' O ' ' N ' ' A' ' 157' ' ' THR . 5.2 tp10 -48.0 -26.59 1.84 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.295 -0.962 . . . . 0.0 108.509 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.674 ' C ' ' H ' ' A' ' 158' ' ' ILE . . . -46.71 90.82 0.0 OUTLIER 'General case' 0 C--O 1.203 -1.379 0 N-CA-C 103.15 -2.908 . . . . 0.0 103.15 170.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.733 ' N ' ' O ' ' A' ' 155' ' ' GLU . 69.3 p -49.77 12.44 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -168.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.674 ' H ' ' C ' ' A' ' 156' ' ' ALA . 0.9 OUTLIER -107.75 -4.05 10.27 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.402 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 172.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.548 ' CB ' ' HA ' ' A' ' 154' ' ' THR . 0.2 OUTLIER -89.09 -33.57 17.06 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 103.174 -2.898 . . . . 0.0 103.174 173.778 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.481 ' CA ' HD22 ' A' ' 163' ' ' LEU . 2.3 mp -62.21 -51.6 67.14 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.74 176.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.589 ' HG3' ' O ' ' A' ' 158' ' ' ILE . 0.0 OUTLIER -48.74 -33.65 10.63 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.394 -1.441 . . . . 0.0 108.553 178.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.473 ' CG2' ' CZ ' ' A' ' 209' ' ' ARG . 1.3 m -57.88 -39.62 78.26 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 119.311 -0.955 . . . . 0.0 108.549 178.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.493 ' CD2' HD11 ' A' ' 205' ' ' LEU . 0.6 OUTLIER -67.26 -8.65 33.47 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.288 -0.965 . . . . 0.0 109.765 178.315 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.491 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -106.36 7.64 31.29 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 120.674 -1.266 . . . . 0.0 110.758 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 49.38 30.42 11.98 Favored Glycine 0 N--CA 1.5 2.951 0 N-CA-C 107.076 -2.41 . . . . 0.0 107.076 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.497 ' CE1' ' HG3' ' A' ' 46' ' ' PRO . 1.9 m-85 -120.19 146.1 46.34 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 122.828 1.299 . . . . 0.0 112.337 -176.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 169' ' ' ALA . 6.7 mtmm -43.9 139.33 2.98 Favored Pre-proline 0 N--CA 1.502 2.128 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.473 ' CB ' HG13 ' A' ' 158' ' ' ILE . 36.6 Cg_endo -61.89 84.93 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.033 0 C-N-CA 117.012 -1.526 . . . . 0.0 113.767 -172.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.485 ' CB ' ' HB3' ' A' ' 47' ' ' ALA . . . -156.04 162.69 40.27 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 172.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.484 ' N ' ' HB2' ' A' ' 69' ' ' CYS . . . -158.12 131.97 3.0 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 117.358 -2.353 . . . . 0.0 111.361 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.602 ' O ' ' O ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -119.71 89.5 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 117.969 -1.492 . . . . 0.0 107.138 176.6 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 43' ' ' MET . 3.0 mp -95.68 138.35 33.47 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.253 0.549 . . . . 0.0 110.374 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.444 ' N ' ' HB3' ' A' ' 43' ' ' MET . 2.8 t -129.59 176.2 8.18 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.897 -1.127 . . . . 0.0 111.064 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.414 ' N ' ' OE1' ' A' ' 40' ' ' GLU . 2.7 tt0 -111.45 -179.46 3.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.201 -0.937 . . . . 0.0 110.06 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -104.61 141.24 36.77 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.108 -0.995 . . . . 0.0 110.001 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.426 ' CB ' ' O ' ' A' ' 62' ' ' GLY . 93.0 m -123.17 155.43 37.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.944 . . . . 0.0 110.382 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.85 171.41 7.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.437 -0.789 . . . . 0.0 110.12 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.475 ' HB3' ' CD2' ' A' ' 61' ' ' HIS . 10.1 p-10 -89.56 5.76 44.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.295 -0.878 . . . . 0.0 111.361 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -72.56 -19.72 61.45 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 121.602 -0.686 . . . . 0.0 109.981 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 90.09 29.64 14.58 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 83.8 m -137.09 147.74 46.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -1.148 . . . . 0.0 110.182 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.42 ' CG ' ' O ' ' A' ' 182' ' ' MET . 0.7 OUTLIER -53.35 95.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.253 -0.904 . . . . 0.0 110.173 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -71.44 107.24 4.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.191 -0.943 . . . . 0.0 110.245 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.413 ' O ' ' CG ' ' A' ' 184' ' ' ARG . 0.1 OUTLIER -140.23 100.2 3.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.901 . . . . 0.0 109.827 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.438 ' CB ' ' HD2' ' A' ' 186' ' ' PRO . . . -179.37 178.08 0.34 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.31 -0.869 . . . . 0.0 109.891 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 185' ' ' ALA . 45.3 Cg_endo -71.82 -16.92 29.49 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.608 1.32 . . . . 0.0 110.413 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -79.46 -31.56 42.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.087 -1.008 . . . . 0.0 110.067 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . 0.435 ' O ' ' HB3' ' A' ' 191' ' ' PHE . 14.0 m -74.35 -56.63 4.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.325 -0.859 . . . . 0.0 110.186 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.447 HG13 ' CD2' ' A' ' 199' ' ' LEU . 2.5 tp -61.7 -22.97 29.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.994 -1.066 . . . . 0.0 109.38 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.446 ' HA ' HD13 ' A' ' 199' ' ' LEU . 23.7 tt0 -81.61 -18.62 44.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.477 -0.764 . . . . 0.0 109.817 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.435 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.1 OUTLIER -71.34 -53.9 12.61 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.992 0.901 . . . . 0.0 109.36 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.431 ' CB ' HD11 ' A' ' 57' ' ' LEU . . . -69.6 -35.63 75.48 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . 0.562 ' HA ' ' CB ' ' A' ' 197' ' ' MET . 14.9 t30 -61.71 -18.6 60.32 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.915 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -81.79 -39.81 23.52 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.918 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -100.98 -54.72 2.74 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 115.499 -2.481 . . . . 0.0 111.892 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.4 ' O ' ' CE ' ' A' ' 197' ' ' MET . 39.6 m-80 -114.94 33.42 5.42 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.172 -1.411 . . . . 0.0 113.889 177.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' MET . . . . . 0.562 ' CB ' ' HA ' ' A' ' 193' ' ' ASN . 0.0 OUTLIER -152.14 148.99 28.29 Favored 'General case' 0 N--CA 1.515 2.803 0 CA-C-N 122.966 2.621 . . . . 0.0 115.632 -179.52 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.434 ' CB ' ' HA ' ' A' ' 19' ' ' ALA . . . -113.12 125.64 54.59 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 176.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.462 ' CD2' ' HB2' ' A' ' 30' ' ' MET . 26.1 mt -94.09 144.47 25.46 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.546 -1.346 . . . . 0.0 112.971 -177.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.459 ' HB ' ' CB ' ' A' ' 19' ' ' ALA . 7.1 p -146.81 110.45 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.422 ' O ' ' CB ' ' A' ' 205' ' ' LEU . 23.9 p -70.69 147.96 48.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 111.707 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.573 ' CD1' ' HG ' ' A' ' 148' ' ' LEU . 0.0 OUTLIER -47.72 -38.52 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 121.304 0.573 . . . . 0.0 110.495 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.403 ' HA ' HD23 ' A' ' 148' ' ' LEU . 10.7 tt0 -48.13 -65.99 0.48 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.08 -1.012 . . . . 0.0 110.737 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 207' ' ' ALA . 6.4 m-20 -80.89 -25.16 37.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.745 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.562 ' HB3' ' HA ' ' A' ' 202' ' ' ILE . 3.1 tm? -64.75 -67.5 0.43 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.334 -0.853 . . . . 0.0 109.422 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.537 ' HB ' HD12 ' A' ' 202' ' ' ILE . 97.9 t -62.67 -21.99 28.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 118.048 -1.461 . . . . 0.0 108.364 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 211' ' ' ALA . . . -53.25 -28.89 29.73 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 175.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.532 ' HA ' ' CE1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -77.85 -36.59 49.82 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.473 ' CZ ' ' CG2' ' A' ' 162' ' ' THR . 16.1 tpt180 -78.6 -58.67 3.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.896 -1.127 . . . . 0.0 110.067 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -51.85 -36.54 48.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.167 -0.958 . . . . 0.0 110.351 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 207' ' ' ALA . . . -72.54 -29.15 63.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 110.222 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -67.87 -24.34 65.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.225 -0.922 . . . . 0.0 110.182 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -108.62 -9.04 15.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 110.714 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.16 120.75 22.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.988 -1.07 . . . . 0.0 110.188 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -108.12 89.6 3.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 110.176 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -162.62 56.51 0.21 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.89 . . . . 0.0 110.251 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.214 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtt . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.229 0.538 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 23' ' ' LEU . 2.6 m120 -83.8 54.09 2.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.921 . . . . 0.0 110.195 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -94.15 -21.15 19.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -0.863 . . . . 0.0 110.294 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.0 t -93.12 -18.07 23.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.916 . . . . 0.0 110.488 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.434 ' CD2' ' HA ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -53.17 -52.85 57.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.1 -1.0 . . . . 0.0 110.335 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.529 ' HG ' ' CZ ' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -94.49 19.39 9.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.41 -0.806 . . . . 0.0 110.064 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.431 ' OG ' ' N ' ' A' ' 8' ' ' SER . 60.7 p -94.49 -60.82 1.63 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.88 -1.137 . . . . 0.0 110.569 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.431 ' N ' ' OG ' ' A' ' 7' ' ' SER . 1.7 p -91.79 28.84 1.68 Allowed 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 121.843 0.83 . . . . 0.0 109.922 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.735 ' O ' ' CG ' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -104.77 75.31 1.19 Allowed 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 122.587 1.184 . . . . 0.0 109.136 -178.58 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.03 74.32 0.36 Allowed Glycine 0 C--N 1.282 -2.432 0 N-CA-C 106.956 -2.457 . . . . 0.0 106.956 176.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.514 ' HB ' ' HB2' ' A' ' 15' ' ' ARG . 61.8 m -149.08 99.74 3.45 Favored Pre-proline 0 C--N 1.278 -2.521 0 N-CA-C 101.093 -3.669 . . . . 0.0 101.093 172.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.46 ' CB ' ' HB2' ' A' ' 208' ' ' TYR . 28.1 Cg_endo -51.17 -28.83 26.86 Favored 'Trans proline' 0 C--N 1.28 -3.063 0 O-C-N 122.754 0.871 . . . . 0.0 110.319 -174.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -86.02 -56.17 3.59 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -93.5 -36.42 12.45 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 118.328 -1.349 . . . . 0.0 111.166 -176.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.514 ' HB2' ' HB ' ' A' ' 11' ' ' THR . 8.3 mmt180 -78.83 -30.05 45.06 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 119.181 -1.007 . . . . 0.0 111.79 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.662 ' CG1' ' CD2' ' A' ' 208' ' ' TYR . 0.4 OUTLIER -89.55 -36.11 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 116.224 -2.19 . . . . 0.0 111.552 -179.167 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.476 ' N ' HG11 ' A' ' 16' ' ' VAL . 6.3 tp10 -63.16 -40.32 97.21 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 117.383 -1.727 . . . . 0.0 108.757 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.469 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 32.5 p-10 -84.38 -23.06 30.26 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.546 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 15' ' ' ARG . . . -71.63 -38.21 70.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.494 -1.379 . . . . 0.0 110.11 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.468 ' HA ' ' CG2' ' A' ' 29' ' ' VAL . 1.6 pp -73.35 -54.27 8.76 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.333 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.606 ' HA ' ' N ' ' A' ' 26' ' ' GLY . . . -69.21 -69.74 0.32 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.877 -1.139 . . . . 0.0 111.807 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 18' ' ' ASN . . . -50.09 -34.89 23.33 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.689 -1.142 . . . . 0.0 112.739 -177.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.473 ' CB ' ' O ' ' A' ' 19' ' ' ALA . 2.6 tt -56.39 -59.89 4.32 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.82 -76.43 0.59 Allowed 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 117.686 -1.606 . . . . 0.0 108.15 173.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.445 ' CG ' ' HB2' ' A' ' 27' ' ' ARG . 5.7 pt-20 -167.28 45.78 0.05 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.102 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.606 ' N ' ' HA ' ' A' ' 21' ' ' ALA . . . 60.47 20.01 54.73 Favored Glycine 0 N--CA 1.481 1.698 0 N-CA-C 107.097 -2.401 . . . . 0.0 107.097 -176.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.52 ' CB ' ' CE1' ' A' ' 45' ' ' PHE . 6.6 mtt180 -118.31 39.25 3.48 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.467 -1.019 . . . . 0.0 109.792 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.453 ' CA ' ' HG3' ' A' ' 197' ' ' MET . . . 178.2 66.41 0.06 OUTLIER Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.317 -1.913 . . . . 0.0 108.317 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.547 ' HB ' ' CD1' ' A' ' 44' ' ' ILE . 6.1 t -144.75 116.97 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.511 ' CB ' HD21 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -84.41 146.37 27.69 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 119.838 -1.789 . . . . 0.0 113.313 -177.59 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.47 ' CG1' ' O ' ' A' ' 31' ' ' VAL . 14.8 p -140.42 90.01 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 175.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.471 ' HB2' ' CG2' ' A' ' 202' ' ' ILE . 1.2 tp 68.95 -60.52 0.45 Allowed 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.861 -1.149 . . . . 0.0 109.776 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.439 ' CB ' ' HB3' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -53.42 -176.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.211 -0.931 . . . . 0.0 110.408 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.461 ' CB ' ' HB ' ' A' ' 189' ' ' ILE . 45.0 m-20 -149.17 -148.77 0.27 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.266 -0.896 . . . . 0.0 110.372 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.508 ' N ' HD12 ' A' ' 189' ' ' ILE . 0.1 OUTLIER 78.05 133.62 0.06 Allowed 'General case' 0 N--CA 1.519 3.003 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 179.552 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.494 ' CB ' ' HB3' ' A' ' 192' ' ' ALA . 0.3 OUTLIER 167.71 157.79 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.739 177.059 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.519 ' NH1' ' CE1' ' A' ' 61' ' ' HIS . 1.6 tpt180 -176.76 -71.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.077 -1.014 . . . . 0.0 110.125 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.402 ' OE1' ' N ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -62.51 -148.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 110.112 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.405 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 24.4 m-80 -84.78 130.63 34.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.975 . . . . 0.0 110.461 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.443 ' HA ' ' CE ' ' A' ' 197' ' ' MET . 1.4 mt-10 59.68 147.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.657 0.742 . . . . 0.0 111.25 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.522 ' O ' ' CE ' ' A' ' 43' ' ' MET . . . -132.6 167.89 22.96 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -86.96 -11.06 51.7 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.288 -1.125 . . . . 0.0 113.919 -179.411 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.522 ' CE ' ' O ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -31.35 -27.82 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.176 0 N-CA-C 116.906 2.187 . . . . 0.0 116.906 -174.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.547 ' CD1' ' HB ' ' A' ' 29' ' ' VAL . 0.8 OUTLIER -138.53 16.18 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.259 0 CA-C-O 122.695 1.236 . . . . 0.0 110.055 178.785 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.52 ' CE1' ' CB ' ' A' ' 27' ' ' ARG . 0.7 OUTLIER -68.66 161.48 70.54 Favored Pre-proline 0 C--N 1.288 -2.083 0 O-C-N 121.172 -0.955 . . . . 0.0 113.564 -175.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.529 ' HB3' ' CB ' ' A' ' 167' ' ' LYS . 55.8 Cg_endo -82.35 129.92 6.05 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 C-N-CA 122.058 1.839 . . . . 0.0 109.409 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.482 ' HB2' ' N ' ' A' ' 170' ' ' GLY . . . -71.69 -1.33 13.44 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.256 -0.903 . . . . 0.0 112.566 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.424 ' HA ' ' CG2' ' A' ' 122' ' ' ILE . 0.1 OUTLIER -86.83 -23.78 25.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.797 -1.19 . . . . 0.0 110.128 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.489 ' O ' ' N ' ' A' ' 51' ' ' THR . 10.1 t -133.26 60.23 1.71 Allowed 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.445 ' HB2' ' CB ' ' A' ' 118' ' ' VAL . 0.0 OUTLIER -52.54 88.94 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.334 0.588 . . . . 0.0 109.739 -179.426 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.489 ' N ' ' O ' ' A' ' 49' ' ' THR . 26.2 p -61.95 172.58 1.31 Allowed 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.83 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.443 HG21 ' CD1' ' A' ' 115' ' ' ILE . 17.7 t -73.91 -5.1 6.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.533 -0.729 . . . . 0.0 110.12 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.429 ' HG2' ' CB ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -50.6 -28.31 8.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.006 -1.059 . . . . 0.0 109.422 179.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.437 ' O ' ' CG2' ' A' ' 58' ' ' THR . 0.0 OUTLIER -86.95 -28.98 22.4 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.203 179.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.431 ' HB3' ' CB ' ' A' ' 111' ' ' ALA . 3.8 mmt -86.23 -41.13 14.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.265 -0.897 . . . . 0.0 109.528 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.46 -53.97 35.12 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.224 -0.923 . . . . 0.0 110.4 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.486 ' CD1' ' N ' ' A' ' 36' ' ' ASP . 0.4 OUTLIER -64.03 -33.4 75.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.216 -0.927 . . . . 0.0 111.059 -179.273 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.475 ' CG2' ' N ' ' A' ' 59' ' ' ILE . 4.4 t -79.33 -46.86 16.87 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.739 -1.226 . . . . 0.0 110.836 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.475 ' N ' ' CG2' ' A' ' 58' ' ' THR . 72.1 mt -53.78 -21.93 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.841 -1.162 . . . . 0.0 109.578 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -84.83 -46.04 11.73 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.378 -0.826 . . . . 0.0 112.257 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.519 ' CE1' ' NH1' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -125.36 -15.04 6.3 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -177.104 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 58' ' ' THR . . . -164.36 -168.95 27.24 Favored Glycine 0 N--CA 1.502 3.081 0 C-N-CA 118.547 -1.787 . . . . 0.0 111.756 -176.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.6 t -126.57 102.35 7.06 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 101.32 -3.585 . . . . 0.0 101.32 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 66' ' ' VAL . . . -104.79 76.43 0.25 Allowed Glycine 0 C--N 1.26 -3.663 0 N-CA-C 105.804 -2.918 . . . . 0.0 105.804 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.48 HG23 ' CD2' ' A' ' 138' ' ' PHE . 3.2 mm -61.34 84.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.535 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.576 ' O ' ' CD1' ' A' ' 138' ' ' PHE . 26.5 m -52.72 157.09 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.508 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.311 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 171' ' ' VAL . 97.4 m -109.64 119.35 39.14 Favored 'General case' 0 C--N 1.29 -2.006 0 O-C-N 121.393 -0.817 . . . . 0.0 110.32 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.487 ' N ' ' CD2' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -87.28 97.81 10.99 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.316 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 74.3 m -70.7 127.28 32.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.467 -0.77 . . . . 0.0 111.794 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.461 ' CD1' ' HB3' ' A' ' 79' ' ' ASP . 24.6 pt -115.97 162.47 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.457 ' CA ' HG12 ' A' ' 158' ' ' ILE . 1.6 m -81.03 170.62 15.99 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 120.55 -1.344 . . . . 0.0 109.7 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.47 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -95.4 -12.47 25.93 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.399 178.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -85.39 -73.18 0.45 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.915 -1.115 . . . . 0.0 111.901 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -85.98 -32.58 21.44 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.497 ' O ' ' N ' ' A' ' 79' ' ' ASP . 10.8 mpt_? -74.07 -31.71 62.96 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.626 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 72' ' ' GLU . 18.2 tttt -72.93 -41.41 64.55 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 119.89 -1.756 . . . . 0.0 108.996 178.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -42.35 -54.1 3.92 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.298 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.483 HD11 ' HG2' ' A' ' 128' ' ' PRO . 0.4 OUTLIER -105.08 -29.49 10.37 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.049 -1.46 . . . . 0.0 109.156 178.35 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.497 ' N ' ' O ' ' A' ' 75' ' ' ARG . 5.9 t0 -112.57 70.79 0.72 Allowed 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.997 0.903 . . . . 0.0 109.612 177.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.532 HD13 ' N ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -80.62 171.34 12.57 Favored Pre-proline 0 C--N 1.286 -2.157 0 O-C-N 121.277 -0.889 . . . . 0.0 112.173 -179.238 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.438 ' HB3' ' CG ' ' A' ' 141' ' ' ARG . 52.9 Cg_endo -84.22 97.79 0.73 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.11 1.058 . . . . 0.0 109.556 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' MET . . . . . 0.438 ' N ' HD23 ' A' ' 80' ' ' LEU . 2.8 ttt -97.39 95.76 7.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.11 -0.994 . . . . 0.0 110.641 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.87 95.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.062 -1.024 . . . . 0.0 110.689 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 82' ' ' MET . 93.7 t -104.66 151.6 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.903 . . . . 0.0 109.997 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -92.9 22.65 4.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.19 -0.943 . . . . 0.0 110.294 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -125.43 19.67 8.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.362 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.469 ' ND2' ' CG2' ' A' ' 96' ' ' THR . 28.3 p30 -105.44 54.62 0.7 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.174 -0.954 . . . . 0.0 110.428 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 52.89 -149.06 0.41 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.235 -0.916 . . . . 0.0 110.08 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.24 -59.9 3.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.099 -1.001 . . . . 0.0 110.314 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 55.39 101.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.291 -0.881 . . . . 0.0 110.231 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -95.16 59.08 2.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.951 . . . . 0.0 110.303 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.78 39.07 66.14 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 41.2 p -96.82 42.36 1.09 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.225 -1.162 . . . . 0.0 110.198 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 141' ' ' ARG . . . 48.2 23.08 2.62 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.492 ' HA ' ' HB3' ' A' ' 140' ' ' LEU . 0.6 OUTLIER -113.75 67.38 0.67 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.855 -1.379 . . . . 0.0 109.534 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.469 ' CG2' ' ND2' ' A' ' 87' ' ' ASN . 0.9 OUTLIER -127.66 14.92 7.03 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.501 ' O ' ' HD2' ' A' ' 139' ' ' PRO . 4.2 p -115.74 145.14 21.87 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 O-C-N 121.007 -1.058 . . . . 0.0 110.683 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.461 ' CB ' ' HA ' ' A' ' 134' ' ' PRO . 0.0 OUTLIER -123.87 -173.79 2.83 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.507 HG13 ' CG2' ' A' ' 137' ' ' VAL . 2.4 pp -145.8 122.82 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 C-N-CA 117.191 -1.803 . . . . 0.0 114.759 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.706 ' CA ' ' HG2' ' A' ' 133' ' ' ARG . 11.4 tm-20 -90.32 163.43 14.74 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.814 177.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.424 ' HB1' ' N ' ' A' ' 105' ' ' VAL . . . -51.73 88.18 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.63 -0.669 . . . . 0.0 112.546 -177.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.463 ' N ' ' O ' ' A' ' 100' ' ' GLU . . . -84.19 -25.6 29.42 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 175.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.23 -6.5 11.31 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.748 -0.595 . . . . 0.0 110.115 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.52 27.47 0.97 Allowed Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.357 -1.401 . . . . 0.0 112.339 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.486 ' CB ' ' HA ' ' A' ' 117' ' ' THR . 7.0 m -139.88 123.53 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 120.954 -1.321 . . . . 0.0 110.655 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.401 ' HB ' ' HB3' ' A' ' 101' ' ' ALA . 10.9 t -148.21 63.86 1.1 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.713 -1.242 . . . . 0.0 111.618 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.418 ' C ' ' H ' ' A' ' 109' ' ' VAL . 6.3 t -131.41 -31.17 1.63 Allowed 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 118.438 -1.305 . . . . 0.0 110.331 177.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.425 ' HA2' ' NH1' ' A' ' 114' ' ' ARG . . . 60.7 -28.33 0.05 OUTLIER Glycine 0 N--CA 1.504 3.195 0 O-C-N 121.588 -0.695 . . . . 0.0 114.023 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.418 ' H ' ' C ' ' A' ' 107' ' ' THR . 11.1 t -125.46 55.82 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.225 -1.75 . . . . 0.0 110.127 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.597 ' O ' ' N ' ' A' ' 114' ' ' ARG . 9.3 t -133.99 71.41 1.46 Allowed 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.431 ' CB ' ' HB3' ' A' ' 55' ' ' MET . . . -25.74 -40.64 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.794 0 CA-C-O 121.59 0.71 . . . . 0.0 112.035 -177.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -69.22 -66.04 0.63 Allowed 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 122.562 1.172 . . . . 0.0 107.881 176.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 117' ' ' THR . 0.2 OUTLIER -64.41 -13.94 53.91 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.099 -1.001 . . . . 0.0 109.445 177.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 110' ' ' SER . 5.0 tpm_? -62.86 -42.92 99.94 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.2 -0.937 . . . . 0.0 108.707 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.487 ' CD1' ' N ' ' A' ' 115' ' ' ILE . 1.7 mp -76.75 -13.49 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 118.557 -1.257 . . . . 0.0 108.178 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.6 m -94.61 -20.92 19.17 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.23 -0.919 . . . . 0.0 108.828 177.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.488 ' N ' ' O ' ' A' ' 113' ' ' ASP . 26.0 p -83.73 -36.85 23.36 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.513 -0.742 . . . . 0.0 109.827 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.445 ' CB ' ' HB2' ' A' ' 50' ' ' MET . 14.2 p -73.99 -41.37 52.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 118.84 -1.144 . . . . 0.0 108.562 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.46 ' O ' ' CB ' ' A' ' 123' ' ' ALA . 3.3 ttt-85 -61.18 -31.41 71.16 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.133 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.427 ' CB ' HG13 ' A' ' 105' ' ' VAL . . . -95.34 -33.07 12.66 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.668 -0.645 . . . . 0.0 111.358 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.43 ' CB ' HD13 ' A' ' 99' ' ' ILE . . . -61.91 -58.16 8.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.027 -1.046 . . . . 0.0 109.712 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.424 ' CG2' ' HA ' ' A' ' 48' ' ' GLU . 0.7 OUTLIER -88.49 23.03 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.395 -0.815 . . . . 0.0 110.693 179.052 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 119' ' ' ARG . . . -95.96 114.81 26.56 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.583 ' C ' ' H ' ' A' ' 126' ' ' ALA . 5.4 t0 -89.99 -82.54 0.27 Allowed 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 117.783 -1.567 . . . . 0.0 113.405 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 124' ' ' ASP . . . 69.6 -43.36 0.46 Allowed Glycine 0 N--CA 1.513 3.797 0 N-CA-C 107.666 -2.173 . . . . 0.0 107.666 -176.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.583 ' H ' ' C ' ' A' ' 124' ' ' ASP . . . -135.72 165.71 24.94 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 103.578 -2.749 . . . . 0.0 103.578 176.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.439 ' C ' ' H ' ' A' ' 129' ' ' SER . 4.4 tttp -65.16 114.68 16.18 Favored Pre-proline 0 C--N 1.304 -1.411 0 CA-C-N 121.361 1.891 . . . . 0.0 108.094 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.483 ' HG2' HD11 ' A' ' 78' ' ' LEU . 35.1 Cg_endo -67.66 26.14 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.283 1.322 . . . . 0.0 112.18 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.439 ' H ' ' C ' ' A' ' 127' ' ' LYS . 0.3 OUTLIER -54.57 -10.16 0.4 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.464 -1.397 . . . . 0.0 111.176 -178.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.434 ' CB ' ' HA ' ' A' ' 102' ' ' ALA . 2.0 m-20 -72.3 9.04 1.11 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.601 -1.312 . . . . 0.0 110.417 177.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.475 ' CD2' ' CG2' ' A' ' 99' ' ' ILE . 4.7 tp -74.67 87.99 2.2 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.446 ' N ' ' HB3' ' A' ' 100' ' ' GLU . 1.6 t-20 -116.13 72.64 0.82 Allowed 'General case' 0 N--CA 1.509 2.501 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.706 ' HG2' ' CA ' ' A' ' 100' ' ' GLU 0.255 0.0 OUTLIER -97.58 -152.76 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.734 0 CA-C-O 115.115 -2.374 . . . . 0.0 110.168 179.163 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.658 ' HA ' ' HB3' ' A' ' 133' ' ' ARG . 56.5 Cg_endo -78.98 127.39 14.67 Favored 'Cis proline' 0 N--CA 1.524 3.31 0 N-CA-C 119.554 2.867 . . . . 0.0 119.554 18.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.592 ' CA ' ' HD2' ' A' ' 133' ' ' ARG . . . -126.99 71.87 0.47 Allowed Glycine 0 N--CA 1.511 3.655 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.338 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 49.3 m80 30.62 35.76 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.544 0 CA-C-O 121.418 0.628 . . . . 0.0 112.562 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.507 ' CG2' HG13 ' A' ' 99' ' ' ILE . 92.6 t -94.5 154.71 3.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.978 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 175.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.576 ' CD1' ' O ' ' A' ' 66' ' ' VAL . 0.2 OUTLIER -131.07 79.07 71.94 Favored Pre-proline 0 C--N 1.294 -1.822 0 C-N-CA 117.939 -1.505 . . . . 0.0 110.726 -176.698 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.501 ' HD2' ' O ' ' A' ' 97' ' ' VAL . 55.8 Cg_endo -107.61 156.44 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 123.515 2.81 . . . . 0.0 107.873 175.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.492 ' HB3' ' HA ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -145.93 140.81 27.21 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 120.722 -1.236 . . . . 0.0 109.715 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 143' ' ' GLN . 1.8 ptm180 -63.51 154.54 32.11 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.75 88.85 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.862 -1.135 . . . . 0.0 108.949 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 141' ' ' ARG . 0.1 OUTLIER -55.59 144.86 25.02 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.924 0.869 . . . . 0.0 111.021 -178.634 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . 0.412 ' N ' ' OE1' ' A' ' 143' ' ' GLN . . . -83.19 53.97 2.64 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.32 0.581 . . . . 0.0 109.504 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.49 ' N ' ' OG1' ' A' ' 154' ' ' THR . . . 147.2 19.8 0.1 Allowed Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.578 -1.296 . . . . 0.0 112.457 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.1 1.98 59.49 Favored Glycine 0 N--CA 1.503 3.138 0 C-N-CA 117.769 -2.158 . . . . 0.0 111.403 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 148' ' ' LEU . 0.3 OUTLIER -116.5 -43.77 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-O 123.943 1.83 . . . . 0.0 107.577 175.217 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.594 ' HA ' ' CD1' ' A' ' 202' ' ' ILE . 2.8 tp -111.6 70.03 0.7 Allowed 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.421 ' CG2' ' O ' ' A' ' 145' ' ' GLY . 46.7 p -77.07 63.39 2.34 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 125.243 2.449 . . . . 0.0 104.789 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.586 ' O ' ' N ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -153.58 155.31 35.9 Favored 'General case' 0 C--N 1.267 -2.993 0 N-CA-C 100.501 -3.888 . . . . 0.0 100.501 176.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.25 61.99 0.16 Allowed Glycine 0 C--N 1.261 -3.588 0 C-N-CA 117.144 -2.455 . . . . 0.0 109.386 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 150' ' ' ARG . . . -110.11 -161.57 18.56 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 120.198 -1.766 . . . . 0.0 110.696 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.649 ' O ' ' N ' ' A' ' 155' ' ' GLU . 10.7 t-80 -66.57 4.48 0.77 Allowed 'General case' 0 C--O 1.188 -2.173 0 CA-C-O 117.366 -1.302 . . . . 0.0 113.964 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.625 ' O ' ' N ' ' A' ' 157' ' ' THR . 15.0 t -24.23 -26.57 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.396 0 CA-C-N 120.797 1.635 . . . . 0.0 115.086 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.649 ' N ' ' O ' ' A' ' 153' ' ' HIS . 18.3 tt0 -56.32 -22.78 32.84 Favored 'General case' 0 N--CA 1.511 2.606 0 O-C-N 119.326 -2.109 . . . . 0.0 105.325 172.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.548 ' CA ' ' HB2' ' A' ' 159' ' ' ASP . . . -83.99 12.6 6.01 Favored 'General case' 0 C--O 1.206 -1.208 0 O-C-N 120.746 -1.221 . . . . 0.0 108.971 174.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.625 ' N ' ' O ' ' A' ' 154' ' ' THR . 20.5 m -63.71 -43.26 97.1 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 175.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.497 ' O ' ' HB3' ' A' ' 161' ' ' MET . 5.7 tp -70.19 -35.59 63.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 116.169 -2.212 . . . . 0.0 105.209 174.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.548 ' HB2' ' CA ' ' A' ' 156' ' ' ALA . 1.2 m-20 -59.1 -20.52 54.25 Favored 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 116.414 -2.114 . . . . 0.0 107.216 175.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.583 ' O ' ' HB2' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -61.87 -28.48 69.53 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 176.32 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.612 ' HB2' ' N ' ' A' ' 169' ' ' ALA . 3.2 ptt? -49.65 -34.29 17.9 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 174.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.486 ' CB ' ' O ' ' A' ' 159' ' ' ASP . 2.7 m -65.23 -29.52 70.32 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.093 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.583 ' HB2' ' O ' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -41.7 -44.65 3.23 Favored 'General case' 0 N--CA 1.523 3.183 0 O-C-N 121.077 -1.014 . . . . 0.0 109.142 178.21 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -48.4 -29.15 3.73 Favored 'General case' 0 N--CA 1.517 2.89 0 CA-C-O 122.515 1.15 . . . . 0.0 109.753 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 106.44 -34.49 5.69 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.75 49.25 0.41 Allowed 'General case' 0 N--CA 1.508 2.472 0 C-N-CA 117.938 -1.505 . . . . 0.0 113.185 172.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.529 ' CB ' ' HB3' ' A' ' 46' ' ' PRO . 1.3 mmtt -135.02 124.11 16.28 Favored Pre-proline 0 C--N 1.292 -1.933 0 CA-C-O 116.305 -1.807 . . . . 0.0 106.872 175.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.43 ' HA ' ' HG3' ' A' ' 161' ' ' MET . 51.9 Cg_endo -91.6 75.94 0.59 Allowed 'Trans proline' 0 C--N 1.318 -1.068 0 C-N-CA 114.05 -3.5 . . . . 0.0 112.499 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.612 ' N ' ' HB2' ' A' ' 161' ' ' MET . . . -165.41 165.47 19.22 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 170.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.482 ' N ' ' HB2' ' A' ' 47' ' ' ALA . . . -139.45 129.02 4.19 Favored Glycine 0 N--CA 1.502 3.091 0 C-N-CA 118.596 -1.764 . . . . 0.0 109.737 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.49 ' O ' ' O ' ' A' ' 42' ' ' ASP . 5.5 p -133.09 95.07 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-N 119.664 1.732 . . . . 0.0 109.804 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 43' ' ' MET . 0.1 OUTLIER -95.08 143.34 26.61 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.605 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.455 ' HB3' ' CG1' ' A' ' 66' ' ' VAL . 5.6 p -107.43 175.05 5.62 Favored 'General case' 0 N--CA 1.515 2.78 0 O-C-N 120.632 -1.293 . . . . 0.0 112.175 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . 0.463 ' N ' ' HB2' ' A' ' 35' ' ' GLU . 6.0 tt0 -143.71 119.01 10.2 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.313 -0.867 . . . . 0.0 111.558 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 35' ' ' GLU . 0.6 OUTLIER -62.58 145.4 54.52 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.821 0.82 . . . . 0.0 111.814 -178.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.428 ' HA ' ' CB ' ' A' ' 182' ' ' MET . 55.1 m -139.67 155.38 47.43 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -72.04 170.98 12.72 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.954 -1.091 . . . . 0.0 110.253 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -85.84 6.38 28.43 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.524 -0.735 . . . . 0.0 111.283 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -109.14 -15.84 14.23 Favored 'General case' 0 C--N 1.289 -2.065 0 O-C-N 121.575 -0.703 . . . . 0.0 110.482 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 109.18 23.16 6.49 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 1.2 p -134.89 98.28 3.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -1.185 . . . . 0.0 110.346 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' MET . . . . . 0.436 ' CG ' ' O ' ' A' ' 182' ' ' MET . 0.0 OUTLIER -95.03 94.47 7.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.321 -0.862 . . . . 0.0 109.816 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -118.03 63.3 0.75 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 118.786 -1.166 . . . . 0.0 110.962 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.426 ' CB ' ' SG ' ' A' ' 188' ' ' CYS . 3.4 mtp180 -147.14 161.95 39.85 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.338 -0.851 . . . . 0.0 109.036 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.542 ' CB ' ' CD ' ' A' ' 186' ' ' PRO . . . -145.87 -68.56 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.068 -1.02 . . . . 0.0 109.704 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.542 ' CD ' ' CB ' ' A' ' 185' ' ' ALA . 45.0 Cg_endo -70.68 -36.99 7.5 Favored 'Trans proline' 0 C--N 1.316 -1.164 0 N-CA-C 109.11 -1.15 . . . . 0.0 109.11 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.402 ' HA ' ' HB2' ' A' ' 190' ' ' GLU . 0.2 OUTLIER -90.16 -16.85 28.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.632 -0.667 . . . . 0.0 109.942 179.197 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . 0.426 ' SG ' ' CB ' ' A' ' 184' ' ' ARG . 0.3 OUTLIER -60.67 -50.81 72.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.391 -0.818 . . . . 0.0 110.479 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.514 ' CG2' ' CD2' ' A' ' 199' ' ' LEU . 6.4 tp -94.77 -28.03 4.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.045 -1.034 . . . . 0.0 109.414 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' A' ' 194' ' ' LYS . 5.0 mm-40 -57.3 -19.99 25.57 Favored 'General case' 0 C--O 1.199 -1.591 0 O-C-N 120.578 -1.326 . . . . 0.0 107.688 175.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.513 ' CD2' ' N ' ' A' ' 192' ' ' ALA . 4.3 t80 -80.84 -62.25 1.72 Allowed 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 122.771 1.272 . . . . 0.0 108.89 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.513 ' N ' ' CD2' ' A' ' 191' ' ' PHE . . . -73.08 -38.53 66.38 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.483 -177.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . 0.521 ' HB3' ' HG ' ' A' ' 199' ' ' LEU . 12.0 m-20 -84.75 -25.12 28.48 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 118.968 -1.093 . . . . 0.0 112.557 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 190' ' ' GLU . 8.3 ttpt -61.76 -37.83 85.76 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 117.502 -1.679 . . . . 0.0 109.408 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -81.45 -51.64 8.1 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 116.206 -2.197 . . . . 0.0 112.085 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.427 ' O ' ' CE ' ' A' ' 197' ' ' MET . 0.2 OUTLIER -112.89 33.2 5.16 Favored 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 117.792 -1.563 . . . . 0.0 113.736 177.647 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' MET . . . . . 0.507 ' HB3' ' CB ' ' A' ' 193' ' ' ASN . 0.0 OUTLIER -158.01 152.36 24.57 Favored 'General case' 0 N--CA 1.508 2.444 0 CA-C-N 121.209 1.822 . . . . 0.0 114.861 -179.104 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.455 ' HB1' ' CD1' ' A' ' 6' ' ' LEU . . . -83.56 139.38 32.9 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 118.675 -1.21 . . . . 0.0 107.935 175.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.521 ' HG ' ' HB3' ' A' ' 193' ' ' ASN . 3.3 mt -118.96 113.66 21.34 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 120.165 -1.584 . . . . 0.0 112.293 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.484 ' CG1' ' O ' ' A' ' 30' ' ' MET . 8.7 p -124.89 177.59 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.661 0 O-C-N 121.243 -0.911 . . . . 0.0 108.615 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.42 ' O ' ' CB ' ' A' ' 205' ' ' LEU . 17.5 m -121.25 156.14 33.13 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.252 -1.53 . . . . 0.0 110.808 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.594 ' CD1' ' HA ' ' A' ' 148' ' ' LEU . 1.2 pp -61.21 -32.7 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 121.061 -1.024 . . . . 0.0 110.229 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 207' ' ' ALA . 2.3 tm-20 -42.28 -67.22 0.28 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.614 -0.679 . . . . 0.0 111.58 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.426 ' O ' ' CB ' ' A' ' 208' ' ' TYR . 3.4 m-20 -87.89 -10.47 50.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.078 -1.014 . . . . 0.0 110.766 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.56 ' O ' ' HB3' ' A' ' 208' ' ' TYR . 9.1 tt -84.38 -51.63 6.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 112.132 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.443 ' N ' HD22 ' A' ' 205' ' ' LEU . 0.1 OUTLIER -84.43 -27.91 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 119.942 -1.723 . . . . 0.0 107.539 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 203' ' ' GLU . . . -63.44 -31.59 72.79 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 173.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.662 ' CD2' ' CG1' ' A' ' 16' ' ' VAL . 0.0 OUTLIER -58.3 -35.92 72.56 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.355 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -29.19 41.67 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.494 ' CG ' ' HB2' ' A' ' 153' ' ' HIS . 55.8 tt0 -69.28 -68.17 0.42 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 122.003 0.906 . . . . 0.0 108.654 178.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -48.66 -26.3 2.21 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.383 0.611 . . . . 0.0 110.23 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -71.88 -31.64 66.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.344 -0.848 . . . . 0.0 110.173 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -104.7 -9.14 18.38 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.774 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.34 130.63 37.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.976 -1.077 . . . . 0.0 110.145 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 20.7 tttt -95.74 118.48 32.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 110.219 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -147.6 37.15 0.9 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 110.211 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.188 -179.928 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ttp . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.211 0.529 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 48.7 p30 -95.87 55.5 1.61 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 110.315 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -93.78 5.15 52.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 0.0 110.771 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 8' ' ' SER . 1.3 p -74.01 -4.82 37.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.054 -1.029 . . . . 0.0 110.969 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.527 ' CB ' ' CD2' ' A' ' 166' ' ' PHE . 4.5 mm? -55.19 -67.05 0.31 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.927 -1.108 . . . . 0.0 110.387 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.515 ' CD1' ' CD2' ' A' ' 20' ' ' LEU . 8.3 tp -61.06 -15.59 34.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.228 -0.92 . . . . 0.0 109.988 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.11 -21.27 20.52 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.068 -1.02 . . . . 0.0 110.304 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.408 ' N ' ' O ' ' A' ' 4' ' ' THR . 22.7 m -92.84 23.75 4.0 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.304 -0.873 . . . . 0.0 109.787 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.51 ' O ' ' CE1' ' A' ' 13' ' ' PHE . 22.3 t80 -140.83 77.2 1.59 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.8 93.88 1.37 Allowed Glycine 0 C--N 1.288 -2.125 0 N-CA-C 106.892 -2.483 . . . . 0.0 106.892 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.542 ' O ' ' N ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -125.56 165.48 26.39 Favored Pre-proline 0 C--N 1.27 -2.89 0 N-CA-C 103.458 -2.793 . . . . 0.0 103.458 179.319 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.428 ' C ' ' O ' ' A' ' 11' ' ' THR . 17.8 Cg_endo -41.86 -24.25 0.28 Allowed 'Trans proline' 0 N--CA 1.515 2.787 0 CA-C-N 122.026 1.759 . . . . 0.0 108.468 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.599 ' O ' ' N ' ' A' ' 16' ' ' VAL 0.272 0.0 OUTLIER -46.75 -21.44 0.2 Allowed 'General case' 0 C--O 1.191 -1.977 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 169.886 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 11' ' ' THR . 32.6 tt0 -48.39 -39.8 23.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.073 -1.642 . . . . 0.0 108.334 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -42.73 99.71 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 175.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.599 ' N ' ' O ' ' A' ' 13' ' ' PHE . 0.4 OUTLIER -60.46 -34.9 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 118.979 -1.088 . . . . 0.0 108.218 175.577 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -51.92 -47.61 64.59 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.587 -1.321 . . . . 0.0 108.798 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.443 ' O ' ' CB ' ' A' ' 22' ' ' ALA . 31.4 t-20 -53.27 -31.09 41.96 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 198' ' ' ALA . . . -89.56 -68.23 0.79 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 122.292 1.044 . . . . 0.0 110.358 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.558 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 0.2 OUTLIER -47.98 -54.7 12.03 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.398 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.494 ' N ' ' CD2' ' A' ' 6' ' ' LEU . . . -67.29 -41.59 85.15 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' A' ' 18' ' ' ASN . . . -32.63 -62.08 0.25 Allowed 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 121.045 0.45 . . . . 0.0 111.136 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.488 HD11 ' HA ' ' A' ' 197' ' ' MET . 2.4 mt -106.67 7.73 30.71 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.321 -1.352 . . . . 0.0 110.703 177.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.558 ' HB2' ' O ' ' A' ' 20' ' ' LEU . 59.3 ttp85 -55.26 -18.95 7.03 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.775 -1.203 . . . . 0.0 107.77 176.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -79.71 46.05 0.74 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 122.798 1.285 . . . . 0.0 109.839 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.495 ' HA2' ' CZ ' ' A' ' 45' ' ' PHE . . . 67.92 16.36 68.25 Favored Glycine 0 C--N 1.292 -1.897 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.991 176.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.447 ' O ' HD11 ' A' ' 23' ' ' LEU . 20.1 mtt180 -99.46 17.31 20.61 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 116.079 -2.248 . . . . 0.0 111.225 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 197' ' ' MET . . . 100.6 106.32 2.84 Favored Glycine 0 N--CA 1.496 2.685 0 C-N-CA 118.982 -1.58 . . . . 0.0 113.181 173.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.456 ' CG1' HG12 ' A' ' 44' ' ' ILE . 2.0 m -145.6 113.71 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 120.174 -1.78 . . . . 0.0 106.743 176.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.468 ' HA ' ' CB ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -75.27 75.17 2.39 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 116.104 -2.238 . . . . 0.0 107.72 -177.691 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.531 ' CG1' HG21 ' A' ' 200' ' ' VAL . 1.5 t -158.31 151.85 7.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 CA-C-N 113.773 -1.558 . . . . 0.0 108.17 176.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.586 ' HB2' ' CD2' ' A' ' 160' ' ' LEU . 0.7 OUTLIER 10.89 -129.56 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.967 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 175.178 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.466 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 13.8 p-10 -176.94 173.99 1.8 Allowed 'General case' 0 N--CA 1.485 1.279 0 O-C-N 120.632 -1.292 . . . . 0.0 111.204 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 35' ' ' GLU . 3.8 p30 -159.94 -143.31 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.539 -0.726 . . . . 0.0 109.624 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.42 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -112.07 -151.9 0.49 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.899 -1.126 . . . . 0.0 110.364 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 55.01 171.08 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.279 -0.888 . . . . 0.0 110.82 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.402 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 7.6 ptt85 -176.07 143.12 0.53 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.362 -0.836 . . . . 0.0 110.054 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -169.45 -81.05 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.104 -0.997 . . . . 0.0 110.732 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.437 ' CB ' ' HA ' ' A' ' 27' ' ' ARG . 1.1 t-20 -57.52 -165.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.167 -0.958 . . . . 0.0 110.563 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.4 -169.01 1.63 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 0.0 110.507 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.436 ' N ' ' HB3' ' A' ' 53' ' ' GLU . . . 75.61 89.02 0.24 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.559 ' HA ' ' CD1' ' A' ' 45' ' ' PHE . 25.4 t70 -78.91 24.11 0.32 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.163 -1.198 . . . . 0.0 112.236 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.468 ' CB ' ' HA ' ' A' ' 30' ' ' MET . 0.4 OUTLIER -81.45 17.16 1.44 Allowed 'General case' 0 N--CA 1.481 1.112 0 O-C-N 120.468 -1.395 . . . . 0.0 113.942 -177.388 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.517 ' CG2' ' CE1' ' A' ' 45' ' ' PHE . 5.2 tp -138.27 16.63 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.794 0 CA-C-O 121.792 0.806 . . . . 0.0 109.724 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.559 ' CD1' ' HA ' ' A' ' 42' ' ' ASP . 89.2 m-85 -107.81 160.1 28.02 Favored Pre-proline 0 N--CA 1.507 2.42 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -173.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -75.62 134.12 16.45 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 123.132 2.555 . . . . 0.0 111.974 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.467 ' CB ' ' CD1' ' A' ' 68' ' ' LEU . . . -50.71 -20.71 1.32 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.234 -0.917 . . . . 0.0 111.807 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -72.67 -26.81 61.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.044 -1.035 . . . . 0.0 110.562 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.492 ' O ' ' N ' ' A' ' 51' ' ' THR . 65.2 p -133.13 58.86 1.75 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . 0.462 ' O ' ' CG1' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -61.91 87.04 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.279 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.492 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -63.56 162.06 13.55 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 122.506 1.146 . . . . 0.0 112.109 -176.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.49 ' CG2' ' CB ' ' A' ' 111' ' ' ALA . 4.3 p -75.1 -2.22 3.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.142 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.473 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 23.8 mt-10 -46.28 -26.66 0.85 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.264 -0.897 . . . . 0.0 110.19 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.449 ' HG2' ' CG2' ' A' ' 66' ' ' VAL . 5.5 tp-100 -88.11 -49.85 6.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.526 -0.734 . . . . 0.0 109.32 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.445 ' O ' ' CG1' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -54.71 -47.09 74.14 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.578 -0.701 . . . . 0.0 109.785 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.04 -55.39 33.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 110.258 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.0 tt -59.27 -44.33 92.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.482 -0.761 . . . . 0.0 110.48 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.465 ' CG2' ' N ' ' A' ' 59' ' ' ILE . 3.0 t -74.94 -47.51 29.2 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.17 -0.956 . . . . 0.0 111.564 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.465 ' N ' ' CG2' ' A' ' 58' ' ' THR . 43.8 mt -47.97 -25.72 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.664 -1.272 . . . . 0.0 109.587 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -77.76 -47.85 18.01 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.49 -0.756 . . . . 0.0 110.826 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -125.31 -9.08 6.98 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 58' ' ' THR . . . -164.99 -168.16 26.7 Favored Glycine 0 N--CA 1.502 3.085 0 O-C-N 120.13 -1.606 . . . . 0.0 111.469 -177.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.1 t -133.11 103.26 5.93 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 101.71 -3.441 . . . . 0.0 101.71 176.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.449 ' N ' ' OG1' ' A' ' 58' ' ' THR . . . -104.63 73.76 0.24 Allowed Glycine 0 C--N 1.264 -3.447 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 -177.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.529 HG13 ' CD2' ' A' ' 138' ' ' PHE . 2.0 tp -64.26 97.2 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.822 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.597 ' O ' ' CD1' ' A' ' 138' ' ' PHE . 3.6 t -50.99 163.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.347 -177.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 80.3 m -111.19 114.81 28.3 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.031 0.919 . . . . 0.0 109.122 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 139' ' ' PRO . 0.1 OUTLIER -90.61 123.35 34.18 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.523 ' HB2' ' CG2' ' A' ' 157' ' ' THR . 0.1 OUTLIER -108.57 143.08 38.08 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 117.232 -1.787 . . . . 0.0 110.415 179.125 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.525 ' HB ' ' HB3' ' A' ' 75' ' ' ARG 0.25 2.0 pp -137.41 137.28 46.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.345 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.45 ' CG2' ' HB2' ' A' ' 75' ' ' ARG . 9.3 t -74.93 179.43 4.92 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.515 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 2.3 mp0 -90.48 -18.59 25.08 Favored 'General case' 0 C--N 1.275 -2.674 0 C-N-CA 119.366 -0.933 . . . . 0.0 110.815 -178.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.57 -74.68 0.19 Allowed 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.823 -1.151 . . . . 0.0 112.797 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -94.66 -37.74 11.17 Favored 'General case' 0 C--N 1.279 -2.463 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.294 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.525 ' HB3' ' HB ' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -69.69 -24.84 63.64 Favored 'General case' 0 C--N 1.284 -2.269 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.543 -179.433 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.515 ' HB2' ' HA ' ' A' ' 72' ' ' GLU . 7.5 tttt -81.41 -38.92 25.74 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 117.459 -1.696 . . . . 0.0 107.489 176.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -42.19 -42.39 3.0 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.409 0.623 . . . . 0.0 109.569 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.429 HD23 ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -107.87 -30.02 8.74 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.448 -1.301 . . . . 0.0 109.026 177.323 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.47 ' O ' ' CD1' ' A' ' 70' ' ' ILE . 0.4 OUTLIER -114.15 69.12 0.7 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.724 178.004 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.515 ' HG ' ' CD ' ' A' ' 81' ' ' PRO . 0.2 OUTLIER -111.45 149.05 40.08 Favored Pre-proline 0 C--N 1.295 -1.789 0 O-C-N 120.785 -1.197 . . . . 0.0 109.163 178.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.515 ' CD ' ' HG ' ' A' ' 80' ' ' LEU . 27.5 Cg_endo -50.86 96.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.187 0 O-C-N 123.393 1.207 . . . . 0.0 110.556 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.11 44.51 1.04 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.427 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 175.24 -54.89 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.138 -0.976 . . . . 0.0 109.73 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.532 ' CG2' ' HA ' ' A' ' 96' ' ' THR . 15.6 m -110.12 109.27 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.358 -0.839 . . . . 0.0 110.234 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 87' ' ' ASN . 8.0 tt0 -98.26 27.58 4.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.216 -0.927 . . . . 0.0 110.099 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -64.97 80.13 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.329 -0.857 . . . . 0.0 110.277 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 85' ' ' GLU . 2.8 t30 -99.2 54.92 0.98 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 110.19 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 53.3 m -154.47 -67.11 0.13 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 110.152 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.78 -47.88 70.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -0.934 . . . . 0.0 110.211 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 53.26 35.81 21.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.927 . . . . 0.0 110.235 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.84 61.56 0.4 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.266 -0.896 . . . . 0.0 110.208 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.98 23.33 76.52 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 95' ' ' PHE . 81.4 p -110.06 -18.51 13.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.232 -1.158 . . . . 0.0 110.661 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 93' ' ' THR . . . -20.55 -42.53 0.01 OUTLIER Glycine 0 N--CA 1.513 3.813 0 C-N-CA 123.442 0.544 . . . . 0.0 113.533 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.503 ' N ' ' O ' ' A' ' 93' ' ' THR . 19.5 m-85 -58.69 99.38 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.962 -1.316 . . . . 0.0 108.974 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.532 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . 70.4 p -118.05 -1.82 11.36 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.032 -1.467 . . . . 0.0 114.915 -177.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.478 ' HB ' ' HG2' ' A' ' 139' ' ' PRO . 1.8 t -121.89 86.52 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.268 -2.957 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.449 ' OG1' ' N ' ' A' ' 135' ' ' GLY . 8.9 t -73.71 123.87 24.92 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 176.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.512 ' HA ' ' HA ' ' A' ' 132' ' ' ASN . 7.7 pt -106.25 123.31 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.641 -1.287 . . . . 0.0 112.793 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 131' ' ' LEU . 0.2 OUTLIER -128.67 105.13 8.06 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.092 177.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.463 ' CA ' HD11 ' A' ' 131' ' ' LEU . . . -48.22 104.25 0.06 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 122.058 0.932 . . . . 0.0 110.62 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 130' ' ' ASP . . . -59.8 -10.9 4.31 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.285 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -0.49 14.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.987 -1.071 . . . . 0.0 111.285 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.76 27.41 0.96 Allowed Glycine 0 N--CA 1.494 2.563 0 C-N-CA 118.993 -1.575 . . . . 0.0 112.556 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.455 ' HB ' ' CB ' ' A' ' 101' ' ' ALA . 21.1 t -108.73 153.94 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.066 -1.255 . . . . 0.0 109.828 178.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 4.4 m -142.08 107.2 4.95 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 103.109 -2.922 . . . . 0.0 103.109 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.504 ' O ' ' C ' ' A' ' 108' ' ' GLY . 23.8 m -56.61 -24.71 49.77 Favored 'General case' 0 C--N 1.273 -2.736 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -175.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.842 ' O ' ' N ' ' A' ' 110' ' ' SER . . . 29.85 48.43 0.13 Allowed Glycine 0 N--CA 1.511 3.644 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 172.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.472 HG21 ' CG ' ' A' ' 136' ' ' HIS . 54.6 t -28.77 67.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.628 0 CA-C-O 125.289 2.471 . . . . 0.0 112.17 -168.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.842 ' N ' ' O ' ' A' ' 108' ' ' GLY . 7.8 t -130.88 65.32 1.55 Allowed 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 109.403 -3.544 . . . . 0.0 103.935 176.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.499 ' O ' ' HB ' ' A' ' 115' ' ' ILE . . . -30.02 -29.91 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.118 -1.401 . . . . 0.0 114.271 -175.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -62.0 -77.9 0.04 OUTLIER 'General case' 0 C--N 1.282 -2.346 0 O-C-N 120.198 -1.564 . . . . 0.0 109.584 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -75.03 -27.81 60.22 Favored 'General case' 0 C--N 1.289 -2.061 0 O-C-N 121.337 -0.852 . . . . 0.0 111.373 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.439 ' HG2' ' CA ' ' A' ' 108' ' ' GLY . 0.0 OUTLIER -83.0 -38.54 22.5 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.334 -178.347 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.499 ' HB ' ' O ' ' A' ' 111' ' ' ALA . 0.1 OUTLIER -66.42 -12.84 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 116.849 -1.941 . . . . 0.0 108.013 178.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.5 m -74.35 -50.54 18.27 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 121' ' ' ALA . 3.9 p -70.63 -22.43 62.52 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.189 -0.944 . . . . 0.0 109.387 178.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.431 HG12 ' CG ' ' A' ' 50' ' ' MET . 63.0 t -66.8 -51.6 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.274 -0.891 . . . . 0.0 109.741 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.43 ' HG2' ' CG2' ' A' ' 49' ' ' THR . 5.5 ttp180 -51.53 -40.54 59.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.518 -0.739 . . . . 0.0 109.955 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.21 -8.49 39.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.583 -0.698 . . . . 0.0 110.572 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 117' ' ' THR . . . -68.31 -44.5 75.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.055 -1.028 . . . . 0.0 111.183 -178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 4.6 mt -83.3 9.34 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.542 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -107.08 71.43 0.83 Allowed 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.774 -1.171 . . . . 0.0 110.556 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.447 ' CB ' ' HD3' ' A' ' 127' ' ' LYS . 0.5 OUTLIER -99.0 -44.38 6.33 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.527 1.156 . . . . 0.0 109.319 177.6 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 124.64 -39.91 2.02 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 105.94 -2.864 . . . . 0.0 105.94 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -135.48 95.1 3.2 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.454 ' N ' ' CD ' ' A' ' 128' ' ' PRO . 7.7 tptt -136.57 53.45 7.49 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 120.784 -1.198 . . . . 0.0 109.761 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 127' ' ' LYS . 49.5 Cg_endo -77.4 -35.14 1.73 Allowed 'Trans proline' 0 C--N 1.3 -1.999 0 N-CA-C 107.552 -1.749 . . . . 0.0 107.552 178.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.3 p -125.86 -17.82 5.28 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.019 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.45 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -77.29 9.6 3.05 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.739 -1.226 . . . . 0.0 112.896 -177.359 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -140.94 74.79 1.47 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.541 -1.349 . . . . 0.0 109.561 179.04 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 0.7 OUTLIER -144.0 48.9 1.38 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.439 -1.413 . . . . 0.0 114.239 176.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.421 ' C ' ' CB ' ' A' ' 100' ' ' GLU . 2.1 mtm180 177.25 108.01 0.12 Allowed Pre-proline 0 N--CA 1.516 2.844 0 CA-C-N 121.897 2.135 . . . . 0.0 112.947 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -126.26 129.05 0.03 OUTLIER 'Cis proline' 0 C--N 1.312 -1.394 0 N-CA-C 103.557 -3.286 . . . . 0.0 103.557 -8.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 137' ' ' VAL . . . -113.65 33.36 5.54 Favored Glycine 0 N--CA 1.503 3.163 0 C-N-CA 117.54 -2.267 . . . . 0.0 113.791 -175.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.472 ' CG ' HG21 ' A' ' 109' ' ' VAL . 14.6 m-70 32.11 37.95 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.903 0 CA-C-N 119.049 1.424 . . . . 0.0 110.311 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.488 ' CG2' ' CG1' ' A' ' 99' ' ' ILE . 54.2 t -86.87 156.12 3.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.597 ' CD1' ' O ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -124.79 79.46 63.7 Favored Pre-proline 0 C--N 1.284 -2.275 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -178.641 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 52.0 Cg_endo -108.79 124.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.074 1.849 . . . . 0.0 110.83 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 140' ' ' LEU . 1.1 pp -128.99 136.82 50.85 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 119.485 -0.886 . . . . 0.0 108.898 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.469 ' CG ' ' CG ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -63.66 137.06 57.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.615 -1.303 . . . . 0.0 108.404 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.478 ' CB ' ' CG2' ' A' ' 158' ' ' ILE . . . -131.26 133.55 45.55 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.094 -1.043 . . . . 0.0 112.15 -178.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.16 143.46 45.24 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.537 -0.727 . . . . 0.0 109.724 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.48 115.71 8.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.478 -0.764 . . . . 0.0 110.6 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 86.93 14.93 63.87 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.14 13.64 63.15 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.489 HG23 ' CB ' ' A' ' 156' ' ' ALA . 14.5 p -89.94 -4.72 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.872 -1.37 . . . . 0.0 110.157 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.451 ' HG ' ' CG1' ' A' ' 206' ' ' VAL . 1.2 mp -90.06 17.56 6.8 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 116.139 -2.224 . . . . 0.0 110.148 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.4 p -130.59 60.99 1.62 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 101.171 -3.64 . . . . 0.0 101.171 168.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.436 ' HG3' ' CG ' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -149.97 140.49 22.47 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 113.794 -1.548 . . . . 0.0 112.755 -178.433 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.428 ' N ' ' HD3' ' A' ' 150' ' ' ARG . . . -104.0 35.09 5.28 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 106.148 -2.781 . . . . 0.0 106.148 173.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.24 163.35 27.8 Favored Glycine 0 N--CA 1.479 1.509 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' HIS . . . . . 0.479 ' CD2' HD11 ' A' ' 172' ' ' LEU . 2.8 p-80 -90.84 -5.03 56.12 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.646 -0.914 . . . . 0.0 109.552 177.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 60.0 p -53.37 -59.25 4.81 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.003 -1.061 . . . . 0.0 109.766 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 159' ' ' ASP . 63.3 mm-40 -59.59 -21.34 60.22 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.489 ' CB ' HG23 ' A' ' 147' ' ' VAL . . . -85.56 6.76 25.77 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.695 ' O ' ' HB3' ' A' ' 160' ' ' LEU . 27.3 m -91.99 -36.5 13.38 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.478 ' CG2' ' CB ' ' A' ' 142' ' ' ALA . 3.2 tp -85.83 -31.44 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 173.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 155' ' ' GLU . 1.7 t70 -56.68 -34.06 67.03 Favored 'General case' 0 C--O 1.199 -1.553 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 174.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.695 ' HB3' ' O ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -45.05 -37.42 4.14 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.349 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' MET . . . . . 0.571 ' HA ' ' HA ' ' A' ' 167' ' ' LYS . 0.0 OUTLIER -50.26 -45.33 54.12 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.871 178.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.442 HG23 ' NE ' ' A' ' 209' ' ' ARG . 4.3 t -97.56 -31.69 12.19 Favored 'General case' 0 N--CA 1.509 2.478 0 CA-C-O 121.895 0.855 . . . . 0.0 111.5 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.589 ' CB ' ' HA ' ' A' ' 160' ' ' LEU 0.272 0.2 OUTLIER -42.98 -58.11 2.56 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -178.58 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.464 ' CB ' HD11 ' A' ' 32' ' ' LEU . . . -110.13 2.24 19.31 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 118.874 -1.13 . . . . 0.0 113.003 -176.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 96.08 -19.2 55.51 Favored Glycine 0 C--N 1.29 -1.999 0 N-CA-C 108.21 -1.956 . . . . 0.0 108.21 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . 0.641 ' C ' ' HD3' ' A' ' 168' ' ' PRO . 0.1 OUTLIER -76.95 137.21 38.91 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.14 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 161' ' ' MET . 2.4 ttmt -121.55 56.47 6.37 Favored Pre-proline 0 C--N 1.31 -1.12 0 O-C-N 120.745 -1.222 . . . . 0.0 110.47 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.641 ' HD3' ' C ' ' A' ' 166' ' ' PHE . 56.5 Cg_endo -108.93 175.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.301 -1.966 0 N-CA-C 107.731 -1.681 . . . . 0.0 107.731 177.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' A' ' 47' ' ' ALA . . . -85.53 104.82 15.65 Favored 'General case' 0 C--N 1.261 -3.247 0 N-CA-C 101.42 -3.548 . . . . 0.0 101.42 173.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.443 ' O ' ' CG2' ' A' ' 157' ' ' THR . . . -93.75 154.52 21.68 Favored Glycine 0 C--N 1.297 -1.617 0 C-N-CA 119.048 -1.549 . . . . 0.0 111.103 -173.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 171' ' ' VAL 0.261 5.6 p -124.05 95.56 3.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LEU . . . . . 0.515 ' CD2' ' HA ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -114.81 114.74 25.95 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 119.93 -1.731 . . . . 0.0 111.018 -178.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.464 ' HB2' ' CG2' ' A' ' 66' ' ' VAL . 4.9 t -109.79 175.64 5.37 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.547 -1.346 . . . . 0.0 110.943 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.73 -147.93 0.41 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.41 -0.806 . . . . 0.0 109.888 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.446 ' CB ' ' HA ' ' A' ' 189' ' ' ILE . 2.1 tm? -116.49 146.36 42.64 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.193 -0.942 . . . . 0.0 109.404 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 52.9 m -131.86 154.97 48.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 0.0 110.319 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -119.53 168.46 10.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 0.0 110.253 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.46 5.57 48.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 111.172 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.13 -19.04 41.18 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.614 -0.679 . . . . 0.0 109.888 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 101.78 29.23 6.27 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.42 ' CG2' ' O ' ' A' ' 181' ' ' THR . 9.7 t -141.72 113.74 8.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.273 -1.133 . . . . 0.0 110.119 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 1.8 ttm -53.34 93.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 110.187 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 181' ' ' THR . . . -69.3 119.28 13.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.938 . . . . 0.0 110.278 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . 0.417 ' CG ' ' O ' ' A' ' 184' ' ' ARG . 2.9 ppt_? -139.98 100.45 3.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.304 -0.872 . . . . 0.0 109.911 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . 179.25 173.57 0.44 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.337 -0.852 . . . . 0.0 110.003 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.73 -11.59 26.04 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.644 1.339 . . . . 0.0 110.76 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -84.93 -63.37 1.34 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.063 -1.023 . . . . 0.0 110.522 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' CYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 191' ' ' PHE . 21.5 p -52.37 -37.56 56.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.01 . . . . 0.0 109.718 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.45 HG13 ' CD1' ' A' ' 199' ' ' LEU . 8.0 tp -73.62 -28.33 24.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 120.604 -1.31 . . . . 0.0 108.27 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -58.85 -20.0 46.82 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.126 177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . 0.45 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.1 OUTLIER -75.34 -51.06 14.07 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.72 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . 0.427 ' HB2' ' CE ' ' A' ' 197' ' ' MET . . . -62.51 -38.5 90.18 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ASN . . . . . 0.51 ' HA ' ' CB ' ' A' ' 197' ' ' MET . 0.0 OUTLIER -64.52 -15.98 61.8 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.103 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.45 -36.75 22.1 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 117.892 -1.523 . . . . 0.0 112.477 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -104.33 -53.59 2.69 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 115.719 -2.392 . . . . 0.0 111.519 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -113.97 32.99 5.49 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.025 -1.47 . . . . 0.0 113.754 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' MET . . . . . 0.51 ' CB ' ' HA ' ' A' ' 193' ' ' ASN . 2.5 ttp -153.67 145.15 23.19 Favored 'General case' 0 N--CA 1.512 2.645 0 C-N-CA 115.065 -2.654 . . . . 0.0 115.441 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.487 ' CB ' ' HB2' ' A' ' 23' ' ' LEU . . . -91.4 142.88 27.2 Favored 'General case' 0 N--CA 1.51 2.568 0 O-C-N 120.884 -1.135 . . . . 0.0 108.128 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.45 ' CD1' HG13 ' A' ' 189' ' ' ILE . 3.0 tp -131.55 94.09 3.47 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.495 -1.378 . . . . 0.0 114.498 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.531 HG21 ' CG1' ' A' ' 31' ' ' VAL 0.253 6.8 m -57.87 -168.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 120.496 -1.378 . . . . 0.0 107.525 175.31 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 205' ' ' LEU . 23.8 m -119.03 110.59 17.28 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 174.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.4 ' HA ' ' HB3' ' A' ' 205' ' ' LEU . 16.6 mt -49.62 -21.99 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.343 -0.848 . . . . 0.0 111.838 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -66.64 0.52 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.814 -1.179 . . . . 0.0 109.334 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.463 ' O ' ' CE1' ' A' ' 208' ' ' TYR . 1.7 m-20 -66.14 -32.82 74.49 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.015 -1.053 . . . . 0.0 109.076 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.761 ' HA ' ' CE2' ' A' ' 208' ' ' TYR . 6.7 tt -45.86 -69.53 0.13 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 123.084 1.421 . . . . 0.0 112.459 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.474 ' N ' HD23 ' A' ' 205' ' ' LEU . 1.4 t -68.42 -11.37 14.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 C-N-CA 117.758 -1.577 . . . . 0.0 108.845 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 204' ' ' ASP . . . -58.64 -30.49 67.33 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 175.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' TYR . . . . . 0.761 ' CE2' ' HA ' ' A' ' 205' ' ' LEU . 1.5 m-85 -62.59 -48.19 80.52 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 177.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ARG . . . . . 0.442 ' NE ' HG23 ' A' ' 162' ' ' THR . 17.8 tpt180 -65.56 -29.16 69.74 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.779 -1.168 . . . . 0.0 109.746 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -73.02 -35.29 66.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.03 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -73.57 -27.05 61.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.364 -0.835 . . . . 0.0 110.039 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -73.62 -31.55 63.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 110.087 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -90.56 -9.45 47.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 110.625 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -111.1 132.78 53.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.987 -1.071 . . . . 0.0 110.207 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -97.37 121.59 39.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.244 -0.91 . . . . 0.0 110.191 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -174.82 156.77 2.33 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.333 -0.855 . . . . 0.0 110.186 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 26.2 m . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.208 179.961 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.727 ' O ' HG12 ' A' ' 16' ' ' VAL . 28.2 Cg_endo . . . . . 0 C--O 1.202 -1.279 0 N-CA-C 110.928 -0.451 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -95.46 -46.36 6.72 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -77.4 -62.63 1.6 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 118.353 -1.339 . . . . 0.0 112.384 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.419 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 26.3 mmm180 -85.58 -10.15 56.31 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 117.538 -1.665 . . . . 0.0 112.981 -177.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -85.93 -26.04 6.44 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.489 0 C-N-CA 114.386 -2.926 . . . . 0.0 108.391 176.11 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.72 -48.89 62.67 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 116.74 -1.984 . . . . 0.0 107.409 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -65.6 -33.2 75.35 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.524 -0.735 . . . . 0.0 109.36 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.5 ' O ' HD23 ' A' ' 23' ' ' LEU . . . -81.75 -22.03 37.49 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.182 -0.949 . . . . 0.0 109.234 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.833 HD21 ' O ' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -53.89 -50.42 66.36 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.175 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.463 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . . . -66.61 -51.51 55.5 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.234 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -47.31 -45.4 24.27 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.519 -0.738 . . . . 0.0 110.507 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.664 HD13 HG11 ' A' ' 29' ' ' VAL . 3.3 pp -91.08 -17.15 26.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.306 -0.871 . . . . 0.0 110.192 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 20' ' ' LEU . 0.9 OUTLIER -54.72 -23.05 15.92 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.273 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.4 41.98 1.11 Allowed 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 118.23 -1.388 . . . . 0.0 110.167 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.539 ' HA3' ' CZ ' ' A' ' 45' ' ' PHE . . . 53.83 31.79 47.12 Favored Glycine 0 C--N 1.291 -1.953 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 176.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -85.3 19.78 2.18 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 116.859 -1.937 . . . . 0.0 110.859 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.564 ' O ' ' HB3' ' A' ' 198' ' ' ALA . . . 98.3 105.73 2.51 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 119.524 -1.322 . . . . 0.0 113.085 173.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.922 HG22 HD12 ' A' ' 44' ' ' ILE . 3.2 p -145.33 118.65 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-N 120.096 1.948 . . . . 0.0 109.968 176.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.776 ' HB3' HD23 ' A' ' 199' ' ' LEU . 1.5 tmt? -105.78 151.78 24.05 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.063 -1.023 . . . . 0.0 110.69 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.724 HG22 ' HB ' ' A' ' 202' ' ' ILE . 4.5 p . . . . . 0 N--CA 1.494 1.729 0 O-C-N 120.898 -1.126 . . . . 0.0 109.504 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.51 ' HA ' ' CA ' ' A' ' 30' ' ' MET . 2.7 p30 . . . . . 0 N--CA 1.506 2.372 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.677 ' O ' HG23 ' A' ' 171' ' ' VAL . 1.8 ttm -93.88 47.07 1.2 Allowed 'General case' 0 C--N 1.288 -2.104 0 O-C-N 120.886 -1.134 . . . . 0.0 113.778 -177.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.922 HD12 HG22 ' A' ' 29' ' ' VAL . 73.4 mt -68.49 20.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.534 3.75 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.776 ' O ' HG22 ' A' ' 171' ' ' VAL . 2.3 m-85 -66.59 162.38 51.07 Favored Pre-proline 0 C--N 1.279 -2.472 0 O-C-N 121.008 -1.057 . . . . 0.0 113.631 -176.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.481 ' HD2' ' CD2' ' A' ' 45' ' ' PHE . 43.8 Cg_endo -66.92 133.73 32.2 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.895 2.397 . . . . 0.0 111.902 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.63 ' HB2' ' N ' ' A' ' 170' ' ' GLY . . . -65.76 -7.21 14.6 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.405 -0.81 . . . . 0.0 112.751 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.774 ' HB2' ' HB2' ' A' ' 123' ' ' ALA . 0.3 OUTLIER -109.99 -14.97 14.16 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.726 -1.234 . . . . 0.0 111.35 -179.307 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 51' ' ' THR . 25.2 m -132.62 59.73 1.72 Allowed 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.581 ' O ' HG23 ' A' ' 115' ' ' ILE . 6.3 mtp -62.67 86.08 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.725 ' C ' HD13 ' A' ' 115' ' ' ILE . 1.7 m -63.99 170.41 3.56 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.773 0.797 . . . . 0.0 110.217 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 1.051 HG22 HD12 ' A' ' 115' ' ' ILE . 7.0 t -85.31 -3.72 8.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 121.731 -0.606 . . . . 0.0 109.586 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 6.3 tp10 -52.86 -39.8 62.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.844 -1.16 . . . . 0.0 108.867 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.524 ' CG ' ' CD1' ' A' ' 45' ' ' PHE . 17.6 mm-40 -82.08 -39.04 23.98 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.784 ' HG3' HD11 ' A' ' 115' ' ' ILE . 19.0 mmt -57.24 -39.11 74.89 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.097 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.501 ' HA ' HD12 ' A' ' 59' ' ' ILE . . . -58.05 -54.29 48.62 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.213 -0.93 . . . . 0.0 108.649 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.891 HD13 ' HE3' ' A' ' 197' ' ' MET . 6.2 tt -63.8 -22.01 66.71 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.699 -0.801 . . . . 0.0 109.464 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.593 HG23 ' C ' ' A' ' 63' ' ' SER . 1.1 m -88.64 -22.8 23.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -0.795 . . . . 0.0 110.265 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 56' ' ' ALA . 22.7 mt -76.83 -23.1 15.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.045 -1.035 . . . . 0.0 109.322 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.53 -64.07 1.1 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.406 -0.809 . . . . 0.0 110.659 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -125.98 42.87 3.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.157 -0.964 . . . . 0.0 111.666 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 58' ' ' THR . . . -155.2 -175.39 26.2 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 119.166 -1.492 . . . . 0.0 109.741 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.593 ' C ' HG23 ' A' ' 58' ' ' THR . 16.8 t -128.37 178.62 6.15 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.472 ' O ' HD13 ' A' ' 65' ' ' ILE . . . -114.11 67.45 0.26 Allowed Glycine 1 C--N 1.253 -4.062 0 N-CA-C 107.42 -2.272 . . . . 0.0 107.42 178.67 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.472 HD13 ' O ' ' A' ' 64' ' ' GLY . 25.1 mm -133.25 84.41 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 114.11 -1.045 . . . . 0.0 108.413 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.826 HG12 ' HB2' ' A' ' 173' ' ' CYS . 29.4 m -103.65 152.55 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.55 -0.719 . . . . 0.0 111.591 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 171' ' ' VAL . 5.3 t -77.55 122.08 24.77 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.081 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.666 ' HG ' HG13 ' A' ' 137' ' ' VAL . 3.1 mm? -87.21 126.24 34.69 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 122.174 0.988 . . . . 0.0 109.404 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.45 ' HB3' ' HA ' ' A' ' 158' ' ' ILE . 3.6 m -89.59 125.08 35.09 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.763 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.52 ' N ' HD13 ' A' ' 158' ' ' ILE . 16.7 tt -138.74 129.46 34.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.083 -1.01 . . . . 0.0 109.853 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.425 ' OG1' ' CG1' ' A' ' 158' ' ' ILE . 1.2 m -89.22 160.37 16.98 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.095 -1.003 . . . . 0.0 109.942 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.443 ' HA ' ' NH1' ' A' ' 75' ' ' ARG . 9.1 pt-20 -50.9 -24.42 3.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.442 -0.786 . . . . 0.0 110.142 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.47 -32.9 19.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 110.041 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.42 ' HB3' HG13 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -62.61 -49.7 74.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 109.939 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.464 ' CD ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -70.91 -34.68 71.77 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.187 0.994 . . . . 0.0 108.565 179.113 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.649 ' O ' ' N ' ' A' ' 79' ' ' ASP . 3.0 tttp -53.38 -66.17 0.44 Allowed 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -46.34 -32.7 3.33 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 124.039 0.837 . . . . 0.0 109.431 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.628 HD11 HD22 ' A' ' 131' ' ' LEU . 0.3 OUTLIER -97.74 43.65 1.06 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 176.059 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 76' ' ' LYS . 11.6 t70 -28.97 76.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 123.553 1.644 . . . . 0.0 113.031 -172.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.753 ' O ' HD23 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -151.25 100.05 3.02 Favored Pre-proline 0 C--N 1.283 -2.304 0 CA-C-N 112.765 -2.016 . . . . 0.0 110.314 177.362 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -106.62 92.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 N-CA-C 108.808 -1.266 . . . . 0.0 108.808 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.901 ' CB ' HG11 ' A' ' 97' ' ' VAL . 3.6 mtt -103.12 46.01 0.94 Allowed 'General case' 0 N--CA 1.483 1.215 0 O-C-N 120.588 -1.32 . . . . 0.0 108.723 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.91 123.54 2.37 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.038 0.447 . . . . 0.0 110.23 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 84' ' ' VAL . 32.8 m . . . . . 0 N--CA 1.494 1.765 0 C-N-CA 118.614 -1.235 . . . . 0.0 110.61 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.522 ' CB ' HG21 ' A' ' 84' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 122.415 1.102 . . . . 0.0 112.246 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.428 ' CG2' ' O ' ' A' ' 139' ' ' PRO . 35.3 m -59.66 81.05 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.274 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.901 HG11 ' CB ' ' A' ' 82' ' ' MET . 7.4 p -33.48 151.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 CA-C-O 122.577 1.18 . . . . 0.0 113.085 -174.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.641 HG22 ' O ' ' A' ' 137' ' ' VAL . 51.1 p -69.67 -178.38 1.46 Allowed 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.535 -175.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.973 HD12 HD23 ' A' ' 131' ' ' LEU . 16.0 pt -146.99 131.64 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.527 ' HB2' ' HA ' ' A' ' 133' ' ' ARG . 3.6 tt0 -103.54 125.12 49.9 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.069 -1.452 . . . . 0.0 113.491 -176.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 1.061 ' HB1' ' HB1' ' A' ' 121' ' ' ALA . . . -51.37 95.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.473 -0.767 . . . . 0.0 110.855 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 130' ' ' ASP . . . -80.5 2.63 24.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.629 -0.669 . . . . 0.0 110.14 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.414 ' CB ' ' HA ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -86.42 15.29 5.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.078 -1.014 . . . . 0.0 110.931 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.464 ' O ' HG21 ' A' ' 117' ' ' THR . . . 127.7 25.02 1.17 Allowed Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.522 -1.323 . . . . 0.0 112.11 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.947 ' HB ' ' HB3' ' A' ' 101' ' ' ALA . 13.0 t -130.17 121.83 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.156 -1.202 . . . . 0.0 109.195 177.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 p -145.91 59.06 1.24 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.594 -1.316 . . . . 0.0 111.523 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.782 HG21 ' OG ' ' A' ' 110' ' ' SER . 1.6 m -138.91 -31.97 0.7 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.805 -1.184 . . . . 0.0 110.983 176.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.23 -32.25 1.12 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.14 57.21 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.733 -1.451 . . . . 0.0 109.375 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.782 ' OG ' HG21 ' A' ' 107' ' ' THR . 1.2 m -129.87 57.44 1.68 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.201 -0.937 . . . . 0.0 109.257 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.506 ' HB1' ' HG3' ' A' ' 55' ' ' MET . . . -34.81 -29.85 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -82.41 -74.86 0.33 Allowed 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.063 -1.023 . . . . 0.0 110.157 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -67.07 -15.62 63.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.564 -0.71 . . . . 0.0 110.87 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.661 ' HG2' HG21 ' A' ' 118' ' ' VAL . 51.2 ttt85 -87.84 -46.79 9.12 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.057 -1.027 . . . . 0.0 110.032 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 1.051 HD12 HG22 ' A' ' 52' ' ' VAL . 35.1 mt -66.07 -10.96 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.679 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.7 m -87.69 -52.5 5.28 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.728 ' CB ' HG22 ' A' ' 105' ' ' VAL . 9.3 p -72.62 -42.9 63.96 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.692 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.772 ' CG2' HG11 ' A' ' 105' ' ' VAL . 47.6 t -57.19 -43.45 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.876 -1.14 . . . . 0.0 108.811 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.582 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -49.33 -39.38 31.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.348 -0.845 . . . . 0.0 109.307 178.755 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.74 -11.62 24.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.709 -0.619 . . . . 0.0 111.043 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 1.061 ' HB1' ' HB1' ' A' ' 101' ' ' ALA . . . -97.25 -59.93 1.69 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.857 -1.152 . . . . 0.0 112.68 -177.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.64 HG23 ' HA ' ' A' ' 48' ' ' GLU . 19.1 tt -66.7 -19.8 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 120.41 -1.431 . . . . 0.0 108.849 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.774 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . . . -106.58 72.49 0.91 Allowed 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.506 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.452 ' HB3' ' CG ' ' A' ' 127' ' ' LYS . 11.8 t0 -98.41 -53.1 3.43 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.335 1.064 . . . . 0.0 110.077 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 124.08 -37.28 2.71 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 106.169 -2.773 . . . . 0.0 106.169 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -132.98 100.51 4.91 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.945 ' HE2' HD13 ' A' ' 131' ' ' LEU . 23.4 mtpp -130.98 54.55 15.08 Favored Pre-proline 0 C--N 1.307 -1.242 0 O-C-N 120.773 -1.204 . . . . 0.0 110.92 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 127' ' ' LYS . 44.1 Cg_endo -72.05 -26.47 18.28 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 N-CA-C 106.921 -1.992 . . . . 0.0 106.921 176.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.79 -18.09 6.15 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.043 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.452 ' HB3' ' NZ ' ' A' ' 127' ' ' LYS . 27.6 m-20 -78.24 9.82 3.5 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.8 -1.187 . . . . 0.0 112.27 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.973 HD23 HD12 ' A' ' 99' ' ' ILE . 2.6 tp -135.08 89.62 2.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.882 -1.136 . . . . 0.0 108.566 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.506 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 36.4 p-10 -116.38 107.6 15.01 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.373 -0.829 . . . . 0.0 111.933 -178.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.803 ' HB2' ' HA ' ' A' ' 134' ' ' PRO 0.269 4.9 ppt_? -82.89 179.93 1.74 Allowed Pre-proline 0 N--CA 1.499 1.976 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.646 -177.525 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.803 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 48.8 Cg_endo -71.68 124.96 9.07 Favored 'Cis proline' 0 N--CA 1.504 2.122 0 C-N-CA 123.352 -1.52 . . . . 0.0 112.299 8.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.853 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -123.98 39.9 2.06 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 53.1 m80 31.21 38.22 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 122.162 0.982 . . . . 0.0 111.914 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 135' ' ' GLY . 54.5 t -126.85 103.11 10.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 176.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.505 ' CA ' HG22 ' A' ' 98' ' ' THR . 6.3 p90 -107.52 89.35 4.93 Favored Pre-proline 0 N--CA 1.492 1.659 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.962 -175.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 56.0 Cg_endo -77.34 124.42 7.13 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 124.125 1.592 . . . . 0.0 110.366 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.583 HD23 HG23 ' A' ' 154' ' ' THR . 1.1 tp -102.65 126.53 49.78 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.42 ' HA ' HG23 ' A' ' 70' ' ' ILE . 56.3 ttp85 -63.64 117.91 7.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.061 -1.024 . . . . 0.0 109.958 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.84 ' O ' HG21 ' A' ' 158' ' ' ILE . . . -130.03 134.17 47.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.578 -0.701 . . . . 0.0 110.516 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.421 ' C ' HG21 ' A' ' 158' ' ' ILE . 0.3 OUTLIER -56.26 133.03 52.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.829 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.692 ' HA ' HG23 ' A' ' 158' ' ' ILE . . . -81.87 115.2 20.96 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.408 -0.807 . . . . 0.0 111.173 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.472 ' CA ' ' NH2' ' A' ' 209' ' ' ARG . . . 86.63 -8.01 77.05 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.56 13.98 60.89 Favored Glycine 0 N--CA 1.483 1.815 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.707 ' CG2' ' HB2' ' A' ' 156' ' ' ALA . 7.6 p -59.7 -14.3 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.931 -1.335 . . . . 0.0 109.971 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.568 ' CD2' HG12 ' A' ' 206' ' ' VAL . 1.0 OUTLIER -92.17 20.13 6.24 Favored 'General case' 0 C--O 1.21 -1.004 0 C-N-CA 116.479 -2.088 . . . . 0.0 110.731 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.6 m -129.39 58.49 1.62 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 101.935 -3.357 . . . . 0.0 101.935 168.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.456 ' HG3' ' CG ' ' A' ' 155' ' ' GLU . 0.2 OUTLIER -153.76 146.11 23.93 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 113.486 -1.688 . . . . 0.0 111.903 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -103.95 34.72 5.55 Favored Glycine 0 N--CA 1.481 1.683 0 N-CA-C 106.124 -2.79 . . . . 0.0 106.124 173.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -145.34 165.98 27.74 Favored Glycine 0 N--CA 1.479 1.501 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.678 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 3.3 p80 -90.84 -6.04 54.79 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.921 -0.752 . . . . 0.0 109.484 176.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.583 HG23 HD23 ' A' ' 140' ' ' LEU . 62.6 m -56.17 -61.71 2.2 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 122.54 1.162 . . . . 0.0 109.353 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.824 ' HA ' ' HB1' ' A' ' 142' ' ' ALA . 9.2 mp0 -57.89 -20.75 39.23 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.707 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . . . -83.35 1.73 39.78 Favored 'General case' 0 C--O 1.201 -1.478 0 O-C-N 121.602 -0.686 . . . . 0.0 109.929 177.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 153' ' ' HIS . 68.8 p -82.2 -51.19 8.18 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.84 HG21 ' O ' ' A' ' 142' ' ' ALA . 3.8 tp -65.76 -31.58 54.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.537 ' OD2' HG12 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -80.56 -18.41 48.46 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.536 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.965 HD13 HD22 ' A' ' 172' ' ' LEU . 1.2 mt -63.41 -37.64 88.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.038 -1.039 . . . . 0.0 110.375 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.582 ' HE3' ' CB ' ' A' ' 166' ' ' PHE . 88.7 mmm -81.53 -27.74 34.28 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.64 HG21 HH21 ' A' ' 209' ' ' ARG . 3.6 m -66.3 -48.79 69.23 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 1.081 HD13 HD21 ' A' ' 205' ' ' LEU . 4.2 pp -72.57 -4.83 33.12 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.369 -0.832 . . . . 0.0 109.328 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.774 ' C ' HD11 ' A' ' 20' ' ' LEU . . . -108.06 18.85 20.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.662 -1.274 . . . . 0.0 109.983 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 59.14 41.86 96.82 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 107.337 -2.305 . . . . 0.0 107.337 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.582 ' CB ' ' HE3' ' A' ' 161' ' ' MET . 1.5 m-85 -138.49 139.29 38.72 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.925 0.869 . . . . 0.0 111.134 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -50.2 134.23 23.49 Favored Pre-proline 0 N--CA 1.498 1.965 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 177.946 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.579 ' O ' HD11 ' A' ' 158' ' ' ILE . 37.3 Cg_endo -64.81 84.46 0.17 Allowed 'Trans proline' 0 C--N 1.298 -2.114 0 C-N-CA 116.593 -1.805 . . . . 0.0 112.911 -174.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' ' 47' ' ' ALA . . . -156.81 111.72 2.81 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 101.399 -3.556 . . . . 0.0 101.399 173.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.63 ' N ' ' HB2' ' A' ' 47' ' ' ALA . . . -157.73 167.76 34.23 Favored Glycine 0 N--CA 1.486 1.996 0 C-N-CA 116.454 -2.784 . . . . 0.0 113.314 -174.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.776 HG22 ' O ' ' A' ' 45' ' ' PHE . 28.5 m -112.46 156.49 13.48 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.965 HD22 HD13 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -157.68 114.0 2.88 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.639 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.826 ' HB2' HG12 ' A' ' 66' ' ' VAL . 34.1 t -130.66 162.25 29.82 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 120.569 -1.332 . . . . 0.0 112.05 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.27 -169.06 1.45 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.199 -0.938 . . . . 0.0 109.491 178.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 1.089 HD21 ' HB2' ' A' ' 192' ' ' ALA . 5.2 mt . . . . . 0 N--CA 1.497 1.911 0 O-C-N 120.89 -1.132 . . . . 0.0 109.582 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' A' ' 175' ' ' LEU . . . . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 121.4 0.619 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.482 ' O ' ' HB3' ' A' ' 185' ' ' ALA . 3.9 mtt180 -136.8 161.68 35.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.353 -0.842 . . . . 0.0 110.333 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 184' ' ' ARG . . . 60.85 160.02 0.11 Allowed Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.349 -0.844 . . . . 0.0 110.871 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.591 ' HA ' HG22 ' A' ' 189' ' ' ILE . 44.5 Cg_endo -70.4 -26.76 24.23 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.739 1.389 . . . . 0.0 110.578 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -60.66 -34.98 75.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.089 -1.007 . . . . 0.0 109.864 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' CYS . . . . . 0.466 ' O ' HD11 ' A' ' 175' ' ' LEU . 5.4 t -74.59 -53.99 8.33 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.362 -0.836 . . . . 0.0 110.218 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.739 HG23 HD22 ' A' ' 199' ' ' LEU . 9.6 tp -62.02 -25.08 36.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 O-C-N 120.653 -1.279 . . . . 0.0 107.644 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 194' ' ' LYS . 36.8 tt0 -64.65 -33.74 76.64 Favored 'General case' 0 C--O 1.194 -1.822 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.313 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 191' ' ' PHE . 0.0 OUTLIER -57.65 -54.94 41.18 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.349 -1.469 . . . . 0.0 108.925 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 1.089 ' HB2' HD21 ' A' ' 175' ' ' LEU . . . -69.87 -44.83 69.01 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.707 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ASN . . . . . 0.753 ' HB2' HD21 ' A' ' 199' ' ' LEU . 1.6 m-20 -82.19 -29.99 31.17 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.061 -1.056 . . . . 0.0 112.902 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 190' ' ' GLU . 15.6 tttt -55.42 -36.64 66.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.462 -1.399 . . . . 0.0 109.384 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -81.8 -52.83 6.73 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 116.116 -2.234 . . . . 0.0 111.781 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.468 ' O ' ' CG ' ' A' ' 197' ' ' MET . 89.4 m-20 -115.58 28.34 8.73 Favored 'General case' 0 N--CA 1.51 2.571 0 C-N-CA 117.073 -1.851 . . . . 0.0 115.254 177.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' MET . . . . . 0.891 ' HE3' HD13 ' A' ' 57' ' ' LEU . 0.8 OUTLIER -160.21 149.96 17.93 Favored 'General case' 0 N--CA 1.514 2.745 0 CA-C-N 121.991 2.178 . . . . 0.0 113.613 179.267 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 28' ' ' GLY . . . -86.73 148.51 25.4 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.416 -1.428 . . . . 0.0 108.482 175.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.776 HD23 ' HB3' ' A' ' 30' ' ' MET . 4.1 mt -122.72 144.3 49.24 Favored 'General case' 0 N--CA 1.511 2.62 0 O-C-N 120.264 -1.523 . . . . 0.0 111.639 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.581 HG22 ' H ' ' A' ' 201' ' ' THR . 3.4 p -149.94 -178.92 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.269 -0.894 . . . . 0.0 110.179 178.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.581 ' H ' HG22 ' A' ' 200' ' ' VAL . 23.5 p -105.54 179.84 4.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.014 . . . . 0.0 110.849 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.724 ' HB ' HG22 ' A' ' 31' ' ' VAL . 4.5 tt -111.96 -32.51 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.446 -0.784 . . . . 0.0 110.349 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.89 -65.06 0.62 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.108 -0.995 . . . . 0.0 110.528 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -75.82 -35.78 59.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.294 -0.879 . . . . 0.0 110.442 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 1.081 HD21 HD13 ' A' ' 163' ' ' LEU . 6.3 tt -52.92 -43.61 66.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.096 -1.003 . . . . 0.0 110.285 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.632 HG13 HG13 ' A' ' 147' ' ' VAL . 1.0 OUTLIER -71.08 -40.35 75.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 O-C-N 120.965 -1.084 . . . . 0.0 108.456 -179.375 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.419 ' HA ' ' CD2' ' A' ' 148' ' ' LEU . . . -55.72 -23.82 31.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.074 -1.016 . . . . 0.0 108.497 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.676 ' CD2' HG11 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -75.81 -35.92 59.87 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.09 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.64 HH21 HG21 ' A' ' 162' ' ' THR . 2.3 tmt_? -55.49 -44.14 76.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.834 . . . . 0.0 109.627 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.501 ' HG3' HD13 ' A' ' 148' ' ' LEU . 0.4 OUTLIER -68.65 -37.31 79.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.432 -0.793 . . . . 0.0 110.157 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -65.07 -22.98 67.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.347 -0.846 . . . . 0.0 110.173 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.18 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.512 ' CB ' ' HB2' ' A' ' 208' ' ' TYR . 22.5 Cg_endo . . . . . 0 C--O 1.215 -0.632 0 CA-C-O 121.485 0.536 . . . . 0.0 111.736 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.438 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 14.1 m-85 -93.54 -37.2 12.03 Favored 'General case' 0 C--N 1.278 -2.511 0 C-N-CA 119.24 -0.984 . . . . 0.0 113.504 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -79.25 -63.33 1.44 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.606 -1.238 . . . . 0.0 112.635 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.711 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.8 tpt180 -90.84 -14.94 30.86 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 118.746 -1.182 . . . . 0.0 111.929 -178.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.994 HG11 ' HB2' ' A' ' 205' ' ' LEU . 2.3 t -98.81 -19.0 6.08 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 C-N-CA 116.359 -2.136 . . . . 0.0 109.615 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 13' ' ' PHE . 3.7 tt0 -83.26 -41.5 18.27 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 176.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -74.04 -22.38 59.57 Favored 'General case' 0 C--N 1.307 -1.239 0 O-C-N 121.749 -0.595 . . . . 0.0 109.504 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 15' ' ' ARG . . . -75.52 -51.94 11.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.016 -1.052 . . . . 0.0 108.992 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.892 HD22 ' OH ' ' A' ' 208' ' ' TYR . 0.4 OUTLIER -49.48 -33.23 13.85 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.442 -0.786 . . . . 0.0 109.8 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' A' ' 24' ' ' ARG . . . -78.0 -68.41 0.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.972 0.891 . . . . 0.0 109.614 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.92 -29.2 1.9 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.495 -0.753 . . . . 0.0 110.135 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.499 ' CB ' ' HB ' ' A' ' 29' ' ' VAL . 1.9 mm? -101.09 -15.37 17.43 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.799 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.488 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -50.23 -24.47 2.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.079 -1.013 . . . . 0.0 108.571 178.286 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.73 42.76 1.11 Allowed 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 118.49 -1.284 . . . . 0.0 110.35 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.518 ' HA2' ' CZ ' ' A' ' 45' ' ' PHE . . . 55.2 25.91 41.33 Favored Glycine 0 C--N 1.291 -1.934 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 176.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.443 ' C ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -88.23 17.6 5.03 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 116.36 -2.136 . . . . 0.0 110.97 -179.711 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 198' ' ' ALA . . . 96.69 108.87 2.54 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 118.893 -1.622 . . . . 0.0 115.113 172.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.039 HG22 HD12 ' A' ' 44' ' ' ILE . 5.8 p -140.69 124.88 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-N 119.539 1.669 . . . . 0.0 108.345 175.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.839 ' HB2' HD23 ' A' ' 199' ' ' LEU . 0.5 OUTLIER -109.03 158.59 17.59 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.869 -1.145 . . . . 0.0 113.312 -177.474 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.893 HG21 HD21 ' A' ' 160' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.541 -0.724 . . . . 0.0 109.3 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.517 ' HB2' ' CB ' ' A' ' 174' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.501 2.095 0 CA-C-O 121.27 0.557 . . . . 0.0 111.597 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.593 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -95.34 53.92 1.56 Allowed 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.29 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.039 HD12 HG22 ' A' ' 29' ' ' VAL . 94.2 mt -61.22 19.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.527 3.391 0 O-C-N 120.428 -1.42 . . . . 0.0 111.991 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.593 ' H ' ' C ' ' A' ' 43' ' ' MET . 22.4 m-85 -85.06 165.09 38.69 Favored Pre-proline 0 C--N 1.291 -1.952 0 O-C-N 120.972 -1.08 . . . . 0.0 112.341 -177.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.503 ' HD3' ' CD2' ' A' ' 166' ' ' PHE . 40.8 Cg_endo -62.79 133.53 42.41 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 122.444 2.096 . . . . 0.0 114.106 -176.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.481 ' HB1' HD13 ' A' ' 68' ' ' LEU . . . -69.22 -2.7 11.2 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.263 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 15.7 tt0 -80.1 -14.99 58.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.906 -1.121 . . . . 0.0 109.653 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.526 ' O ' HG23 ' A' ' 49' ' ' THR . 6.3 t -130.81 58.99 1.68 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 177.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.515 ' HE1' HD11 ' A' ' 68' ' ' LEU . 15.3 ttm -51.53 88.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.673 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.499 ' HA ' HG13 ' A' ' 115' ' ' ILE . 3.2 m -64.65 157.45 27.16 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.693 0.759 . . . . 0.0 110.267 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 1.038 HG23 ' HB1' ' A' ' 111' ' ' ALA . 2.1 p -71.65 -4.87 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.655 -0.653 . . . . 0.0 109.907 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -55.15 -31.41 61.3 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.795 -1.19 . . . . 0.0 108.445 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.928 ' HA ' HD23 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -87.77 -38.27 15.9 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.19 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.844 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -71.87 -40.02 69.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.817 -1.177 . . . . 0.0 109.275 179.487 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.651 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -62.3 -47.08 85.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.558 -0.714 . . . . 0.0 110.772 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.928 HD23 ' HA ' ' A' ' 54' ' ' GLN . 0.8 OUTLIER -57.05 -34.14 67.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.079 -1.013 . . . . 0.0 110.987 -179.237 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.477 ' CA ' ' O ' ' A' ' 62' ' ' GLY . 33.2 p -79.54 -46.72 16.82 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.19 -0.944 . . . . 0.0 111.139 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.0 mt -54.22 -20.42 4.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 O-C-N 121.094 -1.004 . . . . 0.0 110.28 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.502 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 2.9 mtp180 -97.92 -44.56 6.64 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.158 -0.964 . . . . 0.0 113.169 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.502 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 48.5 m80 -125.43 -17.84 5.47 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -176.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.477 ' O ' ' CA ' ' A' ' 58' ' ' THR . . . -165.18 -169.09 28.34 Favored Glycine 0 N--CA 1.503 3.129 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.708 -177.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.6 t -143.1 96.37 2.91 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 102.27 -3.233 . . . . 0.0 102.27 175.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.42 ' H ' HG22 ' A' ' 58' ' ' THR . . . -136.35 72.38 0.46 Allowed Glycine 0 C--N 1.26 -3.681 1 N-CA-C 101.97 -4.452 . . . . 0.0 101.97 178.734 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.441 ' CG2' ' CE2' ' A' ' 138' ' ' PHE . 38.7 mt -60.14 145.28 12.04 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.816 0 CA-C-N 113.613 -1.293 . . . . 0.0 110.067 -176.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.809 HG12 ' CB ' ' A' ' 173' ' ' CYS . 35.2 m -55.98 152.28 2.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.863 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 171' ' ' VAL . 78.9 m -83.03 132.77 35.12 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.717 HD22 HG12 ' A' ' 171' ' ' VAL . 2.9 mm? -89.18 97.98 11.51 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.037 -1.065 . . . . 0.0 108.936 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.582 ' HA ' HG23 ' A' ' 157' ' ' THR . 34.3 m -64.41 125.73 25.58 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 118.776 -1.17 . . . . 0.0 109.794 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.543 ' CA ' HD13 ' A' ' 158' ' ' ILE . 15.2 tt -133.23 146.88 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.017 -1.052 . . . . 0.0 109.823 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.624 HG23 HG12 ' A' ' 158' ' ' ILE . 0.3 OUTLIER -108.62 151.97 25.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 109.643 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 76' ' ' LYS . 18.4 tt0 -50.25 -24.68 3.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.264 -0.897 . . . . 0.0 110.053 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -88.23 -38.24 15.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.323 -0.861 . . . . 0.0 109.969 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.851 ' O ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -62.11 -52.45 63.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.346 -0.846 . . . . 0.0 109.562 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.625 HH21 HG23 ' A' ' 96' ' ' THR . 0.5 OUTLIER -62.84 -40.85 98.7 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.112 0.958 . . . . 0.0 108.784 179.031 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.63 ' O ' ' N ' ' A' ' 79' ' ' ASP . 7.9 tttm -49.53 -62.04 1.77 Allowed 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -47.66 -31.3 4.48 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 121.884 0.849 . . . . 0.0 108.945 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.851 HD12 ' O ' ' A' ' 74' ' ' ARG . 3.0 mt -96.69 44.55 1.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 175.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.63 ' N ' ' O ' ' A' ' 76' ' ' LYS . 20.9 t0 -26.81 78.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 123.85 1.786 . . . . 0.0 112.893 -172.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.641 HD21 HG22 ' A' ' 99' ' ' ILE . 0.2 OUTLIER -150.77 106.36 3.06 Favored Pre-proline 0 C--N 1.286 -2.189 0 CA-C-N 112.315 -2.221 . . . . 0.0 110.181 177.83 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -92.07 94.06 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 N-CA-C 107.852 -1.634 . . . . 0.0 107.852 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.556 ' SD ' HG21 ' A' ' 97' ' ' VAL . 2.8 mmt -99.63 44.45 1.02 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.16 -0.962 . . . . 0.0 109.875 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.3 tpt -68.51 103.07 1.58 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.053 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 95' ' ' PHE . 11.0 t . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.699 ' O ' HG23 ' A' ' 84' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.329 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.625 HG23 HH21 ' A' ' 75' ' ' ARG . 2.8 m -59.25 79.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.589 HG11 ' HD3' ' A' ' 133' ' ' ARG . 18.8 t -35.47 151.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 CA-C-O 123.023 1.392 . . . . 0.0 113.412 -173.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.765 HG23 ' HA ' ' A' ' 134' ' ' PRO . 0.7 OUTLIER -69.64 179.5 2.12 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 113.793 -1.549 . . . . 0.0 113.157 -176.187 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.764 HD12 HD13 ' A' ' 131' ' ' LEU . 19.8 pt -141.9 131.81 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -177.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 132' ' ' ASN . 1.6 tm-20 -111.81 133.94 53.69 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 117.758 -1.577 . . . . 0.0 112.875 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.824 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . . . -52.72 93.28 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.064 -1.023 . . . . 0.0 110.039 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.594 ' HB2' ' HB2' ' A' ' 132' ' ' ASN . . . -82.55 3.82 27.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.965 -1.084 . . . . 0.0 110.911 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -113.02 54.92 0.71 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.775 -1.203 . . . . 0.0 112.236 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.44 -36.41 2.58 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 118.875 -1.631 . . . . 0.0 112.42 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.824 ' HB ' ' HB3' ' A' ' 101' ' ' ALA . 0.8 OUTLIER -100.99 124.4 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 120.962 -1.316 . . . . 0.0 110.187 -178.394 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 p -145.24 61.11 1.3 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.591 -1.318 . . . . 0.0 111.422 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 p -135.3 -32.27 0.94 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.889 -1.132 . . . . 0.0 110.323 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.9 -30.37 0.1 Allowed Glycine 0 N--CA 1.499 2.881 0 O-C-N 121.599 -0.688 . . . . 0.0 113.238 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.3 t -128.63 57.12 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.377 -1.661 . . . . 0.0 110.38 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -129.43 56.94 1.68 Allowed 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.128 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 1.038 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -31.53 -32.29 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -84.28 -77.37 0.27 Allowed 'General case' 0 C--N 1.29 -1.993 0 O-C-N 120.837 -1.165 . . . . 0.0 109.558 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.18 -15.94 28.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.448 -0.782 . . . . 0.0 110.737 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.805 ' HG2' HG23 ' A' ' 118' ' ' VAL . 2.4 ttt180 -90.67 -36.73 14.18 Favored 'General case' 0 C--O 1.202 -1.416 0 O-C-N 121.001 -1.062 . . . . 0.0 110.261 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.726 HD13 ' HA ' ' A' ' 111' ' ' ALA . 0.8 OUTLIER -62.0 -15.37 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 118.417 -1.313 . . . . 0.0 108.956 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.5 m -88.6 -55.27 3.78 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.765 ' CB ' HG13 ' A' ' 105' ' ' VAL . 53.2 p -67.49 -14.0 62.54 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.424 178.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.805 HG23 ' HG2' ' A' ' 114' ' ' ARG . 2.6 t -73.66 -48.64 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -50.52 -36.2 33.02 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.132 178.471 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.704 ' HA ' ' HB3' ' A' ' 123' ' ' ALA . . . -96.44 -13.8 22.86 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.281 0.563 . . . . 0.0 110.476 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.802 ' HB1' ' HB2' ' A' ' 101' ' ' ALA . . . -55.58 -56.48 19.82 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.252 -0.905 . . . . 0.0 109.773 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 19.1 tt -93.69 14.47 2.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 118.677 -1.209 . . . . 0.0 110.243 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.704 ' HB3' ' HA ' ' A' ' 120' ' ' ALA . . . -108.83 72.38 0.82 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 118.973 -1.091 . . . . 0.0 111.136 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.485 ' HB2' ' HZ2' ' A' ' 127' ' ' LYS . 5.1 t70 -99.3 -35.61 9.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.998 -1.064 . . . . 0.0 110.381 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 106.04 -38.37 3.34 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 105.28 -3.128 . . . . 0.0 105.28 -176.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -133.34 98.86 4.35 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.485 ' HZ2' ' HB2' ' A' ' 124' ' ' ASP . 5.4 tptt -132.33 52.94 9.91 Favored Pre-proline 0 C--N 1.307 -1.28 0 O-C-N 120.767 -1.208 . . . . 0.0 110.86 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 127' ' ' LYS . 49.4 Cg_endo -78.0 -35.65 1.31 Allowed 'Trans proline' 0 C--N 1.3 -2.009 0 N-CA-C 106.911 -1.996 . . . . 0.0 106.911 176.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.4 t -126.71 -0.29 6.74 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.345 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.448 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . 0.8 OUTLIER -77.4 9.4 3.26 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.634 -1.292 . . . . 0.0 112.718 -177.61 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.764 HD13 HD12 ' A' ' 99' ' ' ILE . 29.7 mt -117.87 124.89 49.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.716 -1.24 . . . . 0.0 109.337 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.594 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 1.3 m-80 -116.85 93.58 4.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.089 -1.007 . . . . 0.0 112.952 -177.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.785 ' HB2' ' HA ' ' A' ' 134' ' ' PRO 0.274 0.0 OUTLIER -80.71 172.12 10.6 Favored Pre-proline 0 N--CA 1.501 2.101 0 O-C-N 121.815 -0.553 . . . . 0.0 110.72 -179.556 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.785 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 48.2 Cg_endo -73.14 129.75 18.44 Favored 'Cis proline' 0 N--CA 1.502 1.995 0 C-N-CA 123.043 -1.649 . . . . 0.0 112.559 7.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.637 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -123.6 47.31 1.03 Allowed Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 135' ' ' GLY . 49.6 m80 31.19 38.1 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 122.143 0.973 . . . . 0.0 112.07 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.67 HG13 ' HG ' ' A' ' 68' ' ' LEU . 31.3 t -129.43 92.44 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 176.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.462 ' O ' ' CD1' ' A' ' 138' ' ' PHE . 10.4 p90 -107.09 101.91 40.45 Favored Pre-proline 0 N--CA 1.495 1.797 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.218 -176.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 53.2 Cg_endo -98.38 155.59 0.78 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.785 1.413 . . . . 0.0 111.078 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.515 HD12 ' O ' ' A' ' 139' ' ' PRO . 1.3 mp -127.29 116.59 20.78 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.471 ' HA ' HG23 ' A' ' 70' ' ' ILE . 9.2 ttm180 -63.52 115.66 4.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.058 -1.026 . . . . 0.0 110.696 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.997 ' HB2' HG22 ' A' ' 154' ' ' THR . . . -130.67 135.5 47.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.765 -0.584 . . . . 0.0 110.13 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.417 ' O ' ' HG3' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -53.38 143.23 19.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.941 -1.099 . . . . 0.0 110.092 -179.642 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.556 ' HB2' HG23 ' A' ' 158' ' ' ILE . . . -100.4 115.76 30.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.502 -0.749 . . . . 0.0 111.622 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.417 ' N ' ' OD2' ' A' ' 159' ' ' ASP . . . 104.02 -15.0 52.05 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.77 13.1 57.9 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.994 HG21 ' HB2' ' A' ' 156' ' ' ALA . 7.2 p -65.52 -9.09 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.095 -1.239 . . . . 0.0 110.276 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.888 HD22 HG13 ' A' ' 147' ' ' VAL . 4.0 mm? -87.82 15.92 6.47 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 115.683 -2.407 . . . . 0.0 110.079 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.0 m -131.11 60.94 1.65 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 100.937 -3.727 . . . . 0.0 100.937 167.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.78 140.03 22.23 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 113.876 -1.511 . . . . 0.0 112.774 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -104.03 34.83 5.47 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 106.44 -2.664 . . . . 0.0 106.44 173.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.3 160.88 27.92 Favored Glycine 0 N--CA 1.478 1.493 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.604 ' HB3' HD11 ' A' ' 202' ' ' ILE . 10.4 p80 -90.0 -5.5 56.6 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.653 -0.91 . . . . 0.0 109.309 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.997 HG22 ' HB2' ' A' ' 142' ' ' ALA . 6.3 m -54.54 -59.22 4.98 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.076 -1.015 . . . . 0.0 109.437 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.834 ' HA ' ' HB1' ' A' ' 142' ' ' ALA . 21.2 tt0 -57.93 -22.12 47.25 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.994 ' HB2' HG21 ' A' ' 147' ' ' VAL . . . -91.38 8.04 38.15 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 121.715 -0.616 . . . . 0.0 109.377 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.582 HG23 ' HA ' ' A' ' 69' ' ' CYS . 0.6 OUTLIER -92.51 -51.69 5.0 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.375 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.713 HD11 ' O ' ' A' ' 168' ' ' PRO . 6.1 tp -72.77 -32.37 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 176.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.468 ' HB3' ' HA ' ' A' ' 156' ' ' ALA . 11.7 t0 -71.61 -22.28 61.73 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.893 HD21 HG21 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -60.22 -30.98 69.75 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.906 0.86 . . . . 0.0 109.466 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.525 ' HB2' ' HA ' ' A' ' 168' ' ' PRO . 37.2 mmt -83.42 -26.91 29.95 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.706 HG21 ' NE ' ' A' ' 209' ' ' ARG . 2.5 m -71.45 -36.87 71.37 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 176.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.719 ' CD2' ' HA ' ' A' ' 160' ' ' LEU . 3.9 pp -82.03 -4.2 56.24 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.251 -0.98 . . . . 0.0 108.698 177.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.635 ' HB2' HG22 ' A' ' 44' ' ' ILE . . . -109.52 12.1 24.6 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.38 -1.45 . . . . 0.0 109.865 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 58.5 42.49 95.94 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.503 ' CD2' ' HD3' ' A' ' 46' ' ' PRO . 6.3 m-85 -135.41 139.98 44.58 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 122.369 1.081 . . . . 0.0 112.093 -176.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 169' ' ' ALA . 5.1 mttt -48.98 136.6 13.93 Favored Pre-proline 0 N--CA 1.501 2.091 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 177.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.713 ' O ' HD11 ' A' ' 158' ' ' ILE . 37.4 Cg_endo -63.86 84.6 0.14 Allowed 'Trans proline' 0 C--N 1.301 -1.962 0 C-N-CA 116.59 -1.806 . . . . 0.0 113.225 -173.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 46' ' ' PRO . . . -155.94 123.82 5.66 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 100.581 -3.859 . . . . 0.0 100.581 172.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.454 ' N ' ' HB2' ' A' ' 69' ' ' CYS . . . -153.64 159.56 28.74 Favored Glycine 0 N--CA 1.502 3.085 0 CA-C-N 123.869 3.031 . . . . 0.0 113.199 -174.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.717 HG12 HD22 ' A' ' 68' ' ' LEU . 2.9 m -149.65 98.8 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 118.503 -1.279 . . . . 0.0 109.601 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.827 HD11 ' CD1' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -109.75 105.81 15.2 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 117.185 -1.806 . . . . 0.0 113.787 -179.506 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.876 ' SG ' HD21 ' A' ' 57' ' ' LEU . 49.5 t -137.88 159.9 40.76 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.856 ' O ' HD12 ' A' ' 189' ' ' ILE . 1.2 mm-40 174.64 85.68 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.968 0 O-C-N 119.842 -1.786 . . . . 0.0 112.689 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.938 HD21 ' HB3' ' A' ' 188' ' ' CYS . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.891 0 O-C-N 121.206 -0.934 . . . . 0.0 110.83 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.732 ' HB1' ' SG ' ' A' ' 188' ' ' CYS . . . . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.358 0.599 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 185' ' ' ALA . 5.0 ttm180 -129.11 100.41 5.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -0.857 . . . . 0.0 109.442 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.913 ' HB1' ' HD2' ' A' ' 186' ' ' PRO . . . -179.85 -177.18 0.21 Allowed Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.336 -0.852 . . . . 0.0 109.298 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.913 ' HD2' ' HB1' ' A' ' 185' ' ' ALA . 42.8 Cg_endo -70.2 -23.39 28.86 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.342 1.18 . . . . 0.0 110.143 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.423 ' O ' ' CB ' ' A' ' 190' ' ' GLU . 0.4 OUTLIER -81.79 -28.24 33.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.033 -1.042 . . . . 0.0 108.56 178.601 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 188' ' ' CYS . . . . . 0.938 ' HB3' HD21 ' A' ' 175' ' ' LEU . 37.1 m -66.33 -51.56 56.01 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.856 HD12 ' O ' ' A' ' 174' ' ' GLU . 8.0 tp -58.34 -27.8 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.497 ' HA ' HD11 ' A' ' 199' ' ' LEU . 1.0 OUTLIER -60.14 -25.46 65.51 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 176.646 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.656 ' CE2' ' HB3' ' A' ' 183' ' ' ALA . 12.9 m-30 -55.76 -57.48 11.85 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 123.296 1.522 . . . . 0.0 108.093 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.727 ' HB1' ' SD ' ' A' ' 197' ' ' MET . . . -64.17 -46.61 83.25 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.562 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ASN . . . . . 0.663 ' HB3' HD11 ' A' ' 199' ' ' LEU . 1.9 t30 -65.05 -11.88 44.33 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.472 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 190' ' ' GLU . 7.6 tmtt? -78.2 -37.11 46.37 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 117.372 -1.731 . . . . 0.0 111.06 -178.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -108.66 -54.25 2.54 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 115.684 -2.406 . . . . 0.0 111.952 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -114.67 34.63 4.67 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.322 -1.351 . . . . 0.0 113.784 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' MET . . . . . 0.727 ' SD ' ' HB1' ' A' ' 192' ' ' ALA . 2.2 mtt -151.42 150.63 30.67 Favored 'General case' 0 N--CA 1.518 2.949 0 CA-C-N 123.113 2.688 . . . . 0.0 115.466 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 28' ' ' GLY . . . -110.26 147.72 33.28 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.257 -0.902 . . . . 0.0 108.779 177.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.839 HD23 ' HB2' ' A' ' 30' ' ' MET . 10.0 mt -123.51 130.58 52.9 Favored 'General case' 0 N--CA 1.511 2.585 0 O-C-N 120.277 -1.514 . . . . 0.0 111.161 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.903 HG21 HG13 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -109.3 -160.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 120.791 -1.193 . . . . 0.0 111.027 179.232 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.707 ' O ' HD22 ' A' ' 205' ' ' LEU . 0.6 OUTLIER -108.44 -179.92 4.01 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.422 -0.799 . . . . 0.0 110.435 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 153' ' ' HIS . 12.9 tt -106.66 -41.91 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.417 -0.802 . . . . 0.0 111.3 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.512 ' N ' HG23 ' A' ' 202' ' ' ILE . 0.2 OUTLIER -90.38 -40.52 12.02 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.991 -1.068 . . . . 0.0 111.262 -178.959 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 207' ' ' ALA . 0.5 OUTLIER -63.37 -45.1 92.71 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.704 -1.247 . . . . 0.0 110.441 -179.454 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.994 ' HB2' HG11 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -71.28 -31.53 67.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.156 -0.965 . . . . 0.0 112.354 -178.504 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.779 ' H ' HD23 ' A' ' 205' ' ' LEU . 3.7 m -62.32 -29.57 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 119.707 -1.871 . . . . 0.0 106.995 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 211' ' ' ALA . . . -64.61 -38.46 91.08 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.892 ' OH ' HD22 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -56.87 -36.11 69.69 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.313 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.706 ' NE ' HG21 ' A' ' 162' ' ' THR . 0.0 OUTLIER -74.01 -55.26 6.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.418 -0.801 . . . . 0.0 110.0 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.438 ' N ' ' HD3' ' A' ' 209' ' ' ARG . 12.9 tt0 -68.83 -56.35 8.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 110.714 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 207' ' ' ALA . . . -51.19 -31.52 20.53 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.322 -0.861 . . . . 0.0 110.443 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.427 ' CB ' ' O ' ' A' ' 208' ' ' TYR . 48.9 t-80 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.183 -0.948 . . . . 0.0 110.182 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.886 ' HB2' ' HB3' ' A' ' 207' ' ' ALA . 18.7 Cg_endo . . . . . 0 N--CA 1.487 1.146 0 N-CA-C 110.455 -0.633 . . . . 0.0 110.455 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.451 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 9.8 t80 -87.19 -42.65 12.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.904 -0.498 . . . . 0.0 111.628 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.518 ' HA ' ' HB3' ' A' ' 17' ' ' GLU . 15.9 tt0 -89.37 -16.14 31.7 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.723 -1.236 . . . . 0.0 111.916 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.515 ' CD ' HG23 ' A' ' 200' ' ' VAL . 2.0 ttm180 -72.9 -64.46 0.96 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 105.977 -1.861 . . . . 0.0 105.977 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.71 HG11 ' CD2' ' A' ' 208' ' ' TYR . 7.3 p -62.22 -21.21 26.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 C-N-CA 118.721 -1.192 . . . . 0.0 108.323 176.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.518 ' HB3' ' HA ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -57.11 -35.17 69.13 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 119.92 -1.737 . . . . 0.0 106.458 177.092 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.536 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 2.9 m-20 -73.98 -29.37 61.94 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 176.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 1.088 ' HB1' HG11 ' A' ' 29' ' ' VAL . . . -67.83 -50.58 55.94 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.605 HD13 ' O ' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -61.43 -50.77 71.46 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 177.822 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.08 -26.22 62.27 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.668 -1.27 . . . . 0.0 107.966 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 18' ' ' ASN . . . -80.34 -32.55 37.83 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.499 -0.751 . . . . 0.0 109.064 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.539 ' CD2' ' CD2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -50.35 -25.44 3.84 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.093 -1.004 . . . . 0.0 108.83 177.881 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.44 -26.38 15.87 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 1.3 tp10 -144.69 81.09 1.65 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 123.866 1.793 . . . . 0.0 107.241 177.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 126.58 48.8 0.18 Allowed Glycine 0 C--N 1.276 -2.77 1 N-CA-C 102.617 -4.193 . . . . 0.0 102.617 -175.145 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.52 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 1.3 mtt180 -62.78 65.39 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 122.023 0.916 . . . . 0.0 111.715 -175.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 26' ' ' GLY . . . 176.64 98.19 0.11 Allowed Glycine 0 C--N 1.291 -1.964 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.096 HG22 ' HB3' ' A' ' 198' ' ' ALA . 24.6 t -127.0 135.17 64.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 119.161 -1.016 . . . . 0.0 110.134 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.811 ' HG2' HD22 ' A' ' 199' ' ' LEU . 0.1 OUTLIER -100.31 161.24 13.74 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.352 -179.444 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 201' ' ' THR . 11.1 p . . . . . 0 C--N 1.298 -1.651 0 CA-C-O 121.682 0.753 . . . . 0.0 109.263 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.756 ' HB2' HD11 ' A' ' 189' ' ' ILE . 20.1 t70 . . . . . 0 N--CA 1.51 2.542 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.643 ' O ' ' O ' ' A' ' 171' ' ' VAL . 0.0 OUTLIER -93.23 51.13 1.6 Allowed 'General case' 0 C--N 1.293 -1.891 0 O-C-N 120.776 -1.203 . . . . 0.0 113.476 -177.037 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.983 ' C ' HD11 ' A' ' 160' ' ' LEU . 20.7 pt -66.13 27.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 O-C-N 119.464 -2.023 . . . . 0.0 112.397 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.616 ' CZ ' ' NE2' ' A' ' 54' ' ' GLN . 31.4 m-85 -92.6 158.94 37.51 Favored Pre-proline 0 N--CA 1.505 2.292 0 O-C-N 121.064 -1.023 . . . . 0.0 113.184 -177.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.494 ' HB3' ' HB3' ' A' ' 167' ' ' LYS . 43.5 Cg_endo -66.53 130.86 24.6 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.245 1.963 . . . . 0.0 111.251 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.725 ' N ' ' HB1' ' A' ' 169' ' ' ALA . . . -58.9 -10.6 2.57 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 121.478 -0.764 . . . . 0.0 112.903 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.881 ' HA ' HD11 ' A' ' 122' ' ' ILE . 35.9 mt-10 -97.62 -2.58 41.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.631 -1.293 . . . . 0.0 109.542 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.86 57.08 1.82 Allowed 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 176.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.693 ' O ' HG23 ' A' ' 115' ' ' ILE . 25.4 tpp -63.26 86.93 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.526 -178.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 51' ' ' THR . 9.2 t -66.17 128.2 35.16 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.458 -0.776 . . . . 0.0 109.089 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 1.016 HG23 ' HB1' ' A' ' 111' ' ' ALA . 2.8 p -73.85 -2.56 3.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.534 -0.729 . . . . 0.0 109.484 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.49 -36.48 73.83 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.603 -1.239 . . . . 0.0 107.958 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.616 ' NE2' ' CZ ' ' A' ' 45' ' ' PHE . 2.3 mp0 -81.27 -53.96 5.9 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.828 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.429 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -54.56 -24.21 19.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.35 -0.844 . . . . 0.0 109.277 179.257 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.75 -46.87 64.9 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.322 -0.861 . . . . 0.0 109.896 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.77 HD11 HD23 ' A' ' 175' ' ' LEU . 0.7 OUTLIER -68.21 -36.6 79.79 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.057 -1.057 . . . . 0.0 109.952 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.414 ' OG1' ' CE ' ' A' ' 43' ' ' MET . 1.1 m -75.29 -58.17 3.44 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.198 -0.939 . . . . 0.0 110.511 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.426 ' CG1' ' O ' ' A' ' 55' ' ' MET . 96.5 mt -52.71 -22.09 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.941 . . . . 0.0 110.411 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -76.54 -40.62 49.31 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.282 -0.887 . . . . 0.0 111.15 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.01 -5.81 8.44 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.776 -1.203 . . . . 0.0 112.626 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.99 -170.62 23.75 Favored Glycine 0 N--CA 1.496 2.633 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.158 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.4 t -141.24 101.73 4.08 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 102.26 -3.237 . . . . 0.0 102.26 176.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 66' ' ' VAL . . . -111.43 76.8 0.23 Allowed Glycine 0 C--N 1.26 -3.69 0 N-CA-C 104.612 -3.395 . . . . 0.0 104.612 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.695 ' O ' HG23 ' A' ' 65' ' ' ILE . 1.2 tt -58.19 94.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 CA-C-O 123.498 1.618 . . . . 0.0 108.811 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.673 HG23 ' C ' ' A' ' 172' ' ' LEU . 1.4 p -52.55 154.23 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.134 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.807 ' O ' HG12 ' A' ' 171' ' ' VAL . 44.5 t -75.93 162.64 27.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.174 -0.954 . . . . 0.0 110.131 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.84 HD22 HG12 ' A' ' 171' ' ' VAL . 0.3 OUTLIER -125.13 92.67 3.69 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.7 -1.25 . . . . 0.0 108.474 178.497 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.563 ' C ' HG23 ' A' ' 70' ' ' ILE . 1.8 t -93.25 153.88 18.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.428 -1.42 . . . . 0.0 113.073 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.563 HG23 ' C ' ' A' ' 69' ' ' CYS . 3.7 pt -155.29 147.51 12.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.048 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.515 HG22 ' H ' ' A' ' 72' ' ' GLU . 5.1 m -77.86 176.17 9.32 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 120.452 -1.405 . . . . 0.0 108.896 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.515 ' H ' HG22 ' A' ' 71' ' ' THR . 7.6 tt0 -95.16 -11.18 28.58 Favored 'General case' 0 C--N 1.284 -2.244 0 O-C-N 121.291 -0.881 . . . . 0.0 110.282 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -90.64 -75.26 0.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.591 -1.244 . . . . 0.0 111.557 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.58 -26.3 37.98 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 119.391 -0.923 . . . . 0.0 108.961 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.545 ' O ' ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -85.8 -27.47 25.14 Favored 'General case' 0 C--O 1.192 -1.967 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.359 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.1 OUTLIER -68.17 -41.78 81.0 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 121.157 1.799 . . . . 0.0 108.022 178.051 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.75 -58.28 6.85 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.614 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.91 HD22 ' O ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -89.09 -32.05 17.73 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 118.1 -1.44 . . . . 0.0 108.925 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.7 ' N ' HD13 ' A' ' 78' ' ' LEU . 1.4 t0 -116.03 75.32 0.94 Allowed 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.716 -0.615 . . . . 0.0 109.569 177.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.827 HD22 ' O ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -75.46 126.68 87.3 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.669 -1.269 . . . . 0.0 111.827 -177.669 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.631 ' HB3' HG23 ' A' ' 96' ' ' THR . 55.2 Cg_endo -90.82 98.72 0.24 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 122.627 0.803 . . . . 0.0 110.038 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.609 ' SD ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -87.59 97.85 11.09 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.194 -0.941 . . . . 0.0 109.027 179.212 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.0 mtt -47.03 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.624 -0.672 . . . . 0.0 110.543 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.907 HG12 ' O ' ' A' ' 95' ' ' PHE . 14.7 p . . . . . 0 N--CA 1.495 1.811 0 C-N-CA 119.456 -0.897 . . . . 0.0 110.778 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.907 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 122.555 1.169 . . . . 0.0 111.447 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.631 HG23 ' HB3' ' A' ' 81' ' ' PRO . 4.0 m -60.23 78.05 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.343 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' A' ' 95' ' ' PHE . 2.6 p -32.99 149.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 CA-C-O 122.615 1.198 . . . . 0.0 112.183 -176.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.749 HG22 ' O ' ' A' ' 137' ' ' VAL . 5.4 p -70.29 -174.86 0.89 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.915 -175.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.868 HG23 HD22 ' A' ' 131' ' ' LEU 0.27 0.1 OUTLIER -146.44 136.61 17.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 -179.679 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.808 ' O ' HD23 ' A' ' 131' ' ' LEU . 46.7 tt0 -91.83 107.07 18.94 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 117.449 -1.7 . . . . 0.0 112.683 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.981 ' HB1' HG23 ' A' ' 105' ' ' VAL . . . -49.96 93.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.424 0.631 . . . . 0.0 110.754 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.859 ' HB3' ' O ' ' A' ' 130' ' ' ASP . . . -98.35 0.34 45.28 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.717 -1.24 . . . . 0.0 109.513 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.476 ' HB3' ' HB1' ' A' ' 121' ' ' ALA . 12.5 tt0 -82.81 13.74 3.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.062 -1.024 . . . . 0.0 111.299 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.576 ' O ' HG13 ' A' ' 105' ' ' VAL . . . 128.31 25.41 1.06 Allowed Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.31 -1.424 . . . . 0.0 112.562 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.981 HG23 ' HB1' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -161.0 118.03 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 O-C-N 120.92 -1.341 . . . . 0.0 110.742 177.087 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 101' ' ' ALA . 32.0 p -147.68 59.48 1.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.462 -1.399 . . . . 0.0 112.131 176.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.947 HG22 ' HG2' ' A' ' 114' ' ' ARG . 7.6 t -137.49 -28.02 0.92 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 120.528 -1.358 . . . . 0.0 110.706 176.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.26 -28.32 3.4 Favored Glycine 0 N--CA 1.487 2.1 0 O-C-N 121.389 -0.82 . . . . 0.0 111.797 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.08 53.46 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 120.513 -1.581 . . . . 0.0 111.782 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.554 ' CB ' HG21 ' A' ' 107' ' ' THR . 6.6 t -132.8 54.61 1.94 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 1.016 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -41.0 -24.68 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -177.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.458 ' O ' HG23 ' A' ' 116' ' ' THR . . . -78.04 -77.68 0.15 Allowed 'General case' 0 C--N 1.29 -2.017 0 O-C-N 120.289 -1.507 . . . . 0.0 109.913 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.34 -19.78 60.93 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.609 -0.682 . . . . 0.0 112.292 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.947 ' HG2' HG22 ' A' ' 107' ' ' THR . 1.4 mpt_? -95.5 -40.29 9.54 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 118.06 -1.456 . . . . 0.0 111.69 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.712 HG21 ' HB ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -67.98 -11.85 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 117.272 -1.771 . . . . 0.0 108.645 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 112' ' ' ALA . 20.7 p -83.04 -53.34 5.88 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 176.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.653 ' OG1' HG13 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -73.56 -23.44 59.97 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.805 178.753 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.799 HG23 HG11 ' A' ' 105' ' ' VAL . 2.8 t -63.43 -55.92 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.081 -1.012 . . . . 0.0 109.263 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 36.4 ptt85 -52.18 -33.3 40.01 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.719 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.422 ' N ' ' HG3' ' A' ' 119' ' ' ARG . . . -94.27 -9.49 35.91 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.826 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.511 ' CB ' ' CG2' ' A' ' 105' ' ' VAL . . . -98.49 -53.72 3.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.952 -1.093 . . . . 0.0 112.561 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.881 HD11 ' HA ' ' A' ' 48' ' ' GLU . 2.5 pp -67.93 -17.56 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.523 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.446 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . . . -107.24 74.1 0.96 Allowed 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.648 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.491 ' HB3' ' CG ' ' A' ' 127' ' ' LYS . 17.5 t70 -97.29 -63.09 1.16 Allowed 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 122.451 1.12 . . . . 0.0 110.256 178.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 126.8 -39.69 1.92 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.711 -2.156 . . . . 0.0 107.711 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -135.86 94.36 3.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.311 -1.111 . . . . 0.0 109.39 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.491 ' CG ' ' HB3' ' A' ' 124' ' ' ASP . 10.8 mmmt -136.9 57.94 17.15 Favored Pre-proline 0 C--N 1.308 -1.23 0 O-C-N 120.702 -1.249 . . . . 0.0 110.57 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.67 -16.22 52.56 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 N-CA-C 108.389 -1.427 . . . . 0.0 108.389 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.9 m -123.28 -25.38 4.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.577 -0.702 . . . . 0.0 111.373 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.859 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 2.8 t70 -78.39 10.0 3.45 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.749 -1.219 . . . . 0.0 112.428 -178.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.868 HD22 HG23 ' A' ' 99' ' ' ILE . 8.3 mt -140.32 96.56 3.06 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.687 -1.258 . . . . 0.0 108.671 178.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 0.6 OUTLIER -117.88 98.04 6.14 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.266 -0.896 . . . . 0.0 112.31 -178.045 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.822 ' HB2' ' HA ' ' A' ' 134' ' ' PRO . 0.0 OUTLIER -79.5 171.92 11.23 Favored Pre-proline 0 N--CA 1.503 2.214 0 O-C-N 121.717 -0.615 . . . . 0.0 111.305 -178.391 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.822 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 48.2 Cg_endo -73.16 130.84 21.12 Favored 'Cis proline' 0 N--CA 1.505 2.192 0 C-N-CA 123.405 -1.498 . . . . 0.0 113.432 7.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 100' ' ' GLU . . . -132.46 63.6 0.62 Allowed Glycine 0 N--CA 1.499 2.858 0 C-N-CA 119.844 -1.169 . . . . 0.0 111.88 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.505 ' O ' ' CE2' ' A' ' 138' ' ' PHE . 57.4 m80 30.46 38.45 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.986 -0.714 . . . . 0.0 112.801 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.749 ' O ' HG22 ' A' ' 98' ' ' THR . 2.2 t -108.24 132.56 55.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.553 ' CZ ' ' CG1' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -122.69 84.88 49.1 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 120.47 -1.394 . . . . 0.0 108.381 -176.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.711 ' O ' HD22 ' A' ' 140' ' ' LEU . 55.6 Cg_endo -104.3 159.33 0.21 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.961 1.774 . . . . 0.0 114.07 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.711 HD22 ' O ' ' A' ' 139' ' ' PRO . 0.5 OUTLIER -142.67 112.38 6.86 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 176.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.443 ' HB3' ' CB ' ' A' ' 81' ' ' PRO . 2.6 ptt85 -64.77 147.1 53.82 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.033 -1.042 . . . . 0.0 111.724 -176.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -129.55 132.15 46.75 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.69 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.39 143.85 27.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.171 -0.955 . . . . 0.0 109.909 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.18 100.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.407 -0.808 . . . . 0.0 109.42 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.447 ' HA2' ' NH2' ' A' ' 209' ' ' ARG . . . 88.66 20.8 46.14 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.33 13.18 61.68 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 1.01 HG22 ' HA ' ' A' ' 155' ' ' GLU . 0.3 OUTLIER -95.1 25.35 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 O-C-N 120.987 -1.302 . . . . 0.0 108.903 178.705 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.592 HD13 ' CG1' ' A' ' 206' ' ' VAL . 4.5 mm? -93.8 39.32 1.07 Allowed 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 102.36 -3.2 . . . . 0.0 102.36 172.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.547 ' H ' ' C ' ' A' ' 147' ' ' VAL . 48.8 m -102.6 92.25 4.56 Favored 'General case' 0 N--CA 1.409 -2.489 1 N-CA-C 99.002 -4.444 . . . . 0.0 99.002 177.021 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.503 ' O ' ' C ' ' A' ' 151' ' ' GLY . 0.2 OUTLIER -44.49 163.01 0.02 OUTLIER 'General case' 0 C--N 1.26 -3.316 0 CA-C-N 112.694 -2.048 . . . . 0.0 109.232 -173.728 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 150' ' ' ARG . . . -14.48 82.88 0.0 OUTLIER Glycine 0 N--CA 1.515 3.964 0 CA-C-O 124.179 1.988 . . . . 0.0 112.856 -169.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 150' ' ' ARG . . . -114.55 -157.83 11.99 Favored Glycine 0 N--CA 1.472 1.084 0 N-CA-C 106.984 -2.447 . . . . 0.0 106.984 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -92.83 -33.79 14.11 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.07 -1.253 . . . . 0.0 110.114 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.515 ' O ' HG21 ' A' ' 147' ' ' VAL . 41.6 p -97.0 -3.31 41.76 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.435 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 1.01 ' HA ' HG22 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -53.69 -32.26 51.06 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -175.318 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.593 ' CB ' HD13 ' A' ' 205' ' ' LEU . . . -113.89 5.25 16.15 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.153 -1.592 . . . . 0.0 112.336 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.819 HG22 ' C ' ' A' ' 170' ' ' GLY . 0.0 OUTLIER -89.4 -51.36 5.59 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.946 179.543 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.53 ' HA ' HD12 ' A' ' 158' ' ' ILE . 1.1 tp -90.25 -27.01 5.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 116.844 -1.942 . . . . 0.0 107.255 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.786 ' OD2' HG22 ' A' ' 206' ' ' VAL . 12.4 t70 -62.13 -23.65 66.69 Favored 'General case' 0 C--O 1.199 -1.601 0 C-N-CA 115.877 -2.329 . . . . 0.0 105.099 172.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.983 HD11 ' C ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -49.96 -45.13 51.14 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.373 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.485 ' CB ' ' HA ' ' A' ' 168' ' ' PRO . 5.7 ptt? -52.35 -36.37 53.38 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.008 176.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.758 HG21 ' CG ' ' A' ' 209' ' ' ARG . 4.5 m -79.59 -43.92 22.02 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.815 HD13 ' HA ' ' A' ' 160' ' ' LEU . 0.4 OUTLIER -35.54 -37.07 0.08 Allowed 'General case' 0 N--CA 1.517 2.907 0 CA-C-O 122.216 1.008 . . . . 0.0 109.094 178.184 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.478 ' HA ' HD21 ' A' ' 20' ' ' LEU . . . -106.93 -26.99 10.96 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.913 0.863 . . . . 0.0 108.828 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 162' ' ' THR . . . 108.93 -25.89 17.32 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -148.98 57.65 1.03 Allowed 'General case' 0 N--CA 1.505 2.297 0 C-N-CA 117.477 -1.689 . . . . 0.0 113.132 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.494 ' HB3' ' HB3' ' A' ' 46' ' ' PRO . 18.3 mmtt -129.3 73.88 81.36 Favored Pre-proline 0 C--N 1.3 -1.564 0 O-C-N 120.485 -1.385 . . . . 0.0 107.758 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.485 ' HA ' ' CB ' ' A' ' 161' ' ' MET . 39.5 Cg_endo -67.4 84.44 0.36 Allowed 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 116.236 -2.043 . . . . 0.0 110.107 -176.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.725 ' HB1' ' N ' ' A' ' 47' ' ' ALA 0.265 . . -159.56 164.43 34.27 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 176.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.819 ' C ' HG22 ' A' ' 157' ' ' THR . . . -157.63 108.88 0.38 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 118.406 -1.854 . . . . 0.0 109.969 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.84 HG12 HD22 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -133.14 92.68 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.196 -1.725 0 C-N-CA 116.952 -1.899 . . . . 0.0 109.491 177.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.844 HD11 HD12 ' A' ' 160' ' ' LEU . 10.0 mp -103.86 145.4 30.17 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.16 0.505 . . . . 0.0 109.826 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.525 ' N ' ' HB2' ' A' ' 43' ' ' MET . 1.1 t -130.73 167.54 18.66 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.112 -0.993 . . . . 0.0 110.724 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.401 ' N ' ' SG ' ' A' ' 173' ' ' CYS . 13.6 mm-40 -115.28 126.19 54.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.166 -0.959 . . . . 0.0 109.843 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.845 HD12 ' HB2' ' A' ' 188' ' ' CYS . 3.3 tm? . . . . . 0 N--CA 1.497 1.878 0 O-C-N 121.074 -1.016 . . . . 0.0 110.359 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 1.02 ' HB1' ' CB ' ' A' ' 188' ' ' CYS . . . . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 121.375 0.607 . . . . 0.0 110.047 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 188' ' ' CYS . 0.6 OUTLIER -79.07 125.08 28.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.462 -0.774 . . . . 0.0 109.923 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.813 ' HB3' ' HD3' ' A' ' 186' ' ' PRO . . . -38.14 -54.03 2.72 Favored Pre-proline 0 N--CA 1.501 2.084 0 O-C-N 121.809 -0.557 . . . . 0.0 112.391 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.813 ' HD3' ' HB3' ' A' ' 185' ' ' ALA . 47.5 Cg_endo -74.15 -35.12 4.31 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.41 1.216 . . . . 0.0 111.329 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 190' ' ' GLU . 0.0 OUTLIER -83.64 -59.3 2.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.076 -1.015 . . . . 0.0 111.514 -179.006 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 188' ' ' CYS . . . . . 1.02 ' CB ' ' HB1' ' A' ' 183' ' ' ALA . 12.3 p -53.15 -40.09 64.03 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.173 -0.954 . . . . 0.0 110.231 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.756 HD11 ' HB2' ' A' ' 42' ' ' ASP . 3.7 tp -73.33 -29.09 26.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 120.703 -1.248 . . . . 0.0 108.254 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 194' ' ' LYS . 0.1 OUTLIER -58.31 -20.51 43.62 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.759 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.485 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.2 OUTLIER -76.49 -53.85 7.53 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 178.291 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.474 ' HA ' HD22 ' A' ' 57' ' ' LEU . . . -56.28 -25.6 48.82 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ASN . . . . . 0.8 ' CB ' HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -89.38 -23.61 22.15 Favored 'General case' 0 C--O 1.194 -1.863 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 190' ' ' GLU . 0.0 OUTLIER -52.07 -35.59 47.94 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 119.578 -1.951 . . . . 0.0 110.459 -178.842 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.5 -43.27 6.59 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 117.612 -1.635 . . . . 0.0 108.495 176.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.462 ' HB3' ' CA ' ' A' ' 28' ' ' GLY . 81.1 m-20 -103.91 56.22 0.73 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 176.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' MET . . . . . 0.551 ' N ' ' O ' ' A' ' 193' ' ' ASN . 0.4 OUTLIER -66.59 74.72 0.1 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 -172.513 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 1.096 ' HB3' HG22 ' A' ' 29' ' ' VAL . . . -131.01 99.25 4.83 Favored 'General case' 0 C--O 1.197 -1.701 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 172.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.811 HD22 ' HG2' ' A' ' 30' ' ' MET . 44.2 mt -118.21 131.57 56.37 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 119.68 -1.888 . . . . 0.0 111.448 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.641 HG13 ' N ' ' A' ' 201' ' ' THR . 0.5 OUTLIER -129.87 -159.22 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.313 -0.867 . . . . 0.0 111.352 -179.429 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.783 ' O ' HG23 ' A' ' 31' ' ' VAL . 1.7 p -125.46 177.64 6.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.488 -0.758 . . . . 0.0 109.955 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.528 HG23 ' N ' ' A' ' 203' ' ' GLU . 1.4 tp -91.46 -44.46 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.214 -0.929 . . . . 0.0 111.752 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.528 ' N ' HG23 ' A' ' 202' ' ' ILE . 43.9 mt-10 -60.17 -61.9 2.26 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.693 -1.254 . . . . 0.0 110.223 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.462 ' CB ' ' HB3' ' A' ' 12' ' ' PRO . 2.7 m-20 -57.74 -16.95 12.71 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.366 -0.834 . . . . 0.0 110.696 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.803 HD21 HD11 ' A' ' 163' ' ' LEU . 8.4 tt -68.05 -61.15 1.99 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.236 -1.54 . . . . 0.0 110.353 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.786 HG22 ' OD2' ' A' ' 159' ' ' ASP . 2.4 t -60.93 -16.66 14.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 119.848 -1.782 . . . . 0.0 109.277 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.886 ' HB3' ' HB2' ' A' ' 12' ' ' PRO . . . -60.58 -32.77 71.86 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 105.329 -2.101 . . . . 0.0 105.329 174.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.71 ' CD2' HG11 ' A' ' 16' ' ' VAL 0.273 1.1 t80 -50.81 -41.98 57.79 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 175.101 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.758 ' CG ' HG21 ' A' ' 162' ' ' THR . 1.3 ttt85 -78.43 -62.77 1.58 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.153 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -50.41 -37.2 36.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.192 -0.943 . . . . 0.0 110.409 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 207' ' ' ALA . . . -74.75 -26.91 60.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.396 -0.815 . . . . 0.0 110.152 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 110.18 179.901 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.635 ' O ' HG12 ' A' ' 16' ' ' VAL . 34.3 Cg_endo . . . . . 0 C--O 1.208 -1.012 0 N-CA-C 109.712 -0.918 . . . . 0.0 109.712 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.34 -45.27 7.89 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -178.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -81.91 -58.43 2.98 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.259 -1.376 . . . . 0.0 111.524 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.679 ' O ' HG21 ' A' ' 200' ' ' VAL . 0.0 OUTLIER -82.65 -15.26 52.73 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 118.666 -1.214 . . . . 0.0 112.531 -178.253 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.748 ' CG2' HG13 ' A' ' 200' ' ' VAL . 1.1 t -97.94 -29.92 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 116.422 -2.111 . . . . 0.0 110.444 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -73.28 -37.06 66.38 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 115.986 -2.286 . . . . 0.0 107.037 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.853 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 5.4 t30 -74.96 -26.27 59.47 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.621 ' CB ' HD12 ' A' ' 23' ' ' LEU . . . -90.77 -17.01 27.38 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.207 -0.933 . . . . 0.0 109.598 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.907 HD13 ' OH ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -69.29 -51.5 36.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.943 -1.098 . . . . 0.0 109.605 179.472 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.457 ' HA ' ' HB2' ' A' ' 25' ' ' GLU . . . -89.49 -46.22 8.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.076 -1.015 . . . . 0.0 111.034 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.853 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -72.23 -39.54 68.42 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.148 -0.97 . . . . 0.0 111.876 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.045 HD22 ' HB2' ' A' ' 198' ' ' ALA . 56.8 mt -105.05 -24.1 12.85 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.878 -1.139 . . . . 0.0 112.664 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.981 ' NH2' HD12 ' A' ' 163' ' ' LEU . 0.4 OUTLIER -100.34 -6.2 26.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.569 -1.332 . . . . 0.0 110.714 -179.288 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 3.2 tt0 -101.25 44.4 1.01 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 118.117 -1.433 . . . . 0.0 107.949 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.02 2.67 12.43 Favored Glycine 0 C--N 1.296 -1.692 0 C-N-CA 119.911 -1.138 . . . . 0.0 112.616 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.412 ' HB3' ' HA ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -128.55 22.04 5.99 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 121.313 2.557 . . . . 0.0 115.944 -179.628 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.767 ' O ' ' HB3' ' A' ' 198' ' ' ALA . . . 97.09 108.74 2.6 Favored Glycine 0 N--CA 1.501 3.009 0 C-N-CA 117.923 -2.084 . . . . 0.0 116.819 171.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.74 HG12 HD12 ' A' ' 44' ' ' ILE . 30.7 t -140.77 122.08 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.439 -1.624 . . . . 0.0 106.814 173.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.672 ' C ' HD11 ' A' ' 44' ' ' ILE . 1.1 mtt -123.55 150.03 44.53 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 118.727 -1.189 . . . . 0.0 113.937 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.984 HG23 ' HB ' ' A' ' 202' ' ' ILE . 1.1 p . . . . . 0 N--CA 1.498 1.939 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.618 ' OD1' HD13 ' A' ' 189' ' ' ILE . 7.9 m-20 . . . . . 0 N--CA 1.5 2.059 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.671 ' HB3' ' HA ' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -85.71 59.81 5.86 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.233 -0.917 . . . . 0.0 111.233 -178.627 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.987 ' O ' HD21 ' A' ' 160' ' ' LEU . 41.9 mt -56.73 22.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.94 0 O-C-N 120.489 -1.382 . . . . 0.0 114.531 -175.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 43' ' ' MET . 32.3 m-85 -82.92 161.53 57.8 Favored Pre-proline 0 C--N 1.292 -1.919 0 O-C-N 120.344 -1.473 . . . . 0.0 110.557 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.502 ' HB3' ' CB ' ' A' ' 167' ' ' LYS . 48.0 Cg_endo -70.21 131.83 21.39 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.791 1.661 . . . . 0.0 111.434 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 1.029 ' HB3' ' HB1' ' A' ' 169' ' ' ALA . . . -61.9 -13.65 26.75 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.467 -0.771 . . . . 0.0 111.774 -178.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.815 ' HA ' ' HB3' ' A' ' 123' ' ' ALA . 0.2 OUTLIER -88.83 -8.71 53.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.038 -1.039 . . . . 0.0 109.088 178.929 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.456 ' O ' ' N ' ' A' ' 51' ' ' THR . 0.7 OUTLIER -133.9 57.92 1.79 Allowed 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 176.8 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . 1.052 ' O ' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -60.12 87.6 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.811 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.456 ' N ' ' O ' ' A' ' 49' ' ' THR . 13.6 m -64.88 155.59 33.7 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.608 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.862 ' CG2' HG21 ' A' ' 115' ' ' ILE . 14.1 t -71.33 -4.89 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.525 -0.734 . . . . 0.0 110.098 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.46 ' OE1' ' CZ ' ' A' ' 45' ' ' PHE . 3.1 mt-10 -57.24 -25.72 59.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.886 -1.134 . . . . 0.0 108.959 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.529 ' HG3' HG11 ' A' ' 66' ' ' VAL . 1.2 tm0? -75.72 -54.15 7.4 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.708 0.765 . . . . 0.0 110.552 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.594 ' HG2' ' HB2' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -66.36 -45.47 80.0 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.608 -178.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -54.75 -44.51 73.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.086 -1.009 . . . . 0.0 110.649 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.707 HD13 ' HG2' ' A' ' 174' ' ' GLU . 3.1 tt -67.09 -56.01 11.86 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.195 -0.941 . . . . 0.0 109.607 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.72 HG21 ' HA3' ' A' ' 64' ' ' GLY . 11.8 p -65.16 -51.77 59.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.969 -1.082 . . . . 0.0 111.441 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 55' ' ' MET . 7.7 tt -49.92 -25.68 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.053 -1.03 . . . . 0.0 109.198 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 57' ' ' LEU . 9.6 ttm180 -66.52 -61.72 1.84 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.996 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -129.33 -11.77 4.56 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 118.108 -1.437 . . . . 0.0 114.028 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 58' ' ' THR . . . -132.06 -169.67 12.37 Favored Glycine 0 N--CA 1.498 2.796 0 O-C-N 120.468 -1.395 . . . . 0.0 112.12 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.4 t -135.28 104.75 6.0 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 101.122 -3.658 . . . . 0.0 101.122 176.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.72 ' HA3' HG21 ' A' ' 58' ' ' THR . . . -103.32 73.76 0.28 Allowed Glycine 0 C--N 1.262 -3.545 0 N-CA-C 107.781 -2.128 . . . . 0.0 107.781 -176.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.699 ' O ' HG23 ' A' ' 65' ' ' ILE . 0.6 OUTLIER -65.2 90.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.272 -2.765 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.647 HG21 ' HE3' ' A' ' 50' ' ' MET . 28.3 m -51.41 155.57 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 122.049 0.928 . . . . 0.0 113.375 -177.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 171' ' ' VAL . 61.6 m -90.37 111.7 23.02 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.651 HD21 HD13 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -88.44 91.97 9.0 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.527 ' C ' HG23 ' A' ' 70' ' ' ILE . 26.4 p -78.35 161.66 27.03 Favored 'General case' 0 C--N 1.285 -2.204 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.929 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.83 HD11 ' HG3' ' A' ' 81' ' ' PRO . 1.1 pt -151.48 147.84 15.11 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.64 HG22 ' HB2' ' A' ' 75' ' ' ARG . 10.3 t -79.89 172.21 14.09 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 120.294 -1.504 . . . . 0.0 107.939 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.489 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -92.46 -10.98 35.92 Favored 'General case' 0 C--N 1.276 -2.587 0 O-C-N 121.321 -0.862 . . . . 0.0 109.855 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.95 -72.67 0.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.751 -1.218 . . . . 0.0 111.9 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.441 ' NH1' ' HB2' ' A' ' 126' ' ' ALA . 2.1 mtt-85 -87.8 -35.27 17.93 Favored 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 119.346 -0.942 . . . . 0.0 109.137 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.64 ' HB2' HG22 ' A' ' 71' ' ' THR . 3.0 mmt180 -69.7 -31.29 69.23 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.004 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.489 ' CG ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -69.76 -44.22 70.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.236 -1.54 . . . . 0.0 109.075 178.6 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -41.88 -55.11 3.2 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.768 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.991 HD13 ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -104.97 -27.97 11.36 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 117.673 -1.611 . . . . 0.0 110.149 178.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.991 ' N ' HD13 ' A' ' 78' ' ' LEU . 22.6 t0 -115.8 72.9 0.82 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.793 -1.192 . . . . 0.0 110.115 176.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.728 ' O ' HG11 ' A' ' 97' ' ' VAL . 13.9 tp -80.42 121.25 81.32 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.568 -1.332 . . . . 0.0 109.301 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.83 ' HG3' HD11 ' A' ' 70' ' ' ILE . 54.0 Cg_endo -89.4 93.81 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.573 1.301 . . . . 0.0 109.596 178.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.491 ' H ' HG21 ' A' ' 97' ' ' VAL . 1.2 ttt -96.84 42.95 1.08 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.172 -0.955 . . . . 0.0 109.879 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.504 ' HA ' ' CA ' ' A' ' 96' ' ' THR . 0.0 OUTLIER 16.8 107.99 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 84' ' ' VAL . 7.2 p . . . . . 0 N--CA 1.487 1.413 0 C-N-CA 117.277 -1.769 . . . . 0.0 112.635 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.75 ' CD2' HD22 ' A' ' 140' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 122.031 0.92 . . . . 0.0 110.638 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.504 ' CA ' ' HA ' ' A' ' 83' ' ' MET . 0.7 OUTLIER -133.73 37.38 3.28 Favored 'General case' 0 N--CA 1.515 2.809 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -179.623 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.728 HG11 ' O ' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -115.52 110.29 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 O-C-N 120.546 -1.346 . . . . 0.0 110.319 178.283 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.811 HG22 ' O ' ' A' ' 137' ' ' VAL . 14.9 p -75.45 177.19 6.86 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.123 -0.985 . . . . 0.0 110.439 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 1.081 HD12 HD13 ' A' ' 131' ' ' LEU . 27.9 pt -142.31 135.81 28.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 132' ' ' ASN . 10.9 tt0 -86.17 113.37 22.15 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 117.072 -1.851 . . . . 0.0 110.961 -176.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.908 ' HB1' HG13 ' A' ' 105' ' ' VAL . . . -53.02 91.7 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.648 0.737 . . . . 0.0 109.929 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.534 ' H ' HD23 ' A' ' 131' ' ' LEU . . . -106.29 -0.43 24.39 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.407 -0.808 . . . . 0.0 110.504 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.45 ' HB3' ' HB1' ' A' ' 121' ' ' ALA . 27.6 tt0 -86.89 26.97 1.05 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.915 -1.115 . . . . 0.0 111.896 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.645 ' C ' HG21 ' A' ' 117' ' ' THR . . . 126.94 -38.68 2.11 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.422 -1.37 . . . . 0.0 111.466 178.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.908 HG13 ' HB1' ' A' ' 101' ' ' ALA . 5.4 p -101.39 125.7 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.104 -1.233 . . . . 0.0 110.331 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.5 m -143.06 59.62 1.41 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.853 -1.155 . . . . 0.0 110.565 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.9 m -137.27 -30.76 0.84 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.091 -1.005 . . . . 0.0 110.564 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.417 ' CA ' ' CE1' ' A' ' 136' ' ' HIS . . . 78.62 -30.81 1.95 Allowed Glycine 0 N--CA 1.494 2.52 0 O-C-N 121.565 -0.71 . . . . 0.0 111.329 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.17 58.57 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.85 -1.383 . . . . 0.0 109.347 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -128.23 57.49 1.57 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.298 -0.876 . . . . 0.0 109.057 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.594 ' HB2' ' HG2' ' A' ' 55' ' ' MET . . . -33.48 -29.95 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -81.05 -76.94 0.22 Allowed 'General case' 0 C--N 1.291 -1.972 0 O-C-N 120.893 -1.129 . . . . 0.0 110.13 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.81 -13.94 62.71 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.563 -0.711 . . . . 0.0 111.18 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.586 ' HE ' HG21 ' A' ' 118' ' ' VAL . 0.1 OUTLIER -89.65 -44.44 10.05 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.96 -1.087 . . . . 0.0 110.506 -179.671 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 1.052 HG23 ' O ' ' A' ' 50' ' ' MET . 18.4 mm -64.6 -16.92 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.668 -1.213 . . . . 0.0 110.739 -178.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 68.8 p -88.28 -53.45 4.69 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.866 -1.133 . . . . 0.0 108.704 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.645 HG21 ' C ' ' A' ' 104' ' ' GLY . 60.0 m -71.39 -43.19 67.31 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.544 -0.863 . . . . 0.0 110.004 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.586 HG21 ' HE ' ' A' ' 114' ' ' ARG . 4.4 p -52.72 -40.13 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 120.577 -1.327 . . . . 0.0 109.866 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 54.2 ttt180 -51.31 -53.47 35.64 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.851 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -99.29 -6.99 27.01 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 117' ' ' THR . . . -98.35 -26.36 14.52 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 116.056 1.872 . . . . 0.0 116.056 -174.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.716 HD12 ' N ' ' A' ' 123' ' ' ALA . 2.6 pp -121.02 -37.7 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 121.112 1.778 . . . . 0.0 112.091 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.815 ' HB3' ' HA ' ' A' ' 48' ' ' GLU . . . -103.98 75.26 1.27 Allowed 'General case' 0 C--N 1.263 -3.166 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.392 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.479 ' CB ' ' CD ' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -97.27 -54.96 2.99 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.297 1.046 . . . . 0.0 110.154 177.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 124.07 -39.94 2.05 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 105.729 -2.949 . . . . 0.0 105.729 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.441 ' HB2' ' NH1' ' A' ' 74' ' ' ARG . . . -134.63 96.76 3.63 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 175.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.479 ' CD ' ' CB ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -131.75 123.45 19.22 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 120.857 -1.152 . . . . 0.0 113.373 -176.267 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.456 ' HD2' ' CE ' ' A' ' 127' ' ' LYS . 51.8 Cg_endo -81.38 21.02 0.95 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.656 1.345 . . . . 0.0 108.79 175.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 131' ' ' LEU . 2.0 m -92.9 42.29 1.1 Allowed 'General case' 0 C--O 1.202 -1.418 0 O-C-N 121.412 -0.805 . . . . 0.0 109.018 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -26.51 79.37 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 123.991 1.853 . . . . 0.0 111.798 -176.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 1.081 HD13 HD12 ' A' ' 99' ' ' ILE 0.255 5.4 mt -61.44 125.35 23.48 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 112.069 -2.332 . . . . 0.0 108.047 -178.148 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 15.7 p-10 -113.68 99.51 7.78 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.409 -0.807 . . . . 0.0 111.738 -177.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.843 ' HB2' ' HA ' ' A' ' 134' ' ' PRO 0.282 0.5 OUTLIER -82.58 -178.43 1.18 Allowed Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 122.031 -0.418 . . . . 0.0 111.203 -177.611 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.843 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 48.5 Cg_endo -72.69 123.39 8.23 Favored 'Cis proline' 0 N--CA 1.503 2.063 0 C-N-CA 123.674 -1.386 . . . . 0.0 113.327 8.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.747 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -124.04 60.03 0.61 Allowed Glycine 0 N--CA 1.5 2.907 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.105 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.472 ' O ' ' CE2' ' A' ' 138' ' ' PHE . 25.5 p80 32.1 37.97 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.665 0 O-C-N 121.745 -0.856 . . . . 0.0 112.271 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.811 ' O ' HG22 ' A' ' 98' ' ' THR . 54.4 t -91.04 154.87 3.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.617 ' CD1' ' O ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -123.6 84.06 53.37 Favored Pre-proline 0 C--N 1.281 -2.376 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 -178.32 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.859 ' O ' HD23 ' A' ' 140' ' ' LEU . 54.9 Cg_endo -98.42 140.84 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.737 1.388 . . . . 0.0 113.674 -176.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.859 HD23 ' O ' ' A' ' 139' ' ' PRO . 36.1 mt -136.7 112.8 9.73 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.463 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.416 ' CD ' ' HG2' ' A' ' 81' ' ' PRO . 11.1 ttt180 -69.95 127.0 31.36 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.085 -1.009 . . . . 0.0 109.874 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.83 ' HB3' ' CG2' ' A' ' 158' ' ' ILE . . . -132.75 133.19 43.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.063 -1.023 . . . . 0.0 111.329 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -58.84 143.09 48.56 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.247 -0.908 . . . . 0.0 109.532 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.27 106.27 5.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.421 -0.799 . . . . 0.0 110.568 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 86.54 20.98 53.03 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.83 12.85 62.57 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.825 HG21 ' HB2' ' A' ' 156' ' ' ALA . 13.6 p -104.57 18.76 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.972 -1.311 . . . . 0.0 109.427 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.906 HD11 ' HA ' ' A' ' 207' ' ' ALA . 3.7 mm? -94.86 20.39 8.88 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 117.331 -1.748 . . . . 0.0 108.306 176.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 151' ' ' GLY . 29.4 m -126.99 73.46 1.42 Allowed 'General case' 0 C--N 1.29 -1.987 1 N-CA-C 96.183 -5.488 . . . . 0.0 96.183 168.515 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.748 ' HG2' HG21 ' A' ' 206' ' ' VAL . 0.1 OUTLIER -67.21 71.85 0.11 Allowed 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 113.553 -1.658 . . . . 0.0 115.033 -168.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 149' ' ' THR . . . -116.93 28.68 7.21 Favored Glycine 0 N--CA 1.475 1.281 0 N-CA-C 105.611 -2.996 . . . . 0.0 105.611 169.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -148.74 131.38 3.72 Favored Glycine 0 C--N 1.303 -1.265 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.445 ' ND1' ' O ' ' A' ' 153' ' ' HIS . 1.6 t60 -89.79 -5.37 56.99 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.537 HG23 ' N ' ' A' ' 155' ' ' GLU . 14.9 t -93.38 -46.51 7.31 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.225 -0.922 . . . . 0.0 110.821 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.746 ' HG3' HG23 ' A' ' 147' ' ' VAL . 1.2 pt-20 -59.61 -20.73 57.94 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.825 ' HB2' HG21 ' A' ' 147' ' ' VAL . . . -86.77 5.66 35.34 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 121.356 -0.84 . . . . 0.0 108.943 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.52 ' O ' ' CB ' ' A' ' 160' ' ' LEU . 2.5 m -87.05 -51.12 6.19 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.83 ' CG2' ' HB3' ' A' ' 142' ' ' ALA . 4.4 tp -74.39 -17.44 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 115.96 -2.296 . . . . 0.0 106.404 175.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.693 ' CG ' HG11 ' A' ' 147' ' ' VAL . 18.9 t70 -62.21 -29.84 70.67 Favored 'General case' 0 C--O 1.206 -1.215 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 173.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.987 HD21 ' O ' ' A' ' 44' ' ' ILE . 1.7 tm? -50.23 -43.75 53.05 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 176.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.567 ' HB2' ' HA ' ' A' ' 168' ' ' PRO . 0.0 OUTLIER -52.76 -36.21 57.6 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.75 178.508 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.633 HG21 ' HD2' ' A' ' 209' ' ' ARG . 1.5 m -93.17 -51.44 5.02 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 1.075 HD22 HD21 ' A' ' 205' ' ' LEU . 1.8 pp -57.41 -14.47 4.85 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.501 -1.374 . . . . 0.0 111.679 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -77.16 -30.78 55.15 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 120.593 -1.317 . . . . 0.0 108.392 176.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 106.27 -35.43 5.05 Favored Glycine 0 N--CA 1.493 2.475 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.326 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.74 48.19 0.39 Allowed 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 117.792 -1.563 . . . . 0.0 113.097 172.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 161' ' ' MET . 40.4 mmtt -135.95 83.46 34.26 Favored Pre-proline 0 C--N 1.289 -2.061 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 174.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.567 ' HA ' ' HB2' ' A' ' 161' ' ' MET . 44.5 Cg_endo -73.65 81.02 1.91 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 114.781 -3.013 . . . . 0.0 113.798 -173.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 1.029 ' HB1' ' HB3' ' A' ' 47' ' ' ALA . . . -165.76 168.38 16.12 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 171.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.428 ' HA3' ' HB3' ' A' ' 160' ' ' LEU . . . -156.99 129.02 2.29 Favored Glycine 0 N--CA 1.504 3.184 0 C-N-CA 118.28 -1.914 . . . . 0.0 110.276 177.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.985 HG13 ' HB2' ' A' ' 47' ' ' ALA . 6.5 m -141.42 101.43 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.962 HD22 ' HA ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -125.86 101.08 6.67 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 117.177 -1.809 . . . . 0.0 115.045 -176.165 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.489 ' HB3' ' CA ' ' A' ' 64' ' ' GLY . 1.1 m -140.79 141.87 34.74 Favored 'General case' 0 N--CA 1.514 2.736 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 173.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.707 ' HG2' HD13 ' A' ' 57' ' ' LEU . 3.5 tt0 176.82 87.32 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.33 0 CA-C-N 122.632 2.469 . . . . 0.0 115.473 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 188' ' ' CYS . 0.3 OUTLIER . . . . . 0 N--CA 1.508 2.464 0 O-C-N 120.452 -1.405 . . . . 0.0 109.108 175.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 188' ' ' CYS . . . . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 121.223 0.535 . . . . 0.0 109.935 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.588 ' O ' ' HB2' ' A' ' 185' ' ' ALA . 9.5 mtt-85 -105.26 100.15 9.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.341 -0.85 . . . . 0.0 109.825 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.859 ' HB1' ' HD2' ' A' ' 186' ' ' PRO . . . 172.92 178.93 0.12 Allowed Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.309 -0.869 . . . . 0.0 109.831 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.859 ' HD2' ' HB1' ' A' ' 185' ' ' ALA . 43.0 Cg_endo -69.5 -7.72 21.72 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.303 1.159 . . . . 0.0 110.422 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.5 -41.66 19.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.972 -1.08 . . . . 0.0 109.992 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' CYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 183' ' ' ALA . 16.8 p -67.43 -36.32 80.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.966 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.618 HD13 ' OD1' ' A' ' 42' ' ' ASP . 5.2 tp -73.98 -28.33 23.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.754 -1.216 . . . . 0.0 109.079 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.527 ' HA ' ' HB3' ' A' ' 193' ' ' ASN . 35.9 tt0 -71.05 -19.01 62.54 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.721 0.772 . . . . 0.0 109.05 177.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.494 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.7 OUTLIER -75.99 -48.42 21.12 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.128 0.966 . . . . 0.0 109.513 -179.413 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.474 ' C ' ' HB2' ' A' ' 197' ' ' MET . . . -73.79 -35.35 64.92 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 178.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ASN . . . . . 0.655 ' CB ' HD11 ' A' ' 199' ' ' LEU . 1.7 t30 -56.33 -23.36 36.72 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.3 -40.92 20.81 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 118.099 -1.441 . . . . 0.0 112.741 -176.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.25 -56.03 2.6 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 114.966 -2.694 . . . . 0.0 112.055 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' A' ' 197' ' ' MET . 0.1 OUTLIER -117.05 33.74 5.46 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.073 -1.451 . . . . 0.0 113.773 176.796 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 197' ' ' MET . . . . . 0.675 ' HE2' HD12 ' A' ' 57' ' ' LEU . 15.3 mmt -150.35 151.69 33.25 Favored 'General case' 0 N--CA 1.517 2.896 0 CA-C-N 123.034 2.652 . . . . 0.0 114.53 -178.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 1.045 ' HB2' HD22 ' A' ' 23' ' ' LEU . . . -111.59 155.73 22.89 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.033 -1.042 . . . . 0.0 108.916 177.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.655 HD11 ' CB ' ' A' ' 193' ' ' ASN . 48.1 mt -125.58 133.19 52.36 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 120.552 -1.342 . . . . 0.0 109.676 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.748 HG13 ' CG2' ' A' ' 16' ' ' VAL . 1.3 p -170.82 18.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.521 -1.362 . . . . 0.0 113.287 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' THR . . . . . 1.006 HG23 HD22 ' A' ' 205' ' ' LEU 0.271 87.0 m -133.33 150.24 51.87 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 -176.149 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.984 ' HB ' HG23 ' A' ' 31' ' ' VAL . 3.6 tp 149.85 -76.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.844 0 C-N-CA 124.99 1.316 . . . . 0.0 109.704 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.794 ' H ' HG23 ' A' ' 202' ' ' ILE . 1.9 tt0 -93.79 -59.56 1.96 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.337 -1.477 . . . . 0.0 110.723 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.33 -50.32 73.42 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.225 -0.922 . . . . 0.0 111.508 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 1.075 HD21 HD22 ' A' ' 163' ' ' LEU . 3.2 tt -60.5 -23.63 64.68 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.069 -1.019 . . . . 0.0 113.244 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.748 HG21 ' HG2' ' A' ' 150' ' ' ARG . 16.5 m -77.98 -34.82 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 119.65 -1.906 . . . . 0.0 108.14 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.906 ' HA ' HD11 ' A' ' 148' ' ' LEU . . . -68.82 -14.62 63.14 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 174.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.907 ' OH ' HD13 ' A' ' 20' ' ' LEU . 7.6 t80 -81.71 -26.71 34.38 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.798 -0.563 . . . . 0.0 109.608 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.633 ' HD2' HG21 ' A' ' 162' ' ' THR . 0.2 OUTLIER -75.82 -25.77 56.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.096 -1.003 . . . . 0.0 108.69 177.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.503 ' N ' ' HG3' ' A' ' 209' ' ' ARG . 6.8 tt0 -82.72 -59.15 2.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.412 -0.805 . . . . 0.0 109.885 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -51.77 -27.1 11.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.485 -0.759 . . . . 0.0 110.223 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 109.999 179.772 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 14' ' ' GLU . 20.5 Cg_endo . . . . . 0 N--CA 1.508 2.334 0 N-CA-C 106.551 -2.134 . . . . 0.0 106.551 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.803 ' HE2' HD13 ' A' ' 20' ' ' LEU 0.27 16.1 t80 -40.15 -26.83 0.03 OUTLIER 'General case' 0 C--O 1.184 -2.352 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.733 169.098 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 17' ' ' GLU . 1.0 OUTLIER -43.09 -38.14 2.26 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.085 -1.634 . . . . 0.0 109.082 179.28 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.7 mmt-85 -61.78 -46.37 89.87 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 176.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.803 HG21 ' CE2' ' A' ' 208' ' ' TYR . 15.7 m -79.34 -12.67 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 C-N-CA 117.684 -1.606 . . . . 0.0 109.875 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 35.1 tt0 -53.88 -34.54 59.73 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -79.11 -33.08 44.69 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.744 ' O ' ' HB3' ' A' ' 22' ' ' ALA . . . -70.49 -64.87 0.81 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.5 -0.75 . . . . 0.0 110.834 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.803 HD13 ' HE2' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -54.66 -43.95 72.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.2 -0.938 . . . . 0.0 109.127 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 17' ' ' GLU . . . -53.68 -28.37 33.03 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.744 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . -78.24 -33.52 49.7 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 3.8 tt -44.52 -28.04 0.53 Allowed 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.84 0.829 . . . . 0.0 109.582 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.53 -30.84 12.64 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 0.2 OUTLIER -147.7 82.65 1.52 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 123.439 1.59 . . . . 0.0 108.191 177.457 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.657 ' O ' ' HB1' ' A' ' 22' ' ' ALA . . . 126.57 50.64 0.17 Allowed Glycine 0 C--N 1.275 -2.821 1 N-CA-C 102.076 -4.409 . . . . 0.0 102.076 -174.882 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.803 ' CD ' HG21 ' A' ' 51' ' ' THR . 3.1 mtm180 -55.92 91.16 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 122.942 1.353 . . . . 0.0 110.429 -173.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.463 ' HA3' ' HG2' ' A' ' 197' ' ' MET . . . 176.48 105.95 0.19 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.124 -1.512 . . . . 0.0 113.189 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.012 HG13 HG12 ' A' ' 44' ' ' ILE . 1.1 p -140.34 99.21 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.71 ' HB2' HD23 ' A' ' 199' ' ' LEU . 4.9 mtt -97.96 130.42 44.82 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.864 -1.147 . . . . 0.0 114.072 -173.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 1.092 HG12 HD13 ' A' ' 205' ' ' LEU . 35.6 m . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.4 -0.812 . . . . 0.0 109.707 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.776 ' OD2' HD12 ' A' ' 189' ' ' ILE . 5.2 m-20 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 122.281 1.038 . . . . 0.0 111.834 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.941 ' HE3' HD22 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -85.87 54.41 3.12 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.511 -0.743 . . . . 0.0 110.382 -179.173 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.012 HG12 HG13 ' A' ' 29' ' ' VAL . 3.0 pt -63.77 26.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.534 3.763 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 -175.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.965 ' O ' HG22 ' A' ' 171' ' ' VAL . 9.7 m-85 -67.81 161.68 64.68 Favored Pre-proline 0 C--N 1.283 -2.309 0 O-C-N 121.372 -0.83 . . . . 0.0 112.193 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.478 ' HB3' ' HB3' ' A' ' 167' ' ' LYS . 45.6 Cg_endo -68.83 129.58 18.87 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.524 1.483 . . . . 0.0 110.52 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.54 ' N ' ' HB1' ' A' ' 169' ' ' ALA . . . -70.47 -2.59 14.38 Favored 'General case' 0 N--CA 1.508 2.441 0 C-N-CA 119.195 -1.002 . . . . 0.0 112.554 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -85.73 -23.55 27.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.737 -1.227 . . . . 0.0 109.315 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.57 ' O ' HG22 ' A' ' 49' ' ' THR . 51.7 m -132.42 60.56 1.69 Allowed 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 177.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.411 ' O ' HG13 ' A' ' 115' ' ' ILE . 0.4 OUTLIER -52.48 88.09 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.263 0.554 . . . . 0.0 110.056 -178.739 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.803 HG21 ' CD ' ' A' ' 27' ' ' ARG . 1.6 m -66.18 153.42 42.48 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.616 0.722 . . . . 0.0 109.777 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.985 HG23 ' HB1' ' A' ' 111' ' ' ALA . 1.7 p -73.91 -3.78 4.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.569 -0.707 . . . . 0.0 109.668 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.427 ' CG ' ' HB2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -55.8 -32.63 63.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.742 -1.224 . . . . 0.0 108.53 179.287 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.48 ' HB3' ' CD2' ' A' ' 45' ' ' PHE . 5.3 pt20 -81.18 -32.89 33.38 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.51 0.671 . . . . 0.0 110.118 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.763 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -82.22 -46.42 13.75 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.38 -0.825 . . . . 0.0 110.263 -179.782 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.659 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -54.07 -45.05 71.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.951 -1.093 . . . . 0.0 110.142 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 1.073 HD21 HD12 ' A' ' 175' ' ' LEU . 7.3 tt -60.98 -53.21 60.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.384 -0.823 . . . . 0.0 110.359 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.568 ' N ' HD23 ' A' ' 57' ' ' LEU . 8.3 t -74.75 -47.44 31.16 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.422 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.517 ' N ' HG23 ' A' ' 58' ' ' THR . 40.8 mt -46.54 -26.03 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 120.649 -1.282 . . . . 0.0 110.222 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.49 -47.62 17.01 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.385 -0.822 . . . . 0.0 110.785 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -125.18 -7.01 7.1 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.636 -1.29 . . . . 0.0 114.068 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 58' ' ' THR . . . -157.05 -168.23 19.32 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 120.503 -1.373 . . . . 0.0 111.005 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.69 103.77 5.32 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 102.273 -3.232 . . . . 0.0 102.273 176.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.442 ' N ' ' OG1' ' A' ' 58' ' ' THR . . . -104.48 73.03 0.25 Allowed Glycine 0 C--N 1.264 -3.439 0 N-CA-C 106.381 -2.687 . . . . 0.0 106.381 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.841 HG23 ' CZ ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -65.72 90.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.031 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.488 HG21 ' HB ' ' A' ' 171' ' ' VAL . 29.3 m -52.79 150.63 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.003 -177.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.546 ' O ' HG21 ' A' ' 157' ' ' THR . 82.8 m -77.6 119.17 20.79 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 139' ' ' PRO . 0.6 OUTLIER -90.06 92.07 8.82 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 118.617 -1.233 . . . . 0.0 108.551 -179.723 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.541 ' O ' HD13 ' A' ' 158' ' ' ILE . 0.5 OUTLIER -87.57 145.51 26.18 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 122.339 1.066 . . . . 0.0 112.576 -178.062 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.555 HD12 ' O ' ' A' ' 79' ' ' ASP . 9.9 pt -137.58 138.89 44.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.743 HG23 ' HB3' ' A' ' 143' ' ' GLN . 50.0 m -78.59 143.18 36.69 Favored 'General case' 0 C--O 1.199 -1.588 0 O-C-N 120.549 -1.344 . . . . 0.0 108.769 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.451 ' HB3' ' NE ' ' A' ' 141' ' ' ARG . 6.1 pt-20 -41.53 -25.94 0.06 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.788 -0.57 . . . . 0.0 111.799 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.543 ' H ' HG22 ' A' ' 71' ' ' THR . 0.2 OUTLIER -84.46 -49.64 8.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.953 . . . . 0.0 110.496 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -80.83 -25.5 37.71 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.079 0.942 . . . . 0.0 108.666 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.568 ' O ' ' N ' ' A' ' 79' ' ' ASP . 6.5 ttp180 -59.01 -67.99 0.31 Allowed 'General case' 0 C--O 1.19 -2.028 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.473 ' HA ' ' CB ' ' A' ' 80' ' ' LEU . 0.4 OUTLIER -48.66 -55.13 12.17 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.244 -178.352 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -30.01 -50.34 0.12 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 124.362 1.039 . . . . 0.0 111.363 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.734 HD12 HG23 ' A' ' 122' ' ' ILE . 1.6 tm? -134.78 -30.26 1.1 Allowed 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 118.286 -1.365 . . . . 0.0 111.48 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.568 ' N ' ' O ' ' A' ' 75' ' ' ARG . 58.7 m-20 -116.87 69.32 0.75 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.895 -1.128 . . . . 0.0 110.725 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.772 ' O ' HG13 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -74.73 169.39 20.14 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 120.766 -1.209 . . . . 0.0 111.66 -179.114 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.877 ' HA ' HG22 ' A' ' 97' ' ' VAL . 39.7 Cg_endo -65.77 113.33 2.5 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 O-C-N 122.551 0.764 . . . . 0.0 110.809 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.489 ' O ' HG13 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -95.67 43.46 1.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 0.0 110.768 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.426 ' C ' ' O ' ' A' ' 82' ' ' MET . 3.9 ptt? 26.94 62.4 0.09 Allowed 'General case' 0 N--CA 1.51 2.532 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.546 ' CG2' ' HA ' ' A' ' 96' ' ' THR . 19.1 m . . . . . 0 N--CA 1.493 1.693 0 O-C-N 120.833 -1.167 . . . . 0.0 110.235 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' A' ' 139' ' ' PRO . 21.9 m-30 . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.578 HG23 HG23 ' A' ' 97' ' ' VAL . 8.8 t -122.25 -1.15 9.24 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 117.974 -1.49 . . . . 0.0 114.762 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.877 HG22 ' HA ' ' A' ' 81' ' ' PRO . 57.0 t -119.14 79.88 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.619 0 C-N-CA 119.476 -0.889 . . . . 0.0 112.371 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.59 ' HA ' ' HB ' ' A' ' 137' ' ' VAL . 46.0 p -74.92 144.98 43.02 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 119.844 -1.785 . . . . 0.0 107.257 177.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.944 HG13 HG21 ' A' ' 137' ' ' VAL . 2.2 pt -146.86 125.31 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.121 -0.987 . . . . 0.0 110.568 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.591 ' O ' HD23 ' A' ' 131' ' ' LEU . 6.9 tt0 -93.14 108.85 20.37 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 117.621 -1.632 . . . . 0.0 109.511 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.99 ' HB1' HG13 ' A' ' 105' ' ' VAL . . . -50.99 93.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.362 -0.836 . . . . 0.0 110.804 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 100' ' ' GLU . . . -84.18 2.49 39.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.452 -0.78 . . . . 0.0 110.428 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.72 4.21 14.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.993 -1.067 . . . . 0.0 110.702 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.14 26.98 1.16 Allowed Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.76 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.99 HG13 ' HB1' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -146.19 122.53 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.173 -1.192 . . . . 0.0 110.507 179.331 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.3 m -146.63 60.72 1.21 Allowed 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.044 -1.035 . . . . 0.0 110.401 176.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.1 m -135.65 -31.47 0.95 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.811 -1.181 . . . . 0.0 110.73 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.432 ' HA2' ' NH2' ' A' ' 114' ' ' ARG . . . 74.21 -27.74 0.99 Allowed Glycine 0 N--CA 1.494 2.518 0 O-C-N 121.449 -0.782 . . . . 0.0 112.384 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.588 ' HA ' ' HE1' ' A' ' 55' ' ' MET . 0.0 OUTLIER -127.32 57.06 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.469 -1.607 . . . . 0.0 110.604 -179.32 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 114' ' ' ARG . 2.7 t -129.47 54.4 1.83 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.33 -0.856 . . . . 0.0 108.695 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.985 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -34.14 -29.53 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -84.83 -77.58 0.27 Allowed 'General case' 0 C--N 1.288 -2.08 0 O-C-N 120.73 -1.231 . . . . 0.0 109.612 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.413 ' O ' HG23 ' A' ' 117' ' ' THR . 2.1 m-20 -59.45 -17.38 30.63 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.503 -0.748 . . . . 0.0 110.235 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.895 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -89.62 -39.21 13.39 Favored 'General case' 0 C--O 1.203 -1.378 0 O-C-N 120.996 -1.065 . . . . 0.0 110.76 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.752 HD13 ' HA ' ' A' ' 111' ' ' ALA . 1.0 OUTLIER -57.07 -18.4 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 120.306 -1.496 . . . . 0.0 109.368 -178.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.0 m -87.41 -52.93 5.09 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.85 -1.156 . . . . 0.0 108.062 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 121' ' ' ALA . 44.1 p -66.61 -36.85 83.59 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.493 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.895 HG13 ' O ' ' A' ' 114' ' ' ARG . 26.6 m -53.89 -43.4 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 O-C-N 120.349 -1.469 . . . . 0.0 108.603 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.521 ' N ' HG23 ' A' ' 118' ' ' VAL . 0.6 OUTLIER -51.77 -32.18 29.89 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.792 -1.163 . . . . 0.0 107.879 177.223 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.451 ' HA ' ' HB2' ' A' ' 123' ' ' ALA . . . -95.3 -19.59 19.85 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.167 178.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 117' ' ' THR . . . -53.72 -54.01 43.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.918 -1.114 . . . . 0.0 109.131 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.734 HG23 HD12 ' A' ' 78' ' ' LEU . 60.3 mt -88.83 23.32 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.525 177.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . -55.18 146.5 18.59 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.508 ' O ' HD23 ' A' ' 78' ' ' LEU . 28.7 t70 -35.62 -80.19 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.792 0 CA-C-N 119.659 1.118 . . . . 0.0 110.093 -178.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 127' ' ' LYS . . . 54.46 34.5 54.94 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 118.133 -1.984 . . . . 0.0 109.786 174.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.32 91.16 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 123.29 1.519 . . . . 0.0 110.569 -174.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 125' ' ' GLY . 0.1 OUTLIER -137.93 127.28 14.91 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.428 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -53.67 -16.35 8.02 Favored 'Trans proline' 0 C--N 1.294 -2.337 0 O-C-N 122.703 0.844 . . . . 0.0 111.028 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.0 t -123.45 24.17 8.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.844 -1.16 . . . . 0.0 110.56 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.462 ' HB3' ' CB ' ' A' ' 127' ' ' LYS . 11.0 p30 -74.46 4.25 6.29 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.411 -1.431 . . . . 0.0 112.018 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.838 HD13 ' HB ' ' A' ' 99' ' ' ILE . 25.6 mt -143.1 110.83 5.89 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.558 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.6 OUTLIER -86.46 71.69 10.4 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -176.511 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.738 ' HB2' ' HA ' ' A' ' 134' ' ' PRO 0.257 0.0 OUTLIER -85.27 173.08 7.55 Favored Pre-proline 0 C--N 1.291 -1.95 0 O-C-N 121.549 -0.719 . . . . 0.0 110.064 179.966 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.738 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 47.5 Cg_endo -72.66 124.91 9.59 Favored 'Cis proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.832 -1.737 . . . . 0.0 111.524 7.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.974 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -122.08 74.93 0.36 Allowed Glycine 0 N--CA 1.501 2.988 0 C-N-CA 119.452 -1.356 . . . . 0.0 111.866 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.493 ' O ' ' CE2' ' A' ' 138' ' ' PHE . 83.2 m-70 31.18 37.18 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 O-C-N 122.204 -0.586 . . . . 0.0 112.344 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.974 HG23 ' O ' ' A' ' 135' ' ' GLY . 69.3 t -106.07 135.04 45.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 176.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.841 ' CZ ' HG23 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -126.52 81.59 67.93 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -177.672 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.791 ' HG3' HG12 ' A' ' 137' ' ' VAL . 64.3 Cg_endo -112.77 141.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.559 2.173 . . . . 0.0 113.495 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.434 HD21 ' HB ' ' A' ' 154' ' ' THR . 1.1 pp -127.53 148.87 50.33 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.454 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.46 ' HB2' ' CD ' ' A' ' 75' ' ' ARG . 0.9 OUTLIER -91.52 92.55 8.56 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.867 -1.145 . . . . 0.0 110.054 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.8 69.03 1.37 Allowed 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 118.542 -1.263 . . . . 0.0 113.1 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.743 ' HB3' HG23 ' A' ' 71' ' ' THR . 19.6 tm0? -120.9 73.21 1.0 Allowed 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 117.751 -1.579 . . . . 0.0 112.213 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -127.64 38.52 4.03 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 117.733 -1.587 . . . . 0.0 111.459 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 74.44 -4.39 34.9 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 119.277 -1.44 . . . . 0.0 111.419 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.4 28.07 17.67 Favored Glycine 0 N--CA 1.485 1.91 0 O-C-N 120.665 -1.491 . . . . 0.0 113.417 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.953 HG13 HG11 ' A' ' 206' ' ' VAL . 1.5 p -60.48 -15.8 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 120.248 2.024 . . . . 0.0 107.822 177.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.761 HD11 HG12 ' A' ' 206' ' ' VAL . 75.3 mt -94.02 22.63 5.59 Favored 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 116.81 -1.956 . . . . 0.0 110.404 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.1 p -127.44 58.34 1.47 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 101.656 -3.461 . . . . 0.0 101.656 168.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.39 149.89 28.28 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 113.034 -1.894 . . . . 0.0 110.763 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -102.47 34.68 5.53 Favored Glycine 0 N--CA 1.483 1.768 0 N-CA-C 106.293 -2.723 . . . . 0.0 106.293 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -145.48 159.7 27.95 Favored Glycine 0 N--CA 1.478 1.45 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.656 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 29.2 p-80 -89.7 -4.72 57.59 Favored 'General case' 0 C--N 1.292 -1.921 0 O-C-N 121.657 -0.907 . . . . 0.0 108.845 176.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.434 ' HB ' HD21 ' A' ' 140' ' ' LEU . 1.1 p -51.53 -55.31 19.72 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.015 -1.053 . . . . 0.0 109.795 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.447 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . 24.6 mt-10 -59.51 -21.74 60.61 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.812 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . . . -87.24 6.3 33.9 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.647 ' HA ' HD13 ' A' ' 172' ' ' LEU . 17.9 m -93.83 -51.06 5.06 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.159 -0.963 . . . . 0.0 109.52 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.62 ' O ' ' HB3' ' A' ' 161' ' ' MET . 9.7 tp -75.81 -34.15 27.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 116.238 -2.185 . . . . 0.0 105.126 175.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.519 ' HB2' ' HA ' ' A' ' 156' ' ' ALA . 0.8 OUTLIER -59.69 -25.56 64.87 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.084 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.66 ' O ' HD12 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -58.78 -28.89 66.37 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.827 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.62 ' HB3' ' O ' ' A' ' 158' ' ' ILE . 5.6 ttt -51.59 -39.26 57.58 Favored 'General case' 0 N--CA 1.514 2.758 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 174.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.444 ' CB ' ' O ' ' A' ' 159' ' ' ASP . 1.2 m -68.52 -39.26 81.25 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.651 177.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 1.014 HD21 HD21 ' A' ' 205' ' ' LEU . 0.3 OUTLIER -52.1 -57.62 9.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.864 -1.148 . . . . 0.0 108.763 179.038 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' A' ' 167' ' ' LYS . . . -64.63 -27.4 68.91 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.14 0.972 . . . . 0.0 108.545 177.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 96.17 -27.84 15.24 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 166' ' ' PHE . 37.2 p90 -151.05 55.6 0.89 Allowed 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.166 -1.414 . . . . 0.0 112.292 175.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.553 ' HD2' ' HB1' ' A' ' 164' ' ' ALA . 1.9 mttp -129.71 80.2 72.05 Favored Pre-proline 0 C--N 1.296 -1.739 0 CA-C-O 117.23 -1.367 . . . . 0.0 107.777 176.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.434 ' HA ' ' HB2' ' A' ' 161' ' ' MET . 43.2 Cg_endo -72.01 80.58 1.51 Allowed 'Trans proline' 0 C--N 1.32 -0.965 0 C-N-CA 115.367 -2.622 . . . . 0.0 110.636 -176.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.54 ' HB1' ' N ' ' A' ' 47' ' ' ALA . . . -163.26 166.37 23.25 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 104.292 -2.485 . . . . 0.0 104.292 175.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.59 ' HA3' HG22 ' A' ' 157' ' ' THR . . . -157.6 119.49 0.91 Allowed Glycine 0 N--CA 1.485 1.954 0 C-N-CA 116.721 -2.657 . . . . 0.0 112.479 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.965 HG22 ' O ' ' A' ' 45' ' ' PHE . 23.6 m -127.08 134.59 65.73 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.761 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 175.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.689 ' HG ' HG22 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -149.88 113.67 5.06 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.696 -1.252 . . . . 0.0 109.39 -178.849 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.477 ' O ' ' N ' ' A' ' 42' ' ' ASP . 21.5 p -128.65 175.79 8.3 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 120.257 -1.527 . . . . 0.0 111.377 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.417 ' OE2' ' NH2' ' A' ' 184' ' ' ARG . 16.0 pm0 -113.05 154.63 26.23 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.106 -0.996 . . . . 0.0 110.558 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 1.073 HD12 HD21 ' A' ' 57' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.896 0 O-C-N 121.269 -0.895 . . . . 0.0 109.932 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.766 ' HB1' ' SG ' ' A' ' 188' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.284 0.564 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 185' ' ' ALA . 0.2 OUTLIER -125.16 100.01 6.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.816 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.858 ' HB1' ' HD2' ' A' ' 186' ' ' PRO . . . 179.17 178.5 0.28 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.387 -0.821 . . . . 0.0 109.704 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.858 ' HD2' ' HB1' ' A' ' 185' ' ' ALA . 45.9 Cg_endo -72.65 -8.47 22.53 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.603 1.318 . . . . 0.0 110.767 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -81.45 -68.94 0.65 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.984 -1.073 . . . . 0.0 110.307 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' CYS . . . . . 0.766 ' SG ' ' HB1' ' A' ' 183' ' ' ALA . 0.4 OUTLIER -57.74 -30.41 65.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.428 -0.795 . . . . 0.0 110.097 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.852 HG22 HD22 ' A' ' 199' ' ' LEU . 27.2 mm -75.77 -26.3 17.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 120.951 -1.093 . . . . 0.0 109.102 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.489 ' HA ' HD11 ' A' ' 199' ' ' LEU . 12.0 mt-10 -76.76 -19.38 57.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.474 -0.766 . . . . 0.0 109.092 177.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 192' ' ' ALA . 0.8 OUTLIER -70.27 -56.4 6.86 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.179 0.99 . . . . 0.0 108.764 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.692 ' CB ' HD11 ' A' ' 57' ' ' LEU . . . -61.76 -41.78 98.14 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ASN . . . . . 0.665 ' CB ' HD11 ' A' ' 199' ' ' LEU . 2.2 t30 -66.33 -13.3 60.34 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.021 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.99 -37.33 47.45 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 117.636 -1.626 . . . . 0.0 111.578 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' HIS . . . . . 0.405 ' CD2' ' H ' ' A' ' 195' ' ' HIS . 13.7 p80 -108.79 -52.7 2.73 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 115.717 -2.393 . . . . 0.0 111.856 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.462 ' O ' ' HG2' ' A' ' 197' ' ' MET . 44.5 t30 -114.8 33.34 5.43 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.098 -1.441 . . . . 0.0 113.958 177.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' MET . . . . . 0.599 ' CB ' ' HA ' ' A' ' 193' ' ' ASN . 0.0 OUTLIER -151.45 149.71 29.58 Favored 'General case' 0 N--CA 1.52 3.067 0 CA-C-N 123.375 2.807 . . . . 0.0 115.163 -179.524 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.54 ' HB1' ' HB2' ' A' ' 19' ' ' ALA . . . -107.08 154.28 21.38 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 176.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.852 HD22 HG22 ' A' ' 189' ' ' ILE . 43.7 mt -123.44 144.74 49.31 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.277 -1.514 . . . . 0.0 113.171 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.953 HG21 HD12 ' A' ' 205' ' ' LEU . 0.2 OUTLIER -120.28 -161.79 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.782 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.477 ' HB ' ' CB ' ' A' ' 204' ' ' ASP . 0.2 OUTLIER -132.97 142.78 49.04 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.946 -1.096 . . . . 0.0 108.468 177.597 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.512 HG23 ' N ' ' A' ' 203' ' ' GLU . 5.2 tp -45.93 -46.67 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.196 -0.94 . . . . 0.0 111.56 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.512 ' N ' HG23 ' A' ' 202' ' ' ILE . 22.8 tt0 -91.9 -31.49 15.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.883 -1.135 . . . . 0.0 111.016 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.765 ' O ' ' HB3' ' A' ' 207' ' ' ALA . 10.9 t70 -72.99 -39.14 66.32 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.267 -0.896 . . . . 0.0 112.121 -178.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 1.092 HD13 HG12 ' A' ' 31' ' ' VAL . 10.4 tt -58.22 -62.78 1.58 Allowed 'General case' 0 N--CA 1.484 1.264 0 O-C-N 120.687 -1.258 . . . . 0.0 110.641 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.953 HG11 HG13 ' A' ' 147' ' ' VAL . 2.4 t -66.47 -13.55 16.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 C-N-CA 118.086 -1.445 . . . . 0.0 108.122 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 204' ' ' ASP . . . -57.23 -33.18 67.3 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.803 ' CE2' HG21 ' A' ' 16' ' ' VAL . 4.7 m-30 -56.54 -52.38 65.01 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 175.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -41.84 97.38 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.761 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -53.92 -43.12 69.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 109.501 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -57.45 -35.14 69.75 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.47 -0.769 . . . . 0.0 109.221 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.539 -0.726 . . . . 0.0 109.839 179.4 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.883 ' O ' HG12 ' A' ' 16' ' ' VAL . 30.5 Cg_endo . . . . . 0 C--O 1.204 -1.196 0 N-CA-C 111.082 -0.392 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -86.99 -67.14 0.84 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 115.699 1.741 . . . . 0.0 115.699 -177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.56 -45.71 11.5 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 118.521 -1.272 . . . . 0.0 112.336 -175.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.444 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 28.0 mmt-85 -84.78 -12.26 54.04 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 118.238 -1.385 . . . . 0.0 113.325 -177.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.883 HG12 ' O ' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -95.16 -28.16 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 122.856 2.571 . . . . 0.0 108.69 176.604 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -66.29 -52.21 49.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 117.938 -1.505 . . . . 0.0 108.101 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -64.28 -33.93 76.96 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.186 -0.946 . . . . 0.0 108.722 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 23' ' ' LEU . . . -81.01 -5.86 58.1 Favored 'General case' 0 C--O 1.201 -1.47 0 O-C-N 121.188 -0.945 . . . . 0.0 108.606 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.648 HD11 ' O ' ' A' ' 163' ' ' LEU . 0.3 OUTLIER -68.08 -51.7 43.59 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.578 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.37 -49.92 73.03 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.566 ' HB1' ' HB2' ' A' ' 27' ' ' ARG . . . -61.25 -28.57 69.26 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.672 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -60.5 -8.69 2.94 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.534 -0.729 . . . . 0.0 110.765 179.803 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.74 -37.35 10.34 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.384 -0.823 . . . . 0.0 108.969 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -151.57 90.28 1.55 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 123.267 1.508 . . . . 0.0 113.444 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.24 -18.35 5.83 Favored Glycine 0 C--N 1.272 -3.007 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.672 ' O ' ' HA ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -129.42 120.15 25.0 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 178.057 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 198' ' ' ALA . . . -164.2 105.03 0.24 Allowed Glycine 0 C--N 1.27 -3.137 1 N-CA-C 103.017 -4.033 . . . . 0.0 103.017 -175.631 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.667 ' HB ' ' CB ' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -125.1 161.36 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 113.059 -1.57 . . . . 0.0 112.192 -172.442 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.618 ' CA ' ' HA ' ' A' ' 42' ' ' ASP . 1.4 tmm? -98.52 152.61 19.37 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.148 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.706 HG13 HG21 ' A' ' 44' ' ' ILE . 15.6 m . . . . . 0 C--N 1.29 -2.016 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.855 ' OD2' ' HB1' ' A' ' 192' ' ' ALA . 8.3 t70 . . . . . 0 N--CA 1.51 2.548 0 CA-C-O 121.951 0.882 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.64 ' O ' ' O ' ' A' ' 171' ' ' VAL . 0.0 OUTLIER -93.89 54.45 1.96 Allowed 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -177.216 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.96 ' O ' HD21 ' A' ' 160' ' ' LEU . 28.8 pt -64.5 23.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.524 3.265 0 O-C-N 118.93 -2.356 . . . . 0.0 113.282 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.597 ' O ' HG12 ' A' ' 171' ' ' VAL . 6.6 m-85 -77.21 164.4 58.93 Favored Pre-proline 0 N--CA 1.504 2.25 0 C-N-CA 123.805 0.842 . . . . 0.0 113.236 -178.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.468 ' HG2' ' CG2' ' A' ' 49' ' ' THR . 43.0 Cg_endo -66.79 132.8 29.57 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 122.843 2.362 . . . . 0.0 110.212 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.971 ' HB3' ' HB1' ' A' ' 169' ' ' ALA . . . -68.59 -2.71 9.58 Favored 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -176.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.449 ' HG3' HD11 ' A' ' 122' ' ' ILE . 5.7 tt0 -95.71 -22.64 17.42 Favored 'General case' 0 C--N 1.292 -1.905 0 O-C-N 120.662 -1.274 . . . . 0.0 110.491 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.468 ' CG2' ' HG2' ' A' ' 46' ' ' PRO . 4.6 t -134.38 59.02 1.75 Allowed 'General case' 0 C--N 1.315 -0.924 0 O-C-N 120.724 -1.235 . . . . 0.0 107.739 178.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.872 ' O ' HD12 ' A' ' 115' ' ' ILE . 1.5 ppp? -65.0 88.74 0.07 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.511 HG22 ' H ' ' A' ' 53' ' ' GLU . 24.4 m -59.32 147.92 34.16 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 122.139 0.971 . . . . 0.0 110.169 -176.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.991 HG23 ' HB1' ' A' ' 111' ' ' ALA . 12.5 p -72.34 -3.26 3.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.505 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.511 ' H ' HG22 ' A' ' 51' ' ' THR . 6.6 tp10 -58.96 -41.22 86.97 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.523 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 8.8 mm-40 -81.44 -47.63 12.94 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.237 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.757 ' O ' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -54.17 -35.28 62.13 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.572 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.481 ' HA ' ' CG2' ' A' ' 59' ' ' ILE . . . -54.68 -47.3 73.81 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.685 HD23 ' N ' ' A' ' 58' ' ' THR . 4.8 tt -56.02 -53.65 54.35 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.811 0.815 . . . . 0.0 109.573 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.799 HG21 ' SG ' ' A' ' 173' ' ' CYS . 0.9 OUTLIER -69.28 -58.29 4.23 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.605 -0.684 . . . . 0.0 111.23 -178.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.757 HG22 ' O ' ' A' ' 55' ' ' MET . 1.1 tp -52.47 -22.17 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.106 -0.996 . . . . 0.0 110.742 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 4.1 ttt-85 -74.8 -40.69 60.98 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.212 -0.93 . . . . 0.0 110.962 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -122.86 -1.37 8.9 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.958 -1.089 . . . . 0.0 112.129 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.66 -169.96 27.88 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.32 102.7 6.08 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 101.38 -3.563 . . . . 0.0 101.38 176.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 66' ' ' VAL . . . -104.81 74.97 0.24 Allowed Glycine 0 C--N 1.261 -3.625 0 N-CA-C 106.816 -2.514 . . . . 0.0 106.816 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.624 ' O ' HG23 ' A' ' 65' ' ' ILE . 3.2 tp -62.47 90.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.807 HG12 ' HB2' ' A' ' 173' ' ' CYS . 35.5 m -52.13 152.46 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 114.468 -1.242 . . . . 0.0 114.054 -176.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.414 ' N ' ' O ' ' A' ' 172' ' ' LEU . 7.4 t -87.37 114.99 24.48 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 176.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.675 HD23 ' HA ' ' A' ' 171' ' ' VAL . 3.6 mt -87.45 163.96 16.44 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 169' ' ' ALA . 4.7 m -131.48 135.61 47.24 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 118.199 -1.4 . . . . 0.0 113.206 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.655 HG23 ' HB2' ' A' ' 139' ' ' PRO . 2.5 pp -148.82 177.15 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.498 HG22 ' HG3' ' A' ' 72' ' ' GLU . 18.0 m -111.4 159.15 18.29 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.145 -0.972 . . . . 0.0 110.531 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.498 ' HG3' HG22 ' A' ' 71' ' ' THR . 0.1 OUTLIER -49.13 -27.12 3.2 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.475 -0.766 . . . . 0.0 110.62 -179.846 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -56.9 -38.83 73.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 0.0 109.676 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.426 ' O ' ' HB3' ' A' ' 78' ' ' LEU . 1.8 mmt180 -78.26 -32.77 49.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.501 -0.749 . . . . 0.0 110.35 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.544 ' HG2' HD13 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -78.72 -28.82 45.06 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.204 1.002 . . . . 0.0 108.535 179.013 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 79' ' ' ASP . 4.3 ttmm -56.51 -70.26 0.12 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.429 ' C ' ' HB1' ' A' ' 126' ' ' ALA . 0.4 OUTLIER -46.57 -41.04 13.82 Favored 'General case' 0 N--CA 1.508 2.444 0 CA-C-O 121.974 0.892 . . . . 0.0 109.864 177.834 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.64 HD23 ' O ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -96.39 45.77 1.06 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 176.229 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 76' ' ' LYS . 15.2 t70 -28.68 85.39 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 123.745 1.736 . . . . 0.0 112.329 -172.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.046 HD21 HG11 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -148.44 103.75 3.5 Favored Pre-proline 0 C--N 1.29 -2.009 0 CA-C-N 112.558 -2.11 . . . . 0.0 111.906 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -104.91 93.31 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.493 1.462 . . . . 0.0 108.635 175.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.822 ' H ' HG22 ' A' ' 97' ' ' VAL . 14.7 mmt -103.31 107.72 18.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.673 -1.267 . . . . 0.0 111.156 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.483 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 10.6 tmm? -95.89 92.37 6.47 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.862 -1.149 . . . . 0.0 109.654 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.841 HG13 ' O ' ' A' ' 96' ' ' THR . 3.8 m . . . . . 0 N--CA 1.501 2.113 0 C-N-CA 118.301 -1.359 . . . . 0.0 110.303 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.842 ' O ' HD13 ' A' ' 140' ' ' LEU . 5.9 t80 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 122.007 0.908 . . . . 0.0 108.981 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.841 ' O ' HG13 ' A' ' 84' ' ' VAL . 1.4 p -131.05 53.34 1.99 Allowed 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.629 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 1.046 HG11 HD21 ' A' ' 80' ' ' LEU . 57.5 t -86.07 105.67 14.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 O-C-N 121.209 -0.932 . . . . 0.0 112.096 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.733 HG22 HG12 ' A' ' 137' ' ' VAL . 1.0 OUTLIER -75.9 152.18 37.2 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 103.029 -2.952 . . . . 0.0 103.029 174.913 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.782 HD12 ' HB3' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -161.71 138.93 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 C-N-CA 116.708 -1.997 . . . . 0.0 111.513 -176.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.633 ' HB3' ' CB ' ' A' ' 132' ' ' ASN . 1.2 tp10 -99.11 126.5 44.87 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.301 -1.36 . . . . 0.0 111.346 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.488 ' HA ' ' CD2' ' A' ' 131' ' ' LEU . . . -51.24 115.6 1.64 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.41 -0.807 . . . . 0.0 110.886 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.839 ' HB3' ' O ' ' A' ' 130' ' ' ASP . . . -115.74 -6.78 12.12 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.23 -0.919 . . . . 0.0 110.984 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.84 ' HB3' ' HB1' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -75.82 55.45 0.88 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.952 -1.093 . . . . 0.0 111.692 -178.649 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.622 ' O ' HG13 ' A' ' 105' ' ' VAL . . . 73.31 24.24 75.72 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.846 HG21 ' HB3' ' A' ' 120' ' ' ALA . 5.2 m -158.25 122.39 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.412 ' HA ' ' HB3' ' A' ' 101' ' ' ALA . 5.8 m -148.38 63.8 1.08 Allowed 'General case' 0 N--CA 1.484 1.24 0 O-C-N 120.85 -1.156 . . . . 0.0 111.605 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.3 t -131.07 -30.76 1.74 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 118.618 -1.233 . . . . 0.0 110.099 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.409 ' O ' ' NH1' ' A' ' 114' ' ' ARG . . . 63.98 -19.06 0.09 OUTLIER Glycine 0 N--CA 1.5 2.93 0 O-C-N 121.484 -0.76 . . . . 0.0 113.377 178.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.86 55.54 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 119.71 1.755 . . . . 0.0 109.73 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 114' ' ' ARG . 28.6 p -133.2 66.15 1.57 Allowed 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.991 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -27.19 -39.92 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 121.506 0.669 . . . . 0.0 112.589 -177.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -78.59 -72.8 0.36 Allowed 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 122.147 0.975 . . . . 0.0 109.492 178.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -54.51 -23.35 16.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.167 -0.958 . . . . 0.0 109.241 178.791 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 110' ' ' SER . 0.3 OUTLIER -61.14 -45.61 93.97 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.549 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.872 HD12 ' O ' ' A' ' 50' ' ' MET . 1.6 mm -65.13 -15.07 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 117.283 -1.767 . . . . 0.0 107.654 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 m -89.88 -31.29 17.39 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 175.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.734 HG23 ' HB ' ' A' ' 105' ' ' VAL . 91.0 m -70.8 -49.0 51.12 Favored 'General case' 0 C--O 1.204 -1.3 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.555 HG13 ' N ' ' A' ' 119' ' ' ARG . 10.1 p -53.43 -41.46 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 0.0 109.28 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.555 ' N ' HG13 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -57.88 -33.88 69.19 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.413 179.051 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.846 ' HB3' HG21 ' A' ' 105' ' ' VAL . . . -94.03 -36.93 11.9 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.524 -0.735 . . . . 0.0 111.082 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.702 ' HB1' ' CE1' ' A' ' 138' ' ' PHE . . . -56.52 -56.72 17.76 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.03 -1.044 . . . . 0.0 109.407 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.725 HG22 ' HG3' ' A' ' 139' ' ' PRO . 1.6 pp -87.13 19.36 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.284 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.541 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -72.76 146.72 46.18 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.454 ' C ' ' O ' ' A' ' 123' ' ' ALA . 16.8 m-20 -37.18 -79.14 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.721 0 CA-C-N 119.598 1.09 . . . . 0.0 109.595 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 127' ' ' LYS . . . 54.75 34.93 57.06 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.125 -1.988 . . . . 0.0 109.856 173.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.429 ' HB1' ' C ' ' A' ' 77' ' ' GLN . . . -58.96 91.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 123.337 1.541 . . . . 0.0 110.233 -174.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 125' ' ' GLY . 1.9 mttt -137.97 126.57 14.45 Favored Pre-proline 0 C--N 1.303 -1.436 0 CA-C-N 113.377 -1.738 . . . . 0.0 106.422 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -54.69 -17.79 14.16 Favored 'Trans proline' 0 C--N 1.294 -2.315 0 O-C-N 122.61 0.795 . . . . 0.0 110.306 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 25.4 p -124.56 31.65 5.66 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.149 -0.969 . . . . 0.0 109.881 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.839 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -73.77 3.84 5.98 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.524 -1.36 . . . . 0.0 111.797 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.733 ' CB ' HG22 ' A' ' 99' ' ' ILE . 30.7 mt -142.58 130.64 21.89 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.633 ' CB ' ' HB3' ' A' ' 100' ' ' GLU . 0.5 OUTLIER -81.52 72.87 8.58 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.326 -1.484 . . . . 0.0 111.639 -177.847 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.655 ' HB3' ' HA ' ' A' ' 99' ' ' ILE 0.263 0.0 OUTLIER -87.68 152.82 52.21 Favored Pre-proline 0 N--CA 1.502 2.141 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.545 179.72 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.413 ' C ' ' HA ' ' A' ' 133' ' ' ARG . 47.3 Cg_endo -78.36 141.41 64.94 Favored 'Cis proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.215 -1.994 . . . . 0.0 107.787 1.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.536 ' O ' ' O ' ' A' ' 136' ' ' HIS . . . -176.6 95.43 0.1 Allowed Glycine 0 N--CA 1.487 2.078 0 C-N-CA 117.879 -2.105 . . . . 0.0 111.291 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.536 ' O ' ' O ' ' A' ' 135' ' ' GLY . 12.2 m-70 47.3 101.81 0.01 OUTLIER 'General case' 0 C--O 1.206 -1.215 0 CA-C-O 124.283 1.992 . . . . 0.0 109.182 -177.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.733 HG12 HG22 ' A' ' 98' ' ' THR . 19.2 m -49.15 154.48 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.686 0 CA-C-N 112.783 -2.008 . . . . 0.0 112.376 -174.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.782 ' HB3' HD12 ' A' ' 99' ' ' ILE . 1.5 m-85 -146.87 175.42 2.73 Favored Pre-proline 0 C--N 1.29 -1.997 0 CA-C-N 111.434 -2.621 . . . . 0.0 105.271 -174.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.725 ' HG3' HG22 ' A' ' 122' ' ' ILE . 38.4 Cg_endo -57.56 127.88 27.13 Favored 'Trans proline' 0 C--N 1.293 -2.354 0 CA-C-O 123.533 1.389 . . . . 0.0 115.11 -169.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.842 HD13 ' O ' ' A' ' 95' ' ' PHE . 14.6 mt -90.06 172.46 8.82 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 112.96 -1.927 . . . . 0.0 108.965 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.461 ' HB2' ' N ' ' A' ' 72' ' ' GLU . 12.8 ptt85 -126.13 85.16 2.35 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.119 -1.613 . . . . 0.0 115.0 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.589 ' HB3' ' CG ' ' A' ' 95' ' ' PHE . . . -141.48 79.69 1.7 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.742 -1.224 . . . . 0.0 110.837 176.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.585 ' HB2' HG21 ' A' ' 158' ' ' ILE . 0.5 OUTLIER -117.34 75.26 0.97 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.143 -1.598 . . . . 0.0 112.966 -179.353 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -127.04 43.37 3.13 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.637 -1.289 . . . . 0.0 110.982 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 75.83 37.08 40.12 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -100.54 12.35 59.74 Favored Glycine 0 N--CA 1.49 2.285 0 O-C-N 120.91 -1.347 . . . . 0.0 113.521 -176.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.86 HG13 HD22 ' A' ' 148' ' ' LEU . 8.2 p -107.9 -13.9 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-N 120.312 2.056 . . . . 0.0 111.828 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.86 HD22 HG13 ' A' ' 147' ' ' VAL . 4.6 mm? -87.42 13.28 10.25 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 115.041 -2.664 . . . . 0.0 109.876 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 84.2 m -132.93 62.15 1.66 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 100.548 -3.871 . . . . 0.0 100.548 167.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -148.27 135.15 20.05 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.072 -1.422 . . . . 0.0 113.831 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -104.26 36.25 4.5 Favored Glycine 0 N--CA 1.48 1.605 0 N-CA-C 106.177 -2.769 . . . . 0.0 106.177 173.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -142.31 163.8 27.05 Favored Glycine 0 N--CA 1.479 1.55 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.868 ' HA ' ' HB3' ' A' ' 156' ' ' ALA . 54.5 p-80 -90.98 -6.12 54.45 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.883 -0.774 . . . . 0.0 109.765 177.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.403 ' O ' ' HB ' ' A' ' 157' ' ' THR . 6.8 p -56.39 -64.99 0.68 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 122.362 1.077 . . . . 0.0 108.876 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.456 ' HB3' ' CA ' ' A' ' 147' ' ' VAL . 65.9 mm-40 -59.4 -22.16 60.99 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 177.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.868 ' HB3' ' HA ' ' A' ' 153' ' ' HIS . . . -86.02 4.37 38.18 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.226 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.505 HG23 ' SG ' ' A' ' 69' ' ' CYS . 0.6 OUTLIER -83.07 -51.65 7.35 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.328 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.585 HG21 ' HB2' ' A' ' 143' ' ' GLN . 0.2 OUTLIER -74.87 -17.54 16.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 115.923 -2.311 . . . . 0.0 105.996 176.108 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.942 ' CG ' HG12 ' A' ' 206' ' ' VAL . 8.3 t70 -59.29 -26.71 65.19 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 173.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 1.047 HD22 ' HG ' ' A' ' 163' ' ' LEU . 0.4 OUTLIER -53.3 -41.33 65.52 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 175.175 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.572 ' HA ' ' HA ' ' A' ' 168' ' ' PRO . 0.0 OUTLIER -48.2 -33.45 8.54 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 176.909 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.94 HG21 ' HG3' ' A' ' 209' ' ' ARG . 1.3 m -93.29 -31.83 14.55 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.719 177.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 1.047 ' HG ' HD22 ' A' ' 160' ' ' LEU . 0.5 OUTLIER -36.34 -40.94 0.25 Allowed 'General case' 0 N--CA 1.521 3.102 0 O-C-N 121.489 -0.757 . . . . 0.0 110.071 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.541 ' CB ' HD21 ' A' ' 20' ' ' LEU . . . -94.49 -29.24 15.04 Favored 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.103 -0.998 . . . . 0.0 110.909 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.03 -29.99 10.76 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -149.93 47.28 0.93 Allowed 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 117.922 -1.511 . . . . 0.0 111.571 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 169' ' ' ALA . 2.5 mptp? -133.3 68.42 77.36 Favored Pre-proline 0 C--N 1.29 -2.019 0 N-CA-C 103.294 -2.854 . . . . 0.0 103.294 173.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.572 ' HA ' ' HA ' ' A' ' 161' ' ' MET . 42.4 Cg_endo -69.5 80.24 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 115.218 -2.721 . . . . 0.0 114.531 -170.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.971 ' HB1' ' HB3' ' A' ' 47' ' ' ALA . . . -164.29 166.11 21.2 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 171.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 68' ' ' LEU . . . -154.79 135.52 4.72 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 118.019 -2.039 . . . . 0.0 110.356 178.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.675 ' HA ' HD23 ' A' ' 68' ' ' LEU . 2.9 p -121.4 89.83 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.191 -1.991 0 C-N-CA 117.374 -1.73 . . . . 0.0 107.376 177.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.954 HD11 HD23 ' A' ' 160' ' ' LEU . 9.1 mp -95.12 153.81 17.48 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 119.249 0.931 . . . . 0.0 110.11 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.807 ' HB2' HG12 ' A' ' 66' ' ' VAL . 35.7 t -124.71 162.63 23.79 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 122.023 0.916 . . . . 0.0 112.905 -177.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 174' ' ' GLU . 1.3 pt-20 -135.84 107.23 6.86 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.471 HD23 ' SG ' ' A' ' 188' ' ' CYS . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 O-C-N 121.052 -1.03 . . . . 0.0 111.153 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.603 ' HB1' ' SG ' ' A' ' 188' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.224 0.535 . . . . 0.0 110.016 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 185' ' ' ALA . 0.6 OUTLIER -140.69 100.27 3.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 110.07 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.764 ' HB1' ' HD2' ' A' ' 186' ' ' PRO . . . 179.89 173.34 0.49 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 110.213 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.764 ' HD2' ' HB1' ' A' ' 185' ' ' ALA . 43.6 Cg_endo -69.53 -15.64 38.08 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.66 1.348 . . . . 0.0 110.226 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -87.81 -36.8 17.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.11 -0.994 . . . . 0.0 109.855 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' CYS . . . . . 0.603 ' SG ' ' HB1' ' A' ' 183' ' ' ALA . 41.1 t -58.84 -49.3 78.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.394 -0.817 . . . . 0.0 109.462 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.715 HG23 HD21 ' A' ' 199' ' ' LEU . 7.4 tp -76.84 -24.15 15.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.845 -1.159 . . . . 0.0 109.38 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.474 ' HA ' ' CB ' ' A' ' 193' ' ' ASN . 3.7 tt0 -57.41 -23.26 48.3 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.436 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 3.8 t80 -74.95 -46.19 37.21 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.855 ' HB1' ' OD2' ' A' ' 42' ' ' ASP . . . -65.77 -18.44 65.33 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 175.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ASN . . . . . 0.672 ' CG ' HD22 ' A' ' 199' ' ' LEU . 56.9 t30 -85.48 -7.76 58.73 Favored 'General case' 0 C--O 1.207 -1.159 0 O-C-N 121.896 -0.503 . . . . 0.0 109.696 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.59 -51.26 5.79 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.205 -1.559 . . . . 0.0 110.092 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.9 -41.06 12.0 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 118.268 -1.373 . . . . 0.0 107.599 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 198' ' ' ALA . 0.6 OUTLIER -99.34 52.17 0.94 Allowed 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 197' ' ' MET . . . . . 0.609 ' HA ' ' HA ' ' A' ' 193' ' ' ASN . 45.5 ttm -66.72 74.25 0.1 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -173.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.667 ' CB ' ' HB ' ' A' ' 29' ' ' VAL . . . -134.1 106.4 7.18 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 104.057 -2.571 . . . . 0.0 104.057 172.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.715 HD21 HG23 ' A' ' 189' ' ' ILE . 2.9 tp -126.97 120.04 28.13 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 119.734 -1.854 . . . . 0.0 109.606 -177.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.574 HG22 ' H ' ' A' ' 201' ' ' THR . 4.5 p -124.08 -177.0 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.259 -0.901 . . . . 0.0 110.929 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.574 ' H ' HG22 ' A' ' 200' ' ' VAL . 5.5 p -121.01 135.99 55.09 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.117 -0.989 . . . . 0.0 110.501 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 153' ' ' HIS . 68.7 mt -60.76 -37.77 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.483 -0.761 . . . . 0.0 112.093 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -45.16 -65.95 0.46 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.257 -0.902 . . . . 0.0 110.909 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.63 ' O ' ' HB3' ' A' ' 207' ' ' ALA . 0.6 OUTLIER -72.88 -17.85 61.48 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.167 -0.958 . . . . 0.0 110.098 179.237 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.683 HD11 HD21 ' A' ' 163' ' ' LEU . 2.4 tm? -60.44 -68.35 0.31 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.08 -1.012 . . . . 0.0 109.564 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.942 HG12 ' CG ' ' A' ' 159' ' ' ASP . 11.5 m -63.92 -16.12 18.1 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 C-N-CA 117.922 -1.511 . . . . 0.0 109.356 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' A' ' 204' ' ' ASP . . . -56.6 -32.34 65.16 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 174.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.604 ' CE2' ' CG1' ' A' ' 16' ' ' VAL 0.286 0.9 OUTLIER -54.75 -52.15 63.45 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.108 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.94 ' HG3' HG21 ' A' ' 162' ' ' THR . 48.2 ttt180 -56.65 -45.73 81.44 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.6 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.417 ' OE1' ' N ' ' A' ' 211' ' ' ALA . 1.8 tm0? -69.2 -56.0 8.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.218 -0.926 . . . . 0.0 110.184 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ALA . . . . . 0.417 ' N ' ' OE1' ' A' ' 210' ' ' GLN . . . -58.91 -27.42 65.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.438 -0.789 . . . . 0.0 110.182 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' A' ' 208' ' ' TYR . 70.6 t60 . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.863 . . . . 0.0 110.12 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.624 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 54.5 Cg_endo . . . . . 0 C--O 1.201 -1.333 0 N-CA-C 109.182 -1.122 . . . . 0.0 109.182 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -97.71 -70.62 0.71 Allowed 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -74.05 -41.37 61.87 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.798 -177.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -88.12 -17.24 31.42 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 118.258 -1.377 . . . . 0.0 111.96 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.669 HG13 HD23 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -68.6 -28.08 38.78 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.151 0 C-N-CA 114.775 -2.77 . . . . 0.0 107.278 177.133 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 1.2 tm-20 -67.18 -54.7 18.69 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 117.493 -1.683 . . . . 0.0 107.415 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -62.6 -33.26 74.63 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.181 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.715 ' HB1' ' CD1' ' A' ' 23' ' ' LEU . . . -88.12 -6.75 57.73 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.218 -0.926 . . . . 0.0 109.011 178.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.923 HD11 ' HA ' ' A' ' 164' ' ' ALA . 0.2 OUTLIER -61.48 -49.67 75.82 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.383 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . . . -70.94 -54.55 10.95 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.604 -0.838 . . . . 0.0 108.801 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.609 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . . . -49.94 -40.35 43.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.501 -0.749 . . . . 0.0 110.231 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.756 ' HB3' HG13 ' A' ' 29' ' ' VAL . 43.8 mt -90.56 -16.74 28.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.343 -0.848 . . . . 0.0 110.051 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -61.81 -16.53 50.68 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.375 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -92.98 45.26 1.17 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 122.527 1.156 . . . . 0.0 109.968 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.541 ' HA2' ' CZ ' ' A' ' 45' ' ' PHE . . . 58.61 28.68 62.95 Favored Glycine 0 C--N 1.288 -2.114 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 177.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.519 ' HB3' HD23 ' A' ' 23' ' ' LEU . 4.2 ttt-85 -89.31 18.4 5.21 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 116.71 -1.996 . . . . 0.0 110.844 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.804 ' O ' ' HB3' ' A' ' 198' ' ' ALA . . . 96.81 107.11 2.4 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.129 -1.51 . . . . 0.0 115.388 172.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.756 HG13 ' HB3' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -142.25 113.86 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 174.057 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.659 ' HB2' ' CD1' ' A' ' 199' ' ' LEU . 2.3 mtp -124.2 122.55 38.1 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.014 -1.054 . . . . 0.0 110.513 -174.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.626 HG23 HG13 ' A' ' 200' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 O-C-N 120.781 -1.2 . . . . 0.0 110.838 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.587 ' HA ' ' HB3' ' A' ' 30' ' ' MET . 2.4 p30 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 122.128 0.966 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.705 ' HG2' HG12 ' A' ' 66' ' ' VAL . 9.6 tpp -96.19 56.53 1.64 Allowed 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 123.567 0.747 . . . . 0.0 110.416 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.921 ' C ' HD11 ' A' ' 160' ' ' LEU . 41.7 mt -60.73 34.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 O-C-N 121.159 -0.963 . . . . 0.0 113.557 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.947 ' O ' HG22 ' A' ' 171' ' ' VAL . 26.3 m-85 -111.52 162.03 22.81 Favored Pre-proline 0 N--CA 1.502 2.132 0 O-C-N 119.836 -1.79 . . . . 0.0 114.122 -175.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.405 ' HG2' ' OG1' ' A' ' 49' ' ' THR . 46.5 Cg_endo -72.63 131.36 17.19 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.374 2.049 . . . . 0.0 109.271 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.939 ' O ' HG12 ' A' ' 118' ' ' VAL . . . -72.28 -1.47 15.44 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 120.785 -1.197 . . . . 0.0 113.132 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -93.46 -16.77 24.18 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.64 -1.288 . . . . 0.0 109.788 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.405 ' OG1' ' HG2' ' A' ' 46' ' ' PRO . 0.8 OUTLIER -131.61 59.15 1.7 Allowed 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 177.426 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.94 ' SD ' HG11 ' A' ' 118' ' ' VAL . 5.0 tpt -54.46 95.75 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.505 -178.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.0 p -66.53 133.48 50.44 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.731 ' CG2' HG21 ' A' ' 115' ' ' ILE . 2.6 t -77.98 -2.37 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.061 -1.024 . . . . 0.0 108.504 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 26' ' ' GLY . 0.6 OUTLIER -60.77 -40.8 93.92 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.254 -179.406 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.704 ' HA ' ' HE1' ' A' ' 197' ' ' MET . 85.1 mm-40 -80.33 -24.14 40.1 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.594 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.747 ' O ' HG22 ' A' ' 59' ' ' ILE . 11.2 tpt -82.49 -38.06 24.43 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.353 -0.842 . . . . 0.0 109.493 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.93 -42.1 84.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.48 -0.762 . . . . 0.0 109.767 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.944 HD13 ' SD ' ' A' ' 197' ' ' MET . 5.8 tt -65.58 -48.71 71.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 109.322 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.532 ' N ' HD23 ' A' ' 57' ' ' LEU . 37.0 p -67.02 -59.12 3.74 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.365 -0.835 . . . . 0.0 110.979 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.894 HD12 ' HA ' ' A' ' 111' ' ' ALA . 11.3 tt -47.48 -24.79 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.17 -0.956 . . . . 0.0 111.022 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.8 ttt85 -72.07 -45.8 59.35 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.19 -0.944 . . . . 0.0 110.702 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -124.1 5.47 8.57 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.872 -1.143 . . . . 0.0 112.163 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 58' ' ' THR . . . -165.12 -169.27 28.52 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.5 p -139.91 102.26 4.37 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.33 72.91 0.22 Allowed Glycine 0 C--N 1.266 -3.352 0 N-CA-C 105.222 -3.151 . . . . 0.0 105.222 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.578 HG23 ' HZ ' ' A' ' 138' ' ' PHE . 1.7 tt -63.07 106.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.6 0 CA-C-O 122.622 1.201 . . . . 0.0 107.906 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.806 HG21 ' SD ' ' A' ' 50' ' ' MET . 16.5 m -52.53 151.03 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 115.129 -0.942 . . . . 0.0 112.043 -177.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.92 ' C ' HD13 ' A' ' 68' ' ' LEU . 82.5 m -85.9 160.74 19.33 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.92 HD13 ' C ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -137.87 91.76 2.61 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.012 -1.475 . . . . 0.0 108.094 178.068 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.444 ' CB ' ' OG1' ' A' ' 157' ' ' THR . 1.3 m -102.52 152.25 21.37 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 119.046 -1.062 . . . . 0.0 110.472 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.872 ' HA ' HD11 ' A' ' 158' ' ' ILE . 1.1 mt -152.6 -177.73 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.462 ' H ' HG22 ' A' ' 70' ' ' ILE . 22.0 p -86.33 144.71 27.24 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -53.54 -20.03 4.48 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.208 -0.933 . . . . 0.0 110.379 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.422 ' O ' ' CG ' ' A' ' 77' ' ' GLN . 10.1 t70 -79.0 -37.58 38.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.153 -0.967 . . . . 0.0 110.951 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -85.95 -52.44 5.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.21 -0.931 . . . . 0.0 110.629 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.871 ' CD ' HD12 ' A' ' 70' ' ' ILE . 22.4 tpt180 -54.2 -53.93 46.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.166 -0.959 . . . . 0.0 109.54 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.713 ' HG2' HD13 ' A' ' 80' ' ' LEU . 1.1 mtpm? -60.43 -56.67 18.65 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.293 -0.879 . . . . 0.0 111.605 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.422 ' CG ' ' O ' ' A' ' 73' ' ' ASP . 4.9 mt-30 -27.29 -49.41 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.851 1.344 . . . . 0.0 110.997 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 1.005 HD13 ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -136.88 -27.52 1.0 Allowed 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 117.162 -1.815 . . . . 0.0 113.082 177.502 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 1.005 ' N ' HD13 ' A' ' 78' ' ' LEU . 65.9 t0 -121.15 62.97 0.88 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 117.363 -1.735 . . . . 0.0 115.438 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.901 HD21 ' OG1' ' A' ' 96' ' ' THR . 2.2 tt -144.73 104.23 4.55 Favored Pre-proline 0 N--CA 1.506 2.348 0 C-N-CA 115.925 -2.31 . . . . 0.0 113.744 174.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.903 ' O ' HG22 ' A' ' 97' ' ' VAL . 38.3 Cg_endo -101.56 96.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.3 -1.983 0 N-CA-C 107.257 -1.863 . . . . 0.0 107.257 174.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.404 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 9.4 ttt -88.8 45.48 1.29 Allowed 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.21 -0.932 . . . . 0.0 109.553 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.637 ' HB2' HG11 ' A' ' 97' ' ' VAL . 4.7 mmm -57.7 -11.51 2.23 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.655 -0.653 . . . . 0.0 110.656 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 1.001 HG23 HG12 ' A' ' 97' ' ' VAL . 53.6 t . . . . . 0 N--CA 1.5 2.053 0 C-N-CA 116.878 -1.929 . . . . 0.0 109.915 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.721 ' HB2' HG11 ' A' ' 84' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 123.144 1.45 . . . . 0.0 112.237 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.901 ' OG1' HD21 ' A' ' 80' ' ' LEU . 1.2 m -61.41 81.25 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.026 -1.443 . . . . 0.0 109.413 177.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 1.001 HG12 HG23 ' A' ' 84' ' ' VAL . 1.2 m -37.07 155.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.046 0 CA-C-O 122.259 1.028 . . . . 0.0 111.935 -175.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.907 HG22 ' O ' ' A' ' 137' ' ' VAL . 39.4 p -66.52 -176.88 0.5 Allowed 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -174.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.778 HD11 HG23 ' A' ' 117' ' ' THR . 1.1 pp -110.6 146.78 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 122.47 1.129 . . . . 0.0 113.545 -177.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.665 ' N ' ' H ' ' A' ' 133' ' ' ARG . 58.1 tt0 -93.65 163.27 13.61 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.445 ' HB1' ' HB ' ' A' ' 106' ' ' THR . . . -77.69 78.78 4.19 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 116.213 -2.195 . . . . 0.0 107.563 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 129' ' ' SER . . . -106.47 -37.54 6.46 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.455 ' CG ' ' HD2' ' A' ' 127' ' ' LYS . 30.6 tp10 -74.43 -7.92 54.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.55 -0.719 . . . . 0.0 109.894 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.8 24.98 5.59 Favored Glycine 0 N--CA 1.481 1.651 0 C-N-CA 119.604 -1.284 . . . . 0.0 111.703 178.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.539 HG21 ' CB ' ' A' ' 120' ' ' ALA . 2.0 t -114.19 112.13 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 C-N-CA 118.011 -1.475 . . . . 0.0 108.016 177.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.601 HG23 ' O ' ' A' ' 106' ' ' THR . 5.6 t -157.39 66.92 0.5 Allowed 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.0 m -129.99 20.98 5.39 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.416 -1.427 . . . . 0.0 111.847 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 110' ' ' SER . . . 96.55 47.44 2.34 Favored Glycine 0 N--CA 1.502 3.052 0 N-CA-C 107.137 -2.385 . . . . 0.0 107.137 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 109' ' ' VAL . 12.2 p -53.82 51.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -173.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 108' ' ' GLY . 1.9 m -135.29 12.21 3.54 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 117.053 -1.859 . . . . 0.0 112.405 172.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.894 ' HA ' HD12 ' A' ' 59' ' ' ILE . . . -122.12 -81.86 0.64 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 119.89 -1.756 . . . . 0.0 108.983 171.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' A' ' 116' ' ' THR . . . -98.7 -43.6 6.74 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 174.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.481 ' HB3' ' HA ' ' A' ' 109' ' ' VAL . 47.0 t0 -54.15 -29.74 46.58 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.903 ' O ' HG23 ' A' ' 118' ' ' VAL . 2.0 ttt180 -63.85 -51.29 65.3 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 175.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.731 HG21 ' CG2' ' A' ' 52' ' ' VAL 0.254 1.2 mp -67.31 -10.74 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.682 178.212 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.472 ' HB ' ' HA ' ' A' ' 113' ' ' ASP . 54.9 m -90.43 -41.87 11.21 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.89 -1.131 . . . . 0.0 109.112 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.778 HG23 HD11 ' A' ' 99' ' ' ILE . 52.8 m -69.0 -29.13 67.25 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.384 -0.926 . . . . 0.0 108.783 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.94 HG11 ' SD ' ' A' ' 50' ' ' MET . 39.9 t -67.78 -44.01 85.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.08 -27.98 35.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.472 -0.767 . . . . 0.0 109.573 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.539 ' CB ' HG21 ' A' ' 105' ' ' VAL . . . -80.95 -51.92 8.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.514 -0.741 . . . . 0.0 109.516 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.701 ' HA ' HD21 ' A' ' 131' ' ' LEU . . . -54.86 -32.27 60.57 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.801 HD12 ' O ' ' A' ' 47' ' ' ALA . 71.1 mt -93.39 25.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.602 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.775 ' HB3' ' HD3' ' A' ' 127' ' ' LYS . . . -37.63 150.82 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 O-C-N 122.056 -0.403 . . . . 0.0 111.48 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -26.99 -28.58 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 123' ' ' ALA . . . 129.93 -36.04 2.42 Favored Glycine 0 N--CA 1.493 2.448 0 O-C-N 120.282 -1.511 . . . . 0.0 110.61 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -87.92 93.64 9.53 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.761 -1.435 . . . . 0.0 107.14 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.866 ' CB ' HD23 ' A' ' 78' ' ' LEU . 8.3 ttpt -134.3 119.12 14.17 Favored Pre-proline 0 C--N 1.305 -1.35 0 O-C-N 121.226 -0.921 . . . . 0.0 111.19 -178.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -88.29 19.33 1.34 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 N-CA-C 108.178 -1.508 . . . . 0.0 108.178 176.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.688 ' O ' ' N ' ' A' ' 131' ' ' LEU . 0.7 OUTLIER -119.6 41.16 3.2 Favored 'General case' 0 C--O 1.203 -1.38 0 O-C-N 121.3 -0.875 . . . . 0.0 110.727 -177.345 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -37.4 74.6 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 123.236 1.493 . . . . 0.0 110.894 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.701 HD21 ' HA ' ' A' ' 121' ' ' ALA . 0.2 OUTLIER -68.17 107.14 2.65 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 113.469 -1.696 . . . . 0.0 110.938 -176.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.634 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 0.9 OUTLIER -137.4 48.02 2.06 Favored 'General case' 0 N--CA 1.52 3.071 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 178.153 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.665 ' H ' ' N ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER 173.22 108.69 0.06 OUTLIER Pre-proline 0 N--CA 1.51 2.545 0 O-C-N 119.147 -2.22 . . . . 0.0 112.051 174.444 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -134.48 119.46 0.0 OUTLIER 'Cis proline' 0 C--N 1.31 -1.466 0 N-CA-C 103.958 -3.131 . . . . 0.0 103.958 -9.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.95 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -111.67 44.76 1.44 Allowed Glycine 0 N--CA 1.509 3.501 0 C-N-CA 118.063 -2.018 . . . . 0.0 113.106 -175.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.418 ' C ' ' O ' ' A' ' 135' ' ' GLY . 66.4 m170 31.0 37.31 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 122.246 1.022 . . . . 0.0 111.59 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 135' ' ' GLY . 45.1 t -108.91 125.08 65.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.578 ' HZ ' HG23 ' A' ' 65' ' ' ILE . 2.4 p90 -118.77 85.27 27.39 Favored Pre-proline 0 C--N 1.294 -1.818 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.339 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.939 ' O ' HD23 ' A' ' 140' ' ' LEU . 47.6 Cg_endo -95.46 153.36 1.58 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 N-CA-C 108.362 -1.438 . . . . 0.0 108.362 178.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.939 HD23 ' O ' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -150.37 153.03 35.31 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.788 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -65.01 120.0 11.81 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.39 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -129.49 133.12 47.1 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.091 -1.006 . . . . 0.0 111.472 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -78.05 143.73 37.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -0.835 . . . . 0.0 109.627 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.661 ' HB2' HG22 ' A' ' 158' ' ' ILE . . . -103.76 115.51 30.61 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.293 -0.879 . . . . 0.0 111.487 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.422 ' N ' ' OD2' ' A' ' 159' ' ' ASP . . . 117.57 -14.82 13.01 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.55 12.97 56.77 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 1.022 ' CG1' HG11 ' A' ' 206' ' ' VAL . 4.9 p -73.36 -24.61 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.148 -1.207 . . . . 0.0 110.968 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.98 17.95 7.29 Favored 'General case' 0 C--O 1.208 -1.13 0 C-N-CA 115.472 -2.491 . . . . 0.0 110.506 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 25.3 m -131.19 59.55 1.68 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 100.778 -3.786 . . . . 0.0 100.778 166.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.404 ' NE ' ' OE1' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -151.85 148.21 27.55 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 113.76 -1.564 . . . . 0.0 112.432 -178.277 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -104.27 35.3 5.14 Favored Glycine 0 N--CA 1.482 1.756 0 N-CA-C 106.179 -2.768 . . . . 0.0 106.179 173.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.1 135.19 6.11 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.935 ' CD2' HD12 ' A' ' 202' ' ' ILE . 54.1 m80 -74.51 -5.18 41.27 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.241 -1.152 . . . . 0.0 109.666 177.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.413 ' O ' ' OG1' ' A' ' 157' ' ' THR . 59.4 p -53.73 -56.71 15.02 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.942 -1.099 . . . . 0.0 109.687 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.443 ' C ' ' HB ' ' A' ' 147' ' ' VAL . 2.9 mp0 -58.02 -21.66 46.07 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.783 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . . . -83.71 6.26 21.7 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.571 -0.705 . . . . 0.0 109.818 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 153' ' ' HIS . 59.8 p -93.49 -49.26 5.99 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.872 HD11 ' HA ' ' A' ' 70' ' ' ILE . 0.3 OUTLIER -80.09 -32.31 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 116.703 -1.999 . . . . 0.0 107.259 177.557 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.502 ' OD1' HG13 ' A' ' 206' ' ' VAL . 8.7 t70 -61.29 -33.76 74.1 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 105.375 -2.084 . . . . 0.0 105.375 174.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.921 HD11 ' C ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -47.22 -41.25 18.04 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 175.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.488 ' SD ' HD12 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -57.97 -48.4 80.08 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.911 178.508 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.461 ' N ' ' HG2' ' A' ' 161' ' ' MET . 0.0 OUTLIER -63.85 -34.85 78.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.009 -1.057 . . . . 0.0 111.698 -178.756 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 1.086 HD13 HD21 ' A' ' 205' ' ' LEU . 1.7 pp -93.33 -30.87 14.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.925 -1.109 . . . . 0.0 111.763 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.923 ' HA ' HD11 ' A' ' 20' ' ' LEU . . . -115.15 38.02 3.33 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -178.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 167' ' ' LYS . . . 112.78 70.61 0.56 Allowed Glycine 0 N--CA 1.513 3.784 0 C-N-CA 116.667 -2.683 . . . . 0.0 109.831 -177.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.496 ' O ' ' CD2' ' A' ' 166' ' ' PHE . 54.3 p90 -62.43 70.67 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 123.486 1.612 . . . . 0.0 115.099 -172.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.473 ' N ' ' O ' ' A' ' 165' ' ' GLY . 0.0 OUTLIER -113.22 131.95 22.65 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 100.792 -3.781 . . . . 0.0 100.792 171.49 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.806 ' O ' HG23 ' A' ' 70' ' ' ILE . 38.1 Cg_endo -63.58 89.84 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 116.636 -1.776 . . . . 0.0 112.412 -173.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.71 ' HB1' ' HB3' ' A' ' 47' ' ' ALA 0.262 . . -158.18 153.8 26.3 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 176.085 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 157' ' ' THR . . . -147.37 113.52 0.65 Allowed Glycine 0 N--CA 1.497 2.739 0 C-N-CA 117.24 -2.41 . . . . 0.0 110.535 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.947 HG22 ' O ' ' A' ' 45' ' ' PHE . 1.1 m -125.72 144.02 37.23 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.447 0 C-N-CA 117.172 -1.811 . . . . 0.0 109.791 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.555 HD13 ' O ' ' A' ' 171' ' ' VAL . 0.1 OUTLIER -159.69 113.63 2.27 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 177.269 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.506 ' O ' ' N ' ' A' ' 42' ' ' ASP . 1.9 t -126.96 178.0 6.26 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 119.642 -1.911 . . . . 0.0 112.042 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.414 ' HA ' ' OD2' ' A' ' 42' ' ' ASP . 1.6 tm-20 -120.62 148.35 44.01 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.924 -1.11 . . . . 0.0 110.27 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.822 HD22 ' O ' ' A' ' 188' ' ' CYS . 1.6 tp . . . . . 0 N--CA 1.499 1.993 0 O-C-N 121.038 -1.039 . . . . 0.0 110.11 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' ' 175' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.2 0.524 . . . . 0.0 110.111 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.626 ' O ' ' HB3' ' A' ' 185' ' ' ALA . 0.2 OUTLIER -140.11 162.15 35.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.876 . . . . 0.0 110.401 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.835 ' HB1' ' HD2' ' A' ' 186' ' ' PRO . . . 68.9 174.83 0.08 OUTLIER Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.42 -0.8 . . . . 0.0 110.865 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.835 ' HD2' ' HB1' ' A' ' 185' ' ' ALA . 41.1 Cg_endo -66.38 -10.5 27.83 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.481 1.253 . . . . 0.0 110.957 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -72.9 -55.01 7.23 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.046 -1.034 . . . . 0.0 109.864 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' CYS . . . . . 0.822 ' O ' HD22 ' A' ' 175' ' ' LEU . 24.0 p -58.79 -39.53 81.37 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.271 -0.893 . . . . 0.0 110.059 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.717 HG13 HD11 ' A' ' 199' ' ' LEU . 8.7 tp -73.63 -22.59 18.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 118.018 -1.473 . . . . 0.0 109.071 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -56.78 -33.63 66.83 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.438 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.1 OUTLIER -66.03 -40.63 91.18 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.501 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.639 ' HB2' HD13 ' A' ' 175' ' ' LEU . . . -60.32 -49.32 78.05 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.969 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ASN . . . . . 0.606 ' HA ' ' CB ' ' A' ' 197' ' ' MET . 0.1 OUTLIER -73.03 -11.49 60.58 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.282 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -73.75 -34.78 64.88 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 117.47 -1.692 . . . . 0.0 111.365 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -112.11 -52.47 2.78 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 116.165 -2.214 . . . . 0.0 111.489 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -114.2 32.6 5.79 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 117.859 -1.536 . . . . 0.0 114.238 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' MET . . . . . 0.944 ' SD ' HD13 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -153.12 147.44 25.81 Favored 'General case' 0 N--CA 1.517 2.918 0 CA-C-N 123.396 2.816 . . . . 0.0 115.912 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.804 ' HB3' ' O ' ' A' ' 28' ' ' GLY . . . -95.36 127.62 41.55 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 175.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.717 HD11 HG13 ' A' ' 189' ' ' ILE . 0.3 OUTLIER -114.92 107.35 15.28 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 120.41 -1.431 . . . . 0.0 113.512 -176.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 1.03 HG11 HD12 ' A' ' 205' ' ' LEU . 4.4 p -100.05 -173.02 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.245 -0.91 . . . . 0.0 110.07 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.705 HG23 ' H ' ' A' ' 204' ' ' ASP . 4.4 t -111.98 165.08 12.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.071 -1.018 . . . . 0.0 109.796 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.935 HD12 ' CD2' ' A' ' 153' ' ' HIS . 9.9 tt -81.39 -14.27 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.044 -1.035 . . . . 0.0 111.298 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 207' ' ' ALA . 2.1 mt-10 -90.1 -43.63 10.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.934 -1.104 . . . . 0.0 110.598 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.705 ' H ' HG23 ' A' ' 201' ' ' THR . 3.9 t70 -85.48 -14.73 45.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 111.404 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 1.086 HD21 HD13 ' A' ' 163' ' ' LEU . 10.5 tt -77.0 -53.57 7.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.81 -1.181 . . . . 0.0 110.914 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 1.022 HG11 ' CG1' ' A' ' 147' ' ' VAL . 1.1 t -76.75 -29.33 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 117.875 -1.53 . . . . 0.0 107.765 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 203' ' ' GLU . . . -57.1 -30.95 64.79 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.656 ' CD2' HG11 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -62.82 -44.7 95.45 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 177.605 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.439 ' CD ' ' HB ' ' A' ' 162' ' ' THR . 54.7 ttt-85 -61.62 -52.15 65.58 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.739 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.76 -57.61 5.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 110.446 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 207' ' ' ALA . . . -51.51 -23.95 4.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.417 -0.802 . . . . 0.0 110.414 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' HIS . . . . . 0.404 ' HB2' ' O ' ' A' ' 208' ' ' TYR . 2.0 t60 . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.241 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.432 ' C ' ' N ' ' A' ' 14' ' ' GLU . 18.1 Cg_endo . . . . . 0 N--CA 1.518 2.921 0 CA-C-O 123.919 1.55 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.878 ' O ' HG22 ' A' ' 16' ' ' VAL . 1.8 m-30 -51.54 -16.28 0.58 Allowed 'General case' 0 C--O 1.183 -2.413 0 O-C-N 119.747 -1.845 . . . . 0.0 106.619 168.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.566 ' HA ' ' CB ' ' A' ' 17' ' ' GLU . 2.8 mt-10 -44.45 -36.1 2.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.109 -1.62 . . . . 0.0 109.239 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -42.24 90.85 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 176.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.878 HG22 ' O ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -74.91 -29.44 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.183 175.626 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.566 ' CB ' ' HA ' ' A' ' 14' ' ' GLU . 9.2 tt0 -56.64 -56.41 21.74 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.292 -1.505 . . . . 0.0 107.749 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 50.4 t-20 -53.35 -25.96 17.22 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.206 -0.997 . . . . 0.0 108.336 177.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.832 ' HB3' ' O ' ' A' ' 16' ' ' VAL . . . -70.78 -66.43 0.61 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.588 0.709 . . . . 0.0 110.701 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.655 HD11 ' CD1' ' A' ' 44' ' ' ILE . 0.8 OUTLIER -78.92 -33.01 45.86 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.204 -0.935 . . . . 0.0 110.942 -178.604 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 17' ' ' GLU . . . -56.09 -32.5 64.2 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 18' ' ' ASN . . . -67.0 -35.79 80.74 Favored 'General case' 0 C--O 1.207 -1.166 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 176.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.875 HD12 HG23 ' A' ' 29' ' ' VAL . 3.1 tt -48.51 -26.24 2.07 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.164 -0.96 . . . . 0.0 109.75 178.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -91.06 -26.16 19.3 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.807 0.813 . . . . 0.0 108.833 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 22' ' ' ALA . 0.3 OUTLIER -144.42 78.98 1.59 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 177.436 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 126.0 52.59 0.16 Allowed Glycine 0 C--N 1.281 -2.499 1 N-CA-C 101.63 -4.588 . . . . 0.0 101.63 -173.147 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.542 ' HA ' ' HA ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -56.18 80.6 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 122.936 1.35 . . . . 0.0 111.308 -173.526 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 26' ' ' GLY . . . 172.76 104.75 0.18 Allowed Glycine 0 N--CA 1.489 2.201 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.49 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.875 HG23 HD12 ' A' ' 23' ' ' LEU . 1.5 t -116.48 121.77 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.815 ' CE ' ' HB3' ' A' ' 192' ' ' ALA . 0.0 OUTLIER -111.77 131.48 55.29 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 117.996 -1.482 . . . . 0.0 110.52 -178.798 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 200' ' ' VAL . 14.7 p . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.435 -0.791 . . . . 0.0 110.219 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.878 ' OD2' HD22 ' A' ' 57' ' ' LEU . 28.9 t70 . . . . . 0 N--CA 1.514 2.731 0 CA-C-O 121.853 0.835 . . . . 0.0 112.078 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.602 ' O ' ' O ' ' A' ' 171' ' ' VAL . 0.7 OUTLIER -94.66 52.42 1.52 Allowed 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 122.175 0.988 . . . . 0.0 113.094 -178.017 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.854 HD11 ' CD1' ' A' ' 163' ' ' LEU . 13.0 tt -63.48 19.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.846 0 O-C-N 119.399 -2.063 . . . . 0.0 113.154 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.676 ' CZ ' HD21 ' A' ' 23' ' ' LEU . 2.9 m-85 -81.92 162.97 55.58 Favored Pre-proline 0 N--CA 1.498 1.93 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -175.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.507 ' HD2' ' CD2' ' A' ' 45' ' ' PHE . 51.3 Cg_endo -69.82 131.23 20.71 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.642 2.228 . . . . 0.0 110.719 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.946 ' HB3' ' HB1' ' A' ' 169' ' ' ALA . . . -67.58 -20.45 65.38 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.297 -0.961 . . . . 0.0 112.029 -178.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.624 ' HA ' HG21 ' A' ' 122' ' ' ILE . 20.6 tt0 -76.52 -35.08 58.52 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.838 -1.163 . . . . 0.0 111.078 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.503 HG23 ' HG2' ' A' ' 46' ' ' PRO . 4.7 t -132.87 58.81 1.75 Allowed 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.718 ' HB3' HG21 ' A' ' 171' ' ' VAL . 0.3 OUTLIER -65.4 88.13 0.08 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 179.069 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.539 ' HA ' HG12 ' A' ' 115' ' ' ILE . 11.4 m -59.07 170.04 0.96 Allowed 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.713 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.715 HG23 ' HB1' ' A' ' 111' ' ' ALA . 2.7 p -83.16 -2.3 6.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 O-C-N 121.341 -0.85 . . . . 0.0 110.063 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.405 ' HG3' ' HD2' ' A' ' 27' ' ' ARG . 0.8 OUTLIER -63.28 -44.77 94.16 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.481 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.466 ' HB2' ' HG3' ' A' ' 43' ' ' MET . 0.0 OUTLIER -76.19 -35.83 58.94 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.458 178.637 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.474 ' HA ' ' OG1' ' A' ' 58' ' ' THR . 0.0 OUTLIER -70.51 -27.8 64.47 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.143 -0.973 . . . . 0.0 108.525 178.407 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 52' ' ' VAL . . . -56.46 -47.83 78.36 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.754 -0.591 . . . . 0.0 109.709 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.878 HD22 ' OD2' ' A' ' 42' ' ' ASP . 6.7 tt -60.04 -56.81 17.11 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.026 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.64 ' N ' HD23 ' A' ' 57' ' ' LEU . 2.6 p -53.39 -36.0 60.97 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.423 -0.798 . . . . 0.0 109.79 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' A' ' 111' ' ' ALA . 51.2 mt -84.48 -11.33 11.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.568 -0.708 . . . . 0.0 109.178 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -51.53 -51.94 51.14 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.749 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.51 -37.38 2.36 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 116.583 -2.047 . . . . 0.0 112.07 176.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.02 107.53 0.21 Allowed Glycine 0 N--CA 1.499 2.839 0 C-N-CA 118.834 -1.65 . . . . 0.0 111.413 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.499 ' HB2' ' CA ' ' A' ' 58' ' ' THR . 0.6 OUTLIER -165.89 99.99 0.66 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 120.227 2.013 . . . . 0.0 105.69 172.476 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.477 ' HA3' ' CG1' ' A' ' 109' ' ' VAL . . . -123.46 55.77 0.69 Allowed Glycine 0 C--N 1.283 -2.407 0 N-CA-C 106.364 -2.694 . . . . 0.0 106.364 176.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.465 HD13 ' HA ' ' A' ' 65' ' ' ILE . 20.5 mm -147.68 104.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 113.838 -1.181 . . . . 0.0 109.411 175.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.809 HG11 ' HB ' ' A' ' 171' ' ' VAL . 25.5 t -114.96 154.28 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.568 -1.332 . . . . 0.0 110.66 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 138' ' ' PHE . 0.4 OUTLIER -92.15 120.16 32.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.022 -1.674 . . . . 0.0 108.524 178.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.754 ' CD1' ' HB1' ' A' ' 47' ' ' ALA . 3.6 mm? -89.47 98.43 11.76 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.492 ' HB2' ' N ' ' A' ' 170' ' ' GLY . 66.3 m -66.1 129.1 38.63 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.638 -0.664 . . . . 0.0 109.779 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.762 HD11 ' HD3' ' A' ' 75' ' ' ARG . 10.4 tt -153.99 164.79 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.928 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.45 HG22 ' H ' ' A' ' 72' ' ' GLU . 2.1 m -124.85 175.72 7.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.426 -0.797 . . . . 0.0 109.946 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.45 ' H ' HG22 ' A' ' 71' ' ' THR . 13.8 tt0 -73.91 -9.2 58.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.246 -0.909 . . . . 0.0 110.775 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -88.26 -39.87 14.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.972 -1.08 . . . . 0.0 110.53 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.84 -35.87 59.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.246 -0.909 . . . . 0.0 110.188 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.797 ' CZ ' HD12 ' A' ' 99' ' ' ILE . 0.1 OUTLIER -78.48 -29.82 47.0 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.219 1.009 . . . . 0.0 108.6 179.095 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -53.15 -66.04 0.46 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.198 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -47.64 -33.37 6.65 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 122.089 0.947 . . . . 0.0 109.224 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.512 HD21 ' CD2' ' A' ' 131' ' ' LEU . 19.1 tp -96.55 47.13 1.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 175.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 76' ' ' LYS . 1.2 m-20 -22.39 83.9 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 124.458 2.075 . . . . 0.0 112.471 -171.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.692 HD22 ' HD2' ' A' ' 81' ' ' PRO . 3.5 tm? -147.42 112.54 4.03 Favored Pre-proline 0 C--N 1.292 -1.905 0 CA-C-N 111.073 -2.785 . . . . 0.0 109.574 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.692 ' HD2' HD22 ' A' ' 80' ' ' LEU . 46.5 Cg_endo -72.26 99.37 1.01 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.317 1.167 . . . . 0.0 111.046 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.466 ' O ' ' CG ' ' A' ' 82' ' ' MET . 3.6 ptt? -87.0 83.95 7.41 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.323 -0.861 . . . . 0.0 109.386 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.57 ' H ' HG23 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -147.47 67.35 1.13 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.94 -1.1 . . . . 0.0 110.899 -179.257 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.707 ' CG2' HG22 ' A' ' 97' ' ' VAL . 82.8 t . . . . . 0 N--CA 1.495 1.818 0 O-C-N 121.046 -1.033 . . . . 0.0 109.217 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.52 3.052 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.474 HG21 ' N ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -130.34 75.48 1.66 Allowed 'General case' 0 C--N 1.292 -1.906 0 O-C-N 121.303 -0.873 . . . . 0.0 110.997 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.707 HG22 ' CG2' ' A' ' 84' ' ' VAL . 90.3 t -43.98 145.4 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.493 0 O-C-N 120.458 -1.401 . . . . 0.0 110.83 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.614 HG22 ' O ' ' A' ' 137' ' ' VAL . 1.0 OUTLIER -73.98 -174.96 2.01 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.774 0.797 . . . . 0.0 112.329 -177.141 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.797 HD12 ' CZ ' ' A' ' 75' ' ' ARG 0.302 0.1 OUTLIER -149.24 123.55 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -178.049 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 132' ' ' ASN . 3.9 tm-20 -91.2 105.36 17.74 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 117.775 -1.57 . . . . 0.0 112.715 -176.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 105' ' ' VAL . . . -50.6 96.43 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.132 -0.98 . . . . 0.0 110.169 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 130' ' ' ASP . . . -103.16 2.87 35.12 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.114 -0.992 . . . . 0.0 110.061 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.429 ' HB3' ' CB ' ' A' ' 130' ' ' ASP . 7.7 pt-20 -112.26 45.36 1.29 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.066 -1.021 . . . . 0.0 111.448 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.538 ' O ' HG21 ' A' ' 117' ' ' THR . . . 127.65 -37.68 2.28 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 118.946 -1.597 . . . . 0.0 112.723 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.991 HG21 ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -101.43 121.76 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 O-C-N 120.823 -1.398 . . . . 0.0 111.113 -178.619 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.4 p -144.3 58.53 1.33 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.599 -1.24 . . . . 0.0 110.975 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.877 HG21 ' OG ' ' A' ' 110' ' ' SER . 23.9 m -139.52 -32.33 0.65 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.953 -1.092 . . . . 0.0 110.86 176.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.622 ' CA ' ' CE1' ' A' ' 136' ' ' HIS . . . 74.11 -31.96 0.94 Allowed Glycine 0 N--CA 1.493 2.467 0 O-C-N 121.688 -0.632 . . . . 0.0 111.526 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.477 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -131.02 58.0 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.707 -1.466 . . . . 0.0 109.84 179.298 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.877 ' OG ' HG21 ' A' ' 107' ' ' THR . 0.4 OUTLIER -129.54 57.04 1.68 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.028 -1.045 . . . . 0.0 109.579 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.825 ' O ' HD13 ' A' ' 115' ' ' ILE . . . -32.9 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -85.14 -77.48 0.28 Allowed 'General case' 0 C--N 1.288 -2.095 0 O-C-N 120.554 -1.342 . . . . 0.0 109.558 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.02 -16.64 19.43 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.411 -0.806 . . . . 0.0 110.366 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.605 ' HG3' HG23 ' A' ' 118' ' ' VAL . 0.4 OUTLIER -88.77 -36.61 16.01 Favored 'General case' 0 C--O 1.2 -1.552 0 O-C-N 121.063 -1.023 . . . . 0.0 110.869 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.825 HD13 ' O ' ' A' ' 111' ' ' ALA . 0.9 OUTLIER -59.97 -17.19 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 C-N-CA 117.971 -1.491 . . . . 0.0 109.183 -179.153 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.8 m -89.09 -57.48 2.88 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.459 1.123 . . . . 0.0 108.491 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.937 ' OG1' HG13 ' A' ' 105' ' ' VAL . 2.0 p -62.71 -32.42 73.52 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.138 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.605 HG23 ' HG3' ' A' ' 114' ' ' ARG . 9.8 t -54.47 -47.55 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 -48.06 -29.46 3.56 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 117' ' ' THR . . . -85.69 -40.08 16.53 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.676 178.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.991 ' HB2' HG21 ' A' ' 105' ' ' VAL . . . -58.11 -50.77 72.32 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.756 -1.215 . . . . 0.0 109.798 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.687 HG22 ' O ' ' A' ' 122' ' ' ILE . 26.5 mm -87.52 27.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.493 0.663 . . . . 0.0 109.741 178.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.529 ' HB2' ' O ' ' A' ' 120' ' ' ALA . . . -37.42 148.36 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.744 0.783 . . . . 0.0 112.37 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -41.37 -7.61 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 123' ' ' ALA . . . 131.61 28.87 0.61 Allowed Glycine 0 N--CA 1.495 2.633 0 O-C-N 119.8 -1.812 . . . . 0.0 110.775 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.78 167.62 13.03 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.31 -1.112 . . . . 0.0 108.504 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.98 124.07 82.35 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.32 16.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.51 1.268 . . . . 0.0 113.149 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.82 -27.62 65.26 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.177 -1.577 . . . . 0.0 108.768 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.749 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 38.5 m-20 -94.79 27.19 3.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.282 -0.886 . . . . 0.0 109.644 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.748 ' CG ' HG23 ' A' ' 99' ' ' ILE . 9.2 tp -141.38 83.88 1.89 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.274 -0.891 . . . . 0.0 109.191 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.541 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 3.4 m120 -120.32 101.11 7.57 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.099 -1.0 . . . . 0.0 111.995 -178.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.597 ' CB ' ' HA ' ' A' ' 134' ' ' PRO . 0.0 OUTLIER -83.15 -179.01 1.32 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.404 -0.81 . . . . 0.0 111.011 -178.403 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.597 ' HA ' ' CB ' ' A' ' 133' ' ' ARG . 48.6 Cg_endo -73.01 130.31 19.74 Favored 'Cis proline' 0 N--CA 1.5 1.863 0 C-N-CA 123.119 -1.617 . . . . 0.0 113.148 8.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.538 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -132.3 67.95 0.55 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.622 ' CE1' ' CA ' ' A' ' 108' ' ' GLY . 24.5 p80 32.08 36.59 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.484 0 O-C-N 122.105 -0.644 . . . . 0.0 112.075 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.614 ' O ' HG22 ' A' ' 98' ' ' THR . 13.4 t -91.04 154.2 3.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 176.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.681 ' HD1' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -145.34 81.6 10.23 Favored Pre-proline 0 C--N 1.287 -2.139 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -178.667 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.477 ' HD3' HG12 ' A' ' 137' ' ' VAL . 52.3 Cg_endo -99.56 159.9 0.57 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.375 2.05 . . . . 0.0 111.857 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.741 ' HB3' HG21 ' A' ' 157' ' ' THR . 10.9 tp -126.54 113.16 16.41 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -63.72 151.33 42.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.307 -0.871 . . . . 0.0 109.404 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.506 ' CA ' ' HA ' ' A' ' 156' ' ' ALA . . . -62.63 98.19 0.11 Allowed 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.039 0.924 . . . . 0.0 111.821 -177.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 156' ' ' ALA . 1.0 OUTLIER -100.68 146.8 26.74 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.153 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.79 116.0 31.16 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.669 -1.269 . . . . 0.0 112.592 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 112.67 -6.32 26.1 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.063 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.09 9.08 61.29 Favored Glycine 0 N--CA 1.502 3.048 0 C-N-CA 118.466 -1.826 . . . . 0.0 112.788 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.944 HG22 HG13 ' A' ' 202' ' ' ILE . 1.0 OUTLIER -116.48 -45.15 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.24 -1.741 . . . . 0.0 108.51 177.41 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.995 HD22 ' HB2' ' A' ' 150' ' ' ARG . 0.3 OUTLIER -106.77 84.29 1.97 Allowed 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 177.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.425 ' O ' ' CD ' ' A' ' 150' ' ' ARG . 5.1 m -74.3 63.96 1.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 125.335 2.493 . . . . 0.0 104.488 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.995 ' HB2' HD22 ' A' ' 148' ' ' LEU . 12.5 mmt180 -152.68 162.58 41.06 Favored 'General case' 0 C--N 1.271 -2.83 0 N-CA-C 100.23 -3.989 . . . . 0.0 100.23 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -60.57 55.91 0.02 OUTLIER Glycine 0 C--N 1.258 -3.772 0 C-N-CA 117.686 -2.197 . . . . 0.0 112.537 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 150' ' ' ARG . . . -119.28 128.7 7.73 Favored Glycine 0 C--O 1.215 -1.058 0 N-CA-C 106.28 -2.728 . . . . 0.0 106.28 176.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -90.72 1.35 56.93 Favored 'General case' 0 C--N 1.282 -2.344 0 O-C-N 121.969 -0.724 . . . . 0.0 109.312 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.85 ' OG1' HG11 ' A' ' 206' ' ' VAL . 1.9 p -51.52 -18.41 1.09 Allowed 'General case' 0 C--O 1.258 1.521 0 O-C-N 121.389 -0.819 . . . . 0.0 112.476 -176.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.733 ' O ' ' N ' ' A' ' 157' ' ' THR . 5.2 tp10 -48.0 -26.59 1.84 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.295 -0.962 . . . . 0.0 108.509 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.621 ' O ' ' N ' ' A' ' 158' ' ' ILE . . . -46.71 90.82 0.0 OUTLIER 'General case' 0 C--O 1.203 -1.379 0 N-CA-C 103.15 -2.908 . . . . 0.0 103.15 170.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.741 HG21 ' HB3' ' A' ' 140' ' ' LEU . 69.3 p -49.77 12.44 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -168.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.63 ' O ' ' HG3' ' A' ' 161' ' ' MET . 0.9 OUTLIER -107.75 -4.05 10.27 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.402 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 172.889 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.595 ' CB ' ' HA ' ' A' ' 154' ' ' THR . 0.2 OUTLIER -89.09 -33.57 17.06 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 103.174 -2.898 . . . . 0.0 103.174 173.778 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.989 ' HA ' HD23 ' A' ' 163' ' ' LEU . 2.3 mp -62.21 -51.6 67.14 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.74 176.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.63 ' HG3' ' O ' ' A' ' 158' ' ' ILE . 0.0 OUTLIER -48.74 -33.65 10.63 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.394 -1.441 . . . . 0.0 108.553 178.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.922 HG21 ' CZ ' ' A' ' 209' ' ' ARG . 1.3 m -57.88 -39.62 78.26 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 119.311 -0.955 . . . . 0.0 108.549 178.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.989 HD23 ' HA ' ' A' ' 160' ' ' LEU . 0.6 OUTLIER -67.26 -8.65 33.47 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.288 -0.965 . . . . 0.0 109.765 178.315 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.52 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -106.36 7.64 31.29 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 120.674 -1.266 . . . . 0.0 110.758 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 49.38 30.42 11.98 Favored Glycine 0 N--CA 1.5 2.951 0 N-CA-C 107.076 -2.41 . . . . 0.0 107.076 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.502 ' CE1' ' HG3' ' A' ' 46' ' ' PRO . 1.9 m-85 -120.19 146.1 46.34 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 122.828 1.299 . . . . 0.0 112.337 -176.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 169' ' ' ALA . 6.7 mtmm -43.9 139.33 2.98 Favored Pre-proline 0 N--CA 1.502 2.128 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.529 ' HB2' HG13 ' A' ' 158' ' ' ILE . 36.6 Cg_endo -61.89 84.93 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.033 0 C-N-CA 117.012 -1.526 . . . . 0.0 113.767 -172.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.946 ' HB1' ' HB3' ' A' ' 47' ' ' ALA . . . -156.04 162.69 40.27 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 172.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.496 ' N ' ' HB2' ' A' ' 47' ' ' ALA . . . -158.12 131.97 3.0 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 117.358 -2.353 . . . . 0.0 111.361 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.809 ' HB ' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -119.71 89.5 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 117.969 -1.492 . . . . 0.0 107.138 176.6 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.568 ' HA ' ' HB3' ' A' ' 43' ' ' MET . 3.0 mp -95.68 138.35 33.47 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.253 0.549 . . . . 0.0 110.374 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.57 ' SG ' HG21 ' A' ' 58' ' ' THR . 2.8 t -129.59 176.2 8.18 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.897 -1.127 . . . . 0.0 111.064 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -111.45 -179.46 3.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.201 -0.937 . . . . 0.0 110.06 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.709 HD12 ' HB3' ' A' ' 188' ' ' CYS . 3.5 tm? . . . . . 0 N--CA 1.496 1.869 0 O-C-N 121.108 -0.995 . . . . 0.0 110.001 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.93 ' HB1' ' SG ' ' A' ' 188' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.229 0.538 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 185' ' ' ALA . 0.1 OUTLIER -140.23 100.2 3.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.901 . . . . 0.0 109.827 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.857 ' HB1' ' HD2' ' A' ' 186' ' ' PRO . . . -179.37 178.08 0.34 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.31 -0.869 . . . . 0.0 109.891 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.857 ' HD2' ' HB1' ' A' ' 185' ' ' ALA . 45.3 Cg_endo -71.82 -16.92 29.49 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.608 1.32 . . . . 0.0 110.413 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -79.46 -31.56 42.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.087 -1.008 . . . . 0.0 110.067 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' CYS . . . . . 0.93 ' SG ' ' HB1' ' A' ' 183' ' ' ALA . 14.0 m -74.35 -56.63 4.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.325 -0.859 . . . . 0.0 110.186 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.542 ' O ' ' HE1' ' A' ' 30' ' ' MET . 2.5 tp -61.7 -22.97 29.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.994 -1.066 . . . . 0.0 109.38 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.501 ' HA ' ' HB3' ' A' ' 193' ' ' ASN . 23.7 tt0 -81.61 -18.62 44.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.477 -0.764 . . . . 0.0 109.817 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.439 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.1 OUTLIER -71.34 -53.9 12.61 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.992 0.901 . . . . 0.0 109.36 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.815 ' HB3' ' CE ' ' A' ' 30' ' ' MET . . . -69.6 -35.63 75.48 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ASN . . . . . 0.581 ' HA ' ' CB ' ' A' ' 197' ' ' MET . 14.9 t30 -61.71 -18.6 60.32 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.915 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -81.79 -39.81 23.52 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.918 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -100.98 -54.72 2.74 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 115.499 -2.481 . . . . 0.0 111.892 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.417 ' O ' ' HE3' ' A' ' 197' ' ' MET . 18.7 m120 -114.94 33.42 5.42 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.172 -1.411 . . . . 0.0 113.889 177.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' MET . . . . . 0.735 ' SD ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -152.14 148.99 28.29 Favored 'General case' 0 N--CA 1.515 2.803 0 CA-C-N 122.966 2.621 . . . . 0.0 115.632 -179.52 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.518 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . . . -113.12 125.64 54.59 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 176.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.558 HD11 ' CB ' ' A' ' 193' ' ' ASN . 26.1 mt -94.09 144.47 25.46 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.546 -1.346 . . . . 0.0 112.971 -177.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.801 ' O ' HG23 ' A' ' 31' ' ' VAL . 7.1 p -146.81 110.45 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.422 ' O ' ' CB ' ' A' ' 205' ' ' LEU . 23.9 p -70.69 147.96 48.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 111.707 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.944 HG13 HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -47.72 -38.52 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 121.304 0.573 . . . . 0.0 110.495 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 207' ' ' ALA . 10.7 tt0 -48.13 -65.99 0.48 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.08 -1.012 . . . . 0.0 110.737 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.581 ' O ' ' HB3' ' A' ' 207' ' ' ALA . 6.4 m-20 -80.89 -25.16 37.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.745 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.931 HD11 HD13 ' A' ' 163' ' ' LEU . 3.1 tm? -64.75 -67.5 0.43 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.334 -0.853 . . . . 0.0 109.422 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.85 HG11 ' OG1' ' A' ' 154' ' ' THR . 97.9 t -62.67 -21.99 28.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 118.048 -1.461 . . . . 0.0 108.364 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 204' ' ' ASP . . . -53.25 -28.89 29.73 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 175.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.555 ' HA ' ' CE1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -77.85 -36.59 49.82 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.777 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.922 ' CZ ' HG21 ' A' ' 162' ' ' THR . 16.1 tpt180 -78.6 -58.67 3.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.896 -1.127 . . . . 0.0 110.067 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 206' ' ' VAL . 59.5 tp60 -51.85 -36.54 48.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.167 -0.958 . . . . 0.0 110.351 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 207' ' ' ALA . . . -72.54 -29.15 63.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 110.222 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 58.1 t60 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.225 -0.922 . . . . 0.0 110.182 179.954 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.65 ' O ' HG12 ' A' ' 16' ' ' VAL . 28.1 Cg_endo . . . . . 0 C--O 1.211 -0.84 0 N-CA-C 110.319 -0.685 . . . . 0.0 110.319 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -86.02 -56.17 3.59 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -93.5 -36.42 12.45 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 118.328 -1.349 . . . . 0.0 111.166 -176.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.671 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 8.3 mmt180 -78.83 -30.05 45.06 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 119.181 -1.007 . . . . 0.0 111.79 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.799 HG11 ' CD2' ' A' ' 208' ' ' TYR . 0.4 OUTLIER -89.55 -36.11 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 116.224 -2.19 . . . . 0.0 111.552 -179.167 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -63.16 -40.32 97.21 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 117.383 -1.727 . . . . 0.0 108.757 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.91 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 32.5 p-10 -84.38 -23.06 30.26 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.546 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 15' ' ' ARG . . . -71.63 -38.21 70.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.494 -1.379 . . . . 0.0 110.11 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.711 HD13 ' O ' ' A' ' 163' ' ' LEU . 1.6 pp -73.35 -54.27 8.76 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.333 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.659 ' HA ' ' N ' ' A' ' 26' ' ' GLY . . . -69.21 -69.74 0.32 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.877 -1.139 . . . . 0.0 111.807 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.91 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -50.09 -34.89 23.33 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.689 -1.142 . . . . 0.0 112.739 -177.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.933 HD13 ' HB2' ' A' ' 198' ' ' ALA . 2.6 tt -56.39 -59.89 4.32 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.652 ' HB2' HD23 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -123.82 -76.43 0.59 Allowed 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 117.686 -1.606 . . . . 0.0 108.15 173.083 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.461 ' HG3' ' CG ' ' A' ' 27' ' ' ARG . 5.7 pt-20 -167.28 45.78 0.05 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.102 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.659 ' N ' ' HA ' ' A' ' 21' ' ' ALA . . . 60.47 20.01 54.73 Favored Glycine 0 N--CA 1.481 1.698 0 N-CA-C 107.097 -2.401 . . . . 0.0 107.097 -176.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.52 ' CB ' ' CE1' ' A' ' 45' ' ' PHE . 6.6 mtt180 -118.31 39.25 3.48 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.467 -1.019 . . . . 0.0 109.792 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.724 ' O ' ' HB3' ' A' ' 198' ' ' ALA . . . 178.2 66.41 0.06 OUTLIER Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.317 -1.913 . . . . 0.0 108.317 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.718 ' CB ' HD12 ' A' ' 44' ' ' ILE . 6.1 t -144.75 116.97 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.852 ' HG2' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -84.41 146.37 27.69 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 119.838 -1.789 . . . . 0.0 113.313 -177.59 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 1.09 HG22 HG22 ' A' ' 202' ' ' ILE . 14.8 p . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.502 2.138 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.607 ' HE2' ' H ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -31.35 -27.82 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.176 0 N-CA-C 116.906 2.187 . . . . 0.0 116.906 -174.962 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.718 HD12 ' CB ' ' A' ' 29' ' ' VAL . 0.8 OUTLIER -138.53 16.18 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.259 0 CA-C-O 122.695 1.236 . . . . 0.0 110.055 178.785 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.671 ' O ' HG12 ' A' ' 171' ' ' VAL . 0.7 OUTLIER -68.66 161.48 70.54 Favored Pre-proline 0 C--N 1.288 -2.083 0 O-C-N 121.172 -0.955 . . . . 0.0 113.564 -175.881 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.585 ' HB3' ' CB ' ' A' ' 167' ' ' LYS . 55.8 Cg_endo -82.35 129.92 6.05 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 C-N-CA 122.058 1.839 . . . . 0.0 109.409 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.982 ' HB1' HD13 ' A' ' 68' ' ' LEU . . . -71.69 -1.33 13.44 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.256 -0.903 . . . . 0.0 112.566 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.889 ' HA ' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -86.83 -23.78 25.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.797 -1.19 . . . . 0.0 110.128 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.586 ' O ' HG23 ' A' ' 49' ' ' THR . 10.1 t -133.26 60.23 1.71 Allowed 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.743 ' HG3' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -52.54 88.94 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.334 0.588 . . . . 0.0 109.739 -179.426 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.53 ' HA ' HG13 ' A' ' 115' ' ' ILE . 26.2 p -61.95 172.58 1.31 Allowed 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.83 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.52 HG22 HD13 ' A' ' 115' ' ' ILE . 17.7 t -73.91 -5.1 6.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.533 -0.729 . . . . 0.0 110.12 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.843 ' O ' HD23 ' A' ' 57' ' ' LEU . 0.8 OUTLIER -50.6 -28.31 8.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.006 -1.059 . . . . 0.0 109.422 179.413 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.437 ' O ' ' CG2' ' A' ' 58' ' ' THR . 0.0 OUTLIER -86.95 -28.98 22.4 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.203 179.413 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.472 ' HA ' HG22 ' A' ' 58' ' ' THR . 3.8 mmt -86.23 -41.13 14.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.265 -0.897 . . . . 0.0 109.528 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.46 -53.97 35.12 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.224 -0.923 . . . . 0.0 110.4 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.843 HD23 ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -64.03 -33.4 75.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.216 -0.927 . . . . 0.0 111.059 -179.273 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.475 ' CG2' ' N ' ' A' ' 59' ' ' ILE . 4.4 t -79.33 -46.86 16.87 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.739 -1.226 . . . . 0.0 110.836 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.475 ' N ' ' CG2' ' A' ' 58' ' ' THR . 72.1 mt -53.78 -21.93 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.841 -1.162 . . . . 0.0 109.578 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -84.83 -46.04 11.73 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.378 -0.826 . . . . 0.0 112.257 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.36 -15.04 6.3 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -177.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 58' ' ' THR . . . -164.36 -168.95 27.24 Favored Glycine 0 N--CA 1.502 3.081 0 C-N-CA 118.547 -1.787 . . . . 0.0 111.756 -176.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.6 t -126.57 102.35 7.06 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 101.32 -3.585 . . . . 0.0 101.32 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 66' ' ' VAL . . . -104.79 76.43 0.25 Allowed Glycine 0 C--N 1.26 -3.663 0 N-CA-C 105.804 -2.918 . . . . 0.0 105.804 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.772 HG23 ' CD2' ' A' ' 138' ' ' PHE . 3.2 mm -61.34 84.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.535 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.705 HG12 ' HB3' ' A' ' 173' ' ' CYS . 26.5 m -52.72 157.09 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.508 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.311 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.698 ' HB3' HD11 ' A' ' 140' ' ' LEU . 97.4 m -109.64 119.35 39.14 Favored 'General case' 0 C--N 1.29 -2.006 0 O-C-N 121.393 -0.817 . . . . 0.0 110.32 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.982 HD13 ' HB1' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -87.28 97.81 10.99 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.316 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 74.3 m -70.7 127.28 32.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.467 -0.77 . . . . 0.0 111.794 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.594 HD12 ' HB3' ' A' ' 79' ' ' ASP . 24.6 pt -115.97 162.47 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.465 ' CA ' HG12 ' A' ' 158' ' ' ILE . 1.6 m -81.03 170.62 15.99 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 120.55 -1.344 . . . . 0.0 109.7 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.555 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -95.4 -12.47 25.93 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.399 178.904 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -85.39 -73.18 0.45 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.915 -1.115 . . . . 0.0 111.901 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -85.98 -32.58 21.44 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 79' ' ' ASP . 10.8 mpt_? -74.07 -31.71 62.96 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.626 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.555 ' HB2' ' HA ' ' A' ' 72' ' ' GLU . 18.2 tttt -72.93 -41.41 64.55 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 119.89 -1.756 . . . . 0.0 108.996 178.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -42.35 -54.1 3.92 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.298 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.63 HD11 ' C ' ' A' ' 128' ' ' PRO . 0.4 OUTLIER -105.08 -29.49 10.37 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.049 -1.46 . . . . 0.0 109.156 178.35 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.594 ' HB3' HD12 ' A' ' 70' ' ' ILE . 5.9 t0 -112.57 70.79 0.72 Allowed 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.997 0.903 . . . . 0.0 109.612 177.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.72 ' C ' HD22 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -80.62 171.34 12.57 Favored Pre-proline 0 C--N 1.286 -2.157 0 O-C-N 121.277 -0.889 . . . . 0.0 112.173 -179.238 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.654 ' N ' HD22 ' A' ' 80' ' ' LEU . 52.9 Cg_endo -84.22 97.79 0.73 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.11 1.058 . . . . 0.0 109.556 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' MET . . . . . 0.879 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.8 ttt -97.39 95.76 7.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.11 -0.994 . . . . 0.0 110.641 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.87 95.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.062 -1.024 . . . . 0.0 110.689 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 82' ' ' MET . 93.7 t . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.903 . . . . 0.0 109.997 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.489 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.405 ' O ' ' O ' ' A' ' 82' ' ' MET . 0.9 OUTLIER -127.66 14.92 7.03 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.531 ' O ' ' HD2' ' A' ' 139' ' ' PRO . 4.2 p -115.74 145.14 21.87 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 O-C-N 121.007 -1.058 . . . . 0.0 110.683 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.561 HG22 ' H ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -123.87 -173.79 2.83 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.979 ' CG1' HG11 ' A' ' 137' ' ' VAL . 2.4 pp -145.8 122.82 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 C-N-CA 117.191 -1.803 . . . . 0.0 114.759 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.76 ' CA ' ' HG2' ' A' ' 133' ' ' ARG . 11.4 tm-20 -90.32 163.43 14.74 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.814 177.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.638 ' HB2' ' HB ' ' A' ' 106' ' ' THR . . . -51.73 88.18 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.63 -0.669 . . . . 0.0 112.546 -177.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.527 ' HB2' ' N ' ' A' ' 131' ' ' LEU . . . -84.19 -25.6 29.42 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 175.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.23 -6.5 11.31 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.748 -0.595 . . . . 0.0 110.115 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.52 27.47 0.97 Allowed Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.357 -1.401 . . . . 0.0 112.339 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.793 ' HB ' HG22 ' A' ' 117' ' ' THR . 7.0 m -139.88 123.53 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 120.954 -1.321 . . . . 0.0 110.655 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.638 ' HB ' ' HB2' ' A' ' 101' ' ' ALA . 10.9 t -148.21 63.86 1.1 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.713 -1.242 . . . . 0.0 111.618 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.462 HG22 HG21 ' A' ' 117' ' ' THR . 6.3 t -131.41 -31.17 1.63 Allowed 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 118.438 -1.305 . . . . 0.0 110.331 177.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.436 ' HA2' ' NH1' ' A' ' 114' ' ' ARG . . . 60.7 -28.33 0.05 OUTLIER Glycine 0 N--CA 1.504 3.195 0 O-C-N 121.588 -0.695 . . . . 0.0 114.023 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.409 ' N ' ' O ' ' A' ' 107' ' ' THR . 11.1 t -125.46 55.82 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.225 -1.75 . . . . 0.0 110.127 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.597 ' O ' ' N ' ' A' ' 114' ' ' ARG . 9.3 t -133.99 71.41 1.46 Allowed 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' A' ' 55' ' ' MET . . . -25.74 -40.64 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.794 0 CA-C-O 121.59 0.71 . . . . 0.0 112.035 -177.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -69.22 -66.04 0.63 Allowed 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 122.562 1.172 . . . . 0.0 107.881 176.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.807 ' O ' HG23 ' A' ' 117' ' ' THR . 0.2 OUTLIER -64.41 -13.94 53.91 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.099 -1.001 . . . . 0.0 109.445 177.825 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 110' ' ' SER . 5.0 tpm_? -62.86 -42.92 99.94 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.2 -0.937 . . . . 0.0 108.707 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.53 HG13 ' HA ' ' A' ' 51' ' ' THR . 1.7 mp -76.75 -13.49 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 118.557 -1.257 . . . . 0.0 108.178 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.494 ' O ' HG11 ' A' ' 105' ' ' VAL . 2.6 m -94.61 -20.92 19.17 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.23 -0.919 . . . . 0.0 108.828 177.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 113' ' ' ASP . 26.0 p -83.73 -36.85 23.36 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.513 -0.742 . . . . 0.0 109.827 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.758 ' O ' HG22 ' A' ' 122' ' ' ILE . 14.2 p -73.99 -41.37 52.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 118.84 -1.144 . . . . 0.0 108.562 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.98 ' O ' ' HB2' ' A' ' 123' ' ' ALA . 3.3 ttt-85 -61.18 -31.41 71.16 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.133 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.4 ' HB3' HG21 ' A' ' 105' ' ' VAL . . . -95.34 -33.07 12.66 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.668 -0.645 . . . . 0.0 111.358 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.651 ' HB1' HD13 ' A' ' 99' ' ' ILE . . . -61.91 -58.16 8.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.027 -1.046 . . . . 0.0 109.712 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.889 HG21 ' HA ' ' A' ' 48' ' ' GLU . 0.7 OUTLIER -88.49 23.03 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.395 -0.815 . . . . 0.0 110.693 179.052 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.98 ' HB2' ' O ' ' A' ' 119' ' ' ARG . . . -95.96 114.81 26.56 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 126' ' ' ALA . 5.4 t0 -89.99 -82.54 0.27 Allowed 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 117.783 -1.567 . . . . 0.0 113.405 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 124' ' ' ASP . . . 69.6 -43.36 0.46 Allowed Glycine 0 N--CA 1.513 3.797 0 N-CA-C 107.666 -2.173 . . . . 0.0 107.666 -176.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.558 ' H ' ' C ' ' A' ' 124' ' ' ASP . . . -135.72 165.71 24.94 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 103.578 -2.749 . . . . 0.0 103.578 176.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.421 ' C ' ' H ' ' A' ' 129' ' ' SER . 4.4 tttp -65.16 114.68 16.18 Favored Pre-proline 0 C--N 1.304 -1.411 0 CA-C-N 121.361 1.891 . . . . 0.0 108.094 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.63 ' C ' HD11 ' A' ' 78' ' ' LEU . 35.1 Cg_endo -67.66 26.14 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.283 1.322 . . . . 0.0 112.18 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' SER . . . . . 0.421 ' H ' ' C ' ' A' ' 127' ' ' LYS . 0.3 OUTLIER -54.57 -10.16 0.4 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.464 -1.397 . . . . 0.0 111.176 -178.611 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.477 ' CB ' ' HA ' ' A' ' 102' ' ' ALA . 2.0 m-20 -72.3 9.04 1.11 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.601 -1.312 . . . . 0.0 110.417 177.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.534 ' CD2' HG22 ' A' ' 99' ' ' ILE . 4.7 tp -74.67 87.99 2.2 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.474 ' H ' ' HB3' ' A' ' 100' ' ' GLU . 1.6 t-20 -116.13 72.64 0.82 Allowed 'General case' 0 N--CA 1.509 2.501 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.911 ' HB3' ' HA ' ' A' ' 134' ' ' PRO 0.255 0.0 OUTLIER -97.58 -152.76 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.734 0 CA-C-O 115.115 -2.374 . . . . 0.0 110.168 179.163 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.911 ' HA ' ' HB3' ' A' ' 133' ' ' ARG . 56.5 Cg_endo -78.98 127.39 14.67 Favored 'Cis proline' 0 N--CA 1.524 3.31 0 N-CA-C 119.554 2.867 . . . . 0.0 119.554 18.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.928 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -126.99 71.87 0.47 Allowed Glycine 0 N--CA 1.511 3.655 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.338 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 49.3 m80 30.62 35.76 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.544 0 CA-C-O 121.418 0.628 . . . . 0.0 112.562 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.979 HG11 ' CG1' ' A' ' 99' ' ' ILE . 92.6 t -94.5 154.71 3.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.978 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 175.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.772 ' CD2' HG23 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -131.07 79.07 71.94 Favored Pre-proline 0 C--N 1.294 -1.822 0 C-N-CA 117.939 -1.505 . . . . 0.0 110.726 -176.698 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.809 ' C ' HD23 ' A' ' 140' ' ' LEU . 55.8 Cg_endo -107.61 156.44 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 123.515 2.81 . . . . 0.0 107.873 175.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.809 HD23 ' C ' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -145.93 140.81 27.21 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 120.722 -1.236 . . . . 0.0 109.715 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 143' ' ' GLN . 1.8 ptm180 -63.51 154.54 32.11 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.408 ' HB2' ' HB ' ' A' ' 158' ' ' ILE . . . -60.75 88.85 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.862 -1.135 . . . . 0.0 108.949 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 141' ' ' ARG . 0.1 OUTLIER -55.59 144.86 25.02 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.924 0.869 . . . . 0.0 111.021 -178.634 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.594 ' C ' HG21 ' A' ' 154' ' ' THR . . . -83.19 53.97 2.64 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.32 0.581 . . . . 0.0 109.504 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.9 ' O ' HG22 ' A' ' 149' ' ' THR . . . 147.2 19.8 0.1 Allowed Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.578 -1.296 . . . . 0.0 112.457 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.1 1.98 59.49 Favored Glycine 0 N--CA 1.503 3.138 0 C-N-CA 117.769 -2.158 . . . . 0.0 111.403 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.857 ' CG2' HG11 ' A' ' 206' ' ' VAL . 0.3 OUTLIER -116.5 -43.77 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-O 123.943 1.83 . . . . 0.0 107.577 175.217 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.809 ' HA ' HD13 ' A' ' 202' ' ' ILE . 2.8 tp -111.6 70.03 0.7 Allowed 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.9 HG22 ' O ' ' A' ' 145' ' ' GLY . 46.7 p -77.07 63.39 2.34 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 125.243 2.449 . . . . 0.0 104.789 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.586 ' O ' ' N ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -153.58 155.31 35.9 Favored 'General case' 0 C--N 1.267 -2.993 0 N-CA-C 100.501 -3.888 . . . . 0.0 100.501 176.895 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.25 61.99 0.16 Allowed Glycine 0 C--N 1.261 -3.588 0 C-N-CA 117.144 -2.455 . . . . 0.0 109.386 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 150' ' ' ARG . . . -110.11 -161.57 18.56 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 120.198 -1.766 . . . . 0.0 110.696 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.777 ' N ' HD23 ' A' ' 148' ' ' LEU . 10.7 t-80 -66.57 4.48 0.77 Allowed 'General case' 0 C--O 1.188 -2.173 0 CA-C-O 117.366 -1.302 . . . . 0.0 113.964 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.651 ' HA ' HG12 ' A' ' 147' ' ' VAL . 15.0 t -24.23 -26.57 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.396 0 CA-C-N 120.797 1.635 . . . . 0.0 115.086 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.649 ' N ' ' O ' ' A' ' 153' ' ' HIS . 18.3 tt0 -56.32 -22.78 32.84 Favored 'General case' 0 N--CA 1.511 2.606 0 O-C-N 119.326 -2.109 . . . . 0.0 105.325 172.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.718 ' HB2' ' ND1' ' A' ' 153' ' ' HIS . . . -83.99 12.6 6.01 Favored 'General case' 0 C--O 1.206 -1.208 0 O-C-N 120.746 -1.221 . . . . 0.0 108.971 174.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.625 ' N ' ' O ' ' A' ' 154' ' ' THR . 20.5 m -63.71 -43.26 97.1 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 175.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.506 ' O ' ' HB3' ' A' ' 161' ' ' MET . 5.7 tp -70.19 -35.59 63.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 116.169 -2.212 . . . . 0.0 105.209 174.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.566 ' HB2' ' CA ' ' A' ' 156' ' ' ALA . 1.2 m-20 -59.1 -20.52 54.25 Favored 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 116.414 -2.114 . . . . 0.0 107.216 175.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 1.043 ' HA ' HD12 ' A' ' 163' ' ' LEU . 0.2 OUTLIER -61.87 -28.48 69.53 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 176.32 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 161' ' ' MET . . . . . 0.647 ' HB2' ' N ' ' A' ' 169' ' ' ALA . 3.2 ptt? -49.65 -34.29 17.9 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 174.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.486 ' CB ' ' O ' ' A' ' 159' ' ' ASP . 2.7 m -65.23 -29.52 70.32 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.093 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 1.072 HD21 HD21 ' A' ' 205' ' ' LEU . 0.2 OUTLIER -41.7 -44.65 3.23 Favored 'General case' 0 N--CA 1.523 3.183 0 O-C-N 121.077 -1.014 . . . . 0.0 109.142 178.21 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -48.4 -29.15 3.73 Favored 'General case' 0 N--CA 1.517 2.89 0 CA-C-O 122.515 1.15 . . . . 0.0 109.753 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 106.44 -34.49 5.69 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.75 49.25 0.41 Allowed 'General case' 0 N--CA 1.508 2.472 0 C-N-CA 117.938 -1.505 . . . . 0.0 113.185 172.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.585 ' CB ' ' HB3' ' A' ' 46' ' ' PRO . 1.3 mmtt -135.02 124.11 16.28 Favored Pre-proline 0 C--N 1.292 -1.933 0 CA-C-O 116.305 -1.807 . . . . 0.0 106.872 175.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.465 ' HA ' ' HG3' ' A' ' 161' ' ' MET . 51.9 Cg_endo -91.6 75.94 0.59 Allowed 'Trans proline' 0 C--N 1.318 -1.068 0 C-N-CA 114.05 -3.5 . . . . 0.0 112.499 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.958 ' HB1' ' HB3' ' A' ' 47' ' ' ALA . . . -165.41 165.47 19.22 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 170.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 68' ' ' LEU . . . -139.45 129.02 4.19 Favored Glycine 0 N--CA 1.502 3.091 0 C-N-CA 118.596 -1.764 . . . . 0.0 109.737 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.671 HG12 ' O ' ' A' ' 45' ' ' PHE . 5.5 p -133.09 95.07 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-N 119.664 1.732 . . . . 0.0 109.804 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 43' ' ' MET . 0.1 OUTLIER -95.08 143.34 26.61 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.605 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.705 ' HB3' HG12 ' A' ' 66' ' ' VAL . 5.6 p -107.43 175.05 5.62 Favored 'General case' 0 N--CA 1.515 2.78 0 O-C-N 120.632 -1.293 . . . . 0.0 112.175 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -143.71 119.01 10.2 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.313 -0.867 . . . . 0.0 111.558 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.73 HD23 ' SG ' ' A' ' 188' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.504 2.243 0 CA-C-O 121.821 0.82 . . . . 0.0 111.814 -178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.398 0.618 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.434 ' HB3' ' CB ' ' A' ' 188' ' ' CYS . 3.4 mtp180 -147.14 161.95 39.85 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.338 -0.851 . . . . 0.0 109.036 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.844 ' HB3' ' HD3' ' A' ' 186' ' ' PRO . . . -145.87 -68.56 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.068 -1.02 . . . . 0.0 109.704 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.844 ' HD3' ' HB3' ' A' ' 185' ' ' ALA . 45.0 Cg_endo -70.68 -36.99 7.5 Favored 'Trans proline' 0 C--N 1.316 -1.164 0 N-CA-C 109.11 -1.15 . . . . 0.0 109.11 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.469 ' HA ' ' HB2' ' A' ' 190' ' ' GLU . 0.2 OUTLIER -90.16 -16.85 28.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.632 -0.667 . . . . 0.0 109.942 179.197 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 188' ' ' CYS . . . . . 0.73 ' SG ' HD23 ' A' ' 175' ' ' LEU . 0.3 OUTLIER -60.67 -50.81 72.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.391 -0.818 . . . . 0.0 110.479 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.869 HG23 ' CD2' ' A' ' 199' ' ' LEU . 6.4 tp -94.77 -28.03 4.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.045 -1.034 . . . . 0.0 109.414 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' A' ' 194' ' ' LYS . 5.0 mm-40 -57.3 -19.99 25.57 Favored 'General case' 0 C--O 1.199 -1.591 0 O-C-N 120.578 -1.326 . . . . 0.0 107.688 175.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.513 ' CD2' ' N ' ' A' ' 192' ' ' ALA . 4.3 t80 -80.84 -62.25 1.72 Allowed 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 122.771 1.272 . . . . 0.0 108.89 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.513 ' N ' ' CD2' ' A' ' 191' ' ' PHE . . . -73.08 -38.53 66.38 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.483 -177.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ASN . . . . . 0.648 ' HB2' HD21 ' A' ' 199' ' ' LEU . 12.0 m-20 -84.75 -25.12 28.48 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 118.968 -1.093 . . . . 0.0 112.557 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' LYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 190' ' ' GLU . 8.3 ttpt -61.76 -37.83 85.76 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 117.502 -1.679 . . . . 0.0 109.408 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -81.45 -51.64 8.1 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 116.206 -2.197 . . . . 0.0 112.085 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ASN . . . . . 0.427 ' O ' ' CE ' ' A' ' 197' ' ' MET . 0.2 OUTLIER -112.89 33.2 5.16 Favored 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 117.792 -1.563 . . . . 0.0 113.736 177.647 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 197' ' ' MET . . . . . 0.547 ' HB3' ' CB ' ' A' ' 193' ' ' ASN . 0.0 OUTLIER -158.01 152.36 24.57 Favored 'General case' 0 N--CA 1.508 2.444 0 CA-C-N 121.209 1.822 . . . . 0.0 114.861 -179.104 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.933 ' HB2' HD13 ' A' ' 23' ' ' LEU . . . -83.56 139.38 32.9 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 118.675 -1.21 . . . . 0.0 107.935 175.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.869 ' CD2' HG23 ' A' ' 189' ' ' ILE . 3.3 mt -118.96 113.66 21.34 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 120.165 -1.584 . . . . 0.0 112.293 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.669 ' CG1' HD12 ' A' ' 205' ' ' LEU . 8.7 p -124.89 177.59 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.661 0 O-C-N 121.243 -0.911 . . . . 0.0 108.615 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.504 ' N ' HG22 ' A' ' 200' ' ' VAL . 17.5 m -121.25 156.14 33.13 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.252 -1.53 . . . . 0.0 110.808 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 1.09 HG22 HG22 ' A' ' 31' ' ' VAL . 1.2 pp -61.21 -32.7 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 121.061 -1.024 . . . . 0.0 110.229 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 207' ' ' ALA . 2.3 tm-20 -42.28 -67.22 0.28 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.614 -0.679 . . . . 0.0 111.58 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.426 ' O ' ' CB ' ' A' ' 208' ' ' TYR . 3.4 m-20 -87.89 -10.47 50.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.078 -1.014 . . . . 0.0 110.766 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 1.072 HD21 HD21 ' A' ' 163' ' ' LEU . 9.1 tt -84.38 -51.63 6.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 112.132 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.857 HG11 ' CG2' ' A' ' 147' ' ' VAL . 0.1 OUTLIER -84.43 -27.91 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 119.942 -1.723 . . . . 0.0 107.539 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 210' ' ' GLN . . . -63.44 -31.59 72.79 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 173.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.799 ' CD2' HG11 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -58.3 -35.92 72.56 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.355 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -29.19 41.67 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.532 ' HB3' ' HA ' ' A' ' 207' ' ' ALA . 55.8 tt0 -69.28 -68.17 0.42 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 122.003 0.906 . . . . 0.0 108.654 178.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -48.66 -26.3 2.21 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.383 0.611 . . . . 0.0 110.23 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.344 -0.848 . . . . 0.0 110.173 179.655 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 N--CA 1.515 2.787 0 N-CA-C 108.468 -1.397 . . . . 0.0 108.468 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.638 ' O ' HG12 ' A' ' 16' ' ' VAL 0.272 0.0 OUTLIER -46.75 -21.44 0.2 Allowed 'General case' 0 C--O 1.191 -1.977 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 169.886 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.491 ' HA ' ' HB2' ' A' ' 17' ' ' GLU . 32.6 tt0 -48.39 -39.8 23.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.073 -1.642 . . . . 0.0 108.334 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -42.73 99.71 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 175.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.857 HG22 HG12 ' A' ' 200' ' ' VAL . 0.4 OUTLIER -60.46 -34.9 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 118.979 -1.088 . . . . 0.0 108.218 175.577 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.767 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -51.92 -47.61 64.59 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.587 -1.321 . . . . 0.0 108.798 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.944 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 31.4 t-20 -53.27 -31.09 41.96 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.432 ' O ' ' HB1' ' A' ' 198' ' ' ALA . . . -89.56 -68.23 0.79 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 122.292 1.044 . . . . 0.0 110.358 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.825 HD12 HG11 ' A' ' 200' ' ' VAL . 0.2 OUTLIER -47.98 -54.7 12.03 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.398 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.767 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -67.29 -41.59 85.15 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.944 ' HB2' ' O ' ' A' ' 18' ' ' ASN . . . -32.63 -62.08 0.25 Allowed 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 121.045 0.45 . . . . 0.0 111.136 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.948 HD12 ' HA ' ' A' ' 197' ' ' MET . 2.4 mt -106.67 7.73 30.71 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.321 -1.352 . . . . 0.0 110.703 177.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.589 ' HB2' ' O ' ' A' ' 20' ' ' LEU . 59.3 ttp85 -55.26 -18.95 7.03 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.775 -1.203 . . . . 0.0 107.77 176.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -79.71 46.05 0.74 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 122.798 1.285 . . . . 0.0 109.839 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.51 ' HA2' ' CZ ' ' A' ' 45' ' ' PHE . . . 67.92 16.36 68.25 Favored Glycine 0 C--N 1.292 -1.897 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.991 176.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.479 ' O ' HD13 ' A' ' 23' ' ' LEU . 20.1 mtt180 -99.46 17.31 20.61 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 116.079 -2.248 . . . . 0.0 111.225 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 197' ' ' MET . . . 100.6 106.32 2.84 Favored Glycine 0 N--CA 1.496 2.685 0 C-N-CA 118.982 -1.58 . . . . 0.0 113.181 173.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.851 HG22 HD13 ' A' ' 44' ' ' ILE . 2.0 m -145.6 113.71 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 120.174 -1.78 . . . . 0.0 106.743 176.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.483 ' HA ' ' HB3' ' A' ' 43' ' ' MET . 0.0 OUTLIER -75.27 75.17 2.39 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 116.104 -2.238 . . . . 0.0 107.72 -177.691 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.922 HG21 HG22 ' A' ' 200' ' ' VAL . 1.5 t . . . . . 0 C--N 1.287 -2.149 0 CA-C-N 113.773 -1.558 . . . . 0.0 108.17 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.612 ' HA ' ' CD1' ' A' ' 45' ' ' PHE . 25.4 t70 . . . . . 0 N--CA 1.497 1.883 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.589 ' HA ' ' HA ' ' A' ' 172' ' ' LEU . 0.4 OUTLIER -81.45 17.16 1.44 Allowed 'General case' 0 N--CA 1.481 1.112 0 O-C-N 120.468 -1.395 . . . . 0.0 113.942 -177.388 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.851 HD13 HG22 ' A' ' 29' ' ' VAL . 5.2 tp -138.27 16.63 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.794 0 CA-C-O 121.792 0.806 . . . . 0.0 109.724 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.803 ' O ' HG12 ' A' ' 171' ' ' VAL . 89.2 m-85 -107.81 160.1 28.02 Favored Pre-proline 0 N--CA 1.507 2.42 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -173.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -75.62 134.12 16.45 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 123.132 2.555 . . . . 0.0 111.974 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 1.058 ' HB2' HD11 ' A' ' 68' ' ' LEU . . . -50.71 -20.71 1.32 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.234 -0.917 . . . . 0.0 111.807 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -72.67 -26.81 61.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.044 -1.035 . . . . 0.0 110.562 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.654 HG22 ' HG2' ' A' ' 119' ' ' ARG . 65.2 p -133.13 58.86 1.75 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . 0.674 ' CG ' HG11 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -61.91 87.04 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.279 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.492 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -63.56 162.06 13.55 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 122.506 1.146 . . . . 0.0 112.109 -176.492 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.694 ' CG2' ' HB1' ' A' ' 111' ' ' ALA . 4.3 p -75.1 -2.22 3.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.142 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.473 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 23.8 mt-10 -46.28 -26.66 0.85 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.264 -0.897 . . . . 0.0 110.19 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.525 HE21 ' HB ' ' A' ' 58' ' ' THR . 41.4 tp60 -88.11 -49.85 6.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.526 -0.734 . . . . 0.0 109.32 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.895 ' SD ' HD11 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -54.71 -47.09 74.14 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.578 -0.701 . . . . 0.0 109.785 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.04 -55.39 33.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 110.258 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.516 ' C ' HD23 ' A' ' 57' ' ' LEU . 7.0 tt -59.27 -44.33 92.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.482 -0.761 . . . . 0.0 110.48 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.525 ' HB ' HE21 ' A' ' 54' ' ' GLN . 3.0 t -74.94 -47.51 29.2 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.17 -0.956 . . . . 0.0 111.564 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.895 HD11 ' SD ' ' A' ' 55' ' ' MET . 43.8 mt -47.97 -25.72 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.664 -1.272 . . . . 0.0 109.587 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -77.76 -47.85 18.01 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.49 -0.756 . . . . 0.0 110.826 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -125.31 -9.08 6.98 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 58' ' ' THR . . . -164.99 -168.16 26.7 Favored Glycine 0 N--CA 1.502 3.085 0 O-C-N 120.13 -1.606 . . . . 0.0 111.469 -177.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.1 t -133.11 103.26 5.93 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 101.71 -3.441 . . . . 0.0 101.71 176.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.449 ' N ' ' OG1' ' A' ' 58' ' ' THR . . . -104.63 73.76 0.24 Allowed Glycine 0 C--N 1.264 -3.447 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 -177.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.672 ' O ' HG23 ' A' ' 65' ' ' ILE . 2.0 tp -64.26 97.2 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.822 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.976 ' CG1' HG22 ' A' ' 171' ' ' VAL . 3.6 t -50.99 163.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.347 -177.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.882 ' O ' HG21 ' A' ' 157' ' ' THR . 80.3 m -111.19 114.81 28.3 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.031 0.919 . . . . 0.0 109.122 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.058 HD11 ' HB2' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -90.61 123.35 34.18 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.615 ' C ' HD13 ' A' ' 158' ' ' ILE . 0.1 OUTLIER -108.57 143.08 38.08 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 117.232 -1.787 . . . . 0.0 110.415 179.125 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.749 HG21 ' OD2' ' A' ' 79' ' ' ASP 0.25 2.0 pp -137.41 137.28 46.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.345 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.878 HG22 ' HB2' ' A' ' 75' ' ' ARG . 9.3 t -74.93 179.43 4.92 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.606 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 2.3 mp0 -90.48 -18.59 25.08 Favored 'General case' 0 C--N 1.275 -2.674 0 C-N-CA 119.366 -0.933 . . . . 0.0 110.815 -178.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.57 -74.68 0.19 Allowed 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.823 -1.151 . . . . 0.0 112.797 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -94.66 -37.74 11.17 Favored 'General case' 0 C--N 1.279 -2.463 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.294 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.878 ' HB2' HG22 ' A' ' 71' ' ' THR . 0.0 OUTLIER -69.69 -24.84 63.64 Favored 'General case' 0 C--N 1.284 -2.269 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.543 -179.433 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.696 ' HE2' HD12 ' A' ' 80' ' ' LEU . 7.5 tttt -81.41 -38.92 25.74 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 117.459 -1.696 . . . . 0.0 107.489 176.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -42.19 -42.39 3.0 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.409 0.623 . . . . 0.0 109.569 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.788 HD23 ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -107.87 -30.02 8.74 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.448 -1.301 . . . . 0.0 109.026 177.323 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.788 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -114.15 69.12 0.7 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.724 178.004 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.696 HD12 ' HE2' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -111.45 149.05 40.08 Favored Pre-proline 0 C--N 1.295 -1.789 0 O-C-N 120.785 -1.197 . . . . 0.0 109.163 178.856 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.53 ' CD ' ' HG ' ' A' ' 80' ' ' LEU . 27.5 Cg_endo -50.86 96.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.187 0 O-C-N 123.393 1.207 . . . . 0.0 110.556 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.11 44.51 1.04 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.427 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 175.24 -54.89 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.138 -0.976 . . . . 0.0 109.73 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.879 HG23 HG22 ' A' ' 96' ' ' THR . 15.6 m . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.358 -0.839 . . . . 0.0 110.234 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' A' ' 138' ' ' PHE . 19.5 m-85 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.879 HG22 HG23 ' A' ' 84' ' ' VAL . 70.4 p -118.05 -1.82 11.36 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.032 -1.467 . . . . 0.0 114.915 -177.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.655 HG22 ' C ' ' A' ' 80' ' ' LEU . 1.8 t -121.89 86.52 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.268 -2.957 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.449 ' OG1' ' N ' ' A' ' 135' ' ' GLY . 8.9 t -73.71 123.87 24.92 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 176.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 1.025 ' CG1' HG21 ' A' ' 137' ' ' VAL . 7.7 pt -106.25 123.31 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.641 -1.287 . . . . 0.0 112.793 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.554 ' O ' ' HA ' ' A' ' 131' ' ' LEU . 0.2 OUTLIER -128.67 105.13 8.06 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.092 177.799 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.963 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . . . -48.22 104.25 0.06 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 122.058 0.932 . . . . 0.0 110.62 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 130' ' ' ASP . . . -59.8 -10.9 4.31 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.285 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -0.49 14.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.987 -1.071 . . . . 0.0 111.285 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.76 27.41 0.96 Allowed Glycine 0 N--CA 1.494 2.563 0 C-N-CA 118.993 -1.575 . . . . 0.0 112.556 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.963 ' HB ' ' HB3' ' A' ' 101' ' ' ALA . 21.1 t -108.73 153.94 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.066 -1.255 . . . . 0.0 109.828 178.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.409 ' O ' ' HG3' ' A' ' 114' ' ' ARG . 4.4 m -142.08 107.2 4.95 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 103.109 -2.922 . . . . 0.0 103.109 178.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.504 ' O ' ' C ' ' A' ' 108' ' ' GLY . 23.8 m -56.61 -24.71 49.77 Favored 'General case' 0 C--N 1.273 -2.736 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -175.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . 0.842 ' O ' ' N ' ' A' ' 110' ' ' SER . . . 29.85 48.43 0.13 Allowed Glycine 0 N--CA 1.511 3.644 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 172.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.744 HG21 ' CG ' ' A' ' 136' ' ' HIS . 54.6 t -28.77 67.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.628 0 CA-C-O 125.289 2.471 . . . . 0.0 112.17 -168.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.842 ' N ' ' O ' ' A' ' 108' ' ' GLY . 7.8 t -130.88 65.32 1.55 Allowed 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 109.403 -3.544 . . . . 0.0 103.935 176.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.694 ' HB1' ' CG2' ' A' ' 52' ' ' VAL . . . -30.02 -29.91 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.118 -1.401 . . . . 0.0 114.271 -175.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -62.0 -77.9 0.04 OUTLIER 'General case' 0 C--N 1.282 -2.346 0 O-C-N 120.198 -1.564 . . . . 0.0 109.584 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -75.03 -27.81 60.22 Favored 'General case' 0 C--N 1.289 -2.061 0 O-C-N 121.337 -0.852 . . . . 0.0 111.373 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.862 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -83.0 -38.54 22.5 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.334 -178.347 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.612 HD13 ' CA ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -66.42 -12.84 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 116.849 -1.941 . . . . 0.0 108.013 178.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.5 m -74.35 -50.54 18.27 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.716 ' O ' ' HB2' ' A' ' 121' ' ' ALA . 3.9 p -70.63 -22.43 62.52 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.189 -0.944 . . . . 0.0 109.387 178.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 114' ' ' ARG . 63.0 t -66.8 -51.6 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.274 -0.891 . . . . 0.0 109.741 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.654 ' HG2' HG22 ' A' ' 49' ' ' THR . 5.5 ttp180 -51.53 -40.54 59.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.518 -0.739 . . . . 0.0 109.955 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.21 -8.49 39.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.583 -0.698 . . . . 0.0 110.572 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 117' ' ' THR . . . -68.31 -44.5 75.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.055 -1.028 . . . . 0.0 111.183 -178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.542 HG22 ' O ' ' A' ' 122' ' ' ILE . 4.6 mt -83.3 9.34 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.542 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -107.08 71.43 0.83 Allowed 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.774 -1.171 . . . . 0.0 110.556 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.441 ' CB ' ' HD3' ' A' ' 127' ' ' LYS . 0.5 OUTLIER -99.0 -44.38 6.33 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.527 1.156 . . . . 0.0 109.319 177.6 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 124.64 -39.91 2.02 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 105.94 -2.864 . . . . 0.0 105.94 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -135.48 95.1 3.2 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.454 ' N ' ' CD ' ' A' ' 128' ' ' PRO . 7.7 tptt -136.57 53.45 7.49 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 120.784 -1.198 . . . . 0.0 109.761 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 127' ' ' LYS . 49.5 Cg_endo -77.4 -35.14 1.73 Allowed 'Trans proline' 0 C--N 1.3 -1.999 0 N-CA-C 107.552 -1.749 . . . . 0.0 107.552 178.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.3 p -125.86 -17.82 5.28 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.019 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.45 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -77.29 9.6 3.05 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.739 -1.226 . . . . 0.0 112.896 -177.359 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.939 HD12 ' N ' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -140.94 74.79 1.47 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.541 -1.349 . . . . 0.0 109.561 179.04 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.591 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 0.7 OUTLIER -144.0 48.9 1.38 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.439 -1.413 . . . . 0.0 114.239 176.857 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.421 ' C ' ' CB ' ' A' ' 100' ' ' GLU . 2.1 mtm180 177.25 108.01 0.12 Allowed Pre-proline 0 N--CA 1.516 2.844 0 CA-C-N 121.897 2.135 . . . . 0.0 112.947 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -126.26 129.05 0.03 OUTLIER 'Cis proline' 0 C--N 1.312 -1.394 0 N-CA-C 103.557 -3.286 . . . . 0.0 103.557 -8.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -113.65 33.36 5.54 Favored Glycine 0 N--CA 1.503 3.163 0 C-N-CA 117.54 -2.267 . . . . 0.0 113.791 -175.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.744 ' CG ' HG21 ' A' ' 109' ' ' VAL . 14.6 m-70 32.11 37.95 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.903 0 CA-C-N 119.049 1.424 . . . . 0.0 110.311 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 1.025 HG21 ' CG1' ' A' ' 99' ' ' ILE . 54.2 t -86.87 156.12 3.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.597 ' CD1' ' O ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -124.79 79.46 63.7 Favored Pre-proline 0 C--N 1.284 -2.275 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -178.641 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.578 ' HG3' HG12 ' A' ' 137' ' ' VAL . 52.0 Cg_endo -108.79 124.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.074 1.849 . . . . 0.0 110.83 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 140' ' ' LEU . 1.1 pp -128.99 136.82 50.85 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 119.485 -0.886 . . . . 0.0 108.898 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.469 ' CG ' ' CG ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -63.66 137.06 57.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.615 -1.303 . . . . 0.0 108.404 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.791 ' HB3' HG21 ' A' ' 158' ' ' ILE . . . -131.26 133.55 45.55 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.094 -1.043 . . . . 0.0 112.15 -178.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.16 143.46 45.24 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.537 -0.727 . . . . 0.0 109.724 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . 0.493 ' HB1' ' NH2' ' A' ' 209' ' ' ARG . . . -68.48 115.71 8.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.478 -0.764 . . . . 0.0 110.6 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 86.93 14.93 63.87 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.14 13.64 63.15 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.733 HG21 ' HB2' ' A' ' 156' ' ' ALA . 14.5 p -89.94 -4.72 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.872 -1.37 . . . . 0.0 110.157 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.472 ' HG ' HG11 ' A' ' 206' ' ' VAL . 1.2 mp -90.06 17.56 6.8 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 116.139 -2.224 . . . . 0.0 110.148 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.4 p -130.59 60.99 1.62 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 101.171 -3.64 . . . . 0.0 101.171 168.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.459 ' HG3' ' CG ' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -149.97 140.49 22.47 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 113.794 -1.548 . . . . 0.0 112.755 -178.433 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.422 ' N ' ' HD3' ' A' ' 150' ' ' ARG . . . -104.0 35.09 5.28 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 106.148 -2.781 . . . . 0.0 106.148 173.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.24 163.35 27.8 Favored Glycine 0 N--CA 1.479 1.509 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' HIS . . . . . 0.563 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 2.8 p-80 -90.84 -5.03 56.12 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.646 -0.914 . . . . 0.0 109.552 177.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.812 HG22 ' SG ' ' A' ' 67' ' ' CYS . 60.0 p -53.37 -59.25 4.81 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.003 -1.061 . . . . 0.0 109.766 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.498 ' HB2' HG23 ' A' ' 147' ' ' VAL . 63.3 mm-40 -59.59 -21.34 60.22 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.733 ' HB2' HG21 ' A' ' 147' ' ' VAL . . . -85.56 6.76 25.77 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.882 HG21 ' O ' ' A' ' 67' ' ' CYS . 27.3 m -91.99 -36.5 13.38 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.791 HG21 ' HB3' ' A' ' 142' ' ' ALA . 3.2 tp -85.83 -31.44 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 173.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASP . . . . . 0.498 ' O ' HG22 ' A' ' 162' ' ' THR . 1.7 t70 -56.68 -34.06 67.03 Favored 'General case' 0 C--O 1.199 -1.553 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 174.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 1.029 HD13 ' N ' ' A' ' 161' ' ' MET . 0.0 OUTLIER -45.05 -37.42 4.14 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.349 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' MET . . . . . 1.029 ' N ' HD13 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -50.26 -45.33 54.12 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.871 178.875 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 159' ' ' ASP . 4.3 t -97.56 -31.69 12.19 Favored 'General case' 0 N--CA 1.509 2.478 0 CA-C-O 121.895 0.855 . . . . 0.0 111.5 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 1.042 ' CD2' HD21 ' A' ' 205' ' ' LEU 0.272 0.2 OUTLIER -42.98 -58.11 2.56 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -178.58 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -110.13 2.24 19.31 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 118.874 -1.13 . . . . 0.0 113.003 -176.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 96.08 -19.2 55.51 Favored Glycine 0 C--N 1.29 -1.999 0 N-CA-C 108.21 -1.956 . . . . 0.0 108.21 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' PHE . . . . . 0.69 ' C ' ' HD3' ' A' ' 168' ' ' PRO . 0.1 OUTLIER -76.95 137.21 38.91 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.14 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.628 ' HA ' ' HA ' ' A' ' 161' ' ' MET . 2.4 ttmt -121.55 56.47 6.37 Favored Pre-proline 0 C--N 1.31 -1.12 0 O-C-N 120.745 -1.222 . . . . 0.0 110.47 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.816 ' HD2' HD11 ' A' ' 160' ' ' LEU . 56.5 Cg_endo -108.93 175.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.301 -1.966 0 N-CA-C 107.731 -1.681 . . . . 0.0 107.731 177.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.464 ' HB2' ' HD3' ' A' ' 75' ' ' ARG . . . -85.53 104.82 15.65 Favored 'General case' 0 C--N 1.261 -3.247 0 N-CA-C 101.42 -3.548 . . . . 0.0 101.42 173.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.443 ' O ' ' CG2' ' A' ' 157' ' ' THR . . . -93.75 154.52 21.68 Favored Glycine 0 C--N 1.297 -1.617 0 C-N-CA 119.048 -1.549 . . . . 0.0 111.103 -173.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' VAL . . . . . 0.976 HG22 ' CG1' ' A' ' 66' ' ' VAL 0.261 5.6 p -124.05 95.56 3.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LEU . . . . . 0.769 HD21 ' HA ' ' A' ' 157' ' ' THR . 0.3 OUTLIER -114.81 114.74 25.95 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 119.93 -1.731 . . . . 0.0 111.018 -178.576 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.781 ' HB2' HG22 ' A' ' 66' ' ' VAL . 4.9 t -109.79 175.64 5.37 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.547 -1.346 . . . . 0.0 110.943 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLU . . . . . 0.734 ' C ' HD13 ' A' ' 189' ' ' ILE . 0.0 OUTLIER -106.73 -147.93 0.41 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.41 -0.806 . . . . 0.0 109.888 179.261 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.682 HD13 ' C ' ' A' ' 175' ' ' LEU . 2.1 tm? . . . . . 0 N--CA 1.497 1.908 0 O-C-N 121.193 -0.942 . . . . 0.0 109.404 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.234 0.54 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' A' ' 185' ' ' ALA . 2.9 ppt_? -139.98 100.45 3.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.304 -0.872 . . . . 0.0 109.911 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.745 ' HB1' ' HD2' ' A' ' 186' ' ' PRO . . . 179.25 173.57 0.44 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.337 -0.852 . . . . 0.0 110.003 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' PRO . . . . . 0.745 ' HD2' ' HB1' ' A' ' 185' ' ' ALA . 46.5 Cg_endo -72.73 -11.59 26.04 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.644 1.339 . . . . 0.0 110.76 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 190' ' ' GLU . 3.6 mt-10 -84.93 -63.37 1.34 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.063 -1.023 . . . . 0.0 110.522 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' CYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 191' ' ' PHE . 21.5 p -52.37 -37.56 56.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.01 . . . . 0.0 109.718 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.983 HG23 HD21 ' A' ' 199' ' ' LEU . 8.0 tp -73.62 -28.33 24.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 120.604 -1.31 . . . . 0.0 108.27 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.643 ' HA ' HD22 ' A' ' 199' ' ' LEU . 1.4 tt0 -58.85 -20.0 46.82 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.126 177.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' PHE . . . . . 0.463 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.1 OUTLIER -75.34 -51.06 14.07 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.72 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ALA . . . . . 0.443 ' CB ' ' HE3' ' A' ' 197' ' ' MET . . . -62.51 -38.5 90.18 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ASN . . . . . 0.836 ' HB2' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -64.52 -15.98 61.8 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.103 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.45 -36.75 22.1 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 117.892 -1.523 . . . . 0.0 112.477 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -104.33 -53.59 2.69 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 115.719 -2.392 . . . . 0.0 111.519 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -113.97 32.99 5.49 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.025 -1.47 . . . . 0.0 113.754 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' MET . . . . . 0.948 ' HA ' HD12 ' A' ' 23' ' ' LEU . 2.5 ttp -153.67 145.15 23.19 Favored 'General case' 0 N--CA 1.512 2.645 0 C-N-CA 115.065 -2.654 . . . . 0.0 115.441 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.576 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . . . -91.4 142.88 27.2 Favored 'General case' 0 N--CA 1.51 2.568 0 O-C-N 120.884 -1.135 . . . . 0.0 108.128 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.983 HD21 HG23 ' A' ' 189' ' ' ILE . 3.0 tp -131.55 94.09 3.47 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.495 -1.378 . . . . 0.0 114.498 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.922 HG22 HG21 ' A' ' 31' ' ' VAL 0.253 6.8 m -57.87 -168.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 120.496 -1.378 . . . . 0.0 107.525 175.31 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 201' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 205' ' ' LEU . 23.8 m -119.03 110.59 17.28 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 174.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.484 ' HA ' ' HB3' ' A' ' 205' ' ' LEU . 16.6 mt -49.62 -21.99 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.343 -0.848 . . . . 0.0 111.838 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -66.64 0.52 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.814 -1.179 . . . . 0.0 109.334 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.783 ' O ' ' HB3' ' A' ' 207' ' ' ALA . 1.7 m-20 -66.14 -32.82 74.49 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.015 -1.053 . . . . 0.0 109.076 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 1.042 HD21 ' CD2' ' A' ' 163' ' ' LEU . 6.7 tt -45.86 -69.53 0.13 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 123.084 1.421 . . . . 0.0 112.459 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' VAL . . . . . 0.472 HG11 HG13 ' A' ' 147' ' ' VAL . 1.4 t -68.42 -11.37 14.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 C-N-CA 117.758 -1.577 . . . . 0.0 108.845 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.783 ' HB3' ' O ' ' A' ' 204' ' ' ASP . . . -58.64 -30.49 67.33 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 175.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' TYR . . . . . 0.847 ' CE2' ' HA ' ' A' ' 205' ' ' LEU . 1.5 m-85 -62.59 -48.19 80.52 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 177.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ARG . . . . . 0.493 ' NH2' ' HB1' ' A' ' 144' ' ' ALA . 17.8 tpt180 -65.56 -29.16 69.74 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.779 -1.168 . . . . 0.0 109.746 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.462 ' HB2' HD21 ' A' ' 148' ' ' LEU . 30.9 tt0 -73.02 -35.29 66.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.03 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -73.57 -27.05 61.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.364 -0.835 . . . . 0.0 110.039 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 110.087 179.868 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.445 ' SD ' ' CE1' ' A' ' 195' ' ' HIS . 1.6 mtt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.223 0.535 . . . . 0.0 110.234 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.415 ' O ' HD23 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -93.7 56.41 2.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.313 -0.867 . . . . 0.0 110.201 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.455 ' CB ' ' HG3' ' A' ' 194' ' ' LYS . 0.0 OUTLIER -94.11 -22.49 18.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.253 -0.905 . . . . 0.0 110.215 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 p -73.19 -4.75 34.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.882 . . . . 0.0 110.721 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.614 ' CB ' ' HB2' ' A' ' 198' ' ' ALA . 4.3 mm? -50.54 -59.9 3.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.908 -1.12 . . . . 0.0 110.665 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.816 HD12 ' CB ' ' A' ' 198' ' ' ALA . 0.3 OUTLIER -116.16 8.65 14.46 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.309 -0.869 . . . . 0.0 110.641 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.7 t -92.18 -64.68 1.08 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.842 -1.161 . . . . 0.0 110.146 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.6 t -92.36 3.94 54.41 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.326 -0.859 . . . . 0.0 109.173 177.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.423 ' C ' ' HB3' ' A' ' 15' ' ' ARG . 31.2 m-85 -142.03 73.62 1.42 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.479 ' CA ' ' HB2' ' A' ' 15' ' ' ARG . . . -164.49 97.2 0.14 Allowed Glycine 0 C--N 1.291 -1.955 0 N-CA-C 106.608 -2.597 . . . . 0.0 106.608 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.488 ' H ' ' HB2' ' A' ' 15' ' ' ARG . 0.4 OUTLIER -127.0 141.62 41.21 Favored Pre-proline 0 C--N 1.27 -2.872 1 N-CA-C 100.116 -4.031 . . . . 0.0 100.116 176.623 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.727 ' O ' HG12 ' A' ' 16' ' ' VAL . 28.2 Cg_endo -50.4 -46.12 30.79 Favored 'Trans proline' 0 C--N 1.273 -3.437 0 O-C-N 122.847 0.92 . . . . 0.0 110.928 -176.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -95.46 -46.36 6.72 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -77.4 -62.63 1.6 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 118.353 -1.339 . . . . 0.0 112.384 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.488 ' HB2' ' H ' ' A' ' 11' ' ' THR . 26.3 mmm180 -85.58 -10.15 56.31 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 117.538 -1.665 . . . . 0.0 112.981 -177.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -85.93 -26.04 6.44 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.489 0 C-N-CA 114.386 -2.926 . . . . 0.0 108.391 176.11 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.72 -48.89 62.67 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 116.74 -1.984 . . . . 0.0 107.409 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -65.6 -33.2 75.35 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.524 -0.735 . . . . 0.0 109.36 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.5 ' O ' HD23 ' A' ' 23' ' ' LEU . . . -81.75 -22.03 37.49 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.182 -0.949 . . . . 0.0 109.234 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.833 HD21 ' O ' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -53.89 -50.42 66.36 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.175 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.463 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . . . -66.61 -51.51 55.5 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.234 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -47.31 -45.4 24.27 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.519 -0.738 . . . . 0.0 110.507 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.664 HD13 HG11 ' A' ' 29' ' ' VAL . 3.3 pp -91.08 -17.15 26.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.306 -0.871 . . . . 0.0 110.192 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 20' ' ' LEU . 0.9 OUTLIER -54.72 -23.05 15.92 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.273 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.4 41.98 1.11 Allowed 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 118.23 -1.388 . . . . 0.0 110.167 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.539 ' HA3' ' CZ ' ' A' ' 45' ' ' PHE . . . 53.83 31.79 47.12 Favored Glycine 0 C--N 1.291 -1.953 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 176.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -85.3 19.78 2.18 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 116.859 -1.937 . . . . 0.0 110.859 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.564 ' O ' ' HB3' ' A' ' 198' ' ' ALA . . . 98.3 105.73 2.51 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 119.524 -1.322 . . . . 0.0 113.085 173.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.922 HG22 HD12 ' A' ' 44' ' ' ILE . 3.2 p -145.33 118.65 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-N 120.096 1.948 . . . . 0.0 109.968 176.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.776 ' HB3' HD23 ' A' ' 199' ' ' LEU . 1.5 tmt? -105.78 151.78 24.05 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.063 -1.023 . . . . 0.0 110.69 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.724 HG22 ' HB ' ' A' ' 202' ' ' ILE . 4.5 p -124.44 115.27 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.898 -1.126 . . . . 0.0 109.504 177.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.836 HD23 ' O ' ' A' ' 200' ' ' VAL . 0.6 OUTLIER -105.47 152.46 22.99 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.711 -1.243 . . . . 0.0 110.674 -179.246 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.505 ' HB2' HG21 ' A' ' 202' ' ' ILE . 20.4 t0 -133.15 179.72 6.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.396 -0.815 . . . . 0.0 110.203 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -109.77 78.25 1.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.211 -0.93 . . . . 0.0 110.16 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -147.78 -166.11 2.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.283 -0.886 . . . . 0.0 110.191 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -96.31 -62.92 1.2 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.917 . . . . 0.0 110.235 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.2 139.2 29.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.257 -0.902 . . . . 0.0 110.188 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -129.05 141.82 51.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 110.255 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 173' ' ' CYS . 0.6 OUTLIER -173.28 -70.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.874 . . . . 0.0 110.118 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.479 ' OE1' ' CE1' ' A' ' 153' ' ' HIS . 14.0 mp0 -53.94 139.19 34.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 110.112 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.452 ' CA ' ' HG2' ' A' ' 30' ' ' MET . . . -175.93 -141.42 3.82 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 118.76 -1.686 . . . . 0.0 112.134 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.51 ' HA ' ' CA ' ' A' ' 30' ' ' MET . 2.7 p30 -45.26 -20.11 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.372 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.677 ' O ' HG23 ' A' ' 171' ' ' VAL . 1.8 ttm -93.88 47.07 1.2 Allowed 'General case' 0 C--N 1.288 -2.104 0 O-C-N 120.886 -1.134 . . . . 0.0 113.778 -177.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.922 HD12 HG22 ' A' ' 29' ' ' VAL . 73.4 mt -68.49 20.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.534 3.75 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.776 ' O ' HG22 ' A' ' 171' ' ' VAL . 2.3 m-85 -66.59 162.38 51.07 Favored Pre-proline 0 C--N 1.279 -2.472 0 O-C-N 121.008 -1.057 . . . . 0.0 113.631 -176.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.481 ' HD2' ' CD2' ' A' ' 45' ' ' PHE . 43.8 Cg_endo -66.92 133.73 32.2 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.895 2.397 . . . . 0.0 111.902 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.63 ' HB2' ' N ' ' A' ' 170' ' ' GLY . . . -65.76 -7.21 14.6 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.405 -0.81 . . . . 0.0 112.751 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.774 ' HB2' ' HB2' ' A' ' 123' ' ' ALA . 0.3 OUTLIER -109.99 -14.97 14.16 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.726 -1.234 . . . . 0.0 111.35 -179.307 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 51' ' ' THR . 25.2 m -132.62 59.73 1.72 Allowed 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.581 ' O ' HG23 ' A' ' 115' ' ' ILE . 6.3 mtp -62.67 86.08 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.725 ' C ' HD13 ' A' ' 115' ' ' ILE . 1.7 m -63.99 170.41 3.56 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.773 0.797 . . . . 0.0 110.217 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 1.051 HG22 HD12 ' A' ' 115' ' ' ILE . 7.0 t -85.31 -3.72 8.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 121.731 -0.606 . . . . 0.0 109.586 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 6.3 tp10 -52.86 -39.8 62.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.844 -1.16 . . . . 0.0 108.867 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.524 ' CG ' ' CD1' ' A' ' 45' ' ' PHE . 17.6 mm-40 -82.08 -39.04 23.98 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.784 ' HG3' HD11 ' A' ' 115' ' ' ILE . 19.0 mmt -57.24 -39.11 74.89 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.097 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.501 ' HA ' HD12 ' A' ' 59' ' ' ILE . . . -58.05 -54.29 48.62 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.213 -0.93 . . . . 0.0 108.649 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.891 HD13 ' HE3' ' A' ' 197' ' ' MET . 6.2 tt -63.8 -22.01 66.71 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.699 -0.801 . . . . 0.0 109.464 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.593 HG23 ' C ' ' A' ' 63' ' ' SER . 1.1 m -88.64 -22.8 23.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -0.795 . . . . 0.0 110.265 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 56' ' ' ALA . 22.7 mt -76.83 -23.1 15.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.045 -1.035 . . . . 0.0 109.322 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.53 -64.07 1.1 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.406 -0.809 . . . . 0.0 110.659 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -125.98 42.87 3.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.157 -0.964 . . . . 0.0 111.666 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 58' ' ' THR . . . -155.2 -175.39 26.2 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 119.166 -1.492 . . . . 0.0 109.741 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.593 ' C ' HG23 ' A' ' 58' ' ' THR . 16.8 t -128.37 178.62 6.15 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.472 ' O ' HD13 ' A' ' 65' ' ' ILE . . . -114.11 67.45 0.26 Allowed Glycine 1 C--N 1.253 -4.062 0 N-CA-C 107.42 -2.272 . . . . 0.0 107.42 178.67 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.472 HD13 ' O ' ' A' ' 64' ' ' GLY . 25.1 mm -133.25 84.41 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 114.11 -1.045 . . . . 0.0 108.413 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.826 HG12 ' HB2' ' A' ' 173' ' ' CYS . 29.4 m -103.65 152.55 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.55 -0.719 . . . . 0.0 111.591 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 171' ' ' VAL . 5.3 t -77.55 122.08 24.77 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.081 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.666 ' HG ' HG13 ' A' ' 137' ' ' VAL . 3.1 mm? -87.21 126.24 34.69 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 122.174 0.988 . . . . 0.0 109.404 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.45 ' HB3' ' HA ' ' A' ' 158' ' ' ILE . 3.6 m -89.59 125.08 35.09 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.763 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.52 ' N ' HD13 ' A' ' 158' ' ' ILE . 16.7 tt -138.74 129.46 34.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.083 -1.01 . . . . 0.0 109.853 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.425 ' OG1' ' CG1' ' A' ' 158' ' ' ILE . 1.2 m -89.22 160.37 16.98 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.095 -1.003 . . . . 0.0 109.942 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.443 ' HA ' ' NH1' ' A' ' 75' ' ' ARG . 9.1 pt-20 -50.9 -24.42 3.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.442 -0.786 . . . . 0.0 110.142 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.47 -32.9 19.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 110.041 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.42 ' HB3' HG13 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -62.61 -49.7 74.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 109.939 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.464 ' CD ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -70.91 -34.68 71.77 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.187 0.994 . . . . 0.0 108.565 179.113 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.649 ' O ' ' N ' ' A' ' 79' ' ' ASP . 3.0 tttp -53.38 -66.17 0.44 Allowed 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -46.34 -32.7 3.33 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 124.039 0.837 . . . . 0.0 109.431 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.628 HD11 HD22 ' A' ' 131' ' ' LEU . 0.3 OUTLIER -97.74 43.65 1.06 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 176.059 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 76' ' ' LYS . 11.6 t70 -28.97 76.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 123.553 1.644 . . . . 0.0 113.031 -172.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.753 ' O ' HD23 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -151.25 100.05 3.02 Favored Pre-proline 0 C--N 1.283 -2.304 0 CA-C-N 112.765 -2.016 . . . . 0.0 110.314 177.362 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -106.62 92.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 N-CA-C 108.808 -1.266 . . . . 0.0 108.808 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.901 ' CB ' HG11 ' A' ' 97' ' ' VAL . 3.6 mtt -103.12 46.01 0.94 Allowed 'General case' 0 N--CA 1.483 1.215 0 O-C-N 120.588 -1.32 . . . . 0.0 108.723 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.91 123.54 2.37 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.038 0.447 . . . . 0.0 110.23 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 84' ' ' VAL . 32.8 m -83.36 104.39 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 118.614 -1.235 . . . . 0.0 110.61 -178.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 87' ' ' ASN . 7.0 pt-20 -101.48 44.16 1.03 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.502 0.668 . . . . 0.0 109.204 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -61.59 81.05 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.62 0.724 . . . . 0.0 110.982 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.442 ' O ' ' CB ' ' A' ' 88' ' ' THR . 9.3 t-20 -46.19 118.22 1.83 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.622 -0.673 . . . . 0.0 110.89 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.442 ' CB ' ' O ' ' A' ' 87' ' ' ASN . 1.9 m 74.9 -55.38 0.65 Allowed 'General case' 0 N--CA 1.507 2.401 0 O-C-N 121.736 -0.603 . . . . 0.0 110.171 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.72 -25.07 6.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.927 -1.108 . . . . 0.0 109.559 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 92' ' ' GLY . . . -144.71 125.44 14.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.614 -0.679 . . . . 0.0 109.414 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -68.18 67.67 0.12 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.232 -0.917 . . . . 0.0 110.724 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 90' ' ' ALA . . . 51.99 39.03 48.13 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.654 HG23 ' H ' ' A' ' 95' ' ' PHE . 10.2 t -57.61 -18.16 18.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.348 -1.089 . . . . 0.0 110.776 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.44 24.89 4.08 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.654 ' H ' HG23 ' A' ' 93' ' ' THR . 0.6 OUTLIER -58.6 100.14 0.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.309 -1.113 . . . . 0.0 112.246 -178.484 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.428 ' CG2' ' O ' ' A' ' 139' ' ' PRO . 35.3 m -59.66 81.05 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.274 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.901 HG11 ' CB ' ' A' ' 82' ' ' MET . 7.4 p -33.48 151.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 CA-C-O 122.577 1.18 . . . . 0.0 113.085 -174.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.641 HG22 ' O ' ' A' ' 137' ' ' VAL . 51.1 p -69.67 -178.38 1.46 Allowed 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.535 -175.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.973 HD12 HD23 ' A' ' 131' ' ' LEU . 16.0 pt -146.99 131.64 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.527 ' HB2' ' HA ' ' A' ' 133' ' ' ARG . 3.6 tt0 -103.54 125.12 49.9 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.069 -1.452 . . . . 0.0 113.491 -176.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 1.061 ' HB1' ' HB1' ' A' ' 121' ' ' ALA . . . -51.37 95.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.473 -0.767 . . . . 0.0 110.855 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 130' ' ' ASP . . . -80.5 2.63 24.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.629 -0.669 . . . . 0.0 110.14 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.414 ' CB ' ' HA ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -86.42 15.29 5.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.078 -1.014 . . . . 0.0 110.931 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.464 ' O ' HG21 ' A' ' 117' ' ' THR . . . 127.7 25.02 1.17 Allowed Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.522 -1.323 . . . . 0.0 112.11 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.947 ' HB ' ' HB3' ' A' ' 101' ' ' ALA . 13.0 t -130.17 121.83 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.156 -1.202 . . . . 0.0 109.195 177.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 p -145.91 59.06 1.24 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.594 -1.316 . . . . 0.0 111.523 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.782 HG21 ' OG ' ' A' ' 110' ' ' SER . 1.6 m -138.91 -31.97 0.7 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.805 -1.184 . . . . 0.0 110.983 176.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.23 -32.25 1.12 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.14 57.21 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.733 -1.451 . . . . 0.0 109.375 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.782 ' OG ' HG21 ' A' ' 107' ' ' THR . 1.2 m -129.87 57.44 1.68 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.201 -0.937 . . . . 0.0 109.257 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.506 ' HB1' ' HG3' ' A' ' 55' ' ' MET . . . -34.81 -29.85 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -82.41 -74.86 0.33 Allowed 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.063 -1.023 . . . . 0.0 110.157 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -67.07 -15.62 63.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.564 -0.71 . . . . 0.0 110.87 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.661 ' HG2' HG21 ' A' ' 118' ' ' VAL . 51.2 ttt85 -87.84 -46.79 9.12 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.057 -1.027 . . . . 0.0 110.032 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 1.051 HD12 HG22 ' A' ' 52' ' ' VAL . 35.1 mt -66.07 -10.96 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.679 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.7 m -87.69 -52.5 5.28 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.728 ' CB ' HG22 ' A' ' 105' ' ' VAL . 9.3 p -72.62 -42.9 63.96 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.692 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.772 ' CG2' HG11 ' A' ' 105' ' ' VAL . 47.6 t -57.19 -43.45 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.876 -1.14 . . . . 0.0 108.811 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.582 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -49.33 -39.38 31.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.348 -0.845 . . . . 0.0 109.307 178.755 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.74 -11.62 24.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.709 -0.619 . . . . 0.0 111.043 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 1.061 ' HB1' ' HB1' ' A' ' 101' ' ' ALA . . . -97.25 -59.93 1.69 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.857 -1.152 . . . . 0.0 112.68 -177.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.64 HG23 ' HA ' ' A' ' 48' ' ' GLU . 19.1 tt -66.7 -19.8 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 120.41 -1.431 . . . . 0.0 108.849 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.774 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . . . -106.58 72.49 0.91 Allowed 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.506 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.452 ' HB3' ' CG ' ' A' ' 127' ' ' LYS . 11.8 t0 -98.41 -53.1 3.43 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.335 1.064 . . . . 0.0 110.077 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 124.08 -37.28 2.71 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 106.169 -2.773 . . . . 0.0 106.169 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -132.98 100.51 4.91 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.945 ' HE2' HD13 ' A' ' 131' ' ' LEU . 23.4 mtpp -130.98 54.55 15.08 Favored Pre-proline 0 C--N 1.307 -1.242 0 O-C-N 120.773 -1.204 . . . . 0.0 110.92 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 127' ' ' LYS . 44.1 Cg_endo -72.05 -26.47 18.28 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 N-CA-C 106.921 -1.992 . . . . 0.0 106.921 176.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.79 -18.09 6.15 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.043 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.452 ' HB3' ' NZ ' ' A' ' 127' ' ' LYS . 27.6 m-20 -78.24 9.82 3.5 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.8 -1.187 . . . . 0.0 112.27 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.973 HD23 HD12 ' A' ' 99' ' ' ILE . 2.6 tp -135.08 89.62 2.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.882 -1.136 . . . . 0.0 108.566 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.506 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 36.4 p-10 -116.38 107.6 15.01 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.373 -0.829 . . . . 0.0 111.933 -178.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.803 ' HB2' ' HA ' ' A' ' 134' ' ' PRO 0.269 4.9 ppt_? -82.89 179.93 1.74 Allowed Pre-proline 0 N--CA 1.499 1.976 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.646 -177.525 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.803 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 48.8 Cg_endo -71.68 124.96 9.07 Favored 'Cis proline' 0 N--CA 1.504 2.122 0 C-N-CA 123.352 -1.52 . . . . 0.0 112.299 8.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.853 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -123.98 39.9 2.06 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 53.1 m80 31.21 38.22 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 122.162 0.982 . . . . 0.0 111.914 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 135' ' ' GLY . 54.5 t -126.85 103.11 10.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 176.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.505 ' CA ' HG22 ' A' ' 98' ' ' THR . 6.3 p90 -107.52 89.35 4.93 Favored Pre-proline 0 N--CA 1.492 1.659 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.962 -175.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 56.0 Cg_endo -77.34 124.42 7.13 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 124.125 1.592 . . . . 0.0 110.366 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.583 HD23 HG23 ' A' ' 154' ' ' THR . 1.1 tp -102.65 126.53 49.78 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.42 ' HA ' HG23 ' A' ' 70' ' ' ILE . 56.3 ttp85 -63.64 117.91 7.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.061 -1.024 . . . . 0.0 109.958 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.84 ' O ' HG21 ' A' ' 158' ' ' ILE . . . -130.03 134.17 47.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.578 -0.701 . . . . 0.0 110.516 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.421 ' C ' HG21 ' A' ' 158' ' ' ILE . 0.3 OUTLIER -56.26 133.03 52.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.829 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.692 ' HA ' HG23 ' A' ' 158' ' ' ILE . . . -81.87 115.2 20.96 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.408 -0.807 . . . . 0.0 111.173 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.472 ' CA ' ' NH2' ' A' ' 209' ' ' ARG . . . 86.63 -8.01 77.05 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.56 13.98 60.89 Favored Glycine 0 N--CA 1.483 1.815 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.707 ' CG2' ' HB2' ' A' ' 156' ' ' ALA . 7.6 p -59.7 -14.3 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.931 -1.335 . . . . 0.0 109.971 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.568 ' CD2' HG12 ' A' ' 206' ' ' VAL . 1.0 OUTLIER -92.17 20.13 6.24 Favored 'General case' 0 C--O 1.21 -1.004 0 C-N-CA 116.479 -2.088 . . . . 0.0 110.731 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.6 m -129.39 58.49 1.62 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 101.935 -3.357 . . . . 0.0 101.935 168.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.456 ' HG3' ' CG ' ' A' ' 155' ' ' GLU . 0.2 OUTLIER -153.76 146.11 23.93 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 113.486 -1.688 . . . . 0.0 111.903 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -103.95 34.72 5.55 Favored Glycine 0 N--CA 1.481 1.683 0 N-CA-C 106.124 -2.79 . . . . 0.0 106.124 173.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -145.34 165.98 27.74 Favored Glycine 0 N--CA 1.479 1.501 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.678 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 3.3 p80 -90.84 -6.04 54.79 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.921 -0.752 . . . . 0.0 109.484 176.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.583 HG23 HD23 ' A' ' 140' ' ' LEU . 62.6 m -56.17 -61.71 2.2 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 122.54 1.162 . . . . 0.0 109.353 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.824 ' HA ' ' HB1' ' A' ' 142' ' ' ALA . 9.2 mp0 -57.89 -20.75 39.23 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.707 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . . . -83.35 1.73 39.78 Favored 'General case' 0 C--O 1.201 -1.478 0 O-C-N 121.602 -0.686 . . . . 0.0 109.929 177.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 153' ' ' HIS . 68.8 p -82.2 -51.19 8.18 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.84 HG21 ' O ' ' A' ' 142' ' ' ALA . 3.8 tp -65.76 -31.58 54.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.537 ' OD2' HG12 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -80.56 -18.41 48.46 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.536 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.965 HD13 HD22 ' A' ' 172' ' ' LEU . 1.2 mt -63.41 -37.64 88.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.038 -1.039 . . . . 0.0 110.375 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.582 ' HE3' ' CB ' ' A' ' 166' ' ' PHE . 88.7 mmm -81.53 -27.74 34.28 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.64 HG21 HH21 ' A' ' 209' ' ' ARG . 3.6 m -66.3 -48.79 69.23 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 1.081 HD13 HD21 ' A' ' 205' ' ' LEU . 4.2 pp -72.57 -4.83 33.12 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.369 -0.832 . . . . 0.0 109.328 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.774 ' C ' HD11 ' A' ' 20' ' ' LEU . . . -108.06 18.85 20.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.662 -1.274 . . . . 0.0 109.983 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 59.14 41.86 96.82 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 107.337 -2.305 . . . . 0.0 107.337 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.582 ' CB ' ' HE3' ' A' ' 161' ' ' MET . 1.5 m-85 -138.49 139.29 38.72 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.925 0.869 . . . . 0.0 111.134 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -50.2 134.23 23.49 Favored Pre-proline 0 N--CA 1.498 1.965 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 177.946 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.579 ' O ' HD11 ' A' ' 158' ' ' ILE . 37.3 Cg_endo -64.81 84.46 0.17 Allowed 'Trans proline' 0 C--N 1.298 -2.114 0 C-N-CA 116.593 -1.805 . . . . 0.0 112.911 -174.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' ' 47' ' ' ALA . . . -156.81 111.72 2.81 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 101.399 -3.556 . . . . 0.0 101.399 173.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.63 ' N ' ' HB2' ' A' ' 47' ' ' ALA . . . -157.73 167.76 34.23 Favored Glycine 0 N--CA 1.486 1.996 0 C-N-CA 116.454 -2.784 . . . . 0.0 113.314 -174.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.776 HG22 ' O ' ' A' ' 45' ' ' PHE . 28.5 m -112.46 156.49 13.48 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.965 HD22 HD13 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -157.68 114.0 2.88 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.639 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.826 ' HB2' HG12 ' A' ' 66' ' ' VAL . 34.1 t -130.66 162.25 29.82 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 120.569 -1.332 . . . . 0.0 112.05 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.27 -169.06 1.45 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.199 -0.938 . . . . 0.0 109.491 178.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 1.089 HD21 ' HB2' ' A' ' 192' ' ' ALA . 5.2 mt -63.67 90.88 0.06 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.89 -1.132 . . . . 0.0 109.582 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 63' ' ' SER . 3.2 p -110.09 95.13 5.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.074 -1.016 . . . . 0.0 110.36 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -97.86 171.08 8.52 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.11 -0.994 . . . . 0.0 110.138 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -91.34 6.0 47.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.37 -0.831 . . . . 0.0 111.207 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.05 12.69 29.66 Favored 'General case' 0 C--N 1.289 -2.037 0 O-C-N 121.597 -0.689 . . . . 0.0 110.376 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 65.45 32.73 84.39 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 183' ' ' ALA . 78.5 p -81.95 98.96 8.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -1.121 . . . . 0.0 110.167 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 1.7 mmm -63.83 80.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.215 -0.928 . . . . 0.0 110.178 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' A' ' 175' ' ' LEU . . . -57.7 124.43 19.1 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.27 -0.894 . . . . 0.0 110.163 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.482 ' O ' ' HB3' ' A' ' 185' ' ' ALA . 3.9 mtt180 -136.8 161.68 35.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.353 -0.842 . . . . 0.0 110.333 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 184' ' ' ARG . . . 60.85 160.02 0.11 Allowed Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.349 -0.844 . . . . 0.0 110.871 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.591 ' HA ' HG22 ' A' ' 189' ' ' ILE . 44.5 Cg_endo -70.4 -26.76 24.23 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.739 1.389 . . . . 0.0 110.578 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -60.66 -34.98 75.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.089 -1.007 . . . . 0.0 109.864 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' CYS . . . . . 0.466 ' O ' HD11 ' A' ' 175' ' ' LEU . 5.4 t -74.59 -53.99 8.33 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.362 -0.836 . . . . 0.0 110.218 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.739 HG23 HD22 ' A' ' 199' ' ' LEU . 9.6 tp -62.02 -25.08 36.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 O-C-N 120.653 -1.279 . . . . 0.0 107.644 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 194' ' ' LYS . 36.8 tt0 -64.65 -33.74 76.64 Favored 'General case' 0 C--O 1.194 -1.822 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.313 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 191' ' ' PHE . 0.0 OUTLIER -57.65 -54.94 41.18 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.349 -1.469 . . . . 0.0 108.925 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 1.089 ' HB2' HD21 ' A' ' 175' ' ' LEU . . . -69.87 -44.83 69.01 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.707 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ASN . . . . . 0.753 ' HB2' HD21 ' A' ' 199' ' ' LEU . 1.6 m-20 -82.19 -29.99 31.17 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.061 -1.056 . . . . 0.0 112.902 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 190' ' ' GLU . 15.6 tttt -55.42 -36.64 66.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.462 -1.399 . . . . 0.0 109.384 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.445 ' CE1' ' SD ' ' A' ' 1' ' ' MET . 24.0 m80 -81.8 -52.83 6.73 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 116.116 -2.234 . . . . 0.0 111.781 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.468 ' O ' ' CG ' ' A' ' 197' ' ' MET . 89.4 m-20 -115.58 28.34 8.73 Favored 'General case' 0 N--CA 1.51 2.571 0 C-N-CA 117.073 -1.851 . . . . 0.0 115.254 177.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' MET . . . . . 0.891 ' HE3' HD13 ' A' ' 57' ' ' LEU . 0.8 OUTLIER -160.21 149.96 17.93 Favored 'General case' 0 N--CA 1.514 2.745 0 CA-C-N 121.991 2.178 . . . . 0.0 113.613 179.267 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.816 ' CB ' HD12 ' A' ' 6' ' ' LEU . . . -86.73 148.51 25.4 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.416 -1.428 . . . . 0.0 108.482 175.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.776 HD23 ' HB3' ' A' ' 30' ' ' MET . 4.1 mt -122.72 144.3 49.24 Favored 'General case' 0 N--CA 1.511 2.62 0 O-C-N 120.264 -1.523 . . . . 0.0 111.639 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.836 ' O ' HD23 ' A' ' 32' ' ' LEU . 3.4 p -149.94 -178.92 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.269 -0.894 . . . . 0.0 110.179 178.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.581 ' H ' HG22 ' A' ' 200' ' ' VAL . 23.5 p -105.54 179.84 4.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.014 . . . . 0.0 110.849 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.724 ' HB ' HG22 ' A' ' 31' ' ' VAL . 4.5 tt -111.96 -32.51 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.446 -0.784 . . . . 0.0 110.349 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.89 -65.06 0.62 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.108 -0.995 . . . . 0.0 110.528 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -75.82 -35.78 59.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.294 -0.879 . . . . 0.0 110.442 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 1.081 HD21 HD13 ' A' ' 163' ' ' LEU . 6.3 tt -52.92 -43.61 66.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.096 -1.003 . . . . 0.0 110.285 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.632 HG13 HG13 ' A' ' 147' ' ' VAL . 1.0 OUTLIER -71.08 -40.35 75.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 O-C-N 120.965 -1.084 . . . . 0.0 108.456 -179.375 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.419 ' HA ' ' CD2' ' A' ' 148' ' ' LEU . . . -55.72 -23.82 31.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.074 -1.016 . . . . 0.0 108.497 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.676 ' CD2' HG11 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -75.81 -35.92 59.87 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.09 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.64 HH21 HG21 ' A' ' 162' ' ' THR . 2.3 tmt_? -55.49 -44.14 76.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.834 . . . . 0.0 109.627 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.501 ' HG3' HD13 ' A' ' 148' ' ' LEU . 0.4 OUTLIER -68.65 -37.31 79.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.432 -0.793 . . . . 0.0 110.157 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -65.07 -22.98 67.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.347 -0.846 . . . . 0.0 110.173 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -88.05 -22.0 24.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.18 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -106.47 9.56 31.62 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.219 -0.926 . . . . 0.0 110.68 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.89 147.08 51.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.998 -1.064 . . . . 0.0 110.125 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -122.92 126.91 48.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.9 . . . . 0.0 110.223 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -83.41 -22.56 32.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 110.193 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.221 179.979 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mmt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.287 0.565 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -110.96 55.83 0.64 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.249 -0.907 . . . . 0.0 110.222 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.417 ' HB2' ' HA ' ' A' ' 194' ' ' LYS . 1.3 tt0 -90.27 -34.38 15.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.226 -0.921 . . . . 0.0 110.186 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.7 t -93.18 -4.99 51.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.392 -0.818 . . . . 0.0 110.721 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -52.36 -41.46 63.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.034 -1.041 . . . . 0.0 110.401 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.922 HD11 ' HB1' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -116.13 18.22 15.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 110.392 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.0 -29.79 2.27 Favored 'General case' 0 N--CA 1.512 2.67 0 O-C-N 120.738 -1.227 . . . . 0.0 109.431 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.437 ' O ' ' CB ' ' A' ' 15' ' ' ARG . 2.6 m -87.97 38.98 0.87 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.611 ' O ' HG23 ' A' ' 201' ' ' THR . 18.5 p90 -67.26 44.25 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -172.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.38 76.44 0.13 Allowed Glycine 0 C--N 1.285 -2.278 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 169.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.618 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -151.35 90.72 4.0 Favored Pre-proline 0 C--N 1.291 -1.946 0 N-CA-C 100.527 -3.879 . . . . 0.0 100.527 173.277 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.512 ' CB ' ' HB2' ' A' ' 208' ' ' TYR . 22.5 Cg_endo -46.6 -40.48 23.77 Favored 'Trans proline' 0 C--N 1.283 -2.875 0 O-C-N 123.048 1.025 . . . . 0.0 111.736 -172.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.438 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 14.1 m-85 -93.54 -37.2 12.03 Favored 'General case' 0 C--N 1.278 -2.511 0 C-N-CA 119.24 -0.984 . . . . 0.0 113.504 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -79.25 -63.33 1.44 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.606 -1.238 . . . . 0.0 112.635 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.711 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.8 tpt180 -90.84 -14.94 30.86 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 118.746 -1.182 . . . . 0.0 111.929 -178.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.994 HG11 ' HB2' ' A' ' 205' ' ' LEU . 2.3 t -98.81 -19.0 6.08 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 C-N-CA 116.359 -2.136 . . . . 0.0 109.615 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 13' ' ' PHE . 3.7 tt0 -83.26 -41.5 18.27 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 176.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -74.04 -22.38 59.57 Favored 'General case' 0 C--N 1.307 -1.239 0 O-C-N 121.749 -0.595 . . . . 0.0 109.504 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.922 ' HB1' HD11 ' A' ' 6' ' ' LEU . . . -75.52 -51.94 11.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.016 -1.052 . . . . 0.0 108.992 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.892 HD22 ' OH ' ' A' ' 208' ' ' TYR . 0.4 OUTLIER -49.48 -33.23 13.85 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.442 -0.786 . . . . 0.0 109.8 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' A' ' 24' ' ' ARG . . . -78.0 -68.41 0.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.972 0.891 . . . . 0.0 109.614 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.92 -29.2 1.9 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.495 -0.753 . . . . 0.0 110.135 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.499 ' CB ' ' HB ' ' A' ' 29' ' ' VAL . 1.9 mm? -101.09 -15.37 17.43 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.799 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.488 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -50.23 -24.47 2.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.079 -1.013 . . . . 0.0 108.571 178.286 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.73 42.76 1.11 Allowed 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 118.49 -1.284 . . . . 0.0 110.35 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.518 ' HA2' ' CZ ' ' A' ' 45' ' ' PHE . . . 55.2 25.91 41.33 Favored Glycine 0 C--N 1.291 -1.934 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 176.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.443 ' C ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -88.23 17.6 5.03 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 116.36 -2.136 . . . . 0.0 110.97 -179.711 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 198' ' ' ALA . . . 96.69 108.87 2.54 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 118.893 -1.622 . . . . 0.0 115.113 172.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.039 HG22 HD12 ' A' ' 44' ' ' ILE . 5.8 p -140.69 124.88 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-N 119.539 1.669 . . . . 0.0 108.345 175.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.839 ' HB2' HD23 ' A' ' 199' ' ' LEU . 0.5 OUTLIER -109.03 158.59 17.59 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.869 -1.145 . . . . 0.0 113.312 -177.474 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.893 HG21 HD21 ' A' ' 160' ' ' LEU . 0.9 OUTLIER -124.87 110.01 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.541 -0.724 . . . . 0.0 109.3 178.125 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.725 HD21 ' HA ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -176.44 154.59 1.31 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.254 -0.904 . . . . 0.0 110.199 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -154.06 -61.9 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 110.18 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -103.03 158.58 16.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.938 . . . . 0.0 110.215 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.403 ' HA ' ' OD1' ' A' ' 39' ' ' ASN . 4.0 pt-20 -56.8 136.96 55.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.21 -0.931 . . . . 0.0 110.184 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 38' ' ' GLU . 3.9 t0 -167.82 74.62 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 110.28 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 57.7 -85.56 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.368 -0.833 . . . . 0.0 110.456 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -85.57 112.22 20.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.014 -1.054 . . . . 0.0 110.208 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.725 ' HA ' HD21 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -108.43 54.46 0.66 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.192 -0.942 . . . . 0.0 110.113 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.927 ' HB2' HD13 ' A' ' 189' ' ' ILE . 0.0 OUTLIER -176.35 127.01 0.2 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.166 -0.959 . . . . 0.0 110.17 -179.802 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 30' ' ' MET . . . -170.46 64.05 0.17 Allowed Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.556 -1.307 . . . . 0.0 110.758 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.517 ' HB2' ' CB ' ' A' ' 174' ' ' GLU . 0.7 OUTLIER -68.85 -8.0 39.73 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.526 -0.985 . . . . 0.0 111.597 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.593 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -95.34 53.92 1.56 Allowed 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.29 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.039 HD12 HG22 ' A' ' 29' ' ' VAL . 94.2 mt -61.22 19.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.527 3.391 0 O-C-N 120.428 -1.42 . . . . 0.0 111.991 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.593 ' H ' ' C ' ' A' ' 43' ' ' MET . 22.4 m-85 -85.06 165.09 38.69 Favored Pre-proline 0 C--N 1.291 -1.952 0 O-C-N 120.972 -1.08 . . . . 0.0 112.341 -177.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.503 ' HD3' ' CD2' ' A' ' 166' ' ' PHE . 40.8 Cg_endo -62.79 133.53 42.41 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 122.444 2.096 . . . . 0.0 114.106 -176.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.481 ' HB1' HD13 ' A' ' 68' ' ' LEU . . . -69.22 -2.7 11.2 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.263 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 15.7 tt0 -80.1 -14.99 58.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.906 -1.121 . . . . 0.0 109.653 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.526 ' O ' HG23 ' A' ' 49' ' ' THR . 6.3 t -130.81 58.99 1.68 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 177.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.515 ' HE1' HD11 ' A' ' 68' ' ' LEU . 15.3 ttm -51.53 88.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.673 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.499 ' HA ' HG13 ' A' ' 115' ' ' ILE . 3.2 m -64.65 157.45 27.16 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.693 0.759 . . . . 0.0 110.267 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 1.038 HG23 ' HB1' ' A' ' 111' ' ' ALA . 2.1 p -71.65 -4.87 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.655 -0.653 . . . . 0.0 109.907 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -55.15 -31.41 61.3 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.795 -1.19 . . . . 0.0 108.445 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.928 ' HA ' HD23 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -87.77 -38.27 15.9 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.19 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.844 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -71.87 -40.02 69.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.817 -1.177 . . . . 0.0 109.275 179.487 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.651 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -62.3 -47.08 85.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.558 -0.714 . . . . 0.0 110.772 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.928 HD23 ' HA ' ' A' ' 54' ' ' GLN . 0.8 OUTLIER -57.05 -34.14 67.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.079 -1.013 . . . . 0.0 110.987 -179.237 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.477 ' CA ' ' O ' ' A' ' 62' ' ' GLY . 33.2 p -79.54 -46.72 16.82 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.19 -0.944 . . . . 0.0 111.139 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.0 mt -54.22 -20.42 4.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 O-C-N 121.094 -1.004 . . . . 0.0 110.28 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.502 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 2.9 mtp180 -97.92 -44.56 6.64 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.158 -0.964 . . . . 0.0 113.169 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.502 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 48.5 m80 -125.43 -17.84 5.47 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -176.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.477 ' O ' ' CA ' ' A' ' 58' ' ' THR . . . -165.18 -169.09 28.34 Favored Glycine 0 N--CA 1.503 3.129 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.708 -177.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.6 t -143.1 96.37 2.91 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 102.27 -3.233 . . . . 0.0 102.27 175.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.42 ' H ' HG22 ' A' ' 58' ' ' THR . . . -136.35 72.38 0.46 Allowed Glycine 0 C--N 1.26 -3.681 1 N-CA-C 101.97 -4.452 . . . . 0.0 101.97 178.734 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.441 ' CG2' ' CE2' ' A' ' 138' ' ' PHE . 38.7 mt -60.14 145.28 12.04 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.816 0 CA-C-N 113.613 -1.293 . . . . 0.0 110.067 -176.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.809 HG12 ' CB ' ' A' ' 173' ' ' CYS . 35.2 m -55.98 152.28 2.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.863 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 171' ' ' VAL . 78.9 m -83.03 132.77 35.12 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.717 HD22 HG12 ' A' ' 171' ' ' VAL . 2.9 mm? -89.18 97.98 11.51 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.037 -1.065 . . . . 0.0 108.936 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.582 ' HA ' HG23 ' A' ' 157' ' ' THR . 34.3 m -64.41 125.73 25.58 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 118.776 -1.17 . . . . 0.0 109.794 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.543 ' CA ' HD13 ' A' ' 158' ' ' ILE . 15.2 tt -133.23 146.88 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.017 -1.052 . . . . 0.0 109.823 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.624 HG23 HG12 ' A' ' 158' ' ' ILE . 0.3 OUTLIER -108.62 151.97 25.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 109.643 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 76' ' ' LYS . 18.4 tt0 -50.25 -24.68 3.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.264 -0.897 . . . . 0.0 110.053 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -88.23 -38.24 15.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.323 -0.861 . . . . 0.0 109.969 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.851 ' O ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -62.11 -52.45 63.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.346 -0.846 . . . . 0.0 109.562 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.625 HH21 HG23 ' A' ' 96' ' ' THR . 0.5 OUTLIER -62.84 -40.85 98.7 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.112 0.958 . . . . 0.0 108.784 179.031 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.63 ' O ' ' N ' ' A' ' 79' ' ' ASP . 7.9 tttm -49.53 -62.04 1.77 Allowed 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -47.66 -31.3 4.48 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 121.884 0.849 . . . . 0.0 108.945 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.851 HD12 ' O ' ' A' ' 74' ' ' ARG . 3.0 mt -96.69 44.55 1.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 175.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.63 ' N ' ' O ' ' A' ' 76' ' ' LYS . 20.9 t0 -26.81 78.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 123.85 1.786 . . . . 0.0 112.893 -172.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.641 HD21 HG22 ' A' ' 99' ' ' ILE . 0.2 OUTLIER -150.77 106.36 3.06 Favored Pre-proline 0 C--N 1.286 -2.189 0 CA-C-N 112.315 -2.221 . . . . 0.0 110.181 177.83 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -92.07 94.06 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 N-CA-C 107.852 -1.634 . . . . 0.0 107.852 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.556 ' SD ' HG21 ' A' ' 97' ' ' VAL . 2.8 mmt -99.63 44.45 1.02 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.16 -0.962 . . . . 0.0 109.875 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.3 tpt -68.51 103.07 1.58 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.053 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 95' ' ' PHE . 11.0 t -84.33 103.65 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -92.28 21.72 5.0 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.287 -0.883 . . . . 0.0 112.264 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.434 ' HB2' ' HA3' ' A' ' 92' ' ' GLY . 0.6 OUTLIER -68.52 82.15 0.26 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.996 -1.065 . . . . 0.0 108.326 178.293 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -43.11 104.76 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.476 -0.765 . . . . 0.0 112.028 -177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.683 HG21 ' CB ' ' A' ' 91' ' ' TYR . 10.0 m -164.11 166.57 21.17 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.77 -0.581 . . . . 0.0 109.481 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 t -59.97 -60.84 3.19 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.921 -1.112 . . . . 0.0 109.903 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -127.03 20.34 6.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.333 -0.854 . . . . 0.0 109.595 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.683 ' CB ' HG21 ' A' ' 88' ' ' THR . 0.4 OUTLIER -114.63 82.38 1.71 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.539 -0.726 . . . . 0.0 110.066 -179.645 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.474 ' HA2' ' CG1' ' A' ' 84' ' ' VAL . . . 82.86 40.87 9.13 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 93' ' ' THR . 10.1 t -71.37 53.52 0.2 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.848 -0.795 . . . . 0.0 110.479 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 84' ' ' VAL . . . 55.86 24.72 42.6 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 -176.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.699 ' O ' HG23 ' A' ' 84' ' ' VAL . 0.5 OUTLIER -60.81 103.06 0.23 Allowed 'General case' 0 N--CA 1.486 1.329 0 O-C-N 122.136 -0.626 . . . . 0.0 112.661 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.625 HG23 HH21 ' A' ' 75' ' ' ARG . 2.8 m -59.25 79.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.589 HG11 ' HD3' ' A' ' 133' ' ' ARG . 18.8 t -35.47 151.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 CA-C-O 123.023 1.392 . . . . 0.0 113.412 -173.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.765 HG23 ' HA ' ' A' ' 134' ' ' PRO . 0.7 OUTLIER -69.64 179.5 2.12 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 113.793 -1.549 . . . . 0.0 113.157 -176.187 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.764 HD12 HD13 ' A' ' 131' ' ' LEU . 19.8 pt -141.9 131.81 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -177.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 132' ' ' ASN . 1.6 tm-20 -111.81 133.94 53.69 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 117.758 -1.577 . . . . 0.0 112.875 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.824 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . . . -52.72 93.28 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.064 -1.023 . . . . 0.0 110.039 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.594 ' HB2' ' HB2' ' A' ' 132' ' ' ASN . . . -82.55 3.82 27.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.965 -1.084 . . . . 0.0 110.911 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -113.02 54.92 0.71 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.775 -1.203 . . . . 0.0 112.236 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.44 -36.41 2.58 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 118.875 -1.631 . . . . 0.0 112.42 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.824 ' HB ' ' HB3' ' A' ' 101' ' ' ALA . 0.8 OUTLIER -100.99 124.4 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 120.962 -1.316 . . . . 0.0 110.187 -178.394 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 p -145.24 61.11 1.3 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.591 -1.318 . . . . 0.0 111.422 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 p -135.3 -32.27 0.94 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.889 -1.132 . . . . 0.0 110.323 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.9 -30.37 0.1 Allowed Glycine 0 N--CA 1.499 2.881 0 O-C-N 121.599 -0.688 . . . . 0.0 113.238 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.3 t -128.63 57.12 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.377 -1.661 . . . . 0.0 110.38 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -129.43 56.94 1.68 Allowed 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.128 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 1.038 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -31.53 -32.29 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -84.28 -77.37 0.27 Allowed 'General case' 0 C--N 1.29 -1.993 0 O-C-N 120.837 -1.165 . . . . 0.0 109.558 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.18 -15.94 28.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.448 -0.782 . . . . 0.0 110.737 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.805 ' HG2' HG23 ' A' ' 118' ' ' VAL . 2.4 ttt180 -90.67 -36.73 14.18 Favored 'General case' 0 C--O 1.202 -1.416 0 O-C-N 121.001 -1.062 . . . . 0.0 110.261 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.726 HD13 ' HA ' ' A' ' 111' ' ' ALA . 0.8 OUTLIER -62.0 -15.37 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 118.417 -1.313 . . . . 0.0 108.956 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.5 m -88.6 -55.27 3.78 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.765 ' CB ' HG13 ' A' ' 105' ' ' VAL . 53.2 p -67.49 -14.0 62.54 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.424 178.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.805 HG23 ' HG2' ' A' ' 114' ' ' ARG . 2.6 t -73.66 -48.64 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -50.52 -36.2 33.02 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.132 178.471 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.704 ' HA ' ' HB3' ' A' ' 123' ' ' ALA . . . -96.44 -13.8 22.86 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.281 0.563 . . . . 0.0 110.476 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.802 ' HB1' ' HB2' ' A' ' 101' ' ' ALA . . . -55.58 -56.48 19.82 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.252 -0.905 . . . . 0.0 109.773 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 19.1 tt -93.69 14.47 2.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 118.677 -1.209 . . . . 0.0 110.243 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.704 ' HB3' ' HA ' ' A' ' 120' ' ' ALA . . . -108.83 72.38 0.82 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 118.973 -1.091 . . . . 0.0 111.136 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.485 ' HB2' ' HZ2' ' A' ' 127' ' ' LYS . 5.1 t70 -99.3 -35.61 9.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.998 -1.064 . . . . 0.0 110.381 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 106.04 -38.37 3.34 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 105.28 -3.128 . . . . 0.0 105.28 -176.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -133.34 98.86 4.35 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.485 ' HZ2' ' HB2' ' A' ' 124' ' ' ASP . 5.4 tptt -132.33 52.94 9.91 Favored Pre-proline 0 C--N 1.307 -1.28 0 O-C-N 120.767 -1.208 . . . . 0.0 110.86 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 127' ' ' LYS . 49.4 Cg_endo -78.0 -35.65 1.31 Allowed 'Trans proline' 0 C--N 1.3 -2.009 0 N-CA-C 106.911 -1.996 . . . . 0.0 106.911 176.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.4 t -126.71 -0.29 6.74 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.345 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.448 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . 0.8 OUTLIER -77.4 9.4 3.26 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.634 -1.292 . . . . 0.0 112.718 -177.61 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.764 HD13 HD12 ' A' ' 99' ' ' ILE . 29.7 mt -117.87 124.89 49.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.716 -1.24 . . . . 0.0 109.337 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.594 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 1.3 m-80 -116.85 93.58 4.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.089 -1.007 . . . . 0.0 112.952 -177.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.785 ' HB2' ' HA ' ' A' ' 134' ' ' PRO 0.274 0.0 OUTLIER -80.71 172.12 10.6 Favored Pre-proline 0 N--CA 1.501 2.101 0 O-C-N 121.815 -0.553 . . . . 0.0 110.72 -179.556 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.785 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 48.2 Cg_endo -73.14 129.75 18.44 Favored 'Cis proline' 0 N--CA 1.502 1.995 0 C-N-CA 123.043 -1.649 . . . . 0.0 112.559 7.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.637 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -123.6 47.31 1.03 Allowed Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 135' ' ' GLY . 49.6 m80 31.19 38.1 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 122.143 0.973 . . . . 0.0 112.07 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.67 HG13 ' HG ' ' A' ' 68' ' ' LEU . 31.3 t -129.43 92.44 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 176.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.462 ' O ' ' CD1' ' A' ' 138' ' ' PHE . 10.4 p90 -107.09 101.91 40.45 Favored Pre-proline 0 N--CA 1.495 1.797 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.218 -176.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 53.2 Cg_endo -98.38 155.59 0.78 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.785 1.413 . . . . 0.0 111.078 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.515 HD12 ' O ' ' A' ' 139' ' ' PRO . 1.3 mp -127.29 116.59 20.78 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.471 ' HA ' HG23 ' A' ' 70' ' ' ILE . 9.2 ttm180 -63.52 115.66 4.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.058 -1.026 . . . . 0.0 110.696 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.997 ' HB2' HG22 ' A' ' 154' ' ' THR . . . -130.67 135.5 47.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.765 -0.584 . . . . 0.0 110.13 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.417 ' O ' ' HG3' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -53.38 143.23 19.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.941 -1.099 . . . . 0.0 110.092 -179.642 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.556 ' HB2' HG23 ' A' ' 158' ' ' ILE . . . -100.4 115.76 30.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.502 -0.749 . . . . 0.0 111.622 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.417 ' N ' ' OD2' ' A' ' 159' ' ' ASP . . . 104.02 -15.0 52.05 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.77 13.1 57.9 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.994 HG21 ' HB2' ' A' ' 156' ' ' ALA . 7.2 p -65.52 -9.09 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.095 -1.239 . . . . 0.0 110.276 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.888 HD22 HG13 ' A' ' 147' ' ' VAL . 4.0 mm? -87.82 15.92 6.47 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 115.683 -2.407 . . . . 0.0 110.079 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.0 m -131.11 60.94 1.65 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 100.937 -3.727 . . . . 0.0 100.937 167.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.78 140.03 22.23 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 113.876 -1.511 . . . . 0.0 112.774 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -104.03 34.83 5.47 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 106.44 -2.664 . . . . 0.0 106.44 173.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.3 160.88 27.92 Favored Glycine 0 N--CA 1.478 1.493 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.604 ' HB3' HD11 ' A' ' 202' ' ' ILE . 10.4 p80 -90.0 -5.5 56.6 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.653 -0.91 . . . . 0.0 109.309 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.997 HG22 ' HB2' ' A' ' 142' ' ' ALA . 6.3 m -54.54 -59.22 4.98 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.076 -1.015 . . . . 0.0 109.437 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.834 ' HA ' ' HB1' ' A' ' 142' ' ' ALA . 21.2 tt0 -57.93 -22.12 47.25 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.994 ' HB2' HG21 ' A' ' 147' ' ' VAL . . . -91.38 8.04 38.15 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 121.715 -0.616 . . . . 0.0 109.377 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.582 HG23 ' HA ' ' A' ' 69' ' ' CYS . 0.6 OUTLIER -92.51 -51.69 5.0 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.375 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.713 HD11 ' O ' ' A' ' 168' ' ' PRO . 6.1 tp -72.77 -32.37 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 176.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.468 ' HB3' ' HA ' ' A' ' 156' ' ' ALA . 11.7 t0 -71.61 -22.28 61.73 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.893 HD21 HG21 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -60.22 -30.98 69.75 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.906 0.86 . . . . 0.0 109.466 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.525 ' HB2' ' HA ' ' A' ' 168' ' ' PRO . 37.2 mmt -83.42 -26.91 29.95 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.706 HG21 ' NE ' ' A' ' 209' ' ' ARG . 2.5 m -71.45 -36.87 71.37 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 176.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.719 ' CD2' ' HA ' ' A' ' 160' ' ' LEU . 3.9 pp -82.03 -4.2 56.24 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.251 -0.98 . . . . 0.0 108.698 177.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.635 ' HB2' HG22 ' A' ' 44' ' ' ILE . . . -109.52 12.1 24.6 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.38 -1.45 . . . . 0.0 109.865 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 58.5 42.49 95.94 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.503 ' CD2' ' HD3' ' A' ' 46' ' ' PRO . 6.3 m-85 -135.41 139.98 44.58 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 122.369 1.081 . . . . 0.0 112.093 -176.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 169' ' ' ALA . 5.1 mttt -48.98 136.6 13.93 Favored Pre-proline 0 N--CA 1.501 2.091 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 177.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.713 ' O ' HD11 ' A' ' 158' ' ' ILE . 37.4 Cg_endo -63.86 84.6 0.14 Allowed 'Trans proline' 0 C--N 1.301 -1.962 0 C-N-CA 116.59 -1.806 . . . . 0.0 113.225 -173.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 46' ' ' PRO . . . -155.94 123.82 5.66 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 100.581 -3.859 . . . . 0.0 100.581 172.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.454 ' N ' ' HB2' ' A' ' 69' ' ' CYS . . . -153.64 159.56 28.74 Favored Glycine 0 N--CA 1.502 3.085 0 CA-C-N 123.869 3.031 . . . . 0.0 113.199 -174.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.717 HG12 HD22 ' A' ' 68' ' ' LEU . 2.9 m -149.65 98.8 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 118.503 -1.279 . . . . 0.0 109.601 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.827 HD11 ' CD1' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -109.75 105.81 15.2 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 117.185 -1.806 . . . . 0.0 113.787 -179.506 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.876 ' SG ' HD21 ' A' ' 57' ' ' LEU . 49.5 t -137.88 159.9 40.76 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.856 ' O ' HD12 ' A' ' 189' ' ' ILE . 1.2 mm-40 174.64 85.68 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.968 0 O-C-N 119.842 -1.786 . . . . 0.0 112.689 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.938 HD21 ' HB3' ' A' ' 188' ' ' CYS . 0.3 OUTLIER -127.84 104.99 8.13 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.206 -0.934 . . . . 0.0 110.83 178.719 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.452 HG23 ' HB2' ' A' ' 57' ' ' LEU . 1.2 p -140.43 104.57 4.8 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.126 -0.983 . . . . 0.0 110.412 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -98.26 147.55 24.52 Favored 'General case' 0 C--N 1.31 -1.125 0 O-C-N 120.802 -1.186 . . . . 0.0 109.132 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -82.37 5.91 18.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 111.274 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.31 15.34 13.93 Favored 'General case' 0 C--N 1.291 -1.963 0 O-C-N 121.527 -0.733 . . . . 0.0 110.42 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.481 ' HA2' ' CD2' ' A' ' 61' ' ' HIS . . . 56.19 38.78 78.93 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 6.6 m -98.18 98.31 9.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.341 -1.093 . . . . 0.0 111.131 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.424 ' CE ' ' O ' ' A' ' 61' ' ' HIS . 85.4 mtp -55.78 92.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.45 -0.781 . . . . 0.0 109.447 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.732 ' HB1' ' SG ' ' A' ' 188' ' ' CYS . . . -115.41 133.91 55.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.894 . . . . 0.0 110.879 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 185' ' ' ALA . 5.0 ttm180 -129.11 100.41 5.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -0.857 . . . . 0.0 109.442 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.913 ' HB1' ' HD2' ' A' ' 186' ' ' PRO . . . -179.85 -177.18 0.21 Allowed Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.336 -0.852 . . . . 0.0 109.298 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.913 ' HD2' ' HB1' ' A' ' 185' ' ' ALA . 42.8 Cg_endo -70.2 -23.39 28.86 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.342 1.18 . . . . 0.0 110.143 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.423 ' O ' ' CB ' ' A' ' 190' ' ' GLU . 0.4 OUTLIER -81.79 -28.24 33.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.033 -1.042 . . . . 0.0 108.56 178.601 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 188' ' ' CYS . . . . . 0.938 ' HB3' HD21 ' A' ' 175' ' ' LEU . 37.1 m -66.33 -51.56 56.01 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.927 HD13 ' HB2' ' A' ' 40' ' ' GLU . 8.0 tp -58.34 -27.8 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.497 ' HA ' HD11 ' A' ' 199' ' ' LEU . 1.0 OUTLIER -60.14 -25.46 65.51 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 176.646 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.656 ' CE2' ' HB3' ' A' ' 183' ' ' ALA . 12.9 m-30 -55.76 -57.48 11.85 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 123.296 1.522 . . . . 0.0 108.093 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.727 ' HB1' ' SD ' ' A' ' 197' ' ' MET . . . -64.17 -46.61 83.25 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.562 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ASN . . . . . 0.663 ' HB3' HD11 ' A' ' 199' ' ' LEU . 1.9 t30 -65.05 -11.88 44.33 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.472 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.417 ' HA ' ' HB2' ' A' ' 3' ' ' GLN . 7.6 tmtt? -78.2 -37.11 46.37 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 117.372 -1.731 . . . . 0.0 111.06 -178.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -108.66 -54.25 2.54 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 115.684 -2.406 . . . . 0.0 111.952 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -114.67 34.63 4.67 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.322 -1.351 . . . . 0.0 113.784 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' MET . . . . . 0.727 ' SD ' ' HB1' ' A' ' 192' ' ' ALA . 2.2 mtt -151.42 150.63 30.67 Favored 'General case' 0 N--CA 1.518 2.949 0 CA-C-N 123.113 2.688 . . . . 0.0 115.466 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.668 ' HB1' HD12 ' A' ' 6' ' ' LEU . . . -110.26 147.72 33.28 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.257 -0.902 . . . . 0.0 108.779 177.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.839 HD23 ' HB2' ' A' ' 30' ' ' MET . 10.0 mt -123.51 130.58 52.9 Favored 'General case' 0 N--CA 1.511 2.585 0 O-C-N 120.277 -1.514 . . . . 0.0 111.161 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.903 HG21 HG13 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -109.3 -160.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 120.791 -1.193 . . . . 0.0 111.027 179.232 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.707 ' O ' HD22 ' A' ' 205' ' ' LEU . 0.6 OUTLIER -108.44 -179.92 4.01 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.422 -0.799 . . . . 0.0 110.435 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 153' ' ' HIS . 12.9 tt -106.66 -41.91 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.417 -0.802 . . . . 0.0 111.3 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.512 ' N ' HG23 ' A' ' 202' ' ' ILE . 0.2 OUTLIER -90.38 -40.52 12.02 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.991 -1.068 . . . . 0.0 111.262 -178.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 207' ' ' ALA . 0.5 OUTLIER -63.37 -45.1 92.71 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.704 -1.247 . . . . 0.0 110.441 -179.454 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.994 ' HB2' HG11 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -71.28 -31.53 67.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.156 -0.965 . . . . 0.0 112.354 -178.504 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.779 ' H ' HD23 ' A' ' 205' ' ' LEU . 3.7 m -62.32 -29.57 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 119.707 -1.871 . . . . 0.0 106.995 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 211' ' ' ALA . . . -64.61 -38.46 91.08 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.892 ' OH ' HD22 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -56.87 -36.11 69.69 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.313 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.706 ' NE ' HG21 ' A' ' 162' ' ' THR . 0.0 OUTLIER -74.01 -55.26 6.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.418 -0.801 . . . . 0.0 110.0 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.438 ' N ' ' HD3' ' A' ' 209' ' ' ARG . 12.9 tt0 -68.83 -56.35 8.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 110.714 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 207' ' ' ALA . . . -51.19 -31.52 20.53 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.322 -0.861 . . . . 0.0 110.443 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.427 ' CB ' ' O ' ' A' ' 208' ' ' TYR . 48.9 t-80 -78.74 -24.84 44.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.183 -0.948 . . . . 0.0 110.182 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -116.84 25.98 10.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 110.176 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 14.2 ttp85 -62.47 147.09 49.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 110.255 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -115.87 85.98 2.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.247 -0.908 . . . . 0.0 110.23 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -73.41 174.95 7.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.906 . . . . 0.0 110.213 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.168 -179.981 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.218 0.532 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -99.83 55.8 0.95 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 110.232 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.418 ' O ' ' CB ' ' A' ' 7' ' ' SER . 31.6 tt0 -91.85 -22.13 20.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.297 -0.877 . . . . 0.0 110.11 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.45 HG22 ' HB2' ' A' ' 9' ' ' PHE . 11.9 m -60.97 -15.93 37.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.269 -0.894 . . . . 0.0 110.609 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.538 HD22 ' HG3' ' A' ' 197' ' ' MET . 3.1 tp -49.55 -67.06 0.29 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.122 -0.986 . . . . 0.0 110.652 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.608 ' CD2' HG23 ' A' ' 200' ' ' VAL . 0.3 OUTLIER -115.42 5.23 14.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -0.876 . . . . 0.0 110.715 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 3' ' ' GLN . 8.3 t -95.1 -66.21 0.93 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.614 -1.303 . . . . 0.0 111.885 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.26 13.15 32.36 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.198 -0.939 . . . . 0.0 112.034 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.45 ' HB2' HG22 ' A' ' 4' ' ' THR . 0.6 OUTLIER -141.2 58.7 1.53 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.796 -1.19 . . . . 0.0 109.887 -179.461 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 15' ' ' ARG . . . -164.21 167.98 38.42 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 107.392 -2.283 . . . . 0.0 107.392 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.459 ' O ' ' C ' ' A' ' 12' ' ' PRO . 34.4 p -127.87 149.39 70.56 Favored Pre-proline 0 C--N 1.256 -3.49 0 N-CA-C 102.995 -2.965 . . . . 0.0 102.995 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.886 ' HB2' ' HB3' ' A' ' 207' ' ' ALA . 18.7 Cg_endo -40.34 -34.79 1.17 Allowed 'Trans proline' 0 C--N 1.288 -2.627 0 CA-C-N 119.767 0.952 . . . . 0.0 110.455 -176.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.451 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 9.8 t80 -87.19 -42.65 12.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.904 -0.498 . . . . 0.0 111.628 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.518 ' HA ' ' HB3' ' A' ' 17' ' ' GLU . 15.9 tt0 -89.37 -16.14 31.7 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.723 -1.236 . . . . 0.0 111.916 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.515 ' CD ' HG23 ' A' ' 200' ' ' VAL . 2.0 ttm180 -72.9 -64.46 0.96 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 105.977 -1.861 . . . . 0.0 105.977 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.71 HG11 ' CD2' ' A' ' 208' ' ' TYR . 7.3 p -62.22 -21.21 26.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 C-N-CA 118.721 -1.192 . . . . 0.0 108.323 176.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.518 ' HB3' ' HA ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -57.11 -35.17 69.13 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 119.92 -1.737 . . . . 0.0 106.458 177.092 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.536 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 2.9 m-20 -73.98 -29.37 61.94 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 176.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 1.088 ' HB1' HG11 ' A' ' 29' ' ' VAL . . . -67.83 -50.58 55.94 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.605 HD13 ' O ' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -61.43 -50.77 71.46 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 177.822 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.08 -26.22 62.27 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.668 -1.27 . . . . 0.0 107.966 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 18' ' ' ASN . . . -80.34 -32.55 37.83 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.499 -0.751 . . . . 0.0 109.064 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.539 ' CD2' ' CD2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -50.35 -25.44 3.84 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.093 -1.004 . . . . 0.0 108.83 177.881 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.44 -26.38 15.87 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 1.3 tp10 -144.69 81.09 1.65 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 123.866 1.793 . . . . 0.0 107.241 177.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 126.58 48.8 0.18 Allowed Glycine 0 C--N 1.276 -2.77 1 N-CA-C 102.617 -4.193 . . . . 0.0 102.617 -175.145 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.52 ' O ' ' NE2' ' A' ' 54' ' ' GLN . 1.3 mtt180 -62.78 65.39 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 122.023 0.916 . . . . 0.0 111.715 -175.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 26' ' ' GLY . . . 176.64 98.19 0.11 Allowed Glycine 0 C--N 1.291 -1.964 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.096 HG22 ' HB3' ' A' ' 198' ' ' ALA . 24.6 t -127.0 135.17 64.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 119.161 -1.016 . . . . 0.0 110.134 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.811 ' HG2' HD22 ' A' ' 199' ' ' LEU . 0.1 OUTLIER -100.31 161.24 13.74 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.352 -179.444 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 201' ' ' THR . 11.1 p -133.5 94.21 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.682 0.753 . . . . 0.0 109.263 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.448 ' O ' HG22 ' A' ' 202' ' ' ILE . 0.4 OUTLIER -43.72 108.37 0.11 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.534 -0.729 . . . . 0.0 111.63 -178.915 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.732 ' OD2' HD13 ' A' ' 202' ' ' ILE . 4.8 t70 -93.7 -172.82 2.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.548 -0.72 . . . . 0.0 109.869 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -54.76 -174.42 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.162 -0.961 . . . . 0.0 110.134 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -89.47 161.13 16.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -0.937 . . . . 0.0 110.325 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 53.27 178.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 110.311 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.3 44.77 29.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.292 -0.88 . . . . 0.0 110.235 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -58.37 109.28 0.74 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.238 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -153.88 21.46 0.52 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.247 -0.908 . . . . 0.0 110.289 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.464 ' CA ' ' HB3' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -168.01 129.13 1.4 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.94 . . . . 0.0 110.355 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 173' ' ' CYS . . . -177.35 -119.86 0.61 Allowed Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.249 -1.453 . . . . 0.0 111.341 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.756 ' HB2' HD11 ' A' ' 189' ' ' ILE . 20.1 t70 -34.98 -28.32 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -177.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.643 ' O ' ' O ' ' A' ' 171' ' ' VAL . 0.0 OUTLIER -93.23 51.13 1.6 Allowed 'General case' 0 C--N 1.293 -1.891 0 O-C-N 120.776 -1.203 . . . . 0.0 113.476 -177.037 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.983 ' C ' HD11 ' A' ' 160' ' ' LEU . 20.7 pt -66.13 27.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 O-C-N 119.464 -2.023 . . . . 0.0 112.397 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.616 ' CZ ' ' NE2' ' A' ' 54' ' ' GLN . 31.4 m-85 -92.6 158.94 37.51 Favored Pre-proline 0 N--CA 1.505 2.292 0 O-C-N 121.064 -1.023 . . . . 0.0 113.184 -177.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.494 ' HB3' ' HB3' ' A' ' 167' ' ' LYS . 43.5 Cg_endo -66.53 130.86 24.6 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.245 1.963 . . . . 0.0 111.251 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.725 ' N ' ' HB1' ' A' ' 169' ' ' ALA . . . -58.9 -10.6 2.57 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 121.478 -0.764 . . . . 0.0 112.903 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.881 ' HA ' HD11 ' A' ' 122' ' ' ILE . 35.9 mt-10 -97.62 -2.58 41.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.631 -1.293 . . . . 0.0 109.542 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.86 57.08 1.82 Allowed 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 176.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.693 ' O ' HG23 ' A' ' 115' ' ' ILE . 25.4 tpp -63.26 86.93 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.526 -178.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 51' ' ' THR . 9.2 t -66.17 128.2 35.16 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.458 -0.776 . . . . 0.0 109.089 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 1.016 HG23 ' HB1' ' A' ' 111' ' ' ALA . 2.8 p -73.85 -2.56 3.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.534 -0.729 . . . . 0.0 109.484 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.49 -36.48 73.83 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.603 -1.239 . . . . 0.0 107.958 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.616 ' NE2' ' CZ ' ' A' ' 45' ' ' PHE . 2.3 mp0 -81.27 -53.96 5.9 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.828 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.429 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -54.56 -24.21 19.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.35 -0.844 . . . . 0.0 109.277 179.257 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.75 -46.87 64.9 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.322 -0.861 . . . . 0.0 109.896 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.77 HD11 HD23 ' A' ' 175' ' ' LEU . 0.7 OUTLIER -68.21 -36.6 79.79 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.057 -1.057 . . . . 0.0 109.952 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.414 ' OG1' ' CE ' ' A' ' 43' ' ' MET . 1.1 m -75.29 -58.17 3.44 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.198 -0.939 . . . . 0.0 110.511 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.426 ' CG1' ' O ' ' A' ' 55' ' ' MET . 96.5 mt -52.71 -22.09 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.941 . . . . 0.0 110.411 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -76.54 -40.62 49.31 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.282 -0.887 . . . . 0.0 111.15 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.438 ' O ' ' HA ' ' A' ' 177' ' ' ASN . 0.1 OUTLIER -123.01 -5.81 8.44 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.776 -1.203 . . . . 0.0 112.626 -178.589 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.99 -170.62 23.75 Favored Glycine 0 N--CA 1.496 2.633 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.158 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.4 t -141.24 101.73 4.08 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 102.26 -3.237 . . . . 0.0 102.26 176.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 66' ' ' VAL . . . -111.43 76.8 0.23 Allowed Glycine 0 C--N 1.26 -3.69 0 N-CA-C 104.612 -3.395 . . . . 0.0 104.612 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.695 ' O ' HG23 ' A' ' 65' ' ' ILE . 1.2 tt -58.19 94.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 CA-C-O 123.498 1.618 . . . . 0.0 108.811 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.673 HG23 ' C ' ' A' ' 172' ' ' LEU . 1.4 p -52.55 154.23 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.134 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.807 ' O ' HG12 ' A' ' 171' ' ' VAL . 44.5 t -75.93 162.64 27.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.174 -0.954 . . . . 0.0 110.131 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.84 HD22 HG12 ' A' ' 171' ' ' VAL . 0.3 OUTLIER -125.13 92.67 3.69 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.7 -1.25 . . . . 0.0 108.474 178.497 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.563 ' C ' HG23 ' A' ' 70' ' ' ILE . 1.8 t -93.25 153.88 18.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.428 -1.42 . . . . 0.0 113.073 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.563 HG23 ' C ' ' A' ' 69' ' ' CYS . 3.7 pt -155.29 147.51 12.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.048 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.515 HG22 ' H ' ' A' ' 72' ' ' GLU . 5.1 m -77.86 176.17 9.32 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 120.452 -1.405 . . . . 0.0 108.896 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.515 ' H ' HG22 ' A' ' 71' ' ' THR . 7.6 tt0 -95.16 -11.18 28.58 Favored 'General case' 0 C--N 1.284 -2.244 0 O-C-N 121.291 -0.881 . . . . 0.0 110.282 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -90.64 -75.26 0.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.591 -1.244 . . . . 0.0 111.557 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.58 -26.3 37.98 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 119.391 -0.923 . . . . 0.0 108.961 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.545 ' O ' ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -85.8 -27.47 25.14 Favored 'General case' 0 C--O 1.192 -1.967 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.359 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.1 OUTLIER -68.17 -41.78 81.0 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 121.157 1.799 . . . . 0.0 108.022 178.051 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.75 -58.28 6.85 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.614 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.91 HD22 ' O ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -89.09 -32.05 17.73 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 118.1 -1.44 . . . . 0.0 108.925 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.7 ' N ' HD13 ' A' ' 78' ' ' LEU . 1.4 t0 -116.03 75.32 0.94 Allowed 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.716 -0.615 . . . . 0.0 109.569 177.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.827 HD22 ' O ' ' A' ' 80' ' ' LEU . 0.0 OUTLIER -75.46 126.68 87.3 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.669 -1.269 . . . . 0.0 111.827 -177.669 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.631 ' HB3' HG23 ' A' ' 96' ' ' THR . 55.2 Cg_endo -90.82 98.72 0.24 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 122.627 0.803 . . . . 0.0 110.038 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.609 ' SD ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -87.59 97.85 11.09 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.194 -0.941 . . . . 0.0 109.027 179.212 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.0 mtt -47.03 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.624 -0.672 . . . . 0.0 110.543 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.907 HG12 ' O ' ' A' ' 95' ' ' PHE . 14.7 p -88.11 125.37 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 119.456 -0.897 . . . . 0.0 110.778 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 90' ' ' ALA . 0.8 OUTLIER -98.27 27.6 4.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -0.912 . . . . 0.0 110.047 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.552 ' H ' HG22 ' A' ' 84' ' ' VAL . 13.9 t30 -92.46 36.53 1.0 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.343 -0.848 . . . . 0.0 110.362 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.572 ' C ' ' HG1' ' A' ' 88' ' ' THR . 1.1 m120 -105.09 78.15 1.37 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -0.911 . . . . 0.0 110.081 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.572 ' HG1' ' C ' ' A' ' 87' ' ' ASN . 53.2 p 45.15 -92.41 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.716 -0.615 . . . . 0.0 111.026 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.431 ' N ' ' O ' ' A' ' 87' ' ' ASN . 0.2 OUTLIER -52.76 -37.64 59.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.84 -1.163 . . . . 0.0 110.297 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 85' ' ' GLU . . . 53.33 38.48 27.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -0.954 . . . . 0.0 110.236 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -100.15 77.12 1.96 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.299 -0.876 . . . . 0.0 110.199 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.47 39.02 83.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p -60.98 -17.87 54.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -1.117 . . . . 0.0 110.511 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.18 23.61 2.94 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.907 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -59.74 100.51 0.09 Allowed 'General case' 0 N--CA 1.484 1.248 0 O-C-N 120.997 -1.296 . . . . 0.0 111.447 -179.354 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.631 HG23 ' HB3' ' A' ' 81' ' ' PRO . 4.0 m -60.23 78.05 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.343 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' A' ' 95' ' ' PHE . 2.6 p -32.99 149.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 CA-C-O 122.615 1.198 . . . . 0.0 112.183 -176.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.749 HG22 ' O ' ' A' ' 137' ' ' VAL . 5.4 p -70.29 -174.86 0.89 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.915 -175.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.868 HG23 HD22 ' A' ' 131' ' ' LEU 0.27 0.1 OUTLIER -146.44 136.61 17.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 -179.679 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.808 ' O ' HD23 ' A' ' 131' ' ' LEU . 46.7 tt0 -91.83 107.07 18.94 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 117.449 -1.7 . . . . 0.0 112.683 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.981 ' HB1' HG23 ' A' ' 105' ' ' VAL . . . -49.96 93.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.424 0.631 . . . . 0.0 110.754 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.859 ' HB3' ' O ' ' A' ' 130' ' ' ASP . . . -98.35 0.34 45.28 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.717 -1.24 . . . . 0.0 109.513 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.476 ' HB3' ' HB1' ' A' ' 121' ' ' ALA . 12.5 tt0 -82.81 13.74 3.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.062 -1.024 . . . . 0.0 111.299 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.576 ' O ' HG13 ' A' ' 105' ' ' VAL . . . 128.31 25.41 1.06 Allowed Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.31 -1.424 . . . . 0.0 112.562 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.981 HG23 ' HB1' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -161.0 118.03 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 O-C-N 120.92 -1.341 . . . . 0.0 110.742 177.087 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 101' ' ' ALA . 32.0 p -147.68 59.48 1.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.462 -1.399 . . . . 0.0 112.131 176.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.947 HG22 ' HG2' ' A' ' 114' ' ' ARG . 7.6 t -137.49 -28.02 0.92 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 120.528 -1.358 . . . . 0.0 110.706 176.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.26 -28.32 3.4 Favored Glycine 0 N--CA 1.487 2.1 0 O-C-N 121.389 -0.82 . . . . 0.0 111.797 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.08 53.46 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 120.513 -1.581 . . . . 0.0 111.782 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.554 ' CB ' HG21 ' A' ' 107' ' ' THR . 6.6 t -132.8 54.61 1.94 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 1.016 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -41.0 -24.68 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -177.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.458 ' O ' HG23 ' A' ' 116' ' ' THR . . . -78.04 -77.68 0.15 Allowed 'General case' 0 C--N 1.29 -2.017 0 O-C-N 120.289 -1.507 . . . . 0.0 109.913 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.34 -19.78 60.93 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.609 -0.682 . . . . 0.0 112.292 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.947 ' HG2' HG22 ' A' ' 107' ' ' THR . 1.4 mpt_? -95.5 -40.29 9.54 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 118.06 -1.456 . . . . 0.0 111.69 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.712 HG21 ' HB ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -67.98 -11.85 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 117.272 -1.771 . . . . 0.0 108.645 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 112' ' ' ALA . 20.7 p -83.04 -53.34 5.88 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 176.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.653 ' OG1' HG13 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -73.56 -23.44 59.97 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.805 178.753 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.799 HG23 HG11 ' A' ' 105' ' ' VAL . 2.8 t -63.43 -55.92 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.081 -1.012 . . . . 0.0 109.263 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 36.4 ptt85 -52.18 -33.3 40.01 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.719 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.422 ' N ' ' HG3' ' A' ' 119' ' ' ARG . . . -94.27 -9.49 35.91 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.826 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.511 ' CB ' ' CG2' ' A' ' 105' ' ' VAL . . . -98.49 -53.72 3.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.952 -1.093 . . . . 0.0 112.561 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.881 HD11 ' HA ' ' A' ' 48' ' ' GLU . 2.5 pp -67.93 -17.56 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.523 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.446 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . . . -107.24 74.1 0.96 Allowed 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.648 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.491 ' HB3' ' CG ' ' A' ' 127' ' ' LYS . 17.5 t70 -97.29 -63.09 1.16 Allowed 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 122.451 1.12 . . . . 0.0 110.256 178.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 126.8 -39.69 1.92 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.711 -2.156 . . . . 0.0 107.711 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -135.86 94.36 3.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.311 -1.111 . . . . 0.0 109.39 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.491 ' CG ' ' HB3' ' A' ' 124' ' ' ASP . 10.8 mmmt -136.9 57.94 17.15 Favored Pre-proline 0 C--N 1.308 -1.23 0 O-C-N 120.702 -1.249 . . . . 0.0 110.57 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.67 -16.22 52.56 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 N-CA-C 108.389 -1.427 . . . . 0.0 108.389 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.9 m -123.28 -25.38 4.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.577 -0.702 . . . . 0.0 111.373 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.859 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 2.8 t70 -78.39 10.0 3.45 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.749 -1.219 . . . . 0.0 112.428 -178.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.868 HD22 HG23 ' A' ' 99' ' ' ILE . 8.3 mt -140.32 96.56 3.06 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.687 -1.258 . . . . 0.0 108.671 178.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 0.6 OUTLIER -117.88 98.04 6.14 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.266 -0.896 . . . . 0.0 112.31 -178.045 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.822 ' HB2' ' HA ' ' A' ' 134' ' ' PRO . 0.0 OUTLIER -79.5 171.92 11.23 Favored Pre-proline 0 N--CA 1.503 2.214 0 O-C-N 121.717 -0.615 . . . . 0.0 111.305 -178.391 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.822 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 48.2 Cg_endo -73.16 130.84 21.12 Favored 'Cis proline' 0 N--CA 1.505 2.192 0 C-N-CA 123.405 -1.498 . . . . 0.0 113.432 7.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 100' ' ' GLU . . . -132.46 63.6 0.62 Allowed Glycine 0 N--CA 1.499 2.858 0 C-N-CA 119.844 -1.169 . . . . 0.0 111.88 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.505 ' O ' ' CE2' ' A' ' 138' ' ' PHE . 57.4 m80 30.46 38.45 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.986 -0.714 . . . . 0.0 112.801 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.749 ' O ' HG22 ' A' ' 98' ' ' THR . 2.2 t -108.24 132.56 55.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.553 ' CZ ' ' CG1' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -122.69 84.88 49.1 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 120.47 -1.394 . . . . 0.0 108.381 -176.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.711 ' O ' HD22 ' A' ' 140' ' ' LEU . 55.6 Cg_endo -104.3 159.33 0.21 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.961 1.774 . . . . 0.0 114.07 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.711 HD22 ' O ' ' A' ' 139' ' ' PRO . 0.5 OUTLIER -142.67 112.38 6.86 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 176.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.443 ' HB3' ' CB ' ' A' ' 81' ' ' PRO . 2.6 ptt85 -64.77 147.1 53.82 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.033 -1.042 . . . . 0.0 111.724 -176.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -129.55 132.15 46.75 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.69 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.39 143.85 27.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.171 -0.955 . . . . 0.0 109.909 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.18 100.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.407 -0.808 . . . . 0.0 109.42 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.447 ' HA2' ' NH2' ' A' ' 209' ' ' ARG . . . 88.66 20.8 46.14 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.33 13.18 61.68 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 1.01 HG22 ' HA ' ' A' ' 155' ' ' GLU . 0.3 OUTLIER -95.1 25.35 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 O-C-N 120.987 -1.302 . . . . 0.0 108.903 178.705 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.592 HD13 ' CG1' ' A' ' 206' ' ' VAL . 4.5 mm? -93.8 39.32 1.07 Allowed 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 102.36 -3.2 . . . . 0.0 102.36 172.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.547 ' H ' ' C ' ' A' ' 147' ' ' VAL . 48.8 m -102.6 92.25 4.56 Favored 'General case' 0 N--CA 1.409 -2.489 1 N-CA-C 99.002 -4.444 . . . . 0.0 99.002 177.021 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.503 ' O ' ' C ' ' A' ' 151' ' ' GLY . 0.2 OUTLIER -44.49 163.01 0.02 OUTLIER 'General case' 0 C--N 1.26 -3.316 0 CA-C-N 112.694 -2.048 . . . . 0.0 109.232 -173.728 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 150' ' ' ARG . . . -14.48 82.88 0.0 OUTLIER Glycine 0 N--CA 1.515 3.964 0 CA-C-O 124.179 1.988 . . . . 0.0 112.856 -169.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 150' ' ' ARG . . . -114.55 -157.83 11.99 Favored Glycine 0 N--CA 1.472 1.084 0 N-CA-C 106.984 -2.447 . . . . 0.0 106.984 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.404 ' HA ' ' OE1' ' A' ' 40' ' ' GLU . 1.2 m80 -92.83 -33.79 14.11 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.07 -1.253 . . . . 0.0 110.114 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.515 ' O ' HG21 ' A' ' 147' ' ' VAL . 41.6 p -97.0 -3.31 41.76 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.435 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 1.01 ' HA ' HG22 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -53.69 -32.26 51.06 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -175.318 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.593 ' CB ' HD13 ' A' ' 205' ' ' LEU . . . -113.89 5.25 16.15 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.153 -1.592 . . . . 0.0 112.336 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.819 HG22 ' C ' ' A' ' 170' ' ' GLY . 0.0 OUTLIER -89.4 -51.36 5.59 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.946 179.543 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.53 ' HA ' HD12 ' A' ' 158' ' ' ILE . 1.1 tp -90.25 -27.01 5.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 116.844 -1.942 . . . . 0.0 107.255 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.786 ' OD2' HG22 ' A' ' 206' ' ' VAL . 12.4 t70 -62.13 -23.65 66.69 Favored 'General case' 0 C--O 1.199 -1.601 0 C-N-CA 115.877 -2.329 . . . . 0.0 105.099 172.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.983 HD11 ' C ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -49.96 -45.13 51.14 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.373 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.485 ' CB ' ' HA ' ' A' ' 168' ' ' PRO . 5.7 ptt? -52.35 -36.37 53.38 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.008 176.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.758 HG21 ' CG ' ' A' ' 209' ' ' ARG . 4.5 m -79.59 -43.92 22.02 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.815 HD13 ' HA ' ' A' ' 160' ' ' LEU . 0.4 OUTLIER -35.54 -37.07 0.08 Allowed 'General case' 0 N--CA 1.517 2.907 0 CA-C-O 122.216 1.008 . . . . 0.0 109.094 178.184 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.478 ' HA ' HD21 ' A' ' 20' ' ' LEU . . . -106.93 -26.99 10.96 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.913 0.863 . . . . 0.0 108.828 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 162' ' ' THR . . . 108.93 -25.89 17.32 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -148.98 57.65 1.03 Allowed 'General case' 0 N--CA 1.505 2.297 0 C-N-CA 117.477 -1.689 . . . . 0.0 113.132 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.494 ' HB3' ' HB3' ' A' ' 46' ' ' PRO . 18.3 mmtt -129.3 73.88 81.36 Favored Pre-proline 0 C--N 1.3 -1.564 0 O-C-N 120.485 -1.385 . . . . 0.0 107.758 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.485 ' HA ' ' CB ' ' A' ' 161' ' ' MET . 39.5 Cg_endo -67.4 84.44 0.36 Allowed 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 116.236 -2.043 . . . . 0.0 110.107 -176.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.725 ' HB1' ' N ' ' A' ' 47' ' ' ALA 0.265 . . -159.56 164.43 34.27 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 176.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.819 ' C ' HG22 ' A' ' 157' ' ' THR . . . -157.63 108.88 0.38 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 118.406 -1.854 . . . . 0.0 109.969 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.84 HG12 HD22 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -133.14 92.68 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.196 -1.725 0 C-N-CA 116.952 -1.899 . . . . 0.0 109.491 177.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.844 HD11 HD12 ' A' ' 160' ' ' LEU . 10.0 mp -103.86 145.4 30.17 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.16 0.505 . . . . 0.0 109.826 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.525 ' N ' ' HB2' ' A' ' 43' ' ' MET . 1.1 t -130.73 167.54 18.66 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.112 -0.993 . . . . 0.0 110.724 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.401 ' N ' ' SG ' ' A' ' 173' ' ' CYS . 13.6 mm-40 -115.28 126.19 54.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.166 -0.959 . . . . 0.0 109.843 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.845 HD12 ' HB2' ' A' ' 188' ' ' CYS . 3.3 tm? -63.92 120.42 11.93 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.074 -1.016 . . . . 0.0 110.359 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 4.5 m -139.15 155.59 47.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 109.968 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 1.2 t-20 -106.45 163.58 12.74 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.119 -0.988 . . . . 0.0 110.026 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' HIS . 0.3 OUTLIER -90.51 6.5 43.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.407 -0.808 . . . . 0.0 110.951 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.17 16.07 25.38 Favored 'General case' 0 C--N 1.291 -1.968 0 O-C-N 121.636 -0.665 . . . . 0.0 110.205 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 61.42 21.95 60.66 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 183' ' ' ALA . 1.3 p -83.11 121.83 27.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -1.147 . . . . 0.0 110.044 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -60.54 85.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.879 . . . . 0.0 110.249 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 1.02 ' HB1' ' CB ' ' A' ' 188' ' ' CYS . . . -54.64 130.06 38.85 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.214 -0.929 . . . . 0.0 110.047 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 188' ' ' CYS . 0.6 OUTLIER -79.07 125.08 28.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.462 -0.774 . . . . 0.0 109.923 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.813 ' HB3' ' HD3' ' A' ' 186' ' ' PRO . . . -38.14 -54.03 2.72 Favored Pre-proline 0 N--CA 1.501 2.084 0 O-C-N 121.809 -0.557 . . . . 0.0 112.391 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.813 ' HD3' ' HB3' ' A' ' 185' ' ' ALA . 47.5 Cg_endo -74.15 -35.12 4.31 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.41 1.216 . . . . 0.0 111.329 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 190' ' ' GLU . 0.0 OUTLIER -83.64 -59.3 2.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.076 -1.015 . . . . 0.0 111.514 -179.006 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 188' ' ' CYS . . . . . 1.02 ' CB ' ' HB1' ' A' ' 183' ' ' ALA . 12.3 p -53.15 -40.09 64.03 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.173 -0.954 . . . . 0.0 110.231 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.756 HD11 ' HB2' ' A' ' 42' ' ' ASP . 3.7 tp -73.33 -29.09 26.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 120.703 -1.248 . . . . 0.0 108.254 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 194' ' ' LYS . 0.1 OUTLIER -58.31 -20.51 43.62 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.759 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.485 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.2 OUTLIER -76.49 -53.85 7.53 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 178.291 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.474 ' HA ' HD22 ' A' ' 57' ' ' LEU . . . -56.28 -25.6 48.82 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ASN . . . . . 0.8 ' CB ' HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -89.38 -23.61 22.15 Favored 'General case' 0 C--O 1.194 -1.863 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 190' ' ' GLU . 0.0 OUTLIER -52.07 -35.59 47.94 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 119.578 -1.951 . . . . 0.0 110.459 -178.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.5 -43.27 6.59 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 117.612 -1.635 . . . . 0.0 108.495 176.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.462 ' HB3' ' CA ' ' A' ' 28' ' ' GLY . 81.1 m-20 -103.91 56.22 0.73 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 176.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' MET . . . . . 0.551 ' N ' ' O ' ' A' ' 193' ' ' ASN . 0.4 OUTLIER -66.59 74.72 0.1 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 -172.513 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 1.096 ' HB3' HG22 ' A' ' 29' ' ' VAL . . . -131.01 99.25 4.83 Favored 'General case' 0 C--O 1.197 -1.701 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 172.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.811 HD22 ' HG2' ' A' ' 30' ' ' MET . 44.2 mt -118.21 131.57 56.37 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 119.68 -1.888 . . . . 0.0 111.448 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.641 HG13 ' N ' ' A' ' 201' ' ' THR . 0.5 OUTLIER -129.87 -159.22 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.313 -0.867 . . . . 0.0 111.352 -179.429 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.783 ' O ' HG23 ' A' ' 31' ' ' VAL . 1.7 p -125.46 177.64 6.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.488 -0.758 . . . . 0.0 109.955 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.732 HD13 ' OD2' ' A' ' 33' ' ' ASP . 1.4 tp -91.46 -44.46 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.214 -0.929 . . . . 0.0 111.752 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.528 ' N ' HG23 ' A' ' 202' ' ' ILE . 43.9 mt-10 -60.17 -61.9 2.26 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.693 -1.254 . . . . 0.0 110.223 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.462 ' CB ' ' HB3' ' A' ' 12' ' ' PRO . 2.7 m-20 -57.74 -16.95 12.71 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.366 -0.834 . . . . 0.0 110.696 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.803 HD21 HD11 ' A' ' 163' ' ' LEU . 8.4 tt -68.05 -61.15 1.99 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.236 -1.54 . . . . 0.0 110.353 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.786 HG22 ' OD2' ' A' ' 159' ' ' ASP . 2.4 t -60.93 -16.66 14.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 119.848 -1.782 . . . . 0.0 109.277 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.886 ' HB3' ' HB2' ' A' ' 12' ' ' PRO . . . -60.58 -32.77 71.86 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 105.329 -2.101 . . . . 0.0 105.329 174.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.71 ' CD2' HG11 ' A' ' 16' ' ' VAL 0.273 1.1 t80 -50.81 -41.98 57.79 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 175.101 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.758 ' CG ' HG21 ' A' ' 162' ' ' THR . 1.3 ttt85 -78.43 -62.77 1.58 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.153 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -50.41 -37.2 36.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.192 -0.943 . . . . 0.0 110.409 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 207' ' ' ALA . . . -74.75 -26.91 60.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.396 -0.815 . . . . 0.0 110.152 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 28.2 t-80 -68.65 -23.48 64.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 110.18 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -105.52 -9.17 17.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 110.677 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.6 148.06 25.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.068 -1.02 . . . . 0.0 110.223 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.409 ' O ' ' CG ' ' A' ' 215' ' ' LYS . 0.0 OUTLIER -113.36 85.35 2.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.194 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -72.46 -80.31 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.301 -0.875 . . . . 0.0 110.207 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.198 -179.979 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.23 0.538 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -84.39 55.55 3.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.912 . . . . 0.0 110.206 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -94.07 5.23 52.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.341 -0.85 . . . . 0.0 110.773 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 7' ' ' SER . 5.0 m -52.55 -23.08 5.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.938 -1.101 . . . . 0.0 110.402 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.663 HD21 HG21 ' A' ' 189' ' ' ILE . 9.3 tp -53.12 -50.58 64.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 110.26 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.047 HD22 ' CA ' ' A' ' 200' ' ' VAL . 6.3 mt -116.03 17.28 15.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.4 -0.812 . . . . 0.0 109.884 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.439 ' HB3' ' HA ' ' A' ' 4' ' ' THR . 23.2 t -77.42 -63.34 1.4 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.773 -1.204 . . . . 0.0 111.754 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.8 t -79.43 -18.22 52.66 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.126 -0.984 . . . . 0.0 110.585 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -139.68 58.42 1.61 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.606 ' HA2' HG23 ' A' ' 200' ' ' VAL . . . -168.25 97.53 0.13 Allowed Glycine 0 C--N 1.302 -1.356 0 N-CA-C 106.723 -2.551 . . . . 0.0 106.723 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.4 ' H ' ' CB ' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -127.24 138.37 32.62 Favored Pre-proline 0 C--N 1.272 -2.8 0 N-CA-C 102.523 -3.14 . . . . 0.0 102.523 177.351 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.635 ' O ' HG12 ' A' ' 16' ' ' VAL . 34.3 Cg_endo -58.82 -37.0 96.11 Favored 'Trans proline' 0 C--N 1.276 -3.257 0 O-C-N 123.123 1.065 . . . . 0.0 109.712 -177.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.34 -45.27 7.89 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -178.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -81.91 -58.43 2.98 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.259 -1.376 . . . . 0.0 111.524 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.679 ' O ' HG21 ' A' ' 200' ' ' VAL . 0.0 OUTLIER -82.65 -15.26 52.73 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 118.666 -1.214 . . . . 0.0 112.531 -178.253 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.748 ' CG2' HG13 ' A' ' 200' ' ' VAL . 1.1 t -97.94 -29.92 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 116.422 -2.111 . . . . 0.0 110.444 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -73.28 -37.06 66.38 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 115.986 -2.286 . . . . 0.0 107.037 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.853 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 5.4 t30 -74.96 -26.27 59.47 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.621 ' CB ' HD12 ' A' ' 23' ' ' LEU . . . -90.77 -17.01 27.38 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.207 -0.933 . . . . 0.0 109.598 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.907 HD13 ' OH ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -69.29 -51.5 36.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.943 -1.098 . . . . 0.0 109.605 179.472 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.457 ' HA ' ' HB2' ' A' ' 25' ' ' GLU . . . -89.49 -46.22 8.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.076 -1.015 . . . . 0.0 111.034 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.853 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -72.23 -39.54 68.42 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.148 -0.97 . . . . 0.0 111.876 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.045 HD22 ' HB2' ' A' ' 198' ' ' ALA . 56.8 mt -105.05 -24.1 12.85 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.878 -1.139 . . . . 0.0 112.664 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.981 ' NH2' HD12 ' A' ' 163' ' ' LEU . 0.4 OUTLIER -100.34 -6.2 26.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.569 -1.332 . . . . 0.0 110.714 -179.288 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 3.2 tt0 -101.25 44.4 1.01 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 118.117 -1.433 . . . . 0.0 107.949 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.02 2.67 12.43 Favored Glycine 0 C--N 1.296 -1.692 0 C-N-CA 119.911 -1.138 . . . . 0.0 112.616 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.412 ' HB3' ' HA ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -128.55 22.04 5.99 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 121.313 2.557 . . . . 0.0 115.944 -179.628 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.767 ' O ' ' HB3' ' A' ' 198' ' ' ALA . . . 97.09 108.74 2.6 Favored Glycine 0 N--CA 1.501 3.009 0 C-N-CA 117.923 -2.084 . . . . 0.0 116.819 171.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.74 HG12 HD12 ' A' ' 44' ' ' ILE . 30.7 t -140.77 122.08 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.439 -1.624 . . . . 0.0 106.814 173.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.672 ' C ' HD11 ' A' ' 44' ' ' ILE . 1.1 mtt -123.55 150.03 44.53 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 118.727 -1.189 . . . . 0.0 113.937 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.984 HG23 ' HB ' ' A' ' 202' ' ' ILE . 1.1 p -133.09 133.03 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.689 HD12 ' O ' ' A' ' 31' ' ' VAL . 0.2 OUTLIER -154.98 -74.22 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.897 . . . . 0.0 110.218 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 t0 56.96 165.87 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.363 -0.836 . . . . 0.0 110.308 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 50.97 -150.54 0.26 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.183 -0.948 . . . . 0.0 110.423 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -142.32 72.21 1.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.888 . . . . 0.0 110.169 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.77 -166.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 110.298 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.21 -57.61 0.9 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.913 . . . . 0.0 110.232 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -132.04 90.99 2.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.248 -0.907 . . . . 0.0 110.286 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -175.42 -49.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.265 -0.897 . . . . 0.0 110.162 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.419 ' O ' ' NE2' ' A' ' 153' ' ' HIS . 0.0 OUTLIER 56.87 166.02 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.353 -0.842 . . . . 0.0 110.401 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.594 ' HA2' ' HB2' ' A' ' 172' ' ' LEU . . . -158.84 33.52 0.48 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.618 ' OD1' HD13 ' A' ' 189' ' ' ILE . 7.9 m-20 -78.87 -39.61 34.74 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -176.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.671 ' HB3' ' HA ' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -85.71 59.81 5.86 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.233 -0.917 . . . . 0.0 111.233 -178.627 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.987 ' O ' HD21 ' A' ' 160' ' ' LEU . 41.9 mt -56.73 22.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.94 0 O-C-N 120.489 -1.382 . . . . 0.0 114.531 -175.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 43' ' ' MET . 32.3 m-85 -82.92 161.53 57.8 Favored Pre-proline 0 C--N 1.292 -1.919 0 O-C-N 120.344 -1.473 . . . . 0.0 110.557 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.502 ' HB3' ' CB ' ' A' ' 167' ' ' LYS . 48.0 Cg_endo -70.21 131.83 21.39 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.791 1.661 . . . . 0.0 111.434 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 1.029 ' HB3' ' HB1' ' A' ' 169' ' ' ALA . . . -61.9 -13.65 26.75 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.467 -0.771 . . . . 0.0 111.774 -178.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.815 ' HA ' ' HB3' ' A' ' 123' ' ' ALA . 0.2 OUTLIER -88.83 -8.71 53.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.038 -1.039 . . . . 0.0 109.088 178.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.456 ' O ' ' N ' ' A' ' 51' ' ' THR . 0.7 OUTLIER -133.9 57.92 1.79 Allowed 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 176.8 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . 1.052 ' O ' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -60.12 87.6 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.811 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.456 ' N ' ' O ' ' A' ' 49' ' ' THR . 13.6 m -64.88 155.59 33.7 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.608 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.862 ' CG2' HG21 ' A' ' 115' ' ' ILE . 14.1 t -71.33 -4.89 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.525 -0.734 . . . . 0.0 110.098 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.46 ' OE1' ' CZ ' ' A' ' 45' ' ' PHE . 3.1 mt-10 -57.24 -25.72 59.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.886 -1.134 . . . . 0.0 108.959 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.529 ' HG3' HG11 ' A' ' 66' ' ' VAL . 1.2 tm0? -75.72 -54.15 7.4 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.708 0.765 . . . . 0.0 110.552 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.594 ' HG2' ' HB2' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -66.36 -45.47 80.0 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.608 -178.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -54.75 -44.51 73.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.086 -1.009 . . . . 0.0 110.649 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.707 HD13 ' HG2' ' A' ' 174' ' ' GLU . 3.1 tt -67.09 -56.01 11.86 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.195 -0.941 . . . . 0.0 109.607 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.72 HG21 ' HA3' ' A' ' 64' ' ' GLY . 11.8 p -65.16 -51.77 59.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.969 -1.082 . . . . 0.0 111.441 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 55' ' ' MET . 7.7 tt -49.92 -25.68 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.053 -1.03 . . . . 0.0 109.198 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 57' ' ' LEU . 9.6 ttm180 -66.52 -61.72 1.84 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.996 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.508 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 5.6 m-70 -129.33 -11.77 4.56 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 118.108 -1.437 . . . . 0.0 114.028 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 58' ' ' THR . . . -132.06 -169.67 12.37 Favored Glycine 0 N--CA 1.498 2.796 0 O-C-N 120.468 -1.395 . . . . 0.0 112.12 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.4 t -135.28 104.75 6.0 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 101.122 -3.658 . . . . 0.0 101.122 176.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.72 ' HA3' HG21 ' A' ' 58' ' ' THR . . . -103.32 73.76 0.28 Allowed Glycine 0 C--N 1.262 -3.545 0 N-CA-C 107.781 -2.128 . . . . 0.0 107.781 -176.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.699 ' O ' HG23 ' A' ' 65' ' ' ILE . 0.6 OUTLIER -65.2 90.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.272 -2.765 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.647 HG21 ' HE3' ' A' ' 50' ' ' MET . 28.3 m -51.41 155.57 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 122.049 0.928 . . . . 0.0 113.375 -177.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 171' ' ' VAL . 61.6 m -90.37 111.7 23.02 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.651 HD21 HD13 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -88.44 91.97 9.0 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.527 ' C ' HG23 ' A' ' 70' ' ' ILE . 26.4 p -78.35 161.66 27.03 Favored 'General case' 0 C--N 1.285 -2.204 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.929 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.83 HD11 ' HG3' ' A' ' 81' ' ' PRO . 1.1 pt -151.48 147.84 15.11 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.64 HG22 ' HB2' ' A' ' 75' ' ' ARG . 10.3 t -79.89 172.21 14.09 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 120.294 -1.504 . . . . 0.0 107.939 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.489 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -92.46 -10.98 35.92 Favored 'General case' 0 C--N 1.276 -2.587 0 O-C-N 121.321 -0.862 . . . . 0.0 109.855 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.95 -72.67 0.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.751 -1.218 . . . . 0.0 111.9 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.441 ' NH1' ' HB2' ' A' ' 126' ' ' ALA . 2.1 mtt-85 -87.8 -35.27 17.93 Favored 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 119.346 -0.942 . . . . 0.0 109.137 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.64 ' HB2' HG22 ' A' ' 71' ' ' THR . 3.0 mmt180 -69.7 -31.29 69.23 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.004 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.489 ' CG ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -69.76 -44.22 70.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.236 -1.54 . . . . 0.0 109.075 178.6 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -41.88 -55.11 3.2 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.768 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.991 HD13 ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -104.97 -27.97 11.36 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 117.673 -1.611 . . . . 0.0 110.149 178.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.991 ' N ' HD13 ' A' ' 78' ' ' LEU . 22.6 t0 -115.8 72.9 0.82 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.793 -1.192 . . . . 0.0 110.115 176.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.728 ' O ' HG11 ' A' ' 97' ' ' VAL . 13.9 tp -80.42 121.25 81.32 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.568 -1.332 . . . . 0.0 109.301 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.83 ' HG3' HD11 ' A' ' 70' ' ' ILE . 54.0 Cg_endo -89.4 93.81 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.573 1.301 . . . . 0.0 109.596 178.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.491 ' H ' HG21 ' A' ' 97' ' ' VAL . 1.2 ttt -96.84 42.95 1.08 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.172 -0.955 . . . . 0.0 109.879 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.504 ' HA ' ' CA ' ' A' ' 96' ' ' THR . 0.0 OUTLIER 16.8 107.99 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.661 HG13 ' O ' ' A' ' 84' ' ' VAL . 7.2 p -154.24 93.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 117.277 -1.769 . . . . 0.0 112.635 176.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -108.84 9.08 26.84 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.772 -1.171 . . . . 0.0 108.35 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 88' ' ' THR . 64.8 t-20 -136.62 81.59 1.89 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.758 ' O ' HG23 ' A' ' 88' ' ' THR . 11.9 t30 -44.52 87.79 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 119.286 0.948 . . . . 0.0 111.705 -178.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.758 HG23 ' O ' ' A' ' 87' ' ' ASN . 0.0 OUTLIER 176.04 -88.28 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.424 -0.797 . . . . 0.0 110.825 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.626 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -103.27 -45.13 4.98 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.872 -1.143 . . . . 0.0 112.74 -178.356 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 89' ' ' SER . . . 71.5 149.28 0.09 Allowed 'General case' 0 N--CA 1.511 2.618 0 O-C-N 121.131 -0.981 . . . . 0.0 109.995 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -94.0 15.55 16.64 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.112 -0.993 . . . . 0.0 112.1 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 62.36 15.46 52.03 Favored Glycine 0 N--CA 1.497 2.761 0 O-C-N 120.903 -1.123 . . . . 0.0 111.943 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.431 ' CB ' ' HG3' ' A' ' 83' ' ' MET . 0.2 OUTLIER -64.06 -11.55 30.58 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.626 -1.514 . . . . 0.0 110.569 179.198 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.503 ' N ' ' HB2' ' A' ' 83' ' ' MET . . . 50.29 11.02 0.38 Allowed Glycine 0 N--CA 1.5 2.94 0 O-C-N 121.296 -0.877 . . . . 0.0 113.907 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.75 ' CD2' HD22 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -123.99 34.75 4.98 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 120.589 2.194 . . . . 0.0 110.638 178.603 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.504 ' CA ' ' HA ' ' A' ' 83' ' ' MET . 0.7 OUTLIER -133.73 37.38 3.28 Favored 'General case' 0 N--CA 1.515 2.809 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -179.623 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.728 HG11 ' O ' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -115.52 110.29 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 O-C-N 120.546 -1.346 . . . . 0.0 110.319 178.283 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.811 HG22 ' O ' ' A' ' 137' ' ' VAL . 14.9 p -75.45 177.19 6.86 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.123 -0.985 . . . . 0.0 110.439 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.081 HD12 HD13 ' A' ' 131' ' ' LEU . 27.9 pt -142.31 135.81 28.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 132' ' ' ASN . 10.9 tt0 -86.17 113.37 22.15 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 117.072 -1.851 . . . . 0.0 110.961 -176.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.908 ' HB1' HG13 ' A' ' 105' ' ' VAL . . . -53.02 91.7 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.648 0.737 . . . . 0.0 109.929 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.534 ' H ' HD23 ' A' ' 131' ' ' LEU . . . -106.29 -0.43 24.39 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.407 -0.808 . . . . 0.0 110.504 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.45 ' HB3' ' HB1' ' A' ' 121' ' ' ALA . 27.6 tt0 -86.89 26.97 1.05 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.915 -1.115 . . . . 0.0 111.896 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.645 ' C ' HG21 ' A' ' 117' ' ' THR . . . 126.94 -38.68 2.11 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.422 -1.37 . . . . 0.0 111.466 178.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.908 HG13 ' HB1' ' A' ' 101' ' ' ALA . 5.4 p -101.39 125.7 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.104 -1.233 . . . . 0.0 110.331 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.5 m -143.06 59.62 1.41 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.853 -1.155 . . . . 0.0 110.565 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.9 m -137.27 -30.76 0.84 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.091 -1.005 . . . . 0.0 110.564 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.417 ' CA ' ' CE1' ' A' ' 136' ' ' HIS . . . 78.62 -30.81 1.95 Allowed Glycine 0 N--CA 1.494 2.52 0 O-C-N 121.565 -0.71 . . . . 0.0 111.329 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.17 58.57 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.85 -1.383 . . . . 0.0 109.347 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -128.23 57.49 1.57 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.298 -0.876 . . . . 0.0 109.057 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.594 ' HB2' ' HG2' ' A' ' 55' ' ' MET . . . -33.48 -29.95 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -81.05 -76.94 0.22 Allowed 'General case' 0 C--N 1.291 -1.972 0 O-C-N 120.893 -1.129 . . . . 0.0 110.13 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.81 -13.94 62.71 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.563 -0.711 . . . . 0.0 111.18 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.586 ' HE ' HG21 ' A' ' 118' ' ' VAL . 0.1 OUTLIER -89.65 -44.44 10.05 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.96 -1.087 . . . . 0.0 110.506 -179.671 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 1.052 HG23 ' O ' ' A' ' 50' ' ' MET . 18.4 mm -64.6 -16.92 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.668 -1.213 . . . . 0.0 110.739 -178.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 68.8 p -88.28 -53.45 4.69 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.866 -1.133 . . . . 0.0 108.704 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.645 HG21 ' C ' ' A' ' 104' ' ' GLY . 60.0 m -71.39 -43.19 67.31 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.544 -0.863 . . . . 0.0 110.004 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.586 HG21 ' HE ' ' A' ' 114' ' ' ARG . 4.4 p -52.72 -40.13 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 120.577 -1.327 . . . . 0.0 109.866 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 54.2 ttt180 -51.31 -53.47 35.64 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.851 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -99.29 -6.99 27.01 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 117' ' ' THR . . . -98.35 -26.36 14.52 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 116.056 1.872 . . . . 0.0 116.056 -174.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.716 HD12 ' N ' ' A' ' 123' ' ' ALA . 2.6 pp -121.02 -37.7 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 121.112 1.778 . . . . 0.0 112.091 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.815 ' HB3' ' HA ' ' A' ' 48' ' ' GLU . . . -103.98 75.26 1.27 Allowed 'General case' 0 C--N 1.263 -3.166 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.392 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.479 ' CB ' ' CD ' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -97.27 -54.96 2.99 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.297 1.046 . . . . 0.0 110.154 177.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 124.07 -39.94 2.05 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 105.729 -2.949 . . . . 0.0 105.729 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.441 ' HB2' ' NH1' ' A' ' 74' ' ' ARG . . . -134.63 96.76 3.63 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 175.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.479 ' CD ' ' CB ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -131.75 123.45 19.22 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 120.857 -1.152 . . . . 0.0 113.373 -176.267 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.456 ' HD2' ' CE ' ' A' ' 127' ' ' LYS . 51.8 Cg_endo -81.38 21.02 0.95 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.656 1.345 . . . . 0.0 108.79 175.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 131' ' ' LEU . 2.0 m -92.9 42.29 1.1 Allowed 'General case' 0 C--O 1.202 -1.418 0 O-C-N 121.412 -0.805 . . . . 0.0 109.018 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -26.51 79.37 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 123.991 1.853 . . . . 0.0 111.798 -176.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 1.081 HD13 HD12 ' A' ' 99' ' ' ILE 0.255 5.4 mt -61.44 125.35 23.48 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 112.069 -2.332 . . . . 0.0 108.047 -178.148 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 15.7 p-10 -113.68 99.51 7.78 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.409 -0.807 . . . . 0.0 111.738 -177.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.843 ' HB2' ' HA ' ' A' ' 134' ' ' PRO 0.282 0.5 OUTLIER -82.58 -178.43 1.18 Allowed Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 122.031 -0.418 . . . . 0.0 111.203 -177.611 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.843 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 48.5 Cg_endo -72.69 123.39 8.23 Favored 'Cis proline' 0 N--CA 1.503 2.063 0 C-N-CA 123.674 -1.386 . . . . 0.0 113.327 8.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.747 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -124.04 60.03 0.61 Allowed Glycine 0 N--CA 1.5 2.907 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.105 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.472 ' O ' ' CE2' ' A' ' 138' ' ' PHE . 25.5 p80 32.1 37.97 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.665 0 O-C-N 121.745 -0.856 . . . . 0.0 112.271 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.811 ' O ' HG22 ' A' ' 98' ' ' THR . 54.4 t -91.04 154.87 3.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.617 ' CD1' ' O ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -123.6 84.06 53.37 Favored Pre-proline 0 C--N 1.281 -2.376 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 -178.32 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.859 ' O ' HD23 ' A' ' 140' ' ' LEU . 54.9 Cg_endo -98.42 140.84 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.737 1.388 . . . . 0.0 113.674 -176.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.859 HD23 ' O ' ' A' ' 139' ' ' PRO . 36.1 mt -136.7 112.8 9.73 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.463 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.416 ' CD ' ' HG2' ' A' ' 81' ' ' PRO . 11.1 ttt180 -69.95 127.0 31.36 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.085 -1.009 . . . . 0.0 109.874 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.83 ' HB3' ' CG2' ' A' ' 158' ' ' ILE . . . -132.75 133.19 43.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.063 -1.023 . . . . 0.0 111.329 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -58.84 143.09 48.56 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.247 -0.908 . . . . 0.0 109.532 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.27 106.27 5.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.421 -0.799 . . . . 0.0 110.568 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 86.54 20.98 53.03 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.83 12.85 62.57 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.825 HG21 ' HB2' ' A' ' 156' ' ' ALA . 13.6 p -104.57 18.76 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.972 -1.311 . . . . 0.0 109.427 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.906 HD11 ' HA ' ' A' ' 207' ' ' ALA . 3.7 mm? -94.86 20.39 8.88 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 117.331 -1.748 . . . . 0.0 108.306 176.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 151' ' ' GLY . 29.4 m -126.99 73.46 1.42 Allowed 'General case' 0 C--N 1.29 -1.987 1 N-CA-C 96.183 -5.488 . . . . 0.0 96.183 168.515 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.748 ' HG2' HG21 ' A' ' 206' ' ' VAL . 0.1 OUTLIER -67.21 71.85 0.11 Allowed 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 113.553 -1.658 . . . . 0.0 115.033 -168.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 149' ' ' THR . . . -116.93 28.68 7.21 Favored Glycine 0 N--CA 1.475 1.281 0 N-CA-C 105.611 -2.996 . . . . 0.0 105.611 169.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -148.74 131.38 3.72 Favored Glycine 0 C--N 1.303 -1.265 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.535 ' CE1' ' HA3' ' A' ' 41' ' ' GLY . 1.6 t60 -89.79 -5.37 56.99 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.537 HG23 ' N ' ' A' ' 155' ' ' GLU . 14.9 t -93.38 -46.51 7.31 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.225 -0.922 . . . . 0.0 110.821 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.746 ' HG3' HG23 ' A' ' 147' ' ' VAL . 1.2 pt-20 -59.61 -20.73 57.94 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.825 ' HB2' HG21 ' A' ' 147' ' ' VAL . . . -86.77 5.66 35.34 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 121.356 -0.84 . . . . 0.0 108.943 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.52 ' O ' ' CB ' ' A' ' 160' ' ' LEU . 2.5 m -87.05 -51.12 6.19 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.83 ' CG2' ' HB3' ' A' ' 142' ' ' ALA . 4.4 tp -74.39 -17.44 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 115.96 -2.296 . . . . 0.0 106.404 175.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.693 ' CG ' HG11 ' A' ' 147' ' ' VAL . 18.9 t70 -62.21 -29.84 70.67 Favored 'General case' 0 C--O 1.206 -1.215 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 173.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.987 HD21 ' O ' ' A' ' 44' ' ' ILE . 1.7 tm? -50.23 -43.75 53.05 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 176.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.567 ' HB2' ' HA ' ' A' ' 168' ' ' PRO . 0.0 OUTLIER -52.76 -36.21 57.6 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.75 178.508 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.633 HG21 ' HD2' ' A' ' 209' ' ' ARG . 1.5 m -93.17 -51.44 5.02 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 1.075 HD22 HD21 ' A' ' 205' ' ' LEU . 1.8 pp -57.41 -14.47 4.85 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.501 -1.374 . . . . 0.0 111.679 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -77.16 -30.78 55.15 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 120.593 -1.317 . . . . 0.0 108.392 176.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 106.27 -35.43 5.05 Favored Glycine 0 N--CA 1.493 2.475 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.326 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.74 48.19 0.39 Allowed 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 117.792 -1.563 . . . . 0.0 113.097 172.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 161' ' ' MET . 40.4 mmtt -135.95 83.46 34.26 Favored Pre-proline 0 C--N 1.289 -2.061 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 174.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.567 ' HA ' ' HB2' ' A' ' 161' ' ' MET . 44.5 Cg_endo -73.65 81.02 1.91 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 114.781 -3.013 . . . . 0.0 113.798 -173.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 1.029 ' HB1' ' HB3' ' A' ' 47' ' ' ALA . . . -165.76 168.38 16.12 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 171.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.428 ' HA3' ' HB3' ' A' ' 160' ' ' LEU . . . -156.99 129.02 2.29 Favored Glycine 0 N--CA 1.504 3.184 0 C-N-CA 118.28 -1.914 . . . . 0.0 110.276 177.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.985 HG13 ' HB2' ' A' ' 47' ' ' ALA . 6.5 m -141.42 101.43 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.962 HD22 ' HA ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -125.86 101.08 6.67 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 117.177 -1.809 . . . . 0.0 115.045 -176.165 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.489 ' HB3' ' CA ' ' A' ' 64' ' ' GLY . 1.1 m -140.79 141.87 34.74 Favored 'General case' 0 N--CA 1.514 2.736 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 173.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.707 ' HG2' HD13 ' A' ' 57' ' ' LEU . 3.5 tt0 176.82 87.32 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.33 0 CA-C-N 122.632 2.469 . . . . 0.0 115.473 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.783 HD13 ' N ' ' A' ' 176' ' ' THR . 0.3 OUTLIER -128.2 135.0 49.12 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 120.452 -1.405 . . . . 0.0 109.108 175.331 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.783 ' N ' HD13 ' A' ' 175' ' ' LEU . 6.2 t -131.13 92.46 3.21 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.762 -1.211 . . . . 0.0 110.312 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.485 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 4.4 t-20 -121.81 142.25 50.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.425 -1.422 . . . . 0.0 111.385 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.487 ' HA ' ' CE1' ' A' ' 61' ' ' HIS . 9.7 p-10 -80.37 6.44 12.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.078 -1.013 . . . . 0.0 111.345 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.74 -18.68 28.9 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 121.453 -0.78 . . . . 0.0 110.119 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 76.41 23.4 70.79 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 183' ' ' ALA . 69.4 p -128.5 98.83 5.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.299 -1.118 . . . . 0.0 110.177 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.37 76.47 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 110.44 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 188' ' ' CYS . . . -54.77 131.43 43.83 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.355 -0.841 . . . . 0.0 109.935 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.588 ' O ' ' HB2' ' A' ' 185' ' ' ALA . 9.5 mtt-85 -105.26 100.15 9.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.341 -0.85 . . . . 0.0 109.825 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.859 ' HB1' ' HD2' ' A' ' 186' ' ' PRO . . . 172.92 178.93 0.12 Allowed Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.309 -0.869 . . . . 0.0 109.831 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.859 ' HD2' ' HB1' ' A' ' 185' ' ' ALA . 43.0 Cg_endo -69.5 -7.72 21.72 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.303 1.159 . . . . 0.0 110.422 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.5 -41.66 19.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.972 -1.08 . . . . 0.0 109.992 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' CYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 183' ' ' ALA . 16.8 p -67.43 -36.32 80.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.966 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.663 HG21 HD21 ' A' ' 5' ' ' LEU . 5.2 tp -73.98 -28.33 23.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.754 -1.216 . . . . 0.0 109.079 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.527 ' HA ' ' HB3' ' A' ' 193' ' ' ASN . 35.9 tt0 -71.05 -19.01 62.54 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.721 0.772 . . . . 0.0 109.05 177.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.497 ' CE2' ' O ' ' A' ' 176' ' ' THR . 0.7 OUTLIER -75.99 -48.42 21.12 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.128 0.966 . . . . 0.0 109.513 -179.413 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.474 ' C ' ' HB2' ' A' ' 197' ' ' MET . . . -73.79 -35.35 64.92 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 178.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ASN . . . . . 0.655 ' CB ' HD11 ' A' ' 199' ' ' LEU . 1.7 t30 -56.33 -23.36 36.72 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.3 -40.92 20.81 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 118.099 -1.441 . . . . 0.0 112.741 -176.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.25 -56.03 2.6 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 114.966 -2.694 . . . . 0.0 112.055 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' A' ' 197' ' ' MET . 0.1 OUTLIER -117.05 33.74 5.46 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.073 -1.451 . . . . 0.0 113.773 176.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 197' ' ' MET . . . . . 0.675 ' HE2' HD12 ' A' ' 57' ' ' LEU . 15.3 mmt -150.35 151.69 33.25 Favored 'General case' 0 N--CA 1.517 2.896 0 CA-C-N 123.034 2.652 . . . . 0.0 114.53 -178.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 1.045 ' HB2' HD22 ' A' ' 23' ' ' LEU . . . -111.59 155.73 22.89 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.033 -1.042 . . . . 0.0 108.916 177.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.655 HD11 ' CB ' ' A' ' 193' ' ' ASN . 48.1 mt -125.58 133.19 52.36 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 120.552 -1.342 . . . . 0.0 109.676 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 1.047 ' CA ' HD22 ' A' ' 6' ' ' LEU . 1.3 p -170.82 18.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.521 -1.362 . . . . 0.0 113.287 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' THR . . . . . 1.006 HG23 HD22 ' A' ' 205' ' ' LEU 0.271 87.0 m -133.33 150.24 51.87 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 -176.149 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.984 ' HB ' HG23 ' A' ' 31' ' ' VAL . 3.6 tp 149.85 -76.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.844 0 C-N-CA 124.99 1.316 . . . . 0.0 109.704 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.794 ' H ' HG23 ' A' ' 202' ' ' ILE . 1.9 tt0 -93.79 -59.56 1.96 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.337 -1.477 . . . . 0.0 110.723 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.33 -50.32 73.42 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.225 -0.922 . . . . 0.0 111.508 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 1.075 HD21 HD22 ' A' ' 163' ' ' LEU . 3.2 tt -60.5 -23.63 64.68 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.069 -1.019 . . . . 0.0 113.244 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.748 HG21 ' HG2' ' A' ' 150' ' ' ARG . 16.5 m -77.98 -34.82 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 119.65 -1.906 . . . . 0.0 108.14 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.906 ' HA ' HD11 ' A' ' 148' ' ' LEU . . . -68.82 -14.62 63.14 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 174.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.907 ' OH ' HD13 ' A' ' 20' ' ' LEU . 7.6 t80 -81.71 -26.71 34.38 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.798 -0.563 . . . . 0.0 109.608 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.633 ' HD2' HG21 ' A' ' 162' ' ' THR . 0.2 OUTLIER -75.82 -25.77 56.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.096 -1.003 . . . . 0.0 108.69 177.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.503 ' N ' ' HG3' ' A' ' 209' ' ' ARG . 6.8 tt0 -82.72 -59.15 2.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.412 -0.805 . . . . 0.0 109.885 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -51.77 -27.1 11.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.485 -0.759 . . . . 0.0 110.223 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -75.37 -44.62 43.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 109.999 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLU . . . . . 0.413 ' OE1' ' CG2' ' A' ' 162' ' ' THR . 2.6 mt-10 -86.27 -9.26 56.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.32 -0.862 . . . . 0.0 110.59 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -111.06 148.08 33.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.001 -1.062 . . . . 0.0 110.205 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.08 104.8 4.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.176 -0.953 . . . . 0.0 110.292 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . 53.11 -173.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.333 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.225 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.299 0.571 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.404 ' O ' ' HG ' ' A' ' 5' ' ' LEU . 1.9 t-20 -88.18 58.09 4.6 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.904 . . . . 0.0 110.196 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 17.5 pt20 -71.41 -16.11 62.38 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.253 -0.904 . . . . 0.0 110.881 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 5' ' ' LEU . 1.5 p -64.42 -2.68 2.4 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.977 -1.077 . . . . 0.0 112.411 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.917 HD13 ' CE1' ' A' ' 13' ' ' PHE . 3.7 mt -28.8 -71.39 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.876 HD21 ' HG ' ' A' ' 163' ' ' LEU . 0.4 OUTLIER -120.25 -49.42 2.28 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 117.399 -1.72 . . . . 0.0 115.172 -179.742 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.469 ' CB ' ' CG2' ' A' ' 11' ' ' THR . 1.6 t -100.49 -88.77 0.35 Allowed 'General case' 0 N--CA 1.51 2.563 0 CA-C-N 123.121 2.691 . . . . 0.0 111.33 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.414 ' N ' ' OG ' ' A' ' 7' ' ' SER . 75.7 p -116.66 -62.68 1.55 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 117.926 -1.51 . . . . 0.0 109.281 174.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.452 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 47.4 p90 -162.06 30.27 0.12 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.187 174.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.57 95.22 0.1 OUTLIER Glycine 0 N--CA 1.483 1.768 0 C-N-CA 118.625 -1.75 . . . . 0.0 109.826 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.584 ' C ' ' N ' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -130.2 164.04 43.62 Favored Pre-proline 0 C--N 1.273 -2.751 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 178.461 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 14' ' ' GLU . 20.5 Cg_endo -46.23 -16.12 0.21 Allowed 'Trans proline' 0 N--CA 1.508 2.334 0 N-CA-C 106.551 -2.134 . . . . 0.0 106.551 174.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.917 ' CE1' HD13 ' A' ' 5' ' ' LEU 0.27 16.1 t80 -40.15 -26.83 0.03 OUTLIER 'General case' 0 C--O 1.184 -2.352 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.733 169.098 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 17' ' ' GLU . 1.0 OUTLIER -43.09 -38.14 2.26 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.085 -1.634 . . . . 0.0 109.082 179.28 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.7 mmt-85 -61.78 -46.37 89.87 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 176.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.803 HG21 ' CE2' ' A' ' 208' ' ' TYR . 15.7 m -79.34 -12.67 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 C-N-CA 117.684 -1.606 . . . . 0.0 109.875 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 35.1 tt0 -53.88 -34.54 59.73 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -79.11 -33.08 44.69 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.744 ' O ' ' HB3' ' A' ' 22' ' ' ALA . . . -70.49 -64.87 0.81 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.5 -0.75 . . . . 0.0 110.834 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.803 HD13 ' HE2' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -54.66 -43.95 72.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.2 -0.938 . . . . 0.0 109.127 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 17' ' ' GLU . . . -53.68 -28.37 33.03 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.744 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . -78.24 -33.52 49.7 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 3.8 tt -44.52 -28.04 0.53 Allowed 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.84 0.829 . . . . 0.0 109.582 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.53 -30.84 12.64 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 0.2 OUTLIER -147.7 82.65 1.52 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 123.439 1.59 . . . . 0.0 108.191 177.457 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.657 ' O ' ' HB1' ' A' ' 22' ' ' ALA . . . 126.57 50.64 0.17 Allowed Glycine 0 C--N 1.275 -2.821 1 N-CA-C 102.076 -4.409 . . . . 0.0 102.076 -174.882 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.803 ' CD ' HG21 ' A' ' 51' ' ' THR . 3.1 mtm180 -55.92 91.16 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 122.942 1.353 . . . . 0.0 110.429 -173.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.463 ' HA3' ' HG2' ' A' ' 197' ' ' MET . . . 176.48 105.95 0.19 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.124 -1.512 . . . . 0.0 113.189 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.012 HG13 HG12 ' A' ' 44' ' ' ILE . 1.1 p -140.34 99.21 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.71 ' HB2' HD23 ' A' ' 199' ' ' LEU . 4.9 mtt -97.96 130.42 44.82 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.864 -1.147 . . . . 0.0 114.072 -173.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 1.092 HG12 HD13 ' A' ' 205' ' ' LEU . 35.6 m -77.35 90.5 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.4 -0.812 . . . . 0.0 109.707 177.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.716 HD21 ' HA ' ' A' ' 186' ' ' PRO . 0.4 OUTLIER -56.39 127.81 32.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.985 -1.072 . . . . 0.0 110.396 -179.668 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.686 ' N ' HD13 ' A' ' 32' ' ' LEU . 1.7 t70 -99.11 156.35 16.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.183 -0.948 . . . . 0.0 110.189 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -99.8 173.31 6.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 110.243 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 53.2 -178.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.336 -0.852 . . . . 0.0 110.212 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.27 114.38 28.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 110.202 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -138.15 175.33 9.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 110.167 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -103.51 49.49 0.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.328 -0.858 . . . . 0.0 110.238 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -175.25 135.13 0.33 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.203 -0.936 . . . . 0.0 110.279 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.469 ' O ' ' CG ' ' A' ' 153' ' ' HIS . 34.2 mt-10 -137.94 -71.77 0.42 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 110.209 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.93 ' O ' HG22 ' A' ' 31' ' ' VAL . . . 100.96 55.66 0.92 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.776 ' OD2' HD12 ' A' ' 189' ' ' ILE . 5.2 m-20 -78.92 -37.88 38.72 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.169 -1.195 . . . . 0.0 111.834 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.941 ' HE3' HD22 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -85.87 54.41 3.12 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.511 -0.743 . . . . 0.0 110.382 -179.173 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.012 HG12 HG13 ' A' ' 29' ' ' VAL . 3.0 pt -63.77 26.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.534 3.763 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 -175.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.965 ' O ' HG22 ' A' ' 171' ' ' VAL . 9.7 m-85 -67.81 161.68 64.68 Favored Pre-proline 0 C--N 1.283 -2.309 0 O-C-N 121.372 -0.83 . . . . 0.0 112.193 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.478 ' HB3' ' HB3' ' A' ' 167' ' ' LYS . 45.6 Cg_endo -68.83 129.58 18.87 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.524 1.483 . . . . 0.0 110.52 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.54 ' N ' ' HB1' ' A' ' 169' ' ' ALA . . . -70.47 -2.59 14.38 Favored 'General case' 0 N--CA 1.508 2.441 0 C-N-CA 119.195 -1.002 . . . . 0.0 112.554 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -85.73 -23.55 27.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.737 -1.227 . . . . 0.0 109.315 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.57 ' O ' HG22 ' A' ' 49' ' ' THR . 51.7 m -132.42 60.56 1.69 Allowed 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 177.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.411 ' O ' HG13 ' A' ' 115' ' ' ILE . 0.4 OUTLIER -52.48 88.09 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.263 0.554 . . . . 0.0 110.056 -178.739 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.803 HG21 ' CD ' ' A' ' 27' ' ' ARG . 1.6 m -66.18 153.42 42.48 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.616 0.722 . . . . 0.0 109.777 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.985 HG23 ' HB1' ' A' ' 111' ' ' ALA . 1.7 p -73.91 -3.78 4.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.569 -0.707 . . . . 0.0 109.668 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.427 ' CG ' ' HB2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -55.8 -32.63 63.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.742 -1.224 . . . . 0.0 108.53 179.287 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.48 ' HB3' ' CD2' ' A' ' 45' ' ' PHE . 5.3 pt20 -81.18 -32.89 33.38 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.51 0.671 . . . . 0.0 110.118 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.763 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -82.22 -46.42 13.75 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.38 -0.825 . . . . 0.0 110.263 -179.782 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.659 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -54.07 -45.05 71.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.951 -1.093 . . . . 0.0 110.142 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 1.073 HD21 HD12 ' A' ' 175' ' ' LEU . 7.3 tt -60.98 -53.21 60.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.384 -0.823 . . . . 0.0 110.359 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.568 ' N ' HD23 ' A' ' 57' ' ' LEU . 8.3 t -74.75 -47.44 31.16 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.422 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.517 ' N ' HG23 ' A' ' 58' ' ' THR . 40.8 mt -46.54 -26.03 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 120.649 -1.282 . . . . 0.0 110.222 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.49 -47.62 17.01 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.385 -0.822 . . . . 0.0 110.785 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.43 ' O ' ' HA ' ' A' ' 177' ' ' ASN . 1.9 m-70 -125.18 -7.01 7.1 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.636 -1.29 . . . . 0.0 114.068 -178.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 58' ' ' THR . . . -157.05 -168.23 19.32 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 120.503 -1.373 . . . . 0.0 111.005 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.69 103.77 5.32 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 102.273 -3.232 . . . . 0.0 102.273 176.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.442 ' N ' ' OG1' ' A' ' 58' ' ' THR . . . -104.48 73.03 0.25 Allowed Glycine 0 C--N 1.264 -3.439 0 N-CA-C 106.381 -2.687 . . . . 0.0 106.381 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.841 HG23 ' CZ ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -65.72 90.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.031 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.488 HG21 ' HB ' ' A' ' 171' ' ' VAL . 29.3 m -52.79 150.63 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.003 -177.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.546 ' O ' HG21 ' A' ' 157' ' ' THR . 82.8 m -77.6 119.17 20.79 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 139' ' ' PRO . 0.6 OUTLIER -90.06 92.07 8.82 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 118.617 -1.233 . . . . 0.0 108.551 -179.723 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.541 ' O ' HD13 ' A' ' 158' ' ' ILE . 0.5 OUTLIER -87.57 145.51 26.18 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 122.339 1.066 . . . . 0.0 112.576 -178.062 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.555 HD12 ' O ' ' A' ' 79' ' ' ASP . 9.9 pt -137.58 138.89 44.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.743 HG23 ' HB3' ' A' ' 143' ' ' GLN . 50.0 m -78.59 143.18 36.69 Favored 'General case' 0 C--O 1.199 -1.588 0 O-C-N 120.549 -1.344 . . . . 0.0 108.769 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.451 ' HB3' ' NE ' ' A' ' 141' ' ' ARG . 6.1 pt-20 -41.53 -25.94 0.06 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.788 -0.57 . . . . 0.0 111.799 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.543 ' H ' HG22 ' A' ' 71' ' ' THR . 0.2 OUTLIER -84.46 -49.64 8.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.953 . . . . 0.0 110.496 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -80.83 -25.5 37.71 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.079 0.942 . . . . 0.0 108.666 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.568 ' O ' ' N ' ' A' ' 79' ' ' ASP . 6.5 ttp180 -59.01 -67.99 0.31 Allowed 'General case' 0 C--O 1.19 -2.028 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.473 ' HA ' ' CB ' ' A' ' 80' ' ' LEU . 0.4 OUTLIER -48.66 -55.13 12.17 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.244 -178.352 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -30.01 -50.34 0.12 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 124.362 1.039 . . . . 0.0 111.363 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.734 HD12 HG23 ' A' ' 122' ' ' ILE . 1.6 tm? -134.78 -30.26 1.1 Allowed 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 118.286 -1.365 . . . . 0.0 111.48 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.568 ' N ' ' O ' ' A' ' 75' ' ' ARG . 58.7 m-20 -116.87 69.32 0.75 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.895 -1.128 . . . . 0.0 110.725 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.772 ' O ' HG13 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -74.73 169.39 20.14 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 120.766 -1.209 . . . . 0.0 111.66 -179.114 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.877 ' HA ' HG22 ' A' ' 97' ' ' VAL . 39.7 Cg_endo -65.77 113.33 2.5 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 O-C-N 122.551 0.764 . . . . 0.0 110.809 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.489 ' O ' HG13 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -95.67 43.46 1.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 0.0 110.768 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.426 ' C ' ' O ' ' A' ' 82' ' ' MET . 3.9 ptt? 26.94 62.4 0.09 Allowed 'General case' 0 N--CA 1.51 2.532 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.546 ' CG2' ' HA ' ' A' ' 96' ' ' THR . 19.1 m -104.08 130.51 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.833 -1.167 . . . . 0.0 110.235 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -98.26 29.47 3.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 110.231 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -90.04 19.66 4.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.305 -0.872 . . . . 0.0 110.535 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 49.6 p30 -105.24 54.89 0.7 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.138 -0.977 . . . . 0.0 110.134 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.5 m -106.45 -64.7 1.14 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.108 -0.995 . . . . 0.0 110.268 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.78 -22.62 9.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.939 . . . . 0.0 110.175 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.709 ' HB1' ' CG2' ' A' ' 93' ' ' THR . . . -69.28 163.95 23.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 110.224 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -114.23 77.08 1.03 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -0.9 . . . . 0.0 110.411 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.417 ' HA3' ' NH2' ' A' ' 150' ' ' ARG . . . 77.02 39.18 28.36 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.709 ' CG2' ' HB1' ' A' ' 90' ' ' ALA . 45.4 p -89.36 -16.13 31.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.226 -1.161 . . . . 0.0 110.548 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.14 21.95 2.02 Favored Glycine 0 N--CA 1.493 2.446 0 O-C-N 121.355 -0.841 . . . . 0.0 111.241 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' A' ' 139' ' ' PRO . 21.9 m-30 -60.83 99.1 0.08 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.658 -1.495 . . . . 0.0 108.776 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.578 HG23 HG23 ' A' ' 97' ' ' VAL . 8.8 t -122.25 -1.15 9.24 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 117.974 -1.49 . . . . 0.0 114.762 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.877 HG22 ' HA ' ' A' ' 81' ' ' PRO . 57.0 t -119.14 79.88 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.619 0 C-N-CA 119.476 -0.889 . . . . 0.0 112.371 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.59 ' HA ' ' HB ' ' A' ' 137' ' ' VAL . 46.0 p -74.92 144.98 43.02 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 119.844 -1.785 . . . . 0.0 107.257 177.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.944 HG13 HG21 ' A' ' 137' ' ' VAL . 2.2 pt -146.86 125.31 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.121 -0.987 . . . . 0.0 110.568 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.591 ' O ' HD23 ' A' ' 131' ' ' LEU . 6.9 tt0 -93.14 108.85 20.37 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 117.621 -1.632 . . . . 0.0 109.511 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.99 ' HB1' HG13 ' A' ' 105' ' ' VAL . . . -50.99 93.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.362 -0.836 . . . . 0.0 110.804 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 100' ' ' GLU . . . -84.18 2.49 39.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.452 -0.78 . . . . 0.0 110.428 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.72 4.21 14.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.993 -1.067 . . . . 0.0 110.702 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.14 26.98 1.16 Allowed Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.76 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.99 HG13 ' HB1' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -146.19 122.53 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.173 -1.192 . . . . 0.0 110.507 179.331 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.3 m -146.63 60.72 1.21 Allowed 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.044 -1.035 . . . . 0.0 110.401 176.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.1 m -135.65 -31.47 0.95 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.811 -1.181 . . . . 0.0 110.73 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.432 ' HA2' ' NH2' ' A' ' 114' ' ' ARG . . . 74.21 -27.74 0.99 Allowed Glycine 0 N--CA 1.494 2.518 0 O-C-N 121.449 -0.782 . . . . 0.0 112.384 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.588 ' HA ' ' HE1' ' A' ' 55' ' ' MET . 0.0 OUTLIER -127.32 57.06 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.469 -1.607 . . . . 0.0 110.604 -179.32 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 114' ' ' ARG . 2.7 t -129.47 54.4 1.83 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.33 -0.856 . . . . 0.0 108.695 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.985 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -34.14 -29.53 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -84.83 -77.58 0.27 Allowed 'General case' 0 C--N 1.288 -2.08 0 O-C-N 120.73 -1.231 . . . . 0.0 109.612 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.413 ' O ' HG23 ' A' ' 117' ' ' THR . 2.1 m-20 -59.45 -17.38 30.63 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.503 -0.748 . . . . 0.0 110.235 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.895 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -89.62 -39.21 13.39 Favored 'General case' 0 C--O 1.203 -1.378 0 O-C-N 120.996 -1.065 . . . . 0.0 110.76 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.752 HD13 ' HA ' ' A' ' 111' ' ' ALA . 1.0 OUTLIER -57.07 -18.4 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 120.306 -1.496 . . . . 0.0 109.368 -178.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.0 m -87.41 -52.93 5.09 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.85 -1.156 . . . . 0.0 108.062 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 121' ' ' ALA . 44.1 p -66.61 -36.85 83.59 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.493 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.895 HG13 ' O ' ' A' ' 114' ' ' ARG . 26.6 m -53.89 -43.4 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 O-C-N 120.349 -1.469 . . . . 0.0 108.603 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.521 ' N ' HG23 ' A' ' 118' ' ' VAL . 0.6 OUTLIER -51.77 -32.18 29.89 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.792 -1.163 . . . . 0.0 107.879 177.223 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.451 ' HA ' ' HB2' ' A' ' 123' ' ' ALA . . . -95.3 -19.59 19.85 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.167 178.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 117' ' ' THR . . . -53.72 -54.01 43.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.918 -1.114 . . . . 0.0 109.131 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.734 HG23 HD12 ' A' ' 78' ' ' LEU . 60.3 mt -88.83 23.32 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.525 177.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . -55.18 146.5 18.59 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.508 ' O ' HD23 ' A' ' 78' ' ' LEU . 28.7 t70 -35.62 -80.19 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.792 0 CA-C-N 119.659 1.118 . . . . 0.0 110.093 -178.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 127' ' ' LYS . . . 54.46 34.5 54.94 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 118.133 -1.984 . . . . 0.0 109.786 174.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.32 91.16 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 123.29 1.519 . . . . 0.0 110.569 -174.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 125' ' ' GLY . 0.1 OUTLIER -137.93 127.28 14.91 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.428 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -53.67 -16.35 8.02 Favored 'Trans proline' 0 C--N 1.294 -2.337 0 O-C-N 122.703 0.844 . . . . 0.0 111.028 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.0 t -123.45 24.17 8.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.844 -1.16 . . . . 0.0 110.56 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.462 ' HB3' ' CB ' ' A' ' 127' ' ' LYS . 11.0 p30 -74.46 4.25 6.29 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.411 -1.431 . . . . 0.0 112.018 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.838 HD13 ' HB ' ' A' ' 99' ' ' ILE . 25.6 mt -143.1 110.83 5.89 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.558 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.6 OUTLIER -86.46 71.69 10.4 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -176.511 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.738 ' HB2' ' HA ' ' A' ' 134' ' ' PRO 0.257 0.0 OUTLIER -85.27 173.08 7.55 Favored Pre-proline 0 C--N 1.291 -1.95 0 O-C-N 121.549 -0.719 . . . . 0.0 110.064 179.966 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.738 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 47.5 Cg_endo -72.66 124.91 9.59 Favored 'Cis proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.832 -1.737 . . . . 0.0 111.524 7.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.974 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -122.08 74.93 0.36 Allowed Glycine 0 N--CA 1.501 2.988 0 C-N-CA 119.452 -1.356 . . . . 0.0 111.866 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.493 ' O ' ' CE2' ' A' ' 138' ' ' PHE . 83.2 m-70 31.18 37.18 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 O-C-N 122.204 -0.586 . . . . 0.0 112.344 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.974 HG23 ' O ' ' A' ' 135' ' ' GLY . 69.3 t -106.07 135.04 45.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 176.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.841 ' CZ ' HG23 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -126.52 81.59 67.93 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -177.672 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.791 ' HG3' HG12 ' A' ' 137' ' ' VAL . 64.3 Cg_endo -112.77 141.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.559 2.173 . . . . 0.0 113.495 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.58 HD22 ' O ' ' A' ' 93' ' ' THR . 1.1 pp -127.53 148.87 50.33 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.454 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.46 ' HB2' ' CD ' ' A' ' 75' ' ' ARG . 0.9 OUTLIER -91.52 92.55 8.56 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.867 -1.145 . . . . 0.0 110.054 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.8 69.03 1.37 Allowed 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 118.542 -1.263 . . . . 0.0 113.1 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.743 ' HB3' HG23 ' A' ' 71' ' ' THR . 19.6 tm0? -120.9 73.21 1.0 Allowed 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 117.751 -1.579 . . . . 0.0 112.213 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -127.64 38.52 4.03 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 117.733 -1.587 . . . . 0.0 111.459 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 74.44 -4.39 34.9 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 119.277 -1.44 . . . . 0.0 111.419 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.4 28.07 17.67 Favored Glycine 0 N--CA 1.485 1.91 0 O-C-N 120.665 -1.491 . . . . 0.0 113.417 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.953 HG13 HG11 ' A' ' 206' ' ' VAL . 1.5 p -60.48 -15.8 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 120.248 2.024 . . . . 0.0 107.822 177.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.761 HD11 HG12 ' A' ' 206' ' ' VAL . 75.3 mt -94.02 22.63 5.59 Favored 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 116.81 -1.956 . . . . 0.0 110.404 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.1 p -127.44 58.34 1.47 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 101.656 -3.461 . . . . 0.0 101.656 168.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.417 ' NH2' ' HA3' ' A' ' 92' ' ' GLY . 0.0 OUTLIER -153.39 149.89 28.28 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 113.034 -1.894 . . . . 0.0 110.763 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -102.47 34.68 5.53 Favored Glycine 0 N--CA 1.483 1.768 0 N-CA-C 106.293 -2.723 . . . . 0.0 106.293 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -145.48 159.7 27.95 Favored Glycine 0 N--CA 1.478 1.45 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.656 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 29.2 p-80 -89.7 -4.72 57.59 Favored 'General case' 0 C--N 1.292 -1.921 0 O-C-N 121.657 -0.907 . . . . 0.0 108.845 176.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.434 ' HB ' HD21 ' A' ' 140' ' ' LEU . 1.1 p -51.53 -55.31 19.72 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.015 -1.053 . . . . 0.0 109.795 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.447 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . 24.6 mt-10 -59.51 -21.74 60.61 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.812 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . . . -87.24 6.3 33.9 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.647 ' HA ' HD13 ' A' ' 172' ' ' LEU . 17.9 m -93.83 -51.06 5.06 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.159 -0.963 . . . . 0.0 109.52 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.62 ' O ' ' HB3' ' A' ' 161' ' ' MET . 9.7 tp -75.81 -34.15 27.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 116.238 -2.185 . . . . 0.0 105.126 175.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.519 ' HB2' ' HA ' ' A' ' 156' ' ' ALA . 0.8 OUTLIER -59.69 -25.56 64.87 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.084 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.66 ' O ' HD12 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -58.78 -28.89 66.37 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.827 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.62 ' HB3' ' O ' ' A' ' 158' ' ' ILE . 5.6 ttt -51.59 -39.26 57.58 Favored 'General case' 0 N--CA 1.514 2.758 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 174.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.444 ' CB ' ' O ' ' A' ' 159' ' ' ASP . 1.2 m -68.52 -39.26 81.25 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.651 177.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 1.014 HD21 HD21 ' A' ' 205' ' ' LEU . 0.3 OUTLIER -52.1 -57.62 9.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.864 -1.148 . . . . 0.0 108.763 179.038 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' A' ' 167' ' ' LYS . . . -64.63 -27.4 68.91 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.14 0.972 . . . . 0.0 108.545 177.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 96.17 -27.84 15.24 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 166' ' ' PHE . 37.2 p90 -151.05 55.6 0.89 Allowed 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.166 -1.414 . . . . 0.0 112.292 175.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.553 ' HD2' ' HB1' ' A' ' 164' ' ' ALA . 1.9 mttp -129.71 80.2 72.05 Favored Pre-proline 0 C--N 1.296 -1.739 0 CA-C-O 117.23 -1.367 . . . . 0.0 107.777 176.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.434 ' HA ' ' HB2' ' A' ' 161' ' ' MET . 43.2 Cg_endo -72.01 80.58 1.51 Allowed 'Trans proline' 0 C--N 1.32 -0.965 0 C-N-CA 115.367 -2.622 . . . . 0.0 110.636 -176.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.54 ' HB1' ' N ' ' A' ' 47' ' ' ALA . . . -163.26 166.37 23.25 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 104.292 -2.485 . . . . 0.0 104.292 175.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.59 ' HA3' HG22 ' A' ' 157' ' ' THR . . . -157.6 119.49 0.91 Allowed Glycine 0 N--CA 1.485 1.954 0 C-N-CA 116.721 -2.657 . . . . 0.0 112.479 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.965 HG22 ' O ' ' A' ' 45' ' ' PHE . 23.6 m -127.08 134.59 65.73 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.761 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 175.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.719 HD23 ' HA3' ' A' ' 41' ' ' GLY . 0.2 OUTLIER -149.88 113.67 5.06 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.696 -1.252 . . . . 0.0 109.39 -178.849 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.46 ' HB3' ' CG1' ' A' ' 66' ' ' VAL . 21.5 p -128.65 175.79 8.3 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 120.257 -1.527 . . . . 0.0 111.377 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.417 ' OE2' ' NH2' ' A' ' 184' ' ' ARG . 16.0 pm0 -113.05 154.63 26.23 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.106 -0.996 . . . . 0.0 110.558 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 1.073 HD12 HD21 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -82.29 115.48 21.37 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.269 -0.895 . . . . 0.0 109.932 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.588 HG22 ' HA ' ' A' ' 182' ' ' MET . 0.8 OUTLIER -111.47 155.29 23.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 0.0 109.485 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.43 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 2.9 m-20 -107.69 169.27 8.7 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.192 -0.943 . . . . 0.0 110.333 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.36 5.84 47.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.379 -0.826 . . . . 0.0 111.235 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -68.55 -15.91 63.69 Favored 'General case' 0 C--N 1.29 -2.008 0 O-C-N 121.534 -0.729 . . . . 0.0 110.179 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 103.73 23.23 8.4 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 183' ' ' ALA . 6.0 m -142.08 115.78 9.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -1.142 . . . . 0.0 110.154 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.588 ' HA ' HG22 ' A' ' 176' ' ' THR . 2.4 mpp? -52.42 95.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.313 -0.867 . . . . 0.0 110.267 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.766 ' HB1' ' SG ' ' A' ' 188' ' ' CYS . . . -61.37 93.69 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.209 -0.932 . . . . 0.0 110.24 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 185' ' ' ALA . 0.2 OUTLIER -125.16 100.01 6.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.816 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.858 ' HB1' ' HD2' ' A' ' 186' ' ' PRO . . . 179.17 178.5 0.28 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.387 -0.821 . . . . 0.0 109.704 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.858 ' HD2' ' HB1' ' A' ' 185' ' ' ALA . 45.9 Cg_endo -72.65 -8.47 22.53 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.603 1.318 . . . . 0.0 110.767 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -81.45 -68.94 0.65 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.984 -1.073 . . . . 0.0 110.307 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' CYS . . . . . 0.766 ' SG ' ' HB1' ' A' ' 183' ' ' ALA . 0.4 OUTLIER -57.74 -30.41 65.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.428 -0.795 . . . . 0.0 110.097 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.852 HG22 HD22 ' A' ' 199' ' ' LEU . 27.2 mm -75.77 -26.3 17.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 120.951 -1.093 . . . . 0.0 109.102 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.489 ' HA ' HD11 ' A' ' 199' ' ' LEU . 12.0 mt-10 -76.76 -19.38 57.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.474 -0.766 . . . . 0.0 109.092 177.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 192' ' ' ALA . 0.8 OUTLIER -70.27 -56.4 6.86 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.179 0.99 . . . . 0.0 108.764 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.692 ' CB ' HD11 ' A' ' 57' ' ' LEU . . . -61.76 -41.78 98.14 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ASN . . . . . 0.665 ' CB ' HD11 ' A' ' 199' ' ' LEU . 2.2 t30 -66.33 -13.3 60.34 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.021 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.99 -37.33 47.45 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 117.636 -1.626 . . . . 0.0 111.578 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' HIS . . . . . 0.405 ' CD2' ' H ' ' A' ' 195' ' ' HIS . 13.7 p80 -108.79 -52.7 2.73 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 115.717 -2.393 . . . . 0.0 111.856 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.462 ' O ' ' HG2' ' A' ' 197' ' ' MET . 44.5 t30 -114.8 33.34 5.43 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.098 -1.441 . . . . 0.0 113.958 177.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' MET . . . . . 0.599 ' CB ' ' HA ' ' A' ' 193' ' ' ASN . 0.0 OUTLIER -151.45 149.71 29.58 Favored 'General case' 0 N--CA 1.52 3.067 0 CA-C-N 123.375 2.807 . . . . 0.0 115.163 -179.524 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.54 ' HB1' ' HB2' ' A' ' 19' ' ' ALA . . . -107.08 154.28 21.38 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 176.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.852 HD22 HG22 ' A' ' 189' ' ' ILE . 43.7 mt -123.44 144.74 49.31 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.277 -1.514 . . . . 0.0 113.171 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.953 HG21 HD12 ' A' ' 205' ' ' LEU . 0.2 OUTLIER -120.28 -161.79 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.782 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.477 ' HB ' ' CB ' ' A' ' 204' ' ' ASP . 0.2 OUTLIER -132.97 142.78 49.04 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.946 -1.096 . . . . 0.0 108.468 177.597 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.512 HG23 ' N ' ' A' ' 203' ' ' GLU . 5.2 tp -45.93 -46.67 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.196 -0.94 . . . . 0.0 111.56 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.512 ' N ' HG23 ' A' ' 202' ' ' ILE . 22.8 tt0 -91.9 -31.49 15.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.883 -1.135 . . . . 0.0 111.016 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.765 ' O ' ' HB3' ' A' ' 207' ' ' ALA . 10.9 t70 -72.99 -39.14 66.32 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.267 -0.896 . . . . 0.0 112.121 -178.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 1.092 HD13 HG12 ' A' ' 31' ' ' VAL . 10.4 tt -58.22 -62.78 1.58 Allowed 'General case' 0 N--CA 1.484 1.264 0 O-C-N 120.687 -1.258 . . . . 0.0 110.641 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.953 HG11 HG13 ' A' ' 147' ' ' VAL . 2.4 t -66.47 -13.55 16.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 C-N-CA 118.086 -1.445 . . . . 0.0 108.122 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 204' ' ' ASP . . . -57.23 -33.18 67.3 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.803 ' CE2' HG21 ' A' ' 16' ' ' VAL . 4.7 m-30 -56.54 -52.38 65.01 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 175.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.524 ' HB2' HD23 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -61.07 -41.84 97.38 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.761 179.088 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -53.92 -43.12 69.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 109.501 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ALA . . . . . 0.442 ' HA ' ' HB2' ' A' ' 214' ' ' ARG . . . -57.45 -35.14 69.75 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.47 -0.769 . . . . 0.0 109.221 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.466 ' CE1' ' O ' ' A' ' 7' ' ' SER . 2.7 t-160 -55.73 -45.79 77.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.539 -0.726 . . . . 0.0 109.839 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -89.01 -9.14 52.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.512 -0.742 . . . . 0.0 110.779 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.442 ' HB2' ' HA ' ' A' ' 211' ' ' ALA . 0.0 OUTLIER -64.24 115.05 4.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.934 -1.104 . . . . 0.0 110.179 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -123.03 96.59 5.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.883 . . . . 0.0 110.188 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . 53.12 86.96 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.891 . . . . 0.0 110.279 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.231 179.995 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mtp . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.283 0.564 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -83.92 58.15 4.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.902 . . . . 0.0 110.224 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.2 5.97 18.12 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.373 -0.83 . . . . 0.0 110.818 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.5 p -46.94 -25.66 0.83 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.039 -1.038 . . . . 0.0 111.054 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.741 HD11 ' O ' ' A' ' 197' ' ' MET . 0.7 OUTLIER -67.26 -18.99 65.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.025 -1.047 . . . . 0.0 110.12 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.453 HD13 ' HA3' ' A' ' 10' ' ' GLY . 0.1 OUTLIER -113.13 -15.94 12.68 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.245 -0.91 . . . . 0.0 109.5 179.169 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.5 t -92.66 -63.09 1.27 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.992 -1.067 . . . . 0.0 109.801 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.463 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -77.44 -15.07 59.53 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.477 -0.764 . . . . 0.0 109.674 178.932 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.463 ' CD1' ' O ' ' A' ' 8' ' ' SER . 22.4 m-85 -134.76 57.24 1.81 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.453 ' HA3' HD13 ' A' ' 6' ' ' LEU . . . -168.4 96.2 0.12 Allowed Glycine 0 C--N 1.299 -1.48 0 N-CA-C 105.366 -3.093 . . . . 0.0 105.366 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 16' ' ' VAL . 36.1 p -131.53 140.17 37.58 Favored Pre-proline 0 C--N 1.266 -3.042 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.883 ' O ' HG12 ' A' ' 16' ' ' VAL . 30.5 Cg_endo -54.33 -34.09 78.9 Favored 'Trans proline' 0 C--N 1.269 -3.611 0 O-C-N 122.82 0.905 . . . . 0.0 111.082 -177.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -86.99 -67.14 0.84 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 115.699 1.741 . . . . 0.0 115.699 -177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.56 -45.71 11.5 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 118.521 -1.272 . . . . 0.0 112.336 -175.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.452 ' HB3' ' CA ' ' A' ' 10' ' ' GLY . 28.0 mmt-85 -84.78 -12.26 54.04 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 118.238 -1.385 . . . . 0.0 113.325 -177.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.883 HG12 ' O ' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -95.16 -28.16 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 122.856 2.571 . . . . 0.0 108.69 176.604 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -66.29 -52.21 49.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 117.938 -1.505 . . . . 0.0 108.101 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -64.28 -33.93 76.96 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.186 -0.946 . . . . 0.0 108.722 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 23' ' ' LEU . . . -81.01 -5.86 58.1 Favored 'General case' 0 C--O 1.201 -1.47 0 O-C-N 121.188 -0.945 . . . . 0.0 108.606 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.648 HD11 ' O ' ' A' ' 163' ' ' LEU . 0.3 OUTLIER -68.08 -51.7 43.59 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.578 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.37 -49.92 73.03 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.566 ' HB1' ' HB2' ' A' ' 27' ' ' ARG . . . -61.25 -28.57 69.26 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.672 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -60.5 -8.69 2.94 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.534 -0.729 . . . . 0.0 110.765 179.803 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.74 -37.35 10.34 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.384 -0.823 . . . . 0.0 108.969 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -151.57 90.28 1.55 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 123.267 1.508 . . . . 0.0 113.444 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.24 -18.35 5.83 Favored Glycine 0 C--N 1.272 -3.007 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.672 ' O ' ' HA ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -129.42 120.15 25.0 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 178.057 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 198' ' ' ALA . . . -164.2 105.03 0.24 Allowed Glycine 0 C--N 1.27 -3.137 1 N-CA-C 103.017 -4.033 . . . . 0.0 103.017 -175.631 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.667 ' HB ' ' CB ' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -125.1 161.36 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 113.059 -1.57 . . . . 0.0 112.192 -172.442 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.618 ' CA ' ' HA ' ' A' ' 42' ' ' ASP . 1.4 tmm? -98.52 152.61 19.37 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.148 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.706 HG13 HG21 ' A' ' 44' ' ' ILE . 15.6 m -116.46 127.13 74.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.774 HD23 ' N ' ' A' ' 33' ' ' ASP . 5.1 tt -158.66 -72.04 0.09 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.057 -1.027 . . . . 0.0 110.492 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.774 ' N ' HD23 ' A' ' 32' ' ' LEU . 22.0 t0 60.18 155.92 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.236 -0.915 . . . . 0.0 110.098 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 53.35 -150.99 0.34 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.149 -0.97 . . . . 0.0 110.113 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -146.67 121.13 9.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.92 . . . . 0.0 110.186 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.417 ' O ' ' ND2' ' A' ' 39' ' ' ASN . 9.4 m-20 -157.21 83.91 0.93 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 0.0 110.337 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.74 -167.96 0.05 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 110.362 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -70.9 76.16 0.63 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.261 -0.899 . . . . 0.0 110.238 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.642 ' O ' HD12 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -100.78 60.28 0.96 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 110.066 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 174' ' ' GLU . 31.4 mt-10 -85.55 -166.72 1.6 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 110.409 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.465 ' N ' ' HG2' ' A' ' 30' ' ' MET . . . 163.15 33.47 0.02 OUTLIER Glycine 0 N--CA 1.493 2.452 0 C-N-CA 120.014 -1.088 . . . . 0.0 110.55 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.855 ' OD2' ' HB1' ' A' ' 192' ' ' ALA . 8.3 t70 -43.61 -25.52 0.17 Allowed 'General case' 0 N--CA 1.51 2.548 0 O-C-N 121.009 -1.289 . . . . 0.0 111.268 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.64 ' O ' ' O ' ' A' ' 171' ' ' VAL . 0.0 OUTLIER -93.89 54.45 1.96 Allowed 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -177.216 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.96 ' O ' HD21 ' A' ' 160' ' ' LEU . 28.8 pt -64.5 23.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.524 3.265 0 O-C-N 118.93 -2.356 . . . . 0.0 113.282 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.597 ' O ' HG12 ' A' ' 171' ' ' VAL . 6.6 m-85 -77.21 164.4 58.93 Favored Pre-proline 0 N--CA 1.504 2.25 0 C-N-CA 123.805 0.842 . . . . 0.0 113.236 -178.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.468 ' HG2' ' CG2' ' A' ' 49' ' ' THR . 43.0 Cg_endo -66.79 132.8 29.57 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 122.843 2.362 . . . . 0.0 110.212 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.971 ' HB3' ' HB1' ' A' ' 169' ' ' ALA . . . -68.59 -2.71 9.58 Favored 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -176.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.449 ' HG3' HD11 ' A' ' 122' ' ' ILE . 5.7 tt0 -95.71 -22.64 17.42 Favored 'General case' 0 C--N 1.292 -1.905 0 O-C-N 120.662 -1.274 . . . . 0.0 110.491 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.468 ' CG2' ' HG2' ' A' ' 46' ' ' PRO . 4.6 t -134.38 59.02 1.75 Allowed 'General case' 0 C--N 1.315 -0.924 0 O-C-N 120.724 -1.235 . . . . 0.0 107.739 178.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.872 ' O ' HD12 ' A' ' 115' ' ' ILE . 1.5 ppp? -65.0 88.74 0.07 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.511 HG22 ' H ' ' A' ' 53' ' ' GLU . 24.4 m -59.32 147.92 34.16 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 122.139 0.971 . . . . 0.0 110.169 -176.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.991 HG23 ' HB1' ' A' ' 111' ' ' ALA . 12.5 p -72.34 -3.26 3.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.505 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.511 ' H ' HG22 ' A' ' 51' ' ' THR . 6.6 tp10 -58.96 -41.22 86.97 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.523 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 8.8 mm-40 -81.44 -47.63 12.94 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.237 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.757 ' O ' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -54.17 -35.28 62.13 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.572 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.481 ' HA ' ' CG2' ' A' ' 59' ' ' ILE . . . -54.68 -47.3 73.81 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.685 HD23 ' N ' ' A' ' 58' ' ' THR . 4.8 tt -56.02 -53.65 54.35 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.811 0.815 . . . . 0.0 109.573 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.799 HG21 ' SG ' ' A' ' 173' ' ' CYS . 0.9 OUTLIER -69.28 -58.29 4.23 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.605 -0.684 . . . . 0.0 111.23 -178.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.757 HG22 ' O ' ' A' ' 55' ' ' MET . 1.1 tp -52.47 -22.17 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.106 -0.996 . . . . 0.0 110.742 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 4.1 ttt-85 -74.8 -40.69 60.98 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.212 -0.93 . . . . 0.0 110.962 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -122.86 -1.37 8.9 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.958 -1.089 . . . . 0.0 112.129 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.66 -169.96 27.88 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.32 102.7 6.08 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 101.38 -3.563 . . . . 0.0 101.38 176.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 66' ' ' VAL . . . -104.81 74.97 0.24 Allowed Glycine 0 C--N 1.261 -3.625 0 N-CA-C 106.816 -2.514 . . . . 0.0 106.816 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.624 ' O ' HG23 ' A' ' 65' ' ' ILE . 3.2 tp -62.47 90.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.807 HG12 ' HB2' ' A' ' 173' ' ' CYS . 35.5 m -52.13 152.46 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 114.468 -1.242 . . . . 0.0 114.054 -176.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.414 ' N ' ' O ' ' A' ' 172' ' ' LEU . 7.4 t -87.37 114.99 24.48 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 176.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.675 HD23 ' HA ' ' A' ' 171' ' ' VAL . 3.6 mt -87.45 163.96 16.44 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 169' ' ' ALA . 4.7 m -131.48 135.61 47.24 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 118.199 -1.4 . . . . 0.0 113.206 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.655 HG23 ' HB2' ' A' ' 139' ' ' PRO . 2.5 pp -148.82 177.15 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.498 HG22 ' HG3' ' A' ' 72' ' ' GLU . 18.0 m -111.4 159.15 18.29 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.145 -0.972 . . . . 0.0 110.531 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.498 ' HG3' HG22 ' A' ' 71' ' ' THR . 0.1 OUTLIER -49.13 -27.12 3.2 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.475 -0.766 . . . . 0.0 110.62 -179.846 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -56.9 -38.83 73.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 0.0 109.676 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.426 ' O ' ' HB3' ' A' ' 78' ' ' LEU . 1.8 mmt180 -78.26 -32.77 49.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.501 -0.749 . . . . 0.0 110.35 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.544 ' HG2' HD13 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -78.72 -28.82 45.06 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.204 1.002 . . . . 0.0 108.535 179.013 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 79' ' ' ASP . 4.3 ttmm -56.51 -70.26 0.12 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.429 ' C ' ' HB1' ' A' ' 126' ' ' ALA . 0.4 OUTLIER -46.57 -41.04 13.82 Favored 'General case' 0 N--CA 1.508 2.444 0 CA-C-O 121.974 0.892 . . . . 0.0 109.864 177.834 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.64 HD23 ' O ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -96.39 45.77 1.06 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 176.229 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 76' ' ' LYS . 15.2 t70 -28.68 85.39 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 123.745 1.736 . . . . 0.0 112.329 -172.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.046 HD21 HG11 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -148.44 103.75 3.5 Favored Pre-proline 0 C--N 1.29 -2.009 0 CA-C-N 112.558 -2.11 . . . . 0.0 111.906 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -104.91 93.31 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.493 1.462 . . . . 0.0 108.635 175.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.822 ' H ' HG22 ' A' ' 97' ' ' VAL . 14.7 mmt -103.31 107.72 18.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.673 -1.267 . . . . 0.0 111.156 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.483 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 10.6 tmm? -95.89 92.37 6.47 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.862 -1.149 . . . . 0.0 109.654 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.841 HG13 ' O ' ' A' ' 96' ' ' THR . 3.8 m -87.81 148.46 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 118.301 -1.359 . . . . 0.0 110.303 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -92.7 22.8 4.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.329 -0.857 . . . . 0.0 110.629 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -106.68 18.36 21.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.135 -0.978 . . . . 0.0 110.286 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.701 ' CB ' HG22 ' A' ' 96' ' ' THR . 30.2 t30 -106.69 74.39 1.0 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 109.85 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 54.7 -141.99 0.83 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.089 -1.007 . . . . 0.0 109.512 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -50.33 -59.96 3.46 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.747 -1.221 . . . . 0.0 110.351 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 53.1 98.33 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.895 . . . . 0.0 110.456 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.458 ' CZ ' ' OG1' ' A' ' 93' ' ' THR . 37.3 p90 -114.48 41.98 2.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.314 -0.866 . . . . 0.0 110.388 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.33 39.92 25.19 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 93' ' ' THR . 30.5 m -86.67 14.69 6.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.239 -1.154 . . . . 0.0 110.89 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.14 23.15 2.6 Favored Glycine 0 N--CA 1.496 2.677 0 O-C-N 120.956 -1.09 . . . . 0.0 110.711 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.842 ' O ' HD13 ' A' ' 140' ' ' LEU . 5.9 t80 -120.47 36.67 4.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.049 -1.265 . . . . 0.0 108.981 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.841 ' O ' HG13 ' A' ' 84' ' ' VAL . 1.4 p -131.05 53.34 1.99 Allowed 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.629 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 1.046 HG11 HD21 ' A' ' 80' ' ' LEU . 57.5 t -86.07 105.67 14.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 O-C-N 121.209 -0.932 . . . . 0.0 112.096 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.733 HG22 HG12 ' A' ' 137' ' ' VAL . 1.0 OUTLIER -75.9 152.18 37.2 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 103.029 -2.952 . . . . 0.0 103.029 174.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.782 HD12 ' HB3' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -161.71 138.93 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 C-N-CA 116.708 -1.997 . . . . 0.0 111.513 -176.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.633 ' HB3' ' CB ' ' A' ' 132' ' ' ASN . 1.2 tp10 -99.11 126.5 44.87 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.301 -1.36 . . . . 0.0 111.346 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.488 ' HA ' ' CD2' ' A' ' 131' ' ' LEU . . . -51.24 115.6 1.64 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.41 -0.807 . . . . 0.0 110.886 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.839 ' HB3' ' O ' ' A' ' 130' ' ' ASP . . . -115.74 -6.78 12.12 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.23 -0.919 . . . . 0.0 110.984 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.84 ' HB3' ' HB1' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -75.82 55.45 0.88 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.952 -1.093 . . . . 0.0 111.692 -178.649 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.622 ' O ' HG13 ' A' ' 105' ' ' VAL . . . 73.31 24.24 75.72 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.846 HG21 ' HB3' ' A' ' 120' ' ' ALA . 5.2 m -158.25 122.39 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.412 ' HA ' ' HB3' ' A' ' 101' ' ' ALA . 5.8 m -148.38 63.8 1.08 Allowed 'General case' 0 N--CA 1.484 1.24 0 O-C-N 120.85 -1.156 . . . . 0.0 111.605 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.3 t -131.07 -30.76 1.74 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 118.618 -1.233 . . . . 0.0 110.099 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.409 ' O ' ' NH1' ' A' ' 114' ' ' ARG . . . 63.98 -19.06 0.09 OUTLIER Glycine 0 N--CA 1.5 2.93 0 O-C-N 121.484 -0.76 . . . . 0.0 113.377 178.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.86 55.54 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 119.71 1.755 . . . . 0.0 109.73 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 114' ' ' ARG . 28.6 p -133.2 66.15 1.57 Allowed 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.991 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -27.19 -39.92 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 121.506 0.669 . . . . 0.0 112.589 -177.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -78.59 -72.8 0.36 Allowed 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 122.147 0.975 . . . . 0.0 109.492 178.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -54.51 -23.35 16.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.167 -0.958 . . . . 0.0 109.241 178.791 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 110' ' ' SER . 0.3 OUTLIER -61.14 -45.61 93.97 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.549 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.872 HD12 ' O ' ' A' ' 50' ' ' MET . 1.6 mm -65.13 -15.07 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 117.283 -1.767 . . . . 0.0 107.654 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 m -89.88 -31.29 17.39 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 175.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.734 HG23 ' HB ' ' A' ' 105' ' ' VAL . 91.0 m -70.8 -49.0 51.12 Favored 'General case' 0 C--O 1.204 -1.3 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.555 HG13 ' N ' ' A' ' 119' ' ' ARG . 10.1 p -53.43 -41.46 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 0.0 109.28 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.555 ' N ' HG13 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -57.88 -33.88 69.19 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.413 179.051 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.846 ' HB3' HG21 ' A' ' 105' ' ' VAL . . . -94.03 -36.93 11.9 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.524 -0.735 . . . . 0.0 111.082 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.702 ' HB1' ' CE1' ' A' ' 138' ' ' PHE . . . -56.52 -56.72 17.76 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.03 -1.044 . . . . 0.0 109.407 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.725 HG22 ' HG3' ' A' ' 139' ' ' PRO . 1.6 pp -87.13 19.36 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.284 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.541 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -72.76 146.72 46.18 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.454 ' C ' ' O ' ' A' ' 123' ' ' ALA . 16.8 m-20 -37.18 -79.14 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.721 0 CA-C-N 119.598 1.09 . . . . 0.0 109.595 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 127' ' ' LYS . . . 54.75 34.93 57.06 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.125 -1.988 . . . . 0.0 109.856 173.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.429 ' HB1' ' C ' ' A' ' 77' ' ' GLN . . . -58.96 91.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 123.337 1.541 . . . . 0.0 110.233 -174.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 125' ' ' GLY . 1.9 mttt -137.97 126.57 14.45 Favored Pre-proline 0 C--N 1.303 -1.436 0 CA-C-N 113.377 -1.738 . . . . 0.0 106.422 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -54.69 -17.79 14.16 Favored 'Trans proline' 0 C--N 1.294 -2.315 0 O-C-N 122.61 0.795 . . . . 0.0 110.306 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 25.4 p -124.56 31.65 5.66 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.149 -0.969 . . . . 0.0 109.881 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.839 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -73.77 3.84 5.98 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.524 -1.36 . . . . 0.0 111.797 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.733 ' CB ' HG22 ' A' ' 99' ' ' ILE . 30.7 mt -142.58 130.64 21.89 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.633 ' CB ' ' HB3' ' A' ' 100' ' ' GLU . 0.5 OUTLIER -81.52 72.87 8.58 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.326 -1.484 . . . . 0.0 111.639 -177.847 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.655 ' HB3' ' HA ' ' A' ' 99' ' ' ILE 0.263 0.0 OUTLIER -87.68 152.82 52.21 Favored Pre-proline 0 N--CA 1.502 2.141 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.545 179.72 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.413 ' C ' ' HA ' ' A' ' 133' ' ' ARG . 47.3 Cg_endo -78.36 141.41 64.94 Favored 'Cis proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.215 -1.994 . . . . 0.0 107.787 1.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.536 ' O ' ' O ' ' A' ' 136' ' ' HIS . . . -176.6 95.43 0.1 Allowed Glycine 0 N--CA 1.487 2.078 0 C-N-CA 117.879 -2.105 . . . . 0.0 111.291 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.536 ' O ' ' O ' ' A' ' 135' ' ' GLY . 12.2 m-70 47.3 101.81 0.01 OUTLIER 'General case' 0 C--O 1.206 -1.215 0 CA-C-O 124.283 1.992 . . . . 0.0 109.182 -177.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.733 HG12 HG22 ' A' ' 98' ' ' THR . 19.2 m -49.15 154.48 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.686 0 CA-C-N 112.783 -2.008 . . . . 0.0 112.376 -174.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.782 ' HB3' HD12 ' A' ' 99' ' ' ILE . 1.5 m-85 -146.87 175.42 2.73 Favored Pre-proline 0 C--N 1.29 -1.997 0 CA-C-N 111.434 -2.621 . . . . 0.0 105.271 -174.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.725 ' HG3' HG22 ' A' ' 122' ' ' ILE . 38.4 Cg_endo -57.56 127.88 27.13 Favored 'Trans proline' 0 C--N 1.293 -2.354 0 CA-C-O 123.533 1.389 . . . . 0.0 115.11 -169.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.842 HD13 ' O ' ' A' ' 95' ' ' PHE . 14.6 mt -90.06 172.46 8.82 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 112.96 -1.927 . . . . 0.0 108.965 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.461 ' HB2' ' N ' ' A' ' 72' ' ' GLU . 12.8 ptt85 -126.13 85.16 2.35 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.119 -1.613 . . . . 0.0 115.0 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.589 ' HB3' ' CG ' ' A' ' 95' ' ' PHE . . . -141.48 79.69 1.7 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.742 -1.224 . . . . 0.0 110.837 176.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.585 ' HB2' HG21 ' A' ' 158' ' ' ILE . 0.5 OUTLIER -117.34 75.26 0.97 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.143 -1.598 . . . . 0.0 112.966 -179.353 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -127.04 43.37 3.13 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.637 -1.289 . . . . 0.0 110.982 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 75.83 37.08 40.12 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -100.54 12.35 59.74 Favored Glycine 0 N--CA 1.49 2.285 0 O-C-N 120.91 -1.347 . . . . 0.0 113.521 -176.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.86 HG13 HD22 ' A' ' 148' ' ' LEU . 8.2 p -107.9 -13.9 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-N 120.312 2.056 . . . . 0.0 111.828 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.86 HD22 HG13 ' A' ' 147' ' ' VAL . 4.6 mm? -87.42 13.28 10.25 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 115.041 -2.664 . . . . 0.0 109.876 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 84.2 m -132.93 62.15 1.66 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 100.548 -3.871 . . . . 0.0 100.548 167.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -148.27 135.15 20.05 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.072 -1.422 . . . . 0.0 113.831 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -104.26 36.25 4.5 Favored Glycine 0 N--CA 1.48 1.605 0 N-CA-C 106.177 -2.769 . . . . 0.0 106.177 173.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.409 ' HA2' ' OD1' ' A' ' 39' ' ' ASN . . . -142.31 163.8 27.05 Favored Glycine 0 N--CA 1.479 1.55 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.868 ' HA ' ' HB3' ' A' ' 156' ' ' ALA . 54.5 p-80 -90.98 -6.12 54.45 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.883 -0.774 . . . . 0.0 109.765 177.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.403 ' O ' ' HB ' ' A' ' 157' ' ' THR . 6.8 p -56.39 -64.99 0.68 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 122.362 1.077 . . . . 0.0 108.876 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.456 ' HB3' ' CA ' ' A' ' 147' ' ' VAL . 65.9 mm-40 -59.4 -22.16 60.99 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 177.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.868 ' HB3' ' HA ' ' A' ' 153' ' ' HIS . . . -86.02 4.37 38.18 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.226 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.505 HG23 ' SG ' ' A' ' 69' ' ' CYS . 0.6 OUTLIER -83.07 -51.65 7.35 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.328 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.585 HG21 ' HB2' ' A' ' 143' ' ' GLN . 0.2 OUTLIER -74.87 -17.54 16.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 115.923 -2.311 . . . . 0.0 105.996 176.108 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.942 ' CG ' HG12 ' A' ' 206' ' ' VAL . 8.3 t70 -59.29 -26.71 65.19 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 173.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 1.047 HD22 ' HG ' ' A' ' 163' ' ' LEU . 0.4 OUTLIER -53.3 -41.33 65.52 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 175.175 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.572 ' HA ' ' HA ' ' A' ' 168' ' ' PRO . 0.0 OUTLIER -48.2 -33.45 8.54 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 176.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.94 HG21 ' HG3' ' A' ' 209' ' ' ARG . 1.3 m -93.29 -31.83 14.55 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.719 177.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 1.047 ' HG ' HD22 ' A' ' 160' ' ' LEU . 0.5 OUTLIER -36.34 -40.94 0.25 Allowed 'General case' 0 N--CA 1.521 3.102 0 O-C-N 121.489 -0.757 . . . . 0.0 110.071 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.541 ' CB ' HD21 ' A' ' 20' ' ' LEU . . . -94.49 -29.24 15.04 Favored 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.103 -0.998 . . . . 0.0 110.909 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.03 -29.99 10.76 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -149.93 47.28 0.93 Allowed 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 117.922 -1.511 . . . . 0.0 111.571 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 169' ' ' ALA . 2.5 mptp? -133.3 68.42 77.36 Favored Pre-proline 0 C--N 1.29 -2.019 0 N-CA-C 103.294 -2.854 . . . . 0.0 103.294 173.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.572 ' HA ' ' HA ' ' A' ' 161' ' ' MET . 42.4 Cg_endo -69.5 80.24 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 115.218 -2.721 . . . . 0.0 114.531 -170.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.971 ' HB1' ' HB3' ' A' ' 47' ' ' ALA . . . -164.29 166.11 21.2 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 171.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 68' ' ' LEU . . . -154.79 135.52 4.72 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 118.019 -2.039 . . . . 0.0 110.356 178.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.675 ' HA ' HD23 ' A' ' 68' ' ' LEU . 2.9 p -121.4 89.83 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.191 -1.991 0 C-N-CA 117.374 -1.73 . . . . 0.0 107.376 177.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.954 HD11 HD23 ' A' ' 160' ' ' LEU . 9.1 mp -95.12 153.81 17.48 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 119.249 0.931 . . . . 0.0 110.11 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.807 ' HB2' HG12 ' A' ' 66' ' ' VAL . 35.7 t -124.71 162.63 23.79 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 122.023 0.916 . . . . 0.0 112.905 -177.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.434 ' HA ' ' CB ' ' A' ' 40' ' ' GLU . 1.3 pt-20 -135.84 107.23 6.86 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.471 HD23 ' SG ' ' A' ' 188' ' ' CYS . 0.8 OUTLIER -63.36 139.62 58.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.052 -1.03 . . . . 0.0 111.153 -178.586 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.617 ' HA ' ' HB3' ' A' ' 183' ' ' ALA . 98.7 m -139.19 155.54 47.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.678 -0.639 . . . . 0.0 109.555 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -93.46 168.26 11.17 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.957 -1.089 . . . . 0.0 110.252 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -91.3 6.59 44.67 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.714 0.769 . . . . 0.0 111.027 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.14 7.38 19.07 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.659 -0.651 . . . . 0.0 110.514 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 78.32 22.51 67.6 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 183' ' ' ALA . 98.2 m -121.91 109.23 14.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -1.149 . . . . 0.0 109.991 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.432 ' HA ' HG23 ' A' ' 176' ' ' THR . 51.9 mtm -51.65 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.286 -0.884 . . . . 0.0 110.316 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.617 ' HB3' ' HA ' ' A' ' 176' ' ' THR . . . -54.63 111.06 0.73 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -0.922 . . . . 0.0 110.016 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 185' ' ' ALA . 0.6 OUTLIER -140.69 100.27 3.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 110.07 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.764 ' HB1' ' HD2' ' A' ' 186' ' ' PRO . . . 179.89 173.34 0.49 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 110.213 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.764 ' HD2' ' HB1' ' A' ' 185' ' ' ALA . 43.6 Cg_endo -69.53 -15.64 38.08 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.66 1.348 . . . . 0.0 110.226 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -87.81 -36.8 17.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.11 -0.994 . . . . 0.0 109.855 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' CYS . . . . . 0.603 ' SG ' ' HB1' ' A' ' 183' ' ' ALA . 41.1 t -58.84 -49.3 78.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.394 -0.817 . . . . 0.0 109.462 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.715 HG23 HD21 ' A' ' 199' ' ' LEU . 7.4 tp -76.84 -24.15 15.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.845 -1.159 . . . . 0.0 109.38 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.474 ' HA ' ' CB ' ' A' ' 193' ' ' ASN . 3.7 tt0 -57.41 -23.26 48.3 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.436 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 3.8 t80 -74.95 -46.19 37.21 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.855 ' HB1' ' OD2' ' A' ' 42' ' ' ASP . . . -65.77 -18.44 65.33 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 175.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ASN . . . . . 0.672 ' CG ' HD22 ' A' ' 199' ' ' LEU . 56.9 t30 -85.48 -7.76 58.73 Favored 'General case' 0 C--O 1.207 -1.159 0 O-C-N 121.896 -0.503 . . . . 0.0 109.696 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.59 -51.26 5.79 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.205 -1.559 . . . . 0.0 110.092 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.9 -41.06 12.0 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 118.268 -1.373 . . . . 0.0 107.599 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 198' ' ' ALA . 0.6 OUTLIER -99.34 52.17 0.94 Allowed 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 197' ' ' MET . . . . . 0.741 ' O ' HD11 ' A' ' 5' ' ' LEU . 45.5 ttm -66.72 74.25 0.1 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -173.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.667 ' CB ' ' HB ' ' A' ' 29' ' ' VAL . . . -134.1 106.4 7.18 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 104.057 -2.571 . . . . 0.0 104.057 172.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.715 HD21 HG23 ' A' ' 189' ' ' ILE . 2.9 tp -126.97 120.04 28.13 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 119.734 -1.854 . . . . 0.0 109.606 -177.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.574 HG22 ' H ' ' A' ' 201' ' ' THR . 4.5 p -124.08 -177.0 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.259 -0.901 . . . . 0.0 110.929 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.574 ' H ' HG22 ' A' ' 200' ' ' VAL . 5.5 p -121.01 135.99 55.09 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.117 -0.989 . . . . 0.0 110.501 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 153' ' ' HIS . 68.7 mt -60.76 -37.77 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.483 -0.761 . . . . 0.0 112.093 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -45.16 -65.95 0.46 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.257 -0.902 . . . . 0.0 110.909 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.63 ' O ' ' HB3' ' A' ' 207' ' ' ALA . 0.6 OUTLIER -72.88 -17.85 61.48 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.167 -0.958 . . . . 0.0 110.098 179.237 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.683 HD11 HD21 ' A' ' 163' ' ' LEU . 2.4 tm? -60.44 -68.35 0.31 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.08 -1.012 . . . . 0.0 109.564 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.942 HG12 ' CG ' ' A' ' 159' ' ' ASP . 11.5 m -63.92 -16.12 18.1 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 C-N-CA 117.922 -1.511 . . . . 0.0 109.356 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' A' ' 204' ' ' ASP . . . -56.6 -32.34 65.16 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 174.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.604 ' CE2' ' CG1' ' A' ' 16' ' ' VAL 0.286 0.9 OUTLIER -54.75 -52.15 63.45 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.108 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.94 ' HG3' HG21 ' A' ' 162' ' ' THR . 48.2 ttt180 -56.65 -45.73 81.44 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.6 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.417 ' OE1' ' N ' ' A' ' 211' ' ' ALA . 1.8 tm0? -69.2 -56.0 8.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.218 -0.926 . . . . 0.0 110.184 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ALA . . . . . 0.417 ' N ' ' OE1' ' A' ' 210' ' ' GLN . . . -58.91 -27.42 65.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.438 -0.789 . . . . 0.0 110.182 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' A' ' 208' ' ' TYR . 70.6 t60 -72.39 -28.03 62.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.863 . . . . 0.0 110.12 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -89.39 -9.24 51.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -0.869 . . . . 0.0 110.662 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.67 101.67 0.49 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.969 -1.082 . . . . 0.0 110.162 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 216' ' ' ALA . 19.2 mttt -96.55 98.07 9.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.215 -0.928 . . . . 0.0 110.222 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 215' ' ' LYS . . . 57.75 -85.5 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.437 -0.789 . . . . 0.0 110.475 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 215' ' ' LYS . 9.3 t . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.0 -1.062 . . . . 0.0 110.19 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.255 0.55 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -109.75 55.81 0.63 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 110.201 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -78.47 -20.97 49.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 110.222 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.447 ' HA ' ' CB ' ' A' ' 7' ' ' SER . 10.0 t -72.56 -4.93 33.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.873 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 tp -51.49 -65.02 0.63 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.012 -1.055 . . . . 0.0 110.579 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.853 ' CD2' HG23 ' A' ' 200' ' ' VAL . 1.2 tt -89.93 17.57 6.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 110.279 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.447 ' CB ' ' HA ' ' A' ' 4' ' ' THR . 15.8 m -92.6 -63.3 1.24 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.092 -1.005 . . . . 0.0 111.305 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 t -89.73 -24.98 21.4 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.124 -0.985 . . . . 0.0 110.202 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -131.63 58.04 1.74 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.627 ' C ' ' HD3' ' A' ' 12' ' ' PRO . . . -133.24 -174.78 13.69 Favored Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 105.184 -3.166 . . . . 0.0 105.184 -177.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.573 HG22 ' HB3' ' A' ' 15' ' ' ARG 0.251 43.2 p -129.09 65.06 73.09 Favored Pre-proline 0 C--N 1.252 -3.634 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 176.334 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.627 ' HD3' ' C ' ' A' ' 10' ' ' GLY . 54.5 Cg_endo -90.19 -58.07 0.02 OUTLIER 'Trans proline' 0 C--O 1.201 -1.333 0 O-C-N 124.487 1.783 . . . . 0.0 109.182 178.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -97.71 -70.62 0.71 Allowed 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -74.05 -41.37 61.87 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.798 -177.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.573 ' HB3' HG22 ' A' ' 11' ' ' THR . 1.7 mmt180 -88.12 -17.24 31.42 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 118.258 -1.377 . . . . 0.0 111.96 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.669 HG13 HD23 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -68.6 -28.08 38.78 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.151 0 C-N-CA 114.775 -2.77 . . . . 0.0 107.278 177.133 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 1.2 tm-20 -67.18 -54.7 18.69 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 117.493 -1.683 . . . . 0.0 107.415 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -62.6 -33.26 74.63 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.181 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.715 ' HB1' ' CD1' ' A' ' 23' ' ' LEU . . . -88.12 -6.75 57.73 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.218 -0.926 . . . . 0.0 109.011 178.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.923 HD11 ' HA ' ' A' ' 164' ' ' ALA . 0.2 OUTLIER -61.48 -49.67 75.82 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.383 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . . . -70.94 -54.55 10.95 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.604 -0.838 . . . . 0.0 108.801 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.609 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . . . -49.94 -40.35 43.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.501 -0.749 . . . . 0.0 110.231 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.756 ' HB3' HG13 ' A' ' 29' ' ' VAL . 43.8 mt -90.56 -16.74 28.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.343 -0.848 . . . . 0.0 110.051 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -61.81 -16.53 50.68 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.375 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -92.98 45.26 1.17 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 122.527 1.156 . . . . 0.0 109.968 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.541 ' HA2' ' CZ ' ' A' ' 45' ' ' PHE . . . 58.61 28.68 62.95 Favored Glycine 0 C--N 1.288 -2.114 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 177.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.519 ' HB3' HD23 ' A' ' 23' ' ' LEU . 4.2 ttt-85 -89.31 18.4 5.21 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 116.71 -1.996 . . . . 0.0 110.844 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.804 ' O ' ' HB3' ' A' ' 198' ' ' ALA . . . 96.81 107.11 2.4 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.129 -1.51 . . . . 0.0 115.388 172.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.756 HG13 ' HB3' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -142.25 113.86 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 174.057 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.659 ' HB2' ' CD1' ' A' ' 199' ' ' LEU . 2.3 mtp -124.2 122.55 38.1 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.014 -1.054 . . . . 0.0 110.513 -174.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.626 HG23 HG13 ' A' ' 200' ' ' VAL . 0.8 OUTLIER -102.25 125.86 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.781 -1.2 . . . . 0.0 110.838 -179.598 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.636 HD11 ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -177.27 155.27 1.11 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 0.0 110.094 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 29.3 p-10 -174.53 128.54 0.33 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.163 -0.961 . . . . 0.0 110.372 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.3 t0 53.39 97.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -0.94 . . . . 0.0 110.383 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.929 ' OE1' ' HB2' ' A' ' 185' ' ' ALA . 40.8 tt0 -79.61 95.29 5.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.896 . . . . 0.0 110.162 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -80.3 -70.34 0.53 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 110.233 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.04 -25.44 7.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.284 -0.885 . . . . 0.0 110.193 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.84 -69.77 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.301 -0.874 . . . . 0.0 110.29 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.636 ' O ' HD11 ' A' ' 32' ' ' LEU . 2.1 m120 53.32 91.77 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.281 -0.887 . . . . 0.0 110.182 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.533 ' HA ' HD11 ' A' ' 32' ' ' LEU . 26.1 mt-10 -148.0 116.69 6.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.323 -0.861 . . . . 0.0 110.182 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.459 ' O ' HD12 ' A' ' 172' ' ' LEU . . . -177.75 42.18 0.09 OUTLIER Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.36 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.587 ' HA ' ' HB3' ' A' ' 30' ' ' MET . 2.4 p30 -77.15 -6.94 54.82 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.763 -1.434 . . . . 0.0 110.973 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.705 ' HG2' HG12 ' A' ' 66' ' ' VAL . 9.6 tpp -96.19 56.53 1.64 Allowed 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 123.567 0.747 . . . . 0.0 110.416 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.921 ' C ' HD11 ' A' ' 160' ' ' LEU . 41.7 mt -60.73 34.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 O-C-N 121.159 -0.963 . . . . 0.0 113.557 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.947 ' O ' HG22 ' A' ' 171' ' ' VAL . 26.3 m-85 -111.52 162.03 22.81 Favored Pre-proline 0 N--CA 1.502 2.132 0 O-C-N 119.836 -1.79 . . . . 0.0 114.122 -175.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.405 ' HG2' ' OG1' ' A' ' 49' ' ' THR . 46.5 Cg_endo -72.63 131.36 17.19 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.374 2.049 . . . . 0.0 109.271 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.939 ' O ' HG12 ' A' ' 118' ' ' VAL . . . -72.28 -1.47 15.44 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 120.785 -1.197 . . . . 0.0 113.132 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -93.46 -16.77 24.18 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.64 -1.288 . . . . 0.0 109.788 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.405 ' OG1' ' HG2' ' A' ' 46' ' ' PRO . 0.8 OUTLIER -131.61 59.15 1.7 Allowed 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 177.426 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.94 ' SD ' HG11 ' A' ' 118' ' ' VAL . 5.0 tpt -54.46 95.75 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.505 -178.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.0 p -66.53 133.48 50.44 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.731 ' CG2' HG21 ' A' ' 115' ' ' ILE . 2.6 t -77.98 -2.37 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.061 -1.024 . . . . 0.0 108.504 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 26' ' ' GLY . 0.6 OUTLIER -60.77 -40.8 93.92 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.254 -179.406 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.704 ' HA ' ' HE1' ' A' ' 197' ' ' MET . 85.1 mm-40 -80.33 -24.14 40.1 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.594 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.747 ' O ' HG22 ' A' ' 59' ' ' ILE . 11.2 tpt -82.49 -38.06 24.43 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.353 -0.842 . . . . 0.0 109.493 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.93 -42.1 84.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.48 -0.762 . . . . 0.0 109.767 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.944 HD13 ' SD ' ' A' ' 197' ' ' MET . 5.8 tt -65.58 -48.71 71.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 109.322 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.532 ' N ' HD23 ' A' ' 57' ' ' LEU . 37.0 p -67.02 -59.12 3.74 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.365 -0.835 . . . . 0.0 110.979 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.894 HD12 ' HA ' ' A' ' 111' ' ' ALA . 11.3 tt -47.48 -24.79 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.17 -0.956 . . . . 0.0 111.022 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.8 ttt85 -72.07 -45.8 59.35 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.19 -0.944 . . . . 0.0 110.702 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -124.1 5.47 8.57 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.872 -1.143 . . . . 0.0 112.163 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 58' ' ' THR . . . -165.12 -169.27 28.52 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.5 p -139.91 102.26 4.37 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.33 72.91 0.22 Allowed Glycine 0 C--N 1.266 -3.352 0 N-CA-C 105.222 -3.151 . . . . 0.0 105.222 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.578 HG23 ' HZ ' ' A' ' 138' ' ' PHE . 1.7 tt -63.07 106.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.6 0 CA-C-O 122.622 1.201 . . . . 0.0 107.906 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.806 HG21 ' SD ' ' A' ' 50' ' ' MET . 16.5 m -52.53 151.03 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 115.129 -0.942 . . . . 0.0 112.043 -177.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.92 ' C ' HD13 ' A' ' 68' ' ' LEU . 82.5 m -85.9 160.74 19.33 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.92 HD13 ' C ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -137.87 91.76 2.61 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.012 -1.475 . . . . 0.0 108.094 178.068 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.444 ' CB ' ' OG1' ' A' ' 157' ' ' THR . 1.3 m -102.52 152.25 21.37 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 119.046 -1.062 . . . . 0.0 110.472 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.872 ' HA ' HD11 ' A' ' 158' ' ' ILE . 1.1 mt -152.6 -177.73 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.462 ' H ' HG22 ' A' ' 70' ' ' ILE . 22.0 p -86.33 144.71 27.24 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -53.54 -20.03 4.48 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.208 -0.933 . . . . 0.0 110.379 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.422 ' O ' ' CG ' ' A' ' 77' ' ' GLN . 10.1 t70 -79.0 -37.58 38.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.153 -0.967 . . . . 0.0 110.951 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -85.95 -52.44 5.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.21 -0.931 . . . . 0.0 110.629 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.871 ' CD ' HD12 ' A' ' 70' ' ' ILE . 22.4 tpt180 -54.2 -53.93 46.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.166 -0.959 . . . . 0.0 109.54 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.713 ' HG2' HD13 ' A' ' 80' ' ' LEU . 1.1 mtpm? -60.43 -56.67 18.65 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.293 -0.879 . . . . 0.0 111.605 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.422 ' CG ' ' O ' ' A' ' 73' ' ' ASP . 4.9 mt-30 -27.29 -49.41 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.851 1.344 . . . . 0.0 110.997 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 1.005 HD13 ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -136.88 -27.52 1.0 Allowed 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 117.162 -1.815 . . . . 0.0 113.082 177.502 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 1.005 ' N ' HD13 ' A' ' 78' ' ' LEU . 65.9 t0 -121.15 62.97 0.88 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 117.363 -1.735 . . . . 0.0 115.438 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.901 HD21 ' OG1' ' A' ' 96' ' ' THR . 2.2 tt -144.73 104.23 4.55 Favored Pre-proline 0 N--CA 1.506 2.348 0 C-N-CA 115.925 -2.31 . . . . 0.0 113.744 174.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.903 ' O ' HG22 ' A' ' 97' ' ' VAL . 38.3 Cg_endo -101.56 96.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.3 -1.983 0 N-CA-C 107.257 -1.863 . . . . 0.0 107.257 174.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.404 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 9.4 ttt -88.8 45.48 1.29 Allowed 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.21 -0.932 . . . . 0.0 109.553 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.637 ' HB2' HG11 ' A' ' 97' ' ' VAL . 4.7 mmm -57.7 -11.51 2.23 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.655 -0.653 . . . . 0.0 110.656 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 1.001 HG23 HG12 ' A' ' 97' ' ' VAL . 53.6 t -86.52 102.23 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 C-N-CA 116.878 -1.929 . . . . 0.0 109.915 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -101.53 30.85 4.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.681 -0.637 . . . . 0.0 109.681 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.47 ' ND2' ' CG1' ' A' ' 84' ' ' VAL . 34.2 p30 -64.11 80.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.27 -0.893 . . . . 0.0 110.665 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.418 ' N ' ' O ' ' A' ' 85' ' ' GLU . 2.3 m120 -103.14 54.4 0.76 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.359 -0.838 . . . . 0.0 109.717 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.2 p -141.78 -81.42 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.375 -0.828 . . . . 0.0 109.51 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.63 -26.78 64.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.209 -0.932 . . . . 0.0 109.28 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.413 ' CB ' ' OG1' ' A' ' 93' ' ' THR . . . -114.48 174.73 5.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.523 -0.736 . . . . 0.0 109.724 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -114.51 77.71 1.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.1 -1.0 . . . . 0.0 110.836 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.66 42.73 16.66 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.317 -1.42 . . . . 0.0 109.688 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.413 ' OG1' ' CB ' ' A' ' 90' ' ' ALA . 1.5 m -48.58 -21.74 0.63 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.071 -1.252 . . . . 0.0 111.33 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 96' ' ' THR . . . 46.21 26.4 2.24 Favored Glycine 0 N--CA 1.497 2.758 0 O-C-N 120.939 -1.101 . . . . 0.0 110.951 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.721 ' HB2' HG11 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -57.05 87.56 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 123.144 1.45 . . . . 0.0 112.237 -177.628 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.901 ' OG1' HD21 ' A' ' 80' ' ' LEU . 1.2 m -61.41 81.25 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.026 -1.443 . . . . 0.0 109.413 177.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 1.001 HG12 HG23 ' A' ' 84' ' ' VAL . 1.2 m -37.07 155.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.046 0 CA-C-O 122.259 1.028 . . . . 0.0 111.935 -175.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.907 HG22 ' O ' ' A' ' 137' ' ' VAL . 39.4 p -66.52 -176.88 0.5 Allowed 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -174.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.778 HD11 HG23 ' A' ' 117' ' ' THR . 1.1 pp -110.6 146.78 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 122.47 1.129 . . . . 0.0 113.545 -177.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.665 ' N ' ' H ' ' A' ' 133' ' ' ARG . 58.1 tt0 -93.65 163.27 13.61 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.445 ' HB1' ' HB ' ' A' ' 106' ' ' THR . . . -77.69 78.78 4.19 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 116.213 -2.195 . . . . 0.0 107.563 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 129' ' ' SER . . . -106.47 -37.54 6.46 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.455 ' CG ' ' HD2' ' A' ' 127' ' ' LYS . 30.6 tp10 -74.43 -7.92 54.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.55 -0.719 . . . . 0.0 109.894 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.8 24.98 5.59 Favored Glycine 0 N--CA 1.481 1.651 0 C-N-CA 119.604 -1.284 . . . . 0.0 111.703 178.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.539 HG21 ' CB ' ' A' ' 120' ' ' ALA . 2.0 t -114.19 112.13 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 C-N-CA 118.011 -1.475 . . . . 0.0 108.016 177.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.601 HG23 ' O ' ' A' ' 106' ' ' THR . 5.6 t -157.39 66.92 0.5 Allowed 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.0 m -129.99 20.98 5.39 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.416 -1.427 . . . . 0.0 111.847 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 110' ' ' SER . . . 96.55 47.44 2.34 Favored Glycine 0 N--CA 1.502 3.052 0 N-CA-C 107.137 -2.385 . . . . 0.0 107.137 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 109' ' ' VAL . 12.2 p -53.82 51.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -173.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 108' ' ' GLY . 1.9 m -135.29 12.21 3.54 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 117.053 -1.859 . . . . 0.0 112.405 172.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.894 ' HA ' HD12 ' A' ' 59' ' ' ILE . . . -122.12 -81.86 0.64 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 119.89 -1.756 . . . . 0.0 108.983 171.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' A' ' 116' ' ' THR . . . -98.7 -43.6 6.74 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 174.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.481 ' HB3' ' HA ' ' A' ' 109' ' ' VAL . 47.0 t0 -54.15 -29.74 46.58 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.903 ' O ' HG23 ' A' ' 118' ' ' VAL . 2.0 ttt180 -63.85 -51.29 65.3 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 175.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.731 HG21 ' CG2' ' A' ' 52' ' ' VAL 0.254 1.2 mp -67.31 -10.74 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.682 178.212 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.472 ' HB ' ' HA ' ' A' ' 113' ' ' ASP . 54.9 m -90.43 -41.87 11.21 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.89 -1.131 . . . . 0.0 109.112 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.778 HG23 HD11 ' A' ' 99' ' ' ILE . 52.8 m -69.0 -29.13 67.25 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.384 -0.926 . . . . 0.0 108.783 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.94 HG11 ' SD ' ' A' ' 50' ' ' MET . 39.9 t -67.78 -44.01 85.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.08 -27.98 35.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.472 -0.767 . . . . 0.0 109.573 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.539 ' CB ' HG21 ' A' ' 105' ' ' VAL . . . -80.95 -51.92 8.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.514 -0.741 . . . . 0.0 109.516 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.701 ' HA ' HD21 ' A' ' 131' ' ' LEU . . . -54.86 -32.27 60.57 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.801 HD12 ' O ' ' A' ' 47' ' ' ALA . 71.1 mt -93.39 25.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.602 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.775 ' HB3' ' HD3' ' A' ' 127' ' ' LYS . . . -37.63 150.82 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 O-C-N 122.056 -0.403 . . . . 0.0 111.48 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -26.99 -28.58 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 123' ' ' ALA . . . 129.93 -36.04 2.42 Favored Glycine 0 N--CA 1.493 2.448 0 O-C-N 120.282 -1.511 . . . . 0.0 110.61 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -87.92 93.64 9.53 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.761 -1.435 . . . . 0.0 107.14 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.866 ' CB ' HD23 ' A' ' 78' ' ' LEU . 8.3 ttpt -134.3 119.12 14.17 Favored Pre-proline 0 C--N 1.305 -1.35 0 O-C-N 121.226 -0.921 . . . . 0.0 111.19 -178.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -88.29 19.33 1.34 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 N-CA-C 108.178 -1.508 . . . . 0.0 108.178 176.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.688 ' O ' ' N ' ' A' ' 131' ' ' LEU . 0.7 OUTLIER -119.6 41.16 3.2 Favored 'General case' 0 C--O 1.203 -1.38 0 O-C-N 121.3 -0.875 . . . . 0.0 110.727 -177.345 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -37.4 74.6 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 123.236 1.493 . . . . 0.0 110.894 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.701 HD21 ' HA ' ' A' ' 121' ' ' ALA . 0.2 OUTLIER -68.17 107.14 2.65 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 113.469 -1.696 . . . . 0.0 110.938 -176.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.634 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 0.9 OUTLIER -137.4 48.02 2.06 Favored 'General case' 0 N--CA 1.52 3.071 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 178.153 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.665 ' H ' ' N ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER 173.22 108.69 0.06 OUTLIER Pre-proline 0 N--CA 1.51 2.545 0 O-C-N 119.147 -2.22 . . . . 0.0 112.051 174.444 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -134.48 119.46 0.0 OUTLIER 'Cis proline' 0 C--N 1.31 -1.466 0 N-CA-C 103.958 -3.131 . . . . 0.0 103.958 -9.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.95 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -111.67 44.76 1.44 Allowed Glycine 0 N--CA 1.509 3.501 0 C-N-CA 118.063 -2.018 . . . . 0.0 113.106 -175.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.418 ' C ' ' O ' ' A' ' 135' ' ' GLY . 66.4 m170 31.0 37.31 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 122.246 1.022 . . . . 0.0 111.59 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 135' ' ' GLY . 45.1 t -108.91 125.08 65.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.578 ' HZ ' HG23 ' A' ' 65' ' ' ILE . 2.4 p90 -118.77 85.27 27.39 Favored Pre-proline 0 C--N 1.294 -1.818 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.339 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.939 ' O ' HD23 ' A' ' 140' ' ' LEU . 47.6 Cg_endo -95.46 153.36 1.58 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 N-CA-C 108.362 -1.438 . . . . 0.0 108.362 178.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.939 HD23 ' O ' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -150.37 153.03 35.31 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.788 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -65.01 120.0 11.81 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.39 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -129.49 133.12 47.1 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.091 -1.006 . . . . 0.0 111.472 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -78.05 143.73 37.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -0.835 . . . . 0.0 109.627 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.661 ' HB2' HG22 ' A' ' 158' ' ' ILE . . . -103.76 115.51 30.61 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.293 -0.879 . . . . 0.0 111.487 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.422 ' N ' ' OD2' ' A' ' 159' ' ' ASP . . . 117.57 -14.82 13.01 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.55 12.97 56.77 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 1.022 ' CG1' HG11 ' A' ' 206' ' ' VAL . 4.9 p -73.36 -24.61 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.148 -1.207 . . . . 0.0 110.968 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.98 17.95 7.29 Favored 'General case' 0 C--O 1.208 -1.13 0 C-N-CA 115.472 -2.491 . . . . 0.0 110.506 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 25.3 m -131.19 59.55 1.68 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 100.778 -3.786 . . . . 0.0 100.778 166.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.404 ' NE ' ' OE1' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -151.85 148.21 27.55 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 113.76 -1.564 . . . . 0.0 112.432 -178.277 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -104.27 35.3 5.14 Favored Glycine 0 N--CA 1.482 1.756 0 N-CA-C 106.179 -2.768 . . . . 0.0 106.179 173.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.1 135.19 6.11 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.935 ' CD2' HD12 ' A' ' 202' ' ' ILE . 54.1 m80 -74.51 -5.18 41.27 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.241 -1.152 . . . . 0.0 109.666 177.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.413 ' O ' ' OG1' ' A' ' 157' ' ' THR . 59.4 p -53.73 -56.71 15.02 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.942 -1.099 . . . . 0.0 109.687 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.443 ' C ' ' HB ' ' A' ' 147' ' ' VAL . 2.9 mp0 -58.02 -21.66 46.07 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.783 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . . . -83.71 6.26 21.7 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.571 -0.705 . . . . 0.0 109.818 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 153' ' ' HIS . 59.8 p -93.49 -49.26 5.99 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.872 HD11 ' HA ' ' A' ' 70' ' ' ILE . 0.3 OUTLIER -80.09 -32.31 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 116.703 -1.999 . . . . 0.0 107.259 177.557 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.502 ' OD1' HG13 ' A' ' 206' ' ' VAL . 8.7 t70 -61.29 -33.76 74.1 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 105.375 -2.084 . . . . 0.0 105.375 174.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.921 HD11 ' C ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -47.22 -41.25 18.04 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 175.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.488 ' SD ' HD12 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -57.97 -48.4 80.08 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.911 178.508 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.461 ' N ' ' HG2' ' A' ' 161' ' ' MET . 0.0 OUTLIER -63.85 -34.85 78.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.009 -1.057 . . . . 0.0 111.698 -178.756 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 1.086 HD13 HD21 ' A' ' 205' ' ' LEU . 1.7 pp -93.33 -30.87 14.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.925 -1.109 . . . . 0.0 111.763 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.923 ' HA ' HD11 ' A' ' 20' ' ' LEU . . . -115.15 38.02 3.33 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -178.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 167' ' ' LYS . . . 112.78 70.61 0.56 Allowed Glycine 0 N--CA 1.513 3.784 0 C-N-CA 116.667 -2.683 . . . . 0.0 109.831 -177.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.496 ' O ' ' CD2' ' A' ' 166' ' ' PHE . 54.3 p90 -62.43 70.67 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 123.486 1.612 . . . . 0.0 115.099 -172.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.473 ' N ' ' O ' ' A' ' 165' ' ' GLY . 0.0 OUTLIER -113.22 131.95 22.65 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 100.792 -3.781 . . . . 0.0 100.792 171.49 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.806 ' O ' HG23 ' A' ' 70' ' ' ILE . 38.1 Cg_endo -63.58 89.84 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 116.636 -1.776 . . . . 0.0 112.412 -173.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.71 ' HB1' ' HB3' ' A' ' 47' ' ' ALA 0.262 . . -158.18 153.8 26.3 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 176.085 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 157' ' ' THR . . . -147.37 113.52 0.65 Allowed Glycine 0 N--CA 1.497 2.739 0 C-N-CA 117.24 -2.41 . . . . 0.0 110.535 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.947 HG22 ' O ' ' A' ' 45' ' ' PHE . 1.1 m -125.72 144.02 37.23 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.447 0 C-N-CA 117.172 -1.811 . . . . 0.0 109.791 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.555 HD13 ' O ' ' A' ' 171' ' ' VAL . 0.1 OUTLIER -159.69 113.63 2.27 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 177.269 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.487 ' HB3' ' HE2' ' A' ' 43' ' ' MET . 1.9 t -126.96 178.0 6.26 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 119.642 -1.911 . . . . 0.0 112.042 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.414 ' HA ' ' OD2' ' A' ' 42' ' ' ASP . 1.6 tm-20 -120.62 148.35 44.01 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.924 -1.11 . . . . 0.0 110.27 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.822 HD22 ' O ' ' A' ' 188' ' ' CYS . 1.6 tp -69.57 93.07 0.67 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.038 -1.039 . . . . 0.0 110.11 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 9.5 t -139.0 153.69 48.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 110.15 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.453 ' CB ' ' HA2' ' A' ' 62' ' ' GLY . 55.4 t-20 -121.13 157.01 31.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 110.042 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 178' ' ' ASP . 21.5 p-10 -85.51 6.52 26.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.261 -0.899 . . . . 0.0 111.248 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.08 -22.16 20.87 Favored 'General case' 0 C--N 1.29 -2.011 0 O-C-N 121.566 -0.709 . . . . 0.0 110.289 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 105.72 46.0 1.25 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 26.9 m -92.28 159.15 15.75 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.36 -1.082 . . . . 0.0 109.945 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 11.5 mtm -82.69 53.19 2.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.415 -0.803 . . . . 0.0 110.389 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' ' 175' ' ' LEU . . . -105.31 85.22 2.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.202 -0.936 . . . . 0.0 110.111 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.626 ' O ' ' HB3' ' A' ' 185' ' ' ALA . 0.2 OUTLIER -140.11 162.15 35.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.876 . . . . 0.0 110.401 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.929 ' HB2' ' OE1' ' A' ' 35' ' ' GLU . . . 68.9 174.83 0.08 OUTLIER Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.42 -0.8 . . . . 0.0 110.865 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.835 ' HD2' ' HB1' ' A' ' 185' ' ' ALA . 41.1 Cg_endo -66.38 -10.5 27.83 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.481 1.253 . . . . 0.0 110.957 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -72.9 -55.01 7.23 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.046 -1.034 . . . . 0.0 109.864 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' CYS . . . . . 0.822 ' O ' HD22 ' A' ' 175' ' ' LEU . 24.0 p -58.79 -39.53 81.37 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.271 -0.893 . . . . 0.0 110.059 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.717 HG13 HD11 ' A' ' 199' ' ' LEU . 8.7 tp -73.63 -22.59 18.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 118.018 -1.473 . . . . 0.0 109.071 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -56.78 -33.63 66.83 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.438 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.1 OUTLIER -66.03 -40.63 91.18 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.501 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.639 ' HB2' HD13 ' A' ' 175' ' ' LEU . . . -60.32 -49.32 78.05 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.969 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ASN . . . . . 0.606 ' HA ' ' CB ' ' A' ' 197' ' ' MET . 0.1 OUTLIER -73.03 -11.49 60.58 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.282 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -73.75 -34.78 64.88 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 117.47 -1.692 . . . . 0.0 111.365 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -112.11 -52.47 2.78 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 116.165 -2.214 . . . . 0.0 111.489 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -114.2 32.6 5.79 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 117.859 -1.536 . . . . 0.0 114.238 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' MET . . . . . 0.944 ' SD ' HD13 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -153.12 147.44 25.81 Favored 'General case' 0 N--CA 1.517 2.918 0 CA-C-N 123.396 2.816 . . . . 0.0 115.912 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.804 ' HB3' ' O ' ' A' ' 28' ' ' GLY . . . -95.36 127.62 41.55 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 175.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.749 ' C ' HD13 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -114.92 107.35 15.28 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 120.41 -1.431 . . . . 0.0 113.512 -176.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 1.03 HG11 HD12 ' A' ' 205' ' ' LEU . 4.4 p -100.05 -173.02 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.245 -0.91 . . . . 0.0 110.07 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.705 HG23 ' H ' ' A' ' 204' ' ' ASP . 4.4 t -111.98 165.08 12.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.071 -1.018 . . . . 0.0 109.796 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.935 HD12 ' CD2' ' A' ' 153' ' ' HIS . 9.9 tt -81.39 -14.27 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.044 -1.035 . . . . 0.0 111.298 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 207' ' ' ALA . 2.1 mt-10 -90.1 -43.63 10.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.934 -1.104 . . . . 0.0 110.598 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.705 ' H ' HG23 ' A' ' 201' ' ' THR . 3.9 t70 -85.48 -14.73 45.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 111.404 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 1.086 HD21 HD13 ' A' ' 163' ' ' LEU . 10.5 tt -77.0 -53.57 7.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.81 -1.181 . . . . 0.0 110.914 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 1.022 HG11 ' CG1' ' A' ' 147' ' ' VAL . 1.1 t -76.75 -29.33 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 117.875 -1.53 . . . . 0.0 107.765 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 203' ' ' GLU . . . -57.1 -30.95 64.79 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.656 ' CD2' HG11 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -62.82 -44.7 95.45 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 177.605 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.439 ' CD ' ' HB ' ' A' ' 162' ' ' THR . 54.7 ttt-85 -61.62 -52.15 65.58 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.739 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.76 -57.61 5.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 110.446 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 207' ' ' ALA . . . -51.51 -23.95 4.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.417 -0.802 . . . . 0.0 110.414 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' HIS . . . . . 0.404 ' HB2' ' O ' ' A' ' 208' ' ' TYR . 2.0 t60 -82.97 -25.55 32.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.241 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.41 24.91 10.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.186 -0.946 . . . . 0.0 110.183 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -92.6 148.13 22.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.261 -0.899 . . . . 0.0 110.194 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -63.02 86.21 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.932 . . . . 0.0 110.181 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -142.71 160.48 40.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.185 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.191 179.955 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.235 0.541 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -97.83 55.26 1.18 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 0.0 110.234 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.407 ' HG3' ' CE2' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -74.51 -11.49 60.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.93 . . . . 0.0 110.594 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.2 p -68.97 -8.1 41.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.076 -1.015 . . . . 0.0 110.866 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.76 HD23 ' OH ' ' A' ' 208' ' ' TYR . 0.1 OUTLIER -50.88 -24.87 3.9 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.871 -1.143 . . . . 0.0 110.413 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.076 ' CD2' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -112.04 -15.56 13.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.212 -0.93 . . . . 0.0 110.115 179.651 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.9 m -92.49 -42.91 9.46 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.09 -1.006 . . . . 0.0 109.786 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.1 p -94.14 25.48 3.75 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.746 0.784 . . . . 0.0 109.288 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.9 79.79 1.73 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.39 92.3 1.29 Allowed Glycine 0 C--N 1.291 -1.959 0 N-CA-C 106.089 -2.805 . . . . 0.0 106.089 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.826 HG22 ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -127.32 168.24 15.5 Favored Pre-proline 0 C--N 1.27 -2.878 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.826 ' HD2' HG22 ' A' ' 11' ' ' THR . 18.1 Cg_endo -42.08 -19.22 0.1 OUTLIER 'Trans proline' 0 N--CA 1.518 2.921 0 CA-C-N 122.499 1.928 . . . . 0.0 109.321 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.878 ' O ' HG22 ' A' ' 16' ' ' VAL . 1.8 m-30 -51.54 -16.28 0.58 Allowed 'General case' 0 C--O 1.183 -2.413 0 O-C-N 119.747 -1.845 . . . . 0.0 106.619 168.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.684 ' N ' ' O ' ' A' ' 11' ' ' THR . 2.8 mt-10 -44.45 -36.1 2.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.109 -1.62 . . . . 0.0 109.239 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -42.24 90.85 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 176.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 1.076 HG23 ' CD2' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -74.91 -29.44 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.183 175.626 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.783 ' HA ' HD23 ' A' ' 6' ' ' LEU . 9.2 tt0 -56.64 -56.41 21.74 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.292 -1.505 . . . . 0.0 107.749 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 50.4 t-20 -53.35 -25.96 17.22 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.206 -0.997 . . . . 0.0 108.336 177.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.832 ' HB3' ' O ' ' A' ' 16' ' ' VAL . . . -70.78 -66.43 0.61 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.588 0.709 . . . . 0.0 110.701 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.958 HD13 ' CD1' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -78.92 -33.01 45.86 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.204 -0.935 . . . . 0.0 110.942 -178.604 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 17' ' ' GLU . . . -56.09 -32.5 64.2 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 18' ' ' ASN . . . -67.0 -35.79 80.74 Favored 'General case' 0 C--O 1.207 -1.166 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 176.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.875 HD12 HG23 ' A' ' 29' ' ' VAL . 3.1 tt -48.51 -26.24 2.07 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.164 -0.96 . . . . 0.0 109.75 178.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -91.06 -26.16 19.3 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.807 0.813 . . . . 0.0 108.833 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 22' ' ' ALA . 0.3 OUTLIER -144.42 78.98 1.59 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 177.436 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 126.0 52.59 0.16 Allowed Glycine 0 C--N 1.281 -2.499 1 N-CA-C 101.63 -4.588 . . . . 0.0 101.63 -173.147 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.542 ' HA ' ' HA ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -56.18 80.6 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 122.936 1.35 . . . . 0.0 111.308 -173.526 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 26' ' ' GLY . . . 172.76 104.75 0.18 Allowed Glycine 0 N--CA 1.489 2.201 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.49 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.875 HG23 HD12 ' A' ' 23' ' ' LEU . 1.5 t -116.48 121.77 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.815 ' CE ' ' HB3' ' A' ' 192' ' ' ALA . 0.0 OUTLIER -111.77 131.48 55.29 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 117.996 -1.482 . . . . 0.0 110.52 -178.798 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 200' ' ' VAL . 14.7 p -121.48 128.94 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.435 -0.791 . . . . 0.0 110.219 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.752 ' O ' HG22 ' A' ' 201' ' ' THR . 2.6 tt -174.9 164.25 3.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -0.894 . . . . 0.0 110.11 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.493 ' N ' HD23 ' A' ' 32' ' ' LEU . 22.4 t0 -174.98 -66.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.277 -0.89 . . . . 0.0 110.193 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.24 100.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 0.0 110.19 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.12 62.23 0.31 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.9 . . . . 0.0 110.199 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.71 -54.38 9.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 110.256 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -174.31 -72.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.894 . . . . 0.0 110.185 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.41 100.72 6.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.326 -0.859 . . . . 0.0 110.177 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.574 ' CB ' HD11 ' A' ' 32' ' ' LEU . 2.5 m-20 -122.44 138.56 54.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.896 . . . . 0.0 110.212 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.45 ' OE1' ' HA ' ' A' ' 173' ' ' CYS . 18.6 mm-40 -95.8 -171.1 2.27 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.236 -0.915 . . . . 0.0 109.912 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.441 ' C ' ' HA ' ' A' ' 30' ' ' MET . . . 166.61 -61.58 0.22 Allowed Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.496 -1.335 . . . . 0.0 110.844 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.878 ' OD2' HD22 ' A' ' 57' ' ' LEU . 28.9 t70 -36.75 -31.6 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.731 0 O-C-N 121.619 -0.93 . . . . 0.0 112.078 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.602 ' O ' ' O ' ' A' ' 171' ' ' VAL . 0.7 OUTLIER -94.66 52.42 1.52 Allowed 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 122.175 0.988 . . . . 0.0 113.094 -178.017 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.854 HD11 ' CD1' ' A' ' 163' ' ' LEU . 13.0 tt -63.48 19.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.846 0 O-C-N 119.399 -2.063 . . . . 0.0 113.154 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.676 ' CZ ' HD21 ' A' ' 23' ' ' LEU . 2.9 m-85 -81.92 162.97 55.58 Favored Pre-proline 0 N--CA 1.498 1.93 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -175.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.507 ' HD2' ' CD2' ' A' ' 45' ' ' PHE . 51.3 Cg_endo -69.82 131.23 20.71 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.642 2.228 . . . . 0.0 110.719 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.946 ' HB3' ' HB1' ' A' ' 169' ' ' ALA . . . -67.58 -20.45 65.38 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.297 -0.961 . . . . 0.0 112.029 -178.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.624 ' HA ' HG21 ' A' ' 122' ' ' ILE . 20.6 tt0 -76.52 -35.08 58.52 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.838 -1.163 . . . . 0.0 111.078 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.503 HG23 ' HG2' ' A' ' 46' ' ' PRO . 4.7 t -132.87 58.81 1.75 Allowed 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.718 ' HB3' HG21 ' A' ' 171' ' ' VAL . 0.3 OUTLIER -65.4 88.13 0.08 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 179.069 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.539 ' HA ' HG12 ' A' ' 115' ' ' ILE . 11.4 m -59.07 170.04 0.96 Allowed 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.713 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.715 HG23 ' HB1' ' A' ' 111' ' ' ALA . 2.7 p -83.16 -2.3 6.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 O-C-N 121.341 -0.85 . . . . 0.0 110.063 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.405 ' HG3' ' HD2' ' A' ' 27' ' ' ARG . 0.8 OUTLIER -63.28 -44.77 94.16 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.481 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.466 ' HB2' ' HG3' ' A' ' 43' ' ' MET . 0.0 OUTLIER -76.19 -35.83 58.94 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.458 178.637 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.474 ' HA ' ' OG1' ' A' ' 58' ' ' THR . 0.0 OUTLIER -70.51 -27.8 64.47 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.143 -0.973 . . . . 0.0 108.525 178.407 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 52' ' ' VAL . . . -56.46 -47.83 78.36 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.754 -0.591 . . . . 0.0 109.709 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.878 HD22 ' OD2' ' A' ' 42' ' ' ASP . 6.7 tt -60.04 -56.81 17.11 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.026 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.64 ' N ' HD23 ' A' ' 57' ' ' LEU . 2.6 p -53.39 -36.0 60.97 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.423 -0.798 . . . . 0.0 109.79 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' A' ' 111' ' ' ALA . 51.2 mt -84.48 -11.33 11.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.568 -0.708 . . . . 0.0 109.178 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -51.53 -51.94 51.14 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.749 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.479 ' CD2' ' HB3' ' A' ' 178' ' ' ASP . 0.1 OUTLIER -125.51 -37.38 2.36 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 116.583 -2.047 . . . . 0.0 112.07 176.143 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' A' ' 176' ' ' THR . . . 175.02 107.53 0.21 Allowed Glycine 0 N--CA 1.499 2.839 0 C-N-CA 118.834 -1.65 . . . . 0.0 111.413 174.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.499 ' HB2' ' CA ' ' A' ' 58' ' ' THR . 0.6 OUTLIER -165.89 99.99 0.66 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 120.227 2.013 . . . . 0.0 105.69 172.476 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.477 ' HA3' ' CG1' ' A' ' 109' ' ' VAL . . . -123.46 55.77 0.69 Allowed Glycine 0 C--N 1.283 -2.407 0 N-CA-C 106.364 -2.694 . . . . 0.0 106.364 176.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.465 HD13 ' HA ' ' A' ' 65' ' ' ILE . 20.5 mm -147.68 104.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 113.838 -1.181 . . . . 0.0 109.411 175.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.809 HG11 ' HB ' ' A' ' 171' ' ' VAL . 25.5 t -114.96 154.28 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.568 -1.332 . . . . 0.0 110.66 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 138' ' ' PHE . 0.4 OUTLIER -92.15 120.16 32.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.022 -1.674 . . . . 0.0 108.524 178.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.754 ' CD1' ' HB1' ' A' ' 47' ' ' ALA . 3.6 mm? -89.47 98.43 11.76 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.492 ' HB2' ' N ' ' A' ' 170' ' ' GLY . 66.3 m -66.1 129.1 38.63 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.638 -0.664 . . . . 0.0 109.779 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.762 HD11 ' HD3' ' A' ' 75' ' ' ARG . 10.4 tt -153.99 164.79 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.928 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.45 HG22 ' H ' ' A' ' 72' ' ' GLU . 2.1 m -124.85 175.72 7.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.426 -0.797 . . . . 0.0 109.946 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.45 ' H ' HG22 ' A' ' 71' ' ' THR . 13.8 tt0 -73.91 -9.2 58.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.246 -0.909 . . . . 0.0 110.775 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -88.26 -39.87 14.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.972 -1.08 . . . . 0.0 110.53 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.84 -35.87 59.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.246 -0.909 . . . . 0.0 110.188 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.797 ' CZ ' HD12 ' A' ' 99' ' ' ILE . 0.1 OUTLIER -78.48 -29.82 47.0 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.219 1.009 . . . . 0.0 108.6 179.095 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -53.15 -66.04 0.46 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.198 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -47.64 -33.37 6.65 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 122.089 0.947 . . . . 0.0 109.224 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.512 HD21 ' CD2' ' A' ' 131' ' ' LEU . 19.1 tp -96.55 47.13 1.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 175.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 76' ' ' LYS . 1.2 m-20 -22.39 83.9 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 124.458 2.075 . . . . 0.0 112.471 -171.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.692 HD22 ' HD2' ' A' ' 81' ' ' PRO . 3.5 tm? -147.42 112.54 4.03 Favored Pre-proline 0 C--N 1.292 -1.905 0 CA-C-N 111.073 -2.785 . . . . 0.0 109.574 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.692 ' HD2' HD22 ' A' ' 80' ' ' LEU . 46.5 Cg_endo -72.26 99.37 1.01 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.317 1.167 . . . . 0.0 111.046 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.466 ' O ' ' CG ' ' A' ' 82' ' ' MET . 3.6 ptt? -87.0 83.95 7.41 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.323 -0.861 . . . . 0.0 109.386 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.57 ' H ' HG23 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -147.47 67.35 1.13 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.94 -1.1 . . . . 0.0 110.899 -179.257 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.707 ' CG2' HG22 ' A' ' 97' ' ' VAL . 82.8 t -85.91 104.39 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.046 -1.033 . . . . 0.0 109.217 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -98.75 26.73 5.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.129 -0.982 . . . . 0.0 111.219 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -89.95 17.45 6.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.901 -1.124 . . . . 0.0 110.325 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.481 ' HB2' ' HA ' ' A' ' 93' ' ' THR . 31.5 m-80 -107.85 82.76 1.69 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.213 -0.929 . . . . 0.0 110.163 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.456 HG22 ' H ' ' A' ' 89' ' ' SER . 0.2 OUTLIER 54.84 -152.97 0.33 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.055 -1.028 . . . . 0.0 109.956 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.456 ' H ' HG22 ' A' ' 88' ' ' THR . 17.6 t -101.37 -60.57 1.5 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.124 -0.985 . . . . 0.0 110.679 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.12 26.49 3.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.194 -0.941 . . . . 0.0 110.116 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.05 79.4 1.25 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.44 -0.787 . . . . 0.0 109.918 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.3 42.82 11.27 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.481 ' HA ' ' HB2' ' A' ' 87' ' ' ASN . 9.3 p -48.3 -20.01 0.35 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.403 -1.057 . . . . 0.0 111.654 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.27 26.02 4.57 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 120.656 -1.278 . . . . 0.0 110.676 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -61.96 47.16 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.052 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -178.581 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.474 HG21 ' N ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -130.34 75.48 1.66 Allowed 'General case' 0 C--N 1.292 -1.906 0 O-C-N 121.303 -0.873 . . . . 0.0 110.997 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.707 HG22 ' CG2' ' A' ' 84' ' ' VAL . 90.3 t -43.98 145.4 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.493 0 O-C-N 120.458 -1.401 . . . . 0.0 110.83 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.614 HG22 ' O ' ' A' ' 137' ' ' VAL . 1.0 OUTLIER -73.98 -174.96 2.01 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.774 0.797 . . . . 0.0 112.329 -177.141 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.797 HD12 ' CZ ' ' A' ' 75' ' ' ARG 0.302 0.1 OUTLIER -149.24 123.55 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -178.049 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 132' ' ' ASN . 3.9 tm-20 -91.2 105.36 17.74 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 117.775 -1.57 . . . . 0.0 112.715 -176.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 105' ' ' VAL . . . -50.6 96.43 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.132 -0.98 . . . . 0.0 110.169 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 130' ' ' ASP . . . -103.16 2.87 35.12 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.114 -0.992 . . . . 0.0 110.061 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.429 ' HB3' ' CB ' ' A' ' 130' ' ' ASP . 7.7 pt-20 -112.26 45.36 1.29 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.066 -1.021 . . . . 0.0 111.448 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.538 ' O ' HG21 ' A' ' 117' ' ' THR . . . 127.65 -37.68 2.28 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 118.946 -1.597 . . . . 0.0 112.723 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.991 HG21 ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -101.43 121.76 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 O-C-N 120.823 -1.398 . . . . 0.0 111.113 -178.619 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.4 p -144.3 58.53 1.33 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.599 -1.24 . . . . 0.0 110.975 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.877 HG21 ' OG ' ' A' ' 110' ' ' SER . 23.9 m -139.52 -32.33 0.65 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.953 -1.092 . . . . 0.0 110.86 176.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.622 ' CA ' ' CE1' ' A' ' 136' ' ' HIS . . . 74.11 -31.96 0.94 Allowed Glycine 0 N--CA 1.493 2.467 0 O-C-N 121.688 -0.632 . . . . 0.0 111.526 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.477 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -131.02 58.0 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.707 -1.466 . . . . 0.0 109.84 179.298 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.877 ' OG ' HG21 ' A' ' 107' ' ' THR . 0.4 OUTLIER -129.54 57.04 1.68 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.028 -1.045 . . . . 0.0 109.579 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.825 ' O ' HD13 ' A' ' 115' ' ' ILE . . . -32.9 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -85.14 -77.48 0.28 Allowed 'General case' 0 C--N 1.288 -2.095 0 O-C-N 120.554 -1.342 . . . . 0.0 109.558 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.02 -16.64 19.43 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.411 -0.806 . . . . 0.0 110.366 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.605 ' HG3' HG23 ' A' ' 118' ' ' VAL . 0.4 OUTLIER -88.77 -36.61 16.01 Favored 'General case' 0 C--O 1.2 -1.552 0 O-C-N 121.063 -1.023 . . . . 0.0 110.869 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.825 HD13 ' O ' ' A' ' 111' ' ' ALA . 0.9 OUTLIER -59.97 -17.19 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 C-N-CA 117.971 -1.491 . . . . 0.0 109.183 -179.153 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.8 m -89.09 -57.48 2.88 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.459 1.123 . . . . 0.0 108.491 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.937 ' OG1' HG13 ' A' ' 105' ' ' VAL . 2.0 p -62.71 -32.42 73.52 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.138 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.605 HG23 ' HG3' ' A' ' 114' ' ' ARG . 9.8 t -54.47 -47.55 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 -48.06 -29.46 3.56 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 117' ' ' THR . . . -85.69 -40.08 16.53 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.676 178.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.991 ' HB2' HG21 ' A' ' 105' ' ' VAL . . . -58.11 -50.77 72.32 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.756 -1.215 . . . . 0.0 109.798 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.687 HG22 ' O ' ' A' ' 122' ' ' ILE . 26.5 mm -87.52 27.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.493 0.663 . . . . 0.0 109.741 178.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.529 ' HB2' ' O ' ' A' ' 120' ' ' ALA . . . -37.42 148.36 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.744 0.783 . . . . 0.0 112.37 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -41.37 -7.61 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 123' ' ' ALA . . . 131.61 28.87 0.61 Allowed Glycine 0 N--CA 1.495 2.633 0 O-C-N 119.8 -1.812 . . . . 0.0 110.775 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.78 167.62 13.03 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.31 -1.112 . . . . 0.0 108.504 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.98 124.07 82.35 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.32 16.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.51 1.268 . . . . 0.0 113.149 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.82 -27.62 65.26 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.177 -1.577 . . . . 0.0 108.768 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.749 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 38.5 m-20 -94.79 27.19 3.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.282 -0.886 . . . . 0.0 109.644 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.748 ' CG ' HG23 ' A' ' 99' ' ' ILE . 9.2 tp -141.38 83.88 1.89 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.274 -0.891 . . . . 0.0 109.191 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.541 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 3.4 m120 -120.32 101.11 7.57 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.099 -1.0 . . . . 0.0 111.995 -178.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.597 ' CB ' ' HA ' ' A' ' 134' ' ' PRO . 0.0 OUTLIER -83.15 -179.01 1.32 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.404 -0.81 . . . . 0.0 111.011 -178.403 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.597 ' HA ' ' CB ' ' A' ' 133' ' ' ARG . 48.6 Cg_endo -73.01 130.31 19.74 Favored 'Cis proline' 0 N--CA 1.5 1.863 0 C-N-CA 123.119 -1.617 . . . . 0.0 113.148 8.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.538 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -132.3 67.95 0.55 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.622 ' CE1' ' CA ' ' A' ' 108' ' ' GLY . 24.5 p80 32.08 36.59 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.484 0 O-C-N 122.105 -0.644 . . . . 0.0 112.075 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.614 ' O ' HG22 ' A' ' 98' ' ' THR . 13.4 t -91.04 154.2 3.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 176.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.681 ' HD1' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -145.34 81.6 10.23 Favored Pre-proline 0 C--N 1.287 -2.139 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -178.667 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.477 ' HD3' HG12 ' A' ' 137' ' ' VAL . 52.3 Cg_endo -99.56 159.9 0.57 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.375 2.05 . . . . 0.0 111.857 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.741 ' HB3' HG21 ' A' ' 157' ' ' THR . 10.9 tp -126.54 113.16 16.41 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -63.72 151.33 42.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.307 -0.871 . . . . 0.0 109.404 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.506 ' CA ' ' HA ' ' A' ' 156' ' ' ALA . . . -62.63 98.19 0.11 Allowed 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.039 0.924 . . . . 0.0 111.821 -177.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 156' ' ' ALA . 1.0 OUTLIER -100.68 146.8 26.74 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.153 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.79 116.0 31.16 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.669 -1.269 . . . . 0.0 112.592 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 112.67 -6.32 26.1 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.063 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.09 9.08 61.29 Favored Glycine 0 N--CA 1.502 3.048 0 C-N-CA 118.466 -1.826 . . . . 0.0 112.788 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.944 HG22 HG13 ' A' ' 202' ' ' ILE . 1.0 OUTLIER -116.48 -45.15 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.24 -1.741 . . . . 0.0 108.51 177.41 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.995 HD22 ' HB2' ' A' ' 150' ' ' ARG . 0.3 OUTLIER -106.77 84.29 1.97 Allowed 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 177.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.425 ' O ' ' CD ' ' A' ' 150' ' ' ARG . 5.1 m -74.3 63.96 1.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 125.335 2.493 . . . . 0.0 104.488 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.995 ' HB2' HD22 ' A' ' 148' ' ' LEU . 12.5 mmt180 -152.68 162.58 41.06 Favored 'General case' 0 C--N 1.271 -2.83 0 N-CA-C 100.23 -3.989 . . . . 0.0 100.23 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -60.57 55.91 0.02 OUTLIER Glycine 0 C--N 1.258 -3.772 0 C-N-CA 117.686 -2.197 . . . . 0.0 112.537 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 150' ' ' ARG . . . -119.28 128.7 7.73 Favored Glycine 0 C--O 1.215 -1.058 0 N-CA-C 106.28 -2.728 . . . . 0.0 106.28 176.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -90.72 1.35 56.93 Favored 'General case' 0 C--N 1.282 -2.344 0 O-C-N 121.969 -0.724 . . . . 0.0 109.312 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.85 ' OG1' HG11 ' A' ' 206' ' ' VAL . 1.9 p -51.52 -18.41 1.09 Allowed 'General case' 0 C--O 1.258 1.521 0 O-C-N 121.389 -0.819 . . . . 0.0 112.476 -176.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.733 ' O ' ' N ' ' A' ' 157' ' ' THR . 5.2 tp10 -48.0 -26.59 1.84 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.295 -0.962 . . . . 0.0 108.509 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.621 ' O ' ' N ' ' A' ' 158' ' ' ILE . . . -46.71 90.82 0.0 OUTLIER 'General case' 0 C--O 1.203 -1.379 0 N-CA-C 103.15 -2.908 . . . . 0.0 103.15 170.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.741 HG21 ' HB3' ' A' ' 140' ' ' LEU . 69.3 p -49.77 12.44 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -168.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.63 ' O ' ' HG3' ' A' ' 161' ' ' MET . 0.9 OUTLIER -107.75 -4.05 10.27 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.402 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 172.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.595 ' CB ' ' HA ' ' A' ' 154' ' ' THR . 0.2 OUTLIER -89.09 -33.57 17.06 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 103.174 -2.898 . . . . 0.0 103.174 173.778 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.989 ' HA ' HD23 ' A' ' 163' ' ' LEU . 2.3 mp -62.21 -51.6 67.14 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.74 176.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.63 ' HG3' ' O ' ' A' ' 158' ' ' ILE . 0.0 OUTLIER -48.74 -33.65 10.63 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.394 -1.441 . . . . 0.0 108.553 178.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.922 HG21 ' CZ ' ' A' ' 209' ' ' ARG . 1.3 m -57.88 -39.62 78.26 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 119.311 -0.955 . . . . 0.0 108.549 178.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.989 HD23 ' HA ' ' A' ' 160' ' ' LEU . 0.6 OUTLIER -67.26 -8.65 33.47 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.288 -0.965 . . . . 0.0 109.765 178.315 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.52 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -106.36 7.64 31.29 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 120.674 -1.266 . . . . 0.0 110.758 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.593 ' HA2' HD13 ' A' ' 5' ' ' LEU . . . 49.38 30.42 11.98 Favored Glycine 0 N--CA 1.5 2.951 0 N-CA-C 107.076 -2.41 . . . . 0.0 107.076 -177.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.502 ' CE1' ' HG3' ' A' ' 46' ' ' PRO . 1.9 m-85 -120.19 146.1 46.34 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 122.828 1.299 . . . . 0.0 112.337 -176.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 169' ' ' ALA . 6.7 mtmm -43.9 139.33 2.98 Favored Pre-proline 0 N--CA 1.502 2.128 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.529 ' HB2' HG13 ' A' ' 158' ' ' ILE . 36.6 Cg_endo -61.89 84.93 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.033 0 C-N-CA 117.012 -1.526 . . . . 0.0 113.767 -172.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.946 ' HB1' ' HB3' ' A' ' 47' ' ' ALA . . . -156.04 162.69 40.27 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 172.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.496 ' N ' ' HB2' ' A' ' 47' ' ' ALA . . . -158.12 131.97 3.0 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 117.358 -2.353 . . . . 0.0 111.361 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.809 ' HB ' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -119.71 89.5 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 117.969 -1.492 . . . . 0.0 107.138 176.6 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.568 ' HA ' ' HB3' ' A' ' 43' ' ' MET . 3.0 mp -95.68 138.35 33.47 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.253 0.549 . . . . 0.0 110.374 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.57 ' SG ' HG21 ' A' ' 58' ' ' THR . 2.8 t -129.59 176.2 8.18 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.897 -1.127 . . . . 0.0 111.064 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.414 ' N ' ' OE1' ' A' ' 40' ' ' GLU . 2.7 tt0 -111.45 -179.46 3.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.201 -0.937 . . . . 0.0 110.06 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.769 HD13 ' N ' ' A' ' 176' ' ' THR . 3.5 tm? -104.61 141.24 36.77 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.108 -0.995 . . . . 0.0 110.001 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.769 ' N ' HD13 ' A' ' 175' ' ' LEU . 93.0 m -123.17 155.43 37.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.944 . . . . 0.0 110.382 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.85 171.41 7.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.437 -0.789 . . . . 0.0 110.12 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.479 ' HB3' ' CD2' ' A' ' 61' ' ' HIS . 10.1 p-10 -89.56 5.76 44.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.295 -0.878 . . . . 0.0 111.361 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -72.56 -19.72 61.45 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 121.602 -0.686 . . . . 0.0 109.981 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 90.09 29.64 14.58 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 83.8 m -137.09 147.74 46.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -1.148 . . . . 0.0 110.182 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.42 ' CG ' ' O ' ' A' ' 182' ' ' MET . 0.7 OUTLIER -53.35 95.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.253 -0.904 . . . . 0.0 110.173 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.93 ' HB1' ' SG ' ' A' ' 188' ' ' CYS . . . -71.44 107.24 4.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.191 -0.943 . . . . 0.0 110.245 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 185' ' ' ALA . 0.1 OUTLIER -140.23 100.2 3.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.901 . . . . 0.0 109.827 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.857 ' HB1' ' HD2' ' A' ' 186' ' ' PRO . . . -179.37 178.08 0.34 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.31 -0.869 . . . . 0.0 109.891 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.857 ' HD2' ' HB1' ' A' ' 185' ' ' ALA . 45.3 Cg_endo -71.82 -16.92 29.49 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.608 1.32 . . . . 0.0 110.413 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -79.46 -31.56 42.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.087 -1.008 . . . . 0.0 110.067 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' CYS . . . . . 0.93 ' SG ' ' HB1' ' A' ' 183' ' ' ALA . 14.0 m -74.35 -56.63 4.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.325 -0.859 . . . . 0.0 110.186 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.542 ' O ' ' HE1' ' A' ' 30' ' ' MET . 2.5 tp -61.7 -22.97 29.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.994 -1.066 . . . . 0.0 109.38 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.501 ' HA ' ' HB3' ' A' ' 193' ' ' ASN . 23.7 tt0 -81.61 -18.62 44.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.477 -0.764 . . . . 0.0 109.817 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.439 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.1 OUTLIER -71.34 -53.9 12.61 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.992 0.901 . . . . 0.0 109.36 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.815 ' HB3' ' CE ' ' A' ' 30' ' ' MET . . . -69.6 -35.63 75.48 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ASN . . . . . 0.581 ' HA ' ' CB ' ' A' ' 197' ' ' MET . 14.9 t30 -61.71 -18.6 60.32 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.915 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -81.79 -39.81 23.52 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.918 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -100.98 -54.72 2.74 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 115.499 -2.481 . . . . 0.0 111.892 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.417 ' O ' ' HE3' ' A' ' 197' ' ' MET . 18.7 m120 -114.94 33.42 5.42 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.172 -1.411 . . . . 0.0 113.889 177.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' MET . . . . . 0.735 ' SD ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -152.14 148.99 28.29 Favored 'General case' 0 N--CA 1.515 2.803 0 CA-C-N 122.966 2.621 . . . . 0.0 115.632 -179.52 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.518 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . . . -113.12 125.64 54.59 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 176.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.558 HD11 ' CB ' ' A' ' 193' ' ' ASN . 26.1 mt -94.09 144.47 25.46 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.546 -1.346 . . . . 0.0 112.971 -177.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.801 ' O ' HG23 ' A' ' 31' ' ' VAL . 7.1 p -146.81 110.45 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.752 HG22 ' O ' ' A' ' 32' ' ' LEU . 23.9 p -70.69 147.96 48.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 111.707 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.944 HG13 HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -47.72 -38.52 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 121.304 0.573 . . . . 0.0 110.495 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 207' ' ' ALA . 10.7 tt0 -48.13 -65.99 0.48 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.08 -1.012 . . . . 0.0 110.737 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.581 ' O ' ' HB3' ' A' ' 207' ' ' ALA . 6.4 m-20 -80.89 -25.16 37.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.745 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.931 HD11 HD13 ' A' ' 163' ' ' LEU . 3.1 tm? -64.75 -67.5 0.43 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.334 -0.853 . . . . 0.0 109.422 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.85 HG11 ' OG1' ' A' ' 154' ' ' THR . 97.9 t -62.67 -21.99 28.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 118.048 -1.461 . . . . 0.0 108.364 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 204' ' ' ASP . . . -53.25 -28.89 29.73 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 175.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.76 ' OH ' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -77.85 -36.59 49.82 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.777 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.922 ' CZ ' HG21 ' A' ' 162' ' ' THR . 16.1 tpt180 -78.6 -58.67 3.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.896 -1.127 . . . . 0.0 110.067 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 206' ' ' VAL . 59.5 tp60 -51.85 -36.54 48.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.167 -0.958 . . . . 0.0 110.351 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 207' ' ' ALA . . . -72.54 -29.15 63.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 110.222 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -67.87 -24.34 65.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.225 -0.922 . . . . 0.0 110.182 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -108.62 -9.04 15.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 110.714 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.16 120.75 22.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.988 -1.07 . . . . 0.0 110.188 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -108.12 89.6 3.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 110.176 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -162.62 56.51 0.21 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.89 . . . . 0.0 110.251 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.214 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtt . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.229 0.538 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 23' ' ' LEU . 2.6 m120 -83.8 54.09 2.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.921 . . . . 0.0 110.195 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -94.15 -21.15 19.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -0.863 . . . . 0.0 110.294 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.426 ' HA ' ' OG ' ' A' ' 7' ' ' SER . 8.0 t -93.12 -18.07 23.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.916 . . . . 0.0 110.488 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.668 HD13 ' HA ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -53.17 -52.85 57.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.1 -1.0 . . . . 0.0 110.335 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.026 HD13 ' HB1' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -94.49 19.39 9.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.41 -0.806 . . . . 0.0 110.064 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.431 ' OG ' ' N ' ' A' ' 8' ' ' SER . 60.7 p -94.49 -60.82 1.63 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.88 -1.137 . . . . 0.0 110.569 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.431 ' N ' ' OG ' ' A' ' 7' ' ' SER . 1.7 p -91.79 28.84 1.68 Allowed 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 121.843 0.83 . . . . 0.0 109.922 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.735 ' O ' ' CG ' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -104.77 75.31 1.19 Allowed 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 122.587 1.184 . . . . 0.0 109.136 -178.58 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.03 74.32 0.36 Allowed Glycine 0 C--N 1.282 -2.432 0 N-CA-C 106.956 -2.457 . . . . 0.0 106.956 176.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.62 HG22 ' H ' ' A' ' 14' ' ' GLU . 61.8 m -149.08 99.74 3.45 Favored Pre-proline 0 C--N 1.278 -2.521 0 N-CA-C 101.093 -3.669 . . . . 0.0 101.093 172.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.65 ' O ' HG12 ' A' ' 16' ' ' VAL . 28.1 Cg_endo -51.17 -28.83 26.86 Favored 'Trans proline' 0 C--N 1.28 -3.063 0 O-C-N 122.754 0.871 . . . . 0.0 110.319 -174.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -86.02 -56.17 3.59 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.62 ' H ' HG22 ' A' ' 11' ' ' THR . 3.8 tt0 -93.5 -36.42 12.45 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 118.328 -1.349 . . . . 0.0 111.166 -176.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.671 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 8.3 mmt180 -78.83 -30.05 45.06 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 119.181 -1.007 . . . . 0.0 111.79 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.799 HG11 ' CD2' ' A' ' 208' ' ' TYR . 0.4 OUTLIER -89.55 -36.11 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 116.224 -2.19 . . . . 0.0 111.552 -179.167 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -63.16 -40.32 97.21 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 117.383 -1.727 . . . . 0.0 108.757 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.91 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 32.5 p-10 -84.38 -23.06 30.26 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.546 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 15' ' ' ARG . . . -71.63 -38.21 70.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.494 -1.379 . . . . 0.0 110.11 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.711 HD13 ' O ' ' A' ' 163' ' ' LEU . 1.6 pp -73.35 -54.27 8.76 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.333 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.659 ' HA ' ' N ' ' A' ' 26' ' ' GLY . . . -69.21 -69.74 0.32 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.877 -1.139 . . . . 0.0 111.807 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.91 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -50.09 -34.89 23.33 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.689 -1.142 . . . . 0.0 112.739 -177.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.933 HD13 ' HB2' ' A' ' 198' ' ' ALA . 2.6 tt -56.39 -59.89 4.32 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.652 ' HB2' HD23 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -123.82 -76.43 0.59 Allowed 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 117.686 -1.606 . . . . 0.0 108.15 173.083 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.461 ' HG3' ' CG ' ' A' ' 27' ' ' ARG . 5.7 pt-20 -167.28 45.78 0.05 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.102 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.659 ' N ' ' HA ' ' A' ' 21' ' ' ALA . . . 60.47 20.01 54.73 Favored Glycine 0 N--CA 1.481 1.698 0 N-CA-C 107.097 -2.401 . . . . 0.0 107.097 -176.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.52 ' CB ' ' CE1' ' A' ' 45' ' ' PHE . 6.6 mtt180 -118.31 39.25 3.48 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.467 -1.019 . . . . 0.0 109.792 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.724 ' O ' ' HB3' ' A' ' 198' ' ' ALA . . . 178.2 66.41 0.06 OUTLIER Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.317 -1.913 . . . . 0.0 108.317 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.718 ' CB ' HD12 ' A' ' 44' ' ' ILE . 6.1 t -144.75 116.97 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.852 ' HG2' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -84.41 146.37 27.69 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 119.838 -1.789 . . . . 0.0 113.313 -177.59 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 1.09 HG22 HG22 ' A' ' 202' ' ' ILE . 14.8 p -140.42 90.01 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 175.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.774 HD13 HG23 ' A' ' 202' ' ' ILE . 1.2 tp 68.95 -60.52 0.45 Allowed 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.861 -1.149 . . . . 0.0 109.776 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.451 ' CB ' ' HB3' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -53.42 -176.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.211 -0.931 . . . . 0.0 110.408 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.765 ' C ' HD13 ' A' ' 189' ' ' ILE . 45.0 m-20 -149.17 -148.77 0.27 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.266 -0.896 . . . . 0.0 110.372 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.845 ' CD ' HD11 ' A' ' 57' ' ' LEU . 0.1 OUTLIER 78.05 133.62 0.06 Allowed 'General case' 0 N--CA 1.519 3.003 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 179.552 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.933 ' N ' HD13 ' A' ' 57' ' ' LEU . 0.3 OUTLIER 167.71 157.79 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.739 177.059 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.519 ' NH1' ' CE1' ' A' ' 61' ' ' HIS . 1.6 tpt180 -176.76 -71.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.077 -1.014 . . . . 0.0 110.125 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.564 ' OE2' ' HB3' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -62.51 -148.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 110.112 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.402 ' N ' ' OE1' ' A' ' 38' ' ' GLU . 24.4 m-80 -84.78 130.63 34.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.975 . . . . 0.0 110.461 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.489 ' HA ' ' CE ' ' A' ' 197' ' ' MET . 1.4 mt-10 59.68 147.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.657 0.742 . . . . 0.0 111.25 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.522 ' O ' ' CE ' ' A' ' 43' ' ' MET . . . -132.6 167.89 22.96 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -86.96 -11.06 51.7 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.288 -1.125 . . . . 0.0 113.919 -179.411 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.522 ' CE ' ' O ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -31.35 -27.82 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.176 0 N-CA-C 116.906 2.187 . . . . 0.0 116.906 -174.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.718 HD12 ' CB ' ' A' ' 29' ' ' VAL . 0.8 OUTLIER -138.53 16.18 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.259 0 CA-C-O 122.695 1.236 . . . . 0.0 110.055 178.785 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.671 ' O ' HG12 ' A' ' 171' ' ' VAL . 0.7 OUTLIER -68.66 161.48 70.54 Favored Pre-proline 0 C--N 1.288 -2.083 0 O-C-N 121.172 -0.955 . . . . 0.0 113.564 -175.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.585 ' HB3' ' CB ' ' A' ' 167' ' ' LYS . 55.8 Cg_endo -82.35 129.92 6.05 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 C-N-CA 122.058 1.839 . . . . 0.0 109.409 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.982 ' HB1' HD13 ' A' ' 68' ' ' LEU . . . -71.69 -1.33 13.44 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.256 -0.903 . . . . 0.0 112.566 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.889 ' HA ' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -86.83 -23.78 25.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.797 -1.19 . . . . 0.0 110.128 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.586 ' O ' HG23 ' A' ' 49' ' ' THR . 10.1 t -133.26 60.23 1.71 Allowed 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.743 ' HG3' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -52.54 88.94 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.334 0.588 . . . . 0.0 109.739 -179.426 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.53 ' HA ' HG13 ' A' ' 115' ' ' ILE . 26.2 p -61.95 172.58 1.31 Allowed 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.83 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.52 HG22 HD13 ' A' ' 115' ' ' ILE . 17.7 t -73.91 -5.1 6.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.533 -0.729 . . . . 0.0 110.12 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.843 ' O ' HD23 ' A' ' 57' ' ' LEU . 0.8 OUTLIER -50.6 -28.31 8.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.006 -1.059 . . . . 0.0 109.422 179.413 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.437 ' O ' ' CG2' ' A' ' 58' ' ' THR . 0.0 OUTLIER -86.95 -28.98 22.4 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.203 179.413 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.472 ' HA ' HG22 ' A' ' 58' ' ' THR . 3.8 mmt -86.23 -41.13 14.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.265 -0.897 . . . . 0.0 109.528 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.564 ' HB3' ' OE2' ' A' ' 38' ' ' GLU . . . -65.46 -53.97 35.12 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.224 -0.923 . . . . 0.0 110.4 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.933 HD13 ' N ' ' A' ' 36' ' ' ASP . 0.4 OUTLIER -64.03 -33.4 75.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.216 -0.927 . . . . 0.0 111.059 -179.273 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.475 ' CG2' ' N ' ' A' ' 59' ' ' ILE . 4.4 t -79.33 -46.86 16.87 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.739 -1.226 . . . . 0.0 110.836 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.475 ' N ' ' CG2' ' A' ' 58' ' ' THR . 72.1 mt -53.78 -21.93 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.841 -1.162 . . . . 0.0 109.578 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -84.83 -46.04 11.73 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.378 -0.826 . . . . 0.0 112.257 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.519 ' CE1' ' NH1' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -125.36 -15.04 6.3 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -177.104 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 58' ' ' THR . . . -164.36 -168.95 27.24 Favored Glycine 0 N--CA 1.502 3.081 0 C-N-CA 118.547 -1.787 . . . . 0.0 111.756 -176.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.6 t -126.57 102.35 7.06 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 101.32 -3.585 . . . . 0.0 101.32 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 66' ' ' VAL . . . -104.79 76.43 0.25 Allowed Glycine 0 C--N 1.26 -3.663 0 N-CA-C 105.804 -2.918 . . . . 0.0 105.804 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.772 HG23 ' CD2' ' A' ' 138' ' ' PHE . 3.2 mm -61.34 84.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.535 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.705 HG12 ' HB3' ' A' ' 173' ' ' CYS . 26.5 m -52.72 157.09 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.508 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.311 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.698 ' HB3' HD11 ' A' ' 140' ' ' LEU . 97.4 m -109.64 119.35 39.14 Favored 'General case' 0 C--N 1.29 -2.006 0 O-C-N 121.393 -0.817 . . . . 0.0 110.32 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.982 HD13 ' HB1' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -87.28 97.81 10.99 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.316 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 74.3 m -70.7 127.28 32.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.467 -0.77 . . . . 0.0 111.794 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.594 HD12 ' HB3' ' A' ' 79' ' ' ASP . 24.6 pt -115.97 162.47 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.465 ' CA ' HG12 ' A' ' 158' ' ' ILE . 1.6 m -81.03 170.62 15.99 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 120.55 -1.344 . . . . 0.0 109.7 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.555 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -95.4 -12.47 25.93 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.399 178.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -85.39 -73.18 0.45 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.915 -1.115 . . . . 0.0 111.901 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -85.98 -32.58 21.44 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 79' ' ' ASP . 10.8 mpt_? -74.07 -31.71 62.96 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.626 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.555 ' HB2' ' HA ' ' A' ' 72' ' ' GLU . 18.2 tttt -72.93 -41.41 64.55 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 119.89 -1.756 . . . . 0.0 108.996 178.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -42.35 -54.1 3.92 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.298 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.63 HD11 ' C ' ' A' ' 128' ' ' PRO . 0.4 OUTLIER -105.08 -29.49 10.37 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.049 -1.46 . . . . 0.0 109.156 178.35 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.594 ' HB3' HD12 ' A' ' 70' ' ' ILE . 5.9 t0 -112.57 70.79 0.72 Allowed 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.997 0.903 . . . . 0.0 109.612 177.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.72 ' C ' HD22 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -80.62 171.34 12.57 Favored Pre-proline 0 C--N 1.286 -2.157 0 O-C-N 121.277 -0.889 . . . . 0.0 112.173 -179.238 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.654 ' N ' HD22 ' A' ' 80' ' ' LEU . 52.9 Cg_endo -84.22 97.79 0.73 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.11 1.058 . . . . 0.0 109.556 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' MET . . . . . 0.879 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.8 ttt -97.39 95.76 7.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.11 -0.994 . . . . 0.0 110.641 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.87 95.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.062 -1.024 . . . . 0.0 110.689 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 82' ' ' MET . 93.7 t -104.66 151.6 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.903 . . . . 0.0 109.997 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -92.9 22.65 4.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.19 -0.943 . . . . 0.0 110.294 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.697 ' H ' HG12 ' A' ' 84' ' ' VAL . 1.1 t-20 -125.43 19.67 8.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.362 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 1.018 ' ND2' HG22 ' A' ' 96' ' ' THR . 28.3 p30 -105.44 54.62 0.7 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.174 -0.954 . . . . 0.0 110.428 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 89' ' ' SER . 0.2 OUTLIER 52.89 -149.06 0.41 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.235 -0.916 . . . . 0.0 110.08 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.432 ' H ' HG22 ' A' ' 88' ' ' THR . 0.3 OUTLIER -66.24 -59.9 3.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.099 -1.001 . . . . 0.0 110.314 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 89' ' ' SER . . . 55.39 101.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.291 -0.881 . . . . 0.0 110.231 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -95.16 59.08 2.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.951 . . . . 0.0 110.303 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.78 39.07 66.14 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 143' ' ' GLN . 41.2 p -96.82 42.36 1.09 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.225 -1.162 . . . . 0.0 110.198 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 141' ' ' ARG . . . 48.2 23.08 2.62 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.489 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 0.6 OUTLIER -113.75 67.38 0.67 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.855 -1.379 . . . . 0.0 109.534 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . 1.018 HG22 ' ND2' ' A' ' 87' ' ' ASN . 0.9 OUTLIER -127.66 14.92 7.03 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.531 ' O ' ' HD2' ' A' ' 139' ' ' PRO . 4.2 p -115.74 145.14 21.87 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 O-C-N 121.007 -1.058 . . . . 0.0 110.683 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.561 HG22 ' H ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -123.87 -173.79 2.83 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.979 ' CG1' HG11 ' A' ' 137' ' ' VAL . 2.4 pp -145.8 122.82 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 C-N-CA 117.191 -1.803 . . . . 0.0 114.759 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.76 ' CA ' ' HG2' ' A' ' 133' ' ' ARG . 11.4 tm-20 -90.32 163.43 14.74 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.814 177.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.638 ' HB2' ' HB ' ' A' ' 106' ' ' THR . . . -51.73 88.18 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.63 -0.669 . . . . 0.0 112.546 -177.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.527 ' HB2' ' N ' ' A' ' 131' ' ' LEU . . . -84.19 -25.6 29.42 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 175.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.23 -6.5 11.31 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.748 -0.595 . . . . 0.0 110.115 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.52 27.47 0.97 Allowed Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.357 -1.401 . . . . 0.0 112.339 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.793 ' HB ' HG22 ' A' ' 117' ' ' THR . 7.0 m -139.88 123.53 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 120.954 -1.321 . . . . 0.0 110.655 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.638 ' HB ' ' HB2' ' A' ' 101' ' ' ALA . 10.9 t -148.21 63.86 1.1 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.713 -1.242 . . . . 0.0 111.618 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.462 HG22 HG21 ' A' ' 117' ' ' THR . 6.3 t -131.41 -31.17 1.63 Allowed 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 118.438 -1.305 . . . . 0.0 110.331 177.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.436 ' HA2' ' NH1' ' A' ' 114' ' ' ARG . . . 60.7 -28.33 0.05 OUTLIER Glycine 0 N--CA 1.504 3.195 0 O-C-N 121.588 -0.695 . . . . 0.0 114.023 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.409 ' N ' ' O ' ' A' ' 107' ' ' THR . 11.1 t -125.46 55.82 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.225 -1.75 . . . . 0.0 110.127 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.597 ' O ' ' N ' ' A' ' 114' ' ' ARG . 9.3 t -133.99 71.41 1.46 Allowed 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' A' ' 55' ' ' MET . . . -25.74 -40.64 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.794 0 CA-C-O 121.59 0.71 . . . . 0.0 112.035 -177.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -69.22 -66.04 0.63 Allowed 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 122.562 1.172 . . . . 0.0 107.881 176.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.807 ' O ' HG23 ' A' ' 117' ' ' THR . 0.2 OUTLIER -64.41 -13.94 53.91 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.099 -1.001 . . . . 0.0 109.445 177.825 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 110' ' ' SER . 5.0 tpm_? -62.86 -42.92 99.94 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.2 -0.937 . . . . 0.0 108.707 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.53 HG13 ' HA ' ' A' ' 51' ' ' THR . 1.7 mp -76.75 -13.49 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 118.557 -1.257 . . . . 0.0 108.178 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.494 ' O ' HG11 ' A' ' 105' ' ' VAL . 2.6 m -94.61 -20.92 19.17 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.23 -0.919 . . . . 0.0 108.828 177.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 113' ' ' ASP . 26.0 p -83.73 -36.85 23.36 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.513 -0.742 . . . . 0.0 109.827 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.758 ' O ' HG22 ' A' ' 122' ' ' ILE . 14.2 p -73.99 -41.37 52.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 118.84 -1.144 . . . . 0.0 108.562 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.98 ' O ' ' HB2' ' A' ' 123' ' ' ALA . 3.3 ttt-85 -61.18 -31.41 71.16 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.133 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.4 ' HB3' HG21 ' A' ' 105' ' ' VAL . . . -95.34 -33.07 12.66 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.668 -0.645 . . . . 0.0 111.358 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.651 ' HB1' HD13 ' A' ' 99' ' ' ILE . . . -61.91 -58.16 8.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.027 -1.046 . . . . 0.0 109.712 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.889 HG21 ' HA ' ' A' ' 48' ' ' GLU . 0.7 OUTLIER -88.49 23.03 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.395 -0.815 . . . . 0.0 110.693 179.052 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.98 ' HB2' ' O ' ' A' ' 119' ' ' ARG . . . -95.96 114.81 26.56 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 126' ' ' ALA . 5.4 t0 -89.99 -82.54 0.27 Allowed 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 117.783 -1.567 . . . . 0.0 113.405 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 124' ' ' ASP . . . 69.6 -43.36 0.46 Allowed Glycine 0 N--CA 1.513 3.797 0 N-CA-C 107.666 -2.173 . . . . 0.0 107.666 -176.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.558 ' H ' ' C ' ' A' ' 124' ' ' ASP . . . -135.72 165.71 24.94 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 103.578 -2.749 . . . . 0.0 103.578 176.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.421 ' C ' ' H ' ' A' ' 129' ' ' SER . 4.4 tttp -65.16 114.68 16.18 Favored Pre-proline 0 C--N 1.304 -1.411 0 CA-C-N 121.361 1.891 . . . . 0.0 108.094 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.63 ' C ' HD11 ' A' ' 78' ' ' LEU . 35.1 Cg_endo -67.66 26.14 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.283 1.322 . . . . 0.0 112.18 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.421 ' H ' ' C ' ' A' ' 127' ' ' LYS . 0.3 OUTLIER -54.57 -10.16 0.4 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.464 -1.397 . . . . 0.0 111.176 -178.611 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.477 ' CB ' ' HA ' ' A' ' 102' ' ' ALA . 2.0 m-20 -72.3 9.04 1.11 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.601 -1.312 . . . . 0.0 110.417 177.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.534 ' CD2' HG22 ' A' ' 99' ' ' ILE . 4.7 tp -74.67 87.99 2.2 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.474 ' H ' ' HB3' ' A' ' 100' ' ' GLU . 1.6 t-20 -116.13 72.64 0.82 Allowed 'General case' 0 N--CA 1.509 2.501 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.911 ' HB3' ' HA ' ' A' ' 134' ' ' PRO 0.255 0.0 OUTLIER -97.58 -152.76 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.734 0 CA-C-O 115.115 -2.374 . . . . 0.0 110.168 179.163 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.911 ' HA ' ' HB3' ' A' ' 133' ' ' ARG . 56.5 Cg_endo -78.98 127.39 14.67 Favored 'Cis proline' 0 N--CA 1.524 3.31 0 N-CA-C 119.554 2.867 . . . . 0.0 119.554 18.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.928 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -126.99 71.87 0.47 Allowed Glycine 0 N--CA 1.511 3.655 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.338 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 49.3 m80 30.62 35.76 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.544 0 CA-C-O 121.418 0.628 . . . . 0.0 112.562 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.979 HG11 ' CG1' ' A' ' 99' ' ' ILE . 92.6 t -94.5 154.71 3.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.978 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 175.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.772 ' CD2' HG23 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -131.07 79.07 71.94 Favored Pre-proline 0 C--N 1.294 -1.822 0 C-N-CA 117.939 -1.505 . . . . 0.0 110.726 -176.698 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.809 ' C ' HD23 ' A' ' 140' ' ' LEU . 55.8 Cg_endo -107.61 156.44 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 123.515 2.81 . . . . 0.0 107.873 175.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.809 HD23 ' C ' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -145.93 140.81 27.21 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 120.722 -1.236 . . . . 0.0 109.715 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 143' ' ' GLN . 1.8 ptm180 -63.51 154.54 32.11 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.408 ' HB2' ' HB ' ' A' ' 158' ' ' ILE . . . -60.75 88.85 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.862 -1.135 . . . . 0.0 108.949 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 141' ' ' ARG . 0.1 OUTLIER -55.59 144.86 25.02 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.924 0.869 . . . . 0.0 111.021 -178.634 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.594 ' C ' HG21 ' A' ' 154' ' ' THR . . . -83.19 53.97 2.64 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.32 0.581 . . . . 0.0 109.504 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.9 ' O ' HG22 ' A' ' 149' ' ' THR . . . 147.2 19.8 0.1 Allowed Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.578 -1.296 . . . . 0.0 112.457 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.1 1.98 59.49 Favored Glycine 0 N--CA 1.503 3.138 0 C-N-CA 117.769 -2.158 . . . . 0.0 111.403 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.857 ' CG2' HG11 ' A' ' 206' ' ' VAL . 0.3 OUTLIER -116.5 -43.77 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-O 123.943 1.83 . . . . 0.0 107.577 175.217 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.809 ' HA ' HD13 ' A' ' 202' ' ' ILE . 2.8 tp -111.6 70.03 0.7 Allowed 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.9 HG22 ' O ' ' A' ' 145' ' ' GLY . 46.7 p -77.07 63.39 2.34 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 125.243 2.449 . . . . 0.0 104.789 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.586 ' O ' ' N ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -153.58 155.31 35.9 Favored 'General case' 0 C--N 1.267 -2.993 0 N-CA-C 100.501 -3.888 . . . . 0.0 100.501 176.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.25 61.99 0.16 Allowed Glycine 0 C--N 1.261 -3.588 0 C-N-CA 117.144 -2.455 . . . . 0.0 109.386 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 150' ' ' ARG . . . -110.11 -161.57 18.56 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 120.198 -1.766 . . . . 0.0 110.696 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.777 ' N ' HD23 ' A' ' 148' ' ' LEU . 10.7 t-80 -66.57 4.48 0.77 Allowed 'General case' 0 C--O 1.188 -2.173 0 CA-C-O 117.366 -1.302 . . . . 0.0 113.964 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.651 ' HA ' HG12 ' A' ' 147' ' ' VAL . 15.0 t -24.23 -26.57 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.396 0 CA-C-N 120.797 1.635 . . . . 0.0 115.086 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.649 ' N ' ' O ' ' A' ' 153' ' ' HIS . 18.3 tt0 -56.32 -22.78 32.84 Favored 'General case' 0 N--CA 1.511 2.606 0 O-C-N 119.326 -2.109 . . . . 0.0 105.325 172.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.718 ' HB2' ' ND1' ' A' ' 153' ' ' HIS . . . -83.99 12.6 6.01 Favored 'General case' 0 C--O 1.206 -1.208 0 O-C-N 120.746 -1.221 . . . . 0.0 108.971 174.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.625 ' N ' ' O ' ' A' ' 154' ' ' THR . 20.5 m -63.71 -43.26 97.1 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 175.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.506 ' O ' ' HB3' ' A' ' 161' ' ' MET . 5.7 tp -70.19 -35.59 63.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 116.169 -2.212 . . . . 0.0 105.209 174.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.566 ' HB2' ' CA ' ' A' ' 156' ' ' ALA . 1.2 m-20 -59.1 -20.52 54.25 Favored 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 116.414 -2.114 . . . . 0.0 107.216 175.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 1.043 ' HA ' HD12 ' A' ' 163' ' ' LEU . 0.2 OUTLIER -61.87 -28.48 69.53 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 176.32 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' MET . . . . . 0.647 ' HB2' ' N ' ' A' ' 169' ' ' ALA . 3.2 ptt? -49.65 -34.29 17.9 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 174.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.486 ' CB ' ' O ' ' A' ' 159' ' ' ASP . 2.7 m -65.23 -29.52 70.32 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.093 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 1.072 HD21 HD21 ' A' ' 205' ' ' LEU . 0.2 OUTLIER -41.7 -44.65 3.23 Favored 'General case' 0 N--CA 1.523 3.183 0 O-C-N 121.077 -1.014 . . . . 0.0 109.142 178.21 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -48.4 -29.15 3.73 Favored 'General case' 0 N--CA 1.517 2.89 0 CA-C-O 122.515 1.15 . . . . 0.0 109.753 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 106.44 -34.49 5.69 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.75 49.25 0.41 Allowed 'General case' 0 N--CA 1.508 2.472 0 C-N-CA 117.938 -1.505 . . . . 0.0 113.185 172.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.585 ' CB ' ' HB3' ' A' ' 46' ' ' PRO . 1.3 mmtt -135.02 124.11 16.28 Favored Pre-proline 0 C--N 1.292 -1.933 0 CA-C-O 116.305 -1.807 . . . . 0.0 106.872 175.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.465 ' HA ' ' HG3' ' A' ' 161' ' ' MET . 51.9 Cg_endo -91.6 75.94 0.59 Allowed 'Trans proline' 0 C--N 1.318 -1.068 0 C-N-CA 114.05 -3.5 . . . . 0.0 112.499 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.958 ' HB1' ' HB3' ' A' ' 47' ' ' ALA . . . -165.41 165.47 19.22 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 170.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 68' ' ' LEU . . . -139.45 129.02 4.19 Favored Glycine 0 N--CA 1.502 3.091 0 C-N-CA 118.596 -1.764 . . . . 0.0 109.737 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.671 HG12 ' O ' ' A' ' 45' ' ' PHE . 5.5 p -133.09 95.07 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-N 119.664 1.732 . . . . 0.0 109.804 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 43' ' ' MET . 0.1 OUTLIER -95.08 143.34 26.61 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.605 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.705 ' HB3' HG12 ' A' ' 66' ' ' VAL . 5.6 p -107.43 175.05 5.62 Favored 'General case' 0 N--CA 1.515 2.78 0 O-C-N 120.632 -1.293 . . . . 0.0 112.175 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.486 ' N ' ' HB2' ' A' ' 35' ' ' GLU . 6.0 tt0 -143.71 119.01 10.2 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.313 -0.867 . . . . 0.0 111.558 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.73 HD23 ' SG ' ' A' ' 188' ' ' CYS . 0.6 OUTLIER -62.58 145.4 54.52 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.821 0.82 . . . . 0.0 111.814 -178.933 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.675 HG23 ' HB3' ' A' ' 182' ' ' MET . 55.1 m -139.67 155.38 47.43 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 181' ' ' THR . 29.2 m-80 -72.04 170.98 12.72 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.954 -1.091 . . . . 0.0 110.253 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -85.84 6.38 28.43 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.524 -0.735 . . . . 0.0 111.283 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -109.14 -15.84 14.23 Favored 'General case' 0 C--N 1.289 -2.065 0 O-C-N 121.575 -0.703 . . . . 0.0 110.482 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 109.18 23.16 6.49 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.508 ' O ' ' ND2' ' A' ' 177' ' ' ASN . 1.2 p -134.89 98.28 3.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -1.185 . . . . 0.0 110.346 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' MET . . . . . 0.675 ' HB3' HG23 ' A' ' 176' ' ' THR . 0.0 OUTLIER -95.03 94.47 7.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.321 -0.862 . . . . 0.0 109.816 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -118.03 63.3 0.75 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 118.786 -1.166 . . . . 0.0 110.962 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.434 ' HB3' ' CB ' ' A' ' 188' ' ' CYS . 3.4 mtp180 -147.14 161.95 39.85 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.338 -0.851 . . . . 0.0 109.036 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.844 ' HB3' ' HD3' ' A' ' 186' ' ' PRO . . . -145.87 -68.56 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.068 -1.02 . . . . 0.0 109.704 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.844 ' HD3' ' HB3' ' A' ' 185' ' ' ALA . 45.0 Cg_endo -70.68 -36.99 7.5 Favored 'Trans proline' 0 C--N 1.316 -1.164 0 N-CA-C 109.11 -1.15 . . . . 0.0 109.11 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.469 ' HA ' ' HB2' ' A' ' 190' ' ' GLU . 0.2 OUTLIER -90.16 -16.85 28.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.632 -0.667 . . . . 0.0 109.942 179.197 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 188' ' ' CYS . . . . . 0.73 ' SG ' HD23 ' A' ' 175' ' ' LEU . 0.3 OUTLIER -60.67 -50.81 72.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.391 -0.818 . . . . 0.0 110.479 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.869 HG23 ' CD2' ' A' ' 199' ' ' LEU . 6.4 tp -94.77 -28.03 4.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.045 -1.034 . . . . 0.0 109.414 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' A' ' 194' ' ' LYS . 5.0 mm-40 -57.3 -19.99 25.57 Favored 'General case' 0 C--O 1.199 -1.591 0 O-C-N 120.578 -1.326 . . . . 0.0 107.688 175.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.513 ' CD2' ' N ' ' A' ' 192' ' ' ALA . 4.3 t80 -80.84 -62.25 1.72 Allowed 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 122.771 1.272 . . . . 0.0 108.89 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.75 ' HB1' ' O ' ' A' ' 36' ' ' ASP . . . -73.08 -38.53 66.38 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.483 -177.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ASN . . . . . 0.648 ' HB2' HD21 ' A' ' 199' ' ' LEU . 12.0 m-20 -84.75 -25.12 28.48 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 118.968 -1.093 . . . . 0.0 112.557 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' LYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 190' ' ' GLU . 8.3 ttpt -61.76 -37.83 85.76 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 117.502 -1.679 . . . . 0.0 109.408 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -81.45 -51.64 8.1 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 116.206 -2.197 . . . . 0.0 112.085 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.427 ' O ' ' CE ' ' A' ' 197' ' ' MET . 0.2 OUTLIER -112.89 33.2 5.16 Favored 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 117.792 -1.563 . . . . 0.0 113.736 177.647 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 197' ' ' MET . . . . . 0.547 ' HB3' ' CB ' ' A' ' 193' ' ' ASN . 0.0 OUTLIER -158.01 152.36 24.57 Favored 'General case' 0 N--CA 1.508 2.444 0 CA-C-N 121.209 1.822 . . . . 0.0 114.861 -179.104 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 1.026 ' HB1' HD13 ' A' ' 6' ' ' LEU . . . -83.56 139.38 32.9 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 118.675 -1.21 . . . . 0.0 107.935 175.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.869 ' CD2' HG23 ' A' ' 189' ' ' ILE . 3.3 mt -118.96 113.66 21.34 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 120.165 -1.584 . . . . 0.0 112.293 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.907 ' HB ' HD21 ' A' ' 6' ' ' LEU . 8.7 p -124.89 177.59 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.661 0 O-C-N 121.243 -0.911 . . . . 0.0 108.615 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.504 ' N ' HG22 ' A' ' 200' ' ' VAL . 17.5 m -121.25 156.14 33.13 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.252 -1.53 . . . . 0.0 110.808 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 1.09 HG22 HG22 ' A' ' 31' ' ' VAL . 1.2 pp -61.21 -32.7 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 121.061 -1.024 . . . . 0.0 110.229 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 207' ' ' ALA . 2.3 tm-20 -42.28 -67.22 0.28 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.614 -0.679 . . . . 0.0 111.58 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.426 ' O ' ' CB ' ' A' ' 208' ' ' TYR . 3.4 m-20 -87.89 -10.47 50.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.078 -1.014 . . . . 0.0 110.766 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 1.072 HD21 HD21 ' A' ' 163' ' ' LEU . 9.1 tt -84.38 -51.63 6.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 112.132 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.857 HG11 ' CG2' ' A' ' 147' ' ' VAL . 0.1 OUTLIER -84.43 -27.91 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 119.942 -1.723 . . . . 0.0 107.539 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 210' ' ' GLN . . . -63.44 -31.59 72.79 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 173.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.799 ' CD2' HG11 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -58.3 -35.92 72.56 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.355 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -29.19 41.67 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.532 ' HB3' ' HA ' ' A' ' 207' ' ' ALA . 55.8 tt0 -69.28 -68.17 0.42 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 122.003 0.906 . . . . 0.0 108.654 178.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -48.66 -26.3 2.21 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.383 0.611 . . . . 0.0 110.23 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -71.88 -31.64 66.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.344 -0.848 . . . . 0.0 110.173 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -104.7 -9.14 18.38 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.774 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.34 130.63 37.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.976 -1.077 . . . . 0.0 110.145 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 20.7 tttt -95.74 118.48 32.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 110.219 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -147.6 37.15 0.9 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 110.211 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.188 -179.928 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ttp . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.211 0.529 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.436 ' O ' HD23 ' A' ' 5' ' ' LEU . 48.7 p30 -95.87 55.5 1.61 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 110.315 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -93.78 5.15 52.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 0.0 110.771 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 8' ' ' SER . 1.3 p -74.01 -4.82 37.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.054 -1.029 . . . . 0.0 110.969 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.527 ' CB ' ' CD2' ' A' ' 166' ' ' PHE . 4.5 mm? -55.19 -67.05 0.31 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.927 -1.108 . . . . 0.0 110.387 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.02 ' CD1' HD22 ' A' ' 20' ' ' LEU . 8.3 tp -61.06 -15.59 34.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.228 -0.92 . . . . 0.0 109.988 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.11 -21.27 20.52 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.068 -1.02 . . . . 0.0 110.304 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 4' ' ' THR . 22.7 m -92.84 23.75 4.0 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.304 -0.873 . . . . 0.0 109.787 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.51 ' O ' ' CE1' ' A' ' 13' ' ' PHE . 22.3 t80 -140.83 77.2 1.59 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.8 93.88 1.37 Allowed Glycine 0 C--N 1.288 -2.125 0 N-CA-C 106.892 -2.483 . . . . 0.0 106.892 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.542 ' O ' ' N ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -125.56 165.48 26.39 Favored Pre-proline 0 C--N 1.27 -2.89 0 N-CA-C 103.458 -2.793 . . . . 0.0 103.458 179.319 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.428 ' C ' ' O ' ' A' ' 11' ' ' THR . 17.8 Cg_endo -41.86 -24.25 0.28 Allowed 'Trans proline' 0 N--CA 1.515 2.787 0 CA-C-N 122.026 1.759 . . . . 0.0 108.468 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.638 ' O ' HG12 ' A' ' 16' ' ' VAL 0.272 0.0 OUTLIER -46.75 -21.44 0.2 Allowed 'General case' 0 C--O 1.191 -1.977 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 169.886 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 11' ' ' THR . 32.6 tt0 -48.39 -39.8 23.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.073 -1.642 . . . . 0.0 108.334 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -42.73 99.71 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 175.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.857 HG22 HG12 ' A' ' 200' ' ' VAL . 0.4 OUTLIER -60.46 -34.9 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 118.979 -1.088 . . . . 0.0 108.218 175.577 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.767 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -51.92 -47.61 64.59 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.587 -1.321 . . . . 0.0 108.798 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.944 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 31.4 t-20 -53.27 -31.09 41.96 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.432 ' O ' ' HB1' ' A' ' 198' ' ' ALA . . . -89.56 -68.23 0.79 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 122.292 1.044 . . . . 0.0 110.358 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.053 HD21 HD21 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -47.98 -54.7 12.03 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.398 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.978 ' HB2' HD23 ' A' ' 6' ' ' LEU . . . -67.29 -41.59 85.15 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.944 ' HB2' ' O ' ' A' ' 18' ' ' ASN . . . -32.63 -62.08 0.25 Allowed 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 121.045 0.45 . . . . 0.0 111.136 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.948 HD12 ' HA ' ' A' ' 197' ' ' MET . 2.4 mt -106.67 7.73 30.71 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.321 -1.352 . . . . 0.0 110.703 177.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.779 ' HD3' HD22 ' A' ' 6' ' ' LEU . 59.3 ttp85 -55.26 -18.95 7.03 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.775 -1.203 . . . . 0.0 107.77 176.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -79.71 46.05 0.74 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 122.798 1.285 . . . . 0.0 109.839 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.51 ' HA2' ' CZ ' ' A' ' 45' ' ' PHE . . . 67.92 16.36 68.25 Favored Glycine 0 C--N 1.292 -1.897 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.991 176.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.481 ' HA ' ' CB ' ' A' ' 39' ' ' ASN . 20.1 mtt180 -99.46 17.31 20.61 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 116.079 -2.248 . . . . 0.0 111.225 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 197' ' ' MET . . . 100.6 106.32 2.84 Favored Glycine 0 N--CA 1.496 2.685 0 C-N-CA 118.982 -1.58 . . . . 0.0 113.181 173.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.851 HG22 HD13 ' A' ' 44' ' ' ILE . 2.0 m -145.6 113.71 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 120.174 -1.78 . . . . 0.0 106.743 176.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.483 ' HA ' ' HB3' ' A' ' 43' ' ' MET . 0.0 OUTLIER -75.27 75.17 2.39 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 116.104 -2.238 . . . . 0.0 107.72 -177.691 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 1.055 HG12 HD23 ' A' ' 32' ' ' LEU . 1.5 t -158.31 151.85 7.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 CA-C-N 113.773 -1.558 . . . . 0.0 108.17 176.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.055 HD23 HG12 ' A' ' 31' ' ' VAL . 0.7 OUTLIER 10.89 -129.56 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.967 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 175.178 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.833 ' HA ' HD12 ' A' ' 44' ' ' ILE . 13.8 p-10 -176.94 173.99 1.8 Allowed 'General case' 0 N--CA 1.485 1.279 0 O-C-N 120.632 -1.292 . . . . 0.0 111.204 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 35' ' ' GLU . 3.8 p30 -159.94 -143.31 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.539 -0.726 . . . . 0.0 109.624 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.42 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -112.07 -151.9 0.49 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.899 -1.126 . . . . 0.0 110.364 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 55.01 171.08 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.279 -0.888 . . . . 0.0 110.82 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.43 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 7.6 ptt85 -176.07 143.12 0.53 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.362 -0.836 . . . . 0.0 110.054 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -169.45 -81.05 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.104 -0.997 . . . . 0.0 110.732 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.481 ' CB ' ' HA ' ' A' ' 27' ' ' ARG . 1.1 t-20 -57.52 -165.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.167 -0.958 . . . . 0.0 110.563 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.4 -169.01 1.63 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 0.0 110.507 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.442 ' N ' ' HB3' ' A' ' 53' ' ' GLU . . . 75.61 89.02 0.24 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.612 ' HA ' ' CD1' ' A' ' 45' ' ' PHE . 25.4 t70 -78.91 24.11 0.32 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.163 -1.198 . . . . 0.0 112.236 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.589 ' HA ' ' HA ' ' A' ' 172' ' ' LEU . 0.4 OUTLIER -81.45 17.16 1.44 Allowed 'General case' 0 N--CA 1.481 1.112 0 O-C-N 120.468 -1.395 . . . . 0.0 113.942 -177.388 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.851 HD13 HG22 ' A' ' 29' ' ' VAL . 5.2 tp -138.27 16.63 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.794 0 CA-C-O 121.792 0.806 . . . . 0.0 109.724 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.803 ' O ' HG12 ' A' ' 171' ' ' VAL . 89.2 m-85 -107.81 160.1 28.02 Favored Pre-proline 0 N--CA 1.507 2.42 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -173.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -75.62 134.12 16.45 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 123.132 2.555 . . . . 0.0 111.974 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 1.058 ' HB2' HD11 ' A' ' 68' ' ' LEU . . . -50.71 -20.71 1.32 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.234 -0.917 . . . . 0.0 111.807 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -72.67 -26.81 61.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.044 -1.035 . . . . 0.0 110.562 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.654 HG22 ' HG2' ' A' ' 119' ' ' ARG . 65.2 p -133.13 58.86 1.75 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . 0.674 ' CG ' HG11 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -61.91 87.04 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.279 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.492 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -63.56 162.06 13.55 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 122.506 1.146 . . . . 0.0 112.109 -176.492 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.694 ' CG2' ' HB1' ' A' ' 111' ' ' ALA . 4.3 p -75.1 -2.22 3.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.142 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.473 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 23.8 mt-10 -46.28 -26.66 0.85 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.264 -0.897 . . . . 0.0 110.19 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.525 HE21 ' HB ' ' A' ' 58' ' ' THR . 41.4 tp60 -88.11 -49.85 6.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.526 -0.734 . . . . 0.0 109.32 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.895 ' SD ' HD11 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -54.71 -47.09 74.14 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.578 -0.701 . . . . 0.0 109.785 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.04 -55.39 33.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 110.258 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.516 ' C ' HD23 ' A' ' 57' ' ' LEU . 7.0 tt -59.27 -44.33 92.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.482 -0.761 . . . . 0.0 110.48 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.525 ' HB ' HE21 ' A' ' 54' ' ' GLN . 3.0 t -74.94 -47.51 29.2 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.17 -0.956 . . . . 0.0 111.564 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.895 HD11 ' SD ' ' A' ' 55' ' ' MET . 43.8 mt -47.97 -25.72 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.664 -1.272 . . . . 0.0 109.587 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -77.76 -47.85 18.01 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.49 -0.756 . . . . 0.0 110.826 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -125.31 -9.08 6.98 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 58' ' ' THR . . . -164.99 -168.16 26.7 Favored Glycine 0 N--CA 1.502 3.085 0 O-C-N 120.13 -1.606 . . . . 0.0 111.469 -177.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.533 ' H ' HG21 ' A' ' 176' ' ' THR . 1.1 t -133.11 103.26 5.93 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 101.71 -3.441 . . . . 0.0 101.71 176.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.449 ' N ' ' OG1' ' A' ' 58' ' ' THR . . . -104.63 73.76 0.24 Allowed Glycine 0 C--N 1.264 -3.447 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 -177.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.672 ' O ' HG23 ' A' ' 65' ' ' ILE . 2.0 tp -64.26 97.2 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.822 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.976 ' CG1' HG22 ' A' ' 171' ' ' VAL . 3.6 t -50.99 163.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.347 -177.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.882 ' O ' HG21 ' A' ' 157' ' ' THR . 80.3 m -111.19 114.81 28.3 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.031 0.919 . . . . 0.0 109.122 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.058 HD11 ' HB2' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -90.61 123.35 34.18 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.615 ' C ' HD13 ' A' ' 158' ' ' ILE . 0.1 OUTLIER -108.57 143.08 38.08 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 117.232 -1.787 . . . . 0.0 110.415 179.125 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.749 HG21 ' OD2' ' A' ' 79' ' ' ASP 0.25 2.0 pp -137.41 137.28 46.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.345 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.878 HG22 ' HB2' ' A' ' 75' ' ' ARG . 9.3 t -74.93 179.43 4.92 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.606 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 2.3 mp0 -90.48 -18.59 25.08 Favored 'General case' 0 C--N 1.275 -2.674 0 C-N-CA 119.366 -0.933 . . . . 0.0 110.815 -178.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.57 -74.68 0.19 Allowed 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.823 -1.151 . . . . 0.0 112.797 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -94.66 -37.74 11.17 Favored 'General case' 0 C--N 1.279 -2.463 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.294 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.878 ' HB2' HG22 ' A' ' 71' ' ' THR . 0.0 OUTLIER -69.69 -24.84 63.64 Favored 'General case' 0 C--N 1.284 -2.269 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.543 -179.433 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.696 ' HE2' HD12 ' A' ' 80' ' ' LEU . 7.5 tttt -81.41 -38.92 25.74 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 117.459 -1.696 . . . . 0.0 107.489 176.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -42.19 -42.39 3.0 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.409 0.623 . . . . 0.0 109.569 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.788 HD23 ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -107.87 -30.02 8.74 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.448 -1.301 . . . . 0.0 109.026 177.323 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.788 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -114.15 69.12 0.7 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.724 178.004 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.696 HD12 ' HE2' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -111.45 149.05 40.08 Favored Pre-proline 0 C--N 1.295 -1.789 0 O-C-N 120.785 -1.197 . . . . 0.0 109.163 178.856 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.53 ' CD ' ' HG ' ' A' ' 80' ' ' LEU . 27.5 Cg_endo -50.86 96.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.187 0 O-C-N 123.393 1.207 . . . . 0.0 110.556 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.11 44.51 1.04 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.427 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 175.24 -54.89 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.138 -0.976 . . . . 0.0 109.73 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.879 HG23 HG22 ' A' ' 96' ' ' THR . 15.6 m -110.12 109.27 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.358 -0.839 . . . . 0.0 110.234 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 87' ' ' ASN . 8.0 tt0 -98.26 27.58 4.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.216 -0.927 . . . . 0.0 110.099 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -64.97 80.13 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.329 -0.857 . . . . 0.0 110.277 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 85' ' ' GLU . 2.8 t30 -99.2 54.92 0.98 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 110.19 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 53.3 m -154.47 -67.11 0.13 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 110.152 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.78 -47.88 70.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -0.934 . . . . 0.0 110.211 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 53.26 35.81 21.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.927 . . . . 0.0 110.235 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.84 61.56 0.4 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.266 -0.896 . . . . 0.0 110.208 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.98 23.33 76.52 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 95' ' ' PHE . 81.4 p -110.06 -18.51 13.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.232 -1.158 . . . . 0.0 110.661 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 96' ' ' THR . . . -20.55 -42.53 0.01 OUTLIER Glycine 0 N--CA 1.513 3.813 0 C-N-CA 123.442 0.544 . . . . 0.0 113.533 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.503 ' N ' ' O ' ' A' ' 93' ' ' THR . 19.5 m-85 -58.69 99.38 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.962 -1.316 . . . . 0.0 108.974 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.879 HG22 HG23 ' A' ' 84' ' ' VAL . 70.4 p -118.05 -1.82 11.36 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.032 -1.467 . . . . 0.0 114.915 -177.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.655 HG22 ' C ' ' A' ' 80' ' ' LEU . 1.8 t -121.89 86.52 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.268 -2.957 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.449 ' OG1' ' N ' ' A' ' 135' ' ' GLY . 8.9 t -73.71 123.87 24.92 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 176.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.025 ' CG1' HG21 ' A' ' 137' ' ' VAL . 7.7 pt -106.25 123.31 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.641 -1.287 . . . . 0.0 112.793 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.554 ' O ' ' HA ' ' A' ' 131' ' ' LEU . 0.2 OUTLIER -128.67 105.13 8.06 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.092 177.799 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.963 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . . . -48.22 104.25 0.06 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 122.058 0.932 . . . . 0.0 110.62 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 130' ' ' ASP . . . -59.8 -10.9 4.31 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.285 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -0.49 14.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.987 -1.071 . . . . 0.0 111.285 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.76 27.41 0.96 Allowed Glycine 0 N--CA 1.494 2.563 0 C-N-CA 118.993 -1.575 . . . . 0.0 112.556 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.963 ' HB ' ' HB3' ' A' ' 101' ' ' ALA . 21.1 t -108.73 153.94 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.066 -1.255 . . . . 0.0 109.828 178.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.409 ' O ' ' HG3' ' A' ' 114' ' ' ARG . 4.4 m -142.08 107.2 4.95 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 103.109 -2.922 . . . . 0.0 103.109 178.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.504 ' O ' ' C ' ' A' ' 108' ' ' GLY . 23.8 m -56.61 -24.71 49.77 Favored 'General case' 0 C--N 1.273 -2.736 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -175.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . 0.842 ' O ' ' N ' ' A' ' 110' ' ' SER . . . 29.85 48.43 0.13 Allowed Glycine 0 N--CA 1.511 3.644 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 172.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.744 HG21 ' CG ' ' A' ' 136' ' ' HIS . 54.6 t -28.77 67.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.628 0 CA-C-O 125.289 2.471 . . . . 0.0 112.17 -168.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.842 ' N ' ' O ' ' A' ' 108' ' ' GLY . 7.8 t -130.88 65.32 1.55 Allowed 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 109.403 -3.544 . . . . 0.0 103.935 176.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.694 ' HB1' ' CG2' ' A' ' 52' ' ' VAL . . . -30.02 -29.91 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.118 -1.401 . . . . 0.0 114.271 -175.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -62.0 -77.9 0.04 OUTLIER 'General case' 0 C--N 1.282 -2.346 0 O-C-N 120.198 -1.564 . . . . 0.0 109.584 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -75.03 -27.81 60.22 Favored 'General case' 0 C--N 1.289 -2.061 0 O-C-N 121.337 -0.852 . . . . 0.0 111.373 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.862 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -83.0 -38.54 22.5 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.334 -178.347 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.612 HD13 ' CA ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -66.42 -12.84 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 116.849 -1.941 . . . . 0.0 108.013 178.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.5 m -74.35 -50.54 18.27 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.716 ' O ' ' HB2' ' A' ' 121' ' ' ALA . 3.9 p -70.63 -22.43 62.52 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.189 -0.944 . . . . 0.0 109.387 178.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 114' ' ' ARG . 63.0 t -66.8 -51.6 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.274 -0.891 . . . . 0.0 109.741 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.654 ' HG2' HG22 ' A' ' 49' ' ' THR . 5.5 ttp180 -51.53 -40.54 59.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.518 -0.739 . . . . 0.0 109.955 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.21 -8.49 39.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.583 -0.698 . . . . 0.0 110.572 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 117' ' ' THR . . . -68.31 -44.5 75.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.055 -1.028 . . . . 0.0 111.183 -178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.542 HG22 ' O ' ' A' ' 122' ' ' ILE . 4.6 mt -83.3 9.34 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.542 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -107.08 71.43 0.83 Allowed 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.774 -1.171 . . . . 0.0 110.556 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.441 ' CB ' ' HD3' ' A' ' 127' ' ' LYS . 0.5 OUTLIER -99.0 -44.38 6.33 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.527 1.156 . . . . 0.0 109.319 177.6 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 124.64 -39.91 2.02 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 105.94 -2.864 . . . . 0.0 105.94 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -135.48 95.1 3.2 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.454 ' N ' ' CD ' ' A' ' 128' ' ' PRO . 7.7 tptt -136.57 53.45 7.49 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 120.784 -1.198 . . . . 0.0 109.761 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 127' ' ' LYS . 49.5 Cg_endo -77.4 -35.14 1.73 Allowed 'Trans proline' 0 C--N 1.3 -1.999 0 N-CA-C 107.552 -1.749 . . . . 0.0 107.552 178.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.3 p -125.86 -17.82 5.28 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.019 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.45 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -77.29 9.6 3.05 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.739 -1.226 . . . . 0.0 112.896 -177.359 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.939 HD12 ' N ' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -140.94 74.79 1.47 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.541 -1.349 . . . . 0.0 109.561 179.04 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.591 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 0.7 OUTLIER -144.0 48.9 1.38 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.439 -1.413 . . . . 0.0 114.239 176.857 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.421 ' C ' ' CB ' ' A' ' 100' ' ' GLU . 2.1 mtm180 177.25 108.01 0.12 Allowed Pre-proline 0 N--CA 1.516 2.844 0 CA-C-N 121.897 2.135 . . . . 0.0 112.947 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -126.26 129.05 0.03 OUTLIER 'Cis proline' 0 C--N 1.312 -1.394 0 N-CA-C 103.557 -3.286 . . . . 0.0 103.557 -8.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -113.65 33.36 5.54 Favored Glycine 0 N--CA 1.503 3.163 0 C-N-CA 117.54 -2.267 . . . . 0.0 113.791 -175.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.744 ' CG ' HG21 ' A' ' 109' ' ' VAL . 14.6 m-70 32.11 37.95 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.903 0 CA-C-N 119.049 1.424 . . . . 0.0 110.311 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 1.025 HG21 ' CG1' ' A' ' 99' ' ' ILE . 54.2 t -86.87 156.12 3.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.597 ' CD1' ' O ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -124.79 79.46 63.7 Favored Pre-proline 0 C--N 1.284 -2.275 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -178.641 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.578 ' HG3' HG12 ' A' ' 137' ' ' VAL . 52.0 Cg_endo -108.79 124.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.074 1.849 . . . . 0.0 110.83 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.425 ' HB3' ' C ' ' A' ' 94' ' ' GLY . 1.1 pp -128.99 136.82 50.85 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 119.485 -0.886 . . . . 0.0 108.898 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.469 ' CG ' ' CG ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -63.66 137.06 57.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.615 -1.303 . . . . 0.0 108.404 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.791 ' HB3' HG21 ' A' ' 158' ' ' ILE . . . -131.26 133.55 45.55 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.094 -1.043 . . . . 0.0 112.15 -178.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.16 143.46 45.24 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.537 -0.727 . . . . 0.0 109.724 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . 0.493 ' HB1' ' NH2' ' A' ' 209' ' ' ARG . . . -68.48 115.71 8.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.478 -0.764 . . . . 0.0 110.6 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 86.93 14.93 63.87 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.14 13.64 63.15 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.733 HG21 ' HB2' ' A' ' 156' ' ' ALA . 14.5 p -89.94 -4.72 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.872 -1.37 . . . . 0.0 110.157 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.472 ' HG ' HG11 ' A' ' 206' ' ' VAL . 1.2 mp -90.06 17.56 6.8 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 116.139 -2.224 . . . . 0.0 110.148 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.4 p -130.59 60.99 1.62 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 101.171 -3.64 . . . . 0.0 101.171 168.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.459 ' HG3' ' CG ' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -149.97 140.49 22.47 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 113.794 -1.548 . . . . 0.0 112.755 -178.433 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.422 ' N ' ' HD3' ' A' ' 150' ' ' ARG . . . -104.0 35.09 5.28 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 106.148 -2.781 . . . . 0.0 106.148 173.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.24 163.35 27.8 Favored Glycine 0 N--CA 1.479 1.509 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' HIS . . . . . 0.563 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 2.8 p-80 -90.84 -5.03 56.12 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.646 -0.914 . . . . 0.0 109.552 177.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.812 HG22 ' SG ' ' A' ' 67' ' ' CYS . 60.0 p -53.37 -59.25 4.81 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.003 -1.061 . . . . 0.0 109.766 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.498 ' HB2' HG23 ' A' ' 147' ' ' VAL . 63.3 mm-40 -59.59 -21.34 60.22 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.733 ' HB2' HG21 ' A' ' 147' ' ' VAL . . . -85.56 6.76 25.77 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.882 HG21 ' O ' ' A' ' 67' ' ' CYS . 27.3 m -91.99 -36.5 13.38 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.791 HG21 ' HB3' ' A' ' 142' ' ' ALA . 3.2 tp -85.83 -31.44 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 173.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASP . . . . . 0.498 ' O ' HG22 ' A' ' 162' ' ' THR . 1.7 t70 -56.68 -34.06 67.03 Favored 'General case' 0 C--O 1.199 -1.553 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 174.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 1.045 HD23 ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -45.05 -37.42 4.14 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.349 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' MET . . . . . 1.029 ' N ' HD13 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -50.26 -45.33 54.12 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.871 178.875 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 159' ' ' ASP . 4.3 t -97.56 -31.69 12.19 Favored 'General case' 0 N--CA 1.509 2.478 0 CA-C-O 121.895 0.855 . . . . 0.0 111.5 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 1.042 ' CD2' HD21 ' A' ' 205' ' ' LEU 0.272 0.2 OUTLIER -42.98 -58.11 2.56 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -178.58 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.738 ' HB1' HD12 ' A' ' 6' ' ' LEU . . . -110.13 2.24 19.31 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 118.874 -1.13 . . . . 0.0 113.003 -176.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 96.08 -19.2 55.51 Favored Glycine 0 C--N 1.29 -1.999 0 N-CA-C 108.21 -1.956 . . . . 0.0 108.21 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PHE . . . . . 0.69 ' C ' ' HD3' ' A' ' 168' ' ' PRO . 0.1 OUTLIER -76.95 137.21 38.91 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.14 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.628 ' HA ' ' HA ' ' A' ' 161' ' ' MET . 2.4 ttmt -121.55 56.47 6.37 Favored Pre-proline 0 C--N 1.31 -1.12 0 O-C-N 120.745 -1.222 . . . . 0.0 110.47 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.816 ' HD2' HD11 ' A' ' 160' ' ' LEU . 56.5 Cg_endo -108.93 175.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.301 -1.966 0 N-CA-C 107.731 -1.681 . . . . 0.0 107.731 177.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.464 ' HB2' ' HD3' ' A' ' 75' ' ' ARG . . . -85.53 104.82 15.65 Favored 'General case' 0 C--N 1.261 -3.247 0 N-CA-C 101.42 -3.548 . . . . 0.0 101.42 173.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.443 ' O ' ' CG2' ' A' ' 157' ' ' THR . . . -93.75 154.52 21.68 Favored Glycine 0 C--N 1.297 -1.617 0 C-N-CA 119.048 -1.549 . . . . 0.0 111.103 -173.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.976 HG22 ' CG1' ' A' ' 66' ' ' VAL 0.261 5.6 p -124.05 95.56 3.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LEU . . . . . 0.862 HD22 ' CA ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -114.81 114.74 25.95 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 119.93 -1.731 . . . . 0.0 111.018 -178.576 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.781 ' HB2' HG22 ' A' ' 66' ' ' VAL . 4.9 t -109.79 175.64 5.37 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.547 -1.346 . . . . 0.0 110.943 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLU . . . . . 0.734 ' C ' HD13 ' A' ' 189' ' ' ILE . 0.0 OUTLIER -106.73 -147.93 0.41 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.41 -0.806 . . . . 0.0 109.888 179.261 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.682 HD13 ' C ' ' A' ' 175' ' ' LEU . 2.1 tm? -116.49 146.36 42.64 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.193 -0.942 . . . . 0.0 109.404 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.663 ' N ' HD13 ' A' ' 175' ' ' LEU . 52.9 m -131.86 154.97 48.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 0.0 110.319 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -119.53 168.46 10.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 0.0 110.253 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.46 5.57 48.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 111.172 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.13 -19.04 41.18 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.614 -0.679 . . . . 0.0 109.888 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 101.78 29.23 6.27 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.645 HG23 ' O ' ' A' ' 181' ' ' THR . 9.7 t -141.72 113.74 8.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.273 -1.133 . . . . 0.0 110.119 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 1.8 ttm -53.34 93.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 110.187 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.628 ' HB3' ' HA ' ' A' ' 176' ' ' THR . . . -69.3 119.28 13.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.938 . . . . 0.0 110.278 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' A' ' 185' ' ' ALA . 2.9 ppt_? -139.98 100.45 3.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.304 -0.872 . . . . 0.0 109.911 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.745 ' HB1' ' HD2' ' A' ' 186' ' ' PRO . . . 179.25 173.57 0.44 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.337 -0.852 . . . . 0.0 110.003 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.745 ' HD2' ' HB1' ' A' ' 185' ' ' ALA . 46.5 Cg_endo -72.73 -11.59 26.04 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.644 1.339 . . . . 0.0 110.76 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 190' ' ' GLU . 3.6 mt-10 -84.93 -63.37 1.34 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.063 -1.023 . . . . 0.0 110.522 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' CYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 191' ' ' PHE . 21.5 p -52.37 -37.56 56.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.01 . . . . 0.0 109.718 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.983 HG23 HD21 ' A' ' 199' ' ' LEU . 8.0 tp -73.62 -28.33 24.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 120.604 -1.31 . . . . 0.0 108.27 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.643 ' HA ' HD22 ' A' ' 199' ' ' LEU . 1.4 tt0 -58.85 -20.0 46.82 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.126 177.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' PHE . . . . . 0.463 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.1 OUTLIER -75.34 -51.06 14.07 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.72 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ALA . . . . . 0.443 ' CB ' ' HE3' ' A' ' 197' ' ' MET . . . -62.51 -38.5 90.18 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ASN . . . . . 0.836 ' HB2' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -64.52 -15.98 61.8 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.103 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.45 -36.75 22.1 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 117.892 -1.523 . . . . 0.0 112.477 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -104.33 -53.59 2.69 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 115.719 -2.392 . . . . 0.0 111.519 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -113.97 32.99 5.49 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.025 -1.47 . . . . 0.0 113.754 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' MET . . . . . 0.948 ' HA ' HD12 ' A' ' 23' ' ' LEU . 2.5 ttp -153.67 145.15 23.19 Favored 'General case' 0 N--CA 1.512 2.645 0 C-N-CA 115.065 -2.654 . . . . 0.0 115.441 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.576 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . . . -91.4 142.88 27.2 Favored 'General case' 0 N--CA 1.51 2.568 0 O-C-N 120.884 -1.135 . . . . 0.0 108.128 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.983 HD21 HG23 ' A' ' 189' ' ' ILE . 3.0 tp -131.55 94.09 3.47 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.495 -1.378 . . . . 0.0 114.498 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.922 HG22 HG21 ' A' ' 31' ' ' VAL 0.253 6.8 m -57.87 -168.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 120.496 -1.378 . . . . 0.0 107.525 175.31 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 201' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 205' ' ' LEU . 23.8 m -119.03 110.59 17.28 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 174.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.484 ' HA ' ' HB3' ' A' ' 205' ' ' LEU . 16.6 mt -49.62 -21.99 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.343 -0.848 . . . . 0.0 111.838 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -66.64 0.52 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.814 -1.179 . . . . 0.0 109.334 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.783 ' O ' ' HB3' ' A' ' 207' ' ' ALA . 1.7 m-20 -66.14 -32.82 74.49 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.015 -1.053 . . . . 0.0 109.076 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 1.042 HD21 ' CD2' ' A' ' 163' ' ' LEU . 6.7 tt -45.86 -69.53 0.13 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 123.084 1.421 . . . . 0.0 112.459 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.472 HG11 HG13 ' A' ' 147' ' ' VAL . 1.4 t -68.42 -11.37 14.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 C-N-CA 117.758 -1.577 . . . . 0.0 108.845 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.783 ' HB3' ' O ' ' A' ' 204' ' ' ASP . . . -58.64 -30.49 67.33 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 175.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' TYR . . . . . 0.847 ' CE2' ' HA ' ' A' ' 205' ' ' LEU . 1.5 m-85 -62.59 -48.19 80.52 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 177.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ARG . . . . . 0.493 ' NH2' ' HB1' ' A' ' 144' ' ' ALA . 17.8 tpt180 -65.56 -29.16 69.74 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.779 -1.168 . . . . 0.0 109.746 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.462 ' HB2' HD21 ' A' ' 148' ' ' LEU . 30.9 tt0 -73.02 -35.29 66.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.03 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -73.57 -27.05 61.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.364 -0.835 . . . . 0.0 110.039 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -73.62 -31.55 63.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 110.087 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -90.56 -9.45 47.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 110.625 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -111.1 132.78 53.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.987 -1.071 . . . . 0.0 110.207 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -97.37 121.59 39.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.244 -0.91 . . . . 0.0 110.191 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -174.82 156.77 2.33 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.333 -0.855 . . . . 0.0 110.186 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 26.2 m . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.208 179.961 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.727 ' O ' HG12 ' A' ' 16' ' ' VAL . 28.2 Cg_endo . . . . . 0 C--O 1.202 -1.279 0 N-CA-C 110.928 -0.451 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -95.46 -46.36 6.72 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -77.4 -62.63 1.6 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 118.353 -1.339 . . . . 0.0 112.384 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.419 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 26.3 mmm180 -85.58 -10.15 56.31 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 117.538 -1.665 . . . . 0.0 112.981 -177.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -85.93 -26.04 6.44 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.489 0 C-N-CA 114.386 -2.926 . . . . 0.0 108.391 176.11 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.72 -48.89 62.67 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 116.74 -1.984 . . . . 0.0 107.409 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -65.6 -33.2 75.35 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.524 -0.735 . . . . 0.0 109.36 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.5 ' O ' HD23 ' A' ' 23' ' ' LEU . . . -81.75 -22.03 37.49 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.182 -0.949 . . . . 0.0 109.234 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.833 HD21 ' O ' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -53.89 -50.42 66.36 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.175 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.463 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . . . -66.61 -51.51 55.5 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.234 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -47.31 -45.4 24.27 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.519 -0.738 . . . . 0.0 110.507 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.664 HD13 HG11 ' A' ' 29' ' ' VAL . 3.3 pp -91.08 -17.15 26.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.306 -0.871 . . . . 0.0 110.192 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 20' ' ' LEU . 0.9 OUTLIER -54.72 -23.05 15.92 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.273 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.4 41.98 1.11 Allowed 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 118.23 -1.388 . . . . 0.0 110.167 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.539 ' HA3' ' CZ ' ' A' ' 45' ' ' PHE . . . 53.83 31.79 47.12 Favored Glycine 0 C--N 1.291 -1.953 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 176.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -85.3 19.78 2.18 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 116.859 -1.937 . . . . 0.0 110.859 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.564 ' O ' ' HB3' ' A' ' 198' ' ' ALA . . . 98.3 105.73 2.51 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 119.524 -1.322 . . . . 0.0 113.085 173.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.922 HG22 HD12 ' A' ' 44' ' ' ILE . 3.2 p -145.33 118.65 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-N 120.096 1.948 . . . . 0.0 109.968 176.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.776 ' HB3' HD23 ' A' ' 199' ' ' LEU . 1.5 tmt? -105.78 151.78 24.05 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.063 -1.023 . . . . 0.0 110.69 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.724 HG22 ' HB ' ' A' ' 202' ' ' ILE . 4.5 p . . . . . 0 N--CA 1.494 1.729 0 O-C-N 120.898 -1.126 . . . . 0.0 109.504 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.51 ' HA ' ' CA ' ' A' ' 30' ' ' MET . 2.7 p30 . . . . . 0 N--CA 1.506 2.372 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.677 ' O ' HG23 ' A' ' 171' ' ' VAL . 1.8 ttm -93.88 47.07 1.2 Allowed 'General case' 0 C--N 1.288 -2.104 0 O-C-N 120.886 -1.134 . . . . 0.0 113.778 -177.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.922 HD12 HG22 ' A' ' 29' ' ' VAL . 73.4 mt -68.49 20.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.534 3.75 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.776 ' O ' HG22 ' A' ' 171' ' ' VAL . 2.3 m-85 -66.59 162.38 51.07 Favored Pre-proline 0 C--N 1.279 -2.472 0 O-C-N 121.008 -1.057 . . . . 0.0 113.631 -176.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.481 ' HD2' ' CD2' ' A' ' 45' ' ' PHE . 43.8 Cg_endo -66.92 133.73 32.2 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.895 2.397 . . . . 0.0 111.902 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.63 ' HB2' ' N ' ' A' ' 170' ' ' GLY . . . -65.76 -7.21 14.6 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.405 -0.81 . . . . 0.0 112.751 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.774 ' HB2' ' HB2' ' A' ' 123' ' ' ALA . 0.3 OUTLIER -109.99 -14.97 14.16 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.726 -1.234 . . . . 0.0 111.35 -179.307 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 51' ' ' THR . 25.2 m -132.62 59.73 1.72 Allowed 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.581 ' O ' HG23 ' A' ' 115' ' ' ILE . 6.3 mtp -62.67 86.08 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.725 ' C ' HD13 ' A' ' 115' ' ' ILE . 1.7 m -63.99 170.41 3.56 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.773 0.797 . . . . 0.0 110.217 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 1.051 HG22 HD12 ' A' ' 115' ' ' ILE . 7.0 t -85.31 -3.72 8.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 121.731 -0.606 . . . . 0.0 109.586 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 6.3 tp10 -52.86 -39.8 62.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.844 -1.16 . . . . 0.0 108.867 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.524 ' CG ' ' CD1' ' A' ' 45' ' ' PHE . 17.6 mm-40 -82.08 -39.04 23.98 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.784 ' HG3' HD11 ' A' ' 115' ' ' ILE . 19.0 mmt -57.24 -39.11 74.89 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.097 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.501 ' HA ' HD12 ' A' ' 59' ' ' ILE . . . -58.05 -54.29 48.62 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.213 -0.93 . . . . 0.0 108.649 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.891 HD13 ' HE3' ' A' ' 197' ' ' MET . 6.2 tt -63.8 -22.01 66.71 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.699 -0.801 . . . . 0.0 109.464 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.593 HG23 ' C ' ' A' ' 63' ' ' SER . 1.1 m -88.64 -22.8 23.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -0.795 . . . . 0.0 110.265 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 56' ' ' ALA . 22.7 mt -76.83 -23.1 15.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.045 -1.035 . . . . 0.0 109.322 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.53 -64.07 1.1 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.406 -0.809 . . . . 0.0 110.659 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -125.98 42.87 3.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.157 -0.964 . . . . 0.0 111.666 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 58' ' ' THR . . . -155.2 -175.39 26.2 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 119.166 -1.492 . . . . 0.0 109.741 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.593 ' C ' HG23 ' A' ' 58' ' ' THR . 16.8 t -128.37 178.62 6.15 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.472 ' O ' HD13 ' A' ' 65' ' ' ILE . . . -114.11 67.45 0.26 Allowed Glycine 1 C--N 1.253 -4.062 0 N-CA-C 107.42 -2.272 . . . . 0.0 107.42 178.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.472 HD13 ' O ' ' A' ' 64' ' ' GLY . 25.1 mm -133.25 84.41 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 114.11 -1.045 . . . . 0.0 108.413 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.826 HG12 ' HB2' ' A' ' 173' ' ' CYS . 29.4 m -103.65 152.55 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.55 -0.719 . . . . 0.0 111.591 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 171' ' ' VAL . 5.3 t -77.55 122.08 24.77 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.081 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.666 ' HG ' HG13 ' A' ' 137' ' ' VAL . 3.1 mm? -87.21 126.24 34.69 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 122.174 0.988 . . . . 0.0 109.404 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.45 ' HB3' ' HA ' ' A' ' 158' ' ' ILE . 3.6 m -89.59 125.08 35.09 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.763 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.52 ' N ' HD13 ' A' ' 158' ' ' ILE . 16.7 tt -138.74 129.46 34.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.083 -1.01 . . . . 0.0 109.853 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.425 ' OG1' ' CG1' ' A' ' 158' ' ' ILE . 1.2 m -89.22 160.37 16.98 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.095 -1.003 . . . . 0.0 109.942 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.443 ' HA ' ' NH1' ' A' ' 75' ' ' ARG . 9.1 pt-20 -50.9 -24.42 3.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.442 -0.786 . . . . 0.0 110.142 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.47 -32.9 19.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 110.041 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.42 ' HB3' HG13 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -62.61 -49.7 74.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 109.939 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.464 ' CD ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -70.91 -34.68 71.77 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.187 0.994 . . . . 0.0 108.565 179.113 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.649 ' O ' ' N ' ' A' ' 79' ' ' ASP . 3.0 tttp -53.38 -66.17 0.44 Allowed 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -46.34 -32.7 3.33 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 124.039 0.837 . . . . 0.0 109.431 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.628 HD11 HD22 ' A' ' 131' ' ' LEU . 0.3 OUTLIER -97.74 43.65 1.06 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 176.059 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 76' ' ' LYS . 11.6 t70 -28.97 76.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 123.553 1.644 . . . . 0.0 113.031 -172.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.753 ' O ' HD23 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -151.25 100.05 3.02 Favored Pre-proline 0 C--N 1.283 -2.304 0 CA-C-N 112.765 -2.016 . . . . 0.0 110.314 177.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -106.62 92.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 N-CA-C 108.808 -1.266 . . . . 0.0 108.808 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.901 ' CB ' HG11 ' A' ' 97' ' ' VAL . 3.6 mtt -103.12 46.01 0.94 Allowed 'General case' 0 N--CA 1.483 1.215 0 O-C-N 120.588 -1.32 . . . . 0.0 108.723 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.91 123.54 2.37 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.038 0.447 . . . . 0.0 110.23 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 84' ' ' VAL . 32.8 m . . . . . 0 N--CA 1.494 1.765 0 C-N-CA 118.614 -1.235 . . . . 0.0 110.61 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.522 ' CB ' HG21 ' A' ' 84' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 122.415 1.102 . . . . 0.0 112.246 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.428 ' CG2' ' O ' ' A' ' 139' ' ' PRO . 35.3 m -59.66 81.05 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.274 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.901 HG11 ' CB ' ' A' ' 82' ' ' MET . 7.4 p -33.48 151.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 CA-C-O 122.577 1.18 . . . . 0.0 113.085 -174.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.641 HG22 ' O ' ' A' ' 137' ' ' VAL . 51.1 p -69.67 -178.38 1.46 Allowed 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.535 -175.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.973 HD12 HD23 ' A' ' 131' ' ' LEU . 16.0 pt -146.99 131.64 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.527 ' HB2' ' HA ' ' A' ' 133' ' ' ARG . 3.6 tt0 -103.54 125.12 49.9 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.069 -1.452 . . . . 0.0 113.491 -176.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 1.061 ' HB1' ' HB1' ' A' ' 121' ' ' ALA . . . -51.37 95.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.473 -0.767 . . . . 0.0 110.855 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 130' ' ' ASP . . . -80.5 2.63 24.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.629 -0.669 . . . . 0.0 110.14 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.414 ' CB ' ' HA ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -86.42 15.29 5.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.078 -1.014 . . . . 0.0 110.931 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.464 ' O ' HG21 ' A' ' 117' ' ' THR . . . 127.7 25.02 1.17 Allowed Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.522 -1.323 . . . . 0.0 112.11 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.947 ' HB ' ' HB3' ' A' ' 101' ' ' ALA . 13.0 t -130.17 121.83 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.156 -1.202 . . . . 0.0 109.195 177.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 p -145.91 59.06 1.24 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.594 -1.316 . . . . 0.0 111.523 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.782 HG21 ' OG ' ' A' ' 110' ' ' SER . 1.6 m -138.91 -31.97 0.7 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.805 -1.184 . . . . 0.0 110.983 176.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.23 -32.25 1.12 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.14 57.21 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.733 -1.451 . . . . 0.0 109.375 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.782 ' OG ' HG21 ' A' ' 107' ' ' THR . 1.2 m -129.87 57.44 1.68 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.201 -0.937 . . . . 0.0 109.257 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.506 ' HB1' ' HG3' ' A' ' 55' ' ' MET . . . -34.81 -29.85 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -82.41 -74.86 0.33 Allowed 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.063 -1.023 . . . . 0.0 110.157 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -67.07 -15.62 63.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.564 -0.71 . . . . 0.0 110.87 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.661 ' HG2' HG21 ' A' ' 118' ' ' VAL . 51.2 ttt85 -87.84 -46.79 9.12 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.057 -1.027 . . . . 0.0 110.032 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 1.051 HD12 HG22 ' A' ' 52' ' ' VAL . 35.1 mt -66.07 -10.96 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.679 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.7 m -87.69 -52.5 5.28 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.728 ' CB ' HG22 ' A' ' 105' ' ' VAL . 9.3 p -72.62 -42.9 63.96 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.692 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.772 ' CG2' HG11 ' A' ' 105' ' ' VAL . 47.6 t -57.19 -43.45 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.876 -1.14 . . . . 0.0 108.811 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.582 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -49.33 -39.38 31.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.348 -0.845 . . . . 0.0 109.307 178.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.74 -11.62 24.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.709 -0.619 . . . . 0.0 111.043 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 1.061 ' HB1' ' HB1' ' A' ' 101' ' ' ALA . . . -97.25 -59.93 1.69 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.857 -1.152 . . . . 0.0 112.68 -177.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.64 HG23 ' HA ' ' A' ' 48' ' ' GLU . 19.1 tt -66.7 -19.8 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 120.41 -1.431 . . . . 0.0 108.849 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.774 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . . . -106.58 72.49 0.91 Allowed 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.506 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.452 ' HB3' ' CG ' ' A' ' 127' ' ' LYS . 11.8 t0 -98.41 -53.1 3.43 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.335 1.064 . . . . 0.0 110.077 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 124.08 -37.28 2.71 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 106.169 -2.773 . . . . 0.0 106.169 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -132.98 100.51 4.91 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.945 ' HE2' HD13 ' A' ' 131' ' ' LEU . 23.4 mtpp -130.98 54.55 15.08 Favored Pre-proline 0 C--N 1.307 -1.242 0 O-C-N 120.773 -1.204 . . . . 0.0 110.92 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 127' ' ' LYS . 44.1 Cg_endo -72.05 -26.47 18.28 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 N-CA-C 106.921 -1.992 . . . . 0.0 106.921 176.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.79 -18.09 6.15 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.043 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.452 ' HB3' ' NZ ' ' A' ' 127' ' ' LYS . 27.6 m-20 -78.24 9.82 3.5 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.8 -1.187 . . . . 0.0 112.27 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.973 HD23 HD12 ' A' ' 99' ' ' ILE . 2.6 tp -135.08 89.62 2.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.882 -1.136 . . . . 0.0 108.566 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.506 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 36.4 p-10 -116.38 107.6 15.01 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.373 -0.829 . . . . 0.0 111.933 -178.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.803 ' HB2' ' HA ' ' A' ' 134' ' ' PRO 0.269 4.9 ppt_? -82.89 179.93 1.74 Allowed Pre-proline 0 N--CA 1.499 1.976 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.646 -177.525 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.803 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 48.8 Cg_endo -71.68 124.96 9.07 Favored 'Cis proline' 0 N--CA 1.504 2.122 0 C-N-CA 123.352 -1.52 . . . . 0.0 112.299 8.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.853 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -123.98 39.9 2.06 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 53.1 m80 31.21 38.22 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 122.162 0.982 . . . . 0.0 111.914 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 135' ' ' GLY . 54.5 t -126.85 103.11 10.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 176.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.505 ' CA ' HG22 ' A' ' 98' ' ' THR . 6.3 p90 -107.52 89.35 4.93 Favored Pre-proline 0 N--CA 1.492 1.659 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.962 -175.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 56.0 Cg_endo -77.34 124.42 7.13 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 124.125 1.592 . . . . 0.0 110.366 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.583 HD23 HG23 ' A' ' 154' ' ' THR . 1.1 tp -102.65 126.53 49.78 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.42 ' HA ' HG23 ' A' ' 70' ' ' ILE . 56.3 ttp85 -63.64 117.91 7.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.061 -1.024 . . . . 0.0 109.958 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.84 ' O ' HG21 ' A' ' 158' ' ' ILE . . . -130.03 134.17 47.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.578 -0.701 . . . . 0.0 110.516 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.421 ' C ' HG21 ' A' ' 158' ' ' ILE . 0.3 OUTLIER -56.26 133.03 52.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.829 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.692 ' HA ' HG23 ' A' ' 158' ' ' ILE . . . -81.87 115.2 20.96 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.408 -0.807 . . . . 0.0 111.173 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.472 ' CA ' ' NH2' ' A' ' 209' ' ' ARG . . . 86.63 -8.01 77.05 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.56 13.98 60.89 Favored Glycine 0 N--CA 1.483 1.815 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.707 ' CG2' ' HB2' ' A' ' 156' ' ' ALA . 7.6 p -59.7 -14.3 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.931 -1.335 . . . . 0.0 109.971 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.568 ' CD2' HG12 ' A' ' 206' ' ' VAL . 1.0 OUTLIER -92.17 20.13 6.24 Favored 'General case' 0 C--O 1.21 -1.004 0 C-N-CA 116.479 -2.088 . . . . 0.0 110.731 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.6 m -129.39 58.49 1.62 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 101.935 -3.357 . . . . 0.0 101.935 168.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.456 ' HG3' ' CG ' ' A' ' 155' ' ' GLU . 0.2 OUTLIER -153.76 146.11 23.93 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 113.486 -1.688 . . . . 0.0 111.903 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -103.95 34.72 5.55 Favored Glycine 0 N--CA 1.481 1.683 0 N-CA-C 106.124 -2.79 . . . . 0.0 106.124 173.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -145.34 165.98 27.74 Favored Glycine 0 N--CA 1.479 1.501 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.678 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 2.3 p-80 -90.84 -6.04 54.79 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.921 -0.752 . . . . 0.0 109.484 176.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.583 HG23 HD23 ' A' ' 140' ' ' LEU . 62.6 m -56.17 -61.71 2.2 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 122.54 1.162 . . . . 0.0 109.353 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.824 ' HA ' ' HB1' ' A' ' 142' ' ' ALA . 9.2 mp0 -57.89 -20.75 39.23 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.707 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . . . -83.35 1.73 39.78 Favored 'General case' 0 C--O 1.201 -1.478 0 O-C-N 121.602 -0.686 . . . . 0.0 109.929 177.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 153' ' ' HIS . 68.8 p -82.2 -51.19 8.18 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.84 HG21 ' O ' ' A' ' 142' ' ' ALA . 3.8 tp -65.76 -31.58 54.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.537 ' OD2' HG12 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -80.56 -18.41 48.46 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.965 HD13 HD22 ' A' ' 172' ' ' LEU . 1.2 mt -63.41 -37.64 88.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.038 -1.039 . . . . 0.0 110.375 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.582 ' HE3' ' CB ' ' A' ' 166' ' ' PHE . 88.7 mmm -81.53 -27.74 34.28 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.64 HG21 HH21 ' A' ' 209' ' ' ARG . 3.6 m -66.3 -48.79 69.23 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 1.081 HD13 HD21 ' A' ' 205' ' ' LEU . 4.2 pp -72.57 -4.83 33.12 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.369 -0.832 . . . . 0.0 109.328 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.774 ' C ' HD11 ' A' ' 20' ' ' LEU . . . -108.06 18.85 20.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.662 -1.274 . . . . 0.0 109.983 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 59.14 41.86 96.82 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 107.337 -2.305 . . . . 0.0 107.337 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.582 ' CB ' ' HE3' ' A' ' 161' ' ' MET . 1.5 m-85 -138.49 139.29 38.72 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.925 0.869 . . . . 0.0 111.134 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -50.2 134.23 23.49 Favored Pre-proline 0 N--CA 1.498 1.965 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 177.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.579 ' O ' HD11 ' A' ' 158' ' ' ILE . 37.3 Cg_endo -64.81 84.46 0.17 Allowed 'Trans proline' 0 C--N 1.298 -2.114 0 C-N-CA 116.593 -1.805 . . . . 0.0 112.911 -174.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' ' 47' ' ' ALA . . . -156.81 111.72 2.81 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 101.399 -3.556 . . . . 0.0 101.399 173.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.63 ' N ' ' HB2' ' A' ' 47' ' ' ALA . . . -157.73 167.76 34.23 Favored Glycine 0 N--CA 1.486 1.996 0 C-N-CA 116.454 -2.784 . . . . 0.0 113.314 -174.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.776 HG22 ' O ' ' A' ' 45' ' ' PHE . 28.5 m -112.46 156.49 13.48 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.965 HD22 HD13 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -157.68 114.0 2.88 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.826 ' HB2' HG12 ' A' ' 66' ' ' VAL . 34.1 t -130.66 162.25 29.82 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 120.569 -1.332 . . . . 0.0 112.05 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.27 -169.06 1.45 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.199 -0.938 . . . . 0.0 109.491 178.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 1.089 HD21 ' HB2' ' A' ' 192' ' ' ALA . 5.2 mt . . . . . 0 N--CA 1.497 1.911 0 O-C-N 120.89 -1.132 . . . . 0.0 109.582 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' A' ' 175' ' ' LEU . . . . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 121.4 0.619 . . . . 0.0 110.163 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.482 ' O ' ' HB3' ' A' ' 185' ' ' ALA . 3.9 mtt180 -136.8 161.68 35.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.353 -0.842 . . . . 0.0 110.333 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 184' ' ' ARG . . . 60.85 160.02 0.11 Allowed Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.349 -0.844 . . . . 0.0 110.871 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.591 ' HA ' HG22 ' A' ' 189' ' ' ILE . 44.5 Cg_endo -70.4 -26.76 24.23 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.739 1.389 . . . . 0.0 110.578 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -60.66 -34.98 75.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.089 -1.007 . . . . 0.0 109.864 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . 0.466 ' O ' HD11 ' A' ' 175' ' ' LEU . 5.4 t -74.59 -53.99 8.33 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.362 -0.836 . . . . 0.0 110.218 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.739 HG23 HD22 ' A' ' 199' ' ' LEU . 9.6 tp -62.02 -25.08 36.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 O-C-N 120.653 -1.279 . . . . 0.0 107.644 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 194' ' ' LYS . 36.8 tt0 -64.65 -33.74 76.64 Favored 'General case' 0 C--O 1.194 -1.822 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.313 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 191' ' ' PHE . 0.0 OUTLIER -57.65 -54.94 41.18 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.349 -1.469 . . . . 0.0 108.925 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 1.089 ' HB2' HD21 ' A' ' 175' ' ' LEU . . . -69.87 -44.83 69.01 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.707 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . 0.753 ' HB2' HD21 ' A' ' 199' ' ' LEU . 1.6 m-20 -82.19 -29.99 31.17 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.061 -1.056 . . . . 0.0 112.902 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 190' ' ' GLU . 15.6 tttt -55.42 -36.64 66.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.462 -1.399 . . . . 0.0 109.384 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -81.8 -52.83 6.73 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 116.116 -2.234 . . . . 0.0 111.781 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.468 ' O ' ' CG ' ' A' ' 197' ' ' MET . 89.4 m-20 -115.58 28.34 8.73 Favored 'General case' 0 N--CA 1.51 2.571 0 C-N-CA 117.073 -1.851 . . . . 0.0 115.254 177.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' MET . . . . . 0.891 ' HE3' HD13 ' A' ' 57' ' ' LEU . 0.8 OUTLIER -160.21 149.96 17.93 Favored 'General case' 0 N--CA 1.514 2.745 0 CA-C-N 121.991 2.178 . . . . 0.0 113.613 179.267 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 28' ' ' GLY . . . -86.73 148.51 25.4 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.416 -1.428 . . . . 0.0 108.482 175.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.776 HD23 ' HB3' ' A' ' 30' ' ' MET . 4.1 mt -122.72 144.3 49.24 Favored 'General case' 0 N--CA 1.511 2.62 0 O-C-N 120.264 -1.523 . . . . 0.0 111.639 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.581 HG22 ' H ' ' A' ' 201' ' ' THR . 3.4 p -149.94 -178.92 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.269 -0.894 . . . . 0.0 110.179 178.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.581 ' H ' HG22 ' A' ' 200' ' ' VAL . 23.5 p -105.54 179.84 4.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.014 . . . . 0.0 110.849 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.724 ' HB ' HG22 ' A' ' 31' ' ' VAL . 4.5 tt -111.96 -32.51 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.446 -0.784 . . . . 0.0 110.349 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.89 -65.06 0.62 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.108 -0.995 . . . . 0.0 110.528 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -75.82 -35.78 59.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.294 -0.879 . . . . 0.0 110.442 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 1.081 HD21 HD13 ' A' ' 163' ' ' LEU . 6.3 tt -52.92 -43.61 66.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.096 -1.003 . . . . 0.0 110.285 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.632 HG13 HG13 ' A' ' 147' ' ' VAL . 1.0 OUTLIER -71.08 -40.35 75.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 O-C-N 120.965 -1.084 . . . . 0.0 108.456 -179.375 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.419 ' HA ' ' CD2' ' A' ' 148' ' ' LEU . . . -55.72 -23.82 31.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.074 -1.016 . . . . 0.0 108.497 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.676 ' CD2' HG11 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -75.81 -35.92 59.87 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.09 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.64 HH21 HG21 ' A' ' 162' ' ' THR . 2.3 tmt_? -55.49 -44.14 76.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.834 . . . . 0.0 109.627 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.501 ' HG3' HD13 ' A' ' 148' ' ' LEU . 0.4 OUTLIER -68.65 -37.31 79.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.432 -0.793 . . . . 0.0 110.157 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -65.07 -22.98 67.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.347 -0.846 . . . . 0.0 110.173 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.18 -179.99 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.512 ' CB ' ' HB2' ' A' ' 208' ' ' TYR . 22.5 Cg_endo . . . . . 0 C--O 1.215 -0.632 0 CA-C-O 121.485 0.536 . . . . 0.0 111.736 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.438 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 14.1 m-85 -93.54 -37.2 12.03 Favored 'General case' 0 C--N 1.278 -2.511 0 C-N-CA 119.24 -0.984 . . . . 0.0 113.504 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -79.25 -63.33 1.44 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.606 -1.238 . . . . 0.0 112.635 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.711 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.8 tpt180 -90.84 -14.94 30.86 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 118.746 -1.182 . . . . 0.0 111.929 -178.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.994 HG11 ' HB2' ' A' ' 205' ' ' LEU . 2.3 t -98.81 -19.0 6.08 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 C-N-CA 116.359 -2.136 . . . . 0.0 109.615 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 13' ' ' PHE . 3.7 tt0 -83.26 -41.5 18.27 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 176.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -74.04 -22.38 59.57 Favored 'General case' 0 C--N 1.307 -1.239 0 O-C-N 121.749 -0.595 . . . . 0.0 109.504 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 15' ' ' ARG . . . -75.52 -51.94 11.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.016 -1.052 . . . . 0.0 108.992 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.892 HD22 ' OH ' ' A' ' 208' ' ' TYR . 0.4 OUTLIER -49.48 -33.23 13.85 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.442 -0.786 . . . . 0.0 109.8 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' A' ' 24' ' ' ARG . . . -78.0 -68.41 0.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.972 0.891 . . . . 0.0 109.614 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.92 -29.2 1.9 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.495 -0.753 . . . . 0.0 110.135 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.499 ' CB ' ' HB ' ' A' ' 29' ' ' VAL . 1.9 mm? -101.09 -15.37 17.43 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.799 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.488 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -50.23 -24.47 2.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.079 -1.013 . . . . 0.0 108.571 178.286 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.73 42.76 1.11 Allowed 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 118.49 -1.284 . . . . 0.0 110.35 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.518 ' HA2' ' CZ ' ' A' ' 45' ' ' PHE . . . 55.2 25.91 41.33 Favored Glycine 0 C--N 1.291 -1.934 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 176.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.443 ' C ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -88.23 17.6 5.03 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 116.36 -2.136 . . . . 0.0 110.97 -179.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 198' ' ' ALA . . . 96.69 108.87 2.54 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 118.893 -1.622 . . . . 0.0 115.113 172.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.039 HG22 HD12 ' A' ' 44' ' ' ILE . 5.8 p -140.69 124.88 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-N 119.539 1.669 . . . . 0.0 108.345 175.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.839 ' HB2' HD23 ' A' ' 199' ' ' LEU . 0.5 OUTLIER -109.03 158.59 17.59 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.869 -1.145 . . . . 0.0 113.312 -177.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.893 HG21 HD21 ' A' ' 160' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.541 -0.724 . . . . 0.0 109.3 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.517 ' HB2' ' CB ' ' A' ' 174' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.501 2.095 0 CA-C-O 121.27 0.557 . . . . 0.0 111.597 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.593 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -95.34 53.92 1.56 Allowed 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.29 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.039 HD12 HG22 ' A' ' 29' ' ' VAL . 94.2 mt -61.22 19.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.527 3.391 0 O-C-N 120.428 -1.42 . . . . 0.0 111.991 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.593 ' H ' ' C ' ' A' ' 43' ' ' MET . 22.4 m-85 -85.06 165.09 38.69 Favored Pre-proline 0 C--N 1.291 -1.952 0 O-C-N 120.972 -1.08 . . . . 0.0 112.341 -177.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.503 ' HD3' ' CD2' ' A' ' 166' ' ' PHE . 40.8 Cg_endo -62.79 133.53 42.41 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 122.444 2.096 . . . . 0.0 114.106 -176.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.481 ' HB1' HD13 ' A' ' 68' ' ' LEU . . . -69.22 -2.7 11.2 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.263 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 15.7 tt0 -80.1 -14.99 58.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.906 -1.121 . . . . 0.0 109.653 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.526 ' O ' HG23 ' A' ' 49' ' ' THR . 6.3 t -130.81 58.99 1.68 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 177.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.515 ' HE1' HD11 ' A' ' 68' ' ' LEU . 15.3 ttm -51.53 88.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.673 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.499 ' HA ' HG13 ' A' ' 115' ' ' ILE . 3.2 m -64.65 157.45 27.16 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.693 0.759 . . . . 0.0 110.267 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 1.038 HG23 ' HB1' ' A' ' 111' ' ' ALA . 2.1 p -71.65 -4.87 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.655 -0.653 . . . . 0.0 109.907 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -55.15 -31.41 61.3 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.795 -1.19 . . . . 0.0 108.445 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.928 ' HA ' HD23 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -87.77 -38.27 15.9 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.19 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.844 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -71.87 -40.02 69.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.817 -1.177 . . . . 0.0 109.275 179.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.651 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -62.3 -47.08 85.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.558 -0.714 . . . . 0.0 110.772 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.928 HD23 ' HA ' ' A' ' 54' ' ' GLN . 0.8 OUTLIER -57.05 -34.14 67.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.079 -1.013 . . . . 0.0 110.987 -179.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.477 ' CA ' ' O ' ' A' ' 62' ' ' GLY . 33.2 p -79.54 -46.72 16.82 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.19 -0.944 . . . . 0.0 111.139 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.0 mt -54.22 -20.42 4.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 O-C-N 121.094 -1.004 . . . . 0.0 110.28 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.502 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 2.9 mtp180 -97.92 -44.56 6.64 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.158 -0.964 . . . . 0.0 113.169 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.502 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 48.5 m80 -125.43 -17.84 5.47 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -176.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.477 ' O ' ' CA ' ' A' ' 58' ' ' THR . . . -165.18 -169.09 28.34 Favored Glycine 0 N--CA 1.503 3.129 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.708 -177.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.6 t -143.1 96.37 2.91 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 102.27 -3.233 . . . . 0.0 102.27 175.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.42 ' H ' HG22 ' A' ' 58' ' ' THR . . . -136.35 72.38 0.46 Allowed Glycine 0 C--N 1.26 -3.681 1 N-CA-C 101.97 -4.452 . . . . 0.0 101.97 178.734 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.441 ' CG2' ' CE2' ' A' ' 138' ' ' PHE . 38.7 mt -60.14 145.28 12.04 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.816 0 CA-C-N 113.613 -1.293 . . . . 0.0 110.067 -176.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.809 HG12 ' CB ' ' A' ' 173' ' ' CYS . 35.2 m -55.98 152.28 2.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.863 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 171' ' ' VAL . 78.9 m -83.03 132.77 35.12 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.717 HD22 HG12 ' A' ' 171' ' ' VAL . 2.9 mm? -89.18 97.98 11.51 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.037 -1.065 . . . . 0.0 108.936 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.582 ' HA ' HG23 ' A' ' 157' ' ' THR . 34.3 m -64.41 125.73 25.58 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 118.776 -1.17 . . . . 0.0 109.794 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.543 ' CA ' HD13 ' A' ' 158' ' ' ILE . 15.2 tt -133.23 146.88 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.017 -1.052 . . . . 0.0 109.823 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.624 HG23 HG12 ' A' ' 158' ' ' ILE . 0.3 OUTLIER -108.62 151.97 25.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 109.643 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 76' ' ' LYS . 18.4 tt0 -50.25 -24.68 3.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.264 -0.897 . . . . 0.0 110.053 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -88.23 -38.24 15.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.323 -0.861 . . . . 0.0 109.969 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.851 ' O ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -62.11 -52.45 63.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.346 -0.846 . . . . 0.0 109.562 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.625 HH21 HG23 ' A' ' 96' ' ' THR . 0.5 OUTLIER -62.84 -40.85 98.7 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.112 0.958 . . . . 0.0 108.784 179.031 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.63 ' O ' ' N ' ' A' ' 79' ' ' ASP . 7.9 tttm -49.53 -62.04 1.77 Allowed 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -47.66 -31.3 4.48 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 121.884 0.849 . . . . 0.0 108.945 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.851 HD12 ' O ' ' A' ' 74' ' ' ARG . 3.0 mt -96.69 44.55 1.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 175.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.63 ' N ' ' O ' ' A' ' 76' ' ' LYS . 20.9 t0 -26.81 78.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 123.85 1.786 . . . . 0.0 112.893 -172.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.641 HD21 HG22 ' A' ' 99' ' ' ILE . 0.2 OUTLIER -150.77 106.36 3.06 Favored Pre-proline 0 C--N 1.286 -2.189 0 CA-C-N 112.315 -2.221 . . . . 0.0 110.181 177.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -92.07 94.06 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 N-CA-C 107.852 -1.634 . . . . 0.0 107.852 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.556 ' SD ' HG21 ' A' ' 97' ' ' VAL . 2.8 mmt -99.63 44.45 1.02 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.16 -0.962 . . . . 0.0 109.875 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.3 tpt -68.51 103.07 1.58 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.053 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 95' ' ' PHE . 11.0 t . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.699 ' O ' HG23 ' A' ' 84' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.486 1.329 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.625 HG23 HH21 ' A' ' 75' ' ' ARG . 2.8 m -59.25 79.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.589 HG11 ' HD3' ' A' ' 133' ' ' ARG . 18.8 t -35.47 151.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 CA-C-O 123.023 1.392 . . . . 0.0 113.412 -173.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.765 HG23 ' HA ' ' A' ' 134' ' ' PRO . 0.7 OUTLIER -69.64 179.5 2.12 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 113.793 -1.549 . . . . 0.0 113.157 -176.187 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.764 HD12 HD13 ' A' ' 131' ' ' LEU . 19.8 pt -141.9 131.81 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -177.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 132' ' ' ASN . 1.6 tm-20 -111.81 133.94 53.69 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 117.758 -1.577 . . . . 0.0 112.875 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.824 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . . . -52.72 93.28 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.064 -1.023 . . . . 0.0 110.039 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.594 ' HB2' ' HB2' ' A' ' 132' ' ' ASN . . . -82.55 3.82 27.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.965 -1.084 . . . . 0.0 110.911 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -113.02 54.92 0.71 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.775 -1.203 . . . . 0.0 112.236 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.44 -36.41 2.58 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 118.875 -1.631 . . . . 0.0 112.42 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.824 ' HB ' ' HB3' ' A' ' 101' ' ' ALA . 0.8 OUTLIER -100.99 124.4 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 120.962 -1.316 . . . . 0.0 110.187 -178.394 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 p -145.24 61.11 1.3 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.591 -1.318 . . . . 0.0 111.422 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 p -135.3 -32.27 0.94 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.889 -1.132 . . . . 0.0 110.323 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.9 -30.37 0.1 Allowed Glycine 0 N--CA 1.499 2.881 0 O-C-N 121.599 -0.688 . . . . 0.0 113.238 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.3 t -128.63 57.12 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.377 -1.661 . . . . 0.0 110.38 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -129.43 56.94 1.68 Allowed 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.128 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 1.038 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -31.53 -32.29 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -84.28 -77.37 0.27 Allowed 'General case' 0 C--N 1.29 -1.993 0 O-C-N 120.837 -1.165 . . . . 0.0 109.558 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.18 -15.94 28.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.448 -0.782 . . . . 0.0 110.737 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.805 ' HG2' HG23 ' A' ' 118' ' ' VAL . 2.4 ttt180 -90.67 -36.73 14.18 Favored 'General case' 0 C--O 1.202 -1.416 0 O-C-N 121.001 -1.062 . . . . 0.0 110.261 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.726 HD13 ' HA ' ' A' ' 111' ' ' ALA . 0.8 OUTLIER -62.0 -15.37 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 118.417 -1.313 . . . . 0.0 108.956 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.5 m -88.6 -55.27 3.78 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.765 ' CB ' HG13 ' A' ' 105' ' ' VAL . 53.2 p -67.49 -14.0 62.54 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.424 178.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.805 HG23 ' HG2' ' A' ' 114' ' ' ARG . 2.6 t -73.66 -48.64 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -50.52 -36.2 33.02 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.132 178.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.704 ' HA ' ' HB3' ' A' ' 123' ' ' ALA . . . -96.44 -13.8 22.86 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.281 0.563 . . . . 0.0 110.476 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.802 ' HB1' ' HB2' ' A' ' 101' ' ' ALA . . . -55.58 -56.48 19.82 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.252 -0.905 . . . . 0.0 109.773 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 19.1 tt -93.69 14.47 2.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 118.677 -1.209 . . . . 0.0 110.243 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.704 ' HB3' ' HA ' ' A' ' 120' ' ' ALA . . . -108.83 72.38 0.82 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 118.973 -1.091 . . . . 0.0 111.136 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.485 ' HB2' ' HZ2' ' A' ' 127' ' ' LYS . 5.1 t70 -99.3 -35.61 9.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.998 -1.064 . . . . 0.0 110.381 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 106.04 -38.37 3.34 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 105.28 -3.128 . . . . 0.0 105.28 -176.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -133.34 98.86 4.35 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.485 ' HZ2' ' HB2' ' A' ' 124' ' ' ASP . 5.4 tptt -132.33 52.94 9.91 Favored Pre-proline 0 C--N 1.307 -1.28 0 O-C-N 120.767 -1.208 . . . . 0.0 110.86 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 127' ' ' LYS . 49.4 Cg_endo -78.0 -35.65 1.31 Allowed 'Trans proline' 0 C--N 1.3 -2.009 0 N-CA-C 106.911 -1.996 . . . . 0.0 106.911 176.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.4 t -126.71 -0.29 6.74 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.345 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.448 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . 0.8 OUTLIER -77.4 9.4 3.26 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.634 -1.292 . . . . 0.0 112.718 -177.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.764 HD13 HD12 ' A' ' 99' ' ' ILE . 29.7 mt -117.87 124.89 49.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.716 -1.24 . . . . 0.0 109.337 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.594 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 1.3 m-80 -116.85 93.58 4.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.089 -1.007 . . . . 0.0 112.952 -177.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.785 ' HB2' ' HA ' ' A' ' 134' ' ' PRO 0.274 0.0 OUTLIER -80.71 172.12 10.6 Favored Pre-proline 0 N--CA 1.501 2.101 0 O-C-N 121.815 -0.553 . . . . 0.0 110.72 -179.556 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.785 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 48.2 Cg_endo -73.14 129.75 18.44 Favored 'Cis proline' 0 N--CA 1.502 1.995 0 C-N-CA 123.043 -1.649 . . . . 0.0 112.559 7.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.637 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -123.6 47.31 1.03 Allowed Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 135' ' ' GLY . 49.6 m80 31.19 38.1 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 122.143 0.973 . . . . 0.0 112.07 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.67 HG13 ' HG ' ' A' ' 68' ' ' LEU . 31.3 t -129.43 92.44 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 176.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.462 ' CD1' ' O ' ' A' ' 138' ' ' PHE . 10.4 p90 -107.09 101.91 40.45 Favored Pre-proline 0 N--CA 1.495 1.797 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.218 -176.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 53.2 Cg_endo -98.38 155.59 0.78 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.785 1.413 . . . . 0.0 111.078 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.515 HD12 ' O ' ' A' ' 139' ' ' PRO . 1.3 mp -127.29 116.59 20.78 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.471 ' HA ' HG23 ' A' ' 70' ' ' ILE . 9.2 ttm180 -63.52 115.66 4.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.058 -1.026 . . . . 0.0 110.696 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.997 ' HB2' HG22 ' A' ' 154' ' ' THR . . . -130.67 135.5 47.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.765 -0.584 . . . . 0.0 110.13 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.417 ' O ' ' HG3' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -53.38 143.23 19.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.941 -1.099 . . . . 0.0 110.092 -179.642 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.556 ' HB2' HG23 ' A' ' 158' ' ' ILE . . . -100.4 115.76 30.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.502 -0.749 . . . . 0.0 111.622 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.417 ' N ' ' OD2' ' A' ' 159' ' ' ASP . . . 104.02 -15.0 52.05 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.77 13.1 57.9 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.994 HG21 ' HB2' ' A' ' 156' ' ' ALA . 7.2 p -65.52 -9.09 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.095 -1.239 . . . . 0.0 110.276 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.888 HD22 HG13 ' A' ' 147' ' ' VAL . 4.0 mm? -87.82 15.92 6.47 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 115.683 -2.407 . . . . 0.0 110.079 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.0 m -131.11 60.94 1.65 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 100.937 -3.727 . . . . 0.0 100.937 167.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.78 140.03 22.23 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 113.876 -1.511 . . . . 0.0 112.774 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -104.03 34.83 5.47 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 106.44 -2.664 . . . . 0.0 106.44 173.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.3 160.88 27.92 Favored Glycine 0 N--CA 1.478 1.493 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.604 ' HB3' HD11 ' A' ' 202' ' ' ILE . 4.4 p-80 -90.0 -5.5 56.6 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.653 -0.91 . . . . 0.0 109.309 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.997 HG22 ' HB2' ' A' ' 142' ' ' ALA . 6.3 m -54.54 -59.22 4.98 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.076 -1.015 . . . . 0.0 109.437 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.834 ' HA ' ' HB1' ' A' ' 142' ' ' ALA . 21.2 tt0 -57.93 -22.12 47.25 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.994 ' HB2' HG21 ' A' ' 147' ' ' VAL . . . -91.38 8.04 38.15 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 121.715 -0.616 . . . . 0.0 109.377 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.582 HG23 ' HA ' ' A' ' 69' ' ' CYS . 0.6 OUTLIER -92.51 -51.69 5.0 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.375 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.713 HD11 ' O ' ' A' ' 168' ' ' PRO . 6.1 tp -72.77 -32.37 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 176.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.468 ' HB3' ' HA ' ' A' ' 156' ' ' ALA . 11.7 t0 -71.61 -22.28 61.73 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.893 HD21 HG21 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -60.22 -30.98 69.75 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.906 0.86 . . . . 0.0 109.466 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.525 ' HB2' ' HA ' ' A' ' 168' ' ' PRO . 37.2 mmt -83.42 -26.91 29.95 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.706 HG21 ' NE ' ' A' ' 209' ' ' ARG . 2.5 m -71.45 -36.87 71.37 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 176.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.719 ' CD2' ' HA ' ' A' ' 160' ' ' LEU . 3.9 pp -82.03 -4.2 56.24 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.251 -0.98 . . . . 0.0 108.698 177.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.635 ' HB2' HG22 ' A' ' 44' ' ' ILE . . . -109.52 12.1 24.6 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.38 -1.45 . . . . 0.0 109.865 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 58.5 42.49 95.94 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.503 ' CD2' ' HD3' ' A' ' 46' ' ' PRO . 6.3 m-85 -135.41 139.98 44.58 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 122.369 1.081 . . . . 0.0 112.093 -176.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 169' ' ' ALA . 5.1 mttt -48.98 136.6 13.93 Favored Pre-proline 0 N--CA 1.501 2.091 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 177.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.713 ' O ' HD11 ' A' ' 158' ' ' ILE . 37.4 Cg_endo -63.86 84.6 0.14 Allowed 'Trans proline' 0 C--N 1.301 -1.962 0 C-N-CA 116.59 -1.806 . . . . 0.0 113.225 -173.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 46' ' ' PRO . . . -155.94 123.82 5.66 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 100.581 -3.859 . . . . 0.0 100.581 172.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.454 ' N ' ' HB2' ' A' ' 69' ' ' CYS . . . -153.64 159.56 28.74 Favored Glycine 0 N--CA 1.502 3.085 0 CA-C-N 123.869 3.031 . . . . 0.0 113.199 -174.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.717 HG12 HD22 ' A' ' 68' ' ' LEU . 2.9 m -149.65 98.8 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 118.503 -1.279 . . . . 0.0 109.601 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.827 HD11 ' CD1' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -109.75 105.81 15.2 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 117.185 -1.806 . . . . 0.0 113.787 -179.506 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.876 ' SG ' HD21 ' A' ' 57' ' ' LEU . 49.5 t -137.88 159.9 40.76 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.856 ' O ' HD12 ' A' ' 189' ' ' ILE . 1.2 mm-40 174.64 85.68 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.968 0 O-C-N 119.842 -1.786 . . . . 0.0 112.689 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.938 HD21 ' HB3' ' A' ' 188' ' ' CYS . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.891 0 O-C-N 121.206 -0.934 . . . . 0.0 110.83 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.732 ' HB1' ' SG ' ' A' ' 188' ' ' CYS . . . . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.358 0.599 . . . . 0.0 110.879 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 185' ' ' ALA . 5.0 ttm180 -129.11 100.41 5.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -0.857 . . . . 0.0 109.442 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.913 ' HB1' ' HD2' ' A' ' 186' ' ' PRO . . . -179.85 -177.18 0.21 Allowed Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.336 -0.852 . . . . 0.0 109.298 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.913 ' HD2' ' HB1' ' A' ' 185' ' ' ALA . 42.8 Cg_endo -70.2 -23.39 28.86 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.342 1.18 . . . . 0.0 110.143 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.423 ' O ' ' CB ' ' A' ' 190' ' ' GLU . 0.4 OUTLIER -81.79 -28.24 33.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.033 -1.042 . . . . 0.0 108.56 178.601 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . 0.938 ' HB3' HD21 ' A' ' 175' ' ' LEU . 37.1 m -66.33 -51.56 56.01 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.856 HD12 ' O ' ' A' ' 174' ' ' GLU . 8.0 tp -58.34 -27.8 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.497 ' HA ' HD11 ' A' ' 199' ' ' LEU . 1.0 OUTLIER -60.14 -25.46 65.51 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 176.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.656 ' CE2' ' HB3' ' A' ' 183' ' ' ALA . 12.9 m-30 -55.76 -57.48 11.85 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 123.296 1.522 . . . . 0.0 108.093 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.727 ' HB1' ' SD ' ' A' ' 197' ' ' MET . . . -64.17 -46.61 83.25 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.562 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . 0.663 ' HB3' HD11 ' A' ' 199' ' ' LEU . 1.9 t30 -65.05 -11.88 44.33 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.472 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 190' ' ' GLU . 7.6 tmtt? -78.2 -37.11 46.37 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 117.372 -1.731 . . . . 0.0 111.06 -178.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -108.66 -54.25 2.54 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 115.684 -2.406 . . . . 0.0 111.952 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -114.67 34.63 4.67 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.322 -1.351 . . . . 0.0 113.784 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' MET . . . . . 0.727 ' SD ' ' HB1' ' A' ' 192' ' ' ALA . 2.2 mtt -151.42 150.63 30.67 Favored 'General case' 0 N--CA 1.518 2.949 0 CA-C-N 123.113 2.688 . . . . 0.0 115.466 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 28' ' ' GLY . . . -110.26 147.72 33.28 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.257 -0.902 . . . . 0.0 108.779 177.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.839 HD23 ' HB2' ' A' ' 30' ' ' MET . 10.0 mt -123.51 130.58 52.9 Favored 'General case' 0 N--CA 1.511 2.585 0 O-C-N 120.277 -1.514 . . . . 0.0 111.161 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.903 HG21 HG13 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -109.3 -160.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 120.791 -1.193 . . . . 0.0 111.027 179.232 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.707 ' O ' HD22 ' A' ' 205' ' ' LEU . 0.6 OUTLIER -108.44 -179.92 4.01 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.422 -0.799 . . . . 0.0 110.435 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 153' ' ' HIS . 12.9 tt -106.66 -41.91 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.417 -0.802 . . . . 0.0 111.3 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.512 ' N ' HG23 ' A' ' 202' ' ' ILE . 0.2 OUTLIER -90.38 -40.52 12.02 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.991 -1.068 . . . . 0.0 111.262 -178.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 207' ' ' ALA . 0.5 OUTLIER -63.37 -45.1 92.71 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.704 -1.247 . . . . 0.0 110.441 -179.454 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.994 ' HB2' HG11 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -71.28 -31.53 67.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.156 -0.965 . . . . 0.0 112.354 -178.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.779 ' H ' HD23 ' A' ' 205' ' ' LEU . 3.7 m -62.32 -29.57 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 119.707 -1.871 . . . . 0.0 106.995 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 211' ' ' ALA . . . -64.61 -38.46 91.08 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.892 ' OH ' HD22 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -56.87 -36.11 69.69 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.313 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.706 ' NE ' HG21 ' A' ' 162' ' ' THR . 0.0 OUTLIER -74.01 -55.26 6.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.418 -0.801 . . . . 0.0 110.0 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.438 ' N ' ' HD3' ' A' ' 209' ' ' ARG . 22.9 tt0 -68.83 -56.35 8.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 110.714 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 207' ' ' ALA . . . -51.19 -31.52 20.53 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.322 -0.861 . . . . 0.0 110.443 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.427 ' CB ' ' O ' ' A' ' 208' ' ' TYR . 48.9 t-80 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.183 -0.948 . . . . 0.0 110.182 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.886 ' HB2' ' HB3' ' A' ' 207' ' ' ALA . 18.7 Cg_endo . . . . . 0 N--CA 1.487 1.146 0 N-CA-C 110.455 -0.633 . . . . 0.0 110.455 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.451 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 9.8 t80 -87.19 -42.65 12.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.904 -0.498 . . . . 0.0 111.628 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.518 ' HA ' ' HB3' ' A' ' 17' ' ' GLU . 15.9 tt0 -89.37 -16.14 31.7 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.723 -1.236 . . . . 0.0 111.916 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.515 ' CD ' HG23 ' A' ' 200' ' ' VAL . 2.0 ttm180 -72.9 -64.46 0.96 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 105.977 -1.861 . . . . 0.0 105.977 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.71 HG11 ' CD2' ' A' ' 208' ' ' TYR . 7.3 p -62.22 -21.21 26.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 C-N-CA 118.721 -1.192 . . . . 0.0 108.323 176.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.518 ' HB3' ' HA ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -57.11 -35.17 69.13 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 119.92 -1.737 . . . . 0.0 106.458 177.092 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.536 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 2.9 m-20 -73.98 -29.37 61.94 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 176.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 1.088 ' HB1' HG11 ' A' ' 29' ' ' VAL . . . -67.83 -50.58 55.94 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.605 HD13 ' O ' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -61.43 -50.77 71.46 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 177.822 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.08 -26.22 62.27 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.668 -1.27 . . . . 0.0 107.966 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 18' ' ' ASN . . . -80.34 -32.55 37.83 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.499 -0.751 . . . . 0.0 109.064 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.539 ' CD2' ' CD2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -50.35 -25.44 3.84 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.093 -1.004 . . . . 0.0 108.83 177.881 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.44 -26.38 15.87 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 1.3 tp10 -144.69 81.09 1.65 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 123.866 1.793 . . . . 0.0 107.241 177.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 126.58 48.8 0.18 Allowed Glycine 0 C--N 1.276 -2.77 1 N-CA-C 102.617 -4.193 . . . . 0.0 102.617 -175.145 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 23' ' ' LEU . 1.3 mtt180 -62.78 65.39 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 122.023 0.916 . . . . 0.0 111.715 -175.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 26' ' ' GLY . . . 176.64 98.19 0.11 Allowed Glycine 0 C--N 1.291 -1.964 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.096 HG22 ' HB3' ' A' ' 198' ' ' ALA . 24.6 t -127.0 135.17 64.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 119.161 -1.016 . . . . 0.0 110.134 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.811 ' HG2' HD22 ' A' ' 199' ' ' LEU . 0.1 OUTLIER -100.31 161.24 13.74 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.352 -179.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 201' ' ' THR . 11.1 p . . . . . 0 C--N 1.298 -1.651 0 CA-C-O 121.682 0.753 . . . . 0.0 109.263 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.756 ' HB2' HD11 ' A' ' 189' ' ' ILE . 20.1 t70 . . . . . 0 N--CA 1.51 2.542 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.643 ' O ' ' O ' ' A' ' 171' ' ' VAL . 0.0 OUTLIER -93.23 51.13 1.6 Allowed 'General case' 0 C--N 1.293 -1.891 0 O-C-N 120.776 -1.203 . . . . 0.0 113.476 -177.037 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.983 ' C ' HD11 ' A' ' 160' ' ' LEU . 20.7 pt -66.13 27.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 O-C-N 119.464 -2.023 . . . . 0.0 112.397 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.539 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 31.4 m-85 -92.6 158.94 37.51 Favored Pre-proline 0 N--CA 1.505 2.292 0 O-C-N 121.064 -1.023 . . . . 0.0 113.184 -177.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.494 ' HB3' ' HB3' ' A' ' 167' ' ' LYS . 43.5 Cg_endo -66.53 130.86 24.6 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.245 1.963 . . . . 0.0 111.251 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.725 ' N ' ' HB1' ' A' ' 169' ' ' ALA . . . -58.9 -10.6 2.57 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 121.478 -0.764 . . . . 0.0 112.903 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.881 ' HA ' HD11 ' A' ' 122' ' ' ILE . 35.9 mt-10 -97.62 -2.58 41.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.631 -1.293 . . . . 0.0 109.542 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.86 57.08 1.82 Allowed 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 176.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.693 ' O ' HG23 ' A' ' 115' ' ' ILE . 25.4 tpp -63.26 86.93 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.526 -178.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.494 ' O ' HG23 ' A' ' 51' ' ' THR . 9.2 t -66.17 128.2 35.16 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.458 -0.776 . . . . 0.0 109.089 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 1.016 HG23 ' HB1' ' A' ' 111' ' ' ALA . 2.8 p -73.85 -2.56 3.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.534 -0.729 . . . . 0.0 109.484 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.49 -36.48 73.83 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.603 -1.239 . . . . 0.0 107.958 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.483 ' HB3' ' CG ' ' A' ' 43' ' ' MET . 1.0 OUTLIER -81.27 -53.96 5.9 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.828 179.023 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.429 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -54.56 -24.21 19.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.35 -0.844 . . . . 0.0 109.277 179.257 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.75 -46.87 64.9 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.322 -0.861 . . . . 0.0 109.896 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.77 HD11 HD23 ' A' ' 175' ' ' LEU . 0.7 OUTLIER -68.21 -36.6 79.79 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.057 -1.057 . . . . 0.0 109.952 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.414 ' OG1' ' CE ' ' A' ' 43' ' ' MET . 1.1 m -75.29 -58.17 3.44 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.198 -0.939 . . . . 0.0 110.511 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.426 ' CG1' ' O ' ' A' ' 55' ' ' MET . 96.5 mt -52.71 -22.09 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.941 . . . . 0.0 110.411 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -76.54 -40.62 49.31 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.282 -0.887 . . . . 0.0 111.15 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -123.01 -5.81 8.44 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.776 -1.203 . . . . 0.0 112.626 -178.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.99 -170.62 23.75 Favored Glycine 0 N--CA 1.496 2.633 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.158 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.4 t -141.24 101.73 4.08 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 102.26 -3.237 . . . . 0.0 102.26 176.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 66' ' ' VAL . . . -111.43 76.8 0.23 Allowed Glycine 0 C--N 1.26 -3.69 0 N-CA-C 104.612 -3.395 . . . . 0.0 104.612 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.695 ' O ' HG23 ' A' ' 65' ' ' ILE . 1.2 tt -58.19 94.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 CA-C-O 123.498 1.618 . . . . 0.0 108.811 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.673 HG23 ' C ' ' A' ' 172' ' ' LEU . 1.4 p -52.55 154.23 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.134 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.807 ' O ' HG12 ' A' ' 171' ' ' VAL . 44.5 t -75.93 162.64 27.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.174 -0.954 . . . . 0.0 110.131 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.84 HD22 HG12 ' A' ' 171' ' ' VAL . 0.3 OUTLIER -125.13 92.67 3.69 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.7 -1.25 . . . . 0.0 108.474 178.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.563 ' C ' HG23 ' A' ' 70' ' ' ILE . 1.8 t -93.25 153.88 18.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.428 -1.42 . . . . 0.0 113.073 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.563 HG23 ' C ' ' A' ' 69' ' ' CYS . 3.7 pt -155.29 147.51 12.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.048 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.515 HG22 ' H ' ' A' ' 72' ' ' GLU . 5.1 m -77.86 176.17 9.32 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 120.452 -1.405 . . . . 0.0 108.896 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.515 ' H ' HG22 ' A' ' 71' ' ' THR . 7.6 tt0 -95.16 -11.18 28.58 Favored 'General case' 0 C--N 1.284 -2.244 0 O-C-N 121.291 -0.881 . . . . 0.0 110.282 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -90.64 -75.26 0.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.591 -1.244 . . . . 0.0 111.557 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.58 -26.3 37.98 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 119.391 -0.923 . . . . 0.0 108.961 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.545 ' O ' ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -85.8 -27.47 25.14 Favored 'General case' 0 C--O 1.192 -1.967 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.359 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.1 OUTLIER -68.17 -41.78 81.0 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 121.157 1.799 . . . . 0.0 108.022 178.051 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.75 -58.28 6.85 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.614 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.91 HD22 ' O ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -89.09 -32.05 17.73 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 118.1 -1.44 . . . . 0.0 108.925 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.7 ' N ' HD13 ' A' ' 78' ' ' LEU . 1.4 t0 -116.03 75.32 0.94 Allowed 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.716 -0.615 . . . . 0.0 109.569 177.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.827 ' O ' HD22 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -75.46 126.68 87.3 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.669 -1.269 . . . . 0.0 111.827 -177.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.631 ' HB3' HG23 ' A' ' 96' ' ' THR . 55.2 Cg_endo -90.82 98.72 0.24 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 122.627 0.803 . . . . 0.0 110.038 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.609 ' SD ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -87.59 97.85 11.09 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.194 -0.941 . . . . 0.0 109.027 179.212 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.0 mtt -47.03 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.624 -0.672 . . . . 0.0 110.543 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.907 HG12 ' O ' ' A' ' 95' ' ' PHE . 14.7 p . . . . . 0 N--CA 1.495 1.811 0 C-N-CA 119.456 -0.897 . . . . 0.0 110.778 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.907 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 122.555 1.169 . . . . 0.0 111.447 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.631 HG23 ' HB3' ' A' ' 81' ' ' PRO . 4.0 m -60.23 78.05 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.343 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' A' ' 95' ' ' PHE . 2.6 p -32.99 149.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 CA-C-O 122.615 1.198 . . . . 0.0 112.183 -176.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.749 HG22 ' O ' ' A' ' 137' ' ' VAL . 5.4 p -70.29 -174.86 0.89 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.915 -175.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.868 HG23 HD22 ' A' ' 131' ' ' LEU 0.27 0.1 OUTLIER -146.44 136.61 17.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 -179.679 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.808 ' O ' HD23 ' A' ' 131' ' ' LEU . 46.7 tt0 -91.83 107.07 18.94 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 117.449 -1.7 . . . . 0.0 112.683 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.981 ' HB1' HG23 ' A' ' 105' ' ' VAL . . . -49.96 93.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.424 0.631 . . . . 0.0 110.754 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.859 ' HB3' ' O ' ' A' ' 130' ' ' ASP . . . -98.35 0.34 45.28 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.717 -1.24 . . . . 0.0 109.513 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.476 ' HB3' ' HB1' ' A' ' 121' ' ' ALA . 12.5 tt0 -82.81 13.74 3.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.062 -1.024 . . . . 0.0 111.299 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.576 ' O ' HG13 ' A' ' 105' ' ' VAL . . . 128.31 25.41 1.06 Allowed Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.31 -1.424 . . . . 0.0 112.562 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.981 HG23 ' HB1' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -161.0 118.03 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 O-C-N 120.92 -1.341 . . . . 0.0 110.742 177.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 101' ' ' ALA . 32.0 p -147.68 59.48 1.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.462 -1.399 . . . . 0.0 112.131 176.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.947 HG22 ' HG2' ' A' ' 114' ' ' ARG . 7.6 t -137.49 -28.02 0.92 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 120.528 -1.358 . . . . 0.0 110.706 176.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.26 -28.32 3.4 Favored Glycine 0 N--CA 1.487 2.1 0 O-C-N 121.389 -0.82 . . . . 0.0 111.797 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.08 53.46 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 120.513 -1.581 . . . . 0.0 111.782 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.554 ' CB ' HG21 ' A' ' 107' ' ' THR . 6.6 t -132.8 54.61 1.94 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 1.016 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -41.0 -24.68 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -177.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.458 ' O ' HG23 ' A' ' 116' ' ' THR . . . -78.04 -77.68 0.15 Allowed 'General case' 0 C--N 1.29 -2.017 0 O-C-N 120.289 -1.507 . . . . 0.0 109.913 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.34 -19.78 60.93 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.609 -0.682 . . . . 0.0 112.292 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.947 ' HG2' HG22 ' A' ' 107' ' ' THR . 1.4 mpt_? -95.5 -40.29 9.54 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 118.06 -1.456 . . . . 0.0 111.69 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.712 HG21 ' HB ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -67.98 -11.85 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 117.272 -1.771 . . . . 0.0 108.645 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 112' ' ' ALA . 20.7 p -83.04 -53.34 5.88 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 176.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.653 ' OG1' HG13 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -73.56 -23.44 59.97 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.805 178.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.799 HG23 HG11 ' A' ' 105' ' ' VAL . 2.8 t -63.43 -55.92 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.081 -1.012 . . . . 0.0 109.263 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 36.4 ptt85 -52.18 -33.3 40.01 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.719 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.422 ' N ' ' HG3' ' A' ' 119' ' ' ARG . . . -94.27 -9.49 35.91 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.826 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.511 ' CB ' ' CG2' ' A' ' 105' ' ' VAL . . . -98.49 -53.72 3.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.952 -1.093 . . . . 0.0 112.561 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.881 HD11 ' HA ' ' A' ' 48' ' ' GLU . 2.5 pp -67.93 -17.56 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.523 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.446 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . . . -107.24 74.1 0.96 Allowed 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.648 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.491 ' HB3' ' CG ' ' A' ' 127' ' ' LYS . 17.5 t70 -97.29 -63.09 1.16 Allowed 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 122.451 1.12 . . . . 0.0 110.256 178.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 126.8 -39.69 1.92 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.711 -2.156 . . . . 0.0 107.711 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -135.86 94.36 3.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.311 -1.111 . . . . 0.0 109.39 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.491 ' CG ' ' HB3' ' A' ' 124' ' ' ASP . 10.8 mmmt -136.9 57.94 17.15 Favored Pre-proline 0 C--N 1.308 -1.23 0 O-C-N 120.702 -1.249 . . . . 0.0 110.57 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.67 -16.22 52.56 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 N-CA-C 108.389 -1.427 . . . . 0.0 108.389 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.9 m -123.28 -25.38 4.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.577 -0.702 . . . . 0.0 111.373 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.859 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 2.8 t70 -78.39 10.0 3.45 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.749 -1.219 . . . . 0.0 112.428 -178.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.868 HD22 HG23 ' A' ' 99' ' ' ILE . 8.3 mt -140.32 96.56 3.06 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.687 -1.258 . . . . 0.0 108.671 178.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 0.6 OUTLIER -117.88 98.04 6.14 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.266 -0.896 . . . . 0.0 112.31 -178.045 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.822 ' HB2' ' HA ' ' A' ' 134' ' ' PRO . 0.0 OUTLIER -79.5 171.92 11.23 Favored Pre-proline 0 N--CA 1.503 2.214 0 O-C-N 121.717 -0.615 . . . . 0.0 111.305 -178.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.822 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 48.2 Cg_endo -73.16 130.84 21.12 Favored 'Cis proline' 0 N--CA 1.505 2.192 0 C-N-CA 123.405 -1.498 . . . . 0.0 113.432 7.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 100' ' ' GLU . . . -132.46 63.6 0.62 Allowed Glycine 0 N--CA 1.499 2.858 0 C-N-CA 119.844 -1.169 . . . . 0.0 111.88 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.505 ' O ' ' CE2' ' A' ' 138' ' ' PHE . 57.4 m80 30.46 38.45 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.986 -0.714 . . . . 0.0 112.801 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.749 ' O ' HG22 ' A' ' 98' ' ' THR . 2.2 t -108.24 132.56 55.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.553 ' CZ ' ' CG1' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -122.69 84.88 49.1 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 120.47 -1.394 . . . . 0.0 108.381 -176.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.711 ' O ' HD22 ' A' ' 140' ' ' LEU . 55.6 Cg_endo -104.3 159.33 0.21 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.961 1.774 . . . . 0.0 114.07 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.711 HD22 ' O ' ' A' ' 139' ' ' PRO . 0.5 OUTLIER -142.67 112.38 6.86 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 176.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.443 ' HB3' ' CB ' ' A' ' 81' ' ' PRO . 2.6 ptt85 -64.77 147.1 53.82 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.033 -1.042 . . . . 0.0 111.724 -176.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -129.55 132.15 46.75 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.69 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.39 143.85 27.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.171 -0.955 . . . . 0.0 109.909 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.18 100.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.407 -0.808 . . . . 0.0 109.42 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.447 ' HA2' ' NH2' ' A' ' 209' ' ' ARG . . . 88.66 20.8 46.14 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.33 13.18 61.68 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 1.01 HG22 ' HA ' ' A' ' 155' ' ' GLU . 0.3 OUTLIER -95.1 25.35 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 O-C-N 120.987 -1.302 . . . . 0.0 108.903 178.705 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.592 HD13 ' CG1' ' A' ' 206' ' ' VAL . 4.5 mm? -93.8 39.32 1.07 Allowed 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 102.36 -3.2 . . . . 0.0 102.36 172.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.547 ' H ' ' C ' ' A' ' 147' ' ' VAL . 48.8 m -102.6 92.25 4.56 Favored 'General case' 0 N--CA 1.409 -2.489 1 N-CA-C 99.002 -4.444 . . . . 0.0 99.002 177.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.503 ' O ' ' C ' ' A' ' 151' ' ' GLY . 0.2 OUTLIER -44.49 163.01 0.02 OUTLIER 'General case' 0 C--N 1.26 -3.316 0 CA-C-N 112.694 -2.048 . . . . 0.0 109.232 -173.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 150' ' ' ARG . . . -14.48 82.88 0.0 OUTLIER Glycine 0 N--CA 1.515 3.964 0 CA-C-O 124.179 1.988 . . . . 0.0 112.856 -169.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 150' ' ' ARG . . . -114.55 -157.83 11.99 Favored Glycine 0 N--CA 1.472 1.084 0 N-CA-C 106.984 -2.447 . . . . 0.0 106.984 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -92.83 -33.79 14.11 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.07 -1.253 . . . . 0.0 110.114 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.515 ' O ' HG21 ' A' ' 147' ' ' VAL . 41.6 p -97.0 -3.31 41.76 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.435 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 1.01 ' HA ' HG22 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -53.69 -32.26 51.06 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -175.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.593 ' CB ' HD13 ' A' ' 205' ' ' LEU . . . -113.89 5.25 16.15 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.153 -1.592 . . . . 0.0 112.336 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.819 HG22 ' C ' ' A' ' 170' ' ' GLY . 0.0 OUTLIER -89.4 -51.36 5.59 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.946 179.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.53 ' HA ' HD12 ' A' ' 158' ' ' ILE . 1.1 tp -90.25 -27.01 5.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 116.844 -1.942 . . . . 0.0 107.255 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.786 ' OD2' HG22 ' A' ' 206' ' ' VAL . 12.4 t70 -62.13 -23.65 66.69 Favored 'General case' 0 C--O 1.199 -1.601 0 C-N-CA 115.877 -2.329 . . . . 0.0 105.099 172.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.983 HD11 ' C ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -49.96 -45.13 51.14 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.373 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.485 ' CB ' ' HA ' ' A' ' 168' ' ' PRO . 5.7 ptt? -52.35 -36.37 53.38 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.008 176.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.758 HG21 ' CG ' ' A' ' 209' ' ' ARG . 4.5 m -79.59 -43.92 22.02 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.815 HD13 ' HA ' ' A' ' 160' ' ' LEU . 0.4 OUTLIER -35.54 -37.07 0.08 Allowed 'General case' 0 N--CA 1.517 2.907 0 CA-C-O 122.216 1.008 . . . . 0.0 109.094 178.184 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.478 ' HA ' HD21 ' A' ' 20' ' ' LEU . . . -106.93 -26.99 10.96 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.913 0.863 . . . . 0.0 108.828 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 162' ' ' THR . . . 108.93 -25.89 17.32 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -148.98 57.65 1.03 Allowed 'General case' 0 N--CA 1.505 2.297 0 C-N-CA 117.477 -1.689 . . . . 0.0 113.132 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.494 ' HB3' ' HB3' ' A' ' 46' ' ' PRO . 18.3 mmtt -129.3 73.88 81.36 Favored Pre-proline 0 C--N 1.3 -1.564 0 O-C-N 120.485 -1.385 . . . . 0.0 107.758 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.485 ' HA ' ' CB ' ' A' ' 161' ' ' MET . 39.5 Cg_endo -67.4 84.44 0.36 Allowed 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 116.236 -2.043 . . . . 0.0 110.107 -176.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.725 ' HB1' ' N ' ' A' ' 47' ' ' ALA 0.265 . . -159.56 164.43 34.27 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 176.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.819 ' C ' HG22 ' A' ' 157' ' ' THR . . . -157.63 108.88 0.38 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 118.406 -1.854 . . . . 0.0 109.969 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.84 HG12 HD22 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -133.14 92.68 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.196 -1.725 0 C-N-CA 116.952 -1.899 . . . . 0.0 109.491 177.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.844 HD11 HD12 ' A' ' 160' ' ' LEU . 10.0 mp -103.86 145.4 30.17 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.16 0.505 . . . . 0.0 109.826 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.525 ' N ' ' HB2' ' A' ' 43' ' ' MET . 1.1 t -130.73 167.54 18.66 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.112 -0.993 . . . . 0.0 110.724 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.401 ' N ' ' SG ' ' A' ' 173' ' ' CYS . 13.6 mm-40 -115.28 126.19 54.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.166 -0.959 . . . . 0.0 109.843 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.845 HD12 ' HB2' ' A' ' 188' ' ' CYS . 3.3 tm? . . . . . 0 N--CA 1.497 1.878 0 O-C-N 121.074 -1.016 . . . . 0.0 110.359 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 1.02 ' HB1' ' CB ' ' A' ' 188' ' ' CYS . . . . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 121.375 0.607 . . . . 0.0 110.047 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 188' ' ' CYS . 0.6 OUTLIER -79.07 125.08 28.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.462 -0.774 . . . . 0.0 109.923 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.813 ' HB3' ' HD3' ' A' ' 186' ' ' PRO . . . -38.14 -54.03 2.72 Favored Pre-proline 0 N--CA 1.501 2.084 0 O-C-N 121.809 -0.557 . . . . 0.0 112.391 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.813 ' HD3' ' HB3' ' A' ' 185' ' ' ALA . 47.5 Cg_endo -74.15 -35.12 4.31 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.41 1.216 . . . . 0.0 111.329 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 190' ' ' GLU . 0.0 OUTLIER -83.64 -59.3 2.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.076 -1.015 . . . . 0.0 111.514 -179.006 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . 1.02 ' CB ' ' HB1' ' A' ' 183' ' ' ALA . 12.3 p -53.15 -40.09 64.03 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.173 -0.954 . . . . 0.0 110.231 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.756 HD11 ' HB2' ' A' ' 42' ' ' ASP . 3.7 tp -73.33 -29.09 26.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 120.703 -1.248 . . . . 0.0 108.254 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 194' ' ' LYS . 0.1 OUTLIER -58.31 -20.51 43.62 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.759 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.485 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.2 OUTLIER -76.49 -53.85 7.53 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 178.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.474 ' HA ' HD22 ' A' ' 57' ' ' LEU . . . -56.28 -25.6 48.82 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . 0.8 ' CB ' HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -89.38 -23.61 22.15 Favored 'General case' 0 C--O 1.194 -1.863 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 190' ' ' GLU . 0.0 OUTLIER -52.07 -35.59 47.94 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 119.578 -1.951 . . . . 0.0 110.459 -178.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.5 -43.27 6.59 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 117.612 -1.635 . . . . 0.0 108.495 176.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.462 ' HB3' ' CA ' ' A' ' 28' ' ' GLY . 81.1 m-20 -103.91 56.22 0.73 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 176.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' MET . . . . . 0.551 ' N ' ' O ' ' A' ' 193' ' ' ASN . 0.4 OUTLIER -66.59 74.72 0.1 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 -172.513 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 1.096 ' HB3' HG22 ' A' ' 29' ' ' VAL . . . -131.01 99.25 4.83 Favored 'General case' 0 C--O 1.197 -1.701 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 172.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.811 HD22 ' HG2' ' A' ' 30' ' ' MET . 44.2 mt -118.21 131.57 56.37 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 119.68 -1.888 . . . . 0.0 111.448 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.641 HG13 ' N ' ' A' ' 201' ' ' THR . 0.5 OUTLIER -129.87 -159.22 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.313 -0.867 . . . . 0.0 111.352 -179.429 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.783 ' O ' HG23 ' A' ' 31' ' ' VAL . 1.7 p -125.46 177.64 6.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.488 -0.758 . . . . 0.0 109.955 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.528 HG23 ' N ' ' A' ' 203' ' ' GLU . 1.4 tp -91.46 -44.46 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.214 -0.929 . . . . 0.0 111.752 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.528 ' N ' HG23 ' A' ' 202' ' ' ILE . 43.9 mt-10 -60.17 -61.9 2.26 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.693 -1.254 . . . . 0.0 110.223 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.462 ' CB ' ' HB3' ' A' ' 12' ' ' PRO . 2.7 m-20 -57.74 -16.95 12.71 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.366 -0.834 . . . . 0.0 110.696 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.803 HD21 HD11 ' A' ' 163' ' ' LEU . 8.4 tt -68.05 -61.15 1.99 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.236 -1.54 . . . . 0.0 110.353 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.786 HG22 ' OD2' ' A' ' 159' ' ' ASP . 2.4 t -60.93 -16.66 14.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 119.848 -1.782 . . . . 0.0 109.277 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.886 ' HB3' ' HB2' ' A' ' 12' ' ' PRO . . . -60.58 -32.77 71.86 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 105.329 -2.101 . . . . 0.0 105.329 174.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.71 ' CD2' HG11 ' A' ' 16' ' ' VAL 0.273 1.1 t80 -50.81 -41.98 57.79 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 175.101 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.758 ' CG ' HG21 ' A' ' 162' ' ' THR . 1.3 ttt85 -78.43 -62.77 1.58 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.153 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -50.41 -37.2 36.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.192 -0.943 . . . . 0.0 110.409 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 207' ' ' ALA . . . -74.75 -26.91 60.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.396 -0.815 . . . . 0.0 110.152 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.404 ' O ' ' CD2' ' A' ' 212' ' ' HIS . 9.0 t60 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 110.18 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.635 ' O ' HG12 ' A' ' 16' ' ' VAL . 34.3 Cg_endo . . . . . 0 C--O 1.208 -1.012 0 N-CA-C 109.712 -0.918 . . . . 0.0 109.712 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.34 -45.27 7.89 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -178.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -81.91 -58.43 2.98 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.259 -1.376 . . . . 0.0 111.524 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.679 ' O ' HG21 ' A' ' 200' ' ' VAL . 0.0 OUTLIER -82.65 -15.26 52.73 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 118.666 -1.214 . . . . 0.0 112.531 -178.253 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.748 ' CG2' HG13 ' A' ' 200' ' ' VAL . 1.1 t -97.94 -29.92 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 116.422 -2.111 . . . . 0.0 110.444 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -73.28 -37.06 66.38 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 115.986 -2.286 . . . . 0.0 107.037 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.853 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 5.4 t30 -74.96 -26.27 59.47 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.621 ' CB ' HD12 ' A' ' 23' ' ' LEU . . . -90.77 -17.01 27.38 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.207 -0.933 . . . . 0.0 109.598 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.907 HD13 ' OH ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -69.29 -51.5 36.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.943 -1.098 . . . . 0.0 109.605 179.472 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.457 ' HA ' ' HB2' ' A' ' 25' ' ' GLU . . . -89.49 -46.22 8.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.076 -1.015 . . . . 0.0 111.034 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.853 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -72.23 -39.54 68.42 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.148 -0.97 . . . . 0.0 111.876 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.045 HD22 ' HB2' ' A' ' 198' ' ' ALA . 56.8 mt -105.05 -24.1 12.85 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.878 -1.139 . . . . 0.0 112.664 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.981 ' NH2' HD12 ' A' ' 163' ' ' LEU . 0.4 OUTLIER -100.34 -6.2 26.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.569 -1.332 . . . . 0.0 110.714 -179.288 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 3.2 tt0 -101.25 44.4 1.01 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 118.117 -1.433 . . . . 0.0 107.949 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.02 2.67 12.43 Favored Glycine 0 C--N 1.296 -1.692 0 C-N-CA 119.911 -1.138 . . . . 0.0 112.616 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.412 ' HB3' ' HA ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -128.55 22.04 5.99 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 121.313 2.557 . . . . 0.0 115.944 -179.628 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.767 ' O ' ' HB3' ' A' ' 198' ' ' ALA . . . 97.09 108.74 2.6 Favored Glycine 0 N--CA 1.501 3.009 0 C-N-CA 117.923 -2.084 . . . . 0.0 116.819 171.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.74 HG12 HD12 ' A' ' 44' ' ' ILE . 30.7 t -140.77 122.08 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.439 -1.624 . . . . 0.0 106.814 173.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.672 ' C ' HD11 ' A' ' 44' ' ' ILE . 1.1 mtt -123.55 150.03 44.53 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 118.727 -1.189 . . . . 0.0 113.937 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.984 HG23 ' HB ' ' A' ' 202' ' ' ILE . 1.1 p . . . . . 0 N--CA 1.498 1.939 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.618 ' OD1' HD13 ' A' ' 189' ' ' ILE . 7.9 m-20 . . . . . 0 N--CA 1.5 2.059 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.671 ' HB3' ' HA ' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -85.71 59.81 5.86 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.233 -0.917 . . . . 0.0 111.233 -178.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.987 ' O ' HD21 ' A' ' 160' ' ' LEU . 41.9 mt -56.73 22.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.94 0 O-C-N 120.489 -1.382 . . . . 0.0 114.531 -175.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 43' ' ' MET . 32.3 m-85 -82.92 161.53 57.8 Favored Pre-proline 0 C--N 1.292 -1.919 0 O-C-N 120.344 -1.473 . . . . 0.0 110.557 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.502 ' HB3' ' CB ' ' A' ' 167' ' ' LYS . 48.0 Cg_endo -70.21 131.83 21.39 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.791 1.661 . . . . 0.0 111.434 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 1.029 ' HB3' ' HB1' ' A' ' 169' ' ' ALA . . . -61.9 -13.65 26.75 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.467 -0.771 . . . . 0.0 111.774 -178.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.815 ' HA ' ' HB3' ' A' ' 123' ' ' ALA . 0.2 OUTLIER -88.83 -8.71 53.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.038 -1.039 . . . . 0.0 109.088 178.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.456 ' O ' ' N ' ' A' ' 51' ' ' THR . 0.7 OUTLIER -133.9 57.92 1.79 Allowed 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 176.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 1.052 ' O ' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -60.12 87.6 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.456 ' N ' ' O ' ' A' ' 49' ' ' THR . 13.6 m -64.88 155.59 33.7 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.608 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.862 ' CG2' HG21 ' A' ' 115' ' ' ILE . 14.1 t -71.33 -4.89 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.525 -0.734 . . . . 0.0 110.098 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.46 ' OE1' ' CZ ' ' A' ' 45' ' ' PHE . 3.1 mt-10 -57.24 -25.72 59.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.886 -1.134 . . . . 0.0 108.959 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.661 ' NE2' HG13 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -75.72 -54.15 7.4 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.708 0.765 . . . . 0.0 110.552 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.594 ' HG2' ' HB2' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -66.36 -45.47 80.0 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.608 -178.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -54.75 -44.51 73.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.086 -1.009 . . . . 0.0 110.649 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.707 HD13 ' HG2' ' A' ' 174' ' ' GLU . 3.1 tt -67.09 -56.01 11.86 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.195 -0.941 . . . . 0.0 109.607 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.72 HG21 ' HA3' ' A' ' 64' ' ' GLY . 11.8 p -65.16 -51.77 59.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.969 -1.082 . . . . 0.0 111.441 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 55' ' ' MET . 7.7 tt -49.92 -25.68 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.053 -1.03 . . . . 0.0 109.198 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 57' ' ' LEU . 9.6 ttm180 -66.52 -61.72 1.84 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.996 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -129.33 -11.77 4.56 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 118.108 -1.437 . . . . 0.0 114.028 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 58' ' ' THR . . . -132.06 -169.67 12.37 Favored Glycine 0 N--CA 1.498 2.796 0 O-C-N 120.468 -1.395 . . . . 0.0 112.12 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.4 t -135.28 104.75 6.0 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 101.122 -3.658 . . . . 0.0 101.122 176.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.72 ' HA3' HG21 ' A' ' 58' ' ' THR . . . -103.32 73.76 0.28 Allowed Glycine 0 C--N 1.262 -3.545 0 N-CA-C 107.781 -2.128 . . . . 0.0 107.781 -176.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.699 ' O ' HG23 ' A' ' 65' ' ' ILE . 0.6 OUTLIER -65.2 90.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.272 -2.765 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.661 HG13 ' NE2' ' A' ' 54' ' ' GLN . 28.3 m -51.41 155.57 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 122.049 0.928 . . . . 0.0 113.375 -177.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 171' ' ' VAL . 61.6 m -90.37 111.7 23.02 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.651 HD21 HD13 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -88.44 91.97 9.0 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.527 ' C ' HG23 ' A' ' 70' ' ' ILE . 26.4 p -78.35 161.66 27.03 Favored 'General case' 0 C--N 1.285 -2.204 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.929 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.83 HD11 ' HG3' ' A' ' 81' ' ' PRO . 1.1 pt -151.48 147.84 15.11 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.64 HG22 ' HB2' ' A' ' 75' ' ' ARG . 10.3 t -79.89 172.21 14.09 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 120.294 -1.504 . . . . 0.0 107.939 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.489 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -92.46 -10.98 35.92 Favored 'General case' 0 C--N 1.276 -2.587 0 O-C-N 121.321 -0.862 . . . . 0.0 109.855 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.95 -72.67 0.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.751 -1.218 . . . . 0.0 111.9 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.441 ' NH1' ' HB2' ' A' ' 126' ' ' ALA . 2.1 mtt-85 -87.8 -35.27 17.93 Favored 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 119.346 -0.942 . . . . 0.0 109.137 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.64 ' HB2' HG22 ' A' ' 71' ' ' THR . 3.0 mmt180 -69.7 -31.29 69.23 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.004 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.489 ' CG ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -69.76 -44.22 70.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.236 -1.54 . . . . 0.0 109.075 178.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -41.88 -55.11 3.2 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.768 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.991 HD13 ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -104.97 -27.97 11.36 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 117.673 -1.611 . . . . 0.0 110.149 178.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.991 ' N ' HD13 ' A' ' 78' ' ' LEU . 22.6 t0 -115.8 72.9 0.82 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.793 -1.192 . . . . 0.0 110.115 176.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.728 ' O ' HG11 ' A' ' 97' ' ' VAL . 13.9 tp -80.42 121.25 81.32 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.568 -1.332 . . . . 0.0 109.301 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.83 ' HG3' HD11 ' A' ' 70' ' ' ILE . 54.0 Cg_endo -89.4 93.81 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.573 1.301 . . . . 0.0 109.596 178.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.491 ' H ' HG21 ' A' ' 97' ' ' VAL . 1.2 ttt -96.84 42.95 1.08 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.172 -0.955 . . . . 0.0 109.879 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.504 ' HA ' ' CA ' ' A' ' 96' ' ' THR . 0.0 OUTLIER 16.8 107.99 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.661 ' O ' HG13 ' A' ' 84' ' ' VAL . 7.2 p . . . . . 0 N--CA 1.487 1.413 0 C-N-CA 117.277 -1.769 . . . . 0.0 112.635 176.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.75 ' CD2' HD22 ' A' ' 140' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.956 0 CA-C-O 122.031 0.92 . . . . 0.0 110.638 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.504 ' CA ' ' HA ' ' A' ' 83' ' ' MET . 0.7 OUTLIER -133.73 37.38 3.28 Favored 'General case' 0 N--CA 1.515 2.809 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -179.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.728 HG11 ' O ' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -115.52 110.29 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 O-C-N 120.546 -1.346 . . . . 0.0 110.319 178.283 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.811 HG22 ' O ' ' A' ' 137' ' ' VAL . 14.9 p -75.45 177.19 6.86 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.123 -0.985 . . . . 0.0 110.439 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 1.081 HD12 HD13 ' A' ' 131' ' ' LEU . 27.9 pt -142.31 135.81 28.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 132' ' ' ASN . 10.9 tt0 -86.17 113.37 22.15 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 117.072 -1.851 . . . . 0.0 110.961 -176.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.908 ' HB1' HG13 ' A' ' 105' ' ' VAL . . . -53.02 91.7 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.648 0.737 . . . . 0.0 109.929 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.534 ' H ' HD23 ' A' ' 131' ' ' LEU . . . -106.29 -0.43 24.39 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.407 -0.808 . . . . 0.0 110.504 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.45 ' HB3' ' HB1' ' A' ' 121' ' ' ALA . 27.6 tt0 -86.89 26.97 1.05 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.915 -1.115 . . . . 0.0 111.896 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.645 ' C ' HG21 ' A' ' 117' ' ' THR . . . 126.94 -38.68 2.11 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.422 -1.37 . . . . 0.0 111.466 178.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.908 HG13 ' HB1' ' A' ' 101' ' ' ALA . 5.4 p -101.39 125.7 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.104 -1.233 . . . . 0.0 110.331 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.5 m -143.06 59.62 1.41 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.853 -1.155 . . . . 0.0 110.565 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.9 m -137.27 -30.76 0.84 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.091 -1.005 . . . . 0.0 110.564 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.417 ' CA ' ' CE1' ' A' ' 136' ' ' HIS . . . 78.62 -30.81 1.95 Allowed Glycine 0 N--CA 1.494 2.52 0 O-C-N 121.565 -0.71 . . . . 0.0 111.329 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.17 58.57 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.85 -1.383 . . . . 0.0 109.347 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -128.23 57.49 1.57 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.298 -0.876 . . . . 0.0 109.057 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.594 ' HB2' ' HG2' ' A' ' 55' ' ' MET . . . -33.48 -29.95 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -81.05 -76.94 0.22 Allowed 'General case' 0 C--N 1.291 -1.972 0 O-C-N 120.893 -1.129 . . . . 0.0 110.13 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.81 -13.94 62.71 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.563 -0.711 . . . . 0.0 111.18 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.586 ' HE ' HG21 ' A' ' 118' ' ' VAL . 0.1 OUTLIER -89.65 -44.44 10.05 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.96 -1.087 . . . . 0.0 110.506 -179.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 1.052 HG23 ' O ' ' A' ' 50' ' ' MET . 18.4 mm -64.6 -16.92 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.668 -1.213 . . . . 0.0 110.739 -178.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 68.8 p -88.28 -53.45 4.69 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.866 -1.133 . . . . 0.0 108.704 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.645 HG21 ' C ' ' A' ' 104' ' ' GLY . 60.0 m -71.39 -43.19 67.31 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.544 -0.863 . . . . 0.0 110.004 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.586 HG21 ' HE ' ' A' ' 114' ' ' ARG . 4.4 p -52.72 -40.13 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 120.577 -1.327 . . . . 0.0 109.866 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 54.2 ttt180 -51.31 -53.47 35.64 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.851 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -99.29 -6.99 27.01 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 117' ' ' THR . . . -98.35 -26.36 14.52 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 116.056 1.872 . . . . 0.0 116.056 -174.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.716 HD12 ' N ' ' A' ' 123' ' ' ALA . 2.6 pp -121.02 -37.7 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 121.112 1.778 . . . . 0.0 112.091 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.815 ' HB3' ' HA ' ' A' ' 48' ' ' GLU . . . -103.98 75.26 1.27 Allowed 'General case' 0 C--N 1.263 -3.166 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.392 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.479 ' CB ' ' CD ' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -97.27 -54.96 2.99 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.297 1.046 . . . . 0.0 110.154 177.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 124.07 -39.94 2.05 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 105.729 -2.949 . . . . 0.0 105.729 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.441 ' HB2' ' NH1' ' A' ' 74' ' ' ARG . . . -134.63 96.76 3.63 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 175.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.479 ' CD ' ' CB ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -131.75 123.45 19.22 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 120.857 -1.152 . . . . 0.0 113.373 -176.267 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.456 ' HD2' ' CE ' ' A' ' 127' ' ' LYS . 51.8 Cg_endo -81.38 21.02 0.95 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.656 1.345 . . . . 0.0 108.79 175.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 131' ' ' LEU . 2.0 m -92.9 42.29 1.1 Allowed 'General case' 0 C--O 1.202 -1.418 0 O-C-N 121.412 -0.805 . . . . 0.0 109.018 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -26.51 79.37 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 123.991 1.853 . . . . 0.0 111.798 -176.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 1.081 HD13 HD12 ' A' ' 99' ' ' ILE 0.255 5.4 mt -61.44 125.35 23.48 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 112.069 -2.332 . . . . 0.0 108.047 -178.148 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 15.7 p-10 -113.68 99.51 7.78 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.409 -0.807 . . . . 0.0 111.738 -177.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.843 ' HB2' ' HA ' ' A' ' 134' ' ' PRO 0.282 0.5 OUTLIER -82.58 -178.43 1.18 Allowed Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 122.031 -0.418 . . . . 0.0 111.203 -177.611 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.843 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 48.5 Cg_endo -72.69 123.39 8.23 Favored 'Cis proline' 0 N--CA 1.503 2.063 0 C-N-CA 123.674 -1.386 . . . . 0.0 113.327 8.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.747 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -124.04 60.03 0.61 Allowed Glycine 0 N--CA 1.5 2.907 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.105 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.472 ' O ' ' CE2' ' A' ' 138' ' ' PHE . 25.5 p80 32.1 37.97 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.665 0 O-C-N 121.745 -0.856 . . . . 0.0 112.271 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.811 ' O ' HG22 ' A' ' 98' ' ' THR . 54.4 t -91.04 154.87 3.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.617 ' CD1' ' O ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -123.6 84.06 53.37 Favored Pre-proline 0 C--N 1.281 -2.376 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 -178.32 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.859 ' O ' HD23 ' A' ' 140' ' ' LEU . 54.9 Cg_endo -98.42 140.84 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.737 1.388 . . . . 0.0 113.674 -176.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.859 HD23 ' O ' ' A' ' 139' ' ' PRO . 36.1 mt -136.7 112.8 9.73 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.463 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.416 ' CD ' ' HG2' ' A' ' 81' ' ' PRO . 11.1 ttt180 -69.95 127.0 31.36 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.085 -1.009 . . . . 0.0 109.874 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.83 ' HB3' ' CG2' ' A' ' 158' ' ' ILE . . . -132.75 133.19 43.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.063 -1.023 . . . . 0.0 111.329 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -58.84 143.09 48.56 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.247 -0.908 . . . . 0.0 109.532 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.27 106.27 5.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.421 -0.799 . . . . 0.0 110.568 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 86.54 20.98 53.03 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.83 12.85 62.57 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.825 HG21 ' HB2' ' A' ' 156' ' ' ALA . 13.6 p -104.57 18.76 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.972 -1.311 . . . . 0.0 109.427 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.906 HD11 ' HA ' ' A' ' 207' ' ' ALA . 3.7 mm? -94.86 20.39 8.88 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 117.331 -1.748 . . . . 0.0 108.306 176.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 151' ' ' GLY . 29.4 m -126.99 73.46 1.42 Allowed 'General case' 0 C--N 1.29 -1.987 1 N-CA-C 96.183 -5.488 . . . . 0.0 96.183 168.515 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.748 ' HG2' HG21 ' A' ' 206' ' ' VAL . 0.1 OUTLIER -67.21 71.85 0.11 Allowed 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 113.553 -1.658 . . . . 0.0 115.033 -168.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 149' ' ' THR . . . -116.93 28.68 7.21 Favored Glycine 0 N--CA 1.475 1.281 0 N-CA-C 105.611 -2.996 . . . . 0.0 105.611 169.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -148.74 131.38 3.72 Favored Glycine 0 C--N 1.303 -1.265 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.445 ' ND1' ' O ' ' A' ' 153' ' ' HIS . 1.6 t60 -89.79 -5.37 56.99 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.537 HG23 ' N ' ' A' ' 155' ' ' GLU . 14.9 t -93.38 -46.51 7.31 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.225 -0.922 . . . . 0.0 110.821 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.746 ' HG3' HG23 ' A' ' 147' ' ' VAL . 1.2 pt-20 -59.61 -20.73 57.94 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.825 ' HB2' HG21 ' A' ' 147' ' ' VAL . . . -86.77 5.66 35.34 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 121.356 -0.84 . . . . 0.0 108.943 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.52 ' O ' ' CB ' ' A' ' 160' ' ' LEU . 2.5 m -87.05 -51.12 6.19 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.83 ' CG2' ' HB3' ' A' ' 142' ' ' ALA . 4.4 tp -74.39 -17.44 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 115.96 -2.296 . . . . 0.0 106.404 175.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.693 ' CG ' HG11 ' A' ' 147' ' ' VAL . 18.9 t70 -62.21 -29.84 70.67 Favored 'General case' 0 C--O 1.206 -1.215 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 173.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.987 HD21 ' O ' ' A' ' 44' ' ' ILE . 1.7 tm? -50.23 -43.75 53.05 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 176.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.567 ' HB2' ' HA ' ' A' ' 168' ' ' PRO . 0.0 OUTLIER -52.76 -36.21 57.6 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.75 178.508 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.633 HG21 ' HD2' ' A' ' 209' ' ' ARG . 1.5 m -93.17 -51.44 5.02 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 1.075 HD22 HD21 ' A' ' 205' ' ' LEU . 1.8 pp -57.41 -14.47 4.85 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.501 -1.374 . . . . 0.0 111.679 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -77.16 -30.78 55.15 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 120.593 -1.317 . . . . 0.0 108.392 176.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 106.27 -35.43 5.05 Favored Glycine 0 N--CA 1.493 2.475 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.326 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.74 48.19 0.39 Allowed 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 117.792 -1.563 . . . . 0.0 113.097 172.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 161' ' ' MET . 40.4 mmtt -135.95 83.46 34.26 Favored Pre-proline 0 C--N 1.289 -2.061 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 174.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.567 ' HA ' ' HB2' ' A' ' 161' ' ' MET . 44.5 Cg_endo -73.65 81.02 1.91 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 114.781 -3.013 . . . . 0.0 113.798 -173.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 1.029 ' HB1' ' HB3' ' A' ' 47' ' ' ALA . . . -165.76 168.38 16.12 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 171.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.428 ' HA3' ' HB3' ' A' ' 160' ' ' LEU . . . -156.99 129.02 2.29 Favored Glycine 0 N--CA 1.504 3.184 0 C-N-CA 118.28 -1.914 . . . . 0.0 110.276 177.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.985 HG13 ' HB2' ' A' ' 47' ' ' ALA . 6.5 m -141.42 101.43 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.962 HD22 ' HA ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -125.86 101.08 6.67 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 117.177 -1.809 . . . . 0.0 115.045 -176.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.489 ' HB3' ' CA ' ' A' ' 64' ' ' GLY . 1.1 m -140.79 141.87 34.74 Favored 'General case' 0 N--CA 1.514 2.736 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 173.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.707 ' HG2' HD13 ' A' ' 57' ' ' LEU . 3.5 tt0 176.82 87.32 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.33 0 CA-C-N 122.632 2.469 . . . . 0.0 115.473 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 188' ' ' CYS . 0.3 OUTLIER . . . . . 0 N--CA 1.508 2.464 0 O-C-N 120.452 -1.405 . . . . 0.0 109.108 175.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 188' ' ' CYS . . . . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 121.223 0.535 . . . . 0.0 109.935 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.588 ' O ' ' HB2' ' A' ' 185' ' ' ALA . 9.5 mtt-85 -105.26 100.15 9.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.341 -0.85 . . . . 0.0 109.825 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.859 ' HB1' ' HD2' ' A' ' 186' ' ' PRO . . . 172.92 178.93 0.12 Allowed Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.309 -0.869 . . . . 0.0 109.831 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.859 ' HD2' ' HB1' ' A' ' 185' ' ' ALA . 43.0 Cg_endo -69.5 -7.72 21.72 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.303 1.159 . . . . 0.0 110.422 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.5 -41.66 19.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.972 -1.08 . . . . 0.0 109.992 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 183' ' ' ALA . 16.8 p -67.43 -36.32 80.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.966 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.618 HD13 ' OD1' ' A' ' 42' ' ' ASP . 5.2 tp -73.98 -28.33 23.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.754 -1.216 . . . . 0.0 109.079 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.527 ' HA ' ' HB3' ' A' ' 193' ' ' ASN . 35.9 tt0 -71.05 -19.01 62.54 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.721 0.772 . . . . 0.0 109.05 177.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.494 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.7 OUTLIER -75.99 -48.42 21.12 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.128 0.966 . . . . 0.0 109.513 -179.413 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.474 ' C ' ' HB2' ' A' ' 197' ' ' MET . . . -73.79 -35.35 64.92 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 178.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . 0.655 ' CB ' HD11 ' A' ' 199' ' ' LEU . 1.7 t30 -56.33 -23.36 36.72 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.3 -40.92 20.81 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 118.099 -1.441 . . . . 0.0 112.741 -176.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.25 -56.03 2.6 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 114.966 -2.694 . . . . 0.0 112.055 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' A' ' 197' ' ' MET . 0.1 OUTLIER -117.05 33.74 5.46 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.073 -1.451 . . . . 0.0 113.773 176.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' MET . . . . . 0.675 ' HE2' HD12 ' A' ' 57' ' ' LEU . 15.3 mmt -150.35 151.69 33.25 Favored 'General case' 0 N--CA 1.517 2.896 0 CA-C-N 123.034 2.652 . . . . 0.0 114.53 -178.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 1.045 ' HB2' HD22 ' A' ' 23' ' ' LEU . . . -111.59 155.73 22.89 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.033 -1.042 . . . . 0.0 108.916 177.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.655 HD11 ' CB ' ' A' ' 193' ' ' ASN . 48.1 mt -125.58 133.19 52.36 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 120.552 -1.342 . . . . 0.0 109.676 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.748 HG13 ' CG2' ' A' ' 16' ' ' VAL . 1.3 p -170.82 18.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.521 -1.362 . . . . 0.0 113.287 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 1.006 HG23 HD22 ' A' ' 205' ' ' LEU 0.271 87.0 m -133.33 150.24 51.87 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 -176.149 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.984 ' HB ' HG23 ' A' ' 31' ' ' VAL . 3.6 tp 149.85 -76.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.844 0 C-N-CA 124.99 1.316 . . . . 0.0 109.704 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.794 ' H ' HG23 ' A' ' 202' ' ' ILE . 1.9 tt0 -93.79 -59.56 1.96 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.337 -1.477 . . . . 0.0 110.723 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.33 -50.32 73.42 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.225 -0.922 . . . . 0.0 111.508 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 1.075 HD21 HD22 ' A' ' 163' ' ' LEU . 3.2 tt -60.5 -23.63 64.68 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.069 -1.019 . . . . 0.0 113.244 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.748 HG21 ' HG2' ' A' ' 150' ' ' ARG . 16.5 m -77.98 -34.82 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 119.65 -1.906 . . . . 0.0 108.14 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.906 ' HA ' HD11 ' A' ' 148' ' ' LEU . . . -68.82 -14.62 63.14 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 174.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.907 ' OH ' HD13 ' A' ' 20' ' ' LEU . 7.6 t80 -81.71 -26.71 34.38 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.798 -0.563 . . . . 0.0 109.608 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.633 ' HD2' HG21 ' A' ' 162' ' ' THR . 0.2 OUTLIER -75.82 -25.77 56.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.096 -1.003 . . . . 0.0 108.69 177.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.503 ' N ' ' HG3' ' A' ' 209' ' ' ARG . 6.8 tt0 -82.72 -59.15 2.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.412 -0.805 . . . . 0.0 109.885 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -51.77 -27.1 11.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.485 -0.759 . . . . 0.0 110.223 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 109.999 179.772 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 14' ' ' GLU . 20.5 Cg_endo . . . . . 0 N--CA 1.508 2.334 0 N-CA-C 106.551 -2.134 . . . . 0.0 106.551 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.803 ' HE2' HD13 ' A' ' 20' ' ' LEU 0.27 16.1 t80 -40.15 -26.83 0.03 OUTLIER 'General case' 0 C--O 1.184 -2.352 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.733 169.098 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 17' ' ' GLU . 1.0 OUTLIER -43.09 -38.14 2.26 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.085 -1.634 . . . . 0.0 109.082 179.28 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.7 mmt-85 -61.78 -46.37 89.87 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 176.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.803 HG21 ' CE2' ' A' ' 208' ' ' TYR . 15.7 m -79.34 -12.67 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 C-N-CA 117.684 -1.606 . . . . 0.0 109.875 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 35.1 tt0 -53.88 -34.54 59.73 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -79.11 -33.08 44.69 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.744 ' O ' ' HB3' ' A' ' 22' ' ' ALA . . . -70.49 -64.87 0.81 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.5 -0.75 . . . . 0.0 110.834 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.803 HD13 ' HE2' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -54.66 -43.95 72.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.2 -0.938 . . . . 0.0 109.127 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 17' ' ' GLU . . . -53.68 -28.37 33.03 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.744 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . -78.24 -33.52 49.7 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 3.8 tt -44.52 -28.04 0.53 Allowed 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.84 0.829 . . . . 0.0 109.582 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.53 -30.84 12.64 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 0.2 OUTLIER -147.7 82.65 1.52 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 123.439 1.59 . . . . 0.0 108.191 177.457 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.657 ' O ' ' HB1' ' A' ' 22' ' ' ALA . . . 126.57 50.64 0.17 Allowed Glycine 0 C--N 1.275 -2.821 1 N-CA-C 102.076 -4.409 . . . . 0.0 102.076 -174.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.803 ' CD ' HG21 ' A' ' 51' ' ' THR . 3.1 mtm180 -55.92 91.16 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 122.942 1.353 . . . . 0.0 110.429 -173.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.463 ' HA3' ' HG2' ' A' ' 197' ' ' MET . . . 176.48 105.95 0.19 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.124 -1.512 . . . . 0.0 113.189 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.012 HG13 HG12 ' A' ' 44' ' ' ILE . 1.1 p -140.34 99.21 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.71 ' HB2' HD23 ' A' ' 199' ' ' LEU . 4.9 mtt -97.96 130.42 44.82 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.864 -1.147 . . . . 0.0 114.072 -173.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 1.092 HG12 HD13 ' A' ' 205' ' ' LEU . 35.6 m . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.4 -0.812 . . . . 0.0 109.707 177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.776 ' OD2' HD12 ' A' ' 189' ' ' ILE . 5.2 m-20 . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 122.281 1.038 . . . . 0.0 111.834 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.941 ' HE3' HD22 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -85.87 54.41 3.12 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.511 -0.743 . . . . 0.0 110.382 -179.173 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.012 HG12 HG13 ' A' ' 29' ' ' VAL . 3.0 pt -63.77 26.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.534 3.763 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 -175.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.965 ' O ' HG22 ' A' ' 171' ' ' VAL . 9.7 m-85 -67.81 161.68 64.68 Favored Pre-proline 0 C--N 1.283 -2.309 0 O-C-N 121.372 -0.83 . . . . 0.0 112.193 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.478 ' HB3' ' HB3' ' A' ' 167' ' ' LYS . 45.6 Cg_endo -68.83 129.58 18.87 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.524 1.483 . . . . 0.0 110.52 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.54 ' N ' ' HB1' ' A' ' 169' ' ' ALA . . . -70.47 -2.59 14.38 Favored 'General case' 0 N--CA 1.508 2.441 0 C-N-CA 119.195 -1.002 . . . . 0.0 112.554 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -85.73 -23.55 27.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.737 -1.227 . . . . 0.0 109.315 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.57 HG22 ' O ' ' A' ' 49' ' ' THR . 51.7 m -132.42 60.56 1.69 Allowed 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 177.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.411 ' O ' HG13 ' A' ' 115' ' ' ILE . 0.4 OUTLIER -52.48 88.09 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.263 0.554 . . . . 0.0 110.056 -178.739 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.803 HG21 ' CD ' ' A' ' 27' ' ' ARG . 1.6 m -66.18 153.42 42.48 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.616 0.722 . . . . 0.0 109.777 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.985 HG23 ' HB1' ' A' ' 111' ' ' ALA . 1.7 p -73.91 -3.78 4.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.569 -0.707 . . . . 0.0 109.668 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.427 ' CG ' ' HB2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -55.8 -32.63 63.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.742 -1.224 . . . . 0.0 108.53 179.287 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.48 ' HB3' ' CD2' ' A' ' 45' ' ' PHE . 10.2 pt20 -81.18 -32.89 33.38 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.51 0.671 . . . . 0.0 110.118 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.763 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -82.22 -46.42 13.75 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.38 -0.825 . . . . 0.0 110.263 -179.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.659 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -54.07 -45.05 71.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.951 -1.093 . . . . 0.0 110.142 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 1.073 HD21 HD12 ' A' ' 175' ' ' LEU . 7.3 tt -60.98 -53.21 60.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.384 -0.823 . . . . 0.0 110.359 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.568 ' N ' HD23 ' A' ' 57' ' ' LEU . 8.3 t -74.75 -47.44 31.16 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.422 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.517 ' N ' HG23 ' A' ' 58' ' ' THR . 40.8 mt -46.54 -26.03 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 120.649 -1.282 . . . . 0.0 110.222 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.49 -47.62 17.01 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.385 -0.822 . . . . 0.0 110.785 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -125.18 -7.01 7.1 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.636 -1.29 . . . . 0.0 114.068 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 58' ' ' THR . . . -157.05 -168.23 19.32 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 120.503 -1.373 . . . . 0.0 111.005 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.69 103.77 5.32 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 102.273 -3.232 . . . . 0.0 102.273 176.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.442 ' N ' ' OG1' ' A' ' 58' ' ' THR . . . -104.48 73.03 0.25 Allowed Glycine 0 C--N 1.264 -3.439 0 N-CA-C 106.381 -2.687 . . . . 0.0 106.381 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.841 HG23 ' CZ ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -65.72 90.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.031 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.488 HG21 ' HB ' ' A' ' 171' ' ' VAL . 29.3 m -52.79 150.63 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.003 -177.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.546 ' O ' HG21 ' A' ' 157' ' ' THR . 82.8 m -77.6 119.17 20.79 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 139' ' ' PRO . 0.6 OUTLIER -90.06 92.07 8.82 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 118.617 -1.233 . . . . 0.0 108.551 -179.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.541 ' O ' HD13 ' A' ' 158' ' ' ILE . 0.5 OUTLIER -87.57 145.51 26.18 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 122.339 1.066 . . . . 0.0 112.576 -178.062 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.555 HD12 ' O ' ' A' ' 79' ' ' ASP . 9.9 pt -137.58 138.89 44.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.743 HG23 ' HB3' ' A' ' 143' ' ' GLN . 50.0 m -78.59 143.18 36.69 Favored 'General case' 0 C--O 1.199 -1.588 0 O-C-N 120.549 -1.344 . . . . 0.0 108.769 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.451 ' HB3' ' NE ' ' A' ' 141' ' ' ARG . 6.1 pt-20 -41.53 -25.94 0.06 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.788 -0.57 . . . . 0.0 111.799 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.543 ' H ' HG22 ' A' ' 71' ' ' THR . 0.2 OUTLIER -84.46 -49.64 8.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.953 . . . . 0.0 110.496 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -80.83 -25.5 37.71 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.079 0.942 . . . . 0.0 108.666 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.568 ' O ' ' N ' ' A' ' 79' ' ' ASP . 6.5 ttp180 -59.01 -67.99 0.31 Allowed 'General case' 0 C--O 1.19 -2.028 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.473 ' HA ' ' CB ' ' A' ' 80' ' ' LEU . 0.4 OUTLIER -48.66 -55.13 12.17 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.244 -178.352 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -30.01 -50.34 0.12 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 124.362 1.039 . . . . 0.0 111.363 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.734 HD12 HG23 ' A' ' 122' ' ' ILE . 1.6 tm? -134.78 -30.26 1.1 Allowed 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 118.286 -1.365 . . . . 0.0 111.48 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.568 ' N ' ' O ' ' A' ' 75' ' ' ARG . 58.7 m-20 -116.87 69.32 0.75 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.895 -1.128 . . . . 0.0 110.725 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.772 ' O ' HG13 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -74.73 169.39 20.14 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 120.766 -1.209 . . . . 0.0 111.66 -179.114 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.877 ' HA ' HG22 ' A' ' 97' ' ' VAL . 39.7 Cg_endo -65.77 113.33 2.5 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 O-C-N 122.551 0.764 . . . . 0.0 110.809 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.489 ' O ' HG13 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -95.67 43.46 1.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 0.0 110.768 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.426 ' C ' ' O ' ' A' ' 82' ' ' MET . 3.9 ptt? 26.94 62.4 0.09 Allowed 'General case' 0 N--CA 1.51 2.532 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.546 ' CG2' ' HA ' ' A' ' 96' ' ' THR . 19.1 m . . . . . 0 N--CA 1.493 1.693 0 O-C-N 120.833 -1.167 . . . . 0.0 110.235 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' A' ' 139' ' ' PRO . 21.9 m-30 . . . . . 0 N--CA 1.495 1.781 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.578 HG23 HG23 ' A' ' 97' ' ' VAL . 8.8 t -122.25 -1.15 9.24 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 117.974 -1.49 . . . . 0.0 114.762 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.877 HG22 ' HA ' ' A' ' 81' ' ' PRO . 57.0 t -119.14 79.88 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.619 0 C-N-CA 119.476 -0.889 . . . . 0.0 112.371 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.59 ' HA ' ' HB ' ' A' ' 137' ' ' VAL . 46.0 p -74.92 144.98 43.02 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 119.844 -1.785 . . . . 0.0 107.257 177.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.944 HG13 HG21 ' A' ' 137' ' ' VAL . 2.2 pt -146.86 125.31 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.121 -0.987 . . . . 0.0 110.568 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.591 ' O ' HD23 ' A' ' 131' ' ' LEU . 6.9 tt0 -93.14 108.85 20.37 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 117.621 -1.632 . . . . 0.0 109.511 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.99 ' HB1' HG13 ' A' ' 105' ' ' VAL . . . -50.99 93.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.362 -0.836 . . . . 0.0 110.804 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 100' ' ' GLU . . . -84.18 2.49 39.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.452 -0.78 . . . . 0.0 110.428 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.72 4.21 14.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.993 -1.067 . . . . 0.0 110.702 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.14 26.98 1.16 Allowed Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.76 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.99 HG13 ' HB1' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -146.19 122.53 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.173 -1.192 . . . . 0.0 110.507 179.331 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.3 m -146.63 60.72 1.21 Allowed 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.044 -1.035 . . . . 0.0 110.401 176.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.1 m -135.65 -31.47 0.95 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.811 -1.181 . . . . 0.0 110.73 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.432 ' HA2' ' NH2' ' A' ' 114' ' ' ARG . . . 74.21 -27.74 0.99 Allowed Glycine 0 N--CA 1.494 2.518 0 O-C-N 121.449 -0.782 . . . . 0.0 112.384 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.588 ' HA ' ' HE1' ' A' ' 55' ' ' MET . 0.0 OUTLIER -127.32 57.06 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.469 -1.607 . . . . 0.0 110.604 -179.32 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 114' ' ' ARG . 2.7 t -129.47 54.4 1.83 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.33 -0.856 . . . . 0.0 108.695 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.985 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -34.14 -29.53 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -84.83 -77.58 0.27 Allowed 'General case' 0 C--N 1.288 -2.08 0 O-C-N 120.73 -1.231 . . . . 0.0 109.612 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.413 ' O ' HG23 ' A' ' 117' ' ' THR . 2.1 m-20 -59.45 -17.38 30.63 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.503 -0.748 . . . . 0.0 110.235 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.895 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -89.62 -39.21 13.39 Favored 'General case' 0 C--O 1.203 -1.378 0 O-C-N 120.996 -1.065 . . . . 0.0 110.76 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.752 HD13 ' HA ' ' A' ' 111' ' ' ALA . 1.0 OUTLIER -57.07 -18.4 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 120.306 -1.496 . . . . 0.0 109.368 -178.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.0 m -87.41 -52.93 5.09 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.85 -1.156 . . . . 0.0 108.062 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 121' ' ' ALA . 44.1 p -66.61 -36.85 83.59 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.493 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.895 HG13 ' O ' ' A' ' 114' ' ' ARG . 26.6 m -53.89 -43.4 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 O-C-N 120.349 -1.469 . . . . 0.0 108.603 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.521 ' N ' HG23 ' A' ' 118' ' ' VAL . 0.6 OUTLIER -51.77 -32.18 29.89 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.792 -1.163 . . . . 0.0 107.879 177.223 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.451 ' HA ' ' HB2' ' A' ' 123' ' ' ALA . . . -95.3 -19.59 19.85 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.167 178.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 117' ' ' THR . . . -53.72 -54.01 43.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.918 -1.114 . . . . 0.0 109.131 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.734 HG23 HD12 ' A' ' 78' ' ' LEU . 60.3 mt -88.83 23.32 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.525 177.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . -55.18 146.5 18.59 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.508 ' O ' HD23 ' A' ' 78' ' ' LEU . 28.7 t70 -35.62 -80.19 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.792 0 CA-C-N 119.659 1.118 . . . . 0.0 110.093 -178.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 127' ' ' LYS . . . 54.46 34.5 54.94 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 118.133 -1.984 . . . . 0.0 109.786 174.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.32 91.16 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 123.29 1.519 . . . . 0.0 110.569 -174.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 125' ' ' GLY . 0.1 OUTLIER -137.93 127.28 14.91 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.428 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -53.67 -16.35 8.02 Favored 'Trans proline' 0 C--N 1.294 -2.337 0 O-C-N 122.703 0.844 . . . . 0.0 111.028 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.0 t -123.45 24.17 8.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.844 -1.16 . . . . 0.0 110.56 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.462 ' HB3' ' CB ' ' A' ' 127' ' ' LYS . 11.0 p30 -74.46 4.25 6.29 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.411 -1.431 . . . . 0.0 112.018 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.838 HD13 ' HB ' ' A' ' 99' ' ' ILE . 25.6 mt -143.1 110.83 5.89 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.558 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.6 OUTLIER -86.46 71.69 10.4 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -176.511 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.738 ' HB2' ' HA ' ' A' ' 134' ' ' PRO 0.257 0.0 OUTLIER -85.27 173.08 7.55 Favored Pre-proline 0 C--N 1.291 -1.95 0 O-C-N 121.549 -0.719 . . . . 0.0 110.064 179.966 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.738 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 47.5 Cg_endo -72.66 124.91 9.59 Favored 'Cis proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.832 -1.737 . . . . 0.0 111.524 7.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.974 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -122.08 74.93 0.36 Allowed Glycine 0 N--CA 1.501 2.988 0 C-N-CA 119.452 -1.356 . . . . 0.0 111.866 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.493 ' O ' ' CE2' ' A' ' 138' ' ' PHE . 83.2 m-70 31.18 37.18 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 O-C-N 122.204 -0.586 . . . . 0.0 112.344 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.974 HG23 ' O ' ' A' ' 135' ' ' GLY . 69.3 t -106.07 135.04 45.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 176.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.841 ' CZ ' HG23 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -126.52 81.59 67.93 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -177.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.791 ' HG3' HG12 ' A' ' 137' ' ' VAL . 64.3 Cg_endo -112.77 141.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.559 2.173 . . . . 0.0 113.495 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.434 HD21 ' HB ' ' A' ' 154' ' ' THR . 1.1 pp -127.53 148.87 50.33 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.454 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.46 ' HB2' ' CD ' ' A' ' 75' ' ' ARG . 0.9 OUTLIER -91.52 92.55 8.56 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.867 -1.145 . . . . 0.0 110.054 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.8 69.03 1.37 Allowed 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 118.542 -1.263 . . . . 0.0 113.1 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.743 ' HB3' HG23 ' A' ' 71' ' ' THR . 19.6 tm0? -120.9 73.21 1.0 Allowed 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 117.751 -1.579 . . . . 0.0 112.213 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -127.64 38.52 4.03 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 117.733 -1.587 . . . . 0.0 111.459 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 74.44 -4.39 34.9 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 119.277 -1.44 . . . . 0.0 111.419 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.4 28.07 17.67 Favored Glycine 0 N--CA 1.485 1.91 0 O-C-N 120.665 -1.491 . . . . 0.0 113.417 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.953 HG13 HG11 ' A' ' 206' ' ' VAL . 1.5 p -60.48 -15.8 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 120.248 2.024 . . . . 0.0 107.822 177.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.761 HD11 HG12 ' A' ' 206' ' ' VAL . 75.3 mt -94.02 22.63 5.59 Favored 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 116.81 -1.956 . . . . 0.0 110.404 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.1 p -127.44 58.34 1.47 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 101.656 -3.461 . . . . 0.0 101.656 168.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.39 149.89 28.28 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 113.034 -1.894 . . . . 0.0 110.763 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -102.47 34.68 5.53 Favored Glycine 0 N--CA 1.483 1.768 0 N-CA-C 106.293 -2.723 . . . . 0.0 106.293 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -145.48 159.7 27.95 Favored Glycine 0 N--CA 1.478 1.45 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.656 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 29.2 p-80 -89.7 -4.72 57.59 Favored 'General case' 0 C--N 1.292 -1.921 0 O-C-N 121.657 -0.907 . . . . 0.0 108.845 176.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.434 ' HB ' HD21 ' A' ' 140' ' ' LEU . 1.1 p -51.53 -55.31 19.72 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.015 -1.053 . . . . 0.0 109.795 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.447 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . 24.6 mt-10 -59.51 -21.74 60.61 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.812 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . . . -87.24 6.3 33.9 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.647 ' HA ' HD13 ' A' ' 172' ' ' LEU . 17.9 m -93.83 -51.06 5.06 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.159 -0.963 . . . . 0.0 109.52 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.62 ' O ' ' HB3' ' A' ' 161' ' ' MET . 9.7 tp -75.81 -34.15 27.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 116.238 -2.185 . . . . 0.0 105.126 175.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.519 ' HB2' ' HA ' ' A' ' 156' ' ' ALA . 0.8 OUTLIER -59.69 -25.56 64.87 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.084 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.66 ' O ' HD12 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -58.78 -28.89 66.37 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.62 ' HB3' ' O ' ' A' ' 158' ' ' ILE . 5.6 ttt -51.59 -39.26 57.58 Favored 'General case' 0 N--CA 1.514 2.758 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 174.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.444 ' CB ' ' O ' ' A' ' 159' ' ' ASP . 1.2 m -68.52 -39.26 81.25 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.651 177.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 1.014 HD21 HD21 ' A' ' 205' ' ' LEU . 0.3 OUTLIER -52.1 -57.62 9.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.864 -1.148 . . . . 0.0 108.763 179.038 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' A' ' 167' ' ' LYS . . . -64.63 -27.4 68.91 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.14 0.972 . . . . 0.0 108.545 177.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 96.17 -27.84 15.24 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 37.2 p90 -151.05 55.6 0.89 Allowed 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.166 -1.414 . . . . 0.0 112.292 175.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.553 ' HD2' ' HB1' ' A' ' 164' ' ' ALA . 1.9 mttp -129.71 80.2 72.05 Favored Pre-proline 0 C--N 1.296 -1.739 0 CA-C-O 117.23 -1.367 . . . . 0.0 107.777 176.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.434 ' HA ' ' HB2' ' A' ' 161' ' ' MET . 43.2 Cg_endo -72.01 80.58 1.51 Allowed 'Trans proline' 0 C--N 1.32 -0.965 0 C-N-CA 115.367 -2.622 . . . . 0.0 110.636 -176.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.54 ' HB1' ' N ' ' A' ' 47' ' ' ALA . . . -163.26 166.37 23.25 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 104.292 -2.485 . . . . 0.0 104.292 175.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.59 ' HA3' HG22 ' A' ' 157' ' ' THR . . . -157.6 119.49 0.91 Allowed Glycine 0 N--CA 1.485 1.954 0 C-N-CA 116.721 -2.657 . . . . 0.0 112.479 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.965 HG22 ' O ' ' A' ' 45' ' ' PHE . 23.6 m -127.08 134.59 65.73 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.761 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 175.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.689 ' HG ' HG22 ' A' ' 44' ' ' ILE . 0.2 OUTLIER -149.88 113.67 5.06 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.696 -1.252 . . . . 0.0 109.39 -178.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.477 ' O ' ' N ' ' A' ' 42' ' ' ASP . 21.5 p -128.65 175.79 8.3 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 120.257 -1.527 . . . . 0.0 111.377 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.417 ' OE2' ' NH2' ' A' ' 184' ' ' ARG . 16.0 pm0 -113.05 154.63 26.23 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.106 -0.996 . . . . 0.0 110.558 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 1.073 HD12 HD21 ' A' ' 57' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.896 0 O-C-N 121.269 -0.895 . . . . 0.0 109.932 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.766 ' HB1' ' SG ' ' A' ' 188' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.284 0.564 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 185' ' ' ALA . 0.2 OUTLIER -125.16 100.01 6.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.816 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.858 ' HB1' ' HD2' ' A' ' 186' ' ' PRO . . . 179.17 178.5 0.28 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.387 -0.821 . . . . 0.0 109.704 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.858 ' HD2' ' HB1' ' A' ' 185' ' ' ALA . 45.9 Cg_endo -72.65 -8.47 22.53 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.603 1.318 . . . . 0.0 110.767 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -81.45 -68.94 0.65 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.984 -1.073 . . . . 0.0 110.307 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . 0.766 ' SG ' ' HB1' ' A' ' 183' ' ' ALA . 0.4 OUTLIER -57.74 -30.41 65.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.428 -0.795 . . . . 0.0 110.097 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.852 HG22 HD22 ' A' ' 199' ' ' LEU . 27.2 mm -75.77 -26.3 17.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 120.951 -1.093 . . . . 0.0 109.102 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.489 ' HA ' HD11 ' A' ' 199' ' ' LEU . 12.0 mt-10 -76.76 -19.38 57.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.474 -0.766 . . . . 0.0 109.092 177.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 192' ' ' ALA . 0.8 OUTLIER -70.27 -56.4 6.86 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.179 0.99 . . . . 0.0 108.764 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.692 ' CB ' HD11 ' A' ' 57' ' ' LEU . . . -61.76 -41.78 98.14 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . 0.665 ' CB ' HD11 ' A' ' 199' ' ' LEU . 2.2 t30 -66.33 -13.3 60.34 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.021 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.99 -37.33 47.45 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 117.636 -1.626 . . . . 0.0 111.578 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . 0.405 ' CD2' ' H ' ' A' ' 195' ' ' HIS . 13.7 p80 -108.79 -52.7 2.73 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 115.717 -2.393 . . . . 0.0 111.856 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.462 ' O ' ' HG2' ' A' ' 197' ' ' MET . 44.5 t30 -114.8 33.34 5.43 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.098 -1.441 . . . . 0.0 113.958 177.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' MET . . . . . 0.599 ' CB ' ' HA ' ' A' ' 193' ' ' ASN . 0.0 OUTLIER -151.45 149.71 29.58 Favored 'General case' 0 N--CA 1.52 3.067 0 CA-C-N 123.375 2.807 . . . . 0.0 115.163 -179.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.54 ' HB1' ' HB2' ' A' ' 19' ' ' ALA . . . -107.08 154.28 21.38 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 176.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.852 HD22 HG22 ' A' ' 189' ' ' ILE . 43.7 mt -123.44 144.74 49.31 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.277 -1.514 . . . . 0.0 113.171 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.953 HG21 HD12 ' A' ' 205' ' ' LEU . 0.2 OUTLIER -120.28 -161.79 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.477 ' HB ' ' CB ' ' A' ' 204' ' ' ASP . 0.2 OUTLIER -132.97 142.78 49.04 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.946 -1.096 . . . . 0.0 108.468 177.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.512 HG23 ' N ' ' A' ' 203' ' ' GLU . 5.2 tp -45.93 -46.67 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.196 -0.94 . . . . 0.0 111.56 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.512 ' N ' HG23 ' A' ' 202' ' ' ILE . 22.8 tt0 -91.9 -31.49 15.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.883 -1.135 . . . . 0.0 111.016 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.765 ' O ' ' HB3' ' A' ' 207' ' ' ALA . 10.9 t70 -72.99 -39.14 66.32 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.267 -0.896 . . . . 0.0 112.121 -178.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 1.092 HD13 HG12 ' A' ' 31' ' ' VAL . 10.4 tt -58.22 -62.78 1.58 Allowed 'General case' 0 N--CA 1.484 1.264 0 O-C-N 120.687 -1.258 . . . . 0.0 110.641 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.953 HG11 HG13 ' A' ' 147' ' ' VAL . 2.4 t -66.47 -13.55 16.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 C-N-CA 118.086 -1.445 . . . . 0.0 108.122 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 204' ' ' ASP . . . -57.23 -33.18 67.3 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.803 ' CE2' HG21 ' A' ' 16' ' ' VAL . 4.7 m-30 -56.54 -52.38 65.01 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 175.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -41.84 97.38 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.761 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -53.92 -43.12 69.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 109.501 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -57.45 -35.14 69.75 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.47 -0.769 . . . . 0.0 109.221 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.539 -0.726 . . . . 0.0 109.839 179.4 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.883 ' O ' HG12 ' A' ' 16' ' ' VAL . 30.5 Cg_endo . . . . . 0 C--O 1.204 -1.196 0 N-CA-C 111.082 -0.392 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -86.99 -67.14 0.84 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 115.699 1.741 . . . . 0.0 115.699 -177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.56 -45.71 11.5 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 118.521 -1.272 . . . . 0.0 112.336 -175.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.444 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 28.0 mmt-85 -84.78 -12.26 54.04 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 118.238 -1.385 . . . . 0.0 113.325 -177.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.883 HG12 ' O ' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -95.16 -28.16 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 122.856 2.571 . . . . 0.0 108.69 176.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -66.29 -52.21 49.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 117.938 -1.505 . . . . 0.0 108.101 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -64.28 -33.93 76.96 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.186 -0.946 . . . . 0.0 108.722 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 23' ' ' LEU . . . -81.01 -5.86 58.1 Favored 'General case' 0 C--O 1.201 -1.47 0 O-C-N 121.188 -0.945 . . . . 0.0 108.606 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.648 HD11 ' O ' ' A' ' 163' ' ' LEU . 0.3 OUTLIER -68.08 -51.7 43.59 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.37 -49.92 73.03 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.566 ' HB1' ' HB2' ' A' ' 27' ' ' ARG . . . -61.25 -28.57 69.26 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.672 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -60.5 -8.69 2.94 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.534 -0.729 . . . . 0.0 110.765 179.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.74 -37.35 10.34 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.384 -0.823 . . . . 0.0 108.969 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -151.57 90.28 1.55 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 123.267 1.508 . . . . 0.0 113.444 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.24 -18.35 5.83 Favored Glycine 0 C--N 1.272 -3.007 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.672 ' O ' ' HA ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -129.42 120.15 25.0 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 178.057 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 198' ' ' ALA . . . -164.2 105.03 0.24 Allowed Glycine 0 C--N 1.27 -3.137 1 N-CA-C 103.017 -4.033 . . . . 0.0 103.017 -175.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.667 ' HB ' ' CB ' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -125.1 161.36 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 113.059 -1.57 . . . . 0.0 112.192 -172.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.618 ' CA ' ' HA ' ' A' ' 42' ' ' ASP . 1.4 tmm? -98.52 152.61 19.37 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.148 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.706 HG13 HG21 ' A' ' 44' ' ' ILE . 15.6 m . . . . . 0 C--N 1.29 -2.016 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.855 ' OD2' ' HB1' ' A' ' 192' ' ' ALA . 8.3 t70 . . . . . 0 N--CA 1.51 2.548 0 CA-C-O 121.951 0.882 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.64 ' O ' ' O ' ' A' ' 171' ' ' VAL . 0.0 OUTLIER -93.89 54.45 1.96 Allowed 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -177.216 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.96 ' O ' HD21 ' A' ' 160' ' ' LEU . 28.8 pt -64.5 23.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.524 3.265 0 O-C-N 118.93 -2.356 . . . . 0.0 113.282 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.597 ' O ' HG12 ' A' ' 171' ' ' VAL . 6.6 m-85 -77.21 164.4 58.93 Favored Pre-proline 0 N--CA 1.504 2.25 0 C-N-CA 123.805 0.842 . . . . 0.0 113.236 -178.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.468 ' HG2' ' CG2' ' A' ' 49' ' ' THR . 43.0 Cg_endo -66.79 132.8 29.57 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 122.843 2.362 . . . . 0.0 110.212 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.971 ' HB3' ' HB1' ' A' ' 169' ' ' ALA . . . -68.59 -2.71 9.58 Favored 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -176.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.449 ' HG3' HD11 ' A' ' 122' ' ' ILE . 5.7 tt0 -95.71 -22.64 17.42 Favored 'General case' 0 C--N 1.292 -1.905 0 O-C-N 120.662 -1.274 . . . . 0.0 110.491 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.468 ' CG2' ' HG2' ' A' ' 46' ' ' PRO . 4.6 t -134.38 59.02 1.75 Allowed 'General case' 0 C--N 1.315 -0.924 0 O-C-N 120.724 -1.235 . . . . 0.0 107.739 178.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.872 ' O ' HD12 ' A' ' 115' ' ' ILE . 1.5 ppp? -65.0 88.74 0.07 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.511 HG22 ' H ' ' A' ' 53' ' ' GLU . 24.4 m -59.32 147.92 34.16 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 122.139 0.971 . . . . 0.0 110.169 -176.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.991 HG23 ' HB1' ' A' ' 111' ' ' ALA . 12.5 p -72.34 -3.26 3.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.505 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.511 ' H ' HG22 ' A' ' 51' ' ' THR . 6.6 tp10 -58.96 -41.22 86.97 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.523 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 8.8 mm-40 -81.44 -47.63 12.94 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.237 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.757 ' O ' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -54.17 -35.28 62.13 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.481 ' HA ' ' CG2' ' A' ' 59' ' ' ILE . . . -54.68 -47.3 73.81 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.685 HD23 ' N ' ' A' ' 58' ' ' THR . 4.8 tt -56.02 -53.65 54.35 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.811 0.815 . . . . 0.0 109.573 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.799 HG21 ' SG ' ' A' ' 173' ' ' CYS . 0.9 OUTLIER -69.28 -58.29 4.23 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.605 -0.684 . . . . 0.0 111.23 -178.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.757 HG22 ' O ' ' A' ' 55' ' ' MET . 1.1 tp -52.47 -22.17 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.106 -0.996 . . . . 0.0 110.742 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 4.1 ttt-85 -74.8 -40.69 60.98 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.212 -0.93 . . . . 0.0 110.962 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -122.86 -1.37 8.9 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.958 -1.089 . . . . 0.0 112.129 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.66 -169.96 27.88 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.32 102.7 6.08 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 101.38 -3.563 . . . . 0.0 101.38 176.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 66' ' ' VAL . . . -104.81 74.97 0.24 Allowed Glycine 0 C--N 1.261 -3.625 0 N-CA-C 106.816 -2.514 . . . . 0.0 106.816 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.624 ' O ' HG23 ' A' ' 65' ' ' ILE . 3.2 tp -62.47 90.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.807 HG12 ' HB2' ' A' ' 173' ' ' CYS . 35.5 m -52.13 152.46 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 114.468 -1.242 . . . . 0.0 114.054 -176.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.414 ' N ' ' O ' ' A' ' 172' ' ' LEU . 7.4 t -87.37 114.99 24.48 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 176.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.675 HD23 ' HA ' ' A' ' 171' ' ' VAL . 3.6 mt -87.45 163.96 16.44 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 169' ' ' ALA . 4.7 m -131.48 135.61 47.24 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 118.199 -1.4 . . . . 0.0 113.206 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.655 HG23 ' HB2' ' A' ' 139' ' ' PRO . 2.5 pp -148.82 177.15 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.498 HG22 ' HG3' ' A' ' 72' ' ' GLU . 18.0 m -111.4 159.15 18.29 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.145 -0.972 . . . . 0.0 110.531 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.498 ' HG3' HG22 ' A' ' 71' ' ' THR . 0.1 OUTLIER -49.13 -27.12 3.2 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.475 -0.766 . . . . 0.0 110.62 -179.846 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -56.9 -38.83 73.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 0.0 109.676 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.426 ' O ' ' HB3' ' A' ' 78' ' ' LEU . 1.8 mmt180 -78.26 -32.77 49.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.501 -0.749 . . . . 0.0 110.35 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.544 ' HG2' HD13 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -78.72 -28.82 45.06 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.204 1.002 . . . . 0.0 108.535 179.013 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 79' ' ' ASP . 4.3 ttmm -56.51 -70.26 0.12 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.429 ' C ' ' HB1' ' A' ' 126' ' ' ALA . 0.4 OUTLIER -46.57 -41.04 13.82 Favored 'General case' 0 N--CA 1.508 2.444 0 CA-C-O 121.974 0.892 . . . . 0.0 109.864 177.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.64 ' O ' HD23 ' A' ' 78' ' ' LEU . 0.7 OUTLIER -96.39 45.77 1.06 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 176.229 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 76' ' ' LYS . 15.2 t70 -28.68 85.39 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 123.745 1.736 . . . . 0.0 112.329 -172.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.046 HD21 HG11 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -148.44 103.75 3.5 Favored Pre-proline 0 C--N 1.29 -2.009 0 CA-C-N 112.558 -2.11 . . . . 0.0 111.906 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -104.91 93.31 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.493 1.462 . . . . 0.0 108.635 175.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.822 ' H ' HG22 ' A' ' 97' ' ' VAL . 14.7 mmt -103.31 107.72 18.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.673 -1.267 . . . . 0.0 111.156 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.483 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 10.6 tmm? -95.89 92.37 6.47 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.862 -1.149 . . . . 0.0 109.654 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.841 HG13 ' O ' ' A' ' 96' ' ' THR . 3.8 m . . . . . 0 N--CA 1.501 2.113 0 C-N-CA 118.301 -1.359 . . . . 0.0 110.303 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.842 ' O ' HD13 ' A' ' 140' ' ' LEU . 5.9 t80 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 122.007 0.908 . . . . 0.0 108.981 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.841 ' O ' HG13 ' A' ' 84' ' ' VAL . 1.4 p -131.05 53.34 1.99 Allowed 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.629 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 1.046 HG11 HD21 ' A' ' 80' ' ' LEU . 57.5 t -86.07 105.67 14.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 O-C-N 121.209 -0.932 . . . . 0.0 112.096 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.733 HG22 HG12 ' A' ' 137' ' ' VAL . 1.0 OUTLIER -75.9 152.18 37.2 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 103.029 -2.952 . . . . 0.0 103.029 174.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.782 HD12 ' HB3' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -161.71 138.93 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 C-N-CA 116.708 -1.997 . . . . 0.0 111.513 -176.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.633 ' HB3' ' CB ' ' A' ' 132' ' ' ASN . 1.2 tp10 -99.11 126.5 44.87 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.301 -1.36 . . . . 0.0 111.346 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.488 ' HA ' ' CD2' ' A' ' 131' ' ' LEU . . . -51.24 115.6 1.64 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.41 -0.807 . . . . 0.0 110.886 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.839 ' HB3' ' O ' ' A' ' 130' ' ' ASP . . . -115.74 -6.78 12.12 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.23 -0.919 . . . . 0.0 110.984 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.84 ' HB3' ' HB1' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -75.82 55.45 0.88 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.952 -1.093 . . . . 0.0 111.692 -178.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.622 ' O ' HG13 ' A' ' 105' ' ' VAL . . . 73.31 24.24 75.72 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.846 HG21 ' HB3' ' A' ' 120' ' ' ALA . 5.2 m -158.25 122.39 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.412 ' HA ' ' HB3' ' A' ' 101' ' ' ALA . 5.8 m -148.38 63.8 1.08 Allowed 'General case' 0 N--CA 1.484 1.24 0 O-C-N 120.85 -1.156 . . . . 0.0 111.605 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.3 t -131.07 -30.76 1.74 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 118.618 -1.233 . . . . 0.0 110.099 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.409 ' O ' ' NH1' ' A' ' 114' ' ' ARG . . . 63.98 -19.06 0.09 OUTLIER Glycine 0 N--CA 1.5 2.93 0 O-C-N 121.484 -0.76 . . . . 0.0 113.377 178.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.86 55.54 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 119.71 1.755 . . . . 0.0 109.73 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 114' ' ' ARG . 28.6 p -133.2 66.15 1.57 Allowed 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.991 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -27.19 -39.92 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 121.506 0.669 . . . . 0.0 112.589 -177.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -78.59 -72.8 0.36 Allowed 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 122.147 0.975 . . . . 0.0 109.492 178.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -54.51 -23.35 16.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.167 -0.958 . . . . 0.0 109.241 178.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 110' ' ' SER . 0.3 OUTLIER -61.14 -45.61 93.97 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.549 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.872 HD12 ' O ' ' A' ' 50' ' ' MET . 1.6 mm -65.13 -15.07 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 117.283 -1.767 . . . . 0.0 107.654 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 m -89.88 -31.29 17.39 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 175.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.734 HG23 ' HB ' ' A' ' 105' ' ' VAL . 91.0 m -70.8 -49.0 51.12 Favored 'General case' 0 C--O 1.204 -1.3 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.555 HG13 ' N ' ' A' ' 119' ' ' ARG . 10.1 p -53.43 -41.46 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 0.0 109.28 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.555 ' N ' HG13 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -57.88 -33.88 69.19 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.413 179.051 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.846 ' HB3' HG21 ' A' ' 105' ' ' VAL . . . -94.03 -36.93 11.9 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.524 -0.735 . . . . 0.0 111.082 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.702 ' HB1' ' CE1' ' A' ' 138' ' ' PHE . . . -56.52 -56.72 17.76 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.03 -1.044 . . . . 0.0 109.407 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.725 HG22 ' HG3' ' A' ' 139' ' ' PRO . 1.6 pp -87.13 19.36 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.284 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.541 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -72.76 146.72 46.18 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.454 ' C ' ' O ' ' A' ' 123' ' ' ALA . 16.8 m-20 -37.18 -79.14 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.721 0 CA-C-N 119.598 1.09 . . . . 0.0 109.595 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 127' ' ' LYS . . . 54.75 34.93 57.06 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.125 -1.988 . . . . 0.0 109.856 173.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.429 ' HB1' ' C ' ' A' ' 77' ' ' GLN . . . -58.96 91.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 123.337 1.541 . . . . 0.0 110.233 -174.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 125' ' ' GLY . 1.9 mttt -137.97 126.57 14.45 Favored Pre-proline 0 C--N 1.303 -1.436 0 CA-C-N 113.377 -1.738 . . . . 0.0 106.422 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -54.69 -17.79 14.16 Favored 'Trans proline' 0 C--N 1.294 -2.315 0 O-C-N 122.61 0.795 . . . . 0.0 110.306 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 25.4 p -124.56 31.65 5.66 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.149 -0.969 . . . . 0.0 109.881 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.839 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -73.77 3.84 5.98 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.524 -1.36 . . . . 0.0 111.797 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.733 ' CB ' HG22 ' A' ' 99' ' ' ILE . 30.7 mt -142.58 130.64 21.89 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.633 ' CB ' ' HB3' ' A' ' 100' ' ' GLU . 0.5 OUTLIER -81.52 72.87 8.58 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.326 -1.484 . . . . 0.0 111.639 -177.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.655 ' HB3' ' HA ' ' A' ' 99' ' ' ILE 0.263 0.0 OUTLIER -87.68 152.82 52.21 Favored Pre-proline 0 N--CA 1.502 2.141 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.545 179.72 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.413 ' C ' ' HA ' ' A' ' 133' ' ' ARG . 47.3 Cg_endo -78.36 141.41 64.94 Favored 'Cis proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.215 -1.994 . . . . 0.0 107.787 1.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.536 ' O ' ' O ' ' A' ' 136' ' ' HIS . . . -176.6 95.43 0.1 Allowed Glycine 0 N--CA 1.487 2.078 0 C-N-CA 117.879 -2.105 . . . . 0.0 111.291 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.536 ' O ' ' O ' ' A' ' 135' ' ' GLY . 12.2 m-70 47.3 101.81 0.01 OUTLIER 'General case' 0 C--O 1.206 -1.215 0 CA-C-O 124.283 1.992 . . . . 0.0 109.182 -177.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.733 HG12 HG22 ' A' ' 98' ' ' THR . 19.2 m -49.15 154.48 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.686 0 CA-C-N 112.783 -2.008 . . . . 0.0 112.376 -174.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.782 ' HB3' HD12 ' A' ' 99' ' ' ILE . 1.5 m-85 -146.87 175.42 2.73 Favored Pre-proline 0 C--N 1.29 -1.997 0 CA-C-N 111.434 -2.621 . . . . 0.0 105.271 -174.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.725 ' HG3' HG22 ' A' ' 122' ' ' ILE . 38.4 Cg_endo -57.56 127.88 27.13 Favored 'Trans proline' 0 C--N 1.293 -2.354 0 CA-C-O 123.533 1.389 . . . . 0.0 115.11 -169.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.842 HD13 ' O ' ' A' ' 95' ' ' PHE . 14.6 mt -90.06 172.46 8.82 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 112.96 -1.927 . . . . 0.0 108.965 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.461 ' HB2' ' N ' ' A' ' 72' ' ' GLU . 12.8 ptt85 -126.13 85.16 2.35 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.119 -1.613 . . . . 0.0 115.0 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.589 ' HB3' ' CG ' ' A' ' 95' ' ' PHE . . . -141.48 79.69 1.7 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.742 -1.224 . . . . 0.0 110.837 176.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.585 ' HB2' HG21 ' A' ' 158' ' ' ILE . 0.5 OUTLIER -117.34 75.26 0.97 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.143 -1.598 . . . . 0.0 112.966 -179.353 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -127.04 43.37 3.13 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.637 -1.289 . . . . 0.0 110.982 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 75.83 37.08 40.12 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -100.54 12.35 59.74 Favored Glycine 0 N--CA 1.49 2.285 0 O-C-N 120.91 -1.347 . . . . 0.0 113.521 -176.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.86 HG13 HD22 ' A' ' 148' ' ' LEU . 8.2 p -107.9 -13.9 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-N 120.312 2.056 . . . . 0.0 111.828 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.86 HD22 HG13 ' A' ' 147' ' ' VAL . 4.6 mm? -87.42 13.28 10.25 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 115.041 -2.664 . . . . 0.0 109.876 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 84.2 m -132.93 62.15 1.66 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 100.548 -3.871 . . . . 0.0 100.548 167.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -148.27 135.15 20.05 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.072 -1.422 . . . . 0.0 113.831 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -104.26 36.25 4.5 Favored Glycine 0 N--CA 1.48 1.605 0 N-CA-C 106.177 -2.769 . . . . 0.0 106.177 173.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -142.31 163.8 27.05 Favored Glycine 0 N--CA 1.479 1.55 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.868 ' HA ' ' HB3' ' A' ' 156' ' ' ALA . 54.5 p-80 -90.98 -6.12 54.45 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.883 -0.774 . . . . 0.0 109.765 177.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.403 ' O ' ' HB ' ' A' ' 157' ' ' THR . 6.8 p -56.39 -64.99 0.68 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 122.362 1.077 . . . . 0.0 108.876 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.456 ' HB3' ' CA ' ' A' ' 147' ' ' VAL . 65.9 mm-40 -59.4 -22.16 60.99 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 177.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.868 ' HB3' ' HA ' ' A' ' 153' ' ' HIS . . . -86.02 4.37 38.18 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.226 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.505 HG23 ' SG ' ' A' ' 69' ' ' CYS . 0.6 OUTLIER -83.07 -51.65 7.35 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.328 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.585 HG21 ' HB2' ' A' ' 143' ' ' GLN . 0.2 OUTLIER -74.87 -17.54 16.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 115.923 -2.311 . . . . 0.0 105.996 176.108 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.942 ' CG ' HG12 ' A' ' 206' ' ' VAL . 8.3 t70 -59.29 -26.71 65.19 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 173.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 1.047 HD22 ' HG ' ' A' ' 163' ' ' LEU . 0.4 OUTLIER -53.3 -41.33 65.52 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 175.175 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.572 ' HA ' ' HA ' ' A' ' 168' ' ' PRO . 0.0 OUTLIER -48.2 -33.45 8.54 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 176.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.94 HG21 ' HG3' ' A' ' 209' ' ' ARG . 1.3 m -93.29 -31.83 14.55 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.719 177.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 1.047 ' HG ' HD22 ' A' ' 160' ' ' LEU . 0.5 OUTLIER -36.34 -40.94 0.25 Allowed 'General case' 0 N--CA 1.521 3.102 0 O-C-N 121.489 -0.757 . . . . 0.0 110.071 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.541 ' CB ' HD21 ' A' ' 20' ' ' LEU . . . -94.49 -29.24 15.04 Favored 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.103 -0.998 . . . . 0.0 110.909 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.03 -29.99 10.76 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -149.93 47.28 0.93 Allowed 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 117.922 -1.511 . . . . 0.0 111.571 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 169' ' ' ALA . 2.5 mptp? -133.3 68.42 77.36 Favored Pre-proline 0 C--N 1.29 -2.019 0 N-CA-C 103.294 -2.854 . . . . 0.0 103.294 173.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.572 ' HA ' ' HA ' ' A' ' 161' ' ' MET . 42.4 Cg_endo -69.5 80.24 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 115.218 -2.721 . . . . 0.0 114.531 -170.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.971 ' HB1' ' HB3' ' A' ' 47' ' ' ALA . . . -164.29 166.11 21.2 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 171.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 68' ' ' LEU . . . -154.79 135.52 4.72 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 118.019 -2.039 . . . . 0.0 110.356 178.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.675 ' HA ' HD23 ' A' ' 68' ' ' LEU . 2.9 p -121.4 89.83 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.191 -1.991 0 C-N-CA 117.374 -1.73 . . . . 0.0 107.376 177.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.954 HD11 HD23 ' A' ' 160' ' ' LEU . 9.1 mp -95.12 153.81 17.48 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 119.249 0.931 . . . . 0.0 110.11 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.807 ' HB2' HG12 ' A' ' 66' ' ' VAL . 35.7 t -124.71 162.63 23.79 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 122.023 0.916 . . . . 0.0 112.905 -177.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 174' ' ' GLU . 1.3 pt-20 -135.84 107.23 6.86 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.471 HD23 ' SG ' ' A' ' 188' ' ' CYS . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 O-C-N 121.052 -1.03 . . . . 0.0 111.153 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.603 ' HB1' ' SG ' ' A' ' 188' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.224 0.535 . . . . 0.0 110.016 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 185' ' ' ALA . 0.6 OUTLIER -140.69 100.27 3.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 110.07 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.764 ' HB1' ' HD2' ' A' ' 186' ' ' PRO . . . 179.89 173.34 0.49 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 110.213 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.764 ' HD2' ' HB1' ' A' ' 185' ' ' ALA . 43.6 Cg_endo -69.53 -15.64 38.08 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.66 1.348 . . . . 0.0 110.226 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -87.81 -36.8 17.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.11 -0.994 . . . . 0.0 109.855 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . 0.603 ' SG ' ' HB1' ' A' ' 183' ' ' ALA . 41.1 t -58.84 -49.3 78.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.394 -0.817 . . . . 0.0 109.462 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.715 HG23 HD21 ' A' ' 199' ' ' LEU . 7.4 tp -76.84 -24.15 15.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.845 -1.159 . . . . 0.0 109.38 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.474 ' HA ' ' CB ' ' A' ' 193' ' ' ASN . 3.7 tt0 -57.41 -23.26 48.3 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.436 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 3.8 t80 -74.95 -46.19 37.21 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.855 ' HB1' ' OD2' ' A' ' 42' ' ' ASP . . . -65.77 -18.44 65.33 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 175.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . 0.672 ' CG ' HD22 ' A' ' 199' ' ' LEU . 56.9 t30 -85.48 -7.76 58.73 Favored 'General case' 0 C--O 1.207 -1.159 0 O-C-N 121.896 -0.503 . . . . 0.0 109.696 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.59 -51.26 5.79 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.205 -1.559 . . . . 0.0 110.092 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.9 -41.06 12.0 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 118.268 -1.373 . . . . 0.0 107.599 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 198' ' ' ALA . 0.6 OUTLIER -99.34 52.17 0.94 Allowed 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' MET . . . . . 0.609 ' HA ' ' HA ' ' A' ' 193' ' ' ASN . 45.5 ttm -66.72 74.25 0.1 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -173.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.667 ' CB ' ' HB ' ' A' ' 29' ' ' VAL . . . -134.1 106.4 7.18 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 104.057 -2.571 . . . . 0.0 104.057 172.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.715 HD21 HG23 ' A' ' 189' ' ' ILE . 2.9 tp -126.97 120.04 28.13 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 119.734 -1.854 . . . . 0.0 109.606 -177.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.574 HG22 ' H ' ' A' ' 201' ' ' THR . 4.5 p -124.08 -177.0 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.259 -0.901 . . . . 0.0 110.929 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.574 ' H ' HG22 ' A' ' 200' ' ' VAL . 5.5 p -121.01 135.99 55.09 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.117 -0.989 . . . . 0.0 110.501 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 153' ' ' HIS . 68.7 mt -60.76 -37.77 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.483 -0.761 . . . . 0.0 112.093 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -45.16 -65.95 0.46 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.257 -0.902 . . . . 0.0 110.909 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.63 ' O ' ' HB3' ' A' ' 207' ' ' ALA . 0.6 OUTLIER -72.88 -17.85 61.48 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.167 -0.958 . . . . 0.0 110.098 179.237 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.683 HD11 HD21 ' A' ' 163' ' ' LEU . 2.4 tm? -60.44 -68.35 0.31 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.08 -1.012 . . . . 0.0 109.564 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.942 HG12 ' CG ' ' A' ' 159' ' ' ASP . 11.5 m -63.92 -16.12 18.1 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 C-N-CA 117.922 -1.511 . . . . 0.0 109.356 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' A' ' 204' ' ' ASP . . . -56.6 -32.34 65.16 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 174.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.604 ' CE2' ' CG1' ' A' ' 16' ' ' VAL 0.286 0.9 OUTLIER -54.75 -52.15 63.45 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.108 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.94 ' HG3' HG21 ' A' ' 162' ' ' THR . 48.2 ttt180 -56.65 -45.73 81.44 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.6 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.417 ' OE1' ' N ' ' A' ' 211' ' ' ALA . 1.8 tm0? -69.2 -56.0 8.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.218 -0.926 . . . . 0.0 110.184 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . 0.417 ' N ' ' OE1' ' A' ' 210' ' ' GLN . . . -58.91 -27.42 65.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.438 -0.789 . . . . 0.0 110.182 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' A' ' 208' ' ' TYR . 70.6 t60 . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.863 . . . . 0.0 110.12 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.624 ' O ' ' HB ' ' A' ' 16' ' ' VAL . 54.5 Cg_endo . . . . . 0 C--O 1.201 -1.333 0 N-CA-C 109.182 -1.122 . . . . 0.0 109.182 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -97.71 -70.62 0.71 Allowed 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -74.05 -41.37 61.87 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.798 -177.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -88.12 -17.24 31.42 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 118.258 -1.377 . . . . 0.0 111.96 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.669 HG13 HD23 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -68.6 -28.08 38.78 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.151 0 C-N-CA 114.775 -2.77 . . . . 0.0 107.278 177.133 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 1.2 tm-20 -67.18 -54.7 18.69 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 117.493 -1.683 . . . . 0.0 107.415 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -62.6 -33.26 74.63 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.181 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.715 ' HB1' ' CD1' ' A' ' 23' ' ' LEU . . . -88.12 -6.75 57.73 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.218 -0.926 . . . . 0.0 109.011 178.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.923 HD11 ' HA ' ' A' ' 164' ' ' ALA . 0.2 OUTLIER -61.48 -49.67 75.82 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.383 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . . . -70.94 -54.55 10.95 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.604 -0.838 . . . . 0.0 108.801 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.609 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . . . -49.94 -40.35 43.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.501 -0.749 . . . . 0.0 110.231 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.756 ' HB3' HG13 ' A' ' 29' ' ' VAL . 43.8 mt -90.56 -16.74 28.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.343 -0.848 . . . . 0.0 110.051 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -61.81 -16.53 50.68 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.375 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -92.98 45.26 1.17 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 122.527 1.156 . . . . 0.0 109.968 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.541 ' HA2' ' CZ ' ' A' ' 45' ' ' PHE . . . 58.61 28.68 62.95 Favored Glycine 0 C--N 1.288 -2.114 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 177.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.519 ' HB3' HD23 ' A' ' 23' ' ' LEU . 4.2 ttt-85 -89.31 18.4 5.21 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 116.71 -1.996 . . . . 0.0 110.844 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.804 ' O ' ' HB3' ' A' ' 198' ' ' ALA . . . 96.81 107.11 2.4 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.129 -1.51 . . . . 0.0 115.388 172.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.756 HG13 ' HB3' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -142.25 113.86 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 174.057 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.659 ' HB2' ' CD1' ' A' ' 199' ' ' LEU . 2.3 mtp -124.2 122.55 38.1 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.014 -1.054 . . . . 0.0 110.513 -174.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.626 HG23 HG13 ' A' ' 200' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 O-C-N 120.781 -1.2 . . . . 0.0 110.838 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.587 ' HA ' ' HB3' ' A' ' 30' ' ' MET . 2.4 p30 . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 122.128 0.966 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.705 ' HG2' HG12 ' A' ' 66' ' ' VAL . 9.6 tpp -96.19 56.53 1.64 Allowed 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 123.567 0.747 . . . . 0.0 110.416 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.921 ' C ' HD11 ' A' ' 160' ' ' LEU . 41.7 mt -60.73 34.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 O-C-N 121.159 -0.963 . . . . 0.0 113.557 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.947 ' O ' HG22 ' A' ' 171' ' ' VAL . 26.3 m-85 -111.52 162.03 22.81 Favored Pre-proline 0 N--CA 1.502 2.132 0 O-C-N 119.836 -1.79 . . . . 0.0 114.122 -175.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.405 ' HG2' ' OG1' ' A' ' 49' ' ' THR . 46.5 Cg_endo -72.63 131.36 17.19 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.374 2.049 . . . . 0.0 109.271 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.939 ' O ' HG12 ' A' ' 118' ' ' VAL . . . -72.28 -1.47 15.44 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 120.785 -1.197 . . . . 0.0 113.132 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -93.46 -16.77 24.18 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.64 -1.288 . . . . 0.0 109.788 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.405 ' OG1' ' HG2' ' A' ' 46' ' ' PRO . 0.8 OUTLIER -131.61 59.15 1.7 Allowed 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 177.426 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.94 ' SD ' HG11 ' A' ' 118' ' ' VAL . 5.0 tpt -54.46 95.75 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.505 -178.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.0 p -66.53 133.48 50.44 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.731 ' CG2' HG21 ' A' ' 115' ' ' ILE . 2.6 t -77.98 -2.37 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.061 -1.024 . . . . 0.0 108.504 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 26' ' ' GLY . 0.6 OUTLIER -60.77 -40.8 93.92 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.254 -179.406 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.704 ' HA ' ' HE1' ' A' ' 197' ' ' MET . 85.1 mm-40 -80.33 -24.14 40.1 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.594 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.747 ' O ' HG22 ' A' ' 59' ' ' ILE . 11.2 tpt -82.49 -38.06 24.43 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.353 -0.842 . . . . 0.0 109.493 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.93 -42.1 84.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.48 -0.762 . . . . 0.0 109.767 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.944 HD13 ' SD ' ' A' ' 197' ' ' MET . 5.8 tt -65.58 -48.71 71.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 109.322 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.532 ' N ' HD23 ' A' ' 57' ' ' LEU . 37.0 p -67.02 -59.12 3.74 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.365 -0.835 . . . . 0.0 110.979 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.894 HD12 ' HA ' ' A' ' 111' ' ' ALA . 11.3 tt -47.48 -24.79 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.17 -0.956 . . . . 0.0 111.022 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.8 ttt85 -72.07 -45.8 59.35 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.19 -0.944 . . . . 0.0 110.702 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -124.1 5.47 8.57 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.872 -1.143 . . . . 0.0 112.163 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 58' ' ' THR . . . -165.12 -169.27 28.52 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.5 p -139.91 102.26 4.37 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.33 72.91 0.22 Allowed Glycine 0 C--N 1.266 -3.352 0 N-CA-C 105.222 -3.151 . . . . 0.0 105.222 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.578 HG23 ' HZ ' ' A' ' 138' ' ' PHE . 1.7 tt -63.07 106.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.6 0 CA-C-O 122.622 1.201 . . . . 0.0 107.906 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.806 HG21 ' SD ' ' A' ' 50' ' ' MET . 16.5 m -52.53 151.03 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 115.129 -0.942 . . . . 0.0 112.043 -177.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.92 ' C ' HD13 ' A' ' 68' ' ' LEU . 82.5 m -85.9 160.74 19.33 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.92 HD13 ' C ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -137.87 91.76 2.61 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.012 -1.475 . . . . 0.0 108.094 178.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.444 ' CB ' ' OG1' ' A' ' 157' ' ' THR . 1.3 m -102.52 152.25 21.37 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 119.046 -1.062 . . . . 0.0 110.472 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.872 ' HA ' HD11 ' A' ' 158' ' ' ILE . 1.1 mt -152.6 -177.73 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.462 ' H ' HG22 ' A' ' 70' ' ' ILE . 22.0 p -86.33 144.71 27.24 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -53.54 -20.03 4.48 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.208 -0.933 . . . . 0.0 110.379 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.422 ' O ' ' CG ' ' A' ' 77' ' ' GLN . 10.1 t70 -79.0 -37.58 38.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.153 -0.967 . . . . 0.0 110.951 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -85.95 -52.44 5.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.21 -0.931 . . . . 0.0 110.629 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.871 ' CD ' HD12 ' A' ' 70' ' ' ILE . 22.4 tpt180 -54.2 -53.93 46.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.166 -0.959 . . . . 0.0 109.54 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.713 ' HG2' HD13 ' A' ' 80' ' ' LEU . 1.1 mtpm? -60.43 -56.67 18.65 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.293 -0.879 . . . . 0.0 111.605 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.422 ' CG ' ' O ' ' A' ' 73' ' ' ASP . 4.9 mt-30 -27.29 -49.41 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.851 1.344 . . . . 0.0 110.997 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 1.005 HD13 ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -136.88 -27.52 1.0 Allowed 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 117.162 -1.815 . . . . 0.0 113.082 177.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 1.005 ' N ' HD13 ' A' ' 78' ' ' LEU . 65.9 t0 -121.15 62.97 0.88 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 117.363 -1.735 . . . . 0.0 115.438 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.901 HD21 ' OG1' ' A' ' 96' ' ' THR . 2.2 tt -144.73 104.23 4.55 Favored Pre-proline 0 N--CA 1.506 2.348 0 C-N-CA 115.925 -2.31 . . . . 0.0 113.744 174.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.903 ' O ' HG22 ' A' ' 97' ' ' VAL . 38.3 Cg_endo -101.56 96.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.3 -1.983 0 N-CA-C 107.257 -1.863 . . . . 0.0 107.257 174.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.404 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 9.4 ttt -88.8 45.48 1.29 Allowed 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.21 -0.932 . . . . 0.0 109.553 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.637 ' HB2' HG11 ' A' ' 97' ' ' VAL . 4.7 mmm -57.7 -11.51 2.23 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.655 -0.653 . . . . 0.0 110.656 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 1.001 HG23 HG12 ' A' ' 97' ' ' VAL . 53.6 t . . . . . 0 N--CA 1.5 2.053 0 C-N-CA 116.878 -1.929 . . . . 0.0 109.915 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.721 ' HB2' HG11 ' A' ' 84' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 123.144 1.45 . . . . 0.0 112.237 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.901 ' OG1' HD21 ' A' ' 80' ' ' LEU . 1.2 m -61.41 81.25 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.026 -1.443 . . . . 0.0 109.413 177.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 1.001 HG12 HG23 ' A' ' 84' ' ' VAL . 1.2 m -37.07 155.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.046 0 CA-C-O 122.259 1.028 . . . . 0.0 111.935 -175.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.907 HG22 ' O ' ' A' ' 137' ' ' VAL . 39.4 p -66.52 -176.88 0.5 Allowed 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -174.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.778 HD11 HG23 ' A' ' 117' ' ' THR . 1.1 pp -110.6 146.78 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 122.47 1.129 . . . . 0.0 113.545 -177.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.665 ' N ' ' H ' ' A' ' 133' ' ' ARG . 58.1 tt0 -93.65 163.27 13.61 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.445 ' HB1' ' HB ' ' A' ' 106' ' ' THR . . . -77.69 78.78 4.19 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 116.213 -2.195 . . . . 0.0 107.563 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 129' ' ' SER . . . -106.47 -37.54 6.46 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.455 ' CG ' ' HD2' ' A' ' 127' ' ' LYS . 30.6 tp10 -74.43 -7.92 54.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.55 -0.719 . . . . 0.0 109.894 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.8 24.98 5.59 Favored Glycine 0 N--CA 1.481 1.651 0 C-N-CA 119.604 -1.284 . . . . 0.0 111.703 178.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.539 HG21 ' CB ' ' A' ' 120' ' ' ALA . 2.0 t -114.19 112.13 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 C-N-CA 118.011 -1.475 . . . . 0.0 108.016 177.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.601 ' O ' HG23 ' A' ' 106' ' ' THR . 5.6 t -157.39 66.92 0.5 Allowed 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.0 m -129.99 20.98 5.39 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.416 -1.427 . . . . 0.0 111.847 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 110' ' ' SER . . . 96.55 47.44 2.34 Favored Glycine 0 N--CA 1.502 3.052 0 N-CA-C 107.137 -2.385 . . . . 0.0 107.137 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 109' ' ' VAL . 12.2 p -53.82 51.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -173.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 108' ' ' GLY . 1.9 m -135.29 12.21 3.54 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 117.053 -1.859 . . . . 0.0 112.405 172.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.894 ' HA ' HD12 ' A' ' 59' ' ' ILE . . . -122.12 -81.86 0.64 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 119.89 -1.756 . . . . 0.0 108.983 171.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' A' ' 116' ' ' THR . . . -98.7 -43.6 6.74 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 174.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.481 ' HB3' ' HA ' ' A' ' 109' ' ' VAL . 47.0 t0 -54.15 -29.74 46.58 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.903 ' O ' HG23 ' A' ' 118' ' ' VAL . 2.0 ttt180 -63.85 -51.29 65.3 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 175.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.731 HG21 ' CG2' ' A' ' 52' ' ' VAL 0.254 1.2 mp -67.31 -10.74 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.682 178.212 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.472 ' HB ' ' HA ' ' A' ' 113' ' ' ASP . 54.9 m -90.43 -41.87 11.21 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.89 -1.131 . . . . 0.0 109.112 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.778 HG23 HD11 ' A' ' 99' ' ' ILE . 52.8 m -69.0 -29.13 67.25 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.384 -0.926 . . . . 0.0 108.783 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.94 HG11 ' SD ' ' A' ' 50' ' ' MET . 39.9 t -67.78 -44.01 85.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.08 -27.98 35.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.472 -0.767 . . . . 0.0 109.573 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.539 ' CB ' HG21 ' A' ' 105' ' ' VAL . . . -80.95 -51.92 8.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.514 -0.741 . . . . 0.0 109.516 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.701 ' HA ' HD21 ' A' ' 131' ' ' LEU . . . -54.86 -32.27 60.57 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.801 HD12 ' O ' ' A' ' 47' ' ' ALA . 71.1 mt -93.39 25.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.602 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.775 ' HB3' ' HD3' ' A' ' 127' ' ' LYS . . . -37.63 150.82 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 O-C-N 122.056 -0.403 . . . . 0.0 111.48 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -26.99 -28.58 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 123' ' ' ALA . . . 129.93 -36.04 2.42 Favored Glycine 0 N--CA 1.493 2.448 0 O-C-N 120.282 -1.511 . . . . 0.0 110.61 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -87.92 93.64 9.53 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.761 -1.435 . . . . 0.0 107.14 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.866 ' CB ' HD23 ' A' ' 78' ' ' LEU . 8.3 ttpt -134.3 119.12 14.17 Favored Pre-proline 0 C--N 1.305 -1.35 0 O-C-N 121.226 -0.921 . . . . 0.0 111.19 -178.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -88.29 19.33 1.34 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 N-CA-C 108.178 -1.508 . . . . 0.0 108.178 176.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.688 ' O ' ' N ' ' A' ' 131' ' ' LEU . 0.7 OUTLIER -119.6 41.16 3.2 Favored 'General case' 0 C--O 1.203 -1.38 0 O-C-N 121.3 -0.875 . . . . 0.0 110.727 -177.345 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -37.4 74.6 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 123.236 1.493 . . . . 0.0 110.894 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.701 HD21 ' HA ' ' A' ' 121' ' ' ALA . 0.2 OUTLIER -68.17 107.14 2.65 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 113.469 -1.696 . . . . 0.0 110.938 -176.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.634 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 12.9 p30 -137.4 48.02 2.06 Favored 'General case' 0 N--CA 1.52 3.071 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.665 ' H ' ' N ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER 173.22 108.69 0.06 OUTLIER Pre-proline 0 N--CA 1.51 2.545 0 O-C-N 119.147 -2.22 . . . . 0.0 112.051 174.444 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -134.48 119.46 0.0 OUTLIER 'Cis proline' 0 C--N 1.31 -1.466 0 N-CA-C 103.958 -3.131 . . . . 0.0 103.958 -9.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.95 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -111.67 44.76 1.44 Allowed Glycine 0 N--CA 1.509 3.501 0 C-N-CA 118.063 -2.018 . . . . 0.0 113.106 -175.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.418 ' C ' ' O ' ' A' ' 135' ' ' GLY . 66.4 m170 31.0 37.31 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 122.246 1.022 . . . . 0.0 111.59 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 135' ' ' GLY . 45.1 t -108.91 125.08 65.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.578 ' HZ ' HG23 ' A' ' 65' ' ' ILE . 2.4 p90 -118.77 85.27 27.39 Favored Pre-proline 0 C--N 1.294 -1.818 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.339 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.939 ' O ' HD23 ' A' ' 140' ' ' LEU . 47.6 Cg_endo -95.46 153.36 1.58 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 N-CA-C 108.362 -1.438 . . . . 0.0 108.362 178.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.939 HD23 ' O ' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -150.37 153.03 35.31 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.788 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -65.01 120.0 11.81 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.39 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -129.49 133.12 47.1 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.091 -1.006 . . . . 0.0 111.472 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -78.05 143.73 37.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -0.835 . . . . 0.0 109.627 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.661 ' HB2' HG22 ' A' ' 158' ' ' ILE . . . -103.76 115.51 30.61 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.293 -0.879 . . . . 0.0 111.487 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.422 ' N ' ' OD2' ' A' ' 159' ' ' ASP . . . 117.57 -14.82 13.01 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.55 12.97 56.77 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 1.022 ' CG1' HG11 ' A' ' 206' ' ' VAL . 4.9 p -73.36 -24.61 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.148 -1.207 . . . . 0.0 110.968 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.98 17.95 7.29 Favored 'General case' 0 C--O 1.208 -1.13 0 C-N-CA 115.472 -2.491 . . . . 0.0 110.506 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 25.3 m -131.19 59.55 1.68 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 100.778 -3.786 . . . . 0.0 100.778 166.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.404 ' NE ' ' OE1' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -151.85 148.21 27.55 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 113.76 -1.564 . . . . 0.0 112.432 -178.277 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -104.27 35.3 5.14 Favored Glycine 0 N--CA 1.482 1.756 0 N-CA-C 106.179 -2.768 . . . . 0.0 106.179 173.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.1 135.19 6.11 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.935 ' CD2' HD12 ' A' ' 202' ' ' ILE . 54.1 m80 -74.51 -5.18 41.27 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.241 -1.152 . . . . 0.0 109.666 177.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.413 ' O ' ' OG1' ' A' ' 157' ' ' THR . 59.4 p -53.73 -56.71 15.02 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.942 -1.099 . . . . 0.0 109.687 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.443 ' C ' ' HB ' ' A' ' 147' ' ' VAL . 2.9 mp0 -58.02 -21.66 46.07 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.783 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . . . -83.71 6.26 21.7 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.571 -0.705 . . . . 0.0 109.818 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 153' ' ' HIS . 59.8 p -93.49 -49.26 5.99 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.872 HD11 ' HA ' ' A' ' 70' ' ' ILE . 0.3 OUTLIER -80.09 -32.31 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 116.703 -1.999 . . . . 0.0 107.259 177.557 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.502 ' OD1' HG13 ' A' ' 206' ' ' VAL . 8.7 t70 -61.29 -33.76 74.1 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 105.375 -2.084 . . . . 0.0 105.375 174.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.921 HD11 ' C ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -47.22 -41.25 18.04 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 175.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.488 ' SD ' HD12 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -57.97 -48.4 80.08 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.911 178.508 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.461 ' N ' ' HG2' ' A' ' 161' ' ' MET . 0.0 OUTLIER -63.85 -34.85 78.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.009 -1.057 . . . . 0.0 111.698 -178.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 1.086 HD13 HD21 ' A' ' 205' ' ' LEU . 1.7 pp -93.33 -30.87 14.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.925 -1.109 . . . . 0.0 111.763 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.923 ' HA ' HD11 ' A' ' 20' ' ' LEU . . . -115.15 38.02 3.33 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -178.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 167' ' ' LYS . . . 112.78 70.61 0.56 Allowed Glycine 0 N--CA 1.513 3.784 0 C-N-CA 116.667 -2.683 . . . . 0.0 109.831 -177.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.496 ' CD2' ' O ' ' A' ' 166' ' ' PHE . 54.3 p90 -62.43 70.67 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 123.486 1.612 . . . . 0.0 115.099 -172.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.473 ' N ' ' O ' ' A' ' 165' ' ' GLY . 0.0 OUTLIER -113.22 131.95 22.65 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 100.792 -3.781 . . . . 0.0 100.792 171.49 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.806 ' O ' HG23 ' A' ' 70' ' ' ILE . 38.1 Cg_endo -63.58 89.84 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 116.636 -1.776 . . . . 0.0 112.412 -173.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.71 ' HB1' ' HB3' ' A' ' 47' ' ' ALA 0.262 . . -158.18 153.8 26.3 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 176.085 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 157' ' ' THR . . . -147.37 113.52 0.65 Allowed Glycine 0 N--CA 1.497 2.739 0 C-N-CA 117.24 -2.41 . . . . 0.0 110.535 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.947 HG22 ' O ' ' A' ' 45' ' ' PHE . 1.1 m -125.72 144.02 37.23 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.447 0 C-N-CA 117.172 -1.811 . . . . 0.0 109.791 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.555 HD13 ' O ' ' A' ' 171' ' ' VAL . 0.1 OUTLIER -159.69 113.63 2.27 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 177.269 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.506 ' O ' ' N ' ' A' ' 42' ' ' ASP . 1.9 t -126.96 178.0 6.26 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 119.642 -1.911 . . . . 0.0 112.042 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.414 ' HA ' ' OD2' ' A' ' 42' ' ' ASP . 1.6 tm-20 -120.62 148.35 44.01 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.924 -1.11 . . . . 0.0 110.27 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.822 HD22 ' O ' ' A' ' 188' ' ' CYS . 1.6 tp . . . . . 0 N--CA 1.499 1.993 0 O-C-N 121.038 -1.039 . . . . 0.0 110.11 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' ' 175' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.2 0.524 . . . . 0.0 110.111 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.626 ' O ' ' HB3' ' A' ' 185' ' ' ALA . 0.2 OUTLIER -140.11 162.15 35.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.876 . . . . 0.0 110.401 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.835 ' HB1' ' HD2' ' A' ' 186' ' ' PRO . . . 68.9 174.83 0.08 OUTLIER Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.42 -0.8 . . . . 0.0 110.865 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.835 ' HD2' ' HB1' ' A' ' 185' ' ' ALA . 41.1 Cg_endo -66.38 -10.5 27.83 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.481 1.253 . . . . 0.0 110.957 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -72.9 -55.01 7.23 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.046 -1.034 . . . . 0.0 109.864 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . 0.822 ' O ' HD22 ' A' ' 175' ' ' LEU . 24.0 p -58.79 -39.53 81.37 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.271 -0.893 . . . . 0.0 110.059 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.717 HG13 HD11 ' A' ' 199' ' ' LEU . 8.7 tp -73.63 -22.59 18.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 118.018 -1.473 . . . . 0.0 109.071 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -56.78 -33.63 66.83 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.438 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.1 OUTLIER -66.03 -40.63 91.18 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.639 ' HB2' HD13 ' A' ' 175' ' ' LEU . . . -60.32 -49.32 78.05 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.969 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . 0.606 ' HA ' ' CB ' ' A' ' 197' ' ' MET . 0.1 OUTLIER -73.03 -11.49 60.58 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.282 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -73.75 -34.78 64.88 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 117.47 -1.692 . . . . 0.0 111.365 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -112.11 -52.47 2.78 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 116.165 -2.214 . . . . 0.0 111.489 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -114.2 32.6 5.79 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 117.859 -1.536 . . . . 0.0 114.238 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' MET . . . . . 0.944 ' SD ' HD13 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -153.12 147.44 25.81 Favored 'General case' 0 N--CA 1.517 2.918 0 CA-C-N 123.396 2.816 . . . . 0.0 115.912 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.804 ' HB3' ' O ' ' A' ' 28' ' ' GLY . . . -95.36 127.62 41.55 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 175.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.717 HD11 HG13 ' A' ' 189' ' ' ILE . 0.3 OUTLIER -114.92 107.35 15.28 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 120.41 -1.431 . . . . 0.0 113.512 -176.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 1.03 HG11 HD12 ' A' ' 205' ' ' LEU . 4.4 p -100.05 -173.02 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.245 -0.91 . . . . 0.0 110.07 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.705 HG23 ' H ' ' A' ' 204' ' ' ASP . 4.4 t -111.98 165.08 12.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.071 -1.018 . . . . 0.0 109.796 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.935 HD12 ' CD2' ' A' ' 153' ' ' HIS . 9.9 tt -81.39 -14.27 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.044 -1.035 . . . . 0.0 111.298 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 207' ' ' ALA . 2.1 mt-10 -90.1 -43.63 10.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.934 -1.104 . . . . 0.0 110.598 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.705 ' H ' HG23 ' A' ' 201' ' ' THR . 3.9 t70 -85.48 -14.73 45.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 111.404 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 1.086 HD21 HD13 ' A' ' 163' ' ' LEU . 10.5 tt -77.0 -53.57 7.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.81 -1.181 . . . . 0.0 110.914 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 1.022 HG11 ' CG1' ' A' ' 147' ' ' VAL . 1.1 t -76.75 -29.33 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 117.875 -1.53 . . . . 0.0 107.765 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 203' ' ' GLU . . . -57.1 -30.95 64.79 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.656 ' CD2' HG11 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -62.82 -44.7 95.45 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 177.605 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.439 ' CD ' ' HB ' ' A' ' 162' ' ' THR . 54.7 ttt-85 -61.62 -52.15 65.58 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.739 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.76 -57.61 5.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 110.446 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 207' ' ' ALA . . . -51.51 -23.95 4.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.417 -0.802 . . . . 0.0 110.414 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . 0.404 ' HB2' ' O ' ' A' ' 208' ' ' TYR . 19.3 t-160 . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.241 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.432 ' C ' ' N ' ' A' ' 14' ' ' GLU . 18.1 Cg_endo . . . . . 0 N--CA 1.518 2.921 0 CA-C-O 123.919 1.55 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.878 ' O ' HG22 ' A' ' 16' ' ' VAL . 1.8 m-30 -51.54 -16.28 0.58 Allowed 'General case' 0 C--O 1.183 -2.413 0 O-C-N 119.747 -1.845 . . . . 0.0 106.619 168.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.566 ' HA ' ' CB ' ' A' ' 17' ' ' GLU . 2.8 mt-10 -44.45 -36.1 2.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.109 -1.62 . . . . 0.0 109.239 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -42.24 90.85 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 176.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.878 HG22 ' O ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -74.91 -29.44 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.183 175.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.566 ' CB ' ' HA ' ' A' ' 14' ' ' GLU . 9.2 tt0 -56.64 -56.41 21.74 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.292 -1.505 . . . . 0.0 107.749 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 50.4 t-20 -53.35 -25.96 17.22 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.206 -0.997 . . . . 0.0 108.336 177.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.832 ' HB3' ' O ' ' A' ' 16' ' ' VAL . . . -70.78 -66.43 0.61 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.588 0.709 . . . . 0.0 110.701 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.655 HD11 ' CD1' ' A' ' 44' ' ' ILE . 0.8 OUTLIER -78.92 -33.01 45.86 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.204 -0.935 . . . . 0.0 110.942 -178.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 17' ' ' GLU . . . -56.09 -32.5 64.2 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 18' ' ' ASN . . . -67.0 -35.79 80.74 Favored 'General case' 0 C--O 1.207 -1.166 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 176.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.875 HD12 HG23 ' A' ' 29' ' ' VAL . 3.1 tt -48.51 -26.24 2.07 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.164 -0.96 . . . . 0.0 109.75 178.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -91.06 -26.16 19.3 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.807 0.813 . . . . 0.0 108.833 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 22' ' ' ALA . 0.3 OUTLIER -144.42 78.98 1.59 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 177.436 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 126.0 52.59 0.16 Allowed Glycine 0 C--N 1.281 -2.499 1 N-CA-C 101.63 -4.588 . . . . 0.0 101.63 -173.147 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.542 ' HA ' ' HA ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -56.18 80.6 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 122.936 1.35 . . . . 0.0 111.308 -173.526 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 26' ' ' GLY . . . 172.76 104.75 0.18 Allowed Glycine 0 N--CA 1.489 2.201 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.49 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.875 HG23 HD12 ' A' ' 23' ' ' LEU . 1.5 t -116.48 121.77 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.815 ' CE ' ' HB3' ' A' ' 192' ' ' ALA . 0.0 OUTLIER -111.77 131.48 55.29 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 117.996 -1.482 . . . . 0.0 110.52 -178.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 200' ' ' VAL . 14.7 p . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.435 -0.791 . . . . 0.0 110.219 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.878 ' OD2' HD22 ' A' ' 57' ' ' LEU . 28.9 t70 . . . . . 0 N--CA 1.514 2.731 0 CA-C-O 121.853 0.835 . . . . 0.0 112.078 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.602 ' O ' ' O ' ' A' ' 171' ' ' VAL . 0.7 OUTLIER -94.66 52.42 1.52 Allowed 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 122.175 0.988 . . . . 0.0 113.094 -178.017 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.854 HD11 ' CD1' ' A' ' 163' ' ' LEU . 13.0 tt -63.48 19.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.846 0 O-C-N 119.399 -2.063 . . . . 0.0 113.154 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.676 ' CZ ' HD21 ' A' ' 23' ' ' LEU . 2.9 m-85 -81.92 162.97 55.58 Favored Pre-proline 0 N--CA 1.498 1.93 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -175.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.507 ' HD2' ' CD2' ' A' ' 45' ' ' PHE . 51.3 Cg_endo -69.82 131.23 20.71 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.642 2.228 . . . . 0.0 110.719 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.946 ' HB3' ' HB1' ' A' ' 169' ' ' ALA . . . -67.58 -20.45 65.38 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.297 -0.961 . . . . 0.0 112.029 -178.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.624 ' HA ' HG21 ' A' ' 122' ' ' ILE . 20.6 tt0 -76.52 -35.08 58.52 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.838 -1.163 . . . . 0.0 111.078 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.503 HG23 ' HG2' ' A' ' 46' ' ' PRO . 4.7 t -132.87 58.81 1.75 Allowed 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.718 ' HB3' HG21 ' A' ' 171' ' ' VAL . 0.3 OUTLIER -65.4 88.13 0.08 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 179.069 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.539 ' HA ' HG12 ' A' ' 115' ' ' ILE . 11.4 m -59.07 170.04 0.96 Allowed 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.713 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.715 HG23 ' HB1' ' A' ' 111' ' ' ALA . 2.7 p -83.16 -2.3 6.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 O-C-N 121.341 -0.85 . . . . 0.0 110.063 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.405 ' HG3' ' HD2' ' A' ' 27' ' ' ARG . 0.8 OUTLIER -63.28 -44.77 94.16 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.481 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.466 ' HB2' ' HG3' ' A' ' 43' ' ' MET . 0.0 OUTLIER -76.19 -35.83 58.94 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.458 178.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.474 ' HA ' ' OG1' ' A' ' 58' ' ' THR . 0.0 OUTLIER -70.51 -27.8 64.47 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.143 -0.973 . . . . 0.0 108.525 178.407 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 52' ' ' VAL . . . -56.46 -47.83 78.36 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.754 -0.591 . . . . 0.0 109.709 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.878 HD22 ' OD2' ' A' ' 42' ' ' ASP . 6.7 tt -60.04 -56.81 17.11 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.026 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.64 ' N ' HD23 ' A' ' 57' ' ' LEU . 2.6 p -53.39 -36.0 60.97 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.423 -0.798 . . . . 0.0 109.79 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' A' ' 111' ' ' ALA . 51.2 mt -84.48 -11.33 11.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.568 -0.708 . . . . 0.0 109.178 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -51.53 -51.94 51.14 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.749 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.51 -37.38 2.36 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 116.583 -2.047 . . . . 0.0 112.07 176.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 175.02 107.53 0.21 Allowed Glycine 0 N--CA 1.499 2.839 0 C-N-CA 118.834 -1.65 . . . . 0.0 111.413 174.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.499 ' HB2' ' CA ' ' A' ' 58' ' ' THR . 0.6 OUTLIER -165.89 99.99 0.66 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 120.227 2.013 . . . . 0.0 105.69 172.476 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.477 ' HA3' ' CG1' ' A' ' 109' ' ' VAL . . . -123.46 55.77 0.69 Allowed Glycine 0 C--N 1.283 -2.407 0 N-CA-C 106.364 -2.694 . . . . 0.0 106.364 176.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.465 HD13 ' HA ' ' A' ' 65' ' ' ILE . 20.5 mm -147.68 104.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 113.838 -1.181 . . . . 0.0 109.411 175.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.809 HG11 ' HB ' ' A' ' 171' ' ' VAL . 25.5 t -114.96 154.28 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.568 -1.332 . . . . 0.0 110.66 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 138' ' ' PHE . 0.4 OUTLIER -92.15 120.16 32.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.022 -1.674 . . . . 0.0 108.524 178.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.754 ' CD1' ' HB1' ' A' ' 47' ' ' ALA . 3.6 mm? -89.47 98.43 11.76 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.492 ' HB2' ' N ' ' A' ' 170' ' ' GLY . 66.3 m -66.1 129.1 38.63 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.638 -0.664 . . . . 0.0 109.779 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.762 HD11 ' HD3' ' A' ' 75' ' ' ARG . 10.4 tt -153.99 164.79 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.928 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.45 HG22 ' H ' ' A' ' 72' ' ' GLU . 2.1 m -124.85 175.72 7.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.426 -0.797 . . . . 0.0 109.946 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.45 ' H ' HG22 ' A' ' 71' ' ' THR . 13.8 tt0 -73.91 -9.2 58.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.246 -0.909 . . . . 0.0 110.775 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -88.26 -39.87 14.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.972 -1.08 . . . . 0.0 110.53 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.84 -35.87 59.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.246 -0.909 . . . . 0.0 110.188 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.797 ' CZ ' HD12 ' A' ' 99' ' ' ILE . 0.1 OUTLIER -78.48 -29.82 47.0 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.219 1.009 . . . . 0.0 108.6 179.095 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -53.15 -66.04 0.46 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.198 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -47.64 -33.37 6.65 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 122.089 0.947 . . . . 0.0 109.224 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.512 HD21 ' CD2' ' A' ' 131' ' ' LEU . 19.1 tp -96.55 47.13 1.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 175.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 76' ' ' LYS . 1.2 m-20 -22.39 83.9 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 124.458 2.075 . . . . 0.0 112.471 -171.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.692 HD22 ' HD2' ' A' ' 81' ' ' PRO . 3.5 tm? -147.42 112.54 4.03 Favored Pre-proline 0 C--N 1.292 -1.905 0 CA-C-N 111.073 -2.785 . . . . 0.0 109.574 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.692 ' HD2' HD22 ' A' ' 80' ' ' LEU . 46.5 Cg_endo -72.26 99.37 1.01 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.317 1.167 . . . . 0.0 111.046 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.466 ' O ' ' CG ' ' A' ' 82' ' ' MET . 3.6 ptt? -87.0 83.95 7.41 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.323 -0.861 . . . . 0.0 109.386 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.57 ' H ' HG23 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -147.47 67.35 1.13 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.94 -1.1 . . . . 0.0 110.899 -179.257 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.707 ' CG2' HG22 ' A' ' 97' ' ' VAL . 82.8 t . . . . . 0 N--CA 1.495 1.818 0 O-C-N 121.046 -1.033 . . . . 0.0 109.217 179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.528 ' N ' ' CD1' ' A' ' 95' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.52 3.052 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.474 HG21 ' N ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -130.34 75.48 1.66 Allowed 'General case' 0 C--N 1.292 -1.906 0 O-C-N 121.303 -0.873 . . . . 0.0 110.997 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.707 HG22 ' CG2' ' A' ' 84' ' ' VAL . 90.3 t -43.98 145.4 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.493 0 O-C-N 120.458 -1.401 . . . . 0.0 110.83 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.614 HG22 ' O ' ' A' ' 137' ' ' VAL . 1.0 OUTLIER -73.98 -174.96 2.01 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.774 0.797 . . . . 0.0 112.329 -177.141 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.797 HD12 ' CZ ' ' A' ' 75' ' ' ARG 0.302 0.1 OUTLIER -149.24 123.55 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -178.049 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 132' ' ' ASN . 3.9 tm-20 -91.2 105.36 17.74 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 117.775 -1.57 . . . . 0.0 112.715 -176.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 105' ' ' VAL . . . -50.6 96.43 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.132 -0.98 . . . . 0.0 110.169 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 130' ' ' ASP . . . -103.16 2.87 35.12 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.114 -0.992 . . . . 0.0 110.061 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.429 ' HB3' ' CB ' ' A' ' 130' ' ' ASP . 7.7 pt-20 -112.26 45.36 1.29 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.066 -1.021 . . . . 0.0 111.448 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.538 ' O ' HG21 ' A' ' 117' ' ' THR . . . 127.65 -37.68 2.28 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 118.946 -1.597 . . . . 0.0 112.723 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.991 HG21 ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -101.43 121.76 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 O-C-N 120.823 -1.398 . . . . 0.0 111.113 -178.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.4 p -144.3 58.53 1.33 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.599 -1.24 . . . . 0.0 110.975 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.877 HG21 ' OG ' ' A' ' 110' ' ' SER . 23.9 m -139.52 -32.33 0.65 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.953 -1.092 . . . . 0.0 110.86 176.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.512 ' CA ' ' CD2' ' A' ' 136' ' ' HIS . . . 74.11 -31.96 0.94 Allowed Glycine 0 N--CA 1.493 2.467 0 O-C-N 121.688 -0.632 . . . . 0.0 111.526 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.477 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -131.02 58.0 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.707 -1.466 . . . . 0.0 109.84 179.298 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.877 ' OG ' HG21 ' A' ' 107' ' ' THR . 0.4 OUTLIER -129.54 57.04 1.68 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.028 -1.045 . . . . 0.0 109.579 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.825 ' O ' HD13 ' A' ' 115' ' ' ILE . . . -32.9 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -85.14 -77.48 0.28 Allowed 'General case' 0 C--N 1.288 -2.095 0 O-C-N 120.554 -1.342 . . . . 0.0 109.558 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.02 -16.64 19.43 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.411 -0.806 . . . . 0.0 110.366 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.605 ' HG3' HG23 ' A' ' 118' ' ' VAL . 0.4 OUTLIER -88.77 -36.61 16.01 Favored 'General case' 0 C--O 1.2 -1.552 0 O-C-N 121.063 -1.023 . . . . 0.0 110.869 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.825 HD13 ' O ' ' A' ' 111' ' ' ALA . 0.9 OUTLIER -59.97 -17.19 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 C-N-CA 117.971 -1.491 . . . . 0.0 109.183 -179.153 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.8 m -89.09 -57.48 2.88 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.459 1.123 . . . . 0.0 108.491 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.937 ' OG1' HG13 ' A' ' 105' ' ' VAL . 2.0 p -62.71 -32.42 73.52 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.138 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.605 HG23 ' HG3' ' A' ' 114' ' ' ARG . 9.8 t -54.47 -47.55 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 -48.06 -29.46 3.56 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 117' ' ' THR . . . -85.69 -40.08 16.53 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.676 178.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.991 ' HB2' HG21 ' A' ' 105' ' ' VAL . . . -58.11 -50.77 72.32 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.756 -1.215 . . . . 0.0 109.798 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.687 HG22 ' O ' ' A' ' 122' ' ' ILE . 26.5 mm -87.52 27.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.493 0.663 . . . . 0.0 109.741 178.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.529 ' HB2' ' O ' ' A' ' 120' ' ' ALA . . . -37.42 148.36 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.744 0.783 . . . . 0.0 112.37 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -41.37 -7.61 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 123' ' ' ALA . . . 131.61 28.87 0.61 Allowed Glycine 0 N--CA 1.495 2.633 0 O-C-N 119.8 -1.812 . . . . 0.0 110.775 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.78 167.62 13.03 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.31 -1.112 . . . . 0.0 108.504 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.98 124.07 82.35 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.32 16.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.51 1.268 . . . . 0.0 113.149 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.82 -27.62 65.26 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.177 -1.577 . . . . 0.0 108.768 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.749 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 38.5 m-20 -94.79 27.19 3.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.282 -0.886 . . . . 0.0 109.644 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.748 ' CG ' HG23 ' A' ' 99' ' ' ILE . 9.2 tp -141.38 83.88 1.89 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.274 -0.891 . . . . 0.0 109.191 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.541 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 3.4 m120 -120.32 101.11 7.57 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.099 -1.0 . . . . 0.0 111.995 -178.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.597 ' CB ' ' HA ' ' A' ' 134' ' ' PRO . 0.0 OUTLIER -83.15 -179.01 1.32 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.404 -0.81 . . . . 0.0 111.011 -178.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.597 ' HA ' ' CB ' ' A' ' 133' ' ' ARG . 48.6 Cg_endo -73.01 130.31 19.74 Favored 'Cis proline' 0 N--CA 1.5 1.863 0 C-N-CA 123.119 -1.617 . . . . 0.0 113.148 8.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.538 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -132.3 67.95 0.55 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.512 ' CD2' ' CA ' ' A' ' 108' ' ' GLY . 8.5 p-80 32.08 36.59 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.484 0 O-C-N 122.105 -0.644 . . . . 0.0 112.075 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.614 ' O ' HG22 ' A' ' 98' ' ' THR . 13.4 t -91.04 154.2 3.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 176.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.681 ' HD1' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -145.34 81.6 10.23 Favored Pre-proline 0 C--N 1.287 -2.139 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -178.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.477 ' HD3' HG12 ' A' ' 137' ' ' VAL . 52.3 Cg_endo -99.56 159.9 0.57 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.375 2.05 . . . . 0.0 111.857 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.741 ' HB3' HG21 ' A' ' 157' ' ' THR . 10.9 tp -126.54 113.16 16.41 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -63.72 151.33 42.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.307 -0.871 . . . . 0.0 109.404 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.506 ' CA ' ' HA ' ' A' ' 156' ' ' ALA . . . -62.63 98.19 0.11 Allowed 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.039 0.924 . . . . 0.0 111.821 -177.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 156' ' ' ALA . 1.0 OUTLIER -100.68 146.8 26.74 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.153 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.79 116.0 31.16 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.669 -1.269 . . . . 0.0 112.592 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 112.67 -6.32 26.1 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.063 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.09 9.08 61.29 Favored Glycine 0 N--CA 1.502 3.048 0 C-N-CA 118.466 -1.826 . . . . 0.0 112.788 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.944 HG22 HG13 ' A' ' 202' ' ' ILE . 1.0 OUTLIER -116.48 -45.15 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.24 -1.741 . . . . 0.0 108.51 177.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.995 HD22 ' HB2' ' A' ' 150' ' ' ARG . 0.3 OUTLIER -106.77 84.29 1.97 Allowed 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 177.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.425 ' O ' ' CD ' ' A' ' 150' ' ' ARG . 5.1 m -74.3 63.96 1.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 125.335 2.493 . . . . 0.0 104.488 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.995 ' HB2' HD22 ' A' ' 148' ' ' LEU . 12.5 mmt180 -152.68 162.58 41.06 Favored 'General case' 0 C--N 1.271 -2.83 0 N-CA-C 100.23 -3.989 . . . . 0.0 100.23 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -60.57 55.91 0.02 OUTLIER Glycine 0 C--N 1.258 -3.772 0 C-N-CA 117.686 -2.197 . . . . 0.0 112.537 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 150' ' ' ARG . . . -119.28 128.7 7.73 Favored Glycine 0 C--O 1.215 -1.058 0 N-CA-C 106.28 -2.728 . . . . 0.0 106.28 176.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -90.72 1.35 56.93 Favored 'General case' 0 C--N 1.282 -2.344 0 O-C-N 121.969 -0.724 . . . . 0.0 109.312 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.85 ' OG1' HG11 ' A' ' 206' ' ' VAL . 1.9 p -51.52 -18.41 1.09 Allowed 'General case' 0 C--O 1.258 1.521 0 O-C-N 121.389 -0.819 . . . . 0.0 112.476 -176.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.733 ' O ' ' N ' ' A' ' 157' ' ' THR . 5.2 tp10 -48.0 -26.59 1.84 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.295 -0.962 . . . . 0.0 108.509 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.621 ' O ' ' N ' ' A' ' 158' ' ' ILE . . . -46.71 90.82 0.0 OUTLIER 'General case' 0 C--O 1.203 -1.379 0 N-CA-C 103.15 -2.908 . . . . 0.0 103.15 170.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.741 HG21 ' HB3' ' A' ' 140' ' ' LEU . 69.3 p -49.77 12.44 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -168.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.63 ' O ' ' HG3' ' A' ' 161' ' ' MET . 0.9 OUTLIER -107.75 -4.05 10.27 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.402 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 172.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.595 ' CB ' ' HA ' ' A' ' 154' ' ' THR . 0.2 OUTLIER -89.09 -33.57 17.06 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 103.174 -2.898 . . . . 0.0 103.174 173.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.989 ' HA ' HD23 ' A' ' 163' ' ' LEU . 2.3 mp -62.21 -51.6 67.14 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.74 176.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.63 ' HG3' ' O ' ' A' ' 158' ' ' ILE . 0.0 OUTLIER -48.74 -33.65 10.63 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.394 -1.441 . . . . 0.0 108.553 178.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.922 HG21 ' CZ ' ' A' ' 209' ' ' ARG . 1.3 m -57.88 -39.62 78.26 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 119.311 -0.955 . . . . 0.0 108.549 178.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.989 HD23 ' HA ' ' A' ' 160' ' ' LEU . 0.6 OUTLIER -67.26 -8.65 33.47 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.288 -0.965 . . . . 0.0 109.765 178.315 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.52 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -106.36 7.64 31.29 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 120.674 -1.266 . . . . 0.0 110.758 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 49.38 30.42 11.98 Favored Glycine 0 N--CA 1.5 2.951 0 N-CA-C 107.076 -2.41 . . . . 0.0 107.076 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.502 ' CE1' ' HG3' ' A' ' 46' ' ' PRO . 1.9 m-85 -120.19 146.1 46.34 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 122.828 1.299 . . . . 0.0 112.337 -176.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 169' ' ' ALA . 6.7 mtmm -43.9 139.33 2.98 Favored Pre-proline 0 N--CA 1.502 2.128 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.529 ' HB2' HG13 ' A' ' 158' ' ' ILE . 36.6 Cg_endo -61.89 84.93 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.033 0 C-N-CA 117.012 -1.526 . . . . 0.0 113.767 -172.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.946 ' HB1' ' HB3' ' A' ' 47' ' ' ALA . . . -156.04 162.69 40.27 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 172.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.496 ' N ' ' HB2' ' A' ' 47' ' ' ALA . . . -158.12 131.97 3.0 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 117.358 -2.353 . . . . 0.0 111.361 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.809 ' HB ' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -119.71 89.5 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 117.969 -1.492 . . . . 0.0 107.138 176.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.568 ' HA ' ' HB3' ' A' ' 43' ' ' MET . 3.0 mp -95.68 138.35 33.47 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.253 0.549 . . . . 0.0 110.374 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.57 ' SG ' HG21 ' A' ' 58' ' ' THR . 2.8 t -129.59 176.2 8.18 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.897 -1.127 . . . . 0.0 111.064 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -111.45 -179.46 3.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.201 -0.937 . . . . 0.0 110.06 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.709 HD12 ' HB3' ' A' ' 188' ' ' CYS . 3.5 tm? . . . . . 0 N--CA 1.496 1.869 0 O-C-N 121.108 -0.995 . . . . 0.0 110.001 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.93 ' HB1' ' SG ' ' A' ' 188' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.229 0.538 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 185' ' ' ALA . 0.1 OUTLIER -140.23 100.2 3.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.901 . . . . 0.0 109.827 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.857 ' HB1' ' HD2' ' A' ' 186' ' ' PRO . . . -179.37 178.08 0.34 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.31 -0.869 . . . . 0.0 109.891 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.857 ' HD2' ' HB1' ' A' ' 185' ' ' ALA . 45.3 Cg_endo -71.82 -16.92 29.49 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.608 1.32 . . . . 0.0 110.413 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -79.46 -31.56 42.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.087 -1.008 . . . . 0.0 110.067 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . 0.93 ' SG ' ' HB1' ' A' ' 183' ' ' ALA . 14.0 m -74.35 -56.63 4.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.325 -0.859 . . . . 0.0 110.186 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.542 ' O ' ' HE1' ' A' ' 30' ' ' MET . 2.5 tp -61.7 -22.97 29.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.994 -1.066 . . . . 0.0 109.38 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.501 ' HA ' ' HB3' ' A' ' 193' ' ' ASN . 23.7 tt0 -81.61 -18.62 44.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.477 -0.764 . . . . 0.0 109.817 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.439 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.1 OUTLIER -71.34 -53.9 12.61 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.992 0.901 . . . . 0.0 109.36 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.815 ' HB3' ' CE ' ' A' ' 30' ' ' MET . . . -69.6 -35.63 75.48 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . 0.581 ' HA ' ' CB ' ' A' ' 197' ' ' MET . 14.9 t30 -61.71 -18.6 60.32 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.915 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -81.79 -39.81 23.52 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.918 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -100.98 -54.72 2.74 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 115.499 -2.481 . . . . 0.0 111.892 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.417 ' O ' ' HE3' ' A' ' 197' ' ' MET . 39.6 m-80 -114.94 33.42 5.42 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.172 -1.411 . . . . 0.0 113.889 177.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' MET . . . . . 0.735 ' SD ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -152.14 148.99 28.29 Favored 'General case' 0 N--CA 1.515 2.803 0 CA-C-N 122.966 2.621 . . . . 0.0 115.632 -179.52 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.518 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . . . -113.12 125.64 54.59 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 176.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.558 HD11 ' CB ' ' A' ' 193' ' ' ASN . 26.1 mt -94.09 144.47 25.46 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.546 -1.346 . . . . 0.0 112.971 -177.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.801 ' O ' HG23 ' A' ' 31' ' ' VAL . 7.1 p -146.81 110.45 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.422 ' O ' ' CB ' ' A' ' 205' ' ' LEU . 23.9 p -70.69 147.96 48.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 111.707 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.944 HG13 HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -47.72 -38.52 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 121.304 0.573 . . . . 0.0 110.495 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 207' ' ' ALA . 10.7 tt0 -48.13 -65.99 0.48 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.08 -1.012 . . . . 0.0 110.737 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.581 ' O ' ' HB3' ' A' ' 207' ' ' ALA . 6.4 m-20 -80.89 -25.16 37.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.745 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.931 HD11 HD13 ' A' ' 163' ' ' LEU . 3.1 tm? -64.75 -67.5 0.43 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.334 -0.853 . . . . 0.0 109.422 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.85 HG11 ' OG1' ' A' ' 154' ' ' THR . 97.9 t -62.67 -21.99 28.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 118.048 -1.461 . . . . 0.0 108.364 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 204' ' ' ASP . . . -53.25 -28.89 29.73 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 175.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.555 ' HA ' ' CE1' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -77.85 -36.59 49.82 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.922 ' CZ ' HG21 ' A' ' 162' ' ' THR . 16.1 tpt180 -78.6 -58.67 3.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.896 -1.127 . . . . 0.0 110.067 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 206' ' ' VAL . 9.3 tp-100 -51.85 -36.54 48.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.167 -0.958 . . . . 0.0 110.351 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 207' ' ' ALA . . . -72.54 -29.15 63.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 110.222 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 58.1 t60 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.225 -0.922 . . . . 0.0 110.182 179.954 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.65 ' O ' HG12 ' A' ' 16' ' ' VAL . 28.1 Cg_endo . . . . . 0 C--O 1.211 -0.84 0 N-CA-C 110.319 -0.685 . . . . 0.0 110.319 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -86.02 -56.17 3.59 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -93.5 -36.42 12.45 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 118.328 -1.349 . . . . 0.0 111.166 -176.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.671 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 8.3 mmt180 -78.83 -30.05 45.06 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 119.181 -1.007 . . . . 0.0 111.79 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.799 HG11 ' CD2' ' A' ' 208' ' ' TYR . 0.4 OUTLIER -89.55 -36.11 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 116.224 -2.19 . . . . 0.0 111.552 -179.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -63.16 -40.32 97.21 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 117.383 -1.727 . . . . 0.0 108.757 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.91 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 32.5 p-10 -84.38 -23.06 30.26 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.546 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 15' ' ' ARG . . . -71.63 -38.21 70.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.494 -1.379 . . . . 0.0 110.11 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.711 HD13 ' O ' ' A' ' 163' ' ' LEU . 1.6 pp -73.35 -54.27 8.76 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.333 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.659 ' HA ' ' N ' ' A' ' 26' ' ' GLY . . . -69.21 -69.74 0.32 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.877 -1.139 . . . . 0.0 111.807 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.91 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -50.09 -34.89 23.33 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.689 -1.142 . . . . 0.0 112.739 -177.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.933 HD13 ' HB2' ' A' ' 198' ' ' ALA . 2.6 tt -56.39 -59.89 4.32 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.652 ' HB2' HD23 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -123.82 -76.43 0.59 Allowed 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 117.686 -1.606 . . . . 0.0 108.15 173.083 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.461 ' HG3' ' CG ' ' A' ' 27' ' ' ARG . 5.7 pt-20 -167.28 45.78 0.05 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.102 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.659 ' N ' ' HA ' ' A' ' 21' ' ' ALA . . . 60.47 20.01 54.73 Favored Glycine 0 N--CA 1.481 1.698 0 N-CA-C 107.097 -2.401 . . . . 0.0 107.097 -176.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.52 ' CB ' ' CE1' ' A' ' 45' ' ' PHE . 6.6 mtt180 -118.31 39.25 3.48 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.467 -1.019 . . . . 0.0 109.792 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.724 ' O ' ' HB3' ' A' ' 198' ' ' ALA . . . 178.2 66.41 0.06 OUTLIER Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.317 -1.913 . . . . 0.0 108.317 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.718 ' CB ' HD12 ' A' ' 44' ' ' ILE . 6.1 t -144.75 116.97 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.852 ' HG2' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -84.41 146.37 27.69 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 119.838 -1.789 . . . . 0.0 113.313 -177.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 1.09 HG22 HG22 ' A' ' 202' ' ' ILE . 14.8 p . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.502 2.138 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.607 ' HE2' ' H ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -31.35 -27.82 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.176 0 N-CA-C 116.906 2.187 . . . . 0.0 116.906 -174.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.718 HD12 ' CB ' ' A' ' 29' ' ' VAL . 0.8 OUTLIER -138.53 16.18 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.259 0 CA-C-O 122.695 1.236 . . . . 0.0 110.055 178.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.671 ' O ' HG12 ' A' ' 171' ' ' VAL . 0.7 OUTLIER -68.66 161.48 70.54 Favored Pre-proline 0 C--N 1.288 -2.083 0 O-C-N 121.172 -0.955 . . . . 0.0 113.564 -175.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.585 ' HB3' ' CB ' ' A' ' 167' ' ' LYS . 55.8 Cg_endo -82.35 129.92 6.05 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 C-N-CA 122.058 1.839 . . . . 0.0 109.409 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.982 ' HB1' HD13 ' A' ' 68' ' ' LEU . . . -71.69 -1.33 13.44 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.256 -0.903 . . . . 0.0 112.566 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.889 ' HA ' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -86.83 -23.78 25.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.797 -1.19 . . . . 0.0 110.128 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.586 ' O ' HG23 ' A' ' 49' ' ' THR . 10.1 t -133.26 60.23 1.71 Allowed 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.743 ' HG3' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -52.54 88.94 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.334 0.588 . . . . 0.0 109.739 -179.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.53 ' HA ' HG13 ' A' ' 115' ' ' ILE . 26.2 p -61.95 172.58 1.31 Allowed 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.83 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.52 HG22 HD13 ' A' ' 115' ' ' ILE . 17.7 t -73.91 -5.1 6.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.533 -0.729 . . . . 0.0 110.12 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.843 ' O ' HD23 ' A' ' 57' ' ' LEU . 0.8 OUTLIER -50.6 -28.31 8.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.006 -1.059 . . . . 0.0 109.422 179.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.437 ' O ' ' CG2' ' A' ' 58' ' ' THR . 0.0 OUTLIER -86.95 -28.98 22.4 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.203 179.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.472 ' HA ' HG22 ' A' ' 58' ' ' THR . 3.8 mmt -86.23 -41.13 14.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.265 -0.897 . . . . 0.0 109.528 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -65.46 -53.97 35.12 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.224 -0.923 . . . . 0.0 110.4 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.843 HD23 ' O ' ' A' ' 53' ' ' GLU . 0.4 OUTLIER -64.03 -33.4 75.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.216 -0.927 . . . . 0.0 111.059 -179.273 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.475 ' CG2' ' N ' ' A' ' 59' ' ' ILE . 4.4 t -79.33 -46.86 16.87 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.739 -1.226 . . . . 0.0 110.836 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.475 ' N ' ' CG2' ' A' ' 58' ' ' THR . 72.1 mt -53.78 -21.93 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.841 -1.162 . . . . 0.0 109.578 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -84.83 -46.04 11.73 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.378 -0.826 . . . . 0.0 112.257 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.36 -15.04 6.3 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -177.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 58' ' ' THR . . . -164.36 -168.95 27.24 Favored Glycine 0 N--CA 1.502 3.081 0 C-N-CA 118.547 -1.787 . . . . 0.0 111.756 -176.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.6 t -126.57 102.35 7.06 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 101.32 -3.585 . . . . 0.0 101.32 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 66' ' ' VAL . . . -104.79 76.43 0.25 Allowed Glycine 0 C--N 1.26 -3.663 0 N-CA-C 105.804 -2.918 . . . . 0.0 105.804 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.772 HG23 ' CD2' ' A' ' 138' ' ' PHE . 3.2 mm -61.34 84.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.535 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.705 HG12 ' HB3' ' A' ' 173' ' ' CYS . 26.5 m -52.72 157.09 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.508 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.311 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.698 ' HB3' HD11 ' A' ' 140' ' ' LEU . 97.4 m -109.64 119.35 39.14 Favored 'General case' 0 C--N 1.29 -2.006 0 O-C-N 121.393 -0.817 . . . . 0.0 110.32 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.982 HD13 ' HB1' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -87.28 97.81 10.99 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.316 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 74.3 m -70.7 127.28 32.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.467 -0.77 . . . . 0.0 111.794 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.594 HD12 ' HB3' ' A' ' 79' ' ' ASP . 24.6 pt -115.97 162.47 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.465 ' CA ' HG12 ' A' ' 158' ' ' ILE . 1.6 m -81.03 170.62 15.99 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 120.55 -1.344 . . . . 0.0 109.7 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.555 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -95.4 -12.47 25.93 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.399 178.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -85.39 -73.18 0.45 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.915 -1.115 . . . . 0.0 111.901 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -85.98 -32.58 21.44 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 79' ' ' ASP . 10.8 mpt_? -74.07 -31.71 62.96 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.626 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.555 ' HB2' ' HA ' ' A' ' 72' ' ' GLU . 18.2 tttt -72.93 -41.41 64.55 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 119.89 -1.756 . . . . 0.0 108.996 178.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -42.35 -54.1 3.92 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.298 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.63 HD11 ' C ' ' A' ' 128' ' ' PRO . 0.4 OUTLIER -105.08 -29.49 10.37 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.049 -1.46 . . . . 0.0 109.156 178.35 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.594 ' HB3' HD12 ' A' ' 70' ' ' ILE . 5.9 t0 -112.57 70.79 0.72 Allowed 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.997 0.903 . . . . 0.0 109.612 177.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.72 ' C ' HD22 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -80.62 171.34 12.57 Favored Pre-proline 0 C--N 1.286 -2.157 0 O-C-N 121.277 -0.889 . . . . 0.0 112.173 -179.238 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.654 ' N ' HD22 ' A' ' 80' ' ' LEU . 52.9 Cg_endo -84.22 97.79 0.73 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.11 1.058 . . . . 0.0 109.556 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . 0.879 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.8 ttt -97.39 95.76 7.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.11 -0.994 . . . . 0.0 110.641 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.87 95.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.062 -1.024 . . . . 0.0 110.689 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 82' ' ' MET . 93.7 t . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.903 . . . . 0.0 109.997 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.489 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.405 ' O ' ' O ' ' A' ' 82' ' ' MET . 0.9 OUTLIER -127.66 14.92 7.03 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.531 ' O ' ' HD2' ' A' ' 139' ' ' PRO . 4.2 p -115.74 145.14 21.87 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 O-C-N 121.007 -1.058 . . . . 0.0 110.683 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.561 HG22 ' H ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -123.87 -173.79 2.83 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.979 ' CG1' HG11 ' A' ' 137' ' ' VAL . 2.4 pp -145.8 122.82 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 C-N-CA 117.191 -1.803 . . . . 0.0 114.759 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.76 ' CA ' ' HG2' ' A' ' 133' ' ' ARG . 11.4 tm-20 -90.32 163.43 14.74 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.814 177.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.638 ' HB2' ' HB ' ' A' ' 106' ' ' THR . . . -51.73 88.18 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.63 -0.669 . . . . 0.0 112.546 -177.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.527 ' HB2' ' N ' ' A' ' 131' ' ' LEU . . . -84.19 -25.6 29.42 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 175.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.23 -6.5 11.31 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.748 -0.595 . . . . 0.0 110.115 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.52 27.47 0.97 Allowed Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.357 -1.401 . . . . 0.0 112.339 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.793 ' HB ' HG22 ' A' ' 117' ' ' THR . 7.0 m -139.88 123.53 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 120.954 -1.321 . . . . 0.0 110.655 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.638 ' HB ' ' HB2' ' A' ' 101' ' ' ALA . 10.9 t -148.21 63.86 1.1 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.713 -1.242 . . . . 0.0 111.618 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.462 HG22 HG21 ' A' ' 117' ' ' THR . 6.3 t -131.41 -31.17 1.63 Allowed 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 118.438 -1.305 . . . . 0.0 110.331 177.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.436 ' HA2' ' NH1' ' A' ' 114' ' ' ARG . . . 60.7 -28.33 0.05 OUTLIER Glycine 0 N--CA 1.504 3.195 0 O-C-N 121.588 -0.695 . . . . 0.0 114.023 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.409 ' N ' ' O ' ' A' ' 107' ' ' THR . 11.1 t -125.46 55.82 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.225 -1.75 . . . . 0.0 110.127 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.597 ' O ' ' N ' ' A' ' 114' ' ' ARG . 9.3 t -133.99 71.41 1.46 Allowed 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' A' ' 55' ' ' MET . . . -25.74 -40.64 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.794 0 CA-C-O 121.59 0.71 . . . . 0.0 112.035 -177.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -69.22 -66.04 0.63 Allowed 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 122.562 1.172 . . . . 0.0 107.881 176.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.807 ' O ' HG23 ' A' ' 117' ' ' THR . 0.2 OUTLIER -64.41 -13.94 53.91 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.099 -1.001 . . . . 0.0 109.445 177.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 110' ' ' SER . 5.0 tpm_? -62.86 -42.92 99.94 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.2 -0.937 . . . . 0.0 108.707 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.53 HG13 ' HA ' ' A' ' 51' ' ' THR . 1.7 mp -76.75 -13.49 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 118.557 -1.257 . . . . 0.0 108.178 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.494 ' O ' HG11 ' A' ' 105' ' ' VAL . 2.6 m -94.61 -20.92 19.17 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.23 -0.919 . . . . 0.0 108.828 177.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 113' ' ' ASP . 26.0 p -83.73 -36.85 23.36 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.513 -0.742 . . . . 0.0 109.827 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.758 ' O ' HG22 ' A' ' 122' ' ' ILE . 14.2 p -73.99 -41.37 52.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 118.84 -1.144 . . . . 0.0 108.562 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.98 ' O ' ' HB2' ' A' ' 123' ' ' ALA . 3.3 ttt-85 -61.18 -31.41 71.16 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.133 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.4 ' HB3' HG21 ' A' ' 105' ' ' VAL . . . -95.34 -33.07 12.66 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.668 -0.645 . . . . 0.0 111.358 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.651 ' HB1' HD13 ' A' ' 99' ' ' ILE . . . -61.91 -58.16 8.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.027 -1.046 . . . . 0.0 109.712 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.889 HG21 ' HA ' ' A' ' 48' ' ' GLU . 0.7 OUTLIER -88.49 23.03 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.395 -0.815 . . . . 0.0 110.693 179.052 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.98 ' HB2' ' O ' ' A' ' 119' ' ' ARG . . . -95.96 114.81 26.56 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 126' ' ' ALA . 5.4 t0 -89.99 -82.54 0.27 Allowed 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 117.783 -1.567 . . . . 0.0 113.405 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 124' ' ' ASP . . . 69.6 -43.36 0.46 Allowed Glycine 0 N--CA 1.513 3.797 0 N-CA-C 107.666 -2.173 . . . . 0.0 107.666 -176.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.558 ' H ' ' C ' ' A' ' 124' ' ' ASP . . . -135.72 165.71 24.94 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 103.578 -2.749 . . . . 0.0 103.578 176.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.421 ' C ' ' H ' ' A' ' 129' ' ' SER . 4.4 tttp -65.16 114.68 16.18 Favored Pre-proline 0 C--N 1.304 -1.411 0 CA-C-N 121.361 1.891 . . . . 0.0 108.094 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.63 ' C ' HD11 ' A' ' 78' ' ' LEU . 35.1 Cg_endo -67.66 26.14 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.283 1.322 . . . . 0.0 112.18 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . 0.421 ' H ' ' C ' ' A' ' 127' ' ' LYS . 0.3 OUTLIER -54.57 -10.16 0.4 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.464 -1.397 . . . . 0.0 111.176 -178.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.477 ' CB ' ' HA ' ' A' ' 102' ' ' ALA . 2.0 m-20 -72.3 9.04 1.11 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.601 -1.312 . . . . 0.0 110.417 177.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.534 ' CD2' HG22 ' A' ' 99' ' ' ILE . 4.7 tp -74.67 87.99 2.2 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.474 ' H ' ' HB3' ' A' ' 100' ' ' GLU . 1.6 t-20 -116.13 72.64 0.82 Allowed 'General case' 0 N--CA 1.509 2.501 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.911 ' HB3' ' HA ' ' A' ' 134' ' ' PRO 0.255 0.0 OUTLIER -97.58 -152.76 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.734 0 CA-C-O 115.115 -2.374 . . . . 0.0 110.168 179.163 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.911 ' HA ' ' HB3' ' A' ' 133' ' ' ARG . 56.5 Cg_endo -78.98 127.39 14.67 Favored 'Cis proline' 0 N--CA 1.524 3.31 0 N-CA-C 119.554 2.867 . . . . 0.0 119.554 18.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.928 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -126.99 71.87 0.47 Allowed Glycine 0 N--CA 1.511 3.655 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.338 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 49.3 m80 30.62 35.76 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.544 0 CA-C-O 121.418 0.628 . . . . 0.0 112.562 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.979 HG11 ' CG1' ' A' ' 99' ' ' ILE . 92.6 t -94.5 154.71 3.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.978 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 175.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.772 ' CD2' HG23 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -131.07 79.07 71.94 Favored Pre-proline 0 C--N 1.294 -1.822 0 C-N-CA 117.939 -1.505 . . . . 0.0 110.726 -176.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.809 ' C ' HD23 ' A' ' 140' ' ' LEU . 55.8 Cg_endo -107.61 156.44 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 123.515 2.81 . . . . 0.0 107.873 175.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.809 HD23 ' C ' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -145.93 140.81 27.21 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 120.722 -1.236 . . . . 0.0 109.715 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 143' ' ' GLN . 1.8 ptm180 -63.51 154.54 32.11 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.408 ' HB2' ' HB ' ' A' ' 158' ' ' ILE . . . -60.75 88.85 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.862 -1.135 . . . . 0.0 108.949 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 141' ' ' ARG . 0.1 OUTLIER -55.59 144.86 25.02 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.924 0.869 . . . . 0.0 111.021 -178.634 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.594 ' C ' HG21 ' A' ' 154' ' ' THR . . . -83.19 53.97 2.64 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.32 0.581 . . . . 0.0 109.504 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.9 ' O ' HG22 ' A' ' 149' ' ' THR . . . 147.2 19.8 0.1 Allowed Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.578 -1.296 . . . . 0.0 112.457 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.1 1.98 59.49 Favored Glycine 0 N--CA 1.503 3.138 0 C-N-CA 117.769 -2.158 . . . . 0.0 111.403 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.857 ' CG2' HG11 ' A' ' 206' ' ' VAL . 0.3 OUTLIER -116.5 -43.77 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-O 123.943 1.83 . . . . 0.0 107.577 175.217 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.809 ' HA ' HD13 ' A' ' 202' ' ' ILE . 2.8 tp -111.6 70.03 0.7 Allowed 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.9 HG22 ' O ' ' A' ' 145' ' ' GLY . 46.7 p -77.07 63.39 2.34 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 125.243 2.449 . . . . 0.0 104.789 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.586 ' O ' ' N ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -153.58 155.31 35.9 Favored 'General case' 0 C--N 1.267 -2.993 0 N-CA-C 100.501 -3.888 . . . . 0.0 100.501 176.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.25 61.99 0.16 Allowed Glycine 0 C--N 1.261 -3.588 0 C-N-CA 117.144 -2.455 . . . . 0.0 109.386 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 150' ' ' ARG . . . -110.11 -161.57 18.56 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 120.198 -1.766 . . . . 0.0 110.696 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.777 ' N ' HD23 ' A' ' 148' ' ' LEU . 10.7 t-80 -66.57 4.48 0.77 Allowed 'General case' 0 C--O 1.188 -2.173 0 CA-C-O 117.366 -1.302 . . . . 0.0 113.964 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.651 ' HA ' HG12 ' A' ' 147' ' ' VAL . 15.0 t -24.23 -26.57 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.396 0 CA-C-N 120.797 1.635 . . . . 0.0 115.086 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.649 ' N ' ' O ' ' A' ' 153' ' ' HIS . 18.3 tt0 -56.32 -22.78 32.84 Favored 'General case' 0 N--CA 1.511 2.606 0 O-C-N 119.326 -2.109 . . . . 0.0 105.325 172.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.718 ' HB2' ' ND1' ' A' ' 153' ' ' HIS . . . -83.99 12.6 6.01 Favored 'General case' 0 C--O 1.206 -1.208 0 O-C-N 120.746 -1.221 . . . . 0.0 108.971 174.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.625 ' N ' ' O ' ' A' ' 154' ' ' THR . 20.5 m -63.71 -43.26 97.1 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 175.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.506 ' O ' ' HB3' ' A' ' 161' ' ' MET . 5.7 tp -70.19 -35.59 63.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 116.169 -2.212 . . . . 0.0 105.209 174.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.566 ' HB2' ' CA ' ' A' ' 156' ' ' ALA . 1.2 m-20 -59.1 -20.52 54.25 Favored 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 116.414 -2.114 . . . . 0.0 107.216 175.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 1.043 ' HA ' HD12 ' A' ' 163' ' ' LEU . 0.2 OUTLIER -61.87 -28.48 69.53 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 176.32 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 0.647 ' HB2' ' N ' ' A' ' 169' ' ' ALA . 3.2 ptt? -49.65 -34.29 17.9 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 174.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.486 ' CB ' ' O ' ' A' ' 159' ' ' ASP . 2.7 m -65.23 -29.52 70.32 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.093 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 1.072 HD21 HD21 ' A' ' 205' ' ' LEU . 0.2 OUTLIER -41.7 -44.65 3.23 Favored 'General case' 0 N--CA 1.523 3.183 0 O-C-N 121.077 -1.014 . . . . 0.0 109.142 178.21 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -48.4 -29.15 3.73 Favored 'General case' 0 N--CA 1.517 2.89 0 CA-C-O 122.515 1.15 . . . . 0.0 109.753 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 106.44 -34.49 5.69 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.75 49.25 0.41 Allowed 'General case' 0 N--CA 1.508 2.472 0 C-N-CA 117.938 -1.505 . . . . 0.0 113.185 172.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.585 ' CB ' ' HB3' ' A' ' 46' ' ' PRO . 1.3 mmtt -135.02 124.11 16.28 Favored Pre-proline 0 C--N 1.292 -1.933 0 CA-C-O 116.305 -1.807 . . . . 0.0 106.872 175.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.465 ' HA ' ' HG3' ' A' ' 161' ' ' MET . 51.9 Cg_endo -91.6 75.94 0.59 Allowed 'Trans proline' 0 C--N 1.318 -1.068 0 C-N-CA 114.05 -3.5 . . . . 0.0 112.499 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.958 ' HB1' ' HB3' ' A' ' 47' ' ' ALA . . . -165.41 165.47 19.22 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 170.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 68' ' ' LEU . . . -139.45 129.02 4.19 Favored Glycine 0 N--CA 1.502 3.091 0 C-N-CA 118.596 -1.764 . . . . 0.0 109.737 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.671 HG12 ' O ' ' A' ' 45' ' ' PHE . 5.5 p -133.09 95.07 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-N 119.664 1.732 . . . . 0.0 109.804 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 43' ' ' MET . 0.1 OUTLIER -95.08 143.34 26.61 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.605 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.705 ' HB3' HG12 ' A' ' 66' ' ' VAL . 5.6 p -107.43 175.05 5.62 Favored 'General case' 0 N--CA 1.515 2.78 0 O-C-N 120.632 -1.293 . . . . 0.0 112.175 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -143.71 119.01 10.2 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.313 -0.867 . . . . 0.0 111.558 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.73 HD23 ' SG ' ' A' ' 188' ' ' CYS . 0.6 OUTLIER . . . . . 0 N--CA 1.504 2.243 0 CA-C-O 121.821 0.82 . . . . 0.0 111.814 -178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.398 0.618 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.434 ' HB3' ' CB ' ' A' ' 188' ' ' CYS . 3.4 mtp180 -147.14 161.95 39.85 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.338 -0.851 . . . . 0.0 109.036 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.844 ' HB3' ' HD3' ' A' ' 186' ' ' PRO . . . -145.87 -68.56 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.068 -1.02 . . . . 0.0 109.704 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.844 ' HD3' ' HB3' ' A' ' 185' ' ' ALA . 45.0 Cg_endo -70.68 -36.99 7.5 Favored 'Trans proline' 0 C--N 1.316 -1.164 0 N-CA-C 109.11 -1.15 . . . . 0.0 109.11 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.469 ' HA ' ' HB2' ' A' ' 190' ' ' GLU . 0.2 OUTLIER -90.16 -16.85 28.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.632 -0.667 . . . . 0.0 109.942 179.197 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . 0.73 ' SG ' HD23 ' A' ' 175' ' ' LEU . 0.3 OUTLIER -60.67 -50.81 72.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.391 -0.818 . . . . 0.0 110.479 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.869 HG23 ' CD2' ' A' ' 199' ' ' LEU . 6.4 tp -94.77 -28.03 4.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.045 -1.034 . . . . 0.0 109.414 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' A' ' 194' ' ' LYS . 5.0 mm-40 -57.3 -19.99 25.57 Favored 'General case' 0 C--O 1.199 -1.591 0 O-C-N 120.578 -1.326 . . . . 0.0 107.688 175.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.513 ' CD2' ' N ' ' A' ' 192' ' ' ALA . 4.3 t80 -80.84 -62.25 1.72 Allowed 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 122.771 1.272 . . . . 0.0 108.89 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.513 ' N ' ' CD2' ' A' ' 191' ' ' PHE . . . -73.08 -38.53 66.38 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.483 -177.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . 0.648 ' HB2' HD21 ' A' ' 199' ' ' LEU . 12.0 m-20 -84.75 -25.12 28.48 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 118.968 -1.093 . . . . 0.0 112.557 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 190' ' ' GLU . 8.3 ttpt -61.76 -37.83 85.76 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 117.502 -1.679 . . . . 0.0 109.408 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -81.45 -51.64 8.1 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 116.206 -2.197 . . . . 0.0 112.085 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . 0.427 ' O ' ' CE ' ' A' ' 197' ' ' MET . 0.2 OUTLIER -112.89 33.2 5.16 Favored 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 117.792 -1.563 . . . . 0.0 113.736 177.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' MET . . . . . 0.547 ' HB3' ' CB ' ' A' ' 193' ' ' ASN . 0.0 OUTLIER -158.01 152.36 24.57 Favored 'General case' 0 N--CA 1.508 2.444 0 CA-C-N 121.209 1.822 . . . . 0.0 114.861 -179.104 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.933 ' HB2' HD13 ' A' ' 23' ' ' LEU . . . -83.56 139.38 32.9 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 118.675 -1.21 . . . . 0.0 107.935 175.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.869 ' CD2' HG23 ' A' ' 189' ' ' ILE . 3.3 mt -118.96 113.66 21.34 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 120.165 -1.584 . . . . 0.0 112.293 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.669 ' CG1' HD12 ' A' ' 205' ' ' LEU . 8.7 p -124.89 177.59 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.661 0 O-C-N 121.243 -0.911 . . . . 0.0 108.615 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.504 ' N ' HG22 ' A' ' 200' ' ' VAL . 17.5 m -121.25 156.14 33.13 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.252 -1.53 . . . . 0.0 110.808 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 1.09 HG22 HG22 ' A' ' 31' ' ' VAL . 1.2 pp -61.21 -32.7 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 121.061 -1.024 . . . . 0.0 110.229 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 207' ' ' ALA . 2.3 tm-20 -42.28 -67.22 0.28 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.614 -0.679 . . . . 0.0 111.58 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.426 ' O ' ' CB ' ' A' ' 208' ' ' TYR . 3.4 m-20 -87.89 -10.47 50.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.078 -1.014 . . . . 0.0 110.766 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 1.072 HD21 HD21 ' A' ' 163' ' ' LEU . 9.1 tt -84.38 -51.63 6.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 112.132 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.857 HG11 ' CG2' ' A' ' 147' ' ' VAL . 0.1 OUTLIER -84.43 -27.91 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 119.942 -1.723 . . . . 0.0 107.539 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 210' ' ' GLN . . . -63.44 -31.59 72.79 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 173.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.799 ' CD2' HG11 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -58.3 -35.92 72.56 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.355 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -29.19 41.67 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.532 ' HB3' ' HA ' ' A' ' 207' ' ' ALA . 55.8 tt0 -69.28 -68.17 0.42 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 122.003 0.906 . . . . 0.0 108.654 178.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -48.66 -26.3 2.21 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.383 0.611 . . . . 0.0 110.23 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 10.3 t60 . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.344 -0.848 . . . . 0.0 110.173 179.655 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 N--CA 1.515 2.787 0 N-CA-C 108.468 -1.397 . . . . 0.0 108.468 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.638 ' O ' HG12 ' A' ' 16' ' ' VAL 0.272 0.0 OUTLIER -46.75 -21.44 0.2 Allowed 'General case' 0 C--O 1.191 -1.977 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 169.886 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.491 ' HA ' ' HB2' ' A' ' 17' ' ' GLU . 32.6 tt0 -48.39 -39.8 23.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.073 -1.642 . . . . 0.0 108.334 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -42.73 99.71 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 175.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.857 HG22 HG12 ' A' ' 200' ' ' VAL . 0.4 OUTLIER -60.46 -34.9 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 118.979 -1.088 . . . . 0.0 108.218 175.577 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.767 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -51.92 -47.61 64.59 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.587 -1.321 . . . . 0.0 108.798 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.944 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 31.4 t-20 -53.27 -31.09 41.96 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.432 ' O ' ' HB1' ' A' ' 198' ' ' ALA . . . -89.56 -68.23 0.79 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 122.292 1.044 . . . . 0.0 110.358 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.825 HD12 HG11 ' A' ' 200' ' ' VAL . 0.2 OUTLIER -47.98 -54.7 12.03 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.398 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.767 ' HB3' ' O ' ' A' ' 17' ' ' GLU . . . -67.29 -41.59 85.15 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.944 ' HB2' ' O ' ' A' ' 18' ' ' ASN . . . -32.63 -62.08 0.25 Allowed 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 121.045 0.45 . . . . 0.0 111.136 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.948 HD12 ' HA ' ' A' ' 197' ' ' MET . 2.4 mt -106.67 7.73 30.71 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.321 -1.352 . . . . 0.0 110.703 177.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.589 ' HB2' ' O ' ' A' ' 20' ' ' LEU . 59.3 ttp85 -55.26 -18.95 7.03 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.775 -1.203 . . . . 0.0 107.77 176.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -79.71 46.05 0.74 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 122.798 1.285 . . . . 0.0 109.839 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.51 ' HA2' ' CZ ' ' A' ' 45' ' ' PHE . . . 67.92 16.36 68.25 Favored Glycine 0 C--N 1.292 -1.897 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.991 176.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.479 ' O ' HD13 ' A' ' 23' ' ' LEU . 20.1 mtt180 -99.46 17.31 20.61 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 116.079 -2.248 . . . . 0.0 111.225 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 197' ' ' MET . . . 100.6 106.32 2.84 Favored Glycine 0 N--CA 1.496 2.685 0 C-N-CA 118.982 -1.58 . . . . 0.0 113.181 173.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.851 HG22 HD13 ' A' ' 44' ' ' ILE . 2.0 m -145.6 113.71 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 120.174 -1.78 . . . . 0.0 106.743 176.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.483 ' HA ' ' HB3' ' A' ' 43' ' ' MET . 0.0 OUTLIER -75.27 75.17 2.39 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 116.104 -2.238 . . . . 0.0 107.72 -177.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.922 HG21 HG22 ' A' ' 200' ' ' VAL . 1.5 t . . . . . 0 C--N 1.287 -2.149 0 CA-C-N 113.773 -1.558 . . . . 0.0 108.17 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.612 ' HA ' ' CD1' ' A' ' 45' ' ' PHE . 25.4 t70 . . . . . 0 N--CA 1.497 1.883 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.589 ' HA ' ' HA ' ' A' ' 172' ' ' LEU . 0.4 OUTLIER -81.45 17.16 1.44 Allowed 'General case' 0 N--CA 1.481 1.112 0 O-C-N 120.468 -1.395 . . . . 0.0 113.942 -177.388 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.851 HD13 HG22 ' A' ' 29' ' ' VAL . 5.2 tp -138.27 16.63 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.794 0 CA-C-O 121.792 0.806 . . . . 0.0 109.724 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.803 ' O ' HG12 ' A' ' 171' ' ' VAL . 89.2 m-85 -107.81 160.1 28.02 Favored Pre-proline 0 N--CA 1.507 2.42 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -173.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -75.62 134.12 16.45 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 123.132 2.555 . . . . 0.0 111.974 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 1.058 ' HB2' HD11 ' A' ' 68' ' ' LEU . . . -50.71 -20.71 1.32 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.234 -0.917 . . . . 0.0 111.807 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -72.67 -26.81 61.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.044 -1.035 . . . . 0.0 110.562 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.654 HG22 ' HG2' ' A' ' 119' ' ' ARG . 65.2 p -133.13 58.86 1.75 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . 0.674 ' CG ' HG11 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -61.91 87.04 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.279 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.492 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -63.56 162.06 13.55 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 122.506 1.146 . . . . 0.0 112.109 -176.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.694 ' CG2' ' HB1' ' A' ' 111' ' ' ALA . 4.3 p -75.1 -2.22 3.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.142 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.473 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 23.8 mt-10 -46.28 -26.66 0.85 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.264 -0.897 . . . . 0.0 110.19 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.463 ' HB2' ' HB3' ' A' ' 42' ' ' ASP . 5.5 tp-100 -88.11 -49.85 6.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.526 -0.734 . . . . 0.0 109.32 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.895 ' SD ' HD11 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -54.71 -47.09 74.14 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.578 -0.701 . . . . 0.0 109.785 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.04 -55.39 33.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 110.258 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.516 HD23 ' C ' ' A' ' 57' ' ' LEU . 7.0 tt -59.27 -44.33 92.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.482 -0.761 . . . . 0.0 110.48 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.498 HG22 ' HA ' ' A' ' 55' ' ' MET . 3.0 t -74.94 -47.51 29.2 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.17 -0.956 . . . . 0.0 111.564 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.895 HD11 ' SD ' ' A' ' 55' ' ' MET . 43.8 mt -47.97 -25.72 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.664 -1.272 . . . . 0.0 109.587 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -77.76 -47.85 18.01 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.49 -0.756 . . . . 0.0 110.826 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -125.31 -9.08 6.98 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 58' ' ' THR . . . -164.99 -168.16 26.7 Favored Glycine 0 N--CA 1.502 3.085 0 O-C-N 120.13 -1.606 . . . . 0.0 111.469 -177.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.1 t -133.11 103.26 5.93 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 101.71 -3.441 . . . . 0.0 101.71 176.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.449 ' N ' ' OG1' ' A' ' 58' ' ' THR . . . -104.63 73.76 0.24 Allowed Glycine 0 C--N 1.264 -3.447 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 -177.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.672 ' O ' HG23 ' A' ' 65' ' ' ILE . 2.0 tp -64.26 97.2 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.822 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.976 ' CG1' HG22 ' A' ' 171' ' ' VAL . 3.6 t -50.99 163.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.347 -177.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.882 ' O ' HG21 ' A' ' 157' ' ' THR . 80.3 m -111.19 114.81 28.3 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.031 0.919 . . . . 0.0 109.122 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.058 HD11 ' HB2' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -90.61 123.35 34.18 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.615 ' C ' HD13 ' A' ' 158' ' ' ILE . 0.1 OUTLIER -108.57 143.08 38.08 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 117.232 -1.787 . . . . 0.0 110.415 179.125 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.749 HG21 ' OD2' ' A' ' 79' ' ' ASP 0.25 2.0 pp -137.41 137.28 46.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.345 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.878 HG22 ' HB2' ' A' ' 75' ' ' ARG . 9.3 t -74.93 179.43 4.92 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.606 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 2.3 mp0 -90.48 -18.59 25.08 Favored 'General case' 0 C--N 1.275 -2.674 0 C-N-CA 119.366 -0.933 . . . . 0.0 110.815 -178.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.57 -74.68 0.19 Allowed 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.823 -1.151 . . . . 0.0 112.797 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -94.66 -37.74 11.17 Favored 'General case' 0 C--N 1.279 -2.463 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.294 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.878 ' HB2' HG22 ' A' ' 71' ' ' THR . 0.0 OUTLIER -69.69 -24.84 63.64 Favored 'General case' 0 C--N 1.284 -2.269 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.543 -179.433 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.696 ' HE2' HD12 ' A' ' 80' ' ' LEU . 7.5 tttt -81.41 -38.92 25.74 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 117.459 -1.696 . . . . 0.0 107.489 176.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -42.19 -42.39 3.0 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.409 0.623 . . . . 0.0 109.569 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.788 HD23 ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -107.87 -30.02 8.74 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.448 -1.301 . . . . 0.0 109.026 177.323 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.788 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -114.15 69.12 0.7 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.724 178.004 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.696 HD12 ' HE2' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -111.45 149.05 40.08 Favored Pre-proline 0 C--N 1.295 -1.789 0 O-C-N 120.785 -1.197 . . . . 0.0 109.163 178.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.53 ' CD ' ' HG ' ' A' ' 80' ' ' LEU . 27.5 Cg_endo -50.86 96.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.187 0 O-C-N 123.393 1.207 . . . . 0.0 110.556 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.11 44.51 1.04 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.427 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 175.24 -54.89 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.138 -0.976 . . . . 0.0 109.73 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.879 HG23 HG22 ' A' ' 96' ' ' THR . 15.6 m . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.358 -0.839 . . . . 0.0 110.234 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' A' ' 138' ' ' PHE . 19.5 m-85 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.879 HG22 HG23 ' A' ' 84' ' ' VAL . 70.4 p -118.05 -1.82 11.36 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.032 -1.467 . . . . 0.0 114.915 -177.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.655 HG22 ' C ' ' A' ' 80' ' ' LEU . 1.8 t -121.89 86.52 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.268 -2.957 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.449 ' OG1' ' N ' ' A' ' 135' ' ' GLY . 8.9 t -73.71 123.87 24.92 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 176.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 1.025 ' CG1' HG21 ' A' ' 137' ' ' VAL . 7.7 pt -106.25 123.31 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.641 -1.287 . . . . 0.0 112.793 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.554 ' O ' ' HA ' ' A' ' 131' ' ' LEU . 0.2 OUTLIER -128.67 105.13 8.06 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.092 177.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.963 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . . . -48.22 104.25 0.06 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 122.058 0.932 . . . . 0.0 110.62 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 130' ' ' ASP . . . -59.8 -10.9 4.31 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.285 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -0.49 14.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.987 -1.071 . . . . 0.0 111.285 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.76 27.41 0.96 Allowed Glycine 0 N--CA 1.494 2.563 0 C-N-CA 118.993 -1.575 . . . . 0.0 112.556 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.963 ' HB ' ' HB3' ' A' ' 101' ' ' ALA . 21.1 t -108.73 153.94 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.066 -1.255 . . . . 0.0 109.828 178.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.409 ' O ' ' HG3' ' A' ' 114' ' ' ARG . 4.4 m -142.08 107.2 4.95 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 103.109 -2.922 . . . . 0.0 103.109 178.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.504 ' O ' ' C ' ' A' ' 108' ' ' GLY . 23.8 m -56.61 -24.71 49.77 Favored 'General case' 0 C--N 1.273 -2.736 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -175.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . 0.842 ' O ' ' N ' ' A' ' 110' ' ' SER . . . 29.85 48.43 0.13 Allowed Glycine 0 N--CA 1.511 3.644 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 172.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.744 HG21 ' CG ' ' A' ' 136' ' ' HIS . 54.6 t -28.77 67.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.628 0 CA-C-O 125.289 2.471 . . . . 0.0 112.17 -168.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.842 ' N ' ' O ' ' A' ' 108' ' ' GLY . 7.8 t -130.88 65.32 1.55 Allowed 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 109.403 -3.544 . . . . 0.0 103.935 176.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.694 ' HB1' ' CG2' ' A' ' 52' ' ' VAL . . . -30.02 -29.91 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.118 -1.401 . . . . 0.0 114.271 -175.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -62.0 -77.9 0.04 OUTLIER 'General case' 0 C--N 1.282 -2.346 0 O-C-N 120.198 -1.564 . . . . 0.0 109.584 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -75.03 -27.81 60.22 Favored 'General case' 0 C--N 1.289 -2.061 0 O-C-N 121.337 -0.852 . . . . 0.0 111.373 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.862 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -83.0 -38.54 22.5 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.334 -178.347 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.612 HD13 ' CA ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -66.42 -12.84 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 116.849 -1.941 . . . . 0.0 108.013 178.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.5 m -74.35 -50.54 18.27 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.716 ' O ' ' HB2' ' A' ' 121' ' ' ALA . 3.9 p -70.63 -22.43 62.52 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.189 -0.944 . . . . 0.0 109.387 178.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 114' ' ' ARG . 63.0 t -66.8 -51.6 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.274 -0.891 . . . . 0.0 109.741 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.654 ' HG2' HG22 ' A' ' 49' ' ' THR . 5.5 ttp180 -51.53 -40.54 59.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.518 -0.739 . . . . 0.0 109.955 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.21 -8.49 39.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.583 -0.698 . . . . 0.0 110.572 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 117' ' ' THR . . . -68.31 -44.5 75.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.055 -1.028 . . . . 0.0 111.183 -178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.542 HG22 ' O ' ' A' ' 122' ' ' ILE . 4.6 mt -83.3 9.34 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.542 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -107.08 71.43 0.83 Allowed 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.774 -1.171 . . . . 0.0 110.556 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.441 ' CB ' ' HD3' ' A' ' 127' ' ' LYS . 0.5 OUTLIER -99.0 -44.38 6.33 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.527 1.156 . . . . 0.0 109.319 177.6 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 124.64 -39.91 2.02 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 105.94 -2.864 . . . . 0.0 105.94 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -135.48 95.1 3.2 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.454 ' N ' ' CD ' ' A' ' 128' ' ' PRO . 7.7 tptt -136.57 53.45 7.49 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 120.784 -1.198 . . . . 0.0 109.761 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 127' ' ' LYS . 49.5 Cg_endo -77.4 -35.14 1.73 Allowed 'Trans proline' 0 C--N 1.3 -1.999 0 N-CA-C 107.552 -1.749 . . . . 0.0 107.552 178.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.3 p -125.86 -17.82 5.28 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.019 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.45 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -77.29 9.6 3.05 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.739 -1.226 . . . . 0.0 112.896 -177.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.939 HD12 ' N ' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -140.94 74.79 1.47 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.541 -1.349 . . . . 0.0 109.561 179.04 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.591 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 0.7 OUTLIER -144.0 48.9 1.38 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.439 -1.413 . . . . 0.0 114.239 176.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.421 ' C ' ' CB ' ' A' ' 100' ' ' GLU . 2.1 mtm180 177.25 108.01 0.12 Allowed Pre-proline 0 N--CA 1.516 2.844 0 CA-C-N 121.897 2.135 . . . . 0.0 112.947 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -126.26 129.05 0.03 OUTLIER 'Cis proline' 0 C--N 1.312 -1.394 0 N-CA-C 103.557 -3.286 . . . . 0.0 103.557 -8.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -113.65 33.36 5.54 Favored Glycine 0 N--CA 1.503 3.163 0 C-N-CA 117.54 -2.267 . . . . 0.0 113.791 -175.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.744 ' CG ' HG21 ' A' ' 109' ' ' VAL . 14.6 m-70 32.11 37.95 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.903 0 CA-C-N 119.049 1.424 . . . . 0.0 110.311 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 1.025 HG21 ' CG1' ' A' ' 99' ' ' ILE . 54.2 t -86.87 156.12 3.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.597 ' CD1' ' O ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -124.79 79.46 63.7 Favored Pre-proline 0 C--N 1.284 -2.275 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -178.641 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.578 ' HG3' HG12 ' A' ' 137' ' ' VAL . 52.0 Cg_endo -108.79 124.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.074 1.849 . . . . 0.0 110.83 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 1.1 pp -128.99 136.82 50.85 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 119.485 -0.886 . . . . 0.0 108.898 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.469 ' CG ' ' CG ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -63.66 137.06 57.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.615 -1.303 . . . . 0.0 108.404 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.791 ' HB3' HG21 ' A' ' 158' ' ' ILE . . . -131.26 133.55 45.55 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.094 -1.043 . . . . 0.0 112.15 -178.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.16 143.46 45.24 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.537 -0.727 . . . . 0.0 109.724 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . 0.493 ' HB1' ' NH2' ' A' ' 209' ' ' ARG . . . -68.48 115.71 8.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.478 -0.764 . . . . 0.0 110.6 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 86.93 14.93 63.87 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.14 13.64 63.15 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.733 HG21 ' HB2' ' A' ' 156' ' ' ALA . 14.5 p -89.94 -4.72 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.872 -1.37 . . . . 0.0 110.157 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.472 ' HG ' HG11 ' A' ' 206' ' ' VAL . 1.2 mp -90.06 17.56 6.8 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 116.139 -2.224 . . . . 0.0 110.148 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.4 p -130.59 60.99 1.62 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 101.171 -3.64 . . . . 0.0 101.171 168.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.459 ' HG3' ' CG ' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -149.97 140.49 22.47 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 113.794 -1.548 . . . . 0.0 112.755 -178.433 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.422 ' N ' ' HD3' ' A' ' 150' ' ' ARG . . . -104.0 35.09 5.28 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 106.148 -2.781 . . . . 0.0 106.148 173.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.24 163.35 27.8 Favored Glycine 0 N--CA 1.479 1.509 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' HIS . . . . . 0.563 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 2.8 p-80 -90.84 -5.03 56.12 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.646 -0.914 . . . . 0.0 109.552 177.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.812 HG22 ' SG ' ' A' ' 67' ' ' CYS . 60.0 p -53.37 -59.25 4.81 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.003 -1.061 . . . . 0.0 109.766 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.498 ' HB2' HG23 ' A' ' 147' ' ' VAL . 63.3 mm-40 -59.59 -21.34 60.22 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.733 ' HB2' HG21 ' A' ' 147' ' ' VAL . . . -85.56 6.76 25.77 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.882 HG21 ' O ' ' A' ' 67' ' ' CYS . 27.3 m -91.99 -36.5 13.38 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.791 HG21 ' HB3' ' A' ' 142' ' ' ALA . 3.2 tp -85.83 -31.44 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 173.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . 0.498 ' O ' HG22 ' A' ' 162' ' ' THR . 1.7 t70 -56.68 -34.06 67.03 Favored 'General case' 0 C--O 1.199 -1.553 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 174.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 1.029 HD13 ' N ' ' A' ' 161' ' ' MET . 0.0 OUTLIER -45.05 -37.42 4.14 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.349 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' MET . . . . . 1.029 ' N ' HD13 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -50.26 -45.33 54.12 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.871 178.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 159' ' ' ASP . 4.3 t -97.56 -31.69 12.19 Favored 'General case' 0 N--CA 1.509 2.478 0 CA-C-O 121.895 0.855 . . . . 0.0 111.5 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 1.042 ' CD2' HD21 ' A' ' 205' ' ' LEU 0.272 0.2 OUTLIER -42.98 -58.11 2.56 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -178.58 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -110.13 2.24 19.31 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 118.874 -1.13 . . . . 0.0 113.003 -176.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 96.08 -19.2 55.51 Favored Glycine 0 C--N 1.29 -1.999 0 N-CA-C 108.21 -1.956 . . . . 0.0 108.21 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' PHE . . . . . 0.69 ' C ' ' HD3' ' A' ' 168' ' ' PRO . 0.1 OUTLIER -76.95 137.21 38.91 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.14 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.628 ' HA ' ' HA ' ' A' ' 161' ' ' MET . 2.4 ttmt -121.55 56.47 6.37 Favored Pre-proline 0 C--N 1.31 -1.12 0 O-C-N 120.745 -1.222 . . . . 0.0 110.47 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.816 ' HD2' HD11 ' A' ' 160' ' ' LEU . 56.5 Cg_endo -108.93 175.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.301 -1.966 0 N-CA-C 107.731 -1.681 . . . . 0.0 107.731 177.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.464 ' HB2' ' HD3' ' A' ' 75' ' ' ARG . . . -85.53 104.82 15.65 Favored 'General case' 0 C--N 1.261 -3.247 0 N-CA-C 101.42 -3.548 . . . . 0.0 101.42 173.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.443 ' O ' ' CG2' ' A' ' 157' ' ' THR . . . -93.75 154.52 21.68 Favored Glycine 0 C--N 1.297 -1.617 0 C-N-CA 119.048 -1.549 . . . . 0.0 111.103 -173.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . 0.976 HG22 ' CG1' ' A' ' 66' ' ' VAL 0.261 5.6 p -124.05 95.56 3.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LEU . . . . . 0.769 HD21 ' HA ' ' A' ' 157' ' ' THR . 0.3 OUTLIER -114.81 114.74 25.95 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 119.93 -1.731 . . . . 0.0 111.018 -178.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.781 ' HB2' HG22 ' A' ' 66' ' ' VAL . 4.9 t -109.79 175.64 5.37 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.547 -1.346 . . . . 0.0 110.943 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . 0.734 ' C ' HD13 ' A' ' 189' ' ' ILE . 0.0 OUTLIER -106.73 -147.93 0.41 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.41 -0.806 . . . . 0.0 109.888 179.261 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.682 ' C ' HD13 ' A' ' 175' ' ' LEU . 2.1 tm? . . . . . 0 N--CA 1.497 1.908 0 O-C-N 121.193 -0.942 . . . . 0.0 109.404 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.234 0.54 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' A' ' 185' ' ' ALA . 2.9 ppt_? -139.98 100.45 3.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.304 -0.872 . . . . 0.0 109.911 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.745 ' HB1' ' HD2' ' A' ' 186' ' ' PRO . . . 179.25 173.57 0.44 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.337 -0.852 . . . . 0.0 110.003 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' PRO . . . . . 0.745 ' HD2' ' HB1' ' A' ' 185' ' ' ALA . 46.5 Cg_endo -72.73 -11.59 26.04 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.644 1.339 . . . . 0.0 110.76 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 190' ' ' GLU . 3.6 mt-10 -84.93 -63.37 1.34 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.063 -1.023 . . . . 0.0 110.522 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' CYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 191' ' ' PHE . 21.5 p -52.37 -37.56 56.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.01 . . . . 0.0 109.718 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.983 HG23 HD21 ' A' ' 199' ' ' LEU . 8.0 tp -73.62 -28.33 24.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 120.604 -1.31 . . . . 0.0 108.27 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.643 ' HA ' HD22 ' A' ' 199' ' ' LEU . 1.4 tt0 -58.85 -20.0 46.82 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.126 177.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' PHE . . . . . 0.463 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.1 OUTLIER -75.34 -51.06 14.07 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.72 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . 0.443 ' CB ' ' HE3' ' A' ' 197' ' ' MET . . . -62.51 -38.5 90.18 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ASN . . . . . 0.836 ' HB2' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -64.52 -15.98 61.8 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.103 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.45 -36.75 22.1 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 117.892 -1.523 . . . . 0.0 112.477 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -104.33 -53.59 2.69 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 115.719 -2.392 . . . . 0.0 111.519 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -113.97 32.99 5.49 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.025 -1.47 . . . . 0.0 113.754 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' MET . . . . . 0.948 ' HA ' HD12 ' A' ' 23' ' ' LEU . 2.5 ttp -153.67 145.15 23.19 Favored 'General case' 0 N--CA 1.512 2.645 0 C-N-CA 115.065 -2.654 . . . . 0.0 115.441 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.576 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . . . -91.4 142.88 27.2 Favored 'General case' 0 N--CA 1.51 2.568 0 O-C-N 120.884 -1.135 . . . . 0.0 108.128 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.983 HD21 HG23 ' A' ' 189' ' ' ILE . 3.0 tp -131.55 94.09 3.47 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.495 -1.378 . . . . 0.0 114.498 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.922 HG22 HG21 ' A' ' 31' ' ' VAL 0.253 6.8 m -57.87 -168.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 120.496 -1.378 . . . . 0.0 107.525 175.31 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 205' ' ' LEU . 23.8 m -119.03 110.59 17.28 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 174.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.484 ' HA ' ' HB3' ' A' ' 205' ' ' LEU . 16.6 mt -49.62 -21.99 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.343 -0.848 . . . . 0.0 111.838 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -66.64 0.52 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.814 -1.179 . . . . 0.0 109.334 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.783 ' O ' ' HB3' ' A' ' 207' ' ' ALA . 1.7 m-20 -66.14 -32.82 74.49 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.015 -1.053 . . . . 0.0 109.076 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 1.042 HD21 ' CD2' ' A' ' 163' ' ' LEU . 6.7 tt -45.86 -69.53 0.13 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 123.084 1.421 . . . . 0.0 112.459 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . 0.472 HG11 ' HG ' ' A' ' 148' ' ' LEU . 1.4 t -68.42 -11.37 14.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 C-N-CA 117.758 -1.577 . . . . 0.0 108.845 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.783 ' HB3' ' O ' ' A' ' 204' ' ' ASP . . . -58.64 -30.49 67.33 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 175.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' TYR . . . . . 0.847 ' CE2' ' HA ' ' A' ' 205' ' ' LEU . 1.5 m-85 -62.59 -48.19 80.52 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 177.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ARG . . . . . 0.493 ' NH2' ' HB1' ' A' ' 144' ' ' ALA . 17.8 tpt180 -65.56 -29.16 69.74 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.779 -1.168 . . . . 0.0 109.746 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.462 ' HB2' HD21 ' A' ' 148' ' ' LEU . 30.9 tt0 -73.02 -35.29 66.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.03 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -73.57 -27.05 61.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.364 -0.835 . . . . 0.0 110.039 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 110.087 179.868 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.445 ' SD ' ' CE1' ' A' ' 195' ' ' HIS . 1.6 mtt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.223 0.535 . . . . 0.0 110.234 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.415 ' O ' HD23 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -93.7 56.41 2.35 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.313 -0.867 . . . . 0.0 110.201 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.455 ' CB ' ' HG3' ' A' ' 194' ' ' LYS . 0.0 OUTLIER -94.11 -22.49 18.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.253 -0.905 . . . . 0.0 110.215 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.4 p -73.19 -4.75 34.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.882 . . . . 0.0 110.721 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.614 ' CB ' ' HB2' ' A' ' 198' ' ' ALA . 4.3 mm? -50.54 -59.9 3.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.908 -1.12 . . . . 0.0 110.665 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.816 HD12 ' CB ' ' A' ' 198' ' ' ALA . 0.3 OUTLIER -116.16 8.65 14.46 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.309 -0.869 . . . . 0.0 110.641 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.7 t -92.18 -64.68 1.08 Allowed 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.842 -1.161 . . . . 0.0 110.146 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.6 t -92.36 3.94 54.41 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.326 -0.859 . . . . 0.0 109.173 177.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.423 ' C ' ' HB3' ' A' ' 15' ' ' ARG . 31.2 m-85 -142.03 73.62 1.42 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.479 ' CA ' ' HB2' ' A' ' 15' ' ' ARG . . . -164.49 97.2 0.14 Allowed Glycine 0 C--N 1.291 -1.955 0 N-CA-C 106.608 -2.597 . . . . 0.0 106.608 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.488 ' H ' ' HB2' ' A' ' 15' ' ' ARG . 0.4 OUTLIER -127.0 141.62 41.21 Favored Pre-proline 0 C--N 1.27 -2.872 1 N-CA-C 100.116 -4.031 . . . . 0.0 100.116 176.623 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.727 ' O ' HG12 ' A' ' 16' ' ' VAL . 28.2 Cg_endo -50.4 -46.12 30.79 Favored 'Trans proline' 0 C--N 1.273 -3.437 0 O-C-N 122.847 0.92 . . . . 0.0 110.928 -176.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -95.46 -46.36 6.72 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -77.4 -62.63 1.6 Allowed 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 118.353 -1.339 . . . . 0.0 112.384 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.488 ' HB2' ' H ' ' A' ' 11' ' ' THR . 26.3 mmm180 -85.58 -10.15 56.31 Favored 'General case' 0 C--N 1.286 -2.183 0 C-N-CA 117.538 -1.665 . . . . 0.0 112.981 -177.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -85.93 -26.04 6.44 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.489 0 C-N-CA 114.386 -2.926 . . . . 0.0 108.391 176.11 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.72 -48.89 62.67 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 116.74 -1.984 . . . . 0.0 107.409 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -65.6 -33.2 75.35 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.524 -0.735 . . . . 0.0 109.36 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.5 ' O ' HD23 ' A' ' 23' ' ' LEU . . . -81.75 -22.03 37.49 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.182 -0.949 . . . . 0.0 109.234 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.833 HD21 ' O ' ' A' ' 163' ' ' LEU . 0.1 OUTLIER -53.89 -50.42 66.36 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 179.175 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.463 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . . . -66.61 -51.51 55.5 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.234 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -47.31 -45.4 24.27 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.519 -0.738 . . . . 0.0 110.507 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.664 HD13 HG11 ' A' ' 29' ' ' VAL . 3.3 pp -91.08 -17.15 26.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.306 -0.871 . . . . 0.0 110.192 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 20' ' ' LEU . 0.9 OUTLIER -54.72 -23.05 15.92 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.273 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.4 41.98 1.11 Allowed 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 118.23 -1.388 . . . . 0.0 110.167 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.539 ' HA3' ' CZ ' ' A' ' 45' ' ' PHE . . . 53.83 31.79 47.12 Favored Glycine 0 C--N 1.291 -1.953 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 176.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -85.3 19.78 2.18 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 116.859 -1.937 . . . . 0.0 110.859 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.564 ' O ' ' HB3' ' A' ' 198' ' ' ALA . . . 98.3 105.73 2.51 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 119.524 -1.322 . . . . 0.0 113.085 173.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.922 HG22 HD12 ' A' ' 44' ' ' ILE . 3.2 p -145.33 118.65 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-N 120.096 1.948 . . . . 0.0 109.968 176.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.776 ' HB3' HD23 ' A' ' 199' ' ' LEU . 1.5 tmt? -105.78 151.78 24.05 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.063 -1.023 . . . . 0.0 110.69 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.724 HG22 ' HB ' ' A' ' 202' ' ' ILE . 4.5 p -124.44 115.27 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.898 -1.126 . . . . 0.0 109.504 177.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.836 HD23 ' O ' ' A' ' 200' ' ' VAL . 0.6 OUTLIER -105.47 152.46 22.99 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.711 -1.243 . . . . 0.0 110.674 -179.246 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.505 ' HB2' HG21 ' A' ' 202' ' ' ILE . 20.4 t0 -133.15 179.72 6.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.396 -0.815 . . . . 0.0 110.203 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -109.77 78.25 1.11 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.211 -0.93 . . . . 0.0 110.16 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -147.78 -166.11 2.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.283 -0.886 . . . . 0.0 110.191 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -96.31 -62.92 1.2 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.917 . . . . 0.0 110.235 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.2 139.2 29.81 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.257 -0.902 . . . . 0.0 110.188 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -129.05 141.82 51.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 110.255 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.445 ' O ' ' HA ' ' A' ' 173' ' ' CYS . 0.6 OUTLIER -173.28 -70.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.301 -0.874 . . . . 0.0 110.118 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.467 ' OE2' ' CD2' ' A' ' 153' ' ' HIS . 14.0 mp0 -53.94 139.19 34.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 110.112 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.452 ' CA ' ' HG2' ' A' ' 30' ' ' MET . . . -175.93 -141.42 3.82 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 118.76 -1.686 . . . . 0.0 112.134 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.51 ' HA ' ' CA ' ' A' ' 30' ' ' MET . 2.7 p30 -45.26 -20.11 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.372 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.677 ' O ' HG23 ' A' ' 171' ' ' VAL . 1.8 ttm -93.88 47.07 1.2 Allowed 'General case' 0 C--N 1.288 -2.104 0 O-C-N 120.886 -1.134 . . . . 0.0 113.778 -177.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.922 HD12 HG22 ' A' ' 29' ' ' VAL . 73.4 mt -68.49 20.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.534 3.75 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.776 ' O ' HG22 ' A' ' 171' ' ' VAL . 2.3 m-85 -66.59 162.38 51.07 Favored Pre-proline 0 C--N 1.279 -2.472 0 O-C-N 121.008 -1.057 . . . . 0.0 113.631 -176.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.481 ' HD2' ' CD2' ' A' ' 45' ' ' PHE . 43.8 Cg_endo -66.92 133.73 32.2 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.895 2.397 . . . . 0.0 111.902 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.63 ' HB2' ' N ' ' A' ' 170' ' ' GLY . . . -65.76 -7.21 14.6 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.405 -0.81 . . . . 0.0 112.751 -177.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.774 ' HB2' ' HB2' ' A' ' 123' ' ' ALA . 0.3 OUTLIER -109.99 -14.97 14.16 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.726 -1.234 . . . . 0.0 111.35 -179.307 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 51' ' ' THR . 25.2 m -132.62 59.73 1.72 Allowed 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.581 ' O ' HG23 ' A' ' 115' ' ' ILE . 6.3 mtp -62.67 86.08 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.725 ' C ' HD13 ' A' ' 115' ' ' ILE . 1.7 m -63.99 170.41 3.56 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.773 0.797 . . . . 0.0 110.217 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 1.051 HG22 HD12 ' A' ' 115' ' ' ILE . 7.0 t -85.31 -3.72 8.5 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 O-C-N 121.731 -0.606 . . . . 0.0 109.586 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 6.3 tp10 -52.86 -39.8 62.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.844 -1.16 . . . . 0.0 108.867 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.524 ' CG ' ' CD1' ' A' ' 45' ' ' PHE . 17.6 mm-40 -82.08 -39.04 23.98 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.784 ' HG3' HD11 ' A' ' 115' ' ' ILE . 19.0 mmt -57.24 -39.11 74.89 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.097 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.501 ' HA ' HD12 ' A' ' 59' ' ' ILE . . . -58.05 -54.29 48.62 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.213 -0.93 . . . . 0.0 108.649 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.891 HD13 ' HE3' ' A' ' 197' ' ' MET . 6.2 tt -63.8 -22.01 66.71 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.699 -0.801 . . . . 0.0 109.464 178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.593 HG23 ' C ' ' A' ' 63' ' ' SER . 1.1 m -88.64 -22.8 23.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.428 -0.795 . . . . 0.0 110.265 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 56' ' ' ALA . 22.7 mt -76.83 -23.1 15.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.045 -1.035 . . . . 0.0 109.322 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.53 -64.07 1.1 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.406 -0.809 . . . . 0.0 110.659 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.6 m-70 -125.98 42.87 3.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.157 -0.964 . . . . 0.0 111.666 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 58' ' ' THR . . . -155.2 -175.39 26.2 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 119.166 -1.492 . . . . 0.0 109.741 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.593 ' C ' HG23 ' A' ' 58' ' ' THR . 16.8 t -128.37 178.62 6.15 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.472 ' O ' HD13 ' A' ' 65' ' ' ILE . . . -114.11 67.45 0.26 Allowed Glycine 1 C--N 1.253 -4.062 0 N-CA-C 107.42 -2.272 . . . . 0.0 107.42 178.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.472 HD13 ' O ' ' A' ' 64' ' ' GLY . 25.1 mm -133.25 84.41 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-N 114.11 -1.045 . . . . 0.0 108.413 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.826 HG12 ' HB2' ' A' ' 173' ' ' CYS . 29.4 m -103.65 152.55 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.55 -0.719 . . . . 0.0 111.591 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 171' ' ' VAL . 5.3 t -77.55 122.08 24.77 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.457 -0.897 . . . . 0.0 109.081 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.666 ' HG ' HG13 ' A' ' 137' ' ' VAL . 3.1 mm? -87.21 126.24 34.69 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 122.174 0.988 . . . . 0.0 109.404 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.45 ' HB3' ' HA ' ' A' ' 158' ' ' ILE . 3.6 m -89.59 125.08 35.09 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.763 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.52 ' N ' HD13 ' A' ' 158' ' ' ILE . 16.7 tt -138.74 129.46 34.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.083 -1.01 . . . . 0.0 109.853 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.425 ' OG1' ' CG1' ' A' ' 158' ' ' ILE . 1.2 m -89.22 160.37 16.98 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.095 -1.003 . . . . 0.0 109.942 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.443 ' HA ' ' NH1' ' A' ' 75' ' ' ARG . 9.1 pt-20 -50.9 -24.42 3.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.442 -0.786 . . . . 0.0 110.142 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.47 -32.9 19.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 0.0 110.041 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.42 ' HB3' HG13 ' A' ' 70' ' ' ILE . 0.0 OUTLIER -62.61 -49.7 74.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.261 -0.899 . . . . 0.0 109.939 179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.464 ' CD ' ' N ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -70.91 -34.68 71.77 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.187 0.994 . . . . 0.0 108.565 179.113 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.649 ' O ' ' N ' ' A' ' 79' ' ' ASP . 3.0 tttp -53.38 -66.17 0.44 Allowed 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -46.34 -32.7 3.33 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 124.039 0.837 . . . . 0.0 109.431 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.628 HD11 HD22 ' A' ' 131' ' ' LEU . 0.3 OUTLIER -97.74 43.65 1.06 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 176.059 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.649 ' N ' ' O ' ' A' ' 76' ' ' LYS . 11.6 t70 -28.97 76.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 123.553 1.644 . . . . 0.0 113.031 -172.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.753 ' O ' HD23 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -151.25 100.05 3.02 Favored Pre-proline 0 C--N 1.283 -2.304 0 CA-C-N 112.765 -2.016 . . . . 0.0 110.314 177.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -106.62 92.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 N-CA-C 108.808 -1.266 . . . . 0.0 108.808 176.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.901 ' CB ' HG11 ' A' ' 97' ' ' VAL . 3.6 mtt -103.12 46.01 0.94 Allowed 'General case' 0 N--CA 1.483 1.215 0 O-C-N 120.588 -1.32 . . . . 0.0 108.723 178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -41.91 123.54 2.37 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 121.038 0.447 . . . . 0.0 110.23 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 84' ' ' VAL . 32.8 m -83.36 104.39 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 118.614 -1.235 . . . . 0.0 110.61 -178.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 87' ' ' ASN . 7.0 pt-20 -101.48 44.16 1.03 Allowed 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.502 0.668 . . . . 0.0 109.204 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -61.59 81.05 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.62 0.724 . . . . 0.0 110.982 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.442 ' O ' ' CB ' ' A' ' 88' ' ' THR . 9.3 t-20 -46.19 118.22 1.83 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.622 -0.673 . . . . 0.0 110.89 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.442 ' CB ' ' O ' ' A' ' 87' ' ' ASN . 1.9 m 74.9 -55.38 0.65 Allowed 'General case' 0 N--CA 1.507 2.401 0 O-C-N 121.736 -0.603 . . . . 0.0 110.171 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.72 -25.07 6.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.927 -1.108 . . . . 0.0 109.559 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 92' ' ' GLY . . . -144.71 125.44 14.21 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.614 -0.679 . . . . 0.0 109.414 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -68.18 67.67 0.12 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.232 -0.917 . . . . 0.0 110.724 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 90' ' ' ALA . . . 51.99 39.03 48.13 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.654 HG23 ' H ' ' A' ' 95' ' ' PHE . 10.2 t -57.61 -18.16 18.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.348 -1.089 . . . . 0.0 110.776 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.44 24.89 4.08 Favored Glycine 0 N--CA 1.498 2.785 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.654 ' H ' HG23 ' A' ' 93' ' ' THR . 0.6 OUTLIER -58.6 100.14 0.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.309 -1.113 . . . . 0.0 112.246 -178.484 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.428 ' CG2' ' O ' ' A' ' 139' ' ' PRO . 35.3 m -59.66 81.05 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.274 177.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.901 HG11 ' CB ' ' A' ' 82' ' ' MET . 7.4 p -33.48 151.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 CA-C-O 122.577 1.18 . . . . 0.0 113.085 -174.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.641 HG22 ' O ' ' A' ' 137' ' ' VAL . 51.1 p -69.67 -178.38 1.46 Allowed 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.535 -175.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.973 HD12 HD23 ' A' ' 131' ' ' LEU . 16.0 pt -146.99 131.64 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.527 ' HB2' ' HA ' ' A' ' 133' ' ' ARG . 3.6 tt0 -103.54 125.12 49.9 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.069 -1.452 . . . . 0.0 113.491 -176.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 1.061 ' HB1' ' HB1' ' A' ' 121' ' ' ALA . . . -51.37 95.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.473 -0.767 . . . . 0.0 110.855 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' A' ' 130' ' ' ASP . . . -80.5 2.63 24.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.629 -0.669 . . . . 0.0 110.14 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.414 ' CB ' ' HA ' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -86.42 15.29 5.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.078 -1.014 . . . . 0.0 110.931 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.464 ' O ' HG21 ' A' ' 117' ' ' THR . . . 127.7 25.02 1.17 Allowed Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.522 -1.323 . . . . 0.0 112.11 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.947 ' HB ' ' HB3' ' A' ' 101' ' ' ALA . 13.0 t -130.17 121.83 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.156 -1.202 . . . . 0.0 109.195 177.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 p -145.91 59.06 1.24 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.594 -1.316 . . . . 0.0 111.523 177.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.782 HG21 ' OG ' ' A' ' 110' ' ' SER . 1.6 m -138.91 -31.97 0.7 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.805 -1.184 . . . . 0.0 110.983 176.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.23 -32.25 1.12 Allowed Glycine 0 N--CA 1.494 2.527 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.14 57.21 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 120.733 -1.451 . . . . 0.0 109.375 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.782 ' OG ' HG21 ' A' ' 107' ' ' THR . 1.2 m -129.87 57.44 1.68 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.201 -0.937 . . . . 0.0 109.257 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.506 ' HB1' ' HG3' ' A' ' 55' ' ' MET . . . -34.81 -29.85 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -178.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.46 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -82.41 -74.86 0.33 Allowed 'General case' 0 C--N 1.294 -1.843 0 O-C-N 121.063 -1.023 . . . . 0.0 110.157 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 53.6 m-20 -67.07 -15.62 63.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.564 -0.71 . . . . 0.0 110.87 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.661 ' HG2' HG21 ' A' ' 118' ' ' VAL . 51.2 ttt85 -87.84 -46.79 9.12 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.057 -1.027 . . . . 0.0 110.032 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 1.051 HD12 HG22 ' A' ' 52' ' ' VAL . 35.1 mt -66.07 -10.96 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.679 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.7 m -87.69 -52.5 5.28 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.728 ' CB ' HG22 ' A' ' 105' ' ' VAL . 9.3 p -72.62 -42.9 63.96 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.692 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.772 ' CG2' HG11 ' A' ' 105' ' ' VAL . 47.6 t -57.19 -43.45 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 120.876 -1.14 . . . . 0.0 108.811 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.582 ' O ' ' HB3' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -49.33 -39.38 31.29 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.348 -0.845 . . . . 0.0 109.307 178.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.74 -11.62 24.8 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.709 -0.619 . . . . 0.0 111.043 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 1.061 ' HB1' ' HB1' ' A' ' 101' ' ' ALA . . . -97.25 -59.93 1.69 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.857 -1.152 . . . . 0.0 112.68 -177.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.64 HG23 ' HA ' ' A' ' 48' ' ' GLU . 19.1 tt -66.7 -19.8 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 O-C-N 120.41 -1.431 . . . . 0.0 108.849 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.774 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . . . -106.58 72.49 0.91 Allowed 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.506 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.452 ' HB3' ' CG ' ' A' ' 127' ' ' LYS . 11.8 t0 -98.41 -53.1 3.43 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.335 1.064 . . . . 0.0 110.077 178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 124.08 -37.28 2.71 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 106.169 -2.773 . . . . 0.0 106.169 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -132.98 100.51 4.91 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.945 ' HE2' HD13 ' A' ' 131' ' ' LEU . 23.4 mtpp -130.98 54.55 15.08 Favored Pre-proline 0 C--N 1.307 -1.242 0 O-C-N 120.773 -1.204 . . . . 0.0 110.92 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 127' ' ' LYS . 44.1 Cg_endo -72.05 -26.47 18.28 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 N-CA-C 106.921 -1.992 . . . . 0.0 106.921 176.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -123.79 -18.09 6.15 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.043 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.452 ' HB3' ' NZ ' ' A' ' 127' ' ' LYS . 27.6 m-20 -78.24 9.82 3.5 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.8 -1.187 . . . . 0.0 112.27 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.973 HD23 HD12 ' A' ' 99' ' ' ILE . 2.6 tp -135.08 89.62 2.54 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.882 -1.136 . . . . 0.0 108.566 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.506 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 36.4 p-10 -116.38 107.6 15.01 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.373 -0.829 . . . . 0.0 111.933 -178.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.803 ' HB2' ' HA ' ' A' ' 134' ' ' PRO 0.269 4.9 ppt_? -82.89 179.93 1.74 Allowed Pre-proline 0 N--CA 1.499 1.976 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.646 -177.525 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.803 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 48.8 Cg_endo -71.68 124.96 9.07 Favored 'Cis proline' 0 N--CA 1.504 2.122 0 C-N-CA 123.352 -1.52 . . . . 0.0 112.299 8.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.853 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -123.98 39.9 2.06 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 53.1 m80 31.21 38.22 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 122.162 0.982 . . . . 0.0 111.914 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 135' ' ' GLY . 54.5 t -126.85 103.11 10.64 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 104.136 -2.542 . . . . 0.0 104.136 176.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.505 ' CA ' HG22 ' A' ' 98' ' ' THR . 6.3 p90 -107.52 89.35 4.93 Favored Pre-proline 0 N--CA 1.492 1.659 0 C-N-CA 118.417 -1.313 . . . . 0.0 111.962 -175.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 56.0 Cg_endo -77.34 124.42 7.13 Favored 'Trans proline' 0 C--N 1.317 -1.116 0 O-C-N 124.125 1.592 . . . . 0.0 110.366 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.583 HD23 HG23 ' A' ' 154' ' ' THR . 1.1 tp -102.65 126.53 49.78 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.42 ' HA ' HG23 ' A' ' 70' ' ' ILE . 56.3 ttp85 -63.64 117.91 7.48 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.061 -1.024 . . . . 0.0 109.958 -178.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.84 ' O ' HG21 ' A' ' 158' ' ' ILE . . . -130.03 134.17 47.22 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.578 -0.701 . . . . 0.0 110.516 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.421 ' C ' HG21 ' A' ' 158' ' ' ILE . 0.3 OUTLIER -56.26 133.03 52.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.829 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.692 ' HA ' HG23 ' A' ' 158' ' ' ILE . . . -81.87 115.2 20.96 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.408 -0.807 . . . . 0.0 111.173 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.472 ' CA ' ' NH2' ' A' ' 209' ' ' ARG . . . 86.63 -8.01 77.05 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.56 13.98 60.89 Favored Glycine 0 N--CA 1.483 1.815 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.707 ' CG2' ' HB2' ' A' ' 156' ' ' ALA . 7.6 p -59.7 -14.3 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.931 -1.335 . . . . 0.0 109.971 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.568 ' CD2' HG12 ' A' ' 206' ' ' VAL . 1.0 OUTLIER -92.17 20.13 6.24 Favored 'General case' 0 C--O 1.21 -1.004 0 C-N-CA 116.479 -2.088 . . . . 0.0 110.731 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.6 m -129.39 58.49 1.62 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 101.935 -3.357 . . . . 0.0 101.935 168.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.456 ' HG3' ' CG ' ' A' ' 155' ' ' GLU . 0.2 OUTLIER -153.76 146.11 23.93 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 113.486 -1.688 . . . . 0.0 111.903 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -103.95 34.72 5.55 Favored Glycine 0 N--CA 1.481 1.683 0 N-CA-C 106.124 -2.79 . . . . 0.0 106.124 173.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -145.34 165.98 27.74 Favored Glycine 0 N--CA 1.479 1.501 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.678 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 2.3 p-80 -90.84 -6.04 54.79 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.921 -0.752 . . . . 0.0 109.484 176.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.583 HG23 HD23 ' A' ' 140' ' ' LEU . 62.6 m -56.17 -61.71 2.2 Favored 'General case' 0 N--CA 1.5 2.073 0 CA-C-O 122.54 1.162 . . . . 0.0 109.353 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.824 ' HA ' ' HB1' ' A' ' 142' ' ' ALA . 9.2 mp0 -57.89 -20.75 39.23 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.707 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . . . -83.35 1.73 39.78 Favored 'General case' 0 C--O 1.201 -1.478 0 O-C-N 121.602 -0.686 . . . . 0.0 109.929 177.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 153' ' ' HIS . 68.8 p -82.2 -51.19 8.18 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 178.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.84 HG21 ' O ' ' A' ' 142' ' ' ALA . 3.8 tp -65.76 -31.58 54.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.537 ' OD2' HG12 ' A' ' 147' ' ' VAL . 0.4 OUTLIER -80.56 -18.41 48.46 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 177.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.965 HD13 HD22 ' A' ' 172' ' ' LEU . 1.2 mt -63.41 -37.64 88.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.038 -1.039 . . . . 0.0 110.375 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.582 ' HE3' ' CB ' ' A' ' 166' ' ' PHE . 88.7 mmm -81.53 -27.74 34.28 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.64 HG21 HH21 ' A' ' 209' ' ' ARG . 3.6 m -66.3 -48.79 69.23 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 1.081 HD13 HD21 ' A' ' 205' ' ' LEU . 4.2 pp -72.57 -4.83 33.12 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.369 -0.832 . . . . 0.0 109.328 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.774 ' C ' HD11 ' A' ' 20' ' ' LEU . . . -108.06 18.85 20.71 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.662 -1.274 . . . . 0.0 109.983 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 59.14 41.86 96.82 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 107.337 -2.305 . . . . 0.0 107.337 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.582 ' CB ' ' HE3' ' A' ' 161' ' ' MET . 1.5 m-85 -138.49 139.29 38.72 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.925 0.869 . . . . 0.0 111.134 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -50.2 134.23 23.49 Favored Pre-proline 0 N--CA 1.498 1.965 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 177.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.579 ' O ' HD11 ' A' ' 158' ' ' ILE . 37.3 Cg_endo -64.81 84.46 0.17 Allowed 'Trans proline' 0 C--N 1.298 -2.114 0 C-N-CA 116.593 -1.805 . . . . 0.0 112.911 -174.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' ' 47' ' ' ALA . . . -156.81 111.72 2.81 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 101.399 -3.556 . . . . 0.0 101.399 173.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.63 ' N ' ' HB2' ' A' ' 47' ' ' ALA . . . -157.73 167.76 34.23 Favored Glycine 0 N--CA 1.486 1.996 0 C-N-CA 116.454 -2.784 . . . . 0.0 113.314 -174.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.776 HG22 ' O ' ' A' ' 45' ' ' PHE . 28.5 m -112.46 156.49 13.48 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 177.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.965 HD22 HD13 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -157.68 114.0 2.88 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.826 ' HB2' HG12 ' A' ' 66' ' ' VAL . 34.1 t -130.66 162.25 29.82 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 120.569 -1.332 . . . . 0.0 112.05 -178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.27 -169.06 1.45 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.199 -0.938 . . . . 0.0 109.491 178.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 1.089 HD21 ' HB2' ' A' ' 192' ' ' ALA . 5.2 mt -63.67 90.88 0.06 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.89 -1.132 . . . . 0.0 109.582 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 63' ' ' SER . 3.2 p -110.09 95.13 5.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.074 -1.016 . . . . 0.0 110.36 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -97.86 171.08 8.52 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.11 -0.994 . . . . 0.0 110.138 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -91.34 6.0 47.06 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.37 -0.831 . . . . 0.0 111.207 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.05 12.69 29.66 Favored 'General case' 0 C--N 1.289 -2.037 0 O-C-N 121.597 -0.689 . . . . 0.0 110.376 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 65.45 32.73 84.39 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 183' ' ' ALA . 78.5 p -81.95 98.96 8.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -1.121 . . . . 0.0 110.167 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 1.7 mmm -63.83 80.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.215 -0.928 . . . . 0.0 110.178 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' A' ' 175' ' ' LEU . . . -57.7 124.43 19.1 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.27 -0.894 . . . . 0.0 110.163 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.482 ' O ' ' HB3' ' A' ' 185' ' ' ALA . 3.9 mtt180 -136.8 161.68 35.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.353 -0.842 . . . . 0.0 110.333 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.482 ' HB3' ' O ' ' A' ' 184' ' ' ARG . . . 60.85 160.02 0.11 Allowed Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.349 -0.844 . . . . 0.0 110.871 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.591 ' HA ' HG22 ' A' ' 189' ' ' ILE . 44.5 Cg_endo -70.4 -26.76 24.23 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.739 1.389 . . . . 0.0 110.578 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -60.66 -34.98 75.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.089 -1.007 . . . . 0.0 109.864 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . 0.466 ' O ' HD11 ' A' ' 175' ' ' LEU . 5.4 t -74.59 -53.99 8.33 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.362 -0.836 . . . . 0.0 110.218 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.739 HG23 HD22 ' A' ' 199' ' ' LEU . 9.6 tp -62.02 -25.08 36.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 O-C-N 120.653 -1.279 . . . . 0.0 107.644 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.578 ' O ' ' CB ' ' A' ' 194' ' ' LYS . 36.8 tt0 -64.65 -33.74 76.64 Favored 'General case' 0 C--O 1.194 -1.822 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.313 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.422 ' CD1' ' C ' ' A' ' 191' ' ' PHE . 0.0 OUTLIER -57.65 -54.94 41.18 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.349 -1.469 . . . . 0.0 108.925 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 1.089 ' HB2' HD21 ' A' ' 175' ' ' LEU . . . -69.87 -44.83 69.01 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 119.727 -0.789 . . . . 0.0 111.707 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . 0.753 ' HB2' HD21 ' A' ' 199' ' ' LEU . 1.6 m-20 -82.19 -29.99 31.17 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 119.061 -1.056 . . . . 0.0 112.902 -177.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.578 ' CB ' ' O ' ' A' ' 190' ' ' GLU . 15.6 tttt -55.42 -36.64 66.69 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.462 -1.399 . . . . 0.0 109.384 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.445 ' CE1' ' SD ' ' A' ' 1' ' ' MET . 24.0 m80 -81.8 -52.83 6.73 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 116.116 -2.234 . . . . 0.0 111.781 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.468 ' O ' ' CG ' ' A' ' 197' ' ' MET . 89.4 m-20 -115.58 28.34 8.73 Favored 'General case' 0 N--CA 1.51 2.571 0 C-N-CA 117.073 -1.851 . . . . 0.0 115.254 177.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' MET . . . . . 0.891 ' HE3' HD13 ' A' ' 57' ' ' LEU . 0.8 OUTLIER -160.21 149.96 17.93 Favored 'General case' 0 N--CA 1.514 2.745 0 CA-C-N 121.991 2.178 . . . . 0.0 113.613 179.267 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.816 ' CB ' HD12 ' A' ' 6' ' ' LEU . . . -86.73 148.51 25.4 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.416 -1.428 . . . . 0.0 108.482 175.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.776 HD23 ' HB3' ' A' ' 30' ' ' MET . 4.1 mt -122.72 144.3 49.24 Favored 'General case' 0 N--CA 1.511 2.62 0 O-C-N 120.264 -1.523 . . . . 0.0 111.639 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.836 ' O ' HD23 ' A' ' 32' ' ' LEU . 3.4 p -149.94 -178.92 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.269 -0.894 . . . . 0.0 110.179 178.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.581 ' H ' HG22 ' A' ' 200' ' ' VAL . 23.5 p -105.54 179.84 4.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.077 -1.014 . . . . 0.0 110.849 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.724 ' HB ' HG22 ' A' ' 31' ' ' VAL . 4.5 tt -111.96 -32.51 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.446 -0.784 . . . . 0.0 110.349 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.89 -65.06 0.62 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.108 -0.995 . . . . 0.0 110.528 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -75.82 -35.78 59.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.294 -0.879 . . . . 0.0 110.442 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 1.081 HD21 HD13 ' A' ' 163' ' ' LEU . 6.3 tt -52.92 -43.61 66.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.096 -1.003 . . . . 0.0 110.285 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.632 HG13 HG13 ' A' ' 147' ' ' VAL . 1.0 OUTLIER -71.08 -40.35 75.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 O-C-N 120.965 -1.084 . . . . 0.0 108.456 -179.375 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.419 ' HA ' ' CD2' ' A' ' 148' ' ' LEU . . . -55.72 -23.82 31.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.074 -1.016 . . . . 0.0 108.497 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.676 ' CD2' HG11 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -75.81 -35.92 59.87 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.09 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.64 HH21 HG21 ' A' ' 162' ' ' THR . 2.3 tmt_? -55.49 -44.14 76.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.834 . . . . 0.0 109.627 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.501 ' HG3' HD13 ' A' ' 148' ' ' LEU . 0.4 OUTLIER -68.65 -37.31 79.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.432 -0.793 . . . . 0.0 110.157 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -65.07 -22.98 67.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.347 -0.846 . . . . 0.0 110.173 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -88.05 -22.0 24.44 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.303 -0.873 . . . . 0.0 110.18 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -106.47 9.56 31.62 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.219 -0.926 . . . . 0.0 110.68 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.89 147.08 51.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.998 -1.064 . . . . 0.0 110.125 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -122.92 126.91 48.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.9 . . . . 0.0 110.223 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -83.41 -22.56 32.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 110.193 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.221 179.979 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mmt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.287 0.565 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -110.96 55.83 0.64 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.249 -0.907 . . . . 0.0 110.222 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.417 ' HB2' ' HA ' ' A' ' 194' ' ' LYS . 1.3 tt0 -90.27 -34.38 15.78 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.226 -0.921 . . . . 0.0 110.186 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.7 t -93.18 -4.99 51.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.392 -0.818 . . . . 0.0 110.721 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 5' ' ' LEU . 0.2 OUTLIER -52.36 -41.46 63.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.034 -1.041 . . . . 0.0 110.401 -179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.922 HD11 ' HB1' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -116.13 18.22 15.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 110.392 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -47.0 -29.79 2.27 Favored 'General case' 0 N--CA 1.512 2.67 0 O-C-N 120.738 -1.227 . . . . 0.0 109.431 179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.437 ' O ' ' CB ' ' A' ' 15' ' ' ARG . 2.6 m -87.97 38.98 0.87 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.611 ' O ' HG23 ' A' ' 201' ' ' THR . 18.5 p90 -67.26 44.25 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 -172.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -166.38 76.44 0.13 Allowed Glycine 0 C--N 1.285 -2.278 0 N-CA-C 107.323 -2.311 . . . . 0.0 107.323 169.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.618 ' O ' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -151.35 90.72 4.0 Favored Pre-proline 0 C--N 1.291 -1.946 0 N-CA-C 100.527 -3.879 . . . . 0.0 100.527 173.277 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.512 ' CB ' ' HB2' ' A' ' 208' ' ' TYR . 22.5 Cg_endo -46.6 -40.48 23.77 Favored 'Trans proline' 0 C--N 1.283 -2.875 0 O-C-N 123.048 1.025 . . . . 0.0 111.736 -172.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.438 ' O ' ' CB ' ' A' ' 17' ' ' GLU . 14.1 m-85 -93.54 -37.2 12.03 Favored 'General case' 0 C--N 1.278 -2.511 0 C-N-CA 119.24 -0.984 . . . . 0.0 113.504 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -79.25 -63.33 1.44 Allowed 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.606 -1.238 . . . . 0.0 112.635 -176.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.711 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 1.8 tpt180 -90.84 -14.94 30.86 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 118.746 -1.182 . . . . 0.0 111.929 -178.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.994 HG11 ' HB2' ' A' ' 205' ' ' LEU . 2.3 t -98.81 -19.0 6.08 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.66 0 C-N-CA 116.359 -2.136 . . . . 0.0 109.615 178.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 13' ' ' PHE . 3.7 tt0 -83.26 -41.5 18.27 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 176.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -74.04 -22.38 59.57 Favored 'General case' 0 C--N 1.307 -1.239 0 O-C-N 121.749 -0.595 . . . . 0.0 109.504 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.922 ' HB1' HD11 ' A' ' 6' ' ' LEU . . . -75.52 -51.94 11.78 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.016 -1.052 . . . . 0.0 108.992 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.892 HD22 ' OH ' ' A' ' 208' ' ' TYR . 0.4 OUTLIER -49.48 -33.23 13.85 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.442 -0.786 . . . . 0.0 109.8 179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.488 ' HA ' ' HB2' ' A' ' 24' ' ' ARG . . . -78.0 -68.41 0.63 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-O 121.972 0.891 . . . . 0.0 109.614 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.92 -29.2 1.9 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.495 -0.753 . . . . 0.0 110.135 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.499 ' CB ' ' HB ' ' A' ' 29' ' ' VAL . 1.9 mm? -101.09 -15.37 17.43 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.594 -0.842 . . . . 0.0 109.799 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.488 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -50.23 -24.47 2.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.079 -1.013 . . . . 0.0 108.571 178.286 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.73 42.76 1.11 Allowed 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 118.49 -1.284 . . . . 0.0 110.35 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.518 ' HA2' ' CZ ' ' A' ' 45' ' ' PHE . . . 55.2 25.91 41.33 Favored Glycine 0 C--N 1.291 -1.934 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 176.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.443 ' C ' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -88.23 17.6 5.03 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 116.36 -2.136 . . . . 0.0 110.97 -179.711 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 198' ' ' ALA . . . 96.69 108.87 2.54 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 118.893 -1.622 . . . . 0.0 115.113 172.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.039 HG22 HD12 ' A' ' 44' ' ' ILE . 5.8 p -140.69 124.88 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-N 119.539 1.669 . . . . 0.0 108.345 175.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.839 ' HB2' HD23 ' A' ' 199' ' ' LEU . 0.5 OUTLIER -109.03 158.59 17.59 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.869 -1.145 . . . . 0.0 113.312 -177.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.893 HG21 HD21 ' A' ' 160' ' ' LEU . 0.9 OUTLIER -124.87 110.01 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.541 -0.724 . . . . 0.0 109.3 178.125 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.725 HD21 ' HA ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -176.44 154.59 1.31 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.254 -0.904 . . . . 0.0 110.199 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -154.06 -61.9 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.256 -0.903 . . . . 0.0 110.18 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -103.03 158.58 16.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.938 . . . . 0.0 110.215 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.403 ' HA ' ' OD1' ' A' ' 39' ' ' ASN . 4.0 pt-20 -56.8 136.96 55.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.21 -0.931 . . . . 0.0 110.184 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 38' ' ' GLU . 3.9 t0 -167.82 74.62 0.13 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.913 . . . . 0.0 110.28 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 57.7 -85.56 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.368 -0.833 . . . . 0.0 110.456 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -85.57 112.22 20.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.014 -1.054 . . . . 0.0 110.208 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.725 ' HA ' HD21 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -108.43 54.46 0.66 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.192 -0.942 . . . . 0.0 110.113 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.927 ' HB2' HD13 ' A' ' 189' ' ' ILE . 0.0 OUTLIER -176.35 127.01 0.2 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.166 -0.959 . . . . 0.0 110.17 -179.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 30' ' ' MET . . . -170.46 64.05 0.17 Allowed Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.556 -1.307 . . . . 0.0 110.758 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.517 ' HB2' ' CB ' ' A' ' 174' ' ' GLU . 0.7 OUTLIER -68.85 -8.0 39.73 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.526 -0.985 . . . . 0.0 111.597 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.593 ' C ' ' H ' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -95.34 53.92 1.56 Allowed 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -178.29 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.039 HD12 HG22 ' A' ' 29' ' ' VAL . 94.2 mt -61.22 19.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.527 3.391 0 O-C-N 120.428 -1.42 . . . . 0.0 111.991 -179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.593 ' H ' ' C ' ' A' ' 43' ' ' MET . 22.4 m-85 -85.06 165.09 38.69 Favored Pre-proline 0 C--N 1.291 -1.952 0 O-C-N 120.972 -1.08 . . . . 0.0 112.341 -177.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.503 ' HD3' ' CD2' ' A' ' 166' ' ' PHE . 40.8 Cg_endo -62.79 133.53 42.41 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 122.444 2.096 . . . . 0.0 114.106 -176.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.481 ' HB1' HD13 ' A' ' 68' ' ' LEU . . . -69.22 -2.7 11.2 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.263 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 15.7 tt0 -80.1 -14.99 58.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.906 -1.121 . . . . 0.0 109.653 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.526 ' O ' HG23 ' A' ' 49' ' ' THR . 6.3 t -130.81 58.99 1.68 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 177.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.515 ' HE1' HD11 ' A' ' 68' ' ' LEU . 15.3 ttm -51.53 88.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.673 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.499 ' HA ' HG13 ' A' ' 115' ' ' ILE . 3.2 m -64.65 157.45 27.16 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.693 0.759 . . . . 0.0 110.267 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 1.038 HG23 ' HB1' ' A' ' 111' ' ' ALA . 2.1 p -71.65 -4.87 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.655 -0.653 . . . . 0.0 109.907 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -55.15 -31.41 61.3 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.795 -1.19 . . . . 0.0 108.445 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.928 ' HA ' HD23 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -87.77 -38.27 15.9 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.19 179.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.844 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -71.87 -40.02 69.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.817 -1.177 . . . . 0.0 109.275 179.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.651 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -62.3 -47.08 85.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.558 -0.714 . . . . 0.0 110.772 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.928 HD23 ' HA ' ' A' ' 54' ' ' GLN . 0.8 OUTLIER -57.05 -34.14 67.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.079 -1.013 . . . . 0.0 110.987 -179.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.477 ' CA ' ' O ' ' A' ' 62' ' ' GLY . 33.2 p -79.54 -46.72 16.82 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.19 -0.944 . . . . 0.0 111.139 -178.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.0 mt -54.22 -20.42 4.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 O-C-N 121.094 -1.004 . . . . 0.0 110.28 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.502 ' HB3' ' CE1' ' A' ' 61' ' ' HIS . 2.9 mtp180 -97.92 -44.56 6.64 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.158 -0.964 . . . . 0.0 113.169 -178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.502 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 48.5 m80 -125.43 -17.84 5.47 Favored 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -176.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.477 ' O ' ' CA ' ' A' ' 58' ' ' THR . . . -165.18 -169.09 28.34 Favored Glycine 0 N--CA 1.503 3.129 0 C-N-CA 119.003 -1.57 . . . . 0.0 110.708 -177.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.6 t -143.1 96.37 2.91 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 102.27 -3.233 . . . . 0.0 102.27 175.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.42 ' H ' HG22 ' A' ' 58' ' ' THR . . . -136.35 72.38 0.46 Allowed Glycine 0 C--N 1.26 -3.681 1 N-CA-C 101.97 -4.452 . . . . 0.0 101.97 178.734 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.441 ' CG2' ' CE2' ' A' ' 138' ' ' PHE . 38.7 mt -60.14 145.28 12.04 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.816 0 CA-C-N 113.613 -1.293 . . . . 0.0 110.067 -176.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.809 HG12 ' CB ' ' A' ' 173' ' ' CYS . 35.2 m -55.98 152.28 2.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.863 -177.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 171' ' ' VAL . 78.9 m -83.03 132.77 35.12 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 177.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.717 HD22 HG12 ' A' ' 171' ' ' VAL . 2.9 mm? -89.18 97.98 11.51 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 119.037 -1.065 . . . . 0.0 108.936 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.582 ' HA ' HG23 ' A' ' 157' ' ' THR . 34.3 m -64.41 125.73 25.58 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 118.776 -1.17 . . . . 0.0 109.794 -178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.543 ' CA ' HD13 ' A' ' 158' ' ' ILE . 15.2 tt -133.23 146.88 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.017 -1.052 . . . . 0.0 109.823 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.624 HG23 HG12 ' A' ' 158' ' ' ILE . 0.3 OUTLIER -108.62 151.97 25.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.231 -0.918 . . . . 0.0 109.643 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 76' ' ' LYS . 18.4 tt0 -50.25 -24.68 3.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.264 -0.897 . . . . 0.0 110.053 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -88.23 -38.24 15.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.323 -0.861 . . . . 0.0 109.969 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.851 ' O ' HD12 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -62.11 -52.45 63.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.346 -0.846 . . . . 0.0 109.562 179.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.625 HH21 HG23 ' A' ' 96' ' ' THR . 0.5 OUTLIER -62.84 -40.85 98.7 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 122.112 0.958 . . . . 0.0 108.784 179.031 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.63 ' O ' ' N ' ' A' ' 79' ' ' ASP . 7.9 tttm -49.53 -62.04 1.77 Allowed 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -47.66 -31.3 4.48 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 121.884 0.849 . . . . 0.0 108.945 176.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.851 HD12 ' O ' ' A' ' 74' ' ' ARG . 3.0 mt -96.69 44.55 1.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 175.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.63 ' N ' ' O ' ' A' ' 76' ' ' LYS . 20.9 t0 -26.81 78.74 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 123.85 1.786 . . . . 0.0 112.893 -172.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.641 HD21 HG22 ' A' ' 99' ' ' ILE . 0.2 OUTLIER -150.77 106.36 3.06 Favored Pre-proline 0 C--N 1.286 -2.189 0 CA-C-N 112.315 -2.221 . . . . 0.0 110.181 177.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -92.07 94.06 0.19 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 N-CA-C 107.852 -1.634 . . . . 0.0 107.852 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.556 ' SD ' HG21 ' A' ' 97' ' ' VAL . 2.8 mmt -99.63 44.45 1.02 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.16 -0.962 . . . . 0.0 109.875 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.3 tpt -68.51 103.07 1.58 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.053 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 95' ' ' PHE . 11.0 t -84.33 103.65 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -92.28 21.72 5.0 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.287 -0.883 . . . . 0.0 112.264 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.434 ' HB2' ' HA3' ' A' ' 92' ' ' GLY . 0.6 OUTLIER -68.52 82.15 0.26 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.996 -1.065 . . . . 0.0 108.326 178.293 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 26.7 m120 -43.11 104.76 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.476 -0.765 . . . . 0.0 112.028 -177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.683 HG21 ' CB ' ' A' ' 91' ' ' TYR . 10.0 m -164.11 166.57 21.17 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.77 -0.581 . . . . 0.0 109.481 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.0 t -59.97 -60.84 3.19 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.921 -1.112 . . . . 0.0 109.903 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -127.03 20.34 6.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.333 -0.854 . . . . 0.0 109.595 179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.683 ' CB ' HG21 ' A' ' 88' ' ' THR . 0.4 OUTLIER -114.63 82.38 1.71 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.539 -0.726 . . . . 0.0 110.066 -179.645 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.474 ' HA2' ' CG1' ' A' ' 84' ' ' VAL . . . 82.86 40.87 9.13 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.444 -1.063 . . . . 0.0 110.444 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.509 ' O ' HG23 ' A' ' 93' ' ' THR . 10.1 t -71.37 53.52 0.2 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.848 -0.795 . . . . 0.0 110.479 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 84' ' ' VAL . . . 55.86 24.72 42.6 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 -176.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.699 ' O ' HG23 ' A' ' 84' ' ' VAL . 0.5 OUTLIER -60.81 103.06 0.23 Allowed 'General case' 0 N--CA 1.486 1.329 0 O-C-N 122.136 -0.626 . . . . 0.0 112.661 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.625 HG23 HH21 ' A' ' 75' ' ' ARG . 2.8 m -59.25 79.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 176.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.589 HG11 ' HD3' ' A' ' 133' ' ' ARG . 18.8 t -35.47 151.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 CA-C-O 123.023 1.392 . . . . 0.0 113.412 -173.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.765 HG23 ' HA ' ' A' ' 134' ' ' PRO . 0.7 OUTLIER -69.64 179.5 2.12 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 113.793 -1.549 . . . . 0.0 113.157 -176.187 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.764 HD12 HD13 ' A' ' 131' ' ' LEU . 19.8 pt -141.9 131.81 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -177.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.514 ' CB ' ' O ' ' A' ' 132' ' ' ASN . 1.6 tm-20 -111.81 133.94 53.69 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 117.758 -1.577 . . . . 0.0 112.875 -178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.824 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . . . -52.72 93.28 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.064 -1.023 . . . . 0.0 110.039 178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.594 ' HB2' ' HB2' ' A' ' 132' ' ' ASN . . . -82.55 3.82 27.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.965 -1.084 . . . . 0.0 110.911 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -113.02 54.92 0.71 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.775 -1.203 . . . . 0.0 112.236 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.44 -36.41 2.58 Favored Glycine 0 N--CA 1.496 2.674 0 C-N-CA 118.875 -1.631 . . . . 0.0 112.42 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.824 ' HB ' ' HB3' ' A' ' 101' ' ' ALA . 0.8 OUTLIER -100.99 124.4 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 120.962 -1.316 . . . . 0.0 110.187 -178.394 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 13.2 p -145.24 61.11 1.3 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.591 -1.318 . . . . 0.0 111.422 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 p -135.3 -32.27 0.94 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.889 -1.132 . . . . 0.0 110.323 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 64.9 -30.37 0.1 Allowed Glycine 0 N--CA 1.499 2.881 0 O-C-N 121.599 -0.688 . . . . 0.0 113.238 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.3 t -128.63 57.12 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.377 -1.661 . . . . 0.0 110.38 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.495 ' O ' ' N ' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -129.43 56.94 1.68 Allowed 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.128 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 1.038 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -31.53 -32.29 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -84.28 -77.37 0.27 Allowed 'General case' 0 C--N 1.29 -1.993 0 O-C-N 120.837 -1.165 . . . . 0.0 109.558 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.18 -15.94 28.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.448 -0.782 . . . . 0.0 110.737 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.805 ' HG2' HG23 ' A' ' 118' ' ' VAL . 2.4 ttt180 -90.67 -36.73 14.18 Favored 'General case' 0 C--O 1.202 -1.416 0 O-C-N 121.001 -1.062 . . . . 0.0 110.261 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.726 HD13 ' HA ' ' A' ' 111' ' ' ALA . 0.8 OUTLIER -62.0 -15.37 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 118.417 -1.313 . . . . 0.0 108.956 -179.917 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.5 m -88.6 -55.27 3.78 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.765 ' CB ' HG13 ' A' ' 105' ' ' VAL . 53.2 p -67.49 -14.0 62.54 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.424 178.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.805 HG23 ' HG2' ' A' ' 114' ' ' ARG . 2.6 t -73.66 -48.64 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.431 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -50.52 -36.2 33.02 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.607 -0.837 . . . . 0.0 109.132 178.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.704 ' HA ' ' HB3' ' A' ' 123' ' ' ALA . . . -96.44 -13.8 22.86 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.281 0.563 . . . . 0.0 110.476 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.802 ' HB1' ' HB2' ' A' ' 101' ' ' ALA . . . -55.58 -56.48 19.82 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.252 -0.905 . . . . 0.0 109.773 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 19.1 tt -93.69 14.47 2.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 118.677 -1.209 . . . . 0.0 110.243 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.704 ' HB3' ' HA ' ' A' ' 120' ' ' ALA . . . -108.83 72.38 0.82 Allowed 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 118.973 -1.091 . . . . 0.0 111.136 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.485 ' HB2' ' HZ2' ' A' ' 127' ' ' LYS . 5.1 t70 -99.3 -35.61 9.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.998 -1.064 . . . . 0.0 110.381 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 106.04 -38.37 3.34 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 105.28 -3.128 . . . . 0.0 105.28 -176.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -133.34 98.86 4.35 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.485 ' HZ2' ' HB2' ' A' ' 124' ' ' ASP . 5.4 tptt -132.33 52.94 9.91 Favored Pre-proline 0 C--N 1.307 -1.28 0 O-C-N 120.767 -1.208 . . . . 0.0 110.86 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 127' ' ' LYS . 49.4 Cg_endo -78.0 -35.65 1.31 Allowed 'Trans proline' 0 C--N 1.3 -2.009 0 N-CA-C 106.911 -1.996 . . . . 0.0 106.911 176.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 11.4 t -126.71 -0.29 6.74 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.345 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.448 ' HB3' ' CD ' ' A' ' 127' ' ' LYS . 0.8 OUTLIER -77.4 9.4 3.26 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.634 -1.292 . . . . 0.0 112.718 -177.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.764 HD13 HD12 ' A' ' 99' ' ' ILE . 29.7 mt -117.87 124.89 49.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.716 -1.24 . . . . 0.0 109.337 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.594 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 1.3 m-80 -116.85 93.58 4.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.089 -1.007 . . . . 0.0 112.952 -177.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.785 ' HB2' ' HA ' ' A' ' 134' ' ' PRO 0.274 0.0 OUTLIER -80.71 172.12 10.6 Favored Pre-proline 0 N--CA 1.501 2.101 0 O-C-N 121.815 -0.553 . . . . 0.0 110.72 -179.556 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.785 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 48.2 Cg_endo -73.14 129.75 18.44 Favored 'Cis proline' 0 N--CA 1.502 1.995 0 C-N-CA 123.043 -1.649 . . . . 0.0 112.559 7.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.637 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -123.6 47.31 1.03 Allowed Glycine 0 N--CA 1.498 2.772 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 135' ' ' GLY . 49.6 m80 31.19 38.1 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 122.143 0.973 . . . . 0.0 112.07 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.67 HG13 ' HG ' ' A' ' 68' ' ' LEU . 31.3 t -129.43 92.44 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 176.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.462 ' CD1' ' O ' ' A' ' 138' ' ' PHE . 10.4 p90 -107.09 101.91 40.45 Favored Pre-proline 0 N--CA 1.495 1.797 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.218 -176.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 68' ' ' LEU . 53.2 Cg_endo -98.38 155.59 0.78 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.785 1.413 . . . . 0.0 111.078 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.515 HD12 ' O ' ' A' ' 139' ' ' PRO . 1.3 mp -127.29 116.59 20.78 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.471 ' HA ' HG23 ' A' ' 70' ' ' ILE . 9.2 ttm180 -63.52 115.66 4.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.058 -1.026 . . . . 0.0 110.696 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.997 ' HB2' HG22 ' A' ' 154' ' ' THR . . . -130.67 135.5 47.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.765 -0.584 . . . . 0.0 110.13 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.417 ' O ' ' HG3' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -53.38 143.23 19.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.941 -1.099 . . . . 0.0 110.092 -179.642 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.556 ' HB2' HG23 ' A' ' 158' ' ' ILE . . . -100.4 115.76 30.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.502 -0.749 . . . . 0.0 111.622 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.417 ' N ' ' OD2' ' A' ' 159' ' ' ASP . . . 104.02 -15.0 52.05 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.77 13.1 57.9 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.994 HG21 ' HB2' ' A' ' 156' ' ' ALA . 7.2 p -65.52 -9.09 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 O-C-N 121.095 -1.239 . . . . 0.0 110.276 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.888 HD22 HG13 ' A' ' 147' ' ' VAL . 4.0 mm? -87.82 15.92 6.47 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 115.683 -2.407 . . . . 0.0 110.079 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.0 m -131.11 60.94 1.65 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 100.937 -3.727 . . . . 0.0 100.937 167.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.78 140.03 22.23 Favored 'General case' 0 C--N 1.281 -2.389 0 CA-C-N 113.876 -1.511 . . . . 0.0 112.774 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -104.03 34.83 5.47 Favored Glycine 0 N--CA 1.482 1.749 0 N-CA-C 106.44 -2.664 . . . . 0.0 106.44 173.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.3 160.88 27.92 Favored Glycine 0 N--CA 1.478 1.493 0 N-CA-C 109.371 -1.491 . . . . 0.0 109.371 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.604 ' HB3' HD11 ' A' ' 202' ' ' ILE . 4.4 p-80 -90.0 -5.5 56.6 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.653 -0.91 . . . . 0.0 109.309 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.997 HG22 ' HB2' ' A' ' 142' ' ' ALA . 6.3 m -54.54 -59.22 4.98 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.076 -1.015 . . . . 0.0 109.437 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.834 ' HA ' ' HB1' ' A' ' 142' ' ' ALA . 21.2 tt0 -57.93 -22.12 47.25 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 177.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.994 ' HB2' HG21 ' A' ' 147' ' ' VAL . . . -91.38 8.04 38.15 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 121.715 -0.616 . . . . 0.0 109.377 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.582 HG23 ' HA ' ' A' ' 69' ' ' CYS . 0.6 OUTLIER -92.51 -51.69 5.0 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.375 179.377 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.713 HD11 ' O ' ' A' ' 168' ' ' PRO . 6.1 tp -72.77 -32.37 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 176.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.468 ' HB3' ' HA ' ' A' ' 156' ' ' ALA . 11.7 t0 -71.61 -22.28 61.73 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 175.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.893 HD21 HG21 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -60.22 -30.98 69.75 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.906 0.86 . . . . 0.0 109.466 179.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.525 ' HB2' ' HA ' ' A' ' 168' ' ' PRO . 37.2 mmt -83.42 -26.91 29.95 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.706 HG21 ' NE ' ' A' ' 209' ' ' ARG . 2.5 m -71.45 -36.87 71.37 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 176.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.719 ' CD2' ' HA ' ' A' ' 160' ' ' LEU . 3.9 pp -82.03 -4.2 56.24 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 119.251 -0.98 . . . . 0.0 108.698 177.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.635 ' HB2' HG22 ' A' ' 44' ' ' ILE . . . -109.52 12.1 24.6 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.38 -1.45 . . . . 0.0 109.865 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 58.5 42.49 95.94 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 -177.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.503 ' CD2' ' HD3' ' A' ' 46' ' ' PRO . 6.3 m-85 -135.41 139.98 44.58 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 122.369 1.081 . . . . 0.0 112.093 -176.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.462 ' O ' ' N ' ' A' ' 169' ' ' ALA . 5.1 mttt -48.98 136.6 13.93 Favored Pre-proline 0 N--CA 1.501 2.091 0 N-CA-C 106.125 -1.806 . . . . 0.0 106.125 177.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.713 ' O ' HD11 ' A' ' 158' ' ' ILE . 37.4 Cg_endo -63.86 84.6 0.14 Allowed 'Trans proline' 0 C--N 1.301 -1.962 0 C-N-CA 116.59 -1.806 . . . . 0.0 113.225 -173.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 46' ' ' PRO . . . -155.94 123.82 5.66 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 100.581 -3.859 . . . . 0.0 100.581 172.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.454 ' N ' ' HB2' ' A' ' 69' ' ' CYS . . . -153.64 159.56 28.74 Favored Glycine 0 N--CA 1.502 3.085 0 CA-C-N 123.869 3.031 . . . . 0.0 113.199 -174.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.717 HG12 HD22 ' A' ' 68' ' ' LEU . 2.9 m -149.65 98.8 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 118.503 -1.279 . . . . 0.0 109.601 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.827 HD11 ' CD1' ' A' ' 160' ' ' LEU . 0.1 OUTLIER -109.75 105.81 15.2 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 117.185 -1.806 . . . . 0.0 113.787 -179.506 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.876 ' SG ' HD21 ' A' ' 57' ' ' LEU . 49.5 t -137.88 159.9 40.76 Favored 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 175.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.856 ' O ' HD12 ' A' ' 189' ' ' ILE . 1.2 mm-40 174.64 85.68 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.968 0 O-C-N 119.842 -1.786 . . . . 0.0 112.689 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.938 HD21 ' HB3' ' A' ' 188' ' ' CYS . 0.3 OUTLIER -127.84 104.99 8.13 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.206 -0.934 . . . . 0.0 110.83 178.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.452 HG23 ' HB2' ' A' ' 57' ' ' LEU . 1.2 p -140.43 104.57 4.8 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.126 -0.983 . . . . 0.0 110.412 179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -98.26 147.55 24.52 Favored 'General case' 0 C--N 1.31 -1.125 0 O-C-N 120.802 -1.186 . . . . 0.0 109.132 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -82.37 5.91 18.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 111.274 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.31 15.34 13.93 Favored 'General case' 0 C--N 1.291 -1.963 0 O-C-N 121.527 -0.733 . . . . 0.0 110.42 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.481 ' HA2' ' CD2' ' A' ' 61' ' ' HIS . . . 56.19 38.78 78.93 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 6.6 m -98.18 98.31 9.62 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.341 -1.093 . . . . 0.0 111.131 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.424 ' CE ' ' O ' ' A' ' 61' ' ' HIS . 85.4 mtp -55.78 92.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.45 -0.781 . . . . 0.0 109.447 179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.732 ' HB1' ' SG ' ' A' ' 188' ' ' CYS . . . -115.41 133.91 55.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.269 -0.894 . . . . 0.0 110.879 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 185' ' ' ALA . 5.0 ttm180 -129.11 100.41 5.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -0.857 . . . . 0.0 109.442 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.913 ' HB1' ' HD2' ' A' ' 186' ' ' PRO . . . -179.85 -177.18 0.21 Allowed Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.336 -0.852 . . . . 0.0 109.298 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.913 ' HD2' ' HB1' ' A' ' 185' ' ' ALA . 42.8 Cg_endo -70.2 -23.39 28.86 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 O-C-N 123.342 1.18 . . . . 0.0 110.143 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.423 ' O ' ' CB ' ' A' ' 190' ' ' GLU . 0.4 OUTLIER -81.79 -28.24 33.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.033 -1.042 . . . . 0.0 108.56 178.601 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . 0.938 ' HB3' HD21 ' A' ' 175' ' ' LEU . 37.1 m -66.33 -51.56 56.01 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.927 HD13 ' HB2' ' A' ' 40' ' ' GLU . 8.0 tp -58.34 -27.8 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 177.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.497 ' HA ' HD11 ' A' ' 199' ' ' LEU . 1.0 OUTLIER -60.14 -25.46 65.51 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 176.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.656 ' CE2' ' HB3' ' A' ' 183' ' ' ALA . 12.9 m-30 -55.76 -57.48 11.85 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 123.296 1.522 . . . . 0.0 108.093 178.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.727 ' HB1' ' SD ' ' A' ' 197' ' ' MET . . . -64.17 -46.61 83.25 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.562 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . 0.663 ' HB3' HD11 ' A' ' 199' ' ' LEU . 1.9 t30 -65.05 -11.88 44.33 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 120.263 -0.575 . . . . 0.0 110.472 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.417 ' HA ' ' HB2' ' A' ' 3' ' ' GLN . 7.6 tmtt? -78.2 -37.11 46.37 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 117.372 -1.731 . . . . 0.0 111.06 -178.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -108.66 -54.25 2.54 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 115.684 -2.406 . . . . 0.0 111.952 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -114.67 34.63 4.67 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.322 -1.351 . . . . 0.0 113.784 177.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' MET . . . . . 0.727 ' SD ' ' HB1' ' A' ' 192' ' ' ALA . 2.2 mtt -151.42 150.63 30.67 Favored 'General case' 0 N--CA 1.518 2.949 0 CA-C-N 123.113 2.688 . . . . 0.0 115.466 -179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.668 ' HB1' HD12 ' A' ' 6' ' ' LEU . . . -110.26 147.72 33.28 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.257 -0.902 . . . . 0.0 108.779 177.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.839 HD23 ' HB2' ' A' ' 30' ' ' MET . 10.0 mt -123.51 130.58 52.9 Favored 'General case' 0 N--CA 1.511 2.585 0 O-C-N 120.277 -1.514 . . . . 0.0 111.161 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.903 HG21 HG13 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -109.3 -160.12 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 120.791 -1.193 . . . . 0.0 111.027 179.232 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.707 ' O ' HD22 ' A' ' 205' ' ' LEU . 0.6 OUTLIER -108.44 -179.92 4.01 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.422 -0.799 . . . . 0.0 110.435 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 153' ' ' HIS . 12.9 tt -106.66 -41.91 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.417 -0.802 . . . . 0.0 111.3 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.512 ' N ' HG23 ' A' ' 202' ' ' ILE . 0.2 OUTLIER -90.38 -40.52 12.02 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.991 -1.068 . . . . 0.0 111.262 -178.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 207' ' ' ALA . 0.5 OUTLIER -63.37 -45.1 92.71 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.704 -1.247 . . . . 0.0 110.441 -179.454 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.994 ' HB2' HG11 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -71.28 -31.53 67.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.156 -0.965 . . . . 0.0 112.354 -178.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.779 ' H ' HD23 ' A' ' 205' ' ' LEU . 3.7 m -62.32 -29.57 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 119.707 -1.871 . . . . 0.0 106.995 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.537 ' O ' ' HB3' ' A' ' 211' ' ' ALA . . . -64.61 -38.46 91.08 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 176.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.892 ' OH ' HD22 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -56.87 -36.11 69.69 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.313 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.706 ' NE ' HG21 ' A' ' 162' ' ' THR . 0.0 OUTLIER -74.01 -55.26 6.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.418 -0.801 . . . . 0.0 110.0 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.438 ' N ' ' HD3' ' A' ' 209' ' ' ARG . 22.9 tt0 -68.83 -56.35 8.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.876 . . . . 0.0 110.714 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 207' ' ' ALA . . . -51.19 -31.52 20.53 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.322 -0.861 . . . . 0.0 110.443 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.427 ' CB ' ' O ' ' A' ' 208' ' ' TYR . 48.9 t-80 -78.74 -24.84 44.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.183 -0.948 . . . . 0.0 110.182 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -116.84 25.98 10.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 110.176 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 14.2 ttp85 -62.47 147.09 49.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.275 -0.891 . . . . 0.0 110.255 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 9.7 tttm -115.87 85.98 2.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.247 -0.908 . . . . 0.0 110.23 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -73.41 174.95 7.44 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.906 . . . . 0.0 110.213 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.168 -179.981 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.218 0.532 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -99.83 55.8 0.95 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 110.232 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.418 ' O ' ' CB ' ' A' ' 7' ' ' SER . 31.6 tt0 -91.85 -22.13 20.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.297 -0.877 . . . . 0.0 110.11 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.45 HG22 ' HB2' ' A' ' 9' ' ' PHE . 11.9 m -60.97 -15.93 37.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.269 -0.894 . . . . 0.0 110.609 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.538 HD22 ' HG3' ' A' ' 197' ' ' MET . 3.1 tp -49.55 -67.06 0.29 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.122 -0.986 . . . . 0.0 110.652 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.608 ' CD2' HG23 ' A' ' 200' ' ' VAL . 0.3 OUTLIER -115.42 5.23 14.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -0.876 . . . . 0.0 110.715 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 3' ' ' GLN . 8.3 t -95.1 -66.21 0.93 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.614 -1.303 . . . . 0.0 111.885 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.26 13.15 32.36 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.198 -0.939 . . . . 0.0 112.034 -178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.45 ' HB2' HG22 ' A' ' 4' ' ' THR . 0.6 OUTLIER -141.2 58.7 1.53 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.796 -1.19 . . . . 0.0 109.887 -179.461 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 15' ' ' ARG . . . -164.21 167.98 38.42 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 107.392 -2.283 . . . . 0.0 107.392 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.459 ' O ' ' C ' ' A' ' 12' ' ' PRO . 34.4 p -127.87 149.39 70.56 Favored Pre-proline 0 C--N 1.256 -3.49 0 N-CA-C 102.995 -2.965 . . . . 0.0 102.995 178.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.886 ' HB2' ' HB3' ' A' ' 207' ' ' ALA . 18.7 Cg_endo -40.34 -34.79 1.17 Allowed 'Trans proline' 0 C--N 1.288 -2.627 0 CA-C-N 119.767 0.952 . . . . 0.0 110.455 -176.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.451 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 9.8 t80 -87.19 -42.65 12.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.904 -0.498 . . . . 0.0 111.628 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.518 ' HA ' ' HB3' ' A' ' 17' ' ' GLU . 15.9 tt0 -89.37 -16.14 31.7 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.723 -1.236 . . . . 0.0 111.916 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.515 ' CD ' HG23 ' A' ' 200' ' ' VAL . 2.0 ttm180 -72.9 -64.46 0.96 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 105.977 -1.861 . . . . 0.0 105.977 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.71 HG11 ' CD2' ' A' ' 208' ' ' TYR . 7.3 p -62.22 -21.21 26.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 C-N-CA 118.721 -1.192 . . . . 0.0 108.323 176.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.518 ' HB3' ' HA ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -57.11 -35.17 69.13 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 119.92 -1.737 . . . . 0.0 106.458 177.092 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.536 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 2.9 m-20 -73.98 -29.37 61.94 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 176.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 1.088 ' HB1' HG11 ' A' ' 29' ' ' VAL . . . -67.83 -50.58 55.94 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.605 HD13 ' O ' ' A' ' 163' ' ' LEU . 0.2 OUTLIER -61.43 -50.77 71.46 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 177.822 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.08 -26.22 62.27 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.668 -1.27 . . . . 0.0 107.966 176.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.536 ' HB2' ' O ' ' A' ' 18' ' ' ASN . . . -80.34 -32.55 37.83 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.499 -0.751 . . . . 0.0 109.064 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.539 ' CD2' ' CD2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -50.35 -25.44 3.84 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.093 -1.004 . . . . 0.0 108.83 177.881 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.44 -26.38 15.87 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 177.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 1.3 tp10 -144.69 81.09 1.65 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 123.866 1.793 . . . . 0.0 107.241 177.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 126.58 48.8 0.18 Allowed Glycine 0 C--N 1.276 -2.77 1 N-CA-C 102.617 -4.193 . . . . 0.0 102.617 -175.145 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 23' ' ' LEU . 1.3 mtt180 -62.78 65.39 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 122.023 0.916 . . . . 0.0 111.715 -175.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 26' ' ' GLY . . . 176.64 98.19 0.11 Allowed Glycine 0 C--N 1.291 -1.964 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 178.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.096 HG22 ' HB3' ' A' ' 198' ' ' ALA . 24.6 t -127.0 135.17 64.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 119.161 -1.016 . . . . 0.0 110.134 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.811 ' HG2' HD22 ' A' ' 199' ' ' LEU . 0.1 OUTLIER -100.31 161.24 13.74 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.842 -1.143 . . . . 0.0 111.352 -179.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 201' ' ' THR . 11.1 p -133.5 94.21 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.682 0.753 . . . . 0.0 109.263 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.448 ' O ' HG22 ' A' ' 202' ' ' ILE . 0.4 OUTLIER -43.72 108.37 0.11 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.534 -0.729 . . . . 0.0 111.63 -178.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.732 ' OD2' HD13 ' A' ' 202' ' ' ILE . 4.8 t70 -93.7 -172.82 2.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.548 -0.72 . . . . 0.0 109.869 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -54.76 -174.42 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.162 -0.961 . . . . 0.0 110.134 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -89.47 161.13 16.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.201 -0.937 . . . . 0.0 110.325 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 53.27 178.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 0.0 110.311 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.3 44.77 29.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.292 -0.88 . . . . 0.0 110.235 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -58.37 109.28 0.74 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.238 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -153.88 21.46 0.52 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.247 -0.908 . . . . 0.0 110.289 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.464 ' CA ' ' HB3' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -168.01 129.13 1.4 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.94 . . . . 0.0 110.355 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 173' ' ' CYS . . . -177.35 -119.86 0.61 Allowed Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.249 -1.453 . . . . 0.0 111.341 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.756 ' HB2' HD11 ' A' ' 189' ' ' ILE . 20.1 t70 -34.98 -28.32 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.542 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -177.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.643 ' O ' ' O ' ' A' ' 171' ' ' VAL . 0.0 OUTLIER -93.23 51.13 1.6 Allowed 'General case' 0 C--N 1.293 -1.891 0 O-C-N 120.776 -1.203 . . . . 0.0 113.476 -177.037 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.983 ' C ' HD11 ' A' ' 160' ' ' LEU . 20.7 pt -66.13 27.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 O-C-N 119.464 -2.023 . . . . 0.0 112.397 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.539 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 31.4 m-85 -92.6 158.94 37.51 Favored Pre-proline 0 N--CA 1.505 2.292 0 O-C-N 121.064 -1.023 . . . . 0.0 113.184 -177.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.494 ' HB3' ' HB3' ' A' ' 167' ' ' LYS . 43.5 Cg_endo -66.53 130.86 24.6 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.245 1.963 . . . . 0.0 111.251 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.725 ' N ' ' HB1' ' A' ' 169' ' ' ALA . . . -58.9 -10.6 2.57 Favored 'General case' 0 N--CA 1.507 2.401 0 O-C-N 121.478 -0.764 . . . . 0.0 112.903 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.881 ' HA ' HD11 ' A' ' 122' ' ' ILE . 35.9 mt-10 -97.62 -2.58 41.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.631 -1.293 . . . . 0.0 109.542 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.86 57.08 1.82 Allowed 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 176.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.693 ' O ' HG23 ' A' ' 115' ' ' ILE . 25.4 tpp -63.26 86.93 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.741 -0.784 . . . . 0.0 109.526 -178.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.494 ' O ' HG23 ' A' ' 51' ' ' THR . 9.2 t -66.17 128.2 35.16 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.458 -0.776 . . . . 0.0 109.089 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 1.016 HG23 ' HB1' ' A' ' 111' ' ' ALA . 2.8 p -73.85 -2.56 3.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.534 -0.729 . . . . 0.0 109.484 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.49 -36.48 73.83 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.603 -1.239 . . . . 0.0 107.958 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.483 ' HB3' ' CG ' ' A' ' 43' ' ' MET . 1.0 OUTLIER -81.27 -53.96 5.9 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.828 179.023 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.429 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -54.56 -24.21 19.99 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.35 -0.844 . . . . 0.0 109.277 179.257 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.75 -46.87 64.9 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.322 -0.861 . . . . 0.0 109.896 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.77 HD11 HD23 ' A' ' 175' ' ' LEU . 0.7 OUTLIER -68.21 -36.6 79.79 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.057 -1.057 . . . . 0.0 109.952 179.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.414 ' OG1' ' CE ' ' A' ' 43' ' ' MET . 1.1 m -75.29 -58.17 3.44 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.198 -0.939 . . . . 0.0 110.511 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.426 ' CG1' ' O ' ' A' ' 55' ' ' MET . 96.5 mt -52.71 -22.09 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.941 . . . . 0.0 110.411 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -76.54 -40.62 49.31 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.282 -0.887 . . . . 0.0 111.15 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.438 ' O ' ' HA ' ' A' ' 177' ' ' ASN . 0.1 OUTLIER -123.01 -5.81 8.44 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.776 -1.203 . . . . 0.0 112.626 -178.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.99 -170.62 23.75 Favored Glycine 0 N--CA 1.496 2.633 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.158 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 15.4 t -141.24 101.73 4.08 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 102.26 -3.237 . . . . 0.0 102.26 176.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 66' ' ' VAL . . . -111.43 76.8 0.23 Allowed Glycine 0 C--N 1.26 -3.69 0 N-CA-C 104.612 -3.395 . . . . 0.0 104.612 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.695 ' O ' HG23 ' A' ' 65' ' ' ILE . 1.2 tt -58.19 94.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 CA-C-O 123.498 1.618 . . . . 0.0 108.811 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.673 HG23 ' C ' ' A' ' 172' ' ' LEU . 1.4 p -52.55 154.23 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.134 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.807 ' O ' HG12 ' A' ' 171' ' ' VAL . 44.5 t -75.93 162.64 27.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.174 -0.954 . . . . 0.0 110.131 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.84 HD22 HG12 ' A' ' 171' ' ' VAL . 0.3 OUTLIER -125.13 92.67 3.69 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.7 -1.25 . . . . 0.0 108.474 178.497 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.563 ' C ' HG23 ' A' ' 70' ' ' ILE . 1.8 t -93.25 153.88 18.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.428 -1.42 . . . . 0.0 113.073 -177.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.563 HG23 ' C ' ' A' ' 69' ' ' CYS . 3.7 pt -155.29 147.51 12.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.048 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.515 HG22 ' H ' ' A' ' 72' ' ' GLU . 5.1 m -77.86 176.17 9.32 Favored 'General case' 0 C--N 1.314 -0.953 0 O-C-N 120.452 -1.405 . . . . 0.0 108.896 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.515 ' H ' HG22 ' A' ' 71' ' ' THR . 7.6 tt0 -95.16 -11.18 28.58 Favored 'General case' 0 C--N 1.284 -2.244 0 O-C-N 121.291 -0.881 . . . . 0.0 110.282 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -90.64 -75.26 0.47 Allowed 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.591 -1.244 . . . . 0.0 111.557 -177.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.58 -26.3 37.98 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 119.391 -0.923 . . . . 0.0 108.961 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.545 ' O ' ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -85.8 -27.47 25.14 Favored 'General case' 0 C--O 1.192 -1.967 0 C-N-CA 119.202 -0.999 . . . . 0.0 111.359 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.482 ' CB ' ' O ' ' A' ' 72' ' ' GLU . 0.1 OUTLIER -68.17 -41.78 81.0 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 121.157 1.799 . . . . 0.0 108.022 178.051 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.75 -58.28 6.85 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.614 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.91 HD22 ' O ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -89.09 -32.05 17.73 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 118.1 -1.44 . . . . 0.0 108.925 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.7 ' N ' HD13 ' A' ' 78' ' ' LEU . 1.4 t0 -116.03 75.32 0.94 Allowed 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.716 -0.615 . . . . 0.0 109.569 177.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.827 ' O ' HD22 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -75.46 126.68 87.3 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.669 -1.269 . . . . 0.0 111.827 -177.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.631 ' HB3' HG23 ' A' ' 96' ' ' THR . 55.2 Cg_endo -90.82 98.72 0.24 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 122.627 0.803 . . . . 0.0 110.038 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.609 ' SD ' HD23 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -87.59 97.85 11.09 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.194 -0.941 . . . . 0.0 109.027 179.212 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.0 mtt -47.03 92.4 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.624 -0.672 . . . . 0.0 110.543 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.907 HG12 ' O ' ' A' ' 95' ' ' PHE . 14.7 p -88.11 125.37 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 C-N-CA 119.456 -0.897 . . . . 0.0 110.778 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.416 ' O ' ' CB ' ' A' ' 90' ' ' ALA . 0.8 OUTLIER -98.27 27.6 4.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -0.912 . . . . 0.0 110.047 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.552 ' H ' HG22 ' A' ' 84' ' ' VAL . 13.9 t30 -92.46 36.53 1.0 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.343 -0.848 . . . . 0.0 110.362 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.572 ' C ' ' HG1' ' A' ' 88' ' ' THR . 1.1 m120 -105.09 78.15 1.37 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.242 -0.911 . . . . 0.0 110.081 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.572 ' HG1' ' C ' ' A' ' 87' ' ' ASN . 53.2 p 45.15 -92.41 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.716 -0.615 . . . . 0.0 111.026 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.431 ' N ' ' O ' ' A' ' 87' ' ' ASN . 0.2 OUTLIER -52.76 -37.64 59.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.84 -1.163 . . . . 0.0 110.297 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 85' ' ' GLU . . . 53.33 38.48 27.88 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -0.954 . . . . 0.0 110.236 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -100.15 77.12 1.96 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.299 -0.876 . . . . 0.0 110.199 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.47 39.02 83.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p -60.98 -17.87 54.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -1.117 . . . . 0.0 110.511 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.18 23.61 2.94 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 110.454 -1.058 . . . . 0.0 110.454 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.907 ' O ' HG12 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -59.74 100.51 0.09 Allowed 'General case' 0 N--CA 1.484 1.248 0 O-C-N 120.997 -1.296 . . . . 0.0 111.447 -179.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.631 HG23 ' HB3' ' A' ' 81' ' ' PRO . 4.0 m -60.23 78.05 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 114.549 -1.205 . . . . 0.0 109.343 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.467 ' N ' ' O ' ' A' ' 95' ' ' PHE . 2.6 p -32.99 149.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 CA-C-O 122.615 1.198 . . . . 0.0 112.183 -176.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.749 HG22 ' O ' ' A' ' 137' ' ' VAL . 5.4 p -70.29 -174.86 0.89 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.915 -175.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.868 HG23 HD22 ' A' ' 131' ' ' LEU 0.27 0.1 OUTLIER -146.44 136.61 17.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 -179.679 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.808 ' O ' HD23 ' A' ' 131' ' ' LEU . 46.7 tt0 -91.83 107.07 18.94 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 117.449 -1.7 . . . . 0.0 112.683 -177.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.981 ' HB1' HG23 ' A' ' 105' ' ' VAL . . . -49.96 93.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.424 0.631 . . . . 0.0 110.754 179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.859 ' HB3' ' O ' ' A' ' 130' ' ' ASP . . . -98.35 0.34 45.28 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 120.717 -1.24 . . . . 0.0 109.513 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.476 ' HB3' ' HB1' ' A' ' 121' ' ' ALA . 12.5 tt0 -82.81 13.74 3.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.062 -1.024 . . . . 0.0 111.299 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.576 ' O ' HG13 ' A' ' 105' ' ' VAL . . . 128.31 25.41 1.06 Allowed Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.31 -1.424 . . . . 0.0 112.562 178.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.981 HG23 ' HB1' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -161.0 118.03 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 O-C-N 120.92 -1.341 . . . . 0.0 110.742 177.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.426 ' CG2' ' O ' ' A' ' 101' ' ' ALA . 32.0 p -147.68 59.48 1.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.462 -1.399 . . . . 0.0 112.131 176.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.947 HG22 ' HG2' ' A' ' 114' ' ' ARG . 7.6 t -137.49 -28.02 0.92 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 120.528 -1.358 . . . . 0.0 110.706 176.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.26 -28.32 3.4 Favored Glycine 0 N--CA 1.487 2.1 0 O-C-N 121.389 -0.82 . . . . 0.0 111.797 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.08 53.46 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 120.513 -1.581 . . . . 0.0 111.782 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.554 ' CB ' HG21 ' A' ' 107' ' ' THR . 6.6 t -132.8 54.61 1.94 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 1.016 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -41.0 -24.68 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -177.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.458 ' O ' HG23 ' A' ' 116' ' ' THR . . . -78.04 -77.68 0.15 Allowed 'General case' 0 C--N 1.29 -2.017 0 O-C-N 120.289 -1.507 . . . . 0.0 109.913 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -73.34 -19.78 60.93 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.609 -0.682 . . . . 0.0 112.292 -178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.947 ' HG2' HG22 ' A' ' 107' ' ' THR . 1.4 mpt_? -95.5 -40.29 9.54 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 118.06 -1.456 . . . . 0.0 111.69 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.712 HG21 ' HB ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -67.98 -11.85 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 117.272 -1.771 . . . . 0.0 108.645 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.458 HG23 ' O ' ' A' ' 112' ' ' ALA . 20.7 p -83.04 -53.34 5.88 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 176.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.653 ' OG1' HG13 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -73.56 -23.44 59.97 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.805 178.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.799 HG23 HG11 ' A' ' 105' ' ' VAL . 2.8 t -63.43 -55.92 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.081 -1.012 . . . . 0.0 109.263 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 36.4 ptt85 -52.18 -33.3 40.01 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.719 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.422 ' N ' ' HG3' ' A' ' 119' ' ' ARG . . . -94.27 -9.49 35.91 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.826 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.511 ' CB ' ' CG2' ' A' ' 105' ' ' VAL . . . -98.49 -53.72 3.24 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.952 -1.093 . . . . 0.0 112.561 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.881 HD11 ' HA ' ' A' ' 48' ' ' GLU . 2.5 pp -67.93 -17.56 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.523 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.446 ' HB2' ' HG2' ' A' ' 48' ' ' GLU . . . -107.24 74.1 0.96 Allowed 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.648 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.491 ' HB3' ' CG ' ' A' ' 127' ' ' LYS . 17.5 t70 -97.29 -63.09 1.16 Allowed 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 122.451 1.12 . . . . 0.0 110.256 178.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 126.8 -39.69 1.92 Allowed Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.711 -2.156 . . . . 0.0 107.711 -178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -135.86 94.36 3.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.311 -1.111 . . . . 0.0 109.39 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.491 ' CG ' ' HB3' ' A' ' 124' ' ' ASP . 10.8 mmmt -136.9 57.94 17.15 Favored Pre-proline 0 C--N 1.308 -1.23 0 O-C-N 120.702 -1.249 . . . . 0.0 110.57 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.67 -16.22 52.56 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 N-CA-C 108.389 -1.427 . . . . 0.0 108.389 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 13.9 m -123.28 -25.38 4.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.577 -0.702 . . . . 0.0 111.373 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.859 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 2.8 t70 -78.39 10.0 3.45 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.749 -1.219 . . . . 0.0 112.428 -178.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.868 HD22 HG23 ' A' ' 99' ' ' ILE . 8.3 mt -140.32 96.56 3.06 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.687 -1.258 . . . . 0.0 108.671 178.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 0.6 OUTLIER -117.88 98.04 6.14 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.266 -0.896 . . . . 0.0 112.31 -178.045 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.822 ' HB2' ' HA ' ' A' ' 134' ' ' PRO . 0.0 OUTLIER -79.5 171.92 11.23 Favored Pre-proline 0 N--CA 1.503 2.214 0 O-C-N 121.717 -0.615 . . . . 0.0 111.305 -178.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.822 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 48.2 Cg_endo -73.16 130.84 21.12 Favored 'Cis proline' 0 N--CA 1.505 2.192 0 C-N-CA 123.405 -1.498 . . . . 0.0 113.432 7.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 100' ' ' GLU . . . -132.46 63.6 0.62 Allowed Glycine 0 N--CA 1.499 2.858 0 C-N-CA 119.844 -1.169 . . . . 0.0 111.88 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.505 ' O ' ' CE2' ' A' ' 138' ' ' PHE . 57.4 m80 30.46 38.45 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.469 0 O-C-N 121.986 -0.714 . . . . 0.0 112.801 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.749 ' O ' HG22 ' A' ' 98' ' ' THR . 2.2 t -108.24 132.56 55.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 176.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.553 ' CZ ' ' CG1' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -122.69 84.88 49.1 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 120.47 -1.394 . . . . 0.0 108.381 -176.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.711 ' O ' HD22 ' A' ' 140' ' ' LEU . 55.6 Cg_endo -104.3 159.33 0.21 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 121.961 1.774 . . . . 0.0 114.07 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.711 HD22 ' O ' ' A' ' 139' ' ' PRO . 0.5 OUTLIER -142.67 112.38 6.86 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 176.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.443 ' HB3' ' CB ' ' A' ' 81' ' ' PRO . 2.6 ptt85 -64.77 147.1 53.82 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.033 -1.042 . . . . 0.0 111.724 -176.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -129.55 132.15 46.75 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.69 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.39 143.85 27.35 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.171 -0.955 . . . . 0.0 109.909 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -55.18 100.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.407 -0.808 . . . . 0.0 109.42 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.447 ' HA2' ' NH2' ' A' ' 209' ' ' ARG . . . 88.66 20.8 46.14 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.775 -1.73 . . . . 0.0 108.775 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.33 13.18 61.68 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 1.01 HG22 ' HA ' ' A' ' 155' ' ' GLU . 0.3 OUTLIER -95.1 25.35 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 O-C-N 120.987 -1.302 . . . . 0.0 108.903 178.705 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.592 HD13 ' CG1' ' A' ' 206' ' ' VAL . 4.5 mm? -93.8 39.32 1.07 Allowed 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 102.36 -3.2 . . . . 0.0 102.36 172.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.547 ' H ' ' C ' ' A' ' 147' ' ' VAL . 48.8 m -102.6 92.25 4.56 Favored 'General case' 0 N--CA 1.409 -2.489 1 N-CA-C 99.002 -4.444 . . . . 0.0 99.002 177.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.503 ' O ' ' C ' ' A' ' 151' ' ' GLY . 0.2 OUTLIER -44.49 163.01 0.02 OUTLIER 'General case' 0 C--N 1.26 -3.316 0 CA-C-N 112.694 -2.048 . . . . 0.0 109.232 -173.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.503 ' C ' ' O ' ' A' ' 150' ' ' ARG . . . -14.48 82.88 0.0 OUTLIER Glycine 0 N--CA 1.515 3.964 0 CA-C-O 124.179 1.988 . . . . 0.0 112.856 -169.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 150' ' ' ARG . . . -114.55 -157.83 11.99 Favored Glycine 0 N--CA 1.472 1.084 0 N-CA-C 106.984 -2.447 . . . . 0.0 106.984 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.404 ' HA ' ' OE1' ' A' ' 40' ' ' GLU . 1.2 m80 -92.83 -33.79 14.11 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.07 -1.253 . . . . 0.0 110.114 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.515 ' O ' HG21 ' A' ' 147' ' ' VAL . 41.6 p -97.0 -3.31 41.76 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.435 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 1.01 ' HA ' HG22 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -53.69 -32.26 51.06 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -175.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.593 ' CB ' HD13 ' A' ' 205' ' ' LEU . . . -113.89 5.25 16.15 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.153 -1.592 . . . . 0.0 112.336 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.819 HG22 ' C ' ' A' ' 170' ' ' GLY . 0.0 OUTLIER -89.4 -51.36 5.59 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 118.983 -1.087 . . . . 0.0 108.946 179.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.53 ' HA ' HD12 ' A' ' 158' ' ' ILE . 1.1 tp -90.25 -27.01 5.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 116.844 -1.942 . . . . 0.0 107.255 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.786 ' OD2' HG22 ' A' ' 206' ' ' VAL . 12.4 t70 -62.13 -23.65 66.69 Favored 'General case' 0 C--O 1.199 -1.601 0 C-N-CA 115.877 -2.329 . . . . 0.0 105.099 172.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.983 HD11 ' C ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -49.96 -45.13 51.14 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 176.373 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.485 ' CB ' ' HA ' ' A' ' 168' ' ' PRO . 5.7 ptt? -52.35 -36.37 53.38 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 118.725 -1.19 . . . . 0.0 108.008 176.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.758 HG21 ' CG ' ' A' ' 209' ' ' ARG . 4.5 m -79.59 -43.92 22.02 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.815 HD13 ' HA ' ' A' ' 160' ' ' LEU . 0.4 OUTLIER -35.54 -37.07 0.08 Allowed 'General case' 0 N--CA 1.517 2.907 0 CA-C-O 122.216 1.008 . . . . 0.0 109.094 178.184 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.478 ' HA ' HD21 ' A' ' 20' ' ' LEU . . . -106.93 -26.99 10.96 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.913 0.863 . . . . 0.0 108.828 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 162' ' ' THR . . . 108.93 -25.89 17.32 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 111.387 -0.685 . . . . 0.0 111.387 177.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -148.98 57.65 1.03 Allowed 'General case' 0 N--CA 1.505 2.297 0 C-N-CA 117.477 -1.689 . . . . 0.0 113.132 176.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.494 ' HB3' ' HB3' ' A' ' 46' ' ' PRO . 18.3 mmtt -129.3 73.88 81.36 Favored Pre-proline 0 C--N 1.3 -1.564 0 O-C-N 120.485 -1.385 . . . . 0.0 107.758 175.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.485 ' HA ' ' CB ' ' A' ' 161' ' ' MET . 39.5 Cg_endo -67.4 84.44 0.36 Allowed 'Trans proline' 0 C--N 1.316 -1.176 0 C-N-CA 116.236 -2.043 . . . . 0.0 110.107 -176.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.725 ' HB1' ' N ' ' A' ' 47' ' ' ALA 0.265 . . -159.56 164.43 34.27 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 176.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.819 ' C ' HG22 ' A' ' 157' ' ' THR . . . -157.63 108.88 0.38 Allowed Glycine 0 N--CA 1.491 2.327 0 C-N-CA 118.406 -1.854 . . . . 0.0 109.969 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.84 HG12 HD22 ' A' ' 68' ' ' LEU . 0.1 OUTLIER -133.14 92.68 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.196 -1.725 0 C-N-CA 116.952 -1.899 . . . . 0.0 109.491 177.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.844 HD11 HD12 ' A' ' 160' ' ' LEU . 10.0 mp -103.86 145.4 30.17 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.16 0.505 . . . . 0.0 109.826 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.525 ' N ' ' HB2' ' A' ' 43' ' ' MET . 1.1 t -130.73 167.54 18.66 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.112 -0.993 . . . . 0.0 110.724 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.401 ' N ' ' SG ' ' A' ' 173' ' ' CYS . 13.6 mm-40 -115.28 126.19 54.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.166 -0.959 . . . . 0.0 109.843 178.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.845 HD12 ' HB2' ' A' ' 188' ' ' CYS . 3.3 tm? -63.92 120.42 11.93 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.074 -1.016 . . . . 0.0 110.359 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 4.5 m -139.15 155.59 47.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.278 -0.889 . . . . 0.0 109.968 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 1.2 t-20 -106.45 163.58 12.74 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.119 -0.988 . . . . 0.0 110.026 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 61' ' ' HIS . 0.3 OUTLIER -90.51 6.5 43.29 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.407 -0.808 . . . . 0.0 110.951 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.17 16.07 25.38 Favored 'General case' 0 C--N 1.291 -1.968 0 O-C-N 121.636 -0.665 . . . . 0.0 110.205 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 61.42 21.95 60.66 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 183' ' ' ALA . 1.3 p -83.11 121.83 27.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -1.147 . . . . 0.0 110.044 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -60.54 85.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.879 . . . . 0.0 110.249 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 1.02 ' HB1' ' CB ' ' A' ' 188' ' ' CYS . . . -54.64 130.06 38.85 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.214 -0.929 . . . . 0.0 110.047 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 188' ' ' CYS . 0.6 OUTLIER -79.07 125.08 28.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.462 -0.774 . . . . 0.0 109.923 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.813 ' HB3' ' HD3' ' A' ' 186' ' ' PRO . . . -38.14 -54.03 2.72 Favored Pre-proline 0 N--CA 1.501 2.084 0 O-C-N 121.809 -0.557 . . . . 0.0 112.391 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.813 ' HD3' ' HB3' ' A' ' 185' ' ' ALA . 47.5 Cg_endo -74.15 -35.12 4.31 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.41 1.216 . . . . 0.0 111.329 -179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 190' ' ' GLU . 0.0 OUTLIER -83.64 -59.3 2.48 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.076 -1.015 . . . . 0.0 111.514 -179.006 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . 1.02 ' CB ' ' HB1' ' A' ' 183' ' ' ALA . 12.3 p -53.15 -40.09 64.03 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.173 -0.954 . . . . 0.0 110.231 -179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.756 HD11 ' HB2' ' A' ' 42' ' ' ASP . 3.7 tp -73.33 -29.09 26.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 120.703 -1.248 . . . . 0.0 108.254 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 194' ' ' LYS . 0.1 OUTLIER -58.31 -20.51 43.62 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.759 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.485 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.2 OUTLIER -76.49 -53.85 7.53 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 178.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.474 ' HA ' HD22 ' A' ' 57' ' ' LEU . . . -56.28 -25.6 48.82 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . 0.8 ' CB ' HD11 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -89.38 -23.61 22.15 Favored 'General case' 0 C--O 1.194 -1.863 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 190' ' ' GLU . 0.0 OUTLIER -52.07 -35.59 47.94 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 119.578 -1.951 . . . . 0.0 110.459 -178.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.5 -43.27 6.59 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 117.612 -1.635 . . . . 0.0 108.495 176.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.462 ' HB3' ' CA ' ' A' ' 28' ' ' GLY . 81.1 m-20 -103.91 56.22 0.73 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 176.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' MET . . . . . 0.551 ' N ' ' O ' ' A' ' 193' ' ' ASN . 0.4 OUTLIER -66.59 74.72 0.1 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 -172.513 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 1.096 ' HB3' HG22 ' A' ' 29' ' ' VAL . . . -131.01 99.25 4.83 Favored 'General case' 0 C--O 1.197 -1.701 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 172.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.811 HD22 ' HG2' ' A' ' 30' ' ' MET . 44.2 mt -118.21 131.57 56.37 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 119.68 -1.888 . . . . 0.0 111.448 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.641 HG13 ' N ' ' A' ' 201' ' ' THR . 0.5 OUTLIER -129.87 -159.22 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.313 -0.867 . . . . 0.0 111.352 -179.429 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.783 ' O ' HG23 ' A' ' 31' ' ' VAL . 1.7 p -125.46 177.64 6.07 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.488 -0.758 . . . . 0.0 109.955 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.732 HD13 ' OD2' ' A' ' 33' ' ' ASP . 1.4 tp -91.46 -44.46 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.214 -0.929 . . . . 0.0 111.752 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.528 ' N ' HG23 ' A' ' 202' ' ' ILE . 43.9 mt-10 -60.17 -61.9 2.26 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.693 -1.254 . . . . 0.0 110.223 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.462 ' CB ' ' HB3' ' A' ' 12' ' ' PRO . 2.7 m-20 -57.74 -16.95 12.71 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.366 -0.834 . . . . 0.0 110.696 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.803 HD21 HD11 ' A' ' 163' ' ' LEU . 8.4 tt -68.05 -61.15 1.99 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.236 -1.54 . . . . 0.0 110.353 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.786 HG22 ' OD2' ' A' ' 159' ' ' ASP . 2.4 t -60.93 -16.66 14.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 119.848 -1.782 . . . . 0.0 109.277 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.886 ' HB3' ' HB2' ' A' ' 12' ' ' PRO . . . -60.58 -32.77 71.86 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 105.329 -2.101 . . . . 0.0 105.329 174.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.71 ' CD2' HG11 ' A' ' 16' ' ' VAL 0.273 1.1 t80 -50.81 -41.98 57.79 Favored 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 175.101 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.758 ' CG ' HG21 ' A' ' 162' ' ' THR . 1.3 ttt85 -78.43 -62.77 1.58 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.153 179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -50.41 -37.2 36.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.192 -0.943 . . . . 0.0 110.409 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 207' ' ' ALA . . . -74.75 -26.91 60.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.396 -0.815 . . . . 0.0 110.152 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.404 ' O ' ' CD2' ' A' ' 212' ' ' HIS . 9.0 t60 -68.65 -23.48 64.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.238 -0.914 . . . . 0.0 110.18 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -105.52 -9.17 17.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 110.677 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.6 148.06 25.65 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.068 -1.02 . . . . 0.0 110.223 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.409 ' O ' ' CG ' ' A' ' 215' ' ' LYS . 0.0 OUTLIER -113.36 85.35 2.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 110.194 179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -72.46 -80.31 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.301 -0.875 . . . . 0.0 110.207 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 3.9 p . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.198 -179.979 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.23 0.538 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -84.39 55.55 3.42 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.24 -0.912 . . . . 0.0 110.206 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -94.07 5.23 52.38 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.341 -0.85 . . . . 0.0 110.773 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 7' ' ' SER . 5.0 m -52.55 -23.08 5.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.938 -1.101 . . . . 0.0 110.402 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.663 HD21 HG21 ' A' ' 189' ' ' ILE . 9.3 tp -53.12 -50.58 64.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.177 -0.952 . . . . 0.0 110.26 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.047 HD22 ' CA ' ' A' ' 200' ' ' VAL . 6.3 mt -116.03 17.28 15.92 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.4 -0.812 . . . . 0.0 109.884 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.439 ' HB3' ' HA ' ' A' ' 4' ' ' THR . 23.2 t -77.42 -63.34 1.4 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.773 -1.204 . . . . 0.0 111.754 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.8 t -79.43 -18.22 52.66 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.126 -0.984 . . . . 0.0 110.585 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -139.68 58.42 1.61 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.606 ' HA2' HG23 ' A' ' 200' ' ' VAL . . . -168.25 97.53 0.13 Allowed Glycine 0 C--N 1.302 -1.356 0 N-CA-C 106.723 -2.551 . . . . 0.0 106.723 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.4 ' H ' ' CB ' ' A' ' 15' ' ' ARG . 0.2 OUTLIER -127.24 138.37 32.62 Favored Pre-proline 0 C--N 1.272 -2.8 0 N-CA-C 102.523 -3.14 . . . . 0.0 102.523 177.351 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.635 ' O ' HG12 ' A' ' 16' ' ' VAL . 34.3 Cg_endo -58.82 -37.0 96.11 Favored 'Trans proline' 0 C--N 1.276 -3.257 0 O-C-N 123.123 1.065 . . . . 0.0 109.712 -177.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.34 -45.27 7.89 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -178.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -81.91 -58.43 2.98 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 118.259 -1.376 . . . . 0.0 111.524 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.679 ' O ' HG21 ' A' ' 200' ' ' VAL . 0.0 OUTLIER -82.65 -15.26 52.73 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 118.666 -1.214 . . . . 0.0 112.531 -178.253 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.748 ' CG2' HG13 ' A' ' 200' ' ' VAL . 1.1 t -97.94 -29.92 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 116.422 -2.111 . . . . 0.0 110.444 178.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -73.28 -37.06 66.38 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 115.986 -2.286 . . . . 0.0 107.037 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.853 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 5.4 t30 -74.96 -26.27 59.47 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.621 ' CB ' HD12 ' A' ' 23' ' ' LEU . . . -90.77 -17.01 27.38 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.207 -0.933 . . . . 0.0 109.598 179.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.907 HD13 ' OH ' ' A' ' 208' ' ' TYR . 0.9 OUTLIER -69.29 -51.5 36.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.943 -1.098 . . . . 0.0 109.605 179.472 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.457 ' HA ' ' HB2' ' A' ' 25' ' ' GLU . . . -89.49 -46.22 8.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.076 -1.015 . . . . 0.0 111.034 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.853 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -72.23 -39.54 68.42 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.148 -0.97 . . . . 0.0 111.876 -178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.045 HD22 ' HB2' ' A' ' 198' ' ' ALA . 56.8 mt -105.05 -24.1 12.85 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.878 -1.139 . . . . 0.0 112.664 -178.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.981 ' NH2' HD12 ' A' ' 163' ' ' LEU . 0.4 OUTLIER -100.34 -6.2 26.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.569 -1.332 . . . . 0.0 110.714 -179.288 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.457 ' HB2' ' HA ' ' A' ' 21' ' ' ALA . 3.2 tt0 -101.25 44.4 1.01 Allowed 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 118.117 -1.433 . . . . 0.0 107.949 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.02 2.67 12.43 Favored Glycine 0 C--N 1.296 -1.692 0 C-N-CA 119.911 -1.138 . . . . 0.0 112.616 177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.412 ' HB3' ' HA ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -128.55 22.04 5.99 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 121.313 2.557 . . . . 0.0 115.944 -179.628 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.767 ' O ' ' HB3' ' A' ' 198' ' ' ALA . . . 97.09 108.74 2.6 Favored Glycine 0 N--CA 1.501 3.009 0 C-N-CA 117.923 -2.084 . . . . 0.0 116.819 171.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.74 HG12 HD12 ' A' ' 44' ' ' ILE . 30.7 t -140.77 122.08 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.439 -1.624 . . . . 0.0 106.814 173.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.672 ' C ' HD11 ' A' ' 44' ' ' ILE . 1.1 mtt -123.55 150.03 44.53 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 118.727 -1.189 . . . . 0.0 113.937 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.984 HG23 ' HB ' ' A' ' 202' ' ' ILE . 1.1 p -133.09 133.03 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.689 HD12 ' O ' ' A' ' 31' ' ' VAL . 0.2 OUTLIER -154.98 -74.22 0.11 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.897 . . . . 0.0 110.218 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 t0 56.96 165.87 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.363 -0.836 . . . . 0.0 110.308 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 50.97 -150.54 0.26 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.183 -0.948 . . . . 0.0 110.423 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -142.32 72.21 1.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.888 . . . . 0.0 110.169 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.77 -166.96 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 110.298 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.21 -57.61 0.9 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.913 . . . . 0.0 110.232 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -132.04 90.99 2.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.248 -0.907 . . . . 0.0 110.286 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -175.42 -49.0 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.265 -0.897 . . . . 0.0 110.162 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.419 ' O ' ' NE2' ' A' ' 153' ' ' HIS . 0.0 OUTLIER 56.87 166.02 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.353 -0.842 . . . . 0.0 110.401 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.594 ' HA2' ' HB2' ' A' ' 172' ' ' LEU . . . -158.84 33.52 0.48 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.618 ' OD1' HD13 ' A' ' 189' ' ' ILE . 7.9 m-20 -78.87 -39.61 34.74 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -176.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.671 ' HB3' ' HA ' ' A' ' 172' ' ' LEU . 0.0 OUTLIER -85.71 59.81 5.86 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.233 -0.917 . . . . 0.0 111.233 -178.627 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.987 ' O ' HD21 ' A' ' 160' ' ' LEU . 41.9 mt -56.73 22.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.518 2.94 0 O-C-N 120.489 -1.382 . . . . 0.0 114.531 -175.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 43' ' ' MET . 32.3 m-85 -82.92 161.53 57.8 Favored Pre-proline 0 C--N 1.292 -1.919 0 O-C-N 120.344 -1.473 . . . . 0.0 110.557 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.502 ' HB3' ' CB ' ' A' ' 167' ' ' LYS . 48.0 Cg_endo -70.21 131.83 21.39 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 121.791 1.661 . . . . 0.0 111.434 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 1.029 ' HB3' ' HB1' ' A' ' 169' ' ' ALA . . . -61.9 -13.65 26.75 Favored 'General case' 0 N--CA 1.506 2.364 0 O-C-N 121.467 -0.771 . . . . 0.0 111.774 -178.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.815 ' HA ' ' HB3' ' A' ' 123' ' ' ALA . 0.2 OUTLIER -88.83 -8.71 53.83 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.038 -1.039 . . . . 0.0 109.088 178.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.456 ' O ' ' N ' ' A' ' 51' ' ' THR . 0.7 OUTLIER -133.9 57.92 1.79 Allowed 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 176.8 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 1.052 ' O ' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -60.12 87.6 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.456 ' N ' ' O ' ' A' ' 49' ' ' THR . 13.6 m -64.88 155.59 33.7 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.834 -0.746 . . . . 0.0 109.608 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.862 ' CG2' HG21 ' A' ' 115' ' ' ILE . 14.1 t -71.33 -4.89 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.525 -0.734 . . . . 0.0 110.098 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.46 ' OE1' ' CZ ' ' A' ' 45' ' ' PHE . 3.1 mt-10 -57.24 -25.72 59.59 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.886 -1.134 . . . . 0.0 108.959 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.661 ' NE2' HG13 ' A' ' 66' ' ' VAL . 0.1 OUTLIER -75.72 -54.15 7.4 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 121.708 0.765 . . . . 0.0 110.552 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.594 ' HG2' ' HB2' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -66.36 -45.47 80.0 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.608 -178.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -54.75 -44.51 73.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.086 -1.009 . . . . 0.0 110.649 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.707 HD13 ' HG2' ' A' ' 174' ' ' GLU . 3.1 tt -67.09 -56.01 11.86 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.195 -0.941 . . . . 0.0 109.607 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.72 HG21 ' HA3' ' A' ' 64' ' ' GLY . 11.8 p -65.16 -51.77 59.12 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.969 -1.082 . . . . 0.0 111.441 -179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 55' ' ' MET . 7.7 tt -49.92 -25.68 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.053 -1.03 . . . . 0.0 109.198 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 57' ' ' LEU . 9.6 ttm180 -66.52 -61.72 1.84 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.568 -0.853 . . . . 0.0 108.996 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.508 ' HB2' ' HA ' ' A' ' 176' ' ' THR . 5.6 m-70 -129.33 -11.77 4.56 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 118.108 -1.437 . . . . 0.0 114.028 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 58' ' ' THR . . . -132.06 -169.67 12.37 Favored Glycine 0 N--CA 1.498 2.796 0 O-C-N 120.468 -1.395 . . . . 0.0 112.12 -176.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.4 t -135.28 104.75 6.0 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 101.122 -3.658 . . . . 0.0 101.122 176.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.72 ' HA3' HG21 ' A' ' 58' ' ' THR . . . -103.32 73.76 0.28 Allowed Glycine 0 C--N 1.262 -3.545 0 N-CA-C 107.781 -2.128 . . . . 0.0 107.781 -176.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.699 ' O ' HG23 ' A' ' 65' ' ' ILE . 0.6 OUTLIER -65.2 90.2 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.272 -2.765 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 177.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.661 HG13 ' NE2' ' A' ' 54' ' ' GLN . 28.3 m -51.41 155.57 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-O 122.049 0.928 . . . . 0.0 113.375 -177.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 171' ' ' VAL . 61.6 m -90.37 111.7 23.02 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.651 HD21 HD13 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -88.44 91.97 9.0 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.683 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.527 ' C ' HG23 ' A' ' 70' ' ' ILE . 26.4 p -78.35 161.66 27.03 Favored 'General case' 0 C--N 1.285 -2.204 0 C-N-CA 119.578 -0.849 . . . . 0.0 109.929 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.83 HD11 ' HG3' ' A' ' 81' ' ' PRO . 1.1 pt -151.48 147.84 15.11 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.64 HG22 ' HB2' ' A' ' 75' ' ' ARG . 10.3 t -79.89 172.21 14.09 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 120.294 -1.504 . . . . 0.0 107.939 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.489 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -92.46 -10.98 35.92 Favored 'General case' 0 C--N 1.276 -2.587 0 O-C-N 121.321 -0.862 . . . . 0.0 109.855 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -82.95 -72.67 0.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.751 -1.218 . . . . 0.0 111.9 -177.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.441 ' NH1' ' HB2' ' A' ' 126' ' ' ALA . 2.1 mtt-85 -87.8 -35.27 17.93 Favored 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 119.346 -0.942 . . . . 0.0 109.137 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.64 ' HB2' HG22 ' A' ' 71' ' ' THR . 3.0 mmt180 -69.7 -31.29 69.23 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.004 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.489 ' CG ' HD13 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -69.76 -44.22 70.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.236 -1.54 . . . . 0.0 109.075 178.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -41.88 -55.11 3.2 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.768 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.991 HD13 ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -104.97 -27.97 11.36 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 117.673 -1.611 . . . . 0.0 110.149 178.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.991 ' N ' HD13 ' A' ' 78' ' ' LEU . 22.6 t0 -115.8 72.9 0.82 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.793 -1.192 . . . . 0.0 110.115 176.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.728 ' O ' HG11 ' A' ' 97' ' ' VAL . 13.9 tp -80.42 121.25 81.32 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.568 -1.332 . . . . 0.0 109.301 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.83 ' HG3' HD11 ' A' ' 70' ' ' ILE . 54.0 Cg_endo -89.4 93.81 0.33 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.573 1.301 . . . . 0.0 109.596 178.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.491 ' H ' HG21 ' A' ' 97' ' ' VAL . 1.2 ttt -96.84 42.95 1.08 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.172 -0.955 . . . . 0.0 109.879 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.504 ' HA ' ' CA ' ' A' ' 96' ' ' THR . 0.0 OUTLIER 16.8 107.99 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.488 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.661 ' O ' HG13 ' A' ' 84' ' ' VAL . 7.2 p -154.24 93.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 C-N-CA 117.277 -1.769 . . . . 0.0 112.635 176.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -108.84 9.08 26.84 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 118.772 -1.171 . . . . 0.0 108.35 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 88' ' ' THR . 64.8 t-20 -136.62 81.59 1.89 Allowed 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.758 ' O ' HG23 ' A' ' 88' ' ' THR . 11.9 t30 -44.52 87.79 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 119.286 0.948 . . . . 0.0 111.705 -178.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.758 HG23 ' O ' ' A' ' 87' ' ' ASN . 0.0 OUTLIER 176.04 -88.28 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.424 -0.797 . . . . 0.0 110.825 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.626 ' O ' ' HB3' ' A' ' 90' ' ' ALA . 0.1 OUTLIER -103.27 -45.13 4.98 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.872 -1.143 . . . . 0.0 112.74 -178.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 89' ' ' SER . . . 71.5 149.28 0.09 Allowed 'General case' 0 N--CA 1.511 2.618 0 O-C-N 121.131 -0.981 . . . . 0.0 109.995 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 19.7 t80 -94.0 15.55 16.64 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.112 -0.993 . . . . 0.0 112.1 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 62.36 15.46 52.03 Favored Glycine 0 N--CA 1.497 2.761 0 O-C-N 120.903 -1.123 . . . . 0.0 111.943 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.431 ' CB ' ' HG3' ' A' ' 83' ' ' MET . 0.2 OUTLIER -64.06 -11.55 30.58 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.626 -1.514 . . . . 0.0 110.569 179.198 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.503 ' N ' ' HB2' ' A' ' 83' ' ' MET . . . 50.29 11.02 0.38 Allowed Glycine 0 N--CA 1.5 2.94 0 O-C-N 121.296 -0.877 . . . . 0.0 113.907 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.75 ' CD2' HD22 ' A' ' 140' ' ' LEU . 0.1 OUTLIER -123.99 34.75 4.98 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 120.589 2.194 . . . . 0.0 110.638 178.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.504 ' CA ' ' HA ' ' A' ' 83' ' ' MET . 0.7 OUTLIER -133.73 37.38 3.28 Favored 'General case' 0 N--CA 1.515 2.809 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 -179.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.728 HG11 ' O ' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -115.52 110.29 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 O-C-N 120.546 -1.346 . . . . 0.0 110.319 178.283 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.811 HG22 ' O ' ' A' ' 137' ' ' VAL . 14.9 p -75.45 177.19 6.86 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.123 -0.985 . . . . 0.0 110.439 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.081 HD12 HD13 ' A' ' 131' ' ' LEU . 27.9 pt -142.31 135.81 28.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.551 ' CB ' ' O ' ' A' ' 132' ' ' ASN . 10.9 tt0 -86.17 113.37 22.15 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 117.072 -1.851 . . . . 0.0 110.961 -176.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.908 ' HB1' HG13 ' A' ' 105' ' ' VAL . . . -53.02 91.7 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.648 0.737 . . . . 0.0 109.929 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.534 ' H ' HD23 ' A' ' 131' ' ' LEU . . . -106.29 -0.43 24.39 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.407 -0.808 . . . . 0.0 110.504 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.45 ' HB3' ' HB1' ' A' ' 121' ' ' ALA . 27.6 tt0 -86.89 26.97 1.05 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.915 -1.115 . . . . 0.0 111.896 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.645 ' C ' HG21 ' A' ' 117' ' ' THR . . . 126.94 -38.68 2.11 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.422 -1.37 . . . . 0.0 111.466 178.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.908 HG13 ' HB1' ' A' ' 101' ' ' ALA . 5.4 p -101.39 125.7 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.104 -1.233 . . . . 0.0 110.331 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.5 m -143.06 59.62 1.41 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.853 -1.155 . . . . 0.0 110.565 177.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.9 m -137.27 -30.76 0.84 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.091 -1.005 . . . . 0.0 110.564 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.417 ' CA ' ' CE1' ' A' ' 136' ' ' HIS . . . 78.62 -30.81 1.95 Allowed Glycine 0 N--CA 1.494 2.52 0 O-C-N 121.565 -0.71 . . . . 0.0 111.329 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.17 58.57 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.85 -1.383 . . . . 0.0 109.347 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' ' 114' ' ' ARG . 0.5 OUTLIER -128.23 57.49 1.57 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.298 -0.876 . . . . 0.0 109.057 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.594 ' HB2' ' HG2' ' A' ' 55' ' ' MET . . . -33.48 -29.95 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -81.05 -76.94 0.22 Allowed 'General case' 0 C--N 1.291 -1.972 0 O-C-N 120.893 -1.129 . . . . 0.0 110.13 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.81 -13.94 62.71 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.563 -0.711 . . . . 0.0 111.18 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.586 ' HE ' HG21 ' A' ' 118' ' ' VAL . 0.1 OUTLIER -89.65 -44.44 10.05 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.96 -1.087 . . . . 0.0 110.506 -179.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 1.052 HG23 ' O ' ' A' ' 50' ' ' MET . 18.4 mm -64.6 -16.92 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.668 -1.213 . . . . 0.0 110.739 -178.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 68.8 p -88.28 -53.45 4.69 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.866 -1.133 . . . . 0.0 108.704 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.645 HG21 ' C ' ' A' ' 104' ' ' GLY . 60.0 m -71.39 -43.19 67.31 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.544 -0.863 . . . . 0.0 110.004 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.586 HG21 ' HE ' ' A' ' 114' ' ' ARG . 4.4 p -52.72 -40.13 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 120.577 -1.327 . . . . 0.0 109.866 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 48' ' ' GLU . 54.2 ttt180 -51.31 -53.47 35.64 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.464 -0.894 . . . . 0.0 109.851 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -99.29 -6.99 27.01 Favored 'General case' 0 N--CA 1.503 2.196 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' A' ' 117' ' ' THR . . . -98.35 -26.36 14.52 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 116.056 1.872 . . . . 0.0 116.056 -174.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.716 HD12 ' N ' ' A' ' 123' ' ' ALA . 2.6 pp -121.02 -37.7 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 121.112 1.778 . . . . 0.0 112.091 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.815 ' HB3' ' HA ' ' A' ' 48' ' ' GLU . . . -103.98 75.26 1.27 Allowed 'General case' 0 C--N 1.263 -3.166 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.392 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.479 ' CB ' ' CD ' ' A' ' 127' ' ' LYS . 1.0 OUTLIER -97.27 -54.96 2.99 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.297 1.046 . . . . 0.0 110.154 177.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 124.07 -39.94 2.05 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 105.729 -2.949 . . . . 0.0 105.729 -178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.441 ' HB2' ' NH1' ' A' ' 74' ' ' ARG . . . -134.63 96.76 3.63 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 175.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.479 ' CD ' ' CB ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -131.75 123.45 19.22 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 120.857 -1.152 . . . . 0.0 113.373 -176.267 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.456 ' HD2' ' CE ' ' A' ' 127' ' ' LYS . 51.8 Cg_endo -81.38 21.02 0.95 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.656 1.345 . . . . 0.0 108.79 175.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.579 ' O ' ' N ' ' A' ' 131' ' ' LEU . 2.0 m -92.9 42.29 1.1 Allowed 'General case' 0 C--O 1.202 -1.418 0 O-C-N 121.412 -0.805 . . . . 0.0 109.018 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -26.51 79.37 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 123.991 1.853 . . . . 0.0 111.798 -176.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 1.081 HD13 HD12 ' A' ' 99' ' ' ILE 0.255 5.4 mt -61.44 125.35 23.48 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-N 112.069 -2.332 . . . . 0.0 108.047 -178.148 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 15.7 p-10 -113.68 99.51 7.78 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.409 -0.807 . . . . 0.0 111.738 -177.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.843 ' HB2' ' HA ' ' A' ' 134' ' ' PRO 0.282 0.5 OUTLIER -82.58 -178.43 1.18 Allowed Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 122.031 -0.418 . . . . 0.0 111.203 -177.611 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.843 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 48.5 Cg_endo -72.69 123.39 8.23 Favored 'Cis proline' 0 N--CA 1.503 2.063 0 C-N-CA 123.674 -1.386 . . . . 0.0 113.327 8.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.747 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -124.04 60.03 0.61 Allowed Glycine 0 N--CA 1.5 2.907 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.105 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.472 ' O ' ' CE2' ' A' ' 138' ' ' PHE . 25.5 p80 32.1 37.97 0.01 OUTLIER 'General case' 0 N--CA 1.512 2.665 0 O-C-N 121.745 -0.856 . . . . 0.0 112.271 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.811 ' O ' HG22 ' A' ' 98' ' ' THR . 54.4 t -91.04 154.87 3.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 177.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.617 ' CD1' ' O ' ' A' ' 66' ' ' VAL . 0.0 OUTLIER -123.6 84.06 53.37 Favored Pre-proline 0 C--N 1.281 -2.376 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 -178.32 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.859 ' O ' HD23 ' A' ' 140' ' ' LEU . 54.9 Cg_endo -98.42 140.84 0.45 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.737 1.388 . . . . 0.0 113.674 -176.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.859 HD23 ' O ' ' A' ' 139' ' ' PRO . 36.1 mt -136.7 112.8 9.73 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.463 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.416 ' CD ' ' HG2' ' A' ' 81' ' ' PRO . 11.1 ttt180 -69.95 127.0 31.36 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.085 -1.009 . . . . 0.0 109.874 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.83 ' HB3' ' CG2' ' A' ' 158' ' ' ILE . . . -132.75 133.19 43.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.063 -1.023 . . . . 0.0 111.329 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -58.84 143.09 48.56 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.247 -0.908 . . . . 0.0 109.532 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.27 106.27 5.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.421 -0.799 . . . . 0.0 110.568 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 86.54 20.98 53.03 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.83 12.85 62.57 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.825 HG21 ' HB2' ' A' ' 156' ' ' ALA . 13.6 p -104.57 18.76 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.972 -1.311 . . . . 0.0 109.427 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.906 HD11 ' HA ' ' A' ' 207' ' ' ALA . 3.7 mm? -94.86 20.39 8.88 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 117.331 -1.748 . . . . 0.0 108.306 176.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.406 ' O ' ' N ' ' A' ' 151' ' ' GLY . 29.4 m -126.99 73.46 1.42 Allowed 'General case' 0 C--N 1.29 -1.987 1 N-CA-C 96.183 -5.488 . . . . 0.0 96.183 168.515 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.748 ' HG2' HG21 ' A' ' 206' ' ' VAL . 0.1 OUTLIER -67.21 71.85 0.11 Allowed 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 113.553 -1.658 . . . . 0.0 115.033 -168.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 149' ' ' THR . . . -116.93 28.68 7.21 Favored Glycine 0 N--CA 1.475 1.281 0 N-CA-C 105.611 -2.996 . . . . 0.0 105.611 169.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -148.74 131.38 3.72 Favored Glycine 0 C--N 1.303 -1.265 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.535 ' CE1' ' HA3' ' A' ' 41' ' ' GLY . 1.6 t60 -89.79 -5.37 56.99 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 175.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.537 HG23 ' N ' ' A' ' 155' ' ' GLU . 14.9 t -93.38 -46.51 7.31 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.225 -0.922 . . . . 0.0 110.821 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.746 ' HG3' HG23 ' A' ' 147' ' ' VAL . 1.2 pt-20 -59.61 -20.73 57.94 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.825 ' HB2' HG21 ' A' ' 147' ' ' VAL . . . -86.77 5.66 35.34 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 121.356 -0.84 . . . . 0.0 108.943 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.52 ' O ' ' CB ' ' A' ' 160' ' ' LEU . 2.5 m -87.05 -51.12 6.19 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.83 ' CG2' ' HB3' ' A' ' 142' ' ' ALA . 4.4 tp -74.39 -17.44 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 115.96 -2.296 . . . . 0.0 106.404 175.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.693 ' CG ' HG11 ' A' ' 147' ' ' VAL . 18.9 t70 -62.21 -29.84 70.67 Favored 'General case' 0 C--O 1.206 -1.215 0 N-CA-C 104.68 -2.341 . . . . 0.0 104.68 173.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.987 HD21 ' O ' ' A' ' 44' ' ' ILE . 1.7 tm? -50.23 -43.75 53.05 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 176.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.567 ' HB2' ' HA ' ' A' ' 168' ' ' PRO . 0.0 OUTLIER -52.76 -36.21 57.6 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.75 178.508 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.633 HG21 ' HD2' ' A' ' 209' ' ' ARG . 1.5 m -93.17 -51.44 5.02 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 1.075 HD22 HD21 ' A' ' 205' ' ' LEU . 1.8 pp -57.41 -14.47 4.85 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.501 -1.374 . . . . 0.0 111.679 -177.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -77.16 -30.78 55.15 Favored 'General case' 0 N--CA 1.509 2.502 0 O-C-N 120.593 -1.317 . . . . 0.0 108.392 176.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 106.27 -35.43 5.05 Favored Glycine 0 N--CA 1.493 2.475 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.326 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -157.74 48.19 0.39 Allowed 'General case' 0 N--CA 1.506 2.348 0 C-N-CA 117.792 -1.563 . . . . 0.0 113.097 172.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 161' ' ' MET . 40.4 mmtt -135.95 83.46 34.26 Favored Pre-proline 0 C--N 1.289 -2.061 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 174.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.567 ' HA ' ' HB2' ' A' ' 161' ' ' MET . 44.5 Cg_endo -73.65 81.02 1.91 Allowed 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 114.781 -3.013 . . . . 0.0 113.798 -173.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 1.029 ' HB1' ' HB3' ' A' ' 47' ' ' ALA . . . -165.76 168.38 16.12 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 171.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.428 ' HA3' ' HB3' ' A' ' 160' ' ' LEU . . . -156.99 129.02 2.29 Favored Glycine 0 N--CA 1.504 3.184 0 C-N-CA 118.28 -1.914 . . . . 0.0 110.276 177.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.985 HG13 ' HB2' ' A' ' 47' ' ' ALA . 6.5 m -141.42 101.43 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.962 HD22 ' HA ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -125.86 101.08 6.67 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 117.177 -1.809 . . . . 0.0 115.045 -176.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.489 ' HB3' ' CA ' ' A' ' 64' ' ' GLY . 1.1 m -140.79 141.87 34.74 Favored 'General case' 0 N--CA 1.514 2.736 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 173.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.707 ' HG2' HD13 ' A' ' 57' ' ' LEU . 3.5 tt0 176.82 87.32 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.33 0 CA-C-N 122.632 2.469 . . . . 0.0 115.473 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.783 HD13 ' N ' ' A' ' 176' ' ' THR . 0.3 OUTLIER -128.2 135.0 49.12 Favored 'General case' 0 N--CA 1.508 2.464 0 O-C-N 120.452 -1.405 . . . . 0.0 109.108 175.331 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.783 ' N ' HD13 ' A' ' 175' ' ' LEU . 6.2 t -131.13 92.46 3.21 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.762 -1.211 . . . . 0.0 110.312 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.485 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 4.4 t-20 -121.81 142.25 50.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.425 -1.422 . . . . 0.0 111.385 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.487 ' HA ' ' CE1' ' A' ' 61' ' ' HIS . 9.7 p-10 -80.37 6.44 12.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.078 -1.013 . . . . 0.0 111.345 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.74 -18.68 28.9 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 121.453 -0.78 . . . . 0.0 110.119 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 76.41 23.4 70.79 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 183' ' ' ALA . 69.4 p -128.5 98.83 5.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.299 -1.118 . . . . 0.0 110.177 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.37 76.47 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 110.44 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.504 ' HB3' ' HB3' ' A' ' 188' ' ' CYS . . . -54.77 131.43 43.83 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.355 -0.841 . . . . 0.0 109.935 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.588 ' O ' ' HB2' ' A' ' 185' ' ' ALA . 9.5 mtt-85 -105.26 100.15 9.74 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.341 -0.85 . . . . 0.0 109.825 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.859 ' HB1' ' HD2' ' A' ' 186' ' ' PRO . . . 172.92 178.93 0.12 Allowed Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 121.309 -0.869 . . . . 0.0 109.831 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.859 ' HD2' ' HB1' ' A' ' 185' ' ' ALA . 43.0 Cg_endo -69.5 -7.72 21.72 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.303 1.159 . . . . 0.0 110.422 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.5 -41.66 19.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.972 -1.08 . . . . 0.0 109.992 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 183' ' ' ALA . 16.8 p -67.43 -36.32 80.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.966 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.663 HG21 HD21 ' A' ' 5' ' ' LEU . 5.2 tp -73.98 -28.33 23.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.754 -1.216 . . . . 0.0 109.079 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.527 ' HA ' ' HB3' ' A' ' 193' ' ' ASN . 35.9 tt0 -71.05 -19.01 62.54 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.721 0.772 . . . . 0.0 109.05 177.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.497 ' CE2' ' O ' ' A' ' 176' ' ' THR . 0.7 OUTLIER -75.99 -48.42 21.12 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.128 0.966 . . . . 0.0 109.513 -179.413 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.474 ' C ' ' HB2' ' A' ' 197' ' ' MET . . . -73.79 -35.35 64.92 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 178.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . 0.655 ' CB ' HD11 ' A' ' 199' ' ' LEU . 1.7 t30 -56.33 -23.36 36.72 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.3 -40.92 20.81 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 118.099 -1.441 . . . . 0.0 112.741 -176.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.25 -56.03 2.6 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 114.966 -2.694 . . . . 0.0 112.055 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' A' ' 197' ' ' MET . 0.1 OUTLIER -117.05 33.74 5.46 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.073 -1.451 . . . . 0.0 113.773 176.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' MET . . . . . 0.675 ' HE2' HD12 ' A' ' 57' ' ' LEU . 15.3 mmt -150.35 151.69 33.25 Favored 'General case' 0 N--CA 1.517 2.896 0 CA-C-N 123.034 2.652 . . . . 0.0 114.53 -178.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 1.045 ' HB2' HD22 ' A' ' 23' ' ' LEU . . . -111.59 155.73 22.89 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.033 -1.042 . . . . 0.0 108.916 177.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.655 HD11 ' CB ' ' A' ' 193' ' ' ASN . 48.1 mt -125.58 133.19 52.36 Favored 'General case' 0 N--CA 1.507 2.409 0 O-C-N 120.552 -1.342 . . . . 0.0 109.676 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 1.047 ' CA ' HD22 ' A' ' 6' ' ' LEU . 1.3 p -170.82 18.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.521 -1.362 . . . . 0.0 113.287 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 1.006 HG23 HD22 ' A' ' 205' ' ' LEU 0.271 87.0 m -133.33 150.24 51.87 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 116.342 1.979 . . . . 0.0 116.342 -176.149 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.984 ' HB ' HG23 ' A' ' 31' ' ' VAL . 3.6 tp 149.85 -76.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.844 0 C-N-CA 124.99 1.316 . . . . 0.0 109.704 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.794 ' H ' HG23 ' A' ' 202' ' ' ILE . 1.9 tt0 -93.79 -59.56 1.96 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.337 -1.477 . . . . 0.0 110.723 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.33 -50.32 73.42 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.225 -0.922 . . . . 0.0 111.508 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 1.075 HD21 HD22 ' A' ' 163' ' ' LEU . 3.2 tt -60.5 -23.63 64.68 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.069 -1.019 . . . . 0.0 113.244 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.748 HG21 ' HG2' ' A' ' 150' ' ' ARG . 16.5 m -77.98 -34.82 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 119.65 -1.906 . . . . 0.0 108.14 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.906 ' HA ' HD11 ' A' ' 148' ' ' LEU . . . -68.82 -14.62 63.14 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 174.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.907 ' OH ' HD13 ' A' ' 20' ' ' LEU . 7.6 t80 -81.71 -26.71 34.38 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.798 -0.563 . . . . 0.0 109.608 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.633 ' HD2' HG21 ' A' ' 162' ' ' THR . 0.2 OUTLIER -75.82 -25.77 56.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.096 -1.003 . . . . 0.0 108.69 177.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.503 ' N ' ' HG3' ' A' ' 209' ' ' ARG . 6.8 tt0 -82.72 -59.15 2.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.412 -0.805 . . . . 0.0 109.885 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -51.77 -27.1 11.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.485 -0.759 . . . . 0.0 110.223 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -75.37 -44.62 43.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 109.999 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . 0.413 ' OE1' ' CG2' ' A' ' 162' ' ' THR . 2.6 mt-10 -86.27 -9.26 56.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.32 -0.862 . . . . 0.0 110.59 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -111.06 148.08 33.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.001 -1.062 . . . . 0.0 110.205 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.08 104.8 4.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.176 -0.953 . . . . 0.0 110.292 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . 53.11 -173.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.333 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.225 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.299 0.571 . . . . 0.0 110.169 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.404 ' O ' ' HG ' ' A' ' 5' ' ' LEU . 1.9 t-20 -88.18 58.09 4.6 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.904 . . . . 0.0 110.196 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 9' ' ' PHE . 17.5 pt20 -71.41 -16.11 62.38 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.253 -0.904 . . . . 0.0 110.881 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 5' ' ' LEU . 1.5 p -64.42 -2.68 2.4 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.977 -1.077 . . . . 0.0 112.411 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.917 HD13 ' CE1' ' A' ' 13' ' ' PHE . 3.7 mt -28.8 -71.39 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.876 HD21 ' HG ' ' A' ' 163' ' ' LEU . 0.4 OUTLIER -120.25 -49.42 2.28 Favored 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 117.399 -1.72 . . . . 0.0 115.172 -179.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.469 ' CB ' ' CG2' ' A' ' 11' ' ' THR . 1.6 t -100.49 -88.77 0.35 Allowed 'General case' 0 N--CA 1.51 2.563 0 CA-C-N 123.121 2.691 . . . . 0.0 111.33 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.414 ' N ' ' OG ' ' A' ' 7' ' ' SER . 75.7 p -116.66 -62.68 1.55 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 117.926 -1.51 . . . . 0.0 109.281 174.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.452 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 47.4 p90 -162.06 30.27 0.12 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.187 174.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.57 95.22 0.1 OUTLIER Glycine 0 N--CA 1.483 1.768 0 C-N-CA 118.625 -1.75 . . . . 0.0 109.826 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.584 ' C ' ' N ' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -130.2 164.04 43.62 Favored Pre-proline 0 C--N 1.273 -2.751 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 178.461 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.439 ' O ' ' N ' ' A' ' 14' ' ' GLU . 20.5 Cg_endo -46.23 -16.12 0.21 Allowed 'Trans proline' 0 N--CA 1.508 2.334 0 N-CA-C 106.551 -2.134 . . . . 0.0 106.551 174.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.917 ' CE1' HD13 ' A' ' 5' ' ' LEU 0.27 16.1 t80 -40.15 -26.83 0.03 OUTLIER 'General case' 0 C--O 1.184 -2.352 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.733 169.098 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 17' ' ' GLU . 1.0 OUTLIER -43.09 -38.14 2.26 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.085 -1.634 . . . . 0.0 109.082 179.28 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.7 mmt-85 -61.78 -46.37 89.87 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 176.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.803 HG21 ' CE2' ' A' ' 208' ' ' TYR . 15.7 m -79.34 -12.67 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 C-N-CA 117.684 -1.606 . . . . 0.0 109.875 177.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 35.1 tt0 -53.88 -34.54 59.73 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -79.11 -33.08 44.69 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 175.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.744 ' O ' ' HB3' ' A' ' 22' ' ' ALA . . . -70.49 -64.87 0.81 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.5 -0.75 . . . . 0.0 110.834 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.803 HD13 ' HE2' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -54.66 -43.95 72.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.2 -0.938 . . . . 0.0 109.127 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 17' ' ' GLU . . . -53.68 -28.37 33.03 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.744 ' HB3' ' O ' ' A' ' 19' ' ' ALA . . . -78.24 -33.52 49.7 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 177.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 27' ' ' ARG . 3.8 tt -44.52 -28.04 0.53 Allowed 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.84 0.829 . . . . 0.0 109.582 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.53 -30.84 12.64 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.487 ' O ' ' HA ' ' A' ' 22' ' ' ALA . 0.2 OUTLIER -147.7 82.65 1.52 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 123.439 1.59 . . . . 0.0 108.191 177.457 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.657 ' O ' ' HB1' ' A' ' 22' ' ' ALA . . . 126.57 50.64 0.17 Allowed Glycine 0 C--N 1.275 -2.821 1 N-CA-C 102.076 -4.409 . . . . 0.0 102.076 -174.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.803 ' CD ' HG21 ' A' ' 51' ' ' THR . 3.1 mtm180 -55.92 91.16 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 122.942 1.353 . . . . 0.0 110.429 -173.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.463 ' HA3' ' HG2' ' A' ' 197' ' ' MET . . . 176.48 105.95 0.19 Allowed Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.124 -1.512 . . . . 0.0 113.189 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.012 HG13 HG12 ' A' ' 44' ' ' ILE . 1.1 p -140.34 99.21 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 104.36 -2.459 . . . . 0.0 104.36 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.71 ' HB2' HD23 ' A' ' 199' ' ' LEU . 4.9 mtt -97.96 130.42 44.82 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.864 -1.147 . . . . 0.0 114.072 -173.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 1.092 HG12 HD13 ' A' ' 205' ' ' LEU . 35.6 m -77.35 90.5 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.4 -0.812 . . . . 0.0 109.707 177.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.716 HD21 ' HA ' ' A' ' 186' ' ' PRO . 0.4 OUTLIER -56.39 127.81 32.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.985 -1.072 . . . . 0.0 110.396 -179.668 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.686 ' N ' HD13 ' A' ' 32' ' ' LEU . 1.7 t70 -99.11 156.35 16.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.183 -0.948 . . . . 0.0 110.189 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -99.8 173.31 6.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 110.243 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 53.2 -178.92 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.336 -0.852 . . . . 0.0 110.212 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.27 114.38 28.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -0.917 . . . . 0.0 110.202 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -138.15 175.33 9.67 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.302 -0.874 . . . . 0.0 110.167 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -103.51 49.49 0.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.328 -0.858 . . . . 0.0 110.238 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -175.25 135.13 0.33 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.203 -0.936 . . . . 0.0 110.279 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.469 ' O ' ' CG ' ' A' ' 153' ' ' HIS . 34.2 mt-10 -137.94 -71.77 0.42 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 110.209 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.93 ' O ' HG22 ' A' ' 31' ' ' VAL . . . 100.96 55.66 0.92 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.776 ' OD2' HD12 ' A' ' 189' ' ' ILE . 5.2 m-20 -78.92 -37.88 38.72 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.169 -1.195 . . . . 0.0 111.834 -179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.941 ' HE3' HD22 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -85.87 54.41 3.12 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.511 -0.743 . . . . 0.0 110.382 -179.173 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.012 HG12 HG13 ' A' ' 29' ' ' VAL . 3.0 pt -63.77 26.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.534 3.763 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 -175.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.965 ' O ' HG22 ' A' ' 171' ' ' VAL . 9.7 m-85 -67.81 161.68 64.68 Favored Pre-proline 0 C--N 1.283 -2.309 0 O-C-N 121.372 -0.83 . . . . 0.0 112.193 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.478 ' HB3' ' HB3' ' A' ' 167' ' ' LYS . 45.6 Cg_endo -68.83 129.58 18.87 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.524 1.483 . . . . 0.0 110.52 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.54 ' N ' ' HB1' ' A' ' 169' ' ' ALA . . . -70.47 -2.59 14.38 Favored 'General case' 0 N--CA 1.508 2.441 0 C-N-CA 119.195 -1.002 . . . . 0.0 112.554 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -85.73 -23.55 27.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.737 -1.227 . . . . 0.0 109.315 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.57 HG22 ' O ' ' A' ' 49' ' ' THR . 51.7 m -132.42 60.56 1.69 Allowed 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 177.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.411 ' O ' HG13 ' A' ' 115' ' ' ILE . 0.4 OUTLIER -52.48 88.09 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.263 0.554 . . . . 0.0 110.056 -178.739 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.803 HG21 ' CD ' ' A' ' 27' ' ' ARG . 1.6 m -66.18 153.42 42.48 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.616 0.722 . . . . 0.0 109.777 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.985 HG23 ' HB1' ' A' ' 111' ' ' ALA . 1.7 p -73.91 -3.78 4.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.569 -0.707 . . . . 0.0 109.668 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.427 ' CG ' ' HB2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -55.8 -32.63 63.69 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.742 -1.224 . . . . 0.0 108.53 179.287 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.48 ' HB3' ' CD2' ' A' ' 45' ' ' PHE . 10.2 pt20 -81.18 -32.89 33.38 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.51 0.671 . . . . 0.0 110.118 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.763 ' HB3' ' HB2' ' A' ' 111' ' ' ALA . 0.0 OUTLIER -82.22 -46.42 13.75 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.38 -0.825 . . . . 0.0 110.263 -179.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.659 ' HB2' HG22 ' A' ' 52' ' ' VAL . . . -54.07 -45.05 71.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.951 -1.093 . . . . 0.0 110.142 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 1.073 HD21 HD12 ' A' ' 175' ' ' LEU . 7.3 tt -60.98 -53.21 60.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.384 -0.823 . . . . 0.0 110.359 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.568 ' N ' HD23 ' A' ' 57' ' ' LEU . 8.3 t -74.75 -47.44 31.16 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.422 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.517 ' N ' HG23 ' A' ' 58' ' ' THR . 40.8 mt -46.54 -26.03 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 O-C-N 120.649 -1.282 . . . . 0.0 110.222 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.49 -47.62 17.01 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.385 -0.822 . . . . 0.0 110.785 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.43 ' O ' ' HA ' ' A' ' 177' ' ' ASN . 1.9 m-70 -125.18 -7.01 7.1 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.636 -1.29 . . . . 0.0 114.068 -178.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 58' ' ' THR . . . -157.05 -168.23 19.32 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 120.503 -1.373 . . . . 0.0 111.005 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.69 103.77 5.32 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 102.273 -3.232 . . . . 0.0 102.273 176.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.442 ' N ' ' OG1' ' A' ' 58' ' ' THR . . . -104.48 73.03 0.25 Allowed Glycine 0 C--N 1.264 -3.439 0 N-CA-C 106.381 -2.687 . . . . 0.0 106.381 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.841 HG23 ' CZ ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -65.72 90.4 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.031 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.488 HG21 ' HB ' ' A' ' 171' ' ' VAL . 29.3 m -52.79 150.63 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.003 -177.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.546 ' O ' HG21 ' A' ' 157' ' ' THR . 82.8 m -77.6 119.17 20.79 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 177.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 139' ' ' PRO . 0.6 OUTLIER -90.06 92.07 8.82 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 118.617 -1.233 . . . . 0.0 108.551 -179.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.541 ' O ' HD13 ' A' ' 158' ' ' ILE . 0.5 OUTLIER -87.57 145.51 26.18 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 122.339 1.066 . . . . 0.0 112.576 -178.062 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.555 HD12 ' O ' ' A' ' 79' ' ' ASP . 9.9 pt -137.58 138.89 44.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.743 HG23 ' HB3' ' A' ' 143' ' ' GLN . 50.0 m -78.59 143.18 36.69 Favored 'General case' 0 C--O 1.199 -1.588 0 O-C-N 120.549 -1.344 . . . . 0.0 108.769 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.451 ' HB3' ' NE ' ' A' ' 141' ' ' ARG . 6.1 pt-20 -41.53 -25.94 0.06 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.788 -0.57 . . . . 0.0 111.799 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.543 ' H ' HG22 ' A' ' 71' ' ' THR . 0.2 OUTLIER -84.46 -49.64 8.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.953 . . . . 0.0 110.496 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -80.83 -25.5 37.71 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.079 0.942 . . . . 0.0 108.666 179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.568 ' O ' ' N ' ' A' ' 79' ' ' ASP . 6.5 ttp180 -59.01 -67.99 0.31 Allowed 'General case' 0 C--O 1.19 -2.028 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.473 ' HA ' ' CB ' ' A' ' 80' ' ' LEU . 0.4 OUTLIER -48.66 -55.13 12.17 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.244 -178.352 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -30.01 -50.34 0.12 Allowed 'General case' 0 N--CA 1.501 2.082 0 O-C-N 124.362 1.039 . . . . 0.0 111.363 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.734 HD12 HG23 ' A' ' 122' ' ' ILE . 1.6 tm? -134.78 -30.26 1.1 Allowed 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 118.286 -1.365 . . . . 0.0 111.48 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.568 ' N ' ' O ' ' A' ' 75' ' ' ARG . 58.7 m-20 -116.87 69.32 0.75 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.895 -1.128 . . . . 0.0 110.725 177.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.772 ' O ' HG13 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -74.73 169.39 20.14 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 120.766 -1.209 . . . . 0.0 111.66 -179.114 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.877 ' HA ' HG22 ' A' ' 97' ' ' VAL . 39.7 Cg_endo -65.77 113.33 2.5 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 O-C-N 122.551 0.764 . . . . 0.0 110.809 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.489 ' O ' HG13 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -95.67 43.46 1.08 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 0.0 110.768 -179.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.426 ' C ' ' O ' ' A' ' 82' ' ' MET . 3.9 ptt? 26.94 62.4 0.09 Allowed 'General case' 0 N--CA 1.51 2.532 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.546 ' CG2' ' HA ' ' A' ' 96' ' ' THR . 19.1 m -104.08 130.51 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.833 -1.167 . . . . 0.0 110.235 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -98.26 29.47 3.55 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 110.231 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -90.04 19.66 4.8 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.305 -0.872 . . . . 0.0 110.535 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 49.6 p30 -105.24 54.89 0.7 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.138 -0.977 . . . . 0.0 110.134 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.5 m -106.45 -64.7 1.14 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.108 -0.995 . . . . 0.0 110.268 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.78 -22.62 9.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -0.939 . . . . 0.0 110.175 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.709 ' HB1' ' CG2' ' A' ' 93' ' ' THR . . . -69.28 163.95 23.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 110.224 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -114.23 77.08 1.03 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.26 -0.9 . . . . 0.0 110.411 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.417 ' HA3' ' NH2' ' A' ' 150' ' ' ARG . . . 77.02 39.18 28.36 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.709 ' CG2' ' HB1' ' A' ' 90' ' ' ALA . 45.4 p -89.36 -16.13 31.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.226 -1.161 . . . . 0.0 110.548 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.14 21.95 2.02 Favored Glycine 0 N--CA 1.493 2.446 0 O-C-N 121.355 -0.841 . . . . 0.0 111.241 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' A' ' 139' ' ' PRO . 21.9 m-30 -60.83 99.1 0.08 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.658 -1.495 . . . . 0.0 108.776 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.578 HG23 HG23 ' A' ' 97' ' ' VAL . 8.8 t -122.25 -1.15 9.24 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 117.974 -1.49 . . . . 0.0 114.762 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.877 HG22 ' HA ' ' A' ' 81' ' ' PRO . 57.0 t -119.14 79.88 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.619 0 C-N-CA 119.476 -0.889 . . . . 0.0 112.371 178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.59 ' HA ' ' HB ' ' A' ' 137' ' ' VAL . 46.0 p -74.92 144.98 43.02 Favored 'General case' 0 C--N 1.31 -1.128 0 O-C-N 119.844 -1.785 . . . . 0.0 107.257 177.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.944 HG13 HG21 ' A' ' 137' ' ' VAL . 2.2 pt -146.86 125.31 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.121 -0.987 . . . . 0.0 110.568 -177.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.591 ' O ' HD23 ' A' ' 131' ' ' LEU . 6.9 tt0 -93.14 108.85 20.37 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 117.621 -1.632 . . . . 0.0 109.511 179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.99 ' HB1' HG13 ' A' ' 105' ' ' VAL . . . -50.99 93.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.362 -0.836 . . . . 0.0 110.804 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' A' ' 100' ' ' GLU . . . -84.18 2.49 39.46 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.452 -0.78 . . . . 0.0 110.428 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.72 4.21 14.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.993 -1.067 . . . . 0.0 110.702 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.14 26.98 1.16 Allowed Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.76 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.99 HG13 ' HB1' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -146.19 122.53 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.173 -1.192 . . . . 0.0 110.507 179.331 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 5.3 m -146.63 60.72 1.21 Allowed 'General case' 0 N--CA 1.484 1.268 0 O-C-N 121.044 -1.035 . . . . 0.0 110.401 176.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.1 m -135.65 -31.47 0.95 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.811 -1.181 . . . . 0.0 110.73 177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.432 ' HA2' ' NH2' ' A' ' 114' ' ' ARG . . . 74.21 -27.74 0.99 Allowed Glycine 0 N--CA 1.494 2.518 0 O-C-N 121.449 -0.782 . . . . 0.0 112.384 178.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.588 ' HA ' ' HE1' ' A' ' 55' ' ' MET . 0.0 OUTLIER -127.32 57.06 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.469 -1.607 . . . . 0.0 110.604 -179.32 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.496 ' O ' ' CB ' ' A' ' 114' ' ' ARG . 2.7 t -129.47 54.4 1.83 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.33 -0.856 . . . . 0.0 108.695 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.985 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -34.14 -29.53 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.467 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -84.83 -77.58 0.27 Allowed 'General case' 0 C--N 1.288 -2.08 0 O-C-N 120.73 -1.231 . . . . 0.0 109.612 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.413 ' O ' HG23 ' A' ' 117' ' ' THR . 2.1 m-20 -59.45 -17.38 30.63 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.503 -0.748 . . . . 0.0 110.235 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.895 ' O ' HG13 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -89.62 -39.21 13.39 Favored 'General case' 0 C--O 1.203 -1.378 0 O-C-N 120.996 -1.065 . . . . 0.0 110.76 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.752 HD13 ' HA ' ' A' ' 111' ' ' ALA . 1.0 OUTLIER -57.07 -18.4 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 120.306 -1.496 . . . . 0.0 109.368 -178.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.0 m -87.41 -52.93 5.09 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.85 -1.156 . . . . 0.0 108.062 176.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 121' ' ' ALA . 44.1 p -66.61 -36.85 83.59 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.493 179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.895 HG13 ' O ' ' A' ' 114' ' ' ARG . 26.6 m -53.89 -43.4 57.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 O-C-N 120.349 -1.469 . . . . 0.0 108.603 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.521 ' N ' HG23 ' A' ' 118' ' ' VAL . 0.6 OUTLIER -51.77 -32.18 29.89 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.792 -1.163 . . . . 0.0 107.879 177.223 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.451 ' HA ' ' HB2' ' A' ' 123' ' ' ALA . . . -95.3 -19.59 19.85 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.167 178.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 117' ' ' THR . . . -53.72 -54.01 43.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.918 -1.114 . . . . 0.0 109.131 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.734 HG23 HD12 ' A' ' 78' ' ' LEU . 60.3 mt -88.83 23.32 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.525 177.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 124' ' ' ASP . . . -55.18 146.5 18.59 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.508 ' O ' HD23 ' A' ' 78' ' ' LEU . 28.7 t70 -35.62 -80.19 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.792 0 CA-C-N 119.659 1.118 . . . . 0.0 110.093 -178.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 127' ' ' LYS . . . 54.46 34.5 54.94 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 118.133 -1.984 . . . . 0.0 109.786 174.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -59.32 91.16 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 123.29 1.519 . . . . 0.0 110.569 -174.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 125' ' ' GLY . 0.1 OUTLIER -137.93 127.28 14.91 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.428 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -53.67 -16.35 8.02 Favored 'Trans proline' 0 C--N 1.294 -2.337 0 O-C-N 122.703 0.844 . . . . 0.0 111.028 -178.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.0 t -123.45 24.17 8.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.844 -1.16 . . . . 0.0 110.56 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.462 ' HB3' ' CB ' ' A' ' 127' ' ' LYS . 11.0 p30 -74.46 4.25 6.29 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.411 -1.431 . . . . 0.0 112.018 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.838 HD13 ' HB ' ' A' ' 99' ' ' ILE . 25.6 mt -143.1 110.83 5.89 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.558 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.6 OUTLIER -86.46 71.69 10.4 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 -176.511 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.738 ' HB2' ' HA ' ' A' ' 134' ' ' PRO 0.257 0.0 OUTLIER -85.27 173.08 7.55 Favored Pre-proline 0 C--N 1.291 -1.95 0 O-C-N 121.549 -0.719 . . . . 0.0 110.064 179.966 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.738 ' HA ' ' HB2' ' A' ' 133' ' ' ARG . 47.5 Cg_endo -72.66 124.91 9.59 Favored 'Cis proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.832 -1.737 . . . . 0.0 111.524 7.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.974 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -122.08 74.93 0.36 Allowed Glycine 0 N--CA 1.501 2.988 0 C-N-CA 119.452 -1.356 . . . . 0.0 111.866 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.493 ' O ' ' CE2' ' A' ' 138' ' ' PHE . 83.2 m-70 31.18 37.18 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 O-C-N 122.204 -0.586 . . . . 0.0 112.344 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.974 HG23 ' O ' ' A' ' 135' ' ' GLY . 69.3 t -106.07 135.04 45.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 176.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.841 ' CZ ' HG23 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -126.52 81.59 67.93 Favored Pre-proline 0 N--CA 1.495 1.783 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -177.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.791 ' HG3' HG12 ' A' ' 137' ' ' VAL . 64.3 Cg_endo -112.77 141.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.559 2.173 . . . . 0.0 113.495 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.58 HD22 ' O ' ' A' ' 93' ' ' THR . 1.1 pp -127.53 148.87 50.33 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.454 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.46 ' HB2' ' CD ' ' A' ' 75' ' ' ARG . 0.9 OUTLIER -91.52 92.55 8.56 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.867 -1.145 . . . . 0.0 110.054 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -138.8 69.03 1.37 Allowed 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 118.542 -1.263 . . . . 0.0 113.1 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.743 ' HB3' HG23 ' A' ' 71' ' ' THR . 19.6 tm0? -120.9 73.21 1.0 Allowed 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 117.751 -1.579 . . . . 0.0 112.213 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -127.64 38.52 4.03 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 117.733 -1.587 . . . . 0.0 111.459 176.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 74.44 -4.39 34.9 Favored Glycine 0 N--CA 1.497 2.737 0 C-N-CA 119.277 -1.44 . . . . 0.0 111.419 176.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -101.4 28.07 17.67 Favored Glycine 0 N--CA 1.485 1.91 0 O-C-N 120.665 -1.491 . . . . 0.0 113.417 -175.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.953 HG13 HG11 ' A' ' 206' ' ' VAL . 1.5 p -60.48 -15.8 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-N 120.248 2.024 . . . . 0.0 107.822 177.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.761 HD11 HG12 ' A' ' 206' ' ' VAL . 75.3 mt -94.02 22.63 5.59 Favored 'General case' 0 C--O 1.212 -0.913 0 C-N-CA 116.81 -1.956 . . . . 0.0 110.404 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.1 p -127.44 58.34 1.47 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 101.656 -3.461 . . . . 0.0 101.656 168.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.417 ' NH2' ' HA3' ' A' ' 92' ' ' GLY . 0.0 OUTLIER -153.39 149.89 28.28 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 113.034 -1.894 . . . . 0.0 110.763 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -102.47 34.68 5.53 Favored Glycine 0 N--CA 1.483 1.768 0 N-CA-C 106.293 -2.723 . . . . 0.0 106.293 173.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -145.48 159.7 27.95 Favored Glycine 0 N--CA 1.478 1.45 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.656 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 29.2 p-80 -89.7 -4.72 57.59 Favored 'General case' 0 C--N 1.292 -1.921 0 O-C-N 121.657 -0.907 . . . . 0.0 108.845 176.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.434 ' HB ' HD21 ' A' ' 140' ' ' LEU . 1.1 p -51.53 -55.31 19.72 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.015 -1.053 . . . . 0.0 109.795 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.447 ' CB ' ' HA ' ' A' ' 147' ' ' VAL . 24.6 mt-10 -59.51 -21.74 60.61 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.812 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . . . -87.24 6.3 33.9 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.647 ' HA ' HD13 ' A' ' 172' ' ' LEU . 17.9 m -93.83 -51.06 5.06 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 121.159 -0.963 . . . . 0.0 109.52 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.62 ' O ' ' HB3' ' A' ' 161' ' ' MET . 9.7 tp -75.81 -34.15 27.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 116.238 -2.185 . . . . 0.0 105.126 175.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.519 ' HB2' ' HA ' ' A' ' 156' ' ' ALA . 0.8 OUTLIER -59.69 -25.56 64.87 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 174.084 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.66 ' O ' HD12 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -58.78 -28.89 66.37 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 176.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.62 ' HB3' ' O ' ' A' ' 158' ' ' ILE . 5.6 ttt -51.59 -39.26 57.58 Favored 'General case' 0 N--CA 1.514 2.758 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 174.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.444 ' CB ' ' O ' ' A' ' 159' ' ' ASP . 1.2 m -68.52 -39.26 81.25 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.651 177.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 1.014 HD21 HD21 ' A' ' 205' ' ' LEU . 0.3 OUTLIER -52.1 -57.62 9.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.864 -1.148 . . . . 0.0 108.763 179.038 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' A' ' 167' ' ' LYS . . . -64.63 -27.4 68.91 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 122.14 0.972 . . . . 0.0 108.545 177.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 96.17 -27.84 15.24 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' A' ' 166' ' ' PHE . 37.2 p90 -151.05 55.6 0.89 Allowed 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.166 -1.414 . . . . 0.0 112.292 175.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.553 ' HD2' ' HB1' ' A' ' 164' ' ' ALA . 1.9 mttp -129.71 80.2 72.05 Favored Pre-proline 0 C--N 1.296 -1.739 0 CA-C-O 117.23 -1.367 . . . . 0.0 107.777 176.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.434 ' HA ' ' HB2' ' A' ' 161' ' ' MET . 43.2 Cg_endo -72.01 80.58 1.51 Allowed 'Trans proline' 0 C--N 1.32 -0.965 0 C-N-CA 115.367 -2.622 . . . . 0.0 110.636 -176.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.54 ' HB1' ' N ' ' A' ' 47' ' ' ALA . . . -163.26 166.37 23.25 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 104.292 -2.485 . . . . 0.0 104.292 175.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.59 ' HA3' HG22 ' A' ' 157' ' ' THR . . . -157.6 119.49 0.91 Allowed Glycine 0 N--CA 1.485 1.954 0 C-N-CA 116.721 -2.657 . . . . 0.0 112.479 177.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.965 HG22 ' O ' ' A' ' 45' ' ' PHE . 23.6 m -127.08 134.59 65.73 Favored 'Isoleucine or valine' 0 C--O 1.196 -1.761 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 175.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.719 HD23 ' HA3' ' A' ' 41' ' ' GLY . 0.2 OUTLIER -149.88 113.67 5.06 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.696 -1.252 . . . . 0.0 109.39 -178.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.46 ' HB3' ' CG1' ' A' ' 66' ' ' VAL . 21.5 p -128.65 175.79 8.3 Favored 'General case' 0 N--CA 1.51 2.552 0 O-C-N 120.257 -1.527 . . . . 0.0 111.377 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.417 ' OE2' ' NH2' ' A' ' 184' ' ' ARG . 16.0 pm0 -113.05 154.63 26.23 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.106 -0.996 . . . . 0.0 110.558 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 1.073 HD12 HD21 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -82.29 115.48 21.37 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.269 -0.895 . . . . 0.0 109.932 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.588 HG22 ' HA ' ' A' ' 182' ' ' MET . 0.8 OUTLIER -111.47 155.29 23.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.243 -0.911 . . . . 0.0 109.485 179.531 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.43 ' HA ' ' O ' ' A' ' 61' ' ' HIS . 2.9 m-20 -107.69 169.27 8.7 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.192 -0.943 . . . . 0.0 110.333 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.36 5.84 47.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.379 -0.826 . . . . 0.0 111.235 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -68.55 -15.91 63.69 Favored 'General case' 0 C--N 1.29 -2.008 0 O-C-N 121.534 -0.729 . . . . 0.0 110.179 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 103.73 23.23 8.4 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 183' ' ' ALA . 6.0 m -142.08 115.78 9.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -1.142 . . . . 0.0 110.154 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.588 ' HA ' HG22 ' A' ' 176' ' ' THR . 2.4 mpp? -52.42 95.21 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.313 -0.867 . . . . 0.0 110.267 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.766 ' HB1' ' SG ' ' A' ' 188' ' ' CYS . . . -61.37 93.69 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.209 -0.932 . . . . 0.0 110.24 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 185' ' ' ALA . 0.2 OUTLIER -125.16 100.01 6.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.186 -0.946 . . . . 0.0 109.816 179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.858 ' HB1' ' HD2' ' A' ' 186' ' ' PRO . . . 179.17 178.5 0.28 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.387 -0.821 . . . . 0.0 109.704 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.858 ' HD2' ' HB1' ' A' ' 185' ' ' ALA . 45.9 Cg_endo -72.65 -8.47 22.53 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.603 1.318 . . . . 0.0 110.767 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -81.45 -68.94 0.65 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.984 -1.073 . . . . 0.0 110.307 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . 0.766 ' SG ' ' HB1' ' A' ' 183' ' ' ALA . 0.4 OUTLIER -57.74 -30.41 65.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.428 -0.795 . . . . 0.0 110.097 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.852 HG22 HD22 ' A' ' 199' ' ' LEU . 27.2 mm -75.77 -26.3 17.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 120.951 -1.093 . . . . 0.0 109.102 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.489 ' HA ' HD11 ' A' ' 199' ' ' LEU . 12.0 mt-10 -76.76 -19.38 57.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.474 -0.766 . . . . 0.0 109.092 177.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 192' ' ' ALA . 0.8 OUTLIER -70.27 -56.4 6.86 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.179 0.99 . . . . 0.0 108.764 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.692 ' CB ' HD11 ' A' ' 57' ' ' LEU . . . -61.76 -41.78 98.14 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . 0.665 ' CB ' HD11 ' A' ' 199' ' ' LEU . 2.2 t30 -66.33 -13.3 60.34 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.021 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.99 -37.33 47.45 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 117.636 -1.626 . . . . 0.0 111.578 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . 0.405 ' CD2' ' H ' ' A' ' 195' ' ' HIS . 13.7 p80 -108.79 -52.7 2.73 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 115.717 -2.393 . . . . 0.0 111.856 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.462 ' O ' ' HG2' ' A' ' 197' ' ' MET . 44.5 t30 -114.8 33.34 5.43 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.098 -1.441 . . . . 0.0 113.958 177.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' MET . . . . . 0.599 ' CB ' ' HA ' ' A' ' 193' ' ' ASN . 0.0 OUTLIER -151.45 149.71 29.58 Favored 'General case' 0 N--CA 1.52 3.067 0 CA-C-N 123.375 2.807 . . . . 0.0 115.163 -179.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.54 ' HB1' ' HB2' ' A' ' 19' ' ' ALA . . . -107.08 154.28 21.38 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 176.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.852 HD22 HG22 ' A' ' 189' ' ' ILE . 43.7 mt -123.44 144.74 49.31 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 120.277 -1.514 . . . . 0.0 113.171 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.953 HG21 HD12 ' A' ' 205' ' ' LEU . 0.2 OUTLIER -120.28 -161.79 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 177.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.477 ' HB ' ' CB ' ' A' ' 204' ' ' ASP . 0.2 OUTLIER -132.97 142.78 49.04 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.946 -1.096 . . . . 0.0 108.468 177.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.512 HG23 ' N ' ' A' ' 203' ' ' GLU . 5.2 tp -45.93 -46.67 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.196 -0.94 . . . . 0.0 111.56 -178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.512 ' N ' HG23 ' A' ' 202' ' ' ILE . 22.8 tt0 -91.9 -31.49 15.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.883 -1.135 . . . . 0.0 111.016 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.765 ' O ' ' HB3' ' A' ' 207' ' ' ALA . 10.9 t70 -72.99 -39.14 66.32 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.267 -0.896 . . . . 0.0 112.121 -178.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 1.092 HD13 HG12 ' A' ' 31' ' ' VAL . 10.4 tt -58.22 -62.78 1.58 Allowed 'General case' 0 N--CA 1.484 1.264 0 O-C-N 120.687 -1.258 . . . . 0.0 110.641 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.953 HG11 HG13 ' A' ' 147' ' ' VAL . 2.4 t -66.47 -13.55 16.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 C-N-CA 118.086 -1.445 . . . . 0.0 108.122 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 204' ' ' ASP . . . -57.23 -33.18 67.3 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 175.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.803 ' CE2' HG21 ' A' ' 16' ' ' VAL . 4.7 m-30 -56.54 -52.38 65.01 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 175.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.524 ' HB2' HD23 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -61.07 -41.84 97.38 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.761 179.088 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -53.92 -43.12 69.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 109.501 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . 0.442 ' HA ' ' HB2' ' A' ' 214' ' ' ARG . . . -57.45 -35.14 69.75 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.47 -0.769 . . . . 0.0 109.221 179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.466 ' CE1' ' O ' ' A' ' 7' ' ' SER . 2.7 t-160 -55.73 -45.79 77.92 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.539 -0.726 . . . . 0.0 109.839 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -89.01 -9.14 52.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.512 -0.742 . . . . 0.0 110.779 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.442 ' HB2' ' HA ' ' A' ' 211' ' ' ALA . 0.0 OUTLIER -64.24 115.05 4.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.934 -1.104 . . . . 0.0 110.179 -179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 8.5 mttt -123.03 96.59 5.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.286 -0.883 . . . . 0.0 110.188 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . 53.12 86.96 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.891 . . . . 0.0 110.279 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.231 179.995 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mtp . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.283 0.564 . . . . 0.0 110.203 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -83.92 58.15 4.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.902 . . . . 0.0 110.224 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.2 5.97 18.12 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.373 -0.83 . . . . 0.0 110.818 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.5 p -46.94 -25.66 0.83 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.039 -1.038 . . . . 0.0 111.054 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.741 HD11 ' O ' ' A' ' 197' ' ' MET . 0.7 OUTLIER -67.26 -18.99 65.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.025 -1.047 . . . . 0.0 110.12 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.453 HD13 ' HA3' ' A' ' 10' ' ' GLY . 0.1 OUTLIER -113.13 -15.94 12.68 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.245 -0.91 . . . . 0.0 109.5 179.169 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.5 t -92.66 -63.09 1.27 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.992 -1.067 . . . . 0.0 109.801 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.463 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -77.44 -15.07 59.53 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.477 -0.764 . . . . 0.0 109.674 178.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.463 ' CD1' ' O ' ' A' ' 8' ' ' SER . 22.4 m-85 -134.76 57.24 1.81 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.453 ' HA3' HD13 ' A' ' 6' ' ' LEU . . . -168.4 96.2 0.12 Allowed Glycine 0 C--N 1.299 -1.48 0 N-CA-C 105.366 -3.093 . . . . 0.0 105.366 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 16' ' ' VAL . 36.1 p -131.53 140.17 37.58 Favored Pre-proline 0 C--N 1.266 -3.042 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.883 ' O ' HG12 ' A' ' 16' ' ' VAL . 30.5 Cg_endo -54.33 -34.09 78.9 Favored 'Trans proline' 0 C--N 1.269 -3.611 0 O-C-N 122.82 0.905 . . . . 0.0 111.082 -177.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -86.99 -67.14 0.84 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 115.699 1.741 . . . . 0.0 115.699 -177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.56 -45.71 11.5 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 118.521 -1.272 . . . . 0.0 112.336 -175.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.452 ' HB3' ' CA ' ' A' ' 10' ' ' GLY . 28.0 mmt-85 -84.78 -12.26 54.04 Favored 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 118.238 -1.385 . . . . 0.0 113.325 -177.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.883 HG12 ' O ' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -95.16 -28.16 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-N 122.856 2.571 . . . . 0.0 108.69 176.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -66.29 -52.21 49.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 117.938 -1.505 . . . . 0.0 108.101 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -64.28 -33.93 76.96 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.186 -0.946 . . . . 0.0 108.722 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.513 ' O ' ' N ' ' A' ' 23' ' ' LEU . . . -81.01 -5.86 58.1 Favored 'General case' 0 C--O 1.201 -1.47 0 O-C-N 121.188 -0.945 . . . . 0.0 108.606 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.648 HD11 ' O ' ' A' ' 163' ' ' LEU . 0.3 OUTLIER -68.08 -51.7 43.59 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 178.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -56.37 -49.92 73.03 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.566 ' HB1' ' HB2' ' A' ' 27' ' ' ARG . . . -61.25 -28.57 69.26 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.672 ' HA ' ' O ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -60.5 -8.69 2.94 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.534 -0.729 . . . . 0.0 110.765 179.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -96.74 -37.35 10.34 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.384 -0.823 . . . . 0.0 108.969 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -151.57 90.28 1.55 Allowed 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 123.267 1.508 . . . . 0.0 113.444 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.24 -18.35 5.83 Favored Glycine 0 C--N 1.272 -3.007 0 N-CA-C 108.05 -2.02 . . . . 0.0 108.05 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.672 ' O ' ' HA ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -129.42 120.15 25.0 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 178.057 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 198' ' ' ALA . . . -164.2 105.03 0.24 Allowed Glycine 0 C--N 1.27 -3.137 1 N-CA-C 103.017 -4.033 . . . . 0.0 103.017 -175.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.667 ' HB ' ' CB ' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -125.1 161.36 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 113.059 -1.57 . . . . 0.0 112.192 -172.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.618 ' CA ' ' HA ' ' A' ' 42' ' ' ASP . 1.4 tmm? -98.52 152.61 19.37 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.148 178.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.706 HG13 HG21 ' A' ' 44' ' ' ILE . 15.6 m -116.46 127.13 74.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.774 HD23 ' N ' ' A' ' 33' ' ' ASP . 5.1 tt -158.66 -72.04 0.09 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.057 -1.027 . . . . 0.0 110.492 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.774 ' N ' HD23 ' A' ' 32' ' ' LEU . 22.0 t0 60.18 155.92 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.236 -0.915 . . . . 0.0 110.098 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 53.35 -150.99 0.34 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.149 -0.97 . . . . 0.0 110.113 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -146.67 121.13 9.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.92 . . . . 0.0 110.186 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.417 ' O ' ' ND2' ' A' ' 39' ' ' ASN . 9.4 m-20 -157.21 83.91 0.93 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 0.0 110.337 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.74 -167.96 0.05 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.199 -0.938 . . . . 0.0 110.362 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -70.9 76.16 0.63 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.261 -0.899 . . . . 0.0 110.238 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.642 ' O ' HD12 ' A' ' 32' ' ' LEU . 0.9 OUTLIER -100.78 60.28 0.96 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 0.0 110.066 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 174' ' ' GLU . 31.4 mt-10 -85.55 -166.72 1.6 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.242 -0.911 . . . . 0.0 110.409 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.465 ' N ' ' HG2' ' A' ' 30' ' ' MET . . . 163.15 33.47 0.02 OUTLIER Glycine 0 N--CA 1.493 2.452 0 C-N-CA 120.014 -1.088 . . . . 0.0 110.55 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.855 ' OD2' ' HB1' ' A' ' 192' ' ' ALA . 8.3 t70 -43.61 -25.52 0.17 Allowed 'General case' 0 N--CA 1.51 2.548 0 O-C-N 121.009 -1.289 . . . . 0.0 111.268 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.64 ' O ' ' O ' ' A' ' 171' ' ' VAL . 0.0 OUTLIER -93.89 54.45 1.96 Allowed 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -177.216 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.96 ' O ' HD21 ' A' ' 160' ' ' LEU . 28.8 pt -64.5 23.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.524 3.265 0 O-C-N 118.93 -2.356 . . . . 0.0 113.282 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.597 ' O ' HG12 ' A' ' 171' ' ' VAL . 6.6 m-85 -77.21 164.4 58.93 Favored Pre-proline 0 N--CA 1.504 2.25 0 C-N-CA 123.805 0.842 . . . . 0.0 113.236 -178.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.468 ' HG2' ' CG2' ' A' ' 49' ' ' THR . 43.0 Cg_endo -66.79 132.8 29.57 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 122.843 2.362 . . . . 0.0 110.212 177.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.971 ' HB3' ' HB1' ' A' ' 169' ' ' ALA . . . -68.59 -2.71 9.58 Favored 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -176.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.449 ' HG3' HD11 ' A' ' 122' ' ' ILE . 5.7 tt0 -95.71 -22.64 17.42 Favored 'General case' 0 C--N 1.292 -1.905 0 O-C-N 120.662 -1.274 . . . . 0.0 110.491 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.468 ' CG2' ' HG2' ' A' ' 46' ' ' PRO . 4.6 t -134.38 59.02 1.75 Allowed 'General case' 0 C--N 1.315 -0.924 0 O-C-N 120.724 -1.235 . . . . 0.0 107.739 178.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.872 ' O ' HD12 ' A' ' 115' ' ' ILE . 1.5 ppp? -65.0 88.74 0.07 Allowed 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.511 HG22 ' H ' ' A' ' 53' ' ' GLU . 24.4 m -59.32 147.92 34.16 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 122.139 0.971 . . . . 0.0 110.169 -176.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.991 HG23 ' HB1' ' A' ' 111' ' ' ALA . 12.5 p -72.34 -3.26 3.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.505 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.511 ' H ' HG22 ' A' ' 51' ' ' THR . 6.6 tp10 -58.96 -41.22 86.97 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.523 ' HB3' ' HG3' ' A' ' 43' ' ' MET . 8.8 mm-40 -81.44 -47.63 12.94 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.237 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.757 ' O ' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -54.17 -35.28 62.13 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.481 ' HA ' ' CG2' ' A' ' 59' ' ' ILE . . . -54.68 -47.3 73.81 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.685 HD23 ' N ' ' A' ' 58' ' ' THR . 4.8 tt -56.02 -53.65 54.35 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.811 0.815 . . . . 0.0 109.573 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.799 HG21 ' SG ' ' A' ' 173' ' ' CYS . 0.9 OUTLIER -69.28 -58.29 4.23 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.605 -0.684 . . . . 0.0 111.23 -178.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.757 HG22 ' O ' ' A' ' 55' ' ' MET . 1.1 tp -52.47 -22.17 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.106 -0.996 . . . . 0.0 110.742 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 4.1 ttt-85 -74.8 -40.69 60.98 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.212 -0.93 . . . . 0.0 110.962 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -122.86 -1.37 8.9 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.958 -1.089 . . . . 0.0 112.129 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -163.66 -169.96 27.88 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -131.32 102.7 6.08 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 101.38 -3.563 . . . . 0.0 101.38 176.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' A' ' 66' ' ' VAL . . . -104.81 74.97 0.24 Allowed Glycine 0 C--N 1.261 -3.625 0 N-CA-C 106.816 -2.514 . . . . 0.0 106.816 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.624 ' O ' HG23 ' A' ' 65' ' ' ILE . 3.2 tp -62.47 90.63 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.807 HG12 ' HB2' ' A' ' 173' ' ' CYS . 35.5 m -52.13 152.46 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 114.468 -1.242 . . . . 0.0 114.054 -176.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.414 ' N ' ' O ' ' A' ' 172' ' ' LEU . 7.4 t -87.37 114.99 24.48 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 176.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.675 HD23 ' HA ' ' A' ' 171' ' ' VAL . 3.6 mt -87.45 163.96 16.44 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 169' ' ' ALA . 4.7 m -131.48 135.61 47.24 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 118.199 -1.4 . . . . 0.0 113.206 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.655 HG23 ' HB2' ' A' ' 139' ' ' PRO . 2.5 pp -148.82 177.15 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.498 HG22 ' HG3' ' A' ' 72' ' ' GLU . 18.0 m -111.4 159.15 18.29 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.145 -0.972 . . . . 0.0 110.531 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.498 ' HG3' HG22 ' A' ' 71' ' ' THR . 0.1 OUTLIER -49.13 -27.12 3.2 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.475 -0.766 . . . . 0.0 110.62 -179.846 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -56.9 -38.83 73.36 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 0.0 109.676 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.426 ' O ' ' HB3' ' A' ' 78' ' ' LEU . 1.8 mmt180 -78.26 -32.77 49.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.501 -0.749 . . . . 0.0 110.35 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.544 ' HG2' HD13 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -78.72 -28.82 45.06 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 122.204 1.002 . . . . 0.0 108.535 179.013 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 79' ' ' ASP . 4.3 ttmm -56.51 -70.26 0.12 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.429 ' C ' ' HB1' ' A' ' 126' ' ' ALA . 0.4 OUTLIER -46.57 -41.04 13.82 Favored 'General case' 0 N--CA 1.508 2.444 0 CA-C-O 121.974 0.892 . . . . 0.0 109.864 177.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.64 ' O ' HD23 ' A' ' 78' ' ' LEU . 0.7 OUTLIER -96.39 45.77 1.06 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 176.229 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.591 ' N ' ' O ' ' A' ' 76' ' ' LYS . 15.2 t70 -28.68 85.39 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 123.745 1.736 . . . . 0.0 112.329 -172.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.046 HD21 HG11 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -148.44 103.75 3.5 Favored Pre-proline 0 C--N 1.29 -2.009 0 CA-C-N 112.558 -2.11 . . . . 0.0 111.906 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -104.91 93.31 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 121.493 1.462 . . . . 0.0 108.635 175.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.822 ' H ' HG22 ' A' ' 97' ' ' VAL . 14.7 mmt -103.31 107.72 18.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.673 -1.267 . . . . 0.0 111.156 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.483 ' HA ' ' OG1' ' A' ' 96' ' ' THR . 10.6 tmm? -95.89 92.37 6.47 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.862 -1.149 . . . . 0.0 109.654 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.841 HG13 ' O ' ' A' ' 96' ' ' THR . 3.8 m -87.81 148.46 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 C-N-CA 118.301 -1.359 . . . . 0.0 110.303 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -92.7 22.8 4.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.329 -0.857 . . . . 0.0 110.629 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -106.68 18.36 21.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.135 -0.978 . . . . 0.0 110.286 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.701 ' CB ' HG22 ' A' ' 96' ' ' THR . 30.2 t30 -106.69 74.39 1.0 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 0.0 109.85 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 54.7 -141.99 0.83 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.089 -1.007 . . . . 0.0 109.512 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -50.33 -59.96 3.46 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.747 -1.221 . . . . 0.0 110.351 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 53.1 98.33 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.895 . . . . 0.0 110.456 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.458 ' CZ ' ' OG1' ' A' ' 93' ' ' THR . 37.3 p90 -114.48 41.98 2.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.314 -0.866 . . . . 0.0 110.388 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.33 39.92 25.19 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 93' ' ' THR . 30.5 m -86.67 14.69 6.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.239 -1.154 . . . . 0.0 110.89 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.14 23.15 2.6 Favored Glycine 0 N--CA 1.496 2.677 0 O-C-N 120.956 -1.09 . . . . 0.0 110.711 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.842 ' O ' HD13 ' A' ' 140' ' ' LEU . 5.9 t80 -120.47 36.67 4.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.049 -1.265 . . . . 0.0 108.981 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.841 ' O ' HG13 ' A' ' 84' ' ' VAL . 1.4 p -131.05 53.34 1.99 Allowed 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 119.926 -0.71 . . . . 0.0 112.629 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 1.046 HG11 HD21 ' A' ' 80' ' ' LEU . 57.5 t -86.07 105.67 14.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 O-C-N 121.209 -0.932 . . . . 0.0 112.096 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.733 HG22 HG12 ' A' ' 137' ' ' VAL . 1.0 OUTLIER -75.9 152.18 37.2 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 103.029 -2.952 . . . . 0.0 103.029 174.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.782 HD12 ' HB3' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -161.71 138.93 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 C-N-CA 116.708 -1.997 . . . . 0.0 111.513 -176.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.633 ' HB3' ' CB ' ' A' ' 132' ' ' ASN . 1.2 tp10 -99.11 126.5 44.87 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 118.301 -1.36 . . . . 0.0 111.346 -179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.488 ' HA ' ' CD2' ' A' ' 131' ' ' LEU . . . -51.24 115.6 1.64 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.41 -0.807 . . . . 0.0 110.886 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.839 ' HB3' ' O ' ' A' ' 130' ' ' ASP . . . -115.74 -6.78 12.12 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.23 -0.919 . . . . 0.0 110.984 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.84 ' HB3' ' HB1' ' A' ' 120' ' ' ALA . 0.8 OUTLIER -75.82 55.45 0.88 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.952 -1.093 . . . . 0.0 111.692 -178.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.622 ' O ' HG13 ' A' ' 105' ' ' VAL . . . 73.31 24.24 75.72 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.846 HG21 ' HB3' ' A' ' 120' ' ' ALA . 5.2 m -158.25 122.39 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.412 ' HA ' ' HB3' ' A' ' 101' ' ' ALA . 5.8 m -148.38 63.8 1.08 Allowed 'General case' 0 N--CA 1.484 1.24 0 O-C-N 120.85 -1.156 . . . . 0.0 111.605 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.3 t -131.07 -30.76 1.74 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 118.618 -1.233 . . . . 0.0 110.099 177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.409 ' O ' ' NH1' ' A' ' 114' ' ' ARG . . . 63.98 -19.06 0.09 OUTLIER Glycine 0 N--CA 1.5 2.93 0 O-C-N 121.484 -0.76 . . . . 0.0 113.377 178.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -124.86 55.54 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 CA-C-N 119.71 1.755 . . . . 0.0 109.73 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 114' ' ' ARG . 28.6 p -133.2 66.15 1.57 Allowed 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.991 ' HB1' HG23 ' A' ' 52' ' ' VAL . . . -27.19 -39.92 0.01 OUTLIER 'General case' 0 N--CA 1.511 2.593 0 CA-C-O 121.506 0.669 . . . . 0.0 112.589 -177.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -78.59 -72.8 0.36 Allowed 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 122.147 0.975 . . . . 0.0 109.492 178.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 117' ' ' THR . 0.1 OUTLIER -54.51 -23.35 16.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.167 -0.958 . . . . 0.0 109.241 178.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.545 ' N ' ' O ' ' A' ' 110' ' ' SER . 0.3 OUTLIER -61.14 -45.61 93.97 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.549 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.872 HD12 ' O ' ' A' ' 50' ' ' MET . 1.6 mm -65.13 -15.07 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 117.283 -1.767 . . . . 0.0 107.654 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.9 m -89.88 -31.29 17.39 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 175.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.734 HG23 ' HB ' ' A' ' 105' ' ' VAL . 91.0 m -70.8 -49.0 51.12 Favored 'General case' 0 C--O 1.204 -1.3 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.555 HG13 ' N ' ' A' ' 119' ' ' ARG . 10.1 p -53.43 -41.46 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 0.0 109.28 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.555 ' N ' HG13 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -57.88 -33.88 69.19 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.413 179.051 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.846 ' HB3' HG21 ' A' ' 105' ' ' VAL . . . -94.03 -36.93 11.9 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.524 -0.735 . . . . 0.0 111.082 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.702 ' HB1' ' CE1' ' A' ' 138' ' ' PHE . . . -56.52 -56.72 17.76 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.03 -1.044 . . . . 0.0 109.407 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.725 HG22 ' HG3' ' A' ' 139' ' ' PRO . 1.6 pp -87.13 19.36 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.284 178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.541 ' HB2' ' HA ' ' A' ' 120' ' ' ALA . . . -72.76 146.72 46.18 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.454 ' C ' ' O ' ' A' ' 123' ' ' ALA . 16.8 m-20 -37.18 -79.14 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.721 0 CA-C-N 119.598 1.09 . . . . 0.0 109.595 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 127' ' ' LYS . . . 54.75 34.93 57.06 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 118.125 -1.988 . . . . 0.0 109.856 173.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.429 ' HB1' ' C ' ' A' ' 77' ' ' GLN . . . -58.96 91.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 123.337 1.541 . . . . 0.0 110.233 -174.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 125' ' ' GLY . 1.9 mttt -137.97 126.57 14.45 Favored Pre-proline 0 C--N 1.303 -1.436 0 CA-C-N 113.377 -1.738 . . . . 0.0 106.422 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -54.69 -17.79 14.16 Favored 'Trans proline' 0 C--N 1.294 -2.315 0 O-C-N 122.61 0.795 . . . . 0.0 110.306 -179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 25.4 p -124.56 31.65 5.66 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.149 -0.969 . . . . 0.0 109.881 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.839 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 0.9 OUTLIER -73.77 3.84 5.98 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.524 -1.36 . . . . 0.0 111.797 -178.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.733 ' CB ' HG22 ' A' ' 99' ' ' ILE . 30.7 mt -142.58 130.64 21.89 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.633 ' CB ' ' HB3' ' A' ' 100' ' ' GLU . 0.5 OUTLIER -81.52 72.87 8.58 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.326 -1.484 . . . . 0.0 111.639 -177.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.655 ' HB3' ' HA ' ' A' ' 99' ' ' ILE 0.263 0.0 OUTLIER -87.68 152.82 52.21 Favored Pre-proline 0 N--CA 1.502 2.141 0 CA-C-N 114.658 -1.156 . . . . 0.0 110.545 179.72 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.413 ' C ' ' HA ' ' A' ' 133' ' ' ARG . 47.3 Cg_endo -78.36 141.41 64.94 Favored 'Cis proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.215 -1.994 . . . . 0.0 107.787 1.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.536 ' O ' ' O ' ' A' ' 136' ' ' HIS . . . -176.6 95.43 0.1 Allowed Glycine 0 N--CA 1.487 2.078 0 C-N-CA 117.879 -2.105 . . . . 0.0 111.291 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.536 ' O ' ' O ' ' A' ' 135' ' ' GLY . 12.2 m-70 47.3 101.81 0.01 OUTLIER 'General case' 0 C--O 1.206 -1.215 0 CA-C-O 124.283 1.992 . . . . 0.0 109.182 -177.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.733 HG12 HG22 ' A' ' 98' ' ' THR . 19.2 m -49.15 154.48 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.686 0 CA-C-N 112.783 -2.008 . . . . 0.0 112.376 -174.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.782 ' HB3' HD12 ' A' ' 99' ' ' ILE . 1.5 m-85 -146.87 175.42 2.73 Favored Pre-proline 0 C--N 1.29 -1.997 0 CA-C-N 111.434 -2.621 . . . . 0.0 105.271 -174.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.725 ' HG3' HG22 ' A' ' 122' ' ' ILE . 38.4 Cg_endo -57.56 127.88 27.13 Favored 'Trans proline' 0 C--N 1.293 -2.354 0 CA-C-O 123.533 1.389 . . . . 0.0 115.11 -169.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.842 HD13 ' O ' ' A' ' 95' ' ' PHE . 14.6 mt -90.06 172.46 8.82 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 112.96 -1.927 . . . . 0.0 108.965 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.461 ' HB2' ' N ' ' A' ' 72' ' ' GLU . 12.8 ptt85 -126.13 85.16 2.35 Favored 'General case' 0 N--CA 1.516 2.874 0 O-C-N 120.119 -1.613 . . . . 0.0 115.0 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.589 ' HB3' ' CG ' ' A' ' 95' ' ' PHE . . . -141.48 79.69 1.7 Allowed 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.742 -1.224 . . . . 0.0 110.837 176.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.585 ' HB2' HG21 ' A' ' 158' ' ' ILE . 0.5 OUTLIER -117.34 75.26 0.97 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.143 -1.598 . . . . 0.0 112.966 -179.353 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -127.04 43.37 3.13 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.637 -1.289 . . . . 0.0 110.982 176.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 75.83 37.08 40.12 Favored Glycine 0 N--CA 1.498 2.8 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -100.54 12.35 59.74 Favored Glycine 0 N--CA 1.49 2.285 0 O-C-N 120.91 -1.347 . . . . 0.0 113.521 -176.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.86 HG13 HD22 ' A' ' 148' ' ' LEU . 8.2 p -107.9 -13.9 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-N 120.312 2.056 . . . . 0.0 111.828 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.86 HD22 HG13 ' A' ' 147' ' ' VAL . 4.6 mm? -87.42 13.28 10.25 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 115.041 -2.664 . . . . 0.0 109.876 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 84.2 m -132.93 62.15 1.66 Allowed 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 100.548 -3.871 . . . . 0.0 100.548 167.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -148.27 135.15 20.05 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.072 -1.422 . . . . 0.0 113.831 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -104.26 36.25 4.5 Favored Glycine 0 N--CA 1.48 1.605 0 N-CA-C 106.177 -2.769 . . . . 0.0 106.177 173.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.409 ' HA2' ' OD1' ' A' ' 39' ' ' ASN . . . -142.31 163.8 27.05 Favored Glycine 0 N--CA 1.479 1.55 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.868 ' HA ' ' HB3' ' A' ' 156' ' ' ALA . 54.5 p-80 -90.98 -6.12 54.45 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.883 -0.774 . . . . 0.0 109.765 177.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.403 ' O ' ' HB ' ' A' ' 157' ' ' THR . 6.8 p -56.39 -64.99 0.68 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 122.362 1.077 . . . . 0.0 108.876 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.456 ' HB3' ' CA ' ' A' ' 147' ' ' VAL . 65.9 mm-40 -59.4 -22.16 60.99 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 177.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.868 ' HB3' ' HA ' ' A' ' 153' ' ' HIS . . . -86.02 4.37 38.18 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.551 -0.86 . . . . 0.0 109.226 178.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.505 HG23 ' SG ' ' A' ' 69' ' ' CYS . 0.6 OUTLIER -83.07 -51.65 7.35 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 178.328 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.585 HG21 ' HB2' ' A' ' 143' ' ' GLN . 0.2 OUTLIER -74.87 -17.54 16.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 115.923 -2.311 . . . . 0.0 105.996 176.108 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.942 ' CG ' HG12 ' A' ' 206' ' ' VAL . 8.3 t70 -59.29 -26.71 65.19 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 173.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 1.047 HD22 ' HG ' ' A' ' 163' ' ' LEU . 0.4 OUTLIER -53.3 -41.33 65.52 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 175.175 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.572 ' HA ' ' HA ' ' A' ' 168' ' ' PRO . 0.0 OUTLIER -48.2 -33.45 8.54 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 176.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.94 HG21 ' HG3' ' A' ' 209' ' ' ARG . 1.3 m -93.29 -31.83 14.55 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.719 177.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 1.047 ' HG ' HD22 ' A' ' 160' ' ' LEU . 0.5 OUTLIER -36.34 -40.94 0.25 Allowed 'General case' 0 N--CA 1.521 3.102 0 O-C-N 121.489 -0.757 . . . . 0.0 110.071 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.541 ' CB ' HD21 ' A' ' 20' ' ' LEU . . . -94.49 -29.24 15.04 Favored 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.103 -0.998 . . . . 0.0 110.909 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.03 -29.99 10.76 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 177.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -149.93 47.28 0.93 Allowed 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 117.922 -1.511 . . . . 0.0 111.571 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.409 ' O ' ' N ' ' A' ' 169' ' ' ALA . 2.5 mptp? -133.3 68.42 77.36 Favored Pre-proline 0 C--N 1.29 -2.019 0 N-CA-C 103.294 -2.854 . . . . 0.0 103.294 173.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.572 ' HA ' ' HA ' ' A' ' 161' ' ' MET . 42.4 Cg_endo -69.5 80.24 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 115.218 -2.721 . . . . 0.0 114.531 -170.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.971 ' HB1' ' HB3' ' A' ' 47' ' ' ALA . . . -164.29 166.11 21.2 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 171.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 68' ' ' LEU . . . -154.79 135.52 4.72 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 118.019 -2.039 . . . . 0.0 110.356 178.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.675 ' HA ' HD23 ' A' ' 68' ' ' LEU . 2.9 p -121.4 89.83 1.49 Allowed 'Isoleucine or valine' 0 C--O 1.191 -1.991 0 C-N-CA 117.374 -1.73 . . . . 0.0 107.376 177.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.954 HD11 HD23 ' A' ' 160' ' ' LEU . 9.1 mp -95.12 153.81 17.48 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 119.249 0.931 . . . . 0.0 110.11 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.807 ' HB2' HG12 ' A' ' 66' ' ' VAL . 35.7 t -124.71 162.63 23.79 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 122.023 0.916 . . . . 0.0 112.905 -177.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.434 ' HA ' ' CB ' ' A' ' 40' ' ' GLU . 1.3 pt-20 -135.84 107.23 6.86 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.471 HD23 ' SG ' ' A' ' 188' ' ' CYS . 0.8 OUTLIER -63.36 139.62 58.79 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.052 -1.03 . . . . 0.0 111.153 -178.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.617 ' HA ' ' HB3' ' A' ' 183' ' ' ALA . 98.7 m -139.19 155.54 47.74 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.678 -0.639 . . . . 0.0 109.555 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -93.46 168.26 11.17 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 120.957 -1.089 . . . . 0.0 110.252 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -91.3 6.59 44.67 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.714 0.769 . . . . 0.0 111.027 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.14 7.38 19.07 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.659 -0.651 . . . . 0.0 110.514 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 78.32 22.51 67.6 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 183' ' ' ALA . 98.2 m -121.91 109.23 14.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -1.149 . . . . 0.0 109.991 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.432 ' HA ' HG23 ' A' ' 176' ' ' THR . 51.9 mtm -51.65 95.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.286 -0.884 . . . . 0.0 110.316 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.617 ' HB3' ' HA ' ' A' ' 176' ' ' THR . . . -54.63 111.06 0.73 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.225 -0.922 . . . . 0.0 110.016 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 185' ' ' ALA . 0.6 OUTLIER -140.69 100.27 3.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 110.07 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.764 ' HB1' ' HD2' ' A' ' 186' ' ' PRO . . . 179.89 173.34 0.49 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 110.213 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.764 ' HD2' ' HB1' ' A' ' 185' ' ' ALA . 43.6 Cg_endo -69.53 -15.64 38.08 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.66 1.348 . . . . 0.0 110.226 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 77.2 mt-10 -87.81 -36.8 17.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.11 -0.994 . . . . 0.0 109.855 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . 0.603 ' SG ' ' HB1' ' A' ' 183' ' ' ALA . 41.1 t -58.84 -49.3 78.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.394 -0.817 . . . . 0.0 109.462 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.715 HG23 HD21 ' A' ' 199' ' ' LEU . 7.4 tp -76.84 -24.15 15.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 120.845 -1.159 . . . . 0.0 109.38 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.474 ' HA ' ' CB ' ' A' ' 193' ' ' ASN . 3.7 tt0 -57.41 -23.26 48.3 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.436 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 3.8 t80 -74.95 -46.19 37.21 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.855 ' HB1' ' OD2' ' A' ' 42' ' ' ASP . . . -65.77 -18.44 65.33 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 175.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . 0.672 ' CG ' HD22 ' A' ' 199' ' ' LEU . 56.9 t30 -85.48 -7.76 58.73 Favored 'General case' 0 C--O 1.207 -1.159 0 O-C-N 121.896 -0.503 . . . . 0.0 109.696 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.59 -51.26 5.79 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.205 -1.559 . . . . 0.0 110.092 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.9 -41.06 12.0 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 118.268 -1.373 . . . . 0.0 107.599 178.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 198' ' ' ALA . 0.6 OUTLIER -99.34 52.17 0.94 Allowed 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 175.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' MET . . . . . 0.741 ' O ' HD11 ' A' ' 5' ' ' LEU . 45.5 ttm -66.72 74.25 0.1 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -173.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.667 ' CB ' ' HB ' ' A' ' 29' ' ' VAL . . . -134.1 106.4 7.18 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 104.057 -2.571 . . . . 0.0 104.057 172.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.715 HD21 HG23 ' A' ' 189' ' ' ILE . 2.9 tp -126.97 120.04 28.13 Favored 'General case' 0 N--CA 1.506 2.371 0 O-C-N 119.734 -1.854 . . . . 0.0 109.606 -177.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.574 HG22 ' H ' ' A' ' 201' ' ' THR . 4.5 p -124.08 -177.0 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.259 -0.901 . . . . 0.0 110.929 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.574 ' H ' HG22 ' A' ' 200' ' ' VAL . 5.5 p -121.01 135.99 55.09 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.117 -0.989 . . . . 0.0 110.501 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.606 HD11 ' HB3' ' A' ' 153' ' ' HIS . 68.7 mt -60.76 -37.77 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 O-C-N 121.483 -0.761 . . . . 0.0 112.093 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -45.16 -65.95 0.46 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.257 -0.902 . . . . 0.0 110.909 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.63 ' O ' ' HB3' ' A' ' 207' ' ' ALA . 0.6 OUTLIER -72.88 -17.85 61.48 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.167 -0.958 . . . . 0.0 110.098 179.237 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.683 HD11 HD21 ' A' ' 163' ' ' LEU . 2.4 tm? -60.44 -68.35 0.31 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.08 -1.012 . . . . 0.0 109.564 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.942 HG12 ' CG ' ' A' ' 159' ' ' ASP . 11.5 m -63.92 -16.12 18.1 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 C-N-CA 117.922 -1.511 . . . . 0.0 109.356 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.63 ' HB3' ' O ' ' A' ' 204' ' ' ASP . . . -56.6 -32.34 65.16 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 105.858 -1.904 . . . . 0.0 105.858 174.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.604 ' CE2' ' CG1' ' A' ' 16' ' ' VAL 0.286 0.9 OUTLIER -54.75 -52.15 63.45 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 176.108 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.94 ' HG3' HG21 ' A' ' 162' ' ' THR . 48.2 ttt180 -56.65 -45.73 81.44 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.6 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.417 ' OE1' ' N ' ' A' ' 211' ' ' ALA . 1.8 tm0? -69.2 -56.0 8.92 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.218 -0.926 . . . . 0.0 110.184 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . 0.417 ' N ' ' OE1' ' A' ' 210' ' ' GLN . . . -58.91 -27.42 65.23 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.438 -0.789 . . . . 0.0 110.182 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' A' ' 208' ' ' TYR . 70.6 t60 -72.39 -28.03 62.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.32 -0.863 . . . . 0.0 110.12 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -89.39 -9.24 51.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.31 -0.869 . . . . 0.0 110.662 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.67 101.67 0.49 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.969 -1.082 . . . . 0.0 110.162 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 216' ' ' ALA . 19.2 mttt -96.55 98.07 9.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.215 -0.928 . . . . 0.0 110.222 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 215' ' ' LYS . . . 57.75 -85.5 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.437 -0.789 . . . . 0.0 110.475 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 215' ' ' LYS . 9.3 t . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.0 -1.062 . . . . 0.0 110.19 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.255 0.55 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -109.75 55.81 0.63 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.215 -0.928 . . . . 0.0 110.201 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.47 -20.97 49.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.281 -0.887 . . . . 0.0 110.222 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.447 ' HA ' ' CB ' ' A' ' 7' ' ' SER . 10.0 t -72.56 -4.93 33.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.873 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 tp -51.49 -65.02 0.63 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.012 -1.055 . . . . 0.0 110.579 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.853 ' CD2' HG23 ' A' ' 200' ' ' VAL . 1.2 tt -89.93 17.57 6.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 110.279 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.447 ' CB ' ' HA ' ' A' ' 4' ' ' THR . 15.8 m -92.6 -63.3 1.24 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.092 -1.005 . . . . 0.0 111.305 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 t -89.73 -24.98 21.4 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.124 -0.985 . . . . 0.0 110.202 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -131.63 58.04 1.74 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.627 ' C ' ' HD3' ' A' ' 12' ' ' PRO . . . -133.24 -174.78 13.69 Favored Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 105.184 -3.166 . . . . 0.0 105.184 -177.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.573 HG22 ' HB3' ' A' ' 15' ' ' ARG 0.251 43.2 p -129.09 65.06 73.09 Favored Pre-proline 0 C--N 1.252 -3.634 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 176.334 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.627 ' HD3' ' C ' ' A' ' 10' ' ' GLY . 54.5 Cg_endo -90.19 -58.07 0.02 OUTLIER 'Trans proline' 0 C--O 1.201 -1.333 0 O-C-N 124.487 1.783 . . . . 0.0 109.182 178.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -97.71 -70.62 0.71 Allowed 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -177.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -74.05 -41.37 61.87 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 118.783 -1.167 . . . . 0.0 109.798 -177.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.573 ' HB3' HG22 ' A' ' 11' ' ' THR . 1.7 mmt180 -88.12 -17.24 31.42 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 118.258 -1.377 . . . . 0.0 111.96 -179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.669 HG13 HD23 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -68.6 -28.08 38.78 Favored 'Isoleucine or valine' 0 C--O 1.188 -2.151 0 C-N-CA 114.775 -2.77 . . . . 0.0 107.278 177.133 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 1.2 tm-20 -67.18 -54.7 18.69 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 117.493 -1.683 . . . . 0.0 107.415 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 -62.6 -33.26 74.63 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.181 178.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.715 ' HB1' ' CD1' ' A' ' 23' ' ' LEU . . . -88.12 -6.75 57.73 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.218 -0.926 . . . . 0.0 109.011 178.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.923 HD11 ' HA ' ' A' ' 164' ' ' ALA . 0.2 OUTLIER -61.48 -49.67 75.82 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.383 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . . . -70.94 -54.55 10.95 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.604 -0.838 . . . . 0.0 108.801 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.609 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . . . -49.94 -40.35 43.32 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.501 -0.749 . . . . 0.0 110.231 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.756 ' HB3' HG13 ' A' ' 29' ' ' VAL . 43.8 mt -90.56 -16.74 28.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.343 -0.848 . . . . 0.0 110.051 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -61.81 -16.53 50.68 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.375 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -92.98 45.26 1.17 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 122.527 1.156 . . . . 0.0 109.968 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.541 ' HA2' ' CZ ' ' A' ' 45' ' ' PHE . . . 58.61 28.68 62.95 Favored Glycine 0 C--N 1.288 -2.114 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 177.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.519 ' HB3' HD23 ' A' ' 23' ' ' LEU . 4.2 ttt-85 -89.31 18.4 5.21 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 116.71 -1.996 . . . . 0.0 110.844 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.804 ' O ' ' HB3' ' A' ' 198' ' ' ALA . . . 96.81 107.11 2.4 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.129 -1.51 . . . . 0.0 115.388 172.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.756 HG13 ' HB3' ' A' ' 23' ' ' LEU . 0.2 OUTLIER -142.25 113.86 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 174.057 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.659 ' HB2' ' CD1' ' A' ' 199' ' ' LEU . 2.3 mtp -124.2 122.55 38.1 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.014 -1.054 . . . . 0.0 110.513 -174.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.626 HG23 HG13 ' A' ' 200' ' ' VAL . 0.8 OUTLIER -102.25 125.86 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.781 -1.2 . . . . 0.0 110.838 -179.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.636 HD11 ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -177.27 155.27 1.11 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.293 -0.879 . . . . 0.0 110.094 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 33' ' ' ASP . 29.3 p-10 -174.53 128.54 0.33 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.163 -0.961 . . . . 0.0 110.372 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 33.3 t0 53.39 97.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.196 -0.94 . . . . 0.0 110.383 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.929 ' OE1' ' HB2' ' A' ' 185' ' ' ALA . 40.8 tt0 -79.61 95.29 5.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.896 . . . . 0.0 110.162 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -80.3 -70.34 0.53 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.196 -0.94 . . . . 0.0 110.233 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.04 -25.44 7.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.284 -0.885 . . . . 0.0 110.193 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.84 -69.77 0.21 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.301 -0.874 . . . . 0.0 110.29 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.636 ' O ' HD11 ' A' ' 32' ' ' LEU . 2.1 m120 53.32 91.77 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.281 -0.887 . . . . 0.0 110.182 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.533 ' HA ' HD11 ' A' ' 32' ' ' LEU . 26.1 mt-10 -148.0 116.69 6.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.323 -0.861 . . . . 0.0 110.182 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.459 ' O ' HD12 ' A' ' 172' ' ' LEU . . . -177.75 42.18 0.09 OUTLIER Glycine 0 N--CA 1.49 2.242 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.36 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.587 ' HA ' ' HB3' ' A' ' 30' ' ' MET . 2.4 p30 -77.15 -6.94 54.82 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.763 -1.434 . . . . 0.0 110.973 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.705 ' HG2' HG12 ' A' ' 66' ' ' VAL . 9.6 tpp -96.19 56.53 1.64 Allowed 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 123.567 0.747 . . . . 0.0 110.416 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.921 ' C ' HD11 ' A' ' 160' ' ' LEU . 41.7 mt -60.73 34.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 O-C-N 121.159 -0.963 . . . . 0.0 113.557 -176.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.947 ' O ' HG22 ' A' ' 171' ' ' VAL . 26.3 m-85 -111.52 162.03 22.81 Favored Pre-proline 0 N--CA 1.502 2.132 0 O-C-N 119.836 -1.79 . . . . 0.0 114.122 -175.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.405 ' HG2' ' OG1' ' A' ' 49' ' ' THR . 46.5 Cg_endo -72.63 131.36 17.19 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.374 2.049 . . . . 0.0 109.271 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.939 ' O ' HG12 ' A' ' 118' ' ' VAL . . . -72.28 -1.47 15.44 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 120.785 -1.197 . . . . 0.0 113.132 -177.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -93.46 -16.77 24.18 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.64 -1.288 . . . . 0.0 109.788 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.405 ' OG1' ' HG2' ' A' ' 46' ' ' PRO . 0.8 OUTLIER -131.61 59.15 1.7 Allowed 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 177.426 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.94 ' SD ' HG11 ' A' ' 118' ' ' VAL . 5.0 tpt -54.46 95.75 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.505 -178.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.0 p -66.53 133.48 50.44 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.731 ' CG2' HG21 ' A' ' 115' ' ' ILE . 2.6 t -77.98 -2.37 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.061 -1.024 . . . . 0.0 108.504 178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.424 ' CG ' ' O ' ' A' ' 26' ' ' GLY . 0.6 OUTLIER -60.77 -40.8 93.92 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.254 -179.406 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.704 ' HA ' ' HE1' ' A' ' 197' ' ' MET . 85.1 mm-40 -80.33 -24.14 40.1 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.594 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.747 ' O ' HG22 ' A' ' 59' ' ' ILE . 11.2 tpt -82.49 -38.06 24.43 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.353 -0.842 . . . . 0.0 109.493 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -57.93 -42.1 84.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.48 -0.762 . . . . 0.0 109.767 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.944 HD13 ' SD ' ' A' ' 197' ' ' MET . 5.8 tt -65.58 -48.71 71.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 109.322 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.532 ' N ' HD23 ' A' ' 57' ' ' LEU . 37.0 p -67.02 -59.12 3.74 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.365 -0.835 . . . . 0.0 110.979 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.894 HD12 ' HA ' ' A' ' 111' ' ' ALA . 11.3 tt -47.48 -24.79 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 O-C-N 121.17 -0.956 . . . . 0.0 111.022 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.8 ttt85 -72.07 -45.8 59.35 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.19 -0.944 . . . . 0.0 110.702 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -124.1 5.47 8.57 Favored 'General case' 0 N--CA 1.506 2.37 0 O-C-N 120.872 -1.143 . . . . 0.0 112.163 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 58' ' ' THR . . . -165.12 -169.27 28.52 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 -178.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 74.5 p -139.91 102.26 4.37 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 102.803 -3.036 . . . . 0.0 102.803 176.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.33 72.91 0.22 Allowed Glycine 0 C--N 1.266 -3.352 0 N-CA-C 105.222 -3.151 . . . . 0.0 105.222 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.578 HG23 ' HZ ' ' A' ' 138' ' ' PHE . 1.7 tt -63.07 106.78 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.276 -2.6 0 CA-C-O 122.622 1.201 . . . . 0.0 107.906 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.806 HG21 ' SD ' ' A' ' 50' ' ' MET . 16.5 m -52.53 151.03 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 115.129 -0.942 . . . . 0.0 112.043 -177.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.92 ' C ' HD13 ' A' ' 68' ' ' LEU . 82.5 m -85.9 160.74 19.33 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 177.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.92 HD13 ' C ' ' A' ' 67' ' ' CYS . 0.0 OUTLIER -137.87 91.76 2.61 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 118.012 -1.475 . . . . 0.0 108.094 178.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.444 ' CB ' ' OG1' ' A' ' 157' ' ' THR . 1.3 m -102.52 152.25 21.37 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 119.046 -1.062 . . . . 0.0 110.472 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.872 ' HA ' HD11 ' A' ' 158' ' ' ILE . 1.1 mt -152.6 -177.73 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.462 ' H ' HG22 ' A' ' 70' ' ' ILE . 22.0 p -86.33 144.71 27.24 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.428 ' O ' ' CG ' ' A' ' 76' ' ' LYS . 0.0 OUTLIER -53.54 -20.03 4.48 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.208 -0.933 . . . . 0.0 110.379 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.422 ' O ' ' CG ' ' A' ' 77' ' ' GLN . 10.1 t70 -79.0 -37.58 38.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.153 -0.967 . . . . 0.0 110.951 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -85.95 -52.44 5.72 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.21 -0.931 . . . . 0.0 110.629 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.871 ' CD ' HD12 ' A' ' 70' ' ' ILE . 22.4 tpt180 -54.2 -53.93 46.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.166 -0.959 . . . . 0.0 109.54 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.713 ' HG2' HD13 ' A' ' 80' ' ' LEU . 1.1 mtpm? -60.43 -56.67 18.65 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.293 -0.879 . . . . 0.0 111.605 -178.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.422 ' CG ' ' O ' ' A' ' 73' ' ' ASP . 4.9 mt-30 -27.29 -49.41 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.851 1.344 . . . . 0.0 110.997 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 1.005 HD13 ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -136.88 -27.52 1.0 Allowed 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 117.162 -1.815 . . . . 0.0 113.082 177.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 1.005 ' N ' HD13 ' A' ' 78' ' ' LEU . 65.9 t0 -121.15 62.97 0.88 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 117.363 -1.735 . . . . 0.0 115.438 179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.901 HD21 ' OG1' ' A' ' 96' ' ' THR . 2.2 tt -144.73 104.23 4.55 Favored Pre-proline 0 N--CA 1.506 2.348 0 C-N-CA 115.925 -2.31 . . . . 0.0 113.744 174.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.903 ' O ' HG22 ' A' ' 97' ' ' VAL . 38.3 Cg_endo -101.56 96.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.3 -1.983 0 N-CA-C 107.257 -1.863 . . . . 0.0 107.257 174.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.404 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 9.4 ttt -88.8 45.48 1.29 Allowed 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.21 -0.932 . . . . 0.0 109.553 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.637 ' HB2' HG11 ' A' ' 97' ' ' VAL . 4.7 mmm -57.7 -11.51 2.23 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.655 -0.653 . . . . 0.0 110.656 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 1.001 HG23 HG12 ' A' ' 97' ' ' VAL . 53.6 t -86.52 102.23 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 C-N-CA 116.878 -1.929 . . . . 0.0 109.915 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' A' ' 87' ' ' ASN . 0.0 OUTLIER -101.53 30.85 4.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.681 -0.637 . . . . 0.0 109.681 179.093 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.47 ' ND2' ' CG1' ' A' ' 84' ' ' VAL . 34.2 p30 -64.11 80.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.27 -0.893 . . . . 0.0 110.665 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.418 ' N ' ' O ' ' A' ' 85' ' ' GLU . 2.3 m120 -103.14 54.4 0.76 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.359 -0.838 . . . . 0.0 109.717 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.2 p -141.78 -81.42 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.375 -0.828 . . . . 0.0 109.51 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.63 -26.78 64.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.209 -0.932 . . . . 0.0 109.28 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.413 ' CB ' ' OG1' ' A' ' 93' ' ' THR . . . -114.48 174.73 5.81 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.523 -0.736 . . . . 0.0 109.724 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -114.51 77.71 1.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.1 -1.0 . . . . 0.0 110.836 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 77.66 42.73 16.66 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.317 -1.42 . . . . 0.0 109.688 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.413 ' OG1' ' CB ' ' A' ' 90' ' ' ALA . 1.5 m -48.58 -21.74 0.63 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.071 -1.252 . . . . 0.0 111.33 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 96' ' ' THR . . . 46.21 26.4 2.24 Favored Glycine 0 N--CA 1.497 2.758 0 O-C-N 120.939 -1.101 . . . . 0.0 110.951 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.721 ' HB2' HG11 ' A' ' 84' ' ' VAL . 0.1 OUTLIER -57.05 87.56 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 123.144 1.45 . . . . 0.0 112.237 -177.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.901 ' OG1' HD21 ' A' ' 80' ' ' LEU . 1.2 m -61.41 81.25 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 114.026 -1.443 . . . . 0.0 109.413 177.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 1.001 HG12 HG23 ' A' ' 84' ' ' VAL . 1.2 m -37.07 155.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.52 3.046 0 CA-C-O 122.259 1.028 . . . . 0.0 111.935 -175.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.907 HG22 ' O ' ' A' ' 137' ' ' VAL . 39.4 p -66.52 -176.88 0.5 Allowed 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -174.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.778 HD11 HG23 ' A' ' 117' ' ' THR . 1.1 pp -110.6 146.78 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 122.47 1.129 . . . . 0.0 113.545 -177.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.665 ' N ' ' H ' ' A' ' 133' ' ' ARG . 58.1 tt0 -93.65 163.27 13.61 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.445 ' HB1' ' HB ' ' A' ' 106' ' ' THR . . . -77.69 78.78 4.19 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 116.213 -2.195 . . . . 0.0 107.563 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 129' ' ' SER . . . -106.47 -37.54 6.46 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.455 ' CG ' ' HD2' ' A' ' 127' ' ' LYS . 30.6 tp10 -74.43 -7.92 54.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.55 -0.719 . . . . 0.0 109.894 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.8 24.98 5.59 Favored Glycine 0 N--CA 1.481 1.651 0 C-N-CA 119.604 -1.284 . . . . 0.0 111.703 178.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.539 HG21 ' CB ' ' A' ' 120' ' ' ALA . 2.0 t -114.19 112.13 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 C-N-CA 118.011 -1.475 . . . . 0.0 108.016 177.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.601 ' O ' HG23 ' A' ' 106' ' ' THR . 5.6 t -157.39 66.92 0.5 Allowed 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 4.0 m -129.99 20.98 5.39 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.416 -1.427 . . . . 0.0 111.847 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' A' ' 110' ' ' SER . . . 96.55 47.44 2.34 Favored Glycine 0 N--CA 1.502 3.052 0 N-CA-C 107.137 -2.385 . . . . 0.0 107.137 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 109' ' ' VAL . 12.2 p -53.82 51.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 114.892 1.442 . . . . 0.0 114.892 -173.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.539 ' N ' ' O ' ' A' ' 108' ' ' GLY . 1.9 m -135.29 12.21 3.54 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 117.053 -1.859 . . . . 0.0 112.405 172.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.894 ' HA ' HD12 ' A' ' 59' ' ' ILE . . . -122.12 -81.86 0.64 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 119.89 -1.756 . . . . 0.0 108.983 171.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' A' ' 116' ' ' THR . . . -98.7 -43.6 6.74 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 174.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.481 ' HB3' ' HA ' ' A' ' 109' ' ' VAL . 47.0 t0 -54.15 -29.74 46.58 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.903 ' O ' HG23 ' A' ' 118' ' ' VAL . 2.0 ttt180 -63.85 -51.29 65.3 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 175.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.731 HG21 ' CG2' ' A' ' 52' ' ' VAL 0.254 1.2 mp -67.31 -10.74 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 119.672 -0.811 . . . . 0.0 109.682 178.212 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.472 ' HB ' ' HA ' ' A' ' 113' ' ' ASP . 54.9 m -90.43 -41.87 11.21 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.89 -1.131 . . . . 0.0 109.112 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.778 HG23 HD11 ' A' ' 99' ' ' ILE . 52.8 m -69.0 -29.13 67.25 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.384 -0.926 . . . . 0.0 108.783 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.94 HG11 ' SD ' ' A' ' 50' ' ' MET . 39.9 t -67.78 -44.01 85.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -81.08 -27.98 35.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.472 -0.767 . . . . 0.0 109.573 178.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.539 ' CB ' HG21 ' A' ' 105' ' ' VAL . . . -80.95 -51.92 8.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.514 -0.741 . . . . 0.0 109.516 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.701 ' HA ' HD21 ' A' ' 131' ' ' LEU . . . -54.86 -32.27 60.57 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.801 HD12 ' O ' ' A' ' 47' ' ' ALA . 71.1 mt -93.39 25.62 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.602 177.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.775 ' HB3' ' HD3' ' A' ' 127' ' ' LYS . . . -37.63 150.82 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 O-C-N 122.056 -0.403 . . . . 0.0 111.48 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -26.99 -28.58 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.756 0 N-CA-C 115.012 1.486 . . . . 0.0 115.012 -177.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 123' ' ' ALA . . . 129.93 -36.04 2.42 Favored Glycine 0 N--CA 1.493 2.448 0 O-C-N 120.282 -1.511 . . . . 0.0 110.61 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -87.92 93.64 9.53 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.761 -1.435 . . . . 0.0 107.14 177.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.866 ' CB ' HD23 ' A' ' 78' ' ' LEU . 8.3 ttpt -134.3 119.12 14.17 Favored Pre-proline 0 C--N 1.305 -1.35 0 O-C-N 121.226 -0.921 . . . . 0.0 111.19 -178.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -88.29 19.33 1.34 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 N-CA-C 108.178 -1.508 . . . . 0.0 108.178 176.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.688 ' O ' ' N ' ' A' ' 131' ' ' LEU . 0.7 OUTLIER -119.6 41.16 3.2 Favored 'General case' 0 C--O 1.203 -1.38 0 O-C-N 121.3 -0.875 . . . . 0.0 110.727 -177.345 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -37.4 74.6 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 123.236 1.493 . . . . 0.0 110.894 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.701 HD21 ' HA ' ' A' ' 121' ' ' ALA . 0.2 OUTLIER -68.17 107.14 2.65 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 113.469 -1.696 . . . . 0.0 110.938 -176.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.634 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 12.9 p30 -137.4 48.02 2.06 Favored 'General case' 0 N--CA 1.52 3.071 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.665 ' H ' ' N ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER 173.22 108.69 0.06 OUTLIER Pre-proline 0 N--CA 1.51 2.545 0 O-C-N 119.147 -2.22 . . . . 0.0 112.051 174.444 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -134.48 119.46 0.0 OUTLIER 'Cis proline' 0 C--N 1.31 -1.466 0 N-CA-C 103.958 -3.131 . . . . 0.0 103.958 -9.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.95 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -111.67 44.76 1.44 Allowed Glycine 0 N--CA 1.509 3.501 0 C-N-CA 118.063 -2.018 . . . . 0.0 113.106 -175.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.418 ' C ' ' O ' ' A' ' 135' ' ' GLY . 66.4 m170 31.0 37.31 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.466 0 CA-C-O 122.246 1.022 . . . . 0.0 111.59 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.95 HG23 ' O ' ' A' ' 135' ' ' GLY . 45.1 t -108.91 125.08 65.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.578 ' HZ ' HG23 ' A' ' 65' ' ' ILE . 2.4 p90 -118.77 85.27 27.39 Favored Pre-proline 0 C--N 1.294 -1.818 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.339 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.939 ' O ' HD23 ' A' ' 140' ' ' LEU . 47.6 Cg_endo -95.46 153.36 1.58 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 N-CA-C 108.362 -1.438 . . . . 0.0 108.362 178.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.939 HD23 ' O ' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -150.37 153.03 35.31 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.788 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 -65.01 120.0 11.81 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.39 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -129.49 133.12 47.1 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.091 -1.006 . . . . 0.0 111.472 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -78.05 143.73 37.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.364 -0.835 . . . . 0.0 109.627 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.661 ' HB2' HG22 ' A' ' 158' ' ' ILE . . . -103.76 115.51 30.61 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.293 -0.879 . . . . 0.0 111.487 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.422 ' N ' ' OD2' ' A' ' 159' ' ' ASP . . . 117.57 -14.82 13.01 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.55 12.97 56.77 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.069 -1.613 . . . . 0.0 109.069 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 1.022 ' CG1' HG11 ' A' ' 206' ' ' VAL . 4.9 p -73.36 -24.61 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.148 -1.207 . . . . 0.0 110.968 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.98 17.95 7.29 Favored 'General case' 0 C--O 1.208 -1.13 0 C-N-CA 115.472 -2.491 . . . . 0.0 110.506 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 25.3 m -131.19 59.55 1.68 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 100.778 -3.786 . . . . 0.0 100.778 166.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.404 ' NE ' ' OE1' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -151.85 148.21 27.55 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 113.76 -1.564 . . . . 0.0 112.432 -178.277 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -104.27 35.3 5.14 Favored Glycine 0 N--CA 1.482 1.756 0 N-CA-C 106.179 -2.768 . . . . 0.0 106.179 173.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.1 135.19 6.11 Favored Glycine 0 N--CA 1.481 1.644 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.935 ' CD2' HD12 ' A' ' 202' ' ' ILE . 54.1 m80 -74.51 -5.18 41.27 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.241 -1.152 . . . . 0.0 109.666 177.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.413 ' O ' ' OG1' ' A' ' 157' ' ' THR . 59.4 p -53.73 -56.71 15.02 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.942 -1.099 . . . . 0.0 109.687 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.443 ' C ' ' HB ' ' A' ' 147' ' ' VAL . 2.9 mp0 -58.02 -21.66 46.07 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 177.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.783 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . . . -83.71 6.26 21.7 Favored 'General case' 0 N--CA 1.483 1.194 0 O-C-N 121.571 -0.705 . . . . 0.0 109.818 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 153' ' ' HIS . 59.8 p -93.49 -49.26 5.99 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.872 HD11 ' HA ' ' A' ' 70' ' ' ILE . 0.3 OUTLIER -80.09 -32.31 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 116.703 -1.999 . . . . 0.0 107.259 177.557 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.502 ' OD1' HG13 ' A' ' 206' ' ' VAL . 8.7 t70 -61.29 -33.76 74.1 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 105.375 -2.084 . . . . 0.0 105.375 174.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.921 HD11 ' C ' ' A' ' 44' ' ' ILE . 0.6 OUTLIER -47.22 -41.25 18.04 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 175.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.488 ' SD ' HD12 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -57.97 -48.4 80.08 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.911 178.508 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.461 ' N ' ' HG2' ' A' ' 161' ' ' MET . 0.0 OUTLIER -63.85 -34.85 78.85 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.009 -1.057 . . . . 0.0 111.698 -178.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 1.086 HD13 HD21 ' A' ' 205' ' ' LEU . 1.7 pp -93.33 -30.87 14.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.925 -1.109 . . . . 0.0 111.763 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.923 ' HA ' HD11 ' A' ' 20' ' ' LEU . . . -115.15 38.02 3.33 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -178.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 167' ' ' LYS . . . 112.78 70.61 0.56 Allowed Glycine 0 N--CA 1.513 3.784 0 C-N-CA 116.667 -2.683 . . . . 0.0 109.831 -177.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.496 ' CD2' ' O ' ' A' ' 166' ' ' PHE . 54.3 p90 -62.43 70.67 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 CA-C-O 123.486 1.612 . . . . 0.0 115.099 -172.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.473 ' N ' ' O ' ' A' ' 165' ' ' GLY . 0.0 OUTLIER -113.22 131.95 22.65 Favored Pre-proline 0 C--N 1.302 -1.479 0 N-CA-C 100.792 -3.781 . . . . 0.0 100.792 171.49 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.806 ' O ' HG23 ' A' ' 70' ' ' ILE . 38.1 Cg_endo -63.58 89.84 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 116.636 -1.776 . . . . 0.0 112.412 -173.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.71 ' HB1' ' HB3' ' A' ' 47' ' ' ALA 0.262 . . -158.18 153.8 26.3 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 105.044 -2.206 . . . . 0.0 105.044 176.085 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.448 ' CA ' ' O ' ' A' ' 157' ' ' THR . . . -147.37 113.52 0.65 Allowed Glycine 0 N--CA 1.497 2.739 0 C-N-CA 117.24 -2.41 . . . . 0.0 110.535 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.947 HG22 ' O ' ' A' ' 45' ' ' PHE . 1.1 m -125.72 144.02 37.23 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.447 0 C-N-CA 117.172 -1.811 . . . . 0.0 109.791 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.555 HD13 ' O ' ' A' ' 171' ' ' VAL . 0.1 OUTLIER -159.69 113.63 2.27 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 105.145 -2.169 . . . . 0.0 105.145 177.269 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.487 ' HB3' ' HE2' ' A' ' 43' ' ' MET . 1.9 t -126.96 178.0 6.26 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 119.642 -1.911 . . . . 0.0 112.042 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.414 ' HA ' ' OD2' ' A' ' 42' ' ' ASP . 1.6 tm-20 -120.62 148.35 44.01 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.924 -1.11 . . . . 0.0 110.27 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.822 HD22 ' O ' ' A' ' 188' ' ' CYS . 1.6 tp -69.57 93.07 0.67 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.038 -1.039 . . . . 0.0 110.11 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 9.5 t -139.0 153.69 48.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 110.15 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . 0.453 ' CB ' ' HA2' ' A' ' 62' ' ' GLY . 55.4 t-20 -121.13 157.01 31.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 110.042 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 178' ' ' ASP . 21.5 p-10 -85.51 6.52 26.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.261 -0.899 . . . . 0.0 111.248 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.08 -22.16 20.87 Favored 'General case' 0 C--N 1.29 -2.011 0 O-C-N 121.566 -0.709 . . . . 0.0 110.289 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 105.72 46.0 1.25 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 26.9 m -92.28 159.15 15.75 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.36 -1.082 . . . . 0.0 109.945 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 11.5 mtm -82.69 53.19 2.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.415 -0.803 . . . . 0.0 110.389 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' ' 175' ' ' LEU . . . -105.31 85.22 2.22 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.202 -0.936 . . . . 0.0 110.111 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.626 ' O ' ' HB3' ' A' ' 185' ' ' ALA . 0.2 OUTLIER -140.11 162.15 35.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.876 . . . . 0.0 110.401 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.929 ' HB2' ' OE1' ' A' ' 35' ' ' GLU . . . 68.9 174.83 0.08 OUTLIER Pre-proline 0 N--CA 1.503 2.185 0 O-C-N 121.42 -0.8 . . . . 0.0 110.865 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.835 ' HD2' ' HB1' ' A' ' 185' ' ' ALA . 41.1 Cg_endo -66.38 -10.5 27.83 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.481 1.253 . . . . 0.0 110.957 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -72.9 -55.01 7.23 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.046 -1.034 . . . . 0.0 109.864 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . 0.822 ' O ' HD22 ' A' ' 175' ' ' LEU . 24.0 p -58.79 -39.53 81.37 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.271 -0.893 . . . . 0.0 110.059 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.717 HG13 HD11 ' A' ' 199' ' ' LEU . 8.7 tp -73.63 -22.59 18.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 C-N-CA 118.018 -1.473 . . . . 0.0 109.071 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -56.78 -33.63 66.83 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.438 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.1 OUTLIER -66.03 -40.63 91.18 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 177.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.639 ' HB2' HD13 ' A' ' 175' ' ' LEU . . . -60.32 -49.32 78.05 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.969 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . 0.606 ' HA ' ' CB ' ' A' ' 197' ' ' MET . 0.1 OUTLIER -73.03 -11.49 60.58 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.282 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -73.75 -34.78 64.88 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 117.47 -1.692 . . . . 0.0 111.365 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 26.4 m-70 -112.11 -52.47 2.78 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 116.165 -2.214 . . . . 0.0 111.489 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -114.2 32.6 5.79 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 117.859 -1.536 . . . . 0.0 114.238 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' MET . . . . . 0.944 ' SD ' HD13 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -153.12 147.44 25.81 Favored 'General case' 0 N--CA 1.517 2.918 0 CA-C-N 123.396 2.816 . . . . 0.0 115.912 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.804 ' HB3' ' O ' ' A' ' 28' ' ' GLY . . . -95.36 127.62 41.55 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 175.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.749 ' C ' HD13 ' A' ' 6' ' ' LEU . 0.3 OUTLIER -114.92 107.35 15.28 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 120.41 -1.431 . . . . 0.0 113.512 -176.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 1.03 HG11 HD12 ' A' ' 205' ' ' LEU . 4.4 p -100.05 -173.02 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.245 -0.91 . . . . 0.0 110.07 178.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.705 HG23 ' H ' ' A' ' 204' ' ' ASP . 4.4 t -111.98 165.08 12.42 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.071 -1.018 . . . . 0.0 109.796 179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.935 HD12 ' CD2' ' A' ' 153' ' ' HIS . 9.9 tt -81.39 -14.27 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.044 -1.035 . . . . 0.0 111.298 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.612 ' O ' ' HB2' ' A' ' 207' ' ' ALA . 2.1 mt-10 -90.1 -43.63 10.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.934 -1.104 . . . . 0.0 110.598 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.705 ' H ' HG23 ' A' ' 201' ' ' THR . 3.9 t70 -85.48 -14.73 45.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.238 -0.914 . . . . 0.0 111.404 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 1.086 HD21 HD13 ' A' ' 163' ' ' LEU . 10.5 tt -77.0 -53.57 7.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.81 -1.181 . . . . 0.0 110.914 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 1.022 HG11 ' CG1' ' A' ' 147' ' ' VAL . 1.1 t -76.75 -29.33 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 117.875 -1.53 . . . . 0.0 107.765 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 203' ' ' GLU . . . -57.1 -30.95 64.79 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.656 ' CD2' HG11 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -62.82 -44.7 95.45 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 177.605 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.439 ' CD ' ' HB ' ' A' ' 162' ' ' THR . 54.7 ttt-85 -61.62 -52.15 65.58 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.739 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.76 -57.61 5.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.303 -0.873 . . . . 0.0 110.446 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 207' ' ' ALA . . . -51.51 -23.95 4.64 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.417 -0.802 . . . . 0.0 110.414 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . 0.404 ' HB2' ' O ' ' A' ' 208' ' ' TYR . 19.3 t-160 -82.97 -25.55 32.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.241 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.41 24.91 10.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.186 -0.946 . . . . 0.0 110.183 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -92.6 148.13 22.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.261 -0.899 . . . . 0.0 110.194 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -63.02 86.21 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.21 -0.932 . . . . 0.0 110.181 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -142.71 160.48 40.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.185 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.191 179.955 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.235 0.541 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -97.83 55.26 1.18 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 0.0 110.234 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.407 ' HG3' ' CE2' ' A' ' 166' ' ' PHE . 0.0 OUTLIER -74.51 -11.49 60.23 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.93 . . . . 0.0 110.594 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.2 p -68.97 -8.1 41.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.076 -1.015 . . . . 0.0 110.866 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.76 HD23 ' OH ' ' A' ' 208' ' ' TYR . 0.1 OUTLIER -50.88 -24.87 3.9 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.871 -1.143 . . . . 0.0 110.413 -179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.076 ' CD2' HG23 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -112.04 -15.56 13.25 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.212 -0.93 . . . . 0.0 110.115 179.651 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.9 m -92.49 -42.91 9.46 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.09 -1.006 . . . . 0.0 109.786 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.1 p -94.14 25.48 3.75 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.746 0.784 . . . . 0.0 109.288 178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.9 79.79 1.73 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.39 92.3 1.29 Allowed Glycine 0 C--N 1.291 -1.959 0 N-CA-C 106.089 -2.805 . . . . 0.0 106.089 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.826 HG22 ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -127.32 168.24 15.5 Favored Pre-proline 0 C--N 1.27 -2.878 0 N-CA-C 103.418 -2.808 . . . . 0.0 103.418 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.826 ' HD2' HG22 ' A' ' 11' ' ' THR . 18.1 Cg_endo -42.08 -19.22 0.1 OUTLIER 'Trans proline' 0 N--CA 1.518 2.921 0 CA-C-N 122.499 1.928 . . . . 0.0 109.321 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.878 ' O ' HG22 ' A' ' 16' ' ' VAL . 1.8 m-30 -51.54 -16.28 0.58 Allowed 'General case' 0 C--O 1.183 -2.413 0 O-C-N 119.747 -1.845 . . . . 0.0 106.619 168.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.684 ' N ' ' O ' ' A' ' 11' ' ' THR . 2.8 mt-10 -44.45 -36.1 2.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.109 -1.62 . . . . 0.0 109.239 178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -42.24 90.85 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 176.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.076 HG23 ' CD2' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -74.91 -29.44 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.183 175.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.783 ' HA ' HD23 ' A' ' 6' ' ' LEU . 9.2 tt0 -56.64 -56.41 21.74 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.292 -1.505 . . . . 0.0 107.749 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.454 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 50.4 t-20 -53.35 -25.96 17.22 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.206 -0.997 . . . . 0.0 108.336 177.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.832 ' HB3' ' O ' ' A' ' 16' ' ' VAL . . . -70.78 -66.43 0.61 Allowed 'General case' 0 N--CA 1.486 1.337 0 CA-C-O 121.588 0.709 . . . . 0.0 110.701 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.958 HD13 ' CD1' ' A' ' 6' ' ' LEU . 0.8 OUTLIER -78.92 -33.01 45.86 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.204 -0.935 . . . . 0.0 110.942 -178.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 17' ' ' GLU . . . -56.09 -32.5 64.2 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 18' ' ' ASN . . . -67.0 -35.79 80.74 Favored 'General case' 0 C--O 1.207 -1.166 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 176.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.875 HD12 HG23 ' A' ' 29' ' ' VAL . 3.1 tt -48.51 -26.24 2.07 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.164 -0.96 . . . . 0.0 109.75 178.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.6 tmt_? -91.06 -26.16 19.3 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.807 0.813 . . . . 0.0 108.833 178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 22' ' ' ALA . 0.3 OUTLIER -144.42 78.98 1.59 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 177.436 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . 126.0 52.59 0.16 Allowed Glycine 0 C--N 1.281 -2.499 1 N-CA-C 101.63 -4.588 . . . . 0.0 101.63 -173.147 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.542 ' HA ' ' HA ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -56.18 80.6 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 122.936 1.35 . . . . 0.0 111.308 -173.526 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 26' ' ' GLY . . . 172.76 104.75 0.18 Allowed Glycine 0 N--CA 1.489 2.201 0 CA-C-N 114.153 -1.385 . . . . 0.0 110.49 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.875 HG23 HD12 ' A' ' 23' ' ' LEU . 1.5 t -116.48 121.77 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.815 ' CE ' ' HB3' ' A' ' 192' ' ' ALA . 0.0 OUTLIER -111.77 131.48 55.29 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 117.996 -1.482 . . . . 0.0 110.52 -178.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 200' ' ' VAL . 14.7 p -121.48 128.94 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.435 -0.791 . . . . 0.0 110.219 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.752 ' O ' HG22 ' A' ' 201' ' ' THR . 2.6 tt -174.9 164.25 3.43 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.269 -0.894 . . . . 0.0 110.11 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.493 ' N ' HD23 ' A' ' 32' ' ' LEU . 22.4 t0 -174.98 -66.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.277 -0.89 . . . . 0.0 110.193 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.24 100.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 0.0 110.19 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.12 62.23 0.31 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.9 . . . . 0.0 110.199 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.71 -54.38 9.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.218 -0.926 . . . . 0.0 110.256 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -174.31 -72.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.269 -0.894 . . . . 0.0 110.185 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.41 100.72 6.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.326 -0.859 . . . . 0.0 110.177 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.574 ' CB ' HD11 ' A' ' 32' ' ' LEU . 2.5 m-20 -122.44 138.56 54.5 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.896 . . . . 0.0 110.212 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.45 ' OE1' ' HA ' ' A' ' 173' ' ' CYS . 18.6 mm-40 -95.8 -171.1 2.27 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.236 -0.915 . . . . 0.0 109.912 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.441 ' C ' ' HA ' ' A' ' 30' ' ' MET . . . 166.61 -61.58 0.22 Allowed Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.496 -1.335 . . . . 0.0 110.844 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.878 ' OD2' HD22 ' A' ' 57' ' ' LEU . 28.9 t70 -36.75 -31.6 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.731 0 O-C-N 121.619 -0.93 . . . . 0.0 112.078 -178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.602 ' O ' ' O ' ' A' ' 171' ' ' VAL . 0.7 OUTLIER -94.66 52.42 1.52 Allowed 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 122.175 0.988 . . . . 0.0 113.094 -178.017 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.854 HD11 ' CD1' ' A' ' 163' ' ' LEU . 13.0 tt -63.48 19.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.846 0 O-C-N 119.399 -2.063 . . . . 0.0 113.154 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.676 ' CZ ' HD21 ' A' ' 23' ' ' LEU . 2.9 m-85 -81.92 162.97 55.58 Favored Pre-proline 0 N--CA 1.498 1.93 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -175.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.507 ' HD2' ' CD2' ' A' ' 45' ' ' PHE . 51.3 Cg_endo -69.82 131.23 20.71 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.642 2.228 . . . . 0.0 110.719 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.946 ' HB3' ' HB1' ' A' ' 169' ' ' ALA . . . -67.58 -20.45 65.38 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.297 -0.961 . . . . 0.0 112.029 -178.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.624 ' HA ' HG21 ' A' ' 122' ' ' ILE . 20.6 tt0 -76.52 -35.08 58.52 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.838 -1.163 . . . . 0.0 111.078 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.503 HG23 ' HG2' ' A' ' 46' ' ' PRO . 4.7 t -132.87 58.81 1.75 Allowed 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.718 ' HB3' HG21 ' A' ' 171' ' ' VAL . 0.3 OUTLIER -65.4 88.13 0.08 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 179.069 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.539 ' HA ' HG12 ' A' ' 115' ' ' ILE . 11.4 m -59.07 170.04 0.96 Allowed 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.713 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.715 HG23 ' HB1' ' A' ' 111' ' ' ALA . 2.7 p -83.16 -2.3 6.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 O-C-N 121.341 -0.85 . . . . 0.0 110.063 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.405 ' HG3' ' HD2' ' A' ' 27' ' ' ARG . 0.8 OUTLIER -63.28 -44.77 94.16 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 178.481 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.466 ' HB2' ' HG3' ' A' ' 43' ' ' MET . 0.0 OUTLIER -76.19 -35.83 58.94 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.458 178.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.474 ' HA ' ' OG1' ' A' ' 58' ' ' THR . 0.0 OUTLIER -70.51 -27.8 64.47 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.143 -0.973 . . . . 0.0 108.525 178.407 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 52' ' ' VAL . . . -56.46 -47.83 78.36 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.754 -0.591 . . . . 0.0 109.709 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.878 HD22 ' OD2' ' A' ' 42' ' ' ASP . 6.7 tt -60.04 -56.81 17.11 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 119.067 -1.053 . . . . 0.0 109.026 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.64 ' N ' HD23 ' A' ' 57' ' ' LEU . 2.6 p -53.39 -36.0 60.97 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.423 -0.798 . . . . 0.0 109.79 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' A' ' 111' ' ' ALA . 51.2 mt -84.48 -11.33 11.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.568 -0.708 . . . . 0.0 109.178 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -51.53 -51.94 51.14 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.749 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.479 ' CD2' ' HB3' ' A' ' 178' ' ' ASP . 0.1 OUTLIER -125.51 -37.38 2.36 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 116.583 -2.047 . . . . 0.0 112.07 176.143 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' A' ' 176' ' ' THR . . . 175.02 107.53 0.21 Allowed Glycine 0 N--CA 1.499 2.839 0 C-N-CA 118.834 -1.65 . . . . 0.0 111.413 174.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.499 ' HB2' ' CA ' ' A' ' 58' ' ' THR . 0.6 OUTLIER -165.89 99.99 0.66 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 120.227 2.013 . . . . 0.0 105.69 172.476 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.477 ' HA3' ' CG1' ' A' ' 109' ' ' VAL . . . -123.46 55.77 0.69 Allowed Glycine 0 C--N 1.283 -2.407 0 N-CA-C 106.364 -2.694 . . . . 0.0 106.364 176.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.465 HD13 ' HA ' ' A' ' 65' ' ' ILE . 20.5 mm -147.68 104.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 CA-C-N 113.838 -1.181 . . . . 0.0 109.411 175.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.809 HG11 ' HB ' ' A' ' 171' ' ' VAL . 25.5 t -114.96 154.28 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.568 -1.332 . . . . 0.0 110.66 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 138' ' ' PHE . 0.4 OUTLIER -92.15 120.16 32.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.022 -1.674 . . . . 0.0 108.524 178.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.754 ' CD1' ' HB1' ' A' ' 47' ' ' ALA . 3.6 mm? -89.47 98.43 11.76 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.492 ' HB2' ' N ' ' A' ' 170' ' ' GLY . 66.3 m -66.1 129.1 38.63 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.638 -0.664 . . . . 0.0 109.779 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.762 HD11 ' HD3' ' A' ' 75' ' ' ARG . 10.4 tt -153.99 164.79 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.928 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.45 HG22 ' H ' ' A' ' 72' ' ' GLU . 2.1 m -124.85 175.72 7.09 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.426 -0.797 . . . . 0.0 109.946 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.45 ' H ' HG22 ' A' ' 71' ' ' THR . 13.8 tt0 -73.91 -9.2 58.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.246 -0.909 . . . . 0.0 110.775 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -88.26 -39.87 14.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.972 -1.08 . . . . 0.0 110.53 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.84 -35.87 59.81 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.246 -0.909 . . . . 0.0 110.188 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.797 ' CZ ' HD12 ' A' ' 99' ' ' ILE . 0.1 OUTLIER -78.48 -29.82 47.0 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.219 1.009 . . . . 0.0 108.6 179.095 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -53.15 -66.04 0.46 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.198 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -47.64 -33.37 6.65 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 122.089 0.947 . . . . 0.0 109.224 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.512 HD21 ' CD2' ' A' ' 131' ' ' LEU . 19.1 tp -96.55 47.13 1.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 175.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 76' ' ' LYS . 1.2 m-20 -22.39 83.9 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 124.458 2.075 . . . . 0.0 112.471 -171.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.692 HD22 ' HD2' ' A' ' 81' ' ' PRO . 3.5 tm? -147.42 112.54 4.03 Favored Pre-proline 0 C--N 1.292 -1.905 0 CA-C-N 111.073 -2.785 . . . . 0.0 109.574 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.692 ' HD2' HD22 ' A' ' 80' ' ' LEU . 46.5 Cg_endo -72.26 99.37 1.01 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.317 1.167 . . . . 0.0 111.046 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.466 ' O ' ' CG ' ' A' ' 82' ' ' MET . 3.6 ptt? -87.0 83.95 7.41 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.323 -0.861 . . . . 0.0 109.386 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.57 ' H ' HG23 ' A' ' 97' ' ' VAL . 0.0 OUTLIER -147.47 67.35 1.13 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.94 -1.1 . . . . 0.0 110.899 -179.257 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.707 ' CG2' HG22 ' A' ' 97' ' ' VAL . 82.8 t -85.91 104.39 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.046 -1.033 . . . . 0.0 109.217 179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -98.75 26.73 5.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.129 -0.982 . . . . 0.0 111.219 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -89.95 17.45 6.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.901 -1.124 . . . . 0.0 110.325 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.481 ' HB2' ' HA ' ' A' ' 93' ' ' THR . 31.5 m-80 -107.85 82.76 1.69 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.213 -0.929 . . . . 0.0 110.163 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.456 HG22 ' H ' ' A' ' 89' ' ' SER . 0.2 OUTLIER 54.84 -152.97 0.33 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.055 -1.028 . . . . 0.0 109.956 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.456 ' H ' HG22 ' A' ' 88' ' ' THR . 17.6 t -101.37 -60.57 1.5 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.124 -0.985 . . . . 0.0 110.679 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -135.12 26.49 3.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.194 -0.941 . . . . 0.0 110.116 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.05 79.4 1.25 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.44 -0.787 . . . . 0.0 109.918 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.3 42.82 11.27 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.481 ' HA ' ' HB2' ' A' ' 87' ' ' ASN . 9.3 p -48.3 -20.01 0.35 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.403 -1.057 . . . . 0.0 111.654 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 48.27 26.02 4.57 Favored Glycine 0 N--CA 1.495 2.59 0 O-C-N 120.656 -1.278 . . . . 0.0 110.676 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.528 ' N ' ' CD1' ' A' ' 95' ' ' PHE . 0.0 OUTLIER -61.96 47.16 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.052 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 -178.581 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.474 HG21 ' N ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -130.34 75.48 1.66 Allowed 'General case' 0 C--N 1.292 -1.906 0 O-C-N 121.303 -0.873 . . . . 0.0 110.997 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.707 HG22 ' CG2' ' A' ' 84' ' ' VAL . 90.3 t -43.98 145.4 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.493 0 O-C-N 120.458 -1.401 . . . . 0.0 110.83 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.614 HG22 ' O ' ' A' ' 137' ' ' VAL . 1.0 OUTLIER -73.98 -174.96 2.01 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.774 0.797 . . . . 0.0 112.329 -177.141 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.797 HD12 ' CZ ' ' A' ' 75' ' ' ARG 0.302 0.1 OUTLIER -149.24 123.55 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -178.049 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.541 ' CB ' ' O ' ' A' ' 132' ' ' ASN . 3.9 tm-20 -91.2 105.36 17.74 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 117.775 -1.57 . . . . 0.0 112.715 -176.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 105' ' ' VAL . . . -50.6 96.43 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.132 -0.98 . . . . 0.0 110.169 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 130' ' ' ASP . . . -103.16 2.87 35.12 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.114 -0.992 . . . . 0.0 110.061 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.429 ' HB3' ' CB ' ' A' ' 130' ' ' ASP . 7.7 pt-20 -112.26 45.36 1.29 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.066 -1.021 . . . . 0.0 111.448 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.538 ' O ' HG21 ' A' ' 117' ' ' THR . . . 127.65 -37.68 2.28 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 118.946 -1.597 . . . . 0.0 112.723 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.991 HG21 ' HB2' ' A' ' 121' ' ' ALA . 0.0 OUTLIER -101.43 121.76 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 O-C-N 120.823 -1.398 . . . . 0.0 111.113 -178.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 20.4 p -144.3 58.53 1.33 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.599 -1.24 . . . . 0.0 110.975 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.877 HG21 ' OG ' ' A' ' 110' ' ' SER . 23.9 m -139.52 -32.33 0.65 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.953 -1.092 . . . . 0.0 110.86 176.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.512 ' CA ' ' CD2' ' A' ' 136' ' ' HIS . . . 74.11 -31.96 0.94 Allowed Glycine 0 N--CA 1.493 2.467 0 O-C-N 121.688 -0.632 . . . . 0.0 111.526 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.477 ' CG1' ' HA3' ' A' ' 64' ' ' GLY . 0.0 OUTLIER -131.02 58.0 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 120.707 -1.466 . . . . 0.0 109.84 179.298 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.877 ' OG ' HG21 ' A' ' 107' ' ' THR . 0.4 OUTLIER -129.54 57.04 1.68 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.028 -1.045 . . . . 0.0 109.579 -179.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.825 ' O ' HD13 ' A' ' 115' ' ' ILE . . . -32.9 -30.42 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -178.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -85.14 -77.48 0.28 Allowed 'General case' 0 C--N 1.288 -2.095 0 O-C-N 120.554 -1.342 . . . . 0.0 109.558 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.02 -16.64 19.43 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.411 -0.806 . . . . 0.0 110.366 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.605 ' HG3' HG23 ' A' ' 118' ' ' VAL . 0.4 OUTLIER -88.77 -36.61 16.01 Favored 'General case' 0 C--O 1.2 -1.552 0 O-C-N 121.063 -1.023 . . . . 0.0 110.869 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.825 HD13 ' O ' ' A' ' 111' ' ' ALA . 0.9 OUTLIER -59.97 -17.19 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 C-N-CA 117.971 -1.491 . . . . 0.0 109.183 -179.153 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.8 m -89.09 -57.48 2.88 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 122.459 1.123 . . . . 0.0 108.491 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.937 ' OG1' HG13 ' A' ' 105' ' ' VAL . 2.0 p -62.71 -32.42 73.52 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.138 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.605 HG23 ' HG3' ' A' ' 114' ' ' ARG . 9.8 t -54.47 -47.55 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.6 ttt-85 -48.06 -29.46 3.56 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 117' ' ' THR . . . -85.69 -40.08 16.53 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.676 178.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.991 ' HB2' HG21 ' A' ' 105' ' ' VAL . . . -58.11 -50.77 72.32 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.756 -1.215 . . . . 0.0 109.798 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.687 HG22 ' O ' ' A' ' 122' ' ' ILE . 26.5 mm -87.52 27.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 121.493 0.663 . . . . 0.0 109.741 178.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.529 ' HB2' ' O ' ' A' ' 120' ' ' ALA . . . -37.42 148.36 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.744 0.783 . . . . 0.0 112.37 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -41.37 -7.61 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.498 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 123' ' ' ALA . . . 131.61 28.87 0.61 Allowed Glycine 0 N--CA 1.495 2.633 0 O-C-N 119.8 -1.812 . . . . 0.0 110.775 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -67.78 167.62 13.03 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.31 -1.112 . . . . 0.0 108.504 177.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.98 124.07 82.35 Favored Pre-proline 0 C--N 1.296 -1.73 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.32 16.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.51 1.268 . . . . 0.0 113.149 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.82 -27.62 65.26 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.177 -1.577 . . . . 0.0 108.768 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.749 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 38.5 m-20 -94.79 27.19 3.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.282 -0.886 . . . . 0.0 109.644 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.748 ' CG ' HG23 ' A' ' 99' ' ' ILE . 9.2 tp -141.38 83.88 1.89 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.274 -0.891 . . . . 0.0 109.191 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.541 ' O ' ' CB ' ' A' ' 100' ' ' GLU . 3.4 m120 -120.32 101.11 7.57 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.099 -1.0 . . . . 0.0 111.995 -178.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.597 ' CB ' ' HA ' ' A' ' 134' ' ' PRO . 0.0 OUTLIER -83.15 -179.01 1.32 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.404 -0.81 . . . . 0.0 111.011 -178.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.597 ' HA ' ' CB ' ' A' ' 133' ' ' ARG . 48.6 Cg_endo -73.01 130.31 19.74 Favored 'Cis proline' 0 N--CA 1.5 1.863 0 C-N-CA 123.119 -1.617 . . . . 0.0 113.148 8.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.538 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -132.3 67.95 0.55 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.512 ' CD2' ' CA ' ' A' ' 108' ' ' GLY . 8.5 p-80 32.08 36.59 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.484 0 O-C-N 122.105 -0.644 . . . . 0.0 112.075 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.614 ' O ' HG22 ' A' ' 98' ' ' THR . 13.4 t -91.04 154.2 3.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 176.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.681 ' HD1' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -145.34 81.6 10.23 Favored Pre-proline 0 C--N 1.287 -2.139 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -178.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.477 ' HD3' HG12 ' A' ' 137' ' ' VAL . 52.3 Cg_endo -99.56 159.9 0.57 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.375 2.05 . . . . 0.0 111.857 -178.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.741 ' HB3' HG21 ' A' ' 157' ' ' THR . 10.9 tp -126.54 113.16 16.41 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -63.72 151.33 42.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.307 -0.871 . . . . 0.0 109.404 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.506 ' CA ' ' HA ' ' A' ' 156' ' ' ALA . . . -62.63 98.19 0.11 Allowed 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 122.039 0.924 . . . . 0.0 111.821 -177.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 156' ' ' ALA . 1.0 OUTLIER -100.68 146.8 26.74 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 178.153 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -107.79 116.0 31.16 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.669 -1.269 . . . . 0.0 112.592 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 112.67 -6.32 26.1 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 120.014 -1.089 . . . . 0.0 112.063 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.09 9.08 61.29 Favored Glycine 0 N--CA 1.502 3.048 0 C-N-CA 118.466 -1.826 . . . . 0.0 112.788 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.944 HG22 HG13 ' A' ' 202' ' ' ILE . 1.0 OUTLIER -116.48 -45.15 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.24 -1.741 . . . . 0.0 108.51 177.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.995 HD22 ' HB2' ' A' ' 150' ' ' ARG . 0.3 OUTLIER -106.77 84.29 1.97 Allowed 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 177.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.425 ' O ' ' CD ' ' A' ' 150' ' ' ARG . 5.1 m -74.3 63.96 1.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 125.335 2.493 . . . . 0.0 104.488 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.995 ' HB2' HD22 ' A' ' 148' ' ' LEU . 12.5 mmt180 -152.68 162.58 41.06 Favored 'General case' 0 C--N 1.271 -2.83 0 N-CA-C 100.23 -3.989 . . . . 0.0 100.23 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -60.57 55.91 0.02 OUTLIER Glycine 0 C--N 1.258 -3.772 0 C-N-CA 117.686 -2.197 . . . . 0.0 112.537 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.627 ' N ' ' O ' ' A' ' 150' ' ' ARG . . . -119.28 128.7 7.73 Favored Glycine 0 C--O 1.215 -1.058 0 N-CA-C 106.28 -2.728 . . . . 0.0 106.28 176.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . . . . . . . . . 4.3 m170 -90.72 1.35 56.93 Favored 'General case' 0 C--N 1.282 -2.344 0 O-C-N 121.969 -0.724 . . . . 0.0 109.312 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.85 ' OG1' HG11 ' A' ' 206' ' ' VAL . 1.9 p -51.52 -18.41 1.09 Allowed 'General case' 0 C--O 1.258 1.521 0 O-C-N 121.389 -0.819 . . . . 0.0 112.476 -176.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.733 ' O ' ' N ' ' A' ' 157' ' ' THR . 5.2 tp10 -48.0 -26.59 1.84 Allowed 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.295 -0.962 . . . . 0.0 108.509 -178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.621 ' O ' ' N ' ' A' ' 158' ' ' ILE . . . -46.71 90.82 0.0 OUTLIER 'General case' 0 C--O 1.203 -1.379 0 N-CA-C 103.15 -2.908 . . . . 0.0 103.15 170.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.741 HG21 ' HB3' ' A' ' 140' ' ' LEU . 69.3 p -49.77 12.44 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.493 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -168.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.63 ' O ' ' HG3' ' A' ' 161' ' ' MET . 0.9 OUTLIER -107.75 -4.05 10.27 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.402 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 172.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.595 ' CB ' ' HA ' ' A' ' 154' ' ' THR . 0.2 OUTLIER -89.09 -33.57 17.06 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 103.174 -2.898 . . . . 0.0 103.174 173.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.989 ' HA ' HD23 ' A' ' 163' ' ' LEU . 2.3 mp -62.21 -51.6 67.14 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.274 -0.875 . . . . 0.0 108.74 176.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.63 ' HG3' ' O ' ' A' ' 158' ' ' ILE . 0.0 OUTLIER -48.74 -33.65 10.63 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.394 -1.441 . . . . 0.0 108.553 178.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.922 HG21 ' CZ ' ' A' ' 209' ' ' ARG . 1.3 m -57.88 -39.62 78.26 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 119.311 -0.955 . . . . 0.0 108.549 178.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.989 HD23 ' HA ' ' A' ' 160' ' ' LEU . 0.6 OUTLIER -67.26 -8.65 33.47 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.288 -0.965 . . . . 0.0 109.765 178.315 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.52 ' HA ' ' CD2' ' A' ' 20' ' ' LEU . . . -106.36 7.64 31.29 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 120.674 -1.266 . . . . 0.0 110.758 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.593 ' HA2' HD13 ' A' ' 5' ' ' LEU . . . 49.38 30.42 11.98 Favored Glycine 0 N--CA 1.5 2.951 0 N-CA-C 107.076 -2.41 . . . . 0.0 107.076 -177.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.502 ' CE1' ' HG3' ' A' ' 46' ' ' PRO . 1.9 m-85 -120.19 146.1 46.34 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 122.828 1.299 . . . . 0.0 112.337 -176.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 169' ' ' ALA . 6.7 mtmm -43.9 139.33 2.98 Favored Pre-proline 0 N--CA 1.502 2.128 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.529 ' HB2' HG13 ' A' ' 158' ' ' ILE . 36.6 Cg_endo -61.89 84.93 0.1 OUTLIER 'Trans proline' 0 C--N 1.299 -2.033 0 C-N-CA 117.012 -1.526 . . . . 0.0 113.767 -172.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.946 ' HB1' ' HB3' ' A' ' 47' ' ' ALA . . . -156.04 162.69 40.27 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 172.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.496 ' N ' ' HB2' ' A' ' 47' ' ' ALA . . . -158.12 131.97 3.0 Favored Glycine 0 N--CA 1.494 2.516 0 C-N-CA 117.358 -2.353 . . . . 0.0 111.361 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.809 ' HB ' HG11 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -119.71 89.5 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 117.969 -1.492 . . . . 0.0 107.138 176.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.568 ' HA ' ' HB3' ' A' ' 43' ' ' MET . 3.0 mp -95.68 138.35 33.47 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.253 0.549 . . . . 0.0 110.374 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.57 ' SG ' HG21 ' A' ' 58' ' ' THR . 2.8 t -129.59 176.2 8.18 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.897 -1.127 . . . . 0.0 111.064 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.414 ' N ' ' OE1' ' A' ' 40' ' ' GLU . 2.7 tt0 -111.45 -179.46 3.72 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.201 -0.937 . . . . 0.0 110.06 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.769 HD13 ' N ' ' A' ' 176' ' ' THR . 3.5 tm? -104.61 141.24 36.77 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.108 -0.995 . . . . 0.0 110.001 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.769 ' N ' HD13 ' A' ' 175' ' ' LEU . 93.0 m -123.17 155.43 37.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.189 -0.944 . . . . 0.0 110.382 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.85 171.41 7.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.437 -0.789 . . . . 0.0 110.12 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.479 ' HB3' ' CD2' ' A' ' 61' ' ' HIS . 10.1 p-10 -89.56 5.76 44.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.295 -0.878 . . . . 0.0 111.361 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -72.56 -19.72 61.45 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 121.602 -0.686 . . . . 0.0 109.981 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 90.09 29.64 14.58 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 83.8 m -137.09 147.74 46.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -1.148 . . . . 0.0 110.182 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.42 ' O ' ' CG ' ' A' ' 182' ' ' MET . 0.7 OUTLIER -53.35 95.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.253 -0.904 . . . . 0.0 110.173 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.93 ' HB1' ' SG ' ' A' ' 188' ' ' CYS . . . -71.44 107.24 4.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.191 -0.943 . . . . 0.0 110.245 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 185' ' ' ALA . 0.1 OUTLIER -140.23 100.2 3.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.901 . . . . 0.0 109.827 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.857 ' HB1' ' HD2' ' A' ' 186' ' ' PRO . . . -179.37 178.08 0.34 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.31 -0.869 . . . . 0.0 109.891 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.857 ' HD2' ' HB1' ' A' ' 185' ' ' ALA . 45.3 Cg_endo -71.82 -16.92 29.49 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.608 1.32 . . . . 0.0 110.413 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -79.46 -31.56 42.49 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.087 -1.008 . . . . 0.0 110.067 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . 0.93 ' SG ' ' HB1' ' A' ' 183' ' ' ALA . 14.0 m -74.35 -56.63 4.64 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.325 -0.859 . . . . 0.0 110.186 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.542 ' O ' ' HE1' ' A' ' 30' ' ' MET . 2.5 tp -61.7 -22.97 29.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.994 -1.066 . . . . 0.0 109.38 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.501 ' HA ' ' HB3' ' A' ' 193' ' ' ASN . 23.7 tt0 -81.61 -18.62 44.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.477 -0.764 . . . . 0.0 109.817 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.439 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.1 OUTLIER -71.34 -53.9 12.61 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.992 0.901 . . . . 0.0 109.36 -179.593 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.815 ' HB3' ' CE ' ' A' ' 30' ' ' MET . . . -69.6 -35.63 75.48 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . 0.581 ' HA ' ' CB ' ' A' ' 197' ' ' MET . 14.9 t30 -61.71 -18.6 60.32 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.915 178.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -81.79 -39.81 23.52 Favored 'General case' 0 C--N 1.296 -1.749 0 C-N-CA 118.024 -1.47 . . . . 0.0 111.918 -177.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -100.98 -54.72 2.74 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 115.499 -2.481 . . . . 0.0 111.892 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.417 ' O ' ' HE3' ' A' ' 197' ' ' MET . 39.6 m-80 -114.94 33.42 5.42 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.172 -1.411 . . . . 0.0 113.889 177.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' MET . . . . . 0.735 ' SD ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -152.14 148.99 28.29 Favored 'General case' 0 N--CA 1.515 2.803 0 CA-C-N 122.966 2.621 . . . . 0.0 115.632 -179.52 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.518 ' HB3' ' HA ' ' A' ' 19' ' ' ALA . . . -113.12 125.64 54.59 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 176.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.558 HD11 ' CB ' ' A' ' 193' ' ' ASN . 26.1 mt -94.09 144.47 25.46 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.546 -1.346 . . . . 0.0 112.971 -177.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.801 ' O ' HG23 ' A' ' 31' ' ' VAL . 7.1 p -146.81 110.45 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.752 HG22 ' O ' ' A' ' 32' ' ' LEU . 23.9 p -70.69 147.96 48.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 111.707 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.944 HG13 HG22 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -47.72 -38.52 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 121.304 0.573 . . . . 0.0 110.495 179.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.532 ' O ' ' HB2' ' A' ' 207' ' ' ALA . 10.7 tt0 -48.13 -65.99 0.48 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.08 -1.012 . . . . 0.0 110.737 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.581 ' O ' ' HB3' ' A' ' 207' ' ' ALA . 6.4 m-20 -80.89 -25.16 37.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 0.0 109.745 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.931 HD11 HD13 ' A' ' 163' ' ' LEU . 3.1 tm? -64.75 -67.5 0.43 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.334 -0.853 . . . . 0.0 109.422 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.85 HG11 ' OG1' ' A' ' 154' ' ' THR . 97.9 t -62.67 -21.99 28.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 118.048 -1.461 . . . . 0.0 108.364 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 204' ' ' ASP . . . -53.25 -28.89 29.73 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 175.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.76 ' OH ' HD23 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -77.85 -36.59 49.82 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.922 ' CZ ' HG21 ' A' ' 162' ' ' THR . 16.1 tpt180 -78.6 -58.67 3.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.896 -1.127 . . . . 0.0 110.067 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 206' ' ' VAL . 9.3 tp-100 -51.85 -36.54 48.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.167 -0.958 . . . . 0.0 110.351 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 207' ' ' ALA . . . -72.54 -29.15 63.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 110.222 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -67.87 -24.34 65.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.225 -0.922 . . . . 0.0 110.182 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -108.62 -9.04 15.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 0.0 110.714 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.16 120.75 22.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.988 -1.07 . . . . 0.0 110.188 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -108.12 89.6 3.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 110.176 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -162.62 56.51 0.21 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.89 . . . . 0.0 110.251 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.214 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtt . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.229 0.538 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' A' ' 23' ' ' LEU . 2.6 m120 -83.8 54.09 2.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.921 . . . . 0.0 110.195 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -94.15 -21.15 19.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.32 -0.863 . . . . 0.0 110.294 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.426 ' HA ' ' OG ' ' A' ' 7' ' ' SER . 8.0 t -93.12 -18.07 23.03 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.916 . . . . 0.0 110.488 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.668 HD13 ' HA ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -53.17 -52.85 57.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.1 -1.0 . . . . 0.0 110.335 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.026 HD13 ' HB1' ' A' ' 198' ' ' ALA . 0.2 OUTLIER -94.49 19.39 9.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.41 -0.806 . . . . 0.0 110.064 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.431 ' OG ' ' N ' ' A' ' 8' ' ' SER . 60.7 p -94.49 -60.82 1.63 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.88 -1.137 . . . . 0.0 110.569 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.431 ' N ' ' OG ' ' A' ' 7' ' ' SER . 1.7 p -91.79 28.84 1.68 Allowed 'General case' 0 N--CA 1.505 2.299 0 CA-C-O 121.843 0.83 . . . . 0.0 109.922 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.735 ' O ' ' CG ' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -104.77 75.31 1.19 Allowed 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 122.587 1.184 . . . . 0.0 109.136 -178.58 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.03 74.32 0.36 Allowed Glycine 0 C--N 1.282 -2.432 0 N-CA-C 106.956 -2.457 . . . . 0.0 106.956 176.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.62 HG22 ' H ' ' A' ' 14' ' ' GLU . 61.8 m -149.08 99.74 3.45 Favored Pre-proline 0 C--N 1.278 -2.521 0 N-CA-C 101.093 -3.669 . . . . 0.0 101.093 172.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.65 ' O ' HG12 ' A' ' 16' ' ' VAL . 28.1 Cg_endo -51.17 -28.83 26.86 Favored 'Trans proline' 0 C--N 1.28 -3.063 0 O-C-N 122.754 0.871 . . . . 0.0 110.319 -174.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -86.02 -56.17 3.59 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 115.483 1.66 . . . . 0.0 115.483 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.62 ' H ' HG22 ' A' ' 11' ' ' THR . 3.8 tt0 -93.5 -36.42 12.45 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 118.328 -1.349 . . . . 0.0 111.166 -176.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.671 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 8.3 mmt180 -78.83 -30.05 45.06 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 119.181 -1.007 . . . . 0.0 111.79 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.799 HG11 ' CD2' ' A' ' 208' ' ' TYR . 0.4 OUTLIER -89.55 -36.11 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 116.224 -2.19 . . . . 0.0 111.552 -179.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -63.16 -40.32 97.21 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 117.383 -1.727 . . . . 0.0 108.757 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.91 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 32.5 p-10 -84.38 -23.06 30.26 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.546 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.671 ' HB2' ' O ' ' A' ' 15' ' ' ARG . . . -71.63 -38.21 70.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.494 -1.379 . . . . 0.0 110.11 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.711 HD13 ' O ' ' A' ' 163' ' ' LEU . 1.6 pp -73.35 -54.27 8.76 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.17 -1.412 . . . . 0.0 110.333 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.659 ' HA ' ' N ' ' A' ' 26' ' ' GLY . . . -69.21 -69.74 0.32 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.877 -1.139 . . . . 0.0 111.807 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.91 ' HB3' ' O ' ' A' ' 18' ' ' ASN . . . -50.09 -34.89 23.33 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.689 -1.142 . . . . 0.0 112.739 -177.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.933 HD13 ' HB2' ' A' ' 198' ' ' ALA . 2.6 tt -56.39 -59.89 4.32 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.652 ' HB2' HD23 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -123.82 -76.43 0.59 Allowed 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 117.686 -1.606 . . . . 0.0 108.15 173.083 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.461 ' HG3' ' CG ' ' A' ' 27' ' ' ARG . 5.7 pt-20 -167.28 45.78 0.05 Allowed 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 114.454 -1.248 . . . . 0.0 108.102 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.659 ' N ' ' HA ' ' A' ' 21' ' ' ALA . . . 60.47 20.01 54.73 Favored Glycine 0 N--CA 1.481 1.698 0 N-CA-C 107.097 -2.401 . . . . 0.0 107.097 -176.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.52 ' CB ' ' CE1' ' A' ' 45' ' ' PHE . 6.6 mtt180 -118.31 39.25 3.48 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 121.467 -1.019 . . . . 0.0 109.792 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.724 ' O ' ' HB3' ' A' ' 198' ' ' ALA . . . 178.2 66.41 0.06 OUTLIER Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.317 -1.913 . . . . 0.0 108.317 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.718 ' CB ' HD12 ' A' ' 44' ' ' ILE . 6.1 t -144.75 116.97 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.852 ' HG2' HD23 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -84.41 146.37 27.69 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 119.838 -1.789 . . . . 0.0 113.313 -177.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 1.09 HG22 HG22 ' A' ' 202' ' ' ILE . 14.8 p -140.42 90.01 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 175.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.774 HD13 HG23 ' A' ' 202' ' ' ILE . 1.2 tp 68.95 -60.52 0.45 Allowed 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.861 -1.149 . . . . 0.0 109.776 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.451 ' CB ' ' HB3' ' A' ' 172' ' ' LEU . 0.2 OUTLIER -53.42 -176.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.211 -0.931 . . . . 0.0 110.408 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.765 ' C ' HD13 ' A' ' 189' ' ' ILE . 45.0 m-20 -149.17 -148.77 0.27 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.266 -0.896 . . . . 0.0 110.372 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.845 ' CD ' HD11 ' A' ' 57' ' ' LEU . 0.1 OUTLIER 78.05 133.62 0.06 Allowed 'General case' 0 N--CA 1.519 3.003 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 179.552 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.933 ' N ' HD13 ' A' ' 57' ' ' LEU . 0.3 OUTLIER 167.71 157.79 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.739 177.059 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.519 ' NH1' ' CE1' ' A' ' 61' ' ' HIS . 1.6 tpt180 -176.76 -71.4 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.077 -1.014 . . . . 0.0 110.125 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.564 ' OE2' ' HB3' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -62.51 -148.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 110.112 -179.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.402 ' N ' ' OE1' ' A' ' 38' ' ' GLU . 24.4 m-80 -84.78 130.63 34.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.975 . . . . 0.0 110.461 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.489 ' HA ' ' CE ' ' A' ' 197' ' ' MET . 1.4 mt-10 59.68 147.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.657 0.742 . . . . 0.0 111.25 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.522 ' O ' ' CE ' ' A' ' 43' ' ' MET . . . -132.6 167.89 22.96 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -86.96 -11.06 51.7 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.288 -1.125 . . . . 0.0 113.919 -179.411 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.522 ' CE ' ' O ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -31.35 -27.82 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.176 0 N-CA-C 116.906 2.187 . . . . 0.0 116.906 -174.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.718 HD12 ' CB ' ' A' ' 29' ' ' VAL . 0.8 OUTLIER -138.53 16.18 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.259 0 CA-C-O 122.695 1.236 . . . . 0.0 110.055 178.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.671 ' O ' HG12 ' A' ' 171' ' ' VAL . 0.7 OUTLIER -68.66 161.48 70.54 Favored Pre-proline 0 C--N 1.288 -2.083 0 O-C-N 121.172 -0.955 . . . . 0.0 113.564 -175.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.585 ' HB3' ' CB ' ' A' ' 167' ' ' LYS . 55.8 Cg_endo -82.35 129.92 6.05 Favored 'Trans proline' 0 C--N 1.319 -1.026 0 C-N-CA 122.058 1.839 . . . . 0.0 109.409 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.982 ' HB1' HD13 ' A' ' 68' ' ' LEU . . . -71.69 -1.33 13.44 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.256 -0.903 . . . . 0.0 112.566 -177.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.889 ' HA ' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -86.83 -23.78 25.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.797 -1.19 . . . . 0.0 110.128 -179.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.586 ' O ' HG23 ' A' ' 49' ' ' THR . 10.1 t -133.26 60.23 1.71 Allowed 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.743 ' HG3' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -52.54 88.94 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 CA-C-O 121.334 0.588 . . . . 0.0 109.739 -179.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.53 ' HA ' HG13 ' A' ' 115' ' ' ILE . 26.2 p -61.95 172.58 1.31 Allowed 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.726 -0.79 . . . . 0.0 109.83 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.52 HG22 HD13 ' A' ' 115' ' ' ILE . 17.7 t -73.91 -5.1 6.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.533 -0.729 . . . . 0.0 110.12 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.843 ' O ' HD23 ' A' ' 57' ' ' LEU . 0.8 OUTLIER -50.6 -28.31 8.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.006 -1.059 . . . . 0.0 109.422 179.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.437 ' O ' ' CG2' ' A' ' 58' ' ' THR . 0.0 OUTLIER -86.95 -28.98 22.4 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.203 179.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.472 ' HA ' HG22 ' A' ' 58' ' ' THR . 3.8 mmt -86.23 -41.13 14.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.265 -0.897 . . . . 0.0 109.528 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.564 ' HB3' ' OE2' ' A' ' 38' ' ' GLU . . . -65.46 -53.97 35.12 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.224 -0.923 . . . . 0.0 110.4 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.933 HD13 ' N ' ' A' ' 36' ' ' ASP . 0.4 OUTLIER -64.03 -33.4 75.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.216 -0.927 . . . . 0.0 111.059 -179.273 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.475 ' CG2' ' N ' ' A' ' 59' ' ' ILE . 4.4 t -79.33 -46.86 16.87 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.739 -1.226 . . . . 0.0 110.836 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.475 ' N ' ' CG2' ' A' ' 58' ' ' THR . 72.1 mt -53.78 -21.93 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.841 -1.162 . . . . 0.0 109.578 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -84.83 -46.04 11.73 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.378 -0.826 . . . . 0.0 112.257 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.519 ' CE1' ' NH1' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -125.36 -15.04 6.3 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -177.104 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 58' ' ' THR . . . -164.36 -168.95 27.24 Favored Glycine 0 N--CA 1.502 3.081 0 C-N-CA 118.547 -1.787 . . . . 0.0 111.756 -176.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.6 t -126.57 102.35 7.06 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 101.32 -3.585 . . . . 0.0 101.32 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 66' ' ' VAL . . . -104.79 76.43 0.25 Allowed Glycine 0 C--N 1.26 -3.663 0 N-CA-C 105.804 -2.918 . . . . 0.0 105.804 -178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.772 HG23 ' CD2' ' A' ' 138' ' ' PHE . 3.2 mm -61.34 84.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.535 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.705 HG12 ' HB3' ' A' ' 173' ' ' CYS . 26.5 m -52.72 157.09 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.2 -1.508 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.311 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.698 ' HB3' HD11 ' A' ' 140' ' ' LEU . 97.4 m -109.64 119.35 39.14 Favored 'General case' 0 C--N 1.29 -2.006 0 O-C-N 121.393 -0.817 . . . . 0.0 110.32 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.982 HD13 ' HB1' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -87.28 97.81 10.99 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.316 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 74.3 m -70.7 127.28 32.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.467 -0.77 . . . . 0.0 111.794 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.594 HD12 ' HB3' ' A' ' 79' ' ' ASP . 24.6 pt -115.97 162.47 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.465 ' CA ' HG12 ' A' ' 158' ' ' ILE . 1.6 m -81.03 170.62 15.99 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 120.55 -1.344 . . . . 0.0 109.7 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.555 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 0.6 OUTLIER -95.4 -12.47 25.93 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.399 178.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -85.39 -73.18 0.45 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.915 -1.115 . . . . 0.0 111.901 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 -85.98 -32.58 21.44 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 79' ' ' ASP . 10.8 mpt_? -74.07 -31.71 62.96 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.626 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.555 ' HB2' ' HA ' ' A' ' 72' ' ' GLU . 18.2 tttt -72.93 -41.41 64.55 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 119.89 -1.756 . . . . 0.0 108.996 178.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -42.35 -54.1 3.92 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.298 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.63 HD11 ' C ' ' A' ' 128' ' ' PRO . 0.4 OUTLIER -105.08 -29.49 10.37 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.049 -1.46 . . . . 0.0 109.156 178.35 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.594 ' HB3' HD12 ' A' ' 70' ' ' ILE . 5.9 t0 -112.57 70.79 0.72 Allowed 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.997 0.903 . . . . 0.0 109.612 177.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.72 ' C ' HD22 ' A' ' 80' ' ' LEU . 0.0 OUTLIER -80.62 171.34 12.57 Favored Pre-proline 0 C--N 1.286 -2.157 0 O-C-N 121.277 -0.889 . . . . 0.0 112.173 -179.238 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.654 ' N ' HD22 ' A' ' 80' ' ' LEU . 52.9 Cg_endo -84.22 97.79 0.73 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.11 1.058 . . . . 0.0 109.556 179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . 0.879 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.8 ttt -97.39 95.76 7.89 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.11 -0.994 . . . . 0.0 110.641 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -47.87 95.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.062 -1.024 . . . . 0.0 110.689 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.879 HG23 ' O ' ' A' ' 82' ' ' MET . 93.7 t -104.66 151.6 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.256 -0.903 . . . . 0.0 109.997 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -92.9 22.65 4.72 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.19 -0.943 . . . . 0.0 110.294 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.697 ' H ' HG12 ' A' ' 84' ' ' VAL . 1.1 t-20 -125.43 19.67 8.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.191 -0.943 . . . . 0.0 110.362 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 1.018 ' ND2' HG22 ' A' ' 96' ' ' THR . 28.3 p30 -105.44 54.62 0.7 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.174 -0.954 . . . . 0.0 110.428 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 89' ' ' SER . 0.2 OUTLIER 52.89 -149.06 0.41 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.235 -0.916 . . . . 0.0 110.08 179.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.432 ' H ' HG22 ' A' ' 88' ' ' THR . 0.3 OUTLIER -66.24 -59.9 3.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.099 -1.001 . . . . 0.0 110.314 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 89' ' ' SER . . . 55.39 101.31 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.291 -0.881 . . . . 0.0 110.231 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -95.16 59.08 2.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.951 . . . . 0.0 110.303 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.78 39.07 66.14 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 143' ' ' GLN . 41.2 p -96.82 42.36 1.09 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.225 -1.162 . . . . 0.0 110.198 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 141' ' ' ARG . . . 48.2 23.08 2.62 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.489 ' HB2' ' HB3' ' A' ' 140' ' ' LEU . 0.6 OUTLIER -113.75 67.38 0.67 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.855 -1.379 . . . . 0.0 109.534 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 1.018 HG22 ' ND2' ' A' ' 87' ' ' ASN . 0.9 OUTLIER -127.66 14.92 7.03 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.531 ' O ' ' HD2' ' A' ' 139' ' ' PRO . 4.2 p -115.74 145.14 21.87 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 O-C-N 121.007 -1.058 . . . . 0.0 110.683 178.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.561 HG22 ' H ' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -123.87 -173.79 2.83 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 179.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.979 ' CG1' HG11 ' A' ' 137' ' ' VAL . 2.4 pp -145.8 122.82 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 C-N-CA 117.191 -1.803 . . . . 0.0 114.759 -178.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.76 ' CA ' ' HG2' ' A' ' 133' ' ' ARG . 11.4 tm-20 -90.32 163.43 14.74 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.814 177.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.638 ' HB2' ' HB ' ' A' ' 106' ' ' THR . . . -51.73 88.18 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.63 -0.669 . . . . 0.0 112.546 -177.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.527 ' HB2' ' N ' ' A' ' 131' ' ' LEU . . . -84.19 -25.6 29.42 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 175.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.23 -6.5 11.31 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.748 -0.595 . . . . 0.0 110.115 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.52 27.47 0.97 Allowed Glycine 0 N--CA 1.496 2.666 0 C-N-CA 119.357 -1.401 . . . . 0.0 112.339 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.793 ' HB ' HG22 ' A' ' 117' ' ' THR . 7.0 m -139.88 123.53 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 120.954 -1.321 . . . . 0.0 110.655 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.638 ' HB ' ' HB2' ' A' ' 101' ' ' ALA . 10.9 t -148.21 63.86 1.1 Allowed 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.713 -1.242 . . . . 0.0 111.618 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.462 HG22 HG21 ' A' ' 117' ' ' THR . 6.3 t -131.41 -31.17 1.63 Allowed 'General case' 0 N--CA 1.502 2.131 0 C-N-CA 118.438 -1.305 . . . . 0.0 110.331 177.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.436 ' HA2' ' NH1' ' A' ' 114' ' ' ARG . . . 60.7 -28.33 0.05 OUTLIER Glycine 0 N--CA 1.504 3.195 0 O-C-N 121.588 -0.695 . . . . 0.0 114.023 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.409 ' N ' ' O ' ' A' ' 107' ' ' THR . 11.1 t -125.46 55.82 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.225 -1.75 . . . . 0.0 110.127 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.597 ' O ' ' N ' ' A' ' 114' ' ' ARG . 9.3 t -133.99 71.41 1.46 Allowed 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.466 ' HB2' ' HB3' ' A' ' 55' ' ' MET . . . -25.74 -40.64 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.794 0 CA-C-O 121.59 0.71 . . . . 0.0 112.035 -177.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.504 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -69.22 -66.04 0.63 Allowed 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 122.562 1.172 . . . . 0.0 107.881 176.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.807 ' O ' HG23 ' A' ' 117' ' ' THR . 0.2 OUTLIER -64.41 -13.94 53.91 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.099 -1.001 . . . . 0.0 109.445 177.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 110' ' ' SER . 5.0 tpm_? -62.86 -42.92 99.94 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 121.2 -0.937 . . . . 0.0 108.707 179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.53 HG13 ' HA ' ' A' ' 51' ' ' THR . 1.7 mp -76.75 -13.49 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 C-N-CA 118.557 -1.257 . . . . 0.0 108.178 178.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.494 ' O ' HG11 ' A' ' 105' ' ' VAL . 2.6 m -94.61 -20.92 19.17 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.23 -0.919 . . . . 0.0 108.828 177.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 113' ' ' ASP . 26.0 p -83.73 -36.85 23.36 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.513 -0.742 . . . . 0.0 109.827 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.758 ' O ' HG22 ' A' ' 122' ' ' ILE . 14.2 p -73.99 -41.37 52.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 118.84 -1.144 . . . . 0.0 108.562 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.98 ' O ' ' HB2' ' A' ' 123' ' ' ALA . 3.3 ttt-85 -61.18 -31.41 71.16 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.133 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.4 ' HB3' HG21 ' A' ' 105' ' ' VAL . . . -95.34 -33.07 12.66 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.668 -0.645 . . . . 0.0 111.358 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.651 ' HB1' HD13 ' A' ' 99' ' ' ILE . . . -61.91 -58.16 8.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.027 -1.046 . . . . 0.0 109.712 -179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.889 HG21 ' HA ' ' A' ' 48' ' ' GLU . 0.7 OUTLIER -88.49 23.03 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.395 -0.815 . . . . 0.0 110.693 179.052 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.98 ' HB2' ' O ' ' A' ' 119' ' ' ARG . . . -95.96 114.81 26.56 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 126' ' ' ALA . 5.4 t0 -89.99 -82.54 0.27 Allowed 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 117.783 -1.567 . . . . 0.0 113.405 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.435 ' N ' ' OD1' ' A' ' 124' ' ' ASP . . . 69.6 -43.36 0.46 Allowed Glycine 0 N--CA 1.513 3.797 0 N-CA-C 107.666 -2.173 . . . . 0.0 107.666 -176.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.558 ' H ' ' C ' ' A' ' 124' ' ' ASP . . . -135.72 165.71 24.94 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 103.578 -2.749 . . . . 0.0 103.578 176.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.421 ' C ' ' H ' ' A' ' 129' ' ' SER . 4.4 tttp -65.16 114.68 16.18 Favored Pre-proline 0 C--N 1.304 -1.411 0 CA-C-N 121.361 1.891 . . . . 0.0 108.094 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.63 ' C ' HD11 ' A' ' 78' ' ' LEU . 35.1 Cg_endo -67.66 26.14 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.283 1.322 . . . . 0.0 112.18 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.421 ' H ' ' C ' ' A' ' 127' ' ' LYS . 0.3 OUTLIER -54.57 -10.16 0.4 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.464 -1.397 . . . . 0.0 111.176 -178.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.477 ' CB ' ' HA ' ' A' ' 102' ' ' ALA . 2.0 m-20 -72.3 9.04 1.11 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.601 -1.312 . . . . 0.0 110.417 177.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.534 ' CD2' HG22 ' A' ' 99' ' ' ILE . 4.7 tp -74.67 87.99 2.2 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.474 ' H ' ' HB3' ' A' ' 100' ' ' GLU . 1.6 t-20 -116.13 72.64 0.82 Allowed 'General case' 0 N--CA 1.509 2.501 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -176.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.911 ' HB3' ' HA ' ' A' ' 134' ' ' PRO 0.255 0.0 OUTLIER -97.58 -152.76 0.01 OUTLIER Pre-proline 0 N--CA 1.494 1.734 0 CA-C-O 115.115 -2.374 . . . . 0.0 110.168 179.163 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.911 ' HA ' ' HB3' ' A' ' 133' ' ' ARG . 56.5 Cg_endo -78.98 127.39 14.67 Favored 'Cis proline' 0 N--CA 1.524 3.31 0 N-CA-C 119.554 2.867 . . . . 0.0 119.554 18.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.928 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -126.99 71.87 0.47 Allowed Glycine 0 N--CA 1.511 3.655 0 CA-C-N 115.305 -0.862 . . . . 0.0 112.338 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 49.3 m80 30.62 35.76 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.544 0 CA-C-O 121.418 0.628 . . . . 0.0 112.562 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.979 HG11 ' CG1' ' A' ' 99' ' ' ILE . 92.6 t -94.5 154.71 3.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.978 0 N-CA-C 104.389 -2.449 . . . . 0.0 104.389 175.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.772 ' CD2' HG23 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -131.07 79.07 71.94 Favored Pre-proline 0 C--N 1.294 -1.822 0 C-N-CA 117.939 -1.505 . . . . 0.0 110.726 -176.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.809 ' C ' HD23 ' A' ' 140' ' ' LEU . 55.8 Cg_endo -107.61 156.44 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 123.515 2.81 . . . . 0.0 107.873 175.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.809 HD23 ' C ' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -145.93 140.81 27.21 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 120.722 -1.236 . . . . 0.0 109.715 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 143' ' ' GLN . 1.8 ptm180 -63.51 154.54 32.11 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.408 ' HB2' ' HB ' ' A' ' 158' ' ' ILE . . . -60.75 88.85 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.862 -1.135 . . . . 0.0 108.949 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 141' ' ' ARG . 0.1 OUTLIER -55.59 144.86 25.02 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.924 0.869 . . . . 0.0 111.021 -178.634 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.594 ' C ' HG21 ' A' ' 154' ' ' THR . . . -83.19 53.97 2.64 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 121.32 0.581 . . . . 0.0 109.504 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.9 ' O ' HG22 ' A' ' 149' ' ' THR . . . 147.2 19.8 0.1 Allowed Glycine 0 N--CA 1.488 2.125 0 C-N-CA 119.578 -1.296 . . . . 0.0 112.457 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.1 1.98 59.49 Favored Glycine 0 N--CA 1.503 3.138 0 C-N-CA 117.769 -2.158 . . . . 0.0 111.403 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.857 ' CG2' HG11 ' A' ' 206' ' ' VAL . 0.3 OUTLIER -116.5 -43.77 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-O 123.943 1.83 . . . . 0.0 107.577 175.217 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.809 ' HA ' HD13 ' A' ' 202' ' ' ILE . 2.8 tp -111.6 70.03 0.7 Allowed 'General case' 0 C--N 1.281 -2.399 0 N-CA-C 103.849 -2.649 . . . . 0.0 103.849 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.9 HG22 ' O ' ' A' ' 145' ' ' GLY . 46.7 p -77.07 63.39 2.34 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 125.243 2.449 . . . . 0.0 104.789 179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.586 ' O ' ' N ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -153.58 155.31 35.9 Favored 'General case' 0 C--N 1.267 -2.993 0 N-CA-C 100.501 -3.888 . . . . 0.0 100.501 176.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.25 61.99 0.16 Allowed Glycine 0 C--N 1.261 -3.588 0 C-N-CA 117.144 -2.455 . . . . 0.0 109.386 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 150' ' ' ARG . . . -110.11 -161.57 18.56 Favored Glycine 0 N--CA 1.476 1.34 0 O-C-N 120.198 -1.766 . . . . 0.0 110.696 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.777 ' N ' HD23 ' A' ' 148' ' ' LEU . 10.7 t-80 -66.57 4.48 0.77 Allowed 'General case' 0 C--O 1.188 -2.173 0 CA-C-O 117.366 -1.302 . . . . 0.0 113.964 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.651 ' HA ' HG12 ' A' ' 147' ' ' VAL . 15.0 t -24.23 -26.57 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.396 0 CA-C-N 120.797 1.635 . . . . 0.0 115.086 -176.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.649 ' N ' ' O ' ' A' ' 153' ' ' HIS . 18.3 tt0 -56.32 -22.78 32.84 Favored 'General case' 0 N--CA 1.511 2.606 0 O-C-N 119.326 -2.109 . . . . 0.0 105.325 172.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.718 ' HB2' ' ND1' ' A' ' 153' ' ' HIS . . . -83.99 12.6 6.01 Favored 'General case' 0 C--O 1.206 -1.208 0 O-C-N 120.746 -1.221 . . . . 0.0 108.971 174.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.625 ' N ' ' O ' ' A' ' 154' ' ' THR . 20.5 m -63.71 -43.26 97.1 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 103.443 -2.799 . . . . 0.0 103.443 175.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.506 ' O ' ' HB3' ' A' ' 161' ' ' MET . 5.7 tp -70.19 -35.59 63.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 116.169 -2.212 . . . . 0.0 105.209 174.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.566 ' HB2' ' CA ' ' A' ' 156' ' ' ALA . 1.2 m-20 -59.1 -20.52 54.25 Favored 'General case' 0 N--CA 1.507 2.408 0 C-N-CA 116.414 -2.114 . . . . 0.0 107.216 175.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 1.043 ' HA ' HD12 ' A' ' 163' ' ' LEU . 0.2 OUTLIER -61.87 -28.48 69.53 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 176.32 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 0.647 ' HB2' ' N ' ' A' ' 169' ' ' ALA . 3.2 ptt? -49.65 -34.29 17.9 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 174.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.486 ' CB ' ' O ' ' A' ' 159' ' ' ASP . 2.7 m -65.23 -29.52 70.32 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.093 177.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 1.072 HD21 HD21 ' A' ' 205' ' ' LEU . 0.2 OUTLIER -41.7 -44.65 3.23 Favored 'General case' 0 N--CA 1.523 3.183 0 O-C-N 121.077 -1.014 . . . . 0.0 109.142 178.21 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -48.4 -29.15 3.73 Favored 'General case' 0 N--CA 1.517 2.89 0 CA-C-O 122.515 1.15 . . . . 0.0 109.753 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 106.44 -34.49 5.69 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -157.75 49.25 0.41 Allowed 'General case' 0 N--CA 1.508 2.472 0 C-N-CA 117.938 -1.505 . . . . 0.0 113.185 172.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.585 ' CB ' ' HB3' ' A' ' 46' ' ' PRO . 1.3 mmtt -135.02 124.11 16.28 Favored Pre-proline 0 C--N 1.292 -1.933 0 CA-C-O 116.305 -1.807 . . . . 0.0 106.872 175.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.465 ' HA ' ' HG3' ' A' ' 161' ' ' MET . 51.9 Cg_endo -91.6 75.94 0.59 Allowed 'Trans proline' 0 C--N 1.318 -1.068 0 C-N-CA 114.05 -3.5 . . . . 0.0 112.499 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.958 ' HB1' ' HB3' ' A' ' 47' ' ' ALA . . . -165.41 165.47 19.22 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 170.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 68' ' ' LEU . . . -139.45 129.02 4.19 Favored Glycine 0 N--CA 1.502 3.091 0 C-N-CA 118.596 -1.764 . . . . 0.0 109.737 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.671 HG12 ' O ' ' A' ' 45' ' ' PHE . 5.5 p -133.09 95.07 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-N 119.664 1.732 . . . . 0.0 109.804 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 43' ' ' MET . 0.1 OUTLIER -95.08 143.34 26.61 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.605 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.705 ' HB3' HG12 ' A' ' 66' ' ' VAL . 5.6 p -107.43 175.05 5.62 Favored 'General case' 0 N--CA 1.515 2.78 0 O-C-N 120.632 -1.293 . . . . 0.0 112.175 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.486 ' N ' ' HB2' ' A' ' 35' ' ' GLU . 6.0 tt0 -143.71 119.01 10.2 Favored 'General case' 0 N--CA 1.513 2.684 0 O-C-N 121.313 -0.867 . . . . 0.0 111.558 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.73 HD23 ' SG ' ' A' ' 188' ' ' CYS . 0.6 OUTLIER -62.58 145.4 54.52 Favored 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.821 0.82 . . . . 0.0 111.814 -178.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.675 HG23 ' HB3' ' A' ' 182' ' ' MET . 55.1 m -139.67 155.38 47.43 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -72.04 170.98 12.72 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.954 -1.091 . . . . 0.0 110.253 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -85.84 6.38 28.43 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.524 -0.735 . . . . 0.0 111.283 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -109.14 -15.84 14.23 Favored 'General case' 0 C--N 1.289 -2.065 0 O-C-N 121.575 -0.703 . . . . 0.0 110.482 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 109.18 23.16 6.49 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 1.2 p -134.89 98.28 3.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -1.185 . . . . 0.0 110.346 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . 0.675 ' HB3' HG23 ' A' ' 176' ' ' THR . 0.0 OUTLIER -95.03 94.47 7.99 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.321 -0.862 . . . . 0.0 109.816 179.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -118.03 63.3 0.75 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 118.786 -1.166 . . . . 0.0 110.962 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.434 ' HB3' ' CB ' ' A' ' 188' ' ' CYS . 3.4 mtp180 -147.14 161.95 39.85 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.338 -0.851 . . . . 0.0 109.036 178.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.844 ' HB3' ' HD3' ' A' ' 186' ' ' PRO . . . -145.87 -68.56 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.068 -1.02 . . . . 0.0 109.704 178.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.844 ' HD3' ' HB3' ' A' ' 185' ' ' ALA . 45.0 Cg_endo -70.68 -36.99 7.5 Favored 'Trans proline' 0 C--N 1.316 -1.164 0 N-CA-C 109.11 -1.15 . . . . 0.0 109.11 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.469 ' HA ' ' HB2' ' A' ' 190' ' ' GLU . 0.2 OUTLIER -90.16 -16.85 28.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.632 -0.667 . . . . 0.0 109.942 179.197 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . 0.73 ' SG ' HD23 ' A' ' 175' ' ' LEU . 0.3 OUTLIER -60.67 -50.81 72.01 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.391 -0.818 . . . . 0.0 110.479 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.869 HG23 ' CD2' ' A' ' 199' ' ' LEU . 6.4 tp -94.77 -28.03 4.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.045 -1.034 . . . . 0.0 109.414 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' A' ' 194' ' ' LYS . 5.0 mm-40 -57.3 -19.99 25.57 Favored 'General case' 0 C--O 1.199 -1.591 0 O-C-N 120.578 -1.326 . . . . 0.0 107.688 175.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.513 ' CD2' ' N ' ' A' ' 192' ' ' ALA . 4.3 t80 -80.84 -62.25 1.72 Allowed 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 122.771 1.272 . . . . 0.0 108.89 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.75 ' HB1' ' O ' ' A' ' 36' ' ' ASP . . . -73.08 -38.53 66.38 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.483 -177.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . 0.648 ' HB2' HD21 ' A' ' 199' ' ' LEU . 12.0 m-20 -84.75 -25.12 28.48 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 118.968 -1.093 . . . . 0.0 112.557 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . 0.524 ' CB ' ' O ' ' A' ' 190' ' ' GLU . 8.3 ttpt -61.76 -37.83 85.76 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 117.502 -1.679 . . . . 0.0 109.408 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -81.45 -51.64 8.1 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 116.206 -2.197 . . . . 0.0 112.085 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.427 ' O ' ' CE ' ' A' ' 197' ' ' MET . 0.2 OUTLIER -112.89 33.2 5.16 Favored 'General case' 0 N--CA 1.507 2.388 0 C-N-CA 117.792 -1.563 . . . . 0.0 113.736 177.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' MET . . . . . 0.547 ' HB3' ' CB ' ' A' ' 193' ' ' ASN . 0.0 OUTLIER -158.01 152.36 24.57 Favored 'General case' 0 N--CA 1.508 2.444 0 CA-C-N 121.209 1.822 . . . . 0.0 114.861 -179.104 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 1.026 ' HB1' HD13 ' A' ' 6' ' ' LEU . . . -83.56 139.38 32.9 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 118.675 -1.21 . . . . 0.0 107.935 175.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.869 ' CD2' HG23 ' A' ' 189' ' ' ILE . 3.3 mt -118.96 113.66 21.34 Favored 'General case' 0 N--CA 1.508 2.459 0 O-C-N 120.165 -1.584 . . . . 0.0 112.293 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.907 ' HB ' HD21 ' A' ' 6' ' ' LEU . 8.7 p -124.89 177.59 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.661 0 O-C-N 121.243 -0.911 . . . . 0.0 108.615 178.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.504 ' N ' HG22 ' A' ' 200' ' ' VAL . 17.5 m -121.25 156.14 33.13 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.252 -1.53 . . . . 0.0 110.808 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 1.09 HG22 HG22 ' A' ' 31' ' ' VAL . 1.2 pp -61.21 -32.7 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 O-C-N 121.061 -1.024 . . . . 0.0 110.229 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 207' ' ' ALA . 2.3 tm-20 -42.28 -67.22 0.28 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.614 -0.679 . . . . 0.0 111.58 -178.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.426 ' O ' ' CB ' ' A' ' 208' ' ' TYR . 3.4 m-20 -87.89 -10.47 50.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.078 -1.014 . . . . 0.0 110.766 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 1.072 HD21 HD21 ' A' ' 163' ' ' LEU . 9.1 tt -84.38 -51.63 6.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 112.132 -178.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.857 HG11 ' CG2' ' A' ' 147' ' ' VAL . 0.1 OUTLIER -84.43 -27.91 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 119.942 -1.723 . . . . 0.0 107.539 179.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 210' ' ' GLN . . . -63.44 -31.59 72.79 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 173.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.799 ' CD2' HG11 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -58.3 -35.92 72.56 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 176.355 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.45 -29.19 41.67 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.532 ' HB3' ' HA ' ' A' ' 207' ' ' ALA . 55.8 tt0 -69.28 -68.17 0.42 Allowed 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 122.003 0.906 . . . . 0.0 108.654 178.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -48.66 -26.3 2.21 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.383 0.611 . . . . 0.0 110.23 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -71.88 -31.64 66.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.344 -0.848 . . . . 0.0 110.173 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -104.7 -9.14 18.38 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.774 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.34 130.63 37.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.976 -1.077 . . . . 0.0 110.145 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 20.7 tttt -95.74 118.48 32.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.222 -0.924 . . . . 0.0 110.219 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -147.6 37.15 0.9 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.187 -0.946 . . . . 0.0 110.211 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.188 -179.928 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 ttp . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.211 0.529 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.436 ' O ' HD23 ' A' ' 5' ' ' LEU . 48.7 p30 -95.87 55.5 1.61 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -0.935 . . . . 0.0 110.315 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -93.78 5.15 52.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.281 -0.887 . . . . 0.0 110.771 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.416 ' O ' ' N ' ' A' ' 8' ' ' SER . 1.3 p -74.01 -4.82 37.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.054 -1.029 . . . . 0.0 110.969 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.527 ' CB ' ' CD2' ' A' ' 166' ' ' PHE . 4.5 mm? -55.19 -67.05 0.31 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.927 -1.108 . . . . 0.0 110.387 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.02 ' CD1' HD22 ' A' ' 20' ' ' LEU . 8.3 tp -61.06 -15.59 34.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.228 -0.92 . . . . 0.0 109.988 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -92.11 -21.27 20.52 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.068 -1.02 . . . . 0.0 110.304 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 4' ' ' THR . 22.7 m -92.84 23.75 4.0 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.304 -0.873 . . . . 0.0 109.787 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.51 ' O ' ' CE1' ' A' ' 13' ' ' PHE . 22.3 t80 -140.83 77.2 1.59 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.8 93.88 1.37 Allowed Glycine 0 C--N 1.288 -2.125 0 N-CA-C 106.892 -2.483 . . . . 0.0 106.892 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.542 ' O ' ' N ' ' A' ' 14' ' ' GLU . 0.5 OUTLIER -125.56 165.48 26.39 Favored Pre-proline 0 C--N 1.27 -2.89 0 N-CA-C 103.458 -2.793 . . . . 0.0 103.458 179.319 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.428 ' C ' ' O ' ' A' ' 11' ' ' THR . 17.8 Cg_endo -41.86 -24.25 0.28 Allowed 'Trans proline' 0 N--CA 1.515 2.787 0 CA-C-N 122.026 1.759 . . . . 0.0 108.468 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.638 ' O ' HG12 ' A' ' 16' ' ' VAL 0.272 0.0 OUTLIER -46.75 -21.44 0.2 Allowed 'General case' 0 C--O 1.191 -1.977 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 169.886 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' A' ' 11' ' ' THR . 32.6 tt0 -48.39 -39.8 23.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.073 -1.642 . . . . 0.0 108.334 178.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.53 -42.73 99.71 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 104.862 -2.273 . . . . 0.0 104.862 175.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.857 HG22 HG12 ' A' ' 200' ' ' VAL . 0.4 OUTLIER -60.46 -34.9 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 C-N-CA 118.979 -1.088 . . . . 0.0 108.218 175.577 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.767 ' O ' ' HB3' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -51.92 -47.61 64.59 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.587 -1.321 . . . . 0.0 108.798 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.944 ' O ' ' HB2' ' A' ' 22' ' ' ALA . 31.4 t-20 -53.27 -31.09 41.96 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.432 ' O ' ' HB1' ' A' ' 198' ' ' ALA . . . -89.56 -68.23 0.79 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 122.292 1.044 . . . . 0.0 110.358 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.053 HD21 HD21 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -47.98 -54.7 12.03 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.398 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.978 ' HB2' HD23 ' A' ' 6' ' ' LEU . . . -67.29 -41.59 85.15 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -178.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.944 ' HB2' ' O ' ' A' ' 18' ' ' ASN . . . -32.63 -62.08 0.25 Allowed 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 121.045 0.45 . . . . 0.0 111.136 -178.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.948 HD12 ' HA ' ' A' ' 197' ' ' MET . 2.4 mt -106.67 7.73 30.71 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.321 -1.352 . . . . 0.0 110.703 177.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.779 ' HD3' HD22 ' A' ' 6' ' ' LEU . 59.3 ttp85 -55.26 -18.95 7.03 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.775 -1.203 . . . . 0.0 107.77 176.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -79.71 46.05 0.74 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-O 122.798 1.285 . . . . 0.0 109.839 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.51 ' HA2' ' CZ ' ' A' ' 45' ' ' PHE . . . 67.92 16.36 68.25 Favored Glycine 0 C--N 1.292 -1.897 0 CA-C-N 114.376 -1.284 . . . . 0.0 111.991 176.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.481 ' HA ' ' CB ' ' A' ' 39' ' ' ASN . 20.1 mtt180 -99.46 17.31 20.61 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 116.079 -2.248 . . . . 0.0 111.225 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.531 ' O ' ' HA ' ' A' ' 197' ' ' MET . . . 100.6 106.32 2.84 Favored Glycine 0 N--CA 1.496 2.685 0 C-N-CA 118.982 -1.58 . . . . 0.0 113.181 173.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.851 HG22 HD13 ' A' ' 44' ' ' ILE . 2.0 m -145.6 113.71 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 120.174 -1.78 . . . . 0.0 106.743 176.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.483 ' HA ' ' HB3' ' A' ' 43' ' ' MET . 0.0 OUTLIER -75.27 75.17 2.39 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 116.104 -2.238 . . . . 0.0 107.72 -177.691 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 1.055 HG12 HD23 ' A' ' 32' ' ' LEU . 1.5 t -158.31 151.85 7.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 CA-C-N 113.773 -1.558 . . . . 0.0 108.17 176.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.055 HD23 HG12 ' A' ' 31' ' ' VAL . 0.7 OUTLIER 10.89 -129.56 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.967 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 175.178 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.833 ' HA ' HD12 ' A' ' 44' ' ' ILE . 13.8 p-10 -176.94 173.99 1.8 Allowed 'General case' 0 N--CA 1.485 1.279 0 O-C-N 120.632 -1.292 . . . . 0.0 111.204 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 35' ' ' GLU . 3.8 p30 -159.94 -143.31 0.1 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.539 -0.726 . . . . 0.0 109.624 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.42 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -112.07 -151.9 0.49 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.899 -1.126 . . . . 0.0 110.364 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 55.01 171.08 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.279 -0.888 . . . . 0.0 110.82 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.43 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . 7.6 ptt85 -176.07 143.12 0.53 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.362 -0.836 . . . . 0.0 110.054 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -169.45 -81.05 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.104 -0.997 . . . . 0.0 110.732 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.481 ' CB ' ' HA ' ' A' ' 27' ' ' ARG . 1.1 t-20 -57.52 -165.51 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.167 -0.958 . . . . 0.0 110.563 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -101.4 -169.01 1.63 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 0.0 110.507 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.442 ' N ' ' HB3' ' A' ' 53' ' ' GLU . . . 75.61 89.02 0.24 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.612 ' HA ' ' CD1' ' A' ' 45' ' ' PHE . 25.4 t70 -78.91 24.11 0.32 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.163 -1.198 . . . . 0.0 112.236 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.589 ' HA ' ' HA ' ' A' ' 172' ' ' LEU . 0.4 OUTLIER -81.45 17.16 1.44 Allowed 'General case' 0 N--CA 1.481 1.112 0 O-C-N 120.468 -1.395 . . . . 0.0 113.942 -177.388 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.851 HD13 HG22 ' A' ' 29' ' ' VAL . 5.2 tp -138.27 16.63 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.794 0 CA-C-O 121.792 0.806 . . . . 0.0 109.724 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.803 ' O ' HG12 ' A' ' 171' ' ' VAL . 89.2 m-85 -107.81 160.1 28.02 Favored Pre-proline 0 N--CA 1.507 2.42 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 -173.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -75.62 134.12 16.45 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 123.132 2.555 . . . . 0.0 111.974 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 1.058 ' HB2' HD11 ' A' ' 68' ' ' LEU . . . -50.71 -20.71 1.32 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.234 -0.917 . . . . 0.0 111.807 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -72.67 -26.81 61.77 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.044 -1.035 . . . . 0.0 110.562 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.654 HG22 ' HG2' ' A' ' 119' ' ' ARG . 65.2 p -133.13 58.86 1.75 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . 0.674 ' CG ' HG11 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -61.91 87.04 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.279 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.492 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -63.56 162.06 13.55 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 122.506 1.146 . . . . 0.0 112.109 -176.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.694 ' CG2' ' HB1' ' A' ' 111' ' ' ALA . 4.3 p -75.1 -2.22 3.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.142 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.473 ' OE1' ' CE1' ' A' ' 45' ' ' PHE . 23.8 mt-10 -46.28 -26.66 0.85 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.264 -0.897 . . . . 0.0 110.19 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.463 ' HB2' ' HB3' ' A' ' 42' ' ' ASP . 5.5 tp-100 -88.11 -49.85 6.76 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.526 -0.734 . . . . 0.0 109.32 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.895 ' SD ' HD11 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -54.71 -47.09 74.14 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.578 -0.701 . . . . 0.0 109.785 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.04 -55.39 33.34 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 0.0 110.258 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.516 HD23 ' C ' ' A' ' 57' ' ' LEU . 7.0 tt -59.27 -44.33 92.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.482 -0.761 . . . . 0.0 110.48 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.498 HG22 ' HA ' ' A' ' 55' ' ' MET . 3.0 t -74.94 -47.51 29.2 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.17 -0.956 . . . . 0.0 111.564 -178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.895 HD11 ' SD ' ' A' ' 55' ' ' MET . 43.8 mt -47.97 -25.72 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 120.664 -1.272 . . . . 0.0 109.587 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -77.76 -47.85 18.01 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.49 -0.756 . . . . 0.0 110.826 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -125.31 -9.08 6.98 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 58' ' ' THR . . . -164.99 -168.16 26.7 Favored Glycine 0 N--CA 1.502 3.085 0 O-C-N 120.13 -1.606 . . . . 0.0 111.469 -177.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.533 ' H ' HG21 ' A' ' 176' ' ' THR . 1.1 t -133.11 103.26 5.93 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 101.71 -3.441 . . . . 0.0 101.71 176.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.449 ' N ' ' OG1' ' A' ' 58' ' ' THR . . . -104.63 73.76 0.24 Allowed Glycine 0 C--N 1.264 -3.447 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 -177.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.672 ' O ' HG23 ' A' ' 65' ' ' ILE . 2.0 tp -64.26 97.2 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.822 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.976 ' CG1' HG22 ' A' ' 171' ' ' VAL . 3.6 t -50.99 163.43 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.156 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.347 -177.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.882 ' O ' HG21 ' A' ' 157' ' ' THR . 80.3 m -111.19 114.81 28.3 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 122.031 0.919 . . . . 0.0 109.122 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.058 HD11 ' HB2' ' A' ' 47' ' ' ALA . 0.1 OUTLIER -90.61 123.35 34.18 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.615 ' C ' HD13 ' A' ' 158' ' ' ILE . 0.1 OUTLIER -108.57 143.08 38.08 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 117.232 -1.787 . . . . 0.0 110.415 179.125 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.749 HG21 ' OD2' ' A' ' 79' ' ' ASP 0.25 2.0 pp -137.41 137.28 46.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.345 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.878 HG22 ' HB2' ' A' ' 75' ' ' ARG . 9.3 t -74.93 179.43 4.92 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.606 ' HA ' ' HB2' ' A' ' 76' ' ' LYS . 2.3 mp0 -90.48 -18.59 25.08 Favored 'General case' 0 C--N 1.275 -2.674 0 C-N-CA 119.366 -0.933 . . . . 0.0 110.815 -178.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.57 -74.68 0.19 Allowed 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.823 -1.151 . . . . 0.0 112.797 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -94.66 -37.74 11.17 Favored 'General case' 0 C--N 1.279 -2.463 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.294 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.878 ' HB2' HG22 ' A' ' 71' ' ' THR . 0.0 OUTLIER -69.69 -24.84 63.64 Favored 'General case' 0 C--N 1.284 -2.269 0 C-N-CA 119.207 -0.997 . . . . 0.0 110.543 -179.433 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.696 ' HE2' HD12 ' A' ' 80' ' ' LEU . 7.5 tttt -81.41 -38.92 25.74 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 117.459 -1.696 . . . . 0.0 107.489 176.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -42.19 -42.39 3.0 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.409 0.623 . . . . 0.0 109.569 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.788 HD23 ' N ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -107.87 -30.02 8.74 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 118.448 -1.301 . . . . 0.0 109.026 177.323 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.788 ' N ' HD23 ' A' ' 78' ' ' LEU . 0.4 OUTLIER -114.15 69.12 0.7 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 119.178 -1.009 . . . . 0.0 110.724 178.004 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.696 HD12 ' HE2' ' A' ' 76' ' ' LYS . 0.2 OUTLIER -111.45 149.05 40.08 Favored Pre-proline 0 C--N 1.295 -1.789 0 O-C-N 120.785 -1.197 . . . . 0.0 109.163 178.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.53 ' CD ' ' HG ' ' A' ' 80' ' ' LEU . 27.5 Cg_endo -50.86 96.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.187 0 O-C-N 123.393 1.207 . . . . 0.0 110.556 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.11 44.51 1.04 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.427 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 175.24 -54.89 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.138 -0.976 . . . . 0.0 109.73 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.879 HG23 HG22 ' A' ' 96' ' ' THR . 15.6 m -110.12 109.27 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.358 -0.839 . . . . 0.0 110.234 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 87' ' ' ASN . 8.0 tt0 -98.26 27.58 4.58 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.216 -0.927 . . . . 0.0 110.099 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -64.97 80.13 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.329 -0.857 . . . . 0.0 110.277 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' A' ' 85' ' ' GLU . 2.8 t30 -99.2 54.92 0.98 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.255 -0.903 . . . . 0.0 110.19 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 53.3 m -154.47 -67.11 0.13 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 110.152 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.78 -47.88 70.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.205 -0.934 . . . . 0.0 110.211 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . 53.26 35.81 21.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.216 -0.927 . . . . 0.0 110.235 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.84 61.56 0.4 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.266 -0.896 . . . . 0.0 110.208 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.98 23.33 76.52 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 95' ' ' PHE . 81.4 p -110.06 -18.51 13.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.232 -1.158 . . . . 0.0 110.661 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 96' ' ' THR . . . -20.55 -42.53 0.01 OUTLIER Glycine 0 N--CA 1.513 3.813 0 C-N-CA 123.442 0.544 . . . . 0.0 113.533 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.503 ' N ' ' O ' ' A' ' 93' ' ' THR . 19.5 m-85 -58.69 99.38 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.962 -1.316 . . . . 0.0 108.974 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.879 HG22 HG23 ' A' ' 84' ' ' VAL . 70.4 p -118.05 -1.82 11.36 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.032 -1.467 . . . . 0.0 114.915 -177.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.655 HG22 ' C ' ' A' ' 80' ' ' LEU . 1.8 t -121.89 86.52 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.268 -2.957 0 N-CA-C 113.939 1.088 . . . . 0.0 113.939 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.449 ' OG1' ' N ' ' A' ' 135' ' ' GLY . 8.9 t -73.71 123.87 24.92 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 176.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.025 ' CG1' HG21 ' A' ' 137' ' ' VAL . 7.7 pt -106.25 123.31 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.641 -1.287 . . . . 0.0 112.793 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.554 ' O ' ' HA ' ' A' ' 131' ' ' LEU . 0.2 OUTLIER -128.67 105.13 8.06 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.092 177.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.963 ' HB3' ' HB ' ' A' ' 105' ' ' VAL . . . -48.22 104.25 0.06 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 122.058 0.932 . . . . 0.0 110.62 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.45 ' CB ' ' O ' ' A' ' 130' ' ' ASP . . . -59.8 -10.9 4.31 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.285 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -0.49 14.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.987 -1.071 . . . . 0.0 111.285 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.76 27.41 0.96 Allowed Glycine 0 N--CA 1.494 2.563 0 C-N-CA 118.993 -1.575 . . . . 0.0 112.556 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.963 ' HB ' ' HB3' ' A' ' 101' ' ' ALA . 21.1 t -108.73 153.94 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.066 -1.255 . . . . 0.0 109.828 178.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.409 ' O ' ' HG3' ' A' ' 114' ' ' ARG . 4.4 m -142.08 107.2 4.95 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 103.109 -2.922 . . . . 0.0 103.109 178.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.504 ' O ' ' C ' ' A' ' 108' ' ' GLY . 23.8 m -56.61 -24.71 49.77 Favored 'General case' 0 C--N 1.273 -2.736 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 -175.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . 0.842 ' O ' ' N ' ' A' ' 110' ' ' SER . . . 29.85 48.43 0.13 Allowed Glycine 0 N--CA 1.511 3.644 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 172.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.744 HG21 ' CG ' ' A' ' 136' ' ' HIS . 54.6 t -28.77 67.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.628 0 CA-C-O 125.289 2.471 . . . . 0.0 112.17 -168.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.842 ' N ' ' O ' ' A' ' 108' ' ' GLY . 7.8 t -130.88 65.32 1.55 Allowed 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 109.403 -3.544 . . . . 0.0 103.935 176.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.694 ' HB1' ' CG2' ' A' ' 52' ' ' VAL . . . -30.02 -29.91 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.118 -1.401 . . . . 0.0 114.271 -175.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 110' ' ' SER . . . -62.0 -77.9 0.04 OUTLIER 'General case' 0 C--N 1.282 -2.346 0 O-C-N 120.198 -1.564 . . . . 0.0 109.584 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -75.03 -27.81 60.22 Favored 'General case' 0 C--N 1.289 -2.061 0 O-C-N 121.337 -0.852 . . . . 0.0 111.373 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.862 ' O ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -83.0 -38.54 22.5 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.047 -1.061 . . . . 0.0 112.334 -178.347 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.612 HD13 ' CA ' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -66.42 -12.84 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 116.849 -1.941 . . . . 0.0 108.013 178.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 99.5 m -74.35 -50.54 18.27 Favored 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.716 ' O ' ' HB2' ' A' ' 121' ' ' ALA . 3.9 p -70.63 -22.43 62.52 Favored 'General case' 0 N--CA 1.484 1.259 0 O-C-N 121.189 -0.944 . . . . 0.0 109.387 178.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.862 HG23 ' O ' ' A' ' 114' ' ' ARG . 63.0 t -66.8 -51.6 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.274 -0.891 . . . . 0.0 109.741 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.654 ' HG2' HG22 ' A' ' 49' ' ' THR . 5.5 ttp180 -51.53 -40.54 59.84 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.518 -0.739 . . . . 0.0 109.955 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.21 -8.49 39.16 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.583 -0.698 . . . . 0.0 110.572 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.716 ' HB2' ' O ' ' A' ' 117' ' ' THR . . . -68.31 -44.5 75.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.055 -1.028 . . . . 0.0 111.183 -178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.542 HG22 ' O ' ' A' ' 122' ' ' ILE . 4.6 mt -83.3 9.34 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 118.634 -1.226 . . . . 0.0 111.542 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -107.08 71.43 0.83 Allowed 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.774 -1.171 . . . . 0.0 110.556 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.441 ' CB ' ' HD3' ' A' ' 127' ' ' LYS . 0.5 OUTLIER -99.0 -44.38 6.33 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.527 1.156 . . . . 0.0 109.319 177.6 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 124.64 -39.91 2.02 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 105.94 -2.864 . . . . 0.0 105.94 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -135.48 95.1 3.2 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.454 ' N ' ' CD ' ' A' ' 128' ' ' PRO . 7.7 tptt -136.57 53.45 7.49 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 120.784 -1.198 . . . . 0.0 109.761 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.454 ' CD ' ' N ' ' A' ' 127' ' ' LYS . 49.5 Cg_endo -77.4 -35.14 1.73 Allowed 'Trans proline' 0 C--N 1.3 -1.999 0 N-CA-C 107.552 -1.749 . . . . 0.0 107.552 178.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.3 p -125.86 -17.82 5.28 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.019 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.45 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -77.29 9.6 3.05 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.739 -1.226 . . . . 0.0 112.896 -177.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.939 HD12 ' N ' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -140.94 74.79 1.47 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.541 -1.349 . . . . 0.0 109.561 179.04 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.591 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 0.7 OUTLIER -144.0 48.9 1.38 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.439 -1.413 . . . . 0.0 114.239 176.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.421 ' C ' ' CB ' ' A' ' 100' ' ' GLU . 2.1 mtm180 177.25 108.01 0.12 Allowed Pre-proline 0 N--CA 1.516 2.844 0 CA-C-N 121.897 2.135 . . . . 0.0 112.947 175.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -126.26 129.05 0.03 OUTLIER 'Cis proline' 0 C--N 1.312 -1.394 0 N-CA-C 103.557 -3.286 . . . . 0.0 103.557 -8.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.744 ' O ' HG23 ' A' ' 137' ' ' VAL . . . -113.65 33.36 5.54 Favored Glycine 0 N--CA 1.503 3.163 0 C-N-CA 117.54 -2.267 . . . . 0.0 113.791 -175.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.744 ' CG ' HG21 ' A' ' 109' ' ' VAL . 14.6 m-70 32.11 37.95 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.903 0 CA-C-N 119.049 1.424 . . . . 0.0 110.311 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 1.025 HG21 ' CG1' ' A' ' 99' ' ' ILE . 54.2 t -86.87 156.12 3.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.597 ' CD1' ' O ' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -124.79 79.46 63.7 Favored Pre-proline 0 C--N 1.284 -2.275 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -178.641 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.578 ' HG3' HG12 ' A' ' 137' ' ' VAL . 52.0 Cg_endo -108.79 124.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.074 1.849 . . . . 0.0 110.83 -178.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.425 ' HB3' ' C ' ' A' ' 94' ' ' GLY . 1.1 pp -128.99 136.82 50.85 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 119.485 -0.886 . . . . 0.0 108.898 178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.469 ' CG ' ' CG ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -63.66 137.06 57.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.615 -1.303 . . . . 0.0 108.404 179.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.791 ' HB3' HG21 ' A' ' 158' ' ' ILE . . . -131.26 133.55 45.55 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.094 -1.043 . . . . 0.0 112.15 -178.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.16 143.46 45.24 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.537 -0.727 . . . . 0.0 109.724 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . 0.493 ' HB1' ' NH2' ' A' ' 209' ' ' ARG . . . -68.48 115.71 8.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.478 -0.764 . . . . 0.0 110.6 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 86.93 14.93 63.87 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.14 13.64 63.15 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.733 HG21 ' HB2' ' A' ' 156' ' ' ALA . 14.5 p -89.94 -4.72 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.872 -1.37 . . . . 0.0 110.157 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.472 ' HG ' HG11 ' A' ' 206' ' ' VAL . 1.2 mp -90.06 17.56 6.8 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 116.139 -2.224 . . . . 0.0 110.148 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.4 p -130.59 60.99 1.62 Allowed 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 101.171 -3.64 . . . . 0.0 101.171 168.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.459 ' HG3' ' CG ' ' A' ' 155' ' ' GLU . 0.0 OUTLIER -149.97 140.49 22.47 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 113.794 -1.548 . . . . 0.0 112.755 -178.433 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.422 ' N ' ' HD3' ' A' ' 150' ' ' ARG . . . -104.0 35.09 5.28 Favored Glycine 0 N--CA 1.482 1.741 0 N-CA-C 106.148 -2.781 . . . . 0.0 106.148 173.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -144.24 163.35 27.8 Favored Glycine 0 N--CA 1.479 1.509 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' HIS . . . . . 0.563 ' O ' ' HB3' ' A' ' 156' ' ' ALA . 2.8 p-80 -90.84 -5.03 56.12 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 121.646 -0.914 . . . . 0.0 109.552 177.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.812 HG22 ' SG ' ' A' ' 67' ' ' CYS . 60.0 p -53.37 -59.25 4.81 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.003 -1.061 . . . . 0.0 109.766 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.498 ' HB2' HG23 ' A' ' 147' ' ' VAL . 63.3 mm-40 -59.59 -21.34 60.22 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.733 ' HB2' HG21 ' A' ' 147' ' ' VAL . . . -85.56 6.76 25.77 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.882 HG21 ' O ' ' A' ' 67' ' ' CYS . 27.3 m -91.99 -36.5 13.38 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.791 HG21 ' HB3' ' A' ' 142' ' ' ALA . 3.2 tp -85.83 -31.44 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 173.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . 0.498 ' O ' HG22 ' A' ' 162' ' ' THR . 1.7 t70 -56.68 -34.06 67.03 Favored 'General case' 0 C--O 1.199 -1.553 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 174.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 1.045 HD23 ' HB2' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -45.05 -37.42 4.14 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.349 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' MET . . . . . 1.029 ' N ' HD13 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -50.26 -45.33 54.12 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.871 178.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 159' ' ' ASP . 4.3 t -97.56 -31.69 12.19 Favored 'General case' 0 N--CA 1.509 2.478 0 CA-C-O 121.895 0.855 . . . . 0.0 111.5 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 1.042 ' CD2' HD21 ' A' ' 205' ' ' LEU 0.272 0.2 OUTLIER -42.98 -58.11 2.56 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -178.58 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.738 ' HB1' HD12 ' A' ' 6' ' ' LEU . . . -110.13 2.24 19.31 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 118.874 -1.13 . . . . 0.0 113.003 -176.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 96.08 -19.2 55.51 Favored Glycine 0 C--N 1.29 -1.999 0 N-CA-C 108.21 -1.956 . . . . 0.0 108.21 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . 0.69 ' C ' ' HD3' ' A' ' 168' ' ' PRO . 0.1 OUTLIER -76.95 137.21 38.91 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.14 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.628 ' HA ' ' HA ' ' A' ' 161' ' ' MET . 2.4 ttmt -121.55 56.47 6.37 Favored Pre-proline 0 C--N 1.31 -1.12 0 O-C-N 120.745 -1.222 . . . . 0.0 110.47 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.816 ' HD2' HD11 ' A' ' 160' ' ' LEU . 56.5 Cg_endo -108.93 175.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.301 -1.966 0 N-CA-C 107.731 -1.681 . . . . 0.0 107.731 177.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.464 ' HB2' ' HD3' ' A' ' 75' ' ' ARG . . . -85.53 104.82 15.65 Favored 'General case' 0 C--N 1.261 -3.247 0 N-CA-C 101.42 -3.548 . . . . 0.0 101.42 173.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.443 ' O ' ' CG2' ' A' ' 157' ' ' THR . . . -93.75 154.52 21.68 Favored Glycine 0 C--N 1.297 -1.617 0 C-N-CA 119.048 -1.549 . . . . 0.0 111.103 -173.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.976 HG22 ' CG1' ' A' ' 66' ' ' VAL 0.261 5.6 p -124.05 95.56 3.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 179.35 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LEU . . . . . 0.862 HD22 ' CA ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -114.81 114.74 25.95 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 119.93 -1.731 . . . . 0.0 111.018 -178.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.781 ' HB2' HG22 ' A' ' 66' ' ' VAL . 4.9 t -109.79 175.64 5.37 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 120.547 -1.346 . . . . 0.0 110.943 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . 0.734 ' C ' HD13 ' A' ' 189' ' ' ILE . 0.0 OUTLIER -106.73 -147.93 0.41 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.41 -0.806 . . . . 0.0 109.888 179.261 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.682 ' C ' HD13 ' A' ' 175' ' ' LEU . 2.1 tm? -116.49 146.36 42.64 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.193 -0.942 . . . . 0.0 109.404 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.663 ' N ' HD13 ' A' ' 175' ' ' LEU . 52.9 m -131.86 154.97 48.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.131 -0.981 . . . . 0.0 110.319 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -119.53 168.46 10.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 0.0 110.253 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.46 5.57 48.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 111.172 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.13 -19.04 41.18 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.614 -0.679 . . . . 0.0 109.888 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 101.78 29.23 6.27 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.645 HG23 ' O ' ' A' ' 181' ' ' THR . 9.7 t -141.72 113.74 8.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.273 -1.133 . . . . 0.0 110.119 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 1.8 ttm -53.34 93.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 110.187 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.628 ' HB3' ' HA ' ' A' ' 176' ' ' THR . . . -69.3 119.28 13.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.938 . . . . 0.0 110.278 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' A' ' 185' ' ' ALA . 2.9 ppt_? -139.98 100.45 3.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.304 -0.872 . . . . 0.0 109.911 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.745 ' HB1' ' HD2' ' A' ' 186' ' ' PRO . . . 179.25 173.57 0.44 Allowed Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.337 -0.852 . . . . 0.0 110.003 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.745 ' HD2' ' HB1' ' A' ' 185' ' ' ALA . 46.5 Cg_endo -72.73 -11.59 26.04 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.644 1.339 . . . . 0.0 110.76 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' A' ' 190' ' ' GLU . 3.6 mt-10 -84.93 -63.37 1.34 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.063 -1.023 . . . . 0.0 110.522 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' CYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 191' ' ' PHE . 21.5 p -52.37 -37.56 56.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.01 . . . . 0.0 109.718 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.983 HG23 HD21 ' A' ' 199' ' ' LEU . 8.0 tp -73.62 -28.33 24.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 120.604 -1.31 . . . . 0.0 108.27 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.643 ' HA ' HD22 ' A' ' 199' ' ' LEU . 1.4 tt0 -58.85 -20.0 46.82 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.783 -0.767 . . . . 0.0 109.126 177.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . 0.463 ' HB3' ' O ' ' A' ' 188' ' ' CYS . 0.1 OUTLIER -75.34 -51.06 14.07 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.72 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . 0.443 ' CB ' ' HE3' ' A' ' 197' ' ' MET . . . -62.51 -38.5 90.18 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ASN . . . . . 0.836 ' HB2' HD13 ' A' ' 199' ' ' LEU . 0.0 OUTLIER -64.52 -15.98 61.8 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.103 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.45 -36.75 22.1 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 117.892 -1.523 . . . . 0.0 112.477 -176.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -104.33 -53.59 2.69 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 115.719 -2.392 . . . . 0.0 111.519 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -113.97 32.99 5.49 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.025 -1.47 . . . . 0.0 113.754 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' MET . . . . . 0.948 ' HA ' HD12 ' A' ' 23' ' ' LEU . 2.5 ttp -153.67 145.15 23.19 Favored 'General case' 0 N--CA 1.512 2.645 0 C-N-CA 115.065 -2.654 . . . . 0.0 115.441 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.576 ' HB2' ' HG ' ' A' ' 23' ' ' LEU . . . -91.4 142.88 27.2 Favored 'General case' 0 N--CA 1.51 2.568 0 O-C-N 120.884 -1.135 . . . . 0.0 108.128 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.983 HD21 HG23 ' A' ' 189' ' ' ILE . 3.0 tp -131.55 94.09 3.47 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.495 -1.378 . . . . 0.0 114.498 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.922 HG22 HG21 ' A' ' 31' ' ' VAL 0.253 6.8 m -57.87 -168.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 O-C-N 120.496 -1.378 . . . . 0.0 107.525 175.31 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 205' ' ' LEU . 23.8 m -119.03 110.59 17.28 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 174.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.484 ' HA ' ' HB3' ' A' ' 205' ' ' LEU . 16.6 mt -49.62 -21.99 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.343 -0.848 . . . . 0.0 111.838 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.18 -66.64 0.52 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.814 -1.179 . . . . 0.0 109.334 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.783 ' O ' ' HB3' ' A' ' 207' ' ' ALA . 1.7 m-20 -66.14 -32.82 74.49 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.015 -1.053 . . . . 0.0 109.076 178.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 1.042 HD21 ' CD2' ' A' ' 163' ' ' LEU . 6.7 tt -45.86 -69.53 0.13 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 123.084 1.421 . . . . 0.0 112.459 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.472 HG11 ' HG ' ' A' ' 148' ' ' LEU . 1.4 t -68.42 -11.37 14.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 C-N-CA 117.758 -1.577 . . . . 0.0 108.845 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.783 ' HB3' ' O ' ' A' ' 204' ' ' ASP . . . -58.64 -30.49 67.33 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 175.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' TYR . . . . . 0.847 ' CE2' ' HA ' ' A' ' 205' ' ' LEU . 1.5 m-85 -62.59 -48.19 80.52 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 177.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ARG . . . . . 0.493 ' NH2' ' HB1' ' A' ' 144' ' ' ALA . 17.8 tpt180 -65.56 -29.16 69.74 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.779 -1.168 . . . . 0.0 109.746 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.462 ' HB2' HD21 ' A' ' 148' ' ' LEU . 30.9 tt0 -73.02 -35.29 66.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 110.03 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -73.57 -27.05 61.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.364 -0.835 . . . . 0.0 110.039 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -73.62 -31.55 63.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 0.0 110.087 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -90.56 -9.45 47.09 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 110.625 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -111.1 132.78 53.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.987 -1.071 . . . . 0.0 110.207 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 3.7 tttm -97.37 121.59 39.44 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.244 -0.91 . . . . 0.0 110.191 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -174.82 156.77 2.33 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.333 -0.855 . . . . 0.0 110.186 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' SER . . . . . . . . . . . . . 26.2 m . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.208 179.961 . . . . . . . . 0 0 . 1 stop_ save_